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Reduced macrophage number and activation contribute to impaired diabetic wound heal-
ing
J Asai,1,3 K Maruyama,2 M Ii,1 T Thorne,1 PA D’Amore2 and DW Losordo1 1 Cardiovascular
Research, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, 2
Departments of Ophthalmology and Pathology, Schepens Eye Research Institute, Harvard
Medical School, Boston, MA and 3 Department of Dermatology, Graduate School of Medical
Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
Lymphatic vessels in wounds function to maintain normal interstitial tissue pressure by drain-
ing the protein-rich lymph from the interstitial space as well as by facilitating the delivery of
cells that mediate the immune response. Delayed wound healing, such as occurs in diabetic
foot ulcers, appears to be due at least in part to reduced lymphatic development that leads to
persistent edema and delayed removal of infectious debris. Depsite the critical role of lym-
phatic vessels in wound healing, the origin of the cells involved in the formation of lymphatic
vessels in wounds has not been fully defined. Here, we report data, which indicate that both
the formation of lymphatic vessels and presence of activated macrophages are rate limiting
to the healing of diabetic wounds. We have previously shown that macrophages contribute
to the lymphatics that form during the acute phase of corneal wound healing. We now demon-
strate that this is a more general phenomenon and that cells that co-stain for the macrophage
marker F4/80 and the lymphatic maker LYVE-1 contribute to lymphatics in the healing of full
thickness wounds. Notably, LYVE-1 positive lymphatic vessels and CD31-positive blood ves-
sels were significantly reduced in a wound healing in the diabetic mice (p < 0.02) as com-
pared to control mice. The lymphatic-specific receptor, VEGFR3 and its ligand, VEGF-C were
down-regulated in control macrophages incubated in high glucose conditions. These data sug-
gest that impaired wound healing in diabetes may be mediated at least in part by the dys-
function of macrophages that contribute to lymphangiogenesis.
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Adult human skin contains dermal fibroblast subpopulations that differ in their support for
angiogenesis
JM Sorrell, MA Baber and AI Caplan Biology, Case Western Reserve University, Cleveland,
OH
Wound repair in skin requires the restoration of a patent vasculature. Dermal fibroblasts play
a significant role in this process through their interactions with vascular endothelial cells. Adult
human skin contains at least two subpopulations of fibroblasts that differ in their support for
tube formation by endothelial cells in an in vitro assay. This assay system is initiated with con-
fluent layers of adult dermal fibroblasts onto which are seeded human umbilical vein endothe-
lial cells or adult human dermal microvascular endothelial cells. Endothelial cells differenti-
ate and organize into tube-like structures within 3-5 days after seeding. Tube-like structures
remain intact for at least 5 weeks in culture. Superficial papillary fibroblasts and deep retic-
ular fibroblasts from the same piece of skin differ in their support of tube formation in this
assay. Papillary fibroblasts support an elaborate system of elongated and highly branched
tubes, whereas, reticular fibroblasts support abbreviated and unbranched tubes. Preliminary
studies indicate that the difference in fibroblast support is not due to the release of critical
angiogenic factors such as VEGF or FGF-2. Experimental studies indicate that the agent(s)
responsible for vascular support are non-soluble and are either retained in the extracellular
matrix or are a component of the extracellular matrix. Our current hypothesis is that the pres-
ence or absence of anti-angiogenic factors that have yet to be defined are likely responsible
for the differences in fibroblast interaction with endothelial cells. Thus, dermal fibroblast sub-
populations may determine the unique vascular patterns observed in adult skin and they may
also play unique roles in regulating vascular repair of skin wounds.
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Expression of vascular endothelium growth factor receptor 3 and neuropilins (NRPS) on ker-
atinocytes in psoriatic epidermis
M Zheng, X Man, X Yang and S Cai Dermatology, Second Hospital of Zhejiang University,
Hangzhou, Zhejiang, China
Vascular endotheliam growth facter receptors (VEGFRs, including VEGFR-1, VEGFR-2 and VEGFR-
3) and neuropilins (NRPs, including NRP-1 and NRP-2) are high-affinity receptors for VEGF and
are typically considered specific to endothelial cells. We had found that VEGFR-1 and VEGFR-2
were expressed by keratinocytes (KCs)in psoriatic epidermis previously. Here we studied the expres-
sion of VEGFR-3 and NRPs on cultured psoriatic epidermis KCs at the mRNA and protein level as
determined by RT–PCR and Western blot analysis, separately. And we further localize these recep-
tors by immunofluorescence (IF) staining with the same antibodies in psoriasis epidermis. We
detected that psoriatic KCs expressed VEGFR-3 and NRP-1, NRP-2 mRNA, but NRP-1 and NRP-
2 mRNA were at a relatively high level. Immunoblot analysis with monoclonal antibody directly
against VEGFR-3 yielded strong bands of approximately 180 KDa and 200KDa. Monoantibodies
against NRP-1 and NRP-2 showed intense bands of approximately 140 KDa. Immunofluorescence
demonstrated localization of VEGFR-3 and NRPs in all layers of psoriatic epidermis but stratum
corneum. All layers of the epidermis except horny cell layer demonstrated an uniformly pattern of
VEGFR-3, NRP-1 and NRP-2, and sections incubated with anti-NRP-1 and anti-NRP-2 show dif-
fuse intense fluorescence. VEGFR-3 is expressed along the plasma membrane of cells in all layers
of KCs, and a notable strong staining along the basal cell membranes and spinosum KCs adjacent
to the basal. The immunoreactivity for NRPs localize to cell membrane and cytoplasm of KCs. These
data, combined with other data we had previously found, show that human KCs in psoriatic epi-
dermis express all VEGFRs and NRPs that are differentially localized in epidermis. We propose
that the expression of VEGFRs and NRPs on psoriatic epidermis may play important roles in pso-
riatic KC proliferation, differentiation, migration and adhesion. VEGF-VEGFR signaling pathway
may act differently from its traditional one as a vascular inducer in psoriasis.
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FG-4497, a prolyl hydroxylase inhibitor, abrogates tumor necrosis factor-α mediated induc-
tion of cell adhesion molecule expression in human dermal microvascular endothelial cells
TV Cartee,1,3 O Sirenko,2 M Arend,2 L Flippin,2 S Klaus2 and RA Swerlick1,3 1 Dermatology,
Emory University SOM, Atlanta, GA, 2 Fibrogen Co., So. San Francisco, CA and 3
Dermatology, Atlanta VA Affairs Hospital, Atlanta, GA
Previously, we reported that hypoxia and hypoxia mimetics block the transcription of vascu-
lar cell adhesion molecule (VCAM)-1 and intercellular cell adhesion molecule (ICAM)-1 in
human dermal microvascular endothelial cells (HDMECs) in response to TNF-α. Here we
demonstrate that a proprietary, non-metal chelating HIF prolyl hydroxylase (PHD) inhibitor,
FG-4497, induces high levels of hypoxia-inducible factor (HIF)-1α and 2α expression under
normoxic conditions and potently inhibits TNF-α-induced CAM expression. HDMECs were
treated with TNF-α after exposure to hypoxia or pre-incubation with the following HIF prolyl
hydroxylase inhibitors: the iron chelator 2’,2’-dipyridyl (DP), the α-ketoglutarate mimetic
dimethyl oxalyl glycine (DMOG), or FG-4497. Expression of VCAM-1 protein was assessed
by cell-surface ELISA and immunoblot and ICAM-1 by cell-surface ELISA. mRNA and hetero-
geneous nuclear (hn)RNA levels of VCAM-1 and ICAM-1 were measured by quantitative real-
time PCR as a marker of transcriptional activation. All prolyl hydroxylase inhibitors tested
inhibited CAM expression in a dose dependent fashion with FG-4497 10 times more potent
than DMOG. These effects are in part dependent on transcriptional inhibition as VCAM-1
hnRNA levels were markedly reduced in the presence of FG-4497. As previously observed
with iron chelators, activation and nuclear localization of p65, the primary transcription fac-
tor responsible for VCAM-1 and ICAM-1 expression, was preserved in cells pre-treated with
FG-4497 prior to TNF-α administration. Together the data demonstrates that FG-4497 inhibits
TNF-α-mediated CAM gene expression and that HIF prolyl hydroxylase inhibitors possess ther-
apeutic potential to inhibit expression of CAMs.
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The complexities in the initiation and progression of Kaposi’s sarcoma (KS) discovered through
genome-wide expression analysis
E Guttman-Yassky,1 R Bergman,2 A Khatcherian,1 J Jacob,3 N Amariglio,3 G Rechavi,3
JG Krueger1 and R Sarid4 1 Rockefeller University, New York, NY, 2 Rambam, Haifa, Israel, 3
Tel-Hashomer, Ramat-Gan, Israel and 4 Bar-Ilan, Ramat-Gan, Israel
Controversy has surrounded the cellular origin and nature of KS. Recent microarray studies
suggested that KS spindle cells are derived from lymphatic endothelial cells (LEC). The pres-
ent study followed KS progression from the early to the late (nodular) stage. As detected on
Affimetrix U133A arrays, several classes of genes were differentially expressed in the differ-
ent stages of KS compared to normal skin, including genes regulating immune and defense
responses, angiogenesis, apoptosis and proliferation. Hierarchical clustering showed that KS
lesions clustered together, relative to normal skin, with a clear gradient from early KS lesions
to nodular KS lesions. We found a strikingly higher expression of lymphatic and (to a lesser
extent) blood endothelium genes, including LYVE1, Prox1, Angiopoietin 2 and its receptor
Tie2, podoplanin, CXCR4, and VEGFR. LYVE1 expression gradually increased from ~ 5 fold
in early KS up to ~150 fold in nodular KS. In the initiation phase we noticed a higher expres-
sion of growth factors, as compared to more progressive stages. Genes of B, T and dendritic
cells were increased throughout tumor evolution. A gradual increase in gene expression level
of all endothelium markers, as well as metalloproteinases, angiostatic factors and chemokines,
was noticed from normal skin through all KS stages. Conclusions: We have found both LEC
and BEC markers in “KS expression signature” implying that KS spindle cells represent an inde-
terminate endothelial cell phenotype, possibly as a direct or indirect/paracrine consequence
of HHV-8 infection. Our results show a complex inflammatory environment of B, T, dendritic
cells and chemokines during the evolution of KS lesions. As not all spindle cells are infected
by HHV-8, one needs to consider a pathogenic hypothesis where cellular hyperproliferation
is driven by local expression of chemokines and growth factors, without true clonal/neoplas-
tic expansion of cells.
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Characterization of human keratinocytes possessing non-viral, constitutive expression of
VEGF-165 for use in therapeutic skin grafting.
J Straseski,1 A Comer,2 N Akhtar,4 J Murphy,3 S Pirnstill2 and L Allen-Hoffmann1 1 Pathology,
University of Wisconsin-Madison, Madison, WI, 2 Stratatech Corp., Madison, WI, 3 Plastic
Surgery, University of Wisconsin-Madison, Madison, WI and 4 Medical Sciences, University
of Wisconsin-Madison, Madison, WI
Skin graft survival is critically dependent on vascularization. Impaired vessels lead to tissue
ischemia and a lack of nutrients necessary for proper wound healing. Near-diploid, human
keratinocytes (NIKS) were genetically engineered to stably over express VEGF-165, a growth
factor central to vessel formation. Enhanced VEGF mRNA and protein levels were confirmed
in monolayer and organotypic cultures of these modified NIKS (NIKS-VEGF). Compared to
untransfected NIKS keratinocytes, monolayer NIKS-VEGF cultures exhibited 3.5-fold increases
in VEGF mRNA by quantitative PCR. The in vivo angiogenic potential of the NIKS-VEGF ker-
atinocytes was assessed by the mouse corneal micropocket assay (CMA). Using fluorescent
microscopy and image analysis software, angiogenic properties were quantified for each CMA.
Following corneal implantation of a sponge containing NIKS-VEGF cells (n = 8) an average of
47% of the corneal area exhibited neovascularization with no aberrant vascular leakage. No
vessels were induced by media alone. NIKS-VEGF organotypic cultures recapitulated a nor-
mal epidermal architecture, including formation of a stratum corneum with barrier function.
Conditioned medium (CM) from NIKS-VEGF organotypic cultures stimulated human microvas-
cular endothelial cell proliferation and contained an average of 12-fold more total VEGF pro-
tein compared to CM from untransfected NIKS. This robust increase in protein expression was
measurable up to 14 days post-plating. These findings indicate NIKS-VEGF keratinocytes have
enhanced angiogenic properties, generate normal tissue architecture and may be useful for
the consistent delivery of therapeutic levels of VEGF to ischemic wound beds.
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17β-estradiol enhance the mRNA and protein expression of VEGFR-1, VEGFR-2 on HaCaT
cell line
X Yang, M Zheng, X Man and S Cai Dermatology, Second Hospital of Zhejiang University,
Hangzhou, Zhejiang, China
Vascular endothelial growth factor (VEGF) acts primarily as an endothelial cell mitogen via
the specific receptors VEGFR-1 (flt-1) and VEGFR-2 (flk-1). Recently, more and more studies
showed the expression of VEGFRs on non-endothelial cells, including hematopoietic stem
cells, hepatocytes, endometrial epithelium, etc. In our lab, we had detected the expression of
VEGFR-1 and VEGFR-2 on normal keratinocytes and the enhanced proliferation of keratinocytes
by VEGF. Since the natural course of psoriasis is often influenced by pregnancy, indicating the
possible regulatory role of estrogen on keratinocytes proliferation, we therefore examine whether
estrogen has an influence on the expression of VEGFR-1, VEGFR-2 on keratinocytes. Normal
keratinocyte cell line HaCaT cells were exposed to five different dose of 17β-estradiol at10-
12, 10-11, 10-10, 10-9, 10-8M. Moreover, a neutralizing monoclonal antibody to VEGFR-2
was coincubated with 17β-estradiol. The proliferation of HaCaT cells stimulated by 17β-
estradiol were determined by MTT, and the mRNA and protein expression level of VEGFR-1,
VEGFR-2 were determined by RT-PCR and western blotting, separately. We found that VEGFR-
1, VEGFR-2 mRNA and protein were both be expressed on HaCaT cells. 17β-estradiol enhanced
the proliferation of HaCaT cells and expression of VEGFR-1 and VEGFR-2 in a dose depend-
ent manner, which could be partially inhibited by the monoclonal antibody to VEGFR-2. The
mRNA and protein levels of VEGFR-1 and VEGFR-2 in 17β-estradiol treated cells were signif-
icantly higher than untreated control (P < 0.05). These results suggest that estrogen could
increase expression of VEGFR-1 and VEGFR-2 in HaCaT cell line and enhance the prolifera-
tion of keratinocyte partially through the VEGF-VEGFR signaling pathway. The modulation
mechanism of estrogen on VEGFR needs further investigation.
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Calcium enhance mRNA expression of vascular endothelial growth factor receptor (VEGFR)
1, VEGFR-2 and VEGFR-3, but not neuropilins on epidermal keratinocytes
X Man, M Zheng, X Yang and S Cai Dermatology, Second Hospital of Zhejiang University,
Hangzhou, Zhejiang, China
The biological effects of vascular endothelial growth factor (VEGF) are mediated by five known
receptors, VEGF receptor 1 (VEGFR-1,flt-1), VEGFR-2 (KDR/flk-1), VEGFR-3 (flt-4), neuropilin-
1(NRP-1), and neuropilin-2 (NRP-2). VEGF has been studied extensively for its angiogenic and
tumorigenic behavior, affecting endothelial cell or tumor proliferation, motility, and vascular
permeability, which depend on the second messenger Ca2+ influx. To investigate whether
VEGFRs and NRPs are expressed on epidermal keratinocytes, we studied three cultured nor-
mal samples at the mRNA level as determined by RT–PCR. Moreover, five different dose of
calcium chloride at 0, 0.6, 1.2, 2.0, 3.0 mM was added to study if those expression is influ-
enced by calcium. We found that mRNA of all five members of VEGFR family was expressed
on normal epidermal keratinocytes, and NRPs at a relative high level, while VEGFR-3 at a low
level. Expression of VEGFR-1 mRNA is enhanced at all different calcium dose, and reaches
peak after stimulation with calcium chloride at 1.2 mM, then descends from 2.0 mM. While
VEGFR-2 and VEGFR-3 mRNA exhibit maximum at 2.0 mM. Expression of NRP-1 and NRP-
2 mRNA show no calcium dose-dependent. Therefore, we concluded that all three mRNA
isoforms of VEGFRs and their two co-receptors, NRP-1 and NRP-2, were all expressed by ker-
atinocytes in epidermis. Extracellular calcium influx may cause mRNA overexpression of
VEGFR-1, VEGFCR-2 and VEGFR-3 at different dose in keratinocytes. Signaling networks involv-
ing VEGF receptor systems may be influenced by extracellular calcium signals, which could
be integrated and transformed into various biological activities. However, we did not study
the mechanism of how calcium cause overexpression of VEGFRs, which need further investi-
gation.
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Psoriasis-associated fatty acid binding-protein delays onset of replicative senescence in cul-
tured human dermal microvascular endothelial cells
K Chung,1 H Chung,1 M Ha,2 H Lew,1 D Bang1 and K Lee1 1 Department of Dermatology,
Yonsei University College of Medicine, Seoul, South Korea and 2 Department of Biochemistry
and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea
The vast majority of pathophysiologic events involving endothelial cells occur at the level of
microvasculature, and endothelial cells derived from large vessels exhibit different character-
istics from small-vessel endothelial cells. Since primary cells are more similar to their in vivo
counterparts than are immortalized cells, they serve as an important model system for in vivo
applications. Our previous study showed that the over-expression of psoriasis associated-fatty
acid binding protein (PA-FABP) in cultured senescent human dermal microvascular endothe-
lial cell (HMVEC) is closely related to skin aging but the regulation of PA-FABP has not been
studied in these cells. To investigate the mechanism of PA-FABP in the aging process of the
HMVEC, we used an adenoviral vector to over-express PA-FABP in human endothelial cells.
Transient expression of PA-FABP resulted in a 2- to 3-fold increase in the p-Akt compared to
vector-treated controls, which correlated with the low level of p16 expression. These results
demonstrate the importance of PA-FABP in endothelial cell proliferation and indicate that PA-
FABP represses p16 expression, resulting in delayed senescence. In accordance, the amount
of DNA in the S phase was increased approximately 1.5 fold by the PA-FABP treatment, indi-
cating that PA-FABP is a strong activator of the G1 to S phase cell cycle progression in HMVEC.
In conclusion, PA-FABP may play an important role in the defense mechanism against aging
process by regulating the cell cycle related molecules as well as MAPK and Akt signaling.
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Anti-angiogenic effect of vorinostat (suberoylanilide hydroxamic acid, SAHA), a histone
deacetylase inhibitor, in CTCL lesions
X Ni,1 C Kelly,1 R Talpur,1 C Zhang,1 J Breuer-McHam,1 VM Richon2 and M Duvic1 1
Dermatology, UT - MD Anderson Cancer Center, Houston, TX and 2 Merck & Co., Inc.,
Boston, MA
Vorinostat has anti-tumor activity in solid and hematological tumors including cutaneous T-
cell lymphoma (CTCL).  Vorinostat inhibits class I and II histone deacetylases, modulating tran-
scription of a number of genes, thus, its anti-tumor action may be the result of targeting mul-
tiple pathways.  CTCL lesions have increased angiogenesis and VEGF expression and vorinostat
has anti-angiogenesis properties. By microarray, thrombospondin-1 (TSP-1), a 450kDa trimetric
glycoprotein and potent angiogenesis inhibitor, was increased 8 fold by vorinostat in the HH
cell line. We studied lesional skin biopsy specimens from 29 patients with CTCL receiving
vorinostat for microvessel density (MVD) by CD31 staining and for TSP-1 expression before
and after vorinostat treatment at 2 hours, 4, 6 or/and 8 weeks. In 15 of 20 paired lesions,
MVD was decreased at 4 weeks of vorinostat (193.6±85.7) compared to baseline (291.2±141.4)
(p=0.011), and at 6-8 weeks (224.9±91.6) (p=0.202). Moreover, the MVD was significantly
decreased in lesions from responders (n=10)(p<0.001). Dermal TSP-1 staining was increased
in 50% of lesions at 2 hours, 11/18 (61.1%) lesions at week 4, and 6/17 (35.3%) lesions or 4
of 6 (66.7%) responders’ lesions at 8 weeks. These data suggest that at least part of the clini-
cal anti-tumor activity of vorinostat may be attributable to its anti-angiogeneic effect. Addi-
tional investigation of changes in gene expression and identification of predictive protein bio-
markers in responding and non-responding patients is warranted.
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Repeated barrier disruption induces angiogenesis and wrinkle formation
S Iriyama, Y Matsunaga and S Amano Shiseido Research Center, Yokohama-shi, Japan
Recently, we found that repeated barrier disruption (BD) induced wrinkle formation. In a mouse
model of wrinkles induced by chronic ultraviolet B exposure, angiogenesis plays an impor-
tant role in the wrinkle formation, and an increase of vascular endothelial growth factor (VEGF)
and decrease of thrombospondin (TSP)-1 in the epidermis are involved in the angiogenesis.
However, it is unclear whether angiogenesis is also induced in the wrinkle model induced by
repeated BD. Repeated tape-stripping (TS) was carried out on mouse back skin to induce BD
until the transepidermal water loss (TEWL) values reached 4~7 mg/cm2/hour. Blood vessels
were stained immunohistochemically using anti-CD31 antibodies, and the size and number
of blood vessels were determined by computer-assisted quantitative analyses. Gene expres-
sion of VEGF and TSP-1 in the epidermis was analyzed by a quantitative PCR method. TS was
done 3 times a week. Shallow furrows appeared after 1 week, becoming much deeper after
2 weeks and presenting the appearance of fine and regular wrinkles. The repeated BD signif-
icantly increased the size and number of blood vessels in the dermis as compared with nor-
mal skin. VEGF expression was increased and TSP-1 expression was decreased in the epider-
mis at 24 hr after the first BD with TS, and the imbalance between VEGF and TSP-1 expression
was maintained by repeated BD. The angiogenesis and wrinkle formation induced by repeated
BD were significantly suppressed by the simultaneous application of glycine, which is known
to enhance the recovery of BD after TS. These results suggest that the BD with TS on the skin
surface induces up-regulation of VEGF expression and down-regulation of TSP-1 expression
in the epidermis, and a prolonged imbalance between VEGF and TSP-1 expression induces
angiogenesis in the upper dermis, which may be involved in wrinkle formation.
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Plasmin modulates VEGF-A mediated angiogenesis during wound repair
D Roth,1 M Piekarek,1 M Paulsson,2 T Krieg,1 JM Davidson3 and SA Eming1 1 Dermatology,
University of Cologne, Koeln, Germany, 2 Center for Biochemistry, University of Cologne,
Koeln, Germany and 3 Department of Pathology, Vanderbilt University School of Medicine,
Nashville, TN
Vascular endothelial growth factor-A (VEGF-A) is a potent mediator in tissue repair. Recently,
we demonstrated that in contrast to healing wounds, in non-healing wounds, VEGF-A is a tar-
get of proteases present in the wound environment. Protease-inhibitor studies, protein sequenc-
ing and MALDI-TOF mass spectrometry of the VEGF165 cleavage products indicated that plas-
min is one of the serine proteinases critically involved in this degradation process. We demonstrated
that plasmin-catalyzed cleavage of the VEGF-A isoform VEGF165 results in loss of its carboxyl-
terminal heparin-binding domain and significant loss in its bioactivity. Little is known about the
in vivo significance of this process. To investigate the biological relevance of the protease sensi-
tivity of VEGF165 in wound healing we assessed the activity of a VEGF165 mutant resistant to
plasmin proteolysis (VEGF165A111P) in a genetic mouse model of impaired wound healing
(db/db mouse). The stability of the mutant VEGF165 was substantially increased in wound tis-
sue lysates in comparison to VEGF165 wild type, thus indicating a prolonged activity of the
plasmin resistant VEGF165 mutant. The db/db delayed healing phenotype could be reversed by
topical application of VEGF165 wild type or VEGF165A111P. However, resistance of VEGF165
to plasmin cleavage resulted in the increased stability of vascular structures during the late
phase of healing due to increased recruitment of perivascular cells and delayed and reduced
endothelial cell apoptosis. Our data provide the first indication that plasmin-catalyzed cleavage
regulates VEGF165 mediated angiogenesis in vivo. Inactivation of the plasmin cleavage site
Arg110/Ala111 may preserve the biological function of VEGF165 in therapeutic angiogenesis
under conditions in which proteases are highly active, such as wound repair and inflammation.
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Establishment of a VEGF-null mouse keratinocyte cell line
I Mirones and F Larcher Epithelial Biomedicine, CIEMAT, Madrid, Spain
Vascular endothelial growth factor (VEGF) is essential for cutaneous angiogenesis. However,
the actual role of other vascular-especific signalling molecules has not been fully character-
ized due in part to the masking and/or overlapping effects of VEGF-A. In this study we have
been able to generate VEGF-A null keratinocytes obtained from the floxed VEGF mouse through
adenoviral gene transfer of Cre recombinase in vitro. Repeated cell passages under con-
trolled conditions resulted in keratinocyte immortalization allowing keratinocyte cloning.
Southern blot analysis and VEGF ELISA demonstrated the complete loss of both, VEGF gene
and protein in several keratinocyte clones derived from the AdCre-treated bulk population.
Selected clones were assessed for their putative tumorigenic properties as well as for growth
and differentiation characteristics in vitro and in vivo. After subcutaneous injection in nude
mice, none of the clones induced tumor growth. High calcium switch in cultured induced a
cuasi-normal differentiation marker induction. Remarkably, grafting of selected clones to nude
mice in Yuspa/Fusening’s chambers resulted in well-organized epidermal regeneration in the
back of immunodeficient mice. VEGF-A null keratinocytes represent a powerfull tool to assess
for angiogenic pathways independently of the strong VEGF influence.
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The effect of adenovirus-mediated angiopoietin gene transfer on the cutaneous wound
healing
Y Kim,1 J Ku,1 M Kim,1 Y Kim,2 G Koh,3 H Kim1 and Y Park1 1 Department of Dermatology,
Kangnam St. Mary Hospital,The Catholic University of Korea, Seoul, South Korea, 2
Department of Neurology, Kangnam St. Mary Hospital,The Catholic University of Korea,
Seoul, South Korea and 3 Department of Biological Sciences, Biomedical Center, Korea
Advanced Institute of Science and Technology, Daejeon, South Korea
Angiogenesis, formation of new capillary blood vessels, is crucial for cutaneous wound heal-
ing because it enables delivery of oxygen and nutrients to the healing site. Recently it has
been shown that angiopoietin (Ang)-1 has potential therapeutic applications in inducing angio-
genesis, enhancing endothelial cell survival and preventing vascular leakage. However, the
effect of Ang-1 in cutaneous wound healing has not been elucidated. In order to investigate
the potential benefits of gene therapy with Ang-1 on the wound repair, a replication-deficient
recombinant adenovirus vector carrying the chimeric variant of Ang-1, cartilage oligomeric
matrix protein (COMP)-Ang-1 (Ade-COMP-Ang-1) was intravenously injected to the Sprague-
Dawley rats two days before the surgery for full-thickness wounds on the back. We evaluated
the clinical wound closure rate and microvascular number in the tissue samples. At post-oper-
ation day 3, 7 and 14, clinical wound closure rate was 38.3 %, 59.4 % and 92.1 %, respec-
tively, in the Ade-COMP-Ang-1 the treatment groups, compared with 20.5 %, 47.5 % and
87.3 %, respectively, in Ade-LacZ treated control groups. Histopathologically, Ade-COMP-
Ang-1 treated groups showed much more microvessels than the control groups at post-oper-
ation day 7, 14 with a statistical significance (p<.05). From these results, we could infer that
Ade-COMP-Ang-1 gene therapy significantly accelerates cutaneous wound healing by pro-
moting angiogenesis at the site of injury and that Ade-COMP-Ang-1 gene therapy may be
regarded as a therapeutic tool for the treatment of delayed cutaneous wound healing
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The role of moesin in cellular senescence of human dermal microvascular endothelial cells
J Lee, N Chang, I Hong, J Yoo and K Lee Department of Dermatology, Cutaneous Biology
Research Institute, Yonsei University College of Medicine, Seoul, South Korea
Endothelial cells constitute an interface between blood and tissue and act as a medium for
active interaction between plasma and the intracellular environment for homeostasis. Aging
of endothelial cells plays a significant role in the pathophysiology of age-related vascular dis-
eases. However, precise mechanisms for senescence have not been elucidated. This study was
to investigate the role of moesin in endothelial cell senescence. In previous study we have
searched some aging-related proteins using dermal microvascular endothelial cell (HDMEC)
by proteomics tool. Among them changes in expressions of moein, rho GTP dissociation
inhibitor, and actin were detected by matrix-assisted laser desorption ionization time of flight
(MALDI-TOF) and confirmed by immunoblotting, and confocal laser microscopy. Moesin, the
ERM(Ezrin/Moesin/Radixin) protein, is known for its role in linking transmembrane proteins
to the cytoskeleton and in cytoskeletal remodeling. However its role in aging have not been
reported yet. To verify the role of moesin in skin aging, we used moesin-specific short inter-
fering RNA (siRNA) to inhibit the expression of gene of moesin. Western blot and reverse
transcriptase polymerase chain reaction (RT-PCR) were performed to optimize the silencing
effects of moesin-specific siRNA in cultured HDMEC, and then to determine the expression
of moesin, p16, p21, p27, p53 in early and late passage HDMECs. The moesin-specific siRNA
inhibited the expression of moesin, increasing significantly the expression of p16, p21, p27,
p53. HDMEC stained with senescence-associated beta galactosidase were more detected in
late passage HDMEC treated with moesin-specific siRNA than control. In conclusion, moesin
was confirmed to be related in senescence of HDMEC and this fundamental discovery may
be a basis for understanding the mechanism of aging and age-related diseases.
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All-trans retinoic acid antagonizes UV-induced VEGF production and angiogenesis via the
inhibition of ERK activation in human skin keratinocytes
M Kim, Y Kim, K Cho and J Chung Dermatology, Seoul National University Hospital, Seoul,
South Korea
Incident ultraviolet (UV) radiation leads to the upregulation of vascular endothelial growth
factor (VEGF), a potent angiogenic factor, in human skin. However, the molecular basis of
UV-induced angiogenesis in skin remains to be elucidated. In this study, we investigated the
roles of UV exposure on cutaneous angiogenesis, its associated signaling mechanisms, and
the effect of all-trans retinoic acid (tRA) on UV-induced vascularization and VEGF expression.
Using a human epidermal cell line, HaCaT, we found that UV induces VEGF mRNA and pro-
tein expression via the MEK-ERK1/2 pathway but not via the PI3K/Akt pathway, and that tRA
pretreatment significantly inhibits UV-induced VEGF overexpression and ERK1/2 activation.
In human skin in vivo, we confirmed that skin vascularization significantly increased after a
single exposure to UV, as was evidenced by a prominent increase in vessel size, vascular den-
sity, and in the cutaneous area occupied by vessels, and we found that these events are asso-
ciated with VEGF upregulation. Topical pretreatment with tRA under occlusion inhibited not
only UV-induced VEGF upregulation and angiogenesis with a significant reduction of vessel
density but also UV-induced ERK1/2 activation in human skin. Collectively, our data demon-
strates that tRA inhibits the UV-induced angiogenic switch via downmodulation of ERK1/2
activation and consecutive VEGF overexpression. These findings may help us understand the
molecular mechanisms that regulate skin angiogenesis due to UV exposure, and provide evi-
dence of the potential of tRA in terms of preventing angiogenesis-associated skin damage fol-
lowing exposure to UV irradiation.
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p120-catenin regulates clathrin-dependent endocytosis of VE-cadherin and plays an essen-
tial role in vascular development
K Xiao,1 R Oas,1 CM Chiasson,1 D Martin,2 AB Reynolds3 and AP Kowalczyk1 1 Department
of Cell Biology and Dermatology, Emory University, Atlanta, GA, 2 Transgenic Mouse Core
Facility, Emory University, Atlanta, GA and 3 Department of Cancer Biology, Vanderbilt
University, Nashville, TN
p120 catenin is an armadillo family member protein that binds to the juxtamembrane domain
of VE-cadherin, an adhesion molecule critical to vascular barrier function and angiogenesis.
p120 binding inhibits VE-cadherin endocytosis and degradation. A series of approaches were
undertaken to determine the mechanisms by which VE-cadherin is retrieved from the plasma
membrane. Two well established methods to inhibit clathrin dependent endocytosis, K+ deple-
tion and cytosol acidification, dramatically inhibited VE-cadherin internalization. Chlorpro-
mazine, which causes sequestration of the clathrin adaptor protein complex AP2, also inhib-
ited VE-cadherin endocytosis. These findings suggest that p120 inhibits clathrin-mediated
endocytosis of VE-cadherin by interfering with AP2 interactions with the cadherin tail. To exam-
ine the contribution of this p120 regulatory system to vascular biology in vivo, we utilized a
conditional mouse knock out system in which the p120 gene was ablated selectively in vas-
cular endothelial cells using a Cre-lox strategy. Mice harboring a “floxed” p120 allele were
mated with transgenic mice expressing Cre recombinase under the control of the Tie2 pro-
moter. Only 10% of the offspring with the conditional p120 null genotype (flx/flx, Cre+) were
viable, significantly lower than the Mendelian ratio of the crossing (25%). Timed mating exper-
iments demonstrated that vessel branching in the yolk sac of p120 deleted embryos was dra-
matically altered. In addition, p120 deleted animals collected at embryonic day 13.5-14.5
were often pale, and microscopic analysis of the embryos revealed hemorrhages and striking
defects in vascular organization. Together, these results reveal a novel cadherin endocytosis
regulatory mechanism and demonstrate an essential role for p120 in vascular development in
vivo.
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IL-6 and IFN-γ as initiating factors for dermal microvascular angiogenesis in the keratin 14
IL-4-transgenic mouse model of atopic dermatitis
L Chen,1 R Agha-Majzoub,1 J Peterson,1 T Bulj,1 S Lin,1 R Becker3 and L Chan1,2 1
Dermatology, UIC, Chicago, IL, 2 Microbiol/ Immunol, UIC, Chicago, IL, 3 Anatomy and Cell
Biol, UIC, Chicago, IL and 4 Med Service, Jesse Brown VA Med Center, Chicago, IL
Angiogenesis plays an essential role in chronic inflammation such as psoriasis, but its role in
atopic dermatitis is not yet established. We have previously demonstrated in our IL-4-transgenic
mouse model of atopic dermatitis: 1). Increased PECAM-1+ and VEGFR2+ dermal blood ves-
sels, 2). Elevated serum and skin VEGF proteins, 3). Increased skin mRNAs of pro-angiogenic
factors, and 4). Ultrastructural evidence of dermal angiogenesis. In the current study, we sought
to determine: 1). The effect of inflammatory cytokines on the keratinocyte production of VEGF,
a major factor for angiogenesis, 2). The changes of an inflammation-specific angiogenic factor,
guanylate-binding protein (GBP-1), and 3). The quantity of increased microvascular perme-
ability, a hallmark of angiogenesis. RT-Real time PCR determined that IL-6 and IFN-γ upregu-
lated VEGF mRNA expression by primary mouse keratinocytes of the IL-4-transgenic mice 8
hrs post-stimulation and increased the keratinocyte secretion of VEGF protein 48 and 72 hrs
post-stimulation. RT-real time PCR and Western blotting showed that GBP-1 mRNA and pro-
tein were significantly increased in the inflamed skin of transgenic mice compared to non-trans-
genic mouse skin. Microvascular leakage, as demonstrated by intra-vascular Evans Blue injec-
tion and tissue measurement, began in the skin of the transgenic mice before clinical disease
onset and peaked in the chronic disease stage. Furthermore, by Western blotting we provided
protein data confirming our previous findings of increased mRNA levels of PECAM-1, VEGFR2
and Angipoietin-1 in the skin lesions. Since mRNAs of IL-6 and IFN-γ have been shown by us
to be upregulated in the transgenic mouse skin before the onset of clinical disease, our data
support an initiating role of IL-6 and IFN-γ in angiogenesis of our model by upregulating VEGF,
a known factor to induce dermal microvascular leakage and angiogenesis.
www.jidonline.org   3
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The role of Arnt gene in perinatal mouse skin vascularization
S Geng,1 AV Mezentsev,1 M Ishii,1 SM Kalachikov2 and AA Panteleyev1 1 Dermatology,
Columbia University, New York, NY and 2 Genome Center, Columbia University, New York,
NY
As a subunit of hypoxia-induced factor Hif-1, the Aryl hydrocarbon Receptor Nuclear Translo-
cator (Arnt or Hif-1β) plays a key role in control of anaerobic metabolism, erythropoiesis,
angiogenesis, and vasodilation. Angiogenesis is essential for different aspects of skin biology,
including thermoregulation, tumor growth, wound healing, immune response, and hair-folli-
cle cycling. Yet, the role of Arnt in skin vascularization has not been explored previously. Tar-
geted ablation of Arnt in mouse epidermis using the Arnt-flox/K14-Cre model resulted in not
only epidermal-barrier failure, but also in severe abnormalities in dermal vasculature. In Arnt-
null newborn skin, hypervascularization was accompanied by dilatation of blood vessels that
had atrophic or even discontinuous walls. Mechanical stress resulted in noticeable intracuta-
neous bleeding. Immunohistochemistry revealed a significant decline of von Willebrand fac-
tor in the cutaneous vasculature. As was shown by microarray, the majority of the genes dif-
ferentially expressed in Arnt-null epidermis were related to hypoxia/angiogenic pathways.
Expressional studies revealed down-regulation (x17.4) of the Egln3 gene, which plays a key
role both in Hif-1α degradation under normoxic conditions and in support of arterial-wall
integrity. Other downregulated genes that had critical roles in the hypoxic response and vas-
cular remodeling were Bnip3 (x19.7), Btc (x8.7), Edg8 (x6.5), Mt4 (x6.2), and Aldoc (x4.1).
Angiogenesis-related upregulated genes that we identified included Procr (x87.4), Mmp3
(x34.3), Hs3st1 (x31.8), and Lcn7 (x12.6). The prevalence of angiogenic factors on the epi-
dermal microarray, coupled with prominent dermal vascular phenotype in Arnt-flox/K14-Cre
mice, suggests the existence of an Arnt-dependent epidermis-secreted hypoxia-sensing path-
way that controls dermal angiogenesis. Expression of Arnt in blood-vessel free mouse follicu-
lar papillae, along with absence of Arnt in vascularized human papillae, further supports the
role of Arnt pathway in the control of hypoxic response in skin.
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Epidermal progenitor cells modify the ischemic in vivo microenvironment
F Gourronc, CC Oberley and M Dunnwald Dermatology, The University of Iowa, Iowa City,
IA
Ischemia is one of the major sequelae of diabetes, and one that is easily amenable to cell-
based therapy. We recently showed that epidermal progenitor cells (EpPCs) incorporate into
the vasculature and accelerate the restoration of blood flow into diabetic ischemic limbs, sug-
gesting that EpPCs possess unique angiogenic properties. To begin understanding the molec-
ular mechanisms underlying the blood flow restoration, we performed gene array using mRNA
from ischemic muscle two and six days after cell or buffer injection. At two days, we observed
an increased in the number of upregulated genes in EpPCs-injected groups compared to buffer
controls, whereas four days later, the majority of genes were downregulated in EpPCs-injected
muscle. Semi-quantitative RT-PCR for selected angiogenic genes showed that angiopoietin-2,
MMP2, and MMP9 mRNA expression was unchanged in control and ischemic tissues. How-
ever, two days after EpPCs injection, mRNA levels for Flk1 and Tie-2, receptors for VEGF and
Angiopoietin-2 respectively, were increased in ischemic tissue. Levels of TGFbeta3 and PAI-
2 were unchanged at two days, but upregulated six days after EpPCs injection. These results
were compared with gene profiling of isolated EpPCs and differentiated cells before their injec-
tion to determine the contribution of the injected cells to the blood flow restoration. Together,
these results demonstrate that EpPCs, directly or indirectly, modify the ischemic microenvi-
ronment to promote blood flow. Two days after EpPCs injection, the tissue is primed for an
increased response to proangiogenic ligands as the receptors for angiogenic growth factors
were highly upregulated compared to their ligands. These new studies are critical to maximize
the therapeutic potential of EpPCs, as these cells may represent a new therapeutic alternative
for ischemia.
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Phenotypic modulation of skin microvascular endothelial cells by inflammatory cytokines:
a potential role in the etiology of fibrosis
MA Karasek, L Zhou and V Chaudhuri Dermatology, Stanford University, Stanford, CA
Inflammation is associated with the development of fibrosis in skin (scleroderma), lung (idio-
pathic fibrosis) and blood vessels (atherosclerosis). In this study we present evidence that two
major inflammatory cytokines (IL1 beta) and TNF alpha) can induce the permanent transfor-
mation of postembryonic human skin microvascular endothelial cells (HDMEC) into myofi-
broblasts. Human foreskin HDMEC were cultured in Iscove’s complete medium supplemented
with dibutyryl cyclic AMP and isobutyl methyl xanthine in order to maintain cyclic AMP lev-
els and a classical epithelioid cell morphology. Exposure to lL1 beta or TNF alpha induces
HDMEC to transform into spindle–shaped cells with a morphology distinct from epithelioid
HDMEC. Following a short-term exposure to IL1 beta or TNF alpha (<3 days), the transfor-
mation of HDMEC into spindle-shaped cells is reversible. However, following a longer term
exposure (>10 days) to the cytokines, the transformation is permanent. The transformed cells
were characterized as myofibroblasts by the following criteria: at the ultrastructural level by
cytoplasmic microfilaments with dense bodies and attachment plaques, at the molecular level
by the quantitative RTPCR expression of type I collagen and alpha smooth muscle actin genes
and, by immunofluorescence microscopy of alpha smooth muscle actin, type I collagen and
calponin. These results demonstrate that, following long-term exposure to the inflammatory
cytokines TNF alpha and IL1 beta, human skin microvascular endothelial cells have a poten-
tial to transform permanently into myofibroblasts. The transformation of HDMEC to myofi-
broblasts induced by inflammatory cytokines in vitro may provide a new paradigm to begin
to explain the basis for the increased accumulation of matrix proteins and myofibroblasts
pathognomonic of skin fibrogenesis in vivo.
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The effect of parthenolide and hypoestoxide on ultraviolet radiation induced production of
vascular endothelial growth factor in primary human epidermal keratinocytes
D Collins,1 Y E,2 E Shnitkind,2 W Lee,2 T Mammone,1 MS Matsui1 and AR Shalita2 1 Estee
Lauder Research Laboratories, Melville, NY and 2 Department of Dermatology, SUNY
Downstate Medical Center, Brooklyn, NY
It is of considerable interest to develop agents that reduce ultraviolet radiation (UVR)-induced
skin inflammation since it is associated with such adverse effects as premature aging and hyper-
pigmentation. Other groups have found that there is a link between UVR, vascular endothe-
lial growth factor (VEGF) expression, and photodamage. In addition, a signaling molecule
known to be involved in VEGF expression, NF-κB, was shown to block UVR photoaging. There-
fore, parthenolide, an NF-κB inhibitor, and hypoestoxide, an IκB kinase (IKK) inhibitor, could
be useful for the prevention of skin photoaging. This study was conducted to investigate the
effect of parthenolide and hypoestoxide on tumor necrosis factor alpha (TNFα)and UV-induced
VEGF production in normal human epidermal keratinocytes (NHEK) in vitro to correlate NF-
κB inhibition with VEGF expression. NHEK cells were exposed to TNFα (10-200ng/ml), UVA
(2.5-20 J/m2), UVB (5-30mJ/cm2), parthenolide (0.001-10uM) and hypoestoxide (1-100uM).
The expression of VEGF was measured by quantitative ELISA and the cytotoxicity was assessed
by MTT assay. The results showed that both parthenolide and hypoestoxide inhibited TNFα,
UVA- and UVB-induced VEGF production in a dose dependent manner without causing cyto-
toxicity. TNFα, UVA and UVB showed maximal upregulation of VEGF at the doses of 50 ng/ml,
10 J/m2 and 30 mJ/cm2 respectively. VEGF was inhibited by 30-50% after addition of partheno-
lide and hypoestoxide. Angiogenesis has been linked to classic manifestations of chronic UVB-
induced skin damage and aging. This study suggests that parthenolide and hypoestoxide could
be used to inhibit angiogenesis (by downregulating VEGF) and the resultant cutaneous pho-
todamage that is induced by exposure to UV light, and could therefore serve as a novel tar-
get for preventive interventions.
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Effects of chronic UVA1 on skin microvasculature in a mouse ear model
L Zhang,1 PR Bargo,2 M Eisinger1 and N Kollias 2 1 Skin Research Center, Johnson & Johnson
CPPW, Skillman, NJ and 2 Methods & Models Development, Johnson & Johnson CPPW,
Skillman, NJ
To understand the effects of low-dose chronic UVA1 (340-400nm) radiation on skin microvas-
culature, SKH-1 hairless mouse ears (n=6) were irradiated with UVA1 at 10 J/cm2, 1⁄ 4 of min-
imal erythemal dose (MED) of muse back skin, 3 times a week for 8 weeks. Images and non-
invasive measurements were performed every two weeks during the course of UVA1 radiation.
Digital image analysis showed that chronic UVA1 induced persistent vasodilation and initia-
tion of new capillary formation from the pre-existing vessels. Noninvasive fluorescence spec-
troscopy detected that UVA1 increased fluorescence at 345 nm (excitation at 295 nm), cor-
responding to epidermal protein such as tryptophan, and decreased fluorescence at 385 nm
(excitation at 335 nm), which may be related to dermal collagen crosslinking. Immunohisto-
chemical stainings revealed increases in both proliferating cell nuclear antigen (PCNA)-posi-
tive keratinocytes. There was also an increase in epidermal vascular endothelial growth fac-
tor (VEGF) expression and a 1.4-fold increase in dermal vessel density compared to
non-irradiated controls (P < 0.005). Our data indicate that low-dose cumulative UVA1-induced
vascular responses may play an important role in the pathogenesis of skin photodamage.
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Biomarkers of Angiogenesis in Progression from Dysplastic Nevi to Malignant Melanoma
TL Thomas,1 P Bozzo,2 DS Alberts,2 C Curiel,1 K Sabota,2 J Fruehauf,3 J Buckmeir2 and
J Einspahr2 1 Dermatology, University of Arizona, Tucson, AZ, 2 Arizona Cancer Center,
University of Arizona, Tucson,, AZ and 3 Dermatology, University Irvine, Irvine, CA
A significant body of evidence supports the concept that malignant melanoma progresses from
dysplastic melanocytic nevi. Biomarkers of angiogenesis may help delineated whether dys-
plastic nevi represents a true precursor lesion of melanoma and may also elucidate the mech-
anism by which this transformation occurs. Vascular endothelial growth factor (VEGF-C1), and
two endothelial cell markers (CD31 and CD105) were evaluated by immunohistochemistry
in paraffin-embedded tissue in 41 BNs (from 15 individuals), 47 DNs (13 individuals), and 18
primary melanomas. VEGF staining was evaluated using both the staining intensity (0-4+) and
the percentage of cells that were positive for VEGF. These factors were then combined to give
a VEGF score of 0-400.  VEGF expression in melanocytes increased progressively from BN (7.4
± 4.4), to DN (38.5 ± 6.1, p=<0.001 BN vs DN), and melanoma (114.5 ± 27.3, p=0.027 DN
vs melanoma). BN and DN showed similar levels of CD31 and CD105, while both of theses
endothelial markers were significantly increased in melanoma, as compared to either BN or
DN (p<0.001). The histology of benign nevi, dysplastic nevi, and primary melanoma was
confirmed by 2 experience dermatopathologists.  Primary melanomas express both high lev-
els of VEGF as well as both endothelial markers, CD 105 and CD 31. DN had an intermedi-
ate level of melanocyte VEGF expression while endothelial markers, CD 105 and CD 31 were
similar in BN and DN. The higher VEGF expression in dysplastic nevi as compared to benign
nevi may portend malignant neoplastic change in the skin and could serve as a biomarker for
detection and chemopreventive modulation.
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On significance of autoimmunity to epidermal transglutaminase in human dermatitis her-
petiformis skin
M Dmochowski,1 G Wolnik-Trzeciak,1 M Bowszyc-Dmochowska1 and E Kaczmarek2 1
Dermatology, University School of Medicine, Poznan, Poland and 2 Pathology, University
School of Medicine, Poznan, Poland
Human and murine studies suggest that epidermal transglutaminase (TG3) plays a role in der-
matitis herpetiformis (DH). We assessed whether TG3 is deposited at sites of IgA skin deposits
in human DH, whether there is a relationship between levels of serum IgA antibodies to TG3
(IgATG3) and to tissue transglutaminase (IgATG2), and whether the type of IgA deposits in
DH skin is related to IgATG3 or IgATG2. We evaluated the relationship between IgATG3 and
the intensity of eosinophil major basic protein (MBP) deposits in DH skin. In all, 146 DH cases
and controls with other autoimmune/nonautoimmune dermatoses were studied. The TG3 dep-
osition was evaluated using a purified antibody to recombinant human TG3 by immunohis-
tochemical streptavidin/peroxidase method (IP) and/or immunofluorescence (IF). The type of
IgA deposits in DH skin was assessed by direct IF, and IgATG3 and IgATG2 were evaluated
by ELISA. DH cases were assigned to two groups showing granular IgA/IgA1 deposits either
in dermal papillae only (DH1) or along dermo-epidermal junction (DEJ) (DH2). Intensities of
MBP deposits, detected in fresh blister-containing skin by IP, were measured 2-/3-dimen-
sionally by the appropriate software. The TG3 was unequivocally present at sites of IgA deposits
in a minority of DH cases and TG3 was found at DEJ in none of controls. There were unequiv-
ocal vascular deposits of TG3 in the topmost dermis in none of DH cases. The IgATG3 and
IgATG2 were significantly higher in DH than in controls, yet both of these antibodies were
not DH-specific. There was a significant correlation between IgATG3 and IgATG2 in DH, but
there was no such correlation in controls. In DH1 and DH2 groups, IgATG3 as well as IgATG2
were not statistically different. There was no significant correlation between the intensity of
MBP deposits, significantly lower in DH than in bullous pemphigoid, and IgATG3 in DH.
Thus, it seems that autoimmunity to TG3 in human DH at the cutaneous level might not be
as important as hitherto thought.
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Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in para-
neoplastic pemphigus patients
B Zhang, R Zheng, J Wang, D Bu and X Zhu Department of Dermatology, Peking University
First Hospital, Beijing, China
Sera from paraneoplastic pemphigus (PNP) immunoprecipitate multiple antigens from human
epidermal protein extract. These antigens belong to plakin protein family. In this study, we
further characterized the autoantibodies in 12 PNP sera. Immunoblotting using recombinant
linker subdomains of envoplakin, periplakin, desmoplakin and bullous pemphigoid antigen
I (BPAG1) found that 11 of the 12 sera recognized linker subdomains of envoplakin and
periplakin. We then synthesized 12 peptides covering the linker subdomain of envoplakin for
enzyme-linked immunosorbent assay (ELISA) to delineate the epitopes in this region. One of
the peptides, peptide no. 8, was recognized by 9 out of the 12 sera with higher affinity. A
method of ligand-receptor binding assay was designed and performed using this peptide labeled
with fluorescence as the ligand to probe the specific antigen receptor on B-lymphocytes in
tumors from PNP patients. Peptide no. 8 bound to CD20+ cells in Castleman’s tumors from
the patients whose sera were positive to this peptide by ELISA. Our data suggest that the
linker subdoamin of plakin proteins may be one of the major areas recognized by PNP autoan-
itbodies, and epitopes in the linker subdomain of envoplakin recognized by PNP autoanti-
bodies with high affinity are dispersed in several areas and are variable among PNP patients.
We also demonstrate that B-lymphocyte clones specifically reacting to epidermal proteins
exist in Castleman’s tumors from PNP.
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Study on the relationship between expressions of glucocorticoid receptor α and β mRNA in
peripheral blood mononuclear cell of patients with polymyositis/dermatomyositis and the
glucocorticoid efficacy
J Liu,1 A Xu1 and F Song2 1 Department of Dermatology, The Third Hospital of Hangzhou,
Hangzhou, China and 2 Department of Dermatology, China Medical University, Shenyang,
China
Polymyositis and dermatomyositis (PM/DM) belong to idiopathic inflammatory myopathy with
unclear etiological factors and pathogenesis. The glucocorticoid (GC) is still the most exten-
sively used treatment medication, but about 20% of PM/DM patients are resistant to GC ther-
apy. In order to explore the relationship between expressions of guococorticoid receptor (GR)α
and β in peripheral blood mononuclear cell (PBMC) of patients with PM/DM and the GC effi-
cacy, reverse transcription-polymerase chain reaction (RT-PCR) was used to semiquantitate
expressions of GR α and β mRNA in PBMC of 18 PM/DM patients sensitive to GC, and 10
PM/DM patients resistant to GC and 20 health donors as controls. The levels of cortisol in
sera of PM/DM patients and health donors were detected using radioimmunoassay. Our results
showed that there was no significant difference of the levels of cortisol in sera of PM/DM
patients sensitive to GC, resistant to GC and health donors. The expression of GR α mRNA in
PBMC both of PM/DM patients sensitive to GC and resistant to GC was significantly lower
than that of health donors. Moreover expression of GR α mRNA in PBMC of PM/DM patients
resistant to GC was significantly lower than that of patients sensitive to GC (n=28, p<0.05).
While the expression of GR β mRNA in PBMC both of PM/DM patients sensitive to GC and
resistant to GC were significantly higher than that of health donors, but there was no signifi-
cant difference between PM/DM patients sensitive to GC and resistant to GC. These findings
suggest that the lower expression of GR α mRNA in PBMC of PM/DM patients may be related
to PM/DM patients resistant to GC therapy and therefore provide a useful information on early
selection of the immunosuppressive medication in the treatment of PM/DM.
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Scratching and noxious heat stimuli aggravate itch perception in atopic dermatitis
Y Ishiuji,1 A Dawn,1 J Fountain,1 RC Coghill,2 Y Oshiro2 and G Yosipovitch1,2 1 Dermatology,
Wake Forest University School of Medicine, Winston-Salem, NC and 2 Neurobiology and
Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC
The purpose of this study was to examine the effects of scratching and noxious heat stimuli
on itch intensity and skin blood flow in atopic dermatitis. Itch was induced by histamine ion-
tophoresis at both affected and non-affected skin sites in subjects with atopic dermatitis. Repet-
itive noxious heat and scratching stimuli were applied 3 cm distal to the area of induced itch.
Subjects rated their perceived intensity of itch using a computerized visual analogue scale
(COVAS). Skin blood flow was measured by laser Doppler Imager. Our results demonstrate
that scratching intensifies itch perception in atopic dermatitis rather than inhibiting itch as we
observed previously in healthy controls. This phenomenon was observed only in eczematous
lesions. In contrast, in non-affected skin of patients with atopic dermatitis, the pattern was sim-
ilar to that of healthy controls. Histamine iontophoresis at the site of eczematous lesions induced
a two-fold increase in itch intensity compared to healthy controls. Furthermore, heat pain stim-
uli increased histamine-induced itch four-fold in comparison with healthy controls. Noxious
heat also increased itch perception in non-affected skin sites; however, these effects were less
robust than in eczematous areas. Skin blood flow in atopic dermatitis patients was significantly
increased by histamine with noxious heat as well as histamine with scratching compared to
healthy controls. The present study demonstrates that both thermal and mechanical stimuli
aggravate itch perception in eczematous lesions of atopic dermatitis patients. These data strongly
suggest that perception of painful thermal and mechanical stimuli in affected areas of atopic
dermatitis patients differs from that of healthy subjects. The ability of stimuli distal to the site
of induced itch to influence itch perception suggests the possibility of central sensitization in
atopic dermatitis.
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Expression of receptors relevant for neutrophil migration in subjects with atopic dermatitis,
psoriasis and healthy controls
L Bankova,1,2 M Brummet,2 LY McGirt,1,2 G Hosler1 and LA Beck1,2 1 Dermatology, Johns
Hopkins University, Baltimore, MD and 2 Allergy and Clinical Immunology, Johns Hopkins
University, Baltimore, MD
Our hypothesis is that there is a defect in neutrophil (PMN) recruitment in Atopic Dermatitis
(AD) which is not observed in healthy, nonatopic controls (NA) or in psoriasis (PS) subjects.
We have shown that AD skin expresses PMN chemoattractants at comparable levels to PS.
We are currently testing whether there are phenotypic or functional differences between PMNs
from AD, NA and PS subjects. Peripheral blood samples were obtained from AD (n=7), PS
(n=10) and NA (n=7) subjects. PMNs were analyzed by FACS, identifying PMNs with a PE-
conjugated CD16 mAb and indirect IF staining with mAbs specific for β2 integrins, CCR1,
CXCR1 & 2, FMLP receptor(R), C5aR/CD88, C3bR/CD35, PAFR and CRTH2/DP2. To assess
in vivo CXCR1 function, IL-8 (100nM x 15m) induced CD11b upregulation was performed in
whole blood. Unexpectedly, CRTH2 – a chemoattractant receptor for PgD2, found on Th2-
lymphocytes and eosinophils, was detected on PMNs in both NA and PS (%+: 99±2 and 97±1,
and net MFI: 31±8 and 45±6, respectively) but was expressed at lower levels in AD (%+: 10±1,
net MFI: 1±0),(p<0.01). The PAFR was highly expressed on PMNs of PS (net MFI: 19±4) com-
pared to AD subjects (net MFI: 8±1; p<0.05). The β2 integrins - CD11a and CD18 were more
highly expressed in PS (net MFI: 78±7 and 60±5, respectively) compared to NA subjects (net
MFI: 52±14 and 49±2, p<0.05). There were no differences in expression of other PMN chemoat-
tractant receptors. IL-8 induced significant CD11b upregulation in NA (delta net MFI: 68) and
PS (delta net MFI: 47) but no induction in AD (delta net MFI: 0). We have shown that the
PgD2 activating receptor, CRTH2 is present on PMNs. But this receptor is largely undetectable
on AD PMNs and may prove to be a biomarker useful for diagnosis. PMNs from PS subjects
express greater chemoattractant receptors (PAFR), adhesion molecules (CD11a & CD18) and
are more responsive to neutrophil chemoattractants (IL-8) than AD PMNs.
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The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by
repeated application of antigen
R Tamagawa-Mineoka,1 N Katoh,1 E Ueda,1 H Takenaka,1 M Kita2 and S Kishimoto1 1
Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science,
Kyoto, Japan and 2 Microbiology, Kyoto Prefectural University of Medicine Graduate School
of Medical Science, Kyoto, Japan
Platelets contain many bioactive substances, and are essential for hemostasis. They have also
been shown to be important in other processes, including inflammation, but their role in chronic
allergic inflammation of skin, such as that occurring in atopic dermatitis (AD), remains unclear.
The aim of this study was to investigate the role of platelets in a mouse model of chronic con-
tact hypersensitivity induced by repeated hapten application. The model has characteristics sim-
ilar to those of AD. Mice were depleted of platelets to a level of about 1000/µl by administra-
tion of anti-platelet antibody or busulfan, but levels of circulating leukocytes were unchanged.
Ear thickness and swelling, leukocyte infiltration into skin, serum IgE, and scratching behavior
significantly decreased in platelet-depleted mice, compared with controls. Gene array analy-
sis of ear skin showed reduced expression of genes associated with Th2-type lymphocytes in
platelet-depleted mice. Flow cytometry showed increased expression of P-selectin on platelets
and more platelet-leukocyte aggregates in the blood of mice repeatedly challenged with aller-
gen, compared with non-sensitized mice. In platelet-depleted mice, inflammation was restored
by infusion of platelets from sensitized mice. In addition, injection of activated platelet super-
natant into the ear led to increased leukocyte infiltration into skin. This infiltration was blocked
by pretreatment of platelets with PPARγ agonists or addition of neutralizing antibodies against
MIP-1α, RANTES or TARC to the supernatant. These results suggest that platelets induce recruit-
ment of leukocytes into skin by forming platelet-leukocyte aggregates in blood and secreting
chemokines at sites of inflammation. Therefore, control of platelet activity may be useful for
treatment of chronic allergic skin inflammation, such as in AD.
www.jidonline.org   5
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Characterization of desmoglein 3-reactive helper T cells involved in pathogenic IgG pro-
duction in a mouse model for pemphigus vulgaris
H Takahashi,1,2 M Amagai,1 T Nishikawa,1 Y Kawakami2 and M Kuwana3,2 1 Dermatology,
Keio Universisty School of Medicine, Tokyo, Japan, 2 Institute for Advanced Medical
Research, Keio University School of Medicine, Tokyo, Japan and 3 Internal Medicine, Keio
University School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune disease mediated by pathogenic IgG autoantibodies
to desmoglein 3 (Dsg3). It is not known what determines the pathogenicity of helper T cells
in the production of harmful anti-Dsg3 IgG. In this study we isolated and characterized Dsg3-
reactive CD4+ T cells using a PV mouse model by adoptive transfer. Sixteen Dsg3-reactive
CD4+ T-cell lines were established by repeated antigenic stimulation of lymphocytes derived
from Dsg3-immunized Dsg3-/- mice, followed by limiting dilution. All T-cell lines proliferated
in the presence of recombinant Dsg3 and their proliferation was blocked by anti-MHC class
II antibody. Among them monoclonality of 9 T cell lines were confirmed by family PCR for T-
cell receptor Vβ genes. Those T-cell lines were divided into 2 groups, 6 Th1 lines and 10 Th0
lines, by cytokine expression profiles with RT-PCR. To further evaluate in vivo helper activity,
the individual T-cell clones or lines were adoptively transferred with Dsg3-/- splenic B cells into
Rag2-/- mice. Six of 16 T-cell clones or lines induced anti-Dsg3 antibody production in recip-
ient mice, which developed the PV phenotype including skin and oral erosions with the typ-
ical PV histology. Moreover, the direct cell-cell contacts of Dsg3-reactive T cells and B cells,
which are essential for T-B interaction, were observed in the spleen. Interestingly, 4 of 6 Th0
clones showed in vivo helper activity to produce the pathogenic anti-Dsg3 IgG, while none
of 6 Th1 lines did, indicating that one of the possible pathogenic determinants of T cells is Th0
cytokine profile. This is the first direct demonstration for the in vivo involvement of Dsg3-
reactive T cells in pathogenic IgG production. These Dsg3-reactive T cells will provide valu-
able tools to clarify uncovered mechanisms involving T cells in autoantibody production.
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Comparison of white blood cell fractions, oxidation index and level of stress between Japan-
ese acne patients and healthy volunteers
M Takahashi,1 M Tan,1 S Kimura1 and H Ikeno2 1 Beauty Science R&D, POLA, Yokohama,
Japan and 2 Ikeno Clinic, Dermatology & Dermatological Surgery, Tokyo, Japan
In recent years, an increase of ultraviolet light (UV) through the destruction of the ozone layer
has influenced the earth’s environment and therefore, has increased human skin damage
remarkably. We investigated antioxidant action on venous blood, degree of oxidative stress
and subjective stress levels in acne patients and healthy volunteers. A blood sample was
taken from 98 newly diagnosed acne patients and 24 healthy volunteers. A Free Radical Ana-
lytical System (FRAS4) consisting of Biological Antioxidant Potential test (BAP) and Diacron
Reactive Oxygen Metabolites test (d-ROMs) was used to measure the antioxidant action and
the degree of oxidative stress, respectively. The subjective stress level was investigated with a
questionnaire. It is accepted that the sympathetic nervous system becomes dominant under
stress. Abo, et al. also reported the number of granulocytes, particularly neutrophils, increases
when sympathetic nervous system is dominant. Neutrophils and lymphocytes were also meas-
ured by an auto blood cell analyzer in this study. BAP of the acne patients was significantly
lower (p<0.0001) than that of healthy subjects. Difference in the measurement with d-ROMs
was not detected between the two groups. Subjective stress level in the acne patients was
higher than that in the healthy subjects. The acne patients had a higher proportion of neu-
trophils and a lower proportion of lymphocytes compared to the healthy subjects. Among the
acne patients, the neutrophil rate was significantly higher (p<0.05) in the patients with high
subjective stress. In this study, the acne patients had lower antioxidant action, higher subjec-
tive stress and higher neutrophil rate compared to the healthy subjects. It is suggested that the
higher subjective stress with dominant sympathetic nervous system may lead to higher neu-
trophil rate in blood and affected areas, and it may further exacerbate the acne lesion.
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FK506 treatment controls systemic autoimmunity and nephritis in CD40L tg mice
K Loser,1 J Apelt,1 S Balkow,1 K Reichert,3 A Kuhn,2 TA Luger1 and S Beissert1 1 Department
of Dermatology, University of Muenster, Muenster, Germany, 2 German Cancer Research
Center, Institute for Immunogenetics, Heidelberg, Germany and 3 Astellas, Munich, Germany
Autoimmune disorders show a rising incidence worldwide. CD40-CD40L signaling is involved
in the development of autoimmunity characterized by the presence of autoreactive T cells
and autoantibodies. Within the skin transgenic overexpression of CD40L in basal keratinocytes
leads to spontaneous autoimmune dermatitis, which can be adoptively transferred by inject-
ing CD8+ T cells into naive recipient mice, as well as systemic autoimmunity as evidenced
by autoantibodies, nephritis, and proteinuria. To investigate the effects of the calcineurin
inhibitor FK506 on CD40L induced systemic autoimmunity, we systemically treated CD40L
transgenic (tg) mice with FK506 after onset of disease. Age and sex matched controls were
injected with PBS. CD40L tg mice that received PBS continued developing autoimmune der-
matitis similar to untreated tg mice. Interestingly, CD40L tg mice that were injected with FK506
showed significantly reduced autoimmune dermatitis scores. Furthermore, analysis of serum
from PBS treated tg mice showed the presence of autoantibodies. Investigation of the kidneys
and renal function in PBS treated CD40L transgenic mice revealed large immunoglobulin dep-
ositions and glomerulonephritis. Moreover, these mice suffered from severe proteinuria. Impor-
tantly, FK506 treated CD40L tg mice showed complete loss of nephritis, renal immunoglob-
ulin depositions and proteinuria. Additionally, the activation status of splenic and lymph
node CD8+ T cells was determined in PBS and FK506 treated CD40L transgenic mice by mul-
ticolor flow cytometry, demonstrating a diminished development of cytotoxic/autoreactive
CD8+ T cells in FK506 treated CD40L tg mice. These data indicate that calcineurin signaling
is critically involved in CD40L induced autoimmunity and therefore, CD40L induced murine
local and systemic autoimmunity including nephritis can be effectively inhibited using FK506.
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Tetracyclines suppress ATP?S-induced and baseline IL-8, GRO? and MCP-1 production by
the human microvascular endothelial cell-1 (HMEC-1) cell line
A Bender,1 K Seiffert,1 W Ding,1 JA Wagner2 and RD Granstein1 1 Dermatology, Weill
Medical College of Cornell University, New York, NY and 2 Neurology and Neurosciences,
Weill Medical College of Cornell University, New York, NY
Tetracyclines display powerful anti-inflammatory properties in addition to their anti-micro-
bial properties. Such anti-inflammatory activity of tetracyclines is thought to play a role in
inhibiting cutaneous inflammation in patients with rosacea. However, the exact mechanism
of this action remains poorly understood. Previously, we have shown that ATP?S, a hydroly-
sis-resistant ATP analog, augments secretion of pro-inflammatory messengers by HMEC-1 cells,
a transformed human dermal microvascular endothelial cell line with many characteristics of
fresh endothelial cells. Stimulation of release of inflammatory signals by sympathetic trans-
mitters such as ATP may help explain the worsening of rosacea and other inflammatory skin
diseases during periods of stress. We asked whether tetracyclines could inhibit ATP?S-induced
release of pro-inflammatory mediators by HMEC-1 cells. HMEC-1 cells were cultured in the
presence or absence of 10 or 100 µM ATP?S with or without addition of tetracycline or minocy-
cline. Both agents dose-dependently (25-400 µg/ml) and significantly inhibited ATP?S-induced
augmentation of IL-8, monocyte chemoattractant protein 1 (MCP-1), and growth regulated
oncogene ? (GRO?) production by HMEC-1 cells in vitro and also significantly inhibited base-
line production of these factors. At the concentrations tested, tetracycline had no significant
effect on cell viability as determined by Trypan-blue exclusion. These results suggest that inhi-
bition of the production of inflammatory mediators by endothelial cells may be a novel mech-
anism by which tetracyclines are effective in treating rosacea and other inflammatory skin
diseases.
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Rational strategies for antibody-targeted therapy in pemphigus vulgaris (PV)
AS Payne,1 DL Siegel2 and JR Stanley1 1 Department of Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Pathology, University of Pennsylvania, Philadelphia, PA
In previous work we isolated pathogenic and non-pathogenic monoclonal antibodies (mAbs)
from a patient with active mucocutaneous PV using phage display technology. Genetic analy-
sis of greater than 60 anti-desmoglein (Dsg) mAbs from this library shows that pathogenic
mAbs are restricted to only 3 variable heavy chain (VH) genes. To determine the feasibility of
more specific therapy of PV, we sought to target only pathogenic antibodies based on their
VH gene usage. We raised rabbit antibodies against 2 pathogenic but genetically unrelated
mAbs using their cloned single chain variable fragments (scFv) as immunogens. Rabbit anti-
serum was cross adsorbed against irrelevant scFv. Such rabbit IgG specifically binds by ELISA
to its target pathogenic mAb and other pathogenic mAbs that use the same VH gene (even with
different light chains), but not to other anti-Dsg mAbs. Inhibition ELISA shows that rabbit anti-
scFv also block binding of the target mAb, as well as genetically related mAbs, to Dsg sub-
strates. Finally, rabbit antiserum specifically inhibited cell dissociation induced by patho-
genic mAbs encoded by the same VH gene in human keratinocyte culture. To determine if we
could find smaller molecules that specifically bind pathogenic antibodies, we screened a phage
library of linear and constrained peptides against cloned human pathogenic mAbs. As deter-
mined by ELISA binding assays, we found distinct peptides, but with homologous sequences,
that bound pathogenic mAbs encoded by the same VH gene, but not other anti-Dsg mAbs.
These data demonstrate the feasibility of antibody VH gene-targeted approaches to biologic
therapy in PV. In a given patient, customized reagents could be used to adsorb or otherwise
block pathogenic autoantibodies. If a limited set of VH genes and/or antibody idiotypes is con-
served among different PV patients (as suggested by previous studies that demonstrated shared
idiotypes in PV antibodies), these reagents may be more broadly applicable as safer and more
targeted biologic therapies for pemphigus.
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Different anti-desmoglein 3 monoclonal antibodies exert epitope-specific regulation of p120-
catenin phosphorylation and of p120-catenin binding to desmoglein 3 in human squamous
cell line, DJM-1 cell
Y Kawasaki,1 Y Aoyama,1 K Tsunoda,2 M Amagai2 and Y Kitajima1 1 Dermatology, Gifu
University School of Medicine, Gifu, Japan and 2 Dermatology, Keio University School of
Medicine, Tokyo, Japan
Desmoglein 3 (Dsg3) is a transmembrane glycoprotein mediates Ca2+-dependent cell-cell adhe-
sion at desmosome. Several lines of evidence lead to indicate that autoantibodies against Dsg3
play a pathogenic role in blister formation in autoimmune blistering disease, pemphigus vulgaris
(PV). PV-IgG reduces cell surface Dsg3 by its endocytosis and degradation as we have previously
shown. Although its precise mechanisms have been unclear, we have proposed the involvement
of any intracellular signal transductions via Dsg3 by autoantibodies to Dsg3. Four monoclonal
antibodies against Dsg3 (AK mAbs) have different epitopes and show different activities to disrupt
of intracellular adhesion in keratinocytes. Recently, we found that p120-catenin (p120ctn) as a
novel desmosome constituent binds cytoplasmic region of Dsg3. p120ctn is well known to reg-
ulate stability and function of the cadherin/catenin adhesion complex. Here we examined whether
AK mAbs induce phosphorylation of Dsg3 and p120ctn and examined the effects on their mutual
association status. Cell lysates of AK mAb-treated DJM-1 cells were immunopricipitaeted with PV-
IgG (binds specifically to Dsg3 but neither to Dsg1 nor to E-cadherin) and then subjected to West-
ern blotting with anti-phosphotyrosine and anti-p120ctn antibodies. AK mAbs increased the amount
of tyrosine phosphorylation in Dsg3-binding p120ctn but neither Dsg3 nor free p120ctn. Phos-
phorylated p120ctn revealed to vary in molecular weights according to the different AK mAb treat-
ments, indicating that binding of AK mAb to different epitopes induced phosphorylation at dif-
ferent sites of p120ctn and/or of different p120ctn isoforms. These results suggest that each AK
mAb activates different signaling pathways by binding to different epitope, which might be a clue
to reveal regulation of cell-cell adhesion in keratinocytes.
6 Journal of Investigative Dermatology (2006), Volume 126
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Role of substance P in stress-derived degranulation of dermal mast cells in mice
S Kawana,1 Z Liang,1 M Nagano2 and H Suzuki2 1 Dermatology, Nippon Medical School,
Tokyo, Japan and 2 Pharmacology, Nippon Medical School, Tokyo, Japan
The interaction between nerves and mast cells can effect regulation of the immune system
and inflammatory responses. Recent studies have shown that various stressors can induce
degranulation of dermal mast cells in animals. This study was conducted to confirm that sub-
stance P (SP) is involved in the degranulation of dermal mast cells in stress conditions. Using
a communication box system, foot shock stress (FS) and psychological stress (PS) were admin-
istered to mice and the degranulation rate of dermal mast cells, the number of SP-positive
nerve fibers and changes in SP content were determined. The inhibitory effect of a nonpep-
tide NK1-receptor antagonist on these changes was also investigated. Administration of FS
and PS resulted in significantly enhanced degranulation of dermal mast cells and increased
number of SP-positive nerve fibers. FS significantly decreased dermal SP content whereas SP
was increased by PS. We speculated that in the FS group, electrical stimuli to the skin caused
depolarization of primary afferent nerves and SP in nerve endings was released much greater
than that in the PS group, but that the released SP was immediately degraded by mast cell-
derived chymase and cell surface peptidase, including neutral endopeptidase and angiotensin
converting enzyme, resulting in an apparent SP decrease. The above changes were inhibited
by the intraperitoneal injection of the NK1 receptor antagonist. These results suggest that SP
released from nerve endings, has an important role in the degranulation of dermal mast cells
during both stress conditions, and that a tachykinin receptor antagonist exhibits an inhibitory
effect on aggravated stress-induced dermatitis.
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Propionibacterium acnes-induced inflammation and skin lesions in human skin-SCID
chimeras
W Li, L Zhang and M Eisinger Skin Biology, Johnson & Johnson, Skillman,, NJ
Propionibacterium acnes, part of normal skin microflora, has long been associated with
acne, however detailed understanding of its role in the pathogenesis of inflammatory acne
was initiated only recently. Findings that 1) Toll-like receptor 2 (TLR2) present on monocytes,
also present in acne lesions, can mediate production of proinflammatory cytokines when stim-
ulated by P. acnes and 2) demonstration of inducibility of cytokine production by P. acnes in
human keratinocytes in vitro, represent major steps toward understanding the mechanism of
proinflammatory action of P. acnes (Kim et al. 2002; Graham et al. 2004). To investigate the
response of human skin to P. acnes in vivo we used CB-17/scid mice carrying human female
facial skin grafts. Grafts shown to have high levels of sebum, by sebutaping, were used. Live
P. acnes (ATCC11828) were topically applied at 2x106cfu/cm2. Recovery experiments revealed
P. acnes to be alive for at least 3 days. Following one or two applications of P. acnes, patches
of redness and occasional skin lesions were observed within 24 hours on the human skin
grafts. Microscopically the areas of redness revealed the presence of large numbers of human
monocytes expressing TLR2. This was in contrast to vehicle controls that showed only scat-
tered TLR2 expressing cells. Of other immune cells, tested by CD3 and CD22 antibodies, only
minimal if any increase was noted. Compared to the controls, P. acnes infected skins also
expressed much higher levels of IL1-α and β. In the areas of skin lesions there was damage
to the epidemis caused by epidermolysis, containing P. acnes, immune cells and dead ker-
atinocytes. The skin lesions caused by P. acnes suggest possible contribution of P. acnes to
acne scars. As acne is a human specific disease and there is an urgent need for an acne model,
our data may represent the first steps toward achieving this goal.
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CD18-deficient mice reveal that in leukocytoclastic vasculitis neutrophils damage vessels
not from the abluminal, but luminal side
A Sindrilaru,1 S Seeliger,3 T Peters,1 J Ehrchen,2 K Scharffetter-Kochanek1 and C Sunderkotter2
1 Dermatology, University of Ulm, Ulm, Germany, 2 Dermatology, University of Munster,
Munster, Germany and 3 Pediatrics, University of Munster, Munster, Germany
Although several steps in the pathogenesis of immune complex (IC) vasculitis are known, dis-
tinctive questions have not yet been addressed. So far it is not known 1) if neutrophils (PMN)
exert their damaging actions rather from the abluminal than intravascular site so that their
released cytotoxic agents would not be washed away; 2) if the decisive release of cytotoxic sub-
stances from PMN in response to fixed IC would require involvement of ligands in addition to
FcγR or 3) if IC alone are able to recruit PMN in LcV as they do in IC-mediated nephritis. We
addressed these questions on in vivo and in vitro models of LcV using CD18ko mice. When
analyzing the influence of CD18 on FcγR-mediated effector functions relevant for LcV such as
binding to IC, degranulation and oxidative burst, we found that CD18 is not required for ini-
tial, but for sustained oxidative burst and full degranulation strongly correlated with sustained
adhesion to IC. When we elicited the Arthus reaction by injecting BSA iv and anti-BSA into the
ear CD18ko mice in contrast to WT did not develop LcV. Thus the presence of IC was not suf-
ficient for accumulation of PMN and also not for vascular damage during diapedesis. This
allowed us to investigate if vessels would be exclusively damaged by PMN from the perivas-
cular site after injecting ko or wt PMN sc into ears of CD18ko mice, bypassing the recruitment
defect. Intact PMN reached the vessels with deposited IC, but did not damage them. We con-
clude that CD18 is mandatory for PMN transmigration but not for the cytotoxic functions in
LcV and that in vivo PMN do not damage EC from the protected interstitial site, but rather dur-
ing transmigration from the luminal site to the tissue. We therefore speculate that in LcV i) IC
and CD18 mediate a release of cytotoxic contents in close contact to EC and ii) the therapy
with CD18 blocking antibodies will be effective in patients with severe LcV.
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Using genechip to define genetic fingerprint of murine sclerodermatous graft versus host dis-
ease, a model for human scleroderma
L Zhou, D Askew, R Han, C Wu and AC Gilliam Dermatology, Case University and University
Hospitals of Cleveland, Cleveland, OH
The molecular mechanisms governing skin fibrosis in murine sclerodermatous graft versus host
disease (Scl GVHD), a model for human scleroderma, are not known. We used Affymetrix
DNA microarrays representing > 14,000 mouse genes to characterize global gene expression
in skin during development of Scl GVHD in lethally irradiated BALB/c (H-2d) mice transplanted
with B10.D2 (H-2d) bone marrow and spleen cells. These mice develop skin thickening, while
control mice transplanted with syngeneic BALB/c (H-2d) bone marrow and spleen cells do not
develop disease. We focused on molecules known to be altered in scleroderma, as well as
novel molecules that could be targeted for therapy. We found consistent differences between
mice with Scl GVHD and controls in cytokine mRNAs for both Th1-like (IFN-γ) and Th2-like
(IL-6, Il-10, and IL-13) inflammatory patterns. Messenger RNAs for chemokines CCL2, CCL5,
CCL17, and IFN-γ inducible chemokines (CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC)
were elevated. Messenger RNAs for PDGF-c, CTGF, FGF1, EGF, NGF-β, VEGF-α and VEGF-β
were elevated, similar to human scleroderma. Messenger RNAs for cell adhesion molecules,
such as selectin lymphocyte (L), selectin platelet (P), selectin endothelium (E) and VCAM 1
were also upregulated. These constellations of immunologic changes provide a ‘fingerprint”
for fibrosing autoimmune disease. They are useful to understand the pathogenesis of Scl GVHD,
to identify markers for early diagnosis of disease and to devise more effective strategies for
intervention in early scleroderma and sclerodermatous GVHD.
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Relationship between serum levels of MDC and MMP-9 and disease activity in patients with
systemic lupus erythematosus
M Zheng, Y Liu and W Yin Dermatology, Second Affiliated Hospital of Zhejiang University,
School of Medicine, Hangzhou, Zhejiang, China
Systemic lupus erythematosus (SLE) is a complicated autoimmune disease. Although its patho-
genesis is not very clear, it is thought that chemokines and extracellular matrix may be involved
in the development of the disease. Serum levels of macrophage-derived chemokine (MDC)
and matrix metalloproteinase-9 (MMP-9) were investigated in the patients with SLE in order
to determine the relationship between the serum levels and the disease activity of SLE. 23
patients in active stage and 13 patients in inactive stage were evaluated using the SLEDAI
standard, and active disease was indicated by SLEDAI score of more than 8 points. 23 SLE
patients with arthritis and 13 without the lesion according to articular damage. 30 healthy
volunteers, matched in gender and age were recruited as controls. Serum levels of MDC and
MMP-9 were measured by enzyme-linked immuno sorbent assay (ELISA). The Results were as
follows, 1. Significantly decreased serum levels of MDC and MMP-9 were found in SLE as
compared to those in controls, but serum levels of MDC and MMP-9 increased after treatment.
2. Serum levels of MDC and MMP-9 were lower in patients with active disease than those with
inactive disease. 3. Significantly decreased serum levels of MDC and MMP-9 were found in
patients with renal damage than those without. 4. Serum level of MDC was lower in patients
with arthritis than those without, but serum level of MMP-9 has no significant difference in
two groups. The present data suggest that MDC and MMP-9 be involved in the pathogenesis
of SLE, and serum levels of MDC and MMP-9 could be markers of monitoring disease activ-
ity, renal damage, disease progression and improvement in SLE.
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Anti-inflammatory properties of Fenugreek extract
A Perrin, C Gondran, E Bauza, C Dal Farra and N Domloge Research Center, Vincience,
Sophia Antipolis, France
The inflammatory reaction is a positive defensive mechanism activated by organisms when
they are subjected to external aggressions or pathogenic elements. However, chronic or strong
inflammatory reaction can become harmful and lead to cell damage or dysfunctions in the
immune system. Among critical early inflammatory mediators, the pro-inflammatory cytokines
TNF-alpha and IL-1 alpha play an essential role, as they are synthesized first and induce the
activation of the cytokine cascade. Moreover, during inflammation, the enzyme iNOS is over-
expressed in cells and its synthesis is controlled by the presence of cytokines. In this study, we
were interested in evaluating the anti-inflammatory properties of a Fenugreek extract (FG-
extract) on epithelial cells. We studied HaCaT keratinocytes irradiated with 30 mJ/cm2 UVB
and then treated with the active ingredient for 24 h or 48 h. Total cellular TNF-alpha and IL-
1 alpha levels were assessed by ELISA. Moreover, cell expression of the enzyme iNOS was
evaluated by immunostaining, and cell morphology was visualized by hematoxylin-eosin stain-
ing. Our results showed that application of FG-extract improved UV-irradiated and morpho-
logically damaged cells, when applied for 24 h or 48 h. Treatment of cells with FG-extract
resulted in decreased cytokine expression in a time-dependent manner. The expression of TNF-
alpha and IL-1 alpha decreased slightly (-6.5% and –10.4%, respectively) after 24 h of treat-
ment with FG-extract. Whereas, after 48 h of treatment, expression of these cytokines was
clearly down-regulated. TNF-alpha decreased by 37.5%, and IL-1 alpha decreased by 45.7%.
Interestingly, parallel immunostaining studies of iNOS expression, showed similar results, with
a slight decrease after 24 h of treatment, and a significant decrease within 48 h of applica-
tion, demonstrating the net anti-inflammatory effect of FG-extract on the cells. These results
demonstrate that FG-extract possesses very interesting anti-inflammatory properties, and strongly
suggest that Fenugreek extract can be of great use in sun and skin care products.
www.jidonline.org   7
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Localization of TNFα producing cells and reduction in response to TNFα targeted therapy in
psoriasis
DJ Marble,1 K Gordon2 and B Nickoloff3 1 Dermatology, Loyola University, Maywood, IL, 2
Dermatology, Evanston Northwestern Healthcare, Skokie, IL and 3 Pathology, Loyola
University, Maywood, IL
In the cytokine network theory for the immunopathogenesis of psoriasis, TNFα is postulated to
play a key role, and hence has been targeted for therapeutic intervention. To detect and local-
ize TNFα, pre-psoriatic skin (PN) and lesional psoriatic plaques (PP) were examined by immuno-
histochemical staining (n=6 different patients). There is a significant increase (p<0.05) in the
number of TNFα positive cells in PP skin (57±7 cells/ high powered field, HPF) when com-
pared with PN skin (17±2 cells/HPF). TNFα positive cells were primarily distributed immedi-
ately beneath the basement membrane zone, as well as in perivascular and interstitial dermal
sites. PP skin was also characterized by a 4-fold increase in the number of CD68+ macrophages
(p<0.05) as well as an 8-fold increase in CD11c+ dermal dendritic cells (p<0.05) compared to
PN skin. By 2 color immunofluorescence staining, including confocal microscopy, both CD68+
cells as well as CD11c+ cells were expressing TNFα in all samples examined. Moreover, fol-
lowing initiation of anti-TNFα therapy using a monoclonal antibody (adalimumab), the num-
ber of CD11c+ cells, when compared with untreated PP skin (132±14 cells/HPF), significantly
decreased at days 7 (81±5 cells/HPF, p<0.05), 28 (39±5 cells/HPF, p<0.05) and 84 (24±3
cells/HPF, p<0.05), while the number of CD68+ cells, when compared with untreated PP skin
(124±6 cells/HPF), significantly decreased at days 28 (63±5 cells/HPF, p<0.05) and 84 (42±3
cells/HPF, p<0.05). Reductions in CD68+ and CD11c+ cell counts also correlated to clinical
responses as reflected by PASI scores. Other markers for dendritic cells (CD83, CD86) and
macrophages (CD14) showed significant decreases in cell numbers at days 7, 28, and 84 when
compared with untreated PP skin (p<0.05). We conclude that macrophages and dendritic cells
can both produce TNFα in psoriatic plaques, and a biological agent targeting TNFα reduced
the number of TNFα expressing mononuclear cells correlating with clinical responses.
44
High mobility group box 1 expression in murine lupus nephritis
J Zhou, M Zheng, S Cai, X Man and X Yang Dermatology, Second Hospital of Zhejiang
University, Hangzhou, Zhejiang, China
High Mobility Group Box 1 (HMGB1) is well known its nuclear functions. Recent studies have
clearly demonstrated that HMGB1 could control the activation and chemotaxis of inflamma-
tory cells. HMGB1 is a chemotactic and immunoregulatory protein, which can promote an
effective inflammatory immune response. Histopathology of lupus nephritis is characterized
by inflammatory cell infiltration and immunocomplex deposition in glomeruli. The objective
of this study was to determine the role of HMGB1 in lupus nephritis. MRL/MpJ-Fas (lpr) mice
and C57BL/6 mice were monitored from 6 to 20 wk of age for the parameters of proteinuria
and dsDNA. Renal morphologic features were examined at week 6,12 and 20 wk of age by
light microscopy, electron microscopy, and immunohistologic analyses. The mRNA expres-
sion of HMGB1 and monocyte chemoattractant protein-1 (MCP-1) was investigated by RT-
PCR. Immunofluorescence assay was employed to examine the localization of HMGB1 in the
tissue of kidneys. Higher expression of HMGB1 was found in MRL/MpJ-Fas (lpr) than that of
C57BL/6 mice. Expression of HMGB1 was positively correlated with that of MCP-1 mRNA (P
< 0.05). Strong expression of HMGB1 protein was mainly located in glomeruli of MRL/MpJ-
Fas (lpr), especially in the enlarged hypercelluar glomeruli, whereas weak and negative expres-
sion was found in glomeruli of C57BL/6. The results of the present study demonstrate that the
higher expression of HMGB1 was associated with the occurrence of lupus nephritis. It is sug-
gested that higher expression of HMGB1 could enhance the production of many inflamma-
tory mediators such as MCP-1, et al, leading to the inflammatory damages of glomeruli. How-
ever, further studies should be carried out to explore the intrinsic mechanisms.
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Topical treatment with K-13619 suppresses psoriasis-like skin inflammation in IL-1 receptor
antagonist deficient mice
Y Tabunoki,1 T Edano,1 K Murakami,1 T Doi,1 T Koshi,1 A Nakajima,2 Y Iwakura2 and
Y Hattori1 1 Tokyo New Drug Research Laboratories II, Kowa Company, Ltd.,
Higashimurayama, Tokyo, Japan and 2 Division of Cell Biology, Center for Experimental
Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Tokyo, Japan
Psoriasis is an intractable skin disease classified into non-infectious and inflammatory ker-
atosis. This disease is characterized by epidermal hyperplasia and infiltration of inflammatory
cells. Remedies for psoriasis are composed of topical vitamin D3 derivatives, topical/systemic
corticosteroids and so on. In recent years, suppression of TNF-α has been shown to be effec-
tive for the treatment of psoriasis. Accordingly, we tried to develop compounds, which can
inhibit TNF-α activity and regulate keratinocytes like vitamin D3 derivatives. K-13619 is one
of such compounds, and we examined its efficacy in psoriasis-like skin inflammation models.
Anti-inflammatory effects were evaluated by the inhibition of TNF-α-induced cell adhesion
between vascular endothelium cells and leukocytes. Regulatory effects on keratinocyte pro-
liferation and differentiation were analyzed by 3H-thymidine uptake and involucrin expres-
sion, respectively. Anti-psoriatic effects of K-13619 were evaluated using two psoriasis mod-
els, TPA-induced psoriasis model in hairless mice and spontaneous psoriasis-like skin
inflammation model of IL-1 receptor antagonist (IL-1Ra) deficient mice. K-13619 inhibited cell
adhesion induced by TNF-α in a dose dependent manner. K-13619 suppressed the uptake of
3H-thymidine and induced the expression of involucrin about 10 times stronger than calcitriol.
In hairless mice, 5% K-13619 acetone solution showed comparable effects to tacalcitol 20
µg/g ointment (Bonalfa-High). In IL-1Ra deficient mice, prophylactic treatment of 5% K-13619
cream suppressed the development of symptoms completely, and therapeutic treatment resulted
in a significant reduction of the disease severity. These results show that topical treatment of
K-13619 is a promising therapy for psoriasis.
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Signaling elicited by pemphigus (PV)-IgG in cultured epidermal cells: involvement of EGFR
and MAPK cascades 
M Frusic-Zlotkin,1 D Raichenberg,1 B Michel,2 X Wang1 and Y Milner1 1 Biological
Chemistry, Hebrew University Jerusalem, Jerusalem, Israel and 2 Michel Skin Care Inc.,
Beachwood, OH
Pemphigus is a fatal blistering disease of the skin and mucous membranes characterized by
the loss of intercellular adhesion (acantholysis) of keratinocytes due to binding of autoanti-
bodies (PV-IgG) to desmosomal cadherins (dsg 3 and 1) and other antigens at the cell surface.
The signal transduction pathways that lead to acantholysis are not yet well understood. We
have reported that PV-IgG mobilized the Fas apoptotic machinery in vivo (PV patients’ skin)
and in vitro , in cell and organ culture, including the increase in secreted FasL. Recent research
has shown that phosphorylation of cadherins underlies the assembly / disassembly of the adher-
ence and desmosomal junctions. In this work we addressed the involvement of a membranal
receptor tyrosine kinase (EGFR), desmosomal proteins (dsg 3, plakoglobin) and signaling events
in relation to the apoptotic pathway activation by PV-IgG. We investigated the activation of
EGFR and MAPK cascades by PV-IgG and found an increased EGFR autophosphorylation in
skin organ and A431 keratinocytes cultures. Downstream to EGFR, a subsequent phosphory-
lation of ERK1/2 and c-jun and an increase in c-myc level were seen. In organ culture, PV-
IgG induced EGFR internalization, when plakoglobin was still coaggregated with the PV anti-
gen (dsg3) at the cell membrane. Tyrphostin AG-1478, a tyrosine kinase inhibitor, prevented
EGFR autophosphorylation, secretion of FasL, cell death (IC50~5 µM) and lesion formation in
treated A431 cell cultures. In summary, the induction by PV-IgG involves mobilization of mem-
branal receptors dsg3, EGFR and FasR and activation of the signaling pathway EGFR – ERK1/2
– c-jun - c-myc, all to play a role in eliciting apoptotic / acantholytic lesion formation. Our
data also confirm the link between tyrosine kinase receptor pathway and Fas-death pathway.
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Bullous pemphigoid patients do not possess IgG autoantibodies reactive with laminin 5.
VK Salato, Z Lazarova, M Janson, JA Fairley and KB Yancey Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Anti-epiligrin cicatricial pemphigoid (AECP), a mucosal-predominant autoimmune subep-
ithelial blistering disease characterized by IgG autoantibodies against laminin 5 (L5), has
been associated with an increased relative risk (RR) for cancer (overall RR~7, RR in first year
of disease~15). Hence, the identification of AECP patients has assumed great significance. In
contrast to prior studies showing that anti-L5 autoantibodies are a reliable marker for patients
with AECP, a recent study suggested that as many as 40% of patients with bullous pemphigoid
(BP) have IgG reactive with L5. To explore this possibility directly the sera of 100 adult patients
with clinical, histologic, and immunopathologic features of BP were rigorously analyzed. Three
comprehensive screening studies were applied to all sera in this study. Immunofluorescence
(IF) and immunoblot (IB) studies showed that all 100 BP patients were seropositive for IgG
autoantibodies reactive with human epidermal basement membrane (BM) as well as either
BPAG1 and/or BPAG2 in human keratinocyte (HK) extracts. While none of these sera bound
L5 in HK extracts (rabbit anti-L5 IgG, positive control), 13 of 100 sera scored above the cut-
point of a recently developed IgG4 L5 ELISA (sensitivity=0.91, specificity=0.98, Youden
index=0.89). Additional and further specialized studies applied to the 13 samples showing
reactivity in the IgG4 L5 ELISA found that all of these sera from BP patients had: 1) IgG that
bound the epidermal, but not the dermal, side of 1 M NaCl split skin by indirect IF microscopy,
2) no IgG that immunoblotted L5 purified from HK extracellular matrix, and 3) no IgG that
immunoprecipitated L5 from biosynthetically radiolabeled HK extracts. In sum, these com-
prehensive studies demonstrate that anti-L5 autoantibodies are not typically found in the sera
of patients with BP. Anti-L5 autoantibodies remain reliable markers for patients with AECP, a
subepidermal blistering disease associated with an increased RR for cancer.
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Maternal contact hypersensitivity reactions during pregnancy recruit fetal VEGFR2 express-
ing microchimeric cells
SH Nguyen,2 S Aractingi,1,2 M Oster2 and K Khosrotehrani1,2 1 Dermatology, AP-HP, Hopital
Tenon, Paris, France and 2 EA 2396, Laboratoire de Physiopathologie du Developpement,
Universite Pierre et Marie Curie-Paris 6, Paris, France
Fetal cells enter the maternal circulation during all human and murine pregnancy. The pres-
ence of fetal microchimeric cells has been demonstrated in lesional skin of pregnant women
affected with polymorphic eruptions of pregnancy. We aimed at determining in a mouse model
the role of maternal inflammation in attracting microchimeric cells. Wild type female mice
were mated to transgenic males for various reporter genes or wild type male controls. We used
males transgenic for the luciferase gene under the control of an ubiquitous (CMV)(C-Luc) or
the VEGFR2 (V-Luc) promoter. Alternatively we used males transgenic for the EGFP under the
control of the beta-actin promoter. Female pregnant mice were sensitized on day 10 of preg-
nancy with 2% Oxazolone. On day 16 we revealed a contact hypersensitivity reaction (CHR)
by painting the right ear with oxazolone while the left ear received only the vehicle. The pres-
ence of fetal cells was then monitored using one of the following: <v>in vivo</v>imaging to
detect luciferase expressing fetal cell real time quantitative amplification of the egfp trans-
gene or Y chromosome in situ hybridization to detect male microchimeric cells. On female
mice bearing V-Luc fetuses, a fetal signal could be detected only on the right ear that was sig-
nificantly higher when compared to controls (3362 versus 1507 photons/s/cm2, p=0.02). We
also detected fetal cells by real time quantitative PCR in the right as well as the left ear at sim-
ilar frequencies. Finally, we demonstrated the presence of fetal cells in maternal inflamed ears.
Fetal cells were either among the inflammatory cells or were part of the vascular wall. We
demonstrate that maternal inflamed skin can recruit fetal microchimeric cells. The fetal cells
adopt an endothelial phenotype in the inflamed maternal skin. Fetal cells may therefore par-
ticipate in maternal angiogenesis and inflammation.
8 Journal of Investigative Dermatology (2006), Volume 126
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CD18 deficiency induces psoriasiform dermatitis by altering the balance of pathogenic and
regulatory T-cells in a murine psoriasis model
H Wang, T Peters,  Daniel, A Sindrilaru, T Oreshkova, AM Seier and K Scharffetter-Kochanek
Dermatology in IZKF, Dermatology, Ulm, Baden Wuerttemberg, Germany
The objective of the present study was to investigate why the psoriasiform skin disease devel-
ops in CD18 hypomorphic (CD18hypo) PL/J mice. Mice with a hypomorphic mutation of the
CD18 gene (CD18hypo) and mice with a complete deficiency of the CD18 gene (CD18null)
on the PL/J inbred strain or CD18 wild type (CD18wt) mice were employed. CD4+CD25+
regulatory T cells (Treg cells) and CD4+CD25- responder T cells (Tresp cells) were isolated
using CD4+CD25+ Regulatory T cell Isolation Kit for both in vitro proliferation/suppres-
sion/adhesion assays and in vivo treatment. Foxp3 expression in Treg cells was measured using
PE anti-mouse/rat Foxp3 Staining Set. CD18 CD18hypo PL/J mice with reduced levels of the
common chain of beta2 integrins (CD11/CD18) develop an autoimmune skin disease strongly
resembling human psoriasis. In this study we report that CD18 deficiency causes the reduced
number of Treg cells in peripheral lymphoid organs of CD18hypo and CD18null mice. CD18
deficiency does not infuence expression of Foxp3 of Treg cells. Howerever, CD18 deficient
Treg cells are impaired in their inhibitory fuctions in vitro and in vivo. Adoptive transfer of
Treg cells from CD18wt into affected CD18hypo mice significantly resolved the psoriasiform
dermatitis. CD18 deficiency impairs cell adhesion and antigen presentation in both CD18hypo
and CD18null mice. Furthermore, in both in vivo and in vitro experiments Tresp cells from
spleen of affected CD18hypo mice identified as pathogenic T cells exhibit increased early pro-
liferative responses, compared to CD18wt mice. Taken together, our data suggest that due to
CD18 deficiency the reduced suppressor activity of Treg cells in association with accelerated
proliferation of pathogenic Tresp cells leads to the development of the psoriasiform skin dis-
ease in CD18hypo PL/J mice.
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The prevalence of autoantibodies against E-cadherin in pemphigus
F Evangelista, DA Dasher, LA Diaz and N Li Dermatology, The University of North Carolina
at Chapel Hill, Chapel Hill, NC
Pemphigus is a group of autoimmune blistering skin diseases characterized by autoantibod-
ies against the desmosomal cadherins desmoglein 1 (Dsg1) and desmoglein 3 (Dsg3). Patho-
genic autoantibodies against the ectodomain of Dsg1 and Dsg3 are unique features of pem-
phigus foliaceus (PF) and pemphigus vulgaris (PV), respectively. The role of classical cadherins
as immunological targets of PF and PV is unknown. In this study, we tested the sera of patients
with PF, endemic PF, also known as fogo selvagem (FS), and PV against E-cadherin. We con-
structed and expressed the ectodomain of E-cadherin fused with a His-tag in a baculovirus
expression system using a cDNA encoding the full-length of E-cadherin provided by Gumbiner
(Cell Biology, University of Virginia). We tested the immunoreactivity of patient and control
sera to this antigen by immunoprecipitation followed by immunoblotting with anti-His mon-
oclonal antibody. Anti-E-cadherin autoantibodies were detected in 14 of 15 patients with PF
(95%) and in 12 of 14 patients with FS (86%). Anti-E-cadherin autoantibodies were also
detected in 26 of 35 of patients with mucocutaneous type PV (74%), but in none of the patients
with mucosal type PV (n: 7). The presence of anti-E-cadherin autoantibodies correlated with
the presence of autoantibodies against Dsg1. Anti-E-cadherin autoantibodies were not detected
in sera from normal controls (n: 16) or patients with other autoimmune diseases, including
bullous pemphigoid (n: 25), epidermolysis bullosa acquisita (n: 2), and lupus (n: 3). This
study provides the first evidence that the majority of PF/FS and mucocutaneous type PV patients
have circulating autoantibodies against E-cadherin, a classical cadherin located in adherens
junctions between epithelial cells. Ongoing studies may reveal the possibility of cross-reac-
tivity of these autoantibodies with Dsg1/Dsg3 or a distinct population of autoantibodies. It is
feasible that anti-E-cadherin autoantibodies may contribute to the pathogenesis of PF, FS and
mucocutaneous PV.
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Prevalence of anti-desmoglein-3 antibodies in endemic regions of fogo selvagem in Brazil
D Dasher,1 J Hilario-Vargas,1,3 N Li,1 V Aoki,4 G Hans-Filho,5 B Qaqish,2 V dos Santos,6
E Rivitti4 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel Hill, Chapel
Hill, NC, 2 Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3
Facultad de Medicina, Trujillo, Peru, 4 University of Sao Paulo, Sao Paulo, Brazil, 5 University
Federal of Mato Grosso do Sul, Campo Grande, Brazil and 6 Secretaria de Estado de Saude
do Mato Grosso do Sul, Campo Grande, Brazil
Fogo selvagem (FS), the endemic form of pemphigus foliaceus, is an autoimmune blistering
disease characterized by autoantibodies against desmoglein 1 (Dsg1). The Terena reservation
of Limao Verde in Mato Grosso do Sul, Brazil, is a previously identified focus of disease.
Autoantibodies against desmoglein 3 (Dsg3) have also been detected in sera from patients
with FS.  In an effort to further characterize the serological, geographical, and clinical epi-
demiology of the disease, we sought to determine the prevalence of anti-Dsg3 autoantibod-
ies in sera from clinically normal subjects living outside of and in an endemic area. We used
an enzyme-linked immunosorbent assay (ELISA) to detect antibodies against Dsg3 in serum
samples from 21 patients with FS who reside in Limao Verde, 286 normal subjects (without
evidence of clinical disease) from Limao Verde and surrounding locations, and 18 normal sub-
jects from the University of North Carolina (UNC) Blood Bank and laboratory personnel. Anti-
bodies against Dsg3 were found in 9 of the 21 patients with FS (43%), in 52 of 146 normal
subjects from Limao Verde (36%), and in 8 of 140 normal subjects from surrounding areas
(6%). No antibodies were detected in sera from normal subjects from UNC. This study demon-
strates 1) a high prevalence of anti-Dsg3 autoantibodies among normal subjects living in an
area where FS is endemic 2) that the likely environmental trigger of the anti-Dsg1 and anti-
Dsg 3 antibody responses is located amongst the population of this endemic area and 3) that
the population at risk to develop FS may also be at risk to develop an endemic form of pem-
phigus vulgaris as reported by our co-investigators from Brasilia.
52
Association of Stat3 variants and psoriasis in the Newfoundland and Labrador (NL) founder
population
WP Gulliver,1,2 P Rahman,2 K Zipperlen3 and L Peddle3 1 NewLab Clinical Research Inc., St.
John’s, Newfoundland and Labrador, NF, Canada, 2 Memorial University of Newfoundland,
St. John’s, NL, NF, Canada and 3 Newfound Genomics, St. John’s, NL, NF, Canada
The Newfoundland and Labrador (NL) founder population has been used to study psoriasis
and psoriatic arthritis. Significant associations have been noted to TNF Alpha and HLA-Cw6
in psoriasis as well as the IL-1 cluster, CARD15, TNF-alpha and HLA-Cw6 in psoriatic arthri-
tis. We undertake this study of Stat3 therein in this founder population. Stat3 likely encodes a
number of proteins that figure to be critically important in inflammation and immunity. Recently,
Sano et al reported that epidermal keratinocytes in psoriatic lesions are characterized by acti-
vated Stat3 (Nat Med 2005). Furthermore, transgenic mice with keratinocytes expressing a
constitutively active Stat3 develop a skin phenotype resembling psoriasis. Thus we set out to
examine the association between Stat3 variants and psoriasis in the NL founder population.
We assessed 246 psoriasis patients and 217ethnically matched healthy controls from New-
foundland (a recognized founder population). All psoriasis subjects and controls were geno-
typed for Stat3 variants by time-of-flight mass spectrometry. Seven Stat3 SNPs were genotyped.
As noted below the univariate analysis revealed no association between Stat3 variants and
psoriasis. Haplotype analysis using the PHASE software also noted no significant differences
in haplotype frequencies between cases and controls. We failed to observe an association
between Stat3 variants and psoriasis in the NL founder population. Thus these variants are
unlikely to be associated with uncomplicated psoriasis in the NL cohort.  This founder popu-
lation will be useful to confirm other psoriasis genes linkages that are discovered.
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p38MAPK inhibition blocks disease in pemphigus vulgaris mice
P Berkowitz,1 P Hu,1 Z Liu,1 L Diaz1 and DS Rubenstein1,2 1 Dermatology, University of
North Carolina-Chapel Hill, Chapel Hill, NC and 2 Lineberger Comprehensive Cancer
Center, University of North Carolina-Chapel Hill, Chapel Hill, NC
Pemphigus vulgaris (PV) is a life threatening autoimmune blistering skin disease character-
ized by detachment of keratinocytes (acantholysis). It has been proposed that PV IgG might
trigger signaling and this process may lead to acantholysis. Indeed, we recently identified a
rapid and dose dependent phosphorylation of p38MAPK and heat shock protein 27 (HSP27)
following binding of PV antibodies to cultured keratinocytes. In human keratinocyte cultures,
inhibitors of p38MAPK prevented PV IgG induced phosphorylation of HSP27 and more impor-
tantly, prevented the early cytoskeletal changes associated with loss of cell-cell adhesion.
This study was undertaken to (i) determine if p38MAPK and HSP25, the murine HSP27 homolog,
were similarly phosphorylated in an in vivo model of PV and (ii) investigate the potential ther-
apeutic use of p38MAPK inhibition to block blister formation in an animal model of PV. Phos-
phorylation of p38MAPK and HSP25 were observed in the skin of PV IgG treated mice, con-
firming that the same phosphorylation events we had observed in tissue culture also occurred
in vivo. Furthermore, the PV IgG induced phosphorylation of p38MAPK and HSP25 was blocked
in the skin of mice treated with the p38MAPK inhibitor SB202190 and this inhibition of phos-
phorylation correlated with the inhibition of blister formation. Importantly, the inhibitor did
not prevent systemic absorption of the PV IgG nor did it prevent the binding of PV IgG to the
keratinocyte cell surface, indicating that the biologic effect of the inhibitor was occurring down-
stream of antibody binding to keratinocyte dsg3. Our observations in the PV IgG passive
transfer model demonstrate that p38MAPK inhibitors can prevent skin blistering by inhibiting
PV IgG activated signaling in epidermal cells targeted by PV autoantibodies. Inhibiting
p38MAPK may be a particularly attractive and practical approach for treating this life threat-
ening autoimmune skin disease.
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Characterization of an endemic form of pemphigus vulgaris in Brazil
AG Ortega-Loayza,1 R Rocha-Alvarez,2 I Campbell,2 H Friedman,2 V Aoki,3 E Rivitti,3 N Li1
and LA Diaz1 1 Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC,
2 Dermatology, University of Brasilia, Brasilia, Brazil and 3 Dermatology, University of Sao
Paulo, Sao Paulo, Brazil
Pemphigus is a group of idiopathic cutaneous blistering diseases characterized by autoanti-
bodies directed against desmogleins(Dsg). In pemphigus vulgaris(PV),the autoantibodies rec-
ognize Dsg3,while in pemphigus foliaceus(PF) and its endemic form,fogo selvagem(FS),they
bind Dsg1. Autoantibodies against Dsg1 and Dsg3 have been recently detected with rela-
tively high frequency in patients with FS as well as normal individuals living in endemic regions
of Brazil,such as the Limao Verde(LV) reservation,where the prevalence of FS is high. Despite
the presence of anti-Dsg3 antibodies in normal individuals living in LV,there has been no cases
of PV in this human settlement. Our co-investigators in Brazil have described some unique
young patients with clinical and histological features of PV(mucocutaneous type),all living in
endemic regions of FS of the state of Goias and neighboring Brasilia. The purpose of this study
was to characterize the humoral immune response of these patients against Dsg1 and Dsg3
by cold immunoprecipitation(IP) and enzyme-linked immunosorbent assay (ELISA),using the
ectodomain of these molecules produced in the baculovirus expression system. The sera of 8
patients with the presumptive mucocutaneos endemic PV as well as 27 clinically normal rel-
atives of patients with FS who reside in these endemic areas were tested. All 8 patients(100%)
sera bound Dsg3 by IP and 6 of them by ELISA(75%) while 5 sera recognized Dsg1 by IP(62%)
and 4 by ELISA(50%). Anti-Dsg3 autoantibodies were found in 4 of the 27 healthy control sub-
jects by IP and by ELISA(15%) and anti-Dsg1 in 6 individuals by IP(22%) and ELISA(11%).
These findings confirm the presentation of an “endemic variant of PV” in endemic regions of
FS. The occurrence of this form of mucocutaneous PV appears to be extremely rare,but its
occurrence strongly suggest an environmental trigger of this variant of PV.
www.jidonline.org   9
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Dissecting the autoreactive B cell repertoire in pemphigus vulgaris patients
Y Qian,1 SH Clarke2 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel
Hill, Chapel Hill, NC and 2 Microbiology and Immunology, University of North Carolina at
Chapel Hill, Chapel Hill, NC
Pemphigus vulgaris (PV) is a serious blistering disease characterized by an autoantibody response
against desmoglein 3 (Dsg3). This response is likely generated by a limited number of B cell
clones that leads to the production of pathogenic and non-pathogenic anti-Dsg3 autoanti-
bodies. The specificity of the pathogenic anti-Dsg3 autoantibodies would determine the dis-
ease phenotype of PV. The present studies are aimed at disclosing the “variable region gene
usage” by sequence analysis of Dsg3-specific B cell clones from PV. Human-mouse hetero-
hybridomas were generated by fusion of EBV-transformed or freshly isolated peripheral blood
lymphocytes from 5 PV patients with mouse myeloma cells. The ectodomain of recombinant
Dsg3 and Dsg1 were generated in the baculovirus system and used to detect anti-Dsg1 and
anti-Dsg3 antibodies during the screening and cloning of hybridomas. The V genes of both H
and L chain of the Dsg-specific autoantibodies from these hybridomas were sequenced and
analyzed for the H and L chain pairing of the autoantibodies, the diversity of H and L chain
V gene usage, and the extent of somatic mutation. We found a restriction of VH and VL gene
segment usage, as rearranged VH3-23 and VH3-30 genes encode almost half of the H chains
used by the anti-Dsg3 autoantibodies from the patients, while L12 is the most frequently used
VL gene used to encode these autoantibodies. The somatic mutation of these autoantibodies
ranged from unmutated in some, to heavily mutated germline genes in others. Additionally,
we identified clonally-related sets of hybridomas from several individuals based on VH-D-JH
rearrangement identity that reveal ongoing somatic mutation during clonal expansion. Our
results suggest that in PV patients, a limited number of V gene combinations are used to encode
anti-Dsg3 autoantibodies and the response within individuals is oligoclonal. Further analysis
of the monoclonal antibodies shall yield relevant information on the pathogenesis of this
autoimmune disease.
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BDCA1+ dendritic cells are a highly immunogenic myeloid (CD11c+) subset that accumu-
late and mature in psoriasis lesions, and appear to organize T-cells
L Zaba, MA Lowes, J Fuentes-Duculan and JG Krueger Investigational Dermatology,
Rockefeller University, NYC, NY
Recent work has shown that myeloid (CD11c+) dendritic cells (DCs) are greatly increased in
psoriasis lesions. To further characterize myeloid DCs in psoriasis vs. normal controls, we used
6-color flow cytometry (FACS) to study DCs in peripheral blood and skin (dermal émigrés).
FACS markers used to detect three distinct Lin-DR+CD11c+ DC subsets were BDCA1±, BDCA3±
& CD16±. Though normal and psoriatic blood contained all subsets, the BDCA1+ subset was
decreased 2-fold in psoriatic blood compared to normal (p=0.02) and concomitantly increased
in psoriatic lesional tissue. FACS of dermal émigrés showed that many more BDCA1+ cells
were migrating out of psoriatic dermis compared to normal, suggesting BDCA1+ cells in pso-
riatic dermis were increased or had matured into migrating DCs. To distinguish between these
two possibilities we did immunohistochemistry with anti-BDCA1 antibody and double-label
immunoflourescence with BDCA1 and DC-LAMP (a marker of DC maturity). Immunohisto-
chemistry showed a 50% increase of BDCA1+ cells in lesional psoriatic skin, and two-color
immunoflourescence showed a marked increase in BDCA1+DC-LAMP+ cells in psoriatic
skin. Tissue staining also revealed significantly different BDCA1+ cell morphology and local-
ization: Normal skin has small, BDCA1+ cells scattered in the papillary dermis, while psori-
atic skin has large, “dendritic” BDCA1+ cells that infiltrate the epidermis and clump together
with CD3+ cells in the dermis. Finally, to assess function of BDCA1+ DCs we performed a
standard allo-MLR by co-culturing CFDA-SE-labeled T-cells with either BDCA1+, BDCA1-11c+,
or BDCA1-11c- selected cells from psoriatic dermal émigrés. We found that only the BDCA1+
fraction was highly immunostimulatory. From these results, we conclude that BDCA1 is a lin-
eage marker for the dominant myeloid DC subset in psoriatic and normal skin. However, in
psoriasis BDCA1+ DCs become mature and activated, co-localize with T-cells, and may ulti-
mately control autoimmune T-cell activation in psoriasis lesions.
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T cell-monocyte contact bioassay for the identification of small molecule inhibitors that
specifically inhibit T cell-mediated adaptive, but not LPS-mediated innate, immunity
YY Li,1 M Bao,1 J Meurer,2 W Skuballa,3 JG Bauman,4 W Doecke,5 CK Edwards1,6 and
TM Zollner1 1 RBA Dermatology USA, Berlex Biosciences, Richmond, CA, 2 Molecular
Pharmacology, Berlex Biosciences, Richmond, CA, 3 Medicinal Chemistry, Schering AG,
Berlin, Germany, 4 Medicinal Chemistry, Berlex Biosciences, Richmond, CA, 5 CRBA
Inflammation, Schering AG, Berlin, Germany and 6 Dermatology, UCHSC, Aurora, CO
Proinflammatory cytokines such as TNFα are produced in lesional skin of psoriasis patients,
and they play vital roles in maintaining inflammation. It has recently been suggested that acti-
vated T cell contact-mediated monocyte activation leading to the production of proinflam-
matory cytokines, contributes to the pathogenesis of psoriasis and other chronic inflamma-
tory diseases such as psoriatic arthritis and rheumatoid arthritis. Using a T cell
membrane-monocyte contact bioassay, we have identified small molecule antagonists that dif-
ferentially block anti-CD3/anti-CD28 activated T cell mediated, but not LPS stimulated, TNFα
production from monocytes. We selected several kinase inhibitors from the Berlex/Schering
kinase library and tested the effect of these compounds in blocking TNFα production in the T
cell membrane-monocyte contact bioassay. We have demonstrated that one compound BLX-
WS1, a p38 MAP kinase inhibitor, completely inhibited T cell-mediated, without any effect
on LPS stimulated, TNFα production from monocytes. Other BLX-WS1 analogs showed par-
tial inhibition of TNFα production with LPS-stimulation as compared to 100% inhibition of T
cell-mediated TNFα production, whereas PKC inhibitors did not show this differential inhibi-
tion. Therefore, the activated T cell membrane-monocyte contact bioassay can be used to
screen small molecule antagonists that specifically target adaptive but not LPS-mediated innate
immunity. Low molecular weight TNFα inhibitors interfering specifically with T cell mediated
TNFα production, but not with LPS-mediated TNFα production may have a favorable effect/side
effect profile in T cell mediated skin diseases.
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Histamine receptor (HR1, HR2, HR3) profiles in skin lesions of MRL/lpr mice
T Yoshimasu, T Nishide and F Furukawa Wakayama Medical University, Wakayama, Japan
It is supposed that the development of skin lesions of LE is associated with histamine and his-
tamine receptors (HR). Th1 cells express HR1 and induce the production of IFN-γ. On the other
hand, Th2 cells are associated with HR2 and they induce IL-10. Purpose: We determined
cytokine profiles in skin lesions of MRL/lpr(l) mice by RT-PCR method. Furthermore, we assessed
the relationship between the skin lesions and histamine receptors by using immunohisto-
chemical analysis and RT-PCR method. Methods: We sacrificed the MRL/l mice (1 to 5-mo)
and MRL/n mice (5-mo-old). Skin samples were obtained from the upper backs of all exam-
ined mice, and non-lesional skins of MRL/l mice (5-mo-old) with the skin lesions on their upper
backs were also obtained. Results: Skin lesions were clinically seen in MRL/l mice of 5-mo-
old, and they were also confirmed histologically. The skin lesions of MRL/l mice showed TNF-
α and IL-10 but not IFN-γ by RT-RCR method. The expressions of HR1, HR2 and HR3 were
equally seen in hair follicles and around sebaceous glands of all MRL/l mice (1 to 5-mo) and
MRL/n mice by immunohistochemical staining. The expressions of HR1 and HR3 were strongly
seen in the skin of 1-mo-old MRL/l mice by RT-PCR method, however the expressions were
decreased in aged mice of MRL/l, irrespective of presence or absence of skin lesions. The
expression of HR2 was increased in the skin of MRL/l mice at 2-mo compared with those at
1-mo. The expression of HR2 was gradually increased in skin lesions of MRL/l mouse with
age but the expression was decreased in non-lesional skin of MRL/l mouse (5-mo). All expres-
sions of HR1, HR2 and HR3 were decreased in MRL/n mice compared with those of MRL/l
mice. Conclusion: It is suggested that the skin lesions of MRL/l mice are associated with Th2
type immune response which include HR2 expression, not HR1 or HR3 expression.
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Synergistic actions of pemphigus vulgaris (PV) IgG, Fas-ligand (Fas-L) and tumor necrosis fac-
tor-α (TNFα) during induction of basal cell shrinkage and acantholysis
MD Orlov, AI Chernyavsky, J Arredondo and SA Grando Dermatology, University of
California, Davis, CA
This study tested a recently proposed “basal cell shrinkage” hypothesis of pemphigus acan-
tholysis through a quantitative analysis of individual and cooperative effects of PVIgG, Fas-L
and TNFα on keratinocyte volume, size (i.e., spreading) and adhesive properties. The cytoso-
lic volume was quantified by computing the distance between nucleus and cell border, and
cell spreading was measured by computing the distance between nuclei of pairs of adjacent
cells. Exposure of keratinocyte monolayers and organ cultures to the physiologic concentra-
tions of Fas-L, TNFα or IgGs from different PV patients resulted in various degrees of reversible
changes, which were not observed in control cultures either exposed to normal IgG or left
intact. Within 12-24 hrs of exposure, basal cells in experimental cultures lost their ability to
form stress fibers and retracted cytoplasmic aprons, indicating that their cytoskeleton collapsed.
The cell volume and size decreased significantly (p<0.05) as the polygonal cell shape changed
to a round one. The shrunk cells detached from their neighbors and the substrate, resulting in
a reciprocal increase of both the areas of acantholysis and the number of detached keratinocytes,
respectively. Since in the skin of PV patients, keratinocytes are targeted by autoantibodies con-
comitantly with being exposed to autocrine and paracrine pro-apoptotic agents and pro-inflam-
matory cytokines, we combined PV IgGs with Fas-L and/or TNFα in the cell culture experi-
ments. This amplified several fold an ability of PV IgG to cause basal cell shrinkage and
detachment. The obtained results demonstrated for the first time that PV IgG works together
with Fas-L and TNFα to induce acantholysis via basal cell shrinkage, which provides a novel
mechanism explaining successful treatment of PV patients with TNFα inhibitors.
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Two-stage model for induction of autoimmunity: SEB synergizes with interferon-gamma to
induce alopecia areata
A Gilhar,1,2 G Kaufman,1,2 Y Kam,1,2 B Assy,1,2 N Kaplan1,2 and RS Kalish3 1 Skin Research
Laboratory, Rappaport Faculty of Med, Technion-Israel Institute of Technology, Haifa, Israel,
2 Flieman Medical Center, Haifa, Israel and 3 Dermatology, SUNY @ Stony Brook, Stony
Brook, NY
It was hypothesized that induction of T-cell autoimmunity requires two insults, loss of toler-
ance or immune privilege to induce autoreactive T-cells, followed by a stimulus, such as super-
antigen, to expand the autoreactive T-cells. Interferon-gamma (INF-γ) induces hair follicle
expression of MHC class I and II, resulting in loss of immune privilege and induction of alope-
cia areata (AA) in genetically susceptible female C3H/HeJ mice. It was proposed that treat-
ment with Staphylococcal Enterotoxin B (SEB) superantigen would expand autoreactive T-cells
and synergize with INF-γ for induction of AA. C3H/He mice 7 wk old were injected IV with
murine IFN-γ 2 x 104 U (Groups 2 & 3) or PBS (Group 1) for 3 consecutive days, followed by
injections every 7 days. 30 days following the first injection, mice were divided into 3 groups:
Group 1: (PBS alone) received additional PBS injections IV for 2 consecutive days followed
by every 7 days. Group 2: (INF-γ alone) Mice treated 30 days with INF-γ were injected IV with
IFN-γ for two days and followed by every 7 days. Group 3: (INF-γ & SEB) Mice treated 30 days
with INF-γ were injected intraperitoneally with SEB (50 µg) for 2 days followed by injections
with INF-γ every 7 days. Mice were examined for hair loss. Skin was harvested 14 wks after
the first injection for analysis by histology and immunohistochemistry for ICAM-1, and MHC
class I & II. Clinical rates of AA development on back and abdomen of C3H/He male mice
follow. Group 1: PBS alone 7% (1/14), Group 2: INF-γ alone 17% (3/17), Group 3: ING-γ +
SEB 46% (7/15), (p<0.05 for Group 3 vs. Group 1). Female mice did not demonstrate a dif-
ference between INF-γ and (INF-γ + SEB). INF-γ plus SEB was superior to INF-g alone in
inducing AA in a susceptible mouse strain. This supports the hypothesis of a two stage model
for development of autoimmune disease.
10 Journal of Investigative Dermatology (2006), Volume 126
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A novel orf-induced subepidermal immunobullous disease
K White,1 Z Lazarova,2 E Simpson,1 A Cagliarini,2 L Morrison,1 S Kurtz,1 C White,1 W White,3
K Yancey2 and A Blauvelt1 1 Dermatology, Oregon Health & Science University, Portland,
OR, 2 Medical College of Wisconsin, Milwaukee, WI and 3 Wake Forest University, Winston-
Salem, NC
Orf is a parapoxvirus infection that has rarely been associated with erythema multiforme
(EM) or bullous pemphigoid (BP). A 31 y.o. man presented with acute onset of fever, pharyn-
gitis, dyspnea, oral and nasal mucosal erosions, targetoid palmar lesions, and multiple, large,
tense bullae scattered over his scalp, neck, axillae, and groin. One month earlier, the patient
developed a verrucous nodule on the dorsal aspect of his right thumb. Additional history
revealed the patient owned many sheep, some of which had recently developed crusted ero-
sions on their muzzles. Biopsy of the right thumb nodule showed vacuolization of spinous
keratinocytes, some with cytoplasmic viral inclusions. DNA isolated from this tissue contained
orf DNA by PCR. Biopsies of bullae and targetoid lesions showed subepidermal blistering with
neutrophils, basal vacuolization, dyskeratosis, and necrosis. DNA isolated from these tissues
did not contain orf DNA by PCR. Direct immunofluorescence (IF) of perilesional skin showed
strong linear deposition of IgG at the basement membrane; indirect IF showed IgG binding
to the dermal side of salt-split skin. Western blot analyses using patient’s serum and both ker-
atinocyte and dermal extracts did not reveal any known autoantigen. The patient did not have
IgG directed against type VII collagen, BP antigen 1, BP antigen 2, laminin 5, or p200 autoanti-
gen. Another patient with orf-induced subepidermal immunobullous disease has recently been
identified and shown to have circulating IgG reactive with the dermal side of salt-split skin.
In summary, we describe a novel subepidermal immunobullous disease in two patients with
recent orf infection. This disease is clinically and immunologically distinct from EM, BP, epi-
dermolysis bullosa acquisita, anti-epiligrin cicatricial pemphigoid, and p200 pemphigoid. We
postulate that developing immunity against orf virus triggered autoimmunity through molec-
ular mimicry.
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Role of the chymase, mouse mast cell proteinase 4 in experimental bullous pemphigoid
M Zhao,1 W Xu,2 M Abrink,3 W Sui,1 Z Li,1 S Rice,1 L Diaz,1 G Pejler,3 Z Werb4 and Z Liu1
1 University of North Carolina, Chapel Hill, NC, 2 Beijing Friendship Hospital, Beijing, China,
3 Swedish University of Agricultural Sciences, Uppsala, Sweden and 4 University of
California, San Francisco, CA
Bullous pemphigoid (BP) is an autoimmune inflammatory subepidermal blistering disease
associated with autoantibodies against two major hemidesmosomal components, the 230-kD
and BP180. The separation of the epidermis from the dermis occurs within the lamina lucida
of the basement membrane and is accompanied by an extensive inflammatory infiltrate and
destruction of hemidesmosomal and extracellular matrix components. Several proteinases
released from infiltrating inflammatory cells have been detected in BP blister fluids and
lesional/perilesional sites and implicated in BP. Neutrophil elastase (NE) and MMP-9 degrade
the recombinant BP180 and are required for dermal-epidermal separation induced by BP
autoantibodies in a skin culture model. In the IgG passive transfer model of BP, subepidermal
blistering triggered by anti-mouse BP180 IgG (anti-mBP180) also depends on NE and MMP-
9 activities. In this report we determined the role of the chymase, mouse MC proteinases 4
(mMCP-4) and its functional interactions with MMP-9 and plasmin in experimental BP. Mice
deficient in MMP-9 were resistant to experimental BP, while mice deficient in plasminogen
and mMCP-4 showed no clinical BP blisters at 24 h and less intense blister at 48 h post anti-
BP180 IgG injection. Levels of active MMP-9 in the skin of plasminogen- and mMCP-4-defi-
cient mice were significantly reduced as compared to the diseased wild-type mice. These data
suggest that both plasmin and mMCP-4 participate MMP-9 activation. Active MMP-9 then
inactivates α1-proteinase inhibitor and unchecked NE degrades BP180 and other extracellu-
lar matrix components at the dermal-epidermal junction, resulting in BP lesions.
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Desmoglein 1 and 3 IgG auto-antibody titers do not correlate with pemphigus disease activ-
ity in a prospective study
JL Lambert, E Spriet, A Vandewiele and J Naeyaert Dermatology, Ghent University Hospital,
Gent, Belgium
Pemphigus is an auto-immune disease with blistering of skin and mucosa. Immunopatho-
genically, acantholysis of keratinocytes is caused by circulating antibodies against desmoglein
1 (dsg1) and desmoglein 3 (dsg3), transmembrane adhesion molecules of the desmosome.
Former studies suggested a correlation of clinical activity and dsg 1 and dsg 3 auto-antibody
titers. However, all these studies were conducted in a retrospective manner, and contained
small numbers of patients. In order to see whether dsg 1 and dsg 3 auto-antibody measure-
ment can be used as a theranostic (therapeutic and diagnostic) test, we followed 11 patients
(with informed consent) with two major phenotypes of the disease, pemhigus vulgaris and
pemphigus foliaceus in a prospective set up during 24 months. They were seen monthly, or
every two weeks when active lesions. A new score for disease activity was designed : sum
(number of blisters x size) + 10 if Nikolsky I present ; + 30 if Nikolsky I and II present. Size of
a blister was scored from 1 to 3 (skin : 1 = smaller than 4 mm ; 2 = 4-15 mm ; 3 = larger than
15 mm ; mucosa : 1 = smaller than 5mm ; 2 = 5-15 mm ; 3 = larger than 15 mm). Serum sam-
ples were collected at every time point to perform a dsg 1 and dsg 3 ELISA. A correlation
between disease activity and dsg antibody titer could not be observed. Explanations other than
methodological ones could be that other auto-antigens might be involved, or that the com-
mercially available and widely used dsg 1 and 3 ELISA test is not specific enough.
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Activation of p38 MAPK is required for experimental bullous pemphigoid
Z Li, M Zhao, D Rubenstein, L Diaz and Z Liu University of North Carolina, Chapel Hill, NC
Bullous Pemphigoid (BP) is an autoimmune skin disease characterized by separation of epi-
dermis from dermis and infiltration of inflammatory cells. BP autoantibodies recognize two
hemidesmosomal antigens, the BP230 and BP180. Previous studies using IgG passive trans-
fer mouse model demonstrated that subepidermal blistering is triggered by anti-BP180 anti-
bodies and depends on complement, mast cells (MCs) and neutrophils. Binding of anti-BP180
IgG to its target activates the classical pathway of complement system to generate C5a which
in turn activates MCs. However, the nature of the signaling events involved in this disease
process is unknown. p38 mitogen-activated protein kinase (MAPK) is tightly associated with
inflammation and stress stimulation. In this study, we tested whether p38 MAPK plays a role
in experimental BP. Wild-type mice injected intradermally with pathogenic anti-mBP180 IgG
exhibited subepidermal blistering with a significant increase in phosphorylation of p38 MAPK.
In contrast, pretreatment with p38 MAPK inhibitor, SB203580, completely blocked phospho-
rylation of p38 MAPK and subsequent blistering in anti-mBP180 IgG-injected mice. Cultured
mouse MCs treated with recombinant C5a (rC5a) showed significant increase of p38 phos-
phorylation. Local reconstitution of rC5a induced phosphorylation of p38 MAPK in wild-type,
but not MC-deficient mice. However, anti-mBP180 IgG also induced phosphorylation of p38
MAPK in MC-deficient mice. Thus, pathogenic anti-mBP180 antibodies induce phosphoryla-
tion of p38 MAPK in both MC-dependent and MC-independent fashions. This differs from the
pemphigus vulgaris IgG passive transfer model, in which anti-desmoglein 3 antibodies acti-
vate phosphorylation of p38 MAPK within keratinocyte target. Our data suggest that p38 MAPK
is an important signaling pathway in multiple cell lineages in experimental BP and represent
a new therapeutic target for BP.
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Efalizumab causes marked increases in the percentages of circulating T cells expressing
cutaneous lymphocyte antigen (CLA) in patients with atopic dermatitis
E Harper,1 M Boyd,2 T Bakke,3 E Simpson1 and A Blauvelt1 1 Dermatology, OHSU, Portland,
OR, 2 Cancer Institute, OHSU, Portland, OR and 3 Pathology, OHSU, Portland, OR
Efalizumab is a mAb directed against CD11a, a molecule involved in T cell activation and T
cell extravasation from blood into tissue. As part of a pilot study to determine the mechanism
of efalizumab action, 10 patients with severe atopic dermatitis were treated with efalizumab
for 84 wks. PBMC were isolated from patients at wks 0, 28, 56, and 84 and analyzed by 8-
color flow cytometry for expression of activation and adhesion markers. As expected, efal-
izumab treatment led to marked decreases in CD11a mean fluorescent intensity (MFI) on naive
(CD45RA+CD27+CD62L+), central memory (CD45RA-CD27+CD62L+), and effector mem-
ory (CD45RA- CD27-CD62L-) CD4+ T cell subsets (mean at wk 0 vs. wk 84 = 973 vs. 524,
1447 vs. 592, 1674 vs. 655, respectively); similar decreases in CD11a MFI were observed in
all CD8+ T cell subsets. MFI for CD18, a protein that binds to CD11a, was decreased in both
CD4+ and CD8+ T cells. The percentages of CLA+ cells were markedly increased in all three
CD4+ T cells subsets (mean at wk 0 vs. wk 84 = 6.7% vs. 42.4%, 28.6% vs. 55.2%, 34.2%
vs. 59.6%, respectively); similar increases in the percentages of CLA+ cells were observed in
all CD8+ T cell subsets. We also observed increases in the percentages of CD4+ and CD8+ T
cells expressing β7 and CD49d, two antigens used to identify gut-homing T cells. Lastly, efal-
izumab treatment led to decreases in the percentages of 1 day-cultured activated CD4+ and
CD8+ T cells that produced IFN-γ (mean at wk 0 vs. wk 84 = 5.4% vs. 2.0% and 9.4% vs.
4.4%, respectively); no significant changes in IL-4 production were observed. In summary,
efalizumab treatment of atopic dermatitis patients leads to: 1) marked elevations in the per-
centages of T cells expressing classic tissue homing markers (CLA, β7, CD49d) and 2) mod-
est decreases in IFN-γ production by T cells. These data suggest that blockade of T cell extrava-
sation into tissue is the major pathway by which efalizumab leads to improvement in cutaneous
inflammation.
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Modulation of immune markers by a dissociated vitamin D analog
E May, W Doecke, K Asadullah and U Zuegel CRBA Inflammation, Schering AG, Berlin,
Germany
The study assessed (i) the immunomodulatory potential of a novel 1,25-Dihydroxyvitamin D3
analog (ZK 203278) and (ii) the identification of biomarkers for ZK 203278-mediated effects
for subsequent clinical studies. A broad selection of markers was evaluated in vitro using
human PBMCs and ex vivo accompanying a toxicity study in minipigs. In human PBMC, CD25,
CD69, CD154, HLA-DR, and CD28 was analyzed on CD4+ and CD8+ T cells. Monocytes
were screened for CD4, CD14, CD11b, CD54, HLA-DR, CD40, CD80, and CD86 expression.
IFN-gamma, IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-alpha was analyzed using a
bead-based multiplex system after in vitro stimulation with PHA or LPS. Biomarkers were eval-
uated ex vivo from minipigs treated with ZK 203278 at 1, 5 or 20 µg/kg/d for 4 weeks. CD4+
and CD8+ T cells were analyzed regarding activation markers (SLA-DR, SLA-DQ, CD25),
CD45RA, proliferation, and cytokine production (IL-2, IFN-gamma, IL-10). Monocytes were
monitored on CD4, SLA-DR, -DQ and CD14, and on secretion of TNF-alpha. In human PBMCs,
ZK 203278 inhibited monocytic CD4, HLA-DR, CD40, and CD54, whereas CD14 was strongly
increased. Limited effects have been observed on surface markers of T cells. However, secre-
tion of IFN-gamma, IL-2, and TNF-alpha was decreased. A 4-wk-treatment of minipigs resulted
in marginal modulation of the selected markers. After LPS-stimulation CD14 and SLA-DQ
expression was enhanced on monocytes in the high dose groups relative to the vehicle group,
whereas expression of monocytic CD4 was reduced. In conclusion, profound immunomod-
ulatory effects, similar to those of calcitriol have been observed with ZK 203278, most impres-
sively on monocytes. In vitro data and animal experiments showed that ZK 203278 is a cal-
citriol-derivative with considerable immunomodulatory capacities at non-hypercalcemic
dosages and might therefore suit for the systemic treatment of immune diseases in man.
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In vivo documentation of cutaneous inflammation
G Stamatas and N Kollias R&D, Johnson & Johnson, Skillman, NJ
Skin inflammation is often accompanied by edema and erythema. While erythema is the result
of capillary dilation and local increase of oxygenated hemoglobin (oxy-Hb) concentration,
edema is characterized by an increase in extracellular fluid in the dermis leading to local tis-
sue swelling. Edema and erythema are typically graded visually. In this work we tested the
potential of spectral imaging as a non-invasive method for quantitative documentation of
both the erythema and the edema reactions. As examples of dermatological conditions that
exhibit skin inflammation we imaged patients suffering from acne, herpes zoster, and poison
ivy rashes using a hyperspectral-imaging camera. Spectral images were acquired in the visi-
ble and near infrared part of the spectrum, where oxy-Hb and water demonstrate absorption
bands. The values of apparent concentrations of oxy-Hb and water were calculated based on
an algorithm that takes into account spectral contributions of deoxy-hemoglobin, melanin,
and scattering. In each case examined concentration maps of oxy-Hb and water can be con-
structed that represent quantitative visualizations of the intensity and extent of erythema and
edema correspondingly. In summary, we demonstrate that spectral imaging can be used in
dermatology to quantitatively document parameters relating to skin inflammation. Applica-
tions may include monitoring of disease progression as well as efficacy of treatments.
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The intervention of immune adjuvants on the pathogenesis of pemphigus vulgaris antigen
EC1-2 epitope
M Pan, W Li, H Jiang, Y Wang and J Zheng Dermatology, Rui Jin Hospital, Shanghai, China
To study if the antibody subtypes against EC1-2 are related to the pathogenesis of pemphigus
vulgaris antigen (PVA) by using different immune adjuvants. PVA EC1-2 fusion protein, emusi-
fied with complete Freund’s adjuvant (CFA) or Aluminum Hydroxide hydrate [Al(OH)3], was
used to immunize C57BL/6 mouse. After immunization, mice were bled every week. The titers
and isotypes of the specific antibody were checked with ELISA. The related cytokines, includ-
ing Th1-type cytokine IFNγ and Th2-type IL-4, were measured by FACS technology. At day 56
after immunization, mice were sacrificed. Indirect immune-fluorescence (IIF) was performed
and the fragments of skin from normal neonatal mouse were cultured in vitro with the corre-
sponding antisera to study whether the antibody subtypes were specifically binding to their
antigens. It was found that IFNγ expression was elevated in CFA group, while IL-4 was increased
in Al(OH)3 group, more significant changes after boosting. Specific antibodies were detected
in both groups. Interestingly, Th1-dependent IgG2a subtype was significant higher in CFA
group, but Th2-dependent IgG1 subtype antibody was only detected in Al(OH)3 group. For
IIF, weak fluorescence deposit between the epithelial cells was observed by using the antis-
era from CFA group. In contrast, very bright fluorescence deposition was shown from Al(OH)3
group. Furthermore, after cultured with the corresponding sera from these two groups, the skin
specimens were processed for routine histologic study. The intraepithelial blister was seen in
Al(OH)3 group, while only mild acantholysis was observed in CFA group. We concluded that
different antibody subtypes may contribute to the pathogenesis of PVA through EC1-2 antigen
epitope with different immune adjuvants.
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Profiling heat-induced pro-inflammatory cytokine expression in primary keratinocytes
CN Young, A Schrieber, M Abraham, LB Savoy and B Aufiero Dermatology, Wayne State
University, Detroit, MI
Vigorous military exercise and sports in a hot and humid environment can result in exertional
heatstroke (ExHS). This syndrome is characterized by marked hyperthermia
(core body temperature is above 40°C), severe neurologic abnormalities, and varying degrees
of organ dysfunction. However, it is also known that ExHS exerts multiple effects on human
skin tissues, one of which is associated with high levels of circulating pro-inflammatory
cytokines, anti-inflammatory cytokines, and chemokines which promote systemic inflamma-
tory response as well as immunosuppression. Keratinocytes, the predominant cell type found
in the epidermis and an important part of the immune system, produce a variety of cytokines
under many stressful stimuli, including micro-pathogens, UV and ExHS. The role of cytokines
in ExHS in primary human keratinocytes has not been clearly defined. In this study, we deter-
mined cytokine mRNA expression by real-time reverse transcription polymerase chain reac-
tion (real-time RT-PCR) following cellular exposure to heat at 42 degrees for 2 hours. Our
results revealed that TNF-α, IL-1β, IL-6, IL-8, and IFN-gamma increased significantly follow-
ing 2 hour heat treatments at 42 degrees. The results of this study demonstrate elevated levels
of proinflammatory cytokines and chemokines in ExHS-induced human primary keratinocytes.
These cytokines and chemokines may play an important role in the pathogenesis of certain
skin diseases induced by ExHS.
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Anti-psoriasis action of basic esters of fatty alcohols in human skin graft SCID mouse system
A Gilhar,1,2 Y Kam,1,2 G Kaufman,1,2 B Assy,1,2 M Landau,3 RS Kalish4 and IR Cohen5 1 Skin
Research Laboratory, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology,
Haifa, Israel, 2 Flieman Medical Center, Haifa, Israel, 3 Dermatology Unit, Wolfson Medical
Center, Tel Aviv, Israel, 4 Dermatology, SUNY @ Stony Brook, Stony Brook, NY and 5
Weizmann Institute of Science, Rehovot, Israel
Basic esters of long chain fatty alcohols were found to be active in a DTH model. Two such
agents, piperazin-1-yl-acetic acid octadec-(Z)-9-enyl ester bitartrate (TV-3809, Teva) and
aminophenylacetic acid octadec-(Z)-9-enyl ester HCL (TV-3813, Teva) were tested for their
ability to treat psoriasis in the human skin graft / SCID mouse transfer system. Skin grafts
obtained from normal skin (non-psoriasis) were grafted onto beige-SCID mice. 4 mice were
grafted from each donor to generate 4 groups (N=6 mice). IL-2 activated NK-cells from pso-
riasis donors were injected into the grafts 4 weeks later. Two wks later the grafts were treated
daily for 14 days by topical application of test compounds to the grafts in 40µl of PBS. Test
compounds were coded and the investigators were blinded. Group 1: non-treated control,
Group 2: Dexamethasone (50mg/ml) positive control, Group 3: Test compound 0.5mg, Group
4: Test test compound 4mg. After 14 days of topical treatment grafts were harvested and ana-
lyzed by histology and immunohistochemistry. TV-3813 had the greatest activity with signifi-
cant reductions in epidermal thickness (771 vs. 1204) and proliferation index (8.8 vs. 24.9) at
0.5mg per application (p<0.05). Application of 4mg of TV-3813 demonstrated a dose response
with further reduction of thickness (527), and proliferation index (7.8) (p<0.01 vs. untreated).
TV-3809 demonstrated reduced potency with significant reductions in thickness and prolifer-
ation index only at the 4mg dose (p<0.05). Histology demonstrated resolution of psoriasiform
features which was often complete at the higher doses. Thus, basic esters of long chain fatty
alcohols represent a promising new class of immune-modulating drug with activity against
psoriasis in the human / SCID model.
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Autoimmunity against type VII collagen in SKH1 mice is independent of regulatory T cells
L Chen,1 J Peterson,1 S Lin,1 M Faloyin,1 W Zheng1 and L Chan1,2 1 Dermatology, UIC,
Chicago, IL, 2 Microbiol/ Immunol, UIC, Chicago, IL and 3 Med Service, Jesse Brown VA Med
Center, Chicago, IL
Epidermolisis bullosa acquisita is a blister disease characterized by circulating and skin basement
membrane-bound IgG autoantibodies to type VII collagen, a major structure protein of the der-
mal-epidermal junction. Regulatory T cells (CD4+CD25+, Treg) suppress self antigen-mediated
autoimmune responses and inflammatory diseases, and inhibit the function of CD4+CD25-
effector T cells. Thus elimination of Treg may enhance the probability of autoimmune response.
To invistigate the role of Treg in the the autoimmune response to type VII collagen in a mouse
model system, we utilized a rat monoclonal antibody with proven in vivo CD25+ cell-depleting
function, and an isotype rat IgG control. A recombinant mouse type VII collagen NC1 domain
protein, proved to be a true mouse basement membrane protein by an antibody raised in rat, and
mouse serum albumin control, were used as antigens. SKH1 mice, a hairless strain mice with
intact immune system were used as a testing host. Group 1 mice received NC1 immunization
and were depleted of CD25+ cells, group 2 mice received NC1 immunization and rat isotype
control, and group 3 mice received albumin immunization and were depleted of CD25+ cells.
Anti-NC1 IgG autoantibodies with high titers as determined by ELISA (ranging from 1:1,000 to
1:32,000) and Western blotting developed in all mice immunized with NC1 (groups 1 & 2), but
were undetected in group 3 mice. The predominant subclasses of anti-NC1 autoantibodies are
IgG1, IgG2a and IgG2b and these antibodies mainly carry the kappa light chain. Direct immuno-
fluorescence microscopy detected IgG deposition in basement membrane of the NC1-immunized
mice but not in the albumin-immunized mice. Our data suggests that the development of autoim-
munity against type VII collagen in mice is independent of Treg, that the autoimmune response is
mediated by both Th1 and Th2 cells, and that there is predominant kappa light chain usage. The
basement membrane deposition of IgG may eventually lead to blister development.
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Interleukin-32 in the pathogenesis of chronic plaque psoriasis
L Hu,1 EM Callaway,1 JE Fitzpatrick,1 M Fujita,1 T Miyatake,2 L Li,1 KR Shroyer,2 TK Azam,3
S Kim,3 CA Dinarello,3 DA Norris1 and CK Edwards1,3 1 Dermatology, UCHSC at Fitzsimons,
Aurora, CO, 2 Pathology, UCHSC at Fitzsimons, Aurora, CO and 3 Infectious Diseases,
UCHSC, Denver, CO
Psoriasis (CPPs) is characterized by hyperproliferation of keratinocytes and the activation of
autoreactive T-cells (Tc) and dendritic cells (DCs). TNFα and IL-1β are instrumental in lesional
inflammation. IL-32, which induces TNFα, triggers NFκB and p38 MAPK pathways, has pre-
viously been shown to be involved in the early stages of inflammation. Our study investigates
the role of IL-32 in pathogenesis of CPPs by immunohistochemistry (IHC). Biopsy tissues
were obtained from CPPs with active disease (N=3) and subacute spongiotic dermatitis patients
(N=3), as well as healthy human controls (N=3). Colon tissue was used as the positive con-
trol (N=3). A mouse Mab against human IL-32α and mouse IgG1 isotype antibody were used.
Histochemical localization of IL-32 was performed on deparaffinized sections of formalin-
fixed archival tissues by an indirect imunoperoxidase method (EnVision, Dako). IL-32 stain
intensity was scored subjectively on a scale of 0 to 4+. IL-32 was strongly expressed (4+) in
differentiated colon epithelial cells. In CPPs, IL-32 was highly expressed (3+/4+) in basal ker-
atinocytes, and in DCs, with strong nuclear and cytoplasm staining (3+). In subacute spongi-
otic dermatitis, expression of IL-32 was faintly positive (1+). Healthy human skin tissue was
negative for IL-32. These data support the hypothesis that IL-32 is involved in the pathogene-
sis of CPPs, especially in cellular regions of the skin where innate immune mechanisms are
central to host defense.
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Role of TCISMs in the pathogenesis of chronic plaque psoriasis
L Li,1 E Callaway,1 L Hu,1 M Fujita,1 DA Norris1 and CK Edwards1,2 1 Dermatology, UCHSC
at Fitzsimons, Aurora, CO and 2 Infect. Dis., UCHSC, Denver, CO
Chronic plaque psoriasis (CPPs) is an inflammatory disease characterized by hyperprolifera-
tion of keratinocytes, infiltration of activated T-cells (Tc) Mφ, DC, LC, and PMN in the lesional
skin. Inflammatory cell-cell contact occurs in skin lesions leading us to postulate that con-
tact-mediated signaling of Mφ by memory CD45RO+ Tc drives the up-regulation of TNFα/IL-
1β, in-turn driving the pathogenesis of CPP. We show that
CD4+CD45RO+CLA+CCR4+CCR10+ CPPs Tc express membrane-bound molecules which
we refer to as Tc Cytokine Inducing Surface Molecules or “TCISMs”, and they appear to be
instrumental in driving cell-cell contact leading to TNFα/IL1β. A novel human Tc membrane
~40,000 Kd TCISML on αCD3/αCD28 activated CD4+ Tc and CPPs Tc was identified. To test
for TCISML cytokine-inducing activity, CD3+ Tc from healthy donors (N=6) or CPPs patients
(N=6), were tested for TCISML using Tc-Mφ co-culture. After 24h, supernatants were collected
for ELISA. CPPs CD3+ T cells significantly (p<0.05) activated freshly obtained blood mono-
cytes to produce TNFα and IL-1β in comparison to healthy human CD3+ Tc controls. Use of
highly specific, neutralizing αCD40L, αLIGHT, αLFA-1, α4-1BB, αOX-40L, or αTACE mAb’s
did not block TCISML activity in our highly-validated bioassay system. Similar data was observed
using CD4+CD45RO+CLA+ CCR4+CCR10+ CPPs Tc. Transmembrane microarray (PIQOR)
has allowed us to extensively identify and confirm the putative TCISML activity. Our data also
suggest that highly purified Tc membrane preparations contain TCISML. In summary, we
have identified a novel receptor-ligand pair(s) controlling Tc contact-dependent activation of
CPPs cytokine expression. Blocking the production of these cytokines at a more distal level
may lead to new, safer therapeutic approaches to specifically inhibit proinflammatory cytokines
in CPPs.
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Human in vivo demonstration of interferon β initiation of dermatomyositis
A Somani, AR Swick, P Karnik, R Sandhu-Johal, TS McCormick and KD Cooper
Dermatology, University Hospitals and Case Western Reserve University, Cleve., OH
The etiopathogenesis of dermatomyositis (DM) is poorly understood. Recent microarray pro-
filing reveals overexpression of type I interferon genes (IFNs) (α/β) in the disease process. There
is a single report of IFN-β inducing SLE and a few cases of IFN-β-induced subacute cuta-
neous lupus; however, we are unaware of published reports of IFN-β inducing or exacerbat-
ing DM. Type I IFN-induced genes such as myxovirus (influenza virus) resistance 1 (MxA)
and IFN alpha-inducible protein (G1P2), are upregulated in both conditions suggesting IFN
signaling. We report a patient with multiple sclerosis (MS) who developed cutaneous stig-
mata of DM with severe proximal myopathy and dysphagia while receiving IFN-β. Further-
more, reinstitution of IFN-β therapy resulted in severe clinical exacerbation. Examination of
cutaneous IFN signaling, assessed by immunofloresence staining for MxA, revealed a strongly
positive epidermal staining pattern at 2 days post IFN-β treatment of our DM patient. In con-
trast, MxA staining was markedly diminished (comparable to the minimal staining of normal
skin) at 18 days post IFN-β treatment. We next performed in vitro studies examining the effect
of IFN-β treatment on peripheral blood mononuclear cells (PBMCs) obtained from our patient
and normal controls. PBMC samples were rested overnight then incubated +/- IFN-β (100 I.U.)
for 24h, and separated into adherent and non-adherent populations for RNA extraction. Rel-
ative expression of MxA and G1P2 genes were determined using real-time PCR. Whereas nor-
mal IFN-β-induced MxA was 121 + 24, DM induced MxA to 354 + 42 (2.9 fold increase). A
similar hypersensitivity to IFN-β was seen in DM for G1P2 (N= 539 + 198; DM= 2001 + 221)
(3.7 fold increase). This difference in gene expression between the normals and the DM patient
was only observed in the non-adherent (lymphoid) cell population. Taken together, our find-
ings strongly implicate IFN-β in exacerbating dermatomyositis and suggest that the disease
process may be attributable to a heightened responsiveness of lymphoid cells to type I IFNs.
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In vivo capillary ultrafiltration sampling for dynamic proteomic analysis of interstitial microen-
vironment in allergic contact hypersensitivity
C Wang,1,2 A Patel,3 S Barnes2,5 and CA Elmets1,4 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL, 2 Pharmacology & Toxicology, UAB, Birmingham, AL, 3
Forensic Science, UAB, Birmingham, AL, 4 Skin Diseases Research Center, UAB, Birmingham,
AL and 5 Proteomics-Mass Spectrometry Shared Facility, UAB, Birmingham, AL
We have developed a novel technique using capillary ultrafiltration (CUF) to continuously mon-
itor the interstitial microenvironment of the skin to obtain information regarding the changes that
occur among secreted proteins during the development of allergic contact hypersensitivity in
mice. The technique consists of implanting a semi-permeable membrane into the skin to extract
fluids surrounding the target tissue cells without collecting cells themselves. Fluid can be obtained
from animals that are alive and freely-moving, thus enabling a continuous sampling of intersti-
tial fluid proteins during different physiological or disease stages that can then be subjected to
proteomic analysis. This technique was employed to investigate the proteins secreted into the skin
during elicitation of allergic contact hypersensitivity to DNFB in C3H/HeN mice. CUF probes
were implanted in the ears of mice one day before ear challenge. Multiple interstitial samples
were collected before and over a 3-day period after DNFB challenge from each freely-moving
mouse. Analysis of the samples by SDS-PAGE revealed changes in the protein profiles after ear
challenge compared to that obtained before the ears were challenged with DNFB. Greater reso-
lution of profiling protein changes in the tissue fluid was obtained by subjecting the samples to
2D gel electrophoresis. These studies indicate the utility of CUF as a method for in vivo delin-
eation of the protein changes that occur in allergic contact hypersensitivity and potentially other
cutaneous diseases. With the protein identification capability of current mass spectrometry tech-
niques, the outcome of the interstitial microenvironment proteome may provide more detail or
alternative information for understanding of develop of allergic contact hypersensitivity.
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Identification of two distinct CD8+ T cell populations associated with remittent disease in
pemphigus vulgaris
E Lee,2 S Chow,1 R Dionisio,2 D Nguyen,2 K Seiffert,1 JS Manavalan3 and AA Sinha1 1 Division
of Dermatology and Cutaneous Sciences, Michigan State University, East Lansing, MI, 2
Dermatology, Weill Medical College of Cornell University, New York, NY and 3 Pathology,
Columbia University, New York, NY
The cyclical nature of exacerbations and remissions in human autoimmune disease is poorly
understood. The interplay between effector and regulatory T cell populations may be critical
in determining the balance between disease activity and remission. We and others have demon-
strated that autoantibody production in active Pemphigus vulgaris is promoted by DSG3-spe-
cific T cells with a Th2 cytokine profile. The immune mechanisms and T cell phenotypes
involved in disease remission, however, are not well understood. Using a cell surface matrix
technology to enrich for rare activated cytokine-secreting cells, we show a DSG3-specific
upregulation of CD8+ and CD8- IFN-γ secreting T cells in newly remittent disease, indicating
a shift towards a Th1 phenotype. In order to further examine the T cell subtypes operational
in remittent disease, we subsequently analyzed the surface phenotype of disease-associated
CD8+ T cells by flow cytometry. We now demonstrate the existence of two previously uniden-
tified CD8+ subsets in PV. One is an antigen-specific IFN-γ secreting CD8+perforin+ cell type
that is selectively elevated in newly remittent patients. The other is a non-antigen specific CD8+
population expressing the forkhead/winged helix transcription factor FoxP3 that is elevated in
remittent patients regardless of remission length. Our data highlight a principal role for CD8+
T cells in remittent PV. These findings indicate that even after the establishment of the autoim-
mune state, there is an ongoing intrinsic struggle for dominance between different T cell sub-
types that may ultimately determine disease expression.
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Infliximab attenuates inflammatory cytokine expression induced by LPS-treated primary
human keratinocytes
A Schrieber, CN Young and LB Savoy Dermatology, Wayne State University School of
Medicine, Detroit, MI
Keratinocytes, the predominant cell type found in the epidermis, are an important part of the
immune system and produce a variety of cytokines under stressful stimuli such as micro-
pathogens and UV irradiation. Cytokines are intercellular messengers that play an important
role in the pathogenesis of many skin diseases. In inflamed skin, keratinocytes and immune
cells both produce large amounts of tumour necrosis factor (TNF)-alpha, a cytokine with broad
inflammatory effects. Blockade of this proinflammatory cytokine by a monoclonal anti-TNF-
alpha antibody has been effectively used in the treatment of inflammatory skin diseases. TNF-
blocking agents such as etanercept and infliximab are promising biological therapies in the
treatment of psoriasis and psoriatic arthritis because TNF is considered to be essential in driv-
ing the cytokine cascade at sites of cutaneous and synovial inflammation in these diseases.
However, the exact mechanism by which this blockade occurs has not been fully understood.
In order to add to such knowledge, we investigated the effect of anti-TNF therapy on the expres-
sion of other inflammatory cytokines and chemokines induced by lipopolysaccharide (LPS)-
treated human primary keratinocytes. In this study, we determined cytokine mRNA expres-
sion by real-time reverse transcription polymerase chain reaction (real-time RT-PCR) following
cellular exposure to LPS with or without infliximab for six hours. Our results revealed that
mRNA expression of TNF-α, IL-1β, IL-6, IL-8, IL-12, IL-18 and IFN-gamma increased signifi-
cantly following 6 hour LPS treatments. Additional treatment with infliximab significantly and
selectively attenuated mRNA expression of TNF-α, IL6, IL8, and IL12 induced by LPS treated
human primary keratinocytes. This study has shown that infliximab might play an important
regulatory role in signal transduction and attenuating cascade production of some key cytokines
driven by TNF-alpha, which may explain the efficacy of infliximab in treating inflammatory
skin disorders.
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Anti-inflammatory activity of parthenolide-free extracts of feverfew (tanacetum parthenium)
F Liebel, P Lyte, M Garay, L Jumbelic, C Saliou, S Shapiro, K Martin and M Southall J&J
CPPW, Skillman, NJ
Irritated skin is among the most common cutaneous disorders impacting skin appearance and
physiology. We sought to identify safe and effective botanical extracts that deliver benefits for
irritated skin. A Parthenolide-Free Extract (PFE) of Feverfew (Feverfew PFE) was evaluated for
anti-inflammatory activity. Feverfew PFE was found to directly inhibit numerous enzymes that
are involved in cutaneous inflammatory responses such as, Phosphodiesterase-3, Phosphodi-
esterase-4, Protein kinase Ci, non-receptor tyrosine kinase Syk, Glycogen Synthase Kinase-3
and reduce formation of pro-inflammatory lipid mediators via inhibition of the enzyme, 5-
Lipooxygenase.  Feverfew PFE inhibited LPS-stimulated cytokine release from activated
macrophages and was effective in reducing release of pro-inflammatory cytokines from acti-
vated human T-cells. Topical treatment with Feverfew PFE was found to significantly mitigate
inflammation in murine models of irritant contact dermatitis and contact hypersensitivity, and
decrease the subsequent release of TNFa from inflamed tissue. Feverfew PFE was found to both
reduce the stimulated release of chemotactic factors from human epidermal equivalents, and
the chemotaxis of human neutrophils induced by fMLP or IL-8. A cream containing a Partheno-
lide-Free Extract (PFE) of Feverfew was prepared and used to determine the protective prop-
erties of Feverfew PFE against irritated skin in a placebo controlled clinical trial. Topical appli-
cation of a cream containing Feverfew PFE was found to significantly reduce erythema induced
by the vasodilator, Methyl nicotinate, or by neurogenic-induced inflammation of the volar fore-
arm. Furthermore, Feverfew PFE was found to be effective in reducing erythema in both pre-
vention and treatment models of skin irritation. These results demonstrate that Parthenolide-
Free Extract of Feverfew is a novel non-steroidal natural extract with benefits to reduce numerous
inflammatory pathways associated with irritated skin.
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Parthenolide-free extracts of feverfew (tanacetum parthenium) protects skin against UV irra-
diation and external aggression
P Lyte, N Tierney, F Liebel, M Garay, C Saliou, S Shapiro, K Martin and M Southall Johnson
& Johnson, Skillman, NJ
In response to the continuous challenge from environmental-induced oxidative stress, the skin
depends on antioxidant defenses. As the supply of cutaneous antioxidants decreases both with
age and with exposure to environmental stressors, replenishing the skin with antioxidants can
protect against external and inflammation-induced aging. To meet this need a Parthenolide-
free Feverfew Extract (Feverfew PFE), from which the skin sensitizer parthenolide had been
removed, was prepared and used to determine the protective properties of Feverfew PFE against
oxidative stress in the skin. The antioxidant activity of Feverfew PFE was demonstrated against
free radical and superoxide anions. In normal human fibroblasts exposed to cigarette smoke
extract, Feverfew PFE was found to prevent the loss of cellular anti-oxidants. In normal human
keratinocytes exposed to solar-simulated UV light in vitro, Feverfew PFE was found to reduce
the UV-induced reactive oxygen species production and the release of pro-inflammatory medi-
ators and matrix degrading proteins that could mediate the UV-induced inflammatory responses
of the skin. Treatment of hairless mice with Feverfew PFE exposed to chronic low dose UVB
was found to substantially reduce the UV-induced epidermal hyperplasia. The daily use of
formulations containing Feverfew PFE on UV exposed skin was also evaluated in a clinical
trial on Fitzpatrick skin phototypes II and III. Subjects were pre-treated daily with test formu-
lations, followed by exposure to UV-B irradiation. Clinical expert grading and instrumental
analysis demonstrated a significant inhibition of erythema with a Feverfew PFE lotion as com-
pared to placebo as soon as 24 hours and 48 hours post UV exposure. Taken together, a
parthenolide-free Feverfew extract delivers photo-protective and anti-oxidant properties that
can help to replenish epidermal anti-oxidants and protect the skin against aggression-induced
aging. These activities contribute to combat and reverse the deleterious effects of the envi-
ronment in skin aging.
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Effects of lipooxygenase inhibitors on SZ95 sebocyte proliferation
J Mc Carthy, D Collins, K Goldgraben, E Pelle and T Mammone Estee Lauder, Melville, NY
The use of lipooxygenase inhibitors has been observed to reduce sebum production. Zouboulis
et al 2005 has observed reduced sebum synthesis in patients treated orally with the 5-lipoxy-
genase (LO) inhibitor zileuton. Cultured SZ95 sebocytes have been observed to express 5-LO
and 15-LO by Alestas T et al, 2006. A possible mechanism by which this occurs is by reduc-
ing the expression of peroxisome proliferator-activated receptor gamma (PPARg). Inhibition
of LO may reduce the expression of leukotrienes which are signals to PPARg expression. PPARg
is known to be lipogenic in adipocytes and may function the same way in sebocytes. PPAR
ligands have been observed to inhibit lipogenesis in human chest sebaceous glands (Downie
MM et al, 2004). Our lab has observed nordihydroguaiaretic acid (NDGA) and thymoquinone
to be strong inhibitors of 5-LO. With this evidence, we assayed the anti-proliferative effect of
lipooxygenase inhibitors on SZ95 sebocytes. SZ95 sebocytes (purchased from Zouboulis,
Dessau, Germany) were cultured in 96-well plates and treated overnight with NDGA (Sigma),
a preferential lipooxygenase inhibitor or thymoquinone (Sigma), a known inhibitor of 5-LO.
NDGA was observed to significantly reduce sebocyte proliferation by 57% and 82% at con-
centrations of 10 and 100 µM in one experiment and by 70%, and 93% at the same concen-
trations in another. Thymoquinone reduced proliferation of sebocytes by 23%, 48%, and 75%
at 3, 15, and 30 µM. Use of lipooxygenase inhibitors may reduce sebum production by reduc-
ing the expression of PPARg in sebocytes in the sebaceous gland. In addition, the prolifera-
tion of sebocytes may be reduced by the application of LO inhibitors.
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Fas ligand elicits a pro-inflammatory response in human keratinocytes
S Farley,1 A Dotson,1 A Sundholm,1 P Schneider,2 B Magun1 and M Iordanov1 1 Cell &
Developmental Biology, Oregon Health & Science University, Portland, OR and 2
Biochemistry, University of Lausanne, Epalinges, Switzerland
In dermatitis, Fas ligand (FasL) causes apoptotic death of epidermal keratinocytes. Excessive
keratinocyte death during acute dermatitis contributes to the appearance of skin barrier-dis-
ruptive spongiotic lesions in eczematous epidermis. We demonstrate here that FasL can also
potentially aggravate inflammation by triggering the expression of pro-inflammatory cytokines,
chemokines, and adhesion molecules in keratinocytes. Gene expression in FasL-treated HaCaT
cells was investigated by Affymetrix microarray analysis and validated using real-time reverse
transcriptase-polymerase chain reaction (RT PCR). Before the detectable onset of apoptosis,
FasL triggered the mRNA accumulation of stress-responsive transcription factors [c-Fos, c-Jun,
ATF3, and Egr1], inflammatory cytokines [tumor necrosis factor-alpha (TNF-alpha), interleukin
6 (IL-6), and IL-1beta, chemokines [CCL2/MCP-1, CXCL1/GROalpha, CXCL3/GROgamma,
and CXCL8/IL-8 (but not CCL5/RANTES)], and the adhesion molecule ICAM-1. Oligomeriza-
tion of Fas was required both for apoptosis and for gene expression. Inhibition of caspase activ-
ity abolished FasL-dependent apoptosis; however, it failed to suppress the expression of FasL-
induced genes. Additionally, in the presence of caspase inhibitors, but not in their absence,
FasL triggered the accumulation CCL5/RANTES mRNA. Our findings identify a novel pro-
inflammatory role of FasL in keratinocytes that is independent of caspase activity and is sep-
arable from apoptosis. Thus, in addition to causing spongiosis, FasL may play a direct role in
triggering and/or sustaining inflammation in eczemas.
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Global gene expression analysis of psoriasis reveals differences between normal and unin-
volved skin
JE Gudjonsson,1 J Ding,2 R Nair,1 G Abecasis,2 JJ Voorhees1 and JT Elder1 1 Department of
Dermatology, University of Michigan, Ann Arbor, MI and 2 Department of Biostatistics and
Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
Psoriasis is a T-cell mediated chronic inflammatory and hyperproliferative skin disease believed
to be autoimmune in nature. To better understand the complex nature of processes involved
in psoriasis we undertook a comprehensive analysis of gene expression in normal and psori-
atic skin, comparing lesional and nonlesional psoriatic skin to normal skin from non-psoriatic
subjects using Affymetrix Human U133 Plus 2.0 arrays. 20 patients with psoriasis and 20 nor-
mal subjects were recruited into the study. Hierarchical clustering and principal component
analysis (PCA) clearly distinguished the lesional psoriatic skin from the nonlesional psoriatic
and normal skin. When PCA was limited to the uninvolved and normal samples, these sam-
ples separated into two groups with only 5 / 40 misclassified samples (4 normal, 1 uninvolved),
indicative of global differences in gene expression between normal and uninvolved psoriatic
skin. Using the criterion of twofold upregulation, we identified 829 upregulated transcripts in
lesional versus uninvolved, 957 upregulated transcripts in involved versus normal, and 24
upregulated transcripts in uninvolved versus normal skin. Comparison of our data with pre-
viously published gene array studies (Physiol Genomics 13:69-78, 2003) showed > 94%
overlap among the 50 most highly expressed genes in involved vs. nonlesional or normal skin,
with our study identifying several novel transcripts not represented on prior arrays. However,
only 1 of 19 overexpressed transcripts overlapped between uninvolved and normal skin
(S100A7, psoriasin). Ours is the largest study of global gene expression in psoriasis to date
and may facilitate the discovery of key regulatory pathways governing the differential expres-
sion of genes in psoriasis. Furthermore, our data suggests that uninvolved psoriatic skin dif-
fers importantly from normal skin but the basis of this difference awaits further investigation.
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Decreased HLA-G expression in sera from patients with Behçet’s disease
E Lee,1 S In,1 J Heo,1 J Choi,2 K Park2 and D Bang3 1 Dermatology, Ajou University School of
Medicine, Suwon, South Korea, 2 Biology, Sungshin Women’s University, Seoul, South Korea
and 3 Dermatology, Yonsei University College of Medicine, Seoul, South Korea
HLA-G is a nonclassical MHC class I molecule, which regulates immune responses as it
binds different receptors expressed on natural killer (NK) cells, T cells and myeloid cells.
Recently, HLA-G is became increasingly recognized as an important regulator of inflamma-
tory responses and immune functions. HLA-G is not merely expressed in peripheral tissues
during pathological processes such as viral infections, malignancies, and organ plantation,
but also expressed in chronic and cutaneous inflammatory diseases, including psoriasis, and
atopic dermatitis. Previous report showed that HLA-G 1597*delC, 3741_3754*ins14 and hap-
lotypes containing these variants were associated with an increased risk for BD. To elucidate
an influence of polymorphism on HLA-G expression in sera and tissues of patients, we per-
formed RT-PCR analysis, ELISA, and immunohistochemical stain for HLA-G. The mRNAs of
52 Behçet’s disease patients 30 healthy individuals were used for RT-PCR. ELISA was performed
for 60 Behçet’s disease patients and 60 healthy individuals. Immunohistochemical stain was
performed with 8 Behçet’s disease patients, 1 psoriasis patient, and 2 Kaposi’s sarcoma patients.
Serum level of HLA-G was decreased in Behçet’s disease compared to the normal control.
There was a difference in HLA-G concentration between the sera of Behçet disease patients
and normal control. But, we could not find any significant difference at mRNA level accord-
ing to the genetic polymorphism.
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Epidermal transglutaminase deposits in skin of patients with dermatitis herpetiformis
MR Danaldson,1 JJ Zone,1,2 LA Schmidt,1,2 SL Neuhausen,3 CM Hull1,2 and LJ Meyer2,1 1
Dermatology, University of Utah, Salt Lake City, UT, 2 Veterans Affairs Medical Center, Salt
Lake City, UT and 3 University of California at Irvine, Irvine, CA
It has been reported that transglutaminase 3 (TG3) codeposits with IgA in the dermal papillae
of DH patients and is the potential autoantigen of DH. Using a new goat anti-human TG3 anti-
body, we evaluated deposition of TG3 in DH patients. Nine DH patients with active lesions
underwent biopsy of uninvolved and perilesional, non-erythematous skin. Specimens were
analyzed for IgA and TG3 by direct immunofluorescence (DIF). Patients’ sera were assayed
for IgA endomysial antibody (EMA), IgA anti-tissue transglutaminase (TG2), and IgA anti-TG3
ELISA. Granular IgA and TG3 were detected at the dermal-epidermal junction by DIF in unin-
volved and perilesional skin of DH patients. IgA DIF was more intense than TG3 in 72% of
specimens while all specimens showed fewer TG3 granules. Perilesional IgA deposits were
more intense than uninvolved in 5/9 patients and equivalent in the remaining four. When strat-
ified by adherence to gluten-free diet, mean IgA and TG3 DIF were greater for poor (2.12 +/-
0.835, 1.38 +/- 0.518) than strict (1.60 +/- 0.835, 0.900 +/- 0.568). There was strong correla-
tion between anti-TG3 and anti-TG2 antibody ELISA and adherence to GFD. However, seroneg-
ative patients on a strict GFD still had TG3 and IgA deposits. We confirm the codeposition of
TG3 and IgA at the dermal-epidermal junction of DH patients using a new antibody. We also
demonstrate TG3 deposits in uninvolved skin, indicating that factors beyond the presence of
IgA and TG3 are necessary for active lesions. Intensity of IgA deposits by DIF was greater than
TG3, but levels correlated. Although the mechanism of deposition is not clear, IgA deposits
pathognomonic for DH appear to be directed at TG3.
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Plant extracts exhibit both anti-inflammatory and antioxidant properties in normal human
keratinocytes
MD Hines, D Gan, L Mangos and BC Jones Skin Care Research, Mary Kay Inc., Dallas, TX
Studies have linked the use of antioxidants with reductions in the response to inflammatory
stimulation. In this study, we have sought to examine whether extracts derived from natural
materials have the ability to reduce the expression of inflammatory cytokines and act as antiox-
idants. To determine whether the plant extracts reduced cellular peroxides, we examined the
uptake of the peroxide-specific dye, 2’,7’-dichlorofluorescein diacetate by normal human ker-
atinocytes upon addition of varying concentrations of plant extract. Following modification
by cellular peroxides, this dye exhibits an intense green fluorescence when excited by laser
light. Hydrogen peroxide was added exogenously to quickly increase in the peroxide-spe-
cific fluorescence of the cell. We found ten plant extracts which were able to significantly
reduce the level of extracellular peroxide levels 35-89% compared to untreated controls. Three
of the ten materials were able to reduce intracellular peroxide levels (60-98%) without exoge-
nous the addition of peroxide. The ten extracts exhibiting antioxidant capabilities were also
tested for the ability to reduce the expression of pro-inflammatory cytokines in keratinocytes.
The pro-inflammatory cascade was induced by addition of phorbol myrstyl acetate for 6 hours.
The amount of soluble inflammatory cytokines was quantified. We found that 5 of the natu-
ral extracts that showed positive reduction in cellular peroxide significant decreases in IL-1b
(22-48%) compared to control cultures. Nine materials showed decreases in 1L-2, IL-6 and
TNF-a. Of the ten plant-derived extracts which were able to decrease cellular peroxide, only
one material was unable to reduce expression of pro-inflammatory cytokines. These data pro-
vide additional support for plant-derived anti-oxidants in reducing skin inflammation.
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Microarray analysis of gene expression in basal cell carcinomas
M Yu,1 D Zloty,1 L Warshawski,1 B Cowan,1 N Carr,2 J Shapiro,1 BK Lo1 and KJ McElwee1 1
Dermatology, University of British Columbia, Vancouver, BC, Canada and 2 Plastic Surgery,
University of British Columbia, Vancouver, BC, Canada
Basal cell carcinoma (BCC) is the most common form of human cancer. Though the aberrant
signaling role of the Hedgehog pathway is understood, little is known about the downstream
genetic mechanisms underlying basal cell carcinomas. BCC subtype has been based on clin-
ical and histology patterns, but remains inexact. The characterization of molecular events
would improve our understanding of carcinogenesis and classification.
To identify differentially expressed genes in different morphological types of BCC as com-
pared to normal skin epithelium. To search for genes associated with tumorigenesis promo-
tion and to define products significant in BCC survival and growth. Microarray analysis, using
an expanded sequence verified set of Human Genome 21K cDNA glass array, was performed
on tissues obtained from previously untreated patients undergoing surgical resection (6 super-
ficial, 6 nodular, 6 morphea form, 7 normal skin). The significantly differentially expressed
genes were identified using analysis of microarray results in various data sets. Selected genes
were validated using real-time PCR analysis using an expanded set of 27 BCC samples. The
global gene expression profiles in different BCC subtypes and normal skin were distinguish-
able by unpaired T test and one –way ANOVA-analyses. 88 genes were at least 5 fold differ-
entially expressed between BCC (all morphological types) and normal skin (p < 0.01). Many
of these differentially expressed genes were involved in Hedgehog, the cell cycle, apoptosis,
angiogenesis, calcium signaling and other signal transduction regulatory pathways. Other cat-
egories of genes showing statistics differential expression between different subtypes were
associated with cytoskeleton, extracellular matrix, and cell metabolism pathway. Our find-
ings may have important implications for understanding the pathogenesis of BCC.
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Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resist-
ance of A431 squamous cell carcinoma
M Wu1 and K Chow2 1 Dermatolgy, China Medical University, Taichung, N/A, Taiwan and 2
Institute of Biomedical Science, National Chung-Hsing University, Taichung, Taiwan
Dihydrodiol dehydrogenase (DDH) is a member of the aldo-keto reductases superfamily which
may be involved in normal detoxification process of environmental mutagenic hazards like
polycyclic aromatic hydrocarbons (PAH). Previous clinical studies have demonstrated the
over-expression of DDH in various types of cancers, including cutaneous squamous cell car-
cinoma (SCC), and its correlation with tumor progression and grave prognosis. To investigate
possible mechanisms for DDH’s correlation with tumor progression and unfavorable prog-
nosis, DDH expression in SCC A431 cell line was examined by quantitative realtime PCR
and immunoblotting. RNA interference (RNAi) by transduction with retroviral vector con-
taining DDH-targeting small interfering RNA was employed to inhibit DDH expression by
A431 cells. With DDH expression inhibited or not, sensitivity of A431 cells to UVB-induced
apoptosis and cytotoxicity of chemotherapeutic agent bleomycin were then examined and
compared. DDH was found highly expressed by SCC A431 cells, which was barely detectable
in other normal or malignant cutaneous cells, including keratinocytes, fibroblast, and basal
cell carcinoma cell line. RNAi Inhibition of DDH expression in A431 cells led to increased
sensitivity to UVB-induced apoptosis and cytotoxicity of bleomycin treatment. Thus, DDH
may play important roles in tumor progression of SCC via induction of apoptosis- and drug-
resistance.
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Enhanced colloid osmotic pressure reduces tumor interstitial fluid pressure and facilitates
the uptake of macromolecules in a xenograft tumor model
M Hofmann,1,2 M Guschel,1 GS Salvesen,2 A Raa,3 A Bernd,1 J Bereiter-Hahn,4 R Kaufmann,1
H Wiig2 and S Kippenberger1 1 Dept. of Dermatology and Venerology, Medical School of the
JW Goethe University, Frankfurt/Main, Germany, 2 Dept. of Biomedicine, Section of
Physiology, University of Bergen, Bergen, Norway, 3 Dept. of Biomedicine, Section of
Anatomy and Cell Biology, University of Bergen, Bergen, Norway and 4 Kinematic Cell
Research Group, JW Goethe University, Frankfurt/Main, Germany
High tumor interstitial fluid pressure (TIFP) is a characteristic of most solid tumors. Clinically,
TIFP is described as a physical parameter that hampers the uptake of anti-tumor drugs into
tumor tissue and thus lack of therapeutic effects. In the present study the impact of an increased
colloid osmotic pressure (COP) on TIFP was investigated. COP was increased by i.v. injection
of human serum albumin (HSA). Furthermore, the intratumoral distribution of macromolecules
in control and COP increased animals was shown by i.v. injection of fluorescent-coupled dex-
trans. A431 squamous epidermoid vulva carcinoma cells were s.c. implanted into parts of the
back of anesthetized nude mice or nude rats. TIFP was measured three times per week directly
in the central region of solid tumors using the wick-in-needle technique to measure TIFP.
COP was enhanced via injection of hyperosmotic HSA solutions i.v.. During HSA injection
the micropuncture method was used to measure TIFP in peripheral parts of the tumors. In our
experimental set-up we could demonstrate that the increase of COP reduces the TIFP signifi-
cantly. At different time-points after the HSA injection fluorescent-dextrans were i.v. applied.
The distribution of dextrans in tumor tissue with reduced TIFP in contrast to untreated control
tumors was investigated using fluorescence microscopy of cryosectioned tumor tissue. These
data demonstrate for the first time that an increased COP can lower TIFP. Furthermore, our
studies suggest that reduced TIFP can augment the delivery of macromolecules to tumor tis-
sue. Therefore, lowering of TIFP could enhance the efficacy and efficiency of anti-tumor ther-
apies utilising chemotherapeutics.
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Naked hepatocyte growth factor(HGF) plasmid DNA prevents the symptoms of dermal scle-
rosis in a mouse model of scleroderma
M Wu, S Takagawa, T Satoh, K Nishioka and H Yokozeki Dermatology, Tokyo Medical and
Dental University, Tokyo, Japan
Systemic sclerosis (SSc) is a disease of characterized by fibrosis of skin(scleroderma) and
internal organs, vascular abnormalities, and the presence of autoantibodies. Recently, we have
reported that injection of human HGF-HVJ plasmid liposomes can prevent and ameliorate
not only the symptoms of dermal sclerosis but also lung fibrosis, by using bleomycin (BML)
induced scleroderma model mouse, however, there are also important safety issues regarding
viral vectors, the main one being the possibility of provoking a severe immune and inflam-
matory response. Then, we performed transfections of human naked HGF plasmid DNA with-
out any vector and examined this treatment in the preventing of the dermal sclerosis induced
by BLM. Skin tissue and lung from mice injected with naked HGF and or BLM were harvested
and samples prepared for RT-PCR, ELISA to reveal both mRNA and protein of human HGF,
murine HGF, and mouse TGF-beta 1 and collagen content in skin tissue. 100-250 mg/ml naked
HGF plasmid DNA transfections prevented the symptoms of dermal sclerosis induced by a
subcutaneous BLM injection but not lung fibrosis. These results indicated that gene therapy
by the transfection of the naked human HGF plasmid DNA may thus be a useful therapy for
SSc. These data indicated that naked HGF plasmid therapy appears to be a potentially useful
treatment for scleroderma involved with SSc in the future.
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Identification of Slit2 as a tumor suppressor gene
H Kim, H Li, C Elmets, X Xu and H Xu Dermatology, University of Alabama, Birmingham, AL
Slit genes are a family of extracellular glycoproteins that function as chemorepellents in axon
guidance and neuronal cell migration. The activity of Slits is mediated by membrane recep-
tors roundabout (ROBO) molecules. Slit proteins are expressed by normal endothelial and
epithelial cells in many tissues. Recent studies indicate that Slit2 transcription is inactivated
in lung, breast, colorectal and glioma tumors, suggesting that Slits may have tumor suppres-
sive activities. However, it remains to be determined whether Slits suppress tumor develop-
ment and metastasis. To examine the effect of Slit on tumors, Slit2 gene was transfected into
human fibrosarcoma cell line, HT1080, which originally did not express Slit2. Stable trans-
fectants that produce Slit2 were established. The forced expression of Slit2 suppressed the for-
mation of tumor colonies in soft agar cultures compared to parental tumor cells and controls
transfected with an empty vector. In vitro matrigel invasion assay showed that the overex-
pression of Slit2 inhibited tumor cell invasion compared to controls. The growth of Slit2 trans-
fected tumors was reduced in nude mice. Moreover, the metastasis of HT1080 tumor cells in
lungs following intravenous inoculation was suppressed by Slit2 transfection. Collectively, our
studies have demonstrated that Slit2 is a tumor suppressor gene that plays a role in tumor devel-
opment and metastasis. Further studies are required to define mechanisms for Slit2 mediated
tumor suppression and may lead to new therapeutic strategies for tumors.
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Interleukin-12-deficient mice are at greater risk for the development of UV radiation-induced
skin cancers
SM Meeran,1 SK Mantena,1 CA Elmets1,2 and SK Katiyar1,2 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL and 2 Birmingham VA Medical Center,
Birmingham, AL
The treatment of interleukin (IL)-12 reverses UV-induced immune suppression in mice and
possesses anti-tumor activity. To examine the role of IL-12 in photocarcinogenesis, we gener-
ated IL-12 knockout (KO) mice on a C3H/HeN background and subjected them to a photo-
carcinogenesis protocol. Mice were exposed to UV (180mJ/cm2) radiation three times a week
for 35 weeks. The development of UV-induced tumors was more rapid and the tumor inci-
dence and tumor multiplicity was higher in IL-12 KO mice (p<0.05-0.001) than in WT mice.
Moreover, the rate of malignant transformation of UV-induced papillomas to carcinomas was
higher in IL-12 KO mice in terms of carcinoma incidence (55%, p<0.001) and carcinoma mul-
tiplicity (77%, p<0.001). As IL-12 has been shown to have DNA repair ability, we determined
whether the susceptibility towards UV carcinogenesis in IL-12 KO mice is due to deficiency
in repair of UV-induced DNA damage. For this purpose, mice were exposed to UVB (60 mJ/cm2)
and sacrificed immediately or 24 h later. Skin samples were obtained and subjected to immuno-
histochemical detection of CPD+ cells. The percentage of CPD+ cells present in the epider-
mis immediately after UVB exposure was identical in both IL-12 KO and WT mice however
the number of CPD+ cells 24 h after UV exposure was reduced or repaired rapidly in WT mice
than in IL-12 KO mice. Similar results were obtained when epidermal genomic DNA from
each treatment group was analyzed using dot-blot analysis. Our study indicates that IL-12-
deficiency enhances the susceptibility of mice to UV-induced tumorigenesis and malignant
progression of papillomas to carcinomas in mice, and this susceptibility in IL-12 KO mice
may be due, at least in part, to the absence of DNA repair. Further, this study raises the pos-
sibility that in vivo stimulation or exogenous administration of IL-12 or IL-12 therapy may prove
to be beneficial in the prevention of solar UV radiation-induced skin cancers.
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Involvement of matrix metalloproteinase 13 (MMP-13) in stromal-cell-derived factor-1α
(SDF-1α)-induced invasion of human basal cell carcinoma cells
C Chu,1,2 S Jee,1,3 S Cha,2 C Chang2 and M Kuo2 1 Department of Dermatology, National
Taiwan University Hospital, Taipei, Taiwan, 2 Institute of Toxicology, College of Medicine,
National Taiwan University, Taipei, Taiwan and 3 Department of Dermatology, College of
Medicine, National Taiwan University, Taipei, Taiwan
SDF-1α (CXCL12) and its receptor CXCR4 were found to be involved in proliferation, angio-
genesis and metastasis of cancer cells. The aim of this study is to elucidate the mechanism of
locally deep invasion in human basal cell carcinoma (BCC). In this study, we demonstrated a
human BCC cell line had significant expression of CXCR4 mRNA and protein but not SDF-
1α expression. Moreover, we found the invasive histological subtypes of BCCs had frequent
high expression of CXCR4 protein (grade 2-3) as compared to those of non-invasive types
(72.73% vs. 38.71%, P<0.05). The rate of high CXCR4 protein expression among the 19 recur-
rent tumors from 390 BCCs diagnosed during the past 12 years was 89.47%. The in vitro stud-
ies revealed that SDF-1α can induce invasion of BCC cells and up-regulation of MMP-13
mRNA and protein expressions, as well as enhanced MMP-13 enzyme activity. CXCR4 over-
expressed transfectant (BCC/CXCR4) exhibited enhanced SDF-1α-mediated chemo-invasion
comparing to vector control (BCC/pcDNA3). Treatment of BCC cells with the CXCR4 chemi-
cal inhibitor AMD3100, a CXCR4 neutralizing antibody, or CXCR4-specific small interfer-
ence RNA (siRNA) significantly abolished the SDF-1α-induced MMP-13 expression and cell
invasion. Moreover, treatments of MMP-13 inhibitor CL82198 and inhibition of MMP-13
expression by MMP-13-specific siRNA both inhibited the SDF-1α-induced BCC cell invasion
in vitro. Mouse tumorigenicity assay also revealed BCC/CXCR4 cells had greater size of tumors
and more invasive histological types as compared to BCC/pcDNA3 cells. Taken together, our
results suggest that the paracrine effects of SDF-1α from the BCC microenvironment may inter-
play with CXCR4 expressed by BCC and play an important role in regulating invasive potency
of human BCC cells and its function is mediated through up-regulation of MMP-13 gene expres-
sion.
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Protective effect of E- and P-selectin on DMBA cutaneous carcinogenesis
N Yusuf,1 A Iqbal,1 MD Seibert1 and CA Elmets1 1 Dermatology, UAB, Birmingham, AL, 2
Dermatology, UAB, Birmingham, AL, 3 Dermatology, UAB, Birmingham, AL and 4
Dermatology, UAB, Birmingham, AL
The glycoprotein adhesion molecules, E- and P-selectin, play a critical role in cutaneous
immune and inflammatory responses by controlling the migration of leukocytes into and out
of the skin. Although it is known that these molecules contribute to the growth and metasta-
sis of cutaneous tumors, there is little information on their role in the development of cuta-
neous malignancies. To investigate this issue, E- and P-selectin KO mice were examined for
tumor development when subjected to a DMBA initiation/TPA promotion cutaneous car-
cinogenesis protocol. Tumorigenesis, in terms of total number of tumors, tumors/mouse, per-
centage of mice with tumors and tumors/tumor-bearing mice was significantly greater in the
E-selectin KO mice than in wildtype (WT) mice (p<0.001). P-selectin KO mice were also
more susceptible to tumor development than WT mice, although not as great as in E-selectin
KO mice. These results suggest that E- and P-selectin have a protective role in the develop-
ment of DMBA-induced skin carcinogenesis. Approaches that augment their expression may
help to prevent the development of chemically-induced tumors within the skin.
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Mitotic checkpoint induction by the PKCδ catalytic fragment in normal human keratinocytes
and HaCaT cells
LA Sitailo,2 E LaGory3,2 and MF Denning2,1 1 Pathology, Loyola University Chicago,
Maywood, IL, 2 Oncology Institute, Loyola University Chicago, Maywood, IL and 3 Molecular
and Cellular Biochemistry, Loyola University Chicago, Maywood, IL
Tumor suppressor genes are frequently involved in triggering apoptosis, but can also inhibit
cell cycle progression by triggering DNA damage checkpoints. Protein kinase C (PKC) δ is a
candidate tumor suppressor gene for UV-induced squamous cell carcinoma (SCC) since it is
involved in UV-induced apoptosis, is lost in human SCCs, and suppresses tumor formation
when re-expressed in human SCC lines. In our studies examining apoptosis induced by the
PKCδ catalytic fragment (PKCδ-cat), we observed a PKCδ-cat-induced G2/M cell cycle arrest
in both normal human keratinocytes (KCs) and HaCaT cells, which harbor mutant p53. More-
over, expression of PKCδ-cat induced the accumulation of polyploid cells with >4N DNA con-
tent in HaCaT cells. Expression of a PKCδ-cat ATP binding mutant (K378A) did not induce the
G2/M arrest or polyploidy, demonstrating that kinase activity was required. Since polyploidy
can result from cells re-entering the cell cycle after prolonged mitotic arrest without cytoki-
nesis or aberrant mitosis, we examined several molecular markers of mitosis in HaCaT cells
and normal KCs. In both cell types, PKCδ-cat induced serine 10 phosphorylation of histone
H3 (phospho-H3) in cells with G2/M DNA content, indicating an arrest in mitosis independ-
ent of p53 status. Surprisingly, PKCδ-cat also induced phospho-H3 in normal KCs with G1
DNA content and intact nuclear lamin B. Phospho-H3 in interphase cells has been linked to
activation of gene transcription. Phospho-H3 in interphase HaCaT cells was not induced by
PKCδ-cat, suggesting that wild type p53 may be required. These results indicate that PKCδ acti-
vation is able to trigger the mitotic checkpoint in cells with wild type and mutant p53. This
activity may be especially important for limiting the proliferation of cells, such as those found
in actinic keratoses, that harbor mutant p53 as these cells have a defective G1 checkpoint and
may be relatively resistant to apoptosis.
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Tumor suppressor activity of TAp73α in mouse squamous cell carcinoma
JL Johnson, J Lagowski, A Sundberg, S Lawson, Y Liu and M Kulesz-Martin Dermatology,
Oregon Health & Science University, Portland, OR
The tumor suppressive role of newly discovered p53 family members (p63 and p73) remains
controversial. Both p63 and p73 are expressed as multiple protein isoforms, making it diffi-
cult to ascertain which isoforms promote or prevent carcinogenesis. We investigated p53
family functions in genetically related mouse keratinocytes: precancerous 03C, 03C si-p73
(siRNA knock-down of all p73 isoforms in precancerous cells), and malignant 03R (which pro-
duce squamous cell carcinoma - SCC - in mice). Spontaneous conversion of precursor 03C
cells to malignant 03R cells corresponded with a reduction of p63 protein expression and
loss of p73 proteins while wild type p53 was retained. Like the 03R cells, the 03C si-p73 cells
produced SCC in vivo while the 03C control cells produced no tumors. Further, the DNA bind-
ing capabilities of p63 but not p53 were altered after p73 knock-down in the 03C si-p73 cells
as determined by the DNA Affinity Immunoblotting assay. Specifically, we observed reduced
DNA binding of gamma p63 isoforms (both TA and ∆N) in the absence of p73. To determine
which p73 isoforms were important for tumor suppression of SCC, we stably reintroduced
either TAp73α or ∆Np73α into the 03C si-p73 cells followed by injection into mouse neonates.
While 03C si-p73 cells reconstituted with ∆Np73α or control plasmid produced tumors within
four weeks, mice injected with TAp73α-reconstituted cells were tumor free up to nine weeks
post injection (p-value of 0.0351 for time to first appearance of tumor). This suggests that
TAp73α plays a significant tumor suppressive role in SCC. Insight regarding p53 family mem-
bers’ roles in tumor suppression in epithelial cancer could suggest new therapeutic approaches
to human solid tumors of epithelia.
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Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cuta-
neous T-cell lymphoma (CTCL)
A Witkiewicz,2 P Raghunath,1 A Wasik,3 J Junkins-Hopkins,1 D Jones4 and MA Wasik1 1
Pathology, University of Pennsylvania, Philadelphia, PA, 2 Pathology, Thomas Jefferson
University, Philadelphia, PA, 3 Dermatology, Wroclaw Medical Academy, Wroclaw, Poland
and 4 Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX
Localized CTCL skin lesions coprise distinct, often progressive stages patch, plaque, and tumor.
We (Q. Zhang et al. 2000 and 2005) have demonstrated that CTCL-derived malignant T-cell
lines display loss of a tumor suppressor SHP-1 tyrosine phosphatase due to epigenetic silenc-
ing of the SHP-1 gene. The silencing is induced in such CTCL cells by an activated, phos-
phorylated (p-)-STAT3 transcription factor in cooperation with DNA methyltransferase 1
(DNMT1) and histone decetylase 1 (HDAC1), two key members of the epigenetic gene silenc-
ing machinery. To determine the expression pattern of SHP-1, p-STAT3, and DNMT1 at the
various stages of CTCL, we examined by immunohistochemistry formalin-fixed skin biopsies
from 33 patients with histologically proven CTCL. Six of the patients were biopsied before
and after CTCL progression at the patch or plaque and tumor stage, respectively. The remain-
ing 27 specimens comprised of 7 patch, 14 plaque, and 5 tumor stage lesions. In 5 of the 6
patients with progressive disease, we identified loss of SHP-1 expression in the atypical cells
at the tumor stage; 3 of these patients displayed SHP-1 loss in occasional cells at an earlier
stage. The SHP-1 loss was also noted in of 5/5 tumor, 10/14 plaque and only 1/7 patch stage
MF. Expression of p-STAT3 and, to the lesser degree, DNMT1 could be identified in essen-
tially all cases examined. Based on these findings we postulate that expression of p-STAT3
and DNMT1 occurs at the early, patch stage in CTCL and their expression alone seems insuf-
ficient to induce loss of SHP-1 expression. In turn, SHP-1 loss correlates with, and may con-
tribute to, progression of CTCL.
16 Journal of Investigative Dermatology (2006), Volume 126
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Non-denatured soy extracts inhibit UVB-induced skin damage via multiple mechanisms
N Chen, CB Lin, R Scarpa, L Zhang, D Busler, M Kizoulis and M Seiberg The Johnson &
Johnson Skin Research Center, CPPW, A Division of Johnson & Johnson Consumer
Companies, Inc., Skillman, NJ
Sunlight-induced skin damage ranges from erythema and peeling to skin cancer. UV irradia-
tion causes DNA damage, inflammation, and cell death. These events contribute to the devel-
opment of basal and squamous cell carcinomas, the most common type of skin cancer in Cau-
casian population. Earlier data demonstrated that topical treatment with non-denatured soy
extracts slows or delays the progression and development of already-initiated skin tumors,
reduces UVB-induced DNA damage in swine, and eliminates erythema and skin peeling in
humans. Here we show that non-denatured soy extracts are effective in preventing or reduc-
ing UVB-induced damage via multiple mechanisms. In keratinocytes, non-denatured soy
extracts enhanced UVB-induced Checkpoint kinase-1 activation, which is required to delay
cell cycle progression in response to double-strand DNA breaks. The soy extracts also reduced
UVB-induced COX-2 mRNA and protein levels, and PGE2 secretion. Topical treatment of mice
with the Soy extracts prior to UVB irradiation led to a significant reduction in COX-2 mRNA
levels relative to UVB alone, suggesting an anti-inflammatory activity. In addition, these extracts
inhibited VEGF expression in fibroblasts and endothelial tube formation in Matrigel, provid-
ing evidence for possible inhibitory effect on angiogenesis. In summary, non-denatured Soy
extracts could prevent UVB-induced skin damage via multiple mechanisms, including inhi-
bition of inflammation and activation of cell cycle checkpoints. These extracts might also slow
the progression of already initiated skin tumors by affecting angiogenesis. These data suggest
that topical application of non-denatured soy extracts could reduce the risk of skin tumor for-
mation and progression.
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A novel three-dimensional organ construct to study squamous cell carcinoma of the skin in
vitro
DH Obrigkeit,1 FK Jugert,1 HF Merk,1 J Frank2 and F Abuzahra1 1 Department of
Dermatology, University Clinic of the RWTH Aachen, Aachen, Germany and 2 Departmet of
Dermatology, University of Maastricht, Maastricht, Netherlands
Squamous cell carcinoma (SCC) of the skin is a malignant neoplasm that occurs in all ethnic
groups primarily as a result of chronic sun exposure. It constitutes a major health problem
worldwide and its incidence is increasing. There is currently no reliable human system for
the in vitro study of the dynamics of SCC tumor growth and for assessing the efficacy of inno-
vative therapeutic strategies. For this reason we have developed and characterized a novel
three-dimensional human SCC construct with which to assess tumor growth and to evaluate
the mechanism of action of a modified form of photodynamic therapy (PDT) for treating this
type of malignant neoplasm. SCC cells were seeded onto the surface of a three-dimensional
skin equivalent. Tumor growth and invasion was studied histologically and by immunohisto-
chemistry using different markers. After generation of a SCC-like construct in vitro, the ther-
apeutic effects of a modified form of PDT using δ-aminolevulinic acid followed by exposure
a light source with emission at 630 nm were studied. Within five days a SCC-like lesion
developed in vitro. Immunhistochemical characterization revealed loss of epidermal and
dermal differentiation, an increased proliferation rate and, within tumor areas, the expression
of markers specific for cutaneous SCC. Furthermore, typical signs resembling tumor invasion
were observed, e.g. the destruction of the basement membrane. Utilizing a modified form of
PDT revealed tumor regression with apoptosis and necrosis within five days. In this study, we
demonstrated a fully functional three-dimensional SCC-like construct of human skin closely
resembling human SCC in vivo. We further demonstrated suitablity for the study of tumor
development and dynamics in vitro. Using a modified form of PDT, we were able to demon-
strate the utility and possibilities of our construct as a potential screening system for the
development of new treatment strategies for this common type of epidermal neoplasm.
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Dual degradation signals control Gli1 protein stability and basal cell carcinoma formation
E Huntzicker,1 I Estay,1 H Zhen,1 L Lokteva,1 P Jackson2 and AE Oro1 1 Program in Epithelial
Biology, Stanford University, Stanford, CA and 2 Pathology, Stanford University School of
Medicine, Stanford, CA
Gli proteins mediate the transcriptional effects of the Sonic hedgehog (Shh) pathway, which
is implicated in up to 25% of human tumors including Basal cell carcinomas (BCCs). Studies
in mice show that ectopic Shh target gene induction by the transcription factors Gli1 or Gli2
is sufficient to induce BCCs. However, there is a wide variability in the onset and severity of
tumor phenotypes amongst patients with mutations in the Shh pathway, and an unexplained
wide variability of tumor onset in animal models.  Here we demonstrate that Gli1 and Gli2
are degraded by the proteasome and impairment of this process in a mouse model of BCC
significantly accelerates tumor formation. Using a combination of in vitro and cellular meth-
ods we identify two independent destruction signals in Gli1, DN and DC. DN is conserved
in vertebrate and arthropod Gli homologs and is a novel degron with no similarity to known
ubiquitin ligase recognition motifs. Despite this, we show that DN confers proteasome-medi-
ated instability to the otherwise stable heterologous protein GFP. On the other hand, DC is
conserved only in chordate Gli homologs. DC bears a strong similarity to the canonical SCF-
beta-TrCP recognition motif and mediates the interaction of Gli1 with beta-TrCP as determined
by co-immunoprecipitation. Removal of either DN or DC partially stabilizes Gli1 in a cyclo-
heximide pulse-chase assay and significantly accelerates tumor formation in a mouse model
of BCC. Gli1 lacking both degrons is stabilized to an extent comparable to treatment with the
proteasome inhibitor, MG132, and gives rise to a more severe BCC phenotype characterized
by early onset and perinatal lethality. These data suggest that proteasome-dependent destruc-
tion of the Gli1 and Gli2 transcriptional activators is a critical regulator of pathway signaling.
Further, these data argue that control of Gli protein accumulation underlies tumorigenesis and
suggest a new avenue for anti-tumor therapy.
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Green tea polyphenol epigallocatechin-3 gallate (EGCG) inhibits the sonic hedgehog-related
oncogene, Gli1, in human epidermal keratinocytes
DJ Kouba Dermatology, University of Maryland, Baltimore, MD
(-)-epigallocatechin-3-gallate (EGCG) is the major polyphenol constituent of green tea and a
potent antioxidant being tested in a variety of clinical disorders. Herein, we have examined
the effect EGCG has on the expression of the Sonic hedgehog (Shh)-related oncogene, Gli1.
The Gli family of transcription factors are the terminal products of Shh signaling and skin-tar-
geted overexpression of the Gli1 protein in transgenic mouse models leads to basal cell car-
cinoma-like tumors. We have found that when keratinocyte cultures (NHK) derived from neona-
tal foreskins are treated with EGCG, Gli1 mRNA and Gli1 protein are suppressed. By
quantitative, real-time reverse transcription PCR (QRT-PCR) we show that the suppression of
Gli1 transcript occurs in both a time- and dose-dependent fashion, which reaches a plateau
at approximately 20 micrograms/milliliter concentration. Further, Western blot analysis of ker-
atinocyte extracts reated with EGCG demonstrate a dose dependent reduction in Gli1 protein
expression 24h after treatment with EGCG. Examination of the human Gli1 gene promoter in
transient transfection/luciferase assays of keratinocytes either untreated, or treated with EGCG
for 24h after transfection, demonstrated no discernable effect on activity of the Gli1 gene pro-
moter, suggesting alternative methods, such as enhanced mRNA decay may be responsible
for the observed effects. Ongoing studies are examining the precise mechanism by which
EGCG exerts its negative effects on the Gli1 transcript.
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Extracellular matrix laminin-10 in the invasion of human squamous cell carcinomas
TM Steele, J Chen and J Li Dermatology and Cutaneous Surgery, University of Miami, Miami,
FL
The objective of this study was to examine the role of laminin-10 (alpha5, beta1, gamma1)
and its effect on human squamous cell carcinoma (SCC) cell migration and invasion. Recent
research has shown that the aggressive nature of malignant cells is regulated by their extra-
cellular matrix environment. Laminin-10 has been found to be a major component of the base-
ment membranes of epithelia and microvascular blood vessels and is thought to be one of the
key proteins influencing cell behavior. In our study, the RNA interference approach was used
to block the expression of laminin-10. The human SCC-25 cells were transfected with human
laminin alpha 5 chain small interfering RNA (La5 siRNA) to block the mRNA expression of
laminin-10. Reverse Transcription and Polymerase Chain Reaction analysis showed that the
expression of laminin-10 mRNA was suppressed by 78% in the La5 siRNA tranfected group.
To determine the function of laminin-10 in human SCC cell migration, we used a scratch migra-
tion assay and a chamber migration assay. The effect of laminin-10 on tumor cell invasion was
determined by an invasion assay with Matrigel Invasion Chambers. Our results showed that
by blocking gene expression of laminin-10, we could significantly suppress SCC cell migra-
tion and invasion. In the chamber migration assay, the control groups migrated at a rate three
times that of the La5 siRNA transfected groups. In the scratch migration assay, the La5 siRNA
transfected cells had a reduced migration rate by 50% compared to the rate of the control
group. The invasion assay demonstrated a reduction in the ability of the La5 siRNA trans-
fected cells to invade by almost 60% at 24 hours and 70% at 48 hours. Our experiments sug-
gest that laminin-10 may play important roles in tumor invasion and metastasis by influenc-
ing the ability of tumor cells to migrate and invade.
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The expression of N-methyl-D-aspartate receptors in cutaneous squamous cell carcinoma
J Cho, J Ku, M Kim, S Oh, H Kang, H Kim and Y Park Department of Dermatology, College
of Medicine, The Catholic University of Korea, Seoul, South Korea
Ionotropic glutamate receptors of the N-methyl-D-aspartate receptor (NMDAR) type are
expressed on keratinocytes and have been known to play a role in the proliferation, differen-
tiation and cornification of keratinocytes. However, the expression profile of NMDAR in cuta-
neous malignancy has rarely been studied. The aim of this study was to analyze the expres-
sion of NMDAR-1 and to investigate whether NMDAR-1 is a useful prognostic factor in
cutaneous squamous cell carcinoma (SCC). Thirty-two patients with biopsy-proven cuta-
neous SCC were enrolled in this study. Each patient was characterized according to the tumor
size, location, local recurrence and metastasis. The specimens were histologically divided into
two subgroups on the basis of Broader’s system : differentiated and undifferentiated group.
NMDAR-1 expression was examined by immunohistochemistry, and the relative staining inten-
sity was graded by the comparison with that of normal epidermis. There was a significant cor-
relation (p=.0001) of NMDAR-1 expression intensity of tumor cells with the histologic differ-
entiation of SCC. Furthermore, we also found a significant inverse correlation of NMDAR-1
expression intensity of tumor cells with metastatic rate (p=.049). In conclusion, it is suggested
that the NMDAR-1 expression is significantly correlated with differentiation and metastatic
rate of SCC, therefore it might be an candidate for a prognostic indicator of cutaneous SCC.
www.jidonline.org   17
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Allelic imbalances and chromosome 9p microdeletion demonstrated in cutaneous squamous
cell carcinomas using single nucleotide polymorphism microarray analysis
K Purdie,1,2 M Teh,3 C Harwood,1,2 B Young,4 C Proby1,2 and I Leigh1,2 1 Skin Tumour
Laboratory, Cancer Research UK, London, United Kingdom, 2 Centre for Cutaneous
Research, ICMS, Barts and The London School of Medicine and Dentistry, Queen Mary,
University of London, London, United Kingdom, 3 Centre for Clinical and Diagnostic Oral
Sciences, ICMS, Barts and The London School of Medicine and Dentistry, Queen Mary,
University of London, London, United Kingdom and 4 Medical Oncology Laboratory, Cancer
Research UK, London, United Kingdom
Cutaneous squamous cell carcinomas (SCC) are the second most commonly diagnosed can-
cers in Caucasians yet the genetic mechanisms involved in SCC tumorigenesis remain poorly
understood. We have employed single nucleotide polymorphism (SNP) microarray analysis
to examine genome-wide allelic imbalance in 10 primary and 2 metastatic SCC against cor-
responding non-tumour samples. The most frequent genetic changes were loss of heterozy-
gosity (LOH) on chromosomes 3p and 9p, each observed in 7 of 10 primary SCC. Other
recurrent events include LOH on chromosome 13 (5 of 10 primary SCC) and on chromosomes
8p and 17q (each in 4 of 10 tumours) as well as allelic gain on chromosomes 3q and 9q (each
in 4 of 10 tumours). Copy number analysis demonstrated that most LOH was due to deletion.
However, 3 of 5 samples with chromosome 13 LOH and 2 of 7 samples with 9p LOH did not
show copy number loss, implying that LOH was due to somatic recombination leading to
acquired uniparental disomy (UPD), an event not previously demonstrated in SCC. As well as
identifying recurrent patterns of gross chromosomal changes, SNP microarray analysis revealed
a microdeletion on chromosome 9p23 within the protein tyrosine phosphatase receptor type
D (PTPRD) locus. This event was restricted to the 2 primary SCC that had demonstrated metasta-
tic potential. Our data validates SNP microarray analysis as an accurate and sensitive method
for evaluating the global genetic changes underlying SCC tumorigenesis.
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Genomic analysis defines a cancer specific gene expression signature for human squamous
cell carcinoma and identifies potential roles for WNT, FZD and PTN in the pathogenesis of
SCC
AS Haider,1 HG Kaporis,1 J Ott,2 M Blumenberg,3 JG Krueger1 and J Carucci4 1 Laboratory of
Investigative Dermatology, Rockefeller, New York, NY, 2 Laboratory of Statistical Genetics,
Rockefeller, New York, NY, 3 Dermatology, New York University, New York, NY and 4
Dermatology, Weill Medical College of Cornell, New York, NY
Using high-density oligonucleotide arrays we measured expression of >12,000 genes in sur-
gical excisions of invasive human squamous cell carcinomas (SCCs) vs. site-matched controls.
We defined >1900 genes with altered expression in SCCs that were statistically different from
controls. Since SCCs are composed of epithelial cells which are both hyperplastic and inva-
sive, we sought to define gene sets associated with these biologic processes by comparing
gene expression to psoriasis, which is a condition of benign keratinocyte hyperplasia without
malignant potential. We found genes that were commonly up-regulated in both conditions
and unique genes with increased expression in SCCs. Differential gene regulation in these two
conditions was confirmed by real-time RT-PCR and immunhistochemisitry. We found that
benign hyperplasia is associated with upregulation of genes including DEFB4, SERPINB3,
STAT1, K16 and CEACAMs and WNT 5A. Genes specific to malignant hyperproliferation
included WNT receptor FZD6 and prostaglandin metabolizing enzyme HPGD that were
increased in SCC alone. Growth factor PTN was expressed at higher levels in non-tumor
bearing skin adjacent to excised SCC. SCC was further characterized by up-regulation of
other invasion associated genes including MMPs 1, 10, and 13, CTSL2, CST6 as well as
STAT3 and MSMB. Down regulation of iNOS, GZMB, CD8 and CD83 describe the gene
products that are associated with a immune response in SCC. Thus, primary cutaneous SCC
in humans is characterized by a unique gene expression signature, with altered expression of
genes that could control aberrant proliferation or invasion of malignant keratinocytes. Poten-
tial roles for WNT, FZD, and PTN in the pathogenesis of SCC are identified through this expres-
sion profiling.
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T-oligo induces multiple anti-cancer responses in UV-induced skin neoplasms
DA Goukassian,1 Y Chen,1 V Marwaha,2 E Helms,1 J Asai,2 J Bhawan1 and BA Gilchrest1 1
Dermatology, Boston University School of Medicine, Boston, MA and 2 Dermatology, Kyoto
Prefectural University of Medicine, Kyoto, Japan
We have previously reported that DNA oligonucleotides homologous to the telomere 3’ over-
hang (T-oligos) induce multiple anti-cancer responses in normal and malignant cells. To deter-
mine the effect of T-oligos on squamous cell carcinomas (SCC), human SCC12F cells were
treated with T-oligo (pGTTAGGGTTAG 40 µM) or diluent alone. By gel shift assay, within 16h
T-oligo enhanced DNA binding activity of p53 and E2F1, promoters of apoptosis, and inhib-
ited DNA binding of antiapototic and proangiogenic NFkB. Within 24h, T-oligo upregulated
the mRNA and protein levels of p21 and Bax and downregulated mRNA levels of antiapop-
totic Mcl1L. To examine the effect of T-oligos on UV-induced actinic keratoses and SCC in
vivo, we UV-irradiated hairless mice, then injected the resulting neoplasms with T-oligo or
complementary control oligo (0.6 nMole/injection) or saline (vehicle) alone intralesionally
TIW until disappearance or for 5 weeks. T-oligo-injected neoplasms, decreased in volume
(p<0.005) with 21 of the 26 decreased by more than 50%, and 11 of these by more than 76%,
including 5 that disappeared completely. Only 5 increase in volume by an average of 69±61%.
In contrast, the control (saline or control oligo)–injected neoplasms increased in volume
(p<0.04) with 23 of 38 increasing to 200±45% of starting size and the remaining 15 regress-
ing or remaining the same size. One day after the last injection neoplasms were processed for
TUNEL and for markers of proliferation (Ki67) and of panendothelial cells (CD31). T-oligo
increased (p<0.001) the number of TUNEL (+) cells ~6-fold, and decreased the number of Ki67
(+) cells by 25%. T-oligo also decreased tumor blood vessel and lymphatic density by up to
50%, calculated as percent of tissue occupied by CD31 (+) cells within the apparent tumor
and in the immediately surrounding dermis. We conclude that T-oligos activate DNA damage
signaling pathways in UV-induced neoplasms, leading to growth arrest, apoptosis, and/or
decreased neovascularization.
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Delphinidin, a major anthocyanidin in pigmented fruits and vegetables, induces differentia-
tion but not apoptosis in normal human epidermal keratinocytes
DN Syed, F Afaq, N Khan and H Mukhtar Dermatology, University of Wisconsin,Madison,
Madison, WI
Agents that lead to differentiation of epidermal keratinocytes may have therapeutic effects
against wounds and many proliferative skin disorders including cancer and psoriasis. Thus,
identifying a naturally occurring dietary agent that induces differentiation of normal human
epidermal keratinocytes (NHEK) without inducing apoptosis is a highly desirable goal. Del-
phinidin, a major anthocyanidin in pigmented fruits and vegetables, possesses potent antiox-
idant activity. Here, we provide evidence that delphinidin treatment of NHEK induces ker-
atinocyte differentiation. Involucrin, a precursor of keratinocyte cornified envelope is selectively
expressed in suprabasal epidermal layers. Immunoblot and RT-PCR analyses demonstrated
that the treatment of NHEK with delphinidin (10-40 µM) for 24 and 48 hrs resulted in an
increased expression of involucrin both at the protein and mRNA levels. Procaspase 14 is
expressed in epithelial tissue and is associated with terminal differentiation of keratinocytes
and barrier formation. Transglutaminases (TGs) are key enzymes involved in the construction
of a multilayer epithelium that catalyze the formation of isopeptide protein-protein cross-links.
Delphinidin treatment of NHEK induced protein and mRNA expression of procaspase 14,
and increased enzyme activity, protein and mRNA expression of TG I, without affecting TG II.
Delphinidin treatment also resulted in induction of p57/KIP2 and p27/KIP1 involved in dif-
ferentiation/cell cycle regulation. Delphinidin under identical treatment conditions did not
result in induction of apoptosis as evident by lack of effects on: (i) activation of caspase-3,-8,
and -9, (ii) cleavage of PARP, (iii) protein expression of Bcl-2 family, and (iv) cytochrome c
release. These data suggest that delphinidin functions to promote epidermal differentiation, a
critical process for skin regeneration and for the maintenance of normal barrier function. Del-
phinidin could have promise for the treatment of wounds and proliferative skin diseases.
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CD34 expression by hair follicle stem cells is required for skin tumor development in mice
C Trempus,1 R Morris,2 A Elmore,3 M Ehinger,3 M Humble,1 G Kissling,4 M Ito,5 G Cotsarelis,5
N Flagler,6 C Bortner,7 M Sifre7 and R Tennant1 1 NCT, NIEHS, RTP, NC, 2 Columbia
University, New York, NY, 3 Integrated Laboratory Systems, Inc., Durham, NC, 4 Biostatistics
Branch, NIEHS, RTP, NC, 5 University of Pennsylvania School of Medicine, Philadelphia, PA,
6 LEP, NIEHS, RTP, NC and 7 LST, NIEHS, RTP, NC
The glycoprotein CD34 is a cell surface marker expressed on mouse hair follicle bulge region
cells that have stem cell characteristics. A specific function for CD34 has not been fully eluci-
dated, although roles in adhesion, proliferation, and differentiation have been proposed. The
murine two-stage model of skin carcinogenesis involves initiation with a carcinogen, followed
by exposure to a tumor promoter, which induces hyperplasia followed by outgrowth of latent
neoplastic cells into cutaneous tumors. The carcinogen target cell population in this model is
thought to be the hair follicle stem cells. Because of the specific localization of CD34 on this
population, we tested the hypothesis that CD34 may participate actively in tumor develop-
ment in mice. Skin of CD34 knockout mice (from Dr. T. Mak, University of Toronto) and iso-
genic wild type mice was first initiated with DMBA, then promoted with TPA for 20 weeks.
CD34KO mice completely failed to develop papillomas in either of two experiments. Short-
term exposure to TPA resulted in reduced epidermal hyperplasia, reduced infundibulum length,
fewer BrDU positive cells within hair follicles, and hair follicles remaining largely in early stages
of anagen in CD34KO mice. The response of bulge keratinocytes to TPA was assessed using
BrDU-positive label retaining cells. After TPA treatment, bulge cells in CD34KO mice remained
intensely stained for BrDU, compared to the speckled pattern indicative of cell division seen
in WT mice. These data demonstrate that CD34 is required for TPA-induced epidermal hyper-
plasia and subsequent tumor formation in two-stage carcinogenesis. The data also suggests that
bulge cell progeny are responsible for epidermal hyperplasia following TPA treatment.
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Deregulated Aurora A kinase accelerates malignant progression of skin cancers
Y Chen,1 H Sheng,1 S Sen,2 BR Brinkley1 and DR Roop1 1 Baylor College of Medicine,
Houston, TX and 2 M. D. Anderson Cancer Center, Houston, TX
Centrosome abnormalities have been demonstrated to be correlated with carcinogenesis. Cells
from malignant tumors often contain multiple centrosomes that differ from normal centro-
somes in their size and distribution within cells. Aurora A, a centrosome-associated kinase,
was found to be overexpressed in many malignant human tumors. Cells overexpressing Aurora
A exhibited centrosome amplification and aneuploidy. In order to study the molecular mech-
anism by which Aurora A overexpression contributes to the centrosome abnormalities and
tumorigenesis, we generated an inducible mouse model in which the expression of human
Aurora A is controlled by a basal epithelial specific K14 promoter and can be induced by the
application of an antiprogestin, RU486. In this model, Aurora A expression can be detected
in Aurora A/p65 bigenic mice but not in monogenic control mice. Therefore, we initiated a
two stage chemical carcinogenesis experiment to study the function of Aurora A overexpres-
sion during skin carcinogenesis. Treatment with DMBA can cause an activating mutation in
H-ras, which is regarded as a very common initiating event for tumor formation. Accordingly,
we found A-T transitions in codon 61 of H-ras in both Aurora A bigenic and monogenic tumors.
However, we did not find significant difference in the rate of tumor initiation between Aurora
A bigenic and monogenic mice, though Aurora A was highly expressed in the skins of bigenic
mice. Nevertheless, Aurora A bigenic mice developed malignant squamous cell carcinomas
earlier, leading to a decreased survival rate. Additionally, tumors that develop in Aurora A
bigenic mice were more malignant, as evidenced by the increase in metastasis in the lung
and/or neighboring lymph nodes. Consistent with the increased rate of tumor progression, we
observed an amplification of centrosomes in tumors from Aurora A bigenic mice, but not in
control monogenic mice. These data indicate that deregulated Aurora A expression may play
an important role in malignant conversion of skin tumors.
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Chronic inflammation-driven tumor promotion associated with IFNγ-producing, perforin-
defective CD8+ T cells
BY Ng, SJ Roberts, RB Filler, RE Tigelaar and M Girardi Dermatology, Yale University School
of Medicine, New Haven, CT
Chronic inflammation is associated with carcinoma development in several clinical settings,
and we sought to investigate the role of T cells in this phenomenon using the DMBA/TPA
two-stage chemical carcinogenesis protocol. Previously we demonstrated that, paradoxical
to models of immunosurveillance, wild-type (WT) mice have a markedly higher rate of tumor
formation relative to strains lacking CD8+ T cells. Adoptive transfers of antibody-coated mag-
netic bead-enriched peripheral CD8+ T cells into TCRαβ-/- mice confirmed that the increased
mean tumor area (151.9±19.6 vs 64.5±13.2 mm2, p<0.001) and progression to carcinoma
(0.27 vs 0.60 papilloma/ carcinoma ratio, p<0.002) was attributable to the presence of CD8+
T cells. All analyzed strains of mice in which the CD8 compartment was intact (WT, CD4-/-,
CD4-/-TCRγδ-/-) showed significant increases in tumor susceptibility. Putative tumor-promot-
ing (Tpro) cells (TCRαβ+CD8+CD44+ tumor infiltrating-lymphocytes, TILs) were directly com-
pared to their phenotypic equivalents in peripheral blood lymphocytes (PBLs) after sorting to
>99.5% purity. In wild-type (WT) and CD4-deficient mice, CD8+ TILs consistently revealed
a markedly higher relative expression (by semi-quantitative RT-PCR) of IFNγ (10.5±2.1 TIL vs
1.5±0.5 PBL, p=0.028) and TNFα (8.8±1.7 TIL vs 2.0±1.0 PBL, p=0.036), and a striking decrease
in expression of perforin (2.1±0.02 TIL vs 9.3±0.65 PBL, p=0.015). Cytokine-bead analysis
(CBA) comparison of CD8+ and CD4+ TIL in tumors from WT mice confirmed the increased
expression by the CD8+ TIL of IFNγ (30.0±11.2 vs 0.7±1.3 pg/ml, p=0.002) and TNFα (31.3±7.8
vs 2.5±1.7 pg/ml, p<0.001). To our knowledge, this is first demonstration of increased car-
cinogenesis attributable to CD8+ TILs, characterized by their high IFNγ and TNFα production
and defective perforin production relative to phenotypically equivalent PBLs. These studies
may have mechanistic implications for the role of T cells in inflammation-associated car-
cinogenesis.
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Effects of altered calcium ATPase function on epidermal carcinogenesis
RA Kimmel,2 TW Ridky2 and P Khavari1,2 1 VA Palo Alto, Palo Alto, CA and 2 Dermatology,
Stanford Univeristy Medical Center, Stanford, CA
Physiologic calcium levels regulate epidermal adhesion, proliferation and differentiation and
are particularly important for the formation of intercellular junctions. Decreased cell adhesion
is implicated in tumor invasion and dissemination and it has been proposed that levels of adhe-
sion proteins correlate with the malignant potential of epithelial neoplasias. However, the role
of calcium homeostasis and calcium-dependent adhesion in carcinogenesis has not been clearly
demonstrated. Naturally occurring mutations in the Golgi calcium pump, ATP2C1, and the endo-
plasmic reticulum calcium pump, Serca2b, cause Hailey-Hailey (HH) and Darier’s disease (DD),
respectively. These disorders are characterized histologically by disruption of intracellular adhe-
sion in keratinocytes. In order to study the effects of disrupted calcium homeostasis in epider-
mal tumorigenesis, we compared the neoplastic potential of primary human Hailey-Hailey and
Darier’s keratinocytes to a panel of cells from normal patients. Both HH and DD keratinocytes
showed impaired capacity for Ras-driven tumorigenesis in vivo. We next assessed the potential
for mutant forms of ATP2C1a and Serca2b to disrupt calcium homeostasis, intercellular adhe-
sion and invasive neoplasia in otherwise normal keratinocytes. Expression of the ATP2C1 and
Serca2b mutant proteins in normal keratinocytes caused an elevation of intracellular calcium
and showed clefting and blister formation in regenerated epidermis, both features displayed by
similarly grown HH and DD patient cells. This suggests that both diseases arise via expression
of dominant-negative mutant pumps rather than by haploinsufficiency. Similar to HH and DD
keratinocytes, normal cells engineered to express a mutant Ca-ATPase were incapable of Ras-
driven tumorigenesis. These data indicate that disrupted calcium homeostasis leads to abnor-
malities in intracellular adhesion and tumorigenesis.
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Tripartite motif protein Trim32 modulates ultraviolet light (UVB) and TNFα-induced ker-
atinocyte apoptosis through NFκB
A Albor and M Kulesz-Martin Dermatology, Oregon Health and Science University, Portland,
OR
Skin homeostasis requires a delicate balance of proliferation, differentiation and apoptosis to main-
tain the stability and health of the tissue in response to external stimuli. Trim32, a member of the
tripartite domain or RBCC (RING/B2/Coiled-coil) family of ubiquitin or sumo ligases/scaffold pro-
teins, was previously reported by us to participate in the early stages of keratinocyte carcinogenic
transformation and to protect epidermal keratinocytes from apoptosis induced by combined
UVB/TNFα treatment in vitro and by UVB irradiation of the skin in vivo. Based upon the known
role of NFκB in apoptosis and its responsiveness to TNFα and UV light, we examined whether
the NFκB pathway might be involved in the anti-apoptotic effects of Trim32. Isolated mouse ker-
atinocytes were infected with retroviruses expressing Trim32 or GFP proteins and selected with
G418 under low calcium (0.03mM), conditions conducive to proliferation. Cells were treated
with UVB and TNFα (230 J/m2 and 5 ng/ml, respectively). The transcriptional activity of NFκB
was measured by means of a luciferase reporter gene assay, using a constitutively expressed Renilla
reporter to control for transfection efficiency. At these doses, UVB induced apoptosis, which was
synergized by combined treatment with TNFα, while treatment with TNFα alone did not induce
apoptosis. Trim32 virus-infected keratinocytes had increased basal NFκB activity, which was fur-
ther increased after UVB/TNFα treatment, relative to the control GFP-infected keratinocytes. We
have previously described that Trim32 binds and destabilizes Piasγ, a pro-apoptotic member of
the PIAS (protein inhibitor of activated STATS) family of transcriptional regulators. As predicted
from those findings, expression of Piasγ had an effect on NFκB opposite to Trim32, repressing
both its basal transcriptional activity and activity after stimulation with UVB/TNFα. Our results
imply that Trim32 expression protects keratinocytes from apoptosis through induction of NFκB
activity, and point to destabilization of Piasγ as a potential mechanism.
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Identification of putative basal cell carcinoma genes by array-based comparative genomic
hybridization
X Cha,1 T Naylor,2 A Bansal,1 H Lu,1 J Seykora,1 B Weber2 and S Fakharzadeh1,3 1
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Abramson Cancer Center,
University of Pennsylvania, Philadelphia, PA and 3 Veterans Affairs Medical Center,
Philadelphia, PA
A significant proportion of sporadic basal cell carcinomas (BCCs) harbor defects in PTCH or
other known SHH pathway genes. However, we hypothesize that defects in additional or alter-
native genes may contribute to BCC tumorigenesis. To identify putative BCC genes, we per-
formed array-based comparative genomic hybridization (aCGH) using genomic DNA from
43 BCCs to identify regions of chromosomal loss or gain that may harbor tumor suppressor
genes or oncogenes, respectively. Our studies detected loss in the region of the PTCH gene
in 33% of our samples, thus validating use of this method for analysis of BCC. In addition, we
identified 13 regions of loss and 5 regions of gain that were recurrent in at least 25% of our
samples. Using custom designed TaqMan® low density arrays, we examined the expression
of 77 genes localizing to regions of loss and 10 genes within regions of gain in 11 BCCs and
2 normal skin control samples by quantitative RT-PCR. Both PTCH and GLI2 controls showed
markedly increased expression in BCC samples. AZGP1 (ZAG, Zn-alpha(2)-glycoprotein)
showed the greatest change in expression for any gene localizing to a region of loss, with
decreased expression up to several hundred fold in BCC compared to normal skin. FOXF2
demonstrated the highest degree of altered expression for any gene within a region of gain
studied, with up to 37 fold increased expression in BCC. In contrast, FOXQ1, which is included
in the same region of gain and lies adjacent to FOXF2, did not show increased expression in
BCCs. Notably, there were samples that showed differential expression of AZGP1 or FOXF2
at the RNA level but did not show a change in DNA copy number at their loci by aCGH. Given
that AZGP1 and FOXF2 localize to recurrent regions of chromosomal aberration and show
differential expression in BCCs, they represent good candidates for genes involved in the patho-
genesis of BCC.
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Transient activation of BRaf but not Akt3 in human melanocytes results in the up-regulation
of a pro-apoptotic BH3-only gene.
NB Goldstein,1 YG Shellman,1 AV Gadeliya,1 W Johannes,1 M Matsuoka2 and DA Norris1 1
Dermatology, University of Colorado Denver, Health Sciences Center at Fitzsimons, Aurora,
CO and 2 Pharmacology, Keio University School of Medicine, Tokyo, Japan
Two distinct Ras signaling pathways are often activated in primary melanomas - the
Ras/BRaf/MAPK and the Ras/PI3K/Akt pathways. We conducted transient transfection experi-
ments using two melanocyte cell lines in an attempt to dissect the MAPK and PI3K/Akt path-
ways in melanoma tumorigenesis and progression. Using CMV-driven expression vectors for
HA-tagged activated BRaf-V600E, Nras-G12V, and myristoylated AKT3, we transfected plas-
mids into immortalized human melanocytes (PIG1) and neonatal normal human epidermal
melanocyte cells (NHEM), and analyzed cell lysates at 24 hours post-transfection by
immunoblot. FACS analysis showed 75% (NHEM) and 90% (PIG1) transfection efficiency using
a control GFP plasmid, and immunoblotting indicated that the HA-tagged proteins of interest
were consistently expressed. Interestingly, a preliminary protein-level screen of numerous
genes indicated that activated BRaf, but not activated Akt3, up-regulated a BH3-only pro-apop-
totic protein in both PIG1 and NHEM cells. Preliminary qRT-PCR results confirmed a tran-
scriptional level increase of the same pro-apoptotic gene in cells transfected with the BRaf-
V600E construct. Currently, we are assessing the functional relevance of this over-expressed
BH3-only gene, and we are conducting mRNA microarray and proteomics analyses to obtain
a global picture of MAPK and PI3K signaling in melanoma. Based on our preliminary results,
we propose that up-regulation of the MAPK pathway leads to expression of proteins involved
in cell proliferation and neoplastic initiation, while activation of the PI3K pathway results in
expression of anti-apoptotic proteins involved in melanoma progression.
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Overexpression of BMP antagonist noggin in skin leads to pilomatricoma-like tumor forma-
tion and increases epidermal susceptibility to chemical carcinogenesis
AA Sharov,1 AN Mardaryev,1 TY Sharova,1 PA Overbeek2 and VA Botchkarev1 1 Dermatology,
Boston University School of Medicine, Boston, MA and 2 Department of Molecular and Cell
Biology, Baylor College of Medicine, Houston, TX
Bone morphogenetic proteins (BMPs) and their receptors play pivotal roles in the control of
skin development and are also implicated in the control of skin carcinogenesis. In extracel-
lular space, magnitude of BMP signaling is modulated by BMP-antagonists including noggin.
To downregulate (or inhibit) BMP signaling in the epidermis, K14-Noggin transgenic mice were
generated. In contrast to wild-type mice, K14-Noggin mice showed formation of spontaneous
tumors derived from pilo-sebaceous unit. During 6-7 weeks of life, transgenic animals showed
de novo formation of the hair follicle-like structures growing out of the outer root sheath of
anagen hair follicles, which later develop into pilomatricoma-like tumors. In chemical car-
cinogenesis protocol, K5-Noggin mice showed formation of the papilloma-like epidermal
tumors, which were markedly increased in number and size, compared to wild-type animals.
To explore mechanisms underlying the increased sensitivity of K14-Noggin mice to skin car-
cinogenesis, laser capture microdissection, microarray and real-time PCR analyses were
employed. Agilent microarray analysis validated by real-time PCR revealed that in contrast to
hair matrix keratinocytes isolated from anagen hair follicles of wild-type mice, keratinocytes
isolated from pilomatricoma-like tumors of K14-Noggin mice showed markedly increased
expression of regulatory molecules involved in the control of cell proliferation (Shh, Smo,
Wnt5b, Wnt10b, Lef-1, Tcf3, PDGF-alpha). In addition, tumor-derived keratinocytes showed
alterations in expression of genes encoding markers of keratinocyte differentiation. These data
indicate that BMPs are important for homeostatic regulation of cell proliferation in adult epi-
dermis and hair follicles, and that BMP signaling helps to suppress skin carcinogenesis at
least in part via antagonizing Shh and Wnt signaing pathways.
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Differential activation of NFκB subunits in keratinocytes overexpressing ∆Np63 isoforms
KE King, RM Ponnamperuma and WC Weinberg Laboratory of Immunobiology, Office of
Biotechnology Products, CDER/FDA, Bethesda, MD
∆Np63, a p53 homologue, is highly expressed in human squamous cell cancers and experi-
mentally induced mouse skin carcinomas. We have mimicked this overexpression in primary
mouse keratinocytes, and previously reported that full length ∆Np63α blocks Ca2+-mediated
growth arrest and induction of terminal differentiation. Maintenance of proliferative capacity
by overexpressed ∆Np63 requires the ∆N domain but not the α-COOH terminus, as it is also
observed with ∆Np63(p40), a ∆N isotype lacking the α-terminus. In contrast, TAp63 isoforms,
with or without the α-COOH terminus, do not impact proliferation. Only full length ∆Np63α
blocks terminal differentiation, suggesting that the α-terminus is required for the ∆N isoform
to block differentiation. To gain mechanistic insight into the biological effects of p63 overex-
pression and the contribution of the α-COOH terminus to ∆Np63α function, we applied a
transcription factor profiling system, Panomics Array I, to identify altered transcription factor
binding activity in keratinocytes overexpressing ∆Np63α, ∆Np63(p40), or β-gal. ∆Np63 over-
expression activates the NFκB pathway, and specific NFκB subunits are differentially translo-
cated to the nucleus depending on the presence of the α-COOH terminus. No differences
were observed in total cellular expression levels of the NFκB subunit proteins in any of the
cultures. Western blots of nuclear extracts showed that overexpression of either ∆Np63 iso-
type enhances nuclear translocation of C-Rel, a NFκB subunit that has been implicated in both
solid tumors and hematopoietic malignancies. Enhanced nuclear expression of p50 and p65
is seen with ∆Np63(p40) overexpression relative to ∆Np63α or β-gal cultures, and correlates
with subunit binding to DNA consensus sequences seen by EMSA. Blocking translocation of
NFκB subunits with IkBαM superrepressor restores the normal Ca2+-mediated growth regula-
tory response to both populations of ∆Np63 overexpressing cells. These findings link two impor-
tant pathways in cancer development, p53/p63 and NFκB.
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A stabilizing effect of Cyclosporine A on mitochondria enhances survival of skin cells in
response to UVA irradiation
JM Gloeckner,1,2 K Norman,1,2 A Eshaghian1,2 and JE Sligh1,2 1 VA Tennessee Valley
Healthcare System, Nashville, TN and 2 Vanderbilt School of Medicine, Nashville, TN
The success of organ transplantation is related to the use of Cyclosporine A (CsA), a T-cell selec-
tive immunosuppressive agent. However, CsA therapy results in a dramatic increase in the
incidence of squamous cell carcinoma (SCC), possibly a result of impaired immune surveil-
lance, though emerging evidence suggests that CsA directly alters the characteristics of cells
by a cell autonomous mechanism. To investigate the role of CsA in the pathogenesis of SCC
in organ transplant recipients we are exploring the biology of the keratinocyte by evaluating
the ability of CsA to modulate cell death in response to ultraviolet (UV) exposure through its
interaction with Cyclophilin D (CypD), a regulator of the mitochondrial permeability transi-
tion pore (MPTP). We exposed cultured skin cells to repetitive physiological doses of UVA
light over a range of CsA doses and measured cell death using trypan blue, AnnexinV, and PPI
staining. There was an effect of the CypD-binding drugs, CsA and Nim811, to repress cellu-
lar death, whereas the immunosuppressive FK506 (which binds cytosolic immunophilins but
not CypD) had a negligible effect on cell death as compared to control cells treated with vehi-
cle. These results suggest that CsA’s effect on UV-induced cell death is due to its binding of
CypD at the mitochondria, and is independent of its immunosuppressive effects, as exhibited
by the inability of FK506 to repress cell death. UVA also triggers mitochondrial DNA (mtDNA)
damage in the form of deletions. We have characterized a panel of mtDNA deletions that occur
in the skin of patients with SCC including the 4977bp and 6278bp UVA-associated deletions.
We have evaluated the levels of heteroplasmy of these deletions using a quantitative PCR assay
in repetitively irradiated cultured cells and in SCC tumors excised from organ transplant
recipients. The accrual of mtDNA damage in these cells is being investigated for its potential
to support keratinocyte hyperproliferation, and thus contribute to a neoplastic phenotype.
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The p63-IKKa pathway in the control of keratinocyte transformation
B Marinari,1 M Koster,2 M Giustizieri,1 C Ballaro,3 S Alema,3 M Karin,4 DR Roop2 and
A Costanzo1 1 Dep. of Dermatology, University of Rome Tor Vergata, Rome, Italy, 2 Dep. of
Mol. and Cellular Biol., Baylor College, Houston, TX, 3 Biol. and Cell. Institute, CNR, Rome,
Italy and 4 Dep. of Pharmacology, UCSD, La Jolla, CA
The P63 gene belongs to the p53 gene family of tumor suppressor genes and encodes for
sequence specific transcription factors. The DNp63 protein, lacking the transactivation domain,
has been proposed to identify the epidermal stem cells and to regulate their survival and self
renewal. In an attempt to identify new potential p63 targets we have found that the epider-
mal morphogenesis modulator IKKa is tightly regulated at the transcriptional level by differ-
ent isoforms of p63. We have observed that IKKa mRNA expression increases at the onset of
the stratification program. The selective downregulation of DNp63 by siRNA in primary ker-
atinocytes abolishes IKKa activation and the onset of terminal differentiation and increases
keratinocyte proliferation rate. This is consistent with transcriptional assay data performed with
an IKKa-promoter reporter gene showing a strong activation of IKKa transcription by DNp63
isoforms and a low activity of TAp63 isoforms. On the other hand the downregulation of IKKa
in primary keratinocytes hampers the ability of differentiating cells to exit the cell cycle induc-
ing the formation of a K1 expressing proliferative layer that is reminiscent of the embryonic
intermediate layer and of squamous cell carcinoma. The IKKa and p63 expression was eval-
uated in 49 squamous cell carcinomas and in 10 normal skin biopsies by immunohistochemistry.
IKKa expression was found to be downregulated in the vast majority of SCCs while was strongly
expressed in normal epidermis. Interestingly, we could also observe a strong difference in the
nucleo-cytoplasmic distribution of IKKa in SCC(mainly cytoplasmic) vs normal skin (strong
nuclear staining) that is consistent with the presence of K1 positive proliferating cells in SCC.
Our results indicate IKKa as an important p63 target potentially involved in the control of epi-
dermal stem cells proliferation in skin development and in cell transformation.
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Proteome analysis of skin tumors in tuberous sclerosis complex
S Li,1 J Wang,1 J Moss2 and TN Darling1 1 Dermatology, Uniformed Services University,
Bethesda, MD and 2 Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and
Blood Institute, Bethesda, MD
Patients with tuberous sclerosis complex (TSC) develop tumors in multiple organs due to a
mutated tumor suppressor gene, either TSC1 or TSC2, encoding hamartin or tuberin, respec-
tively. Angiofibromas (AF) and periungual fibromas (PF) are common TSC skin tumors that
can be disfiguring. To identify potential new therapeutic targets for TSC-associated tumors,
we characterized molecular alterations in fibroblast-like cells derived from TSC skin tumors
(AF cells or PF cells) as compared to fibroblasts derived from the same patient’s normal-appear-
ing skin (TSC fibroblasts). AF and PF cells from three patients showed dramatically reduced
or undetectable tuberin compared to TSC fibroblasts. Serum-starved AF and PF cells showed
increased phosphorylation of ribosomal protein S6 compared to TSC fibroblasts, consistent
with loss of tuberin function and activation of mTOR signaling. To identify proteins that may
be abnormally expressed due to loss of tuberin, we studied tuberin-negative PF cells from one
patient using two-dimensional polyacrylamide gel electrophoresis. In quadruplicate gels of
proteins extracted from PF cells and TSC fibroblasts, incubated 24 hours with 10% or 1% fetal
bovine serum, 2,435 silver-stained spots were identified. 11 proteins showed increased mean
spot intensities and 15 showed decreased mean spot intensities in PF cells compared to TSC
fibroblasts under both conditions (p<0.05 for each spot). Matrix-assisted laser desorption/ion-
ization time-of-flight mass spectrometry and/or tandem mass spectometry identified two of the
proteins increased in PF cells, cathepsin B and vimentin, and one of the proteins decreased
in PF cells, alpha-tropomyosin. Furthermore, we examined cathepsin B protein levels by West-
ern blot, and found that the ratios of band intensities in TSC tumor cells to TSC fibroblasts were:
patient 1 PF, 2.8, patient 2 AF, 1.2, and patient 3 AF, 1.4, PF1, 1.9, and PF2, 1.5. Cathepsin B,
a protease increased in cancers but not previously studied in TSC, may play roles in TSC tumori-
genesis.
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Comparison of patterns of promoter hypermethylation in cutaneous squamous cell carci-
noma using quantitative-MSP
NJ Liegeois1,2 and JA Califano2 1 Dermatology, Johns Hopkins, Baltimore, MD and 2
Otolaryngotology, Johns Hopkins, Baltimore, MD
Promoter methylation is a common mechanism of inactivation of tumor suppressor genes in
head and neck squamous carcinoma (HNSC) and multiple other types of solid tumors. How-
ever, little is known about its role in the development of cutaneous squamous cell carcinoma
(cSCC). In order to investigate the role of methylation in cSCC, we analyzed genes known to
be methylated in HNSC and other cancer types to determine whether similar epigenetic changes
may influence cSCC development. We evaluated these alterations in cSCC in a quantitative
fashion using real-time quantitative methylation specific PCR (Q-MSP) and compared this to
control tissue from normal subjects. Tumor DNA samples from 45 cSCC as well as DNA from
normal subjects were evaluated for patterns of hypermethylation using Q-MSP. Evaluated tumor
suppressor gene promoter regions were selected using a set of candidate genes known to be
methylated in squamous cancer systems. Genes tested included for DAPK, DCC, MINT-1,
RASSF-1A, p16, MGMT, Cyclin-A1, PGP9.5 and S100-A. Of the 45 tumors, increased pro-
moter methylation was seen for cSCC tumor samples compared with controls for the markers
tested. Correlations between histologic findings, patient background, and degree of anapla-
sia were correlated with methylation status. Promoter methylation is common in cSCC, and
it is likely that such methylation may influence the development or progression of cSCC.
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Effect and regulation of the multidrug resistance P-glycoprotein in human malignancy
F Truzzi, M Yaar and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
A common cause of resistance to cancer chemotherapy is expression of the MDR1 (multidrug
resistance1) gene that encodes a drug efflux pump, P-glycoprotein (P-gly). MDR1 is known to
be downregulated by activated p53 and is especially a problem in cancers lacking functional
p53. We have shown that telomere homolog oligonucleotides (T-oligos) induce DNA damage
responses in cancer cells of diverse lineage, activating p53 and other signaling proteins to cause
cellular apoptosis and/or senescence. T-oligos also modulate the expression of several genes
inappropriately repressed or overexpressed in malignant cells. We therefore examined the inter-
action between T-oligo, a proposed new cancer therapy, and MDR1/P-gly. We first demon-
strated that P-gly-negative parental MCF-7 cells, a malignant human epithelial cell line with wild
type p53, and derived adriamycin–resistant MCF-7 cells (Adr/MCF-7) that are strongly P-gly-pos-
itive and have mutant p53, were both highly responsive to T-oligos undergoing extensive apop-
tosis, suggesting that P-gly does not export this therapeutic DNA molecule from cells. Moreover,
in Adr/MCF-7 cells, T-oligo decreased P-gly level by 50% within 4 days. We then examined P-
gly-positive human MMAN melanoma cells that lack p53 and in which T-oligos are known to
induce apoptosis via upregulation of p73 and E2F1. MMAN cells treated with p73 siRNA (vs.
green fluorescent protein siRNA as control) for 48 hours and processed for western blotting had
minimally detectable p73 and undetectable P-gly. T-oligo-treated MMAN cells showed increased
p73 and E2F1 within 24 hours, as expected, and by days 3 and 8 P-gly levels increased by >100%
and >300%, respectively, during which time cells underwent extensive apoptosis. These data
demonstrate complex MDR1 regulation by p53 and p73 that may vary among tumor cells of dif-
ferent lineage. The data further suggest that, unlike many cancer therapies, T-oligo efficacy is
undiminished by P-gly and in at least some cell lines T-oligos decrease P-gly, possibly rendering
cells more responsive to conventional therapy.
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Search for the target genes of basonuclin: an interdisciplinary approach
H Tseng1,2 and J Wang3 1 Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Cell
and Developmental Biology, University of Pennsylvania, Philadelphia, PA and 3 Center for
Bioinformatics, University of Pennsylvania, Philadelphia, PA
A general issue in studying transcription regulators is the identification of their target genes.
The traditional method for identifying target genes is laborious and cannot be applied to
genome-wide search. Recent development of high-throughput analysis such as microarray
technology and bioinformatic databases provide means to examine a large number of genes
in multiple genomes simultaneously in silico. Here we describe an approach, which utilizes
data from molecular biology, evolutionary biology, bioinformatics, transgenic animal and
microarray, to identify in the entire genome a minimal set of highly likely target genes for a
transcription factor. We search for the target genes of basonuclin, which is highly expressed
in basal keratinocytes of the epidermis. Basonuclin function appears to be associated with
keratinocyte proliferation, and the level of basonuclin is dramatically up-regulated in basal
cell carcinoma (BCC). The action of basonuclin is mediated through three pairs of evolution-
arily conserved zinc fingers. We and others have shown by DNase I footprint assay that basonu-
clin binds to the rDNA promoter and the promoter of its own gene. Using these information,
we built a statistical model for the basonuclin binding sites, which was then used to search
for potential basonuclin target genes in human and mouse genome databases by computa-
tion. The resulting list of genes was screened further by a set of independent criteria (e.g.,
evolutionary conservation and functionality). Finally, the candidate gene list was compared
with a list of genes whose expressions were altered, as detected in a microarray analysis, in
basonuclin-knock-out animals. The genes that are present in both lists are most likely to be
basonuclin targets. Our approach can be used as a first step in identifying transcription fac-
tor target genes, which will yield a small number of highly likely candidates for further molec-
ular characterization.
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Angiogenesis and disrupted epidermal structure in mice coexpressing TGFβ1 and onco-
genic ras
D Bae,1 N Blazanin2 and AB Glick2 1 Pharmacology and Physiology, The George
Washington University, Washington, DC and 2 Center for Molecular Toxicology and
Carcinogenesis, The Pennsylvania State University, University Park, PA
Several studies have shown that oncogenic ras and TGFβ1 have both antagonistic and syner-
gistic effects on skin carcinogenesis, but the mechanism of this is not well characterized. We
used a microarray approach to examine how oncogenic ras alters the transcriptional response
to TGFβ1, and to identify genes that were synergistically regulated by these two signaling path-
ways. The regulation of TGFβ1 immediate early response genes such as ski1, smad7, tieg1,
myc and idb2, and the down regulation of cell cycle control genes was not altered by onco-
genic ras, supporting biochemical data showing lack of effect of ras on TGFβ1 induced Smad2
phosphorylation, nuclear translocation and growth inhibition. However, the induction of most
extracellular matrix genes by TGFβ1 was blocked by oncogenic ras. A cluster of 30 genes
including the protease plasminogen activator (urokinase) that has been associated with tumor
cell invasion were induced by TGFβ1 only in keratinocytes expressing ras. To model this
interaction in vivo we have generated a triple transgenic mouse expressing the K5/rTA trans-
gene and the dox inducible transgenes tetOTGFβ1 and tetOrasV12G. Addition of doxycycline
to triple transgenic mice co-induced TGFβ1 and oncogenic ras in the epidermis, and within
48 hrs produced a rapid increase in vascularity and disorganization of the epidermis without
blocking ras induced hyperplasia. The epidermis from triple transgenic mice had increased
staining for CD31 and VWF confirming the angiogenic response and decreased expression of
E-cadherin in the basal layer. Quantitative-PCR and immunohistochemistry showed that uroki-
nase expression was induced 4 fold in the epidermis of triple transgenic mice. These results
suggest that coexpression of these two signaling pathways in vivo rapidly induces a novel
epidermal phenotype that may provide insight into how these signaling pathways accelerate
cancer development.
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Apoptosis in p53-null human melanoma cells induced by telomere-specific DNA oligonu-
cleotides is mediated by E2F1 and p73
SS Venna, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
DNA oligonucelotides homologous to the 3’ telomere overhang (T-oligos) induce apoptosis in
a variety of cell lines including human melanoma cells. We have shown that T-oligo-induced
apoptosis in p53-null MM-AN cells is preceded by an increase in the p53 homolog p73 and its
cooperating factor E2F1 and is inhibited by 50% in these cells transfected to express a domi-
nant-negative form of p73, suggesting that apoptosis in these melanoma cells is mediated at least
in part by the interaction of E2F1 and p73, as has been reported for other cell types in response
to DNA damage. E2F1 increases p53 levels via p14ARF-mediated stabilization and is known to
bind and transcriptionally activate the p73 promoter, with a consequent increase in p73 protein
level. To test the hypothesis that E2F1 plays a role in T-oligo-induced apoptosis of MM-AN cells,
we transfected MM-AN cells with siRNA to reduce E2F1. Twenty-four hours following this
transfection, the cells were treated with either T-oligo or diluent. After T-oligo treatment, the p73
protein level increased nearly 3-fold over diluent-treated cells, as early as 16 hours and main-
tained through 24 hours in both the control and E2F1 siRNA-treated cells, while E2F1 was
undetectable in siRNA-treated cells. Therefore, the induction of p73 following T-oligo treatment
is independent of E2F1 status. However, apoptosis of MM-AN cells following T-oligo treatment
was inhibited by nearly 50% in cells transfected with E2F1 siRNA compared to controls, sug-
gesting that direct p73-E2F1 protein-protein interactions are not the central mechanism by which
these factors initiate MM-AN cell apoptosis. Interestingly, E2F1 knock-down decreased phos-
phorylation of histone H2AX, a known substrate of the ATM kinase, following T-oligo treatment,
suggesting that E2F1 regulates ATM activity. We propose that E2F1, broadly acting as a tran-
scription factor, regulates the DNA damage response pathways after T-oligo treatment or telom-
ere disruption (mimicked by T-oligos), leading to apoptosis or senescence.
124
β-catenin/Tcf signaling in mouse skin carcinogenesis
VS Spiegelman and N Bhatia Dermatology, University of Wisconsin, Madison, WI
β-catenin/Tcf signal transduction pathway plays an important role in normal embryonic devel-
opment and in malignant transformation of many types of mammalian cells. However, little
is known about its role in non-melanoma skin cancers. In this study, we elucidated the func-
tion of β-catenin/Tcf signaling pathway in skin tumors induced by two stage chemical car-
cinogenesis protocol. As compared to normal skin, 20 and 30 week papillomas and squamous
cell carcinomas (SCCs) showed enhanced expression of β-catenin, mostly localized in cyto-
plasm and nucleus. Transformed keratinocyte cell lines also exhibited cytoplasmic and nuclear
accumulation of β-catenin. Our results revealed that Tcf4 was the most abundant member of
the Lef/Tcf transcription factor family in skin tumors. Ectopic expression of dominant negative
Tcf4 in transformed mouse keratinocytes resulted in diminished cell growth as compared to
the control transfected cells. The well characterized downstream target genes of the β-catenin/Tcf
signaling pathway, c-myc and c-jun were up-regulated in all tumors, although to a greater
extent in 20 and 30 week papillomas. We demonstrated that Wnt 3, 4 and 10b are highly
expressed in all stages of skin tumors. Wnt 4 and 10b are accumulated in less differentiated
cells whereas Wnt 3 is more evidently expressed in differentiated cells of the tumors. Stabi-
lization and nuclear accumulation of β-catenin is usually a result of inefficient phosphoryla-
tion and prevention of subsequent ubiquitination and proteasomal degradation. As AKT is also
known to phosphorylate and inactivate GSK-3β, an important member of the multi-protein
complex responsible for phosphorylation of β-catenin, we also investigated AKT expression
and activation in skin tumors. Our results indicated enhanced expression of AKT and phos-
pho-AKT in papillomas and carcinomas, though mostly in differentiated cells. These data
conclusively show that β-catenin/Tcf signaling plays an integral role in skin carcinogenesis
and provide evidence that Wnt proteins play a primary role, whereas AKT is also partially
responsible in activation of β-catenin/Tcf signaling pathway in skin carcinogenesis.
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Identification of a gene expression signature for benign precursor lesions to cutaneous
squamous cell carcinoma
N Darwiche,1 A Ryscavage,2 L Nolan,2 H Hennings,2 S Yuspa2 and AB Glick3 1 American
University of Beirut, Beirut, Lebanon, 2 LCCTP, NCI, Bethesda, MD and 3 Center for
Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park,
PA
Most chemically induced murine squamous skin papillomas are terminally benign but a
small percentage have a high risk for progression and are the likely precursor lesions to SCC.
To define a molecular signature for the high risk precursor lesions, we have compared the gene
expression profiles of normal skin, chronic TPA treated skin and different classes of chemically
induced tumors. The use of multiple independent tissue samples allowed rigorous statistical
analysis and identification of differentially expressed genes. Unsupervised clustering and mul-
tidimensional scaling of 514 differentially expressed genes (p<.001) showed that 9/10 high
risk papillomas clustered with the SCC, while 1/10 clustered with the low risk papillomas.
There was a complete correlation between the benign tumor expression profile and keratin
markers of progression supporting the validity of this molecular classification. 87 genes dis-
tinguished papilloma classes and of these 28% were downregulated T cell receptor,
immunoglobulin and other immune function related genes suggesting that reduced adaptive
anti-tumor immunity defines papillomas that progress to SCC. Suprisingly, while chronic TPA
treated skin clustered separately from other classes, 64% (51/79) of genes that defined the high
risk signature were similarly expressed in this chronically promoted normal skin, while only
9/79 followed a pattern similar to chronically TPA treated low risk papillomas. Thus high risk
papillomas, analyzed 8 weeks after promoter exposure, maintain an expression pattern sim-
ilar to chronically promoted skin suggesting that these tumors represent autonomous or self
promoting lesions. That the high risk expression signature is evident after 5 weeks of promo-
tion in normal skin suggests that the keratinocyte progenitor of the high risk papilloma and
the keratinocytes that persist in the epidermis following longterm promotion are closely linked.
126
Apigenin versus phorbol ester and green tea - opposing actions of skin cancer chemopre-
ventive agents
S Balasubramanian1 and RL Eckert1,2 1 Physiology and Biophysics, Case Western Reserve
University, Cleveland, OH and 2 Dermatology, Case Western Reserve University, Cleveland,
OH
Apigenin, a plant-derived chemopreventive flavonoid, is known to reduce proliferation of trans-
formed keratinocytes, and to inhibit chemical- and UVB-induced mouse epidermal carcino-
genesis. However, the normal keratinocyte is the carcinogen target in vivo, and the impact of
apigenin treatment on normal keratinocyte function has not been examined. In the present
study, we examine the effect of apigenin on normal human keratinocyte differentiation and
apoptosis. We show that apigenin inhibits the 12-O-tetradecanoylphorbol-13-acetate (TPA)
dependent increase in human involucrin (hINV) promoter activity and that this regulation
requires an AP1 factor binding site, AP1-1, in the hINV promoter proximal regulatory region.
Suppression is concentration-dependent and is complete at apigenin concentrations ≥ 15
µM. Involucrin gene expression is regulated by a nPKC, Ras, MEKK1, MEK3, p38 signaling
cascade that targets AP1 factors to increase hINV promoter activity. Treatment with apigenin
efficiently suppresses nPKC-dependent hINV promoter activity and partially suppresses caRas-
and MEKK1-dependent hINV promoter activation. The apigenin dependent suppression of pro-
moter activity is associated with a reduction in AP1 factor level. Apigenin also inhibits ker-
atinocyte cell proliferation by modulating the levels of cell cycle regulatory proteins, but does
not promote caspase-associated apoptosis. Moreover, treatment with apigenin inhibits a green
tea polyphenol-dependent increase in hINV promoter activity. These findings indicate that api-
genin is a potent suppressor of keratinocyte differentiation and proliferation.
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Hair follicle stem cells: targets in carcinogenesis
RJ Morris,1 S Li,1 C Trempus2 and G Cotsarelis3 1 Dermatology, Columbia Univ. Med. Ctr.,
New York, NY, 2 Cancer Biology, NIEHS, RTP, NC and 3 Dermatology, Univ. Pennsylvania
Sch. Med., Philadelphia, PA
Skin cancer can be induced in mice following exposure to a carcinogen (initiation) and sub-
sequent chronic regenerative epidermal hyperplasia (promotion). Conceivably, any keratinocyte
capable of proliferation could become and remain initiated. However, the long-term persist-
ence and quiescent nature of the initiated lesion suggests a possible stem cell origin. We inves-
tigated the cellular origins of mouse skin tumors using Krt1-15CrePr1;R26R transgenic mice
which express an RU486 inducible Cre in the stem cells of the hair follicle bulge. Mice were
initiated with a single topical application of the carcinogen, 7, 12-dimethylbenz[a]anthracene
(DMBA) followed one week later by application of RU486 and subsequent tumor promotion
with 12-O-tetradecanoylphorbol-13-acetate (TPA). After induction of the recombinase, hair
follicle bulge cells stained blue with X-gal histochemistry as we previously reported. During
tumor promotion, blue cells were found first in squamous hyperplastic foci and later, in papil-
lomas. The blue cells in the lesions included basal and suprabasal cells. Bulge stem cells con-
tributed to over 60% of the lesions studied thus far. Estimated percentages of blue cells in the
center of the lesions ranged from about 1% to about 70%. The squamous hyperplastic foci and
resulting papillomas frequently appeared to involve more than one hair follicle. Nevertheless,
the presence of non-blue cells in the many neoplasms was also apparent. These observations
are consistent with a follicle bulge origin for many, but not all papillomas. These results are
consistent with earlier work from our laboratory where approximately half of the papillomas
arose from the hair follicles. We conclude from these experiments that hair follicle stem cells
are a significant target population in cutaneous carcinogenesis. Studies on the origin of the
non-blue tumor cells as well as bulge stem cell fate in squamous cell carcinomas, and Ha-ras
mutation analysis are currently in progress.
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Characterization of keratinocyte subpopulations in non-melanoma skin cancer using “stem
cell” markers derived from microarray analysis of human hair follicles.
GK Patel,1 M Ohyama,1,2 RL Graham,1 CL Yee,1 A Terunuma,1 A Montemarano,3 K Maggio4
and JC Vogel1 1 Dermatology, National Cancer Institute, Bethesda, MD, 2 Department of
Dermatology, University School of Medicine, Tokyo, Japan, 3 Rockledge Skin Cancer Clinic,
Bethesda, MD and 4 Walter Reed Army Medical Center, Washington, DC
Recently, we utilized laser capture microdissection to isolate distinct keratinocyte (KC) pop-
ulations from human hair follicles, including putative KC stem cells from the bulge area (HF-
KSC). Following Affymetrix microarray analysis, panels of cell surface markers able to iden-
tify distinct KC populations, including HF-KSC, were identified and validated by
immunohistochemistry and colony forming assays. Our hypothesis was that BCC and SCC
could be analyzed using antibodies against these cell surface markers to identify putative
cancer stem cells. When cell surface markers that were positive selectors for HF-KSC, includ-
ing CD200, follistatin, and keratin-15, were used to characterize BCC (n=15) and SCC (n=7)
immunohistochemically, no expression of these HF-KSC markers was detected. In contrast,
the cell surface marker CD71 (transferrin receptor) that was expressed on lower hair follicle
outer root sheath KCs was detected in both BCC and SCC. CD71 was preferentially expressed
by KC at the tumor margins, where proliferating cells were localized. In BCC, these cells also
express the pro-survival protein Bcl-2. CD24, a cell surface marker that was expressed on inner
root sheath KCs and is a marker of KC differentiation, was preferentially found on the slowly
cycling inner cell layers of both BCC and SCC. Another cell surface marker of non-bulge
outer root sheath KCs, CD146, was expressed in the inner cell layers of SCC, but not BCC.
Although cell surface markers for HF-KSC were not found in SCC and BCC, the cell surface
markers CD71, CD24, and CD146 can distinguish KC subpopulations within BCC and SCC
that can be isolated for further analysis by in vivo assays.
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FAS apoptotic pathway abnormalities in CTCL
J Siddiqui,1,2 J Wu,1,2 M Nihal1,2 and GS Wood1,2 1 Dermatology, UW, Madison, WI and 2
Dermatology, VAMC, Madison, WI
We hypothesize that the FAS (CD95) apoptotic pathway is often defective in CTCL. Our data
indicate reduced expression of FAS in many cases of CTCL and suggest multiple mechanisms
for FAS down-regulation. First, a small minority of cases harbor exon mutations that encode
truncated or more subtly defective proteins that might not be expressed or metabolized nor-
mally, or be detectable due to lack of epitopes targeted by anti-FAS antibodies. Second, we
detected FAS promoter mutations in approximately half of the cases tested. They might decrease
enhancer function and thereby reduce transcription of wild-type protein. This has already been
shown for GABP and AP1 sites in Jurkat T cells. Although some of these mutations may be silent,
others are likely to have functional consequences, especially because many involve defined
transcription factor binding sites. Third, up-regulation of activated FAS transcriptional repres-
sors like STAT3 and c-Jun could silence expression of wild-type FAS. Our Western blot analy-
sis indicates that the HH CTCL cell line may be an example of this. Lastly, there are some CTCL
cases and lines that express FAS strongly and lack any FAS promoter or coding region muta-
tions. Relative to HH, they also express lower levels of activated STAT3 and c-Jun. Our data
indicate these cases are represented by CTCL cell lines MyLa and SeAx. Presumably, any resist-
ance to apoptosis observed in such cases would be due to factors other than FAS. It is impor-
tant to note that mechanisms for FAS down-regulation are not necessarily mutually exclusive.
For example, CTCL cases harboring early FAS enhancer mutations might also develop over-
expression of transcriptional repressors like STAT3 and c-Jun that would result in a “one-two
punch” capable of progressively knocking FAS expression down if not completely out.
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γ-H2AX formation in response to interstrand crosslinks requires XPF in human cells
S Mogi1,2 and DH Oh1,2 1 Department of Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Dermatology Research Unit, VA Medical Center, San
Franscisco, CA
DNA interstrand crosslinks are among the most cytotoxic types of DNA damage resulting from
chemotherapeutic agents, including psoralen plus UVA therapy. To further define the molec-
ular mechanisms involved in processing interstrand crosslinks, we monitored the formation
of phosphorylated histone H2AX (γ-H2AX), which is generated in chromatin near double strand
break sites, following DNA damage in normal and repair-deficient human cells. Following
treatment with a psoralen derivative and ultraviolet A radiation doses that produce significant
numbers of crosslinks, γ-H2AX levels in nucleotide excision repair-deficient XP-A fibroblasts
(XP12RO-SV) increased to levels that were twice those observed in normal control GM637
fibroblasts. A partial XPA revertant cell line (XP129) that is proficient in crosslink removal, pro-
duced γ-H2AX levels that were intermediate between those of GM637 and XP-A cells. XP-F
fibroblasts (XP2YO-SV) that are also repair-deficient exhibited γ-H2AX levels below even
control fibroblasts following treatment with psoralen and ultraviolet A radiation. Similarly,
another crosslinking agent, mitomycin C, did not induce γ-H2AX in XP-F cells, although it did
induce equivalent levels of γ-H2AX in XP-A and control GM637 cells. Angelicin, a furo-
coumarin which forms only monoadducts and not crosslinks following ultraviolet radiation,
as well as ultraviolet C radiation, resulted only in weak induction of γ-H2AX in all cells, indi-
cating that the double strand breaks observed with psoralen and ultraviolet A treatment result
preferentially following crosslink formation. These results indicate that XPF is required to
form double strand breaks during interstrand crosslink repair in human cells. Furthermore,
XPA appears to be important to allow psoralen interstrand crosslinks to be processed through
an alternate pathway that does not result in a double strand break intermediate.
131
Promotion of cutaneous neoplasia in mice by MFG-E8
M Neutzner,1 X Feng,1 AB Glick,2 SH Yuspa,3 RE Cannon,4 RW Tennant4 and MC Udey1 1
Dermatology Branch, NCI, NIH, Bethesda, MD, 2 Dept of Veterinary & Biomedical Science, Penn
State University, University Park, PA, 3 Lab of Cellular Carcinogenesis & Tumor Promotion, NCI,
NIH, Bethesda, MD and 4 National Center for Toxicogenomics, NIEHS, NIH, Research Triangle, NC
MFG-E8 is a secreted glycoprotein discovered in association with milk fat globules. MFG-E8 con-
tains 2 N-terminal EGF-like domains and 2 C-terminal discoidin domains (C1, C2). One EGF-like
domain includes an RGD sequence and binds αvβ3/5 integrins and the C2 domain contains a Fac-
tor VIII-like region that binds phosphatidylserine and other phospholipids. MFG-E8 is produced by
macrophages and dendritic cells and facilitates clearance of apoptotic cells by phagocytes. MFG-
E8 is also associated with vessels and promotes angiogenesis. We determined that MFG-E8 is
expressed by tumor cell lines and mouse skin papillomas, suggesting that MFG-E8 may play a role
in tumorigenesis. To test this hypothesis, we studied skin tumor formation in MFG-E8 KO mice and
K14/Tg mice expressing a dominant-negative form of MFG-E8 (MFG-Ig) in epidermis. C57BL/6
MFG-E8 KO and WT mice were treated with DMBA/TPA using a standard protocol and tumor for-
mation was assessed. Tumor development was modestly delayed in KO mice (70% with tumors at
wk 9 vs. 100% in WT mice). Tumor multiplicity peaked at wk 12 for WT mice and wk 14 for MFG-
E8 KO mice with WT mice having ~2x more lesions than KO mice (p<0.007). Tumor development
was also studied in FvB Tg.AC mice that express v-Ha-ras in epidermis after they had been crossed
with C57BL/6 K14/MFG-Ig Tg mice. FvB x C57BL/6 F1 single and double Tg mice were compared
to littermate controls. Tumor development in single and double Tg animals was synchronous up to
wk 3 after initiation of TPA promotion. After wk 4, tumor development in Tg.AC single Tg animals
was more rapid and the papilloma number/mouse was ~2-fold higher than in double Tg mice begin-
ning at wk 6 (p<0.05). Thus, in two different models of skin tumorigenesis, perturbation of MFG-
E8 function decreases lesion frequency. Sources of MFG-E8 and mechanisms underlying this effect
are under investigation.
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Cellular context dictates tumorigenic potential of activated Smo in vivo
LE Michael,1 J Liu,1 A Wang,1 M Grachtchouk,1 JE Brown,1 AN Ermilov,1 AB Glick2 and
AA Dlugosz1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2 Center for
Molecular Toxicology and Carcinogenesis, Pennsylvania State University, State College, PA
Uncontrolled activation of the Hedgehog (Hh) signaling pathway is involved in the develop-
ment of nearly all human basal cell carcinomas (BCCs) and a subset of medulloblastomas,
potentially lethal brain tumors arising in the cerebellum. Both of these tumors may have acti-
vating mutations in the signaling effector SMO, leading to constitutive Hh signaling. We cre-
ated a conditional bitransgenic model of Hh pathway-mediated tumorigenesis using an onco-
genic allele of Smo, designated SmoA1, whose expression can be controlled by the
administration of doxycycline. Targeting of SmoA1 to embryonic skin with a keratin 5 pro-
moter led to the development of widespread epithelial abnormalities that were incompatible
with survival, including extensive basaloid epithelial proliferations. Postnatal induction of
SmoA1 in skin led to focal epithelial hyperplasia, but no frank basal cell carcinomas (BCCs).
In striking contrast, expression of SmoA1 in cerebellar neural progenitors led to the formation
of massive, highly proliferative medulloblastomas by seven weeks of age. Activation of the
Hh pathway in the mouse medulloblastomas was confirmed by in situ hybridization. This
phenotype was seen in 100% of bitransgenic animals, which were generated using two inde-
pendent SmoA1 mouse lines. In addition, tumor-bearing animals fed with doxycycline exhib-
ited focal tumor regression in areas where the transgene was shut down. With this work, we
have shown that while conditional epithelial expression of oncogenic SmoA1 does not appear
to be sufficient to drive the development of frank BCCs in skin, expression of the same trans-
gene in the developing cerebellum leads to the formation of lethal medulloblastomas. Con-
tinued growth of medulloblastomas also appears to require sustained Hh signaling, as inhibi-
tion of transgene expression leads to focal tumor regression.
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Contribution of cytokeratin end domains to tumor development in mice subjected to a two-
stage skin carcinogenesis protocol
J Chen,2 M Merched-Sauvage,2 X Cheng,2 D Roop2,1 and P Koch2,1 1 Molecular & Cellular
Biology, Baylor College of Medicine, Houston, TX and 2 Dermatology, Baylor College of
Medicine, Houston, TX
Based on cell culture experiments and transgenic studies, it has been proposed that cytoker-
atin 10 (K10), which is expressed in post-mitotic terminally differentiating keratinocytes, sup-
presses cell proliferation and acts as a tumor suppressor in vivo. These characteristics have
been linked to the NH2- and COOH-terminal domains of the K10 protein. To test these hypothe-
ses in vivo, we have generated mice (K1014 line) that express the K10 end domains at phys-
iological levels in the proliferative layer and stem cell compartment of the epidermis. We mod-
ified the endogenous K14 gene locus of these mice to encode a protein in which the K10 head
and tail domains were fused to the K14 rod domain. This chimeric protein is synthesized in
the basal layer of the interfollicular epidermis and the outer root sheath of hair follicles. Next
we subjected mutants (n=20) and wild type controls (n=20; matched with respect to gender,
age and genetic background) to a two-stage chemical skin carcinogenesis protocol (DMBA/TPA
protocol). Mutants developed papillomas earlier than control mice and showed a 2-3 fold
increase in the average number of tumors. The tumor progression rate [to squamous cell car-
cinomas (SSC) and spindle cell carcinomas (SPCC)] was not affected by transgene expres-
sion. So far, we have identified one mutant mouse that developed SSCs in the lung as well as
lymph node metastases, both of which expressed the K1014 transgene. The increased sus-
ceptibility of K1014 mice to chemically-induced tumors indicates that the K10 end domains
do not have tumor suppressor function in vivo. Nevertheless, our results demonstrate that
keratin end domains can affect the susceptibility of keratinocytes to papilloma formation in
vivo.
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Decreased carcinogenesis in Langerhans cell-deficient mice
DC Kaplan, BY Ng, SJ Roberts, MC Jenison, RB Filler, WD Shlomchik, MJ Shlomchik and
M Girardi Yale University School of Medicine, New Haven, CT
While most models of immunosurveillance ascribe anti-tumor properties to various immune
components, it is becoming increasingly clearer that under certain conditions pro-tumor effects
are attributable to the presence of specific immune populations. Mice with a selective absence
of Langerhans cells (LCs) have been generated on an FVB background using BAC transgenic
mice in which the regulatory elements from human Langerin were used to drive expression
of an attenuated form of the diphtheria toxin A subunit (Langerin-DTA). These mice have a
selective ablation of epidermal LCs, and show enhanced contact hypersensitivity. To begin to
assess the role of LC in tumor immunosurveillance, groups of Langerin-DTA mice were com-
pared to littermate syngeneic controls under low-dose, two-stage DMBA/TPA chemical car-
cinogenesis protocols where papilloma formation and progression to carcinoma are moni-
tored. By week 11 post-initiation, 73.3% of WT mice were tumor-bearing vs 10.0% of the
control mice (p=0.0019), and by week 18, 53.3% or WT mice manifested carcinoma vs 10.0%
of controls (p=0.023, chi-squared). Total tumor area was 5x higher (23.1±1.6 vs 4.1±4.1 mm2,
p=0.007) and mean carcinomas per mouse was 8x higher (1.60±0.51 vs 0.20±0.20, p=0.02)
in WT than Langerin-DTA mice. Post-treatment in situ immunofluorescence revealed that the
chemical application of DMBA/TPA did not deplete LC from the skin of WT mice, and flow
cytometry analysis of draining lymph nodes showed comparable ratios of CD4, CD8, CD11b,
and CD11c populations in the two groups. Taken together, these data indicate that LCs may
facilitate tumor development and progression. Since we previously have shown a role for
tumor-promoting CD8+ T cells in this model, future studies will assess whether LCs are stim-
ulatory for these cells.
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Constitutive hedgehog signaling activity, via GLI2 expression, is sufficient for salivary gland
tumorigenesis
A Ermilov,1 J Brown,1 E Roessler,2 A Wang,1 J Liu,1 M Grachtchouk,1 N D Silva,3 A Ramirez,4
J Jorcano,4 M Muenke2 and AA Dlugosz1 1 Dermatology, University of Michigan, Ann Arbor,
MI, 2 National Institutes of Health, Bethesda, MD, 3 Department of Oral Medicine, Pathology,
and Oncology, University of Michigan, Ann Arbor, MI and 4 CIEMAT, Madrid, Spain
Although first studied in basal cell carcinoma (BCC), constitutively activated Hedgehog (Hh)
signaling has now been implicated in the initiation and maintenance of a variety of internal
malignancies. We have generated a “gene-switch” mouse model for studying Hh-associated
tumorigenesis, using a transgene which expresses an activated form of the Hh-regulated tran-
scription factor GLI2 following excision of a stop sequence by Cre recombinase. Although
GLI2 gene-switch (GLI2g-s) mice are grossly indistinguishable from control mice, bitransgenic
mice also harboring a K5-Cre transgene developed numerous BCC-like tumors arising in
skin. In addition, nearly all K5-Cre/GLI2g-s mice developed multiple salivary gland tumors
by eight weeks of age. The majority of tumors arose in submandibular glands, but lesions were
also detected in sublingual and parotid glands. The histology of mouse salivary gland tumors
arising in K5-Cre/GLI2g-s mice was similar to human salivary duct carcinoma. In keeping with
this diagnosis, early tumors were located in close proximity to, and appeared to be derived
from, cells in the salivary ducts. Interestingly, the spectrum of salivary gland tumors was dif-
ferent in bitransgenic mice where Cre was expressed in a broader variety of cell types. Addi-
tional tumor phenotypes were observed in these mice, including lesions compatible with a
diagnosis of polymorphous low grade adenocarcinoma. The frequent development of sali-
vary gland tumors in GLI2-expressing mice suggests that deregulated Hh signaling may play
a role in human salivary gland tumorigenesis. In addition, the spectrum of tumors that develop
following activation of GLI2 in multiple salivary gland cell types suggests that tumor pheno-
type is dictated by the developmental potential of tumor progenitor cells.
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Gli2-overexpression in basaloid squamous cell cancer initiation and maintenance
M Grachtchouk,1 AM Snijders,2 A Wang,1 J Liu,1 D Cummings,1 ME Hutchin,1 L Wei,1
D Thomas,1 RC Jordan,2 BL Schmidt,2 AB Glick,3 DG Albertson2 and AA Dlugosz1 1
Dermatology, University of Michigan, Ann Arbor, MI, 2 UCSF, San Francisco, CA and 3
Pennsylvania State University, State College, PA
Deregulated Hedgehog (Hh) signaling is associated with the development of a wide variety
of malignancies. In the great majority of cases, this is due to mutations affecting the Hh recep-
tor Patched or the signaling effector Smoothened, or to constitutively increased levels of Hh
ligands. Recently, high-level amplification of the Hh-regulated transcription factor GLI2 was
discovered in a subset of squamous cell carcinomas (SCCs) with basaloid features arising in
the head & neck region (AM Snijders et al, Oncogene 24:4232-42, 2005), suggesting that
upregulation of Hh pathway transcriptional effectors may be sufficient to drive human tumori-
genesis. We have generated data supporting this concept using bitransgenic mice that over-
express Gli2 in head & neck epithelia under the control of a doxycycline-regulated promoter:
K5-tTA/TRE-Gli2 mice develop rapidly-growing basaloid SCCs within their jaws with nearly
complete penetrance. Nearly all tumors that originated from gingival epithelium arose from
the marginal zone, suggesting that this region contains potential tumor progenitors uniquely
responsive to Gli2 overexpression. In situ hybridization of tumors revealed upregulation of
transcripts encoding Cyclins D1 and D2, the survival factor Bcl2, and classical Hh target genes.
Inactivation of Gli2 transgene expression using doxycycline resulted in profound tumor regres-
sion, but a small number of residual, non-proliferating epithelial cells persisted. Our data
support the idea that GLI2 amplification in human basaloid SCCs plays a causal role in the
pathogenesis of these tumors, and uncover a compartment of potential tumor progenitor cells
in the gingival epithelium. Moreover, the persistence of a residual population of quiescent
epithelial cells, following Gli2 inactivation, suggests that effective shut-down of aberrant Hh
signaling in established cancers may not be sufficient to eliminate all tumor cells.
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Antimicrobial proteins and tumor defense
J Trowbridge, P Kotol, K Yamasaki and R Gallo Medicine, UCSD, San Diego, CA
Antimicrobial proteins (AMPs) are positively charged small proteins and essential effectors of
immune defense against invading microbes. Their antimicrobial activity depends on peptide
structure and target cell surface charge. Some AMPs have also been shown to be tumoricidal
in vitro. Our current work asks if AMPs of the cathelicidin family are important for cutaneous
tumor defense in vitro and in vivo.  In addition, our prior work on the mechanisms of AMP
function has suggested that the interactions between highly cationic cathelicidin peptides
and target cells are modified by the presence of anionic glycosaminoglycans (GAG). GAGs
are key modulators of a number of cellular responses and their expression patterns are altered
in many human tumors including cutaneous tumors, thus alteration of GAG expression by
tumors can enable selective targeting of tumor cells over normal tissues. We show here that
the addition of cathelicidin peptides at physiological concentrations (12 µM) induced a tumo-
ricidal effect on B16F10 mouse melanoma cells as determined in vitro by cell proliferation
assays. This effect was competitively abolished upon the addition of exogenous GAGs. Fur-
thermore, we demonstrate that cathelicidins are active against mouse melanoma tumors in
vivo as the local injection of AM on alternate days for 7 days can attenuate tumor size by 25-
30%. Work is ongoing to determine whether AMP-deficient and AMP-overexpressing mice are
differentially susceptible to cutaneous tumor initiation and growth. This work begins to test
the hypothesis that AMPs participate in skin tumor surveillance in addition to their myriad
other effects upon innate immunity.
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Chemopreventive effects of an apple peel extract for skin cancer
D Eggert, S Reagan-Shaw and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Skin cancer is the most common cancer in the USA. It is also one of the easiest to prevent, by
avoiding exposure to the sun. For prevention of skin cancer, education about the harmful effects
of solar UV light, the need to avoid its overexposure and the use of sunscreens has been empha-
sized. Sadly, these approaches are only partially effective because more than a million new
cases of skin cancers are diagnosed annually in the USA alone. Chemoprevention via natu-
rally occurring agents could be useful in the management of skin cancer. Recent studies have
indicated that apple, especially apple peel, contains high levels of antioxidants and may be
useful against cancer and other chronic diseases. This study was designed to examine the
antiproliferative effects of apple peel extract (APE) against skin cancer. For our study, we
chose to use organic Gala apples because studies have shown high concentrations of polyphe-
nolic antioxidants in their peel. APE was prepared from Gala apples by adding 1 ml of dis-
tilled water per g of peeled skin and blending at high speed. The blended homogenate was
strained, centrifuged, and filter-sterilized. The extract was aliquoted and stored at -20°C. Employ-
ing human epidermoid carcinoma cells (A253 and A431), we evaluated the effect of apple
peel extract on cell growth, cell viability, cell cycle distribution and long term reproductive
potential. Our data demonstrated that treatment of A431 and A253 cells with APE (at con-
centrations of 0.5-2.5%; for 48 hours) resulted in a significant decrease in viability and growth
of these cells. Further, APE treatment resulted in a concentration-dependent decrease in the
colony formation ability of both the cell types. Furthermore, APE was also found to result in
a significant G1-phase arrest of the cell cycle and a downmodulation of the protein levels of
proliferating cell nuclear antigen (PCNA). Based on our results, we suggest that apple peel or
its individual ingredients could be developed as a novel agent for the management of skin can-
cer. Detailed mechanistic in vitro and in vivo studies in appropriate models are needed to
support our findings.
www.jidonline.org   23
ABSTRACTS
139
Laminin-5 α3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway
inactivation but does not disrupt normal epithelial cohesion
MM Tran,1 P Rousselle,2 P Nokelainen,1 N Nguyen,1 DR Keene,3 EF Fincher1 and
MP Marinkovich1 1 Dermatology, Stanford University, Stanford, CA, 2 Institut de Biologie et
de Chimie des Proteines, Lyon, France and 3 Shriners Research Center, Portland, OR
The centrality of laminin-5 in epithelial-mesenchymal cohesion is well known, but only recently
has its critical role in epidermal tumorigenesis come to light. Laminin 5 is secreted as a het-
erotrimer (α3-β3-γ2) with subsequent processing of the α3 chain at residue 1337, liberating
the G4-5 domain. The G4-5 domain is absent in basement membranes of fully-developed
normal tissues but is actively expressed in epidermal carcinomas. Our study investigated the
G4-5 domain’s role in epidermal carcinogenesis with respect to invasion, survival, and pro-
liferation mediated by the PI3K-Akt pathway. Retroviral transduction of laminin-5 α3-null
epidermolysis bullosa keratinocytes with wild-type α3 (α3WT) cDNA or residue 1337-trun-
cated α3 (1337TR) cDNA, restored stable adhesion in a3WT cells but deficient adhesion in
1337TR cells, which could be largely corrected with G4-5 cDNA transduction. α3WT cells
transformed with Ras/IκB cDNAs demonstrated robust PI3K activation, MMP-1 expression,
Matrigel invasion and in vivo tumor formation following SQ injection in mice. Ras/IκB-trans-
formed 1337TR cells showed weak PI3K activity, MMP-1 expression and Matrigel invasion
and failed to form tumors in mice. Retroviral transfer of G4-5 cDNA to transformed 1337TR
cells partially restored PI3K activity, MMP-1 expression and cell invasion. G4-5 antibody
ablated tumor formation in mice injected SQ with Ras/IκB-transformed normal keratinocytes,
promoting tumor apoptosis and inhibiting tumor proliferation as revealed by TUNEL and Ki-
67 studies. Extensive necropsy and electron microscopy exposed no epithelial adhesive defects
or basement membrane abnormalities associated with G4-5 antibody treatment in mice. These
findings testify laminin α3 G4-5 domain is essential for epidermal carcinogenesis and is a tar-
get for a promising antibody therapy.
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Laminin-5 Beta 3 chain promotes epidermal carcinogenesis through type VII collagen bind-
ing and pi3k activation
N Sakai, EA Waterman, NE Nguyen, BA Horst, DP Veitch, CN Dey, S Ortiz-Urda, PA Khavari
and M Marinkovich Epithelial Biology, Stanford University, Stanford, CA
Laminin-5 plays an important role in epidermal carcinogenesis but the underlying mecha-
nisms remain unclear. To further address this we retrovirally expressed two laminin beta-3
chain truncations, termed Tr1 (deletion domain VI) and Tr2 (deletion domains VI-V-III), in
laminin beta-3 negative epidermolysis bullosa keratinocytes. Tr1/Tr2 laminins were properly
assembled, expressed at wild type levels and deposited into keratinocyte extracellular matrix.
Tr1/Tr2-expressing keratinocytes displayed normal migration and spreading but showed
decreased stable adhesion as showed by trypsin detachment assay and showed abnormal local-
ization of actin filaments and focal adhesion components to hemidesmosomes. Despite these
adhesive defects, Tr1 cells transformed with Ras and IkBa produced SCC-like tumors after SQ
injection to nude mice. In contrast, Ras/IkBa transformed Tr2 cells indicated a complete inabil-
ity to form tumors or invade Matrigel. Transformed Tr2 cells showed reduced PI3-kinase activ-
ity compared to transformed Tr1 and wild type cells. Furthermore, PI3-kinase expression
completely restored tumorigenesis and tissue invasion to transformed Tr2 cells after SQ injec-
tion to nude mice. Transformed type VII collagen null keratinocytes were also shown to have
deficient PI3-kinase and invasive activity, which was restored by retroviral transfer of PI3-kinase
cDNA. Purified Tr1 laminin bound to collagen VII by solid phase assay in a normal dose-
dependent manner, whereas purified Tr2 laminin lacked the binding ability to type VII colla-
gen. These studies suggest that domain VI mediates stable adhesion involving transition of focal
adhesions to hemidesmosomes, but this process is unnecessary for tumorigenesis. Instead it
is the binding of laminin beta-3 domain V-III to type VII collagen that promotes epidermal car-
cinogenesis through PI3-kinase activation.
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Tumor suppressor effect of glucocorticoid receptor in skin: implication of stem cells 
D Chebotaev, A Yemelyanov, RM Lavker and I Budunova Dermatology, Northwestern
University, Chicago, IL
Glucocorticoids are potent inhibitors of mouse skin tumorigenesis. The glucocorticoid con-
trol of cellular functions is mediated via the glucocorticoid receptor (GR), a well-known tran-
scription factor. Recently we generated skin-targeted transgenic mice overexpressing GR under
control of the keratin5 (K5) promoter and showed that skin tumor development was dramat-
ically inhibited in those animals. Epidermal stem cells (SC) located in the bulge region of the
hair follicle are believed to be the target cells for skin carcinogenesis. We characterized the
distribution of putative SC detected as label-retaining cells (LRCs) in hair follicles of K5.GR
transgenic mice. We found that the number of LRCs was almost two-fold less in the K5.GR
transgenics compared to w.t. littermates. We also found that GR overexpression led to the
reduced SC clonogenicity in vitro. We evaluated the global effect of GR on gene expression
in SC-enriched populations of CD34+/α6integrin+ bulge keratinocytes and in CD34-/α6inte-
grin+ basal keratinocytes isolated by FACS, as well as in skin tumors harvested from K5.GR
transgenic animals. DNA array analyses revealed that the expression of 70%, 78% and 86%
of GR-responsive genes was inhibited by the GR in SC-enriched keratinocytes, in basal ker-
atinocytes, and in skin tumors respectively. These findings strongly suggest that gene transre-
pression plays an important role in SC maintenance and in the inhibition of skin carcinogen-
esis by GR. Furthermore, in SC-enriched populations of bulge keratinocytes, GR inhibited
several SC-related genes, including TGF-β2, IGFbp5 and S100A4, and strongly affected numer-
ous genes involved in proliferation and in the organ development. These data strongly suggest
that GR-mediated signaling is very important for epidermal SC maintenance, and that the tumor
suppressor role of GR in skin is partially mediated through a reduction in the number and
proliferative potential of hair follicle SCs.
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A role for p63 in maintenance of nucleotide excision repair in human keratinocytes
BE Ferguson,1,2 H Li1,2 and DH Oh1,2 1 Department of Dermatology, University of California,
San Francisco, San Francisco, CA and 2 Dermatology Research Unit, VA Medical Center, San
Francisco, CA
We have recently demonstrated that human epidermal keratinocytes, unlike human fibrob-
lasts, do not require p53 to maintain global genomic repair (GGR) of cyclobutane-pyrimidine
dimers (CPD), the major ultraviolet radiation-induced DNA lesion. Since the cellular mecha-
nisms responsible for the regulation of GGR in keratinocytes remain unclear, we hypothesized
that one or more isoforms of the p53 homolog, p63, participates in governing GGR in human
keratinocytes.  In this study, cultured keratinocytes that express the human papillomavirus type
16 E6 and E7 oncoproteins and that are p53-deficient were also made deficient in p63 using
two distinct approaches. First, two separate siRNA that target sequences common to all p63
isoforms each significantly reduced p63 protein and mRNA levels in the E6/E7 keratinocytes
relative to cells treated with a control non-targeting sequence. Second, a PI3-kinase inhibitor,
LY294002, which has been reported to reduce ∆Np63 was also employed. Following ultravi-
olet radiation, an immunoblot assay was used to monitor GGR in cells over 24 hours. While
E6/E7 keratinocytes treated with a non-targeting sequence repaired CPD with normal kinet-
ics, treatment by each p63-targeting siRNA resulted in a 40% reduction in CPD repair. Simi-
larly, E6/E7 keratinocytes treated with LY294002 repaired 50% fewer CPD than control cells
treated with the vehicle alone. In all cases, p53 and p63 deficiency did not affect GGR of (6-
4) photoproducts, another ultraviolet radiation-induced DNA lesion. These results indicate that
p63 helps to maintain global repair of DNA damage when p53 is absent, and suggest that p53
and p63 co-regulate GGR of CPD in normal human keratinocytes.
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Gene expression profiling in cutaneous T cell lymphoma skin lesions
J Shin, D Jones, D Hurwitz and T Kupper Dermatology, Brigham and Women’s Hospital,
Boston, MA
Cutaneous T Cell Lymphoma (CTCL) is defined by the infiltration of activated and malignant
T cells in the skin. The clinical manifestations and prognosis are highly variable, as are responses
to a wide range of treatment modalities. Transcriptional profiling of other malignancies has
suggested that there is often heterogeneity of gene expression, with profiles falling into two or
more groups. Sometimes, this is associated with useful information allowing for the predic-
tion of clinical course or response to therapy.  In this study, we hypothesized that analysis of
gene expression profiles in punch biopsies of CTCL lesions can improve understanding of the
disease and its management. 61 subjects were enrolled with CTCL grouped in Stages Ia, Ib,
II, and III. After filtering and normalizing the Affymetrix expression data, an initial unsuper-
vised hierarchical clustering resulted in three clusters of subjects. Two of these clusters differ-
entiated more limited CTCL (Stage Ia and Ib) from more aggressive CTCL (Stages Ib, II, and
III). Stage Ib subjects appeared in both clusters, and we noted that those in the limited CTCL
cluster responded relatively well to treatment whereas those in the more aggressive CTCL clus-
ter were more treatment resistant. The third cluster appeared to result from relatively large
numbers of infiltrating lymphocytes in the lesions and did not correlate with other clinical
parameters, except for a relatively large portion of tumor (Stage II) lesions. Further analysis
using supervised clustering and predictive modeling was able to define gene sets significantly
associated with lower stage/treatment responsive CTCL versus higher stage/treatment resist-
ant CTCL. We conclude that gene expression profiling of CTCL reveals signatures differenti-
ating less aggressive and more aggressive CTCL. Additional prospective long-term studies to
validate and refine these findings appear warranted.
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Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven
tumorigenesis
KA Honeycutt,1 M Koster,1 Z Chen,2 M Miers,2 J Nuchtern,2 J Hicks,2 D Roop1 and J Shohet2
1 Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX and 2 Pediatrics,
Baylor College of Medicine, Houston, TX
Minichromosomal maintenance protein 7 (MCM7) is an essential component of the replica-
tion helicase complex (MCM2-7) required for DNA replication. While this function is highly
conserved among eukaryotes, additional functions for the MCM molecules continue to be
described. MCM7 is a marker for proliferation and is up regulated in a variety of tumors includ-
ing prostate, cervical and hypopharyngeal carcinomas. To further investigate the general role
of MCM7 in tumorigenesis, we generated a mouse model with deregulated MCM7 expres-
sion targeted to the basal layer of the epidermis using the K14 promoter (K14.MCM7). When
subjected to a two-stage chemical carcinogenesis protocol (DMBA initiation with TPA pro-
motion), K14.MCM7 mice showed significantly increased incidence and prevalence of tumor
development relative to controls. Furthermore, within 40 weeks of treatment over 45%
K14.MCM7 mice exhibited tumors that had converted to squamous cell carcinomas versus
none in the control group. As predicted from previous skin carcinogenesis studies using DMBA
as the initiating agent, Ras mutations where found in more than 90% of tumors isolated from
K14.MCM7 mice. While previous studies have shown that MCM7 is useful as a proliferation
marker, our data suggest that deregulated MCM7 expression actively contributes to tumor for-
mation, progression and malignant conversion.
24 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
145
Effect of Dsg2 on epithelial cell proliferation, differentiation, and survival: microarray analy-
sis reveals induction of both oncogenes and tumor suppressor genes
D Brennan, Y Hu and MG Mahoney Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Epidermal cell-cell adhesion plays pivotal roles in maintaining tissue architecture and func-
tion as illustrated by the development of several life-threatening skin conditions when cell
adhesion is impaired. Yet, decreased cell-cell adhesion has also been implicated in the devel-
opment of biologically aggressive epithelial tumors highlighting complex roles of cell adhe-
sion molecules in health and disease. To elucidate the role of desmoglein 2 (Dsg2) in skin
biology, we established transgenic mice (Inv-Dsg2) expressing Dsg2 in the superficial epi-
dermis under control of the involucrin promoter. Inv-Dsg2 mice exhibited epidermal hyper-
plasia associated with an increase in cell proliferation possibly mediated by enhanced acti-
vation of the PI-3-kinase/AKT signaling pathways and increased phosphorylation of MAP kinase
substrates. This hyperproliferative phenotype may facilitate the accelerated wound healing in
Inv-Dsg2 mice. Cultured keratinocytes from Inv-Dsg2 skin were more proliferative and clono-
genic than control cells. In addition, Inv-Dsg2 keratinocytes showed enhanced cell survival
in the anchorage-independent state, a trait characteristic for transformed cells. Interestingly,
Inv-Dsg2 mice developed intraepidermal skin lesions resembling precancerous papillomas.
Collectively, our results demonstrate that, in addition to cell-cell adhesion, Dsg2 plays an
unanticipated role in keratinocyte growth and survival. We sought to identify genes associ-
ated with this hyperproliferative phenotype by comparing the expression profile of Inv-Dsg2
with cDNA from wild type mice as control. More than 56 genes were upregulated and 20
genes down-regulated by more than threefold in the Inv-Dsg2 over the wild type skin. Unex-
pectedly, induction of both candidate tumor suppressor genes as well as oncogenes was
detected in the Inv-Dsg2 skin. To gain further insights into these paradoxical findings, we tested
the role of Dsg2 in tumorigenesis using the two-step model of a chemically induced skin car-
cinogenesis.
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Xenobiotic metabolizing capabilities of the EpiDerm in vitro human skin equivalent: utility
for assessing dermal biotransformation of pharmaceuticals and environmental chemicals
J Bolmarcich,1 PJ Hayden,1 G Stolper,1 T Hu,3 M Aardema,3 R Curren2 and M Klausner1 1
MatTek Corp., Ashland, MA, 2 Institute for In Vitro Sciences, Gaithersburg, MD and 3 Procter
and Gamble Co., Cincinnati, OH
The EpiDerm in vitro human skin equivalent has shown utility as an alternative to animal tests
for assessment of skin corrosivity, irritation, and photoxicity. Efforts are now underway to
expand the use of the model for skin genotoxicity screening. Human skin contains xenobi-
otic metabolizing capabilities provided by a variety of phase I (oxidative) and phase II (con-
jugative) enzyme systems. These XMEs can play an important role in biotransformation of
topically exposed chemicals, leading to formation of mutagenic metabolites. The present work
evaluated expression of XMEs in EPI-200. Affymetrix gene expression microarrays were uti-
lized to compare XME gene expression in EpiDerm to that of excised human skin. Numerous
XMEs including cytochrome P450s (CYPs), epoxide hydrolases, flavin-containing monooxy-
genases, N-acetyltransferases, glutathione peroxidases, glutathione S-transferases (GST) and
UDP glycosyltransferases were detected, with a high concordance between specific XMEs
expressed in the ex vivo skin and the EpiDerm model. Additional RT-PCR gene expression
experiments were conducted to evaluate baseline and inducible expression of CYP isoforms
in EpiDerm cultures. 3-Methylcholanthrene (3MC) and β-naphthoflavone (βNF) strongly
increased expression of CYP1A1 and CYP1B1, and slightly enhanced expression of CYP2C19,
CYP2D6, CYP3A4 and CYP3A5. Enhanced metabolism of the CYP1A1 and CYP1B1 sub-
strate ethoxyresorufin confirmed increased activity following treatment with 3MC or βNF. Total
GST activity in EpiDerm was also evaluated by measuring conjugation of glutathione with 1-
chloro-2,4-dinitrobenzene. High baseline GST activity was not further enhanced by 3MC or
βNF treatment. The results demonstrate that the EpiDerm in vitro human skin equivalent pos-
sesses numerous in vivo-like XME activities and may thus be useful for evaluating dermal
metabolism of drugs, cosmetics and environmental chemicals.
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Electrospun three-dimensional (3D) hyaluronan (HA) nanofibrous scaffold: A novel mate-
rial for acute and chronic wounds
Y Ji,2 K Ghosh,1 RA Clark1,3 and M Rafailovich2 1 Biomedical Engineering, SUNY Stony
Brook, Stony Brook, NY, 2 Materials Science and Engineering, SUNY Stony Brook, Stony
Brook, NY and 3 Dermatology, SUNY Stony Brook, Stony Brook, NY
A unique 3D HA nanofibrous scaffold was fabricated to mimic the architecture of natural extra-
celluar matrix using electrospinning. A thiolated HA derivative, 3,3’-dithiobis(propanoic dihy-
drazide)-modified HA (HA-DTPH), was utilized to form 3D nanofibrous scaffolds. In order to facil-
itate fiber formation during electrospinning, polyethylene oxide (PEO) was added to the aqueous
solution of HA-DTPH at an optimized weight ratio of 1:1. The electrospun HA-DTPH/PEO blend
scaffold was subsequently cross-linked by polyethylene glycol diacrylate (PEGDA) in ~10 min.
PEO was then extracted in deionized water to obtain an electrospun HA nanofibrous scaffold.
Scanning electron microscopy was used to investigate the morphology change of electrospun
scaffolds before and after PEO extraction. Electrospun HA scaffolds maintained 3D architecture
of a nanofibrous, microporous scaffold. Although porous size remained 3 - 5 microns in diame-
ter, the average fiber diameter increased from 80nm to 150nm due to fusion of HA nanofibers
during PEO extraction. Fourier transformed infrared spectrum and differential scanning calorme-
try were employed to confirm the absence of PEO after water extraction. Thermal gravity meas-
urements show that the thermal degradation temperature of HA nanofibrous scaffolds increased
about 20°C after crosslinking. NIH 3T3 fibroblasts were seeded on fibronectin-modified HA nanofi-
brous scaffolds for 24 hours in vitro. Cell morphology studies demonstrated that the fibroblasts
attached and spread on nanofibers. Cells demonstrated an extended dendritic morphology char-
acteristic of cells interacting with a scaffold and in contrast to the flattened morphology seen when
cells are plated on plastic. HA nanofibrous scaffolds are biocompatible, microporous and sup-
port cell invasion This biomaterial can be dried and rehydrated without lossing functional activ-
ity and thus has great potential for treatment of acute and chronic wounds.
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Tannic acid increases deposition of elastin by enhancing its biostability in dermal fibroblast
cultures
F Jimenez,1 TF Mitts1,2 and A Hinek1,3 1 Research & Development, Human Matrix Sciences,
LLC, Visalia, CA, 2 Department of Surgery, Loma Linda University School of Medicine, Loma
Linda, CA and 3 Division of Cardiovascular Research, The Hospital for Sick Children, Toronto,
ON, Canada
Increased proteolytic degradation of extracellular matrix is known to be an important mech-
anism of photoaging and other systemic degenerative diseases. The aims of this investigation
were to determine if tannic acid would protect elastin from degradation by various classes of
elastases and to establish if enhancing the biostability of tropoelastin (soluble precursor of
elastin) could contribute to the net deposition of insoluble elastin by cultured dermal fibrob-
lasts. An enzymatic protection assay was used to determine if tannic acid could protect [3H]-
labeled insoluble elastin from degradation by exogenous serine-, cysteine- and metallo- pro-
teinases. Northern and Western blotting, fluorescent immunocytochemistry and metabolic
labeling were used to assess the influence of tannic acid on levels of elastin mRNA, tropoe-
lastin and insoluble elastin respectively in 7 day-old cultures of adult dermal fibroblasts. A
pulse-and-chase experiment was employed to test if tannic acid would increase durability of
soluble and insoluble elastins produced by cultured dermal fibroblasts. Results indicated that
tannic acid protected insoluble elastin from degradation by all tested exogenous elastases
and newly synthesized soluble tropoelastin from degradation by non-specific endogenous
elastase(s). Moreover, tannic acid-treated cultures contained significantly more tropoelastin
and insoluble elastin but did not display enahanced levels of elastin mRNA or cellular prolif-
eration. We therefore conclude that tannic acid effectively protects tropoelastin and insolu-
ble elastin from proteolytic degradation thereby enhancing their net deposition by human der-
mal fibroblasts.
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Transepithelial migration of tumor cells in precancer - a novel in vitro, 3D human tissue model
A Alt-Holland,1 Y Shamis,1 D Theresa,1 Z Weitian,1 A Margulis,1 N Fusenig2 and J Garlick1 1
Tufts University, Boston, MA and 2 German Cancer Research Center, Heidelberg, Germany
We have previously shown that 3D human tissues harboring mixtures of normal human ker-
atinocytes (NHK) and genetically-marked (β-gal), skin-derived tumor cells (II-4) expressing a
dominant negative form of E-cadherin, mimic precancerous lesions of skin. These E-cadherin-
suppressed cells selectively adhered to the basement membrane (BM) interface in vitro as a
prerequisite for invasion into the stroma after in vivo transplantation. However, mechanisms
through which adhesion-deficient, intraepithelial tumor cells migrate through the epithelium
to reach the BM (transepithelial migration) are not known. To further explore the migratory
behavior of E-cadherin-deficient cells within the epithelium during the transition from pre-
cancer to cancer, we developed a human, 3D tissue model for transepithelial migration. E-
cadherin-deficient or -competent cells were layered onto a confluent sheet of NHK that was
generated 2 days earlier by seeding NHK onto a matrix comprised of Type I collagen or BM-
containing dermis (AlloDerm) and fibroblasts. This sequential seeding prevented II-4 cells from
attaching to the BM and generated multilayered tissues in which II-4 cells initially stratified
above NHK. After growth for 7d at an air-liquid interface, tissues were immunostained for β-
gal to monitor the fate of tumor cells that had penetrated between NHK in the spinous layers
and migrated towards the BM. We determined that at least 10% of E-cadherin-deficient cells
transmigrated within the epithelium, while E-cadherin-competent cells were restricted to super-
ficial layers and did not penetrate into the underlying NHK. Double immunohistochemical
stains were performed for β-gal, β-catenin and FAK. Elevated levels of FAK and activated FAK
were seen in actively migrating adhesion-deficient cells. Upon reaching the BM, these cells
were able to degrade the BM interface and initiate invasion. This novel 3D human tissue model
will facilitate analysis of factors directing the transition from precancerous to cancerous con-
ditions of skin.
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Human dermal fibroblasts demonstrate diminished ability to generate traction forces with
chronolocial age: A potential mechanism of poor wound healing in the elderly
Z Pan,2 K Ghosh,1 YJ Liu,3 V Huang,2,1 S Kambhampati,2 SR Ge,2 T Nakamura,3 RA Clark1 and
M Rafailovich2 1 Biomedical Engineering, SUNY Stony Brook, Stony Brook, NY, 2 Materials
Science and Engineering, SUNY Stony Brook, Stony Brook, NY and 3 Mechanical
Engineering, SUNY Stony Brook, Stony Brook, NY
Elderly patients often display diminished wound healing. Elucidation of the underlying mech-
anism(s) responsible for this phenomenon is important as lessons learned may be applicable to
novel approaches for wound treatment. In this study, cell mechanics of dermal fibroblasts from
25, 40 and 84 year females were compared. Cells were cultured on hyaluronan hydrogels teth-
ered with the cell-binding domain of fibronectin at a bulk density of 268 nM (engHAgel). This
engineered construct emulates the second provisional matrix of wounds and has a stiffness (G’
by rheometry studies) of 4.3 kPa, which falls between the stiffness of a fibrin clot and normal
dermis. Fibroblasts were cultured on engHAgel in serum-free DMEM for 6 hours at room tem-
perature and then released by EDTA. The deformation of engHAgel caused by cellular traction
forces was detected by tracing the displacement of fluorescent beads embedded in engHAgel
by confocal imaging before and after cell traction. Cellular traction forces were quantitatively
determined by Finite Element Method in a linear elastic model with a high spatial resolution.
Results were correlated with auxiliary measurements of substrate modulus, cell modulus and
migration. We found that with increasing age, the magnitude of cell traction forces diminished.
Similarly, the ability of cells to adapt to changes in mechanical properties of their environment
and to migrate was impaired. The data suggest either an abnormal linkage system between the
substrate (engHAgel) and the actin cytoskeleton (f-actin) or an attenuated f-actin. Ongoing stud-
ies are focused on delineating which underlying mechanism is at play. Ultimately we believe
our results will bring new fundamental knowledge on poor wound healing in the elderly and
hopefully lead to new therapeutic approaches to these wounds.
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CD10, a marker for specialized mesenchymal cells (onycofibroblasts) in the nail unit
D Lee, K Lee, J Yang and E Lee Dermatology, Sungkyunkwan University, Samsung Medical
Center, Seoul, South Korea
The research on the nail has been focused on the epithelial components in the nail unit.
However, little is known about the mesenchymal cells in the nail unit. CD10 is a cell surface
metalloprotease and it is expressed by a variety of normal and neoplastic lymphoid and non-
lymphoid tissues. We have recently found the expression of CD 10 in the dermal sheath cells
of hair follicles in human scalp tissue, but we did not find it in dermal fibroblasts, and this
suggests that CD 10 may be expressed only in specialized mesenchymal cells. In this study,
we examined the immunohistochemical localization of CD10 and we compared it with the
other markers for mesenchymal cells in the nail unit. CD10 was selectively expressed in the
well-defined areas, the mesenchymal cells and the surrounding extracellular matrix (ECM)
beneath the nail matrix and proximal nail bed. CD10 was negative in the endothelial cells
inside the CD10-positive mesenchyme. Also, in the proximal nailfold CD10 was not expressed
in dermal fibroblasts and surrounding ECM. Other mesenchymal markers, except vimentin,
were negative in the CD10-positive mesenchyme. Based on these finding, we propose call-
ing the specialized mesenchymal cells onychofibroblasts because they can be distinguished
from the dermal fibroblasts by their CD10 expression. We expect that onychofibroblasts, which
may have an influence on the nail matrix for nail formation through epithelial-mesenchymal
interactions, can be important for our better understanding of nail biology.
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Cholinergic regulation of keratinocyte directional migration is mediated by the Ras/Raf-
1/MEK1/ERK signaling pathway altering integrin expression
A Chernyavsky,1 J Arredondo,1 E Karlsson,3 I Wessler2 and SA Grando1 1 Dermatology,
University of California, Davis, CA, 2 Institute of Pathology, Johannes Gutenberg University
of, Mainz, Germany and 3 Experimental Geriatrics, NEUROTEC, Karolinska Institute,
Huddinge, Sweden
Keratinocyte migration is regulated through both the nicotinic and muscarinic classes of acetyl-
choline (ACh) receptors. We sought to identify the signaling pathway mediating the choliner-
gic regulation of chemotaxis and galvanotropism. The pharmacologic and molecular modi-
fiers of the Ras/Raf-1/MEK1/ERK signaling pathway altered both chemotaxis toward choline
and galvanotropism toward the cathode in a similar way, indicating that the same signaling
steps were involved. The galvanotropism was abrogated due to inhibition of ACh production
by hemicholinium-3 and restored by exogenously added carbachol. The concentration gradi-
ents of ACh, and choline toward the cathode in a direct current (DC) electric field were estab-
lished by HPLC measurements. This suggested that keratinocyte galvanotaxis is, in effect,
chemotaxis toward the concentration gradient of ACh which it creates in a DC field due to its
highly positive charge. A time-course immunofluorescence study of the membrane redistrib-
ution of ACh receptors in keratinocytes exposed to a DC field revealed rapid relocation to and
clustering at the leading edge of α7 nicotinic and M1 muscarinic receptors. Their inactivation
with selective antagonists or small interfering RNAs inhibited galvanotropism, which could
be prevented by transfecting the cells with constitutively active MEK1. The endpoint effect of
the cooperative signaling downstream from α7 and M1 through the MEK1/ERK was an upreg-
ulated expression of α2 and α3 integrins, as judged from the results of real-time PCR and
quantitative immunoblotting. Thus, α7 works together with M1 to orient a keratinocyte toward
direction of its future migration. Both α7 and M1 apparently engage the Ras/Raf/MEK/ERK path-
way to upregulate expression of the “sedentary” integrins required for stabilization of the lamel-
lipodium at the keratinocyte leading edge.
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Genetic restriction of anti-desmoglein (Dsg) 1 antibodies in pemphigus foliaceus (PF)
K Ishii,1 H Li,1 C Lin,1 S Kacir,2 M Amagai,3 DL Siegel2 and JR Stanley1 1 Dermatology,
University of Pennsylvania, Philadelphia, PA, 2 Pathology, University of Pennsylvania,
Philadelphia, PA and 3 Dermatology, Keio University, Tokyo, Japan
The first step in determining the feasibility of more specific therapy in PF patients by targeting
anti-Dsg1 autoantibodies is to examine the genetic restriction of such antibodies. To address
this issue we isolated human monoclonal anti-Dsg1 antibodies from a PF patient by phage
display. Using PCR to amplify cDNA encoding the immunoglobulin variable regions of the
heavy and light chains from a PF patient’s lymphocytes, we constructed a library of phage,
each one containing cDNA encoding a single chain variable fragment (scFv) antibody that is
expressed on the surface. We panned this library on Dsg1 to find 22 unique anti-Dsg1 scFv.
Genetic analysis of these antibodies showed a remarkable restriction of the heavy chain vari-
able region (VH) gene usage to only three genes (VH1-18, VH1-08, VH3-09). Light chains were
also restricted, but less so. To determine whether the light chain contributed to the immunore-
activity against Dsg1, we recombined one particular heavy chain with the entire light chain
repertoire. This light chain shuffling experiment showed that only certain sets of light chains
could be paired with the restricted heavy chains to yield anti-Dsg1 antibodies. However, the
immunochemical characteristics of these scFv were determined by their heavy chain usage in
that the three VH genes resulted in three groups of antibodies recognizing: 1) conformational
Dsg1 epitopes with cross-reactivity to Dsg4, 2) conformational Dsg1 epitopes without cross-
reactivity to Dsg4, or 3) denatured Dsg1 epitopes without cross-reactivity to Dsg4. PF sera
from other patients blocked binding of these monoclonal antibodies to Dsg1, suggesting shared
epitopes, and perhaps similar antibody gene usage among patients. Such studies show that in
an individual PF patient, anti-Dsg1 antibodies may result from very few heavy chain genes
and, therefore, targeting such gene products may be possible, at least in any individual patient
and potentially among different patients.
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Induction of complement-fixing autoantibodies against type VII collagen results in subepi-
dermal blistering in mice
C Sitaru,1 MT Chiriac,1 S Mihai,1 J Buning,2 A Gebert,3 A Ishiko4 and D Zillikens1 1
Dermatology, University of Lubeck, Lubeck, Germany, 2 Internal Medicine, University of
Lubeck, Lubeck, Germany, 3 Anatomy, University of Lubeck, Lubeck, Germany and 4
Dermatology, Keio University, Tokyo, Japan
Epidermolysis bullosa acquisita (EBA) is a blistering disease associated with autoantibodies to
type VII collagen, a major constituent of the dermal-epidermal junction (DEJ). Recently, we
developed in vitro and in vivo models that are useful to dissect the pathogenesis of blister
induction by autoantibodies in EBA. However, the induction of the autoimmune response to
type VII collagen cannot be studied in these models. Therefore, in the present study, we attempted
to develop a model of EBA reproducing the active disease by immunization of mice. Animals
of 4 strains, including BALB/c (H2d), FcgammaR2b-deficient (H2b), SJL-1 (H2s), and SKH-1
(outbred), were immunized with a recombinant form of the murine type VII collagen NC1
domain. All mice (n=60) developed circulating serum IgG autoantibodies to type VII collagen
as determined by immunofluorescence and immunoblot studies. These antibodies exclu-
sively bound to the lamina densa of mouse skin by immunoelectron microscopy. Levels of
autoantibodies, evaluated at different time points by ELISA using recombinant antigen, were
similar in all strains. Immunofluorescence analysis of murine skin revealed deposition of IgG
at the DEJ. Importantly, subepidermal blisters developed in 82% of SJL-1 and 56% of BALB/c
mice, but not in SKH-1 and FcgammaR2b-deficient mice. In susceptible animals, deposits of
IgG1, IgG2 and complement C3 were detected at the DEJ. In contrast, in the non-responder
mice, tissue-bound autoantibodies were exclusively of the IgG1 subclass and complement
activation was weak or absent. In conclusion, for the first time, we report an active disease
model in mice reproducing the clinical, histo- and immunopathological as well as ultrastructural
findings in EBA. This model should be most helpful to study the autoimmune response to type
VII collagen and to develop immunomodulatory therapies for this and other autoimmune
blistering diseases.
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Mechanisms of pemphigus vulgaris IgG-induced desmosome disassembly
E Delva, C Calkins, J Jennings, S Smith and A Kowalczyk Emory University, Atlanta, GA
Pemphigus vulgaris (PV) is an autoimmune skin disease in which autoantibodies target the
desmosomal cadherin desmoglein 3 (Dsg3). These autoantibodies cause severe mucosal and
epidermal blistering by disrupting adhesion mediated by desmosomes. The means by which
PV IgG binding results in desmosome disruption is unclear. PV IgG-induced acantholysis could
be due to steric hindrance, activation of signaling pathways, or some combination of these
events. To determine if PV IgG binding to Dsg3 is sufficient to disrupt desmosomes, we com-
pared the effects of PV IgG on keratinocyte adhesion at 4°C versus 37°C. No changes in desmo-
some morphology or adhesive strength were observed when keratinocytes were exposed to
PV IgG at 4°C. In contrast, cells incubated at 37°C with PV IgG exhibited desmosome dis-
ruption & loss of adhesion, suggesting that downstream events after PV IgG binding to Dsg3
are required for desmosome disruption. Furthermore, PV IgG binding to Dsg3 caused Dsg3
to be internalized & trafficked through an endo-lysosomal pathway, resulting in a dramatic
loss of surface Dsg3 over a time course that paralleled the disruption of keratinocyte cell adhe-
sion. Experimental manipulations that block clathrin-mediated endocytosis had no effect on
Dsg3 internalization, whereas cholesterol depleting agents virtually eliminated Dsg3 endo-
cytosis, suggesting that the PV IgG-Dsg3 complex is internalized through a caveolin depend-
ent pathway. In addition to causing internalization, PV IgG treatment caused cell surface Dsg3
to reorganize into linear streaks that colocalized with desmoplakin. However, Dsg3 that was
internalized into endosomes failed to colocalize with desmoplakin. Overall, these data indi-
cate that PV IgG ligation of Dsg3 triggers a coordinated series of events that drive desmosome
disassembly, including Dsg3 endocytosis and degradation. These data further indicate that
the kinetics of Dsg3 turnover may be important in PV pathogenicity & suggest a novel role for
DP in regulating Dsg3 cell surface distribution and dynamics.
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“Micropatterning” of laminin-332 (laminin-5) by keratinocytes in vivo is β4 integrin depend-
ent and determines keratinocyte motile behavior
B Sehgal,1 P DeBiase,1 J Claiborne,1 S Matzno,1 S Hopkinson,1 P Marinkovich,2 A Russell3
and J Jones1 1 Cell and Molecular Biology, Northwestern University, Chicago, IL, 2
Dermatology, Stanford University School of Medicine, Stanford, CA and 3 Cytokinetics, Inc.,
South San Francisco, CA
Whether α6β4 integrin regulates keratinocyte migration is controversial. To assess whether β4
integrin plays a role in migration, we first compared the motility of β4 integrin-deficient (JEB)
keratinocytes with that of their wild-type counterparts. Both cell types express YFP-tagged
laminin-332 so that we can monitor matrix organization in relation to cell motility using live
cell imaging techniques. JEB cells display an aberrant motility behavior in that they move in
tight circles on circular arrays of laminin-332 in their matrix. This motility behavior is inhib-
ited by laminin-332 antagonists. In contrast, wild-type keratinocytes and JEB keratinocytes,
induced to express β4 integrin, assemble laminin-332 in linear tracks over which they migrate.
Laminin-332-dependent migration of JEB keratinocytes along linear tracks is restored when
cells are plated on wild-type keratinocyte matrix, whereas wild-type keratinocytes show rota-
tion on circular arrays of laminin-332 when plated on JEB keratinocyte matrix. The activities
of Rac1 and the actin cytoskeleton-severing protein cofilin are low in JEB keratinocytes com-
pared with wild-type cells and, additionally, in wild-type cells Rac1 complexes with α6β4
integrin. Thus, we investigated the role of the small GTPases and cofilin in regulating laminin-
332 matrix assembly and, hence, keratinocyte motility. Wild-type keratinocytes exhibit the
laminin-332 matrix organization and motile behavior of JEB keratinocytes when Rac1 or cofilin
activities are inhibited. In summary, the organization of laminin-332 matrix is determined by
the α6β4 integrin/actin cytoskeleton via Rac1/cofilin signaling. Furthermore, our results imply
that the organizational state of laminin-332 is a key determinant of the motility of keratinocytes,
an essential element of skin wound healing and invasion of keratinocyte tumor cells.
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EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in nor-
mal and scleroderma fibroblasts
H Ikeda,1 T Sunazuka,2 S Omura,2 H Suzuki,1 S Yamazaki 1 and A Hatamochi1 1 Dokkyo
University School of Medicine, Mibu, Japan and 2 Kitazato Institute, Kitazato University,
Tokyo, Japan
Systemic sclerosis (SSc) is a fibrotic disorder characterized by excessive accumulation of col-
lagen in the skin and a variety of internal organs. The accumulation of collagen is thought to
result from enhanced transcription of collagen in fibroblasts. None of treatment modalities
for patients with SSc has brought satisfactory improvement. We previously presented tran-
scriptional inhibition of type I collagen gene expression in normal and scleroderma fibrob-
lasts by EM703. In this time we investigated the mechanism for the inhibition of transcription
of type I collagen. Three normal and SSc fibroblasts were cultured with routine methods. When
the cell layers had become confluent, the cells were incubated for 48 hours at 37oC in DMEM
containing 1% FBS, supplemented with 10-7 M ~10-5 M of EM703. Amounts of collagen were
measured using ELISA for type I collagen . Northern blots analysis, luciferase assay, elec-
trophoretic gel mobility shift assay were also performed. EM703 reduced collagen produc-
tion( to 40% in maximum) and mRNA levels of α1(I) collagen(to 30% in maximum) in a dose
dependent manner in normal and SSc fibroblasts. COL1A1 transcription was down-regulated
by addition of EM703(10-5 M ) to 30% by the luciferase assay using various length of type I
collagen promoter even deleted to only 133bp. Interestingly EM703 do not inhibit COL1A1
transcription by the Luciferase assay using 332bp promoter with point mutation of CCAAT
box. However, nuclear extracts from fibroblasts treated with EM703 do not change the CCAAT-
binding factor(CBF) binding activity. These results suggest that EM703 inhibits transcription of
type I collagen through CCAAT box in normal and scleroderma fibroblasts
159
Effects of 8-methoxypsoralen on melanocytes adhesion, migration and expression of matrix
metalloproteinase-2 in vitro
X Zhang,1 M Zheng,1 J Feng,2 K Mou2 and H Ma2 1 Dermatology, Second Hospital of
Zhejiang University, Hangzhou, Zhejiang, China and 2 Dermatology, Second Hospital of
Xi’an Jiaotong University, Xi’an, Shanxi, China
8-Methoxypsoralen(8MOP) has long been used for the treatment of vitiligo and revealed good
results, but the mechanism is still not well known. It is generally considered that the migra-
tion of outer root sheath melanocyte precursors into vitiligo lesions play a key role for the
repigmentation and matrix metalloproteinases (MMPs) play an important role for cells migra-
tion. Recent studies show that 8MOP is a mitogenic and melanogenic for normal human
melanocytes. In this report we observed the effects of 8MOP on melanocytes adhesion, migra-
tion and expression of MMPs in vitro. Human melanocytes were obtained from normal human
foreskins and culture dishes coated with fibronectin (FN) were used to perform melanocytes
adhesion assay. Motility was assessed using the Transwell micropore filter method and RT-PCR
methods were employed for MMPs expression assay. The proteolytic activities of the MMPs
secreated in the culture medium were also assessed by gelatin zymography. We also use rho-
damine-conjugated phalloidin to visualize the cytoskeleton actin. We found that 8MOP pro-
mote melanocytes migration and adhesion to FN and induce reorganization of the actin
stress fiber cytoskeleton. 8MOP could induce melanocytes adhesion and migration signifi-
cantly at 10 nM and shown the max. effect on melanocytes adhesion and migration at 100
nM. Treatment with 8MOP could induce strong expression of MMP-2 (gelatinase A, 72-kDa
type IV collagenase), but weak expression of MMP-9 (gelatinase B, 92-kDa type IV collage-
nase). The expression of MMP-2 is significantly increased in a dose dependent manner at the
concertrations tested and MMP-2 was able to be activated in the extracellular environment.
These results suggest that 8MOP play multiple roles such as promoting melanocyte migration
and adhesion in the treatment of vitiligo and that MMP-2 may also contribute to the process.
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A new synthetic peptide that exhibits interesting anti-aging effects
C Gondran, E Bauza, G Bressier, C Dal Farra and N Domloge Research Center, Vincience,
Sophia Antipolis, France
During skin aging, alterations of the main components of the dermis lead to the degradation
of functional skin properties and also carry cosmetic consequences including the loss of skin
firmness and the appearance of wrinkles. In this study, we were interested in evaluating the
in vitro anti-aging effects of a new synthetic heptapeptide on human skin. Cultured human
fibroblasts and skin biopsies were treated with the peptide at 10-6 M for 24 to 72 hours. The
peptide’s effect on the synthesis of collagen I and III, and beta 1 integrin was then evaluated.
Collagen I and III synthesis was assessed using complementary techniques (immunolabeling,
western-blot, and ELISA for cultured fibroblasts; and immunolabeling for skin biopsies). This
study revealed a significant increase in the production of collagen I and III in peptide-treated
fibroblasts after 24 and 48 hours of treatment. These results were confirmed by the studies on
human skin biopsies. As cell-matrix interactions mediated by beta-1 integrin are a target of
the aging process, we also investigated the effect of this peptide on beta-1 integrin synthesis
in human dermal fibroblasts and epidermal keratinocytes. We observed an enhancement of
beta-1 integrin immunolabeling both in peptide-treated fibroblasts and keratinocytes, after
24 and 48 hours of treatment. These results strongly suggest that this peptide can play a role
in the collagen-matrix interaction and in the cohesion of the epidermal basal layer and the
dermal-epidermal junction. Finally, we studied the peptide’s effects on skin repair by using
an in vitro model of wound healing. Peptide treatment was shown to significantly improve
fibroblast migration from the edge of the wound, suggesting that the peptide possesses impor-
tant properties that can be applied to dermal wound repair. Because of its positive effects on
collagen I and III synthesis, on beta-1 integrin expression, and on in vitro wound healing, this
new peptide can be of great use in products that act on skin firmness, and can be particularly
useful in the field of anti-aging skin care.
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Dermal lattice use in alternative methods to animal testing
T Marchand, E Bauza, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, France
In recent years, interest in the development of alternative methods to animal testing has increased
significantly. Accordingly, the search for new in vitro approaches that enable toxicity testing
of cosmetic products has become a central focus of research. However, most alternative meth-
ods do not allow for testing of oil-soluble active ingredients or cosmetic products. Further-
more, the experimental conditions of these alternative tests are, for the most part, very differ-
ent from the human skin. Hence, we were interested in developing a 3D dermal lattice model
that is close to skin dermal structure and which allows for the testing of oil-soluble active ingre-
dients. To meet this goal, it was necessary to determine the adequate quantity of each of the
model’s components, including collagen I and primary fibroblasts. It was also necessary to
determine the time of culture that would make it possible to obtain a reproducible and easy-
to-handle structure. Studies on the porosity of the lattice, revealed the necessity to add mixed
solvents, which enabled a good diffusion of the products throughout the lattice, similar to the
controls. Toxicity evaluation was carried out by measuring the viability of the lattice, by MTT,
after application of the oil-soluble active ingredients for 24 hours. Parallel studies using the
Het-Cam test were also performed. The results of these comparative studies were encourag-
ing and revealed that the lattice is a reliable model for testing oil-soluble active ingredients.
The results provided conclusions similar to those of the Het-Cam method and were repro-
ducible when the same experiments were repeated under the same conditions. These studies
show that this dermal lattice provides an interesting alternative method to animal testing for
the evaluation of oil-soluble active ingredients, and offers experimental conditions that are
close to those found in organisms.
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Comparative study of the dynamics of focal contacts between live keratinocytes and fibrob-
lasts
T Ozawa,1,2 D Tsuruta,2 H Kobayashi,2 T Harada,1,2 K Ikeda,4 A Kawada3 and M Ishii2 1
Plastic and Reconstructive Surgery, Osaka City University Graduate School of Medicine,
Osaka, Japan, 2 Dermatology, Osaka City University Graduate School of Medicine, Osaka,
Japan, 3 Dermatology, Kinki University Medical School, Osaka, Japan and 4 Anatomy, Osaka
City University Graduate School of Medicine, Osaka, Japan
Communication between cells and the extracellular matrix (ECM) impacts the regulation of
various cellular functions. The focal contacts (FCs) are sites of interaction between cells and
the ECM and highly dynamic in mesenchymal cells. Hemidesmosomes (HDs) had been believed
to be stable anchoring structure, but, recent studies showed that HDs are also dynamic. In
addition to HDs, KC also has been reported to have dynamic FCs. Thus, KC has dual adhe-
sion system composed of HDs and FCs. This raises the questions;whether HDs and FCs in KCs
are complexed in one structure (that is, hybrid matrix adhesion) or not; whether HDs and FCs
interact each other or not (whether they are independent or dependent). In order to answer
these questions, we compared the dynamics of FCs probed with GFP-tagged actinin-1 in live
KCs (HaCat cells) and in live fibroblasts (FBs, 3T3 cells). As a result, the velocity of FCs in KCs
was significantly slower than in FBs (81.72±53.51 nm/min vs 116±85.53 nm/min). The size
of FCs in KCs was significantly smaller than in FBs (3.06±1.74 µm2 vs 3.96±2.14 µm2). The
direction of the movements is quite different; that of FCs in KCs are relatively regular (cen-
tripetal; 80%, centrifugal; 2.5%, no movement; 17.5%) but in FBs are rather random (cen-
tripetal; 37%, centrifugal; 12%, along with the membrane; 8%, no movement; 29%, others;
14%). The appearance of newly formed FCs and disappearance of FCs are not significantly
different between KCs and FBs. The difference of mobile fraction (91.14±11.61% vs
80.38±21.53%) and that of t1/2 value (73.86±39.22 s vs 99±15.00 s) in the FRAP analyses
between KCs and FBs was not significant. The difference of velocity, size and the direction of
the movements of FCs between KCs and FBs may suggest the communication of FCs and HDs
in KCs.
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Telomerase expression alters the expression of MMP-1 and cell cycle proteins in human der-
mal fibroblasts
K Chung,1 H Lew,1 H Chung1 and M Ha2 1 Department of Dermatology, Yonsei University
College of Medicine, Seoul, South Korea and 2 Department of Biochemistry and Molecular
Biology, Seoul National University College of Medicine, Seoul, South Korea
Telomere shortening has been implicated as an important mechanism that drives somatic cells
into termination of cellular division and finally into cellular senescence. However, in germ
line cells and tumor cells, of which show distinct characteristics of ceaseless cellular division
without entering cellular senescence, the presence of telomerase prevents the telomore short-
ening. The expression of the catalytic subunit of human telomerase (hTERT) in normal human
fibroblasts allows them to escape replicative senescence. In this study, we expressed hTERT
in human neonatal foreskin fibroblasts (NFB-hTERT) and investigated the influence of hTERT
on the cell cycle and metabolism of type I collagen. With increased passage, the NFB-hTERT
cells showed down-regulation of p16 and cyclin D1 levels while the expression of CDK4 did
not change. The basal level of type I collagen decreased with increased passage in NFB but
the level did not change in NFB-hTERT. Basal level of matrix metalloproteinase 1 (MMP-1)
was reduced in NFB-hTERT and treatment of TNF-α resulted in less induction in NFB-hTERT.
The tumor suppressor proteins p53, p21 and p27 were also down-regulated in NFB-hTERT
and these results suggest the mechanism of inhibition of senescence by hTERT in somatic cells.
www.jidonline.org   27
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Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin mol-
ecule in vitro
J Muto,1 K Kuroda,1 H Wachi,2 S Hirose3 and S Tajima1 1 Dermatology, National Defense
Medical College, Saitama, Tokorozawa, Japan, 2 Clinical Chemistry, Hoshi College of
Pharmacy, Tokyo, Shinagawa, Japan and 3 Biological Science, Tokyo Institute of Technology,
Kanagawa, Japan
Elafin, a member of trappin gene family, has unique primary structure with two functional
domains; a transglutaminase substrate domain at N-terminus and a protease inhibitor domain
at C-terminus. Elafin is considered to be expressed constitutively by epithelial cells not by mes-
enchymal cells. Long –standing UV irradiation causes the accumulation of disintegrated elas-
tic fibers in the upper dermis which is defined as actinic elastosis. Accumulation of elafin was
immunohistochemically detected in the actinic elastosis of sun-damaged skin, whereas no
immunoreactivity was seen in the sun-protected skins. In the UV-irradiated skins, elafin was
detected in the dermis colocalizing with elastic fibers. Incubation of synthetic N-terminal pep-
tide of transglutaminase substrate domain of elafin and elastin molecules in the presence of
tissue transglutaminase in vitro resulted in the formation of higher molecular complex in
SDS-PAGE. Elafin expression was not detected in normal cultured skin fibroblasts but irradi-
ation of UVA or treatment with interleukin-1β(IL-1β) induced elafin expression in cultured skin
fibroblasts at both mRNA and protein levels. These results suggest that (1) dermal fibroblasts
potentially express elafin by UV or IL-1βtreatment and (2) transglutaminase substrate domain
of dermal fibroblast-origin elafin interacts with elastin, which enables protease inhibitor domain
to protect elastin from elastolytic degradation. Elafin-elastin complex may accumulate during
long-standing UV irradiation in the actinic elastosis of sun-damaged skin.
164
The detailed thermal collagen denaturation process and its association with gross shrinkage
revealed by second harmonic generation microscopy
S Lin,1 S Wang,1 W Lo,2 W Lin,3 C Dong2 and S Jee1 1 Department of Dermatology, National
Taiwan University Hospital and College of Medicine, Taipei, Taiwan, 2 Department of Physics,
National Taiwan University, Taiepi, Taiwan and 3 Department of Pathology, National Taiwan
University Hospital, Taipei, Taiwan
Thermal collagen denaturation and the associated collagen shrinkage have a number of impor-
tant medical applications. There is limited understanding of the detailed process of collagen
denaturaion and its association with gross shrinkage due to lack of reliable non-invasive inves-
tigation tools. In this work, we investigate the serial changes of thermal collagen denaturation
and associated shrinkage at 58oC by second harmonic generation (SHG) microscopy. The
change in length is correlated with the findings in SHG microscopy and histology. We find
that collagen shrinks progressively from 0 to 9mins of thermal treatment and remains unchanged
in length upon further thermal treatment. The overall SHG intensity also decreases from 0 min
to 9mins of thermal treatment and becomes barely detectable from further thermal treatment.
Interestingly, SHG images reveal a tiger tail-like all-or-non interrupted pattern of collagen
denaturation from thermal treatment. The bands of denatured collagen progressively widen
from increased thermal treatment and completely replace the adjacent bands of normal col-
lagen after 9mins of thermal treatment. In comparison with histological results, SHG images
provide sharper contrast in differentiating normal from denatured collagen. Further, collagen
shrinkage and the SHG intensity are well correlated in a linear model. Our results show that
collagen denaturation from thermal treatment is inhomogeneous, and that SHG intensity can
be used to predict collagen shrinkage associated with thermal collagen denaturation.
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Intravenously injected recombinant human type VII collagen homes to skin wounds and
promotes wound healing
M Chen, J Remington, Y Huang, Y Hou, T Muirhead and D Woodley Dermatology, University
of Southern California, Los Angeles, CA
Patients with dystrophic epidermolysis bullosa (DEB) have incurable skin fragility, blistering
and multiple skin wounds because of mutations in the gene that encodes for type VII colla-
gen (C7). We showed previously that intravenously injected, molecularly-engineered DEB
fibroblasts (over-expressing human C7) homed to the animal’s wound and continuously deliv-
ered C7 to the basement membrane zone (BMZ) of the host’s skin at the wound site. In this
study, we evaluated the feasibility of intravenous injection of recombinant C7 protein for DEB
treatment. To accomplish this, we first made a 1.0-cm square full-thickness wound on the back
of athymic nude mice. Eight hours later, 30 – 60 microgram of recombinant human C7 was
injected into the tail vein. Skin biopsies from wounded and unwounded areas were obtained
every week two weeks after injection and subjected to immunostaining using an antibody spe-
cific for human C7. Surprisingly, the injected C7 trafficked to the wounded skin and deposited
human C7 at the newly formed BMZ of the mouse’s skin. In contrast, there was no detectable
human C7 expression in unwounded areas or in mice who were not wounded prior to injec-
tion. Most interestingly, the wounds of mice that were injected intravenously with C7 demon-
strated accelerated wound healing compared with control mice that were injected with BSA
or laminin 1. The C7 pro-wound healing ability resides within the triple-helical domain because
intravenous injection with the NC1 domain failed to transport to the BMZ of the wounded skin
or promote wound healing. Similarly, C7 delivered to the wound bed via intradermal injec-
tion of recombinant protein or intravenous injection of gene-corrected DEB fibroblasts also
promoted the closure of skin wounds. Our data demonstrate a previously unrecognized prop-
erty of C7, namely, its ability to promote wound healing. In addition to healing chronic wounds,
this strategy may be particularly useful for patients with DEB who have multiple open wounds
and skin fragility.
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Plakoglobin O-glycosylation regulates keratinocyte cell-cell adhesion
P Hu,1 P Berkowitz,1 VJ Madden2 and DS Rubenstein1,3 1 Dermatology, University of North
Carolina-Chapel Hill, Chapel Hill, NC, 2 Pathology, University of North Carolina-Chapel Hill,
Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center, University of North
Carolina-Chapel Hill, Chapel Hill, NC
O-glycosylation modifies and regulates a variety of intracellular proteins. Plakoglobin, which
functions in both cell-cell adhesion and signal transduction, is modified by O-glycosylation;
however, the significance is unknown. To investigate the functional consequence of plakoglo-
bin O-glycosylation, we cloned and over-expressed in keratinocytes murine O-GlcNAc Trans-
ferase (mOGT), the enzyme that catalyzes the addition of GlcNAc to serine and threonine
residues of intracellular proteins. Over expression of mOGT in murine keratinocytes resulted
in (i) increased glycosylation of plakoglobin (ii) a 2.7 fold increase in plakoglobin’s half-life,
and (iii) increased amounts of plakoglobin in both the detergent soluble and detergent insolu-
ble fractions. Increased O-glycosylation of plakoglobin was observed to drive formation of
plakoglobin based adherens junctions and desmosomes and result in a marked increase in ker-
atinocyte cell-cell adhesion. These observations suggest that O-glycosylation is a potent regu-
lator of plakoglobin’s post-translational stability and keratinocyte cell-cell adhesion.
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The cellular mechanism by which hypoxia increases migration of human dermal fibroblasts
D Woodley,1,2 Y Li,1,2 J Fan,1,2 M Chen1 and W Li1,2 1 Dermatology, University of Southern
California, Los Angeles, CA and 2 Greater Los Angeles Veterans Administration Healthcare
System, Los Angeles, CA
When skin is wounded, human dermal fibroblasts (HDFs) migrate into the wound and deposit
new extracellular matrices, a process known as “fibroplasia”. The coagulation of blood vessels
makes the wound environment very hypoxic, and hypoxia is known to promote the migration
of both human keratinocytes and DFs. However, how hypoxia promotes cell motility is unknown.
We report here that induction of hypoxia inducible factor-1 (HIF-1) is sufficient to replace hypoxia
itself in the promotion of HDF migration. Forced expression of either wild type HIF-1 (HIF-1-wt)
or a constitutively activated HIF-1 mutant (HIF-1-CA) in HDFs under normoxia duplicates hypoxia-
driven enhanced cell migration. In contrast, overexpression of a dominant negative HIF-1 mutant
(HIF-1-DN) not only shows little enhancement of HDF migration under normoxia, but also inhibits
hypoxia-increased cell motility. We also found when cells exhibit enhanced cellular migration
due to hypoxia or due to overexpression of HIF-1-wt- or HIF-1-CA under normoxia, these cells
secrete the heat shock protein, hsp90-alpha, into the conditioned medium (CM). Both the hypoxia-
CM from parental HDFs or normoxia-CM from HIF-1-wt- or HIF-1-CA-overexpressing HDFs, but
not HIF-1-DN, enhanced migration of HDFs in normoxic motility assays. This CM-driven enhance
cell migration was totally nullified by the presence of anti-hsp90-alpha antibody. In concordance
with these data, purified hsp90-alpha added exogenously to normoxic HDF motility assays caused
increased cellular motility to the same level as hypoxia. Immune staining of normal human skin
demonstrated Hsp90-alpha expression predominantly in the epidermis. Lastly, we found that
the mechanism by which hsp90-alpha enhanced HDF migration was by maintaining Akt and
ERK in prolonged activated states. This study demonstratse the cellular mechanism by which
hypoxia enhances cell migration. In addition, the data identify a novel and critical downstream
target for HIF-1 that induces enhanced cell motility.
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Binding kinetic analysis of anti-desmoglein 3 monoclonal antibodies by surface plasmon
resonance technology 
K Tsunoda,1,2 S Iemura,3 T Nakagawa,2 T Natsume3 and M Amagai1 1 Dermatology, Keio
University, Tokyo, Japan, 2 Dentistry and Oral Surgery, Keio University, Tokyo, Japan and 3
Biological Information Research Center, National Institute of Advanced Industrial Science and
Technology, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by autoantibodies against
cell-cell adhesion molecule desmoglein 3 (Dsg3). Previously we have isolated anti-Dsg3 IgG
monoclonal antibodies (AK and NAK mAbs) from PV model mice, and showed that epitope
is an important factor to define the pathogenic activity in blister formation in vitro and in vivo.
In this study we analyzed the binding kinetics of these mAb to Dsg3 by surface plasmon res-
onance technology using BIAcore to explore another factor to define the pathogenic activity.
To measure binding kinetics of anti-Dsg3 mAbs, anti-mouse IgG antibody was immobilized
on sensor chip, and mAbs were applied as ligand and then recombinant Dsg3 as an analyte.
Each AK and NAK mAbs showed different binding kinetics to Dsg3. The kinetic ranking of
these mAbs is not necessarily correlated with the pathogenic activities, although pathogenic
mAbs, such as AK23, tended to have higher binding affinity than most of non pathogenic mAbs.
Furthermore, we examined the binding of mAbs when several mAbs were serially applied,
that should mimic polyclonal situation in patients. The binding of some mAbs were affected
by other mAbs. Thus, the binding kinetic analysis using BIAcore will provide another dimen-
sion to dissect molecular mechanisms of blister formation in pemphigus.
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Spatio-temporal control of laminin-5 and -10 expression during anagen hair growth
K Sugawara,1 D Tsuruta,1 H Kobayashi,1 K Ikeda,2 SB Hopkinson,3 JC Jones3 and M Ishii1 1
Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan, 2 Anatomy,
Osaka City University Graduate School of Medicine, Osaka, Japan and 3 Cell and Molecular
Biology, Northwestern University, Feinberg School of Medicine, Chicago, IL
The epithelium of hair follicle is separated from the mesenchyme by a basement membrane
(BM). The epithelium and mesenchyme likely regulate cooperatively hair growth, regression,
and development by BM components through their interaction with epidermal cell surface
receptors. Laminin-5 and -10, which are BM components, have recently been reported to have
important roles in hair development. Yet, little is known about the role of them especially in
regulating hair cycling. To investigate them during hair cycling, we constructed C57BL/6 hair
cycling model mice, and characterized changes in their expression by real-time RT-PCR and
in situ hybridization for mRNA level, western immunoblot and immunohistochemistry for pro-
tein. At the mRNA level, laminin-10 underwent a steady increase throughout anagen stages,
whereas laminin-5 was up-regulated in epidermal, inner, outer root sheath (ORS) and matri-
cal keratinocytes at anagen II-III, and subsequently increased through each succeeding ana-
gen stage. Levels of laminin-5 proteins also were up-regulated at anagen II, but then were lost
after anagen VI. Consistent with these data, ultrastructurally mature hemidesmosomes, whose
assembly is regulated by laminin-5, were seen in the epidermal and ORS keratinocytes at ana-
gen II, while, at anagen VI, ORS keratinocytes assembled only immature form of them. Expres-
sion levels of mRNA encoding proteases, MMP-2, MT1-MMP and BMP-1, which are involved
in laminin-5 processing, were inversely correlated to the laminin-5 protein levels. Moreover,
we assessed whether laminins regulate hair growth using in vitro hair culture. Human pla-
cental laminin, rich in laminin-10, enhanced hair growth while laminin-5 antagonized the
enhancement. In conclusion, our results indicate that hair growth is determined by upregu-
lation of laminin-10 and downregulation of laminin-5.
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A huge cadherin, Fat2 is expressed in human squamous cell carcinoma
S Matsui, Y Miyachi and N Matsuyoshi Department of Dermatology, Graduate School of
Medicine, Kyoto University, Kyoto, Japan
Cadherins are cell surface glycoproteins that mediate calcium-dependent homophilic adhe-
sion. Cadherin superfamily is classified into several subfamilies and they have conserved repeat
motifs (cadherin repeat) in their extracellular domains. Fat cadherins form a distinct subfam-
ily of the cadherin superfamily, and are huge protein with 34 cadherin repeats, epidermal
growth factor-like motifs, a laminin A-G motif, and a cytoplasmic domain. In Drosophila, Fat
play important roles such as tumor-suppresion and planar cell polarity. However, in mam-
mals, the role of Fat are less well understood. In mammal, four Fat cadherins have been reported
including Fat-J, Fat1, Fat2 and Fat3. Although Fat1 is expressed neuroepithelium, lung, kid-
ney and skin, it has been reported that Fat2 proteins are only localized to thin parallel fiber
of carebellar granule cells so far. The purpose of this study is to examine whether Fat2 is
expressed in human squamous cell carcinoma. First we examined Fat2 mRNA expression in
cell line derived from human squamous cell carcinoma (HSC-1) and dermal fibloblast using
reverse transcription PCR. Then Fat2 mRNA in HSC-1 was amplified by its specific primer but
not in dermal fibloblast. To investigate the properties of Fat2, we produced polyclonal anti-
body. Polyclonal anti-Fat2 antibody against the GST-Fat2 fusion protein (cytoplasmic region)
was raised by immunizing New Zealand White rabbits, because the sequence of Fat2 cyto-
plasmic region are quite different from other Fat members. Fat2 protein was detected in HSC-
1 lysate as a large protein approximately 500 kDa by Western blotting. Furthermore, HSC-1
cells were immunostained using same antibody. Endogeous Fat2 was localized cell-cell bound-
aries similar to other cadherins. In brief, Fat2 mRNA and protein were expressed in HSC-1.
In this study, we identified for the first time that Fat2 is expressed in cell line derived from
human squamous cell carcinoma.
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Pathogenic role of apoptosis in experimental pemphigus
N Li, M Zhao, Z Liu and LA Diaz Dermatology, University of North Carolina at Chapel Hill,
Chapel Hill, NC
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are autoimmune skin blistering dis-
eases characterized by autoantibodies against desmogleins (Dsg) and the loss of intraepider-
mal cell adhesion (acantholysis). While PF autoantibodies target Dsg1, PV autoantibodies
are directed against Dsg3. The mechanism of pemphigus acantholysis is not fully understood.
Apoptotic keratinocytes have been recently detected in lesional and perilesional skin of patients
with pemphigus. In vitro studies have demonstrated that pemphigus IgG is able to induce
keratinocyte apoptosis. The aim of this study was to evaluate the potential involvement of
apoptosis in pemphigus in vivo using the mouse models and determine the temporal rela-
tionship between apoptosis and acantholysis. Neonatal BALB/c mice (1-2 days old) were
injected intradermally with pathogenic PF, PV, or normal human IgG. The mice were exam-
ined at different time points (1, 2, 4, 8, 12, and 24 h) post IgG injections. Apoptosis of epi-
dermal cells was measured by the terminal dUTP nick-end labeling (TUNEL) assay. TUNEL
positively labeled epidermal cells first appeared at 8 h, reached a peak level at 12 h, and
remained 24 h post pemphigus IgG injection. Strikingly, the TUNEL positive cells were scat-
tered in a linear distribution in perilesional regions, and along the roof and floor of the his-
tological blisters. Initial histological and clinical blisters were observed at 12 h and 24 h,
respectively, post pemphigus IgG injections. Injection of normal human IgG failed to induce
TUNEL positive staining or acantholysis. Significantly, the caspase-1-like inhibitor z-YVAD-
cmk blocked the blister formation. These results indicate that 1) PF and PV autoantibodies are
able to induce keratinocyte apoptosis in vivo, 2) apoptosis precedes the onset of acantholy-
sis, and 3) apoptosis may play an important role in the pathogenesis of pemphigus.
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Anoikis is triggered by the association between β1B integrin and caspase-8 in human ker-
atinocytes
R Lotti, A Marconi, K Dallaglio, F Truzzi and C Pincelli Dermatology, University of Modena
and Reggio Emilia, Modena, Italy
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix
(ECM). The anchorage of cells to the ECM is mainly mediated by integrins. We have shown
previously that blockade of β1 integrin signal induces apoptosis through the caspase-8 trig-
gered apoptotic pathway. Anti-β1 integrin activates caspase-8 at 1 hr in human keratinocytes.
As the extrinsic apoptotic pathway is triggered by death receptor signal and anoikis has been
shown to be dependent from Fas/Fas ligand system, we first evaluated the expression of Fas
and Fas ligand in keratinocytes after addition of anti-β1 integrin. Blockade of β1 integrin
failed to up-regulate either Fas or Fas ligand in keratinocytes, as shown by flow cytometry up
to 3 hrs. Moreover, human keratinocytes retrovirally infected with human Fas-associated death
domain (FADD) shRNA underwent anoikis upon treatment with anti-β1 integrin antibody.
These results indicate that death receptors are not involved in caspase-8 mediated anoikis. In
order to evaluate a correlation between caspase-8 and β1 integrin, we have immunoprecipi-
tated β1 integrin in suspended cells and immunoprecipitate was blotted against caspase-8.
We demonstrated that pro-caspase-8 co-immuneprecipitates with β1 integrin and is cleaved
starting at 1hr. On the other hand, β1 integrin does not precipitate with FADD. By confocal
microscopy, pro-caspase-8 co-localizes with β1 integrin. While human keratinocytes express
both β1A and β1B integrin variants, as shown by western blotting, pro-caspase-8 co-immuno-
precipitate only with β1B integrin. These results seem to indicate that unligated β1B integrin
directly activates caspase-8-triggered extrinsic apoptotic pathway, without the involvement of
death receptors.
170
α2β1 Integrin has versatile functions during skin wound healing
MC Zweers,1 Z Zhang,1 F Quondamatteo,2 R Hallinger,1 M Aumailley,1 JM Davidson,3
A Pozzi,3 T Krieg1 and B Eckes1 1 University of Cologne, Cologne, Germany, 2 University of
Goettingen, Goettingen, Germany and 3 Vanderbilt University, Nashville, TN
Integrin α2β1 functions as the major receptor for collagen I on a large number of cell types,
including keratinocytes, fibroblasts, endothelial cells and a variety of inflammatory cells. α2β1
has been implicated in many biological processes, such as migration, adhesion and spread-
ing on collagen. Surprisingly, mice deficient for α2β1 develop normally and show no obvi-
ous deficits. Here, we studied the role of α2β1 in different cellular functions in in vitro and in
vivo models, using α2-siRNA and α2β1-deficient mice that we generated. In vitro, keratinocytes
critically depend on α2β1 for adhesion to collagen, whereas skin fibroblasts can partially com-
pensate for loss of α2β1 by expressing other collagen-binding integrins. However, α2β1 defi-
cient fibroblasts fail to generate mechanical tension in a 3D collagen environment, which
could be attributed to alterations in focal adhesions and activation of Rho GTPases. These
data suggested a pivotal role for α2β1 during wound healing in vivo. Unexpectedly, re-epithe-
lialization of excisional wounds of α2β1 integrin-null mice was not impaired, indicating that
keratinocytes do not require collagen for wound closure. Whereas wound contraction and
myofibroblast differentiation was normal, wound breaking strength was reduced, likely due
to an increase in collagen fibril diameter. Infiltration of inflammatory cells is also dependent
on α2β1: whereas macrophage infiltration was not affected, a significant decrease in number
of mast cells was seen. Interestingly, formation of new blood vessels in wounds of α2β1 null
mice was strongly increased. Expression of angiogenic mediators, e.g. VEGF, IL-1α and MCP1
was not changed, suggesting that the increased angiogenesis is intrinsic to endothelial cells.
In conclusion, loss of α2β1 results in severe cellular deficits that can only partly be compen-
sated for during wound healing.
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The phosphatase slingshot 1 regulates motile behavior of keratinocytes
K Kligys, P DeBiase and J Jones Cell and Molecular Biology, Northwestern University,
Chicago, IL
Keratinocyte motility is a highly regulated process that is central to skin wound repair. We are
dissecting the mechanisms that determine the specific motile behavior of skin cells. In vitro,
wild-type keratinocytes assemble linear tracks of laminin-332 over which they move back
and forth. We can modulate the motile behavior of these cells by inducing expression of
either a dominant-negative mutant of the small GTPase Rac1 or a dominant-inactive mutant
of the actin severing protein cofilin. Keratinocytes expressing either of these two mutant pro-
teins move in circles, a motility behavior that is determined by circular tracks of laminin-332
in their matrix. In this study we investigated how cofilin activity is regulated in keratinocytes.
Cofilin activation occurs as a result of its dephosphorylation on serine residue 3 by the sling-
shot (SSH) family of phosphatases. Dominant-negative Rac1, but not dominant-negative cdc42
nor RhoA, inhibits the activity of cofilin in keratinocytes by indirectly inducing cofilin phos-
phorylation on serine residue 3. To assess which phosphatase is involved in regulating cofilin
function/phosphorylation state in keratinocytes, we induced expression of dominant-negative
SSH1 in wild-type skin cells via adenoviral infection. The motility phenotype of the infected
cells was then assessed. Keratinocytes infected with control virus move in linear tracks and
exhibit the motile behavior of their non-infected wild-type cell counterparts. In sharp con-
trast, wild-type keratinocytes expressing dominant-negative SSH1 protein move in circles and
show decreased cofilin activity. In summary, SSH1 is an important determinant of keratinocyte
migration. It functions by regulating the activity of cofilin which, via its impact on actin cytoskele-
ton dynamics, specifies laminin-332 patterning and keratinocyte motile behavior.
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Blockade of alpha5beta1 integrin-CD151 interaction by ganglioside GT1b inhibits focal adhe-
sion kinase (FAK) signaling
X Wang, P Sun and AS Paller Dermatology and Pediatrics, Northwestern University Medical
School, Chicago, IL
CD151, a member of the tetraspanin superfamily, facilitates integrin-dependent migration of
normal keratinocytes. We and others have shown that epidermal gangliosides associate with
tetraspanins (CD82, CD9) and effect biological change through “glycosynapases”, sites of inter-
action between gangliosides and the carbohydrate chains of cellular glycoproteins or matri-
ces. Given the known inhibitory effect of ganglioside GT1b on keratinocyte and SCC12 squa-
mous carcinoma cell migration, we hypothesized that GT1b may form a glycosynapse that
prevents CD151 interaction with alpha5beta1 integrin and thereby inhibit FAK signaling. The
expression of ganglioside GT1b in SCC12 cells was increased either by stable transfection of
cells with GM2/GD2 synthase gene using an RU486-inducible system or by pharmacologi-
cal addition of purified GT1b; GT1b was depleted either by stable transfection of cells with a
ganglioside-specific plasma membrane sialidase gene or treatment of cells with a chemical
reagent, PPPP. CD151 co-immunoprecipitates with alpha5beta1 integrin only when the inte-
grin is activated by fibronectin or by anti-beta1 stimulatory antibody. Ganglioside depletion
augments this association of CD151 with activated alpha5beta1 integrin, whereas overex-
pression of GT1b or blockade of CD151 eradicates the association. Despite the dissociation
of CD151 from alpha5beta1 integrin in the presence of increased GT1b, GT1b still co-immuno-
precipitates with CD151. Treatment of cells with either pharmacological addition of GT1b or
anti-CD151 antibody leads to a four- to seven-fold diminution in both migration and FAK phos-
phorylation on fibronectin. These studies suggest a role for the association of CD151 with acti-
vated alpha5beta1 in epithelial cell migration. Furthermore, the data implicate ganglioside
GT1b as a regulator of this interaction and potentially of wound healing on a fibronectin matrix.
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Gp140/CDCP1 responds to outside-in signals in epidermal wounds to regulate SFKs and PKCδ
C Wahlgren,1,2 TA Brown,2 CA Dunn,2,3 D Frank,2 RO Sigle2 and WG Carter2,3 1 University
of Washington School of Medicine, Seattle, WA, 2 Fred Hutchinson Cancer Research Center,
Seattle, WA and 3 Pathobiology, University of Washington, Seattle, WA
Gp140 is a transmembrane glycoprotein expressed in cell-cell contacts of basal, suprabasal
and spinous cell layers of quiescent epidermis. We previously reported that Gp140 is phos-
phorylated on tyrosine (Y) residues by Src family kinases (SFKs) in response to changes in ker-
atinocyte adhesion. The purpose of this study was to evaluate how signals through extracel-
lular Gp140 in epidermis interact with SFKs in wound repair. We report: (i) phosphorylation
of Gp140Y734 and SFKY416 is increased in keratinocytes within one hour of wounding of
quiescent epidermis. Inhibition of SFKs prevents outgrowth of keratinocytes identifying a novel
role for endogenous SFKs in wound activation. (ii) Dual signals from cell adhesion and liga-
tion of extracellular Gp140 are necessary to increase phosphorylation of Gp140, SFKs and
protein kinase C delta (PKCδ) in a “Gp140 complex” in cell-cell contacts. This suggests that
interaction with extracellular Gp140 regulates phosphorylation by SFKs and PKC. (iii) Removal
of extracellular Gp140 with trypsin generates a transmembrane fragment p80 and internal-
izes Gp140/80. This suggests that proteolysis of extracellular Gp140 regulates its cell surface
expression. We suggest that Gp140 is an epithelial sentinel that receives outside-in signals to
regulate SFKs in wound repair.
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Plakophilin 2 is required for desmoplakin assembly into desmosomes
AE Bass, LM Godsel, EV Amargo and KJ Green Pathology, Northwestern University Feinberg
School of Medicine, Chicago, IL
Plakophilins (PKPs) are members of the armadillo family of junction and signaling molecules
that localize to the cytoplasmic plaque of desmosomes. Although the crucial function of PKPs
in tissue integrity is underscored by the existence of diseases affecting skin and heart, the
molecular basis of these defects is unknown. To test PKP2’s role in desmosome assembly, siRNA
was used to reduce PKP2 by >90% in keratinocytes. Loss of PKP2 severely impaired recruit-
ment of the intermediate filament (IF) anchoring protein desmoplakin (DP), a known PKP
partner, to desmosomes. To explore the mechanism underlying this defect, we examined the
role of PKP2 in three phases of DP assembly we recently established by live cell imaging: 1)
the appearance of punctate DP-GFP fluorescence at new contact zones within 3 min 2) the
coalescence of DP into cytoplasmic particles within 15 min and 3) translocation of particles
to maturing borders. Analysis of fixed cells showed that PKP2 began to accumulate at contact
zones before DP and later co-localized with cytoplasmic particles that aligned with IF. In RNAi-
treated cells, DP was retained in the cytoplasm as diffuse and particulate pools. To test whether
PKP2/DP particles are assembly competent, we used retrospective analysis of DP-GFP-express-
ing keratinocytes imaged live, and then fixed and stained to identify proteins which co-local-
ized with particles that coalesced and moved toward cell-cell contacts. 100% of assembly
competent DP-GFP particles contained PKP2, but not other membrane or plaque components.
As DP particle translocation is blocked by cytochalasin D treatment, we hypothesized that
PKP2 may couple DP particles with actin. Consistent with this, PKP2 co-localized with micro-
filaments in REF52 fibroblasts lacking desmosomes. Our results suggest that both the accu-
mulation of DP during phase I and translocation of DP during phase III requires PKP2, and
raise the possibility that PKP2 might facilitate precursor translocation through interactions with
the actin-based cytoskeleton.
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NADPH oxidase, xanthine oxidase and mitochondria electron transport system involve the
heat shock-induced ROS generation and MMPs expression in HaCaT cells
M Shin, Y Moon, J Seo, S Kim, Y Lee, K Cho, K Kim, H Eun and J Chung Department of
Dermatology, Seoul National University College of Medicine; Laboratory of Cutaneous Aging
Research, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea
Human skin is exposed to infrared radiation (IR) as well as ultraviolet radiation from natural
sunlight. IR typically causes an increase of skin temperature. In the previous study, we have
found that heat shock-induced ROS stimulates MMP-1 and -9 expressions through mitogen-
activated protein kinases signaling pathways in immortalized human keratinocyte HaCaT cells.
In this study, we investigated the sources of ROS generation by heat shock and their roles in
the heat shock-induced MMPs expression in HaCaT cells. To clarify the exact sources of heat
shock-induced ROS production, we investigated the effects of various ROS-generating enzyme
inhibitors on the heat shock-induced ROS generation. Heat shock-induced ROS generation
was significantly inhibited by diphenylene iodonium (DPI, NADPH oxidase inhibitor), allop-
urinol (xanthine oxidase inhibitor), and rotenone (mitochondrial electron transport system
inhibitor), but not by indomethacin (cycloxygenese inhibitor), hydroxyurea (rinucleotide reduc-
tase inhibitor) and NMMA (nitric oxide synthase inhibitor). In addition, DPI, allopurinol, and
rotenone significantly inhibited the heat shock-induced MMP-1 and -9 expressions. These
results suggest that heat shock increases the ROS production by NADPH oxidase, xanthine
oxidase and mitochondrial electron transport system, which may play important roles in heat
shock-induced MMPs expressions in HaCaT cells.
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Cleaved carboxyl-terminal of desmoglein 1 by staphylococcal exfoliative toxin remains on
the surface of keratinocytes in the process of acantholysis
K Nishifuji1 and M Amagai1 1 Dermatology, Keio University School of Medicine, Tokyo, Japan
and 2 Dermatology, Keio University School of Medicine, Tokyo, Japan
Exfoliative toxin A (ETA) produced by Staphylococcus aureus causes superficial epidermal blis-
ters in patients with bullous impetigo. ETA is known to specifically cleave the extracellular
domain of desmoglein (Dsg) 1, a desmosomal cell-cell adhesion molecule. In this study we
attempted to determine whether the cleavage of Dsg1 by ETA is sufficient to cause the loss of
cell-cell adhesion of keratinocytes or the following internalization of digested Dsg1 or other
desmosomal constituents are necessary. We performed time lapse analysis of desmosomal
components in neonatal mice injected with ETA. Intraepidermal microscopic blister forma-
tion on the injected sites was observed approximately 60 min after ETA injection. Disappear-
ance of the extracellular N-terminal domains of Dsg1 from cell surfaces occurred as early as
30 min after ETA injection while the stump of the cleaved C-terminal domains of Dsg1 remained
on cell surfaces until 120 min. Furthermore, the C-terminal stump of Dsg1 remained on the
acantholytic surface of keratinocytes with other desmosomal components although their stain-
ing intensities were less than those at surrounding cell-cell contact sites. These findings favor
the hypothesis that the major cause of the loss of cell-cell adhesion is due to the direct effect
by the cleavage of the extracellular domain of Dsg1, although the combinational effects with
the secondary signal induction including internalization are not excluded.
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Substantial reduction of the subepidermal nerve plexus in skin of diabetic patients compared
to controls
C Reinisch,1 H Traxler,2 S Piringer,2 S Tangl,3 A Nader4 and E Tschachler1,5 1 Department of
Dermatology, Medical University Vienna, Vienna, Austria, 2 Center of Anatomy and Cell
Biology, Medical University Vienna, Vienna, Austria, 3 Department of Oral Surgery, Dental
School, Medical University Vienna, Vienna, Austria, 4 Institute of Pathology,
Hanuschkrankenhaus, Vienna, Austria and 5 Centre de Recherches et d Investigations
Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly, France
Diabetic neuropathy is one of the most common peripheral neuropathies. Skin biopsies have
successfully been used to evaluate morphological changes associated therewith, as for exam-
ple a tremendous reduction of epidermal nerve fibers at distal body sites. We hypothesized
that terminal Schwann cells in the subepidermal nerve plexus, that are ensheating all nerve
fibers, might be affected in diabetic polyneuropathy as well. To visualize the subepidermal
nerve plexus in its entirety, we used dermal sheet preparations of forefoot skin from diabetic
patients and control individuals and did immunostainings for the neural cell adhesion mole-
cule (NCAM/CD56). Computerised image-analysis was used to quantify the subepidermal
nerve plexus. Whereas dermal sheets of control individuals showed a dense, highly ramified
subepidermal nerve network, in diabetic subjects only a diminished nerve plexus could be
found. Within the diabetic group, we detected an average length of the subepidermal nerve
plexus of 6,724 mm ± 1,261 mm / mm2 (mean ± standard deviation) compared to 12,999 mm
± 2,905 mm / mm2 in the control group. Moreover, in diabetic individuals, the length corre-
lated inversely with the level of blood glucose. In both groups, neither age nor sex was cor-
related with the length of the subepidermal nerve plexus. In conclusion, the subepidermal
nerve network containing terminal Schwann cells was strongly reduced in skin of diabetic
patients. If this reduction in terminal Schwann cells is just a consequence of the nerve fiber
loss or is directly caused by hyperglycemia in diabetes deserves further investigations.
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Time - dependent regulation of tight junction proteins during staphylococcus skin infec-
tion<b/>
U Ohnemus,1 K Kohrmeyer,1 P Houdek,1 M Horstkotte,2 I Moll1 and JM Brandner1 1
Department of Dermatology, Universtity Hospital Hamburg Eppendorf, University of
Hamburg, Hamburg, Germany and 2 Department of Infectious Medicine, Universtity
Hospital Hamburg Eppendorf, University of Hamburg, Hamburg, Germany
Recently, Tight Junction (TJ) – proteins have been described in the epidermis. Together with
adherens junction (AJ) proteins they constitute a barrier function within the skin. As we learnt
from simple epithelia, TJ proteins are targets of bacteria and their toxins in the intestine. There-
fore, we investigated the influence of various staphylococcus strains on TJ, AJ, desmosomal
proteins and actin expression in a porcine skin infection model as well as in human ker-
atinocyte cultures of the cell line HaCaT. Confirmed by immunofluorescence staining, we
found that the pathogen S. aureus induces down-regulation of TJ and zonula adherens pro-
teins within porcine skin. The same applied to TJ and AJ proteins at the cell-cell borders of
HaCaT cells, dependent on the amount of bacteria and period of incubation. In both models
there were no visible changes in desmosomal protein and actin expression. Neither in HaCaT
cells nor in porcine skin the commensal S. epidermidis did cause major alterations. Interest-
ingly, disintegration of TJ proteins proved to be regulated in a time-dependent manner after
infection with S. aureus. First of all the TJ protein ZO-1 was lost within 9 hours following infec-
tion. Secondly, Claudin-1 – staining had a maximal loss within 12 hours. With respect to
occludin, an up-regulation of staining intensity was seen within the first 12 hours, then fol-
lowed by a loss until 24 hours after infection with S. aureus. Taken together our results show
that exfoliative toxin-negative strains of S. aureus may down regulate cell – cell junction pro-
teins by as yet unknown mechanisms. Therefore, TJ are likely to be involved in the patho-
genesis of different staphylococcus strains. By showing a time-dependent order of TJ protein
expression, a dynamic mechanism for bacterial TJ regulation may be unveiled.
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Epidermal and dermal integration into implanted percutaneous biomaterials in mice
Y Fukano,1 Z Tavakkol,1 SN Isenhath,1 ML Usui,1 RA Underwood,1 CA Irvin,2 AJ Marshall,2
KD Hauch,2 BD Ratner,2 P Fleckman1 and JE Olerud1 1 Medicine, University of Washington,
Seattle, WA and 2 Bioengineering, University of Washington, Seattle, WA
Percutaneous devices play an essential role in modern medicine, but are associated with a
significant risk of infection. One approach to circumvent this risk is to heal the wound around
the device by creating a seal at the skin/device interface. In order to fully evaluate the epi-
dermal and dermal interaction with biomaterials, we tested implants in a mouse model. Porous
poly (2-hydroxyethyl methacrylate) [poly(HEMA)] rods with 40 µm pore size were implanted
into two different sites on dorsal skin of 6-8 week old male C57BL/6 mice. Poly(HEMA) rods
were treated with 1) phosphate buffered saline (PBS), 2) 1,1’-carbonyldiimidazole (CDI), and
3) CDI and laminin-5. Samples were harvested at 7, 14 and 28 days after implantation, and
analyzed morphologically using hematoxylin and eosin staining and immunohistochemistry.
Implanted rods remained intact and infection free at all time points. Morphological and
immunohistochemical analysis showed evidence of: 1) epidermal integration, 2) basement
membrane protein expression, and 3) dermal cellular infiltration. Keratinocyte integration was
seen in the pores of CDI-modified poly(HEMA), with and without laminin-5 treatment at 7
days, but was not seen until 14 days in the pores of the PBS-treated poly(HEMA). Basement
membrane proteins such as laminin 5, integrin alpha 6 subunit and integrin beta 4 subunit
showed linear deposition within the poly(HEMA) pores. Dermal cells, including endothelial
cells, macrophages and fibroblasts were also seen within the poly(HEMA) pores. Integration
of dermal components, such as blood vessels and fibroblasts is essential for providing long-
term viability and strength of the skin/device interface. Engineering a stable skin attachment
to percutaneous devices will aid in decreasing the risk of device-associated bacterial infec-
tion.
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Human dermal fibroblast migration is impaired by early non-enzymatic glycation of
fibronectin: A potential mechanism for delayed wound healing in patients with diabetes mel-
litus
S Rana,1 MG Tonnesen2,3 and RA Clark1,3 1 Biomedical Engineering, SUNY Stony Brook,
Stony Brook, NY, 2 Medicine, VAMC, Northport, NY and 3 Dermatology, SUNY Stony Brook,
Stony Brook, NY
Failure of acute wounds to heal in diabetic patients has been found to correlate with elevated
blood glucose levels at the time of surgery and correlates poorly with glycated hemoglobin,
a marker for late glycation events (AGE products) that need weeks to amass. While many
studies have focused on the direct adverse effects of short-term high glucose levels on cells,
few investigations have focused on the effects of short-term elevated glucose on extracellular
matrix (ECM) proteins. Fibronectin (FN) is an ECM protein in the early wound provisional
matrix that is required for migration of fibroblasts in this context.  The aim of this study was
to investigate the effects of early glycation of FN on dermal fibroblast migration. FN-coated
plastic, FN-fibrin (simulates the 1st provisional matrix of wounds), and FN-hyaluronan (sim-
ulates the 2nd provisional matrix of wounds) were glycated in the presence of 3mg/ml glu-
cose for 2 days.  Cell migration in response to 100ng/ml platelet-derived growth factor-BB
(PDGF-BB) was significantly impaired on glycated FN (71.8% decrease, p<0.05), FN-Fibrin
gels (40.0% decrease, p<0.05 ) and FN-hyaluronan gels (93.1% decrease, p<0.05) as deter-
mined by the two-tailed Student’s t test. Although glycation had no effect on cell attachment,
cell viability or apoptosis, cell spreading was markedly inhibited. These data strongly suggest
that glycation of FN for as little as 2 days inhibits cell traction resulting in loss of motogenic
potential of these cells. Studies are underway to better understand the mechanism of this
phenomenon as such elucidation might lead to breakthroughs in the therapy of non healing
wounds of diabetic patients.
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Basement membrane protein expression in the pores of percutaneous biomaterials
Z Tavakkol,1 Y Fukano,1 ML Usui,1 RA Underwood,1 CA Irvin,2 AJ Marshall,2 KD Hauch,2
BD Ratner,2 P Fleckman1 and JE Olerud1 1 Medicine (Dermatology), University of
Washington, Seattle, WA and 2 Bioengineering, University of Washington, Seattle, WA
For many percutaneous medical devices such as prosthetic limb attachment sites, glucose sen-
sors and insulin pumps, long-term skin attachment to the device would stabilize the interface
and lower the risk of bacterial infection. Studies in our laboratory have shown that when car-
bonyldiimidazole-treated porous poly(2-hydoxyethyl methacrylate) [poly(HEMA)] rods are
implanted in the dorsal skin of normal C57BL/6 mice, epidermal and dermal cells migrate
into the poly(HEMA) pores. We studied poly(HEMA) rods implanted in mice as a function of
time (up to 35 days) in order to immunohistochemically evaluate long-term basement mem-
brane protein expression using antibodies to integrin α6 subunit, integrin β4 subunit, α3 chain
of laminin-5 (uncleaved and cleaved) and type VII collagen. We hypothesize that positive
expression of these basement membrane proteins in the biomaterial pores is indicative of the
stable anchorage necessary to secure percutaneous devices and provide a barrier for preventing
bacterial invasion. Integrin α6 subunit, integrin β4 subunit, laminin-5 and type VII collagen
were all expressed in cells within the poly(HEMA) pores and were most prominent in the pores
adjacent to the dermal-epidermal junction. Furthermore, these basement membrane compo-
nents were present as early as 7 days after implantation of the poly(HEMA) in mouse skin, indi-
cating early integration and attachment of cells to the biomaterial. The formation of a base-
ment membrane by cells at the skin-biomaterial interface is critical for stable skin attachment
to percutaneous devices and creation of an epidermal ‘seal’. Porous poly(HEMA), or a bio-
material with similar properties, may be an excellent candidate for percutaneous applications
where skin integration is desired.
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Desmoglein 4 is colocalized with DSG2 in human breast and prostate epithelia
A Getz ,1 H Bazzi,1 L Langbein,2 JK Wahl,3 MG Mahoney4 and AM Christiano1,5 1 Genetics
and Development, Columbia Univeristy, New York, NY, 2 Department of Cell Biology,
German Cancer Research Center, Heidelberg, Germany, 3 Department of Oral Biology,
University of Nebraska Medical Center, Omaha, NE, 4 Department of Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 5 Dermatology,
Columbia University, New York, NY
Desmosomes are intercellular junctions found in tissues that undergo a high degree of mechan-
ical stress. Desmosomal cadherins, which in humans include four desmoglein isoforms (DSG
1-4) and three desmocollin isoforms (DSC 1-3), are an essential component of the desmosome
acting both extracellularly and intracellularly to anchor cells to one another. In previous stud-
ies we found that DSG4 is expressed in the more differentiated suprabasal layers of the epi-
dermis as well as the more differentiated layers of the hair follicle. Recent studies have focused
on examining the expression of DSG4 in other human tissues, including secretory epithelial
tissues such as the mammary gland and prostate. An earlier study of the expression of desmo-
somal cadherins by Runswick et al. (2001) showed that they are differentially expressed in the
mammary gland, while another study by Whittock and Bower (2003) showed that DSG4 mRNA
is expressed in human prostate, salivary gland, and testes. Using immunofluorescence analy-
sis, we found that DSG4 is colocalized with DSG2 in both luminal and myoepithelial cells of
the breast, while DSG3 and DSC3 appear to be present in myoepithelial cells alone and DSG1
and DSC1 are absent in both. Similarly, we found that DSG2 and DSG4 are colocalized in
the luminal cells of the prostate while DSG1, DSG3, DSC1 and DSC3 are absent in this tis-
sue. Future studies will focus on examining the distribution of desmosomal cadherins in breast,
prostate, and skin tumors in order to assess whether the pattern of distribution is altered in
these types of epithelial cancers.
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Beta 4 integrin regulates directional migration
CE Pullar,1 B Baier,1 P Marinkovich2 and R Isseroff1 1 Dermatology, University of California,
Davis, Davis, CA and 2 Dermatology, Stanford University, Palo Alto, CA
Endogenous direct current electric fields (EF) are present during embryogenesis and are gener-
ated in vivo upon wounding, providing guidance cues for directional cell migration (galvano-
taxis) required in these processes. EFs can also be exploited to dissect the mechanisms under-
lying directional cell migration. To understand the role of beta (B) 4 integrin in directional
migration, the migratory paths of either B4 integrin-null human keratinocytes, or those in which
the normal B4 integrin was re-expressed, were tracked during exposure to EFs of physiologic
magnitude (100mV/mm). We found that expression of the B4 integrin in the ligand-bound state
was required for directional (cathodal) migration. Expression of a ligand binding-defective B4,
or the inclusion of an antibody that blocks B4 binding to laminin 5, prevented the directional
migratory response. On the other hand, migratory speed was little affected by the absence of
a functional ligand binding B4. B4 integrin-mediated directional migration required activated
Rac as the expression of a dominant negative Rac mutant or addition of a Rac inhibitor pre-
vented the directional response. In contrast, expression of a constitutively active Rac restored
the directional migratory response in B4-adhesion defective cells. The directional responses of
both B4-null and B4-expressing cells were potentiated in the presence of EGF, suggesting that
directional migration in response to EFs is modulated by at least two distinct but synergistic
Rac signaling pathways. Indeed, expression of a B4 integrin with deleted cytoplasmic domain
results in partial loss of directionality in the presence of EGF, but maintenance of speed. These
studies show that the extracellular ligand-binding domain of B4 integrin and activation of its
downstream Rac-dependent signaling pathway via the cytoplasmic domain, are required for
keratinocyte directional migration in response to a galvanotactic stimulus.
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Role of cathepsin K in the turnover of the dermal extracellular matrix during wound heal-
ing
J Bhawan1,2 and TM Ruenger1 1 Dermatology, Boston University School of Medicine, Boston,
MA and 2 Dermatopathology Section, Boston University School of Medicine, Boston, MA
Cathepsins (cat) are a group of cystein proteinases that are involved in various aspects of extra-
cellular matrix (ECM) turnover. CatB, catD, catG, and catL have been described to be expressed
in skin or skin cells, but so far not catK. The collagenolytic activity of catK plays a pivotal role
in bone resorption and lung matrix homeostasis, as CatK knockout mice develop osteopetro-
sis and are prone to lung fibrosis. In order to study the role of catK in cutaneous ECM turnover,
we studied the expression of catK in human skin, fibrosing skin conditions, and in cultured
primary human neonatal fibroblasts using immuno-histochemistry. Normal skin exhibited only
low levels or no expression of catK in dermal fibroblasts and melanocytes. In stark contrast,
dermal fibroblasts in surgical scars (n=10, 2 to 15 months old) showed very strong cytoplas-
mic catK expression, while fibroblasts in the immediate vicinity of the scars showed no or only
minimal catK expression. CatK expression in the dermal fibroblasts was strongest in young
scars and declined with time. Even in older scars, however, catK expression was higher in the
scars than in the surrounding tissue. Exponentially growing fibroblasts cultured on glass slides
showed strong catK staining in the perinuclear endosomal compartment, consistent with intra-
cellular degradation of internalized collagen in lysosomes, as described previously for osteo-
clasts and lung fibroblasts. In contrast, confluent fibroblasts growth arrested by contact inhi-
bition showed no or very weak catK staining. Scraping of the confluent cells and re-growth of
fibroblasts into the groove (artificial wound healing model) resulted in re-expression of catK.
CatK was found to be strongly expressed in keloids, but only weakly in fibrotic areas of mor-
phea (n=5). Our data suggest that catK may play an important role in dermal ECM homeostasis
and the dynamic equilibrium between matrix synthesis and proteolytic degradation, by coun-
teracting fibrosing during wound healing with its collagenolytic activity.
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Molecular characterization of the BMP target genes in dermal fibroblasts
R Atoyan,1 M Fessing,1 T Efimova2 and VA Botchkarev1 1 Dermatology, Boston University
School of Medicine, Boston, MA and 2 Dermatology, Washington University, St. Louis, MO
Bone morphogenetic proteins (BMPs) are multifunctional growth factors that induce biologi-
cal effects through BMP receptor complex followed by activation of the BMP-Smad or BMP-
MAPK signal transduction pathways. BMP signaling is involved in the control of proliferation
and differentiation of mesenchymal cells, extracellular matrix remodeling and angiogenesis.
To understand mechanisms underlying the effects of BMPs on mesenchymal cells, primary
human dermal fibroblasts (DF) were used as a model. Dermal fibroblasts expressed all three
BMP receptors (BMPR-IA/IB, BMPR-II), and BMP-4 treatment resulted in phosphorylation of
Smad1/5/8 proteins. Also, BMP-4 treatment stimulated phsphorylation of ERK1/2, p38 MAPK
and JNK kinases, thus suggesting activation of the BMP-MAPK pathway. Affymetrix microar-
ray and real-time PCR analyses of dermal fibroblasts after BMP-4 treatment revealed signifi-
cant increase in expression of several BMP target genes (DLX2, ID1/2/4, SMAD6/7), as well
as changes in expression of a number of genes implicated in the control of extracellular
matrix remodeling/adhesion (ADAMTS1, ADAM12, COMP, CTGF, DDR1, COL15A1,
COL21A1, TIMP3, UGCG), metabolism (SF1,CA12, AFURS1, ALDH1A1,APOD, CPT1A,
IMPA2) and signaling/transcription (BAMBI, BMP6, IGFBP3, KLF5, NR2F1, RAB3B, TFAP2C,
TGFBR3,SFRS6). These data suggest that dermal fibroblasts serve as a target for BMPs in human
skin and that BMP signaling is capable of modulating dermal fibroblast functions via activa-
tion of the BMP-Smad and BMP-MAPK signaling pathways.
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Assessment of c-Myc levels allows for early diagnosis of pemphigus vulgaris
L Williamson,1 T Hunziker,2 MM Suter1 and EJ Muller1 1 Animal Pathology, University of
Bern, Bern, Switzerland and 2 Dermatology, University of Bern, Bern, Switzerland
We previously reported that nuclear accumulation of c-Myc and hyperproliferation in both
lesional and perilesional epithelia is a characteristic feature in pemphigus vulgaris (PV) . Here
we addressed in a retrospective immunofluorescence study on paraffin-embedded biopsies
whether this phenomenon is common to other autoimmune bullous diseases, skin disorders
with known hyperproliferation, or toxic epidermal necrolysis (TEN), a clinically relevant dif-
ferential diagnosis of PV. None of the disorders investigated presented with an increase in
epidermal nuclear c-Myc comparable to that seen in PV patients. We further demonstrate that
disease progression in the patient correlates with nuclear c-Myc accumulation which is
detectable well before the formation of acantholytic blisters. Together, these results suggest a
novel procedure to rapidly and efficiently diagnose PV of an early stage that consists in i)
assessment of nuclear c-Myc in a comparative immunofluorescence analysis of a formalin-
fixed perilesional biopsy taken for routine diagnosis followed by ii) serological confirmation
by a desmoglein (Dsg) 3 ELISA test.
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The cytoplasmic membrane-proximal region of Desmoglein 3 is critical for p120-catenin
binding to desmoglein 3
Y Aoyama,1 M Kanno,1 M Nagai,1 Y Yamamoto,1 M Ozawa2 and Y Kitajima1 1 Dermatology,
Gifu University School of Medicine, Gifu, Gifu, Japan and 2 Biochemistry, Kagoshima
University, Kagoshima, Kagoshima, Japan
p120-catenin (p120-ctn) is an armadillo family protein, which is implicated in the regulation
cadherin-based cell adhesion to control cadherin internalization and degradation. Previously
we reported that p120-ctn was co-immunoprecipitaed with either Desmoglein (Dsg) 1 or 3,
and labeling of anti-p120-ctn antibody was localized to the intracellular face of desmosome
in saponin-treated cultured keratinocyte examined by pre-embedding immunogoled EM. To
clarify the role of p120-ctn at desmosome, firstly we identified the domains of Dsg3 that are
critical for p120-ctn binding. We constructed expression vectors containing flag tagged mutant
forms of mouse dsg3 with increasing truncations eliminating various cytoplasmic subdo-
mains from the carboxy-terminus, which is ∆ICS1-810, ∆ICS1-761, ∆IA1-714 and ∆IA1-641
respectively. These constructs and mouse HA tagged p120-ctn were transiently co-transfected
into HEK293 cells. Extracts were subjected to immunoprecipitation with anti-HA antibody.
Recovered p120-ctn contained Dsg3. To confirm the association of these proteins in cultured
keratinocyte, we determined the localization of these recombinant proteins in DJM-1 cells.
p120-ctn was found to bind to ∆ICS1-810, ∆ICS1-761, ∆IA1-714, but not ∆IA1-641. On the
other hand, plakoglobin bound to ∆ICS1-810, but not others. p120-ctn bound to the mem-
brane proxmal domain including IA region (641-714AA) of cytoplasmic domain of Dsg3. An
additional deletion in this region prevented the association with p120-ctn and abolished the
localization to cell membrane and accumulated in the cytoplasm. Transiently expressed p120-
ctn and Dsg3 were co-localized at cell-cell contact in human squamous cell line DJM-1 cells.
Further examination is nessesary to confirm other proteins required for the association of these
proteins. These results suggest that p120-ctn can associate to not only classical cadherin, but
also desmosomal cadherin as a new member of desmosomal constituents.
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K6PC-5, a novel sphingosine kinase activator, improves intrinsic aged murine skin
E Choi,1 J Youm,2 M Kwon,3 M Kim,1,2 H Jeon,1 B Park3 and S Lee2,4 1 Dermatology, Yonsei
University Wonju College of Medicine, Wonju, South Korea, 2 BK 21 Project for Medical
Science, Yonsei University College of Medicine, Seoul, South Korea, 3 Neopharm Co., Ltd.,
Daejeon, South Korea and 4 Yonsei University College of Medicine, Seoul, South Korea
Sphingosine-1-phosphate (S1P) having a universal intracellular signaling role for intracellular
calcium regulation, is known as a new bioactive sphingolipid metabolite, which involves
diverse cellular responses including proliferation, differentiation, motility, and survival. Sphin-
gosine kinase activator, K6PC-5, which was newly synthesized by us, induced keratinocyte
differentiation in vitro and in vivo by increasing intracellular S1P levels and intracellular cal-
cium mobilization. To elucidate the effects of K6PC-5 on intrinsic aged skin, K6PC-5 and
vehicle were applied twice a day for 14 days on 56 week old hairless mice skin, and then fuc-
tional, light and electon microscopic studies, and western blot were performed. There were
no changes in SC hydration, basal transepidermal water loss, skin surface pH and barrier recov-
ery rate. Slight strengthened tendency in SC integrity was found in the aged mice to which
K6PC-5 was applied, but corneodesmosome density was not increased on electron-micro-
scope examination. Fibroblasts, type 1 collagen, and dermal thickness were increased in the
dermis of aged mice to which K6PC-5 was applied. Matrix metalloproteinase 13 showed slightly
decreasing tendency in treated skin. K6PC-5, a novel sphingosine kinase activator, shows anti-
aging effect on intrinsic aged murine skin by increasing fibroblasts, collagen synthesis and
eventually dermal thickness.
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Elevated cystein-rich protein 61 (CYR61/CCN1), mediates aberrant collagen homeostasis in
chronologically-aged and photoaged human skin.
T Quan, T He, Y Shao, S Kang, JJ Voorhees and GJ Fisher Dermatology, University of
Michigan, Ann Arbor, MI
Alterations of human skin connective tissue structure and function are prominent features of
both chronological aging, and solar ultraviolet (UV) irradiation-induced premature aging (pho-
toaging). These skin connective tissue abnormalities result, in part, from reduced synthesis and
elevated degradation of type I collagen, the most abundant structural protein in skin. Here we
report that cystein-rich protein 61 (CYR61/CCN1), a novel mediator of collagen homeostasis,
is predominantly expressed in the dermis of normal adult human skin (11-fold vs epidermis,
n=5, p<0.05), and is substantially elevated in the dermis of chronologically-aged (80+years)
and photoaged human skin in vivo. In cultured human skin fibroblasts, elevated expression
by transfection of CYR61 substantially reduced type I procollagen mRNA and protein by 52%
and 71%, respectively (n=3, p<0.05). In contrast, elevated expression of CYR61 increased
MMP-1 mRNA (8.6-fold, n=3, p<0.05) and protein (4.2-fold, n=3, p<0.05), which initiates
collagen degradation. Interestingly, elevated CYR61 down-regulated TGF-β type II receptor
mRNA (51%, n=3, p<0.05), and protein (59%, n=3, p<0.05), thereby impairing the TGF-β
pathway, a critical pathway of collagen homeostasis. This impairment of TGF-β pathway reduced
type I procollagen and raised MMP-1 expression. Furthermore, elevated CYR61 activated MAP
kinase and transcription factor AP-1, which functions to stimulate MMP-1 expression. Given
the ability of CYR61 to regulate both synthesis of type I procollagen and degradation of fib-
rillar collagen, it is likely that elevated-expression of CYR61 contributes to aberrant collagen
homeostasis observed in chronologically-aged and photoaged human skin.
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High-affinity interaction of the NC1 domain of collagen VII with laminin 5 and collagen IV
facilitates stabilization of the basement membrane zone
R Brittingham, J Uitto and A Fertala Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Collagen VII is a major component of anchoring fibrils, a structure within the basement mem-
brane zone located between the epidermis and dermis. Critical anchoring functions of col-
lagen VII depend on its ability not only to form homotypic fibrils but also to bind to other
macromolecules with which it forms heterotypic complexes. It has been shown that the abil-
ity of collagen VII to bind other macromolecules present in the basement membrane of skin
depends on the N-terminal NC1 domain, but the affinities of the NC1 domain for the bind-
ing of interacting partners are not known. Because the process in which macromolecules
organize themselves into ordered matrices is driven by the high-affinity site-specific binding
between defined regions of interacting components our goal was to define the affinities of the
NC1 domain for selected macromolecules known to take part in stabilizing the dermal-epi-
dermal junction. Utilizing DNA constructs encoding mini procollagen VII and the NC1 domain
(kind gift from Dr. Y. Gache) we expressed recombinant proteins in HK 293 cells. Employing
an optical biosensor we analyzed the kinetics of binding of the NC1 domain and mini pro-
collagen VII to laminin 5, collagen IV, and collagen I. We demonstrated that the procollagen
VII interacts strongly with laminin 5 and collagen IV with Kd values in the range of 10e-9 M.
In contrast, the NC1-mediated binding of procollagen VII to collagen I was weak with a Kd
value of 10e-6 M. Our experiments also show that the NC1 domain utilizes the same site to
bind to both laminin 5 and collagen IV. We postulate that the ability of the NC1 domains to
bind with high affinity to laminin 5 and collagen IV is most important for stabilization of the
basement membrane itself and that because of low affinity, the NC1-collagen I binding is less
important for stabilization of the dermal-epidermal junction.
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Synergistic effect of retinaldehyde and hyaluronate fragments in skin hyperplasia
G Kaya,1 C Tran,1 O Sorg,1 R Hotz,1 D Grand,1 P Carraux,1 L Didierjean,1 I Stamenkovic2 and
J Saurat1 1 Dermatology, University Hospital of Geneva, Geneva, Switzerland and 2
Pathology, University Hospital of Lausanne, Lausanne, Switzerland
Retinoids are known to modulate keratinocyte differentiation and to stimulate epidermal hyper-
plasia. In this study we first analyzed the effect of an association of retinaldehyde (RAL) and
intermediate hyaluronate (HA) fragments (HAFi : 50-400 kDa) on in vitro proliferation of ker-
atinocytes from SKH1, DBA/1 and (CD44-/-) mice. The combined treatment (RAL + HAFi)
was more potent than RAL or HAFi alone for keratinocyte proliferation and HA production,
except for (CD44-/-) keratinocytes, which did not proliferate. Antibodies against HB-EGF, erbB1
or TIMP-3 abrogated the RAL- and HAFi-induced keratinocyte proliferation. Topical applica-
tion of (RAL + HAFi) for 3 days resulted in a significant epidermal hyperplasia and keratinocyte
proliferation in SKH1 and DBA/1 mice, whereas no epidermal hyperplasia and keratinocyte
proliferation was observed in (CD44-/-) mice. Finally we applied topical (RAL + HAFi) twice
a day to the forearm skin of elderly patients showing important skin atrophy. After 1 month of
treatment, we observed a significant epidermal hyperplasia and an increase in epidermal and
dermal HA content as well as in CD44 and erbB1 amounts, accompanied by a significant
clinical improvement. Our results indicate that RAL and HAFi show a synergy in vitro and in
vivo in the proliferative response of keratinocytes, in the increase in CD44 expression and in
the production of HA and pro-HB-EGF in mouse skin, and that the combination of RAL and
HAFi seems to have a therapeutic effect in age-related human skin atrophy.
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Contribution of E-cadherin and aPKC to epidermal barrier function
I Helfrich,1 C Michels,1 P Zigrino,2 S Eming2 and C Niessen1 1 Center for Molecular Medicine
Cologne, University of Cologne, Cologne, Germany and 2 Department of Dermatology,
University of Cologne, Cologne, Germany
Recently, we have found that in vivo inactivation of E-cadherin in the epidermis of mice resulted
in perinatal death due to disturbed skin water barrier function as a result of structural and func-
tional alterations in tight junctions, found in the granular layer of the epidermis. This corre-
lated with the loss of active aPKC and the small GTPase Rac from the membrane. To further
analyse how E-cadherin regulates epidermal barrier function, we have set-up an in vitro bar-
rier assay for keratinocytes and found that E-cadherin negative keratinocytes were dramati-
cally impaired in barrier formation. Using this assay we are presently characterizing if the
adhesive or signalling activity of E-cadherin is required for proper tight junction formation. In
addition, the role of aPKC in barrier formation was assessed. In simple epithelia aPKC forms
a complex with the polarity proteins Par3 and Par6, which contributes to tight junction for-
mation. To understand the role of this polarity complex in the skin, we have characterized the
localization of Par3/Par6/aPKC in skin under both normal homeostasis and pathological con-
ditions, such as wounding. To examine if aPKC activity indeed plays a role in epidermal bar-
rier regulation, we have inhibited aPKC by expressing dominant negative constructs in ker-
atinocytes. We found that this inhibited in vitro barrier formation, implicating aPKC in the
formation epidermal tight junctions. In addition, these studies also suggest that aPKC requires
the interaction with Par3 for barrier formation.
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Mechanical stretch induces extracellular matrix proteins, adhesion molecules, and actin-
related cytoskeleton proteins, by regulating Rho, cdc42 and Rac family gene expression in
normal human keratinocytes
M Komine,1 S Yano,1,3 H Okochi,2 M Blumenberg3 and K Tamaki1 1 Dermatology, University
of Tokyo, Tokyo, Tokyo, Japan, 2 Regenerative Medicine, Research Institute, International
Medical Center of Japan, Tokyo, Tokyo, Japan and 3 Dermatology, Biochemistry, New York
University Medical Center, New York, NY
Epidermis endures mechanical stresses in various situations. To study the effects of mechani-
cal stretching on keratinocytes in vitro, we cultured normal human keratinocytes on silicon
wells, and cyclically stretched these wells with electric device. Western blot demonstrated
that mechanical stretch induced activation of ERK and p38, but not JNK. EGF receptor inhibitor
inhibited the activation of p38 and decreased the whole phosphorylation level of ERK, but
leaving its induction. Calcium channel blocker inhibited the activation of ERK, but not p38.
To totally assess the regulation of gene expression by mechanical stretch, RNA was extracted
after 24 hours of cyclic stretch, and samples were subjected to Affymetrix DNA microarray
system which detects 47000 transcripts. This procedure was repeated 4 times. Some of the
results were confirmed with real time PCR or Western blot. Genes of weak regulation less
than twice or unstable results were excluded. The regulated genes were categorized into 46
different categories. Among the 584 regulated genes, transcription factors and cytoskeleton-
related proteins were the ones which contain the most regulated genes, 84 and 62, respec-
tively. Cytoskeleton-related proteins showed that 19 of 20 genes of Rho, cdc42 and Rac path-
way and 26 of 29 actin cytoskeleton-related genes were up-regulated. 16 of 17 extracellular
matrix proteins were up-regulated, and 12 of 17 adhesion molecules were up-regulated. Rho,
cdc42 and Rac family members are small GTPases, which regulate cell proliferation, anti-
apoptosis, antin-cytoskeleton reorganization, vesicle trafficking and gene expression. Mechan-
ical stretching causes cytoskeleton reorganization, which needs induction of these small
GTPases, accompanying excretion of extracellular matrix protein and remodeling of cellular
junctions.
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The focal contact protein kindlin-1 is phosphorylated and involved in maintenance of actin
cytoskeleton integrity and keratinocyte motility
C Baer,1 M Aumailley,2 U Schloetzer-Schrehardt,3 L Bruckner-Tuderman1 and C Has1 1
Department of Dermatology, University of Freiburg, Freiburg, Germany, 2 Department of
Biochemistry, University of Koeln, Koeln, Germany and 3 Department of Ophtalmology,
University of Erlangen, Erlangen, Germany
Kindlin-1 belongs to a novel family of focal contact proteins, the kindlins, involved in attach-
ment of the actin cytoskeleton to the plasma membrane and in integrin mediated cellular
processes. Kindlin-1 deficiency is associated with the Kindler syndrome, an autosomal reces-
sive genodermatosis with skin blistering, poikiloderma, photosensitivity and, occasionally, car-
cinogenesis. We disclosed several loss-of-function mutations in the KIND1 gene and showed
that kindlin-1 deficiency leads to changed morphology of actin cytoskeleton and abnormal
cell motility. For characterization of kindlin-1 protein, antibodies were generated against two
recombinant GST-kindlin-1 fragments. In the skin, the antibodies produced a linear signal at
the dermal-epidermal junction, and immunoelectron microscopy revealed kindlin-1 to be
localized between the hemidesmosomes in basal keratinocytes. Immunoblots with lysates of
normal human keratinocytes and HaCaT cells revealed a 74 kDa/78 kDa double band, cor-
responding to the predicted molecular mass of 77.3 kDa. No signal was detected in fibrob-
lasts or COS-7 cells. Expression of recombinant kindlin-1 in COS-7 cells generated the 78 kDa
band. To characterize the two kindlin-1 forms, we selectively isolated phosphorylated proteins
from cell lysates and showed that the 78 kDa form is in the phosphorylated fraction. Dephos-
phorylation with lamba protein phosphatase of HaCaT cell lysates led to a significant decrease
of the 78 kDa signal in immunoblots. These results support the hypothesis that kindlin-1 plays
a role in signal transduction, cytoskeleton regulation and cell motility.
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A glycine substitution mutation in the type VII collagen gene causes mild recessive dystrophic
epidermolysis bullosa in a large consanguineous pakistani family
L Kraemer,1 M Wajid1 and AM Christiano1,2 1 Dermatology, Columbia University, New York,
NY and 2 Genetics & Development, Columbia University, New York, NY
Dystrophic epidermolysis bullosa is an inherited mechanobullous skin disease caused by a
mutation in the type VII collagen gene (COL7A1). The majority of glycine substitutions in this
gene typically underlie dominant dystrophic epidermolysis bullosa (DDEB), whereas different
types and combinations of mutations cause the mild recessive form. Paradoxically, however,
recessively inherited glycine substitutions have also been reported in COL7A1. In this study,
we have examined the molecular basis of a large inbred family of Pakistani origin with a his-
tory of blistering, nail deformities and erosions on the trauma-exposed areas of the body with
the intent to establish a precise diagnosis and pattern of inheritance. The family consisted of
three affected and four unaffected individuals with extensive consanguinity. We performed
PCR and automated sequence analysis of the COL7A1 gene in affected members of the fam-
ily. We identified a new glycine substitution within the collagenous region in exon 94 of the
COL7A1 gene, which is clinically silent in the heterozygous carriers but causes mild reces-
sive dystrophic epidermolysis bullosa (RDEB) when homozygous in affected individuals. This
glycine substitution, designated G2422V, resulted in the conversion of a glycine codon (GGA)
to valine (GTA) and presumably causes destabilization of the protein. This mutation, located
within a collagenous segment, resides 1084bp upstream of the non-collagenous region 2 (NC-
2). It is surrounded by other silent glycine mutations, one of which resides 27 amino acids
upstream in the same exon 94 (G2395D), another in exon 95 (G2569R), and is flanked by
dominantly inherited glycine mutations located in exon 93 and 105. This finding sheds fur-
ther light upon regions of the type VII collagen triple helix that are tolerant of glycine substi-
tutions and expands the allelic series of COL7A1 mutations underlying mild RDEB.
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Collagen-Krox (c-Krox) transcription factor increases collagen gene transcription and pro-
tein synthesis in human dermal fibroblasts
M Kypriotou ,2 C Chadjichristos,2 R Widom,3 G Beauchef,2 T Oddos,1 O Von Stetten,1
S Jimenez,4 J Pujol 2 and P Galera2 1 Department of Pharmacology, Johnson & Johnson
Consumer France, Val de Reuil, France, 2 Laboratoire de Biochimie du Tissu Conjonctif,
Faculte de Medecine, CAEN, France, 3 Department of Medicine, Boston University School of
Medicine, Boston, MA and 4 Department of Anatomy, Jefferson Medical College, Thomas
Jefferson University, Philadelphia, PA
Type I collagen is the major component of the dermis. Changes in its synthesis may occur
during skin aging and are partly responsible for the appearance of aging signs. C-Krox, a tran-
scription factor belonging to the zinc finger family, is found mainly in skin. It was shown to
stimulate collagen synthesis in mice. We have investigated the role of the human c-Krox (hc-
Krox) on the regulation of collagen synthesis in normal human dermal fibroblasts. Expression
vector encoding hc-Krox was transiently transfected into normal dermal fibroblast from neona-
tal and adult donors. We measured the transcription of collagen I sub-chains gene by real
time RT-PCR and the level of neo-synthesized collagen molecule by incorporation of tritiated
proline. The level of COL1A1 and COL1A2 mRNAs and total collagen neo-synthesis was
markedly increased under forced hc-krox expression whatever the age of the donors. More-
over, hc-krox siRNA induced a significant decrease in COL1A1 transcription and collagen I
mRNA levels. hc-Krox up-regulates human COL1A1 gene transcriptional activity through a -
112/-61 bp region. This region can bind specifically c-Krox. A decoy strategy that targets the
-112/-61 bp sequence of COL1A1 was found to decrease the transactivating potential of hc-
Krox. These results showed that human c-Krox, as in mouse, is a transcription factor that
binds COL1A1 promoter and activates its transcriptional activity and is responsible for enhanced
collagen synthesis in skin dermal fibroblasts.
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Cell adaptation to substrate mechanics: implications for tissue engineering design of wound
healing products
K Ghosh,1 E Guan,2 X Ren,4 S Ge,2 Y Liu,3 T Nakamura,3 M Rafailovich2 and RA Clark1,4 1
Biomedical Engineering, SUNY Stony Brook, Stony Brook, NY, 2 Materials Science and
Engineering, SUNY Stony Brook, Stony Brook, NY, 3 Mechanical Engineering, SUNY Stony
Brook, Stony Brook, NY and 4 Dermatology, SUNY Stony Brook, Stony Brook, NY
Tissue repair and development depends largely on how cells sense and respond to multiple
extracellular matrix (ECM) cues. Although biological signaling has long been known to gov-
ern cell phenotype, recent reports implicate ECM mechanics in playing an equally central role.
Here we studied how the alterations in ECM mechanics affect cell migration in vitro and tis-
sue repair in vivo. To this end we used our recently developed acellular, bioactive hydrogel
matrix, composed of crosslinked hyaluronan and three fibronectin functional domains (FNfds),
as an ECM mimic. Hydrogel mechanics was modulated by using different crosslinker con-
centration. When adult human dermal fibroblasts (AHDFs) were seeded on hydrogel matrices
with varying stiffness, their migration was found to increase linearly with matrix stiffness. Fur-
ther studies revealed that AHDFs seeded on stiffer surfaces had larger surface moduli and more
stretched actin cytokeleton than those seeded on softer substrates. These data indicated that
the AHDF cytoskeleton was able to sense underlying substrate stiffness, which then manifested
itself into the observed migration response. Using a combination of digital image speckle cor-
relation and finite element analysis, we further showed that AHDFs exert larger forces and
generate greater strain energy on the stiffer surfaces than on the more compliant ones. More
importantly, tissue cells preferentially invaded the stiffer hydrogels in vivo, suggesting that
mechanotransduction via these substrates stimulates cells to override the greater physical resist-
ance arising from higher crosslinking densities. These findings have important implications
for the design of tissue engineered products for acute and chronic wounds
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Cadherin endocytosis is a driving force for cadherin adhesive dimer disassembly
S Troyanovsky, E Sokolov and R Troyanovsky Internal Medicine, Washington University
School of Medicine, St. Louis, MO
E-cadherin is a transmembrane protein that mediates Ca2+-dependent cell-cell adhesion. Our
previous experiments have revealed two types of E-cadherin dimeric complexes in which cad-
herin molecules align in lateral or adhesive modes. While stable in solution, adhesive dimers
are short-lived in vivo. The difference in the stability of adhesive dimers in vivo and in vitro
implies that a special cellular process is required for cadherin dimer dissociation. To evaluate
this mechanism, we have developed a new assay allowing us to assess the dynamics of adhe-
sive dimer assembly in adherens junctions. Using this assay we showed that cadherin dimer
dynamics do not change after inhibition of either the actin filament or microtubule functions,
or of either serine or tyrosine protein kinases. Inhibition of endocytosis by ATP depletion, hyper-
tonic (0.4M sucrose) or acidic media, however, led to a rapid and dramatic increase in total
dimer amounts. In all cases, when the level of adhesive dimers reached a plateau (approxi-
mately 5 min after administration of hypertonic media), the assembly of new adhesive dimers
stalled completely. These cells, in a striking difference from the control, become unable to
disintegrate both their intercellular contacts and adhesive dimers in response to calcium deple-
tion. These data suggest that endocytosis is the main pathway for the dissociation of E-cad-
herin adhesive dimers. Its inhibition blocks the replenishment of the monomeric cadherin
pool, thereby inhibiting new dimer formation. This suggestion has been corroborated by immu-
noelectron microscopy, which revealed cadherin-enriched coated pit-like structures in close
association with adherens junctions.
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Differential regulation of desmocollin genes by cutaneous signaling pathways.
X Cheng,2 M Merched-Sauvage2 and P Koch2,1 1 Molecular & Cellular Biology, Baylor College
of Medicine, Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
We have recently shown that mice which synthesize a truncated Dsc1 receptor show dra-
matically increased desmocollin 2 (dsc2) expression in the epidermis. Global gene expres-
sion profiling suggested that NFkB components might contribute to dsc2 deregulation in
these mice. CHIP assays confirmed that NFkB components can bind to the dsc2 promoter, and
reporter transfection assays demonstrated that these transcription factors (c-Rel, RelA) increase
promoter activity. We decided to extend our preliminary analysis to determine the effects of
transcription factors from major cutaneous signaling cascades (e.g. NFkB, WNT, Notch) on the
activity of the proximal promoters of mouse dsc1, dsc2 and dsc3. We generated luciferase
reporter constructs containing 2kb of the proximal promoter sequences from all three desmo-
collin genes. Initially, we transfected MDCK cells with these reporter constructs and expres-
sion vectors for various transcription factors. MDCK was chosen because these polarized sim-
ple epithelial cells can be transfected with high efficiency, express endogenous dsc2 and dsc3,
and are a well established cell system to study cadherin biology. Selected combinations of
reporter and transcription factor constructs were also tested in the human keratinocyte cell
line N’TERT. Our results thus far demonstrate that NFkB components specifically activate the
dsc2 promoter, while nuclear plakoglobin and notch pathway components activate the dsc3
promoter. In summary, these in vitro results suggest that major cutaneous signaling pathways
differentially regulate dsc genes, a hypothesis which can now be tested in vivo.
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Elastic fiber assembly: mapping of elastin and fibulin 1 protein/protein interactions
N Fujimoto, S Aho, R Brittingham, A Fertala and J Uitto Dermatology, Jefferson Medical
College, Philadelphia, PA
Elastic fibers consist of elastin and the microfibrillar components. One of the micro fibrillar
proteins is fibulin-1 which exists in four distinct variants, 1A-1D, the 1C and 1D being abun-
dantly present in a number of connective tissues. In this study, we examined the interactions
of recombinant elastin and fibulin-1C/D, first by yeast two-hybrid genetic system, followed by
confirmation by β-galactosidase assay. Distinct interactions between elastin C-terminal end
(aa 668-719) and two segments of the C-terminal domain III of fibulin-1D (aa 602-621 and
679-703) were detected. The strength and kinetics of the elastin/fibulin-1D interactions were
determined by a biosensor assay which revealed a Kd of ~86nM for fibulin-1D while the cor-
responding value for fibulin-1C was about three times lower. Since the domain III segments
used for binding assay are different between 1C and 1D, our results suggest that different
binding sites are involved in elastin versus fibulin-1C/1D interactions.
204
E-cadherin suppression is coordinates with elevated FAK expression and redistribution lead-
ing to a highly motile, invasive phenotype
A Alt-Holland,1 Y Shamis,1 W Zhang,1 T DesRochers,1 A Margulis,1 K Riley,2 I Herman,2
N Fusenig3 and G J.1 1 Tufts University School of Dental Medicine, Boston, MA, 2 Department of
Physiology, Tufts University School of Medicine, Boston, MA and 3 GCRC, Heidelberg, Germany
Advanced epithelial carcinogenesis are linked to altered E-cadherin expression, yet the role
of E-cadherin-mediated adhesion during premalignant stages of cancer development is not
well understood. We have shown that 3D, human tissues harboring early-stage skin-derived
tumor cells (HaCaT-II-4) expressing a dominant negative E-cadherin fusion protein, mimic pre-
malignancy and linked to a switch to highly invasive carcinoma.  To delineate the migratory
properties of E-cadherin suppressed cells, we have studied their motility, actin and focal
adhesions organization. Scrape-wounded, E-cadherin-deficient cultures showed accelerated
wound closure and time-lapse analysis revealed independent and disoriented cell migration,
while E-cadherin-competent cells migrated as polarized, coherent sheets. Immunostaining of
E-cadherin-deficient cells showed cortical actin and enriched beta-actin, and cytoplasmic dis-
tribution of vinculin and p-Tyrosine-rich structures. Focal Adhesion Kinase (FAK) was found
in a perinuclear distribution and immunoblotting demonstrated increased levels of FAK. In
contrast, E-cadherin-competent cells revealed focal localization of vinculin, p-Tyrosine-rich
structures and FAK, peripherally at the termini of actin network. Furthermore, FAK inhibitor
Tyrphostin AG1007 reversibly inhibited E-cadherin-deficient cell migration. Finally, FAK and
active FAK were elevated in migrating and invading E-cadherin-deficient cells in 3D epithe-
lial tissues. These results demonstrate that E-cadherin suppression directs a highly motile phe-
notype, associated with alteration in cytoskeletal and focal adhesion organization and linked
to the elevated expression and redistribution of FAK. This may play a role in integrating sig-
nals regulating adhesion, migration and invasion processes in these cells during early carci-
noma, and may contribute to the highly invasive tumor cell phenotype seen in vivo.
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Retinol metabolism in cultured dermal and subcutaneous fibroblasts
CC Chipev, A Pinkas-Sarafova and M Simon Oral Biology and Pathology, SUNY at Stony
Brook, Stony Brook, NY
Retinoic acid (RA) is a transcription factor ligand which modulates the phenotype of resident
skin cells such as fibroblasts, whose production and turnover of extracellular matrix is mod-
ulated by retinoids. Retinoic acid can be supplied to target tissues from the circulation, where
it is present in nM concentrations or can be biosynthesized from retinol in a two step dehy-
drogenation process with retinal as intermediate. The retinol for this reaction is supplied by
the circulation at concentrations from 1-2 µM. Because fibroblasts isolated from subcutaneous
fat differ from those isolated from dermis in their ability to undergo adipose conversion, and
adipose tissue is a source of retinylesters, we postulated that fibroblasts isolated from the sub-
cutaneous fat might differ in their ability to metabolize retinol to retinylester. We found that
when grown with 3H-retinol these fibroblasts did in fact accumulate 2-4 fold more 3H-
retinylesters than did their dermal counterparts. Both esterification reactions were mediated
by acyl CoA: retinol acyltransferase(s). Interestingly, we also found that the subcutaneous fat
fibroblasts had a greater capacity to generate RA. In the presence of 2 mM NAD/NADP, their
microsomes converted retinol to retinal 5-fold faster than did microsomes from dermal fibrob-
lasts, and in the presence of 2 mM NAD, their cytosol converted retinal to RA more than 5 to
10-fold faster than did cytosol from dermal fibroblasts. Thus, fibroblasts of the subcutaneous
fat have the capacity to store retinylesters in time of retinol sufficiency and to serve as a
source of substrate retinol for oxidation to RA in times of retinol (and RA) insufficiency.
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Suprabasal expression of Dsg2 offered differential protection against blister formation medi-
ated by PF antibodies and exfoliative toxins
D Brennan, Y Hu and MG Mahoney Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Desmosomal mediated cell-cell adhesion is crucial for maintaining proper epidermal struc-
ture and function as evidenced by several severe and potentially fatal skin disorders involv-
ing impairment of desmosomal proteins. Pemphigus foliaceus (PF) and staphylococcal scalded
skin syndrome (SSSS) are two traumatizing skin blistering diseases targeting the desmosomal
adhesion protein desmoglein 1 (Dsg1) resulting in acantholysis in the superficial epidermis.
In SSSS, Dsg1 is cleaved by the serine proteases, exfoliative toxins (ET). Conversely, the mech-
anism of autoantibody-induced loss of cell adhesion in PF is still unresolved since evidence
supports both the direct inhibition of Dsg1 transinteraction and the activation of intracellular
signaling cascades. To further investigate the mechanism of PF IgG-mediated acantholysis, we
developed transgenic mice expressing Dsg2 in the superficial epidermis. Neonatal transgenic
and wild type mice were injected with ETA or purified PF IgG. In response to ETA, no changes
were observed in desmosomal protein localization despite dramatic blister formation in both
transgenic and wild type mice. Suprabasal expression of Dsg2 offered very limited protection
against ETA-mediated blister formation, thereby demonstrating that mechanically Dsg2 can-
not fully compensate for loss of Dsg1. However, suprabasal Dsg2 provided enhanced pro-
tection against blister formation in response to PF IgG. Unlike wild type animals where PF
IgG induced extensive internalization of desmosomal proteins, Inv-Dsg2 mice showed increased
stabilization and reduced internalization of desmosomal proteins including Dsg1. These results
demonstrate that in addition to providing some cell-cell adhesive properties, Dsg2 was able
to compensate for loss of Dsg1 by PF IgG-mediated dissociation through some other alterna-
tive mechanism. Collectively our data supports the recent findings for the role of intracellu-
lar signaling cascades in the molecular mechanism of PF IgG-induced destabilization of Dsg1-
containing desmosomes.
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Age related collagen measurement by means of in vivo scanning laser confocal microscopy
image analysis
M Luedtke, G Payonk, J Nikolovski, B Wiegand and N Kollias Johnson & Johnson Consumer
and Personal Products Worldwide, Skillman, NJ
An in vivo scanning laser confocal microscope (SLCM) was used to measure 15 healthy
mothers (ages 25-35) and their biological children (ages 6 months – 2 years). The SLCM images
start at the stratum corneum of the epidermis and progress down through the epidermal lay-
ers, dermal epidermal junction and the top layers of the dermis. The reflected laser light cre-
ates 1.6um optical sections and represents single scattering events at a given depth. The
mean intensity of the single scattering events across a given section can characterize the
changes in index of refraction in the tissue as a function of depth. At ~100um into the skin,
mothers and older infants appear to have a slight increase of reflected signal as a function of
depth. In the mothers and older infants, the mean intensity can be expressed as an exponen-
tial decay with a ‘knee’ present representing a change in index of refraction. This change in
intensity could be linked to collagen cross-linking and depends on which type of collagen is
visible with in vivo SLCM at a given age. Upon further examination the younger infants have
an exponential decay in mean intensity without the ‘knee’ present indicating a lack of the
change in index of refraction. This occurrence illustrates to the importance of translating and
correlating which types of collagen or structures are visible within SLCM images related to
age. The lack of change of index at depth in infants merits further investigation.
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Matrix metalloproteinase (MMP) expression in the EpiDerm-FT skin equivalent: relevance
to dermal wound healing and blistering skin diseases
PJ Hayden, C Cooney, G Stolper and M Klausner MatTek Corp., Ashland, MA
MMPs play an important role in dermal wound healing, tissue remodeling, blistering dis-
eases, tumor invasion and metastasis. In the current work, the expression of MMPs was eval-
uated in a full-thickness in vitro human skin equivalent, EpiDerm-FT. Normal human epider-
mal keratinocytes (KC) and dermal fibroblasts (FB) were cultured to produce the highly
differentiated full-thickness skin equivalents. Histologic examination of EpiDerm-FT shows a
collagen dermis populated by viable FB and an epidermis of stratified KC including basal,
spinous, granular and stratum corneum components. Examination of the dermal-epidermal
junction by transmission electron microscopy (TEM) revealed a well-developed basement
membrane. RT-PCR analysis revealed the expression of MMP1 (interstitial collagenase), MMP2
(gelatinase A), MMP-3 (stromelysin 1), MMP7 (matrilysin), MMP9 (gelatinase B), MMP10
(stromelysin 2), MMP11 (stromelysin 3), MMP13 (collangenase 3) and MMP14 (membrane-
inserted) in the EpiDerm-FT model. Prior to addition of epidermal KC, contracted collagen
matrices containing dermal FB expressed significant amounts of MMP1 and MMP2, but little
MMP9. Following addition of the epidermal component, MMP9 expression was increased.
Subsequent separation of the dermal and epidermal components prior to RT-PCR analysis
revealed that the epidermal KC contributed significant amounts of MMP-1, MMP3 and MMP11.
The dermal component contributed a relatively greater amount of MMP-2, MMP7, MMP9,
MMP10 and MMP14. The results indicate that epidermal KC have significant influence over
expression of MMPs by dermal FB. EpiDerm-FT represents an important tool for elucidation
of KC-FB interactions related to MMP expression, wound healing, blistering skin diseases and
matrix remodeling.
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Unique innate response to injury is mediated through recognition of hyaluronan by TLR4 and
CD44
KR Taylor and RL Gallo Division of Dermatology, University of California, San Diego, San
Diego, CA
Glycosaminoglycans (GAGs) influence many biological processes including growth factor
activity, cytokine/chemokine function, microbial invasion and protease activity. Hyaluronan
(HA), a high molecular weight (MW) component of the dermis and epidermis, is broken
down to lower MW oligosaccharides (sHA) following injury and initiates immune signals
through Toll-like receptor 4 (TLR4). We hypothesized that the immune response following sHA
will differ from LPS despite sharing TLR4 as a common receptor. To test this, sHA and LPS
were injected ip in mice. Mice injected with LPS showed changes consistent with sepsis
while sHA injected mice appeared normal. Furthermore, sHA injection immediately before
LPS was protective. To determine the mechanism behind these responses to LPS or sHA, we
investigated downstream events and accessory molecules required for signaling by using human
and mouse monocytic cell lines as well as an HEK293 cell line transfected with TLR4 and
TLR4/MD-2. Microarray data identified several gene products induced by both sHA and LPS
(MIP-2, IL-6), or induced only by LPS (VEGF, VCAM) or only by sHA (HAS2, IFN-γ). Similar to
LPS, sHA required TLR4 and MD-2 to induce MIP-2 but unlike LPS, sHA did not require CD14.
CD44-deficient mice or macrophages derived from their bone marrow had a decrease in the
MIP-2 response to sHA by 70% and 49%, respectively, thus suggesting that CD44 serves as a
co-receptor with TLR4 in the recognition of sHA. We confirmed this suggestion by: 1. Show-
ing that TLR4 and CD44 are in close proximity at the cell surface following sHA treatment
and 2. Demonstrating that TLR4 could be immunoprecipitated (IP) with antibodies to CD44.
Control IP with other abundant cell surface receptors (EGFR) did not precipitate TLR4. These
results indicate that sHA uses a unique signaling complex of MD2/TLR4/CD44 to trigger a
response and explains for the first time a mechanism for TLR response to physical injury that
is distinct to that induced by microbial invasion.
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Use of accuSkin in vitro human 3-d skin equivalent model for disease modeling and toxicol-
ogy testing
K Chui,1 B Schnegelsberg,1 D Finlay,1 M Chen,2 D Woodley2 and W Hoeffler1 1 Xgene
Corporation, Sausalito, CA and 2 Dept. of Medicine, U. Southern California, Los Angeles, CA
AccuSkinTM is an, in vitro 3-D skin model created using Xgene’s patented technology, where
a mixed cell slurry of human keratinocytes and Fibroblasts placed in 96-transwell inserts, spon-
taneously self-sort to create a distinct epidermis and dermis. This is a significant advance over
our previous work that first documented sorting in vivo, and showed its use in RDEB cells to
restore collagen VII. Here we further advance these observations to show that the gene cor-
rected RDEB cells can be used to reform a normal phenotype skin in vitro. IHC data reveal-
ing correct localization of markers was conducted, as has been done previously for Accuskin,
where K1/10, involucrin, and filaggrin in epidermis and collagen I, IV, elastin, vimentin had
been documented. Thus our method can be used to create unique skin disease models. To
advance the use of Accuskin for toxicological testings we developed a noninvasive fluores-
cent lucifer yellow assay that can simultaneously document barrier integrity while using the
same samples to measure cell viability in response to potentially toxic compounds. The lucifer
yellow solution is loaded on top, and if lucifer yellow leaks from the top to bottom chamber,
leakage is measured by fluorescence units in the lower well. We recommend the use of this
simple new method for detecting invisible structural changes directly in the test-compound-
treated well.
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Umbilical cord blood mesenchymal stem cells: prospects in curing skin diseases
F Rouan,1 B Saitta2 and J Uitto1 1 Dermatology and Cutaneous Biology, Jefferson Medical
College, Thomas Jefferson University, Philadelphia, PA and 2 Laboratory of Cell and Matrix
Biology, Coriell Institute, Camden, NJ
Human umbilical cord blood mesenchymal stem cells (UCB-MSC) are multipotent cells that
can differentiate into adipogenic, osteogenic, and chondrogenic lineages. MSC can also con-
tribute to the structure of different non-haematopoietic tissues, including skin, and they have
the ability to enhance repair and promote skin healing. In attempts to understand the physi-
ological importance of these cells in skin we introduced UCB-MSC tagged with green fluo-
rescent protein (GFP) into mouse blastocysts or adult mice trough the tail vein injection.
These mice were sacrificed 1- 4 weeks after birth or injection, respectively. We collected dif-
ferent tissue samples from injected mice that were evaluated for the presence of GFP using
fluorescence microscopy and PCR analysis. Our results showed that GFP was detected in the
epidermal and the dermal layers of mouse skin in both models, as well as other tissues such
as esophagus, intestine, kidney, liver, brain and heart in tail vein injected mice. These results
indicate that MSC distribute broadly in different mouse tissues and may participate in ongo-
ing cellular turnover and replacement. Furthermore, the presence of UCB-MSC in the epi-
dermis suggests that these cells could contribute to skin structure and function. In vitro results
revealed that UCB-MSC express a number of matrix proteins, such as cytokeratins, collagen
VII, β1 integrin, laminin 5, and involucrin. These results corroborate the idea that UCB-MSC
when used as a tool for cell-based therapy could provide a platform for successful strategy
that can provide a dynamic therapeutic approach responding to the pathologic conditions of
different skin diseases, such as epidermolysis bullosa.
212
Quantitative measurement of bathing and moisturizer induced changes in skin hydration in
atopic dermatitis subjects
C Chiang2 and LF Eichenfield1,2 1 Pediatric and Adolescent Dermatology, Children’s Hospital,
San Diego, San Diego, CA and 2 University of California San Diego School of Medicine, San
Diego, CA
This study directly quantifies hydration status of the skin during various bathing and moistur-
izing regimens. 10 volunteers, 5 with a diagnosis of AD and 5 with healthy skin, each under-
went four bathing and/or moisturizer regimens over two separate days. The regimens consisted
of bathing alone, bathing and immediate moisturizer, bathing and delayed moisturizer, and
moisturizer alone. Moisturizer used was Cetaphil cream. Skin hydration was measured by the
Nova DPM 9003, with a pre-intervention baseline measurement, and every 10 min for 90
min post-intervention. In AD subjects, moisturizer alone yielded a significantly (p<0.05) greater
average hydration over 90 min (206.2% of baseline hydration) than the “soak and seal” method
of bathing with immediate moisturizer (141.6%), bathing and delayed moisturizer (141%),
and bathing alone (91.4%). In addition, the last hydration endpoint at 90 min was not signif-
icantly different between moisturizer alone (186%) and the “soak and seal” method(109.4%).
Controls yielded similar results but there was only a significantly greater average hydration of
moisturizer alone (215%) versus bathing alone (94.6%). The 90 min endpoint was not signif-
icantly different between moisturizer alone (184.2%) vs the “soak and seal” method (138%).
Moisturizer alone gave superior immediate skin hydration, achieving average results greater
than the traditional “soak and seal” recommendation, though with no significant difference
at the 90 min endpoint. This study displays skin hydration effects of bathing and moisturizer
regimens that may be relevant for atopic dermatitis management.
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Enzastaurin-induced apoptosis via AKT signaling and caspase-3 activation in cutaneous T-cell
lymphoma
C Querfeld,1,3 TM Kuzel,2,3 J Guitart,1,3 N Krett3 and ST Rosen2,3 1 Department of
Dermatology, Northwestern University, Chicago, IL, 2 Department of Medicine, Division of
Hematology/Oncology, Northwestern University, Chicago, IL and 3 Robert H. Lurie
Comprehensive Cancer Center, Northwestern University, Chicago, IL
Primary cutaneous T-cell lymphoma (CTCL) is a slowly progressive malignancy for which there
is no cure and patients ultimately develop advanced or relapsed disease that is refractory to
standard treatment options. No treatment has been shown to prolong disease-free or overall
survival and therefore, there is a great need for the development of novel emerging therapies.
Enzastaurin, an acyclic bisindolylmaleimide, is a selective orally administered PKC β inhibitor.
It is currently used in clinical trials for the treatment of refractory glioblastoma and large B-
cell lymphoma. We investigated the effects of the PKC β inhibitor Enzastaurin on the viabil-
ity of two CTCL cell lines. It decreased cell viability, increased annexin V-FITC positive cells,
and increased the proportion of sub-G1 populations in both cell lines that was not reversed
by the T-cell growth stimulating cytokines IL-2, IL-7, IL-15. Enzastaurin at clinically relevant
concentrations caused apoptosis of CTCL cell lines in association with activation of caspase-
3 and cleavage of poly (ADP-Ribose) polymerase (PARP) as well as downregulation of Akt
phosphorylation and its downstream effectors GSK3β and ribosomal protein S6. There was no
enzastaurin-stimulated change in phosphorylated PKC β levels. The phosphatidylinositol 3-
kinase (PI3K)/Akt pathway has been implicated in the growth and survival of hematologic
malignancies and inhibition of this pathway is considered as a therapeutic target. PKC acti-
vation contributes to PI3K/AKT activation, but it is unknown how Enzastaurin may interfere
with signaling through this pathway. Our results demonstrate that Enzastaurin induces apop-
tosis, at clinically achievable concentrations, through AKT signaling, and provide the ration-
ale to use it in CTCL patients.
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Low-dose oral flutamide (125mg/day) for the treatment of acne in women
JC Shaw1 and M Hogan2 1 Dermatology, University of Toronto, Toronto, ON, Canada and 2
McMaster University DeGroot School of Medicine, Hamilton, ON, Canada
The purpose of this study was to evaluate the efficacy and safety of a low daily dose of the
androgen receptor blocker flutamide in the treatment of acne in adult women. Higer doses
have been used successfully in women with hirsutism, but there has been concern about hepa-
totoxicity with doses greater than 500 mg/day. The study was an open, retrospective analysis
of 32 consecutive women aged 14-51, with acne, who were given flutamide (125 mg/day) and
followed for 2 to 21 months. Efficacy, tolerance, and safety were assessed. 21 women returned
for follow up. 17 out of 21 noted a marked improvement of their acne and rapid reduction in
seborrhea. 5 patients discontinued their treatment; 2 stated emotional volatility as their rea-
son, 2 had minor gastrointestinal distress, and 1 had a minor elevation of serum ALT. A low
dose of oral flutamide (125 mg/day) is an effective modality in the treatment of acne in women,
and a reasonable alternative to other androgen receptor blockers. The treatment appears to be
well tolerated. Monitoring of liver functions is indicated. Larger studies with low-dose flu-
tamide are warranted to further investigate efficacy and potential for liver toxicity.
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Encapsulated melanin microparticles: a novel platform for therapeutic radioprotection
AJ Friedman,1,2 MH Naveti,1 A Alfieri2 and JM Friedman1 1 Department of Physiology and
Biophysics, Albert Einstein College of Medicine, Bronx, NY, 2 Department of Radiation
Oncology, Albert Einstein College of Medicine, Bronx, NY and 3 Division of Dermatology,
Albert Einstein College of Medicine, Bronx, NY
Protection from secondary radiation dermatitis following external beam radiotherapy is an
ongoing therapeutic challenge. A preparation that either attenuates radiation and/or scavenges
resulting free radicals would be of considerable value in limiting cutaneous and mucomem-
branous damage caused by radation-based oncotherapy. We have developed an immuno-
genically neutral slow release melanin encapsulated micro particle infusion that can be injected
into the subcutaneous space without eliciting an immunogenic response. Initial studies demon-
strate conferred protection to all involved tissues and structures from the erythematous and
desquamative changes associated with radiotherapy. A population of Balb/C mice (N=5) were
selected to undergo a standard therapeutic treatment dose of 30 Gy/15min. The right dorsal
leg served as the microsystem treatment group, and the left dorsal leg served as the control.
Erythematous and desquamative changes were followed over a 35 day period adhereing to
the standard radiation reaction scoring system (Fowler, JF, et al.). Desquamation was evalu-
ated on a 0 – 3 (+/-) scale, 0 representing no change seen and 3 representing breakdown of
the majority of skin field with moist exudates. Results indicated a significant difference in cuta-
neous skin changes between the control and treated groups (1-1.5 point difference on the
breakdown scale). Postmortem histological studies were conducted, which illustrated the pres-
ence of the melanin microparticles within both epidermal and dermal strata over 1 month fol-
lowing subcutaneous injection.
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Inhibition of the constitutive activation of NF-κB pathway by an IKK2 inhibitor - AS602868
– associates with apoptosis induction in human cutaneous T cell lymphoma
A SORS,1 F Jean-Louis,1 L Dubertret,1 L Parmentier,2 M Dreano,2 G Courtois,1 H Bachelez1
and L Michel1 1 Dermatology, INSERM U697, PARIS, France and 2 Research Alliance
Management, SERONO International SA, GENEVA, Switzerland
The NF-κB signaling pathway is involved in apoptosis regulation and in the resistance of sev-
eral malignancies to cell death. We previously established that NF-κB is constitutively activated
in cutaneous T cell lymphoma (CTCL) cells, plays a key role in their survival and chemoresis-
tance, and that inhibition of NF-κB nuclear translocation either by the super repressor ∆nIκBα
or by proteasome inhibitors induces apoptosis in CTCL cells. The aim of the present study was
to investigate in vitro the effects on CTCL survival and chemoresistance of a pharmacological
inhibition of the IκB kinase (IKK) complex at the level of its subunit 2 (IKK2) by the anilinopy-
rimidine derivative AS602868. We evaluated the effects of AS602868 (0.1-30 µM) on the via-
bility of CTCL cell lines (SeAx, MyLa) lines and circulating tumor cells from patients with Sezary
syndrome (n=6) according to a dose- and time-dependent protocol. AS602868 was tested either
alone or in combination with antineoplastic agents such as etoposide (1-10µM), doxorubicin
(1µM) or vincristine (12.5µM). The modifications of NF-κB activity were studied by electrophoretic
mobility shift assay or immunocytochemistry. Results show that in both tumor cells from SS
patients and in CTCL cell lines, AS602868 down regulates the constitutive nuclear transloca-
tion of NF-κB and induces a potent apoptotic cell response, associated with annexin V/pro-
pidium iodide staining and mitochondrial transmembrane potential alterations, as well as pro-
caspase 3 and PARP cleavage. Moreover, AS602868 potentiates the apoptotic effects of etoposide,
vincristine and doxorubicine. Importantly, AS602868 does not alter viability of PBMCs from
healthy donors. These results indicate that pharmacologic inhibition of the NF-κB pathway by
IKK2 inhibitors may be an interesting innovating approach for the treatment of CTCL.
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Interleukin-12 production by monocytes from psoriatic patients and its inhibition by
cyclosporin A
Y Tada, A Asahina, T Takekoshi, M Kishimoto, H Mitsui, H Saeki, M Komine and K Tamaki
Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
Psoriasis is a cutaneous disorder characterized by inflammation and epidermal hyper-prolif-
eration. According to the predominant expression of IL-2 and IFN-γ and the lack of IL-4 in
skin lesions, psoriasis is believed to be characterized by the Th1-dominant pattern. IL-12 is a
cytokine known as a powerful mediator for Th1-type differentiation of T helper cells. Recently,
enhanced expression of IL-12 in psoriatic skin compared with normal skin has been shown,
and the dominant source of IL-12 was indicated to be skin-infitrating macrophages. Thus, up-
regulation of monocyte IL-12 production may play an important role in promoting the Th1
cytokine pattern observed in psoriasis. One of the strong inducers of IL-12 by monocytes is
Toll-like receptor (TLR) ligands, such as lipopolysaccharide (LPS) and Staphylococcus aureus
Cowan strain I (SAC). LPS and SAC induce IL-12 production through binding to TLR4 and
TLR2, respectively. In this study, we assessed TLR2 and TLR4 expression on psoriatic mono-
cytes and investigated whether IL-12 production by LPS- and SAC-stimulated monocytes was
altered in psoriasis. Monocytes were stimulated with IFN-γ plus LPS or SAC. The amount of
IL-12 p70 produced by stimulated monocytes was evaluated by ELISA. We found that LPS-,
but not SAC-stimulated psoriatic monocytes produced more IL-12 than monocytes from nor-
mal controls (2002.0±884.6 pg/ml vs 988.8±724.9 pg/ml) (p<0.005), although there was no
significant difference in TLR4 expression between monocytes of the two groups. Interestingly,
LPS-stimulated monocytes from psoriatic patients treated with cyclosporin A (CsA) produced
significantly decreased amounts of IL-12 compared to those patients not treated with CsA
(2002.0±884.6 pg/ml vs 771.1±566.9 pg/ml) (p<0.0005) (10 samples each). Our results sug-
gest that IL-12 production by monocytes may have a critical role in the pathogenesis of pso-
riasis, and that the therapeutic effect of CsA on psoriasis may be achieved by correcting the
deviation of Th1/Th2 balance.
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Effect of natural polyphenols and triterpens on skin cytokines and aging markers
FR Bonte,1 M Bonnet Duquennoy1 and F Joly2 1 R & D, LVMH, St. Jean de Braye, France and
2 SEPHRA, Puteaux, France
The functional longevity of the skin decreases with age due to the production of excess free
oxygen radicals (ROS) and dysregulation of the cytokine network. The syntheses of IL4, IL10
and IL8 in the epidermis are particularly linked to immunosenescence. This pro-inflamma-
tory state results in the attraction of dermal macrophages and neutrophils with proteolytic
activities. We showed recently that the concentrations of metallothioneins, which are involved
in nuclear DNA protection and repair, are sub-normal in the skin of women chronically exposed
to sunlight. ELISA studies showed that a complex and specific mixture of polyphenols and
triterpenes extracted from orchids roots inhibited the peroxidation of cell membrane lipids
and the production of the cytokine IL8 by preconfluent cultures of normal human keratinocytes
stimulated with interleukin beta 1. A 0.5% mixture inhibited production by 23% and a 1 %
mixture by 34%. Human peripheral blood cells prepared from three donors were stimulated
by incubating them for 72h with a mixture of PMA (10 ng/ml) and PHA-P (10µg/ml), with or
without the molecular orchid extract. The extract inhibited the secretion of IL4 in a dose
dependent manner (0.1% inhibited secretion by 17% and 1% by 29%). We used an in-house
quantitative low-density microarray technique (OLISA, oligosorbent array) to show that nor-
mal human keratinocytes incubated with the extract for 24 hours increased their expression
of the genes encoding metallothioneins 1 & 2 and the anti-inflammatory cytokine IL10, which
is also important for tissue function longevity. These data confirm that this specific orchid
extract is a potential new skin anti-aging agent.
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In vivo reflectance confocal microscopy of mycosis fungoides
AC Agero,1 PL Myskowski,1 M Gill,2 C Benvenuto-Andrade,1 A Scope,1 AC Halpern1 and
S Gonzalez1 1 Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY and 2
Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY
Mycosis fungoides (MF) can be a diagnostic challenge, needing multiple and/or sequential skin
biopsies to establish or confirm its diagnosis. In vivo reflectance confocal microscopy (RCM)
allows non-invasive imaging with cellular resolution. This study aimed to describe relevant con-
focal features of MF using in vivo RCM and correlate these with findings observed on histopathol-
ogy. Seventeen patients with 20 lesions consistent with MF underwent RCM imaging followed
by biopsy for histopathology analysis. Histology confirmed the diagnosis of MF for 7 lesions.
In patch-type lesions, RCM demonstrated weakly refractile oval to round structures within the
spinous layer which seemed to correspond with epidermotropic lymphocytes on histology.
However, these round structures were difficult to distinguish from surrounding keratinocytes
due to minimal differences in contrast. More prominent confocal features were observed in
plaque-type lesions. The epidermis was characterized by discrete collections of monomorphous
mildly refractile oval to round cells within small vesicle-like dark spaces. Surrounding ker-
atinocytes had thickened and blurred intercellular demarcation and were infiltrated by small
mildly refractile round structures. Corresponding histology revealed multiple Pautrier’s microab-
scesses on a background of minimal to mild spongiosis and epidermotropism. Dermal papil-
lary rings at the dermal-epidermal (DE) junction were faintly refractile or absent on RCM, with
marked loss of resolution and contrast in the dermis. Thus, RCM failed to visualize dense der-
mal infiltration or deep nodular collections of tumor cells seen on histopathology. RCM has
shown limitations, but we have demonstrated that it can successfully identify lesions with more
marked epidermal changes such as prominent spongiosis with Pautrier’s microabscesses, and
may also detect presence of epidermotropic lymphocytes. RCM shows promise as a real-time
guide for optimal biopsies of multiple suspect lesions.
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Curcumin induces apoptosis in cutaneous T cell lymphoma cells through targeting Stat3 and
NF-kB signaling pathways
C Zhang,1 G Sethi,2 P Hazarika,1 X Ni,1 B Aggarwal2 and M Duvic1 1 Dermatology, U. T. M.
D. Anderson Cancer Center, Houston, TX and 2 Experimental Therapeutics, U. T. M. D.
Andenson Cancer Center, Houston, TX
Defective T-cell apoptosis and constitutive activation of Stat3 and NF-kB are implicated in the
pathogenesis of cutaneous T-cell lymphomas (CTCL). Pharmacological modulation of apop-
tosis and related signaling pathways may provide a novel therapeutic approach for CTCL.
Curcumin (diferuloylmethane), a naturally occurring yellow pigment isolated from the rhi-
zomes of the East Indian plant Curcuma longa, inhibits cell growth and induces apoptosis in
a number of tumor cell lines and animal models. Human clinical trials indicated no dose-lim-
iting toxicity when administered at doses up to 12 g/day. The purpose of this study was to
address the pro-apoptotic effect of curcumin on CTCL cell lines (MJ, Hut78, and HH) and
peripheral blood lymphocytes (PBL) from three Sézary syndrome (SS) patients with high per-
centage (44-96%) of circulating malignant T cells (CD4+CD26-). Cells were treated with cur-
cumin at 0, 5, 10, and 20 uM for 24 and either 48 or 72 hrs. Apoptosis was measured by flow
cytometry analysis of annexin V/PI binding population. Stat3 and NF-kB signaling pathways
were detected by Western blot and electrophoretic mobility gel shift assay. The results show
that curcumin induced apoptosis in a time and concentration-dependent manner in three cell
lines over the untreated controls. Curcumin at 5-20 uM for 72 hrs also caused apoptosis of
three SS patients’ PBL in a concentration-dependent manner. Curcumin down-regulated expres-
sion of Stat3 and phospho-Stat3 proteins as well as Stat3-regulated genes (anti-apoptotic pro-
tein bcl-2 and inhibitor of apoptosis protein survivin) in all three cell lines. Curcumin also sup-
pressed NF-kB binding in two of three cell lines. Caspase-3 was activated and PARP was cleaved
following curcumin treatment. These data suggest that curcumin induces apoptosis in not
only CTCL cell lines but also patients’ Sézary cells through targeting Stat3 and NF-kB signal-
ing pathways and provide the rationale for a clinical trial for CTCL patients.
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Extensive alopecia areata: retrospective analysis of treatment based on histopathologic find-
ings
S Zeller,1,2 A Magembe2 and M Hordinsky2,3 1 Hennepin County Medical Center,
Minneapolis, MN, 2 University of Minnesota, Minneapolis, MN and 3 Dermatology,
University of Minnesota, Minneapolis, MN
Alopecia areata (AA) is an organ-specific T-cell mediated autoimmune disease. Currently there
exists no gold standard for the treatment of extensive AA (>95% scalp hair loss). Multiple
therapeutic agents are frequently used in combination with variable success. Extensive AA and
disease of long duration are generally more resistant to treatment. One approach that has not
yet been described in the literature is the selection of therapeutic agents on the basis of
histopathologic observations in scalp biopsy specimens. The objective of this analysis is to
evaluate the effectiveness of a treatment algorithm based on the histopathology of extensive
AA. We selected 19 patients (13 women, 6 men) with extensive alopecia areata. 57.9% (11/19
participants) had complete scalp hair loss (alopecia totalis), and 31.6% (6/19 participants)
had entire body hair loss (alopecia universalis). The average duration of disease in this popu-
lation was 15.3 months (median, 12). All patients donated two 4 mm scalp biopsy specimens
at their initial presentation. Based on patient preference, topical (Class 1), intralesional (Kena-
log 10), or oral steroids were prescribed if prominent peribulbar inflammation was present.
Rogaine (2% or 5%) was added if there was significant anagen follicle miniaturization or shift
to telogen. Treatment efficacy was evaluated after an average of 176.7 days (median, 168).
Presence of terminal, vellus, and indeterminate fibers was documented. Terminal hair growth
was observed in 73.7% (14/19 participants), indeterminate fibers in 15.8 % (3/19 participants),
and vellus fibers in 10.5% (2/19 participants). Cosmetically significant hair re-growth was not
noted in any study participants after 5-6 months therapy. The results of this preliminary explo-
ration indicate that treatment of extensive alopecia areata based on histopathology may be an
effective strategy that warrants further prospective investigation.
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A peptide antagonist of CXCR4 restores sensitivity of B16 murine melanoma cells to killing
by GP100-specific cytolytic T cells and increases the efficacy of cyclophosphamide in treat-
ing established lung metastases
C Lee,1 T Kakinuma,1 J Wang,1 H Zhang,1 S Jaber,1 D Palmer,2 N Restifo2 and S Hwang1 1
Dermatology Branch, National Cancer Institute, Bethesda, MD and 2 Surgery Branch,
National Cancer Institute, Bethesda, MD
The chemokine receptor, CXCR4, promotes cancer cell survival and metastasis. Inhibition of
CXCR4 with a peptide antagonist, T22, blocks metastatic implantation of CXCR4-transduced B16
(CXCR4-B16) melanoma cells in lung, but not the outgrowth of established metastases, raising
the question of how T22 can best be used in a clinical setting. We first established calcein-release
and annexin-V cytotoxicity assays to determine specific conditions under which CXCR4 activa-
tion promoted B16 cell survival. While the treatment of CXCR4-luc-B16 cells with the CXCR4
ligand, CXCL12, did not protect cells from killing induced by cisplatin or cyclophosphamide
(CPA), CXCL12 markedly reduced Fas-dependent killing by gp100-specific (PMEL) CD8+ T cell-
mediated killing. T22 pretreatment restored sensitivity of CXCR4-B16 cells to PMEL killing, even
in the presence of CXCL12. Since CPA boosts host anti-tumor immunity in vivo, we used single,
low-dose CPA treatment as a model of immunotherapy. Wild-type mice inoculated via tail vein
with CXCR4-Luc-B16 cells on day 0 and treated with T22 on day 4-7 showed equivalent surface
lung nodules versus those treated with PBS. While mice treated with CPA (d 5) showed a ~50%
reduction in lung nodules compared to these mice, mice treated with T22 (d 4-7) followed by
CPA (d 5) showed a further ~70% reduction (p<0.05) in metastases compared to CPA-treated
animals. In SCID mice, however, CPA alone and CPA + T22 both reduced tumor burden by
~56%.  Thus, CXCR4 activation was only effective in protecting B16 cells from PMEL T cell-medi-
ated killing, and this was reversed by blocking CXCR4 with T22. While T22 had no effect on
established metastases by itself, it synergized with CPA treatment in reducing metastatic lesions,
suggesting a novel strategy for augmenting the efficacy of immunotherapy.
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Production of a β defensin-3-expressing human skin substitute using an ex vivo, nonviral
genetic engineering strategy
AL Gibson,1 CL Thomas-Virnig,1,2 S Schlosser,1 J Centanni,2 C Johnston2 and B Allen-
Hoffmann1,2 1 Pathology, University of Wisconsin-Madison, Madison, WI and 2 Stratatech
Corporation, Madison, WI
Infection remains a significant obstacle in the treatment of acute and chronic wounds. Levels
of host defense peptides (HDPs) are modulated in these wounds. We hypothesized that con-
stitutive expression of a human β defensin-3 (hBD-3) transgene in keratinocytes would result
in enhanced antimicrobial activity. NIKS human keratinocytes were stably transfected ex vivo
with the full-length human hBD-3 gene under the control of a cell type-specific promoter.
Clonal cell populations were screened for transgene expression by quantitative RT-PCR. NIKS-
hBD-3 candidate clones were assessed for development of appropriate tissue architecture dur-
ing organotypic culture. Those clones exhibiting normal tissue histology and expressing >10-
fold more hBD3 were assayed for antimicrobial activity. Two assays were used to test for
antimicrobial activity of NIKS-hBD-3 candidate clones, untransfected NIKS, and two strains
of primary human keratinocytes. Conditioned medium (CM) from keratinocyte monolayers
was tested in a 96 well kinetic bacterial assay using S. carnosus. Bacterial growth was moni-
tored at 15 min intervals for 7 hrs by measuring the optical density at 620 nm. Chemically
synthesized hBD-3 was used to generate a standard curve for each assay. In a bacterial con-
tact assay, organotypic cultures were incubated with S. carnosus for 2 hours and viable bac-
teria were enumerated by spiral plating. Both monolayer and organotypic cultures of NIKS-
hBD-3 candidate clones exhibited increased antimicrobial activity relative to untransfected
NIKS and primary human keratinocytes. Immunohistochemistry analysis showed that hBD-3
protein was concentrated in the upper layers of the organotypic cultures following exposure
to bacteria. Cultured human skin tissue generated with NIKS-hBD-3 keratinocytes is an inno-
vative therapeutic approach for the delivery of a constant supply of hBD-3 to promote heal-
ing of burns and chronically infected hard to heal skin ulcers.
224
Depletion of regulatory T cells from melanoma bearing individuals augments the immune
response following vaccination
S Fondel, K Mahnke, S Schallenberg, K Schoenfeld and AH Enk Dept.of Dermatology,
University Hospital Heidelberg, Heidelberg, Germany
CD4+/CD25+ regulatory T cells (Treg) suppress proliferation of effector T cells in vivo. Although
this function is mandatory in healthy individuals to suppress autoimmunity, during cancer
treatment Treg may prevent an effective therapy. To investigate in a pilot study whether removal
of Treg has beneficial effects for melanoma therapy, melanoma bearing individuals were treated
repeatedly with ONTAK® (a fusion protein containing IL-2 and diphtheria toxin) to remove
Treg. After injection of 5 µg/Kg bodyweight we noticed a reduction of CD25+/FoxP3+ cells in
peripheral blood. However, this decline was incomplete and 2 weeks after the last applica-
tion of ONTAK® approx 50% of the original number of CD25+ T cells remained in the blood.
Subsequently the patients were vaccinated with MelanA/gp100 and the contact sensitizer DCP
was applied. In the follow up, blood samples were continuously analysed for the presence of
MelanA/gp100 specific T lymphocytes by tetramer staining and IFNγ ELISPOT. Additionally
the DCP hypersensitivity was tested by elicitation of an eczema following topical application
of DCP. Our results show, that parallel to decreasing numbers of Tregs in the blood, the num-
ber of MelanA/gp100 specific T-lymphocytes increases. Moreover, individuals that appeared
resistant to DCP-induced hypersensitivity reactions when Treg were present, displayed vast
eczemas after depletion of Treg. Thus these data indicate that depletion of Treg from melanoma
patients augments the cellular response to vaccination antigens and contact allergens. Fur-
ther evaluation of the study cohort will show whether this also affects tumor growth and sur-
vival of melanoma patients.
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Induction of protective immunity against melanoma by intra-tumor administration of a den-
dritic cell-stimulatory anticancer drug, vinblastine
H Tanaka, H Matsushima, N Mizumoto and A Takashima Dermatology, UT Southwestern
Medical Center, Dallas, TX
Through unbiased functional screening of 54 anticancer drugs, we recently identified a unique
class of drugs, termed Type 1, that deliver activation signals to dendritic cells (DCs) at sub-
toxic doses. In this study, we tested the hypothesis that selected Type 1 drugs may exhibit dual
therapeutic efficacy by directly killing tumor cells and by promoting anticancer immunity via
DC activation. A prototypic Type 1 drug, vinblastine (VBL), was found to induce phenotypic
maturation of murine bone marrow (BM)-derived DCs and human DCs generated from CD34+
hematopoietic progenitors. VBL also stimulated both murine and human DCs to elaborate a
number of pro-inflammatory cytokines and chemokines. Unlike other conventional DC-stim-
ulatory agents, VBL markedly (8 to 10-fold) augmented the capacity of murine and human DCs
to incorporate FITC-conjugated dextran. Furthermore, VBL treatment markedly improved the
efficacy of BM-DCs to “cross-present” exogenous protein antigen, ovalbumin (OVA), to OVA-
reactive naive CD8 T cells isolated from OT-I transgenic mice. Local s.c. injection of VBL
induced emigration of Langerhans cells in mice, as well as their phenotypic maturation in situ.
When co-injected with OVA, VBL significantly boosted both humoral and cellular immune
responses to OVA, signifying its potent adjuvanticity. Direct injection of a small dose (4.5
µg/animal) of VBL into B16-F1 melanoma tumors not only inhibited the tumor growth signif-
icantly (P<0.01), but also primed the generation of melanoma-specific CTL activity. By con-
trast, no CTL activity was inducible by intra-tumor injection of vehicle alone or a control anti-
cancer drug, cisplatin (CDDP), that failed to cause DC activation. Our results may revolutionize
the field of cancer chemotherapy by introducing an entirely new protocol designed to kill only
a fraction of tumor cells as a source of tumor-associated antigens while activating tumor-infil-
trating DCs to uptake and cross-present the antigens to CD8 effector T cells.
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Imidazoquinolines are toll receptor agonists which potently and broadly enhance the cellu-
lar immune response of immunodepressed cutaneous T-cell lymphoma patients: synergy with
interferon gamma and IL-18
M Wysocka, S Newton, BM Benoit, JH Lin, LJ Montaner and AH Rook Dermatology,
University of Pennsylvania, Philadelphia, PA
Patients with advanced cutaneous T-cell lymphoma (CTCL) exhibit profound defects in cell
mediated immunity partially resulting from marked deficiencies in the numbers of peripheral
blood dendritic cells (DCs) and in their capacity to make DC derived cytokines (IL-12, IL-15
and IFNa). Because host immune function appears to play an integral role in mediating dis-
ease-controlling responses in CTCL, we investigated the effects of synthetic imidazoquinolines
which have been recognized as immune stimulatory by virtue of activation of DCs by signal-
ing through Toll like receptors (TLR) 7 and 8. TLR 7, 8 and 7/8 agonists were cultured with
freshly isolated peripheral blood mononuclear cells (PBMC) from patients with advanced CTCL
and normal volunteers and a broad panel of immune functions assessed. All three TLR ago-
nists significantly induced high levels of IFNa, while the TLR 8 and 7/8 ligands induced IL-12,
IL-15 and IFNg. The ability to synergistically enhance IL-12 or IFNg production could be
achieved by prior priming of PBMC with IFNg or IL-18, respectively. The cytokine inducing
effects of the TLR agonists were associated with marked activation of NK and CD8+ T-cells
assessed by CD69 expression and cytolytic activity. Furthermore, striking upregulation of CD80
expression on DCs and monocytes also occurred. Thus, imidazoquinolines exhibit the ability
to potently and broadly enhance the immune response of patients with advanced CTCL. Impor-
tantly, synergistic interactions occur between imidazoquinolines and other immune activat-
ing cytokines indicating the benefit of using a combination of several biological modifiers tar-
geting different cellular pathways. Such pre-clinical findings have typically been associated
with significant clinical improvement when put into clinical practice and therefore have impor-
tant implications for the potential enhancement of anti-tumor immunity among patients with
advanced CTCL.
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Efficacy and tolerability of a combined topical therapy of sodium L-ascorbyl-2-phosphate
and clindamycin for acne vulgaris in comparison with monotherapy
H Ikeno1 and T Nishikawa2 1 Dermatology, Ikeno Clinic, Tokyo, Japan and 2 Medicine and
Nursing, Hokkaido University of Education, Sapporo, Japan
Sodium L-ascorbyl-2-phosphate (APS) is a derivative of vitamin C and works as a powerful
scavenger of active oxygen species. One of the pathophysiologic factors in acne is an oxi-
dization of fatty acid and squalene. APS is very effective in suppressing this oxidization. Our
previous reports, at the SID meetings in 2002 and 2003, showed the efficacy of 5% APS
lotion in the treatment of acne vulgaris. We hypothesized that a combined topical therapy with
APS and Clindamycin (CL) may have more advantages than each one as monotherapy. The
purpose of this study was to determine the clinical efficacy and safety of the combined topi-
cal therapy (5% APS and 1% CL lotion) by comparing it with each one as monotherapy in the
treatment of acne vulgaris. In a randomized, multicenter, open label, parallel study, one hun-
dred and fifty patients with facial acne were divided and assigned to receive 5% APS lotion
plus 1% CL lotion (APS+CL) (n=50), 5% APS lotion (APS) (n=50), and 1% CL lotion (CL) (n=50),
with twice-daily treatment. Evaluations of efficacy and safety were performed at weeks 4, 8,
and 12 by a blinded evaluator. Patients were instructed to refrain from receiving any other
treatments or drugs for acne for 4 weeks prior to enrollment in the study. A total of 143 patients
completed the study. The number of patients, evaluated as good and excellent, was 41/47 on
APS+CL, 37/50 on APS, and 31/46 on CL. No serious adverse events were reported in any
group. The efficacy rate for APS+CL, APS, and CL was 87.2%, 74.0% and 67.4% respectively.
The efficacy of APS+CL was superior to APS, and CL alone. It can be concluded that combi-
nation therapy with APS+CL is more effective than APS or CL monotherapy, which is widely
prescribed in western countries for the treatment of acne vulgaris.
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Ojective assessment of efficacy by barrier cream: significance of barrier and water recovery
in non-lesional dry skin of atopic dermatitis
T Matsuki,1 S Sato,1 H Matsuki,2 K Kiyokane2 and G Imokawa3 1 Department of
Dermatology, Sanno Hospital, Tokyo, Japan, 2 Department of Dermatology, Osaka Medical
University, Osaka, Japan and 3 Skin Science Research Institute, Tochigi, Japan
Atopic dermatitis (AD) can be considered a barrier disease in which antigens and irritants,
which easily penetrate clinically normal, non-lesional skin due to its defective barrier func-
tion, trigger and worsen the dermatitis. Thus, replenishing the disrupted barrier function of
non-lesional skin of AD patients to healthy control levels seems to be a key for preventing the
refractory nature of the dermatitis. In this study, we characterized the barrier function and the
water conditions with respect to disease severity and determined whether topical applica-
tions of a synthetic ceramide (CER) cream can improve the two parameters to the levels cor-
responding to healthy control. Relationship between TEWL and capacitance values in asso-
ciation with the AD severity revealed that the two parameters are well distributed corresponding
to the severity of AD. Comparison between the CER or an ordinary moisturizing (OM) cream
treatment and non-treatment during the 4 weeks of therapy revealed that whereas those two
parameters of the OM cream or non-treated skin remained within the levels of the mild to
moderate AD skin at 4 weeks, those of the CER cream-treated skin were distributed into the
levels of healthy control skin. Because properties of dry skin, such as dryness and scaling in
the non-lesional skin which were significantly improved by the treatment of the two creams
or the non-treatment during 4 weeks of therapy mainly using steroids, do not necessarily reflect
the intensity of barrier disruption, measurement of the barrier function in concert with clini-
cal observations is required for precise clinical evaluation during skin treatment of AD patients.
Our results further demonstrate that the use of skin care products is an essential requirement
for repairing the barrier function, which suggests a high clinical significance for using mois-
turizing materials capable of replenishing the barrier function of the skin.
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Mortality in pyoderma gangrenosum is associated with male sex, older age and haemato-
logical disease
BC Hackett, S Collins and FC Powell Regional Centre of Dermatology, Mater Misericordiae
University Hospital,, Dublin, Ireland
The outcome of Pyoderma Gangrenosum (P.G.) can be unpredictable and there is a signifi-
cant associated mortality. The mortality rate and factors associated with it have been poorly
defined to date. A retrospective study of 52 patients with P.G. seen over 20 years (follow-up
1-180 months) revealed a mortality rate of 25% (13 patients). Fifty-four percent of P.G. patients
who died were male (30.76% of the remainder of the group were male). Average age of pres-
entation was 64.8 years in the patients who died (compared with 49.7 years in other P.G.
patients). Eighty-five percent of the group who died had an associated medical disorder
(compared with 71.7% of the other P.G. patients). Haematological disease (Chronic Lym-
phocytic Leukaemia in 2 cases, Polycythaemia Rubra Vera in 3 cases, IgA Myeloma and
Myelodysplasia) was seen in 54% of the group of P.G. patients that died, but in only 7.7% of
the remaining P.G. patients. All patients that died had either Ulcerative P.G. (77%) or Bullous
P.G. (23%), and no patient with Vegetative or Pustular P.G. died. The 3 deaths in the Bullous
group had associated haematological disease. No specific therapy for P.G. was associated
with an increased mortality. Von Den Driesch reported that, in his experience of 44 P.G. patients
seen over a 12-year period, a poor outcome in P.G. was seen in male patients with P.G. and
associated haematological diseases. This study provides further evidence of the poor outcome
in this group of patients. It has identified factors associated with mortality in the setting of
P.G. such as male sex, age of presentation greater than 60 years, Bullous or unremitting
Ulcerative P.G. and haematological disease.
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Combined treatment of intratumoral injection of dendritic cells and topical application of
imiquimod for murine melanoma
J Lee,1 G Choi,1 J Shin1 and S Song2 1 Dermatology, Inha University Hospital, Incheon, South
Korea and 2 Clinical Research Center, Inha University Hospital, Incheon, South Korea
Dendritic cells (DCs) are the most effective antigen-presenting cells for T-cells, and they have
potential to induce tumor-specific immune responses leading to tumor rejection. DCs have
been used in numerous clinical trials to induce antitumor immune response in cancer patients.
Imiquimod is a Toll-like receptor-7 ligand (TLR7), acting as an immune response modifier
and inducer of cytokines in vitro and in vivo. It has been shown to have potent antiviral and
antitumor activity. Topical cutaneous application of imiquimod can induce the maturation of
immature DCs and recruitment of plasmacytoid DCs. In our study, after intradermal tumors
were established using B16F10 melanoma cells in syngeneic C57BL/6 mice, we evaluated a
synergistic effect of topical application of imiquimod plus intratumoral injection of syn-
geneic bone marrow-derived DCs for the treatment of melanoma. Four groups (untreated con-
trol, DC alone, imiquimod alone and imiquimod plus DC) were included in the animal study,
five mice for each group. The imiquimod cream was applied to shaved abdominal skin once
daily after tumor cell inoculation. On day 12, when the tumor size reached about 3-5 mm in
diameter, DCs were injected intratumorally (i.t) four times on days 12, 14, 16 and 20 (2 ×
106cells/mouse for each injection in 50 ul of PBS). The results demonstrate that combined
treatment of topical application of imiquimod and intratumoral injection of DCs led to sig-
nificant tumor regression, in contrast to partial eradication of the tumors with imiquimod or
DCs alone. These findings suggest that combination therapy of topical application of imiquimod
and intratumoral administration of DCs is potent strategy for the treatment of melanoma.
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Meta-analysis of efficacy and safety of alefacept, efalizumab, and etanercept for psoriasis
AK Brimhall,1 HT Jacobe2 and A Menter3,2 1 The University of North Texas Health Science
Center, Fort Worth, TX, 2 Dermatology, UT Southwestern Medical Center, Dallas, TX and 3
Dermatology, Baylor University Medical Center, Dallas, TX
This study is a systematic literature review using meta-analysis to analyze the efficacy and
safety of three FDA-approved biologic therapies for psoriasis: alefacept, efalizumab, and etan-
ercept. Systematic literature searches were performed independently for each biologic using
identical search strategies. The Cochrane Handbook for Systemic Reviews of Interventions
4.2.4 guidelines were used to search MEDLINE and other databases. Thereafter, titles, abstracts
and full reports were screened to select randomized, controlled, double-blind, monotherapy
trials. The results for both efficacy and safety are reported quantitatively as odds ratios (ORs)
and graphically as Forrest Plots. Data from a total of 10 trials including 4,798 patients were
compiled: 1,639 alefacept patients, 1,603 efalizumab patients, and 1,556 etanercept patients.
The OR for achievement of 75% improvement in PASI (PASI 75) for alefacept was 3.83 (p=.001),
for efalizumab 9.22 (p=.001), and for etanercept 13.83 (p=.001). Patients in the efalizumab
treatment group reported at least one adverse event (AE) 148% more often than patients in
the placebo group (p=.001). Similarly, serious adverse events (SAEs) were reported 334% more
often in the efalizumab group compared to the placebo group (p=.017). Total AEs and SAE
were not reported across trials of alefacept and etanercept. This analysis of 10 randomized
controlled trials with a total of 4,798 patients further validates the efficacy of alefacept, efal-
izumab, and etanercept for the treatment of psoriasis. Concern regarding the omission of per-
tinent safety data from clinical trial reports of alefacept and etanercept and previously unre-
ported statistical significance of increased SAEs and AEs in Efalizumab trials is raised. With
the absence of direct comparisons, this meta-analysis is an invaluable tool for indirect com-
parison and reporting low frequency safety events.
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An inhibitory effect for pigmentation and eliminating effect on the preexisting pigmentation
by yeast-extracted melanoston
J Kim and Y Ahn Dermatology, Hanyang University Guri Hospital, Guri City, Gyunggi-Do,
South Korea
The ultraviolet radiation may cause changes to the structural and functional components of
the skin, such as hyperpigmentation especially in the Asian populations. The effective skin
whitening agents have been reported are arbutin, hydroquinone, tretinoin, and Kojic acid.
However, more effective skin whitening agents are desirable since the above agents have some-
what weaker effects for whitening and some side effects. Melanoston is a new melanogene-
sis inhibitor isolated from yeast. However, only a part is have known about the mechanism of
this agent. In this study, using topical preparations of melanoston, we examed the inhibitory
effect in reference to the in vivo activities of tyrosinase. The activities of tyrosinase of guinea
pig’s epidermis were assessed using immunohistochemical methods. The activities of tyrosi-
nase was estimated and revealed that the lowest level observed were at the 3rd week after
application of 0.1% and 0.01% melanoston on the skin of guinea pigs, and melanoston has
relative strong inhibitory effect on tyrosinase as compared with the vehicle, and the arbutin.
Additionally, the 8-weeks clinical trial was conducted to determine the clinical efficacy and
safety of melanoston. Patch tests for examining possible irritation and/or allergic reactions with
0.5% melanoston. Participants were educated to apply melanoston and vehicle on 7 small
areas of skin for 8 weeks before and after UVB exposure, and were examined daily for the first
week and weekly thereafter. In the patch tests there were no positive cases seen among all
those enrolled cases. Differences of the degree of the pigmentation between areas treated with
0.5% melanoston and the areas applied only with vehicle, before and after UVB exposure,
were considered to be significant. There were no untoward effects found during the period this
study. This experiment have shown that the melanoston has an inhibitory effect on the melano-
genesis and some eliminating effect of established pigmentation.
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An open study comparing sodium α-tocopheryl phosphate lotion with vehicle lotion for the
treatment of erythema and hyperpigmentation in post-inflammatory acne lesions
K Ohmori,1,2 H Ikeno1 and T Nishikawa3 1 Dermatology, Ikeno Clinic, Tokyo, Japan, 2 Plastic
& Reconstructive Surgery, Tokyo Metropolitan Police Hospital, Tokyo, Japan and 3 Medicine
and Nursing, Hokkaido University of Education, Sapporo, Japan
Recently, vitamin E is receiving growing attention in dermatology because of its antioxidant
properties. We reported the efficacy of Sodium α-tocopheryl phosphate (VEP) in the treat-
ment of hyperpigmentation in post-inflammatory acne lesions at the dermatologic meeting of
2002 in Japan. VEP is one of vitamin E derivative and the major lipophilic antioxidant. Being
easily absorbed into epidermis and dermis, it is effective for the removal of active oxygen
species, especially NO in deep dermis. Erythema in post-inflammatory acne lesions are diffi-
cult to be well treated, as they accompany the dilation of blood vessels in deep dermis. We
hypothesized that VEP may be effective for the treatment of not only hyperpigmentation but
erythema in post-inflammatory acne lesions because of its antioxidant properties. In a ran-
domized, multicenter, single-blind, parallel study, forty patients were assigned to receive 1%VEP
(n =20), vehicle (n =20) topically. Efficacy was assessed in 5 grades at the beginning and at 4,
12, and 24 weeks of treatment based on digital CCD microscopic device. Patients were
instructed to refrain from receiving any other treatments, such as administration of vitamin C,
vitamin E, hydroquinone, and retinoid for 4 weeks prior to enrolment in the study. The num-
ber of patients who complied with the treatment protocol was 19 on VEP, 17 on vehicle. The
number of patients who were evaluated as good and excellent was 14 on VEP, 6 on vehicle.
Efficacy rate for VEP was 73.7%, vehicle 35.3%. The efficacy of VEP was superior to vehicle(
p< 0.01 ). This data supports the hypothesis that VEP showed the excellent efficacy in the
treatment of erythema and hyperpigmentation of post-inflammatory acne lesions.
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Non-invasive intravital imaging system for demarcating melanoma margins
SR Rudrabhatla, WM Petroll and ME Mummert UT Southwestern, Dallas, TX
Accurate demarcation of cutaneous melanoma margins is critical for the efficacy of surgery.
In vivo confocal laser scanning microscopy (CLSM) is a new tool that may allow non-invasive
assessment of melanoma margins in patients. The development of fluorescent probes that bind
strongly to tumors, but not normal skin could facilitate the mapping of tumor margins in fine
detail by CLSM. Hyaluronan (HA), a glycosaminoglycan composed of repeating N-acetylglu-
cosamine and glucuronic acid subunits, is expressed abundantly by nearly all malignant
melanomas and thus may serve as a molecular marker for this cancer. We have developed a
novel 12-mer HA-binding peptide (termed “Pep-1”) that binds strongly to HA on cell surfaces
but weakly to HA in the extracellular matrix. Pep-1 may therefore serve as a new probe for
the demarcation of melanoma margins in vivo. For CLSM experiments we labeled Pep-1 and
a scrambled version of the Pep-1 amino acid sequence (termed the “scrambled control”) with
the fluorescent dye, tetramethylrhodamine isothiocyanate (TRITC). B16-F10 melanoma cells
engineered to express the green fluorescence protein (GFP) gene were inoculated into the ear
skin of C57BL/6 mice. When tumors reached 3 mm in diameter, the mice were intravenously
injected with TRITC-Pep-1 or the TRITC-scrambled control (0.02 mg/kg). Fluorescent signals
for GFP and TRITC were collected under CLSM 16 hr after peptide injections. GFP+ tumors
were distinguishable from the surrounding tissue by uniform and robust binding of TRITC-Pep-
1, but not the TRITC-scrambled control. In fact, TRITC-Pep-1 signals were 100-times higher
in the tumors than the uninvolved skin. By contrast, the TRITC-scrambled control showed lit-
tle or no binding in either tumors or skin. Our results validate the utility of Pep-1 as a novel
probe for demarcating melanoma margins in living animals.
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Confocal reflectance mosaicing of basal cell carcinomas in Mohs surgical skin excisions
YG Patel, KS Nehal, AC Halpern and M Rajadhyaksha Department of Medicine, Dermatology
Services, Memorial Sloan-Kettering Cancer Center, New York, NY
Mohs surgery is a procedure for microscopically excising basal cell carcinomas (BCCs) while
preserving the surrounding normal skin. Serial excisions are made, each excision being guided
by examination of the frozen histology of the previous. Mohs surgery is time-consuming (20-
40 minutes per excision) and tedious because several (2-20) excisions must be made and frozen
histology prepared for each. Confocal reflectance mosaicing may enable rapid examination
of BCCs directly in fresh skin excisions with minimal need for histology, thereby increasing
the efficiency of Mohs surgery. Soaking the excision in acetic acid compacts the chromatin,
which increases nuclear backscatter, and brightens the nuclei (acetowhitening). Acetic acid
concentrations of 1%, 2%, 3%, 5% and 10% required minimum soaking times of 5 minutes,
3 minutes, 1 minute, and 30 seconds, respectively. Cross-polarized mosaics displayed improved
contrast to that of brightfield. Cross-polarization suppresses the brightness of the cytoplasm
and dermis relative to the brightened nuclei, thus enhancing BCC nuclei-to-dermis contrast
in confocal mosaics. Comparison of mosaics to histology revealed that large macronodular
BCCs are easily detected but smaller micronodular and infiltrative BCCs tend to remain unde-
tected in the dermis. At present, mosaicing to display up to 12mm x 12mm of an excision
require 9 minutes.
236
Antibacterial action of some botanical extracts on Staphylococcus epidermis
JJ Wille and R Toronyi Research Center, Bioderm Technologies, Inc., Eastampton, NJ
Staphylococcus epidermis is a common bacterium associated with malodor in human uder-
arms. Antiperspirant,AP, and anti-odor, AO, personal care products generally contain anti-bac-
terial agents to eliminate odors. Recent interest has shifted to the use of natural products to
kill malodorous bacteria in AP/AO products. Here we report the successful use of several botan-
ical extracts as effective antibacterial agents against an S. epidermis isolate from human armpit
skin. They include the following botanical extracts: 1) hydroalcoholic extracts from Eleagnus
umbelifera ripe berries, 2) water extracts from powdered corn tassels, Zea mays, 3) hydroal-
coholic extracts of green tea leaves,Camellia sinensis, and 4)water extracts of the fruit of prickly
ash,Pericarpium zanthoxyl. The extracts were first tested for self-sterilization by inoculating an
aliquot of a 10%(w/v) botanical extract into sterile beef heart infusion medium(BHI) and incu-
bated at 37oC for 48 hrs. Various dilutions of each self-sterilizing extract were challenged
tested by adding 0.05ml of S. epidermis (10exp5 cells/ml) in 1.0 ml of sterile saline and incu-
bated at 37oC for 48 hrs. Positive controls become slightly turbid while extracts showing anti-
bacterial activity remain clear. Aliquots of the challenge tests are further inoculated into fresh
sterile BHI for an additional 48 hrs. The absence of any bacterial growth in the post-challenge
test assures the the minimal bactericidal concentration kills at least 5 logs of bacteria. These
results indicate that all of the botanicals tested above do contain active antibacterial agents.
Independent tests suggest the activity resides in the polyphenolic fraction of each of the tested
extracts.
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Aloe Vera promotes dermal fibroblast proliferation and migration
Q Ma, J Chen, R Chirinos and J Li Dermatology and Cutaneous Surgery, University of Miami,
Miami, FL
The objective of this study was to evaluate the effects of plant Aloe Vera extract on cell pro-
liferation and migration during skin wound repair. The mucilaginous gel extract from the filet
of the Aloe Vera leaf has been incorporated in a vast array of topical preparations and used
for decades as a folk remedy for frostbite, burns, radiation dermatitis, wounds, skin infections
and sun care products. Despite its wide use as a viable broad-spectrum alternative therapy of
choice, the physiological function and mechanisms of Aloe Vera extracts in enhancing wound
repair has not been clearly elucidated. Since cell proliferation and migration are the two key
steps for wound healing after injury, in this study we tested effects of an Aloe Vera solution
derived from whole leaf of Aloe Vera extract, Coats Whole Leaf Aloe Vera (Coats Aloe Inter-
national), on cell proliferation and migration. Normal primary human skin dermal fibroblasts
were grown in DMEM medium supplemented with 2% FBS and treated with Aloe Vera solu-
tion at concentrations of 2% and 3.3% or the preservative controls (the same solution com-
ponents without Aloe Vera). For cell proliferation analysis, the cell counts and viability were
recorded for a total of 5 days. For cell migration analysis, a scratch wound migration model
was used and cell migration was recorded under a phase-contrast microscope at time 0 and
48 hours. The results of the study showed that the fibroblasts treated with the Aloe Vera solu-
tion grew much faster than those cells in the control medium. The total numbers of cells with
2% Aloe Vera were 1.5, 2.5, 3.1, and 5.1 fold of those controls at the days 1, 2, 3 and 5, respec-
tively. A relative weaker stimulatory effect of the Aloe Vera on fibroblast migration, about
10~23% increased gap filling rate, was also observed. This study suggests that promoting fibrob-
last proliferation and migration might be one of the mechanisms that Aloe Vera may serve to
accelerate wound healing.
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Superior clinical outcome for patients receiving allogeneic over autologous stem cell trans-
plant in mycosis fungoides and Sezary syndrome
PA Wu,1 K Stockerl-Goldstein,2 SA Reddy,1 RT Hoppe3 and YH Kim1 1 Dermatology, Stanford
University, Stanford, CA, 2 BMT, Stanford Univ, Stanford, CA and 3 Rad Onc, Stanford Univ,
Stanford, CA
There has been no evidence to base our current notion that allogeneic stem cell transplant
(SCT) is more effective than autologous SCT in pts with mycosis fungoides (MF) and/or Sezary
syndrome (SS). A patient-level meta analysis was performed to compare the outcome of allo
vs. auto SCT in pts with MF/SS with 38 cases from the literature. Five unpublished Stanford
pts were added in the analyses. Overall survival (OS) and freedom-from-relapse (FFR) were
calculated from time of transplant to last follow-up or event, and the actuarial curves were
plotted with the Kaplan-Meier technique. The allo SCT group consisted of 20 pts (11 F, 9 M)
with median pt age of 38 y (21-59 y). The clinical stages at SCT were 16 IVA, 3 IIB, and 1 IB.
Ten of 20 pts with allo SCT received non-myeloablative regimens. The auto SCT group con-
sisted of 23 pts (10 F, 13 M) with median age of 47 y (20-67 y). Five pts had stage IVB, 8 IVA,
9 IIB, and 1 IB at SCT. OS results showed a more favorable outcome of pts who received allo
SCT (p < 0.03) with 1-, 2-, and 5-year survival rates of 85%, 79%, and 79% in the allo SCT
group vs. 65%, 56%, and 36% in the auto SCT group. FFR outcome results also showed a
more durable response in pts who received allo SCT (p < 0.0005). The relapse-free rates at 1
and 2 years were 73% and 73% in the allo group vs. 22% and 16% in the auto group, respec-
tively. In the allo group, the majority (80%) of pts experienced graft vs. host disease (GVHD),
mostly with mild to moderate severity, and 2 deaths related to GVHD. Although many of the
disease relapses in the auto group were observed to be milder than pre-SCT, the majority of
the deaths (11 of 13) were due to eventual progressive disease. These results support the belief
that allo SCT may offer better survival and relapse-free outcomes over auto SCT in MF/SS. The
potential for chronic GVHD complication of allo SCT will need to be considered for the over-
all quality of life determination.
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Cis-urocanic acid inhibits growth of melanoma cells in vitro and in vivo
J Kallio,1 JK Laihia,2 L Leino2 and V Kahari1 1 Medicity, University of Turku, Turku, Finland
and 2 BioCis Pharma Ltd., Turku, Finland
Urocanic acid [UCA; 3-(1H-Imidazol-4-yl)-2-propenoic acid] is an endogenous compound
of the epidermis. UV-induced photoisomerization of trans-UCA to cis-UCA is considered a
factor leading to UV-induced immunosuppression, although the mechanism of action is
unknown. We have previously observed that cis-UCA penetrates the cell membrane and
decreases the cytosolic pH at mildly acidic extra cellular conditions, resulting in suppression
of various cellular functions. Here, we have examined the effect of cis-UCA-induced intra-
cellular acidification on tumor cell growth in culture and in vivo. Incubation of A2058 human
metastatic melanoma cells with cis-UCA at pH 6.5 for 20-92 h significantly and dose-depend-
ently inhibited proliferation of the cells. Cis-UCA also augmented the anti-proliferative effect
of camptothecin (CPT) on A2058 cells. The effect of cis-UCA on melanoma cells was further
examined in a xenograft model in vivo. A2058 melanoma cells (1x10 5) were injected sub-
cutaneously into the neck of SCID/SCID mice (n=24) and the tumors were allowed to develop.
The xenografts were then intratumorally injected 2-3 times a week with PBS (vehicle control),
cis-UCA, CPT, or cis-UCA in combination with CPT, tumor size being measured concurrently.
After 16 days, the mice were sacrificed and tumors were collected and fixed for immunohis-
tochemistry. Marked inhibition of growth was detected in cis-UCA and CPT injected tumors
compared to PBS injected controls. Histological examination of tumors showed extensive
cell death in all cis-UCA and CPT injected tumors, but not in control tumors. Staining of pro-
liferating cells for Ki67 showed reduction of proliferating cells in cis-UCA injected tumors.
Adverse local skin reactions or systemic complications related to drug treatments were not
detected. In conclusion cis-UCA-induced intracellular acidification can be utilized to inhibit
tumor cell growth, suggesting cis-UCA as a promising novel therapeutic agent against cancer
and other hyperproliferative conditions.
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Effect of topical R115866 (Rambazole™) gel on the expression of biomarkers in the skin of
healthy volunteers
M Cools,1 E Pavez-Lorie,3 M Borgers,1 G Cauwenbergh,2 L Vandeplassche,1 L Wouters,1
H Torma3 and A Vahlquist3 1 Barrier Therapeutics, Geel, Belgium, 2 Barrier Therapeutics Inc,
Princeton, NJ and 3 Dermatology, Univ Hosp, Uppsala, Sweden
R115866 is a novel azole derivative which potently and selectively inhibits cytochrome P450-
dependent all-trans retinoic acid (RA) catabolism. Due to this mechanism, and in contrast to
retinoids, R115866 enhances endogenous RA levels primarily in tissues where RA is metabolized.
Currently, an oral clinical development program for keratinization disorders has been started. A
topical gel has been developed for treatment of acne. In order to assess whether topical R115866
could exert retinoid mimicking effects, a biomarker trial was initiated. In this randomized, dou-
ble-blind, left-right, placebo-controlled trial, the expression of biomarkers in the skin of 15 healthy
subjects was evaluated after once daily application of the gel at two different concentrations (0.35%
or 0.07%) on intact skin at the buttocks during 9 days. The biomarkers analyzed with real-time
PCR were cellular retinoic acid binding protein-2 (CRABP-2), the cytokeratins K2e and K4, the
RA 4-hydroxylase genes CYP26A1, CYP26B1 and CYP2S1, IL-1 and retinaldehyde dehydroge-
nase (RALDH). Treatment with R115866 dose-dependently increased CRABP-2, K4 and CYP26A1
expression while decreasing K2e and IL-1 expression. Immunocytochemistry confirmed the PCR
data for K4 since no staining was observed in the vehicle-treated biopsies and a dose-dependent
increase in the R115866-treated biopsies was seen. In addition, 0.35% R115866 increased epi-
dermal thickness. During the 9 days treatment, no itching, irritation, stinging, burning or vesicu-
lation occurred, except for one subject who reported mild itching after 8 days of treatment with
0.35% R115866. In conclusion, the effects seen with topical R115866 (except for the IL-1 expres-
sion and the lack of irritation) are in line with the reported effects of currently marketed concen-
trations of topical RA and warrant further investigation of topical R115866 in acne. Reduction of
IL-1 might suggest that R115866 possesses anti-inflammatory activities.
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Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA
H Xin, J Qin, B Bodner, L Stennett, LA Sitailo and BJ Nickoloff Pathology, Loyola University
Chicago, Maywood, IL
The proteasome has emerged as an exciting target for anticancer therapy. Bortezomib, a
novel and specific proteasome inhibitor is under investigation as a single agent for treating
numerous malignancies. We previously observed Bortezomib induced melanoma cell death
by up-regulating a pro-apoptotic BH-3 only protein NOXA. At the same time, Mcl-1, an anti-
apoptotic Bcl-2 family member, also accumulated as a consequence of proteasome inhibi-
tion, which may decrease the pro-apoptotic efficacy of Bortezomib. The current study employs
a rational molecular combination strategy for enhancing antitumor Bortezomib effects by tar-
geting Mcl-1 in human melanoma. When NOXA is up regulated in Bortezomib treated
melanoma cells, co-immunoprecipitation assays revealed binding between NOXA and Mcl-
1. Furthermore, forced overexpression of Mcl-1 in RJ002L melanoma cells using a retroviral
construct reduced (approximately 40%) killing by Bortezomib (1 µM, 24 hrs). Several
approaches targeting Mcl-1 reduction included: low dose UV light radiation (5 mJ/cm2), knock-
down with siRNA, and chemical blockade with a purine nucleoside analogue, fludarabine.
Low dose UV light caused rapid (within 6 hrs) reduction of Mcl-1 (approximately 80%), but
not Bcl-2 or Bcl-xL, in melanoma. Pretreating with low dose UV light plus Bortezomib (n=3)
produced synergistic enhancement of melanoma killing (UV alone 24±4%, Bortezomib alone
30±3%, UV + Bortezomib 66±6%). Transfection of specific Mcl-1 siRNA to melanoma cells
(n=3) reduced Mcl-1 levels by 50%, accompanied by an increase in cell death from 25±2%
to 45±4%. Pretreating melanoma cells with fludarabine (5µM, 24hrs) reduced the Bortezomib
associated Mcl-1 accumulation by 50%. Combining fludarabine with Bortezomib (n=5) trig-
gered an additive pro-apoptotic effect on melanoma cells (fludarabine alone 21±2%, Borte-
zomib alone 24±3%, fludarabine + Bortezomib 43±4%). These results indicate that simulta-
neous inhibition of Mcl-1 plus induction of NOXA represents a rational combination therapeutic
approach to enhance the effectiveness of Bortezomib in cancer therapy.
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Efalizumab for severe atopic dermatitis- a pilot study in adults
R Takiguchi, JM Hanifin, S Tofte, B Simpson, A Blauvelt and EL Simpson Dermatology,
Oregon Health & Science University, Portland, OR
Moderate to severe atopic dermatitis often cannot be adequately controlled with topical agents.
The continuous use of current systemic therapies for atopic dermatitis is limited by end-organ
toxicities. A safe, effective systemic therapy for patients with moderate to severe atopic der-
matitis is greatly needed. Our objective was to evaluate the safety and efficacy of efalizumab,
an inhibitor of T-lymphocyte activation and migration, in adults with severe atopic dermati-
tis. An investigator-initiated, prospective, open-label, pilot study was conducted involving 10
subjects with severe atopic dermatitis. Subjects received an initial conditioning dose of efal-
izumab of 0.7 mg/kg followed by 1.0 mg/kg weekly for another 11 weeks for a total of 12
doses. The primary efficacy outcome was the change in the mean Eczema Area and Severity
Index (EASI) score from baseline as measured at week 12. Monitoring of adverse events con-
tinued for 8 weeks after discontinuation of therapy. EASI scores improved from a mean base-
line score of 37.1 ± 13.46 to 17.6 ± 14.5 at Week 12 for a mean improvement of 52.3%
(p<0.0001). Six out of ten patients reached at least a 50% improvement in EASI score by Week
12. Pruritus levels decreased from 6.9 cm to 4.9 cm utilizing a visual analogue score (P<0.015).
Overall, efalizumab was well-tolerated. There were two significant adverse events during the
course of this study- thrombocytopenia and a worsening of disease beyond baseline levels
after discontinuation. Efalizumab therapy resulted in significant clinical improvements in 10
patients with severe atopic dermatitis. Efalizumab may serve as a good alternative to current
systemic immunosuppressants used for atopic dermatitis, however double-blind controlled
studies are needed to confirm its efficacy and safety.
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Hyperthermia induces cell death in basal cell carcinoma by non-conventional apoptotic path-
ways
YG Shellman, WR Howe, D Ribble, L Miller, M Ash, T Pacheco and DA Norris Dermatology,
University of Colorado Health Sciences Center, Aurora, CO
Hyperthermia treatment is a promising approach for cancer treatment. We have shown that
basal cell carcinoma cells (BCC) are very sensitive to hyperthermia treatment and revealed “a
window of opportunity” to induce apoptosis in these cells at low CEM43 (cumulative equiv-
alent minutes at 430C) but not at high CEM43, which induces necrosis. In this report, we fur-
ther investigated the molecular mechanisms of hyperthermia-induced apoptosis. Our data sug-
gest that hyperthermia treatment induced caspase 3/7 activation, but not caspase 8 or caspase
9 activation. These data indicated that hyperthermia treatment might induce apoptosis in a
non-conventional way, and that it might provide a scientific basis for combination treatment
with chemo- or radiation therapies. Almost all human BCC have mutations in the genes involved
in Sonic hedgehog (Shh) pathways, and activation of Shh pathway signaling is a requirement
for BCC formation. Here, we examined the effects of cyclopamine, an inhibitor of Shh sig-
nals, on basal cell carcinoma’s cell sensitivity to hyperthermia. Preliminary data suggest that
cyclopamine did not affect BCC cell sensitivity to hyperthermia, suggesting that activation of
Shh signaling in BCC did not provide further survival advantages for the cells. Taken together,
hyperthermia induced non-conventional apoptotic pathways in BCC cells and activation of
Shh did not make BCC more resistant to hyperthermia treatment, indicating that hyperthermia
might be a good alternative or additional approach for cancer treatment.
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Investigator blinded study on the potential benefits of daily shaving compared to shaving 2-
3 times weekly in the management of Pseudofolliculitis barbae
DA Guzman Sanchez,1 F Camacho,2 R Balkrishnan,3 R Inabinet,1 D Shander4 and
A McMichael1 1 Dermatology, Wake Forest University School of Medicine, Winston-Salem,
NC, 2 Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem,
NC, 3 Public Health, Ohio College of Pharmacy and School of Public Health, Columbus, OH
and 4 Research, Gillette Advanced Technologies, Boston, MA
Pseudofolliculitis barbae (PFB) is a common dermatologic disease among many ethnic groups,
but presents a large problem for African-american males. It is a chronic inflammatory and
potentially disfiguring condition.The etiology appears multifactorial; the shape of the hair fol-
licle, hair cuticle and the direction of the hair growth each play a role in this process. Many
treatment options are available, however none of one are completely curative. Shaving regi-
mens are often provided to patients from relatives, dermatologists and primary physicians with
no information to support one regimen or another. The purpose of this study was to evaluate
the impact of daily shaving regimen compared to 2-3 times weekly shaving, on decreased
number of lesions and reduced clinical severity scores on the overall appearance in men with
PFB. 47 adult male patients with PFB were included in the study. Patients completed a 60 day
regimen of daily shaving or a 60 day regimen of shaving three times a week. Lesions were
counted QOL was assessed. Assessments were performed before starting the shaving regimen
and at week 2, 4 and 8. Clinical course was documented by standardized photography. Pre-
liminary results for the first 24 patients showed that patients in the group of daily shaving reg-
imen did showed improvement in the number of inflammatory lesions. The total count of
papules, pustules and ingrown hairs were significantly less at baseline comparing to week 8
(p= 0.0430). The investigator assessment of response to treatments in the daily shaving group,
showed statistically significant improvement at week 8 comparing to baseline (p= .0001). These
results suggest improvement in lesion counts and improved appearance in the daily shaving
regimen group.
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Comparisons of prospectively-collected presenting symptoms of biopsy-proven basal cell carci-
noma, squamous cell carcinoma, melanoma, and seborrheic keratosis in an elderly population
SK Askari,1 AK Bangerter1 and EM Warshaw1,2 1 Center for Chronic Disease Outcomes,
Minneapolis VA Medical Center, Minneapolis, MN and 2 Department of Dermatology,
University of Minnesota, Minneapolis, MN
The purpose is to compare presenting symptoms of basal cell carcinomas (BCC), squamous
cell carcinomas (SCC), malignant melanomas (MM), and seborrheic kertatoses (SK). This
study was part of a larger study of 3,039 skin neoplasms in 2,152 patients at the Minneapolis
VA Medical Center. At presentation, participants were asked about symptoms of specific skin
lesions. Response categories included: itching, bleeding, change in size, tenderness, burning,
no symptoms, and other. Pearson chi-square analyses were used to test associations of lesion
type and symptoms in pairwise comparisons. For the purposes of this exploratory analysis,
data was assumed to be not correlated. 411 BCC, 238 SCC, 39 MM, and 224 SK biopsy-proven
neoplasms identified in 748 participants (average age 72.8 yrs) were included in this sub-
study. Tenderness was at least 2.6 times more commonly reported with SCCs (40%) as com-
pared to MM (RR 15.9, CI 2.28-110.69), SK (RR 3.0, CI 2.11-4.39), or BCC (RR 2.6, CI 1.97-
3.38, all p values <.0001). No symptoms were at least twice as commonly associated with
MM (82%) as compared to SCC (RR 3.31, CI 2.54-4.32), BCC (RR 2.26, CI 1.86-2.75), or SK
(RR 2.0 CI 1.61-2.48, all p values <.0001). Bleeding was at least 1.6 times more commonly
associated with BCC (37%) as compared to SK (RR 2.3, CI 1.67-3.20), SCC (RR 1.6, CI 1.22-
2.05) or MM (all p values <.007). Itching was reported one-fifth as often with MM (5%) as
compared to SCCs (RR .19, CI 0.05-0.73), SKs (RR .20, CI 0.05-0.79), and BCCs (RR .23, CI
0.06-0.88, all p values <.01). This study suggests that MM may be asymptomatic more often
than previously recognized. Tenderness was more commonly associated with SCC, and bleed-
ing with BCC than other tumors. Limitations include 1) small numbers of MM, 2) veteran pop-
ulation which is largely male and elderly.
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Phase I study of transimmunization for cutaneous T cell lymphoma
M Girardi,1 CL Berger,1 LD Wilson,2 IR Christensen,1 KR Thompson,1 EJ Glusac1 and
RL Edelson1 1 Dermatology, Yale University School of Medicine, New Haven, CT and 2
Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
Extracorporeal photochemotherapy (ECP) is a widely used immunotherapy for cutaneous T
cell lymphoma (CTCL). It involves four sequential steps: conversion of blood monocytes into
dendritic antigen presenting cells (DC) by repetitive adherence and disadherence to plastic
surface, reinfusion of the new DC, presumed in vivo loading of the new DC with apoptotic
malignant leukocytes, expansion of the anti-tumor CD8 T-cell pool. To assess the safety of a
methodology designed to increase ex vivo contact between the apoptotic malignant cells and
new DC by overnight incubation prior to reinfusion, a single-center, open-label, Phase I clin-
ical study of a revised procedure, referred to as “Transimmunization”, was conducted in
CTCL patients. Twenty-seven subjects were treated monthly for 3 to 5 months, alone or in com-
bination with electron beam therapy. Because the cell transfer to the overnight incubation
phase is not yet automated, careful precautions against potential bacterial contamination were
taken. None of the samples obtained after overnight culture demonstrated any aerobic or anaer-
obic bacterial contamination. In addition, none of the treated patients demonstrated fever (T
≥ 38°C) within five days post-reinfusion. However, one patient was admitted with fever and
documented bacteremia/sepsis one week following his second treatment. For those receiving
Transimmunization alone, there was an overall diminution in infiltrative lesions in 11 (55%)
of 20 patients. In the 12 leukemic CTCL patients, there was a significant mean reduction of
50.1% in the circulating malignant cells, as determined with family-specific anti-T-cell recep-
tor Vβ monoclonal antibodies (p<0.021). Because this therapy permits the synchronous induc-
tion and tumor loading of DC, with minimal toxicity, Transimmunization may merit further
investigation in CTCL and other malignancies.
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Caffeine consumption enhances the therapeutic effectiveness of methotrexate and sul-
fasalazine in psoriasis
YR Helfrich, P Liao, L Halili, T Hamilton, J Lambert, JJ Voorhees and S Kang Dermatology,
University of Michigan, Ann Arbor, MI
Methotrexate (MTX) and sulfasalazine (SSZ) are therapies for psoriasis. Their anti-inflamma-
tory effects are thought to be mediated through inhibition of 5-amidoimidazole-4-carboxam-
ide ribonucleotide (AICAR) transformylase, resulting in AICAR accumulation. AICAR inhibits
adenosine deaminase, leading to increased levels of adenosine, which has anti-inflammatory
properties. Methylxanthines, including caffeine, are adenosine receptor antagonists, which
could reduce the efficacy of MTX and SSZ. One study in rheumatoid arthritis found that
increased caffeine consumption led to decreased responsiveness to MTX therapy. On the other
hand, chronic caffeine intake leads to an increase in cAMP which has been shown to have
antiproliferative and immunosuppressive effects. In vitro, caffeine has also been found to sup-
press TNF-alpha production. cAMP biosynthetic capacity is lower in psoriatic skin than in nor-
mal controls, suggesting that elevation of cAMP might lead to improvement in psoriasis. We
designed a study to assess how caffeine consumption affects the efficacy of MTX/SSZ in patients
with psoriasis. Surveys were administered to 21 patients who had taken or were taking MTX/SSZ
for treatment of psoriasis. Patients were asked to assess how effective the drug had been in
improving their disease and to quantify their weekly caffeine consumption. In a two-step analy-
sis, we initially found a weak correlation between caffeine consumption and effectiveness of
MTX/SSZ (r=0.35, p=0.12). In a subsequent linear regression model controlling for gender,
duration of psoriasis, drug dose and years of use, increased caffeine consumption was asso-
ciated with a better response to MTX/SSZ (p=0.02). Our data suggest that caffeine consump-
tion enhances the efficacy of MTX/SSZ in psoriasis, findings opposite those seen in rheuma-
toid arthritis. In psoriasis patients on MTX/SSZ, presumably caffeine’s ability to elevate cAMP
levels appears to be more important than its role as an adenosine receptor antagonist.
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A comparison of patient experience with published treatments of pachyonychia congenita
MJ Eliason,1 LM Milstone2 and SA Leachman1 1 Dermatology, University of Utah, Salt Lake
City, UT and 2 Dermatology, Yale University, New Haven, CT
Pachyonychia congenita (PC) is an autosomal dominant disorder of keratinization with no
definitive treatment. PC is rare and few effective treatments are reported in the literature. We
hypothesize that a fusion of subjective data from PC patients with data from the published lit-
erature will expand our knowledge regarding effective therapies. Subjective data was obtained
from the IRB-approved International Pachyonychia Congenita Research Registry (IPCRR). IPCRR
participants are physician-screened, submit comprehensive medical history questionnaires,
and undergo optional genetic testing. We analyzed: 1) 73 IPCRR participant records and 2)
the worldwide literature of all available PC case reports and case series that contained treat-
ments (33 publications, 54 patients). As expected, both data sets found the use of oral antibi-
otics to be helpful for nail infections and oral leukokeratosis. Pain is rarely mentioned in der-
matology textbooks, although 63/73 IPCRR participants related requisite, regular use of pain
medication. Systemic retinoid use was reported in 24/54 (44%) published cases and in 10/73
(14%) IPCRR participants. Eighteen of these 24 (75%) from the literature, and 10/10 (100%)
from the IPCRR discontinued treatment. Eleven of 24 (46%) published cases reported a reduc-
tion in hyperkeratosis with oral retinoid use. Oral retinoids reduced pain in three of 24 (13%)
published cases and 0/10 IPCRR participants. Of note, 3/10 IPCRR participants report increased
blistering pain when hyperkeratosis is reduced with retinoids. Other findings in this study
include novel treatments and a variety of grooming techniques not found in the literature.
These data demonstrate that pain is more prevalent in the PC population than reported in the
literature. Oral retinoids, while often effective in reducing the hyperkeratosis, are not consis-
tently effective in reducing pain. Refinement of retinoid use and further treatment options are
needed for this disabling condition.
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Development of protein therapeutics for junctional epidermolysis bullosa
V Alexeev, A Kelly and J Uitto Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
The junctional forms of epidermolysis bullosa (JEB), a group of mechanobullous diseases inher-
ited in an autosomal recessive pattern, are characterized by the development of blisters and
erosions following minor trauma to the skin, with separation of skin layers within the lamina
lucida of the cutaneous basement membrane zone (BMZ). JEB is frequently associated with
mutations in the LAMA3, LAMB3 or LAMC2 genes encoding α3, β3, and γ2 subunits of laminin
5, respectively. At present, there are no specific therapies for JEB. The goal of this study was
to develop protein-based approaches for JEB treatment that would allow replacement of a
mutant chain of laminin 5 with its normal copies. First, the conditions for medium-scale in
vitro production and purification of full-length β3 chain of human laminin 5 were estab-
lished, and delivery of the recombinant polypeptides into the cytoplasm of β3-deficient human
keratinocytes in culture isolated from patients with Herlitz type JEB (H-JEB) was optimized. As
determined by immunofluorescent analysis, approximately 90% of protein-treated keratinocytes
took up the recombinant protein. Significantly, in the majority of the H-JEB cells treated with
recombinant β3 chain, restoration of the assembly, secretion, and deposition of the trimeric
laminin 5 onto the plastic substrata were detected. Although the extent of laminin 5 forma-
tion and secretion in β3-treated H-JEB cells was less than that noted in normal human ker-
atinocytes, it was sufficient to restore cellular adhesion. Further investigations on available
pre-clinical animal models will evaluate the feasibility of the proposed approach for treat-
ment of JEB in a manner that would allow accelerated healing of blisters and alleviate painful
symptoms in patients with these currently intractable diseases.
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Immune regulatory effects of interleukin-21 in cutaneous T-cell lymphoma
J Yoon, M Wysocka, SB Newton, JH Lin, S Hess and AH Rook University of Pennsylvania,
Philadelphia, PA
IL-21, the most recently discovered member of the common gamma chain cytokine family, is
secreted by activated CD4+ T cells and has been found to have pleotropic effects on immune
function, influencing both humoral and cell-mediated immune responses through the regu-
lation of T, B, dendritic, and natural killer (NK) cells. Since Cutaneous T-cell Lymphoma (CTCL)
is a clonally derived malignancy of CD4+ T-cells, with advanced disease being characterized
by profound defects in host cellular immune function, IL-21 could play an important role in
modulating patient immune responses to tumor cells. Normal donor and patient peripheral
blood mononuclear cells (PBMCs) were cultured with IL-21 and tested for cell activation, cyto-
toxicity, apoptosis, and proliferation. Marked cytokine release from patients PBMCs follow-
ing culture with IL-21 was exemplified by up to a 10 fold increase in interferon gamma pro-
duction. This was associated with a significant enhancement of NK cytolytic activity. Although
IL-21 failed to demonstrate pro-apoptotic effects on the malignant CD4+ T-cells, it is note-
worthy that the cytokine had no demonstrable effects on proliferation of the malignant cells.
Thus, IL-21 may play an important role in enhancing the host immune response of CTCL
patients through the induction of immune stimulatory cytokines leading to increased activa-
tion and cytolytic activity of T and NK cells.
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Dysregulation of kallikrein expression in the epidermis: a cause of rosacea?
K Yamasaki, J Schauber, AB Coda, A Bardan, VB Morhenn and RL Gallo Dermatology,
University of California San Diego and VA San Diego Healthcare System, San Diego, CA
Cathelicidin, a cationic multifunctional peptide produced by some epithelial and bone-mar-
row-derived cells, has two major functions; killing microbes and modifying leukocyte recruit-
ment. Prior data have suggested that enzymatic processing of cathelicidin alters function and
theoretically can cause several undesirable effects on host tissues. We observed that human
cathelicidin is abnormally abundant in the epidermis of patients with rosacea and hypothe-
sized that unlike normal individuals these patients may be unable to properly process the
peptide. To test this we developed a Surface Enhanced Laser Desorption/Ionization Time-of-
Flight Mass Spectrometry (SELDI-TOF-MS) system to measure the mass of cathelicidin in very
small skin samples. The size and predicted sequence of cathelicidin found in patients with
rosacea was similar to each other but consistently different than normal skin (n=6). Peptides
unique to rosacea that were not previously known, as well as a 4X-increased amount of LL-
37, was seen in affected individuals. These, but not peptides from normal skin, induced IL-8
secretion from cultured human keratinocytes and induced erythema when injected in the
skin of either Balb/C or C57/Bl6 mice. Histological examination of injected skin revealed that
rosacea peptides induced telangiectacia, thrombosis, and erythrocyte extravasation and stim-
ulated the recruitment of neutrophils and lymphocytes. To explore the mechanism behind the
abnormal generation of cathelicidin peptides we evaluated the expression of kallikrein 5 (KLK5),
a serine protease recently identified as involved in the processing of cathelicidin. The epider-
mis from patients with rosacea showed greatly increased expression of KLK5. These data impli-
cate abnormal proteolytic processing as a potential etiologic explanation for rosacea and sug-
gest a novel therapeutic approach to this disorder.
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Adalimumab treatment augments Langerhans cells and diminishes activated CD83+ den-
dritic cells in psoriatic skin lesions
RE Schopf1 and A Haevecker1 1 Dermatology, Johannes Gutenberg Univ., Mainz, Germany
and 2 Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Expression of CD83 is the most specific marker of activated and mature dendritic cells (DCs).
We compared CD83+ DCs before and after treatment in psoriatic skin lesions of 15 patients
treated with Adalimumab, a humanized monoclonal antibody against TNF-alpha. Other
DCs, expressing CD1, i.e. Langerhans cells, and S-100 protein in the suprabasal layers of the
epidermis (non-melanocytes) were also examined. 5 patients with eczematous dermatitis
and 5 with lichen planus served as controls. At week 0, patients received a loading dose of
80 mg Adalimumab, then 40 mg every other week starting at week 1 until week 11 by sub-
cutaneous injection. Week 12 was the end of observation. Skin biopsies for staining with H&E,
anti-CD1, S-100, and anti-CD83 were taken at weeks 0 and 12. Epidermal thickness was meas-
ured with a microscopic micrometer grid. Numbers of epidermal DCs were determined as the
means in 3 high-power fields. We found a diminution of the psoriasis area and severity index
(PASI) from 23.6 +/-2.1 at week 0 to 2.5 +/ 1.0 (mean +/ SE) at week 12. The epidermal thick-
ness of non-lesional skin was: 0.1 +/- 0.03, of lesional skin at week 0: 0.44 +/- 0.03, at week
12: 0.19 +/- 0.02 mm. DC counts changed as follows (pre- vs. post-treatment (uninvolved
skin)): CD1 increased from 3.8 +/- 2.8 to 11.1 +/- 5.1 (p<0.01, Wilcoxon test) (7.7 +/- 1.1),
S-100 from 5.11 +/- 1.0 to 9.1 +/- 1.1 (p<0.01) (5,99 +/- 0.5); by contrast CD83 decreased
from 3.27 +/- 0.42 to 1.1 +/- 0.36 (p<0.01) (0.33 +/-0.16). Epidermal thickness correlated
directly with CD83+ DC counts (p<0.01). Patients with eczema or lichen planus all expressed
diminished DCs compared to psoriasis (p<0.01). Our results demonstrate that successful treat-
ment with Adalimumab on one hand increases diminished epidermal Langerhans cell den-
sity, and on the other, down-regulates activated and mature CD83+ dendritic cells in psori-
atic skin lesions. This suggests that DCs may play an important role in pathogenesis of psoriasis.
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Telomere homolog oligonucleotides regulate hTERT expression
M Yaar, I Panova, S Heo, J Kubera, MS Eller and BA Gilchrest Dermatology, Boston University
School of Medicine, Boston, MA
Telomerase is an enzyme complex that maintains telomere length. Its expression in stem cells,
germ line cells, and cancer cells leads to their immortality and low levels of telomerase are
also detected in highly proliferative normal somatic cells. Telomerase inhibitors are now in
clinical trials as cancer therapy despite concerns that loss of telomerase activity in normal
cells may have adverse effects. hTERT, the catalytic sub-unit, is known to be upregulated by
c-Myc and downregulated by p53 and p73. Because telomere homolog olignonucleotides
(T-oligos) induce and activate p53 and p73, leading to rapid anti-cancer responses such as
apoptosis and senescence, we sought to determine if T-oligos might also affect hTERT. In an
epithelial carcinoma line MCF-7 (wild type p53) treated once with T-oligo (GTTAGGGTTAG
40 µM) or diluent alone, T-oligo induced the protein levels of p53 (545%) and p73 (230%)
and activated p53, as shown by serine 15 phosphorylation (2500%). By RT-PCR, at 48, 72 and
96 hours T-oligo decreased hTERT mRNA level and half life. Conversely, in MCF-7 cells lack-
ing functional p53, T-oligo did not affect hTERT levels. Furthermore, p73 downregulation by
siRNA did not affect T-oligo-mediated hTERT downregulation. Unexpectedly, T-oligo increased
hTERT level in normal fibroblasts and increased their telomere length by ~20% over 2 weeks.
Mad-1 protein, a transcription factor that competes with c-Myc for promoter binding, was
constitutively high in normal epithelial cells but low in MCF-7 cells. In MCF-7 cells T-oligo
induced Mad-1 >300% within 1 and 2 hours and decreased c-Myc level 83% within 24 hours.
In SCID mice injected IV with MCF-7 cells to generate metastases, T-oligo (20 IV injections
over 10 days) increased survival (p<0.01, Kaplan-Meier): 75% of the mice appeared healthy
through 30 weeks, while all diluent-treated mice died within 6 weeks. These data further sup-
port a role for T-oligo treatment of systemic malignancy and suggest that hTERT downregula-
tion may contribute to its longterm efficacy without adversely affecting telomerase activity in
normal cells.
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Diagnosis of arthritis in psoriasis patients presenting with joint pain to a dermatology-rheuma-
tology clinic
E Mody,2 E Husni3 and A Qureshi1 1 Department of Dermatology, Brigham and Women’s
Hospital, Boston, MA, 2 Division of Rheumatology, Immunology, Allergy, Brigham and
Women’s Hospital, Boston, MA and 3 Department of Rheumatology and Immunologic
Diseases, Cleveland Clinic Foundation, Cleveland, OH
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. Currently
there are no formally accepted diagnostic criteria for PsA in adults. When untreated, PsA can
be progressive in some patients leading to permanent joint destruction. Consecutive patients
presenting to a dermatology-rheumatology clinic at an academic medical center with psoria-
sis and joint pain were included in this study. All 71 patients were simultaneously evaluated
by a board-certified dermatologist and rheumatologist. The average age was 55 years and 52%
were female. On the basis of history, examination and radiographs, 41% (29/71) patients were
diagnosed with PsA, 27% (19/71) with osteoarthritis, 14% (10/71) with PsA plus osteoarthritis
and 3% with gout. A total of 14% patients reporting joint pain were not classified into a par-
ticular type of arthritis. Overall, 55% (39/71) were diagnosed with PsA in this population. The
mean age of patients in the PsA group was 49 years and non-PsA group was 57 years (P=0.01).
Family history of psoriasis in a first- or second-degree relative was reported by 7% participants.
Radiograph data was available for 51 participants and 39% (20/51) had erosions present. Data
on Schober’s test was available for 52 participants and the test was abnormal in 24% (16/52)
- 88% with an abnormal Schober’s were diagnosed with PsA (p=0.001). About 40% (28/70) of
participants reported morning stiffness of greater than 1 hour - 82% with morning stiffness were
diagnosed with PsA (p=0.001). Psoriatic arthritis may be more common among psoriasis patients
than previously reported. Interestingly, a large proportion of patients had coexisting PsA and
osteoarthritis. Thus joint symptoms in psoriasis patients are complex to diagnose. Care for
patients with psoriasis and PsA can be optimized in a multi-disciplinary environment.
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Relationship between periodontal findings and Behçet’s disease: a controlled study
A Akman,1 H Kacaroglu,2 L Donmez,3 A Bacanli1 and E Alpsoy1 1 Dermatology, Akdeniz
University, Antalya, Turkey, 2 Dentistry, Akdeniz University, Antalya, Turkey and 3 Public
Health, Akdeniz University, Antalya, Turkey
The aim of this study was to evaluate periodontal status of patients with Behçet’s disease (BD)
and whether it is associated with clinical severity score. Eighty-six patients with BD, 63 recur-
rent aphthous stomatitis (RAS) and 82 healty subjects were included in the study. Patients
with BD were also assesed for clinical severity score which was calculated as the sum of 1
point each for mild symptoms, 2 points each for moderate symptoms and 3 points each for
severe disease manifestations. Periodontal status of all subjects were evaluated according to
the community periodontal index of treatment needs (CPITN). Periodontal condition of every
patient is reported as the worst CPITN condition. The mean CPITN were observed to be higher
in patients with BD (1.79±0.96) compared to healty controls (1.18±0.98) (P<0.001). However,
there was no a significant difference between patients with RAS (1.22±0.87) and healty con-
trols. There was an association between clinical severity score and periodontal disease sever-
ity (P=0.007). Our results show that oral health is impaired in BD and associated with disease
severity. Therefore, improvement of the oral health in patients with BD may affect their dis-
ease course, decrease therapy requriment, leading to a better prognosis.
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Detection of disseminated superficial actinic porokeratosis using in vivo reflectance confo-
cal microscopy
S Astner,1 T Forschner,1 J Roewert,1 P Jaen,2 S Gonzalez2,3 and E Stockfleth1 1 Department of
Dermatology, University of Charite Medical School, Berlin, Germany, 2 Dermatology Service,
Hospital Ramon y Cajal, Madrid, Spain and 3 Dermatology Service, Memorial Sloan Kettering
Cancer Center, New York, NY
Disseminated superficial actinic porokeratoses (DSAP) is a distinct histopathological entity
with clinical resemblance to actinic keratoses (AK). While the presence of a cornoid lamella
in the histologic specimen clearly distinguishes DSAP from AK, the differentiation on clinical
ground alone is often difficult to accomplish. Reflectance confocal microscopy (RCM) has pre-
viously been used to evaluate AK non-invasively and characteristic parameters have been iden-
tified. This clinical investigation was aimed to define the diagnostic parameters for DSAP using
RCM, and to determine whether distinguishing characteristics from AK’s can be obtained. We
present 10 patients with a histologically confirmed diagnosis of DSAP. Patients were recruited
from two academic dermatologic outpatient clinics, and all patients have been evaluated using
in vivo RCM. Images were subjected to evaluation by experts in the field and have been analysed
in correlation with routine histology. The results of our analysis indicates the presence of super-
ficial disruptive changes in the stratum corneum, severe architectural disarray and structures
resembling a cornoid lamella as common RCM features of DSAP. The absence of inflamma-
tion and parakeratoses may be more characteristic for DSAP when compared to AK, while the
presence of a sharp demarcation to the surrounding normal skin is typical for DSAP. Our results
indicated a possible role for RCM in the detection of DSAP and a distinction from AK may be
feasible. To test the applicability of our findings, the sensitivity and specificity of RCM in the
diagnosis of DSAP should be evaluated in future studies.
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RNA recovery and gene expression at different anatomical locations using non-invasive tape
stripping
N Benson, R Wong and V Tran DermTech International, La Jolla, CA
In this work we further define and expand the utility of tape stripping for the recovery of RNA
from the surface of the skin. We have tape stripped 12 subjects at 15 different anatomical loca-
tions and found significant differences between subjects and anatomical locations. When
ranked by median RNA recovery we find the following order (highest to lowest): mastoid >
forehead > chest > upper back > mid back > cheek > lower back > deltoid > forearm > abdomen
> ventral thigh > inner arm > shin > dorsal thigh > lower leg. In samples of RNA from seven
of these sites we have assayed 5 housekeeping gene mRNAs, IL-8, TNFα and VEGF mRNAs
by semi-quantitative RT-PCR. We show that expression of the housekeeping genes is uniform
at all sites and amongst individuals while IL-8 and TNFα mRNAs are expressed in very differ-
ent quantities both at different body sites and between individuals at specific anatomical
sites. VEGF mRNA was uniformly expressed at some sites and variable at others. We have char-
acterized the effect of 4, 8 and 12 tape strips on transepidermal water loss and quantified
RNA recovery at the upper back. Our data shows a significant and high correlation between
the number of tapes used to strip a site and TEWL but no strong correlation between TEWL
and RNA recovery or number of tapes and RNA recovery. Given the significantly different
recovery of RNA from different body sites and the absence of correlation of RNA recovery
and number of tape strips we conclude that tape strip recovered RNA is not derived primarily
from corneocytes but from other cells associated with the stratum corneum, cells whose dis-
tribution varies along the surface of the skin.
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Effectiveness of psoriasis treatment in a day care program: a PASI analysis
J Zhang, E Stebbing, H Lui, J Shapiro and Y Zhou Medicine, University of British Columbia,
Vancouver, BC, Canada
It is well established that day care treatment programs are effective for managing psoriasis.
However, the effectiveness has not been well documented using standardized evaluation
parameters. The goal of this study was to analyze the efficacy of a psoriasis day care program
using modified Psoriasis Area and Severity Index (PASI) as a benchmark. A total of 132 psori-
asis patients treated in the Vancouver Psoriasis Day Care Center in the past two years were
evaluated. They received combined UVB phototherapy with topical treatments such as anthralin,
tar, and /or corticosteroids over a two week period. A physician global assessment (PGA)
scale (0% for no improvement to 100% for complete improvement) was used to evaluation
treatment efficacy for all patients. In addition, the baseline and day 10 PASI were assessed for
64 patients. The average baseline PASI was 13.6. By day 10, there was a 68.1% reduction in
psoriasis severity based on PGA using a scale of 0% (no improvement) to 100% (remission).
Based on PASI analysis, the average PASI reduction by day 10 was 59.6%, with 75% patients
achieving greater than 50% reduction, 30% patients achieving greater than 75% reduction,
and 3% having greater than 90% PASI reduction. With an average 59.6% reduction of PASI
at day 10, a day care program combining UVB and topical treatments over a two week period
seems to be a rapid and effective therapy for treating moderate to severe psoriasis.
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Comparison of the skin penetration of clindamycin phosphate from foam and gel vehicles
J Lenn, L Madlambayan, M Brown, H Hofland and W Chern Center for Skin Biology,
Connetics Corporation, Palo Alto, CA
Current research into treatments for acne vulgaris is often focused on developing an improved
vehicle for existing drugs. Clindamycin phosphate (CPh), the most frequently prescribed top-
ical antibiotic for acne vulgaris, was first introduced in the U.S. as a lotion. Subsequent for-
mulations included a solution and a gel. Most recently CPh (1%) was formulated in fragrance-
free, stain-free, quick-breaking, low-residue foam. The percutaneous absorption of CPh from
this foam vehicle was compared with that from a gel vehicle in an in vitro human skin pene-
tration assay. Human split-thickness skin sections were placed in diffusion cells. A finite dose
(15.6 mg/cm2) of [3H] clindamycin 1% foam or 1% gel was applied to fresh skin samples from
4 separate donors. Phosphate buffered solution (pH 7.4), was continuously pumped through
the receiving chamber, and fractions were collected every 4 hours for 24 hours. At 24 hours
after application, the surface of the skin membrane was washed, stripped and the remaining
skin section was split into epidermis and dermis to measure the drug content within these lay-
ers. The amount of CPh found in the epidermis after application of the foam (25.6% of the
applied dose) was approximately twice as much as that recovered from the gel formulation
(13.1%). The difference in the delivery of CPh to the dermis from the foam (5.9% of the applied
dose) and the gel (5.1%) was less pronounced. Less than 1% of the applied dose reached the
receptor fluid. The rate of delivery of CPh from the foam (20.0 ng/cm2/hr) was approximately
3 times faster than that from the gel (6.9 ng/cm2/hr). This in vitro study showed that clindamycin
foam delivered a higher amount of CPh to the skin (total), with the majority residing in the
epidermis, compared to clindamycin gel. The foam vehicle provided a more rapid delivery of
CPh into the epidermis than the gel vehicle.
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(-)-Epigallocatechin-3-gallate (EGCG) modulates FAS (APO-1/CD95) expression in CTCL
derived lines
M Nihal,1 J Wu1 and GS Wood1,2 1 Dermatology, UW-Madsion, Madison, WI and 2
Dermatology, VAMC, Madison, WI
FAS (APO-1/CD95) is a transmembrane glycoprotein belonging to the tumor necrosis fac-
tor/nerve growth factor receptor that mediates apoptosis upon cross-linking with Fas-ligand.
Tumor cells expressing abnormal or reduced Fas are resistant to apoptosis and thus accumu-
late in lesional tissues. Our data indicate that Fas is often under-expressed in CTCL. New ther-
apeutic approaches for reversing resistance of apoptosis in CTCL may play in the treatment of
CTCL. In this context, we evaluated the potential of (-)-Epigallocatechin-3-gallate (EGCG),
the major polyphenolic antioxidant found in green tea, to up-regulate cell surface expression
of FAS by CTCL lines (HH, SeAx, MyLa) as well as HTLV-I associated lymphoma (MJ), T-ALL
(Jurkat) and normal PBMC. Our data demonstrated that a low concentration of EGCG (5 µM;
for 48 hours) resulted in a significant up regulation of FAS positive cells, in SeAx (50% change
in MFI) and MyLa (24% change in MFI) by flow cytometry. In HH, Jurkat and MJ cells, EGCG
treatment caused slight increase in FAS expression, which was not statistically significant. Inter-
estingly, Western blot analysis with anti phospho-STAT3 (Ser 727) and anti phospho-c-Jun
(Ser 73) demonstrated that the level of activated STAT3 and c-Jun correlated inversely with the
ability of EGCG to up-regulate FAS among the CTCL lines HH, SeAx and MyLa. Because STAT3
and c-Jun cooperate to repress FAS expression, our results suggest that EGCG may up-regu-
late FAS at the transcriptional level and that transcriptional repressors oppose this action. These
results identify two subsets of CTCL defined by differences in FAS, STAT3 and c-Jun levels as
well as response to EGCG. They suggest a pro-apoptotic role of EGCG via up regulation of Fas
in CTCL and possibly a chemotherapeutic/chemopreventive role in a subset of CTCL patients.
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Pimecrolimus reduces calcium-dependent eosinophil activation
DA Plager,1 SA Henke,1 Y Matsuwaki,1 A Madaan,1 DL Squillace,1 RA Dierkhising,1
A Parneix-Spake2 and H Kita1 1 Mayo Clinic College of Medicine, Rochester, MN and 2
Novartis Pharmaceuticals Corporation, E Hanover, NJ
Pimecrolimus is a calcineurin inhibitor that inhibits T cell and mast cell activation and effec-
tively treats atopic dermatitis, however, its effects on eosinophils, a cell type implicated in
allergic disease pathology, are unknown. We examined the effects of pimecrolimus on
eosinophil superoxide anion production, degranulation, and survival. Purified eosinophils
from normal donors or donors with a history of atopic disease were incubated with serial
dilutions of pimecrolimus (µM to nM) and then stimulated with platelet activating factor (PAF),
interleukin 5 (IL5), secretory IgA (sIgA), or Alternaria alternata (Alt) fungus extract (Alt and its
products are implicated in eosinophil-associated allergic inflammation and eosinophil degran-
ulation). Eosinophil activation was monitored by cytochrome c reduction resulting from super-
oxide anion production and by a 2-site immunoassay for eosinophil-derived neurotoxin (EDN)
in cellular supernatants, as a marker of degranulation. Eosinophil survival was measured by
propidium iodide exclusion using flow cytometry after four days in culture. PAF-induced super-
oxide anion production, a calcium-dependent response, from both normal and atopic donors
was inhibited about 30% with ≤1 µM pimecrolimus. Superoxide anion production induced
by IL5 and sIgA was not consistently inhibited by pimecrolimus. In contrast, EDN release,
which ultimately depends on calcium, was inhibited about 25% with PAF, IL5, and sIgA stim-
ulation for normal and atopic donor eosinophils. Furthermore, Alt-induced EDN release was
inhibited 35% with as low as 1 nM pimecrolimus. Finally, increased eosinophil survival, which
is promoted by IL5 and sIgA, but not by PAF, was not significantly influenced by pimecrolimus.
Overall, pimecrolimus moderately inhibits calcium-dependent eosinophil superoxide anion
production and EDN release — this may contribute to its efficacy in treating atopic dermati-
tis by impacting allergic components of the condition.
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Switching between biological agents: implications for the use of adalimumab (Humira) ther-
apy in psoriasis
D Zimmer,1 J Cather2 and H Jacobe1 1 Dermatology, UT Southwestern Medical Center,
Dallas, TX and 2 Texas Dermatology Associates, Dallas, TX
TNFα inhibitors are useful in the treatment of psoriatric arthritis and psoriasis. At this time only
etanercept, a fusion protein, is FDA approved for psoriasis and psoriatic arthritis. Infliximab,
a monoclonal chimeric antibody, are approved for psoriatic arthritis and adalimumab, a human-
ized monoclonal antibody. Since most trials exclude patients who received prior anti-TNFα
therapy, relatively little is known about the efficacy and safety of changing from one drug to
another. In this retrospective study, we examined the efficacy and safety of switching patients
from etanercept or infliximab to adalimumab. We conducted a retrospective case review of
20 patients with plaque-type psoriasis who received weekly or every other week subcutaneous
injections of adalimumab. Nine (45%) of the patients had been previously treated with etan-
ercept or etanercept and infliximab and 11 (55%) patients were naïve to TNFα antagonist ther-
apies. Seven (77.8%) of the patients previously treated with biologics and 8 (72.7%) of the
patients naïve to TNFα blocking agents reported near to complete clearance of their psoriatic
skin lesions with adalimumab therapy. Two (22.2%) and three patients (27.3%) from those
respective groups reported no clearance of their psoriatic plaques while receiving adalimumab
injections. Adalimumab is a useful alternative treatment for psoriasis patients who experience
adverse reactions or sub-optimal responses to other therapies. Most patients had a rapid and
sustained improvement in disease activity within 4-16 weeks of initiating treatment. The clin-
ical improvement demonstrated by patients naïve to biologics was similar to that of patients
who had previously failed other anti-TNFα therapies.
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The Stanford experience with utilizing the new WHO classification of cutaneous lymphomas
for cutaneous B cell lymphoma
S Reddy,1 S Kohler,3 S Horwitz,4 K Sutherland,1 RT Hoppe2 and YH Kim1 1 Dermatology,
Stanford Medical Center, Stanford, CA, 2 Radiation Oncology, Stanford Medical Center,
Stanford, CA, 3 Dermatopathology, Stanford, Stanford, CA and 4 Medical Oncology,
Memorial Sloan-Kettering, New York, NY
Primary Cutaneous B cell Lymphomas (CBCLs) represent distinct clinicopathologic entities
with superior prognosis compared to their nodal counterparts. Previously, the WHO CBCLs
were classified as either marginal zone (MZ), follicular (FL), or diffuse large cell (DLC) lym-
phomas. In the new WHO/EORTC Classification of Cutaneous Lymphomas (WHOc), CBCLs
are classified as either MZ, Follicle center (FC) or DLC-leg type (DLCL). WHOc combined FL
and DLC into the category of FC lymphoma because of their similar indolent nature. Only
DLCL was considered to be aggressive thus separately categorized. In order to assess the util-
ity of the WHOc categories, we reclassified cases with particular attention to former DLC and
its placement into either FC and DLCL. We retrospectively reviewed 139 cases of CBCL man-
aged at Stanford. Our cases were classified according to the WHOc as follows: 49 MZ, 80
FCC, and 9 LBCL. The median follow-up was 46 months. The 5 year overall survival (OS) and
disease specific survival (DSS) were respectively 86 and 95 %.  For the MZ and FC subtypes
the 10 year OS/DSS percentages were as follows: 89/100, and  86/95 respectively. For DLCL
the 5 year OS/DSS percentages were 17/33. There were 22 deaths of which 7 were disease
specific. There were no disease related deaths for MZL. Of the 7 disease related deaths 4 were
DLC-leg type and 3 were FC (all formerly classified as DLC).  All three of these FC pts initially
presented with loco/regional disease, 2 with scalp presentations. Prior to the WHOc we treated
a loco/regional presentation of DLC with radiotherapy, reserving chemotherapy only for cases
with diffuse skin involvement. For the most part, the classification performed well, although
our data raise concerns that not all DLCs reclassified as FC behave in a benign fashion with
some cases leading to death despite aggressive therapy.
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Measurement of skin texture as a function of age through polarization imaging
PR Bargo and N Kollias Methods and Models Development, Johnson & Johnson CPPW,
Skillman, NJ
A system based on polarization imaging was developed to quantify skin texture on women
of several age groups. Images of the side of the face were acquired with a digital camera posi-
tioned at 90 degrees from the flash, which illuminated the front of the subject’s face. A linear
polarizer was positioned in front of the flash and another polarizer (analyzer) in front of the
camera. Images were taken with the orientation of both polarizers either parallel (horizontal-
horizontal), perpendicular (vertical-vertical) or crossed (vertical-horizontal). Measurements of
texture in a 1 cm2 area of featureless cheek skin was determined as a function of age for
women 9 to 70 years old. Results showed that skin roughness increased linearly from teens
until the age of 35 reaching a plateau thereafter. These results indicate that most of the changes
in skin texture besides larger features such as wrinkles occur until the age of 35.
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The efficacy and safety of MimyX Cream in reducing the risk of relapse in atopic dermatitis
A Laumann,1 S Lai,1 AW Lucky,2 J Schlessinger,3 M Jarratt,4 TM Jones5 and EL Simpson6 1
Northwestern, Chicago, IL, 2 Dermatology Research Associates, Cincinnati, OH, 3 Advanced
Skin Research Center, Omaha, NE, 4 Derm Research, Inc, Austin, TX, 5 J & S Studies, Inc.,
Bryan, TX and 6 Dermatology, Oregon Health & Science University, Portland, OR
Atopic dermatitis is characterized by recurring disease exacerbations followed by periods of
disease stability. Defects in the skin barrier of patients with atopic dermatitis are thought to
promote skin inflammation. A new topical cream designed to improve skin barrier function
may provide better control of the disease when added to routine emollient therapy. The pur-
pose of this study was to determine whether the addition of MimyX Cream to emollient ther-
apy could delay flares of atopic dermatitis. MimyX Cream contains palmitamide MEA and
other lipids that have been shown to enhance skin barrier repair and improve the signs and
symptoms of atopic dermatitis. A multi-center, investigator-blind, right-left comparison study
was conducted to determine the efficacy of MimyX Cream added to emollient maintenance
therapy in reducing the risk of relapse of atopic dermatitis. Subjects (N=74) in remission with
a history of frequent flares were enrolled. Subjects were randomized to apply emollient alone
to one side of the body and MimyX Cream plus emollient to the other side twice daily. The
median time to flare in the MimyX-treated side was 43 days versus 29 days (48% longer) for
the control emollient alone (P<0.03). The number of subjects with a flare on the MimyX Cream
side was 59.5% and 74.3% on the emollient side (P=0.05). One subject during treatment and
9 subjects at the end of the study reported stinging or burning with MimyX with all episodes
rated as mild in severity. In conclusion, the addition of MimyX Cream to routine emollient
therapy significantly increased the time to flare in subjects with atopic dermatitis. Use of Mimyx
Cream represents a safe, well-tolerated method of improving the control of atopic dermatitis
and may reduce the need for topical anti-inflammatory therapies.
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Systemic immunomodulatory effects of polypodium leucotomos (PL) as an adjuvant to PUVA
therapy in generalized vitiligo
E Reyes,1 P Jaen,2 E de Eusebio,2 J Cuevas,3 S Gonzalez4 and M Alvarez-Mon1,5 1 National
Biotechnology Center (CNB-CSIC) Associated Unit, Medicine, University of Alcala, Alcala de
Henares, Spain, 2 Dermatology, Hospital of Guadalajara, Guadalajara, Spain, 3 Pathology,
Hospital of Guadalajara, Guadalajara, Spain, 4 Dermatology, Memorial Sloan-Kettering
Cancer Center, New York, NY and 5 Immune System Diseases and Oncology, Hospital
Principe de Asturias, Alcala de Henares, Spain
An extract of the fern PL has demonstrated to have photoprotective and immunomodulatory prop-
erties. In order to optimize PUVA treatment for management of vitiligo patients, we investigated
the effects of PL as adjuvant to PUVA. A randomized, double-blind, placebo-controlled, clinical
trial was designed to study effects of PUVA+PL on T cells from 19 vitiligo patients. Peripheral
blood was collected for immunological assessment at baseline and after 12 weeks of treatment.
Repigmentation response was evaluated and graded as <25%, 25-50% and >50%. At baseline
we observed an abnormal activation of T cells in vitiligo patients with an increased CD25 and
HLA-DR expression and decreased percentage of CD45RO+CD8+ cells as compared to controls.
PUVA+PL normalized the expression of these markers, and suppressed the normal proliferation
of PBMCs to mitogens. Furthermore, it significantly increased the percentage of the CD45RA+
subset with a significant concomitant decrease of CD45RO+ cells in the CD8 subset. In contrast,
PUVA+placebo did not significantly change any of these parameters with respect to baseline.
We also found that the percentage of subjects with a skin repigmentation >50% was significantly
higher in PUVA+PL compared to PUVA+placebo. We observed a significant correlation between
the clinical response and the percentage of CD3+CD25+ cells (r=-0.493). We concluded that PL
when used as adjuvant to PUVA inhibits T lymphocyte activation and proliferation in vitiligo
patients and improve the clinical response. On another hand, CD3+CD25+ cell expression may
be a good immunologic parameter to evaluate clinical response to PUVA.
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Phase II preliminary results suggest SGN-30 (Anti-CD30 monoclonal antibody) is active and
well-tolerated in patients with cutaneous anaplastic large cell lymphoma
M Duvic,1 J Kunishige,1 Y Kim,2 S Reddy,2 A Forero-Torres,3 L Pinter-Brown,4 M Rarick,5
J Zic,6 S Worobec,7 K Flessland8 and J Barton 8 1 M.D.Anderson Cancer Center, Houston, TX,
2 Stanford University, Stanford, CA, 3 University of Alabama, Birmingham, AL, 4 University
of California, Los Angeles, CA, 5 Kaiser-Permanente, Portland, OR, 6 Vanderbilt University,
Nashville, TN, 7 University of Illinois, Chicago, IL and 8 Seattle Genetics, Inc., Bothell, WA
The antitumor activity and safety of SGN-30, a chimeric mAb directed against CD30, was eval-
uated in patients with CD30+ primary cutaneous anaplastic large cell lymphoma (cALCL) with
progression after ≥1 prior systemic therapy. SGN-30 was administered monthly by IV begin-
ning at 4 mg/kg for a maximum of 6 consecutive doses. If there was no response by Physicians
Global Assessment after 2 doses, SGN-30 was given at 12 mg/kg for the remaining infusions.
Five of 6 patients enrolled (83%) achieved an objective response prior to the 6th dose (1 CR
and 4 PR). All eventually received SGN-30 at 12 mg/kg. One patient with a history of Myco-
sis Fungoides (MF) with cALCL and concurrent CD30+ large cell transformation had complete
resolution of multiple trunk lesions after 5 doses and maintained a durable CR of >173 days.
Four patients achieved PR with durations of 72, 84, >83, and >271 days. One patient with
concurrent Lymphomatoid Papulosis (LyP) received a single 4 mg/kg dose nine days after dis-
continuing methotrexate and came off the study with PD. The most common adverse events
(AEs) were pedal edema, arthralgia and insomnia, each of which ocurred in 2 patients. There
were two grade 3/4 AEs considered possibly related to SGN-30 (pruritis and increased num-
ber of lesions). SGN-30 showed antitumor activity and was very well tolerated. Patients with
cALCL, CD30+ large cell transformation of MF and LyP patients are currently being enrolled
in a revised treatment regimen of 12 mg/kg every 2-3 weeks for up to 18 doses.
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Selective killing of malignant lymphocytes by silicon phthalocyanine Pc 4-photodynamic ther-
apy
A Hsia, JD Miller, H Scull, K Morrissey, C Yan, KD Cooper and ED Baron Dermatology, Case
Western Reserve/University Hospitals of Cleveland, Cleveland, OH
This study was performed to characterize and evaluate the levels of apoptosis in peripheral
blood mononuclear cells (PBMCs) induced by the drug silicon phthalocyanine Pc4 and com-
pare it to currently used 8-methoxypsoralen (8-MOP) photophoresis for Sezary syndrome
patients. PBMCs were isolated by Ficoll-Histopaque centrifugation from each patient’s whole
and WBC rich blood. For PDT, two concentrations (20 and 70nM) of Pc4 were added to the
PBMCs isolated from whole blood and were incubated at 37°C for 16 to 18 hours following
laser light activation of the drug. The PBMCs were phenotyped by flow cytometry into three
distinct populations (CD4+CD7+, CD4+CD7-, and CD11b+ monocytes). Levels of apoptosis
induced in each population were characterized by permeabilization with digitonin and an
APO2.7 PE conjugated antibody stain. Flow cytometric analysis showed a preferential induc-
tion of apoptosis in CD4+CD7- malignant cells (characteristic of Sezary syndrome) compared
to bystander CD11b+ monocytes, in both the 20nM and 70nM Pc 4 doses. A dose-dependant
relationship was also observed, evidenced by the 70nM dose inducing apoptosis in a higher
percentage of malignant cells than the 20nM dose. Signs of apoptosis were seen in 43.9% of
the malignant cells and 17.7% of monocytes after treatment with the 70 nM dose of Pc 4-
PDT. These results were compared to those obtained from a Sezary syndrome patient after
undergoing extracorporeal photophoresis (ECP) with 8-MOP + UVA. ECP induced apoptosis
in 52% of the malignant cells compared to only 10% of the monocytes. These data suggest
that Pc 4 treatment followed by light exposure may be a potential treatment in CTCL patients
as it induces preferential killing of the pathogenic T-cells, similar to what is observed after
ECP.
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Lenalidomide in patients with cutaneous T-cell lymphoma: preliminary data of a phase II trial
C Querfeld,1,3 TM Kuzel,2,3 J Guitart1,3 and ST Rosen2,3 1 Dept. of Dermatology, Northwestern
University, Chicago, IL, 2 Dept. of Medicine, Div. of Hematology/Oncology, Northwestern
University, Chicago, IL and 3 Robert H. Lurie Comprehensive Cancer Center, Northwestern
University, Chicago, IL
CTCL presents a unique challenge in that no treatment has been shown to prolong survival
and patients ultimately develop advanced or persistant disease that is refractory to standard
treatments. The immunomodulatory properties of lenalidomide (Revlimid®), a thalidomide
analogue, provided the rationale to use this agent in patients with CTCL. Preliminary data from
this phase II trial are reviewed. Methods: Eleven patients are evaluable for response and tox-
icity. Patients received 25 mg lenalidomide daily for 21 days with 7 days rest of a 28-day cycle.
Response was assessed after every cycle using Composite Assessment (CA) of Index Lesion
Disease Severity for skin lesions, absolute Sézary cell count for quantification of circulating
malignant lymphocytes and CT scans for measurement of adenopathy or visceral disease. The
median patient age was 61 years (47-66y) and patients had received a median of 6 prior treat-
ments (2-9y). A total of 4 patients have achieved a partial response. Eight patients have expe-
rienced minor responses such as regression of cutaneous tumors and lymphadenopathy, and/or
skin improvement from generalized erythroderma to less severe erythema with less scaling.
Six patients developed progressive disease by developing new lesions and/or recurrence of
indicator lesions. Most patients experienced an initial flare. A re-growth of former hair loss
was observed in 4 patients. The most common toxicities were anemia, fatigue, burning, pru-
ritus, and lower leg edema, and were usually mild (grade I or II). Two patients developed
grade III neutropenia requiring treatment with G-CSF in one patient. One patient discontin-
ued treatment after one cycle because of neurological symptoms (slurred speech) possibly
related to the study drug. Lenalidomide has shown efficacy in heavily pretreated patients with
advanced MF/SS and a mild toxicity profile. Accrual is ongoing.
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New UCP-like peptide exhibits significant in vivo slimming properties
N Domloge, E Bauza, G Oberto, A Berghi and C Dal Farra Research Center, Vincience,
Sophia Antipolis, France
Due to the public’s growing interest in the body’s appearance, slimming active ingredients
have become an important focus in skin and cosmetic research. Our prior studies on estab-
lished preadipocyte 3T3-L1 cells have shown that our new synthetic UCP-like peptide reduces
adipocyte storage of triglycerides in lipid droplets. In this clinical study, we undertook further
investigation of the peptide by evaluating its in vivo slimming effect. A double-blind compar-
ative study against placebo was performed on 21 healthy women volunteers, age 20 to 46.
Volunteers applied a cream formula with 1% of the peptide on one thigh and a placebo on
the other, twice a day, for 4 weeks. The result of the peptide’s slimming effect was determined
by clinical observation and by centimetric measurements of the thighs (perimeter), followed
by statistical treatment using the Wilcoxon non-parametric test for matched pairs. Measure-
ments of thighs treated with the peptide for 4 weeks showed a very significant decrease of -
2.76mm (p=0.011). Responding subjects, those who showed a decrease in thigh measure-
ment, represented 66% of the volunteers in this study. The difference before and after treatment
in responding subjects (-5.64mm) was highly significant (p=0.00005), with a minimum decrease
of -1mm and a maximum of -1cm. In the sample as a totality, comparison between the UCP-
like peptide and the placebo revealed a consistent significant difference in favor of the pep-
tide-treated side (p=0.0303), with a diminution of -2.23mm between the 2 averages. In the
group of responding subjects, the difference between the 2 averages was -4.5mm and was
highly significant (p=0.0019). This double-blind study, against placebo, demonstrates the sig-
nificant slimming effects of the peptide after only 4 weeks of treatment. These results strongly
suggest that this new UCP-like peptide can be of great use in the slimming products of mod-
ern cosmetics.
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Phase I clinical trial using topical silicon phthalocyanine Pc 4-photodynamic therapy for the
treatment of malignant and pre-malignant skin conditions: an update
JD Miller,1 O Nancy,2 HM Scull,1 A Hsia,1 KD Cooper1 and ED Baron1 1 Dermatology, Case
Western Reserve, Cleveland, OH and 2 Radiation Oncology, Case Western Reserve,
Cleveland, OH
Silicon phthalocyanine Pc 4 is an investigational second-generation photosensitizer for pho-
todynamic therapy (PDT) developed at Case Western Reserve University. We are currently con-
ducting a Phase I clinical trial using topical Pc 4-PDT for cutaneous pre-malignant and malig-
nant lesions. The goal is to determine the safety and toxicity of this novel treatment and obtain
preliminary efficacy data. Translational mechanistic studies have also been performed to help
elucidate the apoptotic mechanism of Pc 4-PDT. The trial involves the application of a pre-
determined concentration of Pc 4 solution to skin lesions and irradiating with visible light (675
nm) via a laser one hour later. The design is a dose-escalation trial and a maximum of 13 dos-
ing combinations and 42 study subjects are estimated to establish safety/toxicity parameters.
Patients are evaluated clinically pre and post treatment. Photosensitivity is also monitored via
minimum erythema dose testing. Presently, we are at the midpoint of enrollment and have
treated 22 patients (20 patients-mycosis fungoides/1 patient-multiple basal cell carcinomas/1
patient-multiple squamous cell carcinomas). No significant adverse events have been observed,
and no systemic absorption of Pc 4 has been detected at 1, 2, 24, and 48 hours. We have seen
partial to complete response in 6 patients. Correlational studies on mechanism have shown
upregulation of caspase-3 in Pc-4-PDT-treated skin biopsies of the responders when compared
to controls. No pain has been reported, however, the responders have consistently described
a mild tingling sensation during laser irradiation. Pc 4-PDT is a promising non-invasive novel
therapy for pre-malignant and malignant skin conditions with an excellent safety profile. Com-
pletion of this trial will provide the necessary information for an efficacy-oriented Phase II trial,
which will further provide correlational data to elucidate Pc 4-PDT mechanisms.
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Non-invasive analysis of keratin expression for pachyonychia congenita clinical trials
SA Leachman,1 MJ Eliason,1 N Benson,2 S Malmstrom,1 W McLean,3 LM Milstone,4
R Kaspar,5 JT Celebi6 and FJ Smith3 1 Dermatology, University of Utah, Salt Lake City, UT, 2
DermTech International, San Diego, CA, 3 University of Dundee, Dundee, Scotland, United
Kingdom, 4 Dermatology, Yale University, New Haven, CT, 5 , Transderm, Inc, Santa Cruz, CA
and 6 Dermatology, Columbia University, New York, NY
Pachyonychia congenita (PC) is a rare, autosomal dominant disorder of keratinization caused
by a mutation in one of four keratin (K) genes, K6a, K6b, K16, and K17. Future therapeutic
agents for PC will likely target the affected keratin and reduce its expression. Simple, quanti-
tative and reproducible measures of keratin expression in vivo are needed to test these agents.
The purpose of this study was to investigate whether tape-stripping could be used as a non-
invasive method to reliably collect and quantify keratin expression in PC patients. Tape-stripped
skin samples from affected and unaffected body sites were obtained from 31 PC patients.
RNA was extracted, reverse-transcribed, and K16, beta-actin, and GAPDH gene expression
were quantitated by real-time qRT-PCR. K6a cDNA was also sequenced from these samples
and compared to cDNA derived from skin shavings. The qRT-PCR analyses confirmed that the
cDNA was usually of sufficient quality to quantitate expression of K16 and control genes. As
expected, the expression of K16 in affected plantar skin was much higher relative to actin
control than that seen in cells from the mastoid process, an unaffected site. Homozygous wild-
type sequence from controls could be discriminated from heterozygous patient sequence hav-
ing a K6a mutation in tape-stripped and shaved skin. Collectively, these data demonstrate that
expression levels of PC keratins can be assessed in tape-stripped (or shaved) epidermis. Opti-
mization and validation of this methodology should permit quantitative molecular analysis of
PC skin before, during, and after treatment with novel keratin inhibitors. Use of these quanti-
tative and allele-specific assays in clinical trials will conclusively establish whether PC ker-
atin expression has been successfully reduced in vivo.
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Using the internet to assign to randomize numbers to patients in large multicenter study in
3rd degree burns
JT Mitchel,1 R Koren2 and L Gerstl2 1 Target Health Inc., New York, NY and 2 Mediwound
Ltd, Yavna, Israel
Global Internet-based clinical trials (G-IBCTs) can offer convenient, cost-effective solutions
for streamlining aspects of the clinical research process. One potential challenge for global
trials is the management of central randomization, especially where there are diverse clinical
research centers throughout the world. The study was a multicenter, multinational clinical
trial designed to evaluate a new debriding agent for the treatment of deep dermal and 3rd
degree burns. Clinical research sites were in the United States, Europe, Eastern Europe, Israel
and India. Since there was concern about patient enrollment, a decision was made early in
the protocol design to create a central randomization schema for the entire study, including
stratification by wound size. In order to see the randomization form, and thus be assigned
treatment, baseline eCRF forms had to be completed for individual patients. Since this was,
in part, a blinded study, a unique pharmacist role was created, for drug assignment. This form
was not visible to any other clinical research site personnel. As new sites were added, the ran-
domization allocation was seamless. While an IVRS application was considered, the diverse
geographic regions and the concern about phone connectivity, quickly ended that consider-
ation. The presentation will graphically illustrate how the system worked and evaluate the
advantages and some disadvantages of centrally randomizing patients.
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Randomized vehicle-controlled trial of pimecrolimus cream 1% in adult patients with mild
to moderate head and neck atopic dermatitis intolerant of, or dependent on TCS
S Weise-Riccardi,1 S Calvieri,2 J Ortonne,3 DF Murrell,4 VC Ho,5 S Emady-Azar6 and CF Paul7
1 RD, Novartis Pharma AG, Basel, Switzerland, 2 Universita degli Studi di Roma, Rome, Italy,
3 Hopital de l’Archet, Nice, France, 4 St. George Hospital, University of New South Wales,
Sydney, NSW, Australia, 5 University of British Columbia, Vancouver, BC, Canada, 6 Novartis
Pharma AG, Basel, Switzerland and 7 Novartis Pharma AG, Basel, Switzerland
A 12 week multicentre study consisting of 6 week double blind, randomised, vehicle-con-
trolled, parallel-group phase, followed by 6 week open label phase assessed the safety and
efficacy of pimecrolimus cream 1% in mild to moderate head and neck AD of patients intol-
erant of, or dependent on TCS.  200 patients, in a 1:1 ratio, applied drug twice daily in DB
phase and, upon completion, on an “as needed” basis in the OL phase. Primary objective:
Efficacy of pimecrolimus by testing that a greater percentage of pimecrolimus-treated patients
vs. vehicle-treated patients would achieve a facial Investigators Global Assessment score of
clear or almost clear at the end of 6 weeks. Secondary objectives: Effect of pimecrolimus vs.
vehicle on: head & neck Eczema Severity Index score, pruritus score, time to clearance of
facial AD at end of DB phase, and safety. Skin atrophy was assessed with dermatoscopy.  At
end of the DB phase, 47% of pimecrolimus-treated patients vs. 16% of vehicle patients achieved
facial IGA of 0 or 1. A statistically significant difference was seen on head & neck EASI scores
(51% of responders in pimecrolimus arm vs. 18% of responders in vehicle arm) at end of DB
phase. 70% of pimecrolimus vs. 34% of vehicle-treated patients reported no pruritus at 6
weeks. Median time to clearance was 43 days for pimecrolimus-treated patients vs. >50 for
vehicle-treated patients. 45% pimecrolimus vs. 19% vehicle achieved eyelid dermatitis clear-
ance (p<0.001). Significant improvement in skin atrophy as compared to baseline at end of
DB phase was seen for pimecrolimus patients. Pimecrolimus was well tolerated and AEs
occurred in similar frequency in both treatment groups.
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Pulse thalidomide for treatment-resistant cutaneous disorders
GM Graff and M Girardi Dermatology, Yale University School of Medicine, New Haven, CT
Thalidomide has demonstrated efficacy across a variety of dermatologic conditions – includ-
ing cutaneous lupus erythematosus, cutaneous sarcoidosis, and prurigo nodularis – presum-
ably due to its immunomodulatory and antiangiogenic effects. However, the use of this med-
ication is limited in dose and duration by its neurotoxicity. We utilized a pulse-thalidomide
protocol (PTP) whereby a cohort of five patients with a variety of cutaneous disorders refrac-
tory to primary treatment modalities were treated with oral thalidomide, 100 mg nightly for
three months, followed by a maintenance dose of 50 mg two to three times per week. Patients
were monitored closely by electrophysiologic testing before and during treatment. Patients
treated included: a 61-year-old man with subacute cutaneous lupus erythematosus (SCLE),
manifesting as numerous annular, erythematous, crusted plaques over the trunk, unrespon-
sive to oral hydroxychloroquine, a 52-year-old woman with systemic sarcoidosis and dyspig-
mented plaques over the face and trunk, unresponsive to hydroxychloroquine for four months,
a 46-year-old woman with discoid lupus erythematosus (DLE) with a hyperpigmented, verru-
cous plaque causing malfunction her left lower eyelid, a 78-year-old woman with SCLE and
Parkinson’s Disease, who could not tolerate hydroxychloroquine due to allergy, and a 52-year-
old HIV-positive man with severe pruritus and prurigo nodules over the neck, trunk, flanks,
and extremities. In all patients, the PTP resulted in nearly complete to complete clinical
responses within 5 month of treatment, and the response was maintained or improved despite
the lower dose. Furthermore, using the PTP, we were able to prevent or minimize the most
prevalent side effect, peripheral neuropathy. This cohort of patients had no or little (≤10%)
decrease in electrophysiologic studies on nerve conduction, yet they saw complete or near-
complete skin clearing of their respective disorders. This experience suggests that the utility
of thalidomide in the management of resistant cutaneous disorders may perhaps be best
found in a PTP that minimizes the risk-to-benefit ratio.
46 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
277
The CLASI is a useful clinical instrument to measure activity and damage in patients with
cutaneous lupus erythematosus
ZL Bonilla-Martinez,1 J Albrecht,1 L Taylor,1 J Okawa1 and VP Werth1,2 1 Derm, U of Penn.,
Phila, PA and 2 Derm, Phila VA Medical Center, Phila, PA
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index) measures activ-
ity and damage scores in different anatomical locations in cutaneous lupus erythematosus
(CLE). We previously validated the CLASI in terms of intra- and inter-rater reliability (Albrecht
et al., JID 2005). We now sought to assess its responsiveness to clinical improvement in CLE.
We followed 9 CLE patients (5 DLE, 2 SCLE, 2 DLE/SLE), beginning before a new drug inter-
vention until 56 days had elapsed on the new therapy. In addition to the two CLASI scales
(activity and damage), four validation measures were employed: physicians’ and patients’
assessments of patient’s global skin health rating, patients’ assessments of pain, and patients’
assessments of itch. To assess clinical improvement, change scores were calculated for each
parameter as the percentage difference between pre- versus post-treatment values. During
therapy, the CLASI showed a 48% decrease in disease activity, but a 32% increase in dam-
age. The change in CLASI activity score tightly correlated with the changes in physicians’
assessment of skin health (r=-0.97, p<0.01), and patients’ assessment of skin health (r=-0.83,
p=0.01) and pain (r=0.98, p<0.01). There was a strong correlation between the changes in
CLASI activity score and in patients’ assessment of their itch (r=0.67, p=0.10). Of the five
patients who showed clinical improvement based on activity score and global skin health
scores (2 DLE, 2 DLE/SLE, 1 SCLE), the CLASI score activity decreased by 64%. In conclu-
sion, the CLASI activity score is a useful measure of therapeutic response and correlates tightly
with the improvement of global skin health, pain and itch. Moreover, the CLASI damage
score can continue to increase even when the activity score decreases, indicating the impor-
tance of reporting these two scores separately.
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Validation of a self-administered questionnaire for diagnosis of facial seborrheic dermatitis
J Levin,1 S Mahajan,2 JF Fowler,3 SL Gottlieb,4 D Roling,5 M Duh,1 J Sung,2 A Parneix-Spake2
and JM Gelfand5 1 Analysis Group, Inc., Boston, MA, 2 Novartis Pharmaceuticals
Corporation, East Hanover, NJ, 3 University of Louisville, Louisville, KY, 4 Dermatology and
Skin Sugery Center, Exton, PA and 5 University of Pennsylvania, Philadelphia, PA
We developed a brief, self-administered 8-item questionnaire to facilitate the diagnosis of
facial seborrheic dermatitis (SD) in epidemiologic research where physician diagnoses are not
available. We then performed a cross-sectional study to determine the sensitivity and speci-
ficity of our instrument as compared to a dermatologist’s assessment. An algorithm was devel-
oped to classify patient responses. A report of flaky skin on the eyebrows or sides of the nose
was classified as facial SD. The questionnaire was administered over a 3 week period at 3 pri-
vate dermatology practices to consecutive patients with dermatologist-diagnosed facial SD.
An equal number of age and gender matched controls, from the same population but with-
out a diagnosis of facial SD, were included. A total of 46 patients were enrolled in the study
with an average age of 50y. Of the 23 SD cases, 43% (n=10) had a previously documented
diagnosis of facial SD, with an average severity of 2.3 on a scale from 1 (mild) to 5 (severe)
for their current condition. 48% of cases (n=11) and 35% of controls (n=8) had other facial
conditions, the most common being actinic keratoses (n=6 for cases, n=5 for controls). The
questionnaire had a sensitivity of 95.7% (95% CI = 78.1%-99.9%), a specificity of 91.3%
(95% CI = 72.0%-98.9%), a positive predictive value of 91.7% (95% CI = 73.0%-99.0%) and
a negative predictive value of 95.5% (95% CI = 77.2%-99.9%). The results of our study demon-
strate promising test characteristics for our questionnaire’s ability to accurately diagnose facial
SD. A larger sample size would be needed to further validate the instrument.
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Use of a questionnaire-based melanoma risk assessment tool in 6,564 subjects: analysis of
results and implications for screening
RJ Drugge,1 MA Naylor,2 RG Smith,3 CT Nguyen,1 C Tuluca4 and CC Brown5 1 Dermatology
Imaging Center, Stamford, CT, 2 Oklahoma Medical Research Foundation, Oklahoma City,
OK, 3 Intermountain Laboratories, Sheridan, WY, 4 Boston University, Boston, MA and 5
Dermazone Solutions LLC, Clearwater, FL
We tested a questionnaire-based, melanoma risk assessment tool in a cohort of 6,564 sub-
jects. The tool consisted of 14 questions, each weighted based on relative risk. A total score
was determined for each subject. A total score equal to or greater than 10 placed the subject
into a more rigorous skin cancer screening protocol. Multivariate correlation and binary regres-
sion analysis were used to determine independence between questions and correlation strength
between responses and the presence or absence of skin cancer. One-half of the population was
determined to be at-risk, given that the cut-off of 10 was also the median score of the popula-
tion. Of the 6,564 tested, 974 tested positive for some form of skin cancer. The probability of
skin cancer with a score of 10 was 14.2%, very near the probability of the population whole
(14.8%), while a score of 20 yielded a probability of 39%. The risk scores correlated with the
presence of skin cancer, with a 95% confidence interval for the logistic regression coefficient
of 1.14 to 1.17. Using a cutoff value of 10, measures of association analysis showed total scores
were consistent with the presence of skin cancer 2/3 of the time, yet inconsistent with the pres-
ence of cancer 1/3 of the time. Diagnostic efficiency for this model was studied by varying the
cutoff values and reanalyzing the data. Using cutoff values of 9, 12, and 15, 68%, 44%, and
23%, respectively, of the population being tested ended up in the more rigorous screening
group. The same cutoff values also resulted in capturing 84%, 65%, and 42%, respectively, of
the skin cancer incidences. Predictive value and utility of individual questions was also deter-
mined. We conclude that risk assessment, utilizing modifications of this quickly administered
questionnaire-based assessment tool, can improve efficiency of skin cancer capture.
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Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population
J Abu Sa’d,2 M Indelman,1 E Pfendner,3,4 T Falik-Zaccai,5 M Mizrahi,1 S Shalev,6 D Ben
Amitai,7 A Raas-Rothshild,8 A Adir-Shani,6 Z Borochowitz,9 R Gershoni,1 D Landau,10
G Richard,3,4 R Bergman,1 J Uitto,3 M Kanaan2 and E Sprecher1 1 Rambam Medical Center,
Haifa, Israel, 2 Bethlehem University, Bethlehem, Israel, 3 Thomas Jefferson University,
Philadelphia, PA, 4 GeneDx, Gaithersburg, MD, 5 Western Galilee Hosp., Naharya, Israel, 6
Haemek Hosp., Afula, Israel, 7 Rabin Medical Center, PetachTikva, Israel, 8 Haddasah Hosp.,
Jerusalem, Israel, 9 BnaiZion Hosp., Haifa, Israel and 10 Soroka Hosp., BeerSheva, Israel
Epidermolysis bullosa (EB) encompasses a large group of inherited blistering skin disorders
caused by mutations in at least 10 genes. Numerous studies mainly performed in European
and US families with EB have revealed a number of characteristic epidemiological and genetic
features, which form the basis for current diagnostic and counseling strategies. However, lit-
tle is currently known about the molecular epidemiology of EB in Middle East populations. In
the present study, we assessed 62 families of different ethnic background residing in Israel
and Palestine with a referral diagnosis of EB. DNA samples obtained from these patients were
assessed for mutations in the 10 genes known to be associated with EB. Our results show that
EB subtype distribution and patterns of inheritance in our cohort markedly differ from previ-
ously reported series. Junctional EB represented more than 30% of the cases compared to less
than 5% in European and US series. EB simplex was inherited in one third of the cases in an
autosomal recessive fashion whereas it is mostly an autosomal dominant disorder in Western
populations. We also failed to detect recurrent mutations frequently encountered in Europe
and in the US, and we did not consistently observe genotype-phenotype correlations for-
merly established in Western regions. In conclusion, the molecular epidemiology of EB in the
Middle East is significantly different from that previously delineated in Europe and the US. Our
data suggest that such discrepancies may exist for other genetically heterogeneous genoder-
matoses and indicate the need for population-specific diagnostic and management approaches.
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Protection against ultraviolet-induced matrix metalloproteinase 1 (MMP1) upregulation: a
comparison of sunscreen versus sunscreen plus antioxidants 
HM Scull,1 JD Miller,1 K Hanneman,1 A Ali,1 J Khouri,1 M Mary,2 KD Cooper1 and ED Baron1
1 Dermatology, Case Western Reserve/University Hospitals of Cleveland, Cleveland, OH and
2 Estee Lauder Research, Melville, NY
Solar ultraviolet (UV) irradiation is known to activate matrix metalloproteinases. Recent stud-
ies have determined that MMP1 is the major enzyme implicated in collagen damage and
photoaging of UV-irradiated human skin. This study was performed to evaluate the protective
role of sunscreen versus sunscreen plus antioxidants on UV-induced activation of MMP1.
This was a double blinded study. Skin punch biopsies were obtained from UV irradiated skin
treated with either a sun protection factor (SPF) 10 sunscreen, or a product with the same sun-
screen but with added antioxidants. Normal skin and unprotected UV exposed skin were also
sampled as controls. Individual minimum erythema doses (MEDs) and SPF values were
accounted for in delivering 2 MED of solar simulated radiation (SSR). Immunohistochemical
staining was performed to detect MMP1 activity. The percentage of positively (brown)-stained
areas in the epidermis and dermis were calculated using Image-Pro Plus (Media Cybernetics
Inc., San Diego, California). Data were compared between control and UV-irradiated skin, as
well as product-treated skin samples using Student’s t-test. A p-value of <0.05 was considered
significant. Both products were shown to reduce the expression of MMP1 relative to unpro-
tected UV-irradiated controls. Sunscreen alone decreased the amount of MMP1 per area by
a factor of 1.75, and sunscreen plus antioxidants diminished MMP1 production by a factor of
2.45. This study demonstrates that antioxidants and sunscreen can work synergistically in vivo.
Efforts to improve photoprotection strategies should take into account these results.
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The increased risk of myocardial infarction in patients with psoriasis
JM Gelfand,1,2 AL Neimann,1,2 DB Shin,1 X Wang,2 DJ Margolis1,2 and AB Troxel2 1
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Center for Clinical
Epidemiology and Biostastistics, University of Pennsylvania, Philadelphia, PA
Psoriasis is the most common Th-1 immunologic disease. Evidence has linked Th-1 diseases
to myocardial infarction (MI). Psoriasis has been associated with cardiovascular diseases in
hospital-based studies that did not control for major cardiovascular risk factors. We conducted
a population-based cohort study using data collected by general practitioners participating in
the General Practice Research Database in the United Kingdom. Psoriasis patients were clas-
sified as severe if they ever received a systemic therapy for psoriasis. Controls were selected
from the same practices and start dates as the psoriasis patients. Cox proportional hazards
models were estimated, adjusting for the major cardiovascular risk factors (age, gender, dia-
betes, hyperlipidemia, hypertension, history of myocardial infarction, smoking). We identi-
fied 556,995 control patients and 127,139 and 3,837 patients with mild and severe psoriasis,
respectively. The respective adjusted and unadjusted hazard ratios for the risk of MI compared
to controls were 1.11 (1.07, 1.17) and 1.05 (1.00, 1.10) for patients with mild psoriasis and
were 1.43 (1.18, 1.72) and 1.28 (1.06, 1.54) for patients with severe psoriasis. Patient age mod-
ified the risk of having an MI. For example, for a patient with mild or severe psoriasis who is
30 years old the adjusted relative risk of having an MI is 1.29 (1.14, 1.46) and 3.10 (1.98, 4.86)
respectively. For a 60 year old patient with mild or severe psoriasis the adjusted relative risk
of MI is 1.08 (1.03, 1.13) and 1.36 (1.13, 1.64) respectively. Psoriasis may confer an inde-
pendent risk of MI. The risk is greatest in young psoriasis patients with severe disease.
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Testing and reducing the skindex-29 using rasch analysis: skindex-17
T Nijsten,1 F Sampogna,2 M Chren3 and D Abeni2 1 Dermatology, Erasmus MC, Rotterdam,
Netherlands, 2 Health Services Research Unit, Dermatological Institute IDI-IRCCS, Rome,
Italy and 3 Dermatology, University of California at San Francisco, San Francisco, CA
The Skindex is a well studied dermatology-specific health related quality of life (HRQOL)
instrument. To test the Skindex-29 using Rasch analysis and, if necessary, to refine it so that it
would fit this item response theory based model. The Skindex-29 of 454 Italian dermatologi-
cal patients was subjected to Rasch analysis to investigate threshold order, differential item
functioning (DIF), and item and overall fit to the model. The Skindex-29 did not fit the Rasch
model (p<0.001). The 5 point scoring system was re-grouped into 3 categories and demon-
strated logical response order for all but one item. Rasch analyses of a combined emotion and
social functioning subscale of the Skindex-29 resulted in a 12 item psychosocial subscale. Five
of 7 items were retained in a symptoms subscale. Both subscales fitted the model (p=0.32 and
p=0.13, respectively) without significant individual item misfit or DIF (p>0.05). Classical psy-
chometric properties such as response distribution, item-rest correlation, item complexity
and internal consistency of the two subscales of the Skindex-17 were at least adequate. The
Skindex-17 is a Rasch reduced version of the Skindex-29 with two independent scores that
can be used in the measurement of HRQOL in dermatological patients.
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Prevalence of cardiovascular risk factors in patients with psoriasis: a population–based study
using the General Practice Research Database
AL Neimann,1,2 DB Shin,1 X Wang,2 DJ Margolis,1,2 AB Troxel2 and JM Gelfand1,2 1
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Center for Clinical
Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
Psoriasis is a common immune-mediated disease of the skin. Studies have linked chronic
inflammation, specifically TH-1-mediated inflammation, to cardiovascular disease. In addi-
tion, multiple studies have suggested that certain cardiovascular risk factors may be more preva-
lent among psoriasis patients. We conducted a period prevalence study using data collected
by general practitioners participating in the General Practice Research Database in the United
Kingdom. Patients were classified as having psoriasis if they received a diagnostic code con-
sistent with psoriasis. Controls were selected from the same practices and start dates as the
psoriasis patients. Patients were classified as having risk factors if they ever received a code
for diabetes, hypertension, hyperlipidemia or current smoking during the time that the prac-
tice was considered “up to standard”. Analyses were performed using conditional logistic
regression, and adjustments were made considering all of the cardiovascular risk factors as
well as person-time of observation by the general practitioner, age, and gender. We identified
556,995 control patients and 131,560 patients with psoriasis. Psoriasis patients had a higher
adjusted odds of diabetes (1.21 [1.17, 1.25]), hypertension (1.12 [1.09, 1.14]), and hyper-
lipidemia (1.21 [1.17, 1.25]) than controls. They were also more likely to be current smokers
(1.38 [1.36, 1.41]) than controls. The respective prevalence rates of risk factors in psoriasis
patients versus controls were as follows: diabetes (4.4% versus 3.3%), hypertension (14.8%
versus 11.9%), hyperlipidemia (4.8% versus 3.3%), and smoking (28.1% versus 21.3%). Results
of this study suggest that diabetes, hypertension, hyperlipidemia, and smoking may be asso-
ciated with psoriasis. These associations are important as they are part of the burden of pso-
riasis and can be potentially important in managing and counseling patients.
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Is there an association between the use of topical calcineurin inhibitors and skin cancer?
D Margolis, O Hoffstad and W Bilker Dermatology, Biostatistics, University of Pennsylvania,
Philadelphia, PA
Two topical agents are available for the treatment of atopic dermatitis (AD), pimecrolimus
and topical tacrolimus. They are both topical calcineurin inhibitors (TCI) and there has been
concern that their use could be associated with an increased risk of non-melanoma skin can-
cer (NMSC). We conducted a case-control study to investigate whether those who used TCI
in the past few years were more likely than those with other dermatologic illnesses to develop
an NMSC. This case-control study was based within the ambulatory care population of patients
seen at a large academic dermatology practice between 2002 and 2005. 1000 cases were ran-
domly selected with histology confirmed NMSC and 4,000 controls were randomly selected
who had inflammatory dermatitis. All exposure data were obtained from study subjects using
a self-administered questionnaire. For the primary analysis, unadjusted and adjusted associ-
ations were estimated by multivariable logistic regression for exposure to TCI. We received
responses from 70.7% of those surveyed. Overall, 25.7% reported exposure to TCI. TCI expo-
sure was 14.4% for the cases and 30.7% for the controls. For our primary analyses, a com-
parison between those with NMSC and those without, the unadjusted odds ratio was 0.38
(0.31, 0.47) and the adjusted (age, gender, previous NMSC, history of AD) was 0.54 (0.41,
0.69). In other words, the prevalence of TCI exposure was less in our cases then our controls.
Nearly the same unadjusted and adjusted effect estimates were noted if only those with a his-
tory of AD were included in the analysis and if NMSC were separated into basal cell carci-
nomas and squamous cell carcinomas. Furthermore, if exposure was limited to pimecrolimus,
then the adjusted effect was 0.66 (0.50, 0.89) and if limited to topical tacrolimus, it was 0.43
(0.30, 0.60). The apparent protective effect increased with the use of an increasing number of
tubes. In conclusion, TCI use is not associated with an increased risk of NMSC. In fact, a pro-
tective effect may be present, which demonstrates a dose and potency response.
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The effect of oral nonsteroidal anti-inflammatory drugs on non-melanoma skin cancer
D Peng,1,2 V Holland1 and M Cockburn2 1 Dermatology, University of Southern California,
Los Angeles, CA and 2 Preventive Medicine, University of Southern California Keck School of
Medicine, Los Angeles, CA
Substantial evidence in murine models suggests a potential chemoprotective capacity for the
regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) against nonmelanoma skin
cancer (NMSC); the present study attempts to determine if regular non-aspirin NSAID use influ-
ences human NMSC. Data on 336 Veteran’s Administration patients with biopsy confirmed
NMSC were retrospectively reviewed to identify a) total number of NMSC lesions, consider-
ing basal cell (BCC) and squamous cell carcinoma (SCC) jointly and individually; b) latency
time between the first and second lesion; c) latency time between the first and third lesion;
and d) overall subsequent occurrence rates. Information on non-aspirin NSAID prescriptions
for these patients was subsequently obtained, and regular use defined as at least 6 of 12 months
or 12 of 24 months. Regular NSAID over 24 months is seen to result in a statistically signifi-
cant increase in NMSCs (p<0.01). Likewise, an increase in total number of BCCs is seen over
24 months exposure (p<0.01). This correlation is not appreciated after a 12 month period
with either BCC (p = 0.15) or NMSC (p = 0.1), nor seen with regard to SCC subsequent to 12
months (p = 0.68) or 24 months of regular NSAID use (p = 0.19). No significant difference
between exposure groups is seen with regard to median latency times and subsequent occur-
rence rates in both separate and combined analysis of NMSC subtypes (p=0.275 is lowest p-
value). Contrary to the majority of the available literature, regular NSAID use rather appears
to increase total number of NMSCs diagnosed over a two year period, at least with regard to
BCC. NSAID use is not apparently related to tumor latency or subsequent occurrence rates
among NMSC patients. While inherent limitations of our study may explain our observations,
these preliminary findings suggest that regular NSAID use does not bear the chemoprotective
capacity currently inferred from animal studies and instead may engender risk for human
NMSC.
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Childhood Atopic Dermatitis Index (CADIS): reliability, discriminative and concurrent valid-
ity, and responsiveness
S Chamlin,1 D Cella,2 J Lai,2 M Williams,3 I Frieden,3 A Mancini1 and M Chren3,4 1 Division
of Pediatric Dermatology, Children’s Memorial Hospital, Chicago, IL, 2 Center on Outcomes
Research and Education, Evanston Northwestern Healthcare, Evanston, IL, 3 Department of
Dermatology, University of California, San Francisco, CA and 4 San Francisco Veterans Affairs
Medical Center, San Francisco, CA
To measure the effects of atopic dermatitis on the quality of life of affected young children
and their families, we developed and refined a prototype instrument, the Childhood Atopic
Dermatitis Impact Scale (CADIS). The refined 45-item CADIS instrument has two dimensions
with five domains: child dimensions (symptoms and activity limitation/behavior) and parent
dimensions (family/social function, sleep, and emotions). The CADIS has substantial evidence
of content and construct validity. The goal of this work was to test reliability, concurrent and
discriminative validity and responsiveness of the CADIS. Two hundred seventy parents of young
children with atopic dermatitis responded to the instrument. Test-retest reliability was meas-
ured for each domain score and the total CADIS score at 48 hours using the intraclass corre-
lation coefficient of reliability. Concurrent validity was demonstrated by comparing CADIS
scores with SCORAD index scores. To determine discriminant validity, we compared CADIS
scores of patients in 3 severity groups based on SCORAD index scores. Responsiveness to
change over a 4-week period was evaluated by comparing CADIS scores and patient responses
to a global item about overall skin condition. The results of this work provide strong evidence
of the reliability, validity and responsiveness of the 45-item CADIS and support its use as an
outcomes measure in clinical and research settings.
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Status of pharmaceutical companies’ dermatology-related postmarketing study commitments
to the Food and Drug Administration (FDA)
RA Bognet,1 DS Chiang1 and KA Katz2 1 Med Schl, TJU, Phila, PA and 2 Derm, Univ Penn,
Phila, PA
Controversy over Cox-2 inhibitors has heightened interest in the safety of prescription medicines.
One method of monitoring safety is via postmarketing study commitments (PMSCs), which phar-
maceutical companies commit to at the time of, and as a condition for, FDA approval. There is con-
cern that the execution of some PMSCs is behind schedule. Our goal was to determine the status of
existing PMSCs for medicines with dermatology-related indications. We included medicines adver-
tised in Archives of Dermatology from 1995 to 2005 and/or listed by CenterWatch as FDA-approved
for dermatology-related indications from 1995 to 2003. We ascertained PMSC status by searching
the FDA website in 12/05. Using Fisher’s exact tests, we compared the proportion of delayed der-
matology-related PMSCs by regulatory category (drugs vs. biologics). We also compared the pro-
portions of delayed PMSCs for dermatology-related drugs and biologics to those for drugs and bio-
logics overall, as reported by the FDA in the Federal Register in 2005. Of 181 dermatology-related
medicines, 24% had at least one existing PMSC for a dermatology-related indication (median 1,
range 1-14). These included 38 of 174 drugs (21.8%, median 1, range 1-6) from 27 companies and
6 of 7 biologics (85.7%, median 1, range 1-14) from 6 companies. Of the 85 total existing derma-
tology-related drug PMSCs, 79% were pending, 12% ongoing, 0% delayed, 0% terminated, and
9% submitted. Of the 34 total existing dermatology-related biologic PMSCs, 27% were pending,
38% ongoing, 15% delayed, 0% terminated, and 21% submitted. The proportion of delayed der-
matology-related PMSCs differed significantly for drugs compared to biologics (p=0.002). The pro-
portion of dermatology-related PMSCs for drugs and biologics did not significantly differ compared
to PMSCs for drugs and biologics overall (p=0.62 and 0.79, respectively). Timely PMSC fulfillment
may provide valuable information for physicians, patients, regulators and pharmaceutical compa-
nies regarding safety and efficacy of medicines used for dermatologic diseases.
48 Journal of Investigative Dermatology (2006), Volume 126
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Survival outcomes for melanoma patients diagnosed by a dermatologist versus a primary
care physician
ML Pennie,1 E Veledar,2 C Steven3 and SC Chen1,4 1 Department of Dermatology, Emory
University, Atlanta, GA, 2 Department of Medicine, Emory University, Atlanta, GA, 3
Department of Health Policy and Management, Rollins School of Public Health, Emory
University, Atlanta, GA and 4 Department of Health Services Research and Development,
Atlanta VAMC, Atlanta, GA
Studies have investigated the difference between dermatologists and primary care physicians
(PCP) in their ability to diagnose melanoma as well as the melanoma stage and thickness at
diagnosis. However, information is lacking in other outcome measures.  This study assesses
whether there is a survival benefit for melanoma patients diagnosed by a dermatologist vs. a
PCP. The study population for this retrospective analysis is all patients in the SEER-Medicare
database with a diagnosis of melanoma between 1990 and 1998. Additionally, all patients
had a pathology code confirming the melanoma diagnosis. We defined the diagnosing physi-
cian as the physician type identified in the office visit with the first melanoma diagnosis
code. However, if a PCP visit occurred within 6 months prior to a dermatology visit, and that
visit included a skin diagnostic code, we assumed that the PCP detected the lesion and sub-
sequently referred the patient to a dermatologist. Patient survival data was available through
1999. Statistical differences in outcomes were identified using the Chi-squared or Fisher exact
test. P-values less than or equal to 0.05 were considered significant. A total of 2020 patients
had sufficient data to be included in the analysis. Dermatologists diagnosed 1467 (72.6%)
patients and PCPs diagnosed 553 (27.4%). Cancer related mortality at 2 yrs was 13% for
patients diagnosed by a dermatologist versus 21% by a PCP (p<0.001). Non-cancer mortal-
ity was similar for the two groups: 14% for dermatologists and 15% for PCP (p=0.12). A diag-
nosis of melanoma by a dermatologist provides a significant survival advantage over those
patients diagnosed by a PCP. It is likely that melanomas diagnosed by dermatologists are
thinner and at an earlier stage, thus resulting in lower cancer-related mortality.
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A prognostic model for development of second primary melanoma
DB Shin,1 JA Brauer,1 AB Troxel,2 S Khan1 and ME Ming1,2 1 Dept of Dermatology, University
of Pennsylvania, Philadelphia, PA and 2 Dept of Biostatistics and Epidemiology, University of
Pennsylvania, Philadelphia, PA
Existing studies of risk factors for development of second primary melanomas have been lim-
ited by short follow-up times, lack of multivariate analyses, and a relatively circumscribed set
of exposure variables. To address these shortcomings, we performed a case-control study exam-
ining 183 cases who developed a second primary melanoma after having presented with a
single primary melanoma to our Pigmented Lesion Group (PLG) from 1972 – 2005. Controls
were 366 PLG patients who also presented with a single melanoma and who had been fol-
lowed for comparable amounts of time, but who did not develop an additional melanoma.
Subjects had an average follow-up time of 11.93 years. Thirty-three clinical and microscopic
characteristics were initially studied. A multivariate model, contructed using both independ-
ently predictive factors and other clinically relevant adjustment variables, resulted in signifi-
cantly better fit than any univariate model, as measured by the Hosmer-Lemeshow test
(p=0.707). In order of predictive strength (adjusted p-values), the significant risk factors were
presence of clinically dysplastic nevi (p=0.001), total body mole count greater than 25
(p=0.004), axial location of the first melanoma (p=0.013), presence of vertical growth phase
in the first melanoma (p=0.015), positive family history of melanoma (p=0.026), and older
age at the time of first melanoma (p=0.039). Positive personal history of non-melanoma skin
cancer and presence of extensive freckling had borderline significance (p-values of 0.077
and 0.079, respectively), while sex and Breslow thickness of the first melanoma were not
found to be significant in the final model (0.518 and 0.942, respectively). This analysis iden-
tified 6 independent risk factors that were significantly associated with development of a sec-
ond primary melanoma. The multivariate model that was developed had significantly improved
predictive ability when compared to univariate models and may help provide improved risk
stratification for patients.
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Beta adrenergic drug use is associated with decreased incidence of venous leg ulcers
D Margolis,1 R Isseroff2 and O Hofstad1 1 Dermatology, Biostatistics, University of
Pennsylvania, Philadelphia, PA and 2 Dermatology, Univ CA, Sacramento, CA
Venous leg ulcers are an increasingly common medical condition whose pathogenesis is not
fully understood. Although associated with a failure of epithelialization, dermal fibroblasts
and local inflammation likely contribute to the pathogenesis as well. Prior investigations
have demonstrated that β-adrenergic agents can alter the proliferative and migratory pheno-
type of these cells. We hypothesize their use may modulate the incidence of venous ulcers.
The purpose of study was to begin to evaluate whether venous leg ulcers are associated with
β-blockers or β-agonists use. We conducted a retrospective cohort study of the commonly
used General Practice Research Database from the United Kingdom, a population-based med-
ical record data set. We evaluated the medical records of more than 400,000 individuals
over the age of 65 evaluated by General Practitioners between 1987 and 2002.  About 15.6%
of the population was exposed to a β-agonist and 15.3% was exposed to a β-blocking agent.
We preformed logistic regression to evaluate the association between these agents and venous
leg ulcer. All odds ratios are fully adjusted (age, gender, and history of congestive heart fail-
ure, angina, hypertension, myocardial infarction, glaucoma, emphysema, and asthma) and
reported with 95% confidence intervals. The association between β-blocker use and venous
leg ulcer was 0.86 (0.83, 0.88) and between β-agonist use and venous leg ulcer was 0.48
(0.47, 0.50). In other words, individuals with a history of venous leg ulcer were less likely to
be exposed to a β-agonist or a β-blocker prior to the onset of their venous leg ulcer. This poten-
tially protective effect was more pronounced for those that used β-agonist, which has been
shown to increase dermal fibroblast migration and to decrease leukocyte activation. In con-
clusion, consistent with in vitro and animal studies these agents may have an effect on wound
repair and could present novel therapeutic tools for leg ulcers. This clinical correlation needs
to be confirmed by randomized clinical trials.
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Upper respiratory tract infection in household contacts of acne patients
WP Bowe,1 O Hoffstad2 and DJ Margolis1,2 1 Dermatology, University of Pennsylvania,
Philadelphia, PA and 2 Biostatistics and Epidemiology, University of Pennsylvania,
Philadelphia, PA
Individuals with acne are often exposed to antibiotics for prolonged periods of time. We recently
demonstrated an approximately 2-fold increased odds of upper respiratory tract infection (URTI)
associated with antibiotic use for acne. Some have postulated that antibiotic exposure of any
individual in a group may affect infectious illnesses of everyone in a group. We conducted a
cohort study using the same UK General Practice Research Database (GPRD) to determine if
household contacts of acne patients with documented URTIs are also at increased risk of devel-
oping a URTI. We identified GPRD subjects aged 15 to 65 years who were household con-
tacts of an individual aged 15-35 with acne. As in our previous study, all household contacts
were followed for 1 year. Logistic regression was used to measure associations between devel-
opment of a URTI and exposure to an acne patient either with a URTI or on antibiotics. Of
the 98,094 contacts identified, 16.9% shared a household with an acne patient who devel-
oped a URTI, and 83.1% lived with an acne patient who did not develop a URTI. A house-
hold contact of an acne patient who had a URTI was about 43% more likely to develop a URTI
than one without this exposure (OR=1.43 CI=1.33-1.52, p<.001). These results did not change
significantly after adjusting for age, sex, practice, year of diagnosis and exposure to an acne
patient on antibiotics. Interestingly, after adjusting for age, sex, practice, year of diagnosis, and
exposure to an acne patient with a URTI, we found that contacts of acne patients on antibi-
otics were not more likely to develop a URTI than contacts of acne patients not using antibi-
otics (OR=.94 CI=.89-1.00, p=.063). This study demonstrates that the increased risk of URTI
seen in acne patients on antibiotics affects not only the acne patients, but their households as
well. However, the increased rate of URTI in the household members is likely due to direct
transmission of URTI infectious agents and not to a household member’s exposure to another’s
use of an antibiotic.
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Quality of life in the actinic neoplasia syndrome: the VATTC trial
MA Weinstock,1,2 M Chren,3 K Marcolivio1 and . VATTC Trial Group4 1 V A Med Ctr,
Providence, RI, 2 Brown U, Providence, RI, 3 UCSF, San Francisco, CA and 4 VAMC Trial
Group
Actinic Neoplasia Syndrome is a common chronic condition characterized by sun-induced
damage, including actinic keratoses and skin cancers. Affected patients are predisposed to
additional malignancies and often receive many treatments. We describe their skin-related
quality of life (QoL) and key correlates. We hypothesized that QoL would be worse in those
with more extreme forms of this syndrome, and addressed this in the pre-intervention assess-
ment of the VATTC Trial, a randomized study of 1131 veterans at high risk of keratinocyte car-
cinoma (KC)(i.e. basal or squamous cell carcinoma) defined by 2 or more KCs in the prior 5
years. The mean age was 71 years; 97% were men. All were free of skin cancer and had not
used a topical 5-FU, calcipotriene, or retinoid product in 60 days. Skin-related QoL was meas-
ured using Skindex-29, which has 3 subscales: Symptoms, Emotions, and Functioning. AK
count at enrollment and KCs in the prior 5 years were quantified on a 1 to 5 scale. Past 5-FU
use was assessed by patient report. All 3 QoL scales were worse in this sample than in per-
sons without skin disease. Worse QoL was associated with higher AK count, more KCs, past
5-FU use, and greater sun sensitivity. Younger age was associated with worse QoL on the
Emotions and Functioning scale, and women had worse QoL on the Symptoms scale. Visible
photodamage as assessed by the examining dermatologist was not related to QoL. In multi-
variate analysis, AK count was the only variable independently related to worse QoL in all 3
dimensions. Other variables that independently correlated with QoL were: for the Symptoms
scale, past 5-FU use, sun sensitivity, and gender; for the Emotions scale, KC count, prior 5-FU
use, and age; and for the Functioning scale, age. The Actinic Neoplasia Syndrome affects QoL
even in the absence of tumors and AKs are key correlates of this effect. Prior KCs, prior 5-FU
use, sun sensitivity and younger age also are associated with worse QoL in this syndrome.
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Statins, non-steroidal anti-inflammatory drugs (NSAIDs) and calcium channel blockers are
prescribed less frequently for patients who later develop melanoma
ME Ming,1,2 DB Shin,1 JA Brauer1 and AB Troxel2 1 Dept of Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Dept of Biostatistics and Epidemiology, University of
Pennsylvania, Philadelphia, PA
Some laboratory and epidemiologic data indicate that statins and NSAIDs may have chemo-
preventive properties against melanoma, but these agents have not been examined adequately
in human studies. To assess the association between primary cutaneous melanoma and these
medications, we performed a large, nested case-control study using the General Practice Research
Database, which contains information on 9.1 million patients seen in Great Britain from 1987
to 2003. Cases were 4,564 patients at least 40 years old with the diagnosis of melanoma, while
controls were 69,769 patients at least 40 years old who did not have melanoma and who had
been assigned the diagnosis of nevus. Patients were considered to be exposed to a medication
of interest if they had received a prescription at least 6 months before diagnosis assignment.
We examined the use of statins, NSAIDs, beta-blockers, diuretics, and calcium-channel block-
ers (CCBs) in separate analyses for each medication. Univariate and multivariate logistic regres-
sion (controlling for age and sex) were performed. The odds of being prescribed statins were
significantly lower for patients who later developed melanoma as compared to those assigned
the diagnosis of nevus (OR=0.73, 95%CI: 0.56-0.95). Similarly, the odds of being prescribed
NSAIDs were also significantly lower for melanoma patients (OR=0.72, 95%CI: 0.68-0.77). In
contrast, the odds for beta-blockers (OR=0.98, 95%CI:0.90-1.07) and diuretics (OR=1.05,
95%CI:0.97-1.14) were not significantly different. Unexpectedly, the odds ratio for CCBs was
0.88 (95%CI: 0.79-0.98). CCBs have not been examined in melanoma but have inhibited the
growth of other malignancies in pre-clinical models. Controlling for CCB use did not have a
significant effect on the odds ratios for statins or for NSAIDs. Statins, NSAIDs, and possibly CCBs
may have chemopreventive properties against melanoma and warrant further investigation.
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Tolerability of high dose topical tretinoin: the VATTC Trial
A Geng,1,2 MA Weinstock1,2 and . VATTC Trial Group3 1 VA Med Ctr, Providence, RI, 2 Brown
U, Providence, RI and 3 VA Med Ctrs, Washington, DC
The dose limiting side effect of topical tretinoin is retinoid dermatitis, and this is a frequent
reason for failure to use this medication in young acne patients. We completed a randomized
keratinocyte cancer chemoprevention trial in an elderly VA population, and report on the tol-
erability in this population of tretinoin 0.1% cream applied to the face and ears for 1.5 to 5.5
years. We randomized 1131 patients (mean age 71 years, 97% men) to apply the tretinoin
cream or a vehicle control identical in appearance once per day, with instructions to increase
to twice daily as tolerated, and to decrease the frequency of use if side effects were bother-
some. Patients were examined by a study dermatologist and interviewed about their frequency
of use and side effects at 6 month intervals. We evaluated three measures: reported side effects,
frequency of application, and attendance at study visits. The tretinoin group reported more
side effects than the control group at 6 months (55% vs. 35%, p<.0001). Side effects decreased
over time in both groups but to a greater extent in the tretinoin group, and the difference
became nonsignificant at 30 months. Burning was the most common specific side effect,
reported by 35% of the tretinoin group and 14% of controls at 6 months (p<.0001), and this
difference also decreased over time. The severity of burning was mild among the majority
who reported this symptom and did not differ by treatment group. Other side effects were less
common but showed similar patterns. The tretinoin group also was using the cream less fre-
quently than the vehicle control group (30% twice daily and 15% not at all, vs. 42% and 9%
in the controls), and this difference persisted for the duration of the study. Finally, there was
little difference in the attendance at study visit. We conclude that high dose tretinoin is well
tolerated by a large proportion of older men, and tolerability improves over time, but it is not
as well tolerated as the vehicle control in the first 2 years of use. High dose tretinoin is feasi-
ble to use in this population.
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A randomized trial to improve skin cancer detection and prevention practices among sib-
lings of melanoma patients
A Geller and B Gilchrest Boston Univ. School of Med., Boston, MA
Identifying high-risk individuals for melanoma education and risk reduction may be a viable
strategy to curb the incidence of melanoma which has risen precipitously in the past 50 years.
We report a randomized trial testing an intervention that provided personalized telephone
counseling and individually tailored materials to siblings of recently-diagnosed melanoma
patients. The purpose of this study was to test whether an intervention could lead to improve-
ments in siblings’ skin cancer risk reduction practices. Intervention condition participants
received (1) an initial motivational and goal-setting telephone intervention session delivered
by the health educator; (2) three sets of computer-generated materials specifically tailored to
individual responses from the baseline survey; and (3) three telephone counseling sessions
with the health educator, timed to follow receipt of the mailed materials. 494 siblings were
recruited to the study and 403 siblings remained in the study through at least six months. At
12 months, intervention siblings were more likely to examine all moles, including those on
the back (OR 1.76(95% CI, 1.06-2.91). Compared with baseline, the number of participants
in both groups that had received a skin cancer examination more than doubled, with no dif-
ferences between groups. At 12 months, two-thirds of siblings in both groups reported rou-
tine use of sunscreen, but there were no differences in change over baseline between the two
groups. However, intervention siblings were less likely to report being tanned at the end of
summer, (OR 0.72 (95% CI, 0.47-1.09). This study is the one of the first, to our knowledge, to
address skin cancer risk reduction strategies in a sample of individuals who have a recent
family diagnosis of melanoma. Diagnosis of melanoma in a family member provides an impor-
tant opportunity to intervene with others in that family. This intervention may provide a use-
ful foundation for future efforts to target the more than half million siblings at risk for melanoma,
a lethal but preventable disease.
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Reporting of study design in abstracts in the Archives of Dermatology and the Journal of the
American Academy of Dermatology
R Ubriani,1 N Smith2 and KA Katz1 1 Derm, Univ Penn, Phila, PA and 2 Univ Penn, Phila, PA
Interest in evidence-based dermatology has increased. As described in many “users’ guides”
to the literature, each design type used in clinical research has inherent strengths and weak-
nesses. Identifying designs used in published studies can facilitate critical appraisal of the lit-
erature. In our experience, many dermatologists have difficulty classifying articles by study
design, and many articles do not explicitly note the type of design used. To explore the latter
point, we performed a cross-sectional study of articles published between 12/04 and 11/05
as “Studies” in the Archives of Dermatology (Archives) or “Reports” in the Journal of the
American Academy of Dermatology (JAAD). For articles in both journals, we determined
whether its abstract included one of the study-design-related keywords recommended for use
in abstracts by the Archives in its “Instructions to Authors.” These keywords include “ran-
domized control trial,” “nonrandomized control trial,” “double-blind,” “placebo control,”
“crossover trial,” “before-after trial,” “gold standard,” “blinded or masked comparison,” “incep-
tion cohort,” “cohort,” “validation cohort,” “validation sample,” “case-control,” “survey,” “cross-
sectional study,” “case series,” “cost-effectiveness analysis,” “cost-utility analysis,” and “cost-
benefit analysis.” The JAAD does not publish a list of recommended study-design-related
keywords for use in abstracts. We compared proportions of abstracts including a study-design-
related keyword in the Archives and the JAAD using a chi-square test. In the Archives, 43 of
87 abstracts (49.4%, 95% CI 38.5%, 60.4%) included at least one keyword, compared with
19 of 93 abstracts (20.4%, 95% CI 12.8%, 30.1%) in the JAAD (p<0.001). While study-design-
related keywords are included significantly more frequently in abstracts in the Archives com-
pared to the JAAD, many abstracts in both journals did not state the study design used. Con-
sistent and clear indication of the design used in studies may better enable editors, reviewers,
and readers to critically assess the dermatology literature.
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Prevalence of melasma among premenopausal Latino women in Dallas and Fort Worth, TX,
USA
K Werlinger,1 I Guevara,1 C Gonzales,2 E Rincon,3 R Haley,4 R Caetano5 and A Pandya1 1
Dermatology, UT Southwestern Medical Center, Dallas, TX, 2 Physician Assistant Studies, UT
Southwestern Medical Center, Dallas, TX, 3 Rincon and Associates, Dallas, TX, 4 Internal
Medicine, UT Southwestern Medical Center, Dallas, TX and 5 UT School of Public Health,
Houston, TX
Melasma is common among Latino women; however, its prevalence in the general popula-
tion is unknown. Objective: The purpose of this study was to develop a valid instrument for
determining the presence of melasma in Latino women and to administer this instrument by
telephone to premenopausal Latino women living in the Dallas-Fort Worth area of Texas. A
group of 60 Latino women with and without melasma were given a telephone questionnaire
in Spanish to determine their ability to self-diagnose melasma. Presence or absence of melasma
was determined by exam prior to the telephone interview. This questionnaire was then used
to interview 500 additional premenopausal Latino women by telephone. The questionnaire
was found to have a sensitivity of 93% and a specificity of 82% in patient’s ability to self-diag-
nose melasma. The prevalence of melasma using this questionnaire in 500 premenopausal
Latino women was 8.8%. Women who lived in Dallas, an area with more recent immigrants
than Ft. Worth, were more likely to report having melasma than those living in Ft. Worth. Span-
ish as a primary language was found to be a more important risk factor for reporting melasma
than city of residence. Melasma is common among premenopausal Latino women in the Dal-
las-Ft. Worth area. A validated English and Spanish instrument has been developed which
can be used to determine the prevalence of melasma in other parts of the world. The finding
that melasma is apparently more common in recent immigrants warrants further investiga-
tion.
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Rosacea: prevalence, skin type, photodamage and flushing in an Irish population.
MA Mc Aleer,1 FC Powell,1 SM Langan1 and P Fitzpatrick2 1 Regional Center of Dermatology,
Mater Misericordiae University Hospital, Dublin, Ireland and 2 School of Public Health and
Population Science, University College Dublin, Dublin, Ireland
A two phase, ongoing, prospective, epidemiological study of 1,000 Irish persons (500 indoor
and 500 outdoor workers) has been initiated to determine the prevalence of rosacea, and its
relationship to photodamage. The sample size allows detection in each group of workers of an
estimated prevalence of 2%, with a range of 1-3%. In phase one, 456 indoor workers (hospi-
tal employees) have been examined to date. The mean age of the study population was 37 years,
82% were female, 83% had skin types I or II, and the mean photodamage score was 2.75 (ranked
0-8 on a photonumeric scale). Results analysed so far have revealed a prevalence rate of rosacea
of 2.95%. No significant relationship was shown between rosacea, degree of photodamage, or
other markers of photodamage. A significant association was shown with frequent
flushing(p=0.04), erythema(p=<0.01) and telangectasia(p=<0.01). The mean age of subjects
with rosacea was 43 years, and they were significantly older than those without rosacea (p=0.04).
In a Celtic, sun sensitive population, a high prevalence rate of rosacea is expected. The preva-
lence in this study(2.95%) is significantly lower than that reported in a study of 809 Swedish
employees (10%). This difference may be related to the difficulty in distinguishing between
erythematotelangectatic rosacea (which comprised 82% of the Swedish rosacea patients) and
photodamaged skin. The prevalence of rosacea in our study is similar to those of a study in Aus-
tralia, where the prevalence was found to be 1.4%3. The relatively low prevalence of rosacea
in the Australian study, and the lack of association with photodamage in our study to date, sug-
gests that sun exposure may not be a relevant factor in the causation of the disease.
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Association of inflammatory skin disease and depression in the elderly: results of a mail sur-
vey
C Bartus,1 OJ Hoffstad,3 JC Filip,3 TT Brown1 and DJ Margolis2,3 1 School of Medicine,
University of Pennsylvania, Philadelphia, PA, 2 Department of Dermatology, University of
Pennsylvania, Philadelphia, PA and 3 Center for Clinical Epidemiology and Biostatistics,
University of Pennsylvania, Philadelphia, PA
There is an increasing interest in quantifying the burden of skin disease, but little is known
about the burden of skin disease in individuals aged 65 and over. The purpose of this study
was to quantify the psychological burden of skin disease in individuals aged 65 and over using
a mailed survey questionnaire. The questionnaire consisted of general medical history ques-
tions including questions inquiring about inflammatory skin disease, the Geriatric Depression
Scale-15, and the SF-12. A random sample of patients from the geriatric medicine program
affiliated with the University of Pennsylvania Health System in Philadelphia, Pennsylvania was
selected to participate. 419 surveys were returned from 806 eligible subjects (52.0%), and 319
(76.1%) were completed and available for analysis. For individuals with any reported history
of an inflammatory skin disease, they were 1.6 times (95% CI 1.2-2.1, p=.004) more likely to
suffer from depressive symptoms than those without skin conditions.  For those affected by a
skin condition in the last 6 months, they were also 1.6 times (95% CI 1.1-2.3, p=.027) more
likely to suffer from depressive symptoms. There was no difference in overall health-related
quality-of-life for those with reported skin disease when compared to those with no history of
inflammatory skin disease. These findings suggest that older persons with a reported history
of skin disease are more likely to experience symptoms of depression. In evaluating and treat-
ing elderly persons with skin disease, the clinician should be aware of potential co-morbid
depressive symptoms in older persons with inflammatory skin disease.
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The association of health provider specialty and density and melanoma prognosis in the
United States
MJ Eide,1,2 MA Weinstock3,2 and MA Clark2 1 Derm, Henry Ford Hospital, Detroit, MI, 2
Comm Hlth, Brown U, Providence, RI and 3 Derm, Brown Med, Providence, RI
The objective of this descriptive study was to quantify the effect of health provider specialty
and density on melanoma prognosis in a dataset representative of the US population. Data
from 17,702 cases of melanoma reported to the Surveillance Epidemiology and End Results
(SEER) program from 1988-1993 were merged with socioeconomic data from the 1990 US
Census and county-level physician data from the 1990 Area Resource File. Regression analy-
sis was used to model prognosis, defined by multiple indices, including the ratio of melanoma
mortality to incidence (MIR). The density of physicians (per 100,000 residents) in SEER coun-
ties was calculated for dermatologists (Median 3, Range 0-27), family practitioners (Median
14, Range: 0-87) and internists (Median 34, Range 0-161). Provider specialty and density were
significantly associated with several measures of prognosis. Melanoma patients who resided
in counties with a higher density of dermatologists had better prognosis with a lower MIR (β=
-50 x 10-4, SE 8 x 10-4), thinner melanoma (β= -2.4, SE=0.8), and less likelihood of an advanced
stage (log-odds=-410 x 10-4, SE= 200 x 10-4) or death (log-odds= 660x 10-4, SE= 200 x 10-
4). However an increased density of family practitioners was associated with worse progno-
sis (thicker melanoma, higher MIR, higher likelihood of advanced stage or death). Control-
ling for age, sex, race, marital status, and socioeconomic status, physician density and specialty
remained significant predictors of melanoma prognosis. Demographic factors, socioeconomic
status and health care accessibility all predict melanoma prognosis. The specialty and den-
sity of health care providers were consistently predictive across analyses of several operational
definitions of melanoma prognosis.  These findings suggest that melanoma prognosis may be
improved by promoting policies and interventions that facilitate both quality and access-to-
care, including the potentially important role of specialty care in the detection and treatment
of melanoma.
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Descriptive epidemiology of dermatofibrosarcoma in the United States, 1973-2002
VD Criscione1,2 and MA Weinstock1,2 1 Dermatology, V A Medical Center, Providence, RI
and 2 Dermatology, Brown University, Providence, RI
Dermatofibrosarcoma protuberans (DFSP) is an uncommon tumor of the skin for which the
descriptive epidemiology is not well described. We investigated the incidence of this cancer
using the Surveillance, Epidemiology, and End Results (SEER-9) registry data of the U S National
Cancer Institute, 1973-2002. The overall annual incidence was 4.2 per million (all incidence
rates are age-adjusted to the 2000 US population). Of the 2885 reported cases, 42% occurred
on the trunk, 23% on the upper extremity, 18% on the lower extremity, and 16% on the head
and neck. Age adjusted incidence increased by approximately fifty percent over a thirty year
period beginning in 1973, although this trend was seen only in whites and there was a slight
decline in the most recent 5 year period. We noted a substantially higher annual incidence
of DFSP among blacks (6.5 per million, vs. 3.9 among whites and 3.2 among other racial
groups). There was little difference in incidence rates between men and women, with a slight
excess in women (4.4.vs. 4.2 per million), although among the elderly, men had higher rates.
Crude incidence rates were found to be the highest between the ages of 30 and 50, and the
differences in rates among the nine SEER registries were modest and did not follow a clear
geographic trend. The racial disparity in incidence of DFSP is substantial, and the cause uncer-
tain. Prior reports had suggested men were more commonly affected, which was not true in
our data. We also noted increased incidence over the past three decades, with the exception
of the most recent 5 year period. Epidemiologic investigation of the patterns of occurrence of
this disorder are important to gain further insight into etiology and plan public health strate-
gies.
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Are Cochrane Skin Group systematic reviews really better than other systematic reviews in
dermatology?
AP Collier,2 LF Heilig,4 LM Schilling,3,4 H Williams5 and R Dellavalle1,2 1 Dermatology,
Denver Dept. of Veterans Affairs Medical Center, Denver, CO, 2 Dermatology, University of
Colorado at Denver and Health Sciences Center, Denver, CO, 3 Medicine, University of
Colorado at Denver and Health Sciences Center, Denver, CO, 4 Preventive Medicine and
Biometrics, University of Colorado at Denver and Health Sciences Center, Denver, CO and
5 Queens Medical Center, University of Nottingham, Nottingham, United Kingdom
Cochrane Collaboration systematic reviews are designed to produce high quality systematic
reviews. It is unclear whether the methods employed in producing Cochrane Skin Group (CSG)
reviews produce reviews of higher quality than other systematic reviews in dermatology. The
objective is to determine how the methodologic quality of CSG reviews published in The Cochrane
Library and in peer-reviewed journals compare to non-Cochrane systematic reviews. Two blinded
investigators independently assessed review quality using the validated Oxman and Guyatt scale
of systematic review quality. 38 systematic reviews (17 CSG reviews published in The Cochrane
Library, 11 CSG reviews published in peer-reviewed journals, and 10 non-Cochrane reviews
published in peer-reviewed journals were included in this study. Cochrane Library reviews
included quality of life and adverse outcomes more often than non-Cochrane reviews (65% vs.
10%, p<0.014). Compared to non-Cochrane reviews, CSG reviews, in both peer-reviewed
journals and The Cochrane Library were more likely to include comprehensive search strategies
(11/11 and 17/17 vs. 6/10, p-value<0.04), take steps to minimize selection bias (11/11 and 16/17
vs. 3/10, p-value<0.003) and appropriately assess the validity of all included trials (10/11 and
16/17 vs. 4/10, p-value<0.04). Overall, both CSG reviews published in The Cochrane Library
and in peer-reviewed journals had higher overall quality scores than non-Cochrane reviews
(mean= 6.1 and 6.0 vs. 4.1, p-value<0.002) indicating superior quality. Cochrane systematic
review methodology leads to higher quality reviews on dermatologic topics.
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Psychometric properties of Beer Sheva Psoriasis Severity Score
AD Cohen, D Van-Dijk, L Naggan  and DA Vardy Ben Gurion University, Beer Sheva, Israel
The Beer-Sheva Psoriasis Severity Score (BPSS) is a novel instrument designed for use in rou-
tine clinical conditions. The objective was to review the psychometric properties of the BPSS.
The sample used to study the BPSS included 70 patients with psoriasis vulgaris treated by cli-
matotherapy at the Dead Sea. Psoriasis severity was assessed using BPSS and PASI. Factor
analysis was used for data reduction. Internal consistency analysis was performed. Correla-
tion matrices were generated to compare BPSS factors. Factor analysis demonstrated that BPSS
included six factors which explained 74.0% of the variance, as follows: “patients’ assessment”
26.0%, “physicians’ assessment” 13.2%, “palms and soles involvement” 11.9%, “genitals,
nails, and pruritus” 9.0%, “face involvement” 7.3%, and “scalp involvement” 6.6%. Total scale
Cronbach’s alpha was 0.76. Alpha for the factors ranged between 0.39 and 0.81. BPSS is a
comprehensive tool for measuring psoriasis severity.
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Cardiovascular risk among US psoriasis patients: evidence from two large healthcare data-
bases
D Robinson, Jr,1 M Bala,1 Y Wu,1 C Paramore,3 K Fraeman4 and A Kimball2 1 Centocor
Clinical Research & Development, Inc., Malvern, PA, 2 Harvard Medical School, Boston, MA,
3 MEDTAP Institute at UBC, Bethesda, MD and 4 AK Analytical Programming, Olney, MD
Cardiovascular disease and risk factors among psoriasis patients have not been well-stud-
ied.Two large national US claims databases: Dataset A and Dataset B, were used to examine
this association. Continuously-enrolled adult patients between 2001-2002 with ≥ 1 medical
service claim were studied.ICD-9 codes were used to identify the psoriasis population, car-
diovascular disease or risk factors:atherosclerosis, type 2 diabetes (DMT2), and hypertension
(HTN). Non-psoriasis controls were randomly matched 3:1 to each psoriasis case based on
age, gender, region and previous insurance coverage. Overall chronic disease burden for
patients was determined using the Charlson Comorbidity Index (CCI) derived from medical
claims and the RxRisk measure based on prescribed drug claims.Odds ratio (OR) was calcu-
lated and confidence intervals (95% CI) were estimated with the Mantel Haenzel statistic. Sen-
sitivity analysis explored expansive and restrictive definitions of case-identifying psoriasis ICD-
9 codes. A total of 23,897 and 30,558 psoriasis patients were identified in the two datasets.
Mean age (SD) was 51.8 (16.4) and 45.4 (13.40) in Datasets A and B, respectively; 55% and
53% were female.Median CCI and Rx Risk scores were somewhat higher in psoriasis patients
than controls across the datasets. This trend was stronger in Dataset A.In Dataset A, psoriasis
patients had a higher risk for atherosclerosis (OR=1.24, CI 1.12-1.36), HTN (OR=1.12, CI
1.08-1.15), and DMT2 (OR=1.17,CI 1.12-1.23)compared to controls. Similar results were seen
in Dataset B,with the following ORs: 1.34 (CI 1.18-1.52), 1.18 (CI 1.15-1.21), and 1.22 (CI
1.17-1.28), respectively. These results persisted under sensitivity analysis. Data from two large
healthcare claims databases suggest a higher risk for cardiovascular disease and risk factors
among psoriasis patients. Further research needs to verify these findings and explore causa-
tion.
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Characteristics associated with early and late melanoma metastases
JA Brauer,1 AB Troxel,2 DB Shin1 and ME Ming1,2 1 Dept of Dermatology, Univ of
Pennsylvania, Philadelphia, PA and 2 Dept of Biostatistics and Epidemiology, Univ of
Pennsylvania, Philadelphia, PA
Although differences in risk factors for metastases at different times have been seen in other
cancers, no prior study of early and late metastasis in melanoma has been performed that exam-
ined a large number of clinical and tumor characteristics. We performed a case-control study
of melanoma patients initially presenting with local disease only to our Pigmented Lesion Clinic
from 1972–2005. Cases were 321 patients with a first metastasis within the first 3 years after
definitive melanoma excision (early metastases, EM), and 230 patients with a first metastasis at
3 years or later (late metastases, LM). For each case, a control patient with melanoma but with-
out metastases in the same time period was chosen. Univariate and multivariate logistic regres-
sion were used. We studied thirty-three clinical and tumor characteristics. Multivariate models
showed that compared to their control group, EM patients were more likely to have thicker
lesions (OR=1.97, 95%CI:1.60-2.44, p<0.001), microscopic satellites (OR=4.47, CI:1.57-12.72,
p<0.01), ulcerated tumors (OR=3.09, CI:1.66-5.73, p<0.001), location of the melanoma on the
head and neck (OR=2.06, CI:1.02-4.18, p=0.04) or trunk (OR=2.67, CI:1.58-4.52, p<0.001),
personal history of cancer besides skin cancer (OR=3.98, CI:1.37-11.58, p=0.01), and family
history of melanoma (OR=2.14, CI:1.01-4.51, p=0.046). Compared to their control group, LM
patients also were more likely to have thicker lesions (OR=1.73, CI:1.30-2.29, p<0.001) and
microscopic satellites (OR=5.64, CI:1.23-25.87, p=0.03). However, the remaining risk factors
for EM all had lower and non-significant ORs for LM patients compared to their controls. In
addition, male sex was not a risk factor for EM but was significantly associated with LM (OR=1.70,
CI:1.03-2.80, p=0.04). It appears that differences exist in risk factors for early vs. late metasta-
sis of melanoma, which may highlight important variations in the pathophysiology of metasta-
sis at different time periods and may also affect patient management.
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Mortality from cutaneous bullous diseases in the United States from 1979 through 2002
KG Lewis1 and MA Weinstock2,1 1 Dermatology, Brown Medical School/Rhode Island
Hospital, Providence, RI and 2 Dermatoepidemiology Unit, VA Medical Center-Providence,
Providence, RI
We sought to quantify mortality due to bullous diseases of the skin in the Unites States and to
examine trends over time. Our data derive from the death certification statistics compiled by
the National Centers for Health Statistics from 1979 through 2002. The accuracy of death cer-
tification was not verified. The overall age-adjusted (to the 2000 U.S. standard) annual mor-
tality rate from bullous diseases of the skin was 10.3 (per ten million, n=5848 deaths). We
evaluated mortality rates in four disease subgroups: the EM group including erythema multi-
forme, Stevens-Johnson syndrome and toxic epidermal necrolysis (4.1, n=2378), pemphigus
(2.3, n=1226), pemphigoid (2.8, n=1530), and epidermolysis bullosa (1.1, n=714). Overall
mortality was relatively constant over time. Rates for pemphigus decreased between 1979-
1986 and 1995-2002 from 3.0 to 2.0, whereas pemphigoid mortality increased from 2.1 to
3.1 over the same time interval. Mortality due to EM-related diseases and epidermolysis bul-
losa did not change dramatically over time. The mortality rate for the EM group was substan-
tially higher among blacks (19.2) compared to whites (2.5). Rates were similar between races
and genders for the remaining disease subgroups. Mortality due to pemphigoid, pemphigus
and EM was highest in the elderly, although the rate of increase with age was more rapid in
pemphigus and pemphigoid than in the EM group. Mortality from epidermolysis bullosa was
highest among infants. Overall, mortality from bullous disease in the United States is low and
has been relatively constant over time. Mortality from pemphigus has decreased over time
whereas rates for pemphigoid have increased and now exceed those of pemphigus. Mortality
from EM-related disease is substantially higher among blacks compared to whites.
308
Melanomas arising in nevus-prone individuals are more likely to harbor a BRAF/NRAS muta-
tion
NE Thomas,1 A Alexander,1 SN Edmiston,1 RC Millikan,1 P Groben,1 H Hao,1 D Tolbert,1
M Berwick,2 K Busam,3 C Begg,3 D Mattingly,1 D Ollila1 and K Conway1 1 Dermatology and
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 2
University of New Mexico, Albuquerque, NM and 3 Memorial Sloan-Kettering Cancer Center,
New York, NY
We conducted a population-based study of 214 cases of first primary cutaneous invasive
melanoma in North Carolina in 2000. As part of an interview about melanoma risk factors,
patients reported number of nevi on their backs. Their melanomas also underwent standard-
ized histopathology review and were screened for mutations in and around BRAF codons
466/600 and NRAS codons 12/13/61. BRAF and NRAS mutations were found in 43.0% and
13.6%, respectively, of melanomas and were exclusive of each other.  Melanoma patients with
an increased number of back nevi were more likely to have a melanoma harboring a BRAF or
NRAS mutation. In particular, 71.4% of patients with greater than 25 back nevi had a BRAF or
NRAS mutant melanoma compared to 41.8% of those with 4 or fewer back nevi. Adjusting for
age, increased back nevi remained independently correlated with BRAF/NRAS mutant melanoma
(odds ratio [OR] = 1.9, 95% confidence interval [CI] = 1.0-3.7 for 5-25 back nevi and OR =
3.3, 95% CI = 1.4-7.6 for greater than 25 back nevi compared to 4 or fewer back nevi). Fur-
ther, histological evidence of a nevus contiguous to the melanoma also predicted a BRAF/NRAS
mutant melanoma (OR 2.6, 95% CI 1.1 to 6.2, age-adjusted). In addition, the dermal nevus
cells of ten contiguous nevi were isolated using laser capture microdissection and analyzed for
BRAF/NRAS mutations. 8/10 (80%) contiguous nevi had exactly the same BRAF/NRAS muta-
tional status as their corresponding melanomas (κ=0.71). Our data support the theory of dis-
tinct melanoma subgroups and indicate that BRAF/NRAS mutant melanomas are associated
with a nevus-prone phenotype. Also, our findings that a histologically contiguous nevus is pre-
dictive of a BRAF/NRAS mutant melanoma and that contiguous nevi and melanomas generally
harbor the same mutation indicate that a subset of melanomas arise from nevi.
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Reliability of willingness-to-pay and self-reported annual income in patients with toenail ony-
chomycosis
PM Cham,1 SC Chen,2,3 JP Grill1 and EM Warshaw1,4 1 Minneapolis VAMC, Minneapolis, MN,
2 Dermatology, Emory University, Atlanta, GA, 3 Atlanta VAMC, Atlanta, GA and 4
Dermatology, University of Minnesota, Minneapolis, MN
Willingness-to-pay (WTP) is a health economics measure that assesses the overall disease
impact on a patient’s health-related quality of life. The aim of this pilot study was to investi-
gate the reliability of WTP and annual income in patients with toenail onychomycosis. 46 of
306 patients who were enrolled in a larger, randomized, double-blind, controlled trial of 2
different dosing regimens of terbinafine at the Minneapolis VAMC participated in this substudy.
To measure WTP, patients completed a self-administered questionnaire and chose 1 of 10 cat-
egories of payment ($0-50 - >$800) for a theoretical treatment of their current nail fungus
with an 85% cure rate. Patients also indicated their annual income by selecting from 10 cat-
egories ($0-10,000 - >$200,000). Both questions were repeated 1 month later. 55% who
responded at baseline and 1 month had the same response to WTP at both visits (24/44). A
quadratic-weighted kappa (Fleiss-Cohen) indicated moderate agreement (0.41, 95%CI: 0.16,
0.67, p=0.01), utilizing the 10 categories. Results were similar using 6 categories after the
highest four were collapsed into 1 category (0.50, 95%CI: 0.24, 0.75, p<0.01). Spearman rank
order correlation of WTP responses at baseline vs. 1 month indicated moderate reliability
(0.57, p<0.01). Responses to annual income showed strong agreement with 71% of patients
(30/42) reporting the same income category (kappa=0.88, 95% CI: 0.69, 1.06, p<0.01) and
for collapsed categories (0.72, 95%CI: 0.47, 0.96, p<0.01). Similarly, the Spearman rank order
coefficient indicated strong reliability using the original categories (0.68, p <0.01). To our
knowledge, this pilot study is the first to examine reliability of WTP and annual income in
skin diseases. Responses to WTP showed moderate agreement whereas annual income indi-
cated strong agreement. Major limitations include: 1) use of predetermined response cate-
gories for WTP and 2) veteran study population, most of whom do not pay for their health care.
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Outcomes of quality-of-life and willingness-to-pay from a randomized trial of pulse vs. con-
tinuous terbinafine for toenail onychomycosis
PM Cham,1 SC Chen,2,3 JP Grill1 and EM Warshaw1,4 1 Minneapolis VAMC, Minneapolis, MN,
2 Dermatology, Emory University, Atlanta, GA, 3 Atlanta VAMC, Atlanta, GA and 4
Dermatology, University of Minnesota, Minneapolis, MN
The disease burden of onychomycosis has been evaluated by quality-of-life (QOL) question-
naires but not willingness-to-pay (WTP), a health economics measure. We utilized a nail-spe-
cific QOL questionnaire (NailQoL) and WTP as secondary outcomes for patients who partic-
ipated in a clinical trial of terbinafine for toenail onychomycosis. 306 patients who participated
in a randomized, double-blind, controlled trial of standard continuous dose (250mg daily for
3 months) vs. pulse dose (500mg daily for one week per month for 3 months) terbinafine at
the Minneapolis VAMC completed 1) a self-administered NailQoL questionnaire and 2) indi-
cated their WTP for a theoretical 85% cure of their current nail fungus from a payment scale
of 10 categories ($0-50 to >$800). NailQoL consists of 15 questions which assess the fre-
quency of disease burden on a patient’s emotion (10 questions), symptoms(4), and function(1)
over the last 6 months. Patients also reported their annual income. Questions were repeated
at the conclusion of the clinical trial 18 months later. The major clinical outcomes of this
study have been reported elsewhere. Briefly, patients who received the continuous dose were
statistically significantly more likely to attain mycological cure and complete cure of the tar-
get nail as well as complete cure of all toenails. Similarly, for QOL outcomes, patients who
received continuous treatment (n=153) had a greater reduction (improvement) in symptom (-
14.1 vs. -10.6, p=0.19) and total scores (-13.1 vs. -11.0, p=0.33) than the pulse treatment
group (n=153), although these results were not statistically significant. Observed shifts at 18
months in the distribution of WTP by treatment groups were also not statistically significant
using several analytical methods and even after controlling for income. NailQoL scores and
WTP were not statistically significantly different in patients treated with 2 different doses of
terbinafine for toenail onychomycosis.
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Responsiveness of NailQoL: a nail-specific quality of life instrument
SC Chen,1,2 PM Cham,3 JP Grill3 and EM Warshaw3,4 1 Dermatology, Emory University,
Atlanta, GA, 2 Atlanta VAMC, Atlanta, GA, 3 Minneapolis VAMC, Minneapolis, MN and 4
Dermatology, University of Minnesota, Minneapolis, MN
The disease burden of onychomycosis has been measured in cross-sectional studies using gen-
eral and nail-specific quality of life (QOL) instruments. Little data exists about the respon-
siveness of these instruments in patients with successful treatment. We developed a nail-spe-
cific QOL instrument (NailQoL), from Skindex-29 and additional questions. NailQoL consists
of 15 questions that assess the burden of toenail onychomycosis on emotion (10 questions),
symptom (4), and function (1) over the last 6 months. The purpose of this study was to evalu-
ate the responsiveness of NailQoL. 306 patients with a mycologically confirmed diagnosis of
toenail onychomycosis who participated in a larger, randomized, double-blind, controlled 3
month trial of continuous vs. pulse dose terbinafine completed a NailQoL survey at baseline
and 18 months. Mycological cure of the target toenail, complete cure of the target toenail,
and complete cure of all toenails were primary clinical outcomes for the trial. Lower (improved)
NailQoL total scores were statistically significantly associated with complete cure of the tar-
get toenail (20.6 vs. 28.0, p<0.01) and complete cure of all toenails (17.8 vs. 27.5, p<0.01),
a borderline significant association was observed with mycological cure of the target toenail
(24.2 vs. 27.8, p=0.10). Lower function scores were also associated with complete cure of all
toenails, just approaching statistical significance (23.4 vs.32.8, p=0.10). NailQoL emotion,
symptom, and total scores decreased on average by at least 18 points (p-values all ≤0.01) for
patients with complete cure of the target toenail and for patients with complete cure of all
toenails, almost twice the reduction in average scores in patients who did not achieve these
outcomes. NailQoL was responsive to complete cure status of the target toenail and all toe-
nails but not mycological cure. Function scores were based on a single item; therefore more
items relating to function may be needed to better assess responsiveness in this domain.
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Responsiveness of willingness-to-pay in patients treated for toenail onychomycosis
SC Chen,1,2 PM Cham,3 JP Grill3 and EM Warshaw3,4 1 Dermatology, Emory University,
Atlanta, GA, 2 Atlanta VAMC, Atlanta, GA, 3 Minneapolis VAMC, Minneapolis, MN and 4
Dermatology, University of Minnesota, Minneapolis, MN
Willingness-to-pay (WTP) is a health economics method of contingent valuation which has only
recently been investigated for skin conditions. This pilot study investigated the responsiveness
of WTP in patients successfully treated for toenail onychomycosis. As part of a randomized,
double-blind, controlled trial of continuous vs. pulse dose terbinafine for toenail onychomy-
cosis at the Minneapolis VAMC, 306 participants indicated their WTP and annual income at
baseline and at 18 months. For WTP, patients chose one of 10 categories of payment ($0-50 to
>$800) for a theoretical treatment for their current nail fungus with an 85% cure rate. Primary
clinical outcomes included mycological cure of the target toenail, complete cure of the target
toenail, and complete cure of all toenails. Association of WTP with each of these 3 clinical out-
comes (ignoring treatment group) was examined using several statistical methods (Wilcoxon
two-sample test and Cochran-Mantel-Haenszel statistic test). Even after controlling for annual
income, the distribution of WTP responses (reduced to 6 categories: $0-50 to >$300) at 18
months was not associated with mycological or complete cure of the target toenail. Patients
who attained complete cure of all toenails (n=53) vs. those who did not (n=204) had a statisti-
cally significantly greater percentage reporting an increase in WTP from baseline to 18 months
(43% vs. 29%, p=0.04, χ2). This study is the first, to our knowledge, to examine change in WTP
in patients treated for toenail onychomycosis. WTP did not significantly change with myco-
logical or complete cure of target toenails alone, but there was a statistically significant increase
in the percentage of individuals reporting higher WTP at 18 months than at baseline who had
complete cure of all toenails. Major limitations of this study include: 1) predefined and arbi-
trary WTP categories and 2) a veteran study population that typically have excellent medical
coverage and therefore may be inexperienced with valuing medical services.
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Willingness-to-pay stated preferences for eight health-related quality of life domains in pso-
riasis patients
M Delfino,1 E Wittenberg,3 C Taylor2 and A Qureshi1 1 Department of Dermatology, Brigham
and Women’s Hospital, Boston, MA, 2 Department of Dermatology, Massachusetts General
Hospital, Boston, MA and 3 Institute for Technology Assessment, Massachusetts General
Hospital, Boston, MA
Psoriasis is a chronic skin condition that has a major impact on health-related quality of life
(HRQOL). Psoriasis also accounts for a major portion of the overall burden of skin disease.
‘Willingness-to-pay’ (WTP) is a contingent valuation method used to elicit stated preferences.
We evaluated WTP in US$ for eight domains of health related quality of life based on vali-
dated HRQOL measures: intimacy, physical comfort, self-care, ability to work or volunteer,
ability to concentrate, emotional health, social comfort and ability to sleep. We hypothesized
that a domain of health more severely affected by psoriasis would elicit a larger WTP amount
for a hypothetical “cure” that would eliminate all impairment in that domain. The questions
were framed to ask participants how much they would be willing to pay to obtain complete
reversal of a domain of health. Patients with history of psoriasis were interviewed. About
48% were female, 60% had a college degree or further education and 38% had an income
level >$45,000/year. More than 75% respondents ranked physical comfort, emotional health
and social comfort in the top four domains affecting HRQOL related to psoriasis. Ability to
work or volunteer and ability to concentrate were ranked the lowest. Median WTP for a
hypothetical cure of a particular domain was highest for physical comfort ($2000, 25th quar-
tile=$500, 75th quartile=$5500) and emotional health ($2000, 25th quartile=$250, 75th quar-
tile=$5000). The lowest median WTP was for ability to sleep ($625, 25th quartile=$50, 75th
quartile=$5000). This study demonstrates an approach to eliciting patients’ preferences for
aspects of quality of life affected by psoriasis. The dollar amounts reflect strength of prefer-
ence for aspects of an individual’s HRQOL. Further work is on-going to better understand the
role of stated preferences in evaluating HR-QOL for patients with psoriasis.
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Trends in sunburn, sun protection, and sun related attitudes in US youth, 1998 to 2004
VE Cokkinides,1 MA Weinstock,2,3 K Glanz,4 J Albano,1 E Ward1 and M Thun1 1 American
Cancer Society, Atlanta, GA, 2 V A Medical Center, Providence, RI, 3 Brown University,
Providence, RI and 4 Emory University, Atlanta, GA
Sun exposure in childhood is an important risk factor for developing skin cancer as an adult.
Despite extensive efforts to reduce sun exposure among the young, there are no population
based data on trends in sunburns and sun protection practices in the young. The aim of this
study was to describe nationally representative trend data on sunburns, sun protection and
attitudes related to sun exposure among United States youth. Cross-sectional telephone sur-
veys of youth aged 11 to 18 years in 1998 (N=1196) and in 2004 (N=1613) were conducted
using a two-stage sampling process to draw population-based samples. The surveys asked
identical questions about sun protection, number of sunburns experienced, and attitudes
toward sun exposure. Time trends were evaluated using pooled logistic regression analysis.
In 2004, 69% of subjects reported having been sunburned during the summer, not signifi-
cantly less than in 1998 (72%). There was a significant decrease in the percentage of those
aged 11 to 15 years who reported sunburns and a non significant increase among the 16 to
18 year olds. The proportion of youth who reported regular sunscreen use increased signifi-
cantly from 31 % to 39 %. Little change occurred in other recommended sun protection
practices. Changes in sun protection practices overall were small among youth between 1998
and 2004, despite widespread sun protection campaigns. Nevertheless, the decrease in sun-
burns among younger teens may be cause for optimism regarding future trends. Overall,
there was rather limited progress in improving sun protection practices and reducing sunburns
among United States youth between 1998 and 2004.
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Predicting treatment response in chronic pruritic patients at a university-based dermatol-
ogy clinic 
K Harris,1 B Camp,2 H Volkman,3 J Foster,4 B Sikora,4 M Fuller,5 R Swerlick4,6 and S Chen4,6 1
School of Medicine, University of Washington, Seattle, WA, 2 Medical University, SUNY Upstate,
Syracuse, NY, 3 Texas College of Osteopathic Medicine, University of North Texas Health Science
Center, Fort Worth, TX, 4 School of Medicine, Emory University, Atlanta, GA, 5 Columbia School
of Medicine, University of Missouri, Columbia, MO and 6 Atlanta VA Medical Center, Atlanta, GA
Pruritic patients are often divided into those with known etiology and those with primary pru-
ritus. This study aims to assess if this division is a positive predictor of treatment response in
chronic pruritic patients. Medical records of patients diagnosed with pruritus lasting ≥6 months
at a university dermatology clinic between 2000-05 were reviewed. Ordinal logistic regression
analysis assessed the effects of having a systemic etiology, a specific skin disease, age, gender,
pruritus distribution and duration on treatment response. Analysis was conducted on all patients
and patients stratified by treatment group. 230 patients were divided into treatment groups:top-
ical agents only (9%), antihistamines/antileukotrienes (41%), chronic antibiotics (14%), systemic
immunosuppressants (31%) and other (4%). Among patients of all treatment groups combined,
no independent variables were significant predictors of treatment response. Analysis of the four
largest treatment groups revealed one significant predictor: in patients treated with only topical
agents, diagnosis of a specific skin disease predicted poorer treatment response (OR 0.06, p =
0.02). The presence of a systemic etiology or specific skin disease did not predict improved
response in chronic pruritic patients at a university-based dermatology clinic. In patients treated
with topical agents only, a specific skin disease predicted worse response, suggesting patients
with a specific skin disease may require more than topical agents alone. Systemic disease and
specific skin disease may offer little value in predicting improved treatment response due to dif-
ficulty in accurately diagnosing the cause of pruritus and/or lack of treatment specificity in tar-
geting etiology-specific pruritus or pathways common to all pruritus.
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Senior U.S. dermatology resident perspectives on training and workforce issues
S Freeman,2 DA Barzilai,3 A Freiman,4 A Collier,2 S Muller,5 A Kimball6 and R Dellavalle1,2 1
Dermatology, Denver Dept. of Veterans Affairs Medical Center, Denver, CO, 2 Dermatology,
University of Colorado at Denver and Health Sciences Center, Denver, CO, 3 Dermatology,
Brown University, Providence, RI, 4 Dermatology, McGill University, Montreal, QC, Canada,
5 Dermatology, University of Nevada, Las Vegas, NV and 6 Dermatology, Mass. General and
Brigham and Women’s Hospital, Boston, MA
The objective is to assess resident attitudes regarding dermatology residency training and work-
force issues. Design: A 44-question survey given to senior U.S. dermatology residents attend-
ing the 6th Annual Las Vegas Dermatology Seminar. The main outcome is Resident satisfac-
tion as measured by a 5-point Likert scale. 57 of 113 residents responded (~15% of all US
senior dermatology residents). 70% and 72% were satisfied with the availability and quality
of mentors. 82% had between 1 and 3 faculty members they considered mentors. Of those
with mentors, 35% reported spending no time with them [the monthly range of time spent was
0-630 minutes, mean 89, median 23]. The number of peer-reviewed papers authored by res-
idents prior to entering dermatology residencies ranged from 0 to 25 (median 5) and the num-
ber of papers authored during residency ranged from 0 to 19 (median 4.5). Residents were
most satisfied with pathology slide sessions (score 4.4 of 5) and medical dermatology train-
ing (4.4), while trainees were least satisfied with business management training (2.5) and time
allotted for independent study (3.3). Training aspects most important to respondents were med-
ical dermatology (4.9) and clinical unknowns (4.8), while aspects least important were der-
matoscopy (3.5) and encouragement of research (3.6). While 61% agreed that there is a short-
age of dermatologists, only 28% felt that the number of residency positions should be expanded.
61% and 93% disagreed with industry sponsoring and self-sponsoring of training positions.
Residents desire improved training business management, better program responsiveness to
resident input, and more time dedicated to independent study.
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Number, characteristics, and completeness of clinical-trial registrations in psoriasis and atopic
dermatitis
RD Quain1 and KA Katz2 1 University of Pennsylvania School of Medicine, Philadelphia, PA
and 2 Dermatology, University of Pennsylvania, Philadelphia, PA
Controversy over the failure to publish results of clinical trials linking adolescent suicidality
to anti-depressant treatment has increased interest in clinical-trial registration. In 7/05 the Inter-
national Committee of Medical Journal Editors (ICMJE) began requiring prospective registra-
tion as a condition for publication in an ICMJE journal. Trials ongoing as of 7/05 were required
to register by 9/13/05. Archives of Dermatology, British Journal of Dermatology, and Journal
of Investigative Dermatology have adopted this policy. There has been concern that some reg-
istrations are vague or incomplete. We assessed (1) numbers and characteristics of trials in pso-
riasis and atopic dermatitis (AD) registered at clinicaltrials.gov (ct.gov) and the International
Standard Randomised Controlled Trial Number (ISRCTN) Register at controlled-trials.com,
which both conform to ICMJE registry specifications, and (2) the completeness of information
in registrations, based on ICMJE criteria. We identified trials by searching ct.gov (conditions:
“psoriasis,” “atopic dermatitis”) and the ISRCTN Register (search: “psoriasis,” “atopic der-
matitis”) through 12/31/05. We included only studies related to therapeutic interventions for
AD or psoriasis. We identified 156 registered trials, including 128 (82%) at ct.gov (36 [28%]
in AD, 92 [72%] in psoriasis) and 28 (18%) at the ISRCTN Register (23 [82%] in AD, 5 [18%]
in psoriasis). Companies funded 87 trials (56%), governments 28 (18%), universities or organ-
izations 21 (13%), and a combination of funders 20 (13%). 36% (n=13) of AD trials and 26%
(n=24) of psoriasis trials at ct.gov were registered in 9/05. 150 registrations (96%) listed the
specific name of the intervention studied, 89 (57%) listed the specific measure used (eg, “PASI”),
69 (44%) listed the criteria to gauge success (eg, ≥75% decrease), and 62 (41%) listed the
time of assessment (eg, 12 weeks). While trial registrations in AD and psoriasis are increasing,
more complete information may increase the value of trial registration for
dermatologists and their patients.
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Use of placebo and active control groups in clinical trials in psoriasis published between
2001 and 2005
DS Chiang,1 RA Bognet1 and KA Katz2 1 Medical School, Thomas Jefferson University,
Philadelphia, PA and 2 Dermatology, University of Pennsylvania, Philadelphia, PA
Use of placebo and active control groups in clinical trials has been widely debated, with argu-
ments focusing on the ethics and value of each. Placebo controlled trials give control group
participants shams not expected to confer benefit, while active controlled trials give control
group participants existing treatments expected to confer benefit. Our goals were (1) to assess
the frequency of use of placebo and active controls in psoriasis trials published from 2001 to
2005, and (2) to identify factors associated with choice of control group. We searched the
Cochrane Central Register of Controlled Trials to identify controlled trials for psoriasis published
from 1/1/01 to 12/20/05. Articles were included if the primary endpoint was clinical, results
from the trial were being published for the first time, the abstract was in English, and the arti-
cle was full-length. We identified 194 potentially relevant articles, of which 189 were available
for review. We ultimately analyzed 124 articles from 32 journals. Trials were classified by type
of control group, location and funding source. Associations were assessed using logistic regres-
sion modeling in Stata 8.2, and odds ratios were converted to risk ratios using the “nlcom” com-
mand. 78 trials (61%) used active controls only, while 50 (39%) used placebos. 31 trials (24%)
were conducted exclusively in the USA, while 97 (76%) were not. 61 trials (48%) were funded
exclusively by pharmaceutical companies, while 61 (48%) were not, and information was not
available for 6 (5%). In univariable analyses, placebos were more commonly used in trials
conducted exclusively in the USA (risk ratio [RR] 2.26, 95% CI 1.38, 3.15, p<0.001) and in tri-
als funded exclusively by pharmaceutical companies (RR 1.88, 95% CI 1.00, 2.77, p<0.001).
Multivariable analysis yielded similar results. There was no effect modification between trial
location and funding source. Use of placebo compared to active controls in psoriasis clinical
trials is more common in the USA and in pharmaceutical company-sponsored studies.
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Characteristics of pruritic patients at a university-based dermatology clinic
K Harris,1 H Volkman,2 B Camp,3 B Sikora,4 M Fuller,5 R Swerlick4,6 and S Chen4,6 1 School
of Medicine, University of Washington, Seattle, WA, 2 Texas Osteopathic College of Medicine,
University of North Texas Health Science Center, Fort Worth, TX, 3 Medical University, SUNY
Upstate, Syracuse, NY, 4 School of Medicine, Emory University, Atlanta, GA, 5 Columbia
School of Medicine, University of Missouri, Columbia, MO and 6 Atlanta VA Medical Center,
Atlanta, GA
This study assessed the demographic characteristics, clinical work up, treatment and response
of pruritic patients. A retrospective chart review was conducted of patients diagnosed with
pruritus at a university-based dermatology clinic between 2000-05. 399 charts were reviewed.
Most patients were female (63%) and Caucasian (75%). Ages ranged from 17 to 94 years with
a mean of 56 +/- 16 years. Pruritus duration ranged from 0-720 months with a mean of 33 +/-
58 months. 73% of patients had generalized pruritus. Most patients did not have a systemic
cause of pruritus (65%). Of those with a systemic etiology (n = 138), thyroid disease (36%)
and malignancy (18%) were most common. Many patients had only non-specific spongiotic
dermatitis or no specific skin condition (44%). Of those with a specific skin condition (n=225),
atopic dermatitis/xerosis/contact dermatitis (45%), urticaria (28%) and infection/bites (11%)
were common. Nearly half the charts did not include laboratory testing (49%). Of those with
testing (n=204), 31% had abnormalities. Iron deficiency (24%) and thyroid abnormalities (20%)
were most common. For the 399 patients, treatments ordered were antihistamines/
antileukotrienes (44%), systemic immunosuppressants (23%), topical agents only (17%), chronic
antibiotics (11%) and psychotropic drugs and/or bile acid sequestrants (5%). Documented
treatment response was (n= 273) partial response (31%), near complete response (24%),
complete response (18%), temporary response (15%) and minimal response (13%). A signif-
icant proportion of pruritus at a university-based outpatient dermatology clinic is generalized
and not attributable to systemic disease or a specific skin condition. Pruritus is treated with a
variety of drugs. Most patients seem to respond to their treatment regimen.
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Ethics board review of prospective clinical studies submitted to JAAD
AC Perkins, J Choi and AB Kimball Harvard Medical School, Boston, MA
In recent years there has been an increasing focus on human subject protection, and on doc-
umentation of ethical review in published clinical research. The JAAD states in its instructions
to authors, “studies involving live human subjects must have been approved by the author’s
Institutional Review Board or its equivalent. If applicable, this should be mentioned in the
methods section of all manuscripts.” The objective of this study was to determine what pro-
portion of prospective studies on human subjects submitted to the clinical trials and thera-
peutics section for review lacked mention of review by an IRB or ethics board, and to deter-
mine the outcome of these manuscripts. 146 prospective studies were submitted to a single
associate editor, who receives the majority of reports requiring IRB review, from 7/1/04-12/2/05.
Of the 146, 52 (36%) had no mention of IRB or consent (“Nirb/Ncons”). An additional 22
papers (15%) mentioned obtaining patient consent but not IRB review (“Nirb/Ycons”). Of the
Nirb/Ncons papers, 48% (n=25) were returned asking for IRB information. Of those 25 man-
uscripts, IRB info was provided for 12 (48%), 4 (16%) lacked IRB approval and were rejected,
4 (16%) were withdrawn, 4 (16%) were never returned, and one (4%) was determined exempt
as a case note. Of the Nirb/Ycons papers, 15 (68%) were returned asking for IRB information.
Of those 15 manuscripts, IRB info was provided for 8 (53%), one (6.7%) lacked IRB approval
and was rejected, 3 (20%) were withdrawn, 2 (13%) were never returned, and one (6.7%)
was clarified as retrospective. The overall acceptance rate was 23% of Nirb/Ncons papers,
27% of the Nirb/Ycons papers, and 29% of those mentioning IRB. Despite the international
acceptance of the principles put forth by the Declaration of Helsinki, one half of authors sub-
mitting papers on prospective clinical studies to JAAD over eighteen months did not initially
provide evidence of ethical review. Of the 40 papers for which IRB information was subse-
quently requested, the reason for omission was likely oversight in half the cases, but in oth-
ers ethics review was not obtained.
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Use of complementary and alternative medicine (CAM) among adults with skin disease:
results from a national survey
N Smith,1,3 DB Shin1 and J Mao2,3 1 Dept. of Dermatology, Univ. of Pennsylvania,
Philadelphia, PA, 2 Dept. of Family Medicine, Univ. of Pennsylvania, Philadelphia, PA and 3
Dept. of Biostatistics and Epidemiology, Univ. of Pennsylvania, Philadelphia, PA
The purpose of this cross-sectional study was to estimate CAM use among adults with skin
disease in the United States by analyzing data from the 2002 National Health Interview Sur-
vey. We defined CAM to encompass 4 types of ‘alternative medical systems’ and 5 types of
‘biologically based therapies’. Subjects were classified as having ‘skin problems’ if they reported
having ‘skin problems’ in the past year. Subjects were classified as CAM users if they reported
using at least one CAM modality in the past year. Adjustments were made for sampling weights,
which were determined for age, gender, race and/or ethnicity based on the 2000 Census con-
trol total. Descriptive analyses were performed to determine the use of various CAM modali-
ties. To compare CAM use between two groups, an adjusted relative risk was calculated from
an odds ratio generated from logistic regression. There were 31,007 completed interviews in
our study (response rate 74%). Of those, 8.7% (95% CI: 8.3,9.1) were classified as having ‘skin
problems’. Of this group with ‘skin problems’, 32.52% (95%CI: 30.48,34.63) were CAM users.
The 5 most common CAM modalities used in this group were natural products, special diets,
megavitamins, homeopathy, and acupuncture. The 5 most common natural products used were
echinacea, ginkgo biloba, ginseng, garlic supplements, and glucosamine. Approximately 2.12%
(95%CI: 1.51,2.97) of adults used CAM specifically to treat ‘skin problems’. After adjusting
for age, sex, race, region, and education, we found that when compared to adults without
‘skin problems’, those with ‘skin problems’ had a relative risk of 1.49 (95%CI:1.39,1.60) for
using CAM. CAM use among adults with ‘skin problems’ is common and may be greater than
CAM use among adults without ‘skin problems.’ Dermatologists should be aware of different
CAM modalities and should remain diligent about asking questions regarding CAM use to their
patients.
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Comparison of two skin disease-specific quality of life questionnaires: DLQI vs. Skindex
B Camp,1 M Pennie,2 K Harris,3 C Traywick2 and S Chen2,4 1 SUNY Upstate Medical Univ,
Syracuse, NY, 2 Emory Univ School of Med, Atlanta, GA, 3 Univ of WA School of Med,
Seattle, WA and 4 VA Medical Center, Atlanta, GA
Dermatology Life Quality Index (DLQI) and Skindex are surveys that assess the impact of skin
disease on patient quality of life (QOL). Our objective was to explore the behavior of these
instruments in patients recruited from a general dermatology clinic at an academic medical
center. Patients completed both DLQI (10 questions, scale 0-30) and Skindex-29 (30 ques-
tions, scale 0-100). Disease severity was recorded using Dermatology Index of Disease Sever-
ity (DIDS) (scale 0-4). Non-parametric tests were used and a p-value less than 0.05 was con-
sidered statistically significant. There were 51 participants. Accounting for missing information,
53% (25/47) were female, 77% (36/47) were Caucasian, and 19% were African American.
Age ranged from 19 to 78 years (mean 48.1, SD 17.0). Of 49 complete DLQI surveys, the
mean score was 5.92 (range 0-24, SD 5.44), and of 50 complete Skindex surveys the mean
score was 28.99 (range 1.72-73.28, SD 20). Severity was recorded as 1 (minimal) most fre-
quently (27/50). The most common diagnosis was acne (6/51). DLQI and Skindex composite
scores did not differ significantly across gender or race. Age did not correlate with DLQI or
Skindex composite score. DLQI composite scores correlated strongly with Skindex compos-
ite scores (r=0.78, p<0.01). Severity correlated with DLQI and Skindex composite scores (r=.30,
p=0.04 r=0.42, p<0.01). There was not a significant difference in DLQI scores across sever-
ity scores. There was a significant difference in Skindex composite scores across severity scores
grouped as follows: 0-1, 2, and 3-4 (p=0.01). DLQI and Skindex are useful for evaluating QOL
in general dermatology clinic patients because scores are not related to age and are not dif-
ferent among gender and racial groups. Correlation between the scores on each instrument
and between each instrument with severity suggests the surveys overlap in their behavior. How-
ever, Skindex appears to discriminate better between severity levels.
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Development and evaluation of PASE: A self-administered psoriatic arthritis screening and
evaluation tool
A Qureshi,1 D Cohen,1 E Mody3 and E Husni2 1 Department of Dermatology, Brigham and
Women’s Hospital, Boston, MA, 2 Department of Rheumatology and Immunologic Diseases,
Cleveland Clinic Foundation, Cleveland, OH and 3 Division of Rheumatology, Immunology,
Allergy, Brigham and Women’s Hospital, Boston, MA
The incidence and prevalence of psoriatic arthritis is unknown at the population level. Psori-
atic arthritis can lead to severe destructive joint disease if left untreated or undiagnosed. We
have developed a self-administered questionnaire that dermatologists can use to screen pso-
riasis patients for evidence of psoriatic arthritis and refer to rheumatology. The Psoriatic Arthri-
tis Screening and Evaluation (PASE) questionnaire contains 15 five-choice items separated into
two subscales: symptoms and function. PASE minimum score was 15 and maximum score
75. Of the 45 consecutive participants responding to the questionnaire prior to systemic ther-
apy, 18 were diagnosed with psoriatic arthritis plus psoriasis and 27 with psoriasis alone by
a dermatologist and rheumatologist working in collaboration. Mean age was 53 years and 21
were female. The psoriatic arthritis group was younger (mean age difference 8.5 years, p=0.06).
In the psoriatic arthritis group, total median PASE score was 53 (25th, 75th percentiles = 49,
63). In the psoriasis alone group, total median PASE score was 40 (25th, 75th percentiles =
30, 47), p<0.01. Sensitivity was 0.83 and specificity was 0.70 for the total score. Similarly,
median function score for psoriatic arthritis was 27 (25th, 75th percentiles = 25, 31) and median
function score for psoriasis alone was 19 (25th, 75th percentiles = 15, 22), p<0.01. Median
symptom score for psoriatic arthritis was 24 (25th, 75th percentiles = 23, 30) and median
symptom score for psoriasis alone was 19 (25th, 75th percentiles = 14, 24), p<0.01. There is
a need to identify patients with PsA so that timely therapy can be initiated and long term dis-
ability avoided. The PASE questionnaire will be a useful adjunct to clinical care for potential
PsA seen in dermatology clinics. Further work is needed to test PASE in a larger sample of
psoriasis patients.
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Update on the dermatology workforce, 2005
KL Brown,1 J Resneck2 and A Boer Kimball1 1 Dermatology, Harvard Medical School, Boston,
MA and 2 Dermatology, University of California San Francisco School of Medicine, San
Francisco, CA
The workforce balance in dermatology has gained attention in recent years due to data indi-
cating a relative shortage of dermatologists. Concurrently, osteopathic doctors and physician
assistants have entered dermatology in substantial ways, increasing in number by 9.2% and
49% between 2000 and 2004, respectively. Physician Assistants and Nurse Practitioners now
comprise 21% of the Dermatology workforce. Given these fairly rapid changes, fluctuations
in the supply and demand of dermatologic services might be expected. In order to assess for
such changes, anonymous surveys administered to practicing dermatologists were examined
for surrogate indicators of supply and demand. Survey response rates for 2002 and 2005 were
34.8% (1425/4090) and 30.0% (1619/5371), respectively. The mean wait time for new patient
appointments with dermatologists was 36 days in 2002 and 34 days in 2005. Although the
percentage of practices looking for new associates remained unchanged (33%) since 2002,
the mean duration of these searches increased from 16 months in 2002 to 20 months in 2005.
Physician perception about the current adequacy of the workforce also did not change mean-
ingfully during this time. Despite growth in the workforce, including a substantial influx of
non-MD providers, little has changed thus far in the metrics used for analyzing the sufficiency
of the dermatology workforce. These trends will be important to monitor in the future, as the
supply and professional characteristics of dermatologic providers evolve.
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Clinical interpretation of Skindex scores
B Camp,1 K Harris,2 M Pennie,3 C Traywick3 and S Chen3,4 1 SUNY Upstate Medical Univ,
Syracuse, NY, 2 Univ of WA School of Med, Seattle, WA, 3 Emory Univ School of Med,
Atlanta, GA and 4 VA Medical Center, Atlanta, GA
Dermatology Life Quality Index (DLQI) and Skindex are among the most commonly used
quality of life (QOL) indices for assessing the psychosocial impact of dermatologic disease.
While the clinical meaning of DLQI scores has been translated1, Skindex scores have yet to
be analyzed in the same manner. This study’s purpose is to explore and interpret the mean-
ing of Skindex composite scores. General dermatology clinic patients at an academic med-
ical center completed Skindex-29 and the Global Question (GQ), “Overall, during the past
week how often have you been bothered by this skin problem?” scored on a 0-4 scale. Dis-
ease severity was rated with Dermatology Index of Disease Severity. Skindex scores were
grouped into 2, 5, and 10-point intervals because not all possible Skindex scores were rep-
resented. The mean, median, and mode of GQ scores were calculated for these intervals of
Skindex scores. By plotting the GQ values against the Skindex intervals, bands of Skindex
scores could be identified that corresponded to specific GQ scores. The κ coefficient for each
banding pattern was used to measure agreement between GQ and Skindex scores. The range
of Skindex scores was 1.72-73.28. GQ response correlated with Skindex score (r=0.63, p<0.01)
and severity (r=0.39, p=0.01). Plotting GQ versus Skindex scores in 2 and 5-point intervals
revealed bands of Skindex scores of 0-15, 16-50, and 51-73 that frequently had GQ scores
of 0-1, 2, and 3, respectively (κ=0.449). Plotting Skindex scores in 10-point intervals revealed
bands of 0-19, 20-49, and 50-73 that corresponded to GQ scores of 0-1, 2, and 3, respec-
tively (κ=0.417). Grouping Skindex scores in relation to GQ response may contribute to the
clinical meaningfulness of Skindex scores. We interpret Skindex scores between 0-19 to be
of minimal QOL impact, 20-49 mild, and 50-73 moderate despite the lower κ value for this
model its graph showed sharper cut-off points between bands. We would expect scores at a
point above 73 to signify a large impact.
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Psoriasis phenotype vs treatment response: responder and non-responder cohorts treated
with UV light are more distinct phenotype than cohorts treated with systemic agents
J Panko,1 K Callis,1 B Wong,1 A Motaal1 and G Krueger1 1 Dermatology, University of Utah,
Salt Lake City, UT and 2 LineaGen, Salt Lake City, UT
The Utah Psoriasis Initiative (UPI) is a data collection tool used to phenotype psoriasis patients.
In this study we stratified UPI patients based on reported response to psoriasis treatment and
compared and contrasted the phenotypic variation between the responder and non-respon-
der cohorts. Patients are asked list treatments they have used for psoriasis. They are asked to
state, for each treatment tried, whether they generally cleared, partially cleared, or cleared
minimally to not at all. A large amount of phenotypic information is also gathered. For each
treatment used, patients in the cohorts who cleared (responders) or had minimally clearing
(non-responders) were stratified and phenotypic features were compared. Patients who par-
tially cleared were excluded from this analysis. Chi-squared or ANOVA analyses were done
to determine the significance of differences between the groups. The frequency of each phe-
notypic trait in responders and non-responders was compared with frequencies in the UPI
population as a whole. Topical steroid responders were likely to have small, thin plaques. Nat-
ural sunlight responders were more likely to be female, have a family history of psoriasis, and
to have small thin plaques. Tanning bed responders were more likely not to have psoriatic
arthritis and to have thin plaques. PUVA responders were more likely not to have psoriatic
arthritis. Methotrexate responders were more likely to not to drink alcohol. There were no
significant differences in phenotype that associated with response or non-response in those
who used acitretin, thioguaunine, etanercept, or alefacept. These results show that phenotypic
differences in psoriasis associate with response and non-response to various treatments. This
same process will be used to identify differences in haplotype frequencies between groups.
Longitudinal follow-up data is being collected to more precisely assess patient response to
medications over time.
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Patient-reported outcomes of nonmelanoma skin cancer treated in different practice set-
tings
M Chren,1,2 A Sahay,2 D Bertenthal2 and S Sen1,2 1 UCSF, San Francisco, CA and 2 San
Francisco VAMC, San Francisco, CA
Patient-reported outcomes are an important measure of quality of care for non-fatal conditions
such as nonmelanoma skin cancer (NMSC). To compare the quality of care for NMSC at a pri-
vate and a VA setting, we assessed quality-of-life outcomes of NMSC treatments, controlling for
potential confounders, including sociodemographic characteristics, severity of tumors, and pre-
treatment quality of life. 633 patients with newly-diagnosed NMSC were enrolled at the time of
biopsy of cancer and followed for one to two years after treatment. The numbers of patients
treated with electrodessication and curettage (ED&C), excision, and Mohs surgery, respectively,
at the private site were 82, 92, and 147, and at the VA were 54, 159, and 99. Tumor-related
quality of life was measured with Skindex-16. Skindex scores vary from 0 to 100, and are reported
in three domains: Symptoms, Emotional effects, and effects on Functioning. Overall, 508 patients
(80%) responded after therapy. In all treatment groups, patients at the VA were older, poorer,
sicker, and had worse pre-treatment quality of life in the Symptoms and Functioning but not the
Emotional domains. At both sites, patients treated with ED&C improved only minimally in qual-
ity of life after treatment. Patients treated with excision and Mohs surgery improved in Symp-
toms and Emotional effects. For example, in the Mohs group, at the private and VA sites, respec-
tively, mean adjusted change scores for Symptoms were 9.9 and 7.2, and for Emotions were 21.4
and 19.9. In multivariable linear regression models adjusting for pre-treatment characteristics,
however, there was no difference between the two sites (P>0.05) in the amount of improvement
in quality of life in any treatment group. In sum, VA patients with NMSC were older, poorer, and
had worse pre-treatment skin-related quality of life than patients treated in a private site. Nev-
ertheless, there was no difference in quality-of-life outcomes after treatment between VA and
private patients, which suggests similar quality of care for NSMC at the two sites.
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Utah Psoriasis Initiative follow-up study: an assessment of changes in phenotypic charac-
teristics as a function of time
J Panko, T Nelson, B Wong, K Callis and G Krueger Dermatology, University of Utah, Salt
Lake City, UT
Overtime, changes in individual psoriasis case presentation and behavior can be observed.
These changes include variation in plaques location, appearance of co-morbid conditions,
and diminished or increased response to medications. Though many analyses have been
done on psoriatic subjects at a fixed time, few have been longitudinal, evaluation as a func-
tion of time. For this study we collected phenotypic data from individual psoriasis patients at
two time points and assessed the changes in each patient’s phenotype. Through question-
naire, interview and clinical exam, we collected disease phenotype information from 776
patients with psoriasis. Phenotype information collected included response to medications,
presence of nail disease, psoriatic arthritis, koebner phenomenon, family history, morphol-
ogy of plaques, and body surface area covered with disease. Very recently follow-up ques-
tionnaires, containing the phenotype questions initially collected, were sent to 526 patients
who had been enrolled previously (range 12 to 26 months). At the time of abstract prepara-
tion 75 questionnaires had been returned and were used for a preliminary analysis changes
in phenotype as a function of time. The preliminary analysis demonstrates that 95% of patients
reported no change in the family history of their disease, 2.5%reported having gained a fam-
ily history and2.5% reported no longer having a family history. For psoriatic arthritis 91%
reported the same answer when asked if they had been diagnosed with psoriatic arthritis5%
reported having lost the diagnosis and4%reported having gained it. For nail disease 72%
reported no change in the presence or absence of nail disease while7% reported having lost
nail disease and 21% gained it. This analysis is now being extended to the entire 526 cohort
and will give insights into changes psoriasis phenotype over time. We propose that subsequent
longitudinal phenotyping will elucidate the evolution of subtypes of psoriasis.
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Quality of life among patients with psoriasis and psoriatic arthritis and patients with psori-
asis only
DH Ciocon MD,1 EJ Horn2 and AB Kimball1 1 Clinical Unit for Research Trials in Skin,
Brigham and Women’s and Massachusetts General Hospitals, Boston, MA and 2 National
Psoriasis Foundation, Portland, OR
Five to 40% of patients with psoriasis (Ps) develop psoriatic arthritis (PsA), a chronic and poten-
tially disabling inflammatory arthritis. Two previous studies demonstrated that patients with
Ps and PsA experience greater detriment to their health-related quality of life (HRQOL) than
patients with Ps only, but neither controlled for skin disease severity. We tested this hypothe-
sis in a heterogeneous US population derived from the Spring 2005 National Psoriasis Foun-
dation (NPF) Survey in which 426 telephone/online interviews were conducted with individ-
uals reporting a history of Ps. Respondents were grouped according to those with Ps and PsA
(n=140) and those Ps only (n=278). No significant differences were detected in patient self-
assessment of skin disease severity. Respondents with Ps and PsA were slightly older (mean
age 54 vs mean age 51, p = 0.04) and more likely to be female (67% vs 52%, p=.003), unem-
ployed (18% vs 9%, p = .007), and members of the NPF (78% vs 66%, p=.01). They also
reported an earlier age of disease onset (24 vs. 31, p =.001). With respect to HRQOL, indi-
viduals with Ps and PsA were more likely to report somatic complaints (itching, soreness) and
socioeconomic difficulty, while those with Ps only were more likely to report emotional impair-
ment (self-consciousness, embarrassment). However, there was no difference in overall dis-
ease-related quality of life, as measured by patient global self-assessment and the PQOL-12.
Respondents with Ps and PsA were also more likely to report being “very satisfied” with cur-
rent treatment than those with Ps only (34% vs 23 %, p=0.01). Contrary to previous reports,
this study demonstrates that individuals with Ps and PsA do not report significantly greater
reductions in QOL and treatment satisfaction compared to those with Ps only, even in pres-
ence of similar skin disease severity, but do report qualitative differences in their daily activ-
ities and experiences.
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Cytokine modulation of retinoic acid-inducible gene-I (RIG-I) expression in human epider-
mal keratinocytes in vivo and in vitro
H Kitamura,1 Y Matsuzaki,1 K Kimura,1 H Nakano,1 T Imaizumi,2 K Satoh2 and K Hanada1 1
Department of Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan and 2
Department of Vascular Biology, Institute of Brain Science, Hirosaki University School of
Medicine, Hirosaki, Japan
Retinoic acid-inducible gene-I (RIG-I) is a member of the DExH/D box family proteins and
designated as a putative RNA helicase, which plays various roles in gene expression and cel-
lular functions. RIG-I is also involved in anti-viral responses. The present study was designed
to investigate the effects of interferon (IFN)-γ and tumor necrosis factor (TNF)-α on RIG-I expres-
sion in human keratinocytes, and the expression of RIG-I in skin lesions of psoriasis vulgaris,
in which IFN-γ and TNF-α are considered to be involved in its pathogenesis. The levels of
RIG-I mRNA and protein were upregulated in HaCaT keratinocytes in the presence of IFN-γ
or TNF-α. Immunohistochemically, RIG-I was detected in the cytoplasm of the spinous and
granular layers of psoriatic skin. Furthermore, the expression of RIG-I diminished markedly in
well-differentiated normal human epidermal keratinocytes upon incubation in high-calcium
medium. Our results suggest that RIG-I is involved in the differentiation and proliferation of
keratinocytes in psoriasis vulgaris.
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A comparative study of exfoliation with lactic acid and a mushroom derived acid protease
WP Smith Dermac Laboratory, Wellington, FL
We have compared the results of accelerated exfoliation with a topical acid protease derived
from the Mucor miehei mushroom (10000 International units/mg) and 8% lactic acid (LA) pH
3.5, on skin aesthetic parameters and stratum corneum function. The study was double-blind,
products were applied twice daily in a half-face protocol, and all aspects of the study were
subject to Dermac’s IRB approval. Twenty subjects completed this four week study. Both treat-
ments increased skin cell renewal as assessed via dansyl chloride by about 30% throughout
the study. LA treatment elevated trans-epidermal water loss (TEWL) rates by 67.6% (Student T
Test p value <.05) at two weeks, and 38.5% (p <.05) at four weeks. No significant changes in
TEWL were observed in the enzyme treated group (changes less than 5%). The LA treated group
also showed increased skin sensitivity as demonstrated by a clinically elevated stinging response
to 80% ethanol applied to the nasal fold area. Increases of 95% (p <.05) and 57% (p <.05)were
observed after two and four weeks with LA treatment compared to 23% (p >.05) and 16% (p
>.05) for the enzyme treated group. The stratum corneum was more fragile in the LA treated
group at both two and four weeks as evidenced by tape-stripping experiments. Control and
enzyme treated subjects required on the average between 6.8-9.9 tape strippings to double
TEWL rates, while the LA treated group only needed 4.3 strips after two weeks and 5.3 after
four weeks. Comparable improvements in skin appearance were observed with both treat-
ments including improved skin firmness measured via ballistometry, and texture, smoothness
and wrinkle reduction measured via image analysis of skin replicas. While both acid protease
and LA induced exfoliation improve skin’s appearance, only LA negatively impacts stratum
corneum structure and function consistent. This is consistent with increased skin sensitivity
often observed with alpha hydroxy acid treatments.
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Immunohistochemical study of Choline Acetyltransferase of Peripheral Type (pChAT) in rat
skin
K Hanada,1 I Tooyama,2 H Kimura2 and S Kishimoto1 1 Dermatology, Kyoto Prefectural
University of Medicine, Kyoto, Japan and 2 Molecular Neuroscience Research Center, Shiga
University of Medical Science, Otsu, Japan
Visualization of cholinergic nerves in the integumental system has been hampered by the
lack of suitable techniques. However, recently introduced immunohistochemistry for choline
acetyltransferase of a peripheral type (pChAT) has been shown to detect many known periph-
eral cholinergic elements. Here, we report pChAT-immunoreactive nerve fibers in the rat toe.
Intensely stained nerve fibers were distributed in association with eccrine sweat glands, blood
vessels, hair follicles, and portions just beneath the epidermis. These results suggest that pChAT-
positive nerves appear to participate in sympathetic cholinergic supply to the sweat gland
and parasympathetic input to vascular walls. Moreover, pChAT also appears to play a role in
cutaneous sensory endings, and the finding was supported by the presence of many pChAT-
positive neuronal cells in the dorsal root ganglion.
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A new neurocosmetic approach for a global improvement in sensitive skin
I Isabelle and J Nicolay Biology, Exsymol, Monaco, Monaco
Sensitive skin remains an imprecise phenomenon, often regarded as a complex multifactor
syndrome with a lack of clinical signs. The peripheral nervous system is suspected to be a key
player in this skin condition mainly associated to sensory perceptions. We had previously
shown that a compound endowed with neurotrophic and neuroprotective properties improves
superficial innervation and epidermal barrier function that is a common impairment feature
of sensitive skins. To evidence the correlation between alteration of the superficial innerva-
tion and skin low tolerance, a clinical study was carried out on 12 volunteers with sensitive
skins from 23 to 49 years-old. This controlled, randomized, double-blind study was carried
out in winter time in cross-over during 5 weeks. A two-week (S1-S2) daily facial treatment
session was followed by a one-week “wash-out” period (no treatment), and a second two-
week treatment session (S4-S5). Two moisturizing creams designed for high tolerance were
used, without the neuroactive (B) and with the neuroactive ingredient (A). Two groups of vol-
unteers received alternatively A or B (first or second treatment session). Ten evaluation crite-
ria (erythema, desquamation, dryness, roughness, warmth, burning, itching, stinging, tight feel-
ing, discomfort) were evaluated by a dermatologist and completed by self-evaluation. The
clinical evaluation under dermatological control has shown that both creams A and B glob-
ally improve the skin condition. Results of the two groups taken together evidence the bene-
fits associated with the neuroactive ingredient resulting in a clear improvement for three cri-
teria: desquamation, stinging and tight feeling. An improvement index was used to analyze
the incidence of the neuroactive ingredient on the measured parameters. In conclusion, this
study demonstrates that the daily use of a cosmetic cream containing a neuroprotective ingre-
dient efficiently reduces skin hyperreactivity (in this case triggered by a cold and windy weather).
It also evidences the involvement of a neurogenic disorder in the “intolerance syndrome”
named sensitive skin.
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Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal ker-
atinocytes in normal human skin and differentiated 3D-skin models
JM Baron,1 R Heise,1 J Mey,2 M Neis,1 Y Marquardt,1 S Joussen,1 H Ott,1 M Megahed,1
DR Bickers3 and HF Merk1 1 Dept. of Dermatology and Allergology, RWTH Aachen
University, Aachen, Germany, 2 Institute for Biology II, RWTH Aachen, Aachen, Germany and
3 Department of Dermatology, Columbia University, College of Physicians and Surgeons,
New York, NY
Retinoids are potent regulators of cell proliferation, cell differentiation, and morphogenesis.
Metabolic transformation of all-trans RA to 4-hydroxylated RA, a less active and more read-
ily excreted polar species appears to be primarily catalyzed by the highly specific cytochrome
P450 (CYP) enzyme 26AI. In this study we have examined the expression and inducibility of
CYP26AI by all-trans RA in normal human epidermal keratinocytes (NHEK) and dermal fibrob-
lasts at the RNA- and protein level. Analysis of monolayer cultures of NHEK and fibroblasts
by quantitative real-time PCR and RT-PCR revealed no basal levels of CYP26AI expression
which were enhanced by addition of 10-6 M all-trans RA. Immunofluorescence and western
blot analysis showed a weak expression of CYP26AI in DMSO treated cells, which was induced
by stimulation with all-trans RA. Using a newly developed peptide antibody we further exam-
ined the localisation of CYP26AI expression in normal skin and 3D skin models cultured for
7-21 days. In contrast to cell culture monolayers strong constitutive expression of CYP26AI
was restricted to basal epidermal keratinocytes, as well as eccrine sweat glands and sebaceous
glands. These studies verify the capacity of human skin to metabolise RA even though sub-
stantial differences exist in CYP expression between normal skin and 3D skin models com-
pared to monolayer cultures. Complex metabolic processes that maintain retinoid homeosta-
sis may therefore be better studied in model systems more closely resembling in vivo skin. In
light of our prior studies documenting the functional activity of RA metabolites, expression of
CYP26 in the sebaceous gland epithelium supports the suggestion that retinoic acid meta-
bolic pathways are relevant to the pathogenesis and treatment of acne.
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Topical application of neuronal nitric oxide synthase inhibitor accelerate cutaneous barrier
recovery and prevent epidermal hyperplasia induced by barrier disruption
K Ikeyama, S Fuziwara and M Denda Shiseido Co., Ltd., Yokohama, Japan
Nitric oxide (NO) acts as a key mediator in normal homeostasis as well as in pathologic
states. The effects of NO on skin barrier recovery rate were evaluated in hairless mouse. Top-
ical application of NOS inhibitor and nNOS inhibitor accelerated the barrier recovery after
tape stripping while application of iNOS inhibitor did not affect the barrier recovery rate. Top-
ical application of NO donor S-nitroso-N-acetyl-D, L-penicillamine (SNAP) delayed the bar-
rier recovery rate. Topical application of guanylyl cyclase (GC) inhibitors accelerated the bar-
rier recovery, while GC activator delayed the barrier recovery. In cultured keratinocytes,
SNAP increased the intracellular calcium concentration ([Ca2+]i) by single-cell image analy-
sis employing FURA-2/AM and the increase was blocked by 1H-[1,2,4]oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ), NO sensitive GC inhibitor. Topical application of both nNOS
inhibitor and NO sensitive GC inhibitor also reduced the epidermal hyperplasia induced by
barrier disruption under low environmental humidity. These results suggest that NO plays an
important role as a signal of cutaneous barrier homeostasis and epidermal hyperplasia induced
by barrier disruption.
336
Withdrawn
56 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
337
Monitoring of CpG oligodeoxynucleotide (ODN) uptake in cultured HaCaT keratinocytes
and in a full-thickness skin model
A Dorn,1,2 A Bock,2 R Graf,2 N Zoeller,1,2 A Bernd,1 J Bereiter-Hahn,3 R Kaufmann1 and
S Kippenberger1 1 Department of Dermatology and Venerology, University Hospital
Frankfurt / Main, Frankfurt / Main, Germany, 2 Phenion GmbH & Co.KG, Frankfurt / Main,
Germany and 3 Kinematic Cell Research Group, J. W. Goethe-University, Frankfurt / Main,
Germany
In immune cells, CpG-ODN are intensively studied as bioactive molecules. They are taken
up via endocytosis and accumulate in the endosome where they bind to the Toll-like recep-
tor 9 (TLR-9) which leads to a signalling cascade evoking immune stimulation. The expres-
sion of TLR-9 in epidermal keratinocytes was shown recently, suggesting a relevance of CpG-
ODN in epithelial cells. In the present study we used confocal laser scanning microscopy for
uptake- and trafficking-studies of fluorescence labelled CpG-ODN of different lengths in
HaCaT cells. We demonstrated that after a few minutes two CpG-ODN, a 20-mer and a 6-
mer, enter HaCaT cells forming a corona-like structure close to the cell membrane. The 20-
mer was detected in perinuclear aggregates after 30 minutes, whereas the 6-mer accumu-
lated in the nucleus. Immunohistochemistry was used for uptake-studies in a full-thickness
skin model (Phenion® FT skin model) after topical application. This skin model comprises
stratified keratinocyte layers grown on a fibroblast containing matrix. After topical applica-
tion of CpG-ODN on top of the Phenion® FT skin model, the majority of fluorescence was
detected within the stratum corneum. Nevertheless, after 4 hours a considerable amount of
the 6-mer approximated to the stratum basale. In this experimental set-up the 20-mer accu-
mulated in more superficial skin layers. In conclusion our findings show that CpG-ODN of
different lengths are able to enter epithelial cells. The different subcellular distribution of both
CpG-ODN suggests different biological activity. Experiments using the Phenion® FT skin
model showed that after topical application a delivery of CpG-ODN is possible and particu-
larly short molecules are able to reach the proliferative cell layer. These findings suggest
CpG-ODN as pharmacological active molecules also in skin keratinocytes.
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Vibrational microspectroscopy and imaging of molecular composition and structure during
human corneocyte maturation
DJ Moore,1 G Zhang,2 R Mendelsohn2 and CR Flach2 1 R&D, ISP, Wayne, NJ and 2
Chemistry, Rutgers University, Newark, NJ
The outermost region of the epidermis, the stratum corneum (SC), provides an essential bar-
rier to water loss and protects against exogenous substances. The functional integrity of the
SC depends on a complex maturation and exfoliation process, which is often perturbed in
skin diseases and when the skin is damaged by environmental stresses. The current study
describes the development of new biophysical measurements that provide insights into the
structural and compositional changes accompanying SC, and particularly corneocyte, matu-
ration. Infrared (IR) spectroscopic imaging and Raman microscopy were employed to evalu-
ate the molecular changes occurring with the maturation of corneocytes isolated from differ-
ent depths in healthy human SC. The quality of spectra from both the IR and Raman
measurements of individual corneocytes was high and revealed depth dependent variations
in molecular composition. Spectral changes were identified as arising from alterations in the
concentration of the major constituents of natural moisturizing factor (NMF), important in
maintaining SC hydration. A significant decrease in the concentration of NMF was observed
for corneocytes isolated from superficial compared to deeper SC layers (layer 3 vs. layer 11,
respectively). In conclusion, a generally applicable IR parameter that measures the relative
NMF concentration in isolated corneocytes was developed and is introduced in this presen-
tation. Furthermore, the potential biomedical applications of vibrational imaging in evaluat-
ing corneocyte composition and molecular structure in the treatment of NMF-related diseases
are discussed.
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Chronic oxazolone-induced allergic contact dermatitis in hairless mice: similarities to atopic
dermatitis and response to acidification and occlusion
M Man,1 Y Shi,4 J Hachem,2 KR Feingold3 and PM Elias1 1 Dermatology, VAMC/UCSF, San
Francisco, CA, 2 Dermatology, Vrije Universiteit, Brussels, Belgium, 3 Metabolism,
VAMC/UCSF, San Francisco, CA and 4 Dalian Skin Disease Hospital, Liaoning, China
Topical sensitization with oxazolone, followed by a single challenge, produces an inflam-
matory dermatosis analogous to acute allergic contact dermatitis (ACD). In contrast, sensiti-
zation of mice with another sensitizer, DNCB, followed by repeated challenges, produces an
atopic dermatitis (AD)-like dermatosis. Repeated applications of oxazolone to hairless mice
(OxzMice), as with repeated DNCB, result in abnormal basal barrier function, delayed bar-
rier recovery kinetics, increased surface pH, decreased stratum corneum (SC) hydration, and
an inflammatory infiltrate with features similar to human AD. The basis for the epidermal func-
tional abnormalities, which mimic AD, include: epidermal hyperplasia, abnormal epidermal
differentiation, decreased epidermal lipid (ceramide) synthesis, and aberrant lamellar body
secretion. Based upon the hypothesis that the epidermal functional abnormalities could drive
the clinical inflammatory phenotype, we next assessed whether either non-specific barrier
restoration with petrolatum, or reversal of the surface pH abnormality with polyhydroxyl (PHA)
‘superacids,’ would normalize epidermal function, and also decrease epidermal hyperplasia,
differentiation and inflammation. Both petrolatum and PHAs largely reversed all of the above
abnormalities, including a reduction in inflammation. Thus, OxzMice 1) straddle the bound-
ary of chronic ACD and AD; 2) further demonstrate the importance of ‘outside-inside’ dynam-
ics in the pathogenesis of inflammatory dermatoses; and 3) provide a disease analogue that
could be used to screen barrier-related therapies.
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Biological variation in stratum corneum protease activities in normal skin
R Voegeli,1 AV Rawlings,2 S Doppler1 and T Schreier1 1 Pentapharm Ltd., Basel, Switzerland
and 2 AVR Consulting Ltd., Northwich, United Kingdom
The distribution of key serine protease activities (urokinase, plasmin, kallikrein 5, kallikrein
7, tryptase) in different layers of the stratum corneum (SC) on different body sites was investi-
gated in clinically normal subjects. Consecutive tape stripping (D-Squame) on the ventral fore-
arm and on the cheek of ten healthy Caucasian subjects was performed. The protein content
of the tape strippings was quantified by absorption measurements with the novel IR densito-
meter SquameScan 850A and the enzyme activities by use of fluorogenic peptide substrates.
The mean plasmin-like activity on the first nine strippings was seven times higher on the
cheek than on the forearm (1.4 vs. 0.2 nU/µg protein/tape). The corresponding urokinase-like
activity was 12 times (0.61 vs. 0.05 nU/µg protein/tape), the tryptase-like activity 15 times
(1.56 vs. 0.11 nU/µg protein/tape), the kallikrein 5-like activity four times (1.57 vs. 0.37 nU/µg
protein/tape) and the kallikrein 7-like activity twice (0.42 vs. 0.21 nU/µg protein/tape) higher
on the cheek. Distinct protease gradients were found on the forearm with highest activity in
the outermost layers of the SC. The cheek showed less pronounced activity gradients. It can
be concluded that: (i) in normal healthy skin the outer SC exhibits more serine protease activ-
ity compared with its deeper layers, (ii) protected skin areas show less protease activities than
skin areas that are exposed to the environment possibly indicating sub-clinical inflammation
on these body sites, (iii) compared with the forearm urokinase-like and plasmin-like activities
were elevated on SC strippings from the cheek confirming activation of the plasminogen cas-
cade and (iv) tryptase-like activity in the SC is also elevated in samples from the cheek possi-
bly indicating involvement of mast cells in these barrier compromised body sites. Although
elevation of the activities of urokinase, plasmin, kallikrein 5, kallikrein 7 and now tryptase
were observed on clinically normal cheeks we anticipate even higher activities in skin con-
ditions where the epidermal barrier is impaired.
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Differential proteomic analysis of human skin keratinocytes before and after UVB radiation
B Chen,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial Hospital, Nanjing, China and 2 Providence
College, Providence, RI
Human skin epidermis bears the majority of photo-damage with a result of skin thinning, wrin-
kling, keratosis, and malignancy. To identify the proteomic change of human skin keratinocytes
induced by UVB radiation, and to elucidate the molecular mechanism of reconstruction of
keratinocytes after UVB radiation, protein samples were extracted from keratinocytes (HaCaT)
irradiated with UVB at the dose of 10 mJ/cm2 and were separated by immobilized pH gradi-
ent two-dimensional (2-D) gel electrophoresis. After Coomassie blue staining, the 2-D elec-
trophoretogram was analyzed using Imaging Master 2D analysis Software. The differential pro-
teins were cut off from the Coomassie-blue stained gel and digested in gel with trypsin, and
then identified by peptide mass fingerprinting based on MALDI-TOF-MS and database search-
ing. Our results show that: (1) average protein spots were 582±31, 595±28 in HaCaT cells
before and after UVB radiation respectively, the matched spots were 483 ±29, 491±27 respec-
tively, and the average matching rate was 82.9%, 82.5% respectively; (2) a total of 433±25
protein spots were matched between the electrophoretic maps of HaCaT cells before and after
UVB radiation. 44 differential protein spots were identified. 5 protein spots were expressed
only in the cells before UVB radiation and 15 protein spots were expressed after UVB radia-
tion. The expression levels of 15 protein spots after UVB radiation were higher than those
before UVB radiation, and the expression levels of 9 protein spots in HaCaT cells after UVB
radiation were lower than those before UVB radiation; (3) parts of differential spots were cut
off from the Coomassie blue stained gel, and 21 spots were preliminarily identified. These pro-
teins are associated with stress response, cytoskeleton, apoptosis, growth inhibition, the main-
tenance of structural integrity, translational control, energy metabolism, the scavenging of
free radicals and protein synthesis and degradation.
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Hyaluronan-CD44 interaction stimulates keratinocyte differentiation,lamellar body forma-
tion, secretion and permeability barrier homeostasis
LY Bourguignon,1 M Ramez,1 E Gilad,1 P Singleton,1 M Man,2 D Crumrine,2 P Elias2 and
K Feingold1,2 1 Medicine, University of California-San Francisco and VA Medical Center, San
Francisco, CA and 2 Dermatology, University of California-San Francisco and VA Medical
Center, San Francisco, CA
In this study we investigated whether hyaluronan (HA)-CD44 interaction influences epider-
mal structure and function. Our data show that CD44 deficiency is accompanied by reduc-
tion in HA staining in CD44 knock out (k/o) mouse skin leading to a marked thinning of epi-
dermis vs. wild-type mouse skin. A significant delay in the early barrier recovery (following
acute barrier disruption) occurs in CD44 k/o vs. wild-type mouse skin. To assess the basis for
these alterations in CD44 k/o mouse epidermis, we determined that differentiation markers
are greatly reduced in the epidermis of CD44 k/o vs. wild-type mice, while conversely HA
binding to CD44 triggers differentiation in cultured human keratinocytes. CD44 downregula-
tion (using CD44siRNA) also inhibits HA-mediated keratinocyte differentiation. Slower bar-
rier recovery in CD44 k/o mice could be further attributed to reduced lamellar body (LB) for-
mation, loss of apical polarization of LB secretion, and down-regulation of cholesterol synthesis.
Accordingly, HA-CD44 binding stimulates both LB formation and secretion. Together, these
observations demonstrate new roles for HA-CD44 interaction in regulating both epidermal
differentiation and lipid synthesis/secretion, which in turn influence permeability barrier home-
ostasis. HA-CD44 signaling could comprise a novel approach to treat skin disorders charac-
terized by abnormalities in differentiation, lipid synthesis, and/or barrier function.
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A modified and improved chromatin immunoprecipitation (ChIP) approach to identify in vivo
targets of ∆Np63 in epidermal Keratinocytes
S Sinha, B Birkaya, R Romano, K Ortt, P Nagarajan, K Smalley, B Shannon and Y Choi SUNY
at Buffalo, Buffalo, NY
p63 is a member of the p53 family of transcription factors that plays an important role in skin
epidermal development and differentiation. To date the panel of p63 target genes have been
derived primarily from the over-expression of p63 in non-keratinocyte cell lines that normally
do not express the protein. To better elucidate the biological role of p63 in regulating gene
expression in keratinocytes we performed in vivo chromatin immunoprecipitation (ChIP) exper-
iments to isolate p63-binding sites. For this purpose we developed polyclonal antibodies that
are highly specific for the ∆N isoform of p63 which is the most prevalent, if not the sole iso-
form of p63 expressed in keratinocytes. In addition, we included an extra step in the ChIP
procedure to enrich for p63 targets by screening the library of immunoprecipitated DNA for
its ability to bind recombinant GST-p63 in vitro. Cloning and sequencing of p63-ChIP-derived
DNA fragments from keratinocytes identified more than 50 novel and potential p63 target
loci that were located close to or embedded within known or predicted genes. Identity of these
target genes suggests that they may be involved in a myriad of cellular processes including
those of transcriptional regulation, cell adhesion, signaling and metabolism. We have con-
firmed the binding of ∆Np63 to several of these genomic loci by replicate ChIP assays and are
currently performing additional experiments to examine if and how ∆Np63 regulates the expres-
sion of the target genes through these novel regulatory elements. This unbiased genomic
approach has allowed us to uncover bona-fide targets of ∆Np63 and serves as the initial step
in further analysis of the transcriptional regulatory mechanisms that are governed by p63 in
skin epidermal keratinocytes.
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Inducing SIRT1, the human homologue to longevity gene Sir2, in human fibroblasts modu-
lates FOXO expression and increases cell viability
E Bauza, C Dal Farra and N Domloge Research Center, Vincience, Sophia Antipolis, France
Studies have shown that in nematodes, the role of Sir2 in increasing lifespan depends on the
presence of DAF-16, a member of the FOXO family of Forkhead transcription factors. Together
with the deacetylase SIRT1, FOXO3 has been revealed to play an important role in human
cell biology and in stress management. In its active state, FOXO is localized in the nuclei
where it preferentially induces pro-apoptotic genes, such as FasL and BIM. However, depend-
ing on the stress level and needs of the cell, FOXO activates antioxidant genes as well. As our
prior studies have demonstrated that SIRT1, the human homologue to Sir2, is expressed in
human skin cells, we were interested in studying SIRT1 and FOXO3 expression in the aging
process of skin cells. Using immunostaining and immunoblotting methods, in these studies,
we investigated the effect of SIRT1 induction on FOXO3 expression and cell viability in nor-
mal and in vitro aged human fibroblasts. Our data showed that inducing SIRT1 in young human
fibroblasts slightly increased cell viability, compared to control cells where SIRT1 was not
induced, while FOXO3 level remained similar to the control. This result correlated with SIRT1
level in cells, when treated with the selectively-inducing active ingredient. Interestingly, in in
vitro aged cells, SIRT1 induction correlated with a significant increase in cell viability and
FOXO3 expression. Interestingly, this increased expression of FOXO3 was predominantly cyto-
plasmic. Furthermore, this increase in FOXO3 was not accompanied by an increase in apop-
tosis (parallel studies). These findings confirm that this augmentation of FOXO3 expression is
modulated by its desacetylation by SIRT1 (which also increased). Taken together, these results
demonstrate the essential physiological role that SIRT1 plays, especially in cell aging and apop-
tosis. These findings highlight the interest of increasing SIRT1 expression in the skin, an activ-
ity that can be of great use in anti-aging skin care products.
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SIRT1 induction in human skin cells increases cell viability and decreases signs of senescence
C Dal Farra, E Bauza, T Marchand and N Domloge Research Center, Vincience, Sophia
Antipolis, France
The expression of SIRT1, the human homologue to yeast Sir2, has been linked to lifespan exten-
sion. Our prior studies have shown that SIRT1 is expressed in human skin keratinocytes and
fibroblasts, and is physiologically induced to prevent stress and aging. Hence, we were inter-
ested in studying the correlation between the expression of SIRT1, induced specifically in human
skin cells by an active ingredient, and the modulation of cell aging, by evaluating cell viabil-
ity and senescence. In vitro aged human keratinocytes and fibroblasts were used in this study.
Induced-SIRT1 expression level was evaluated by immunostaining and immunoblotting. Cell
viability studies were performed using the MTT method, and cell senescence studies were per-
formed using beta-galactosidase, a specific biomarker that is absent from quiescent and differ-
entiated cells. Our results revealed that when in vitro-aged cells (up to P16 for fibroblasts and
P6 for keratinocytes) were treated with the SIRT1-inducing active ingredient, for 24 h, they
exhibited a net increase in nuclear protein SIRT1 expression. This increase reached 73% in
immunoblotting studies. In parallel, MTT studies revealed an increase in cell viability in the
SIRT1-induced cells, compared to control cells where SIRT1 was not induced. Interestingly,
the expression of the senescent biomarker beta-galactosidase, was considerably diminished in
the SIRT1-induced cells. The aged SIRT1-induced cells exhibited a decrease in number of stained
cells and in staining intensity, compared to the control. These studies demonstrate that SIRT1
induction in aged human skin cells correlates with a decrease in the expression of a senescence
marker and with an extension of the lifespan of these cells. This method can thus be of great
use in anti-aging skin research and in the development of skin care products.
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Effect of liposome on permeability and drug retention of sodium fluorescein in human skin:
an experimental study
J Zhu,1 D Luo,1 X Lin,1 Q Ma,2 Y Kuang2 and X Zhang1 1 Department of Dermatology, the
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China and
2 Department of Chemistry, Southeast University, Nanjing, China
Liposome is a new escipient. In order to investigate the effect of liposome on the permeabil-
ity and drug distribution of water-soluble drug in human skin, we determined a percutaneous
experiment. With an improved Franz diffusion cell and 0.125%sodium fluorescein (NaFl) lipo-
some suspension as the water-soluble model drug, the distribution of fluorescence in human
skin was observed under fluorescence microscope at 4,8 and 12h respectively after the diffu-
sion experiment had started. NaFl solution and NaFl emulsion of the same concentration as
the model drugs served as the control for this experiment. The NaFl content in the different
lays of the skin were detected by spectrofluorimetry at different intervals. In comparison with
NaFl solution and NaFl emulsion, liposome NaFl suspension resulted in largest amount of
NaFl retention in human epidermis but smallest amount in human dermis and the receiver
cell, with also highest fluorescence intensity in human epidermis and lowest fluorescence
intensity in the dermis. It is suggested liposome can increase the water-soluble drug concen-
trations in epidermis and decrease the drug concentrations in dermis. It is good for more
effective treatment of epidermis diseases.
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Characterization of desmoglein 1 and 3 hydrolysis by skin kallikrein proteases hK5 (SCTE)
and hK7 (SCCE).
NM Schechter, E Choi, C Lin, Y Hanakawa and JR Stanley Department of Dermatology,
University of Pennsylvania, Philadelphia, PA
The hydrolysis of desmoglein 1 (Dsg1) by staphloccocal exfoliative toxin has shown that pro-
teolytic cleavage of a single adhesion protein can produce disease. Recent studies suggest
that degradation of Dsg1 by serine proteases hK5 (stratum corneum tryptic protease) and/or
hK7 (stratum corneum chymotryptic protease) may contribute to the pathology of Netherton
Syndrome. To understand more fully the susceptibility of Dsgs to endogenous skin proteases,
we examined the ability of hK5 and hK7 to hydrolyze recombinant Dsg1 and 3 extracellular
domains (Dsg-ED), and Dsg1 and 3 on cultured keratinocytes. Hydrolysis was detected by
Western blotting using anti-Dsg1 or 3 antibodies, or an anti-Etag antibody, which detects the
presence of an Etag label on the C-terminus of Dsg-EDs. Incubation of Dsg1- or 3-EDs with
high concentrations (0.1-1.0 µM) of hK5 or hK7 at pH 8.0 produced only limited cleavage
after 60 min, except for Dsg3 by hK7.  Extensive degradation of Dsg1- and 3- EDs by both
hK5 and hK7 was observed after treatment with EDTA, which alters Dsg conformation by
removal of bound Ca2+. Lowering the pH to 5.0 in incubations, which would partially proto-
nate Asp/Glu residues involved in Ca2+ binding, made Dsg1-ED more susceptible to cleavage
by hK7. Interestingly both Dsg1 and Dsg3 expressed on cultured keratinocytes at neutral pH
appeared markedly more sensitive to hydrolysis by both hK5 and hK7 as treatment for 30 min
with only 0.1 µM protease degraded each Dsg. The results indicate that the susceptibility of
Dsg1, at least to hK7, may increase in the low pH environment of the stratum corneum, and
that both Dsg1 and Dsg3 in desmosomal structures may be more susceptible to proteolysis
than their extracellular domains in solution.
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Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syn-
drome-type B patients suggests an over-desquamation of corneocytes
N Komatsu,1,3 Y Suga,5 K Saijoh,4 AC Liu,1 S Khan,1 Y Mizuno,5 S Ikeda,5 A Jayakumar,6
GL Clayman,6 F Shirasaki,3 K Takehara3 and EP Diamandis1,2 1 Pathology & Laboratory
Medicine, Mt. Sinai Hospital, Toronto, ON, Canada, 2 Laboratory Medicine & Pathobiology,
University of Toronto, Toronto, ON, Canada, 3 Dermatology, Kanazawa University,
Kanazawa, Japan, 4 Hygiene, Kanazawa University, Kanazawa, Japan, 5 Dermatology,
Juntendo University, Tokyo, Japan and 6 Head & Neck Surgery, University of Texas M. D.
Anderson Cancer Certer, Houston, TX
Peeling skin syndrome type B (PSS-type B) is a congenital skin disease associated with continual
skin peeling and ichthyotic erythroderma, known to display various clinical similarities with Nether-
ton syndrome (caused by genetic defects of SPINK5). Human tissue kallikreins are a family of 15
trypsin-like or chymotrypsin-like secreted serine proteases (hK1-hK15) found in a variety of tissues.
At least 8 different hKs have been identified in the stratum corneum (SC) as desquamation-related
proteases. The pathogenesis of PSS-type B, the relationship between its clinical features and hK
expression, and the reasons for its similarities with Netherton syndrome are unknown. Here, we
describe the clinical features of two PSS-type B patients from two unrelated Japanese families, who
displayed intact SPINK5, a detachment of the SC directly above the stratum granulosum or pos-
sessed a few layers of parakeratosis, and showed increased number of epidermal cell layers that
express hK6, hK8, hK13 and SPINK5 protein in the skin. The patients also showed significantly
high levels of multiple kallikreins in both the SC and serum and elevations of the SC protease activ-
ities.  We propose a hypothetical model for the pathogenesis of PSS-type B involving over-expres-
sion of multiple kallikreins and elevation of SC protease activities, leading to over-desquamation
of corneocytes. The clinical similarities between PSS-type B and Netherton syndrome might be
explained by a common manifestation, the over-desquamation of corneocytes. We conclude that
PSS-type B is another over-desquamation disease, in addition to Netherton syndrome.
58 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
349
Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Cha-
narin-Dorfman syndrome)
M Demerjian,1 D Crumrine,1 L Milstone,2 ML Williams1,3 and PM Elias1 1 Dermatology,
University of California San Francisco and VAMC, San Francisco, CA, 2 Dermatology, Yale
University School of Medicine, New Haven, CT and 3 Pediatrics, University of California San
Francisco, San Francisco, CA
Neutral lipid storage disease (NLSDI; Chanarin-Dorfman syndrome) is an ichthyosiform syn-
drome attributed to mutations in a thioesterase, CGI-58. The presence of oil red O-positive,
neutral lipid droplets in tissue biopsies, and/or the presence of these droplets in leukocytes
on blood smears, coupled with a constellation of multisystem abnormalities, including an
ichthyosiform erythroderma, are together diagnostic of NLSDI. Atopy and pruritus are also
commonly present in NLSDI. We investigated the pathogenesis of the ichthyosiform erythro-
derma in patients from 3 unrelated kindreds with NLSDI. Basal permeability barrier function
and stratum corneum (SC) integrity were abnormal, but less pronounced in lichenified sites,
and barrier recovery rates were faster than normal, as in atopic dermatitis. The basal barrier
abnormality was linked to the secretion of lipid microinclusions within lamellar bodies (LB),
which then form a non-lamellar phase within the SC interstices, shown by combined ruthe-
nium tetroxide post-fixation and LR-white (lipid-retaining) embedding. With colloidal lan-
thanum nitrate perfusion, excess water/solute movement was restricted to the SC interstices,
and could be further localized to non-lamellar domains. Thus, segregation of stored neutral
lipids within LB, followed by secretion into the SC interstices, where the stored lipids form a
non-lamellar phase, underlies the permeability barrier abnormality in NLSDI. Analogous phase
separation of excess stored lipid provides a unifying pathogenic mechanism in several other
inherited disorders of lipid metabolism, and explains the barrier abnormalities in recessive x-
linked ichthyosis and in type 2 Gaucher’s disease.
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β2-adrenergic receptor blockade accelerates burn wound healing
RK Sivamani,1 CE Pullar,1 B Griffths,1 BS Baier,1 DG Greenhalgh2 and RR Isseroff1 1
Dermatology, University of California, Davis, Davis, CA and 2 Burn and Plastic Surgery,
Shriners Hospital, Sacramento, CA
The directed migration of keratinocytes is an essential step in burn wound re-epithelializa-
tion. In previous work, we demonstrated that activation of the β2-adrenergic receptor (β2-
AR) inhibited keratinocyte migration and delayed incisional wound healing. Since burn
wounded patients have elevated levels of circulating β2-AR activator epinephrine (EPI), we
asked whether blockade of β2-ARs increases keratinocyte migration and has the potential to
accelerate burn wound re-epithelialization. When cultured human keratinocytes were incu-
bated with EPI at levels equivalent to those measured post-burn (10 nM), their migratory speed
decreased by 75%, and the addition of the β2-AR blocker timolol (TIM, 10 µM) restored the
migratory speed to control levels. When confluent cultures of human keratinocytes were scratch
wounded, EPI pretreatment reduced healing by 70% and the addition of TIM reversed the
effects of EPI and accelerated healing by 20%. Western blot analysis of scratch wounded
confluent keratinocyte cultures showed downregulation of the β2-AR one hour after the scratch,
and addition of TIM delayed this β2-AR downregulation. Finally, we developed an ex vivo
model of burn wound healing by applying a heated brass rod to excised human skin. At day
ten after the burn, re-epithelialization was delayed 14% when treated with β2-AR activator
isoproterenol (10 µM), and was conversely enhanced 37% when treated with TIM. We have
demonstrated that the burn wound adrenergic environment significantly decreased keratinocyte
migration and delayed burn wound re-epithelialization. Furthermore, the addition of the β2-
AR blocker TIM significantly enhanced keratinocyte migration and accelerated burn wound
re-epithelialization. Our western blots suggest that keratinocytes respond to wounding by
releasing local factors, like epinephrine, that are capable of binding and downregulating the
β2-AR. Since burn patients have upregulation of epinephrine, pharmacologic modification of
β2-ARs could affect burn healing and outcomes.
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Influence of Chitosan on wound healing is dependent on concentration and molecular weight
and involves changes in the expression of connexin 43
JM Brandner,1 P Houdek,1 C Scholz2 and I Moll1 1 Department of Dermatology and
Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany and 2 Cognis
Deutschland GmbH und Co KG., Duesseldorf, Germany
Chitosan, which is derived by deacetylation of Chitin, is one of the few natural cationic poly-
mers. The various Chitosan types differ in their origin, degree of deacetylation, molecular weight
and solubility. As reports concerning the ability of Chitosan to improve wound healing (WH)
are contradictory, we investigated whether the influence of Chitosan on WH is dependent on
concentration and/or molecular weight. Moreover, we were interested in putative mechanisms
of Chitosan effects. We investigated three Chitosan types of the same origin (Pandalus Borealis)
which only differ in their molecular weights (Chitopharm L, Chitopharm S, and Oligochitosan)
by using an established porcine wound healing model. The objective was to determine the
influence on WH in general, as well as on proliferation, apoptosis, and direct cell-cell commu-
nication. As interactions of Chitosan and tight junctions (TJ) were reported we also investigated
the distribution of TJ proteins. We observed that all investigated Chitosan types inhibited WH at
higher concentrations (1%, 0.1%) while the high molecular weight Chitosan was able to pro-
mote WH significantly at lower concentrations. The acceleration of WH was accompanied by
an increase of proliferative cells at the wound margins and in the regenerating epidermis. The
inhibition of WH at higher concentrations was accompanied by a decrease of proliferative cells
and by a repression of down regulation of connexin 43 at the wound margins and therefore an
altered direct cell-cell communication during initial WH. Changes in the distribution of TJ pro-
teins were mainly negligible. The results show clearly that the type as well as the concentration
of Chitosan determine its influence on WH. The elucidation of signal transduction pathways
involved in alteration of the number of proliferative cells and in changes of connexin expres-
sion and their putative interdependencies will contribute to our knowledge of WH in future.
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Psoriatic animal model validation index
BJ Nickoloff Pathology, Loyola, Maywood, IL
Recognizing that no model perfectly reflects all complexities of psoriasis, animal models do
allow study of specific pathways in a reproducible setting. Investigators have probed geneti-
cally engineered rodents and used xenograft transplantation models creating lesions to under-
stand psoriasis, and serve as a platform for discovery of new treatments. If models are inter-
preted inappropriately, progress in understanding mechanisms of disease and core pathogenic
pathways could be hampered. Patients may be unnecessarily exposed to drugs whose theo-
retical basis for testing was imperfect. To fill the void that exists regarding objective criteria for
models, a quantitative assessment tool for evaluating strengths/weaknesses of animal-based
studies of psoriasis is presented. As models bearing likeness to psoriasis are emerging from
many laboratories, it is crucial that rigorous comparisons be made using a scoring system that
is both practical and reproducible. This proposed validation index is designed with a maxi-
mum number of points tallying 100, weighted as follows: Clinical – well-demarcated plaques=4;
lesions provoked by trauma=4; arthritis=3; nail lesions=3; no alopecia=2; Auspitz sign=2; no
lesional skin cancer=2. Histological – parakeratosis=4; no granular cells=3; interfollicular
thickening=3; rete ridge elongation=3; prominent dermal vascularity=3; Munros abscess=2;
mast cells=1; absence of eosinophils=1. Immunophenotypic – loss of loricrin=4; keratin 16=3;
CD1d on keratinocytes (KCs)=3; increase in dendritic cells=3; increase in macrophages=3;
ICAM-1 by KCs=2; memory T cells=2. Biochemical – increased Ki67 proliferation=5; increased
TGFα=4; nuclear phospho STAT3=4; increased VEGF=1. Pharmacological – skin lesions
improve with Cyclosporin A=4; methotrexate=4; TNFα inhibitor=4; antibiotic=3; Vitamin D=2;
steroid=3. Genetic – gene targeted matched to PSORS 1-6 loci (1 point/locus match)=6.
Using this scorecard, the STAT3c transgenic model rates 57 points and the SCID-Hu xenograft
model rates 70 points. Further models require evaluation and investigators should create an
international consortium to further modify, validate, and reach consensus for a quantitative
evaluation tool.
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Activators of nuclear hormone ‘liposensor’ receptors reverse the adverse epidermal effects
of exogenous glucocorticoids
M Demerjian,1 K Aberg,1 E Choi,1 PM Elias1 and KR Feingold1,2 1 Department of
Dermatology, UCSF and VA Medical Center, San Francisco, CA and 2 Department of
Medicine (Metabolism), UCSF and VA Medical Center, San Francisco, CA
While glucocorticoids (GC) are known to exert beneficial effects (anti-inflammation), they also
have adverse cutaneous effects, such as decreased epidermal differentiation, decreased ker-
atinocyte proliferation, and decreased cutaneous barrier function. Thus, the purpose of this
study was to develop strategies to prevent these toxicities using simultaneous topical treat-
ments in clobetasol-treated mice and humans. First, we assessed the effects of a triple-lipid
mixture of stratum-corneum (SC) lipids (ceramide, free fatty acid, and cholesterol). This mix-
ture reversed the super-potent GC-induced abnormality in cutaneous barrier function in humans,
as previously shown in mice (Kao, et al. JID 116:443-451, 2003), but the lipids alone did not
reverse the GC-induced abnormalities in either keratinocyte proliferation or differentiation in
mice. Since activators of certain nuclear hormone receptors, such as PPARα, β/δ, γ, and LXRα/β,
regulate keratinocyte proliferation and differentiation in mouse skin, we next assessed the
effects of these activators on keratinocyte proliferation and differentiation during GC treat-
ment. Co-application of either ciglitazone (PPAR γ activator), clofibrate (PPARα ligand) or
22R(OH) cholesterol (LXR activator) with clobetasol normalized the expression of the ker-
atinocyte differentiation markers, involucrin, filaggrin and loricrin. In contrast, PPAR β/δ did
not affect the expression of these markers. In addition, topical application of PPARα, β/δ, or
LXR activators normalized keratinocyte proliferation in GC-treated murine skin, as measured
by PCNA. In contrast, no effect on proliferation was seen after ciglitazone co-treatment. Together,
these studies suggest that naturally-occurring PPAR and LXR activators, together with triple-
component, barrier lipids, can reverse important adverse effects of super-potent topical GC
on the epidermis.
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Psychological stress inhibits epidermal antimicrobial peptide production in a glucocorticoid-
dependent fashion
K Aberg,1 RL Gallo,3 TM Mauro,1 KR Feingold2 and PM Elias1 1 Dermatology, VAMC/UCSF,
San Francisco, CA, 2 Metabolism, VAMC/UCSF, San Francisco, CA and 3 Dermatology, UC
San Diego, San Diego, CA
The adverse effects of psychological stress (PS) on epidermal structure and function can be
attributed largely to increased levels of glucocorticoids (GC), and systemic/topical GC mimic
the effects of PS. PS/GC’s negative effects were further linked to profound inhibition of both
epidermal lipid synthesis and lamellar body (LB) production/secretion. Since delivery of pro-
teins to nascent LB is dependent upon concurrent lipid deposition, we hypothesized that PS/GC
could also inhibit the delivery of two LB-delivered, antimicrobial peptides (AMP), mBD3
(murine homologue of hBD2) and LL-37 (carboxyterminal peptide product of CRAMP [murine
homologue of hCAP18]), thereby reducing antimicrobial defense during PS/GC. Insomnia-
induced PS and both systemic/topical GC down-regulated epidermal mBD3 and LL-37 expres-
sion in hairless mice (shown by rt-PCR and immunoflorescence) in parallel with reduced LB
production, epidermal lipid synthesis, and impaired permeability barrier recovery after acute
abrogations. Blockade of either GC production (by the CRH inhibitor, antalarmin) or GC periph-
eral action (by Ru486) normalized AMP levels during PS. Blockade of endogenous GC also
increased expression of these peptides in normal murine epidermis, suggesting that physio-
logic levels of GC suppress AMP. Finally, topical co-administration of a triple-lipid mixture of
barrier lipids, which normalizes LB production and barrier function during PS/GC, also nor-
malized epidermal AMP expression. Together, these results 1) provide a mechanistic basis for
the adverse effects of PS/GC on cutaneous antimicrobial defense; 2) could explain the low,
constitutive expression of these AMPs in normal epidermis; and 3) suggest that appropriate
topical lipid formulations could normalize epidermal AMP levels during PS/GC.
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Interdependence and co-regulation of the epidermal permeability and antimicrobial barri-
ers
K Aberg,1 E Choi,2 RL Gallo,3 TM Mauro,1 KR Feingold4 and PM Elias1 1 Dermatology,
VAMC/UCSF, San Francisco, CA, 2 Dermatology, Yonsei University, Wonju, South Korea, 3
Dermatology, UC San Diego, San Diego, CA and 4 Metabolism, VAMC/UCSF, San Francisco,
CA
Two unrelated antimicrobial peptides (AMP); i.e., human β defensin 2 (hBD2) and the car-
boxypeptide cleavage product of hCAP18, LL-37, are packaged in epidermal lamellar bodies
(LB) and co-secreted with barrier lipids and other proteins at the stratum granulosum-stratum
corneum (SC) interface. Since our prior studies showed that delivery of enzyme proteins requires
prior/concurrent deposition of lipids in nascent LB organelles, we hypothesized that AMP
production/secretion could be co-regulated by permeability barrier requirements. Acute per-
meability barrier disruption, TEWL levels ≥ 5 mg/cm2/hr, achieved by either acetone wipes or
repeated tape strippings, removed not only stainable lipids, but also both mBD3 (murine homo-
logue of hBD2) and LL-37 (from CRAMP, the murine homologue of hCAP18) from the SC of
hairless mice, shown by immunohistochemistry. Barrier lipids and AMP returned to pre-treated
levels in parallel, and blockade of permeability barrier recovery and lipid deposition by appli-
cation of a vapor-impermeable wrap also prevented restoration of AMP to normal in murine
SC. If lipid delivery to nascent LB requires concurrent/prior protein deposition, we hypothe-
sized conversely that reduction of LB-deposited AMP could alter lipid deposition, and hence
permeability barrier homeostasis. Indeed, transgenic CRAMP knockout mice displayed delayed
barrier recovery kinetics after acute insults, attributable to aberrant LB contents and incom-
plete lamellar membrane formation. These studies demonstrate: 1) the co-regulation of the per-
meability and antimicrobial barriers in response to barrier insults; and 2) the importance of
AMP for the generation of lipid-replete LB and permeability barrier homeostasis.
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The profilaggrin N-terminus forms homodimers, and heterodimers with annexin II and strat-
ifin (14-3-3 sigma)
OT Lawrence,1 JA Huard,1 S Sea1 and R Presland1,2 1 Oral Biology, University of Washington,
Seattle, WA and 2 Medicine (Dermatology), University of Washington, Seattle, WA
Profilaggrin is a high molecular weight phosphoprotein that is expressed in the granular layer
of epidermis and other keratinizing epithelia. It consists of two distinct domains, an N-termi-
nal domain that includes an S100-like calcium-binding domain, and multiple filaggrin domains.
During keratinocyte differentiation, it is proteolytically processed to generate filaggrin, a
cytoplasmic, keratin-associated protein, and the N-terminal domain, which localizes to both
the nucleus and cytoplasm of terminally differentiating keratinocytes. Since S100 proteins func-
tion by binding to, and regulating the function of, target proteins in a calcium-dependent man-
ner, we examined the protein-protein interactions of the profilaggrin N-terminus (PNT) using
immunoprecipitation, yeast two-hybrid assays (Y2H), and in vitro binding assays. The human
PNT (293 amino acids) forms homodimers in yeast, as measured by growth on histidine-minus
media. This interaction requires most of the B domain located downstream of the profilaggrin
S100 (A) domain. These results were confirmed by in vitro binding assays with recombinant
peptides. In addition to forming homodimers, the PNT associates with a number of other tar-
get proteins, including the cytoplasmic proteins annexin II and stratifin (14-3-3 sigma). Using
the Y2H assay, we localized the profilaggrin-annexin II association by deletion analysis to the
A domain of human profilaggrin and the N-terminal 14 amino acids of annexin II. This same
region of annexin II binds to two other S100 proteins, S100A4 and S100A10. Annexin II also
associates with the mouse profilaggrin A domain. Human stratifin binds to the N-terminal
domain of human profilaggrin, as measured by Y2H assay and immunoprecipitation. These
studies show that the PNT forms homodimers and binds to a number of other target proteins.
The functional significance of these interactions is currently under investigation.
357
The role of proline-rich protein tyrosine kinase 2 (Pyk2) in differentiation-dependent sig-
naling in normal human keratinocytes
EM Schindler, M Baumgartner and T Efimova Dermatology/Medicine, Washington University
School of Medicine, St. Louis, MO
A non-receptor tyrosine kinase Pyk2 has been shown to regulate a broad range of biological
responses in a number of cell types. However, the role of Pyk2 signaling in skin has not been
elucidated. Our previous studies show that Pyk2 is expressed in human keratinocytes and is
activated by keratinocyte differentiating agents TPA and calcium. Furthermore, our data reveal
a predominantly nuclear localization of Pyk2 protein in keratinocytes. We now investigate
the intracellular mechanisms by which Pyk2 is activated in keratinocytes during differentia-
tion, and examine the function of Pyk2 signaling in regulation of expression of a differentia-
tion marker involucrin. PKC and Src kinase inhibitors, and chelation of intracellular calcium,
inhibit TPA-induced activation of Pyk2. Immunofluorescence studies and cell fractionation
experiments show that the nuclear Pyk2 levels are not altered by treatment with TPA or cal-
cium for up to 24 or 48 h, respectively. Notably, activated phosphorylated Pyk2 is localized
prominently in the nucleus. Co-transfection of human involucrin promoter construct with
expression plasmid encoding wild type Pyk2 increases the involucrin promoter activity as
efficiently as TPA treatment. Synergistic promoter activation is observed when Pyk2-transfected
cells are treated with TPA. Pyk2-dependent promoter activation is inhibited by dominant-neg-
ative forms of MEKK1 and p38 MAPK. Treatment with PKC inhibitor blocks the TPA-induced,
but not the Pyk2-induced involucrin promoter activity. Taken together, these data argue that
Pyk2 acts downstream of PKC and upstream of MEKK1 and p38 MAPK to regulate involucrin
transcription. This regulation appears to be physiologically relevant, as adenovirus-mediated
Pyk2 expression in keratinocytes increases the endogenous involucrin protein levels. In sum-
mary, these studies extend our knowledge of the molecular mechanisms involved in control
of epidermal differentiation, and provide new insights into the roles of Pyk2 signaling in epi-
dermis.
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Galectin-3 is a positive regulator of keratinocyte migration
W Liu, DK Hsu, F Liu and RR Isseroff Dermatology, UC, Davis, Davis, CA
Keratinocyte migration is an essential step in skin wound re-epithelialization. Delay in the skin
wound healing process by defects in keratinocyte migration is a serious medical problem. We
have studied the role of galectin-3, a carbohydrate-binding protein, in keratinocyte migration.
Compared with wild-type keratinocytes, galectin-3-deficient (gal3 -/-) cells exhibited a reduced
migration speed in a single cell migration assay in vitro (0.87 µm/min vs 1.32µm/min). In addi-
tion, gal3 -/- cells healed scratch wounds in a cultured monolayer of cells more slowly than
wild-type (38% less) in the presence of mitomycin C to prevent proliferation. By immunoflurores-
cence staining, galectin-3 was found to be localized diffusely in the cytosol of stationery ker-
atinocytes, but was temporarily re-localized to the leading edge of the migratory cells 30 min-
utes after scratch wounding. Although high levels of exogenously added recombinant galectin-3
caused enhanced keratinocyte migration in a lactose inhibitable fashion, lactose alone did not
alter migration rate. The results suggest that extracellular galectin-3 does not contribute to
migration under normal conditions, but rather, intracellular galectin-3 does. Clarifying the role
of galectin-3 in keratinocyte migration should improve understanding of the migration process
of this cell type and help develop a novel drug for impaired skin wound healing.
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Multiple human tissue kallikreins are regulated by lympho-epithelial Kazal-type inhibitor and
digest desmoglein 1
CA Borgono,1,2 IP Michael,1,2 N Komatsu,1 G Sotiropoulou,3 A Jayakumar,4 H Wu,4
GL Clayman,4 SI Blaber,5 M Blaber,5 SD Mikolajczyk6 and EP Diamandis1,2 1 Pathology &
Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada, 2 University of Toronto,
Toronto, ON, Canada, 3 University of Patras, Patra, Greece, 4 University of Texas M.D.
Anderson Cancer Center, Houston, TX, 5 Florida State University, Tallahassee, FL and 6
Hybritech Incorporated, San Diego, CA
Multiple members of the human tissue kallikrein (hK) family, a group of 15 secreted serine proteases,
are present in the stratum corneum (SC). hK5 and hK7 are implicated in desquamation via proteoly-
sis of corneodesmosomes and their regulation by serine protease inhibitors detected in the SC, e.g.
lympho-epithelial Kazal-type inhibitor (LEKTI), secretory leukocyte peptidase inhibitor (SLPI) and elafin,
has been reported. However, the contribution of other hKs to desquamation and their regulation by
SC inhibitors is currently unknown. In this study we aimed to determine: 1) the interactions between
recombinant hK1, hK2, hK5, hK6, hK13 and hK14 and recombinant LEKTI [4 fragments containing
inhibitory domains 1-6 (rLEKTI1-6), 6-9 (rLEKTI6-9’), 9-12 (rLEKTI9-12) and 12-15 (rLEKT12-15)], SLPI
and elafin by kinetic inhibition assays and 2) digestion of recombinant desmoglein 1 (DSG1) by hKs.
rLEKTI1-6, 6-9’ and 9-12 inhibited the activity of all hKs, except hK1 and hK2, in a potent and non-
competitive manner. Ki values for rLEKTI1-6 inhibition of hK5, hK6, hK13 and hK14 ranged from 2.3-
28.4nM for rLEKTI1-6, 6.1-221nM for rLEKTI6-9’ and 2.7-416nM for rLEKTI9-12. Lower Ki values
(<11nM) were consistently observed for hK5 and hK14. rLEKTI12-15 exhibited relatively moderate
inhibition on hKs; no inhibition was observed by SLPI or elafin. Certain hKs could also process LEKTI
between domains 9 and 10. Apart from hK13, all hKs studied digested DSG1 within and between
extracellular DSG1 cadherin domains. Our findings indicate that multiple hKs, in addition to hK5
and hK7, may: 1) represent specific inhibitory targets of LEKTI, 2) be involved in processing of LEKTI
leading to activation and 3) contribute to desquamation via cleavage of DSG1.
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Cholesterol depletion augments the proapoptotic effect of death receptor ligands in squa-
mous cell carcinoma cells
S Hartmann-Petersen and R Gniadecki Dept of Dermatology, Bispebjerg Hospital,
Copenhagen NV, Denmark
Cholesterol is an important building block of cell membranes, and mediates formation of
submicroscopic domains called lipid rafts. Recent research has shown, that these rafts serve
as platforms for several transmembrane receptors, and are important in receptor-mediated
signaling events. We have previously shown that cholesterol depletion from cell membranes
activates the death receptor Fas and induces apoptosis in HaCaT keratinocytes. Tumor necro-
sis factor-related apoptosis-inducing ligand (TRAIL) is a death receptor ligand, shown to induce
apoptosis in cancer cells but not in normal cells. The SCC25 cells are derived from human
squamous cell carcinoma. They are known to express an inactive form for Fas, incapable to
induce apoptosis. We show here, that treatment of SCC25 cells with cholesterol depleting
agents (mevastatin, methyl-b-cyclodextrin) induces cell death, and activates the caspase-medi-
ated pathway. Furthermore, cholesterol depletion sensitizes SCC25 cells to TRAIL-mediated
apoptosis, even though TRAIL alone does not induce cell death in the conditions used. In
HaCaT cells a similar sensitization to FasL- and TRAIL-induced apoptosis is seen after cho-
lesterol depletion. Our results indicate, that altering lipid raft function by depleting cholesterol
from the cell membranes is a novel way of inducing cell death in transformed epidermal cells
via death receptors.
60 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
361
Changes in molecular weight and localization of epidermal hyaluronan following UVB irra-
diation
M Tobiishi,1 T Sayo,1 H Koishikawa,1 O Ishikawa2 and S Inoue1 1 Basic Research Laboratory,
Kanebo Cosmetics INC, Odawara, Japan and 2 Department of Dermatology, Gunma
University Graduate School of Medicine, Maebashi, Japan
Hyaluronan (HA) is known to play a role in keratinocyte proliferation and differentiation, and
have shown different biological activities depending on the molecular size. To investigate
changes in HA characteristics following ultraviolet (UVB) irradiation, hairless mice were irra-
diated with 0.2J/cm2 of UVB, after which the molecular weight and localization of HA in epi-
dermis samples were determined using a Sephacryl S-1000 and biotinylated HA-binding
protein staining, respectively. One day after UVB irradiation, when epidermal hyperplasia had
not yet developed, strong HA signals were detected in the basal layer and epidermal HA con-
tent, measured by a sandwich assay, was twice that in pre-irradiated epidermis, while the
molecular size of epidermal HA was more than 106 kDa in the Sephacryl S-1000 profile. Three
days after UVB irradiation, when epidermal hyperplasia and increased transepidermal water
loss (TEWL) were observed, HA signals were detected in the basal layer extending to just below
the granular layer. Furthermore, the HA content remained increased, while the average molec-
ular size become low. At 6 days after UVB irradiation, along with the recovery of TEWL, HA
signals were attenuated in the stratum spinosum and HA content recovered to the pre-irradi-
ated level, although the molecular size remained low. In addition, the co-localized expres-
sion of CD44 (HA-specific membrane receptor) and HA following UVB irradiation was con-
firmed using CD44/HA double staining. Our results for the first time demonstrated the drastic
changes in molecular size and localization of HA occur following UVB irradiation, and pro-
vide the evidence that low molecular HA is induced by UVB irradiation in mouse epidermis.
In a future study, we intend to investigate the associations of quality and quantity changes of
HA with UVB-induced hyper-proliferation and disruption of epidermal permeability barrier
function.
363
Effects of extracellular calcium level on functional tight junction formation in normal human
keratinocytes
T Yuki,1 A Haratake,1 H Koishikawa,1 K Morita,2 Y Miyachi2 and S Inoue1 1 Basic Research
Laboratory, Kanebo Cosmetics Inc., Odawara, Japan and 2 Department of Dermatology,
Kyoto University Graduate School of Medicine, Kyoto, Japan
In simple epithelia, components of the intercellular junctions known as tight junctions (TJ)
are considered to be responsible for the formation of the permeability barrier. Recent devel-
opments in molecular biology have revealed that TJ are located in the stratum granulosum
where they contribute to the barrier function of the epidermis. In this study, we examined the
effects of extracellular calcium (Ca2+) level on the in vitro development of TJ in normal human
keratinocytes (NHK). Confluent NHK were transferred to a medium containing either low
(0.1mM) or high (1.8mM) external Ca2+ concentrations. The permeability barrier function
assessed by transepithelial electric resistance and paracellular tracer flux was developed and
reached a maximum at 96 hours after transferring to the high Ca2+ medium, but did not develop
in the low Ca2+. In fact, under the high Ca2+ conditions, typical TJ structures interspersed
between desmosomes were confirmed by an electron microscopy. However, occludin and
claudin-1 proteins increased time-dependently in a Ca2+- independent manner. Immunoflu-
orescence analysis of occludin and claudin-1 revealed that NHK junction maturation scarcely
occurred in the low Ca2+ medium, and occludin and claudin-1 were detected in cell-cell con-
tact sites as dotted lines, although NHK in the high Ca2+ medium had fully-matured intercel-
lular junctions with aligned location of occludin and claudin-1 in a linear fashion. We deduced
that dysfunction of the permeability barrier in the low Ca2+ medium is due to the lack of mat-
uration of TJ components. Furthermore, TJ in stratified keratinocytes were shown to be expressed
in flattened suprabasal cells by a double immunolabeling method. Taken together, our results
indicate that NHK have the ability to produce TJ in flattened suprabasal cells and establish a
permeability barrier. Furthermore, assembly of TJ proteins into functional units is required for
effective permeability barrier development.
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Proteomic analysis of caspase-14 gene knock down in a human skin equivalent model
M Stichenwirth,1 M Mildner,1 L Eckhart1 and E Tschachler1,2 1 Department of Dermatology,
Medical University Vienna, Vienna, Austria and 2 Centre d’ Investigations Epidermiques et
Sensorielles (CE. R. I. E.S.), Neuilly, France
Caspase-14 is highly expressed in differentiated epidermal keratinocytes and is present in its
catalytically active form in the stratum corneum. Although these properties suggest a role of
caspase-14 in terminal differentiation of keratinocytes, the precise physiological function of
caspase-14 has not been clarified so far. To identify the substrate protein(s) and proteins reg-
ulated indirectly by caspase-14, we knocked down by specific RNA interference the caspase-
14 gene in human epidermal skin equivalent models and analyzed the proteome of these
skin models by 2D electrophoresis and LC-ESI-MS/MS. Primary human keratinocytes were
transfected with si-RNAs specific for caspase-14 and for unrelated control genes. The trans-
fected cells were cultured as the epidermal component of 3-dimensional skin equivalent mod-
els for 7 days. Western blot analysis showed that after transfection the expression of caspase-
14 was reduced by more than 95%. The caspase-14 knock down skin equivalents did not show
any gross morphological differences to control skin equivalents. However, 2D electrophore-
sis revealed that a series of proteins were missing or strongly reduced in abundance after cas-
pase-14 gene knock down. These proteins included caspase-14, which confirmed the valid-
ity of our analysis, and several distinct species of keratins. Our findings provide the basis for
the elucidation of the physiological role of caspase-14 in epidermal differentiation.
364
Epidermal regulation of AQP3 expression and hyaluronan synthesis (2); retinoic acid up-reg-
ulates AQP3 expression in cultured normal human keratinocytes and mouse epidermis
Y Sugiyama,1 K Yamazaki,1 A Kusaka,1 S Aiba2 and S Inoue1 1 Basic Research Laboratory,
Kanebo Cosmeteics Inc., Odawara, Japan and 2 Department of Dermatology, Tohoku
University Graduate School of Medicine, Sendai, Japan
The aquaporins are a family of water channel proteins with at least 13 known members in
human tissues. Aquaporin-3 (AQP3), highly expressed in the epidermis, permeates small solutes
such as glycerol and urea as well as water. Impairments in the hydration, elasticity, barrier
recovery, and wound healing of skin in AQP3 null mice indicate that AQP3 plays important
roles in skin physiology. Many features of AQP3 remain unclear, however, including the fac-
tors that regulate its expression in the epidermis. In the present study, we treated cultured nor-
mal human keratinocytes and mouse skin with retinoic acid (RA) and then analyzed AQP3
expression using RNase protection assays, immunoblotting and immunohistochemistry. Stim-
ulating keratinocytes cultured in a low-calcium medium with RA (0.03–1 µM) for 24 h induced
distinct and dose-dependent increases in AQP3 expression at both mRNA and protein levels.
The response was detected by as early as 2 h after the stimulation, and detected in differenti-
ated cells cultured in a high-calcium medium and in the epidermal cells of skin-equivalent
cultures. Topical application of RA induced mRNA expression of AQP3 as well as hyaluronan
synthase genes (Has2 and Has3) in mouse epidermis within 12 h of the treatment and with-
out any epidermal hyperplasia. The maximum amount of the up-regulated AQP3 mRNA at 24
h decreased time-dependently, although the induction of both Has transcripts were enhanced
for at least 48 h. The significant increase in AQP3 expression at protein level between the basal
and granular layers was confirmed through immunohistochemical analyses. These results
suggest that RA is a co-regulatory factor for AQP3 expression and hyaluronan synthesis in epi-
dermal keratinocytes. Transcriptional activation mediated by nuclear RA receptors is thought
to be involved in the regulation by RA of AQP3, Has2 and Has3 expression.
362
Lipid phase mixing and membrane structure in HaCaT keratinocytes
D Vind-Kezunovic and R Gniadecki Dept. of Dermatology D92, Bispebjerg Hospital,
Copenhagen NV, Denmark
Lipid rafts are sphingolipid- and cholesterol-rich microdomains, which are known to regulate
crucial membrane processes such as signal transduction, apoptosis and cell adhesion. Rafts
are composed of lipids organized in a liquid-ordered phase, Lo, in contrast to the bulk mem-
brane lipids, which are structurally more disorganized in the liquid-disordered phase, Ld. Lo
can be visualized on fluorescence microscopy when stained with cholera toxin B subunit
labeled FITC (FITC-CTx), which binds specifically to the abundant raft component ganglio-
side GM1. We have previously demonstrated that in the cultured keratinocyte line HaCaT,
FITC-CTx form micrometer large aggregates of clustered rafts, where molecular mobility meas-
ured by fluorescence recovery after photobleaching is very slow. The Ld phase can be traced
specifically with the lipophilic fluorescent dye 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocar-
bocyanine percholorate (Dil-C18). Current results show that in intact HaCaT cells FITC-CTx
and DiI-C18 spatially merge suggesting phase mixing. The molecular mobility of Dil-C18 is
several order of magnitude faster than that of CTx, indicating percolation of Ld in HaCaT
cells. Cholesterol removal from the plasma membrane with methyl-β-cyclodextrin (MBCD)
further decreases the mobility of CTx. More importantly, in MBCD-treated cells, a clear Lo/Ld
phase separation occurs. Ld is confined into approximately 1 µm large vesicles budding off
the plasma membrane. When HaCaT cells are treated with MBCD and the actin polymeriza-
tion inhibitor, Latrunculin A, the vesicles contain both the Lo- and Ld- phases. We propose a
model of the HaCaT cell membrane consisting of an immobile, non-percolating Lo phase and
a highly mobile, connected Ld phase. The opposing roles of lipid rafts and the actin cytoskele-
ton in lipid phase separation may have significance for the understanding of the regulation of
membrane curvature and membrane signaling in keratinocytes.
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Kinetics of membrane raft formation: fatty acid domains in stratum corneum lipid models
DJ Moore1 and R Mendelsohn2 1 R&D, ISP, Wayne, NJ and 2 Chemistry, Rutgers University,
Newark, NJ
The major barrier to permeability in skin resides in the outermost layer of the epidermis, the
stratum corneum (SC). The major SC lipid components are ceramides, free fatty acids, and cho-
lesterol. Ternary mixtures containing these constituents are widely used for physico-chemical
characterization of the barrier. Prior X-Ray diffraction and IR spectroscopy studies have revealed
the existence of ordered lipid chains packed in orthorhombic subcells. To monitor the kinet-
ics of formation of regions rich in fatty acids, the current study utilizes a modification of the
method developed to monitor component demixing in n-alkane mixtures. The approach is
based on changes in the scissoring or rocking mode contours in the IR spectra of (orthorhom-
bically packed) ordered chains. In the current study, equimolar mixtures of ceramides (either
non-hydroxy fatty acid sphingosine ceramide or α-hydroxy fatty acid sphingosine ceramide)
with chain perdeuterated fatty acids (either palmitic or stearic acid) and cholesterol reveal a
time evolution of the scissoring contour of the deuterated fatty acid chains following quench-
ing from relatively high temperatures where random mixing occurs. Segregation of domains
enriched in the fatty acid component is observed. The kinetics of segregation are sensitive to
the quenching temperature and to the chemical composition of the mixture. The kinetic regimes
are conveniently catalogued with a power law of the form P= Ktα where P is a (measured)
property related to domain composition. The time scales for demixing in these experiments
are similar to times observed in several studies that have tracked the restoration of the in vivo
permeability barrier following non-thermal challenges to SC integrity. Further evidence for
the physiological importance of the current measurements is the detection of these phases in
native SC. The current work constitutes the first direct, structure-based determination of the
kinetics of barrier formation in relevant skin lipid barrier models.
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Connexin 26 regulates epidermal barrier, wound remodeling and promotes psoriatic pro-
gression
J Segre,1 A Djalilian,1,2 E Seo,1 D McGaughey,1,2 J Cheng,1 M Tomic3 and A Ishida-Yamamoto4
1 NHGRI/NIH, Bethesda, MD, 2 NEI/NIH, Bethesda, MD, 3 NICHD/NIH, Bethesda, MD and
4 Asahikawa Medical College, Asahikawa, Japan
Inflammatory skin disorders result in significant epidermal changes, including keratinocyte
hyperproliferation, incomplete differentiation and impaired epidermal barrier. Here we test
whether conversely an impaired epidermal barrier can promote progression of an inflamma-
tory response. Mice lacking the transcription factor Kruppel-like factor 4 (Klf4) have a severe
defect in epidermal barrier acquisition. Transcription profiling of Klf4-/- newborn skin revealed
similar changes in gene expression to involved psoriatic plaques, including a significant upreg-
ulation of the gap junction protein connexin (Cx) 26. Phenocopying the expression observed
in psoriatic plaques and Klf4-/- skin, we ectopically expressed Cx26 from the epidermal spe-
cific Involucrin (INV) promoter (INV-Cx26) and demonstrate that down-regulation of Cx26 is
required for proper epidermal barrier acquisition during development. As juveniles and adults,
persistent ectopic Cx26 expression keeps wounded epidermis in a hyperproliferative state
and blocks the transition to remodeling, resulting in psoriaform dermatitis.  Mechanistically,
we show that ectopic expression of Cx26 in keratinocytes results in increased release of ATP,
which delays epidermal barrier recovery and promotes an inflammatory response in the res-
ident immune cells.  These results provide a molecular link between barrier acquisition in
utero, epidermal remodeling post wounding and psoriatic progression. More generally, these
results suggest that the most effective treatments for inflammatory skin disorders might con-
comitantly suppress the immune response and enhance epidermal differentiation to restore
the epidermal barrier.
368
A critical role for PKCα in keratinocyte growth arrest
A Jerome1 and MF Denning1,2 1 Molecular Biology Program, Loyola University Chicago,
Maywood, IL and 2 Oncology Institute, Loyola University Chicago, Maywood, IL
In normal skin, proliferation is confined to the basal layer of the epidermis. During terminal
differentiation, keratinocytes (KCs) detach from the underlying basement membrane and
undergo irreversible growth arrest. Protein kinase C (PKC) activation has been linked to the
KC granular layer differentiation program, however the role of PKC isoforms in irreversible
growth arrest is unclear. PKCα is localized at cell membranes in the first suprabasal KCs of
normal epidermis, suggesting activation in vivo in the lower spinous layers where growth arrest
occurs. Furthermore, several human squamous cell carcinoma (SCC) lines have defective PKCα
activation, and suprabasal proliferation is a hallmark of SCC. To investigate the role of PKCα
in KC growth arrest, we constructed a constitutively active PKCα (PKCα ∆22-28) by deleting
the auto-inhibitory pseudosubstrate domain from human PKCα. PKCα ∆22-28 had high con-
stitutive enzyme activity and elevated particulate association, as determined by subcellular
fractionation. Retroviral transduction of PKCα ∆22-28 into normal human KCs caused an
irreversible growth arrest resulting in decreased cell counts, reduced colony forming efficiency,
and inhibition of DNA synthesis. PKCα ∆22-28 expression caused a G1 arrest, but not apop-
tosis, indicating that active PKCα was sufficient to trigger a cell cycle arrest consistent with
KC terminal differentiation. To determine if PKCα was required for differentiation-associated
growth arrest, we down-regulated PKCα in normal human KCs by expressing a small hairpin
siRNA and generated organotypic raft cultures. Down-regulation of PKCα resulted in reduced
epidermal thickness and increased basal and suprabasal Ki67 and PCNA staining. Of note,
suprabasal Ki67 positive cells were observed only in the PKCα siRNA rafts. Taken together,
these results identify PKCα as both necessary and sufficient for triggering growth arrest dur-
ing human KC differentiation, and suggest that aberrant PKCα regulation in SCCs may con-
tribute to the enhanced suprabasal proliferation observed in these tumors.
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Retinoic acid increases aquaporin 3 (AQP3) expression in skin
G Bellemere, O Von Stetten and T Oddos Pharmaco-toxicology Laboratory, Johnson &
Johnson Consumer France, Val De Reuil, France
Topical application of retinoids on skin is known to induce dryness. In order to ascertain
whether AQP3, a membrane protein involved in water transport, could mediate retinoid-
induced skin dryness, we have investigated the effects of retinoic acid (RA) on AQP3 expres-
sion and function in cultured normal human epidermal keratinocytes (NHEK) and skin explants.
Treatment of NHEK with RA for 3 h and 24 h markedly increased the concentration of AQP3
transcripts and protein as assessed by real time PCR and western blotting procedures. Using
selective agonists of retinoic acid receptor (RAR) subtypes expressed in the skin we have demon-
strated that RARg is predominantly mediating RA effect. RA stimulated also glycerol influx in
NHEK, suggesting that the increase in AQP3 gene and protein expression was accompanied
by an enhancement of its biological activity. When RA was topically applied onto skin explants
for 24 h a strong increase in the concentration of AQP3 transcripts was noted in the epider-
mis. Concurrently, an accumulation of AQP3 was visualized by immunohistochemistry mainly
in the epidermal basal layers. Taken together, the present results show that RA increased
AQP3 expression and enhanced its biological activity. Skin dryness induced by topical retinoids
may be due to a disorganisation of stratum corneum structure together with an increase in
water transport through the epidermis following AQP3 stimulation.
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Peroxisome proliferator-activated receptor delta/gamma knockout mice exhibit defective
permeability barrier homeostasis and increased inflammation
M Man,2 GD Barish,1 RM Evans,1 D Crumrine,2 PM Elias2 and KR Feingold3 1 Biological
Sciences, Salk Institute/UCSD, San Diego, CA, 2 Dermatology, VAMC/UCSF, San Francisco,
CA and 3 Metabolism, VAMC/UCSF, San Francisco, CA
PPARβ/δ is a ubiquitous member of the ‘liposensor’ subfamily of nuclear hormone receptors,
whose endogenous ligands and functions still remain largely unknown. Addition of PPARβ/δ
activators to cultured human keratinocytes or murine epidermis 1) stimulates keratinocyte dif-
ferentiation, without a concurrent inhibition of proliferation; 2) accelerates permeability bar-
rier repair ; 3) increases epidermal lipid synthesis ; and 4) reduces cutaneous inflammation.
Since these results suggest that PPARβ/δ could play an important role in cutaneous home-
ostasis, we assessed here the skin phenotype of mice, deficient in epidermal PPARβ/δ (targeted
epidermal PPARβ/δ knock out). Gross cutaneous abnormalities were not evident and stratum
corneum hydration, basal transepidermal water loss, and surface pH were not altered. How-
ever, PCNA staining was increased, indicating increased cell proliferation, but the expression
of differentiation markers, such as loricrin, filaggrin, and involucrin, was similar to wild type
mice. Though basal permeability barrier function was normal, k.o. mice displayed a signifi-
cant delay in permeability barrier recovery after either tape stripping or acetone treatment in
comparison to wild-type littermates. Delayed barrier recovery correlated with decreased pro-
duction and secretion of lamellar bodies, and with reduced numbers of extracellular lamel-
lar membranes in the stratum corneum. Finally, k.o. mice displayed increased inflammation
in response to TPA treatment, a model of irritant contact dermatitis. Together, these results
demonstrate that PPARβ/δ in keratinocytes: 1) is required for normal epidermal barrier func-
tion; 2) regulates keratinocyte proliferation; and 3) modulates cutaneous inflammation.
371
Calcium regulation of FOXE1 transcription in human keratinocytes
M Bullock,1,2 M Jehani,1 M Ludgate2 and PE Bowden 1 1 Dermatology, Cardiff University,
Cardiff, United Kingdom and 2 Centre for Endocrine & Diabetes Sciences, Cardiff University,
Cardiff, United Kingdom
Patients with non-functional FOXE1 (forkhead transcription factor) present with congenital
hypothyroidism and “spiky” hair. In the thyroid, calcium binding to DREAM, a calcium-depend-
ent transcriptional repressor of FOXE1, results in dissociation of DREAM from DNA and acti-
vation (de-repression) of FOXE1. In order to characterise the expression and functional activity
of FOXE1 during keratinocyte proliferation and differentiation, an immortalised human epi-
dermal keratinocyte line (HaCaT) has been studied. Keratinocytes cultured in low Ca2+ (0.06-
0.15 mM) maintain a proliferative phenotype and elevating Ca2+ concentrations to 1.5 mM or
above induces terminal differentiation. HaCaT cells were plated in low Ca2+ which was increased
to 1.8mM at 70-80% confluence and cultures were maintained for 6 days. Total mRNA was
extracted at various time points, reverse transcribed and transcripts of FOXE1 and the APRT
housekeeper gene were amplified by real time PCR using SYBR green and a Stratagene MX3000.
Variations in FOXE1 functional activity were measured in HaCaT cells that expressed a FOXE1
responsive luciferase reporter. In low Ca2+ medium, cell contact with increasing confluence
induced differentiation, and this was accompanied by a 2-fold increase in FOXE1 transcripts.
During the first 24-hrs post-shift, a transient dip (3-fold) in FOXE1 transcript levels was observed.
Levels then rose achieving a 3-5 fold increase, before finally declining. This was accompanied
by expression of differentiation markers, keratin 10 and filaggrin, evaluated by immunocyto-
chemistry. Similar results were obtained in the HaCaT subclone which displayed a 3-fold increase
in luciferase activity. Furthermore, conventional RT-PCR identified DREAM expression in HaCaT
cells. Thus, we have shown that FOXE1 transcript levels and transcriptional activity increase as
keratinocyte differentiation proceeds in vitro, but the question still remains as to whether DREAM
modulates FOXE1 transcription in keratinocytes as in the thyroid.
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Focal adhesion kinase controls epidermal barrier homeostasis by regulating sodium-proton
exchanger type 1 expression
D Ilic,1 M Man,1 D Crumrine,1 G Dolganov,4 N Larocque,3 S McDonagh,3 K Red-Horse,3
BE Brown,1 P Xu,1 B Kovacic-Millivojevic,3 SJ Fisher,3 KR Feingold,2 PM Elias1 and
TM Mauro1 1 Dermatology, VAMC/UCSF, San Francisco, CA, 2 Metabolism, VAMC/UCSF,
San Francisco, CA, 3 Cell & Tissue Biology, UC San Francisco, San Francisco, CA and 4
Pulmonary, UC San Francisco, San Francisco, CA
Ubiquitously expressed FAK, linked to multiple intracellular signaling pathways, is involved
in control of cell motility, invasion, proliferation, and survival. However, most work on FAK
has been conducted in fibroblasts. Using mice with a keratinocyte-restricted deletion of fak
(FAKK5KO), we report here a novel role for FAK in epidermis; i.e., in maintenance of perme-
ability barrier homeostasis and stratum corneum (SC) integrity. Formation and maintenance
of the cutaneous permeability barrier and SC integrity are processes controlled by SC pH. We
found first that skin pH was significantly higher in the FAKK5KO mice and that key acidifying
mechanism, Na+/H+ exchanger 1 (NHE1), was downregulated. Loss of FAK resulted in pH-
dependent abnormalities in barrier function and SC integrity, attributable to delayed extra-
cellular lipid processing and accelerated corneodesmosome degradation, respectively. Abnor-
mal barrier function could be rescued when FAKK5KO mouse skin was exposed to the ambient
pH typical of normal mouse skin (pH-5.5). These findings demonstrate a novel role for FAK in
epidermis, including its requirement for optimum epidermal permeability function and SC
integrity at least in part via its regulation of NHE1 expression and therefore SC pH.
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13-cis retinoic acid induces apoptosis in SEB-1 sebocytes via an RAR-independent mecha-
nism
AM Nelson,1 KL Gilliland,1 Z Cong1 and DM Thiboutot1,2 1 Jake Gittlen Cancer Research
Foundation, Pennsylvania State University, College of Medicine, Hershey, PA and 2
Department of Dermatology, Pennsylvania State University, College of Medicine, Hershey, PA
Isotretinoin (13-cis Retinoic Acid, 13-cis RA), the most potent agent that affects all the path-
ogenic features of acne, is a teratogen. The mechanism of action of isotretinoin in the treat-
ment of acne remains largely unknown. If the actions of 13-cis RA on sebaceous glands can
be defined, it may be possible to design safer alternative therapies. We have shown that 13-
cis RA induces apoptosis in SEB-1 sebocytes as evidenced by increased Annexin V-FTIC
staining, increased TUNEL positive cells, and increased cleaved caspase 3 protein expression
at 48 and 72 hours. However, the ability of 13-cis retinoic acid to induce apoptosis cannot
be recapitulated by 9-cis retinoic acid or all-trans retinoic acid, and it is not inhibited in the
presence of retinoid acid receptor (RAR) pan antagonist AGN 193109, suggesting an RAR-
independent apoptotic effect. In addition, fenretinide, a synthetic retinoid known to act by
RAR- independent mechanisms, also induces apoptosis in SEB-1 sebocytes. Taken together
these data demonstrate that 13-cis RA induces apoptosis in sebocytes by a retinoid acid recep-
tor (RAR) independent mechanism, which may contribute to its sebosuppressive effect and
the resolution of acne.
375
Gene array expression profiling in acne lesions reveals marked up-regulation of genes involved
in inflammation and matrix remodeling
KL Gilliland,1 NR Trivedi,1 W Zhao,3 W Liu3 and DM Thiboutot1,2 1 Jake Gittlen Cancer
Research Foundation, Pennsylvania State University College of Medicine, Hershey, PA, 2
Department of Dermatology, Pennsylvania State University College of Medicine, Hershey, PA
and 3 Health Evaluation Sciences, Pennsylvania State University College of Medicine,
Hershey, PA
The pathogenesis of acne has been linked to multiple factors such as increased sebum pro-
duction, inflammation, follicular hyperkeratinization and the action of Propionibacterium
acnes within the follicle. In an attempt to understand the specific genes involved in inflam-
matory acne, we performed gene expression profiling in acne patients. Skin biopsies were
obtained from an inflammatory papule and from normal skin in 6 patients with acne. Biop-
sies were also taken from normal skin of 6 subjects without acne. Gene array expression pro-
filing was conducted comparing lesional to nonlesional skin in acne patients and comparing
nonlesional skin from acne patients to skin from normal subjects. Within the acne patients,
211genes are up-regulated in lesional skin compared to nonlesional skin. A significant pro-
portion of these genes are involved in pathways that regulate inflammation and extra-cellu-
lar matrix remodeling and they include matrix metalloproteinase’s 1 & 3, interleukin–8, human
β defensin 4 and granzyme B. These data indicate a prominent role of matrix metallopro-
teinases, inflammatory cytokines and anti-microbial peptides in acne lesions. These studies
are the first describing the comprehensive changes in gene expression in inflammatory acne
lesions and are valuable in identifying potential therapeutic targets in inflammatory acne
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Regulation of ABCA1 expression in human keratinocytes and murine epidermis
Y Jiang, B Lu, P Kim, B Brown, PM Elias and KR Feingold Metabolism & Dermatology, 111F,
NCIRE, VAMC, UCSF, San Francisco, CA
Keratinocytes require cholesterol for the formation of the cutaneous permeability barrier; hence,
factors that regulate cholesterol homeostasis in keratinocytes are of great importance. ABCA1
is a membrane transporter that is primarily responsible for the efflux of cholesterol from cells
and plays a pivotal role in regulating cellular cholesterol levels. In this study we demonstrate
that ABCA1 is expressed in cultured human keratinocytes (CHK) and in murine epidermis using
Northern blot and real time PCR to measure mRNA levels and Western blot for protein levels.
ABCA1 is expressed to a similar extent in differentiated vs. undifferentiated CHK, and in both
the upper (stratum corneum/stratum granulosum/stratum spinosum) and lower (stratum basale)
epidermis of mice. Following acute permeability barrier disruption by tape stripping or ace-
tone treatment, ABCA1 expression declines, which would decrease cellular cholesterol efflux,
making more cholesterol available for regeneration of the barrier. In addition, during rat fetal
epidermal development, ABCA1 expression decreased at days 19 and 20 of gestation (term =
22 days), which is the crucial period for the formation of a competent barrier. Excess choles-
terol synthesis after barrier disruption would also increase the formation of activators of LXR
(oxysterols), which in turn would stimulate ABCA1 expression and cholesterol efflux, thereby
ultimately restoring cellular cholesterol levels back to normal. Accordingly, LXR activators
markedly stimulate ABCA1 expression in CHK in a dose- and time-dependent fashion. When
topically applied, LXR activators increase ABCA1 expression by ~10-fold in mouse epidermis.
Finally, PPARα and PPARβ/δ, but not PPARγ activators, also increase ABCA1 expression in CHK,
albeit to a lesser extent than LXR activators. Thus, ABCA1 is expressed in keratinocytes where
it is regulated by activators of LXR and PPARs. ABCA1 expression varies according to altered
cholesterol requirement for permeability barrier homeostasis.
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TIG3 - a multifunctional regulator of keratinocyte differentiation
R Jans,1 MT Sturniolo1 and RL Eckert1,2 1 Physiology & Biophysics, Case Western Reserve
University, SOM, Cleveland, OH and 2 Dermatology, Case Western Reserve University, SOM,
Cleveland, OH
TIG3 is a low molecular weight, membrane-associated protein that regulates keratinocyte dif-
ferentiation and survival by activating type I transglutaminase (TG1). TG1 is the membrane-
anchored enzyme that catalyzes formation of protein-protein crosslinks during the terminal
stages of keratinocyte differentiation. Identifying how TIG3 regulates TG-1 activity is critical
for understanding the mechanism by which TIG3 potentiates keratinocyte differentiation. In
the present study, we show that full-length TIG3(1-164) induces differentiation-like cell death
in keratinocytes. However, mutants lacking the amino-terminal domain, TIG3(100-164),
TIG3(112-164) and TIG3(124-164), cause apoptosis-like cell death characterized by mem-
brane blebbing, cell rounding and poly-ADP-ribose polymerase (PARP) and procaspase-3
cleavage. Like wild-type TIG3, TIG3(41-164) and TIG3(100-164) interact with TG1. Unlike
wild-type TIG3(1-164) and TIG3(41-164), which are distributed in both the soluble and par-
ticulate fractions, TIG3(100-164), TIG3(112-164) and TIG3(124-164) localize exclusively in
punctate perinuclear structures. Moreover, fusion of the carboxy-terminal domain of TIG3 to
green fluorescent protein, TIG3(134-164)-GFP, results in enhanced accumulation of the fusion
protein in the particulate fraction. In contrast, the carboxy-terminal mutant TIG3(1-134) fails
to interact with TG1, lacks membrane association, and does not cause a phenotype. These
findings suggest that the TIG3 amino-terminus is required for TIG3-dependent keratinocyte dif-
ferentiation, and that the carboxy-terminal domain is required for TIG3 membrane-anchoring
and for interaction with TG1. Taken together, our data suggest that TIG3 is a multifunctional
and multidomain protein regulator of keratinocyte survival that may have different physio-
logical roles depending on its intracellular status.
374
Potential upregulation of cyclin-dependent kinase inhibitors by the Dlx3 homeodomain tran-
scription factor
S Stimpson,1 N Radoja,1 M Blumenberg2 and MI Morasso1 1 Developmental Skin Biology
Unit, NIH/NIAMS, Bethesda, MD and 2 Departments of Dermatology and Biochemistry,
NYU, New York, NY
Dlx3 promotes epidermal differentiation and is strongly induced in cultured primary mouse
keratinocytes with media containing high calcium concentration. Expression of the Dlx3 home-
odomain transcription factor is found primarily in the differentiated layers of the epidermis,
hair matrix and osteoblast. In a previous study, we showed that Dlx3 overexpression leads to
a reduction in cell proliferation in both normal and transformed human epithelial cells. We
are currently investigating the role of Dlx3 in the regulation of genes encoding cyclin depend-
ent kinase inhibitors (CKIs). There are two CKI families, Cip/Kip and Ink4A. We analyzed sta-
ble transduced epithelial cells overexpressing Dlx3 by micro-array, quantitative-PCR, and west-
ern blot analysis for expression of p21Cip1, p57Kip1 and p16INK4A genes. Keratinocyte
senescence marker p16INK4A remained unchanged in both Dlx3 expressing and non-express-
ing cells, while p21Cip1 and p57Kip1 were induced. In order to further investigate the mech-
anism that leads to this upregulation, we tested the ability of Dlx3 to transcriptionally regu-
late the expression of CKIs. This study presents evidence that reduced cell proliferation in
normal and transformed cells overexpressing Dlx3 is potentially mediated by induction of
cyclin dependent kinase inhibitors, p21Cip1 and p57Kip1 expression.
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The Hoxb13 transcription factor represses hyaluronan synthase 2 (HAS2) promoter activity
JA Mack,1,2 J Monslow1 and EV Maytin1,2 1 Biomedical Engineering, Cleveland Clinic,
Cleveland, OH and 2 Dermatology, Cleveland Clinic, Cleveland, OH
In addition to its role as a support structure for several tissues, hyaluronan (HA) has been impli-
cated as a positive mediator of cell migration and proliferation, and a negative mediator of
cellular differentiation. HA is also thought to play important roles in the inflammatory response
and has been linked to cutaneous fetal scarless wound healing. This important and highly
dynamic molecule is synthesized by one or more of the hyaluronan synthases (HAS1, 2, and/or
3) and catabolized by hyaluronidases. While a fair amount is known about how these enzymes
function, molecules that are directly involved in the regulation of their expression have yet to
be identified. We previously determined that loss of the transcription factor Hoxb13 in mouse
skin resulted in increased HA levels in both the epidermis and dermis, and that overexpres-
sion of Hoxb13 in a rat epidermal keratinocyte (REK) organotypic model resulted in loss of
HA and accelerated differentiation. Together, these data suggested that Hoxb13 may regulate
the expression of one or more of the HA metabolic genes. In the current study, we investi-
gated the possibility that Hoxb13 regulates HAS2 expression. Overexpression of Hoxb13 in
REKs significantly downregulated the expression of HAS2 as demonstrated by both semi-quan-
titative and real-time PCR. An examination of the HAS2 promoter showed that it contains sev-
eral Hox gene core consensus binding sites, two of which match predicted consensus bind-
ing sites for the Hox13 paralogous group. Transient transfection of REKs with a series of 10
HAS2-luciferase reporter deletion constructs demonstrated that the HAS2 promoter is highly
active in these cells as shown by robust luciferase activity. Co-transfection of Hoxb13 with a
HAS2 reporter construct carrying a predicted Hoxb13 binding site significantly suppressed
luciferase activity in a dose-dependant manner, while loss of this site abrogated the suppres-
sion. Together, these data suggest that Hoxb13 directly regulates the HAS2 promoter.
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Identification of cutaneous serine protease activity as a modulator of innate immunity
K Yamasaki,1 J Schauber,1 AB Coda,1 H Lin,1 NM Schechter,2 C Bonnart,3 P Descargues,3
A Hovnanian3,4 and RL Gallo1 1 Dermatology, University of California San Diego, San Diego,
CA, 2 Dermatology, University of Pennsylvania, Philadelphia, PA, 3 Inserm, Universite Paul-
Sabatier, Toulouse, France and 4 Genetics, CHU Purpan, Toulouse, France
Keratinocytes and granulocytes produce cathelicidin, an antimicrobial peptide whose absence
increases susceptibility to microbial infection. We hypothesized that proteolytic processing of
cathelicidin may be important to skin immune defense. To study this, human skin was ana-
lyzed by Surface Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
(SELDI-TOF-MS). LL-37, the best known human cathelicidin, was detected, but was not a major
cathelicidin in skin. Rather, alternate processed forms predominated in skin. To understand
the mechanism controlling this we purified potential processing enzymes at the skin surface
by HPLC and identified serine proteases stratum corneum tryptic enzyme (SCTE) and stratum
corneum chymotryptic protease (SCCE). Cathelicidin colocalized with these enzymes in the
spinous to granular layer of the epidermis. Treatment of LL-37 with recombinant SCTE and
SCCE generated new functional antimicrobial peptides against S. aureus mprf (SCTE gener-
ated KS-30, KS-22, and LL-29 by cleavage after Arg/Lys residues 7, 8 or 15, respectively, whereas
SCCE generated RK-31 and KR-20 by cleavage after Phe 6 and 17, respectively). Prolonged
digestion resulted in loss of peptide activity. Treatment of keratinocytes with siRNA to these
enzymes, or protease inhibitors, inhibited cathelicidin processing. Furthermore, mice lacking
a serine protease inhibitor (LEKTI-deficient mice, a mouse model of Netherton syndrome)
showed increased antimicrobial activity compared to wild type. SELDI-TOF-MS revealed cathe-
licidin was completely processed to mature peptides in LEKTI-deficient mice while WT litter-
mates had mainly the pro-form. These data show that the biological activity of cathelicidin is
dependent upon proteolytic processing and that serine proteases in the skin modulate innate
immune responses to microbial infection.
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α6 integrin-bright/CD71-dim human keratinocytes exhibit stem cell activity in a long-term
in vivo competitive repopulation assay while “side population” (SP) keratinocytes resembling
hematopoietic SP stem cells do not
A Terunuma, V Kapoor, WG Telford, MC Udey and JC Vogel National Cancer Institute,
Bethesda, MD
To assess the extensive repopulating ability of keratinocyte stem cell (KSC) candidates, it is
essential to have an in vivo assay system to monitor the expansion of the cell population of
interest for long periods of time. In the in vivo competitive repopulation assay utilized in the
present studies, bioengineered human epidermis is grafted onto immuno-compromised mice
and intrinsic MHC-Class I antigens are used to quantify expansion of competing populations.
Using this system, we assessed the long-term repopulating abilities of two populations of can-
didate KSC: α6 integrin-bright/CD71-dim keratinocytes (α6-bri/CD71-dim KC) and side pop-
ulation keratinocytes (SP-KC) that have a dye-exclusion phenotype when stained with Hoechst
33342 vital dye. The latter population resembles hematopoietic SP stem cells, and has been
proposed to contain KSC. Distinct populations of α6-bri/CD71-dim KC, SP-KC, or total ker-
atinocytes were prepared from fresh HLA-A2(+) skin tissue samples using preparative flow
cytometry, and mixed with competing HLA-A2(-) cultured total keratinocytes (passage 3) to
prepare human skin equivalents that were subsequently grafted onto the backs of nude mice.
Grafts were serially transplanted every 8 to 16 weeks to provide proliferative stress and assess
long-term repopulating ability. After the first serial transplantation, α6-bri/CD71-dim KC revealed
a significant growth advantage over total keratinocytes (P < 0.05), while SP-KC showed little
expansion even after two sets of serial transplantation over 33 weeks. Thus, this long-term in
vivo competitive repopulation assay involving serial transplantation revealed that α6-bri/CD71-
dim KC have a growth advantage over a total keratinocyte population and are enriched for
KSC. Additionally, although SP-KC possess the dye-exclusion phenotype of hematopoietic SP
stem cells, they do not exhibit a property of KSC.
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Evaporative caloric losses due to an impaired permeability barrier may contribute to growth
failure in children with atopic dermatitis (AD)
M Demerjian,1,3 JL Sugarman,1,2 MB Heyman,2 DG Moskowitz,1 CO Barland1,3 and
ML Williams1,2 1 Department of Dermatology, UCSF, San Francisco, CA, 2 Department of
Pediatrics, UCSF, San Francisco, CA and 3 Department of Dermatology, VAMC, San
Francisco, CA
AD is a very common dermatosis of childhood. In patients with severe, chronic disease it may
result in impaired growth, but whether this is due to the disease per se, dietary restrictions for
allergen avoidance or treatment with corticosteroids is unclear. The epidermal permeability
barrier is impaired in AD in parallel with disease severity. Recently we demonstrated that
increased rates of trans-epidermal water loss (TEWL) through a deficient barrier may underlie
growth failure in children with severe forms of ichthyosis. Thus, we examined here the rela-
tionship between the growth of children with AD and epidermal barrier dysfunction. Height,
weight and barrier function were measured in 89 children with mild to severe AD attending
the pediatric dermatology practice at UCSF. We assessed disease severity using the OSAAD
score, an objective measure that relies on TEWL and corneocyte hydration measurements.
Growth was determined by calculating age- and gender-specific Z scores for weight and height.
Daily evaporative caloric losses derived from TEWL measurements (0.58 Kcal/ml) on repre-
sentative areas of uninvolved, mildly and severely involved areas multiplied by their respec-
tive body surface area. Caloric losses significantly correlated with Z scores for weight (t=-2.34,
p=-0.02), but not with Z scores for height (t=-0.8, p=0.4). Moreover, Z scores tended to be
lower for both weight and height in relation to OSAAD scores, but did not reach statistical
significance (p=0.39 and p=0.5 respectively). Sustained caloric losses through an impaired
epidermal permeability barrier may contribute to impaired growth in children with atopic der-
matitis. Because of fluctuations in disease activity, weight gain may be more commonly
impeded. With sustained, severe disease, both height and weight may be impacted.
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A mutation in a splice acceptor site of the desmoglein 1 gene underlies striate keratoderma
in a large Pakistani kindred
M Colombo,1 A Getz,2 J Rockey,2 M Wajid2 and AM Christiano2,3 1 Thomas Jefferson
University, Philadelphia, PA, 2 Genetics and Development, Columbia Univeristy, New York,
NY and 3 Dermatology, Columbia University, New York, NY
Striate keratodermas (PPKS) are a rare autosomal dominant form of palmoplantar keratoderma,
a skin disorder characterized by a thickening of the skin on the palms and soles. PPKS is char-
acterized by hyperkeratosis extending along the length of each finger and on the palm of the
hand, as well as by patches of hyperkeratosis on the soles. We report a four-generation Pak-
istani kindred in which eleven members were affected with PPKS. Clinically, these patients
present with hyperkeratotic palms and with linear hyperkeratosis on the fingers. The hyperk-
eratosis is especially prominent on the flexor aspects of the fingers and in the creases of the
palm. Additionally, focal hyperkeratosis is seen on the sole of the toes as well as the ball and
heel of the foot. Based on previous reports of DSG1 mutations in PPKS, we performed direct
DNA sequencing analysis which revealed a heterozygous G-to-T transversion in the 3’ splice
acceptor site of intron 11 of the DSG1 gene designated 1688 -1 GÇT. We predict that this
mutation will lead to the skipping of exon 12 which is out of frame (134 nt), subsequent
degradation of the mutant mRNA by nonsense mediated RNA decay, and probable haploin-
sufficiency for DSG1. We report a novel splice site mutation in the DSG1 gene, which in
PPKS further underscores the significance of the desmoglein gene family in diseases of epi-
dermal integrity.
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Imaging human stratified squamous epithelia using nonlinear optical microscopy
EM Gill,1 CA Ivarie,2 KW Eliceiri,3 N Ramanujam,4 JG White3 and BL Allen-Hoffmann2 1
Biomedical Engineering, University of Wisconsin, Madison, WI, 2 Pathology and Laboratory
Medicine, University of Wisconsin, Madison, WI, 3 Molecular Biology, University of
Wisconsin, Madison, WI and 4 Biomedical Engineering, Duke University, Durham, NC
We compared native neonatal skin, adult skin and human skin equivalents using the nonlinear
optical techniques of Multiphoton Laser Scanning Microscopy (MPLSM) and Second Harmonic
Generation (SHG) imaging. Using these techniques we visualized living skin tissue in 3D. Skin
equivalents were generated using NIKS keratinocytes seeded onto dermal equivalents containing
primary human dermal fibroblasts and type I collagen. Samples were imaged from the epider-
mal side with an excitation wavelength of 890 nm, and a 60x water immersion lens. Autoflu-
orescence and SHG contributed to the intrinsic optical signal observed with MPLSM. Epider-
mal stratification was clearly evident in all imaged tissues. However, MPLSM analysis revealed
differences within the dermal compartments of all tissue sources, with those of neonatal skin
and the skin equivalent having similar character. Our findings show that MPSLM imaging of
skin equivalents provides high resolution, real time analysis of a human skin tissue model.
Because there were structural differences in the dermal compartment, we chose to enzymati-
cally perturb higher order collagen structure. To demonstrate the feasibility of monitoring pro-
teolytic degradation of collagen in skin using MPLSM, a dermal equivalent was treated with
collagenase and imaged over time. After 20 min, a precipitous decrease in the MPLSM signal
was observed, and was concomitant with collagen degradation as measured by SDS-PAGE.
These data demonstrate that collagen structure can be perturbed experimentally and monitored
in real time. The current results demonstrate that cellular and extracellular structures in both
epidermal and dermal compartments of human skin are resolvable with MPLSM microscopy.
MPLSM analysis of human skin equivalents shows potential as a powerful tool for the study of
epithelial-stromal interactions during wound healing and pathogenesis.
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Beta-adrenergic receptor antagonists accelerate skin wound healing: evidence for a cate-
cholamine synthesis network in the epidermis
CE Pullar, A Rizzo and R Isseroff Dermatology, University of California, Davis, Davis, CA
Here we describe a study designed to investigate the effect of beta-adrenergic receptor (B-AR)
antagonists on skin re-epithelialization and delineate the corresponding mechanisms. Upon
injury, keratinocytes migrate directionally into the wound bed to initiate re-epithelialization,
essential for restoration of barrier integrity. Keratinocytes express a high level of B2-ARs that
play a role in cutaneous homeostasis, as aberrations in either keratinocyte B2-AR function or
density are associated with various skin diseases. Here we report the novel findings that B-AR
antagonists increase the rate of keratinocyte migration, ERK phosphorylation, electric field-
directed directional migration and ultimately accelerate wound re-epithelialization in an ex
vivo human skin model of a chronic wound. In this model B-AR antagonist-treated wounds
heal within 4-5 days in the presence of 5% serum, while untreated (control) wounds fail to
heal under the same conditions. Control wounds do re-epithelialize, however, only 4 days
after the addition of 10% serum. Previously, we have demonstrated that B-AR agonists delay
skin wound re-epithelialization via protein phosphatase 2A activation. Here we demonstrate
that keratinocytes express two key enzymes required for catecholamine (B-AR agonist) syn-
thesis, tyrosine hydroxylase and phenylethanolamine-N-methyl transferase, both localized
within keratinocyte cytoplasmic vesicles. We hypothesize that the mechanism for the B-AR
antagonist-mediated augmentation of wound repair is due to B2-AR blockade, preventing the
binding of endogenously synthesized catecholamines. Our work describes a novel endoge-
nous B-AR mediator network in the skin that can regulate skin wound repair. Further investi-
gation of this network will improve our understanding of both the skin repair process and the
multiple modes of action of one of the most frequently prescribed class of drugs, hopefully
resulting in a new treatment for chronic wounds.
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Evaluation of natural change of skin function in split-thickness skin grafts by noninvasive bio-
engineering methods
Y Kim, Y Kim, J Lim, M Kim, H Kim and Y Park Department of Dermatology, Kangnam St.
Mary Hospital,The Catholic University of Korea, Seoul, South Korea
Autologous split-thickness skin grafts (STSG) are still considered the mainstay for the treatment
of the large full-thickness wounds. After this procedures, sequele such as color or contour
change, contracture, hypertrophy and the loss of elasticity can occur. However, there have been
few studies reporting the natural change of the skin function in STSG after this procedure.
Eighteen patients (15 males and 3 females) ranging in age from 7 to 78 years were eligible for
the study. They had been surgically treated with STSG for their skin defects that resulted from
injury or tumor resection. The skin functions of the graft and the control site on the right-to-left
counter part of the graft were sequentially evaluated by non-invasive bioengineering methods,
including an evaporimeter, corneometer, mexameter, and cutometer at post-operation day
0.5, 1, 2, 3, 6, 9 and 12 months. All the data were calculated as the ratio of the value of skin
graft to that of the intra-individual control site in order to minimize the bias of temperature,
humidity, patient age and gender, the donor or recipient site, etc. The TEWL of the graft was
similar to that of the normal skin for the first two months, and then it fluctuated a little for the
following months. The values of the skin hydration testing generally decreased during the fol-
low-up period. Compared with the value of the normal skin, erythema of the skin graft was
highly maintained for the whole period. For the pigmentation, the ratio initially remained around
1, and it tended to increase after 6 months. The skin pliability of the graft was abruptly decreased
at 0.5 month, and it recovered and was maintained around the ratio 0.9 from 3 month to 12
months. However, the value did not reach that of the normal skin. Our results showed that the
STSGs had changed within the frame of the skin function, including the TEWL, epidermal hydra-
tion, color and pliability, throughout one year after surgery.
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Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-dependent increase
in 2-OH ceramides during keratinocyte differentiation
Y Uchida,1 NL Alderson,2 S Douangpanya,1 PM Elias,1 H Hama2 and WM Holleran1 1
Dermatology, University of California San Francisco/V.A. Medical Center, San Francisco, CA
and 2 Medicine, Medical University of South Carolina, Charleston, SC
Ceramides (Cer) in the stratum corneum (SC) comprise a heterogeneous mixture of molecu-
lar species, which subserve the epidermal permeability barrier. In addition to variations in
sphingol and carbon chain length of their amide-linked fatty acids (FA), hydroxylation at both
the α (or 2)-position and the ω-position of the amide-linked FA contribute to the molecular
diversity of epidermal Cer. Recent studies revealed that FA 2-hydroxylase, encoded by the
gene FA2H, is primarily responsible for the synthesis of 2-hydroxy (OH)-containing sphin-
golipids in extracutaneous tissues. We assessed here, whether FA2H accounts for the synthe-
sis of both 2-OHCer and its glucosylated form, 2-OH glucosylCer (GlcCer), and whether
changes in its expression occur with keratinocyte (KC) differentiation. RT-PCR and Western
immunoblot analysis showed that FA2H mRNA and protein are not only expressed in cul-
tured human KC and human epidermis, but also that FA2H expression, as well as FA 2-hydrox-
ylase activity, increase with differentiation (mRNA 390-560%; activity >1300% of undiffer-
entiated cells). Blockade of FA2H expression with siRNA significantly diminished
2-OHCer/GlcCer production, demonstrating that FA2H accounts for 2-OHCer generation in
KC. Interestingly, although FA2H expression and 2-OH free FA production increased early in
KC differentiation, 2-OHCer/GlcCer production only increased late in differentiation, sug-
gesting that the upregulation of FA2H is accompanied by upregulation of Cer synthesis, lead-
ing to the unique 2-OHCer/GlcCer in epidermis. Since 2-OHCer are important components
of the epidermal permeability barrier, these differentiation-linked increases in FA2H expres-
sion appear essential for epidermal permeability barrier formation, presumably by facilitat-
ing hydrogen bonds within lamellar membranes in the SC interstices.
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The secret life of caspase-14
G Denecker,1 E Hoste,1 T Hochpied,1 B Gilbert,1 P Ovaere,1 K D’Herde,2 C VandenBroucke,3
S Lippens,1 L Schoonjans,4 C Libert,1 P Vandenabeele1 and W Declercq1 1 Department of
Molecular Biomedical Research, University of Ghent - VIB, Ghent, Belgium, 2 Department of
Anatomy, Embryology, Histology, Medical Physics, University of Ghent, Ghent, Belgium, 3
Department of Pathology, University of Ghent, Ghent, Belgium and 4 Department of
Transgene Technology, University of Leuven, Leuven, Belgium
Caspase-14 is expressed in the differentiating keratinocytes of the epidermis and the hairfol-
licles. In addition, caspase-14 could also be detected in the Hassall’s body’s of the thymus. In
the skin caspase-14 activation occurs in the uppermost layers of the epidermis and correlates
with epidermal cornification. To unravel the possible role of caspase-14 during skin differen-
tiation, we have generated caspase-14-deficient mice. Caspase-14 knock-out mice were
born normally with the expected Mendelian ratio. The absence of caspase-14 protein was
confirmed both by western blot and immunohistochemistry. Histological sections of the back
skin and thymus of newborn wild-type and caspase-14-deficient mice revealed no macro-
scopical differences. Immunohistochemical analysis of other early and late differentiation
markers demonstrated a normal expression pattern of K1, K10, K14, loricrin, involucrin and
filaggrin. However, the skin of caspase-14-deficient mice had a more shiny appearance and
showed a lichiniform phenotype. Electron microscopic analysis indicated the presence of high
numbers composite keratohyalin granules in the caspase-14-deficient epidermis. These gran-
ules are normally used as profilaggrin stores. In accordance, caspase-14 mice show an altered
profilaggrin-processing pattern when analyzed by western blotting. These data argue for a role
of caspase-14 in the final steps of keratinocyte differentiation. Further analysis of different
physiological parameters is ongoing in order to unravel the secret life of caspase-14.
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The different effects of high-frequency and low-frequency sonophoresis on epidermal per-
meability barrier and dermal remodeling cascade
H Kim,1 J Jun,1 K Choi,2 E Choi,3 S Ahn3 and S Lee1 1 Dermatology, Yongdong Severance
Hospital, Yonsei University College of Medicine, Seoul, South Korea, 2 Laboratory of Electron
Microscopy,Seoul Health College, Seoung Nam, South Korea and 3 Dermatology, Yonsei
University Wonju College of Medicine, Wonju, South Korea
The application of ultrasound enhances the skin permeability to a variety of molecules
(sonophoresis).The enhancement induced by ultrasound is particularly significant at low-fre-
quencies ( f < 100 kHz, low-frequency sonophoresis).We have already reported that ion-
tophorhesis and high-frequency (f=1-3 mHz) sonophorhesis at energies that do not provoke
a barrier abnormality stimulate epidermal cytokine expression and lamellar body secretion,
which are linked to altered epidermal calcium levels. Attenuation of an acoustic wave is
inversely proportional to its frequency, and thus the more the frequency increases, the less
deeply the ultrasound penetrates into and under the skin.Our results show that high- frequency
sonophothesis has stronger effects on epidermal barrier repair response than low-frequency
sonophoresis, they were shown to stimulate the expression of epidermal cytokine(ex. IL-1
and TNF-alpha) and epidermal lipid synthesis enzymes(ex. HMG-CoA reductase, fatty acid
synthetase and serine palmitoyl transferase) in real time RT-PCR and immunohistochemical
staining. Lamellar body secretion was accelerated in stratum granulosum shortly after the treat-
ment of high and low frequency sonophoresis and there were no siginificant differences. After
daily repeated treament for 7 days, elevation of dermal collagen and matrix metalloprotease
3,9 expressions, and induction and activation of the transcription factors AP-1 were more sig-
nificant after low-frequency sonophoresis treatment than high frequency sonophoresis. In con-
clusion, high-frequency sonophoresis has stronger effects on epidermal peameability barrier
while of low –frequency sonophorhesis is superior in activation of dermal remodeling/wound
healing cascade.
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Opposing roles of ceramide hydrolysis and recycling in UVB-induced apoptosis of ker-
atinocytes
E Houben,1 PM Elias,2 WM Holleran2 and Y Uchida2 1 Toxicology, Vrije University Brussels,
Brussels, Belgium and 2 Dermatology, University of California San Francisco/V.A. Medical
Center, San Francisco, CA
Ceramides (Cer) are not only critical constituents of the epidermal permeability barrier, but
also apoptogenic signals for ultraviolet B (UVB)-induced apoptosis in keratinocytes (KC). Since
epidermis is continuously exposed to UVB, the regulation of both de novo Cer synthesis and
its subsequent recycling are critical for epidermal function. Therefore, we assessed the role of
Cer recycling in the response of cultured human keratinocytes (CHK) to UVB irradiation. Whereas
both low- (<35mJ/cm2) and high- (≥45mJcm2) dose UVB inhibit CHK proliferation, but apop-
tosis occurred only following high-dose UVB (Uchida et al., 2003). While both Cer synthesis
and total content increased following both UVB doses, it normalized only in low-dose UVB-
treated CHK. Neither de novo Cer synthesis nor hydrolysis of sphingomyelin alone accounted
for the Cer accumulation; rather a newly-defined mechanism; i.e., the sequential sphin-
gomyelinÇCerÇsphingosine(Sph)ÇCer salvage (recycling) pathway is responsible. Accord-
ingly, although both acidic- and neutral-ceramidase (aCDase and nCDase, respectively) activ-
ities declined after low- and high-dose UVB, a sustained decrease of the corresponding
mRNA/protein levels was only noted in high-dose-UVB-cells. Moreover, coincubation of CHK
with siRNA for either aCDase and/or nCDase, sensitized KC to low-dose UVB-induced apop-
tosis via Cer accumulation. Finally, blockade of Sph-to-sphingosine-1-phosphate (S1P) by siRNA
to this enzyme, also sensitized KC to low-dose UVB-induced apoptosis, demonstrating that
further metabolic conversion of Sph to S1P attenuates the apoptotic effects of elevated Cer. Thus,
the Cer hydrolysis has opposing roles in the Cer-induced apoptosis in CHK following UVB irra-
diation; first, CDase-dependent Cer hydrolysis increases apoptogenic Cer generation via the
recycling pathway, while in parallel, a/nCDase(s) activity(ies), coupled with downstream phos-
phorylation of Sph to S1P, protect KC against UVB-induced, Cer-mediated apoptosis.
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The membrane bound chemokine CXCL16 is constitutive expressed in keratinocytes and pro-
teolytic cleaved by ADAM 10
F Scholz,1 E Proksch,1 A Schulte,2 F Adamski,2 C Hundhausen,2 A Schwarz2 and A Ludwig2
1 Dermatology, University of Kiel, Kiel, Germany and 2 Biochemistry, University of Kiel, Kiel,
Germany
Chemokines are a large family of small proteins, are released upon stimulation and are involved
in processes like inflammation and wound healing. The CXC-chemokine CXCL16 is a mem-
brane bound chemokine and consists of a short cyctoplasmatic tail, a single membrane bound
α-helix, a high glycosylated mucin like stalk and a 10 kDa chemokine domain. CXCL16 is
expressed as a membrane-borne adhesion molecule on the cell surface and is released as a
soluble chemoattractant. Both functions are carried out by binding of CXCL16 to its receptor
CXCR6. We here provide first evidence that CXCL16 is expressed by epidermal keratinocytes
of healthy human skin and released into the wound exudates of injured murine skin. In vitro
the transmembrane CXCL16-variant is constitutively expressed on the surface of human HaCaT
and murine PAM212 keratinocyte cell lines. In these cell lines as well as in primary human
and murine keratinocyte cultures the soluble CXCL16 variant is constantly released into the
conditioned medium. This release is preferentially mediated by the disintegrin-like metallo-
proteinase ADAM10 but not by the closely related metalloproteinase ADAM17 as shown by
the use of the metalloproteinase inhibitors Marimastat (broad spectrum inhibitor), GW280264X
(preferentially blocking ADAM 17) and GI254023X (preferentially blocking ADAM 10) and
by siRNA knockdown experiments. The CXCL16-shedding is reduced in the absence of serum
but further enhanced by cell stimulation with ionomycin or by UVB irradiation. Finally, shed
CXCL16 from keratinocytes was shown to activate its receptor CXCR6 that is expressed on
distinct cells exclusively located in the dermis. Thus, the transmembrane chemokine CXCL16
is constitutively expressed by keratinocytes shed to a soluble form upon cell activation and
may target CXCR6-expressing cells in the dermis
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K6PC-5, a sphingosine kinase activator, induces intracellular calcium mobilization and dif-
ferentiation in HaCaT cells
J Youm,1 J Hong,2 D Shin,1,2 M Kwon,3 B Park3 and S Lee1,4 1 Brain Korea 21 Project for Medical
Science, Yonsei University, Seoul, South Korea, 2 Department of Oral Biology, Yonsei University
College of Dentistry, Seoul, South Korea, 3 NeoPharm Co., Ltd., Daejeon, South Korea and 4
Department of Dermatology, Yonsei University College of Medicine, Seoul, South Korea
Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, regulates many cellular
responses including growth, differentiation, survival, motility, rearrangements of cytoskeleton,
cardiogenesis, angiogenesis, and immunity. It has been also suggested that S1P has important
intracellular functions for calcium mobilization as acts extracellularly and intracellularly. We
synthesized a novel sphingosine kinase activator, K6PC-5, recently to apply it to skin. In this
study, we have investigated how K6PC-5 generates intracellular calcium signaling and whether
it affects differentiation in HaCaT cells. The Ca2+-sensitive dye Fura-2 was used to measure
the intracellular Ca2+ concentration ([Ca2+]i). The intracellular [Ca2+]i was increased tran-
siently with a dose-dependent manner by K6PC-5 and S1P, and [Ca2+]i oscillations are also
induced. K6PC-5- and S1P-induced Ca2+ oscillations are dependent on extracellular Ca2+.
DMS inhibited the Ca2+ increases of K6PC-5, although not completely, but did not that of S1P.
PTX and U73122 inhibited the intracellular Ca2+ increases of S1P, but did not inhibit that of
K6PC-5. K6PC-5-induced Ca2+ oscillations used thapsigargin-sensitive Ca2+ pool. 2-APB and
Gd3 inhibited K6PC-5-induced Ca2+ signal, suggesting that Ca2+ influx are essential for K6PC-
5-induced Ca2+ oscillations. K6PC-5 and S1P increased the mRNA levels of differentiation-
associated marker proteins of keratinocytes including involucrin, loricrin, and filaggrin in
HaCaT cells. These results indicate that K6PC-5 activates sphingosine kinase directly and has
a different Ca2+ signaling pathway from that of exogenous S1P, although shares the intracel-
lular Ca2+ store in the ER. We expect that K6PC-5 can be a new therapeutic compound for
the abnormal differentiation of skin epidermis such as atopic dermatitis.
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K6PC-5, a sphingosine kinase activator, prevents the skin atrophy induced by topical steroid
J Youm,1,2 M Kwon,2 B Park,2 S Ahn,3 E Choi3 and S Lee1,4 1 Brain Korea 21 Project for
Medical Science, Yonsei University, Seoul, South Korea, 2 Neopharm Co., Ltd., Daejeon,
South Korea, 3 Department of Dermatology, Yonsei University Wonju College of Medicine,
Wonju, South Korea and 4 Department of Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
Skin atrophy is one of the prominent side effects of topical and systemic application of glu-
cocorticoids. Skin barrier impairment is also reported as a steroid-induced side effect. Although
it is well known for steroids to induce skin atrophy, studies on prevention and minimizing
steroid induced atrophy are rare. Sphigosine-1-phosphate (S1P), phosphorylated from sphin-
gosine by sphingosine kinase, is recently emerging as an important signaling mediator, which
involves diverse cellular responses including proliferation, differentiation, motility, and sur-
vival. A sphingosine kinase activator, K6PC-5, which was newly synthesized by us, induced
intracellular calcium mobilization in HaCaT cells, keratinocyte differentiation and fibroblast
proliferation in vitro and in vivo. In this study, we investigated the effect of K6PC-5 on skin
atrophy induced by a topical steroid. Clobetasol propionate was applied once a day, and K6PC-
5 and vehicle were applied twice a day for 9 days on the skin of hairless mice. Functional and
morphologic studies were performed. There were significant changes in basal transepidermal
water loss, skin surface pH, and skin fold thickness, but no change in SC hydration. Slight
strengthening in SC integrity was expressed in skin to which K6PC-5 was applied after 6 days
of treatment, but barrier recovery rate was not significant. K6PC-5 inhibited the decrease of
epidermal thickness and dermal collagen density induced by topical steroid. These results
show that K6PC-5 could prevent and/or minimize the atrophogenic effect of steroids by reg-
ulating epidermal and dermal cellular functions of the skin through S1P.
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7-Dehydrocholesterol improves the maturation of the human stratum corneum
L Hellemans,1 L Van Overloop,1 L Declercq1 and D Maes2 1 Estee Lauder Companies, Oevel,
Belgium and 2 Estee Lauder Companies, Melville, NY
During the terminal differentiation process the formation of the cornified envelope (CE) involves
the cross-linking of CE precursor proteins like involucrin, loricrin, small prolin-rich proteins and
keratins via the formation of γ-glutamyl-ε-lysine isopeptide bonds by Ca2+ dependent transglu-
taminases. Further cross-linking results in the maturation of the CE from fragile to rigid cor-
neocytes during the stratum corneum (SC) maturation. We developed a novel method to meas-
ure the SC maturation based on quantification of the degree of cross-linking reflecting the end
result of the transglutaminase activity on D-squame® tape strippings. In line with literature data
we could show that (1) there is a progressive increase in the maturation from deeper layers
towards the uppermost layers of the SC and (2) there are body site differences in the degree of
SC maturation with a higher maturation on the arm compared to the face. The latter might indi-
cate that photodamage reduces the SC maturation. Here the effect of UV on the SC maturation
index was evaluated. Repeated exposure to mild levels of sunbed UV over a period of 2 weeks
lead to a decrease in the SC maturation on the arms with a partial recovery 2 weeks later. Treat-
ment with 0.1% 7-dehydrocholesterol (7-DHC) on the arms could partially prevent the UV
induced decrease in SC maturation, while on the face this resulted in a full recovery of the SC
maturation 2 weeks after the repeated UV up to a level equalling the SC maturation on the arms.
It is hypothesized that treatment with 7-DHC which is a precursor of vitamin D3 and calcitriol
(the hormone important for the calcium metabolism) might affect the in situ working of the
Ca2+ dependent transglutaminase resulting in an improved SC maturation.
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Impaired skin barrier function, impaired epidermal differentiation and pronounced expres-
sion of beta-defensin-2 in tinea corporis
E Proksch, J Jensen, C Neumann and J Brasch University of Kiel, Kiel, Germany
Tinea corporis is a superficial mycotic infection of the skin caused by dermatophytes. Clini-
cally tinea corporis may resemble eczema or even psoriasis. We previously have shown that
profound changes in skin barrier function and epidermal differentiation are present in eczema.
Therefore, we were interested in the epidermal changes in dermatophytosis. We determined
skin barrier function, stratum corneum hydration, epidermal proliferation and differentiation,
as well as the expression of the antimicrobial peptide beta-defensin-2 in ten patients with tinea
corporis caused by Trichophyton rubrum. We measured a significant increase in transepider-
mal water loss as a sign of a barrier dysfunction and a reduction in stratum corneum hydra-
tion in tinea corporis lesional compared to non-lesional skin. Epidermal proliferation in lesional
skin was several fold increased and in accordance there was expression of proliferation and
inflammation associated keratins K6, K16, and K17. Enhanced epidermal proliferation facili-
tates the removal of invading dermatophytes in tinea corporis. Expression of basal keratins K5
and K14 was extended to suprabasal layers and expression of the suprabasal differentiation
associated K10 was reduced in tinea. Also, there was a reduction of the cornified envelope
proteins involucrin, loricrin and filaggrin. Filaggrin degradation products were reported to be
important for water binding. Therefore, the reduction in filaggrin explains the reduced skin
hydration and clinical signs of dry skin in tinea corporis. Surprisingly, pronounced human beta-
defensin-2 staining was found. Human beta-defensin-2 is known to be effective in innate immu-
nity against candida albicans, but it remains unknown if it has antimicrobial potency against
Trichophyton rubrum. Together we describe an impaired skin barrier function, enhanced epi-
dermal proliferation and changes in differentiation as well as expression of human beta-defensin-
2 in tinea corporis, which may be directed against dermatophytes.
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Expression of anti-microbial peptides in murine epidermis is increased by UVB exposure
M Kim,1,2 H Jeon,1 J Goo,1 S Ahn,1 Y Park,2 S Lee2 and E Choi1 1 Dermatology, Yonsei
University Wonju College of Medicine, Wonju, South Korea and 2 Dermatology, Yonsei
University College of Medicine, Seoul, South Korea
Mammalian epidermis expresses β-defensin and cathelicidin, major antimicrobial peptides
(AMP), which have important role in innate immunity and decrease in atopic eczema lesions.
In human epidermis, human β-defensin 2 is packaged in the lamellar body, and LL-37, a human
cathelicidin, is co-localized with the stratum corneum intercellular lipid lamellae. Also, immuno-
histochemistry showed that the expression of CRAMP, a cathelicidin in mouse skin, and mouse
β-defensin 2 (mBD-2) are dependant on the change of SC intercellular lipid. UVB is frequently
prescribed in severe atopic eczema. To observe the change of AMP expression after UVB expo-
sure, hairless mice were exposed to 40mJ UVB daily for 3 days. At 6h after last exposure, skin
specimens were taken, and then western blot, immunohistochemical stain, and real time RT-
PCR for mBD-2 and CRAMP was performed. In UVB exposed epidermis, the expression of
mBD-2 and CRAMP was increased in western blot and immunohistochemistry. Also, mRNA of
mBD-2 and CRAMP were increased compared to control skin. From our study, we conclude
that short term and low dose UVB exposure induces epidermal AMP expression, which might
give a supplemental explanation of the beneficial effect of UV in atopic dermatitis.
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Topical calcineurin inhibitors delay epidermal permeability barrier recovery, which can be
recovered by barrier replacement therapy
M Kim,1 H Jeon,1 M Kim,1 M Cho,2 S Lee3 and E Choi1 1 Dermatology, Yonsei University
Wonju College of Medicine, Wonju, South Korea, 2 Pathology, Yonsei University Wonju
College of Medicine, Wonju, South Korea and 3 Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
Topical calcineurin inhibitors such as pimecrolimus and tacrolimus, both of which have anti-
inflammatory and immunosuppressive effects, have been recently used to treat a number of
dermatologic diseases including atopic dermatitis, vitiligo and psoriasis. They have been used
instead of topical glucocorticoids, because they have similar efficacy, but rare side effects such
as skin atrophy and telangiectasia compared with topical glucocorticoids. Recently, it has been
reported that even short-term topical glucocorticoids compromise epidermal permeability bar-
rier homeostasis. We performed this study to determine whether topical calcineurin inhibitors
disrupt epidermal permeability barrier homeostasis, and how to prevent this disruption. In
humans, topical pimecrolimus and tacrolimus applied twice a day for 5 days, delay the bar-
rier recovery after acute barrier disruption by tape stripping without an increase on basal
transepidermal water loss. With physiologic lipid mixtures containing equimolar ratio of
ceramide, cholesterol and free fatty acid, and multilamellar emulsion containing pseudoce-
ramide, the impaired barrier homeostasis induced by topical pimecrolimus and tacrolimus
was recovered. In hairless mice, just 2 day treatment starts to impair the basal barrier state,
and 4 day treatment disrupted significantly. However, SC integrity was not changed. In topi-
cal calcineurin inhibitor treated epidermis, a decrease in Nile red stain, and decrease in num-
ber of lamellar bodies and secretion were observed, but not corneodesmosome density. Our
results indicate that topical calcineurin inhibitors can disrupt epidermal permeability barrier
even in normal skin and for short term, but which might be recovered by barrier replacement
therapy with physiologic lipid mixture or multilamellar emulsion containing pseudocermide.
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The expression of transglutaminases in the various acne lesions
D Suh,1 Y Cho,1 I Kim2 and S Lee3 1 Dermatology, Seoul National University College of
Medicine, Seoul, South Korea, 2 Molecular Genomic Medicine, Seoul National University
College of Medicine, Seoul, South Korea and 3 Oral Pathology, Kangnung National University
College of Dentistry, Kangnung, South Korea
Transglutaminases (TGases) is a family of calcium-dependent enzymes that catalyze the post-
translational modification of proteins by the formation of isopeptide bonds. TGases play vari-
ous roles in cell adhesion, wound repair, tissue stabilization, programmed cell death and dif-
ferentiation. Four TGase family members are known to be expressed in the human epidermis
- TGase 1, TGase 2, TGase 3, TGase 5. In the pathogenesis of acne, it is considered that abnor-
mal keratinization of follicle, and subsequently increased cohesiveness of corneocytes is one
of the most important phenomenon in formation of acne lesions. There may be a possibility
that the functions of TGases are involved in the formation and development of acne lesions,
which has never been investigated. We investigated and analyzed the expression pattern of
TGase 1, TGase 2 and TGase 4 in the various acne lesions - white comedone, black comedone,
papule, pustule - and normal epidermis with immunohistochemistry and in situ hybridization.
We also performed apoptosis staining and compared it with the expression pattern of TGases.
TGase 2 and 4 were expressed in the epidermis, sebaceous glands, hair follicles and eccrine
glands. TGase 1 was found mainly in the basal layer of epidermis. The degree of TGases stain-
ing was decreased in the acne lesions than in the normal skin. In this study, TGase 4, which
had been known to be only in the prostatic tissue, was found in the epidermis and sebaceous
glands. This finding was confirmed by RNA in situ hybridization. The degree of apoptosis was
also decreased in the acne lesions than in the normal skin. We also suggest that TGases may
play a role in the pathogenesis of acne, and this may be related with apoptosis.
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Psoriasin (S100A7) - an anti-bacterial role in wounds
K Lee1,2 and R Eckert1,2 1 Physiology and Biophysics, Case School of Medicine, Cleveland,
OH, 2 Dermatology, Case School of Medicine, Cleveland, OH and 3 Environmental Health
Sciences, Case School of Medicine, Cleveland, OH
S100 proteins comprise a family of small, calcium-activated EF-hand proteins that are encoded
within the epidermal differentiation complex at 1q21. A member of this family, S100A7 (pso-
riasin) is increased by fifty-fold in epidermal diseases such as psoriasis. However, the func-
tion of this protein has remained an enigma and it is not yet clear whether S100A7 has a role
in the genesis of disease or is increased in response to the disease environment. To gain insight
regarding its function, we examined the role of S100A7 in the context of epidermal injury, an
environment susceptible to bacterial colonization. The normally modest level of S100A7
expression is dramatically increased in the wound environment, with large amounts of the
protein produced by keratinocytes surrounding the wound margin. S100A7 monomer is pres-
ent in the wound exudate, and both monomers and high molecular weight cross-linked
forms are present in the overlying granulation tissue. To determine a possible role of S100A7
in the wound environment, we monitored the bactericidal activity of the protein. Our stud-
ies show that S100A7 adheres to bacteria and is effective at reducing bacterial survival.
Mutations in the putative zinc binding motif or the conserved carboxyl-terminal calcium-bind-
ing EF-hand motif reduce the ability of S100A7 to inhibit bacterial survival at low S100A7
concentrations. However, these mutants are active when used at high concentrations. Epi-
dermal fatty acid binding protein (E/FABP), an S100A7 binding partner, is also present at
increased levels in the wound environment. These results, which show that S100A7 is bacte-
ricidal, are the first to define a functional role for S100A7 in the wound environment. These
findings have critically important clinical implications and suggest that S100A7, like the
defensins, act to protect the body from invasion by potentially deadly bacteria.
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Characterization of the association of desmoplakin and plectin with desmin
L Fontao,1 M Champliaud,1 K Lapouge,1 Y Gontier,1 D Paulin,2 KJ Green3 and L Borradori1 1
Clinic of Dermatology, University Hospital, Geneva, Switzerland, 2 Molecular Biology and
Differentiation, University Paris 7, Paris, France and 3 Departments of Pathology and
Dermatology, Feinberg School of Medicine,, Chicago, IL
Desmoplakin (DP) and plectin (PL) are plakin family members connecting the intermediate
filament (IF) system to other cytoskeletal networks and/or plasma membrane sites. DP and PL
gene defects cause congenital skin disorders associated with muscular dystrophy and/or car-
diomyopathy, an observation attesting to the importance of these proteins in maintenance of
the integrity of keratinocytes and striated muscle cells. Previous studies have shown that the
tail domain of DP and PL is important for their binding to the IF proteins vimentin and prob-
ably desmin as well as to the epidermal keratins K5/K14. We have here characterized sequences
within these proteins implicated in their association. Our results show that: 1) the C-terminal
regions of DP and PL bind to desmin in pull down assays, and codistribute with the desmin
IF network in transfected cells; 2) in yeast two-hybrid assays, a region encompassing the B
subdomain and linker region of DP and PL interacts with desmin; however, their C-extrem-
ity is also implicated; 3) PL binds to sequences located in the N-terminal half of the rod domain
of desmin, while DP preferentially associates with the C-terminal rod half and tail of desmin.
The assembly state of desmin seems to affect these interactions; 4) in contrast to what observed
with desmin, DP binds to the N-terminal rod half of K5/K14; 5) distinct mutations in either
DP or desmin associated with inherited cardiomyopathy,impair DP-desmin interactions. Our
findings demonstrate that DP and PL interact with desmin and that their binding involves a
different set of sequences on desmin. Furthermore, DP interacts with distinct IF types by means
of different recognition sites on these IF proteins. These observations provide novel insights
into the association between plakins and IF proteins and increase our understanding of plakin-
and IF-related human diseases.
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Ribonuclease inhibitor is cleaved by stratum corneum proteases
A Abtin,1 L Eckhart,1 M Mildner,1 M Ghannadan1 and E Tschachler1,2 1 Department of
Dermatology, Medical University of Vienna, Vienna, Austria and 2 Centre d Investigations
Epidermiques et Sensorielles (CE. R. I. E. S.), Neuilly, France
Ribonuclease inhibitor (RI) is a cytoplasmic protein that inhibits various members of the RNase1
family of RNases. Here we investigated the regulation of RI in keratinocytes. In the epidermis
RI increased in abundance from the basal layer to the granular layer whereas it was unde-
tectable by immunohistochemistry in the stratum corneum. These data were confirmed by
Western blot analysis which showed that RI was upregulated during keratinocyte differentia-
tion in vitro but was absent in stratum corneum extracts. Stratum corneum contained strong
RNase activity which could be blocked by addition of recombinant RI in a concentration-
dependent manner. Western blot analysis revealed that RI was cleaved during incubation
with stratum corneum extracts. Taken together, our findings indicate that stratum corneum con-
tains proteases which degrade RI, probably to allow for skin surface RNase activity.
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The proximal and distal regulatory regions of the human involucrin gene promoter - an impor-
tant role for transcriptional factors and co-activators
JF Crish,1 G Ramamurthy,1 F Bone1 and RL Eckert1,3 1 Physiology/Biophysics, Case School of
Medicine, Cleveland, OH, 2 Oncology, Case School of Medicine, Cleveland, OH and 3
Dermatology, Case School of Medicine, Cleveland, OH
Involucrin is an important keratinocyte differentiation marker. The human involucrin (hINV)
gene promoter has two distinct regulatory regions - the proximal and distal regulatory regions
(PRR, DRR). To study the role of these regions in vivo, we constructed human involucrin pro-
moter transgenic mice. We show that the full-length involucrin promoter drives differentia-
tion-appropriate expression in epidermis, cervix, and esophagus. Mutation of the DRR AP1
transcription factor binding site (AP1-5) completely eliminates transgene expression in all tis-
sues, while mutation of the DRR Sp1 factor binding site reduces overall expression, but does
not alter the differentiation-dependence. Additional studies identify a DRR immediate suprabasal
element (ISE). Deletion of the ISE results in altered differentiation-associated expression result-
ing in loss of transgene expression in the immediate suprabasal layers. These studies suggest
that AP1 and Sp1 factors are required for appropriate differentiation-dependent involucrin
expression, and that multiple, spatially distinct, DNA elements must be engaged to drive nor-
mal in vivo expression. Fra-1 is a key AP1 transcriptional regulator that is required for human
involucrin expression. We show that the p300 nuclear histone acetyltransferase synergistically
increases Fra-1 dependent involucrin promoter activity. Chromatin immunoprecipitation reveals
that Fra-1 and p300 are bound to the DRR region, and co-precipitation studies reveal that Fra-
1 forms a complex with p300 that includes JunB, and P11 column chromatography removes
a factor that is required for p300 interaction with the Fra-1/JunB heterodimer. These findings
indicate that a complex which includes Fra-1/JunB, p300 and additional bridge proteins is
required for synergistic activation of involucrin promoter activity by a complex that includes
Fra-1/JunB and p300.
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The langerhans cell hypothesis in cutaneous T cell lymphomas revisited
J Valencak,1 C Jonak,1 M Der-Petrossian,1 B Streubel,2 A Chott,2 R Knobler1 and F Trautinger1
1 Department of Dermatology, Medical University of Vienna, Vienna, Austria and 2
Department of Pathology, Medical University of Vienna, Vienna, Austria
Based on experimental models and early morphological studies the Langerhans cell (LC)
hypothesis suggests that cutaneous T cell lymphomas (CTCL) are diseases of chronic T cell
stimulation by LC mediated antigen presentation. In the present work we used langerin (CD207)
and CD3 to investigate the spatial association of LC and T cells in various types of CTCL in
situ. 27 paraffin embedded specimens with the diagnoses of mycosis fungoides (MF, n=19),
primary cutaneous anaplastic large cell lymphoma (PCALCL, n=1), lymphomatoid papulosis
(LyP, n=2), and primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma
(PCPTCL, n=5) were double-labeled with monoclonal antibodies against langerin and CD3.
Samples were evaluated by confocal laser scan microscopy. In epidermotropic infiltrates of
MF we found that the distribution and density of epidermal LC was unchanged compared to
normal skin. Dermal infiltrates in MF and PCPTCL were in most cases associated with increased
numbers of dermal LC, that were located between the CD3+ cells. In PCALCL and LyP, a clear
association between LC and CD3+ cells could not be found. Our results indicate that in MF
an association between LC and CTCL cells might exist. In contrast, in PCALCL and LyP, which
are characterized by a different phenotype and clinical presentation, this association could
not be found. We conclude that the LC hypothesis might not apply to all types of CTCL.
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Alteration of the environmental stress response during cellular senescence: preventive effect
of the insaponifiable from Argan (Argania spinosa) pulp
C Baudouin, M Haure, P Afonso and M Charveron Cell Biology Laboratory, Pierre Fabre
Research institute, Toulouse, France
Aging is an inevitable and irreversible event. First signs are visible on the skin. The massive
release of reactive oxygen species causes oxidative stress, a powerful mediator of early skin
aging. Fundamental skin alterations are prominent in epidermis and dermis and involve fibrob-
lasts, that lose their reactivity during proliferative senescence. Aging is associated with a strong
decreasing of environmental stress response: a decline in the inductability of some heat shock
proteins has been observed during aging. HSPs possess essential function to maintain protein
integrity and play a key role in the “adaptative response” by protecting organisms from stress.
In this study, we have induced fibroblasts senescence by an oxidative treatment (H2O2) and
we have analyzed the induction level of 72-kDa HSP (HSP72) after heat treatment, in young
and senescent fibroblasts. First, we have demonstrated a marked decrease in the expression
of the inducible HSP72 protein and mRNA in senescent fibroblasts exposed to heat shock in
comparison to young fibroblasts. Before the evaluation of Argan in this model, we have ana-
lyzed its effect against oxidative cellular injury at membrane level. Thus, we have shown the
antioxidant dose-dependent property of the vegetal extract with a maximal lipid peroxidation
reduction of more than 35% at 3µg/ml. Finally, we have clearly shown that this vegetal extract
(1-3µg/ml) totally restored the HSP72 protein induction in senescent fibroblasts and dose-
dependently restored the HSP72 mRNA induction also. In conclusion, the age-related alter-
ations of the HSP72 induction could seriously increase the vulnerability of organ like skin to
environmental stress. The insaponifiable from Argan pulp possesses antioxidant activity and
is able to limit biological consequences of cellular senescence like the lost of the HSP72
inductability. These in vitro studies reinforce the preventive properties of the insaponifiable
from Argan pulp against skin disorders observed during aging.
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Differentiation-induced expression of specific C/EBP isoforms in skin and prostate epithe-
lial cells
S Anand,1 N Sato,1 T Hasan3 and EV Maytin2,1 1 Biomedical Engineering, Cleveland Clinic,
Cleveland, OH, 2 Dermatology, Cleveland Clinic, Cleveland, OH and 3 Wellman Center for
Photomedicine, Harvard Medical School, Boston, MA
CCAAT enhancer binding proteins (C/EBPs) are a family of leucine zipper transcription fac-
tors that control proliferation and differentiation in a cell- and tissue-specific manner. Recent
studies have established their functions in diverse cellular environments of adipocytes, hepa-
tocytes, keratinocytes, etc. We are studying the role of differentiation-inducing agents in the
expression of C/EBPs in keratinocytes and prostate carcinoma cells (LNCaP). We are also inter-
ested in the effects of forced expression of C/EBPs on expression of coproporphyrinogen oxi-
dase (CPO), a heme biosynthetic enzyme that can increase the production of protoporphyrin
IX (PpIX) during ALA-mediated photodynamic therapy (PDT) of cancers. Because Vitamin D
(Vit D) is known to induce cellular differentiation and PpIX production in LNCaP cells, we
asked whether Vit D can induce a similar effect in organotypic cultures of rat epidermal ker-
atinocytes (REKs) grown at the air-liquid interface in the presence of Vit D, followed by ALA
(1mM, 4h) prior to harvest. Confocal images of frozen sections revealed increased PpIX lev-
els in response to subnanomolar concentrations of the Vit D. Vit D specifically induced expres-
sion of LAP and LIP, two isoforms of C/EBPβ in REKs. The response of LNCaP cells to Vit D
was quite different, resulting in several-fold inductions of C/EBPδ and of LIP, the inhibitory
isoform of C/EBPβ. Induction of a CPO-promoter luciferase construct by C/EBPs was demon-
strated by co-transfection followed by luciferase assays in LNCaP cells. In gel shift assays,
C/EBP consensus binding sites from the CPO promoter interacted with nuclear lysates from
COS-7 cells overexpressing C/EBPs. Together, these findings establish transcriptional regula-
tion of CPO by C/EBPs. Overall, the data suggest that differentiating agents which increase
C/EBP transcription factors may be useful to increase CPO expression and PpIX levels prior to
PDT, thus enhancing PDT efficacy.
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∆Np63α promotes caspase-dependent apoptosis of human epidermal keratinocyte by mod-
ulating Bax and Bcl-xL levels
L Zhu,1,2 EA Rorke1,3 and RL Eckert1,2 1 Physiology & Biophysics, Case School of Medicine,
Cleveland, OH, 2 Dermatology, Case School of Medicine, Cleveland, OH and 3
Environmental Health Sciences, Case School of Medicine, Cleveland, OH
The p63 family of tumor suppressor proteins play an important role in regulating renewal and
differentiation in surface epithelia. In the present study we examine the impact of expression
of TAp63α and ∆Np63α on survival of cultured normal human foreskin keratinocytes. Expressed
TAp63α and ∆Np63α is detected in the nucleus of cells after adenovirus-mediated delivery.
In contrast to TAp63α, ∆Np63α expressing keratinocytes display decreased proliferation and
enhanced membrane blebbing. This phenotype is associated with altered expression of cell
cycle regulatory proteins including increased p53 and p21, and decreased cyclin D1 and
cyclin E suggesting that the reduction in cell proliferation is due to changes in cell cycle reg-
ulators in the G1 phase of the cell cycle. Cyclin B1, cdk2 and cdk4 levels are not changed.
In addition, expression of ∆Np63α results in a loss of mitochondrial membrane potential and
enhanced cleavage of procaspase-9, -8 and -3, and PARP. The activation of apoptosis is asso-
ciated with increased expression of an unusual high molecular weight form of Bax that was
detected with two independent anti-bax antibodies, a reduction in the level of the anti-apop-
totic protein, Bcl-xL, and an increase in pro-apoptotic Bcl-xS expression. These studies indi-
cate that ∆Np63α has the ability to reduce normal human keratinocyte survival by reducing
cell proliferation and increasing apoptosis.
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New role for adipose tissue in skin physiology and wound healing
R Mandil-Levin,1,2 E Brener,1 M Ben Hamo,2 O Nov,1 M Meir,2 I Solomonik,2 T Tennenbaum1
and L Braiman-Wiksman2 1 Bar Ilan University, Ramat Gan, Israel and 2 HealOr Ltd., Ness
Ziona, Israel
Maintenance of normal skin physiology is crucial for the prevention of pathological changes
that are associated with aging and variety of chronic diseases such as diabetes and vascular
disease. Here we show, for the first time, that subcutaneous fat and its derived hormones
(adipokines) directly affect skin physiology and are actively involved in wound healing
processes. While the functional role of visceral adipose tissue is to provide protective padding
and to function as an endocrine organ, subcutaneous (SC) fat is considered to exclusively
provide insulation. We have studied the role of SC fat in skin in vitro and in vivo utilizing pri-
mary skin keratinocytes treated with adipocytes-secreted hormones: adipsin or adiponectin.
Cell migration, differentiation and proliferation were analyzed. In addition, we have performed
in vivo wound healing experiments on the back of C57BL mice. Wounds were treated with
PBS (control), adipsin or adiponectin and healing processes were analyzed 6 days post wound-
ing. Wound healing assessment was studied utilizing immunohistochemistry on paraffin embed-
ded tissue sections following the distribution of keratin 14 (basal epidermal layer formation),
keratin 1 (spinous layer differentiation), PCNA (mitosis) and H&E (dermal contraction and
remodeling) at the wound gap. Our in vivo studies show that early stages of wound healing
are associated with recruitment of adipocytes to the wound area. Moreover, adipsin and
adiponectin substantially promoted keratinocytes migration and differentiation in vitro. These
observations were further corroborated by in vivo studies where topical treatment with adipsin
or adiponectin accelerated wound healing stages including: epidermal closure, epidermal dif-
ferentiation and dermal contraction when compared to non treated wounds. Taken together,
our results indicate an important role for SC fat in skin wound healing which is facilitated
through secretion of adipokines such as adipsin and adiponectin.
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Inhibitory activity of physiological LEKTI fragments
CC Deraison,1 CC Bonnart,1 FF Lopez,2 RR Robinson,3 AA Jayakumar,4 FF Wagberg,5
MM Bratssand,6 JJ Hachem7 and A Hovnanian1,8 1 INSERM U563, Toulouse, France, 2
INSERM U531, Toulouse, France, 3 Wellcome Trust Centre for Human Genetics, Oxford,
United Kingdom, 4 Department of Head and Neck Surgery, Houston, TX, 5 Arexis AB,
Gothenburg, Sweden, 6 Dermatology and Venereology, Umea, Sweden, 7 Vrije Universiteit,
Brussels, Belgium and 8 Medical Genetics, Toulouse, France
LEKTI is a 15-domain serine protease inhibitor whose defective expression is responsible for the
severe autosomal recessive ichthyosiform skin condition, Netherton syndrome (NS). Pro-LEKTI is
rapidly cleaved by proprotein convertases before secretion of LEKTI fragments. Using transfection
of CHO and furin-deficient CHO cells with a cDNA encoding LEKTI, we demonstrate a key role
of furin in the processing of pro-LEKTI. Unlike CHO cells, furin-deficient CHO cells were unable
to process pro-LEKTI. Colocalization of LEKTI and furin in the granular layer is consistent with a
role of furin in physiological LEKTI processing. LEKTI proteolytic fragments of similar molecular
weights ranging from 10 to 65 kDa, were detected in the medium of transfected CHO and human
keratinocytes, as well as in human epidermis. Therefore, they probably correspond to biologi-
cally active LEKTI domains. Several LEKTI fragments were produced in heterologous systems:
D1, D1-D6, D5, D6, D8-D11, D9-D15. Their inhibitory activity was determined against a large
panel of serine proteinases involved in skin desquamation and inflammation. D8-D11 showed
the most potent inhibitory capacity, with a Ki<10 nM for kallikreins hK5 and hK14. Kinetic study
of the interaction between D8-D11 and hK5 revealed a rapid and irreversible inhibition (kD =
3,27.10-12 M). In contrast, D1-D6, D5, D6 and D9-D15 were less potent inhibitors of hK5 (10
nM<Ki<120 nM). D1-D6, D5 and D8-D11 but not D9-D15 inhibited hK7 with a Ki of 60 nM.
This inhibition profile of LEKTI fragments confirms that LEKTI is a key regulator of enzymes involved
in desquamation (hK5, hK7 and hK14). Our results demonstrate the high specificity of each LEKTI
fragment and highlight the importance of proteinase / inhibitor balance in skin physiology.
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Pattern of lipid peroxidation in heat-treated keratinocytes
MJ Abraham, CN Young and B Savoy Dermatology, Wayne State University School of
Medicine, Detroit, MI
Lipid peroxidation results in cellular injury and is often indicative of oxidative stress in cells.
Lipid peroxides are unstable and decompose to form many compounds including reactive car-
bonyl compounds, of which malondialdehyde (MDA) is widely used as an indicator of lipid
peroxidation. Despite widespread knowledge that heat induces lipid peroxidation, heat-induced
peroxidation in skin cells is poorly understood. In this study, we investigated the susceptibil-
ity of primary keratinocytes as well as immortalized human keratinocytes (HaCaT cells) to lipid
peroxidation induced by heat stress. Keratinocytes were cultured and heat-treated at 42 degrees
celsius over a range of time. Lipid peroxidation was assessed by measuring the amount of MDA
produced by the cells over 10 minute intervals. When primary keratinocytes, derived from
neonatal foreskin, were exposed to heat MDA production increased over time. At 30 minutes,
a three-fold increase above background (untreated primary keratinocytes) was observed. Peak
MDA production occurred at 1 hour (4 times above background) and returned to basal levels
by 2 hours. HaCaT cells, an immortalized keratinocyte cell line, were also tested. Similarly,
MDA production was observed to increase over time in response to heat. This study reveals
that cultured human skin cells exposed to heat-induced oxidative stress exhibit lipid peroxi-
dation as determined by MDA production. Furthermore, the data suggest that skin-derived
human cell lines provide a useful model system for the evaluation of antioxidant therapy.
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Regulation of epidermal late-differentiation genes via Arnt-dependent pathway in primary
mouse keratinocytes requires chromatin remodeling
AV Mezentsev,1 SM Kalachikov2 and AA Panteleyev1 1 Dermatology, Columbia University,
New York, NY and 2 Genome Center, Columbia University, New York, NY
To evaluate a role of histone acetylation in the regulation of genes comprising the epidermal
differentiation complex and assess the contribution of Arnt to chromatin remodeling, we per-
formed a transfection of primary mouse keratinocytes with the Arnt-expressing vector, pAL-
TER-mArnt, followed by the treatment of cells with trichostatin A (TSA), a specific inhibitor of
histone deacetylases. Total RNA isolated from the harvested cells was converted to cDNA
and analyzed for the expression of selected genes that are members of the epidermal-differ-
entiation complex located on mouse Chromosome 3. Although cell transfection led to 10-
fold increase of Arnt mRNA, regardless of treatment with TSA, it had different consequences
for gene expression in TSA-treated versus untreated cells. Interestingly, the expressions of Ivl
and of Lor, the most upregulated genes (25 and 60 fold, respectively) in the transfected and
TSA-treated cells, did not appear in the Arnt-transfected keratinocytes that had normal his-
tone-deacetylases activity (no TSA treatment). The opposite effect, downregulation, although
in the lower range was observed in Arnt-transfected and TSA-treated cells for Sprr2i (20%) and
Sprr2j (60%). In addition, S100a8, S100a9, and Sprr1a were faintly upregulated (~50%) in the
transformed TSA-treated cells, and the expression of Sprrl1 was slightly upregulated in the
transfected cells, regardless of treatment of those cells with TSA. The level of S100a10 was
not affected. We conclude that the function of Arnt in the control of epidermal late-differen-
tiation genes is not limited to the role of transcription factor and may also comprise partici-
pation in chromatin remodeling via an interaction as a cofactor with histone deacetylation
complexes. This interaction is probably reflected in Arnt-induced downregulation of the selected
genes even in the presence of the histone deacetylases inhibitor and in strong upregulation
of late-differentiation genes in the Arnt-deficient keratinocytes.
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The patterns of periderm shedding in mice and the role of Arnt in regulation of this process
AV Mezentsev,1 SM Kalachikov2 and AA Panteleyev1 1 Dermatology, Columbia University,
New York, NY and 2 Genome Center, Columbia University, New York, NY
The periderm is a transitory epithelial sheet that forms an interface between the embryonic
epidermis and the amniotic fluid. The functions and fate of the periderm in murine fetal skin,
as well as the molecular mechanisms that control its development and shedding, have not
yet been elucidated. It is a common view that, as occurs in humans, shedding of the murine
periderm occurs prenatally and is a prerequisite for the formation of the epidermal barrier.
However, it was also shown that the murine periderm is retained to postnatal days 4-5. Here,
we used EM, immunohistochemistry, qPCR and microarray hybridization to study the peri-
natal epidermis in wild type and Arnt-flox/K14-Cre mice that die immediately after birth due
to barrier defects. In contrast to human periderm, mouse periderm is bilayered and is shed in
two steps: the overlaying outer periderm (OP) is shed prenatally, whereas the glycogen-rich
inner periderm (IP) is retained after birth, likely providing an additional provisional barrier
during transition of mouse newborns into the terrestrial environment. The Arnt-null epidermis
is characterized by impeded development of the IP (abnormal peridermal granules) and by
atypical postnatal retention of the OP. On the molecular level, retention of both peridermal
layers in the Arnt-null newborns is reflected by upregulation of periderm-specific keratins Krt2-
6a and Krt-18. Neonatal Arnt-null epidermis also showed upregulation of Gjb2, Capn2, and
Areg, which are all specific for early stages of mouse periderm development. EM revealed
retention of gap junctions (GJ) in the superficial layers of Arnt-null epidermis. This finding is
in line with upregulation of Gjb2 (Gjb2 is a major component of GJ and a negative regulator
of periderm shedding) and suggests a possible pathomechanism of OP retention in the Arnt-
null pups. Our results broaden the role of the Arnt gene in epidermal development, and sug-
gest that deferral of periderm development may contribute to the failure of permeability-bar-
rier formation in Arnt-null fetuses.
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Ultrastructural localization of laminin 5 and integrins α6β4 and α3β1 in the epithelial tongue
of in vivo human cutaneous wounds
RA Underwood,1 ML Usui,1 WG Carter2,3 and JE Olerud1 1 Medicine/Div. Dermatology,
University of Washington, Seattle, WA, 2 Pathobiology, University of Washington, Seattle, WA
and 3 Fred Hutchinson Cancer Research Center, Seattle, WA
Subsequent to wounding, keratinocytes must quickly restore barrier function. In vitro wound
models and wounds created on transgenic animals serve to elucidate many cellular mechanisms
of wound closure. To evaluate these mechanisms in vivo, we used ultrathin cryomicrotomy to
concomitantly observe tissue ultrastructure and immunogold localization of laminin 5 and asso-
ciated integrins α6β4 and α3β1 in unwounded skin and 1 to 2 day human cutaneous wounds.
In unwounded basal keratinocytes, localization of the β4 integrin subunit shows expected
dominant hemidesmosomal association and minor lateral cell-cell expression. The expression
pattern in the migrating epithelial tongue remains plasma membrane localized but without asso-
ciation with morphologically identifiable hemidesmosomes. Reduced cell periphery labeling is
seen in leading edge keratinocytes with concentrations of β4 in cytoplasmic vesicles and cell
projections. The α3 integrin subunit is associated with filopodia and does not concentrate in
cytoplasmic vesicles. The association of the α3 subunit with filopodia is independent of the basal
vs. suprabasal position or adjacent vs. proximal location of keratinocytes to the migrating tongue
and exhibits an apparent inverse relationship with desmosomal density. Immunogold labeling
of the uncleaved α3 chain of laminin 5 shows increased cytoplasmic localization in basal cells
adjacent to the leading edge with strongest labeling at the migrating tip. Labeling then decreases
gradiently along the wound face toward the upper layers of the epidermis. Proximal to the migrat-
ing tongue, where the basement membrane is being reestablished, moderate cytoplasmic label-
ing of basal cells is seen with deposition of laminin 5 in the lamina lucida. Localization of laminin
5 and integrin subunits β4 and α3 in the in vivo human cutaneous wound is consistent with
mechanisms of re-epithelialization hypothesized from wound healing models.
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Human S100A15 is regulated by calcium, cytokines, and bacterial compounds
AS Buchau,1 G Kukova,1 V Lewerenz,1 R Wolf,1,2 T Ruzicka1 and M Walz1 1 Department of
Dermatolgy, Heinrich Heine University, Duesseldorf, Germany and 2 Center of Cancer
Research, National Institute of Health, Bethesda, WA
The human S100A15, a new member of the calcium-binding S100 family, was found to be
overexpressed in psoriatic lesional and non-lesional skin in comparison to normal skin. In nor-
mal skin, S100A15 expression is restricted to the basal cell layer, whereas in psoriatic skin
S100A15-staining has been found also in upper epidermal layers. Two transcript forms of 0,5
kb (S100A15S) and 4,4 kb (S100A15L) were detected. The functional relevance of this protein
is still under investigation. Various members of the S100 proteins are overexpressed in inflam-
matory skin diseases, wound healing, and skin cancer. Most of the S100 genes are located on
chromosome 1q21, that encodes the epidermal differentiation complex. It is assumed that
S100A15 plays a role in differentiation processes and innate immune responses in the skin.
The aim of this in vitro study was to identify effects on the mRNA-expression of S100A15
upon stimulation with calcium, cytokines and bacterial compounds. We performed RT-PCR
analysis using specific for primers for both S100A15 transcripts to study the influence of these
stimuli on the mRNA-expression of S100A15S and S100A15L in human primary keratinocytes
(HKC). Treatment of HKC with calcium concentrations of 0,12mM and 1,2mM to induce ker-
atinocyte differentiation resulted in increased expression of S00A15S and S100A15L. Stimu-
lation experiments with TNF-alpha, IFN-gamma and IL-1beta lead to an increase of S100A15L-
mRNA after 6 and 24 hours. S100A15S-mRNA was downregulated by TNF-alpha after 1 hour
and IL-4 and IL-13 after 6 hours treatment. After stimulation of HKC with the supernatant and
pellet obtained from heat-killed Staphylococcus aureus, Escherichia coli, and Pseudomonas
aeruginosa an upregulation of mRNA-expression of both S100A15 isoforms was observed.
These data demonstrate that the expression of human S100A15 is regulated by calcium,
cytokines and bacterial compounds. In future, further experiments are necessary to elucidate
the function of this protein.
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Hyaluronic acid and managing cytotoxic agents
R Verdicchio1 and O Mills2 1 Verdi Enterprises, Succasunna, NJ and 2 Robert Wood Johnson
Medical School, New Brunswick, NJ
Hyaluronic acid (HA) and its salts are polymeric mucopolysaccarides which are film formers
and slowly release the HA into the skin. Most HA is retained as a protective barrier in the stra-
tum corneum. HA can hold up to 1000 times its weight of water making it the most highly
hydrophilic compound known. HA is found in all tissues of the body with about 56% of the
total found in the skin. The polymer matrix likely contains interstitial spaces which can hold
drugs making it effective via injection in vivo and topically. Hydrophobic drugs such as fluo-
rouracil (FU) can travel through the matrix for delivery. HA’s ability to repair and restore healthy
skin at the cellular level cannot be overestimated. HA can be used for the promotion and
restoration of abraided skin including mitigation and or deletion of side effects often associ-
ated with drugs used for actinic keratosis (AK) and other skin conditions. Drugs designed for
the treatment of AKs such as 3% diclofenac sodium (DS) with 2.5% HA are well tolerated and
effective. DS is a hydrophobic compound which likely is released via the above mechanism
with small amounts of HA. Both effectively penetrate pre-cancerous lesions suggestive of a
synergy. Preclinically HA has was an effective carrier, enhanced cellular penetration, lower
toxicity, increased response rates and prolonged survival. One trial with HA in combination
with FU and doxorubicin showed no alteration of pharmoknetics. HA likely can be com-
bined with other cytotoxic agents particularly for skin such as in the treatment of AKs. The
treatments using FU etc in a 5% cream employ either stearic or isostearic acid as emulsifier
components and the chemistry would suggest that HA/drug interference is unlikely as HA has
alternating carboxylic acid groups which would be less likely to complex with the tertiary
amine in FU compared to stearic/isostearic monomers. The benefits of using HA as a carrier
for topical 5FU to treat AK’s would likely mitigate side effects and enhance cellular uptake.
The mechanism for mitigation of side-effects could be a sustained release of the drug from the
polymer matrix.
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Robust bone marrow stem cells migrate to the engrafted newborn mouse skin and provide
the epidermal keratinocytes
K Tamai,1,2 T Yamazaki,1 S Otsuru,1 Y Kikuchi,1 T Chino,1 I Katayama,2 J Uitto3 and Y Kaneda1
1 Gene Therapy Science, Osaka University Graduate School of Medicine, Suita, Osaka,
Japan, 2 Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
and 3 Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA
Despite recent studies on the plasticity of bone marrow stem cells (BMSCs) to the epidermal
keratinocytes, the rarity of the BMSCs-derived keratinocytes in vivo have evoked controver-
sial arguments on the roles of BMSCs for maintenance of the epidermal structures. Here, we
investigated our hypothesis that maximal recruitment of BMSCs, if any, would occur in the
engrafted newborn mouse skin, which must develop enormous number of the follicular and
interfollicular keratinocytes under severe hypoxic condition. Concretely, the skin sheets of
newborn and adult mice were surgically engrafted onto the back of 8 week-old mice with
prior transplantation of GFP-transgenic bone marrow cells after lethal dose X-ray irradiation,
and examined appearance of GFP-positive epidermal cells in the grafts in various time points.
In a week after the skin grafting, dense migration of GFP+ mesenchymal cells appeared in the
upper dermis of the newborn skin graft, whereas only sparse GFP+ cells in the adult skin graft.
In 2 to 4 weeks after engraftment, various regions of newly generated follicular and interfol-
licular epidermis were significantly composed of GFP+ keratinocytes, and some regions exhib-
ited full thickness of GFP+ epidermis, suggesting existence of BMSCs-derived epidermal stem
cells. Recruitment of the GFP-transgenic BMSCs to the skin graft was further enhanced by trans-
plantation of the type VII collagen gene (COL7A1) null newborn mouse skin, which required
rapid proliferation of the epidermal keratinocytes due to frequent detachment of the epider-
mis from the dermis. The COL7A1 null skin graft exhibited more than 50% occupancy of the
follicular and interfollicular epidermis with GFP+ keratinocytes at 4 weeks after engraftment.
These data suggest that BMSCs may provide epidermal stem cells in the newborn skin, espe-
cially of severe epidermolysis bullosa patients.
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Desmoglein 1 coordinates early morphogenetic events during human epidermal develop-
ment in vitro
S Getsios,1 LJ Sheu,2 RL Dusek,2 C Simpson,2 T Gocken,2 ML Cornwell,2 S Crawford2 and
KJ Green2,1 1 Dermatology, Northwestern University Feinberg School of Medicine, Chicago,
IL and 2 Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL
Desmoglein 1 (Dsg1) is concentrated in desmosomes present in the upper layers of skin. Acute
loss of Dsg1 function causes superficial skin blisters in adults with pemphigus foliaceus but
the epidermis remains relatively intact in patients with DSG1 mutations, resulting instead in
a palmoplantar keratoderma. Meanwhile, this adhesion molecule is already present during
epidermal development in day 14 mouse embryos. These observations led us to hypothesize
that Dsg1 regulates early morphogenetic events which complement its adhesive role in the
uppermost skin layers. To focus on these initial stages, we used an organotypic model of human
epidermis and found that Dsg1 expression was coincident with the onset of stratification and
continued to increase over time. Viral delivery of shRNAs was used to reduce Dsg1 levels
(>80%), resulting in widened intercellular spaces and ultrastructural alterations in the suprabasal
layer desmosomes. The lack of Dsg1 profoundly inhibited the vertical expansion of keratinocytes
compared to controls, resulting in a thinner epidermis but without detectable differences in
Ki67 or TUNEL labeling, suggesting the steady state of the epidermis was not grossly affected
at this stage of development. Whereas structural proteins (desmocollin 1, keratin 10) present
in the suprabasal layers of controls were low in Dsg1-silenced cultures, premature cornified
envelope formation revealed by conventional electron microscopy and an increase in the
levels of late stage markers, such as loricrin and transglutaminase 1, indicated that terminal
differentiation was accelerated in the absence of Dsg1. Remarkably, the onset of Dsg1 expres-
sion coincided with enhanced transit of keratinocytes out of the basal layer allowing for the
recovery of this stratified epithelium. We believe these studies place Dsg1 in an early instruc-
tive pathway that drives the transit of keratinocytes through the epidermal differentiation pro-
gram.
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A bioengineered model of epidermal barrier injury: acetone treatment leads to hyperplasia
and differentiation in REK organotypic cultures
G Ajani,1 N Sato,1 JA Mack1,2 and EV Maytin1,2 1 Biomedical Engineering, Cleveland Clinic
Foundation, Cleveland, OH and 2 Dermatology, Cleveland Clinic Foundation, Cleveland, OH
Repeated injury to the stratum corneum of the skin by friction, soap, and organic solvents
elicits a hyperproliferative response characteristic of atopic dermatitis and xerotic eczema.
Previous studies by us and others have shown that acetone, applied to the skin of hairless mice,
leads to disruption of the stratum corneum and causes epidermal hyperplasia. To better under-
stand the molecular mechanism(s) behind this response, we have developed a bioengineered
in vitro model of acetone-induced injury in a 3-D, organotypic epidermis. Our model has the
unique feature of not requiring fibroblasts to support keratinocyte growth and stratification.
Rat epidermal keratinocytes (REKs), grown at an air-liquid interface for five days on a colla-
gen raft can differentiate, stratify, and develop all morphological and molecular markers of a
true epidermis, including a well-developed cornified layer. Five day lift cultures were treated
with 30-second exposures of topically-applied acetone and then harvested at 48 hours. The
tissue was then subjected to standard histological, immunohistochemical, and western analy-
ses along with computer aided measurements. Hyperplasia was maximal at 3 acetone expo-
sures, whereas tissue death occurred at 4 or more acetone exposures. Proliferation was upreg-
ulated with 2 exposures as shown by a significant increase in Ki67 (p<.01) and BRDU (p<
.025) labeled cells in the suprabasal layers. Three exposures led to heightened differentiation
as evident by (1) a large increase in K10 and Filaggrin, (2) increased transglutaminase activ-
ity, and (3) a thickened stratum corneum (p<.025). In summary, we have established an organ-
otypic epidermal model of barrier injury in which acetone exposure leads to epidermal hyper-
plasia and/or enhances differentiation, depending upon the extent of injury. The fact that this
model requires no dermal elements provides a unique opportunity to study the intrinsic ker-
atinocyte response to barrier injury.
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Skin-specific calcium-binding protein, Scarf and its roles during epidermal differentiation
J Hwang,1 O Kalinin,1 M Hwang,1 E Anderson,2 MJ Kim,3 SH Lee3 and MI Morasso1 1
Developmental Skin Biology Unit, NIAMS/NIH, Bethesda, MD, 2 Proteomics and Mass
Spectrometry Facility, OD, NIDDK/NIH, Bethesda, MD and 3 Department of Dermatology,
Yonsei University College of Medicine, Seoul, South Korea
The novel Ca++-binding protein Scarf (skin Calmodulin-related factor) belongs to Calmod-
ulin-like protein family and is expressed in the suprabasal (differentiated) layers of the epi-
dermis starting at day 15.5 of mouse embryonic development. To better understand the func-
tion of Scarf during epidermal stratification we performed studies to determine Scarf interacting
factors. Immunohistochemical detection of Scarf and its interacting proteins after acute epi-
dermal Ca gradient disruption (repeated tape-stripping of hairless mouse skin) were carried
out. Concomitantly, to obtain a detailed expression pattern of Scarf throughout development,
we generated transgenic mice carrying the reporter gene beta-galactosidase under the con-
trol of the endogenous Scarf promoter (Scarf/LacZ). These studies established that: 1. Scarf
interacts with 14-3-3 sigma, 14-3-3 beta, annexin V, calreticulin, ERp72 and nucleolin, most
of which are engaged in calcium-related signaling pathway. 2. Expression of Scarf is induced
by epidermal calcium gradient disruption while expression of 14-3-3 sigma and 14-3-3 beta
is repressed. Tape stripping has no effect on calreticulin, ERp72 and nucleolin expression. 3.
The temporal and spatial detection of the beta-galactosidase reporter in the Scarf/LacZ trans-
genic mice, suggest that Scarf expression precedes the formation of the water barrier in the
stratified epidermis.
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Epidermal stem cells: the relationship between rapid adhesion to collagen and long-term
repopulating ability
L Strachan and R Ghadially Dept. of Dermatology, UCSF & VAMC-SF, San Francisco, CA
Epidermal stem cells (ESCs) are responsible for maintaining and healing the epidermis in the
midst of constant keratinocyte turnover. Previously, our lab has shown that 1 in 35,000 total
murine epidermal cells are capable of long-term reconstitution (over 9 weeks) of a squamous
epithelium using a competitive repopulating assay in combination with limiting dilution analy-
sis (PNAS 2003 <b>100</b>:11412). Given that adhesion to ECM proteins is a negative reg-
ulator of keratinocyte differentiation, it has been proposed that collagen-adhering keratinocytes
may be enriched for ESCs. In support of this concept, human keratinocytes that rapidly adhere
to collagen IV have a higher colony-forming efficiency (CFE) compared to those cells that
adhere slowly or not at all. However, the long-term repopulating ability of clonogenic ker-
atinocytes is unknown, and it has not been established whether ESCs are a subset of the colony-
forming population or a separate population altogether. Thus, we questioned whether rapidly
adhering murine keratinocytes would be enriched in ESCs and sought to determine the rela-
tionship between the clonogenicity and long-term repopulating (LTR) ability of these cells. As
shown previously, approximately 20% of murine keratinocytes rapidly adhered to 10 µg/mL
collagen IV within 5 minutes and roughly 30% adhered slowly (within 20 minutes). We found
that the frequency of LTR cells within a population of murine keratinocytes that rapidly adhered
to collagen (RACs) was similar to that of total keratinocytes. Interestingly, LTR cells were not
limited to the RAC group of cells. Furthermore, groups of cells that had similar CFEs differed
markedly in their ability for LTR. By comparing the CFEs of collagen-adhering keratinocytes
alongside with their ability to produce epidermis in a long-term functional assay, we have been
able to establish the relationship between short-term in vitro assays for clonogenicity and long-
term repopulating ability in vivo. Our results suggest that clonogenic assays may not be an
accurate surrogate for long-term repopulation assays to asses stemness.
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Topically applied Essential Fatty Acids (EFAs)
O Mills1 and D Besece2 1 Dermatology, Robert Wood Johnson Medical School, Doylestown,
PA and 2 Medical Affairs, JSJ Pharmaceuticals, Doylestown, PA
An essential fatty acid vehicle is used for the application of urea 40%. Urea has a long his-
tory of safety and efficacy in treating dry skin. The EFA components: Butyrospermum Parkii
Fruit Oil, Glycine Soja Sterol, Helianthus Annuus Oil, and Stearic Acid act to normalize trans-
epidermal water loss (TEWL), maintain hydration and elasticity, hydrate through penetration
and not occlusion and replace naturally occurring lipids in the extracellular matrix. This pres-
entation examines the role of this topically applied vehicle system. In addition to intrinsic fac-
tors, skin cells are vulnerable to environmental factors which can disrupt healthy functioning
skin. Essential fatty acids can address both intrinsic and extrinsic factors that influence the
organ’s health. Recently reported studies have shown the EFA system resisted removal of SC
layers, thereby preserving the integrity of the barrier. Strengthening the barrier through topi-
cal treatment applications should be of benefit in ameliorating the symptoms of skin irritation
as the result of exogenous trauma. Essential fatty acids bring a supportive system to skin cells
which helps in normalization.
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Functional roles of the erbB3 receptor in human keratinocytes
DL Farrington,1 DA Lewis2 and DF Spandau1,2 1 Biochemistry & Molecular Biology, Indiana
University School of Medicine, Indianapolis, IN and 2 Dermatology, Indiana University
School of Medicine, Indianapolis, IN
Key regulators of both the proliferative and differentiation signal transduction pathways in
epidermal keratinocytes are the erbB family of transmembrane tyrosine kinase receptors. Dereg-
ulation of erbB1, erbB2, erbB3 and erbB4 activity, due to mutation or change in expression,
is seen in many types of cancer. We have identified that three of the four erbB family mem-
bers are expressed in epidermal keratinocytes and in normal human keratinocytes grown in
vitro. The erbB1 receptor is widely expressed, has been extensively studied and is associated
with the induction of proliferative. Less is known about the function of erbB2 receptor in skin
but expression and activation is associated with the induction of differentiation. Although the
erbB3 receptor has been shown to be a critical signaling protein in other cell types, very lit-
tle is known about its function in the skin. Previous reports from our laboratory have demon-
strated that the erbB3 receptor is critically important for the appropriate response of human
keratinocytes to exposure to UVB. We have now examined the expression and localization of
erbB3 in normal human epidermis as well as in human keratinocytes grown in culture. The
expression pattern of erbB3 in these cells correlates with a functional role for erbB3 in ker-
atinocyte differentiation and the response to cellular stress. Specific changes in keratinocyte
nutritional support can greatly influence the expression of erbB3 protein and thus alter the
relative composition of all of erbB family members. Again, these changes are consistent with
a functional role for erbB3 in the differentiation of keratinocytes.
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Expression and characterization of constitutively active human caspase-14
MK Kuechle,1 K Park,3 Y Choe,2 CS Craik,2 OT Lawrence3 and RB Presland3 1 Dermatology,
University of Washington, Seattle, WA, 2 Pharmaceutical Chemistry,, University of California,
San Francisco, San Francisco, CA and 3 Oral Biology, University of Washington, Seattle, WA
Caspase-14 is strongly expressed in stratifying, squamous epithelia, yet its role in epidermal
homeostasis has remained elusive. Unlike other caspases studied to date, caspase-14 does not
autoactivate when overexpressed in heterologous systems, rendering study of its regulation and
function difficult. To overcome this difficulty, we engineered a constitutively active form of
human caspase-14 by reversing the order of the large and small subunits in the procaspase-14
polypeptide chain. The hexahistidine-tagged reverse engineered human caspase-14, expressed
and purified from E. coli by nickel-chelate affinity chromatography, was active against the syn-
thetic caspase substrates YVAD and WEHD, and was inhibited by the pan-caspase inhibitor
zVAD-fmk. Using positional scanning of a synthetic combinatorial library, we determined the
substrate specificity of human caspase-14. As expected for a caspase, the P1 position showed
a strict requirement for aspartic acid (D). The P2 and P3 positions displayed a broader prefer-
ence, with charged residues preferred over hydrophobic residues at P3. The P4 position exhib-
ited a preference for aromatic or aliphatic amines, e.g. tryptophan (W) and tyrosine (Y), with
weaker activity shown with leucine (L) and isoleucine (I). Overall, a consensus consisting of
W/Y-X-X-D approximates the cleavage specificity of reverse caspase-14. The reverse caspase-
14 isolated from both E. coli and cultured mammalian cells demonstrated enzymatic activity
without the requirement for proteolytic processing. Overexpression of active caspase-14 in
mammalian cells had no apparent effect on cell morphology or viability. The reverse engi-
neered, constitutively active human caspase-14 should facilitate the search for relevant sub-
strates and be an invaluable tool for the study of enzyme activity regulation in vivo.
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Desmoglein 4 is expressed in the desmosomes of highly differentiated keratinocytes of human
epidermis and hair follicle
H Bazzi,1 A Getz,1 MG Mahoney,3 A Ishida-Yamamoto,4 L Langbein,5 JK Wahl6 and
AM Christiano2,1 1 Genetics & Development, Columbia University, New York, NY, 2
Dermatology, Columbia University, New York, NY, 3 Dermatology and Cutaneous Biology,
Thomas Jefferson University, Philadelphia, PA, 4 Dermatology, Asahikawa Medical College,
Asahikawa, Japan, 5 Cell Biology, German Cancer Research Center, Heidelberg, Germany
and 6 Oral Biology, University of Nebraska, Omaha, NE
Cell-cell junctions that seal the layers of the highly differentiated epidermal keratinocytes play
a pivotal role in the continuum of the skin barrier. Specifically, desmosomes, with their cell-
cell linking desmogleins (DSG) and desmocollins (DSC), are evolutionarily well adapted struc-
tures to withstand high mechanical stress and tension. We previously identified the newest
member of the DSG family, termed DSG4, in humans and rodents. We have also shown that
DSG4 mutations lead to hair shaft defects and other skin abnormalities in mice, rats and humans.
In this study, we studied in detail the expression pattern of DSG4 in the human epidermis and
hair follicle. Using highly specific and well characterized antibodies, we show that DSG4 reac-
tivity is localized mainly to the granular layer of the human epidermis as well as the hair shaft
cortex. We also show that DSG4 is expressed in highly differentiated human keratinocytes in
vitro, thus recapitulating its expression pattern in vivo. Moreover, using immuno-electron
microscopy in vivo and a GFP-tagged Dsg4 in vitro, we demonstrate for the first time that DSG4
is localized to desmosomes. Overall, we provide strong evidence that correlates DSG4 expres-
sion with the highest terminally differentiated states of human epidermal keratinocytes.
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Dermokine and keratinocyte differentiation associated protein are coordinately induced dur-
ing epidermal morphogenesis
H Bazzi,1 KA Fantauzzo,1 GD Richardson,3 CA Jahoda3 and AM Christiano2,1 1 Genetics &
Development, Columbia University, New York, NY, 2 Dermatology, Columbia University,
New York, NY and 3 School of Biological & Biomedical Sciences, Durham University,
Durham, United Kingdom
The mammalian epidermis and hair follicle (HF) are unique developmental systems charac-
terized by their capacity for continuous renewal (epidermis) and cycling (HF). The HF arises
due to a series of reciprocal signaling interactions between the embryonic skin epithelium
and mesenchyme. These early events of HF induction take place at around e14.5 days post
coitus (dpc) in the mouse, concomitant with the transformation of the simple epithelium to a
more differentiated and stratified epithelium. In this study, we performed microarray analysis
to study global gene expression changes during epidermal morphogenesis in the mouse at 12
hour intervals between e12.5 and e15.5 dpc. At each time point, we used enzymatic and
mechanical techniques to separate the embryonic skin dermis from the epidermis and each
RNA sample was hybridized to Affymetrix MOE430A arrays. Our list of significant transcrip-
tional changes has uncovered several new players in epidermal and HF morphogenesis (Rd12,
Gsn, Fap, Dlx5, Vav3) in addition to corroborating previously identified ones (Lor, K1/10, Dsc1,
Lef1, Ptch1/2, Bmp2). Interestingly, two recently identified genes that encode the secreted
peptides dermokine (Dkn) and keratinocyte differentiation associated protein (Kdap) are among
the most highly induced transcripts in the differentiating embryonic epidermis (>1000 fold).
Dkn and Kdap reside within a ~40Kb genomic cluster on mouse chromosome 7 that encodes
several soluble mediators of keratinocyte differentiation. Their temporally coordinated and
dramatic transcriptional upregulation during epidermal development suggests that they play
a significant role in the stratification process.
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Differential expression of claudin-1 and AQP3 on Chinese skin with aging and photoaging
M Juan,1 E Noblesse,1 M Bonnet-Duquennoy,1 N Lachmann,1 A Bernois,1 M Dumas,1
H Adhoute,2 J Sun,3 R Kurfurst,1 S Schnebert1 and F Bonte1 1 LVMH Recherche, St Jean de
Braye, France, 2 Dermexpert, Paris, France and 3 Chinese Academy of Medical Sciences,
Nanjing, China
The hydration properties of the skin are functions of a well-differentiated epidermis and a water
impermeable horny layer. Tight junction proteins (claudin-1) are key proteins in the control of
the water distribution of the interface between the horny layer and the epidermis. Aquaporin-
3 (AQP-3) forms molecular transmembrane water channels involved in epidermal water dif-
fusion. In human skin, the AQP3 protein is abundant in keratinocytes, expressed in all the lay-
ers of the human living epidermis and functional in terms of water flux. This study focuses on
the expression of AQP3 and claudin-1 in the epidermis of Chinese women as a function of
the age and the sun–exposure. A total of 30 healthy Chinese Women (21 to 68 years) took part
in this study of the clinical and histological features of their skin. Punch biopsies were taken
from photoprotected areas and photoexposed areas. Immunostaining on skin sections was per-
formed using an affinity-purified rabbit polyclonal antibody raised against the C-terminal
peptide sequence of AQP3 isoform and with a rabbit polyclonal antibody against Claudin-1
(Zymed). The staining was revealed by immunofluorescence and the expression of AQP3 and
Claudin-1 was quantified by pictures analysis after confocal microscopy observations. We
don’t observed any variation in AQP3 epidermis expression with age, whatever the sunlight
exposure. Moreover, we noted an decrease of this AQP3 expression in photoexposed skin,
especially observed for people over 40 years old, indicating that the response to chronic expo-
sure is age-dependant. For the claudin-1 expression, we observed an increase with age in the
sunprotected areas in comparison with the sunexposed areas. This difference is statistically
significant for the youngest group of subjects (<40 years old). We also observed statistically
decrease of the claudin-1 expression with the photoexposure.
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Caveolin-1 incorporation into lipid rafts in the outer stratum granulosum suppresses lamel-
lar body secretion in parallel with initiation of terminal differentiation
T Roelandt,1 M Huth,2 E Houben,1 D Crumrine,2 A Kutsumo,1 C Giddelo,1 KR Feingold,2
PM Elias2 and J Hachem1,2 1 Dermatology, AZ-VUB, Brussels, Belgium and 2 Dermatology
Research & Metabolism, University of California San Francisco, San Francisco, CA
Although Caveolin-1 (cav-1) has been proposed to facilitate lamellar body secretion, cav-1
knockout(ko)mice reportedly display a normal cutaneous phenotype. We hypothesized that
acute perturbations of the permeability barrier might reveal an abnormal phenotype in these
mice. Yet, tape stripping-induced barrier disruption instead revealed supernormal (i.e.,acceler-
ated barrier recovery) in cav-1 mice. Cav-1 null mice displaced increased lipid raft formation,
compared to wild-type (wt) mice following acute barrier perturbations, assessed by the in situ
cholera toxin assay. Increased raft formation was associated increased secretion of lamellar body
contents at the stratum granulosum (SG)-stratum corneum (SC) interface. In contrast, normal
hairless (and wt) mice displayed increased cav-1 deposition at the SG-SC interface 3 hours
after acute barrier disruption, although cav-1 protein mass did not change at any time point
after barrier disruption. These results:1) demonstrate that cav-1 ko mice display an abnormal
cutaneous phenotype that is revealed after the skin is stressed by tape stripping;2) rather than
facilitating secretion, as previously proposed, the principal function of cav-1 appears to serve
as a ‘brake’ on lamellar body secretion, perhaps in preparation for terminal differentiation.
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Identification of histamine receptors and reduction of squalene levels by an antihistamine
in sebocytes
E Pelle, J McCarthy, D Maes and T Mammone Skin Biology, Estee Lauder Res Labs, Melville,
NY
Acne is a common, worldwide dermatological affliction. Although the basic etiology of acne
is related to the colonization of skin by p. Acne, there are several other contributing factors
responsible for the production of lesions and inflammation all of which can be addressed in
the development of anti-acne treatments. Sebocytes are the major cell of the sebaceous gland
and are responsible for producing sebum. If sebum interferes with the process of follicular ker-
atinization, pore blockage occurs, leading to lesion formation. Thus, if sebum production could
be curtailed during an episode of acne growth, then perhaps the blockage of pores would be
reduced. Based on preliminary data (Discovery Partners, LLC) which showed that topically
applied diphenhydramine (DPH), an antihistamine, reduced stratum corneum lipids, we inves-
tigated the potential response of sebocytes to antihistamines.  Sebocytes (SZ95) were obtained
from C. Zouboulis and this cell line was then maintained and sub-cultivated in cell culture.
RT-PCR analysis revealed the presence of histamine receptor H1, but not H2, and thus indi-
cated that histamines and, conversely, antihistamines could modulate sebocyte function directly.
When sebocytes were incubated with 50 and 100 uM DPH, H1 receptor expression remained
unchanged but a significant decrease in squalene levels was observed. As determined by HPLC,
untreated sebocytes contained 6.27 (+/- 0.73) nmoles squalene/106 cells whereas for DPH-
treated cells the levels were 2.37 (+/- 0.24) and 2.03 (+/- 0.97) nmoles squalene/106 cells for
50 and 100 uM, respectively. Additionally, a cell viability test did not show any cytotoxicity
associated with DPH at these concentrations. In conclusion, our data show the presence of
histamine receptors on sebocytes, demonstrate how an antagonist to these receptors modu-
lated cellular function, and suggest that antihistamines may have a beneficial effect for the
treatment of acne.
www.jidonline.org   71
ABSTRACTS
427
Cytochrom P450 expression in skin equivalents
MM Neis, AF Wendel, Y Marquardt, S Joussen, R Heise, JM Baron and HF Merk Dermatology
and Allergology, RWTH, Aachen, Germany
Our long term goal is the development and optimization of an in vitro model for the study of
drug metabolism in human skin. Cytochrom P450 (CYP) enzymes are necessary for phase
one drug metabolism. Little is known about expression or inducibility of CYPs in organotypic
skin models. The only data that exists was obtained from human skin samples or mono layer
cell culture experiments with keratinocytes and fibroblasts. We constructed an organotypic
skin model by embedding fibroblasts from neonatal foreskins in a collagen matrix from calf
skin and by seeding keratinocytes on top. For comparison we bought commercialized skin
models from different companies. To induce enzyme activity models were treated with liquor
carbonis detergens. RNA was isolated by phenol chloroform extraction and purified. Gene
expression patterns were studied by cDNA microarray analysis. Microarray data was confirmed
by real time PCR. For quality control of the models and to detect and localize enzyme expres-
sion immunofluorescence staining was performed with antibodies against CYPs and struc-
tural proteins. The immunofluorescence staining demonstrated the regular structure of our
models. We could proof that CYP 1A1, 1B1, 2E1, 2J2, 3A5, 4B1 and 3A5 are expressed in
organotypic skin models. The expression of CYP 1A1 and 1B1 was highly inducible by treat-
ment with liquor carbonis detergens. The demonstration of CYP expression in organotypic skin
models is an essential step in the development of an in vitro model for the study of drug metab-
olism in human skin, because these enzymes are crucial for drug metabolism.
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Cholesterol inhibition down-regulates ceramide metabolism in human epidermal ker-
atinocytes.
JF Kerbleski,1,2 S Douangpanya,1,2 C Khaledy,1,2 PM Elias,1,2 Y Uchida1,2 and WM Holleran1,2
1 Department of Dermatology, University of California San Francisco, San Francisco, CA and
2 Dermatology Research Unit, V.A. Medical Center, San Francisco, CA
Since formation of the three critical epidermal barrier lipids, ceramides (Cer), cholesterol (Chol)
and free fatty acids, is simultaneously elevated during epidermal differentiation and in response
to barrier perturbations, we investigated possible mechanisms for coordinate regulation of their
respective biosynthetic pathways. Specifically, to determine whether levels of Chol might alter
corresponding Cer formation, we employed lovastatin (Lov), an inhibitor of HMG-CoA reduc-
tase, to reduce Chol formation/content in cultured human keratinocytes (CHK). Using real-
time quantitative PCR (qPCR), mRNA levels for key genes in the Chol and Cer pathways were
compared in CHK treated with Lov (5µM). As anticipated, mRNA levels for HMG-CoA reduc-
tase were elevated by Lov at 24h in both undifferentiated CHK (60-70% confluent in KGM
with 0.07mM Ca2+, 2.62±0.34-fold of control, p<0.02) and more-differentiated CHK (post-
confluent in 1.2 mM Ca2+ for 3d, 4.08±0.2-fold, p<0.01). In differentiated CHK, elevations in
HMG-CoA reductase mRNA levels were evident 1h after Lov treatment with peak values at
16h (4.64±0.36-fold of control, p<0.001). Conversely, mRNA levels for Cer synthesis genes,
including serine palmitoyltransferase (SPT), sphingomyelin synthase (SMS2), and glucosylCer
synthase (GCS), were decreased by Lov by 7h and maximally diminished for all Cer genes at
16h (0.66±0.06, 0.61±0.05, and 0.67±0.04-fold of control for SPT2, SMS2, and GCS, respec-
tively, p<0.05 for each). Consistent with the qPCR data, syntheses of Chol and the major sphin-
golipid species (Cer, GC, and SM) were significantly decreased after 24h of Lov. These data
reveal that decreased Chol production/levels lead to decreased de novo Cer synthesis, an effect
mediated by decreases in mRNA levels for key enzymatic steps in the Cer pathway, suggest-
ing coordinate regulation of Chol and Cer syntheses in the epidermis.
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Characterization of the human 3D in vitro skin model AccuGraftTM for wound grafting
B Schnegelsberg, K Chui and WK Hoeffler Xgene Corporation, Sausalito, CA
Current in vitro skin models consist of an epidermis or a composite model with keratinocytes
and fibroblasts embedded in a bovine collagen matrix or a biopolymer scaffold. Such mod-
els are based on solid dermal support membranes, complicating grafting applications by cre-
ating a physical barrier to the wound bed. In contrast, we have created an AccuGraftTM model
as an allogenic skin graft for burn patients. AccuGraftTM is based on our previously devel-
oped AccuskinTM 96-well product, both composed of normal primary human fibroblasts and
keratinocytes. In our current model we cultivate a mixed cell slurry in transwell inserts con-
taining 96-well plates for up to 14 days, which allows our patented cell self-sorting to occur,
creating distinct epidermal and dermal layers. H&E staining reveals undifferentiated full-thick-
ness human skin with the expected inverted morphology composed of a dermis, an epider-
mis and a basement membrane zone, both in serum containing or serum-free conditions.
Immuno-histological characterization using involucrin, CK 1/10, collagen I, collagen IV, laminin
5 and vimentin antibodies confirms that undifferentiated keratinocytes are on the bottom and
fibroblasts are at the top of the tissue. This unique feature of the AccuGraftTM allows the tis-
sue to be applied to the wound bed directly without a supporting matrix, suggesting a higher
cell survival supported by undifferentiated keratinocytes migrating into the wound bed, thereby
promoting healing and re-epitheliazation. MTT data show that the cells survive for up to 30
days in culture. ELISA results indicate that the AccuGraftTM in vitro skin model shows low lev-
els of TNF-β, IL-6 and IL-12. Therefore, we propose to use AccuGraftTM in future SCID mice
and human grafting experiments. Here we show that we have generated the first animal-prod-
uct free self-sorted full thickness human in vitro skin model with an inverted morphology
designed for skin grafting applications to avoid complications by solid dermal supports.
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The ultrastructural changes after the treatment with high and low frequency sonophoresis
H Kim,1 K Choi,2 J Jun,1 E Choi,3 S Ahn3 and S Lee1 1 Dermatology, Yongdong Severance
Hospital, Yonsei University College of Medicine, Seoul, South Korea, 2 Laboratory of Electron
Microscopy,Seoul Health College, Seoung Nam, South Korea and 3 Dermatology, Yonsei
University Wonju College of Medicine, Wonju, South Korea
Sonophoresis uses ultrasound to increase the percutaneous absorption of a drug. Even though
the mechanisms of action are incompletely defined, cavitation is believed to be responsible
for the ultrasonic permeabilization of cells and tissues such as skin. In a direct comparison,
low-frequency sonophoresis has always been proven to be more effective than high-frequency
sonophoresis, perhaps because of the inverse relationship between cavitation and frequency.
In this study, we examined the ultrastructural changes in electron micrographs after the treat-
ment with low-frequency sonophoresis and high-frequency sonophoresis. Immediately, that
is, at 15min after low-frequency sonophoresis, most of 2um~4um sized intracellular cavities
were observed in stratum basale, while some perinuclear cavities were shown in stratum gran-
ulosum and spinosum. The average number of cavities per cell was 3. At 3-hour after treat-
ment, the diameter of cavities were decreased (500nm~1um) and the average number of cav-
ities per cell was increased. (8~12 cavities per cell). The small sized cavity maintained the
intact round morphology, but large sized cavity were somewhat disrupted and fused with other
cavities . The numbers of perinuclear cavities were increased. By 6-hour after treatment, the
size of intracellular cavities was slightly decreased and the number was at maximum. At 12-
hour and 24-hour, most of cavities have disappreared, and the remaining cavities were very
small and restricted to perinuclear area. After the treatment with the high-frequency sonophore-
sis, these sequential changes were similar, but the sizes and numbers of cavities were smaller
than those of low-frequency sonophoresis. We suggest that these ultrastructural changes may
provide a new approach to explain the mechanisms of action in sonophresis treatment, and
perinulear cavities can be the direct physical signal of the barrier recovery.
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Physical characterization of the stratum corneum of an in vitro human skin substitute pro-
duced by the auto-assembly method and its comparison with normal human skin by ATR-
FTIR spectroscopy
R Pouliot,1,3 G Bernard2,3 and M Auger2 1 Pharmacy, Laval University, Quebec, QC, Canada,
2 Chemistry, Laval University, Quebec, QC, Canada and 3 Laboratoire d’Organogenese
Experimentale, St-Sacrement Hospital, Quebec, QC, Canada
Recent biotechnological progresses in the field of tissue engineering allow the conception,
development and production of biomaterials that can replace tissues or organs. It has been
demonstrated that tissue reconstruction can be applied to several different tissues such as skin,
blood vessels, cartilage, bones and corneas. Reconstructed human skin can be used as treat-
ment for deep burn patients. An in vitro human skin substitute may be obtained by the auto-
assembly method by culturing fibroblasts in a culture medium to produce dermal sheets. The
cultured keratinocytes are then added on top of two superimposed dermal sheets to produce
reconstructed human skin. After 21 days at the air-liquid interface, the skin substitute closely
resembles in vivo human skin. FTIR spectroscopy is a well-established method to evaluate the
order of hydrocarbon chains in terms of population of trans and gauche conformers, the pack-
ing behaviour, and phase transitions. It has been identified that stratum corneum permeabil-
ity depends on conformational order of lipids present in skin. Using a variety of techniques,
such as ATR-FTIR, we compared the physicochemical properties of the stratum corneum in
skin models derived from psoriatic cells with those derived from normal cells. The auto-assem-
bly method was used to produce substitutes affect by psoriasis, a very complex dermatosis.
Psoriatic skin is known to be more permeable than normal human skin. Our results suggest
that the stratum corneum of our psoriatic skin substitutes is less organized and more perme-
able than the one of normal human skin. The observations made from psoriatic skin substi-
tutes produced by tissue engineering concur with the observations made from psoriatic lesions
found on patients.
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Netherton’s syndrome in a patient with a heterozygous mutation and homozygous G1258A
polymorphism of SPINK5 (serine protease inhibitor, Kazal-type 5)
W Di, C Ong, RE Callard, RC Hennekam and JI Harper Institute of Child Health, UCL,
London, United Kingdom
It has been demonstrated that SPINK5 is a gene involved in skin barrier function. Mutations of
the gene cause Netherton’s syndrome (NS), a rare severe autosomal recessive skin condition.
The importance of SPINK5 in the skin has been further highlighted by the finding that G1258A
polymorphism (SNP) in SPINK5 is associated with atopic dermatitis (AD), a common skin dis-
ease sharing some clinical features with NS. However, the influence of this SNP on the integrity
and function of the epidermis remains to be established. In this study, we attempted to illus-
trate functional changes of SPINK5 with this SNP in the epidermis by examining skin tissues
with various genotypes of SPINK5 including mutation/mutation, mutation/wild type (wt) with
SNP and wt/wt. In addition to examination of the clinical phenotype and expression of SPINK5
encoding the protein LEKTI (lympho-epithelial Kazal type-related inhibitor), the function of
LEKTI was assessed by studying the regulation of its down-stream substrates: stratum corneum
trypsin-like enzyme (SCTE), desmoglein I (DesI) and protein markers associated with epider-
mal proliferation and differentiation (P&D). Results showed that patients with SPINK5 muta-
tions in both alleles had Netherton’s syndrome, a defective LEKTI expression, an increased
expression of SCTE, decreased expression of DesI and abnormal expressions of P&D markers.
One patient who had one mutant allele and one wild type allele and a homozygous G1258A
SNP, showed expression of LEKTI, but abnormal expressions of SCTE, DesI, and P&D markers
similar to that seen with mutations in both alleles. This patient had clinical features of Nether-
ton’s syndrome, including erythroderma and trichorrhexis invaginata of the hair shaft. As NS is
a recessive disorder, the disease phenotype occurs when a patient has mutations on both alle-
les. The finding in our patient, with a similar clinical phenotype, of one mutant allele and one
wt allele with G1258A SNP suggests impaired function of LEKTI with the polymorphism.
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Mechanism of immune rejection of transduced keratinocytes: Implications for cutaneous
gene therapy
Z Lu and S Ghazizadeh Dermatology, Columbia University, New York, NY
Host immune responses to therapeutic gene products are potentially serious complications
in the treatment of cutaneous genetic diseases by gene therapy. Controlling immune responses
to the therapeutic antigen is therefore critical for effective gene therapy. Using both in vivo
and ex vivo methods of gene transfer to mouse epidermal stem cells, we have previously shown
sustained transgene expression in mice tolerant to transgene products. In non-tolerant mice,
however, expression of a neoantigen resulted in potent immune responses and transgene
loss. Despite immune-mediated loss of transgene in both methods of gene transfer, the mech-
anisms of immune activation are likely to be different. In the current study, we have charac-
terized and compared immune responses in ex vivo and in vivo models of epidermal gene
transfer using green fluorescent protein (GFP) as a model antigen. In vivo transduction of mouse
skin with a retroviral vector encoding GFP resulted in Th1-type responses including GFP-spe-
cific CTL activity, a predominance of serum IgG2a, and gamma interferon-secreting cells
within the spleens and draining lymph nodes of transduced mice. In contrast, mice trans-
planted with ex vivo transduced keratinocytes expressing the same antigen displayed Th2-type
immune responses. These responses were characterized by greater levels of interleukin 4
secreted by lymphocytes, a lack of class I-restricted CTL immunity or memory, and a pre-
dominance of anti-GFP IgG1in serum. Moreover, histochemical analysis of the transduced tis-
sue indicated intense thickening of the epidermis and dermis, infiltration of inflammatory cells
including eosinophils, and degranulation of mast cells. Pretreatment of ex vivo transduced
mice with neutralizing anti-IL5 antibody to suppress eosinophil infiltration resulted in pro-
longed transgene expression. These findings underscore differences in the mechanism of
immune activation between ex vivo and in vivo methods of gene transfer and have important
implications in development of strategies for modulation of immune responses in gene ther-
apy.
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Novel mutations in cases of xeroderma pigmentosum group A with mild phenotype
Y Takahashi,1,2 Y Endo,1 K Onuma,1 Y Sugiyama,1 S Inoue,1 Y Tomita,3 M Takigawa2 and
S Moriwaki4 1 Basic Research Laboratory, Kanebo Cosmetics Inc., Odawara, Japan, 2
Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan, 3
Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan and 4
Dermatology, Osaka Medical College, Takatsuki, Japan
Xeroderma pigmentosum (XP) is an autosomal recessive disease associated with a defect in
post-UV DNA repair and is clinically characterized by hypersunsensitivity, abnormal pig-
mentation, and a high incidence of skin cancer. There are seven different genetic comple-
mentation groups, A through G, and a variant form. Thirty percent of patients with XP also
develop neurological abnormalities. The most frequently observed type of XP in Japan is XPA,
which is the severest form both in cutaneous and neurological symptoms. Here we analyzed
mutations observed in four middle-aged (30-45 y/o), newly diagnosed Japanese XPA patients
(XP17HM, XP21HM, XP42HM and XP43HM) whose cutaneous and neurological symptoms
were very mild. RFLP analysis showed that all patients had a heterozygous G->C transversion
at the splice acceptor site of XPA intron 3, where there is a strong hotspot of mutation in Japan-
ese XPA patients. We identified novel heterozygous mutations in exon 6, which were a sin-
gle base insertion (690insT) in XP17HM and a four bases insertion (T779insTT and 780insTT)
in other patients. These mutations led to the frameshift that created new premature termina-
tion codons, which were verified by detection of the estimated size of truncated proteins with
Western blotting. The amount of XPA mRNA was markedly reduced in all cases, even though
the expression level of protein was significant. These mutations are thought to be closely related
to the mild phenotype because they were located nearer to the C-terminal end than any of
the previously reported mutations in XPA patients. In particular, the very mild neurological
symptom in these patients implies that the truncation of XPA protein by these mutations causes
the impaired ability of the domain of exon 6, which interacts with transcription factor IIH.
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The common C2125T rather than a new del2084G mutation in the XPD gene determines
the xeroderma pigmentosum phenotype in a 15y old boy
S Emmert,1 T Ueda,2 U Zumsteg,3 SG Khan,2 P Laspe,1 K Zachmann,1 D Leibeling,1
A Bircher4 and KH Kraemer2 1 Dermatology, University Goettingen, Goettingen, Germany, 2
Basic Research Laboratory, National Cancer Institute, Bethesda, MD, 3 Pediatrics, University
Hospital Basel, Basel, Switzerland and 4 Dermatology, University Hospital Basel, Basel,
Switzerland
We examined a newly diagnosed 15y old boy (XP2GO) with signs of xeroderma pigmento-
sum (XP) and progressive neurologic symptoms. The parents are not consanguineous. Increased
sun sensitivity led to the diagnosis of XP at 2y of age and a strict UV protection scheme was
implemented. Besides recurrent conjunctivitis and bilateral pterygium, only mild freckling is
present on his lips until today. He exhibits reduced deep tendon reflexes, progressive deaf-
ness, and progressive mental retardation. Enhanced MRI shows diffuse frontal cerebral atro-
phy. Brittle hair with a tiger-tail pattern or cachectic dwarfism, cataracts, pigmentary retinopa-
thy, and spasticity are absent which would be typical symptoms of trichothiodystrophy (TTD)
or Cockayne syndrome (CS), respectively. XP2GO fibroblasts showed a reduced post-UVC
cell survival (D10=7.4 J/m2) and a reduced nucleotide excision repair capability as reflected
by reduced host cell reactivation of a UV-treated luciferase gene-containing reporter plas-
mid. Cotransfection of different wild-type XP cDNA containing plasmids assigned XP2GO to
the XP complementation group D. Mutational analysis of the XPD gene in XP2GO revealed
two different mutations: a common R683W amino acid change (C2125T) known to be asso-
ciated with XP and a novel frameshift mutation fs670Ç693ter (del2084G). The latter muta-
tion potentially behaves as a null allele. Thus, the R683W mutation predominately determines
the clinical XP with neurologic abnormalities phenotype, as mutations in the XPD gene may
result in six distinct clinical phenotypes, XP, XP with neurologic abnormalities, TTD, and XP/CS
complex, XP/TTD, or COFS syndrome.
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Hair follicle stem cell-targeted gene transfer and reconstitution system
Y Nakagiri,1,2 M Akiyama1 and H Shimizu1 1 Department of Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Japan and 2 Kao Corporation Biological
Science Laboratories, Tochigi, Japan
Gene transfer to hair follicle (HF) epithelium is an attractive approach for not only treating skin
diseases, but also many systemic disorders. In order to obtain stable and persistent transgene
expression and maximize the beneficial transgene therapeutic effects, the stem cell popula-
tion which locate in the bulge region of HF should preferentially be targeted. In this study, we
attempted to develop a gene transfer system for HF epithelial stem cells to maximize the ben-
eficial therapeutic effects. At first, we established a HF stem cell-rich culture system using cells
from rat vibrissa bulge cells. In vitro, primary cultures of bulge derived cells display self-renewal
characteristics of stem cells even if they are removed from their native niche and induced to
proliferate in culture. For persistent and stable transgene expression in HF stem cells, we trans-
ferred retroviral vectors encoding reporter genes into cultured HF stem cells. Subsequently,
we regenerated an entire HF epithelium and interfollicular epidermis engrafting cultured bulge
derived cells mixed with cultured dermal papilla cells into a silicone chamber implanted on
to the backs of immunodeficient mice. 4 weeks after transplantation, the grafts exhibited tufts
of hairs as well as complete interfollicular epidermis. We succeeded in reconstituting HFs
and their appendages in which these cells harbored a transgene reporter. The transgene expres-
sion was observed in all skin epithelial compartments including the HF epithelium, sebaceous
gland and epidermis. In addition, transgene expression was observed for at least 6 months.
We concluded that this “hair follicle stem cell-targeted gene transfer and reconstitution sys-
tem” may enable the stable expression of transgene in any part of the cutaneous epithelium
and provide longstanding therapeutic benefits if used for gene therapy. In addition, this sys-
tem has the potential to produce a reliable means for gene-function analysis and gene ther-
apy.
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Loss of heterozygosity and microsatellite instability in disseminated superficial actinic poro-
keratosis
ZV Zhang,1,2 W Huang,2 L Xiang,1 Z Niu,2 L Yang,2 C Gu1 and Z Zheng1 1 Department of
Dermatology, Huashan Hopspital, Fudan University, Shanghai, China and 2 Department of
Genetics, Chinese National Human Genome Center at Shanghai, Shanghai, China
Disseminated superficial actinic porokeratosis (DSAP) is an uncommon autosomal dominant
chronic keratinization disorder, characterized by multiple superficial keratotic lesions sur-
rounded by a slightly raised keratotic border. Recently, it was proposed that cytoskeleton dis-
organization in epidermal cells was likely associated with the pathogenesis of DSAP. The aim
of this study was to investigate the potential molecular mechanism leading to development of
lesions. Based on our previous genome-wide scan in a six-generation Chinese family with
DSAP, 100 heterozygous microsatellite markers spanning the whole genome were selected.
We studied specimens from 3 patients in this family with DSAP. DNA from lesional skins and
normal control DNA from the patients’ blood mononuclear cells were extracted. Using poly-
merase-chain-reaction microsatellite analysis, loss of heterozygosity and microsatellite insta-
bility can be assessed by Genescan and Genotyper software (ABI Prism). We identified both
loss of heterozygosity and microsatellite instability in DSAP lesions. All specimens we exam-
ined showed high frequency of loss of heterozygosity at seven or more loci on different chro-
mosomes. Our findings showed apparent genetic instability of the DSAP lesions. Ineffective
DNA mismatch repair system may be involved in the potential molecular mechanism of DSAP.
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Polymorphisms and the haplotype of STAT5A are associated with psoriasis in Koreans
J Lee,1 J Namkung,1 E Kim,1 T Park2 and J Yang1 1 Dermatology, Sungkyunkwan University,
Samsung Medical Center, Seoul, South Korea and 2 Statistics, Seoul National University,
Seoul, South Korea
Psoriasis is an autoimmune disease induced by T helper (Th)-1 lymphocytes and it is a type of
generalized inflammation. STAT 5 is expressed in most cell types. We wanted to discover
whether the STAT5A polymorphisms and haplotypes influence the susceptibility to disease
and the phenotype in psoriasis vulgaris patients. We obtained the DNA from 249 psoriasis
patients and 723 non-psoriasis subjects (535 atopic dermatitis patients and 188 normal con-
trols). We sequenced the whole genome of STAT5A and we found 13 polymorphisms, includ-
ing 7 new ones. We selected 4 single nucleotide polymorphisms (SNPs) to perform further
genotyping for a larger population, based on their linkage disequilibrium between the mark-
ers and the minor allele frequency (MAF). We evaluated the 4 SNPs of STAT5A for all the pso-
riasis and non-psoriasis subjects. All the polymorphisms were successfully genotyped. Hap-
lotype reconstruction revealed 5 of 8 possible haplotypes. Two SNPs in intron 8 (rs2293157),
2 SNPs in exon 16 (rs16967659) and one haplotype (TAT) showed significant association
with the psoriasis phenotype, and especially with early onset psoriasis. Our data indicates that
genetic variation within the STAT5A gene significantly contributes to the psoriasis phenotype.
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Towards profiling the gene expression of fibroblasts from atopic dermatitis patients: human
8K cDNA microarray
Y Park,1,2 Y Lyou,2 D Lee1 and J Yang1,2 1 Dermatology, Sungkyunkwan University School of
Medicine, Samsung Medical Center, Seoul, South Korea and 2 Clinical Research Center,
Samsung Biomedical Research Institute, Seoul, South Korea
cDNA microarray (human 8K) profiling of the primary cultured AD patients-derived fibrob-
lasts was conducted by a pooling method of the recruited 22 normal controls, the 10 extrin-
sic type (ADe) patients and the 10 intrinsic type (ADi) patients. SAM analysis of the microar-
ray results (2-fold cutoff) was conducted to select the candidate genes. Quantification by
real-time PCRs confirmed the array data in the randomized paired samples (normal vs. ADe
n = 10; normal vs. ADi n = 10). As a result, we listed the 22 up-regulated and 95 down-reg-
ulated genes in the AD fibroblasts. Real-time PCR results showed that several genes such as
hyaluronan synthase 2 (HAS2), tumor necrosis factor-alpha-induced protein 6 (TNFAIP6) and
interleukin 8 (IL8) were matched with the array results with statistical significance. These results
suggest gene expression profiles that are associated with AD and this implied that fibroblasts
may play important roles in the AD pathogenesis. We provided new insights into 3 candidate
genes such as HAS2, TNFAIP6 and IL8 with respect to their involvement in AD disease.
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Profiling of the dysregulated genes in the extrinsic type of atopic dermatitis: human 34K
oligochip microarray study
Y Park,1,2 Y Lyou2 and J Yang1,2 1 Dermatology, Sungkyunkwan University School of Medicine,
Samsung Medical Center, Seoul, South Korea and 2 Clinical Research Center, Samsung
Biomedical Research Institute, Seoul, South Korea
To gain more insights into the atopic dermatitis (AD) pathogenesis, we investigated the gene
alterations of extrinsic type of AD (ADe) from the patients’ biopsy samples via human 34K-
oligochip microarray. Significance analysis of microarray (SAM) results showed that 97 genes
were up-regulated and 131 genes were down-regulated compared to the normal control sub-
jects with a higher than 2-fold expression changes. Several important genes such as cytokines,
chemokines, antimicrobial peptides, immune response genes, lipids-related genes, extracel-
lular matrix (ECM) associated genes, and proteolytic enzymes were found to associate with
ADe. Interestingly, ECM related genes were mainly detected in the up-regulated patterns,
implied that they are closely associated with ADe pathogenesis in the local tissues. RT-PCR
results consistently showed that FceRI, fatty acid binding protein 7 (FABP7) and carboxypep-
tidase A3 (CPA3) were up-regulated while arylsulfatase F (ARSF), amphiregulin (AREG), gap
junction protein beta 2 (GJB2), glycolipid transfer protein (GLTP), hyaluronan synthase 3 (HAS3),
and histone 4H4 (HIST4H4) detected as down-regulated in ADe patients. Our large scale
microarray provided information to figure out the AD pathogenesis and its complexity, espe-
cially for the extrinsic type of AD.
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The recurrent N767S mutation in the ATP2A2 gene in a Japanese family with hemorrhagic
Darier’s disease mimicking epidermolysis bullosa simplex with mottled pigmentation
T Hamada,1 S Yasumoto,1 F Ono,1 JA McGrath2 and T Hashimoto1 1 Department of
Dermatology, Kurume University School of Medicine, Kurume, Japan and 2 Genetic Skin
Disease Group, St John’s Institute of Dermatology, King’s College School of Medicine, St
Thomas’ Hospital, London, United Kingdom
Darier’s disease (DD) is an autosomal dominant disorder caused by heterozygous mutations
in the ATP2A2 gene that encodes SERCA2. Clinically DD may show considerable heterogeneity
and data on specific genotype-phenotype correlation are limited. We studied a Japanese fam-
ily containing 10 affected individuals spanning three generations with an unusual clinical pres-
entation, acral hemorrhagic DD (HDD), that mimicked epidermolysis bullosa simplex asso-
ciated with mottled pigmentation. Affected family members had vesicles with surrounding
erythema on the hands and feet. Small pigmented brown-black macules were also evident on
the lower legs but there were no skin abnormalities in seborrheic areas. Light microscopy
revealed suprabasal clefting with acantholysis, while vacuolar changes within basal ker-
atinocytes or dyskeratotic cells were not present. To establish an accurate diagnosis in this
pedigree we sequenced the KRT5/14 and ATP2A2 genes. No mutations were found in KRT5/14
but we detected a heterozygous missense mutation, N767S, in ATP2A2. The presence and seg-
regation of the mutation was confirmed by restriction endonuclease digestion with HpyCH4IV.
The mutation N767S has been identified previously in non-Japanese subjects with HDD and
this particular amino acid substitution thus represents the most common mutation in HDD.
This finding provides a basis for genotype-phenotype correlation in this clinical variant of
DD. For optimal mutation detection, therefore, in individuals with HDD of any ethnic back-
ground, we recommend initial mutation screening by PCR amplification of exon 15 of ATP2A2
followed by restriction endonuclease digestion with HpyCH4IV. Such an approach will rap-
idly disclose the presence of the N767S mutation in several cases of HDD.
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The molecular basis of lipoid proteinosis: spectrum of mutations in the extracellular matrix
protein 1 gene (ECM1)
I Chan,1 L Liu,1 T Hamada,2 V Wessagowit1 and JA McGrath1 1 Genetic Skin Disease Group,
St John’s Institute of Dermatology, London, United Kingdom and 2 Department of
Dermatology, Kurume University School of Medicine, Kurume, Japan
Lipoid proteinosis (Urbach-Wiethe disease; hyalinosis cutis et mucosae) is an autosomal reces-
sive skin and mucous membrane disorder associated with a hoarse voice, skin infiltration and
scarring. In 2002, the disorder was mapped to chromosome 1q21 and pathogenic mutations
were identified in the ECM1 gene, encoding the glycoprotein extracellular matrix protein 1.
To ascertain the spectrum of pathogenic ECM1 mutations in lipoid proteinosis, we have
sequenced ECM1 in over 50 affected individuals and have identified 33 different mutations.
The mutations occurred in all exons but 20/33 were sited within exons 6 or 7 of the 10-exon
ECM1 gene. There were 14 small insertion or deletions, 12 nonsense mutations, 4 missense
mutations, two splice site mutations, and one large deletion (>1-kb). A number of ancestral
and recurrent mutations were documented. The most common recurrent hotspot mutation was
507delT in exon 6. This was detected on different genetic backgrounds in 6 unrelated fami-
lies. Other recurrent mutations included Q32X (exon 2) and R243X (exon 7). Ancestral mutant
alleles included 501insC (exon 6; Northern Europe) and Q276X (exon 7; South Africa). The
missense mutations comprised V10G (exon 1), F167I or F167L (exon 6) and L210P (exon 7).
The two splice site mutations were IVS1+1G>A and IVS7+1G>A. Despite the spectrum of
mutations identified, genotype-phenotype correlation was unpredictable with no association
of particular ECM1 mutations with clinical features such as intracranial calcification, epilepsy,
degree of laryngeal hoarseness or extent of skin involvement. This study provides insight into
optimal mutation detection approaches in lipoid proteinosis but demonstrates the limited
usefulness of delineating specific ECM1 gene mutations beyond just making an accurate molec-
ular diagnosis of this particular genodermatosis.
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Laminin 5 revertant skin expands during life
AM Pasmooij, HH Pas and MF Jonkman Dermatology, University Medical Center Groningen,
Groningen, Groningen, Netherlands
Somatic reversion of inherited mutations, i.e. ‘natural gene therapy’, giving rise to revertant
mosaicism has been described for a number of human genetic diseases. Although selective
growth advantages of revertant cells over their protein-deficient counterparts have been observed
in the genetic disorders of hepatocytes and blood cells, we show here for the first time the vis-
ible expansion of revertant keratinocytes during life. The investigated proband with non-Her-
litz junctional epidermolysis bullosa was compound heterozygous for a transition in exon 7
(628GÇA) and a nonsense mutation in exon 14 (R635X) in the LAMB3 gene resulting in a
severe reduction of laminin 5 expression. Remarkably, the skin of the patient’s left lower leg
that had always been fragile, reverted during life to being clinically unaffected without any
blistering tendency. Immunohistochemistry of the revertant skin revealed normal expression
of laminin 5. Interestingly, mutation detection disclosed the presence of different LAMB3 sec-
ond-site mutations correcting both the 5’ splice-site mutation 628GÇA. In one biopsy the
628+42GÇA mutation resulted in the use of a cryptic splice site in intron 7, giving rise to an
mRNA transcript with retention of 66 nt of intron 7, and consequently a 22-amino acid larger
β3-chain. In another biopsy the cells positive for laminin 5 showed a 596GÇC transversion
changing the glycine to an alanine codon (G199A), but more importantly, strengthening the
natural 5’ donor splice site of intron 7. Our data show that re-expression of laminin 5 has selec-
tion advantage for revertant epidermal stem cells compared to their silent counterparts. These
findings have important implications for gene therapy of EB, since its success might depend
on whether corrected stem cells will gain selective growth advantage.
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Development of genetically-modified human skin equivalents (HSE) for systemic in vivo deliv-
ery of atrial natriuretic peptide (ANP) for the treatment of hypertension.
J Therrien,1 CL Tock,1 M Ohyama1,2 and JC Vogel1 1 Dermatology Branch, National Cancer
Institute / NIH, Bethesda, MD and 2 Department of Dermatology, Keio Univ. School of Med.,
Tokyo, Japan
Skin is a very attractive organ for targeted gene therapy to systemically deliver therapeutic
proteins to treat cancers, skin diseases or systemic diseases. Since skin is a renewable tissue,
achieving long-term stable expression of a therapeutic gene requires targeting keratinocytes
stem cells (KSC), but specific extracellular markers to isolate living pure KSC populations do
not exist. We have therefore developed an in vivo system using a bicistronic retroviral vector
expressing the desired therapeutic gene and a linked selectable marker, multi-drug resistant
gene (MDR). Topical colchicine treatment can be used to select and enrich for cells express-
ing the bicistronic vector. As a model to validate our system we have chosen ANP as a thera-
peutic gene to treat systemic hypertension. ANP infusion can decrease blood pressure in hyper-
tensive patients and animal models, but stable long-term expression of ANP is required for
clinical application. We have now constructed and produced a retroviral vector containing
ANP and MDR genes with a viral titer 104-105 cfu/ml. HSE expressing ANP/MDR have been
engineered in vitro and have normal histology, similar to normal human skin. Prior to colchicine
selection, up to 33% and 39% of transduced human fibroblasts and human keratinocytes,
respectively, contain and express a functional MDR marker protein. The ANP expression by
bioengineered HSE was confirmed by immunofluorescence labeling and by a radio-immuno
assay (RIA) specific for ANP. The RIA shows that HSE expressing ANP were able to secrete
high levels of ANP, ~2400 pg/ml/4h, into the culture media. Taken together, these results sug-
gest that grafting genetically-modified HSE expressing ANP in immunocompromised mice
maybe able to produce sufficient ANP, systemically, to decrease blood pressure in the recip-
ient mice.
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Mutations in the desmoglein 4 gene are associated with monilethrix-like congenital hypotri-
chosis
Y Shimomura,1 F Sakamoto,1 N Kariya,1 K Matsunaga2 and M Ito1 1 Department of
Dermatology, Niigata University School of Medicine, Niigata, Japan and 2 Department of
Dermatology, Fujita Health University School of Medicine, Aichi, Japan
The gene encoding human desmoglein 4 (DSG4) was recently cloned, and a mutation in this
gene has been reported in several consanguineous Pakistani families affected with localized
autosomal recessive hypotrichosis (LAH). In addition, various mutations in the Dsg4 gene have
been identified in animal models of hypotrichosis that share a characteristic phenotype called
“lanceolate hair”. To date, the features of the hair shaft anomaly in patients with LAH have
not been well described. We report a Japanese patient affected with congenital hypotrichosis
that was originally diagnosed as monilethrix because she had a hair-shaft abnormality that
resembled moniliform hair. However, no mutations were found in the type II hair keratin genes,
hHb1, hHb3, and hHb6, whose mutations cause monilethrix. Instead, we identified novel
compound heterozygous mutations in the DSG4 gene of our patient. On the maternal allele
is a novel S192P transition within the ECII domain of DSG4; on the paternal allele is a novel
2039insT mutation leading to the generation of unstable transcripts. Here we present the obser-
vation that mutations in the DSG4 gene can cause monilethrix-like congenital hypotrichosis.
Based on our findings, we propose that LAH and monilethrix could overlap.
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Strain differences in vitamin A metabolism predispose C57BL/6J mice to cicatricial alope-
cia
HB Everts,1 DE Ong,1 L Sperling,2 LE King1 and JP Sundberg3,1 1 Vanderbilt University
Medical Center, Nashville, TN, 2 Uniformed Services University, Bethesda, MD and 3 The
Jackson Laboratory, Bar Harbor, ME
C57BL/6J mice sporadically get follicular dystrophy, follicular rupture, foreign body granulo-
mas, and various degrees of scarring, which is similar to human central centrifugal cicatricial
alopecia. Since disease severity and frequency varies with nutritional factors, markers of vita-
min A metabolism were compared between various strains and substrains of mice. Immuno-
histochemistry was performed with antibodies against retinol (Dhrs9/eRoldh) and retinal
(Aldh1a1, 2, and 3) dehydrogenases, and cellular retinol (Crbp) and retinoic acid (Crabp2)
binding proteins in samples from two separate studies. In the first study, C57BL/6J and C3H/HeJ
mice were wax stripped and samples collected every 3 days for 33 days. This was done to
experimentally reproduce barbering as a potential initiating cause of the skin disease. No dif-
ferences were found in progression through the hair cycle between these mouse strains and
no follicular dystrophy was induced. However, differences were found in the expression pat-
terns of some markers of vitamin A metabolism. Most notable was the reduced expression of
Crbp in the B6 mouse compared with the C3H/HeJ mouse during early anagen and late cata-
gen, stages when no clinical alopecia were seen in B6 mice. In a second study, four sub-
strains of B6 mice were compared. Dhrs9 was markedly upregulated in the 2 substrains with
the greater frequency of disease. We found that all four B6 substrains tested, but not C3H/HeJ
mice, had polymorphisms in alcohol dehydrogenase 4 (Adh4) that were previously reported
to reduce its activity. While Dhrs9 and Adh4 both oxidize retinol to retinal, only Dhrs9 rec-
ognizes Crbp-bound retinol. In addition, Adh4 was proposed to be involved in removal of
excess retinol. These data suggest that vitamin A metabolism may be altered in C57BL/6J mice,
thereby predisposing them to scarring alopecia resembling the central centrifugal cicatricial
alopecia that is seen in humans.
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Collaboration between dominant negative tuberin and p16 deficiency results in develop-
ment of T cell lymphoma in transgenic mice
B Govindarajan,1 JL Arbiser,1 C Cohen2 and DW Martin2 1 Dermatology, Emory University,
Atlanta, GA and 2 Pathology, Emory University, Atlanta, GA
Tuberous sclerosis is an autosomal dominant disorder that causes morbidity and mortality due
to seizures, mental retardation, hamartomas and benign and malignant neoplasms.Previously,
we generated a transgenic mouse that expresses a dominant negative tuberin behind the
cytomegalovirus promoter. This allele of tuberin causes upregulation of akt and reactive oxy-
gen, thus causing aberrant signaling and subsequent upregulation of vascular endothelial
growth factor. We have previously demonstrated that reactive oxygen induces neoplasia through
inactivation of p16. This can occur through hypermethylation of p16 or transcriptional silenc-
ing of p16 tumor suppressor gene through oncogenic proteins such as Id-1. Since dominant
negative tuberin activates reactive oxygen and akt, we hypothesized that crossing our trans-
genic mice into mice lacking p16 would result in malignant neoplasia. Consistent with our
hypothesis, an increased incidence of T cell lymphomas, compared with normal p16 defi-
cient mice was observed. These T cell lymphomas have a striking predilection of the liver, sim-
ilar to lymphomas associated with hepatitis C infection. Of intertest, chronic hepatitis C infec-
tion is associated with silencing of p16. Our transgenic mice thus act as a modifier of existing
genetic traits, and allow us to assess the effect of increased reactive oxygen signaling on a
defined genetic defect.
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Evolution in primates  of  a suite of late-differentiation related proteins including Desmoglein1
and components of the epidermal differentiation complex
LA Goldsmith and D Rubenstein Dermatology, UNC, Chapel Hill, NC
Genetic analysis suggests that in Primates there has been extensive evolution both of
desmoglein1(DSG1) coded on Chromsome 18  and proteins of the  Epidermal Differentiation
complex (EDC) coded on chromosome1. An in silico approach used public data bases to char-
acterize the evolutionary divergence of DSG1,EDC proteins and control proteins in two pri-
mates: rhesus monkey(Macaca mulatta)and man(h). Comparing hDSG1 with rhesus: 5% of
the amino acid residues in DSG1 residues 1-497(EC1 to EC4)  were divergent; in contrast  48%
of the residues in the 498-541 segment of EC5 were divergent. Furthermore, there was increased
amino acid divergence, between man and rhesus when the following EDC proteins were com-
pared (%difference in parentheses): involucrin(14.3), filaggrin(30.9), trichohyalin(14.4),
repetin(13.2) and hornerin(44). In contrast, other proteins in the EDC(including karzin,cornifin
A and B,PGLYRP 3 and 4, and S100 proteins), other desmosomal related proteins(including
plakoglobin, plakophilin 1 and 2, corneodesmosin,periplakin,desmoplakin,envoplakin), ker-
atin10, transglutaminases 1 and 3,RARs,RXRs and VDR had amino acid variability within the
range for the overall differences between rhesus and human genes. Nonsynonomous muta-
tions, altering amino acids, were more common in EC5 of hDSG1 than in the EC1-4 regions,
or cytoplasmic domain. Additionally, nonsynonomous mutations of hDSG1 EC5 were more
common  than in homologous regions of hDSG3,hDSG4, hDSG2, hDSC1, and hDSC2. The
non-neutral evolutionary changes between a protein partially on the cell surface(DSG1) and
a submembrane internal structure, the cell envelope, may be mediated through signaling path-
ways such as p38 MAP kinases or structurally mediated connections. These results suggest cel-
lular responses to the external physical and biological environment of the primate differenti-
ated keratinocytes have evolved in a relatively short evolutional time span.
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To investigate a pedigree with Dowling-Degos disease and mutation analysis of ADAR gene
M Li,1,2 X Dai,1,2 L Yang1,2 and X Zhu1,2 1 Department of Dermatology, The Wuxi Second
Affiliated Hospital of Nanjing Medical University, Wuxi, Jiangsu, China and 2 Department of
Dermatology, Wuxi No.2 People’s Hospital, Wuxi, Jiangsu, China
The objective of this study is to investigate clinical manifestation and pathogeny of a pedigree
with Dowling-Degos. Dowling-Degos disease is a rare genodematosis characterized by retic-
ulate pigmentary macules of the flexural areas. It was first reported by Wilson-Jones and Grice
in 1978 in their description of 10 patients. DDD is always associated with comedones and
follicular scarring. DDD has been reported in associated with hidradenitis suppurativa, men-
tal retardation, reticulate acropigmentation of Kitamura and trichilemmal cyst also. Here, We
investigated this pedigree and recorded the clinical features of every patient through the
proband. We also study the histopathology and ultrastructure of the lesion of the proband.
Mutation scanning was carried by PCR and direct sequencing. We can see typical pigmenta-
tion of the flexure and idiopathic guttate hypomelanosis on the abdomen and back. The biopsy
showed an epidermis that was acanthotic and had a pigmented and filiform or club shaped
epidermal ridge system that enclosed keratin pseudocysts. The ultrastructure showed increas-
ing melanin content in epidermal keratinocytes but no changes in the number of melanocytes.
No mutation was found in ADAR gene in this family. On the whole, we first report Dowling-
Degoes disease associated with idiopathic guttate hypomelanosis. we did not identify any
mutations in the ADAR gene of patients with Dowling-Degoes, indicating that this disease is
completely different from DSH.
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Fibroblasts are better gene therapy target than keratinocytes for retroviral COL7A1 transfer
D Sawamura, M Goto, K Ito, M Abe, W Nishie, K Sakai, A Shibaki, M Akiyama and
H Shimizu Dermatology, Hokkaido University School of Medicine, Sapporo, Japan
Dystrophic Epidermolysis Bullosa (DEB) is an inherited blistering skin disorders caused by
mutations in the type VII collagen gene (COL7A1) encoding type VII collagen. Therapeutic
introduction of COL7A1 into skin cells holds significant promise for the treatment of DEB.
The purpose of this study was to establish an efficient retroviral transfer method for COL7A1
into DEB epidermal keratinocytes and dermal fibroblasts, and to determine which gene-trans-
ferred cells can most efficiently express collagen VII in the skin. We demonstrated that gene
transfer using a combination of VSV-G pseudotyped retroviral vector and retronectin intro-
duced COL7A1 effectively into keratinocytes and fibroblasts from a DEB patient with lack of
COL7A1 expression. We have produced skin grafts with the gene-transferred or untreated DEB
keratinocytes and fibroblasts, and have transplanted them into nude rats. Interestingly, the
series of skin graft experiments showed that the gene-transferred fibroblasts supplied higher
amount of collagen VII to the new dermal-epidermal junction than the gene-transferred ker-
atinocytes. Also, an ultrastructural study revealed that collagen VII from gene-transferred cells
formed proper anchoring fibrils. These results indicate that fibroblasts show more potential as
target cells than keratinocytes in COL7A1 gene therapy of DEB.
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Follow-up analysis of PSORS9 in Chinese families: refine the critical interval to chromo-
some 4q31-32 and provide strong linkage evidence for early onset patients by order subset
analysis
X Zhang,1 K Yan,1 W Huang,2 S Yang,1 X Fan,1 M Gao,1 Y Cui,1 L Sun,1 Z Wang2 and J Liu3 1
Anhui Medical University, Hefei, China, 2 Chinese National Human Genome Center at
Shanghai, Shanghai, China and 3 Genome Institute of Singapore, Singapore, Singapore
Psoriasis linkage to 4q28-32 was initially identified by our previous genome-wide scan in 61
Chinese multiplex families of psoriasis. In this study, we performed a follow-up analysis of
PSORS9 using a greatly expanded sample size and considerably improved marker coverage.
By analyzing 13 markers surrounding PSORS9 in 151 families, we identified highly signifi-
cant LOD scores (HLOD = 4.53) at the marker interval D4S2997-D4S3033. Furthermore, our
analysis of the independent sample of 90 new families identified strong linkage evidence
(HLOD = 4.33), NPL = 3.15 (p = 0.00004)) at the same region. Both the linkage evidences
from the whole set of 151 families and the independent set of 90 new families suppressed the
suggested genome-wide criteria for significant linkage evidence and therefore confirmed the
original linkage finding at 4q28-32 from our genome-wide scan. We also incorporated mean
age at onset of each family as a covariate in linkage analysis using a procedure of ordered
subset analysis and clearly demonstrated that evidence for linkage to PSORS9 is concentrated
in the families of early-onset psoriasis. Using the GENEFINDER analysis and the 1-LOD-
down supporting interval analysis, we refined the location of PSORS9’s underline suscepti-
bility gene to a region of about 6 cM at 4q31.2-32.1. Taken together, our expanded follow-up
study of PSORS9 provided confirmative evidence for linkage, refined the location of under-
line susceptibility gene and thus greatly facilitates future susceptibility gene identification.
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Follicular occlusion triad: a case report and identification of the locus at chromosome 1p21.1-
1q25.3
S Yang,1,3 M Gao,1,3 P Wang,1,3 Y Cui,1,3 D Lin,1,3 K Zhang,2 Y Liang,1,3 L Sun,1,3 K Yan,1,3
F Xiao,1,3 W Huang2 and X Zhang1,3 1 Anhui Medical University, Hefei, China, 2 Chinese
National Human Genome Center at Shanghai, Shanghai, China and 3 Key Laboratory of
Genome Research at Anhui, Hefei, Anhui, China
The follicular occlusion triad is a rare autosomal dominant cutaneous disorder. It may occur
together with acne conglobata, hydradenitis suppurativa and dissecting cellulites of the scalp.
The genetic basis for this disease is unknown. In this study, we performed a genome-wide
scan in a four-generation Chinese family to map the chromosome location of the responsible
gene. We firstly identified a locus at chromosome 1p21.1-1q25.3 with the maximum LOD
score of 3.26 at the marker D1S2624 (at recombination fraction = 0.00).The other two point
LOD scores ≥3 were observed at markers D1S2695, D1S2726, D1S252 and D1S2777. Hap-
lotype analysis localized this locus to a 76 Mb region flanked by D1S248 and D1S2711. This
is the first locus for the follicular occlusion triad and it is useful for understanding of the molec-
ular mechanism of this disease.
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Restoration of type VII collagen expression and function in a mouse model of dystrophic
epidermolysis bullosa by lentivirus-mediated gene transfer
DT Woodley, R Ram, Y Huang, J Remington, Y Hou, P Bandyopadhyay and M Chen
Dermatology, University of Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders
caused by mutations in the type VII collagen (COL VII) gene and subsequent perturbations in
anchoring fibrils. We showed previously that intradermal injection of lentiviral vectors express-
ing human COL VII into an RDEB skin equivalent transplanted onto nude mice stably cor-
rected the subepidermal blistering and restored both Col VII and anchoring fibrils at the base-
ment membrane zone (BMZ). In this study, we assessed the ability of lentiviral vectors to achieve
COL VII gene transfer in vivo in a preclinical COL VII null DEB mouse that recapitulates the
clinical and ultrastructural features of RDEB. One to two day old DEB mice were intrademally
injected with increasing doses of vesicular stomatitis virus envelop G pseudotyped lentiviral
vectors encoding the COL VII transgene. Skin biopsies were obtained at various times after
injection and subjected to immunostaining using an antibody specific for human COL VII and
antibodies specific for cell-surface proteins to identify cell types. As early as two days after
injection, mouse fibroblasts and keratinocytes transduced by the lentiviral vectors synthe-
sized and deposited human COL VII within the mouse’s BMZ. Surprisingly, the delivered COL
VII expression was not only detected at the injection sites but also in sites far way from the
injection such as the paws and ventral surface of the animal. These results suggest that lentivi-
ral vectors may transported through the blood stream. The newly expressed COL VII reversed
the DEB phenotype characterized by poor epidermal-dermal adherence and anchoring fibril
defects and reduced new blister formation. Further, restoration of COL VII function signifi-
cantly increased the survival rate of the DEB mice. These data indicate that efficient and long-
term in vivo COL VII gene transfer into skin via direct lentiviral vector injection may offer a
valuable approach for the treatment of DEB.
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Injection of recombinant human type VII collagen corrects the disease phenotype in a dys-
trophic epidermolysis bullosa mouse.
J Remington,1 Y Huang,1 Y Hou,1 P Bandyopadhyay,1 R Ram,1 J Uitto,2 DT Woodley1 and
M Chen1 1 Dermatology, University of Southern California, Los Angeles, CA and 2 Jefferson
Medical College, Philadelphia, PA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders
caused by mutations in the type VII collagen (COL VII) gene. We showed previously that intra-
dermal injection of recombinant COL VII into transplanted human DEB skin equivalents sta-
bly restored COL VII expression at the basement membrane zone (BMZ) in vivo and reversed
the RDEB disease features. Prior to applying this approach to humans, it is necessary to uti-
lize a preclinical animal model to determine its safety and efficacy. In this study, we evalu-
ated the feasibility of protein therapy in a COL VII null DEB mouse which recapitulates the
clinical, immunohistochemical, and ultrastructural characteristics of RDEB in humans. We
intradermally injected purified human COL VII (10-15 microgram/injection) daily for 3 days
into the middle back of 1 to 2 day old DEB mice (N = 20) that exhibited blisters mostly on the
paws and ventral surface. Skin biopsies were obtained at various times after injection and
subjected to immunostaining and immunoelectron microscopy using an antibody specific for
human COL VII. We found that the injected human COL VII transported and incorporated
into the mouse’s BMZ as early as 2 days after injection and formed anchoring fibrils. Most
interestingly, the injected human protein was not only detected at the BMZ of the injection
sites, but also at remote areas far away from the injection site. The restoration of COL VII cor-
rected the RDEB disease features, including dermal-epidermal separation, new blister forma-
tion, and anchoring fibril defects. In addition, protein therapy also significantly increased the
life span of the animals. Our studies provide the first evidence for using protein therapy to
correct a skin disease in a preclinical animal model. These studies advance the prospects for
therapy for DEB patients and bring therapy for DEB one step closer to reality.
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Mapping and identification of a mutation in SAMD9 in 5 families affected with nor-
mophosphatemic familial tumoral calcinosis
O Topaz,1,2 M Indelman,1 I Chefetz,1,2 D Geiger,2 Y Althschuler,3 M Choder,2 A Metzker,4
D Berkovich,5 J Uitto,6 R Bergman,1,2 G Richard6,7 and E Sprecher1,2 1 Rambam Medical Center,
Haifa, Israel, 2 Technion Israel Institute of Technology, Haifa, Israel, 3 Hebrew University,
Jerusalem, Israel, 4 Sourasky Medical Center, Tel Aviv, Israel, 5 Migal, Kiryat-Shmona, Israel, 6
Thomas Jefferson University, Philadelphia, PA and 7 GeneDx, Gaithersburg, MD
Familial tumoral calcinosis (FTC) is a rare autosomal recessive disorder characterized by pro-
gressive deposition of cutaneous calcified masses resulting in painful ulcerative lesions. FTC is
classified into hyperphosphatemic FTC, resulting from mutations in GALNT3 or FGF23, and nor-
mophosphatemic FTC (NFTC) the genetic cause of which is still elusive. We identified 5 families
of Jewish Yemenite origin affected with NFTC. All patients initially presented with an erythema-
tous rash, followed at the age of 4-10 years by calcinosis cutis and gingivitis. Using a genome-
wide marker screen, we mapped NFTC to a 2.3 Mb interval on 7q21-7q21.3 (max. lod score=3.4)
harboring 23 positional candidate genes. A homozygous transition in SAMD9, a gene coding for
a protein of unknown function, was found to segregate with the disease in all families. This genetic
alteration results in substitution K1495E, affecting a residue highly conserved in mammals and
birds. We screened a panel of 1230 control chromosomes derived from unrelated healthy indi-
viduals of Jewish extraction. One of 92 individuals of Jewish Yemenite origin was found to be a
heterozygous carrier for this mutation and for the disease haplotype. These data suggest a founder
mutation carrier rate of 5X10-3, which fits the expected prevalence of the disease in the Israeli
Jewish Yemenite population. SAMD9 was found to be strongly expressed in endothelial cells and
significantly less in other tissues, corroborating histopathological studies which revealed initial
damage to dermal blood vessels in incipient FTC lesions. In conclusion our data demonstrate that
FTC is a genetically heterogeneous disease and suggest that SAMD9 may play a role in the con-
trol of extraosseous calcium deposition.
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Fine mapping of psoriasis-susceptibility locus within the HLA class II region
T Mabuchi,1 A Oka,2 Y Umezawa,1 T Matsuyama,1 Y Kubota,3 J Nakayama,3 T Terui,4
M Ozawa,5 S Yasumoto,6 T Hashimoto,6 S Ikeda,7 Y Matsumoto,8 H Sueki,9 M Iijima,9
H Inoko2 and A Ozawa1 1 Dermatology, Tokai University School of Medicine, Isehara,
Kanagawa, Japan, 2 Molecular Life Science, Tokai University School of Medicine, Isehara,
Kanagawa, Japan, 3 Dermatology, Fukuoka University School of Medicine, Fukuoka,
Fukuoka, Japan, 4 Dermatology, Nihon University School of Medicine, Itabashi, Tokyo, Japan,
5 Dermatology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 6
Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan, 7
Dermatology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan, 8 Dermatology,
Aichi Medical University School of Medicine, Aichi, Aichi, Japan and 9 Dermatology, Showa
University School of Medicine, Shinagawa, Tokyo, Japan
The association between psoriasis and the HLA antigens have been widely known. Besides
HLA class I antigens such as HLA-Cw6, the association with some alleles of HLA class II
genes have been reported. However, the role of the HLA class II region in susceptibility to
psoriasis is unknown. In order to map the psoriasis-susceptibility locus within the HLA class
II region, three hundred seventy five unrelated Japanese patients with psoriasis vulgaris and
375 unrelated Japanese healthy controls were studied by an association analysis using 15 poly-
morphic microsatellite markers. As a result, statistically significant differences were found at
three microsatellite loci. These results suggest that one of the psoriasis susceptibility genes
locates on HLA class II region in addition to HLA class I region. Summary of the results will
be reported in this meeting.
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A new approach to dissecting skin disease pathogenesis through cellular genomics
AS Haider,1 I Cardinale,1 M Blumenberg,3 J Ott,1 L Giuli,1 MA Lowes,1 JC Carucci2 and
JG Krueger1 1 Dermatology, The Rockefeller University, New York, NY, 2 Weill Medical
College, New York, NY and 3 New York Unversity, New York, NY
Eventually it will be possible to define and organize molecular pathology of skin diseases
through quantification of disease-specific gene sets. However, a major challenge arising from
large-scale expression studies in skin diseases is that assignment of expressed genes to spe-
cific cell types is not possible. Accordingly, to assist with analysis of psoriasis, and other skin
diseases including carcinomas in our laboratory, we defined cell-specific and activation-spe-
cific gene sets by studying cultured cell types relevant to these diseases. Analogous to mon-
oclonal antibodies that define cell lineages, we have now defined much larger sets of expressed
“lineage” genes that distinguish keratinocytes, fibroblasts, T-lymphocytes, monocytes and den-
dritic cells (DCs). Of note, most of our “lineage genes” differ from “lineage molecules” iden-
tified via monoclonal antibodies-this establishes a distinct view of molecular processes asso-
ciated with cellular differentiation. In addition, we have defined gene sets associated with
T-cell activation, DC maturation, and cytokine responses of several different cell types. We
applied these maps to gain insight into psoriasis vulgaris.  Surprisingly, psoriasis lesions express
more DC related genes (including those of mature DCs) than T-cell related genes, as well as
a large set of 116 genes defined as interferon-γ responsive. In contrast, only 20 TNF-regulated
genes were identified. Interestingly, a significant set of IL-20 induced genes was identified in
psoriasis, which induce both interferon and TNF-responsive genes. Our analysis suggests that
products of myeloid dendritic cells (IL-23, IL-20, nitric oxide, and many chemokines) are the
major upstream inflammatory inducers of psoriasis. A comparison with genes up-regulated
in squamous cell carcinomas also identifies DC-derived genes as most characteristic of pso-
riasis. These data show how cell-directed genomic analyses of skin disease may change con-
cepts of cellular pathogenesis.
459
Identification of elements regulating the alternate splicing of lysyl hydroxylase 2 (LH2) using
a functional 353bp LH2 minigene construct
HN Yeowell,1 LC Walker,1 MA Overstreet,1 A Siddiqui,1 DM Mauger2 and MA Garcia-
Blanco1,2 1 Medicine, Duke Univ Med Ctr, Durham, NC and 2 Mol Genet and Microbiol,
Duke Univ Med Ctr, Durham, NC
Lysyl hydroxylases catalyse the hydroxylation of specific lysines in collagen that are precur-
sors for cross-link formation essential for collagen integrity. Lysyl hydroxylase 2 (LH2) exists
in two alternatively spliced forms. The major form is the long transcript with the inclusion of
a 63bp exon (exon 13A) that is spliced out in the short form. LH2(long) and LH2(short) appear
to have specificity for hydroxylation of lysines in the telopeptide and helical collagen domains,
respectively. As LH2(long) is over-expressed in fibrotic cells, our goal is to define the regula-
tory elements affecting the splicing pathway. We have inserted 353bp of LH2 sequence con-
taining the alternatively-spliced exon 13A into a two-exon, one-intron adenovirus-derived
splicing plasmid, to give a functional minigene. Following transfection into HEK293 cells, the
pattern of minigene splicing in both transient and stable cell lines reflected that of endoge-
nous splicing of LH2 (LH2(long) to (short): 1 to 2). We have shown that cycloheximide (CHX)
suppresses endogenous expression of LH2(long) in HEK293 cells, suggesting that a newly-
synthesized protein factor is required for expression of the long transcript. CHX also sharply
decreased the long transcript in the minigene in the stable cell lines. The viability of the mini-
gene construct was supported by mutation of the weak splice site of intron 13A to a consen-
sus sequence. Stably-transfected cells showed inclusion of exon 13A to give a single long tran-
script of LH2, in contrast to the endogenous expression of both long and short transcripts.
This minigene provides us with a tool to examine the effect of both exon and intron enhancer
and suppressor sequences on the alternate splicing of LH2. As the expression of LH2(long)
and pyridinoline cross-links are significantly increased in fibrotic conditions such as sclero-
derma, analysis of the factors controlling the splicing pattern may offer potential sites for
therapeutic intervention.
461
Transgenic bone marrow cell transplantation in fetal mouse circulation induces continuous
immunotolerance against cutaneous transgene products after birth
T Chino,1,2 K Tamai,1,3 M Endo,1 S Otsuru,1 T Yamazaki,1 Y Kikuchi,1 I Katayama,3 Y Kitajima,2
J Uitto4 and Y Kaneda1 1 Gene Therapy Science, Osaka University Graduate School of
Medicine, Suita, Osaka, Japan, 2 Dermatology, Gifu University School of Medicine, Gifu, Gifu,
Japan, 3 Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
and 4 Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA
Since complete knockout mutations of the gene in both alleles will break immunotolerance
against the defected gene product, how to prevent adverse immune reaction against therapeu-
tic transgene products is critical issue for successful cutaneous gene therapy for severe reces-
sive diseases. In this study, we investigated effect of transgenic bone marrow cell transplanta-
tion (BMT) via fetal mouse circulation for induction of immunotolerance against cutaneous
transgene products. Concretely, we isolated GFP+ bone marrow cells (BMCs) from GFP-trans-
genic mice (C57/BL6 background) of 8 weeks after birth, and transplanted those GFP+ BMCs to
day 14 embryo of wild type syngeneic mice via a fetal vein in the uterus. On 8 weeks after birth
of the BMT mice, significant number of the transplanted GFP+ BMCs-derived cells were observed
in the skin, the thymus, the liver, the heart, the lung, the intestine, and in the bone marrow, indi-
cating successful induction of immunotolerance against GFP+ cells. We then transplanted the
full-thickness skin grafts of the GFP-transgenic mice on the back of the wild syngeneic mice
pretreated with or without fetal GFP+ BMT. More than 90% of the GFP+ skin was successfully
engrafted on the mice with fetal GFP+ BMT, whereas none of the skin grafts survived on the
control mice without fetal GFP+ BMT. Neither antibody nor cytotoxic lymphocyte (CTL) was
raised against GFP in the mice with fetal GFP+ BMT before and after the GFP+ skin engraft-
ment, suggesting efficient induction of central immune tolerance against transgene products by
fetal transgenic BMT. These results may provide future perspective for clinical application of the
fetal transgenic BMT to overcome adverse immune reaction against cutaneous gene therapy.
460
Efficient gene silencing in a human organotypic skin model
M Mildner,1 C Ballaun,1 M Stichenwirth,1 R Bauer,1 S Karner1 and E Tschachler1,2 1
Dermatology, Medical Univesity Vienna, Vienna, Austria and 2 CE.R.I.E.S., Paris, France
Knock out and transgenic animal models are indispensable tools to investigate the contribu-
tions of specific genes to organ development and homeostasis. Due to the expensive techni-
cal prerequisites as well as the long durations of animal experiments, the search for in vitro
alternatives has been intensified in recent years. Here we present a method to analyze spe-
cific gene knock down in a human in vitro skin equivalent model based on differentiating epi-
dermal keratinocytes on a fibroblast/ECM reconstructed dermis. Twenty four hours prior to
their seeding onto the dermal equivalents, human keratinocytes in monolayer cultures were
transfected with stealth siRNA for VEGF or matriptase. Skin equivalents with so treated KC
were subsequently grown for 7 days at the air/culture medium interface. Successful knock
down of the respective genes was confirmed by ELISA from the culture medium and Western
blot analysis of cell lysates, respectively. As reported for keratinocyte specific knock out ani-
mals, VEGF deficient skin equivalents did not show any signs of altered keratinocyte differ-
entiation. By contrast and similar to the skin of matriptase knock out mice transplanted onto
SCID mice, we found extensive hyper- and parakeratosis as well as impaired filaggrin pro-
cessing in the skin equivalents transfected with matriptase siRNA. Taken together our data show
for the first time that a knock down of specific genes mimicking the phenotypes of in vivo ani-
mal models can be achieved in a defined cell population in a complex in vitro organ culture
system. Using this approach will allow to reduce animal experiments in dermatological research
in the future.
458
Forced expression of the heat shock protein H11 causes growth arrest and apoptosis of
melanoma cells and inhibits tumor growth in xenograft models
B Li, JM Laing, C Smith and L Aurelian Pharmacology and Experimental Therapeutics,
University of Maryland School of Medicine, Baltimore, MD
The small heat shock protein H11 evidences cell-type specific silencing by aberrant DNA
methylation and its forced expression (with the de-methylating agent Aza-C) triggers apopto-
sis. The present studies use melanoma cells stably transfected with a tetracycline sensitive H11,
to examine the effect of H11 overload on cell fate determination. Doxycycline (Dox) treat-
ment caused a time-dependent increase in H11 expression, reaching maximal levels on day
3 post treatment. H11 overload was associated with growth arrest (first seen on days 1-2 post
Dox) and apoptosis. Activation of caspases-9 and-3 was seen as early as day 1 post Dox. It
was accompanied by a time-dependent increase in the % TUNEL+ (apoptotic) cells (70-85%
on days 3-4 post Dox). Immunoprecipitation/immunoblotting and immunocomplex PK assays
indicated that H11 bound and activated TAK1. TAK1 was not activated by the apoptosis dom-
inant negative H11 mutant, W51C, and caspase activation was inhibited with the dominant
negative TAK1 mutant K63W or the p38MAPK pharmacologic inhibitor SB203580. The data
indicate that apoptosis is caused by H11 mediated activation of the TAK1/p38MAPK pathway.
Growth arrest, resulting from H11 overload, was also caused by activated TAK1 through
phosphorylation of β-catenin and inhibition of MITF and CDK2, which are required for
melanoma cell proliferation. Studies of A2058 and LM xenografts indicated that Aza-C sig-
nificantly (p<0.001) reduced tumor growth through apoptosis caused by H11 overload
(H11/TUNEL co-localization in residual tumor cells). The data suggest that H11 is a promis-
ing target for the molecular therapy of melanoma and identify additional members of the pro-
apoptotic cascade.
462
Genome expression analysis of laser microdissected formalin-fixed and paraffin-embbeded
samples
A Meves and MR Pittelkow Dermatology, Mayo Clinic, Rochester, MN
The diagnosis of dermatologic disease is often biopsy-based. Most specimens are formalin-
fixed and paraffin-embbeded (FFPE) for routine H&E staining and/or immunohistochemistry.
Tertiary care referral centers with a high throughput of dermatologic specimens harbor thou-
sands of FFPE samples, including those with rare pathologies. We have sought to establish a
technique for genome expression analysis of laser microdissected FFPE samples using less than
1000 cells as starting material. FFPE specimens of nodular melanoma vs. dermal nevi were
microdissected using a PALM MicroBeam laser microdissection microscope and subsequent
pressure catapulting. RNA was extracted, purified and reverse transcriped using both random
and poly-dT primers. In contrast to conventional Eberwine-based amplification methods, cDNA
was amplified both at the 3’ and 5’ end. The resulting poly-A-sense RNA was subsequently
labeled for Affymetrix gene chip analysis by standard labeling techniques. While this ampli-
fication technique is promising, a number of caveats exist. Because cDNA synthesis of degraded
RNA is performed by using both random and poly-dT primers, overrepresentation of riboso-
mal RNA remains a problem. Protocol modifications are underway to further improve the accu-
racy and robustness of analysis.
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Oxidized phospholipids and UVA-1 irradiation share overlapping regulatory patterns for
antioxidant response genes
F Gruber,1 H Mayer,2 M Bilban,3 B Lengauer,1 E Muzig,3 R de Martin,2 O Wagner3 and
E Tschachler1,4 1 Dermatology, Medical University of Vienna, Vienna, Austria, 2 Center for
Biomolecular Medicine, Medical University of Vienna, Vienna, Austria, 3 KIMCL, Medical
University of Vienna, Vienna, Austria and 4 CE.R.I.E.S, Neuilly sur Seine, France
Arachidonic acid containing phospholipids that are present in cellular membranes and lipopro-
teins can gain biological properties as soon as they are modified by oxidation. We have pre-
viously identified UVA-1 irradiation as a novel source for the generation of specific oxdiation
products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC) that can induce
expression of the protective gene heme oxygenase 1 (HO-1). Preliminary data showed that
also other, but not all UVA-1 regulated genes can be induced by oxidation of PAPC. We hypoth-
esized that besides these genes a larger subset of protective, UVA-1 regulated genes would
also be responsive to treatment with oxidized phospholipids. To address this question, we
performed an expression analysis using microarray chips. Dermal fibroblasts were treated with
either UVA-1, PAPC or OxPAPC. We identified 39 genes, roughly 10% of the UVA-1 regu-
lated genes, to be also regulated by OxPAPC. Many of these are cytoprotective genes (phase
2 detoxifying enzymes),and redox-regulated cytokines. Bioinformatic analysis of the data
revealed that most enhancer regions of these genes contain antioxidant response element (ARE)
binding sites. In contrast, the genes regulated by UVA-1 alone were clustered by the “Bios-
phere” software into four groups that are responsive to IL-6 signaling and the transcription
factors AP-1, BMP-2 and CEBPB, respectively. Thus, we could demonstrate that a substantial
part of UVA-1 induced gene regulation can be attributed to lipid oxidation products of the
major membrane lipid PAPC. Induction of cell protective genes but not of other UVA-1 induced
proinflammatory genes like COX-2 or IL-6 makes oxidized phospholipids promising mole-
cules for drug development.
464
Twelve novel mutations in 14 xeroderma pigmentosum group A families: phenotype-geno-
type correlation and haplotype analysis
K Imoto,1 K Oh,1 J Boyle,1 H Inui,1 C Nadem,1 T Ueda,1 DB Busch,4 E Gozukara,2 S Khan,1
D Tamura,1 J DiGiovanna1,3 and KH Kraemer1 1 Basic Research Laboratory, National
Institutes of Health, Bethesda, MD, 2 Inonu Univ Med School, Malatya, Turkey, 3
Dermatology, Brown Med School, Providence, RI and 4 Deceased, AFIP, Washington, DC
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder. XP group A (XP-A) patients
have mutations in the XPA gene and a defect in nucleotide excision repair (NER). In this study
of 14 XP kindreds, we identified 14 mutations. There was 1 missense mutation and 6 dele-
tions, 4 nonsense, and 3 splice mutations that cause premature termination. Twelve muta-
tions were novel. We classified patients into 3 groups based on age and extent of neurologic
disease (mild, intermediate and severe) and found a genotype/phenotype correlation. Two
mutations were found in multiple kindreds. In order to examine whether these frequent muta-
tions arose from an ancestral mutational event or represented a mutational hotspot in the XPA
gene, haplotype analysis was employed. Four single nucleotide polymorphisms (SNPs) within
the XPA gene distinguished four haplotypes in the general population. Two haplotypes were
found in the 3 XP kindreds with 349 del CTTAT,  suggesting a possible mutation hotspot. One
haplotype was found in the 4 XP kindreds with 555G>C mutation, suggesting that this muta-
tion arose from a common ancestor.
465
Association study of a functional polymorphism in the Interleukin 1 receptor-like 1 gene
(IL1RL1, ST2) in atopic dermatitis
E Greisenegger,1 F Zimprich,2 T Kalhs,3 G Stingl,1 A Zimprich2 and T Kopp1 1 Department of
Dermatology, DIAID, Medical University of Vienna, Vienna, Austria, 2 Department of
Neurology, Medical University of Vienna, Vienna, Austria and 3 Medical and Chemical
Laboratory Diagnostics, Dostal, Vienna, Austria
The Interleukin 1 receptor-like 1 gene (IL1RL1, ST2), a member of the interleukin 1 receptor
family, produces a soluble and a membrane-bound form by alternative splicing which play a
crucial role in the TH2 immune response. Recently, a strong association of a functional poly-
morphism in the distal promoter region of the ST2 gene with atopic dermatitis was reported
in a Japanese population sample. The aim of our study was to investigate whether there is an
association of this polymorphism with atopic dermatitis in an Austrian population. Thus we
genotyped 169 patients with atopic dermatitis and 148 nonatopic normal volunteers as healthy
controls, all of European descent, for a functional polymorphism (rs6543116) in the ST2 gene
by direct sequencing. Although we found a slight underrepresentation of A-alleles and A-
homozygotes in the control population of similar magnitude (minor allele frequency of
rs6543116: 31,5% in controls and 37% in atopic dermatitis patients) as reported by Shimizu
et al.(2005), the results of this underpowered study did not reach statistical significance. We
conclude that more investigations are needed to assess the role of this interesting polymor-
phism in atopic dermatitis. Our data will be useful for future meta-analysis on this subject.
466
Hutchinson-gilford progeria syndrome mutant lamin A G608G localization and functional
implications
D McClintock,1 LB Gordon2 and K Djabali1 1 Department of Dermatology, Columbia
University, New York, NY and 2 Department of Pediatrics, Brown University School of
Medecine, Providence, RI
Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare disorder that is char-
acterized by accelerated aging and early death, frequently from coronary artery disease. Patients
with HGPS present very characteristic features: short stature, alopecia, sculpted nose, promi-
nent scalp veins, loss of subcutaneous fat, and prominent joints. Mutations in the LMNA gene
are responsible for this syndrome; as such HGPS belongs to the super-family of laminopathies.
The most common HGPS mutation corresponds to a heterozygous de novo single-base pair
substitution, G608G (GGC>GGT), within exon 11 of LMNA. This silent mutation elicits a par-
tial altered splicing leading to the deletion of 50 amino acids at the carboxyl-terminal tail
domain of prelamin A; the resulting product is denoted progerin. The lamins, the lamin A in
particular, are nuclear structural proteins that bind a number of important cellular regulators
and therefore may play a role in regulating their accessibility to fulfill their function. The prog-
erin mutation appears to elicit a tissue-specific pattern of alterations, involving primary tis-
sues with renewal potency: muscle, skin, and bone. We have generated a polyclonal anti-
body that specifically recognizes progerin. This novel and unique tool allowed us to detect
for the first time the truncated lamin A product progerin in HGPS fibroblast cells carrying the
LMNA G608G mutation. This formidable reagent also allows to define the cellular HGPS
phenotype and learn more about lamin A function(s).
467
Interaction of recombinant adenovirus with plasmacytoid dendritic cells in vitro and in vivo
E Basner-Tschakarjan,1 D Tormo,1 E Gaffal,1 S Buechs,1 A Limmer,2 H Wagner,3 H Hochrein3,4
and T Tueting1 1 Dermatology, University of Bonn, Bonn, Germany, 2 Institute of Molecular
Medicine and Experimental Immunology, University of Bonn, Bonn, Germany, 3 Institute of
Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich,
Germany and 4 Immunology Research, Bavarian Nordic, Martinsried, Germany
Recombinant replication-deficient adenovirus (Ad) induces short term expression of transgenes
in an immunogenic form. This presents a major obstacle for the use in gene therapy which
requires long term gene expression but is desired for DNA vaccination approaches against
infection and cancer. In our studies we explore the interaction of Ad with the network of den-
dritic cells (DC) which control adaptive immunity. We show antigen expression not only in
conventional dendritic cells (cDC) but also in plasmacytoid DC (pDC) with subsequent phe-
notypic maturation and secretion of IFN-a and IL-6 in both DC populations thus bridging the
innate and the adaptive immune system. In vitro recombinant Ad activates DC and induces
production of cytokines largely independent of toll-like receptor 9 (TLR9) which is capable of
recognizing double-stranded DNA viruses. However, a detailed comparative analysis shows
that recognition of recombinant adenovirus by TLR9 does occur. Most importantly, the induc-
tion of CD8+ cytotoxic T lymphocytes (CTL) is largely TLR9-independent in vivo. In conclu-
sion, our results provide important mechanistic insight how recombinant Ad stimulate cyto-
toxic cellular immune responses and highlights the advantages of further developing
recombinant Ad as a vector for DNA vaccination approaches.
468
Sequential assembly of nucleotide excision repair factors at sites of DNA damage in XP-B
cells
K Oh,1 SG Khan,1 K Imoto,1 N Jaspers,2 A Raams,2 T Ueda,1 A Lehmann,3 P Friedmann,4
S Emmert,5 A Gratchev,6 K Lachlan,4 A Lucassan4 and KH Kraemer1 1 Basic Research
Laboratory, National Cancer Institute, Bethesda, MD, 2 Genetics, Erasmus Univ, Rotterdam,
Netherlands, 3 Univ of Sussex, Brighton, United Kingdom, 4 Southampton Univ,
Southampton, United Kingdom, 5 Dermatology, Goettingen Univ, Goettingen, Germany and
6 Dermatology, Heidelberg Univ, Mannheim, Germany
The XPB gene encoding a DNA helicase, is a subunit of the basal transcription factor TFIIH,
and is also involved in nucleotide excision repair (NER). We studied cells from 5 xeroderma
pigmentosum group B (XP-B) kindreds: 3 with severe XP Cockayne syndrome complex (XP/CS),
1 with mild XP/CS and 1 with XP with only deafness (XP33BR). Cellular recruitment of NER
factors was examined using local UV irradiation through filters with 5 micron pores com-
bined with fluorescent antibody labeling. XPC was rapidly recruited to local UV damage sites
in all the XP-B and normal cells, thus reflecting its role in damage recognition prior to the func-
tion of XPB.  In cells from severely affected XP/CS patients, XPG and XPA proteins were nor-
mally recruited to DNA damage sites but persisted for at least 24 hours. An ELISA assay showed
marked delay in the repair of UV-induced 6-4 photoproducts in the severe XP/CS cells. This
indicates that localization of XPG and XPA is independent of XPB however, their persistence
reflects failure of removal of DNA damage. Surprisingly, cells from the mild XP/CS and the
XP33BR patients showed delayed recruitment of XPG and XPA to local UV damage sites sug-
gesting that partial functioning of XPB impairs localization of these proteins. γ-H2AX appeared
at DNA breaks induced after UV irradiation in all cells tested but persisted for more than 24
hours only in cells from severe XP/CS patients. The recruitment, persistence and removal of
DNA repair proteins at sites of damage is a complex process and may not always lead to
repair of DNA damage.
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Splice mutations in the XPD gene and absence of neurological symptoms
J Boyle,1 T Ueda,1 V Gonzalez,1 K Oh,1 K Imoto,1 H Inui,1 DB Busch,2 S Khan,1 D Tamura,1
JJ DiGiovanna1,3 and KH Kraemer1 1 Basic Research Laboratory, National Cancer Institute,
Bethesda, MD, 2 Deceased, AFIP, Washington, DC and 3 Dermatology, Brown Med School,
Providence, RI
Xeroderma pigmentosum (XP) complementation group XP-D is characterized by increased
UV sensitivity and skin cancer incidence, and in some patients severe neurological degener-
ation. We assigned cells from 21 XP kindreds to XP-D by co-transfection of wild-type XPD
cDNA in the host cell reactivation (HCR) assay. Sequence analysis determined that 17 kin-
dreds were heterozygous for the common R683W mutation in the XPD gene. Of these kin-
dreds, 8 had neurological disease (including progressive cognitive impairment, sensorineural
deafness, and peripheral neuropathy), 4 had a normal neurological examination, and the
others were either too young to exclude neurological involvement or were not evaluated at
NIH. The 4 patients without neurological symptoms have splice mutations in the second allele.
The presence of some normal splicing in the second allele of 2 of these patients produced
wild-type XPD mRNA rather than the inclusion of part of intron 7. Normal splicing in the sec-
ond allele of the other two patients produced a partially active missense mutation in exon 22
rather than a 45 bp deletion. Therefore the increased DNA repair resulting from some normal
splicing in the second allele may be sufficient to prevent neurological symptoms in these XP-
D patients heterozygous for the common R683W mutation.
471
Complete maternal isodisomy of chromosome 3 in a child with recessive dystrophic epi-
dermolysis bullosa but no other phenotypic abnormalities
H Fassihi,1 L Lu,1 V Wessagowit,1 L Ozoemena,1 C Jones,1 PJ Dopping-Hepenstal,1
JE Denyer,2 DJ Atherton,2 JE Mellerio1,2 and JA McGrath1 1 Genetic Skin Disease Group, St
Johns Institute of Dermatology, The Guys, Kings College and St Thomas School of Medicine,
London, United Kingdom and 2 Department of Dermatology, Great Ormond Street Hospital
for Children, London, United Kingdom
The mechanobullous disease Hallopeau-Siemens recessive dystrophic epidermolysis bullosa
(HS-RDEB) (OMIM 226600) results from mutations in the type VII collagen gene (COL7A1)
on chromosome 3p21.31. Typically, there are frameshift, splice site or nonsense mutations
on both alleles. We report a patient with HS-RDEB who was homozygous for a new frameshift
mutation, 345insG, in exon 3 of COL7A1. However, sequencing of parental DNA showed
that although the patient’s mother was a heterozygous carrier of this mutation, the father’s
DNA contained only wild-type sequence. Microsatellite marker analysis confirmed paternity
and genotyping of 28 microsatellites spanning chromosome 3 revealed that the affected child
was homozygous for every marker tested with all alleles originating from a single maternal
chromosome 3. Thus the HS-RDEB phenotype in this patient is due to complete maternal isodi-
somy of chromosome 3 and reduction to homozygosity of the mutant COL7A1 gene locus.
This is the first case of uniparental disomy to be described in HS-RDEB and is only the third
example of this abnormality of chromosome 3 to be reported. The severity of the HS-RDEB
in this case was similar to other affected individuals and no additional phenotypic abnor-
malities were observed, suggesting an absence of maternally imprinted genes on chromosome
3. Demonstration of uniparental disomy also has important implications for genetic counsel-
ing since there has been no report of recurrence of disease in subsequent pregnancies for any
autosomal recessive disorder.
473
Distinct roles of the vitamin D receptor coavtivators DRIP, SRC2, and SRC3 in human epi-
dermal keratinocyte differentiation
N Hawker, Y Oda and D Bikle Endocrine Research Unit, University of California and
Veterans Affairs Medical Center, San Francisco, CA
It is well known that the active metabolite of vitamin D, 1,25(OH)2D3, stimulates differenti-
ation and inhibits proliferation in epidermal keratinocytes through interaction with the vita-
min D receptor (VDR). We have recently observed that the two major VDR coactivator com-
plexes, DRIP and SRC are sequentially utilized during keratinocyte differentiation. Here we
show that knockdown of both DRIP205 and VDR, but not SRC3 with siRNA give a hyper-
proliferative phenotype in undifferentiated keratinocytes as measured by XTT and BrdU,
whereas both coactivator complexes are involved in differentiation, but at different stages. In
order to assess the function of VDR and its coactivators during differentiation we observed
keratinocytes at two stages of development. Primary human keratinocytes grown for three days
in 1.2mM Ca+2 induce both differentiation markers Loricrin (LOR) and Filaggrin (FLG) as
measured by quantitative real time PCR. We observed that VDR and DRIP205 knockdown
inhibited the expression of both LOR and FLG, while knockdown of SRC2 and SRC3 did not.
Keratinocytes grown for ten days in medium containing 10% fetal bovine serum form a pseu-
doskin, complete with a stratum corneum. In the pseudoskin, DRIP, SRC, and VDR all appear
to be required for LOR and FLG expression. Interestingly, when total cornified envelope pro-
duction is measured by incorporation of 35S-Methionine, both VDR and SRC2 knockdown
result in less cornified envelope formation, while DRIP205 and SRC3 have little effect on this
process. We conclude from these studied that VDR is required throughout epidermal ker-
atinocyte development, while of its coactivators, DRIP205 functions to inhibit proliferation
and promote differentiation early in development, SRC2 and SRC3 promote later stages of dif-
ferentiation and SRC2 promotes cornified envelope formation.
472
Prevalent loss-of-expression mutations in the gene encoding filaggrin cause ichthyosis vul-
garis
FJ Smith,1 AD Irvine,2 A Sandilands,1 G O’Regan,2 A Terron-Kwiatkowski,1 Y Zhao,1 H Liao,1
LE Campbell,1 AT Evans,3 DR Goudie,4 S Lewis-Jones,5 CS Munro,6 RB Presland,7,8
P Fleckman8 and W McLean1 1 Human Genetics Unit, University of Dundee, Dundee,
United Kingdom, 2 Dermatology, Our Lady’s Hospital for Sick Children, Dublin, Ireland, 3
Pathology, Ninewells Hospital, Dundee, United Kingdom, 4 Clinical Genetics, Ninewells
Hospital, Dundee, United Kingdom, 5 Dermatology, Ninewells Hospital, Dundee, United
Kingdom, 6 Dermatology, Southern General Hospital, Glasgow, United Kingdom, 7 Oral
Biology, University of Washington, Seattle, WA and 8 Dermatology, University of Washington,
Seattle, WA
Ichthyosis vulgaris (IV; OMIM# 146700) is the most common inherited disorder of keratinization
and one of the most frequent monogenic disorders in humans. We have identified homozy-
gous or compound heterozygous mutations R501X and 2282del4 in the filaggrin gene as the
cause of moderate or severe IV in 14 kindreds and 18 isolated cases. These mutations are semi-
dominant - heterozygotes exhibit a very mild phenotype with incomplete penetrance. Using
this inheritance model, we obtained a highly significant 2-point lod score of 8.11 with no
recombination. These two mutations show a combined carrier frequency of 9% in populations
of European origin explaining the high incidence of IV. Both mutations terminate protein trans-
lation in the first repeat domain and therefore represent filaggrin null-alleles. Consistent with
this, immunohistochemistry and immunoblotting confirmed that no processed filaggrin is made
in homozygous or compound heterozygous patients. These patients had an absent granular
layer histologically, confirming that profilaggrin is a major component of keratohyalin gran-
ules. In an additional family, the proband was compound heterozygous for R501X and a “pri-
vate” mutation, 3702delG. During terminal differentiation, profilaggrin is cleaved into multi-
ple filaggrin peptides that aggregate keratin filaments. The resultant matrix is cross-linked to
form a major component of the cornified cell envelope. Loss or reduction of this major epi-
dermal structural protein leads to varying degrees of impaired keratinization.
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Differential expression of XPC protein and localization at UV damage is associated with
severe or mild clinical phenotypes in xeroderma pigmentosum group C patients
SG Khan,1 J Boyle,1 K Imoto,1 K Oh,1 N Armstrong,1 D Tamura,1 JJ DiGiovanna1,2 and
KH Kraemer1 1 Basic Research Laboratory, National Cancer Institute, Bethesda, MD and 2
Dermatology, Brown Med School, Providence, RI
Our previous studies demonstrated that cells from 2 severely affected xeroderma pigmento-
sum (XP) siblings had undetectable levels of XPC mRNA, while the cells from 3 mildly affected
siblings had 3-5 % of normal levels. (Hum. Mol. Genetics, 13: 343 - 352, 2004). These cells
have mutations in two different functional branch point sequences in XPC intron 3. Post-UV
survival of the cells from a severely affected patient (XP101TMA) was much lower than that
of a mildly affected patient (XP72TMA). ELISA assay of DNA photoproducts revealed virtually
absent repair of 6-4 photoproducts (PP) in XP101TMA and nearly normal repair of 6-4 PP in
XP72TMA. We studied the expression of XPC protein and its localization at sites of UV dam-
age in cells from these patients. XP101TMA had no detectable XPC protein on Western blot-
ting, in contrast XP72TMA had barely detectable levels. Immunofluorescence and confocal
laser-scanning of cells exposed to UV through filters with 5 micron pores revealed a failure
of localization of XPC and XPG nucleotide excision repair (NER) proteins at the sites of UV-
induced DNA damage in the XP101TMA cells. This confirmed the primary role of XPC pro-
tein in DNA damage recognition in the preincision complex as well as for recruitment of
other NER factors. In contrast, XP72TMA cells showed localization of a small amount of XPC
protein at the UV-induced DNA lesions followed by localization of XPG, XPB, XPD, XPA, and
XPF. Taken together, these results suggest that the levels of full-length XPC mRNA and thus the
functional protein may be a determinant of severe or mild phenotypes in XP-C patients.
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Genome wide linkage analysis of a recessive alopecia with SNP markers reveals a new locus
on chromosome 13
A Vitebsky ,1 E Sousa,2 C Haynes,4 D Gordon4 and AM Christiano1,3 1 Genetics and
Development, Columbia Univeristy, New York, NY, 2 Hospital Sao Marcos, Teresina, Brazil, 3
Dermatology, Columbia University, New York, NY and 4 Rockefeller, New York, NY
To date, several mutations have been identified that lead to alopecia, but many more cases
with yet unidentified causes remain. Investigating these cases has the potential to unravel
new genes involved in hair development. Mapping of new genes has traditionally been done
with microsatellite panels. Recently, the SNP genotyping array has emerged as an attractive
alternative. The ease and speed of sample preparation, the high resolution of the SNP map,
and high throughput in sample preparation led us to investigate this technology for mapping
of a novel form of autosomal recessive alopecia. A Brazilian family with 6 affected and 7
unaffected offspring was chosen for this study. Affected individuals presented with no scalp
hair and absence of eyebrows and eyelashes. A scalp biopsy from an affected individual
revealed a disorganized, deteriorated hair follicle. The Affymetrix GeneChip 10K mapping
array was used to perform a genome wide scan for the disease locus. Initial analysis of affected
genotypes with the Transmission Disequilibrium Test (TDT) allowed us to identify an initial 20
Mb candidate region on chromosome 13q12.12-q14.13. Subsequent multipoint analysis of
all samples yielded a LOD score of 3.28, obtained for 6 markers spanning a 7.8 Mb region
on chromosome 13q14.11-q14.2. This refined interval contains 45 genes and 17 predictions.
We sequenced several candidate genes in this region including TSC22D1, a transcription fac-
tor expressed in the developing feather bud as well as the murine hair follicle; AK057244 and
KIAA085, transcripts with similarity to trichohyalin, a structural component of the inner root
sheath and medulla of the hair follicle. No mutation has been identified in these candidate
genes. As new information becomes available, other candidate genes will be explored. This
study reports the first localization of a human hair disorder to chromosome 13.
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Dlx3 as a downstream target of p63
N Radoja,1 L Guerrini,2 N LoIacono,2,3 G Merlo,3 A Costanzo,4 G LaMantia,5 V Calabro5 and
MI Morasso1 1 Developmental Skin Biology Unit, NIH/NIAMS, Bethesda, MD, 2 Department
of Biomolecular and Biotechnological Sciences, University of Milan, Milan, Italy, 3 Dulbecco
Telethon Institute, Milan, Italy, 4 Department of Dermatology, University of Tor Vergata,
Rome, Italy and 5 Department of Structural and Functional Biology, University of Naples,
Naples, Italy
Dlx3 is a homeobox transcription factor that promotes differentiation and is expressed in the
ectodermal component of epithelial/mesenchymal derived structures such as hair, teeth, limb
buds, mammary gland primordium and in the differentiated layers of the stratified epidermis.
Analysis of the proximal promoter of Dlx3 has led to the delineation of major control ele-
ments, with a p53-like binding region, immediately upstream of CCAAT box, playing an impor-
tant role in the expression of the Dlx3 gene. This region binds p63 in vitro and in vivo. The
p63 protein colocalizes with Dlx3 in the embryonic ectoderm. Dlx3 is regulated by specific
isoforms of p63, and mutant p63 proteins derived from AEC, LMS and SHFM exhibit altered
transactivation ability of the Dlx3 promoter. Together these data suggest that a misregulation
of Dlx3 expression might be involved in the pathogenesis of human syndromes associated to
p63 molecular lesions.
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Alternative splicing of the gli1 oncogene is regulated by both transacting factors and pro-
moter activity
J Rothnagel, J Beesley, H Tom and X Wang Biochemistry, The University of Queensland,
Brisbane, QLD, Australia
The oncogene GLI1, encodes a zinc-finger transcription factor that is regulated by the Sonic
hedgehog-Patched signaling pathway. Aberrant signaling of this pathway results in over-expres-
sion of GLI1, which is associated with the development of basal cell carcinomas (BCCs). We
have previously identified two alternative GLI1 transcripts in human tissues that differ in their
5’-untranslated regions (5’-UTRs). The longer 5’-UTR variant is formed by the splicing of exons
1 and 1A and contains multiple uATGs and uORFs, which directly result in translation repres-
sion of the main ORF. The shorter 5’-UTR, which is generated by skipping of exon 1A, lacks
these features and is associated with very high levels of expression of the main ORF. Notably,
the longer form is the predominant transcript in normal adult and neonatal skin, while the
shorter form is the only variant detected in BCCs. In order to identify functional RNA trans-
acting factors, we made a human GLI1 pre-mRNA minigene comprising of the GLI1 genomic
region linked to a GFP reporter. We expressed the minigene in both transiently and stably
transfected cells including CHO, HeLa, HaCaT and HEK293. We tested the ability of several
splicing modulators to influence splicing decisions of the GLI1 minigene. Of these only
Tra2beta1, and hnRNPI (PTB) produced a significant change in the ratio of spliced products.
We also tested the influence of promoter activity on splicing outcomes by comparing the
ratio of spliced products of minigene driven by the CMV promoter with that of the GLI1 pro-
moter in stably transfected cells. Significantly, we observed promoter-dependant differences
in pre-mRNA processing. These results support our hypothesis that the large increase in GLI1
levels observed in BCCs is due to increased skipping of exon 1A gene as a result of increased
transcription as well as altered splicing factor activity.
477
Genetic association analysis of NOD27 as a candidate gene for psoriasis susceptibility
R Hiremagalore,1 N Inohara,2 RP Nair,1 PE Stuart,1 S Jenisch,4 M Weichenthal,3 HW Lim,5
E Christophers,3 JJ Voorhees,1 G Nunez2 and JT Elder1 1 Dermatology, Univ Michigan, Ann
Arbor, MI, 2 Pathology, Univ Michigan, Ann Arbor, MI, 3 Dermatology, Univ Kiel, Kiel,
Germany, 4 Immunology, Univ Kiel, Kiel, Germany and 5 Dermatology, Henry Ford Hospital,
Detroit, MI
We have previously mapped a psoriasis susceptibility locus (PSORS8) to chromosome 16q by
linkage analysis, and this genomic region has also been implicated in psoriatic arthritis. Pso-
riasis is 7 times more common in Crohn’s disease (CD) patients than in controls, and a CD
susceptibiliby gene, NOD2 (CARD15), maps to the PSORS8 locus. However, we and others
have been unable to establish an association between psoriasis and NOD2. NOD27, a gene
with structural similarity to NOD2 containing a large number of leucine-rich repeats, is also
located within our linkage peak on chromosome 16. In the present study we examined asso-
ciation of NOD27 to psoriasis in a large family cohort. We re-sequenced all 52 exons con-
stituting the 13 known splice variants of NOD27 in 33 unrelated individuals (15 psoriatics and
18 controls) and identified 2 indels (insertion-deletions) and 24 SNPs. Both indels were frameshift
variations and 10 of the 24 SNPs were missense variations. The 2 indels and the 10 missense
variations were genotyped in 678 psoriasis pedigrees consisting of 2723 individuals. Family
based haplotyping and association tests were performed using FBAT. None of the SNPs, either
independently or in combination as haplotypes, showed significant association with psoria-
sis. We conclude that the NOD27 polymorphisms we have identified are not significantly asso-
ciated with psoriasis in our study cohort. Nevertheless, given the strong clinical association
between psoriasis and CD, a comprehensive association scan of the PSORS8 linkage peak and
continued exploration of CD candidate genes mapping to other genomic regions are warranted
in psoriasis.
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Comparative analysis of gene expression profiles between human skin-derived cells using
cDNA microarray
J Lee, J Lee and C Kim Dermatology, Chungnam National University, Daejeon, South Korea
The skin is composed of a variety of cell types including keratinocyte, melanocyte and fibrob-
last. The characteristics of these cells are determined by the specific gene expression pattern,
respectively. Therefore, it is important to know the difference in gene expression pattern between
skin-comprising cells to understand the specified roles of each cell type. In order to get bet-
ter insight into the characteristics of three major skin cells, such as epidermal keratinocytes
(KC), melanocytes (MC), dermal fibroblasts (FB), we performed cDNA microarray analysis. We
cultured normal human epidermal keratinocytes, melanocytes, dermal fibroblasts from 5
donors. Total RNAs were extracted, then pooled to reduce the individual variations. Using
these RNA samples, we performed microarray analysis. Total 6 chips were used by loop design
(cy5-cy3: KC-FB, FB-MC, MC-KC, FB-KC, MC-FB, KC-MC) and three experiments have been
performed in each cell type. Total 12,500 genes were selected as reliable genes expressing
significantly at least one of three cells. We selected genes that showed more than 5 fold
induction just in one cell type as compared with other two cell types. As a result, we obtained
46 fibroblast-specific genes, 62 keratinocyte-specific genes and 56 melanocyte-specific genes.
Many of those involve the genes that have been known to be characteristically expressed in
each cell types. In addition, we found that some genes that have been unknown to be spe-
cific functions for the skin derived cells were included. Quantitative RT–PCR was used to ver-
ify the expression of several unknown genes that showed cell type-specific induction. Those
genes identified to be characteristic of skin-derived cells may be very useful to understand
their functions in the skin.
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Expression profiling of calcium-induced genes and their network in keratinocytes
W Lee,2 J Lim,2 C Kim1 and J Lee1 1 Dermatology, College of Medicine, Chungnam National
University, Daejeon, South Korea and 2 Traditional Medicine and Bioscience, Daejeon
University, Daejeon, South Korea
In normal epidermis, proliferation and differentiation processes are tightly regulated. Calcium
causes many important biological changes in epidermis with biochemical alterations of ker-
atinocyte differentiation, which can provide an excellent model for the study of differentia-
tion in vitro. To gain more insight into the molecular mechanism of keratinocyte differentia-
tion, the gene expression profiles of calcium induced keratinocyte differentiation were analyzed
using cDNA microarray. Time-course cDNA microarray analysis (1, 3, 7, and 14 days after cal-
cium treatment) revealed the global gene expression profile during keratinocyte differentia-
tion. Of the 17 kb genes tested, more than 100 genes showed more than twofold change in
expression level at least once over four time points. Using self-organizing map analysis, these
genes can be clustered into several groups according to their expression pattern. However,
gene expression profiles contributing to the spatiotemporal regulation of keratinocyte differ-
entiation are not sufficient to understand the mechanism of keratinocyte differentiation. There-
fore, we tried to find out the biologic pathways mediated by protein-protein interactions and
their associated networks during keratinocyte differentiation. We used Psimap technique that
predicted protein-protein interactions based on the structural classification of protein (SCOP)
in protein data bank (PDB). As a result, we obtained putative functional network of genes
involved in calcium-induced keratinocyte differentiation. We think that our results provide
important clues to understand the keratinocyte differentiation process.
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Slurp1 is a late marker of epidermal differentiation and is absent in Mal de Meleda
B Favre,1 L Plantard,1 L Aeschbach,1 N Brakch,2 S Christen,1 P deViragh,1 C Munro,3
M Huber1 and D Hohl1 1 Dermatology, University Hospital CHUV, Lausanne, Switzerland, 2
Internal Medicine, University Hospital CHUV, Lausanne, Switzerland and 3 Dermatology,
South Glasgow University Hospitals NHS Trust, Glasgow, United Kingdom
SLURP1 is a secreted member of the LY6/PLAUR protein family. Mutations in SLURP1 gene
are the cause of Mal de Meleda (MDM), a rare autosomal recessive genetic disease, charac-
terized by inflammatory palmoplantar keratoderma. In this study, we have analyzed the expres-
sion of SLURP1 in normal and MDM skin, aiming at the development of a rapid screening test.
SLURP1 was found to be a marker of late differentiation, predominantly expressed in the
granular layer of skin, notably the acrosyringium. Moreover, SLURP1 was also identified in
several biological fluids such as sweat, saliva, tears and urine from normal volunteers. In pal-
moplantar sections from MDM patients, as well as in their sweat, mutant SLURP1, including
the new variant R71H-SLURP1, was either absent or barely detectable. Transfected HEK 293T
cells expressed the MDM mutant SLURP1 containing the single amino acid substitution G86R
but did not tolerate the MDM mutation W15R located in the signal peptide. Thus most MDM
mutations in SLURP1 affect either the integrity or stability of SLURP1, making possible the
use of an immunologic test as a screening procedure.
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Genomic actions of estrogen receptors-alpha and beta are limited by their low levels of
expression in primary human dermal fibroblasts.
L Rittie, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Reduced estrogen production after menopause is associated with progressive loss of skin col-
lagen. Topical treatment with estrogen stimulates collagen production by dermal fibroblasts
in post-menopausal women. In this study, primary adult human dermal fibroblasts (HDF) in
culture were used to investigate the mechanisms by which estrogen increases skin collagen.
Surprisingly, estrogen treatment (10-100nM) of HDF did not alter type I procollagen mRNA
(real-time RT-PCR) or protein (ELISA) levels, in monolayer culture, three-dimensional colla-
gen matrix, or skin equivalents. Estrogen action is mediated by specific estrogen receptors
(ERs): ER-alpha, ER-beta, and GPR30. Estrogen receptor mRNA levels were quantified in cul-
tured HDF, and dermal cells obtained directly from human skin by laser capture microdis-
section. ER-alpha and ER-beta mRNA levels were 6-fold and 3-fold lower, respectively, in HDF
than in isolated dermal cells. GRP30 mRNA levels were 2-fold higher in cultured HDFs,
compared to isolated dermal cells. Endogenous ER-alpha protein was not detectable in HDF,
measured by immunoprecipitation/western-blot, or ELISA (sensitivity 40pg/ml). Furthermore,
neither basal nor estrogen-stimulated ER transcriptional activity was detectable in HDF, as
determined by reporter gene assay. Expression of ER-alpha by transient transfection resulted
in detectable ER-alpha protein in HDF nuclei, and ER-driven reporter gene activity. Expres-
sion of ER-beta did not stimulate ER-driven reporter gene expression. Expression of ER-alpha
and/or ER-beta was not sufficient to confer estrogen stimulation of collagen production in
HDF. In contrast, estrogen rapidly stimulated activation of Erk1/2 MAP kinase (5.1±2.8-fold,
n=5), and induced immediate early genes c-Fos (16.5±1.8-fold, n=3) and Egr-1 (9.3±2.5-fold,
n=3). Taken together, these data indicate that the increased collagen production observed after
estrogen treatment of human skin in vivo is either indirect, or requires factors that are absent
in HDF cultures.
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WRN-mediated DNA damage responses localize to telomeres
MS Eller,1 H Backvall,1 K Reddy,1 PL Opresko,2 VA Bohr3 and BA Gilchrest1 1 Dermatology,
Boston University School of Medicine, Boston, MA, 2 Environmental and Occupational
Health, University of Pittsburgh, Pittsburgh, PA and 3 Molecular Gerontology, National
Institute on Aging, Baltimore, MD
Recent studies have shown that disruption of the telomere (tel) loop structure is more impor-
tant than tel length in triggering DNA damage responses (DDR) and that these responses may
serve to modify telomeric chromatin, recruit repair proteins and restore proper tel structure.
To further study these events, we used as a probe DNA oligonucleotides homologous to the
tel 3’ overhang (T-oligos) that, like tel loop disruption, also induce DDR including p53 acti-
vation (phosphorylation). In 15% of normal fibroblasts, phospho-histone H2AX foci, known
to form at sites of DNA damage and disrupted tels, co-localized with the tel-binding protein
TRF1, found specifically at telomeres, as shown by immunofluorescent staining. After 2 days
of T-oligo treatment, however, this number greatly increased (p = 0.0005) to over 80%. These
foci formed without tel disruption as shown by retention of intact 3’ overhangs in T-oligo-
treated cells. T-oligo also induced phosphorylation/activation of the ATM kinase, known to
directly phosphorylate p53, Chk2 and H2AX, events that also occur at times of tel disruption.
Non-hydrolyzable T-oligos did not produce these effects. We then examined the role of WRN,
a 3’ to 5’ exonuclease mutated in the cancer-prone progeroid Werner syndrome. WRN asso-
ciates with tels during replication and its mutation leads to early senescence and defects in
tel maintenance. Normal fibroblasts and U2OS osteosarcoma cells made deficient in WRN
by RNAi showed greatly reduced H2AX, p53 and ATM phosphorylation after T-oligo treat-
ment. These data strengthen the hypothesis that T-oligos act at tels, mimicking the tel 3’ over-
hang. They also suggest that WRN hydrolyzes T-oligos or the tel 3’ overhang at times of tel
loop resolution, leading to ATM activation and local DDR that are important for restoring the
proper tel loop structure. This model can explain the defective tel maintenance phenotype of
Werner syndrome cells.
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The novel Connexinx 26 Gly11Glu heterozygous mutation is responsible of a case of KID
Syndrome, via the impairment of membrane trafficking and connexon assembly
A Terrinoni,1 B Didona,1 A Codispoti,2 L Zocchi2 and G Melino1,2 1 IDI-IRCCS, Rome, Italy,
2 Dep Exp. Medicine and Bioch. Sci., Univ Tor Vergata, Rome, Italy and 3 Toxicology Unit,
Medical Research Council, Rome, United Kingdom
The KID (MIM 148210) syndrome is a congenital disorder that affects the epidermis and
other ectodermal tissues such as the inner ear. KID syndrome has been associated to a num-
ber of mutation in the Cx 26 (GJB2) gene. Connexins (Cx), share a common pattern of struc-
tural motifs or domains, four trans-membrane (M1 to M4), two extra cellular (E1, E2), and three
cytoplasmic (NT, CL, CT). The interaction of six connexins leads to the formation of the con-
nexon or hemichannel. Cxs can interact in a homomeric or heteromeric way to form the con-
nexon. The gap junction is composed by numerous aggregated connexons allowing the
exchange of different molecules In this work, we present a 50 year old female sporadic patient,
presenting eyelids xerodermic, diffuse ichthyosis and large hyperkeratotic plaques; erythe-
matous and verrucous plaques, with well-delineated borders, in hands and feet, and PPK.
Furthermore a diagnosis of bilateral, profound sensorineural hearing loss has been established.
Molecular analysis revealed the presence of a G to A transversion causing the novel Gly11Glu
aminoacidic substitution. The glycin in position 11 is located in the cytoplasmic NT domain,
that presumably control the voltage gating and the calcium fluxes. NEHK cells, transfected
using wild type Cx26 showed a classical punctate staining suggestive of aggregation of the
protein at the plasma membrane, the mutated Cx26 did not form aggregates, showing cyto-
plasmic localization with some perinuclear distribution. In some cases cells transfected with
the mutant showed an apoptotic phenotype. In conclusion one of the effects of the Gly11Glu
mutation is (i) the impairment of its trafficking to the plasmamembrane and the failure in the
assembly of connexons and gap junction.
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SIRT1 is human fibroblasts lifespan regulator
G Blander,1 MS Matsui,2 T Mammone2 and L Guarente1 1 MIT, Cambridge, MA and 2 The
Estee Lauder Companies, Melville, NY
Sir2 regulates life span in many organisms, including yeast, C. elegans, and Drosophila. This
gene encodes an NAD+-dependent deacetylase, and is broadly conserved from bacteria to
higher eukaryotes. The human Sir2 gene family comprises seven members, SIRT1-7. The human
ortholog, SIRT1 is an NAD+-dependent deacetylase, with enzymatic properties indistinguishable
from the yeast Sir2. We therefore asked whether SIRT1 could modulate specific aspects of
fibroblasts replication by using known activators and inhibitors of SIRT1 and measuring expres-
sion of relevant markers.  We found that SIRT1 regulates the number of replications in cul-
tured human fibroblasts cells, that inhibition of SIRT1 (either by inhibitory RNA or by nicoti-
namide treatment) results in premature senescence, that spontaneous senescence in culture
is accompanied by reduced levels of SIRT1, and that overexpression of SIRT1 extends the lifes-
pan of normal human fibroblasts in culture. The importance of this finding relates to the poten-
tial role of SIRT1 in regulating the chronological age of an individual’s skin and to the differ-
entiation and function of skin appendages such as hair follicles and sebocytes.
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Gene expression profiles of oxidative stress-induced and replication-induced senescent adult
human dermal fibroblasts.
T He, TH Quan, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor,
MI
Cellular senescence is a useful model for understanding the molecular basis of aging. Expo-
sure of cells to acute oxidative stress or multiple population doublings are used to induce
senescence in vitro. We have compared gene expression profiles in these two senescence mod-
els using global genome wide screening by cDNA microarray analysis. Primary adult human
dermal fibroblasts (HDF) were induced to undergo oxidative stress-induced senescence (OSIS)
by exposure to hydrogen peroxide, or replicative senescence (RS) by multiple passages. Both
OSIS and RS HDF exhibited similar senescent phenotypes, including loss of proliferative capac-
ity, increased cell size, flattened morphology, and high expression of senescence associated
β-galactoside activity. Using Significance Analysis of Microarray software (>2-fold change,
p<0.05), 246 (2.8%) and 388 (4.4%) out of 8793 genes were found to be significantly changed
in OSIS or RS HDF, respectively, compared to untreated early passage HDF. Concordant alter-
ations in OSIS and RS HDF were observed in 170 genes; 19 genes upregulated (nucleosome
assemble, cell cycle arrest), 151 genes downregulated (DNA damage response, CDK, DNA
repair and replication, extracellular matrix-related). OSIS induced 65 genes (energy metabo-
lism, DNA damage response. G-protein regulation, p53-regulated genes) that were unchanged
in RS HDF. RS altered 207 genes (127 elevated, 80 reduced) that were unchanged in OSIS
HDF. RS-altered genes represented a wide spectrum of biological functions including protein
modification and proteolysis, metabolism, transcription and translation regulation, and signal
transduction. In summary, although the phenotype of OSIS and RS HDF are similar, their gene
expression profiles are clearly distinct. These differences in gene expression profiles can be
exploited to assess the relative contribution of oxidative stress versus replication to the aging
process of fibroblasts (obtained by laser capture microdissection) in human skin in vivo.
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Distinct patterns of gene expression in androgenetic and senescent alopecia: a microarray-
based study
P Mirmirani,2,1 S Oshtory,1,2 S Daoud,2,1 TS McCormick,2,1 KD Cooper1,2 and P Karnik2,1 1
Dermatology, University Hospitals of Cleveland, Cleveland, OH and 2 Dermatology, Case
Western Reserve University, Cleveland, OH
Androgenetic (AGA) and senescent alopecia (SA) are common, non-scarring hair loss disorders. The
histopathology of both disorders involves follicular downsizing and yet, they differ in the age of onset,
pattern of hair loss and hormonal involvement. To understand the molecular pathogenesis, we ana-
lyzed transcriptional profiles of scalp biopsies from three groups of men aged 60 and older. Group
1-Controls (n=8, pooled) had no visible hair thinning. Group 2-SA (n=8, pooled) developed diffuse
hair thinning after age 60. Group 3-AGA (n=8, pooled) had male pattern hair thinning prior to age
40. Microarray analysis (Affymetrix Human-U133B) was used to generate molecular profiles of the
three groups and the data analyzed with GCOS and GeneSpring. In AGA, genes required for ana-
gen onset (Wnt-β-catenin, TGF-α, TGF-β, Stat-3, Stat-1), epithelial signal to dermal papilla (PPARδ,
IGF-1), hair shaft differentiation (Notch, Msx2, KRTs, KAPs), and anagen maintenance (Msx2, Activin,
IGF-1) were downregulated and genes for catagen (BDNF, BMP2, BMP7, VDR, IL1, ER) and telogen
induction and maintenance (VDR, RAR) were upregulated. In contrast, the transcriptional profile of
SA was similar to aging systems. In SA, genes involved in epithelial signal to dermal papilla (FGF5),
actin cytoskeleton (DST, ACTN2, TNNI3, and PARVB) and mitochondrial function (JAK2, PRKD3,
AK2, TRAP1, TRIO, ATP12A, MLL4, STK22B) were downregulated, while oxidative stress and inflam-
matory response genes were upregulated. Thus, follicular downsizing in AGA is associated with
decreased molecular signals required for anagen onset and maintenance and increased catagen
and telogen induction. In contrast, follicular downsizing in SA is likely the result of loss of commu-
nication between the dermal papilla and stem cells (bulge) for anagen onset. These marked differ-
ences between AGA and SA confirm that these are two distinct clinical disorders and present diverse
mechanisms for a final common phenotype of follicular downsizing.
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Examining interaction of a novel keratinocyte-derived coregulator with retinoid receptors
I Gurevich, JD Ciarlo, AM Flores and BJ Aneskievich Pharmaceutical Sciences, University of
Connecticut, Storrs, CT
Retinoic acid (RA) control of epidermal keratinocyte gene expression and differentiation is
mediated through nuclear receptors (NR) activated either by all trans and 9-cis RA (RARs) or
9-cis RA alone (RXR). Human epidermal keratinocytes preferentially express RARalpha,
RARgamma and RXRalpha. Like other members of the NR superfamily, retinoid receptor activ-
ity is also governed by interaction with transcriptional accessory proteins known as NR coreg-
ulators. These proteins contribute to either activation or repression of NR-mediated gene tran-
scription. We identified a new NR coregulator protein from a human keratinocyte cDNA library
via a yeast two-hybrid screen and examined its interaction with retinoid receptors character-
istically expressed in human keratinocytes. A BLAST search identified it as a protein shown
previously to interact only with HIV proteins. Sequence analysis revealed that this candidate
coregulator possesses both NR box motifs (LXXLL) and receptor interacting domains
(RIDs,LXXXI/LXXXL), classically associated with coactivators and corepressors respectively.
Mammalian two-hybrid assays showed the coregulator interacts preferentially with RARalpha,
much less so with RARgamma and not with RXRalpha in the presence of their respective lig-
ands. The novelty of this coregulator stems from its ligand dependent interaction with the recep-
tor and yet a functional consequence of repressing RAR-mediated gene transcription. Muta-
genesis of the coregulator’s LXXLL motifs significantly reduced but did not abolish interaction
with RARs suggesting physical association with RAR based on the RIDs. Mutagenesis of RAR
AF2 domains abolished interaction with the coregulator. However, the RARalpha AF2 domain
in the context of RXRalpha was not sufficient for interaction suggesting an ancillary require-
ment for other RAR domains. Understanding interaction requirements displayed by this coreg-
ulator may provide opportunity for new interpretations of pharmacological activity of retinoid
receptors in cutaneous diseases treated with retinoids.
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Skin equivalents producing erythropoietin as an in vitro model for skin gene therapy
F Scheidemann, M Loeser, I Nachtigall and W Pfuetzner Dermatology, Ludwig-Maximillians-
Universitaet, Munich, Germany
Skin gene therapy offers an interesting approach for correcting sytemic diseases by producing
a required protein, such as erythropoietin (EPO), in genetically modified cells. To test this appli-
cation in vitro and determine the best suited target cells, either primary human keratinocytes
(KC) or fibroblasts (FB) were transduced with a retroviral vector encoding human EPO. As a
model of human skin, skin equivalents (SE) were prepared out of FB, embedded in a collagen
gel (4 x 105/SE), and KC, seeded on the top of the gel (1 x 106/SE). Comparison of both cell
types in a monolayer culture (70% confluency) showed a similar amount of EPO secreted by
FB and KC (82.0+/-10.2 and 80.2+/-11.3 mU/105 cells, respectively), as measured by ELISA.
Interestingly, SE consisting out of transduced FB but normal KC produced significantly more
EPO than SE with transduced KC but normal FB (25.3+/-1.6 and 2.7+/-1.2 mU/SE, respec-
tively). The highest amount of EPO-secretion was detected in SE containing both transduced
KC and FB (30.5+/-2.3 mU/SE). When Monitoring EPO-secretion of transduced KC grown in
monolayer culture overtime, beginning at 70% confluence (with KC showing high prolifera-
tive activity) and ending several days after reaching 100% confluence (and KC starting to dif-
ferentiate), a loss of EPO-production was observed. Since the epidermis is a stratified tissue
with proliferative KC in the basal layers and non-proliferative, differentiating KC in the suprabasal
layers, it is possible that the secretory acitivity of KC might differ depending on their state of
differentiation. Our results show that the skin could be used as a biofactory for systemic deliv-
ery of EPO, with transduced FB showing higher secretory activity than KC when studied in a
skin model system closely reflecting the in-vivo situation. However, a further increase of
EPO-production by KC might be achieved by topically selecting for KC transduced with a bi-
cistronic vector carrying the EPO-gene linked to a selectable gene, such on the multi-drug
resistance gene.
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A metabolic enzyme of the short-chain dehydrogenase/reductase superfamily moonlights as
a transcriptional repressor
NG Markova, A Pinkas-Sarafova and M Simon Oral Biology & Pathology, SUNY Stony Brook,
Stony Brook, NY
Transcriptional repression often depends on the action of co-repressor complexes with intrin-
sic enzymatic activities. The composition of these complexes is modulated by pyridine dinu-
cleotide co-factors and is thus directly reflective of the metabolic state of the cells. The pres-
ent work provides evidence that an enzyme, hRoDH-E2, with cytoplasmic,
membrane-associated NAD(P)(H)-dependent retinol dehydrogenase activity functions in the
nucleus as a repressor of epidermal transcription. The repressive function requires nuclear
translocation of the protein and is not directly related to its role in retinoic acid production.
By using chromatin immunoprecipitation, in vitro transcription and transient transfection
approaches, we find that both in vivo and in vitro the protein is recruited over epidermal pro-
moters and represses their activity by altering the function of other DNA-bound regulators,
such as Sp1, AP1 and RBP-Jkappa. The repressive function is associated with the ability of
hRoDH-E2 to modulate the acetylation/deacetylation activity of the regulatory complexes in
the vicinity of the transcription initiation site in a pyridine dinucleotide dependent mode. The
cellular localization and the functional characteristics of hRoDH-E2 are consistent with it being
one converging point of at least two major pathways controlling epithelial homeostasis – the
retinoid and Notch. Ultimately, the effect of the protein on the homeostasis of a given cell at
any particular moment will be a resultant of its two functions - as a cytoplasmic metabolic
enzyme and as a nuclear transcriptional repressor. The ability of hRoDH-E2 to bind NAD(P)(H)
may allow the protein to monitor the metabolic state of the cells in response to various stim-
uli and transmit the changes to the transcription apparatus by modulating the composition of
the repressor complexes and by regulating its own enzymatic activities. These findings add
hRoDH-E2 to the small group of metabolic enzymes, which could directly link the cytoplas-
mic and nuclear functions within the cell.
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Mast cell tryptase overexpression is associated with inflammation in Spink5–/– skin grafts, a
model for Netherton syndrome
AA Briot,1 CC Bonnart,1 PP Descargues,1 CC Deraison1 and A Hovnanian1,2 1 INSERM U563,
Toulouse, France and 2 Medical Genetics, Toulouse, France
Netherton syndrome (NS) is a severe autosomal recessive genodermatosis caused by muta-
tions in SPINK5. We generated Spink5–/– mice (KO), which replicate the key features of NS,
including premature desquamation, impaired keratinization, hair malformation and a pro-
found skin barrier defect. As KO mice undergo rapid postnatal lethality, newborn mouse skin
was grafted on SCID mice to study phenotypic changes in KO adult skin. KO grafts developed
alopecic, scaly and erythematous lesions. The KO graft, in contrast to newborn KO mice skin,
reproduced all the major histological and ultrastructural features observed in NS skin. In
addition to these major defects in differentiation and proliferation of the epidermis, inflam-
matory infiltrates were present in the dermis of KO graft. A high number of polynuclear
eosinophilic cells and mast cells were seen in the infiltrate. Tryptase, a major factor of inflam-
mation released by mast cells, showed a marked increased expression on immunohistochemistry
and western blot analysis in KO grafts. Casein zymography analysis of epidermal extracts
showed SCTE and SCCE hyperactivity, and an additional activity at 34 kDa in KO graft. These
results are consistent with this protease corresponding to an active form of tryptase monomers.
As no infection was detected in KO graft, the inflammation seen could be due to barrier dis-
ruption and/or protease dysregulation. These anomalies could promote the release of media-
tors from keratinocytes and the recruitment of inflammatory cells. Activated mast cells are
known to release a number of inflammatory mediators including tryptase. This could partici-
pate in the phenotypical aggravation observed in adult KO skin. The high similarity between
NS skin and Spink5–/– graft demonstrates that skin grafting provides a suitable model to study
the long-term effects of loss of LEKTI expression in skin. This model will help the understand-
ing of the mechanisms by which protease dysregulation and barrier dysfunction lead to inflam-
matory events.
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Altered markers of T-cell activation in mycosis fungiodes revealed by gene profiling with
oligonucleotide microarray anlalysis
EP Tierney, AJ Wilson, H Gibson, BF Chong and HK Wong Dermatology, Henry Ford Health
System, Detroit, MI
Mycosis Fungoides (MF) is a malignancy of CD4 T cells that home to the skin. The pathogen-
esis of this malignancy remains unclear. Our objective was to define gene expression patterns
to serve as markers of detection, prognosis and predictors of treatment response. We com-
pared purified T cells from patients with Sezary MF with purified memory T cells from normal
patients after stimulation for 0, 2 and 6 hrs. Gene expression was analyzed using Affymetrix
gene chips (54,000 transcripts) and GeneSpring. We identified genes upregulated in purified
T cells of MF patients relative to ctrl memory T cells at 0hr (baseline)(5+ fold, 1,173 genes),
2hrs (823) and 6hrs (1,270). The genes most highly up-regulated in MF included killer Ig like
receptor (R)(145.4 fold), plastin 3 (118.4), E-cadherin (82.2), endothelin R type B (82.0), ankyrin
2 (72.8) and plakophilin 2 (59.7). Concomittantly, we identified genes which were downreg-
ulated in the purified T cells of MF patients relative to control memory T cells at 0hr (5+ fold,
598 genes), at 2hrs (881) and 6hrs (1,035). The genes which most highly down-regulated in
MF included IL-3 (209.6), chemokine R-6 (159.2), natural killer cell gr 7 (123.9), CD26 (119.5),
CD7 (65.3) and natural killer lectin R (65.0). Array results were validated with qRT-PCR which
confirmed marker genes, such as CTLA4, plastin 3, IL2, IL4 and KIAA0808, where expression
correlated with disease stage in all patients (n=16). Genes were analyzed by ontologic group-
ing as well as by K-means analysis of kinetic patterns of expression. We found that MF T cells
express novel genes involved in immune modulation, proliferation and differentiation and
simultaneously lose the ability to express another subset of genes found in control memory T
cells. These results suggest novel mechanisms and markers in the pathogenesis of MF and iden-
tify a variety of novel targets for the development of markers of disease stage as well as unique
therapeutics.
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Persistent plectin expression with variable intrafamilial disease severity in Epidermolysis Bul-
losa with Muscular Dystrophy
M Titeux,1 J Mejia,1 A Decha,1 C Prost,2 R Spurny,3 L Tonasso,1 M Arne-Bes,4 G Wiche3 and
A Hovnanian1,5 1 INSERM, U563, Toulouse, France, 2 EA3410, Paris XIII University, Bobigny,
France, 3 Molecular Cell Biology, Vienna University, Vienna, Austria, 4 Service of Neurology,
Rangueil Hospital, Toulouse, France and 5 Department of Medical Genetics, Purpan
Hospital, Toulouse, France
Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) is an autosomal recessive
disorder caused by mutations in PLEC1 encoding plectin. Most EBS-MD cases reported result
from mutations leading to loss of plectin expression. We describe two affected kindred with
contrasting EBS-MD severity and persistent plectin expression. The 30-year-old patient pre-
sented since birth with mild skin blistering and developed progressive, disabling muscular dys-
trophy of the upper limbs. Her 24-year-old sister presented skin blistering during infancy with
no muscular manifestations. Skin immunohistology analysis showed positive but reduced
plectin staining at the basement membrane zone. β4 integrin expression was normal, while
electron microscopy revealed the absence of hemidesmosomal inner plaques. Plectin immunos-
taining on cultured EBS-MD keratinocytes showed a patchy distribution contrasting with the
uniform staining observed on normal keratinocytes. Both patients were compound heterozy-
gotes for two novel mutations: p.Q2602X and p.L1486P. p.L1486P co-segregated with
p.R2859H (a known SNP), p.H1349R and p.E2798K substitutions. Of 25 healthy control indi-
viduals genotyped, all carried a glutamic acid residue at position 2798 and 11 were het-
erozygous for the p.H1349R change. In silico modelling showed p.E2798K to introduce only
subtle changes in the position of C-α atoms with very high secondary structure conservation.
In contrast p.L1486P is predicted to disrupt the α-helical plectin rod domain, and is thus
likely to be a causative mutation. These results indicate the presence of mutant plectin that is
defective in its association with cytoskeleton and cell adhesion structures. The variable intra-
familial severity suggests the possibility of modifying genes in EBS-MD.
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The IFN-α response gene OAS1 is over-expressed in keratinocytes and infiltrating lympho-
cytes in cutaneous lupus erythematosus
SS Chow,1 K Seiffert,1 S Peters2 and AA Sinha1 1 Division of Dermatology and Cutaneous
Sciences, Michigan State University, East Lansing, MI and 2 Pathology and Laboratory
Medicine, Weill Medical College of Cornell University, New York, NY
A prominent IFN-α response gene signature has been described in systemic lupus erythe-
matosus (SLE). By microarray analysis, our group has shown the upregulation of several IFN-
α response genes in the skin and blood of chronic cutaneous lupus erythematosus (CLE)
patients, suggesting overlapping mechanisms may be operative in the etiopathogenesis of
systemic and local (skin) disease. The small form of the 2’-5’-oligoadenylate synthetase (OAS1)
gene represents one IFN-regulated sequence that is upregulated in both SLE and CLE. Nested
primer PCR evaluation by our group revealed that the 9-2 isoform of OAS1 is upregulated in
CLE. 9-2 OAS1 has been reported to promote apoptotic activity in mammalian cells, but its
function in human tissues has not been previously explored. In this study, we performed
immunohistochemical analysis using a monoclonal antibody recognizing the small form (p42)
of OAS1 to localize OAS1 expression in CLE tissues. We detect no significant OAS1 staining
in healthy control skin and mild to moderate staining of basal keratinocytes in nonlesional
CLE skin. The most intense staining was observed in basal keratinocytes of lesional CLE skin.
Within individual keratinocytes, OAS1 antibody stained predominantly intracytoplasmic
regions. Intense OAS-1 staining was also observed among infiltrating immunocytes of lesional
skin. Co-staining with anti-CD20 and anti-CD3 antibodies reveals that OAS1 appears to be
expressed within infiltrating B and T lymphocytes, respectively. The demonstration of OAS1
up-regulation in both keratinocytes and infiltrating lymphocytes in CLE strengthens the ration-
ale for investigating the functional role of OAS1 in LE, specifically to test the hypothesis that
OAS1 has dual roles in type I IFN regulated apoptotic pathways - being a potentially pro-apop-
totic mediator in keratinocytes and an anti-apoptotic mediator in lymphocytes.
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Transcription regulation of the CTLA-4 gene in primary human T cells depends of coopera-
tion between NF-AT and GATA3
HK Wong and HM Gibson Dermatology Research, Henry Ford Health System, Detroit, MI
CTLA-4 is a member of the co-stimulatory molecule, which negatively regulates T cell acti-
vation.  This gene has been shown to be expressed at a higher level in the CD45RO+ CD4+
T cell subset and Treg cells. In contrast to CD28, which is expressed constitutively, the expres-
sion of CTLA-4 is tightly regulated between resting and stimulated human T cells. Regulation
has been analyzed in tumor cell lines and murine cells, but the study of CTLA-4 regulation
in primary human T cell has been limited.  We show that CTLA-4 is highly inducible gene in
primary purified T cells and in T cells from CTCL.  To understand the mechanism for CTLA-4
expression, we have cloned the upstream promoter region of the human CTLA-4 gene and
identified proximal promoter regions critical for induction in human T cells. We have identi-
fied a proximal regulatory region within the first 500bp of the promoter that confers inducible
regulation of CTLA-4 expression using transient reporter assays in human T cells, both in Jurkat
cells and in primary human T cells. This regulatory region is important in mediating induc-
tion by phorbol esters and calcium ionophore and has consensus recognition sequence for
NF-AT.  By EMSA, NF-AT can bind specifically to the CTLA-4 promoter with high affinity as
confirmed by competition with NF-AT oligos and antibodies to NF-AT.  We show that NF-AT
acts at this region transcriptionally by ChIP assays.  In T cells, GATA3 plays a role in direct-
ing T cell specific transcription of Th2-specific cytokine genes. In cotransfection studies using
the CTLA-4 promoter, GATA3 stimulates expression and is dependent on the presence of the
NF-AT site. This finding suggests the cooperation of GATA3 with NF-AT in activating CTLA-4
in T cells. Understanding the nature of the NF-AT and additional factors that interact with the
CTLA-4 promoter may provide insights into the molecular mechanism for the regulation of
the CTLA-4 gene.
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VDR and Hairless expression in human epithelial tissue and hair follicle
A Casta,2 H Kim,3 K Djabali1 and AM Christiano1,3 1 Dermatology, Columbia University, New
York, NY, 2 Nutrition, Columbia University, New York, NY and 3 Genetics and Development,
Columbia University, New York, NY
The understanding of the molecular events governed by the hairless protein in hair follicle
development and biology has achieved significant progress. The protein domains of hairless
and its known interacting partners have revealed the existence of cellular mechanism(s) in
which hairless might be involved. Hairless is a single zinc-finger protein which is thought to
act as a transcriptional co-repressor. In humans, there are two hairless isoforms results from
alternative splicing of exon 17. Previous studies in our lab identified three LXXLL motifs, known
as NR (nuclear receptor) boxes which might mediate Hairless interaction with the Vitamin D
receptor. Both proteins play a critical role in the mammalian hair cycle and strong pheno-
typic similarities exist in hairless and VDR null mice, as well as in the human papular atrichia
caused by a hairless gene mutation and vitamin D dependent rickets, caused by mutations in
VDR. In this study, we analyzed the gene expression pattern of both hairless and VDR, dur-
ing the human hair follicle cycle and in several human tissues. During anagen and catagen
of the hair follicle, we show that both proteins are co-expressed in the nucleus in several hair
follicle compartments except in the dermal papilla and the inner root sheath (IRS), in which
only nuclear hairless is expressed. Likewise, VDR is expressed alone in Henley’s and Hux-
ley’s layers of the IRS showing perinuclear subcellular localization. The analysis of human tis-
sue reveals that both genes are co-expressed in the epithelium. While in the human breast
and prostate epithelium hairless localizes to the nucleus and VDR is perinuclear, in the epithe-
lium of the human esophagus both proteins co-localize to the nucleus. Upon RT-PCR analy-
sis for specific hairless isoform expression, we find prostate, skin and esophagus express both
isoforms A and B, while breast tissue expresses exclusively isoform A. These findings suggest
differential expression of hairless isoforms in a cell-type and tissue-specific manner.
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Analysis of T-plastin gene regulation, a gene highly expressed in Sezary T cells
HM Gibson, AJ Wilson and HK Wong Dermatology Research, Henry Ford Health System,
Detroit, MI
Differential gene expression analysis has identified T-plastin as a gene highly expressed in cuta-
neous T-cell lymphoma, particularly from patients with Sezary syndrome (SS). Plastins are pro-
teins that have actin bundling functions with 2 major isoforms, L-plastin and T-plastin. There
is tissue specific distribution of plastins with T-plastin restricted to epithelial and mesenchy-
mal cells whereas L-plastin is found in hematopoietic cells. The significance of T-plastin in
CTCL is not known, however its expression in T cells is highly abnormal. In analysis of PBMC
and T cells from patients with SS, we have confirmed the high expression of T-plastin in SS T
cells. SS PBMC have greater than 500 fold higher expression of T-plastin than normal. In analy-
sis of cell lines that express T-plastin, expression is readily detected in adherent cells such as
human 293 cells and HeLa cells.  T-plastin is not detected in T cell line such as Jurkat T cells
or lymphoid cells such as CEM. However cell lines derived from SS such as Hut102 and HH
have higher levels of T-plastin expression. This suggests the presence of specific factors that
control the expression of the T-plastin gene. To better understand the mechanism of T-plastin
regulation, we have cloned the T-plastin promoter into reporter plasmids. Transfection studies
show that the proximal promoter confers potent transcription activation in 293 cells, a cell
line that expresses T-plastin to high levels relative to control promoter. In Jurkat T cells, the
expression directed by the T-plastin promoter is low relative to the CMV promoter, indicating
the presence of cell-type dependent transcription factors that play a role in stimulating high
level expression of T-plastin in 293 cells. The promoter will be dissected to identify the sequences
that are important in transcription regulation to provide insight into the pathway that may
become aberrant in SS to activate the T-plastin gene.
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The leukotriene B4 omega-hydroxylase CYP4F3A is expressed in human epidermis: regula-
tion by cellular differentiation state and induction by retinoids
L Du,2 A Kalsotra,3 HW Strobel,3 PA Ladd2 and DS Keeney1,2 1 Research Service, VA
Tennessee Valley Healthcare System, Nashville, TN, 2 Medicine/Dermatology &
Biochemistry, Vanderbilt University, Nashville, TN and 3 Biochemistry & Molecular Biology,
University of Texas, Houston, TX
The potent pro-inflammatory lipid leukotriene B4 (LTB4) mediates leukocyte chemotaxis and
adhesion and prevents leukocyte apoptosis. In neutrophils, cytochrome P450-dependent
omega-hydroxylation (CYP4F gene products) is a major LTB4 inactivation pathway. The rela-
tive importance of this pathway and mechanisms regulating CYP4F gene expression are poorly
understood in the skin—an important target organ in host defense. In this study we used
quantitative real-time PCR to measure CYP4F mRNA expression levels in human epidermis
and cultured epidermal cells, in different physiological states. All six CYP4F transcripts (CYP4F2,
4F3A, 4F3B, 4F8, 4F11, 4F12) were expressed in adult and neonatal epidermis, and all but
CYP4F8 were expressed in human epidermal cell cultures. We differentiated epidermal cul-
tures for six days in the presence of 100 nM retinoic acid or vehicle. CYP4F2, 4F3A, 4F3B
and 4F12 mRNA levels were significantly greater in Day 6 differentiating cells (vs. Day 0 pro-
liferating cells).  All except CYP4F12 mRNA levels were significantly greater in retinoic acid
treated cells (vs. Day 6 vehicle), even though retinoic acid inhibited in vitro differentiation.
Retinoic acid also increased microsomal CYP4F immunoreactivity and LTB4 omega-hydrox-
ylase activities (vs. vehicle). We identified two mechanisms up-regulating CYP4F expression
and function in human epidermis. One mechanism involves differentiation-specific factors.
The other involves pharmacological levels of retinoids. We conclude epidermal CYP4Fs may
function in the biosynthesis and/or disposition of pro-inflammatory and pro-resolving lipid
mediators and may be important targets for therapeutic interventions in inflamed skin.
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Gender effects on the mineralization of connective tissues in a murine PXE model, the Abcc6-
/- mouse
Q Jiang, Q Li, J LaRusso and J Uitto Dermatology, Jefferson Medical College, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) results from mutations in the ABCC6 gene. Affected indi-
viduals commonly present with mineralization of connective tissues, primarily in the skin,
eyes and the cardiovascular system. A question of gender modifiers in PXE has been raised
based on clinical findings that the clinically observed ratio of females vs. males affected by
PXE is 2:1. This study was designed to investigate the role of gender as an independent con-
tributor to the phenotypic profile in PXE. We performed a sex-phenotype correlation analysis
on two groups, female (F) and male (M), consisting of seven Abcc6-/- mice per group at 3
months of age. The degree of mineralization of muzzle skin, a biomarker of the progress of
PXE processes, was quantified by computerized morphometic analysis of H.E. stained sec-
tions, and calcium and phosphate levels in tissues were determined colorimetrically using
cresolphthalein complexone and malachite green. Our results show that both female and male
Abcc6-/- mice demonstrated significantly enhanced mineralization, as determined both mor-
phometically and chemically in comparison to wild-type mice (p<0.05). Nevertheless, the
mean PXE severity scores were equally high (1.03<u>+</u>0.25 and 0.71<u>+</u>0.41, M
and F, respectively, for corrected mineralized area; 51.35<u>+</u>15.35 and
42.26<u>+</u>13.41, M and F, respectively, for the level of calcium and phosphate product)
and did not differ when age-matched male and female mice, homozygous for the Abcc6-/-
allele, were compared. Our results suggest that gender is not a major phenotypic modifier of
the mineralization phenotype in the present murine model of PXE, at least up to three months
of age. The clinical findings on female preponderance may be due to gender differences in
reporting of symptoms, different hormonal control in humans, and/or epigenetic factors.
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A keratin K1 somatic deletion cause a patchy plantar epidermolytic naevus
B Didona,1 A Terrinoni,2 L Zocchi,3 A Codispoti3 and G Melino4 1 I Dermatological
Departement, Istituto Dermopatico dell’Immacolata, Rome, Italy, 2 I Dermatologic
Departement, Istituto Dermopatico dell’Immacolata, Rome, Italy, 3 Biochemistry
Laboratory,IDI-irccs,c/o Departement of Experimental Medecine and Biochemical Sciences.,
University of Rome “Tor Vergata”., Rome, Italy and 4 Departement of Exeperimental
Medecine and Biochemical Sciences, University of Rome “Tor Vergata”., Rome, Italy
Palmoplantar keratodermas(PPK) are a group of dermatological disorders caused by mutation
in many genes, such as keratins(KRT), connexins and others. Recently, some KRT1 mutations
have been correlated with distinct phenoty- pes, all caracterised by the presence of PPK. We
describe a 18 year male sporadic patient showing a patchy hyperkeratosis only in the left
sole. Histological esamination of a skin sample from this lesion showed a typical aspect of
epidermolitic hyperkeratosis. Mutation analysis of KRT1 gene demonstrated the presence of
a deletion of 20 bp in the V2 domain, leading in a frame- shift in translation of the c-term of
protein and premature stop. Mutation analysis in DNA from multiple skin samples of unin-
volved plantar area and from blood lymphocytes revelead no mutations in the KRT1 gene. This
is the first report of a patchy plantar epidermolytic naevus caused by KRT1 mutation.
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Role of calcification inhibitors in the pathogenesis of mineralization of connective tissues in
PXE
Q Jiang, J LaRusso, S Sadowski and J Uitto Dermatology and Cutaneous Biology, Thomas
Jefferson University, Philadelphia, PA
Mineralization of connective tissues, with considerable morbidity in the skin, eyes and the
cardiovascular system, is characteristic of pseudoxanthoma elasticum (PXE), a heritable dis-
order caused by mutations in the ABCC6 gene. However, the pathomechanisms of mineral-
ization of connective tissues are currently unknown. In general, mineralization proceeds when
the balance of the promoting factors outweighs the inhibitory proteins. In order to determine
the role of matrix gla protein (MGP), a local inhibitor, and α-fetuin, a systemic inhibitor, in
the process of mineralization in PXE, we i) measured serum levels of the two inhibitors in
Abcc6-/- and wild-type control mice by ELISA; ii) examined calcified connective tissues from
Abcc6-/- mice by immunostaining for the presence of the inhibitors; and iii) cultured human
smooth muscle cells (HSMC) with serum from Abcc6-/- or Abcc6+/+ mice in calcification-
inducing medium high in inorganic phosphate for elastin production and calcium deposits.
There was a decrease in serum α-fetuin levels and slight increase in serum MGP levels in
Abcc6-/- mice compared to age-matched wild-type control mice. Both α-fetuin and MGP co-
localized with mineralization of connective tissues. In vitro, HSMC incubated with Abcc6-/-
serum demonstrated more calcium deposit than those incubated with normal serum, sug-
gesting a lesser ability of PXE serum to prevent the growth of mineral deposits; and less insol-
uble elastin but more soluble elastin, implying a disruption in elastin assembly. These data
suggest that α-fetuin and MGP are involved in the process of mineralization of connective tis-
sues in PXE, and they support the notion that PXE is a metabolic disorder.
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Aberrant mineralization of connective tissues in a mouse model for PXE is associated with
deposition of bone-associated proteins
Q Jiang,1 Q Li,1 T Freeman,2 J LaRusso1 and J Uitto1 1 Dermatology, Jefferson Medical
College, Philadelphia, PA and 2 Orthopedic Surgery, Thomas Jefferson University,
Philadelphia, PA
Pseudoxanthoma elasticum (PXE), an inherited multi-organ disorder, is caused by mutations
in the ABCC6 gene and characterized by progressive mineralization of the connective tissue
in the skin, Bruch’s membrane in the retina and the cardiovascular system. However, the cel-
lular and molecular events leading to mineralization of soft tissues in PXE are unknown. To
characterize the mineralization process and to determine if the mineralization observed in a
PXE animal model, the Abcc6-/- mouse, is related to actively regulated cell-mediated processes
rather than passive precipitation of calcium and phosphorus in the setting of deranged min-
eral metabolism, the vibrissae sheath of Abcc6-/- mice, a biomarker of PXE progression, was
investigated by histological examination and colorimetric methods using o-cresolphthalein
complexone and malachite green for mineralization and then evaluated for the presence of
bone matrix proteins by immunohistochemistry. An elevated calcium-phosphate product in
the vibrissae sheath of Abcc6-/- mice was detected colorimetrically, consistent with the his-
tological findings by H.E. and Alizarin red stains. The levels of calcium-phosphate product in
blood of Abcc6-/- mice were normal compared to those in wild-type mice. The elevated cal-
cium-phosphate product seemed not to be associated with bone loss as determined by micro
CT. Positive staining for type I collagen, alkaline phosphatase, ANK and cbfa1 was strongly
correlated with mineralization, and the location of immunostaining for mineralization inhibitors,
MGP and α-fetuin, was strongly associated with the presence of the mineralization process.
The data suggest that the deposition of these proteins precedes mineralization and actively
regulates this process locally and systemically, raising hope that directed interventions can
arrest this pathologic process.
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A database for the microarray based molecular classification of skin diseases
B Peters,1 C Mauch,2 JM Baron,4 J Wenzel,3 T Krieg,2 HF Merk,4 T Bieber3 and A Bosio1 1
MACSmolecular Business Unit, Miltenyi Biotec GmbH, Cologne, Germany, 2 Department of
Dermatology, University of Cologne, Cologne, Germany, 3 Department of Dermatology,
University of Bonn, Bonn, Germany and 4 Department of Dermatology, University of
Aachen, Aachen, Germany
As part of a large scale study, we have analyzed the gene expression of human biopsies of
healthy skin, congenital nevi, skin affected by one of four inflammatory skin diseases, or one
of three skin cancers. 820 cDNA microarray analyses were performed with the objective to
develop a microarray based molecular classification system for the diagnosis and prognosis
of skin diseases. An essential role in the development of discriminatory gene expression pat-
terns and the interpretation of clinical and gene expression data must be ascribed to a reli-
able data management system. For data collection and analysis in the study, the SkinSAYS
database was designed. The database covers the complete genomics data as well as over 600
clinical parameters organized in 15 different tables. The database combines a Microsoft Access
based database for patient data management and an Oracle based query function for data
retrieval. Clinical data is correlated to the matching gene expression profiles in an Oracle
based Laboratory Information and Management System. The study setup presented here allows
for a most comprehensive cross-reference between all clinical and genomics data sets. Most
importantly, the database can easily be extended by additional indications and clinical cen-
tres.
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Characterizing susceptibility to phenotypic variations of psoriasis by comparing allelic asso-
ciation signals on PSORS loci chromosomes
J Panko,1 B Wong,1 S Schrodi,3 K Callis,1 M Cargill3 and G Krueger1 1 Dermatology,
University of Utah, Salt Lake City, UT, 2 LineaGen, Salt Lake City, UT and 3 Celera
Diagnostics, Alameda, CA
Though the existence of a genetic component of psoriasis has been repeatedly observed, the
genes predisposing patients to psoriasis and its varied morphologies remain largely unknown.
In this analysis we compare the allelic association peaks in psoriasis cases stratified by phe-
notype. We collected DNA and phenotypic data on 500 psoriasis patients. We then pooled
DNA into groups based on several phenotypes, e.g., psoriatic arthritis and thickness of lesions
in the untreated state, thereby stratifying the data. In each pool we measured the allele fre-
quencies at numerous genetic markers on chromosomes 1, 3, 4, 6, 17 and 19 (these chro-
mosomes house the recognized PSORS loci that associate with psoriasis). After selecting all
markers with allelic association, p <.05, we separated cases into 2 groups based on presence
or absence of 7 phenotypic characteristics. The moving averages of the transformed p values
were plotted against the location of markers on the chromosomes. Charted plots were super-
imposed for each group. Peaks were observed in different locations that stratified patients based
on different phenotypic characteristics. The most pronounced peaks were observed for mark-
ers located on chromosome 6. We conclude from this analysis that psoriasis patients can be
stratified based on phenotype. Allele frequencies of markers are different between those patients
based on the presence or absence of specific phenotype traits. This demonstrates that variants
in genes in this and other regions may dictate phenotypic differences in patients with psoria-
sis.
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Genomic sequencing and haplotype analysis identify HLA-C as the PSORS1 gene
RP Nair,1 PE Stuart,1 I Nistor,1 R Hiremagalore,1 S Jenisch,2 M Weichenthal,3 GR Abecasis,4
HW Lim,5 E Christophers,3 JJ Voorhees1 and JT Elder1 1 Dermatology, Univ of Michigan, Ann
Arbor, MI, 2 Immunology, Univ of Kiel, Kiel, Germany, 3 Dermatology, Univ of Kiel, Kiel,
Germany, 4 Biostatistics, Univ of Michigan, Ann Arbor, MI and 5 Dermatology, Henry Ford
Hospital, Detroit, MI
Previous studies have narrowed the interval containing the major psoriasis susceptibility
locus PSORS1 to a ~300 kb region containing HLA-C and ten other genes. In an effort to
identify the PSORS1 gene, we cloned and sequenced this region from both chromosomes of
five individuals. Two of the sequenced haplotypes are associated with psoriasis (risk), and the
other eight are unassociated (nonrisk). Comparison of sequence for the two risk haplotypes
identified a 298 kb region of homology, extending from just telomeric of HLA-B to the HCG22
gene, flanked by highly nonhomologous regions. Combinatorial analysis of exonic variations
revealed that HCG27, PSORS1C3, OTF3, TCF19, HCR, STG, and HCG22 bear no alleles
unique to risk haplotypes among the ten sequenced haplotypes. SPR1 and SEEK1 both have
mRNA alleles unique to risk, but only HLA-C and corneodesmosin (CDSN) yield predicted
protein alleles unique to risk. The risk alleles of HLA-C and CDSN (HLA-Cw6 and CDSN*TTC)
were genotyped in 678 families with early-onset psoriasis; 620 of these were also typed for
34 microsatellite markers spanning PSORS1. As determined using the pedigree disequilibrium
test, recombinant haplotypes retaining HLA-Cw6 but lacking CDSN*TTC were significantly
(pc = 0.014) associated with psoriasis, whereas recombinants retaining CDSN*TTC but lack-
ing HLA-Cw6 were not associated despite 98% statistical power to detect variants with a RR
= 3 under an additive model. By grouping recombinants with similar breakpoints, the most
telomeric 25% of the 298 kb candidate interval could also be excluded with 98% power. Bar-
ring the possibility of non-protein-encoding mutation(s) in the remainder of the interval, which
is currently being addressed in a large collaborative study, these results identify HLA-Cw6 as
the disease allele at PSORS1 conferring susceptibility to early-onset psoriasis.
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Locus heterogeneity in inherited anonychia
Y Ishii,1 M Wajid1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY
and 2 Genetics and Development, Columbia University, New York, NY
Isolated anonychia (absence of nails) without any associated abnormalities is a very rare anom-
aly among congenital nail disorders. Anonychia families with recessive inheritance have been
reported in the literature, however, the responsible gene(s) are still unknown. Here, we report
a large consanguineous Pakistani family with autosomal recessive transmission of isolated
anonychia. All affected individuals showed typical anonychia of fingernails and toenails, with-
out any associated anomalies of ectodermal appendages and teeth. As a first step toward local-
izing the gene underlying the disease in this family, linkage analysis was performed with
microsatellite markers on chromosome 17q25, the only reported locus for the recessive form
of isolated anonychia. Analysis of 11 microsatellite markers (D17S808, D17S1821, D17S789,
D17S840, D17S1351, D17S515, D17S1864, D17S1301, D17S1817, D17S937, D17S1847)
within and around the linkage interval on chromosome 17q25 showed a high frequency of
heterozygous genotypes (more than 50%) in the affected individuals for almost all of the mark-
ers examined. This result indicates that the responsible locus in this anonychia family is dis-
tinct from the locus on chromosome 17q25. We are now performing homozygosity mapping
using Affymetrix SNP microarrays, to identify a novel locus involved in this form of recessive
anonychia.
507
A knock down approach for correcting epidermolytic hyperkeratosis
J Chen1 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
Epidermolytic hyperkeratosis (EHK) is caused by mutations in either keratin K1 or K10, and it
is inherited in an autosomal dominant fashion. These mutations lead to defective suprabasal
keratinocytes, resulting in blisters and hyperkeratosis. Current treatment is limited to reliev-
ing the symptoms for this monogenic disease. Therefore, therapeutic strategies based on gene
therapy approaches represent an attractive option for a permanent corrective therapy for
EHK. Our laboratory previous developed a conditional mouse model for EHK which is viable,
due to the fact that the expression of a mutant K10 allele can be restricted to a focal area of
the skin. Once the mutant K10 allele is activated in epidermal stem cells, these stem cells
give rise to defective progeny that form hyperkeratotic lesions which persist for the life of the
mouse. This mouse model also revealed that partial suppression of the mutant K10 allele may
be sufficient to eliminate the clinical phenotype. To test this therapeutic strategy, we have
developed siRNAs that specifically target mutant K10 transcripts for degradation, without
affecting wild type K10 transcripts. These siRNAs have been introduced into lentiviral vec-
tors, which were subsequently used to transduce cells expressing both wild type and mutant
K10 constructs. Under these conditions, efficient knock down of mutant, but not wild type
K10 transcripts was observed. We are currently using this lentiviral vector to transduce ker-
atinocytes isolated from our EHK mouse model and testing whether correction of the EHK
phenotype will be achieved in vivo when these cells are introduced into a graft on nude
mice.
509
Delivery and efficacy of topical nuclear factor kappa B decoy in porcine skin
B Schryver, D Ruhrmund, J Alleman, J Zang, L Komuves, M Dajee, LM McEvoy and
RO Ehrhardt Immunology, Corgentech, South San Francisco, CA
The human skin barrier continues to present challenges for the development of topical appli-
cations for skin diseases. Although research in rodent models provides valuable information
in skin biology, many preclinical studies in investigative dermatology are performed prefer-
ably in pig as the skin is considered to be a more representative model for human skin. The
nuclear factor kappa B (NF-kB) transcription factor plays a central role in cutaneous inflam-
matory diseases. Transcription factor decoys are potential therapeutic agents based on target
specific drug design. The aim of this study was to develop a large animal model to test both
delivery and efficacy of NF-kB decoy (NFkBD) in cutaneous inflammation. An immunofluo-
rescence study demonstrated delivery of 0.5% topical NFkBD in keratinocytes and dermal
cells in pig skin. Semi-quantitative analyses indicated that over 80% cells in pig skin are NFkBD
positive. We further confirmed this observation using a real-time PCR-based analytical method
to quantify NFkBD penetration in treated tissue. In a UVB-induced pig-skin inflammation
model, histological analyses indicated decreased inflammatory cell infiltrate in response to
NFkBD treatment. Specifically, alkaline phosphate-positive neutrophil infiltration was signif-
icantly reduced with topical NFkBD application. More importantly, RTPCR analyses demon-
strated that UVB-induced pro-inflammatory genes like IL-8 and Mip-2alpha are effectively
decreased by 30-50% with topical NFkBD treatment of inflamed pig-skin lesions. Since block-
ade of NF-kB function is associated with induction of apoptosis, we analyzed UVB-inflamed
pig skin by an immunohisotchemical assay for caspase-3 activation. Enhanced apoptosis of
immune cells mediated by topical NFkBD application on UVB-inflamed pig skin was observed.
This study illustrates a functional topical NFkBD delivery system in pig skin and shows the
therapeutic potential of this drug in cutaneous inflammation. Topical NFkBD is currently in
phase I/II clinical trials for mild to moderate atopic dermatitis.
508
Topical NF-kB Decoy oligonucleotide restores cutaneous homeostasis in skin inflammation
M Dajee, T Muchamuel, S Brian, S Katie, L Kumoves, LM McEvoy and RO Ehrhardt Research,
Corgentech, South San Franscisco, CA
The stratum corneum (SC) provides an important permeability barrier for the epidermis. Dur-
ing skin inflammation this barrier is seriously compromised. Although topical steroids act as
potent anti-inflammatory drugs, they exert adverse effects like disease rebound associated with
compromised SC integrity. Previously, we demonstrated the potential of topical NF-kB Decoy
(NFkBD) as a very effective anti-inflammatory agent for the treatment of atopic dermatitis. Cur-
rently, topical NFkBD is in phase I/II clinical trials for mild to moderate atopic dermatitis. The
aim of this study is to determine the role of topical NFkBD in restoration of barrier function.
Rapid rebound of inflammation was seen after BMV withdrawal, however, the NFkBD thera-
peutic benefit was maintained for up to 2 weeks. Rebound associated with steroid withdrawal
has been linked to compromised epidermal permeability barrier (EPB) and SC integrity lead-
ing to increased epidermal water loss and susceptibility to exogenous insults. Increase of TEWL
in inflamed lesions was restored to normal levels by topical NFkBD, but not by BMV treat-
ment. This was further supported by penetration of X-gal through compromised EPB in BMV
treated tissue. In addition, unlike NFkBD that showed normal kinetics of barrier recovery, BMV
treatment showed a significant delay of barrier recovery at 3hrs, 6hrs and 24hrs. Steroid asso-
ciated barrier dysfunction was confirmed by aberrant gene regulation of inflammation-asso-
ciated CK6, CK16 and SKALP expression. Furthermore, SC lipid staining of BMV treated tis-
sue demonstrates an interrupted pattern of staining in the intercellular membrane region of
the SC. Lastly, rebound in the BMV-treated group was mostly caused by a compromised skin
barrier since flare-ups were ameliorated with the application of emollient and even more so
through anti-bacterial ointment. In summary, in addition to its strong anti-inflammatory action,
BMV caused severe barrier dysfunction while NFkBD treatment restored cutaneous home-
ostasis during skin inflammation.
506
Sustained survival and production of recombinant protein by genetically engineered human
fibroblasts after intradermal injection
Z Siprashvili,1 TW Ridky1 and P Khavari2,1 1 Dermatology, Stanford Univeristy Medical
Center, Stanford, CA and 2 VA Palo Alto, Palo Alto, CA
Sustainable gene delivery via direct injection of genetically engineered fibroblasts into intact
skin is a significant goal in cutaneous gene transfer. Although, many cell types are potential
gene therapy candidates, primary skin fibroblasts are attractive due their robust growth and
ease of handling. Genetically engineered autologous fibroblasts have been successfully used
to produce therapeutic proteins in vivo, but durability of protein production has not been
addressed. We therefore generated primary human skin fibroblasts transduced with a retrovi-
ral vector containing the luciferase reporter gene under control of the LTR promoter. Cells were
injected in full-thickness mouse skin (n=5 mice/group) and in vivo gene delivery was quanti-
tated in real-time over the course of one year using in vivo bioluminescence detection. Luciferase
expression decreased by 10-fold during the first 7 days after injection with further 3-fold reduc-
tion from 7-14 days post injection before stabilizing at levels that lasted for the duration of the
experiment. Persisting engineered fibroblasts displayed an average reporter activity of 1.8 x
107 photons/sec after stabilization. Primary fibroblasts were localized to lower dermal cells
in mouse skin. These data indicate that genetically engineered primary fibroblasts are capa-
ble of sustained long-term cutaneous protein delivery highlighting the potential of durable
autologous cell based therapy in humans.
510
Gene therapy approaches for epidermolysis bullosa simplex
DR Roop1,2 and W Buitrago1 1 Molecular and Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
Epidermolysis bullosa simplex (EBS) is an autosomal-dominant blistering disease. No effec-
tive treatment is available for EBS making gene therapy the only permanent corrective option.
We generated a transgenic mouse model that mimics EBS-DM at the genetic and phenotypic
level in which the expression of the mutant K14 allele (mtK14) can be restricted to a small
area of the skin. Focal activation of the mtK14 gene by a topical inducer results in formation
of blisters that heal after a few weeks and never reappear. The mtK14 gene is activated in epi-
dermal stem cells and the EBS stem cells are replaced by normal stem cells migrating from
the untreated areas. Furthermore, using a grafting assay, we demonstrated that EBS keratinocytes
have diminished capacity to repopulate the graft sites compared to normal keratinocytes. Taken
together, these observations explain the absence of mosaic forms of EBS and suggest that if
EBS stem cells were removed from a patient, genetically corrected and returned to a blistered
area, they would have a selective growth advantage over defective EBS stem cells. Mice express-
ing the mtK14 allele at levels about 50% of wild type K14 (wtK14) fail to exhibit a phenotype,
suggesting that if the wtK14:mtK14 ratio is above a threshold, the skin will have a normal
appearance and function. We hypothesize that gene therapy for EBS may only require alter-
ation of the wtK14:mtK14 ratio towards the wtK14 allele without correcting or completely sup-
pressing the mtK14 allele. This could be achieved by partial suppression of the mtK14 allele
or by overexpression of the wtK14 allele. Thus, we have developed lentiviral vectors encod-
ing siRNA constructs that specifically cleave the mtK14 transcripts in transduced cells. We
have also developed a lentiviral vector carrying the wtK14 gene that effectively transduces ker-
atinocytes with long-term transgene expression in tissue culture and in the graft site. Cur-
rently, we are testing whether EBS keratinocytes will form a normal epidermis when trans-
duced with these lentiviral vectors and grafted onto nude mice.
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Development of single nucleotide-specific therapeutic siRNAs for treatment of the skin dis-
order pachyonychia congenita
R Hickerson,1 FJ Smith,2 I McLean,2 D Leake3 and RL Kaspar1 1 TransDerm, Santa Cruz, CA,
2 Ninewells Medical School, Dundee, United Kingdom and 3 Dharmacon, Inc, Lafayette, CO
RNA interference offers a novel approach for treating genetic disorders including the rare
monogenic skin disorder pachyonychia congenita (PC). PC is caused by mutations in keratin
(K) 6a, K6b, K16 and K17 genes, including small deletions and single nucleotide (nt) changes.
Transfection experiments of a fusion gene consisting of K6a and a yellow fluorescent reporter
(YFP) resulted in normal keratin filament formation in transfected cells as assayed by fluores-
cence microscopy. Similar constructs containing a single nt change (resulting in N171K) showed
keratin aggregate formation. A sequence walk of all possible N171K mutant-specific small
inhibitory RNAs (siRNAs) identified inhibitors that showed single nt specific down-regulation
of mutant K6a. The two lead siRNAs showed 81 and 80% inhibition of mutant K6a gene expres-
sion and little to no inhibition of wildtype (wt) gene expression. In order to test whether lead
siRNAs could discriminate mutant mRNA in the presence of both wt and mutant forms, a dom-
inant negative tissue culture model was developed. As predicted for a dominant negative dis-
ease, expression of both wt and mutant K6a forms resulted in defective keratin filament for-
mation (keratin aggregates observed in 80-90% of cells). Addition of either lead K6a
mutant-specific siRNAs allowed normal filament structure formation (only 30 and 21% of cells
contained keratin aggregates compared to 87% in the presence of a non-specific control siRNA).
Previously, we have shown that specific siRNAs (but not non-specific controls) strongly inhibit
reporter gene expression in mouse skin (intradermal injection into footpads). The lead K6a siR-
NAs will be tested in similar animal studies. Our results indicate that siRNAs can discriminate
single nt mutations and further suggest that “designer siRNAs” may allow effective treatment
for a host of genetic skin disorders including PC.
512
Global transcriptional profiling of human epidermal keratinocytes to interleukin 1-α
S Yano,1 R Walsh,1 T Banno2 and M Blumenberg1 1 Dermatology, NYU School of Medicine,
New York, NY and 2 Dermatology, Tsukuba University, Tsukuba, Ibaraki, Japan
IL-1 alpha (IL-1α) is a proinflammatory and immunomodulatory cytokine that plays a crucial
role in many inflammatory reactions of the skin. Its excessive production and release by ker-
atinocytes has been implicated in psoriasis, bullous diseases and other skin diseases includ-
ing bacterial infections. To characterize the molecular effects of IL-1α in epidermis, we used
large oligonucleotide DNA microarrays and defined the transcriptional changes in human epi-
dermal keratinocytes 1h, 4h, 24h, and 48h after treatment with IL-1α. We found that 388 genes
are significantly regulated and >50 % of these genes are regulated at 4h post-treatment. RT-
PCR and Western blots confirmed the regulation of all genes tested. We found that IL-1α prefer-
ably up-regulates adhesion, receptor, secreted, regulator, proliferation, and differentiation-
associated genes. Specifically, IL-8, IL-19, many chemokines, SKALP/elafin, complement
component C3, and S100A proteins were up-regulated, which implicates IL-1α in the patho-
genesis of psoriasis. Secreted cytokines, growth factors, and receptors are the primary targets
of IL-1α regulation, and these, in turn, effect the secondary changes. IL-1α induced both pro-
liferation-associated genes and differentiation marker genes, such as transglutaminase 1 and
involucrin. In vitro, IL-1α promoted keratinocyte cell growth and cell apoptosis at the same
time. This suggests that IL-1α plays an important role in abnormal proliferation and differen-
tiation seen in psoriatic epidermis. IL-1α also induced NFkB activation of keratinocytes, which
was shown by NFkB translocation to the nucleus, IkBa degradation, and activation of many
NFkB-related genes. Interestingly, comparing these data with previous results of TNFα and
IFNγ regulated genes, we found that the gene expression pattern was more similar between
IL-1α and TNFα than between IL-1α and IFNγ. In summary, IL-1α has not only inflammatory
effects but also the role of wound healing, cell motility, and apoptosis.
513
Regulation of Hop gene expression upon calcium-induced differentiation of normal human
keratinocytes
G Park,1,2 E Kim,2 H Kim2 and J Yang1,2 1 Dermatology, Sungkyunkwan University, Samsung
Medical Center, Seoul, South Korea and 2 Clinical Research Center, Samsung Biomedical
Research Institute, Seoul, South Korea
The homeodomain only protein (Hop) was originally identified as a key regulator of cardiac
development with unusual characteristics. Hop is an atypical homeodomain protein, which
lacks DNA binding activity that is expressed in embryonic and postnatal cardiac myocytes. In
this study, we found that Hop was differentially expressed in the late stage of calcium-induced
keratinocytes differentiation. By performing the real time RT-PCR, northern, and western analy-
sis, the expression of Hop was at least started at 3 days after calcium treatment in the normal
human keratinocytes and reached at maximum at 7 days. Hop is differentially expressed in
the granular layers in normal foreskin, but is not expressed in the poor differentiated squamous
cell carcinoma as well as basal layer, proliferating keratinocytes of normal skin. However, the
expression of Hop is not detected in HaCaT, human transformed keratinocytes and A431, squa-
mous cell carcinoma as a protein, suggesting that Hop has a function related with anti-pro-
liferative activity as well as cellular differentiation in keratinocytes. Besides calcium, phorbol
ester induced the expression of Hop and protein kinase C inhibitor blocked the calcium-
induced expression of Hop, demonstrating that the expression of Hop was regulated by pro-
tein kinase C-dependent manner. In addition to, p38 MAPK signaling was involved in the reg-
ulation of Hop expression. These results suggest that Hop is differentially expressed in the
differentiated, not in proliferating keratinocytes and suprabasal layer of epidermis and regu-
lated by protein kinase C and p38 MAPK signaling upon calcium-induced differentiation of
normal human keratinocytes.
514
Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of ker-
atinocyte α7 nicotinic receptor
J Arredondo,1 A Chernyavsky,1 KE Pinkerton2 and SA Grando1 1 Dermatology, University of
California, Davis, CA and 2 Center for Health and the Environment, University of California,
Davis, CA
Nicotine and tobacco-derived nitrosamines have been shown to exhibit their pathobiologic
effects, in part, due to activation the nicotinic acetylcholine receptors (nAChRs), mainly α7
nAChR, expressed by epidermal and oral keratinocytes (KCs). This study was designed to gain
a mechanistic insight into α7-mediated nicotine toxicity. We investigated the signaling path-
ways downstream of α7 nAChR in keratinocyte monolayers exposed for 24 hrs to aged and
diluted sidestream cigarette smoke (ADSS) or equivalent concentration of pure nicotine. By
both real-time PCR and In-cell Western, KCs stimulated with ADSS or nicotine showed mul-
tifold increases of the transcription factor STAT-3. These effects could be completely blocked
or significantly (p<0.05) diminished if the cells were pretreated with the α7 antagonist α-bun-
garotoxin (αBTX) or transfected with anti-α7 small interfering RNA (siRNA-α7). The use of pro-
tein kinase inhibitors and dominant negative constructs revealed that signaling through Ras/Raf-
1/MEK1/ERK pathway mediated α7-dependent upregulation of STAT-3. Knockout mutation of
α7 gene prevented ERK1/2 activation by nicotine. Using the gel mobility shift assay, we demon-
strated that an increased protein-binding activity of STAT-3 caused by ADSS or pure nicotine
was mediated by phosphoprylated-JAK-2. Activation of JAK-2/STAT-3 pathway could be pre-
vented by αBTX or siRNA-α7. Thus, nuclear transactivation of STAT-3 in KCs exposed to tobacco
products is mediated via an intracellular signaling downstream from α7 that proceeds via two
complementary pathways. The Ras/Raf-1/MEK1/ERK cascade culminates in upregulated expres-
sion of the gene encoding STAT-3, whereas recruitment and activation of tyrosine kinase JAK-
2 phosphorylates it. Elucidation of this novel mechanism of nicotine-depended nuclear trans-
activation of homodimer STAT-3 identifies keratinocyte α7 nAChR as a promising molecular
target to prevent, reverse, or retard pathobiologic effects of nicotine by receptor inhibitors.
515
Ligand-independent activation of the EGF receptor in normal human epidermal keratinocytes
by cholesterol depletion or hydrogen peroxide
H Ameels, S Lambert, C Mathay, K Nikolova, M Herin and YG Poumay Cell & Tissue
Laboratory, University of Namur, Namur, Belgium
Activation of the epidermal growth factor receptor (EGFR) by ligands modulates the pheno-
type of the normal keratinocyte and hence controls its proliferation and differentiation. When
activated by EGF, the receptor dimerizes and is phosphorylated on tyrosine residues due to
the tyrosine kinase activity present in its cytoplasmic tail. This recruits adaptor proteins which
then initiate intracellular signal transduction towards mitogen-activated protein kinases
ERK1/ERK2 that control gene expression. Simultaneously, the ligand-activated EGFR is inter-
nalised by clathrin-dependent endocytosis in order to exert a negative feed-back on the amount
of EGFR. Recently, it was found that ligand-independent activation of the EGFR can occur in
many cell types including keratinocytes. In this study, we analyzed cell signalling and recep-
tor localization in normal keratinocytes. Ligand-independent activation of EGFR by depletion
of membrane cholesterol or by incubation with hydrogen peroxide was compared with the
activation of EGFR by EGF. The three conditions induce tyrosine phosphorylation of EGFR fol-
lowed by phosphorylation of ERK1/ERK2. Although EGF only slightly activates phosphoryla-
tion of the stress-related MAPK p38, cholesterol depletion and hydrogen peroxide induce a
stronger activation of p38. EGF-binding and hydrogen peroxide induce internalisation of EGFR,
whereas the receptor remains at the plasma membrane after cholesterol depletion. Addition
of EGF to cholesterol-depleted keratinocytes induces a stronger phosphorylation of EGFR,
together with its concomitant internalisation. The ligand-independent signalling is sensitive to
antioxidant. However, cholesterol depletion cannot initiate the endocytosis of EGFR observed
after EGF-binding or treatment with hydrogen peroxide. Thus, conditions needed for EGFR
activation in keratinocytes do not result necessarily in identical receptor processing.
516
Acitretin induces apoptosis and change of relative signaling pathway in epidermoid carci-
noma cell line
S Cai, M Zheng and L Chen Dermatology, Second Hospital of Zhejiang University,
Hangzhou, Zhejiang, China
The aim is to study the effects of acitretin on A431 cell line and try to elucidate the molecular
mechanismsin of inducing growth inhibition and apoptosis by Acitretin using A431 cells in vitro.
After the treatment with acitretin, inhibition of cellular growth were determined by measuring
MTT dye absorption of living cells. Morphological changes was observed by electron microscopy,
apoptosis was assessed by flow cytometry, and the clear evidence of apoptosis was determined
with the Annexin-V staining. The mRNA expression levels of STAT3, cyclinD1 and p42/44MAPK
were detected by reverse transcriptase polymerase chain reaction (RT-PCR). The protein expres-
sion levels of P-STAT3 and CyclinD1 were observed by Western blot in A431 cells. These sam-
ples were treated with Acitretin at the concentration of 10-5mol/L in different time intervals. The
results were as follows. a. It was found that acitretin could significantly inhibit the growth of A431
cells in vitro in a dose-and time-dependent manner. By electron microscopy, morphological changes
revealed characteristics of cell apoptosis. DNA flow cytometric analysis indicated that acitretin
could induce more sub-G1 phase in A431 cell and more cell positive stained with Annexin-V with
the longer co-cultured time. b. Acitretin could significantly inhibit the expression of STAT3 and
CyclinD1 mRNA in A431 cells in vitro in a time-dependent manner. The p-STAT3 and CyclinD1
protein levels were down regulated. The Acitretin could also down regulate the p42/4MAPK mRNA
in A431 cells. c. After incubation with Acitretin, the mRNA level of CyclinD1 in A431 cells was
positively correlated with that of STAT3. The protein level of CyclinD1 was also paralleled with
that of p-STAT3. However there were no correlation on mRNA levels between CyclinD1 and
p42/44MAPK.It is concluded that acitretin play an inhibitory role in the tumor cell growth and
induce the cell apoptosis and the regulation of the Jak/STAT3 signaling pathway may play an impor-
tant role in inducing growth inhibition and apoptosis by acitretin in A431 cells.
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Lovastatin modulates flotillin-2 expression and actin cytoskeleton in melanoma cells
P Hazarika,1 D Babu,1 S Heldt1,2 and M Duvic1 1 Dermatology, MD Anderson Cancer
Center, Houston, TX and 2 Baylor College of Medicine, Houston, TX
Lovastatin, a 3-hydroxy 3-methylglutaryl CoA (HMG- CoA) reductase inhibitor, inhibits cho-
lesterol synthesis, is associated with reduced risk of melanoma and solid tumors, and induces
apoptosis of melanoma cell lines. Cholesterol is a major component of lipid rafts that sequester
growth factor receptors including G-protein coupled receptors involved in signal transduc-
tion pathways. When flotillin-2 (flot-2), a caveolae/lipid raft associated protein, is over-expressed,
it induces filopodia, confers serum independent growth and transforms a non-tumorigenic
SB2 melanoma cell line to highly metastatic line [Cancer Res 64: 7361-9, 2004]. Since flot-
2 has two putative cholesterol recognition/interaction amino acid motifs and promotes recruit-
ment of plasma membrane cholesterol, we studied the effect of lovastatin on flotillin-2 expres-
sion in melanoma and glioma cells. Lovastatin treatment of cells at 4 µM for 72 hours decreased
flot-2 expression (20-36%) in SB2, A375SM, Mel501 melanoma but not in glioma cell lines.
Total Rho expression was decreased in both melanoma (28-44%) and aggressive glioma lines
SNB-19, HFU251 (25 and 11%) but not in non-aggressive glioma line LN229. Lovastatin inhib-
ited melanoma cell proliferation by 29-45%, and glioma cells by 7.8- 65%. Lovastatin treat-
ment of A375SM cells disrupted the actin cytoskeleton in the same manner as knocking
down flot-2 by siRNA oligos. Flot-2 is associated to inner plasma membrane through myris-
toylation and palmitoylation, and thus was not affected by lovastatin compared to RhoA mem-
brane association that requires geranyl-geranylation. Flotillin-2 appears to be an upstream reg-
ulator of the Rho-GTPase signal transduction pathway that controls the actin cytoskeleton
implicated in invasive properties of melanoma metastases. Chemoprevention effects of statins
may also involve their ability to modulate flotillin-2 expression.
519
Specific binding of fibroblast growth factor-1 (FGF1) to integrins is required for FGF1 sig-
naling
S Mori, RR Isseroff and Y Takada Dermatology, UC Davis, Sacramento, CA
Fibroblast growth factors (FGFs) are a family of heparin-binding growth factors and are criti-
cally involved in cell proliferation and migration. While integrins play a critical role in FGF
signaling through “FGF receptor (FGFR)-integrin crosstalk”, the mechanism of the crosstalk is
unclear. It has been reported that substrate-bound FGF2 promotes endothelial cell adhesion
by interacting with integrin alphaVbeta3 and induces endothelial cell proliferation, motility,
and the recruitment of FGFR-1 in the cell substrate contact. It is unclear how integrins inter-
act with FGF2 or whether this interaction is biologically relevant since heat-denatured FGF2
still supports integrin binding. Here we show that immobilized FGF1, a most studied FGF fam-
ily member, binds to integrin alphaVbeta3 and alpha5beta1. We located the integrin-binding
site by using molecular modeling and mutagenesis. The alphaVbeta3-binding site in FGF1 is
close to or overlaps with the heparin-binding site but is distinct from the FGFR-binding site.
The alphaVbeta3 and heparin binding sites in FGF1 are distinct since a point mutation of Arg
of FGF1 to Glu (the charge reversal mutation) reduced its binding to integrin but did not
affect its binding to heparin. FGF1 mutants that do not bind to integrin were defective in induc-
ing DNA synthesis, mitogen activated kinase (ERK1/2) activation, phosphorylation of focal
adhesion kinase, migration, and chemotaxis in mouse fibroblasts. We demonstrated that the
integrin-binding defective mutants showed dominant negative effects in migration of fibrob-
lasts. These results suggest that the direct binding of FGF to integrins through a clearly defined
integrin-binding site plays a critical role in FGF signaling.
521
p75 neurotrophin receptor (p75NTR) signals apoptosis either alone or in association with
its co-receptor sortilin in human keratinocytes
F Truzzi, A Marconi, P Atzei, R Lotti, K Dallaglio and C Pincelli Dermatology, University of
Modena and Reggio Emilia, Modena, Italy
The p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and sig-
nals apoptosis in many cell settings. In the nervous system, while pro-NGF induces apopto-
sis by binding p75NTR and its co-receptor sortilin, mature neurotrophins (NT) bind to p75NTR
alone and trigger cell death, in the absence of the NT high-affinity receptor trk. The aim of
the present study was to evaluate the expression and function of p75NTR in human ker-
atinocytes. p75NTR was detected in a subpopulation of basal keratinocytes, as shown by dou-
ble staining with keratin 10 and transglutaminase-I. p75NTR was more expressed in transit
amplifying cells that are more susceptible to apoptosis, than in stem keratinocytes which are
completely protected from cell death. Beta-amyloid, that acts as a ligand for p75NTR, induced
apoptosis in human keratinocytes, as shown by MTT assay and by flow cytometry. Moreover,
BDNF, which can signal only through p75NTR, due to the lack of its high-affinity receptor
trkB, induced apoptosis in keratinocytes, as shown by TUNEL. This effect was partially blocked
by anti-p75NTR antibody. Furthermore, BDNF induced JNK phosphorylation through p75NTR,
indicating that p75NTR possesses its own signal in human keratinocytes. Sortilin was detected
in human keratinocytes at the mRNA and at the protein level. Pro-NGF induced apoptosis in
human keratinocytes, in a dose-dependent manner. HaCat cells overexpressing p75NTR
expressed higher levels of sortilin, as compared to parental HaCat cells. Finally, caspase
assay showed that apoptosis was significantly induced by pro-NGF in HaCat keratinocytes
transfected with p75NTR and sortilin, but not in unstimulated HaCat cells (p<0.05). These
results indicate that p75NTR acts as a proapoptotic receptor in human keratinocytes. Depend-
ing on the ligand, p75NTR can induce apoptosis in human keratinocytes either alone or by
interacting with the co-receptor sortilin, even in the presence of trk.
520
FK506 induces interleukin-6 secretion from cultured human keratinocytes: a potential role
in tacrolimus-induced skin irritation
CE Lan,1 H Yu,2 C Wu,3 S Huang1 and G Chen1 1 Department of Dermatology, Kaohsiung
Medical University, Kaohsiung, Taiwan, 2 Department of Dermatology, National Taiwan
University, Taipei, Taiwan and 3 Faculty of Biomedical laboratory Science, Kaohsiung Medical
University, Kaohsiung, Taiwan
The aim of our study was to explore the regulation of interleukin-6 and -8 by FK506 on cul-
tured keratinocytes. The UVB-irradiated keratinocytes were treated with FK506 to simulate the
interactions between inflamed skin and FK506 in vitro. The levels of interleukin-6 and -8
present in the culture supernatant were determined. In addition, the protein levels of differ-
ent pathways, including p38 mitogen-activated protein kinase (p38 MAPK) and activator pro-
tein-1 (AP-1) were determined at various time points. Specific inhibitors were also used to
determine the functional roles of these pathways. Our results showed that FK506 upregulates
the interleukin-6 secretion from UVB-irradiated keratinocytes via upregulation of p38 MAPK
pathway. The levels of interleukin-8 were not significantly altered by FK506. In addition, the
AP-1 pathway and intracellular cAMP levels of keratinocytes were not significantly altered by
FK506 treatment. Since upregulation of interleukin-6 is involved in the process of chemically-
induced skin irritation and topical FK506 is associated with increased skin irritation in human
dermatitis model, our results provide a reasonable explanation for this commonly encoun-
tered yet often neglected clinical phenomenon.
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All-trans retinoic acid induced hyaluronan production and hyperplasia are mediated by EGFR-
ERK signaling in epidermal keratinocytes
S Pasonen-Seppanen,1 E Maytin,2 K Torronen,1 J Hyttinen,1 A Kultti,1 M Tammi1 and R Tammi1
1 Institute of Biomedicine, University of Kuopio, Kuopio, Kuopio, Finland and 2 Department
of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH
All-trans retinoic acid (RA) is widely used in the therapy of several skin disorders such as pso-
riasis and acne. However, the mechanisms by which retinoids control cell proliferation and
differentiation, are not completely understood, but may involve the regulatory matrix mole-
cule hyaluronan. Hyaluronan is a large ECM molecule, which influences keratinocyte migra-
tion, proliferation and differentiation. In the present work the effects of all-trans RA on epi-
dermal morphology and hyaluronan metabolism were examined in mouse skin in vivo and in
organotypic and monolayer cultures of rat keratinocytes. Topical treatment of mouse epider-
mis with all-trans RA (1-14 d) led to an increase in epidermal hyaluronan and its CD44 recep-
tor, with hyperplasia of the epidermis. These effects were reproduced in the organotypic ker-
atinocyte cultures. All-trans RA upregulated the hyaluronan synthases Has2 and Has3 in
organotypic cultures. The epidermal hyperplasia and hyaluronan production induced by all-
trans RA were blocked with 1) AG1478, an inhibitor of the epidermal growth factor receptor
(EGFR); 2) UO126 an inhibitor of the MEK kinase and 3) GM6001, an inhibitor of the matrix
metalloproteinases. These effects were consistent with the findings that all-trans RA upregu-
lated HB-EGF mRNA and increased the phosphorylation of EGFR, ERK1/2, JNK and c-JUN.
Studies with protein synthesis inhibitor cycloheximide showed that the activation of ERK1/2
after all-trans RA treatment does not require de novo protein synthesis. The results suggest
that the effects of all-trans RA on keratinocyte proliferation and hyaluronan synthesis are partly
mediated through EGFR-signaling, and the activation of this signaling pathway is a primary
response to all-trans RA.
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Ligation of dectin-2 by hyphae on antigen presenting cells triggers signaling by FcRγ, that
then mediates phagocytosis and upregulated IL-1Ra expression.
X Yang, K Sato, P Cruz, Jr and K Ariizumi Dermatology, UT Southwestern Medical Center,
Dallas, TX
Pattern recognition receptors (PRR) expressed APC play a critical role in recognizing microbes
and regulating immune responses generated against pathogens. Previously we reported that:
C-type lectin dectin-2 is a PRR for hyphal (but not yeast) forms of dimorphic fungi; after bind-
ing to hyphae, it transduces protein tyrosine phosphorylation despite lacking signal motifs in
its intracellular domain; and in APC, these processes lead to phagocytosis of hyphae and
upregulated expression of IL-1Ra mRNA and protein. To better understand how dectin-2 trans-
duces intracellular signals, we posited an association with the FcRγ receptor since: FcRγ inter-
acts with other molecules through transmembrane arginine; and dectin-2 contains this argi-
nine residue. To assess whether dectin-2 can bind FcRγ, we used anti-V5Ab to precipitate extracts
of RAW macrophages transfected with V5 epitope-tagged dectin-2 gene (Dec2V5), and then
used anti-FcRγ Ab for Western blotting. Clearly, dectin-2 co-precipitated endogenous FcRγ.
We also observed surface dectin-2 to co-localizae with FcRγ on RAW cells. To determine whether
membrane arginine is required for dectin-2/FcRγ binding, we created a dectin-2 mutant with
arginine replaced by valine to co-precipitate FcRγ. Since FcRγ is known to escort the partner
protein to the cell surface, we asked whether co-expression of FcRγ induces surface expression
of dectin-2; FACS analysis revealed this to be so in FcRγ- and Dec2V5 transfected COS-1 cells.
Finally, we examined effects of C. albicans yeast/hyphae downstream events in Dec2V5-express-
ing RAW cells. As in previous studies, hyphae (but not yeast) induced phagocytosis and upreg-
ulated IL-1Ra expression. In parallel, hyphae (but not yeast) triggered phosphorylation of FcRγ.
Most importantly, PP2, an inhibitor of src kinases (known to associate with FcRγ) blocked phago-
cytosis and IL-1Ra expression in hyphae-treated Dec2V5 RAW cells. Our results indicate that
dectin-2 employs FcRγ to mediate phagocytosis and IL-1Ra expression.
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Notch-1 signaling modulates TNF-Induced NF-κB signaling in human keratinocytes
LL Song, V Chaturvedi, B Bodner, Y Peng, BJ Nickoloff and L Miele Pathology, Loyola
University Chicago, Maywood, IL
TNF-α is a key inflammatory cytokine implicated in the immunopathogenesis of psoriasis. Ker-
atinocytes (KCs) within plaques are characterized by enhanced NF-κB signaling and altered
Notch-1 levels, accompanied by immunocytes expressing TNF-α. Notch-1 can either activate
or inhibit NF-κB depending on cellular context. To determine if signaling abnormalities within
KCs in response to persistent inflammatory reaction instigated by immunocytes plays a role
in the abnormal cell fate decisions of KCs, we explored functional consequence of altered
Notch signaling in the NF-κB pathway. Knocking down (by approximately 50%) endogenous
Notch-1 levels by siRNA in cultured human KCs caused two-fold up-regulation of NF-κB activ-
ities in response to the stimulation of TNF-α (10 ng/ml) in a time-dependent manner, as deter-
mined by NF-κB promoter-driven luciferase assays. Consistent with this observation, forced
over-expression of the active form of Notch-1 in KCs by using transient transfection signifi-
cantly (70-90%) down-regulated TNF-α induced NF-κB activity at 15, 30, and 120 min as
reflected by luciferase assays. In addition, enhanced Notch-1 activity was accompanied by
markedly elevated levels (approx 3-fold) of the NF-κB inhibitor, IκBα. Taken together, these
results indicate Notch signaling clearly modulates TNF-α induced NF-κB signaling in normal
KCs. In KCs, the primary effect of Notch at physiological levels is to inhibit NF-κB. In the pres-
ence of decreased Notch-1 levels, TNF-α induced NF-κB activity is enhanced. Thus, chronic
exposure to TNF-α of KCs in psoriatic plaques may lead to Notch downregulation and abnor-
mally high NF-κB activity. This may result in an altered program of KC differentiation, as well
as a vicious circle of inflammatory reactions, promoting the release of more TNF-α and other
cytokines. Therapeutic agents that target Notch-1 levels or activity in epidermal KCs may restore
the physiological differentiation program and reduce cytokine-mediated, NF-κB-induced inflam-
matory reactions.
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Heat shock protein-90: an abundant extracellular molecule in epidermis and a potent stim-
ulus of keratinocyte re-epithelialization
W Li,1,2 M Fedesco,1 J Fan,1,2 J Cheng,1 B Bandyopadhay,1 Y Li,1,2 J Feilds,1 Y Han,1 M Chen1
and D Woodley1,2 1 Dermatology, University of Southern California, Los Angeles, CA and 2
the Greater Los Angeles Veterans Administration Healthcare System, Los Angeles, CA
Re-epithelialization is the process by which human keratinocytes (HKs) laterally migrate across
the wound bed from the cut appendages and the wound margins to resurface the wound. It
is critical for restoring the skin as a permeability barrier to prevent water loss and sepsis. The
jump-start mechanism of this process, however, remains unclear. In this study, we report that
the heat shock protein 90-alpha (hsp90-alpha), a historically intracellular stress-responsive
chaperone, is abundant in human epidermis, but surprisingly in the extracellular environ-
ment rather than within cells. In vitro, we found that hsp90-alpha is secreted into the condi-
tioned medium (CM) by HKs, but not by dermal fibroblasts. Human serum and selected sol-
uble mitogens and motogens enhance HK secretion of hsp90-alpha. The addition of recombinant
hsp90-alpha shows selective promotion of HK migration, but not melanocyte migration. In
contrast, hsp90-alpha does not affect HK proliferation. Inhibition of extracellular hsp90-
alpha with an anti-hsp90-alpha neutralizing antibody, blocked HK migration induced by human
serum, TGF-alpha or hypoxia. Mechanistically, extracellular hsp90-alpha-triggered HK migra-
tion requires sustained activation of AKT and ERK. The data along with the unique and natu-
rally occurring location of hsp90-alpha in human skin suggests that the abundant extracellu-
lar hsp90-alpha serves to initiate HK migration and re-epithelialization following a skin wound.
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The gene profile of human keratinocytes exhibiting “enhanced cell motility” via growth fac-
tor stimulation.
J Cheng, J Fan, B Bandyopadhay, S Guan, M Chen, D Woodley and W Li Dermatology,
University of Southern California, Los Angeles, CA
HK migration is initiated by ECM and then further enhanced and given the direction by a sol-
uble growth factor. The purpose of this study was to define the early gene profile of HKs
undergoing growth factor-enhanced cell migration. In order not to confound the results with
growth factor-induced proliferation genes, we nullified HK cell division by 10 micrograms/ml
of TGF-beta, which selectively inhibits HK proliferation, but not migration. To further narrow
down migration-related genes, we independently induced HK migration with two potent pro-
motility factors and specifically focused on the commonly regulated genes. Hence, HKs were
sparsely plated onto type I collagen in the presence of TGF-beta to “initiate” migration. After
30 min of pre-treatment with TGF-beta, the sub-confluent HK cultures were stimulated by TGF-
alpha or insulin for 30, 60 and 120 minutes (in the continued presence of TGF-beta). RNAs
were isolated from the HKs and subjected to DNA microarray analyses. Using a 2.5-fold or
greater cut off for significant gene modulation by both TGF-alpha and insulin, we found that
1) six immediate early genes (30 min stimulation) were up-regulated and seven down-regu-
lated, 2) 130 early genes (60 min stimulation) genes up-regulated and 56 genes down-regu-
lated, and 3) 169 delayed genes (120 min stimulation) were up-regulated and 151 genes down-
regulated. Notable genes thought to be associated with cell migration were modulated including
RhoGTPases that are responsible for cytoskeletal organization, MMPs associated with HK
migration, and integrin receptors. To verify the microarray data, selected genes were confirmed
by RT-PCR and analyzed statistically. The function of selected genes in regulation of HK migra-
tion was further investigated by siRNA technique. We propose that the majority of HK genes
modulated by both TGF-alpha or insulin constitutes the initial (2 hrs) cellular migration sig-
naling program. This is the first systematic study on cell migration-specific gene profile.
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Smad signaling regulates collagenase-3 (MMP-13) expression, invasion, and growth of cuta-
neous squamous carcinoma cells
S Leivonen,1 R Ala-aho,1 K Koli,2 R Grenman,1 J Peltonen1 and V Kahari1 1 Dermatology,
University of Turku, Turku, Finland and 2 University of Helsinki, Helsinki, Finland
Squamous cell carcinoma (SCC) cells of the skin specifically express collagenase-3 (MMP-13),
the expression of which correlates with their invasion capacity. Transforming growth factor-
beta (TGF-beta) enhances MMP-13 and collagenase-1 (MMP-1) expression and invasion of
SCC cells via p38 mitogen-activated protein kinase signaling pathway. In this study, we exam-
ined the role of Smad signaling in regulating invasion and growth of head and neck SCC cells.
Treatment with TGF-beta resulted in activation of Smad2 and Smad3 in SCC cells, but had no
effect on their proliferation, viability, or expression of p15, p21, and p27 CDK inhibitors. Basal
activation of Smad3 and p38 was noted in SCC cells without exogenous TGF-beta stimula-
tion, and adenoviral expression of Smad7 and dominant negative Smad3 inhibited p38 acti-
vation in these cells. Adenoviral overexpression of Smad3 potentiated the upregulatory effect
of TGF-beta on MMP-13 expression by SCC cells. Disruption of Smad signaling by adenovi-
ral expression of kinase-defective TGF-beta type I receptor (ALK5), Smad7, and dominant
negative Smad3 potently suppressed the basal and TGF-beta-induced expression of MMP-13
and MMP-1 in SCC cells, and inhibited their basal and TGF-beta-induced invasion through
type I collagen and Matrigel Adenoviral overexpression of Smad7 in cutaneous and oral SCC
cells significantly inhibited their implantation and subsequent growth of xenografts in skin of
SCID mice in vivo, as compared to LacZ adenovirus transduced control cells. Together, these
results show, that Smad signaling plays an important role in promoting the invasive pheno-
type of human cutaneous SCC cells by upregulating their collagenase expression.
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p53 homolog, p51/p63, suppresses apoptosis in ultraviolet-B irradiated keratinocytes through
Akt activation
E Ogawa, R Okuyama, Y Kusakari, T Egawa, A Hashimoto, H Watanabe, H Tagami and S Aiba
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
p53 plays an important role in cell apoptosis that led us to examine the role that p51, a p53
homologue, might play in apoptotic process. DeltaNp51B, one p51 isoform, is highly expressed
in the epidermis, where ultraviolet-B (UVB) irradiation frequently induces keratinocyte apop-
tosis. We investigated on the role of p51 on apoptosis in UV-B irradiation. DeltaNp51B
decreased after UV-B irradiation inversely correlated to p53. In an attempt to further investi-
gate the function of p51 in UV-B induced apoptosis, we first introduced p51 adenovirus expres-
sion vectors into primary mouse keratinocytes, and then examined cell characters. While
DeltaNp51B did not alter keratinocyte apoptosis after UV-B irradiation significantly, TAp51B,
which is not endogenously express so much, exhibited a 30-40% decrease in the number of
apoptotic cells as compared with a control LacZ expression. Secondly, we decreased the
expression of endogenous DeltaNp51B using p51 specific siRNAs. Opposite to p51 over-
expression, DeltaNp51B down-regulation increased the number of apoptotic cells. UV-B
induced apoptosis was negatively controlled by endogenous DeltaNp51B, whose expression
might be enough for its effect. On the other hand, TAp51B has an added effect to endogenous
DeltaNp51B, not inverse effect. Furthermore, both types of p51 increased Akt activation whose
inhibition cancelled p51 effect to UV-B induced apoptosis. The degree of apoptosis protec-
tion and Akt phosphorylation were higher in TAp51B which was unstable compared with
DeltaNp51B. These data suggested that not only Delta-N isoform of p51 but also TA isoform
negatively controls UV-B induced apoptosis via Akt activation.
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KIT D816V mutation alters the mechanism of JAK3 phosphorylation in mastocytosis mast cells
I Chan, S Kasprowicz and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
Previous studies from our laboratory have shown that JAK3/Stats are important intracellular
signaling kinases involved in the growth and survival of mastocytosis mast cells expressing
autoactivated KIT with a V560G mutation. JAK3-specific inhibitors significantly reduce the
growth of these mastocytosis mast cells and thus may be useful in the treatment of masto-
cytosis. KIT-D816V is another auto-activating mutation that is distinctively associated with
adult-onset mastocytosis. This KIT-D816V has been shown to induce cytokine-independent
growth of mast cells in vitro and in vivo. In order to elucidate whether JAK3/Stats are impor-
tant in KIT-D816V signaling, the JAK3 specific inhibitor, Whi-P131 (20µM) which blocks the
ATP-binding site of JAK3, was added to cell cultures for 5 days and cell proliferation was
determined by a MTT assay. Mastocytosis mast cells expressing KIT-D816V were less sus-
ceptible to Whi-P131 treatment than mastocytosis cell lines expressing KIT-V560G. Whi-
P131 inhibition on JAK3 phosphorylation was also examined by Western blot hybridization.
After treating the cells lines with Whi-P131 (20µM) for 1 hr, the phosphorylation of both
JAK3 and Stat3 was markedly diminished in the mastocytosis mast cell lines (HMC-1 and
RMT) expressing the KIT-V560G and in SCF-stimulated myeloid leukemia cell line K562
which expresses wild type KIT. In contrast, phosphorylation of JAK3 and Stat3 were not
affected in the mastocytosis mast cell line HMC-1.2 that expressed KIT-D816V. The results
of this study indicate that KIT V560G and D816V mutants have different intracellular sig-
naling pathways controlling mast cell growth. KIT-V560G appears to dependent on the JAK3
ATP-binding domain for JAK-3 phosphorylation whereas the KIT-D816V seems to activate
the JAK3/Stats pathway independent of the JAK3 ATP-binding site. It becomes clear that
inhibitors that block the JAK3/Stats pathway can be useful for the treatment of mastocyto-
sis, but agents that inhibit JAK3 activation by blocking the ATP-binding site may less effi-
cient in patients with the KIT-D816V mutation.
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hBD1-induced keratinocyte migration is mediated through HB-EGF/EGFR transactivation
mechanism
S Tokumaru, Y Shirakata, Y Hanakawa, X Dai, K Kameda, M Tohyama, K Sayama and
K Hashimoto Dermatology, Ehime University School of Medicine, Toon City, Ehime, Japan
The closure of skin wounds is essential for resistance against microbial pathogens, and ker-
atinocyte migration is an important step in skin wound healing. It has been reported that human
beta defensins (hBD), antimicrovial peptides, are chemotactic for dendritic cells, T-lympho-
cyte and mast cells. However the effect of hBDs on keratinocyte migration has not been clearly
elucidated. First, we examined the effect of hBD1 on keratinocyte migration by Boyden cham-
ber assay. hBD1 increased keratinocyte migration 1.3-fold at 1µg/ml optimally. Several groups
reported that ligands for G-protein-coupled receptor (GPCR) induced EGF receptor (EGFR)
transactivation by HB-EGF shedding (the proteolytic conversion of membrane-anchored HB-
EGF to the soluble one, which binds to EGFR and results in EGFR activation). Last year we
reported that antimicrovial peptide, LL-37-induced keratinocyte migration occurs via EGFR
transactivation. Since hBD receptor is GPCR, we hypothesized that hBD1-induced keratinocyte
migration is mediated by EGFR transactivation. Addition of hBD1 at 1µg/ml induced the phos-
phorylation of EGFR with a maximum at 30 min. This EGFR phosphorylation is inhibited almost
completely by OSU-8, an HB-EGF converting proteinase inhibitor, CRM197, an inhibitor for
soluble HB-EGF, anti-EGFR antibody and AG1478, EGFR kinase-specific inhibitor. Further-
more, these inhibitors also suppressed hBD1-induced keratinocyte migration. Taken together,
our study demonstrates that hBD1-induced keratinocyte migration is mediated through HB-
EGF/EGFR transactivation mechanism.
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Ligand binding to Lewis (Le)X and sialyl-LeX moieties of epidermal growth factor receptor
(EGFR) promotes EGFR signaling and is blocked by ganglioside GM3
AS Paller, Q Yan, P Sun and X Wang Pediatrics and Dermatology, Northwestern Univ. Med
School, Chicago, IL
Ganglioside GM3, the predominant ganglioside of keratinocyte and squamous carcinoma
membranes, inhibits ligand-dependent activation of EGFR. This leads to the suppression of
EGFR signaling, thus inhibiting cell proliferation. We have shown that GM3 is able to bind
directly to EGFR via carbohydrate-carbohydrate interactions. However, the carbohydrate moi-
eties that allow this interaction are unclear. Recent characterization of the oligosaccharides
of the EGFR shows significant content of LeX, LeY and sialyl-LeX determinants as well as the
bloodgroup A and H antigens. We hypothesized that these surface components may be involved
in EGF and TGF-alpha ligand-induced EGFR activation and serve as the carbohydrate groups
that interact with GM3. Our studies showed that antibodies directed against LeY, LeX and sia-
lyl-LeX, but not antibodies directed against bloodgroup A and H antigens, inhibit ligand-
induced EGFR phosphorylation and Ras/extracellular regulated kinase. This suggests that these
carbohydrate moieties play a role in initiating EGFR signaling. Furthermore, slot blot, ELISA
and bead binding analyses showed that GM3, but not the control gangliosides GM1 or GM2,
binds to LeX and sialyl-LeX. The LeY moiety, which is able to induce EGFR phosphorylation
in the absence as well as the presence of ligands, binds EGF and TGF-alpha, but not gan-
glioside GM3. Taken together, these data suggest that blood group determinants, LeY, LeX
and sialyl-LeX, are required for the activation of EGFR signaling, and that LeX and sialyl-LeX
are the binding sites on the EGFR that permit GM3 to inhibit signaling.
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Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of
c-Jun-N-terminal kinase-1
C Katagiri, J Nakanishi and T Hibino Shiseido Life Science Reserach Center, Yokohama, Japan
Protection from UV irradiation is the fundamental issue for living organisms. Although a criti-
cal role of melanin is well understood for the protection of basal keratinocytes, other factors
remain essentially unknown. Our previous study revealed that SCCA1 could suppress UV-
induced apoptosis in human keratinocytes via the suppression of c-Jun N-terminal kinase (JNK).
Here, we demonstrate that SCCA1 specifically inhibits JNK1 among the mitogen activated pro-
tein kinase (MAPK) family and up-regulation of SCCA1 was enough to protect UV-induced
keratinocyte apoptosis. First we examined the effects of SCCA1 on the MAPK family members,
including JNK1-3, ERK1-2, and p38α kinases. In the presence of SCCA1, JNK1 activity on c-
Jun phosphorylation was markedly reduced. In contrast, kinase activities of JNK2, JNK3, ERK1/2
or p38α were not affected by SCCA1. SCCA1 was detected in the keratinocyte extract precip-
itated with anti-JNK1 antibody after UV irradiation, indicating the binding of SCCA1 with JNK1.
In SCCA knockdown HaCaT cells established with siRNA, UV-induced apoptosis significantly
increased. In this condition, c-Jun phosphorylation was strongly up-regulated. Furthermore, we
established 12 individual clones that stably express SCCA1 using 3T3/J2 cells (1-2800-fold
expression). SCCA1-expressing clones showed a strong correlation between the expression lev-
els and the suppression of UV-induced apoptosis. We have generated involucrin promoter-
driven SCCA1 transgenic mice with hairless phenotype (HR-1) and investigated the effect of
UV stress. The mutant mice demonstrated remarkable resistance against UV irradiation main-
taining the epidermal structure, whereas the wild HR-1 mice showed degeneration of epider-
mis under repeated 200 mJ/cm2 UV exposure. These findings reveal an unexpected serpin func-
tion and define a novel UV protection mechanism in human skin.
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PPARγ/C/EBPα signaling pathway plays a key role in 1,25-dihydroxyvitamin D3-induced ker-
atinocyte differentiation
Y Shirakata, X Dai, S Tokumaru, Y Hanakawa, L Yang, M Tohyama, S Hirakawa, K Sayama
and K Hashimoto Dermatology, Ehime University School of Medicine, Toon City, Ehime,
Japan
The active vitamin D3 regulates cell proliferation and differentiation. In epidermal keratinocytes,
1,25-dihydroxyvitamin D3 suppresses cell proliferation and induces keratinocyte differentia-
tion upon binding to its receptor. However, the mechanism of vitamin D3-induced keratinocyte
differentiation has not been fully elucidated yet. Peroxisome proliferation-activated receptors
(PPARs) are ligand-activated transcription factors that regulate the expression of target genes
involved in many cellular functions including cell proliferation, differentiation and
immune/inflammation response. Among the members of PPARs, PPARγ activation has been
demonstrated to stimulate keratinocytes differentiation and induce involucrin gene. This led
us to the hypothesis that PPARγ is involved in keratinocyte differentiation induced by VD3.
First, we showed treatment with VD3 induced rapid expression of PPARγ, not other members
of PPAR family, as well as C/EBPα, the downstream molecule of PPARγ. And the induction of
PPARγ and C/EBPα preceded the expression of differentiation marker molecules such as involu-
crin and loricrin. To further confirm the hypothesis, we constructed adenovirus expressing the
dominant negative form of PPARγ (Ax-dn-PPARγ), which blocks the binding of ligand to PPARγ
and inhibits its transcription activation. We found that transfection of Ax-dn-PPARγ suppressed
the induction of involucrin and loricrin by VD3. Furthermore, treatment with HX-531, the
inhibitor of PPARγ/RXR, also inhibited VD3-induced involucrin expression as well as the VD3-
induced morphological change. Taken together, for the first time, our study demonstrates that
PPARγ/C/EBPα signaling pathway plays a pivotal role in VD3-induced kratinocyte differentia-
tion.
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Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the
canonical pathway of Wnt signaling in normal keratinocytes
L Yang, K Yamasaki, Y Shirakata, X Dai, S Tokumaru, M Tohyama, Y Hanakawa, K Kameda,
K Sayama and K Hashimoto Dermatology, Ehime University School of Medicine, Toon City,
Ehime, Japan
Bone morphogenetic protein-2 (BMP-2) and Wnt are involved in the normal development and
tumorigenesis of several organs, and in the development of skin and skin appendages as a
morphogen. However, the crosstalk between BMP-2 and the Wnt/β-catenin signaling path-
way is not clear. The purpose of this study is toexamine BMP-2-dependent expression of Wnt
and its receptor frizzled in normal human keratinocytes. The mRNA expression of the Wnt and
frizzled families was analyzed by reverse transcription-polymerase chain reaction (RT-PCR)
or ribonuclease protection assay. β-Catenin expression was measured using RT-PCR and West-
ern blotting. TCF/LEF activity was analyzed using the luciferase reporter assay.We detected
the expression of Wnt-2b/13, -4, -5a, -5b, -7a, -7b, and -10a, frizzled-1, -4, -5, -6, -8, -9, and
-10, MFRP, and SFRP-1/SARP-2 in keratinocytes. BMP-2 increased Wnt-2b/13, -5b, and -7b,
and frizzled-6, -8, and -10. Conversely, BMP-2 suppressed Wnt-10a and SFRP-1/SARP-2.
Although Wnt-4 expression was not affected by BMP-2 in confluent conditioned keratinocytes,
BMP-2 suppressed cell density-dependent Wnt-4 induction. The transcriptional activity of T-
cell factor/lymphoid enhancing factor TCF/LEF), which is a target of the canonical Wnt path-
way, was upregulated by BMP-2 in both time- and dose-dependent manners. However, BMP-
2-dependent differentiation of keratinocytes suppressed TCF/LEF transcriptional activity. These
results suggest that BMP-2 modulates the expression of molecules involved in Wnt signaling,
and activates the canonical Wnt pathway in normal human keratinocytes. Moreover, Wnt sig-
naling may be influenced by the fate of keratinocytes, such as proliferation, migration, and
differentiation.
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Fibroblast growth factor-7 stimulates the proliferation of human epithelioid sarcoma cells
H Sato, Y Fujisawa, T Takahashi, Y Kawachi and F Otsuka University of Tsukuba, Tsukuba,
Japan
Human epithelioid sarcoma (ES) is a highly malignant soft tissue tumor possessing both epithe-
lial and mesenchimal features. ES actively grows and frequently recurs after the complete resec-
tion. Although the progression of this aggressive neoplasm has been shown to be regulated by
several cytokines-dependent signaling cascades, candidate factors modulating ES cells have
not fully been explored. Up to date, epidermal growth factor (EGF), transforming growth fac-
tor-alpha (TGF-alpha), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF)-
1 and FGF-2 have been reported as contributory cytokines to ES cells proliferation. Based on
the epithelioid property of ES, we focused the effect of FGF-7 (keratinocyte growth factor) on
ES cells in the present study. ES cells were incubated with or without FGF-7 and tested for
their proliferation using MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide]
colorimetric bioassay. FGF-7 augmented the proliferation of ES cells in dose- and time-depend-
ent manners. The effect of FGF-7 was higher than those of EGF and TGF-alpha. The findings
imply the possible contribution of FGF-7 to ES progression via stimulation of the mitogenic
activity.
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Stromal-cell-derived factor-1α (SDF-1α)-induced collagenase-3-dependent invasion in human
basal cell carcinoma cells via ERK1/2 MAPK Pathway
S Jee,1 C Chu,1,2 S Cha2 and M Kuo2 1 Dermatology, National Taiwan University Hospital and
National Taiwan University College of Medicine, Taipei, Taiwan and 2 Institute of Toxicology,
College of Medicine, National Taiwan University, Taipei, Taiwan
Basal cell carcinoma (BCC) is the most common skin neoplasms in human and is character-
ized by locally aggressive with little metastatic potential. Previously, we have found that SDF-
1α can induce invasion activity of BCC cells in a dose-dependent and time-dependent man-
ner. SDF-1α also induced up-regulation of collagenase-3 (MMP-13) mRNA levels and increased
MMP-13 protein secretion, as well as enhanced MMP-13 enzyme activity in parental BCC
cells in a time-dependent manner. The aim of this study is to investigate the signal transduc-
tion pathways involved in SDF-1α-CXCR4 axis-induced MMP-13 expression in human BCC
cells. Western blot analysis in BCC cells treated with SDF-1α revealed elevated levels of
phospho-ERK1/2 at 15 min, while phospho-Akt and the other MAPK pathways p38 MAPK
and JNK were not activated. Treatment with PD98059 (an ERK1/2 inhibitor) inhibited SDF-
1α-induced up-regulation of MMP-13 mRNA, its protein secretion or SDF-1α-induced BCC
invasion. In addition, treatment with SB203580 (a p38 MAPK inhibitor) and SP600125 (a JNK
inhibitor) neither inhibited SDF-1α-induced up-regulation of MMP-13 nor inhibited SDF-1α-
induced BCC invasion. Taken together, our results suggest that SDF-1α-induced transcriptional
regulation of MMP-13 and MMP-13-dependent invasion in human BCC cells is through acti-
vation of ERK1/2 MAPK pathway.
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Cholesterol depletion from the plasma membrane induces autophagy in HaCaT keratinocytes
RL Eefsen,1 U Wojewodzka2,1 and R Gniadecki1 1 Dermatology, Bispebjerg Hospital,
Copenhagen NV, Denmark and 2 Lab of Cell Ultrastructure, Polish Academy of Science,
Warsaw, Poland
Lipid raft, cholesterol-enriched membrane microdomains have an important role in membrane
signaling processes. Earlier studies from this laboratory have shown that slight membrane
cholesterol depletion in HaCaT keratinocytes leads to lipid raft disruption and ligand-inde-
pendent activation of EGFR and growth stimulation via ERK1/2. In contrast, profound choles-
terol depletion leads to cell cycle block and cell death. In this study we describe a new phys-
iological effect of the perturbation of membrane cholesterol – an autophagic response. Depletion
of cholesterol from lipid rafts by methyl-b-cyclodextrin (MbCD) or filipin III, results in the for-
mation of autophagosomes, which can be inhibited by a known blocker of autophagy, 3-methy-
ladenine. Moreover, cholesterol depletion had a marker and abrupt effect on mitochondria.
A rapid loss of mitochondrial membrane potential DY followed by mitochondria swelling and
release of cytochrome c and AIF (apoptosis inducing factor) were observed. Loss of DY could
not be prevented by cyclosporin A or bongkrekic acid. Also other known apoptosis and
autophagy blockers such as zVAD, wortmannnin, or bafilomycin 1A did not inhibit autophago-
some occurrence or loss of mitochondrial function. Since cholesterol in the membranes is
often perturbed by different damaging factors (e.g. free radicals, ultraviolet radiation) the
autophagic response reported here could constitute a novel pathway of the stress response in
keratinocytes.
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The growth regulation of neurofibroma cells by tumor necrosis factor alpha
Y Nakamura, T Takahashi, X Xu, Y Kawachi and F Otsuka Department of Dermatology,
Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder with an influence of
approximately 1 in 3000 births and is characterized by multiple neurofibromas, café-au-lait
spots and central nervous system tumors. The appearance of multiple neurofibromas and other
neural crest tumors suggests that some humoral or growth factors may influence the devel-
opment of these tumors. In this study, we investigated the role of tumor necrosis factor (TNF)
alpha in cellular proliferation using neurofibroma (NF) cells derived from NF-1 patients. An
MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide] colorimetric bioassay
was performed after the incubation of NF cells with or without TNF alpha. Proliferation of NF
cells was accelerated by TNF alpha in a dose- and time-dependent manner whereas some
other growth factors did not serve as the mitogen. The results suggest a participation of TNF
alpha in continuous growth of multiple NFs via stimulating a mitogenic activity. TNF alpha
was first identified as a protein causing suppression of tumor cell proliferation. The following
three decades have elucidated the diverse biological functions of TNF alpha involving inflam-
mation, apoptosis, cell differentiation and proliferation in the immune system or tumor pro-
gression. It has however been unclear why TNF alpha selectively acts as an apoptotic agent
or a mitogenic factor in some cell types but not other types, although much has been learned
about the mechanism of the TNF signals including NF-kappaB. The mitogenic effect of TNF
alpha reported is restricted to certain cell types, thereby implying a putative efficacy of anti-
TNF alpha drugs such as infliximab.
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The role of PKC in skin pathophysiology
M Meir,1 I Solomonik,1 E Brener,2 R Mandil-Levin,2 T Tennenbaum2 and L Braiman-
Wiksman1 1 HealOr Ltd, Ness-Ziona, Israel and 2 Faculty of Life Sciences, Bar Ilan University,
Ramat Gan, Israel
Protein kinase C (PKC) family is known to be involved in skin physiology and pathology. In this
study we investigated PKC involvement in burns and diabetic related wounds. Diabetes is involved
in skin related pathologies including impaired wound healing and the development of chronic
untreatable ulcers. Diabetic wound model in vivo included longitudinal full thickness wound
incisions (20mm) performed on the upper backs of STZ (200mg/kg) injected mice. Burn wounds
were investigated in a case study of a dog suffering from a burn of an unknown origin. Mor-
phological analysis of healing progression was performed during the experiment followed by a
novel quantitative immunohistochemical assessment protocol utilizing specific markers. The
assessment included the following parameters: re-epithelialization, epidermal differentiation,
granulation tissue formation, collagen deposition, dermal contraction, inflammation and tissue
remodeling. The results demonstrated that diabetic mice displayed wound healing impairment
exhibited in all critical parameters compared to non diabetic controls: epidermal closure (20%
vs. 100%), epidermal differentiation (0 vs. 100%), dermal contraction (0 vs. 40%), granulation
tissue formation (40% vs. 90%) and inflammation (70% vs. 17%). Based on previous PKC stud-
ies in skin we developed a PKC based formulation designated HO/03/03 (activator of a nPKC
with an inhibitor of a cPKC). Topical treatment of diabetic wounds with HO/03/03 accelerated
critical healing stages including: epidermal closure (71% vs. 17%), epidermal differentiation
(33% vs. 0%) and dermal contraction (28% vs. 0%) compared to diabetic non treated wounds.
In addition it significantly reduced the inflammatory response characteristic of impaired dia-
betic wounds. In the burn wound case study, treatment of a debilitating wound (non-healing for
a period of 40 days) with HO/03/03 promoted complete wound closure after 50 days of daily
topical treatment. The results demonstrate that HO/03/03 overcomes both diabetic related impaired
wound healing and non healing burn wounds.
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Hepatocyte growth factor/scatter factor modulates the invasion activity of Paget cells
T Takahashi,1 F Otsuka1 and I Ando2 1 Department of Dermatology, University of Tsukuba,
Tsukuba, Japan and 2 Department of Dermatology, Mizonokuchi Branch Hospital of Teikyo
University, Kawasaki, Japan
Paget cells sometimes migrate through basement membrane (BM) and invade into dermal tis-
sue although they generally show a slow proliferation and a long time existence within epi-
dermis. The penetration may be involved in the function of their integrin molecules responsi-
ble for adhesion to BM components. It has still been unclear whether Paget cells could
spontaneously acquire the opportunity of BM invasion or could be given the chance by some
factors. In the present study, we assessed the effect of hepatocyte growth factor/scatter factor
(HGF/SF), which has been reported to play important roles in progression of certain tumor
types, on the invasion of human Paget cells into extracellular matrix. Following the confir-
mation of c-Met expression by flow cytometry analysis, Paget cells were incubated with or
without HGF/SF and tested for their invasion activity into Matrigel. Invasion assay using mod-
ified Boyden chamber showed that the invasion of Paget cells was enhanced by HGF/SF but
not by epidermal growth factor used as a control. In accordance to the finding, HGF/SF aug-
mented beta3 integrin subunit expression on Paget cell surface and enhanced attachment of
Paget cells to fibronectin and laminin in a dose-dependent manner. The HGF/SF effect was
attenuated by anti-c-Met neutralizing antibody. Mitogenic activity of Paget cells was not affected
by HGF/SF, as shown by MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide]
colorimetric bioassay and cell cycle analysis. The results suggest a possible contribution of
HGF/SF to augmentation of invasion potential of Paget cells and the prognosis in Paget carci-
noma patients.
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Influence of fibroblast growth factor-6 on the invasion activity of dermatofibrosarcoma pro-
tuberans cells
M Kawashima, T Takahashi, Y Fujisawa, Y Kawachi and F Otsuka Department of
Dermatology, University of Tsukuba, Tsukuba, Ibaraki, Japan
Fibroblast growth factors (FGFs) compose a family of growth factors implicated in a variety of
developmental events. Whereas FGF-2 is widely expressed in many tissues and has been proven
to play an important role in tumor progression, the relevance of other FGF members has still
been unclear. FGF-6, a protooncogene product, is expressed in both epithelial and mes-
enchymal derivatives and has autocrine and/or paracrine roles. Recent studies have shown
important roles of FGF-6 in the proliferation and differentiation of myogenic cells. However,
FGF-6 action on fibroblast lineages has largely been unexplored. We herein show that FGF-
6 enhanced an invasion activity of dermatofibrosarcoma protuberans (DFSP) cells via up-reg-
ulation of alphav integrin subunit expression. The FGF-6 effect was dose- and time-depend-
ent, which was confirmed by flow cytometry. DFSP cells whose alphav integrin was elicited
by FGF-6 showed the higher invasion activity into extracellular matrix. The FGF-6 effect was
attenuated by anti-FGF-R neutralizing monoclonal antibody (mAb), notably anti-FGF-R IV
mAb. Neither morphological change nor increase of proliferation was observed in FGF-6-stim-
ulated DFSP cells. The findings suggest that FGF-6 could contribute to DFSP progression in
dermal tissue through the modulation of integrin expression.
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On the biological role and organization of the corticotropin releasing hormone (CRH) sig-
naling system of the skin
AT Slominski,1 B Zbytek,1 MA Zmijewski,1 RM Slominski1 and J Wortsman2 1 Pathology,
University of Tennessee Health Science Center, Memphis, TN and 2 Internal Medicine,
Southern Illinois University, Springfield, IL
The hypothalamic hormone CRH and its related peptides are also produced in the skin that
is dependent on species (human vs mice) and anatomical location. Local peptide production
is regulated by ultraviolet radiation (UVR), glucocorticoids and phase of the hair cycle. The
skin also expresses the corresponding receptors (CRH-R1 and CRH-R2), with CRH-R1 being
the major receptor in humans. CRH-R1 is expressed in epidermal and dermal compartments,
while CRH-R2 predominantly in dermal structures. The CRH-R1 gene generates multiple splic-
ing variants through a process modulated by UVR, cAMP and TPA. The phenotypic effects of
CRH in human skin cells are largely mediated by CRH-R1a and its activation increases the
concentrations of intracellular cAMP, IP3, or Ca2+ with subsequent activation of protein kinases
A and C dependent pathways. CRH also modulates the activity of NF-kB, AP-1 and CREB.
The cellular functions affected by activation of CRH-R1 depend on cell type and nutritional
status and include modulation of differentiation program(s), proliferation, viability and immune
activity. CRH is also a component of a local structure organized similarly to the hypothal-
amo-pituitary-adrenal (HPA) axis. In normal epidermal melanocytes and dermal fibroblasts
CRH stimulates cAMP accumulation, increases POMC gene expression and production of
ACTH, which are abolished by the CRH-R1 antagonist, antalarmine. Melanocytes also respond
to CRH and ACTH with enhanced production of cortisol and corticosterone, which is abol-
ished by POMC gene silencing or by antalarmine. Fibroblasts respond to CRH and ACTH with
enhanced production of corticosterone but not cortisol, with ACTH being more potent stim-
ulator. The above regulations are absent in cultured keratinocytes. Thus, cutaneous HPA axis
appears to function as a unit, with activity and organization dependent on cell type and their
location.
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Asymmetric regulation of gene expression in the response of fibroblasts to serum depriva-
tion
H Liu,1 E Segal2 and HY Chang1 1 Dermatology (Program in Epithelial Biology), Stanford
University School of Medicine, Stanford, CA and 2 Computer Science and Applied
Mathematics, The Weizmann Institute of Science, Rehovot, Israel
Serum, the soluble fraction of clotted blood, is an important mitogenic signal in wound heal-
ing and tissue homeostasis. Many key genes involved in growth control were initially identi-
fied by their unique temporal patterns of expression in response to serum stimulation. Many
serum-induced genes play a role in wound healing as well as in cancer progression. In con-
trast, the transcriptional response of fibroblasts to serum deprivation, which leads to cessa-
tion of cell division and an altered metabolic state termed quiescence, is much less under-
stood. Here we characterized the dynamic gene expression patterns genome-wide in human
fibroblasts in response to serum deprivation using human cDNA microarrays. We found a
unique set of serum deprivation early response genes (SDERGs) that were not regulated by
serum stimulation. Bioinformatic analysis of 1973 microarrays representing 22 human tumor
types revealed that SDERGs were coordinately repressed in several types of human epithelial
cancers. A targeted RNA interference screen confirmed that several SDERGs are required for
the cessation of DNA synthesis in response to serum deprivation. These results suggest that
serum deprivation activates unique signal transduction pathways to enforce cellular quies-
cence, and that genes responsive to serum deprivation may constitute novel growth inhibitors
that are abrogated in human cancers.
545
Role of CSN5 in epidermal homeostasis
DJ Wong, AS Adler, M Lin, H Liu and HY Chang Program in Epithelial Biology, Stanford
University School of Medicine, Stanford, CA
The skin is constantly subjected to diverse stresses that require dynamic and robust signaling
networks to maintain homeostasis. Ubiquitination plays a central role in the regulation of a
vast array of cellular signaling cascades by targeting proteins for proteasome-dependent destruc-
tion in an inducible manner, thereby altering cellular fates. A critical molecule in ubiquitin
signaling is CSN5, the catalytic subunit of the COP9 signalosome complex, which activates
E3 ubiquitin ligases. Using a novel linkage analysis method to identify regulator genes whose
copy number aberration are sufficient to induce a gene expression signature in cancer, we
found that amplification of CSN5 locus with c-MYC on chromosome 8q is a hallmark of human
tumors with increased risk of metastasis and patient mortality. We demonstrate that CSN5 bio-
chemically activates c-MYC by increasing its ubiquitination and transcriptional activity, and
collaborates with c-MYC to increase cell proliferation and induce invasion through basement
membrane matrix in vitro. In order to examine how CSN5 integrates diverse ubiquitin-medi-
ated pathways, such as c-MYC, physiologically in the skin epidermis in vivo, we have pro-
duced transgenic mice expressing wild type CSN5 or catalytic mutant CSN5 under the con-
trol of the keratin 5 promoter.
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IGF-1 induces lipogenesis and sterol response element binding protein-1
TM Smith,1 KL Gilliland,1 Z Cong,1 GA Clawson1,2 and DM Thiboutot1,3 1 Jake Gittlen Cancer
Research Foundation, Pennsylvania State University College of Medicine, Hershey, PA, 2
Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA
and 3 Department of Dermatology, Pennsylvania State University College of Medicine,
Hershey, PA
An understanding of the molecular signaling involved in sebaceous gland lipid production is
needed to develop therapeutic targets to improve acne. In the SEB-1 sebaceous model, we have
previously shown that high dose insulin (1µM) induces lipogenesis and sterol response ele-
ment binding protein-1 (SREBP-1), while 100nM insulin does not. Other groups have demon-
strated that treatment with IGF-1 increases lipogenesis in both primary human sebocytes and
in the rat preputial model. The present study has the following aims: 1) to determine if a phys-
iologically relevant dose of IGF-1 (20ng/mL) will induce lipogenesis in the SEB-1 cells, and 2)
to determine if this increase in lipogenesis is accompanied by an increase SREBP-1 protein.
Here we report that IGF-1 does, in fact, increase lipogenesis and SREBP-1 protein in the SEB-
1 model. To the best of our knowledge, we are the first group to show a direct correlation between
IGF-1 stimulation and SREBP-1 protein levels. From this, we conclude that IGF-1 is an impor-
tant molecule in sebaceous gland lipogenesis and its effects are mediated by SREBP-1.
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Over-expressing RhoC promotes anchorage-independent growth and survival in human
melanoma cells
Y Shellman, Y XU, M Fujita and DA Norris Dermatology, UCHSC, Aurora, CO
RhoC plays an important role in tumor progression and metastasis. Over-expression of RhoC
in various human cancers has been correlated with the metastatic tumors and poor progno-
sis of cancer patients in most cases. To understand the mechanism how RhoC promotes
melanoma progression, we have established stable transfectants over-expressing RhoC, using
a human radial growth phase melanoma cell line, WM35. We have previously reported that
this RhoC transfected melanoma cell line showed enhanced invasion ability. In this report,
we have examined whether RhoC increases cell proliferation and/or provides survival advan-
tages in human melanoma cells. Standard cell proliferation assays with anchorage-depend-
ent growth condition (monolayer on plastic culture dishes) showed that over-expressing RhoC
did not improve cell proliferation. However, soft agar assays indicated that RhoC promoted
anchorage independent growth which is important for cancer cells to survive in their metasta-
tic process. Treatment of these cells with PI3K, Akt, or ROCK inhibitors blocked RhoC-induced-
growth in soft agars, suggesting that PI3K/Akt and ROCK signaling are important for RhoC-
induced-anchorage-independent growth. Our preliminary data also showed that RhoC enhances
expression of phosphorylated-Stat3. We propose that P- Stat3 may be the candidate of the
downstream effectors of AKT pathway and ROCK pathway in anchorage independent growth.
In addition, we examined whether RhoC protected cells treated with various apoptotic induc-
ing agents, including Akt inhibitor III, Paclitaxel, Cisplatin, Betulinic acid, manumycin,
rapamycin, camptothecin. Our preliminary data suggested that RhoC might provide WM35
cell survival advantages treated with some but not all of the agents tested. Taken together, our
data suggest that RhoC might promote melanoma progression in part through providing cell
survival advantage to melanoma cells.
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Src kinase-dependent recruitment of phosphatidylinositol 3-kinase to the E-cadherin-p120
complex is required for calcium-induced phospholipase C-gamma1 activation and human
keratinocyte differentiation
Z Xie and DD Bikle Endocrine Unit, VA Medical Center / UCSF and NCIRE, San Francisco,
CA
Epidermal keratinocytes undergo a well-defined program of terminal differentiation as they
migrate from the stratum basale to the stratum corneum. In vitro, many of these differentia-
tion-specific processes can be reproduced by culturing keratinocytes in media containing high
calcium concentrations. Addition of calcium to these cells in culture induces a rapid and
homogeneous response, triggering a terminal differentiation program that closely resembles
that of differentiating keratinocytes in vivo. However, very little is known about early molec-
ular events triggering keratinocyte differentiation. We have previously demonstrated that cal-
cium-induced human keratinocyte differentiation requires an intracellular calcium rise caused
by src- and fyn-mediated phosphatidylinositol 3-kinase (PI3K) dependent activation of phos-
pholipase C-gamma1. In this study, we sought to identify upstream signaling pathways nec-
essary for calcium activation of PI3K and its subsequent activation of phospholipase C-gamma1.
We found that calcium induces the recruitment of src, fyn and PI3K to E-cadherin at the plasma
membrane of human keratinocytes within 2 minutes. Inhibition of src family kinases blocked
this recruitment. In the cadherin-catenin complex, gamma-catenin and p120 contain puta-
tive YxxM PI3K binding sites. Knocking-down E-cadherin or p120 expression blocked calcium
activation of PI3K and phospholipase C-gamma1, as well as the induction of keratinocyte dif-
ferentiation markers involucrin and transglutaminase. However, knocking-down gamma-catenin
expression had no effect. These data indicate that src kinase-dependent recruitment of PI3K
to E-cadherin-p120 complex at the plasma membrane is required for calcium-induced phos-
pholipase C-gamma1 activation and, ultimately, keratinocyte differentiation.
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TNFR1 signaling to JNK opposes NF-kB to promotes epidermal neoplasia
JY Zhang,1 S Tao,3 TW Ridky3 and P Khavari2,3 1 Duke University, Durham, NC, 2 VA Palo
Alto, Palo Alto, CA and 3 Dermatology, Stanford Univeristy Medical Center, Stanford, CA
Epidermal homeostasis has recently been shown to depend on antagonist regulation cell cycle
progression by NF-kB and JNK pathways via convergence on the core cell cycle regulator,
Cdk4. In normal epidermis, TNFR1 is a major upstream inducer of both NF-kB and JNK activ-
ity, as demonstrated genetically with TNFR1 knockout mice. In the epidermal cancer, squa-
mous cell carcinoma (SCC), NF-kB appears to be dysfunctional in a significant proportion of
tumors. Examination of tissue microarrays of 52 human SCCs also demonstrated JNK induc-
tion in 81%. JNK activation reverses Cdk4 down-regulation by oncogenic Ras and cooperates
with Ras to convert normal human epidermis directly into invasive tumors indistinguishable
from SCC. Inhibiting TNFR1 and JNK function using genetic and pharmacologic approaches
abolished Ras-driven invasive human epidermal neoplasia and tumor formation by a panel of
human SCC lines, including A431, SCC25 and CAL27. Moreover, antibodies to TNFR1 also
blocked tumorigenesis in all these model systems, indicating that TNF blockade, widely used
in inflammatory disorders, may be of utility in cancer. These findings indicate that epidermal
homeostasis depends on a balance of signals emanating from TNFR1 to the growth-promot-
ing JNK cascade and the growth-inhibitory NF-kB pathway and that altering the balance of
these opposing functions may represent a potential therapeutic strategy in human SCC.
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Epidermal keratinocyte as a source and target for BMP signaling
MY Fessing,1 R Atoyan,1 B Shander,1 T Efimova2 and VA Botchkarev1 1 Dermatology, Boston
University School of Medicine, Boston, MA and 2 Dermatology, Washington University, St.
Louis, MO
Bone morphogenic proteins (BMP) are members of TGF-beta superfamily regulating a large
variety of biological responses in several cells and tissues, including skin and hair follicles.
Following BMP binding to the BMP receptors, downstream signaling is activated through BMP-
Smad and BMP-MAP kinase pathways. To gain insights into the role of BMP signaling in human
epidermis, we studied the expression and role of BMP signaling in primary human keratinocytes
(KCs). RT-PCR analysis showed that primary human KCs express mRNA for BMP-2, BMP-4
and BMP-6, as well as for all BMP and activin receptors. Treatment of KCs with BMP-4 resulted
in dynamic phosphorylation of BMP-dependent SMAD1/5/8. However, BMP-4 did not show
any effects on phosphorylation of key MAP kinases (p38, p42/p44 and JNK/SAPK). Microar-
ray analysis and/or quantitative RT-PCR revealed that in KCs, BMP-4 induce dynamic changes
in expression of genes encoding transcription factors involved in cell differentiation and cell
fate determination (ID1, ID2, ID4, RUNX3, DLX2, DLX3, KLF4, HEY1, HR, HOXC1). Also,
expression of several signaling molecules were changed (BMP-6, SMAD6, SMAD7, BAMBI,
POSTN, IGFB3, CXCL14, THBS2). In addition, the expression levels of several extracellular
matrix and cell adhesion molecules (PODXL, LMNB1, TLN2, DMN, NRCAM), as well as
selected matrix metalloproteinases and their inhibitors (MMP1, MMP3, MMP9, TIMP3) were
also affected. BMP-4 treatment also caused upregulation of the involucrin mRNA and protein
expression in KCs, and infection of KCs with adenovirus expressing dominant negative form
of the BMPR-IB resulted in the decrease of involucrin expression. Furthermore, BMP signal-
ing positively regulated involucrin promoter activity in HaCaT cells. These data suggest that
epidermal KCs serve as a source and target for BMP signaling and that BMP-Smad signaling
plays important roles in the control of keratinocyte adhesion, differentiation, and extracellu-
lar matrix remodeling.
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Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor recep-
tor signaling and proliferation in human keratinocytes.
Y Xu, LJ Tan, V Grachtchouk, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Epidermal growth factor receptor (EGFR) is a major regulator of keratinocyte growth and sur-
vival. EGFR activation results from ligand-induced tyrosine phosphorylation, which is catalyzed
by intrinsic tyrosine kinase (iTK) activity. Inhibition of membrane-associated receptor type pro-
tein tyrosine phosphatase (RPTP) activity increases EGFR tyrosine phosphorylation to levels
comparable to ligand activation. Thus EGFR activation is regulated by the dynamic balance
between iTK and PTP activities. We have employed functional expression profiling to identify
RPTPs that dephosphorylate EGFR. Co-expression of candidate RPTPs and EGFR in EGFR minus
CHO cells revealed that RPTP-kappa, but not other RPTPs expressed in human keratinocytes,
dephosphorylated EGFR. RPTP-kappa reduced both basal (80%, n=4) and EGF-dependent (66%,
n=4) EGFR tyrosine phosphorylation, in CHO cells. Overexpression of wild-type or catalyti-
cally inactive RPTP-kappa reduced or enhanced, respectively, basal and EGF-induced EGFR
tyrosine phosphorylation in human primary keratinocytes. Furthermore, siRNA-mediated knock-
down of RPTP-kappa increased basal (2.5-fold, n=2) and EGF-stimulated (2-fold, n=3) EGFR
tyrosine phosphorylation, and consequently, augmented downstream Erk1/2 activation (2.5-
fold, n=3) in human primary keratinocytes. Overexpression of RPTP-kappa in subconfluent ker-
atinocytes reduced keratinocyte proliferation 90% (n=3). Interestingly, endogenous RPTP-kappa
levels increased as human primary keratinocyte reached confluency and exhibited reduced pro-
liferation. In situ hybridization and immunohistochemistry revealed that RPTP-kappa is pre-
dominantly expressed in non-proliferative suprabasal keratinocytes in human skin in vivo. Taken
together, these data demonstrate that RPTP-kappa is a heretofore unrecognized key regulator
of EGFR tyrosine phosphorylation and EGF-dependent signal transduction pathways and pro-
liferation in human keratinocytes in vitro and likely in vivo.
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NF-κB signaling is a negatively regulated by the N-terminal part of HBO1
R Contzler,1 T Roger,2 D Hohl1 and M Huber1 1 Department of Dermatology, CHUV,
Lausanne, Switzerland and 2 Division of Infectious Diseases, CHUV, Lausanne, Switzerland
HBO1 (Histone acetyltransferase Binding to ORC1) is a nuclear protein belonging to the MYST
family of histone acetyltransferase which is expressed in human and murine epidermis. It inter-
acts with numerous partner proteins thereby forming multiprotein complexes regulating DNA
replication and transcription. It has previously been shown that HBO1 repressed androgen
receptor (AR) activity in a testosterone-dependent manner. Since AR showed mutual tran-
scriptional interference with p65 we investigated the influence of HBO1 on NF-κB signalling
in epithelial cells. In transfected 293T cells HBO1 downregulated dose-dependently the NF-
κB response activated either by TNFα or by RelA, RelB or cRel. The inhibition of NF-κB by
HBO1 was not dependent on the presence of testosterone in the medium indicating that HBO1
does not require AR for repression. Analysis of HBO1 mutants with either N- and C-terminal
deletions or with a change in a highly conserved amino acid of the acetyl-CoA binding site
showed that the first 240 amino acids of HBO1 are important for NF-κB repression. This part,
containing a serine-rich domain and one CCHHC zinc finger previously found in transcrip-
tion factors regulating the expression of neural genes, has been implicated previously in the
negative effect of HBO1 on AR. Therefore, in addition to its acetyltransferase activity HBO1
harbors a N-terminal repressor function regulating different classes of transcription factors
which are important for skin homeostasis.
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Telomere homolog oligonucleotides activate diverse DNA damage-like response pathways
Y Choe, YM Lenzy, H Backvall, Y Farahvash, H Park, MS Eller, M Yaar and BA Gilchrest
Dermatology, Boston University School of Medicine, Boston, MA
Telomeres end in a 3’ single-stranded overhang which is tucked within the proximal telom-
ere duplex forming a loop structure. Disruption of this loop exposes the 3’ overhang and
induces DNA damage-like responses including p53 and histone H2AX phosphorylation. Recent
work has demonstrated that these DNA damage like responses are required to restore proper
telomere structure after replication. Providing cells with DNA oligonucleotides homologous
to the telomere 3’ overhang (T-oligos) induces the same DNA damage-like responses, strongly
suggesting a critical role for the overhang in recognition of disrupted telomeres as damaged
DNA and completion of DNA replication. Members of the phosphoinositide-3-kinase related
family, particularly ATM and DNA-PK, are known to be involved in telomere maintenance and
ATM has been shown to be activated by telomere disruption. To examine the contributions of
ATM and DNA-PK to telomere-mediated DNA damage-like responses, we treated normal
human fibroblasts and HT1080 fibrosarcoma cells with T-oligos. Phosphorylation of p53 and
H2AX was seen within 24 hours in both cell types. Phosphorylation of ATM, indicating acti-
vation, was seen in HT1080 cells, but much less so in normal fibroblasts. ATM knock-down
by RNAi markedly reduced T-oligo-induced p53 and H2AX phosphorylation in HT1080 by
85% but only by 50% in normal fibroblasts in which the effect was of shorter duration. Con-
versely, the DNA-PK inhibitor NU7026 and DNA-PK knock-down greatly reduced T-oligo-
induced phosphorylations and entry into senescence as measured by β-Gal activity in fibrob-
lasts but had no effect in HT1080 cells. These phosphorylation events were also greatly impaired
in fibroblasts from DNA-PK-mutant SCID mice compared to their normal counterparts. These
data strongly suggest that DNA-PK is a major mediator of DNA damage-like responses to T-
oligos in normal fibroblasts, whereas ATM assumes this function in the HT1080 transformed
fibroblast line. These data establish a role for both kinases in telomere repair and maintenance.
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Delineating the role of PKCδ tyrosine phosphorylation in skin physiology
E Yousufov,1 Z Dvashi,1 M Huber2 and T Tennenbaum1 1 Bar Ilan University, Ramat Gan,
Israel and 2 University of Freiburg and Max Planck Institute for Immunobiology, Freiburg,
Germany
PKCδ is implicated in signaling pathways leading to migration, proliferation and differentia-
tion of keratinocytes. Tyrosine phosphorylation of PKCδ following various stimuli is crucial
for regulation of its enzymatic activity, cellular localization and protein associations. In pre-
vious studies, we have identified a role for PKCδ in insulin induced signaling in skin. In our
laboratory we constructed recombinant adenoviruses of PKCδY187F and PKCδY565F and
examined their importance in skin physiology following overexpression in primary ker-
atinocytes. First we investigated the proliferation rate of keratinocytes. WT PKCδ as well as
Y565F overexpressing (OE) cells enhanced proliferation in comparison to control cells as
measured by thymidine incorporation. However, no increase in proliferation was observed in
Y187F overexpressing cells. Next, we performed scratch assays to examine cell migration.
While WT PKCδ,Y565F and Y187F induced cell migration, the most striking effect was observed
in Y187F OE cells. DN PKCδ failed to close the wound gap. Interestingly, insulin stimulation
led to additional increase in migration of WT PKCδ and Y565F cells, while DN PKCδ and
Y187F cells migration was not altered. In addition, we studied the differentiation potential of
cells by elevating calcium concentrations in the growth medium. WT PKCδ and Y565F dra-
matically reduced expression of spinous differentiation markers Keratin 1 (K1) and Keratin 10
(K10), while granular markers expression was induced. DN PKCδ resulted in induced expres-
sion of K1 and K10, while Filaggrin expression was abolished. Consequently, Y187F mim-
icked DN PKCδ effects. Altogether, these results indicate that PKCδ activity is regulated through
tyrosine phosphorylation and specifically the 187 tyrosine site is crucial for cell differentia-
tion and insulin induced proliferation and migration.
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Insulin receptor translocation and signaling in skin is mediated by PKC delta
M Gartsbein,1 T Kuroki2 and T Tennenbaum1 1 Bar Ilan University, Ramat Gan, Israel and 2
Gifu University, Gifu, Japan
Transcriptional activation of STAT3 is modulated by cytokines and growth factors including
insulin. We have previously shown that primary keratinocytes express functional insulin recep-
tor (IR) and IGFR and that insulin and IGF-1 regulate keratinocyte proliferation and differen-
tiation. Furthermore, we have identified an insulin specific signaling pathway which is regu-
lated by PKCδ-STAT3 activation and association to induce cell proliferation. In the present
study we have utilized primary skin keratinocytes and recombinant adenoviruses of WTPKCδ,
kinase inactive PKCδ mutant, and WTSTAT3 to examine the crosstalk between PKCδ and STAT3
activation in insulin mediated cell proliferation. We found that, insulin stimulation induced
STAT3-IR association followed by STAT3 activation and nuclear translocation of the IR-STAT3
complex.  Inhibition of IR activation decreased STAT3-IR and STAT3-PKCδ association, acti-
vation and nuclear translocation of the STAT3-IR complex. PKCδ activation mediated STAT3-
IR complex formation and STAT3 tyrosine phosphorylation. Furthermore, the activated form
of PKCδ was essential for insulin induced IR-PKCδ-STAT3 association and keratinocytes pro-
liferation. In concordance with these results, abrogation of PKCδ activity inhibited insulin-
induced PKCδ-STAT3 complex formation, STAT3 activation and STAT3-IR nuclear transloca-
tion. This study suggests for the first time a role for PKCδ in directing insulin receptor signaling
in skin which involves STAT3-IR complex formation, nuclear translocation and activation
mediating insulin induced keratinocytes proliferation. Defective regulation of this pathway as
it appears in diabetes patients, suggests a role for insulin mediated PKCδ signaling in the devel-
opment of insulin resistance and the pathophysiology of diabetes.
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Phosphorylated Srcasm downregulates Fyn through its GAT domain thereby reverting pso-
riasiform hyperplasia
W Li, C Marshall, E Ayli, J Gelfand and JT Seykora Dermatology, University of Pennsylvania,
Philadelphia, PA
It is important that growth-promoting signals are effectively regulated in the epidermis to main-
tain function and prevent neoplasia. Increased epidermal expression of Fyn induces psoriasi-
form epidermal hyperplasia that can be reverted by increasing expression of Srcasm (p <0.0001),
while a mutated Srcasm, lacking Fyn phosphorylation sites, cannot correct this phenotype. Novel
data is presented characterizing the mechanism of Srcasm-dependent Fyn downregulation and
the psoriatic features of the K14-Fyn mice. Western blot analysis of K14-Fyn skin lysates demon-
strates high levels of Fyn, activated Src kinases, and keratin 6; the levels of these molecules are
much lower in lysates from K14-Fyn/Srcasm mice but remain high in K14-Fyn/Srcasm-P mice.
Infection of primary K14-Srcasm keratinocytes with Fyn adenovirus yields consistently lower
Fyn levels than parallel studies in control and K14-Srcasm-P keratinocytes, confirming that lower
Fyn levels are associated with higher Srcasm levels. Inhibition of lysosome function raises Fyn
levels in K14-Srcasm keratinocytes suggesting a lysosomal component of Srcasm-dependent Fyn
downregulation. A structure-function analysis of Srcasm demonstrates that the Fyn phosphory-
lation sites and the GAT domain are required for Srcasm-dependent Fyn downregulation. Addi-
tional studies reveals an optimal stoichiometry between Fyn and Srcasm that results in efficient
downregulation of the kinase. Given that K14-Fyn mice exhibit psoriasiform hyperplasia, human
biopsy specimens of psoriasis and unremarkable epidermis were stained to evaluate levels of
activated Src kinases. Psoriasis biopsies demonstrate higher levels of activated Src kinases than
unremarkable epidermis. Immunohistochemical staining of K14-Fyn skin demonstrates a marked
increase in activated STAT-3, which was normalized in K14-Fyn/Srcasm mice but maintained in
K14-Fyn/Srcasm-P mice. Together, these data suggest that Fyn may play a role in promoting pso-
riasiform hyperplasia, and that Srcasm, as a regulator of Src kinases, can correct this phenotype.
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Poly (ADP-ribose) polymerases play a role in DNA damage responses induced by oligonu-
cleotides homologous to the telomere 3’ overhang
H Backvall, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Telomeres are large tracts of a repeated DNA sequence (TTAGGG in mammals) located at
chromosome ends, which shorten with each round of DNA replication. Disruption of the nor-
mal telomere loop structure leads to exposure of the telomere 3’ overhang and activation of
DNA damage responses resulting in senescence or apoptosis. Exogenously added DNA oligonu-
cleotides homologous to the telomere 3’ overhang (T-oligos) also induce these responses,
including phosphorylation of p53 and histone H2AX, suggesting that exposure of the 3’ over-
hang is critical to these telomere-mediated responses. Poly (ADP-ribose) polymerases (PARPs),
a family of proteins that modify proteins in response to DNA damage and are involved in the
p53 pathway activated by genotoxic stress, have also been implicated in telomere mainte-
nance. To examine the contributions of PARPs to telomere-mediated DNA damage responses,
we used a chemical inhibitor or RNAi to reduce PARP activity in normal fibroblasts prior to
treatment with T-oligo. The general PARP-inhibitor 3-aminobenzamide greatly reduced the T-
oligo-induced phosphorylation of both p53 at ser15 and H2AX at ser139, demonstrating a role
for PARPs in T-oligo-induced DNA damage responses. Using RNAi directed against PARP-1
or against the telomere-associated PARP, tankyrase-1, reduced the level of these proteins by
95% and 85%, respectively. Compared to control cells, PARP-1-depleted fibroblasts showed
a 20% reduction of T-oligo-induced phosphorylation of p53 with no effect on the phospho-
rylation of H2AX. However, phosphorylation of H2AX after T-oligo treatment was reduced by
more than 70% in tankyrase-1-depleted fibroblasts with only a slight reduction in phospho-
rylation of p53 (10%). Treatment of fibroblasts with tankyrase-2 siRNA did not affect T-oligo
responses. Together, these data demonstrate overlapping yet distinct roles for PARP-1 and
tankyrase-1 in mediating DNA damage responses induced by T-oligo treatment and suggest
that these enzymes also play a role in similar responses to disrupted telomeres.
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PKCδ and PKCα direct specificity of insulin signaling in skin keratinocytes
E Brener,1 M Gartsbein,1 T Kuroki,3 E Wertheimer2 and T Tennenbaum1 1 Bar Ilan University,
Ramat Gan, Israel, 2 Tel Aviv University, Tel Aviv, Israel and 3 Gifu University, Gifu, Japan
One of the serious complications resulting from the diabetic state is impaired wound healing.
We have previously demonstrated that insulin plays a crucial role in skin cell physiology,
involving PKCδ and PKCα. Therefore, we have investigated the role of PKCα and PKCδ in the
insulin signaling pathway utilizing primary keratinocytes model system. In skin as in insulin
sensitive tissues activation of insulin receptor (IR) leads to phosphorylation of IRS proteins,
which become platforms for downstream elements. Characterization of PKC dependent down-
stream elements in the insulin signaling pathway was performed utilizing recombinant PKC
adenovirus constructs of wild type (WT) and inactive dominant negative (DN) mutants of PKCδ
and PKCα. In primary keratinocytes, following insulin stimulation, PKCδ was found to be asso-
ciated with IR and IRS2 but not with IRS1. At the same time PKCα was found to be associated
with IRS1 and IRS2, but not with IR. Inhibition of PKCδ abrogated PKCδ association with IR
and IRS2. Furthermore, inhibition of PKCδ shifted the insulin receptor association from IR-
IRS1 to IR-IRS2. Interestingly, WT-PKCδ led to the opposite effect by inhibiting IRS2 but not
IRS1 activation. In contrast, inhibition of PKCα led to decrease in IR-IRS2 association and
activation. Next, we analyzed the effect of PKCδ and PKCα on activation of PI3K-Akt and
Ras-MAPK pathways. PI3K was found to bind IRS2 but not IRS1. Activation of PKCδ inhibited
IRS2-PI3K association, PI3K activation and insulin induced Akt activation, while Ras and MAPK
activity was enhanced. In contrast, PKCα activation increased IRS2-PI3K association and
insulin-induced Akt activation and decreased Ras and MAPK activity. In summary: PKCδ acti-
vation directs insulin signaling through the IRS1/Ras-MAPK pathway while PKCα activation
leads to activation of the IRS2/PI3K-Akt pathway. Overall, regulation of PKCδ and PKCα serves
as a divergence point in directing insulin mediated signaling in keratinocytes.
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Interactions between the IGF-1R, NF-κB, and stress-response proteins following UVB-irra-
diation of human keratinocytes
DA Lewis,1 DL Farrington2 and DF Spandau1,2 1 Dermatology, Indiana University School of
Medicine, Indianapolis, IN and 2 Biochemistry & Molecular Biology, Indiana University
School of Medicine, Indianapolis, IN
The relationship between exposure to the ultraviolet B (UVB) wavelengths in sunlight and the
development of skin cancer has been well documented, but the exact mechanism underlying
this association remains unclear. UVB-irradiation of normal human keratinocytes induces a
complex network of signaling pathways, including the activation of the transcription factor
NF-κB. By analyzing the specific subunit composition of UVB-induced NF-κB, we have found
that UVB-induced NF-κB contains primarily p50 (NFκB1) homodimers subunits. We have pre-
viously demonstrated that the activation status of the insulin-like growth factor-1 receptor (IGF-
1R) is critically important in regulating the appropriate cellular response to UVB irradiation
in cultured normal human keratinocytes. In the absence of an activated IGF-1R, human ker-
atinocytes are exquisitely sensitive to UVB-induced apoptosis. When UVB-induced NF-κB
was examined in the absence of activated IGF-1Rs, we found increased levels of the p50
homodimers. Therefore, signaling from the IGF-1R suppresses UVB-induced NF-κB homod-
imers, suggesting that this subunit composition of NF-κB correlates with the induction of apop-
tosis. Suppression of IGF-1R function also altered the UVB-response of the stress proteins
p53, p38, and p21. We have also previously demonstrated through epidemiological studies
that aging-dependent failure of the IGF-1R signaling network may be critically important in
the development of aging-associated skin cancer. We have now further examined the rela-
tionship between aging, UVB irradiation, and the IGF-1R by determining the influence of aging
on changes in the IGF-1R signaling network in human skin.
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Phosphatidylglycerol normalizes keratinocyte proliferation in vitro and accelerates wound
healing in vivo
WB Bollag1,2 and X Zhong2 1 Medicine (Dermatology), Medical College of Georgia, Augusta,
GA and 2 Institute of Molecular Medicine and Genetics, Medical College of Georgia,
Augusta, GA
Phospholipase D (PLD) catalyzes both phospholipid hydrolysis to produce phosphatidic acid
and also, in the presence of primary alcohols, a transphosphatidylation reaction to generate
phosphatidylalcohols. Indeed, PLD2 can utilize the physiological primary alcohol glycerol to
form phosphatidylglycerol (PG). We recently demonstrated that in keratinocytes aquaporin-3
(AQP3), an efficient glycerol transporter, is associated with PLD2. We hypothesized that AQP3
provides glycerol to PLD2 for PG synthesis and that this lipid modulates keratinocyte func-
tion. To test this idea, primary mouse epidermal keratinocytes were treated with PG liposomes.
In proliferative cells PG inhibited DNA synthesis and induced a dose-dependent increase in
transglutaminase activity, a marker of late differentiation. Conversely, PG increased DNA syn-
thesis in slowly dividing keratinocytes, suggesting an ability of this lipid to normalize ker-
atinocyte proliferation in vitro. The effect of PG on wound healing in vivo was then examined.
Two full-thickness skin punch biopsies were made on the backs of outbred mice. For each
mouse one wound was (a) untreated or treated with 2M glycerol in water or (b) treated with
phosphate-buffered saline lacking divalent cations (PBS-) or PBS- containing 100 µg/mL PG
liposomes. The rate of wound healing was followed over 4 days by digital photography and
computer image analysis, and the percentage of wound healing on day 4 relative to day 1
determined for each of the 4 groups. As anticipated based on previous reports, glycerol treat-
ment improved wound healing. Interestingly, PG also significantly stimulated wound healing.
Thus, our results support the idea that in epidermal keratinocytes AQP3 supplies glycerol to
PLD2 for the synthesis of PG, a lipid signal in keratinocytes. Further, PG may be useful for
normalizing skin function (i.e., decreasing division in rapidly growing keratinocytes and increas-
ing proliferation in slowly dividing cells) and accelerating epidermal wound healing.
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Differential role of Smad2 and Smad3 in mediating TGFβ1 overexpression induced psoria-
sis-like skin inflammation
AG Li,1 Y Siddiqui,1 C Deng2 and X Wang1 1 Oregon Health & Science University, Portland,
OR and 2 NIH/NIDDK, Bethesda, MD
Transforming growth factor beta (TGFβ) represents a family of pluripotent proteins, in which
TGFβ1 is the most abundant isoform in many tissues. TGFβ1 has dual effects on many bio-
logical processes, such as exerting both anti- and pro-inflammatory roles. Imbalance between
such dual effects may lead to pathological conditions. We have shown that mice overexpressing
wildtype TGFβ1 in keratinocytes driven by a keratin 5 promoter (K5.TGFβ1wt) spontaneously
develop an inflammatory disorder resembling human psoriasis, a typical Th1 skin inflamma-
tion. Our study suggests that TGFβ1 is likely a pro-inflammatory cytokine in the skin by induc-
ing or recruiting molecules that are involved in a Th1 inflammation. To further understand the
underlying mechanisms, we cross-bred K5.TGFβ1wt transgenics to mice carrying heterozy-
gous deletion of Smad2 or Smad3, two major intracellular mediators of TGFβ signaling. The
levels of TGFβ1 overexpression remained unaffected in either K5.TGFβ1wt/Smad3+/- or
K5.TGFβ1wt/Smad2+/- compound mice as compared to K5.TGFβ1wt transgenics. However,
haploinsufficiency of Smad3, but not Smad2, almost completely alleviated the inflammatory
phenotypes induced by TGFβ1 overexpression. Further analyses revealed significantly reduced
expression of growth factors (e.g., amphiregulin), chemokines (e.g., MIP-2), inflammatory
cytokines (e.g., TNFα), as well as angiogenic factors (e.g., VEGF) in K5.TGFβ1wt/Smad3+/- skin
in comparison with K5.TGFβ1wt skin. In contrast, expression levels of these molecules in
K5.TGFβ1wt/Smad2+/- skin remained similar to those in K5.TGFβ1wt skin. Our data indicate
that Smad2 and Smad3 play distinct roles in mediating TGFβ1 overexpression induced inflam-
matory phenotypes. Particularly, Smad3 may be required for TGFβ1 to induce or recruit the
above molecules that are essential in the development of psoriasis-like skin inflammation. It
is of great importance to determine whether Smad2 or Smad3 regulates the expression of dif-
ferent sets of target genes at transcriptional levels in future studies.
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Differential expression of Tumor Necrosis Factor Receptor-Associated factor 1 (TRAF1) in
cutaneous CD30+ lymphoproliferations enables the distinction of lymphomatoid papulosis
from cutaneous anaplastic large cell lymphoma
C Assaf,1 B Hirsch,2 F Wagner,2 M Grunbaum,2 S Gellrich,1 A Lukowsky,1 W Sterry,1 H Stein2
and H Durkop2 1 Dermatology, Charite, Berlin, Germany and 2 Pathology, Charite, Berlin,
Germany
The CD30-positive lymphoproliferative disorders lymphomatoid papulosis (LyP), primary cuta-
neous anaplastic large cell lymphoma (cALCL) are lesions that overlap clinically, histopatho-
logically, and immunophenotypically. Their biologic behaviors, however, vary considerably.
In particular, lesions of LyP regress spontaneously while those of cALCL and sALCL (systemic
ALCL) persist and often progress with potential involvement of lymph nodes and visceral organs.
The NFkB related gene product tumor necrosis factor (TNF) receptor associated factor 1 is a
member of the recently defined TRAF family and takes part in the signal transduction of CD30.
In this study we developed a novel TRAF1 antibody that recognizes a formalin resistant epi-
tope. Applying this antibody to one hundred and twenty-five cases of cutaneous CD30+ lym-
phoproliferations and 15 cases of nodal CD30+ ALCL were immunostained. The novel TRAF1
antibody labelled strongly CD30+ cells of lymphomatoid papulosis. In contrast, primary and
secondary cutaneous ALCL revealed only a weak to negative staining, which is also displayed
by the staining results of the nodal CD30+ ALCL. These results indicate that reliable immunos-
taining of routine biopsy material for TRAF1 protein is feasible. Moreover we demonstrate
that TRAF1 reliably distinguish lymphomatoid papulosis from primary or secondary cutaneous
anaplastic large cell lymphoma.This is of crucial diagnostic importance, since therapy of LyP
offers only a small advantage while patients suffering from ALCL derive severe benefit from
radio- and/or chemotherapy.
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Molecular screening for GS2-lipase regulators: inhibition of keratinocyte retinylester hydrol-
ysis by TIP47
JG Gao and M Simon Oral Biol & Pathol., SUNY at Stony Brook, Stony Brook, NY
Maintenance of retinoic acid within a narrow concentration range is critical for normal epi-
dermal tissue morphogenesis. Under conditions of retinol sufficiency, it is imperative to limit
retinoic acid biosynthesis from serum-derived retinol. In epidermis this is accomplished by
esterifying retinol with long chain fatty acids. Retinylester pools serve as a source of retinol
for retinoic acid production under retinol deficiency and when required for proper differenti-
ation. We have recently identified the GS2-lipase as a retinylester hydrolase in keratinocytes
by screening keratinocytes cDNA libraries. Because GS2-lipase has a robust activity that can
affect the intracellular retinol levels, we postulated that its activity must be regulated. There-
fore, we screened keratinocyte cDNA expression libraries for the putative regulators. Herein,
we report the identity of an inhibitor, TIP47, which prevents retinylester hydrolysis catalyzed
by GS2-lipase and hormone sensitive lipase. Using a series of deletion mutants we found two
regions of TIP47 involved in the inhibitory activity. To our knowledge, TIP47 is the first reported
protein that inhibits retinyester hydrolases. Since this protein is known to transport mannose-
6-phosphate receptors from endosome to trans-golgi and to be distributed between the cyto-
plasm and lipid droplets, it may prove to have an important role in coordinating retinoid and
non-retinoid lipid signal transduction.
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C-Myc alters skin stem cell fate by directly activating genes encoding Wnt signaling antag-
onists
Y Wei and DR Roop Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX
The Wnt signaling pathway is a key regulator of stem cell maintenance and cell fate determi-
nation in numerous tissues including skin. Wnt proteins bind to Frizzled transmembrane recep-
tors, initiating a signaling cascade resulting in β-catenin nuclear translocation and activation
of β-catenin responsive genes. Previous studies have shown that high levels of β-catenin divert
multipotent stem cells to a hair follicle fate, while blocking β-catenin allows adoption of an
epidermal or sebaceous gland fate. We have developed a mouse model which allows the
induction of c-Myc in the basal layer of the epidermis and in hair follicles, the location of epi-
dermal stem cells and multipotent stem cells, respectively. This model also allows the induc-
tion of c-Myc at different stages of skin and appendage development. When c-Myc was induced
at E14.5, we observed an acceleration of sebaceous gland development, suggesting that c-
Myc may alter stem cell fate by inhibiting Wnt signaling. There are two functional classes of
secreted Wnt antagonists: the dickkopf (DKK) class, which includes Dkk1-4,  and the soluble
frizzled related protein (sFRP) class, which contains sFRP1, 2, 4, 5 and Frzb (sFRP3). While
Dkk proteins bind to low density lipoprotein receptor related proteins (LRP5 and 6) contained
within the Wnt receptor complex and influence Wnt signaling by preventing normal LRP-Fz-
Wnt interactions, sFRP proteins compete directly with Frizzled receptors for interactions with
Wnts. We performed gene expression profiling to identify potential targets induced by c-Myc.
Among these targets, we found genes encoding proteins that belong to both groups of Wnt
antagonists: Dkk1 and Frzb. These results were confirmed by RT-PCR. We also performed chro-
matin immunoprecipitation with a c-Myc antibody to confirm that c-Myc occupied the pro-
moters of both Dkk1 and Frzb in the c-Myc induced embryonic skins exhibiting accelerated
formation of sebaceous glands. In summary, these results indicate that c-Myc alters the fate of
multipotent stem cells in part by inducing expression of natural Wnt antagonists.
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Keratinocytes co-express TRANCE and its functional receptor TRANCE-R: existence of a poten-
tial autocrine signalling pathway
J Barbaroux,1 J Mee,1 C Mueller2 and R Groves1 1 St. John’s Institute of Dermatology, Kings
College London, London, United Kingdom and 2 INSERM U255, Instutut Biomedical des
Cordeliers, Paris, France
The TNF superfamily molecules TRANCE, its functional receptor TRANCE-R and a decoy recep-
tor osteoprotegerin (OPG), have been associated with numerous activities including regulation
of dendritic cell (DC) function, differentiation and activation of osteoclasts as well as control of
lymph node and mammary gland organogenesis. In a previous study we defined expression and
function of TRANCE-R on Langerhans cells. We were therefore interested to explore whether
molecules of this ligand/receptor system might be expressed and functional in epidermis. Nor-
mal human skin (n=3) and keratinocyte cultures (n=3) were analysed by immunofluorescence
and RT-PCR for TRANCE, TRANCE-R and OPG expression. We observed mRNA for both TRANCE
and TRANCE-R in in vitro second passage keratinocyte cultures. Ligand and receptor were also
detected in vivo by immunofluorescence on frozen sections of human skin. In cultured ker-
atinocytes, TRANCE was evident in cytoplasmic vesicles and flow cytometry indicated that
TRANCE-R was present on the cell membrane of keratinocytes, though at lower levels than
observed on LC. OPG was secreted into the supernatant of cultured keratinocytes as assessed
by ELISA. In order to explore the functional response of keratinocytes to exogenous TRANCE,
we assessed the transcriptome of keratinocytes stimulated by TRANCE 100ng/ml for 24 hours.
Using Affymetrix U133A microarrays we observed increased expression of genes associated with
KC differentiation such as TG1, SKALP and kallikreins 7, 10 and 13 together with a decrease in
mRNA levels of pro-apoptotic genes including Bax and p53 induced genes such as p53AIP1
and PLAGL1. These data indicate that TRANCE and TRANCE-R are co-expressed by keratinocytes,
and likely result in a functional autocrine system in epidermis. We hypothesise that TRANCE
signalling may play a role in regulation of keratinocyte growth, differentiation and apoptosis.
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Differential expression and function of EGF receptor ligands influence autocrine keratinocyte
proliferation and morphology
S Stoll,1 JL Johnson,1 L Rittie1 and JT Elder1,2 1 Dermatology, University of Michigan, Ann
Arbor, MI and 2 VA Medical Center, Ann Arbor, MI
EGFR becomes activated in response to multiple members of the EGF family, including
amphiregulin (AR), HB-EGF, and TGF-α. We have previously shown that autocrine prolifera-
tion of normal human KC (NHK) in culture is strongly dependent upon AR, with little or no
contribution from either HB-EGF or TGF-α. We hypothesized that this might be due to dif-
ferential ligand expression and/or shedding. By ELISA, we found that NHK and immortalized
N-TERT KC secrete substantial amounts of AR (1-2 ng / 106 cells in 24 h) into the culture
medium, whereas TGF-α is present at much lower levels (~ 0.1 - 0.2 ng / 106 cells in 24 h)
and soluble HB-EGF is undetectable. To determine whether the high abundance of soluble
AR might be due to increased gene expression of AR, we utilized QRT-PCR to compare the
levels of AR, HB-EGF, and TGF-α in NHK under autocrine conditions. AR mRNA was 24 times
more than TGF-α and 71 times more than HB-EGF (n = 2). These results indicate that NHK
are dependent upon AR for autocrine growth because they express and shed much more AR
than TGF-α or HB-EGF. In order to better assess the biological effects of AR and HB-EGF in
NHK, we expressed each GF under the control of the CMV promoter. Each vector increased
expression of its encoded GF by ~ 0.5 ng / 106 cells in 24 h. However, expression of HB-EGF
increased shedding of AR by 6-fold (n = 3 independent infections). Interestingly, expression
of HB-EGF but not AR resulted in profound morphological and cellular changes highly sim-
ilar to the ones that occur during the process of epithelial-mesenchymal transformation (EMT).
Similar changes in AR expression and cell morphology were also seen in cells that were forced
to express a short, soluble form of HB-EGF, indicating that transmembrane pro-HB-EGF is not
important in this process. Taken together, our data suggest that soluble HB-EGF is capable of
provoking EMT in NHK when overexpressed and that AR may mediate this phenomenon.
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The endocannabinoid/endovanilloid anandamide regulates proliferation and apoptosis of
human keratinocytes via novel signaling interactions between vanilloid receptor-1 (TRPV1)
and cannabinoid receptor-1 (CB1)
T Biro,1 A Dajnoki,1 A Telek,1 E Bodo,2 N Dobrosi,1 BI Toth1 and R Paus2 1 Department of
Physiology, University of Debrecen, MHSC, Debrecen, Hungary and 2 Department of
Dermatology, University Hospital Schleswig-Holstein, Lubeck, Germany
Several cell populations of human skin (e.g. epidermal and hair follicle keratinocytes, den-
dritic cells) express the vanilloid receptor-1 (TRPV1) and cannabinoid receptor-1 (CB1).
Here, we have investigated the in vitro-effects of the endocannabinoid anandamide (AEA,
which acts as an agonist for both CB1 and TRPV1) on the human epidermal keratinocyte cell
line HaCaT, and have defined the functional roles of CB1 and TRPV1. By Western blot, immuno-
cytochemistry, and Q-PCR, both receptors were identified on HaCaT cells. As was assessed
by MTT-based colorimetric proliferation and annexin-V-based apoptosis assays, AEA inhib-
ited proliferation and induced apoptosis of HaCaT cells (dose-dependently: 0.1-30 microM).
Intriguingly, these effects of AEA were equally inhibited by the specific CB1 antagonist AM-
251 (1 microM) and the specific TRPV1 antagonists, iodo-resiniferatoxin (I-RTX, 50 nM) and
capsazepine (1 microM). However, when the CB1 and TRPV1 antagonists were co-adminis-
tered, there were no additive effects of the two antagonists. This suggested that AEA may not
simultaneously act on both receptors, but may sequential activate one after the other CB1
and TRPV1 mediated signaling pathways. To test this hypothesis, functional calcium imaging
was used for measuring exclusively TRPV1 activity. The results suggest that AEA primarily acts
on CB1 which, in turn, activates TRPV1. Thus, human epidermal keratinocytes not only dis-
play a fully functional endocannabinoid/endovanilloid system, but also exhibit novel signal-
ing interactions between CB1 (a metabotropic, G-protein-coupled receptor) and TRPV1 (a lig-
and-gated, calcium permeable channel) and their intracellular signal transduction pathways.
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Amphiregulin modulation by cAMP stimulating agents in human keratinocyte
J Ray, K Squillace and MR Pittelkow Dermatology, Mayo Clinic, Rochester, MN
Molecular mechanisms underlying psoriasis are being intensively investigated. Epidermal ker-
atinocytes, T cells as well as stromal factors have been implicated in cooperatively initiating
and amplifying pathological events leading to psoriasis. Amphiregulin (AR), an epidermal
growth factor (EGF)-like growth factor is expressed by epidermal keratinocytes and over-
expressed in psoriasis. AR is a potent autocrine mitogen for keratinocytes. AR has also been
shown to be induced in T cells by stimulating the cyclic AMP (cAMP) Ç protein kinase A (PKA)
pathway. We sought to determine if AR is regulated by a cAMP-dependent pathway in human
keratinocytes. Human keratinocytes grown at subconfluence or to cell confluence were exposed
to selected cAMP stimulators such as forskolin or cholera toxin and, in some cases, the cAMP-
dependent protein kinase inhibitor H89 and incubated for various times at a range of drug
concentrations. AR expression was analyzed by both quantitative PCR and Northern blotting
to compare transcript levels and modulation by cAMP stimulating agents. AR was strongly
expressed in subconfluent keratinocytes and down-regulated at confluence by 7-12 fold. Rest-
ing human peripheral blood mononuclear cells expressed nil levels of AR. Confluent cells
expressing low levels of AR were incubated with forskolin. At 30 min and 1 h, AR expression
was induced transiently by cAMP stimulation greater than 2-fold but subsequently decreased
by 4 h to 0.16-fold of control levels. Expression of AR was also modulated by cholera toxin,
and effects of EGFR inhibition were also examined coordinately with cAMP stimulation to
compare relative contributions by these independent pathways of activation. Auto-induced
AR in keratinocytes may also be cooperatively enhanced by paracrine expression of AR in acti-
vated, lesional T-cells of psoriasis. Further modulation may be mediated by cAMP dependent
pathways in keratinocytes. Together, persistently up-regulated AR expression by both ker-
atinocytes and T-cells may sustain pro-inflammatory events that induce and perpetuate psori-
asis in genetically prone individuals.
566
CAML Expression and regulation of cell growth and survival in human keratinocytes, tumor
cell lines and skin malignancies
N Atanaskova,1 RJ Bram2 and MR Pittelkow1 1 Dermatology, Mayo Clinic, Rochester, MN and
2 Pediatrics, Mayo Clinic, Rochester, MN
Calcium modulating cyclophilin ligand (CAML) is an endoplasmic reticulum protein that has
been implicated as an integral regulator of epidermal growth factor receptor (EGFR) recy-
cling. Currently, the role of CAML and its involvement in epidermal homeostasis and skin
tumorigenesis is unknown. We hypothesized that EGFR recycling, coupled to CAML, serves
as an important regulator of normal and pathologic skin cell growth. We demonstrated the
presence of CAML in human keratinocytes, melanocytes, SCC-25 and A375 cell lines by quan-
titative PCR and Western blotting techniques. We further showed that CAML RNA and pro-
tein levels were consistently higher in SCC25 cell lines when compared to human keratinocytes.
In addition, human tissue samples from basal cell and squamous cell carcinomas (BCC and
SCC) and malignant melanoma exhibited distinct expression and localization of CAML by
immunostaining. Concordantly, higher levels of CAML RNA and protein were present in both
SCC and BCC tumor samples when compared to normal skin tissue. Using siRNA techniques
to inhibit expression of CAML in human keratinocytes, melanocytes, SCC 25 and A375 cell
lines, level of CAML protein were significantly decreased by 72 hours after transfection. The
inhibition of CAML expression in these cell lines significantly reduced their cell growth.
Phase microscopy imaging indicated that downregulation of CAML altered cell morphology
and affected cell-to-cell contacts. Further investigation showed that CAML siRNA transfected
cells were more sensitive to treatment with the apoptotic agent camptothecin, and exhibited
increased cell death compared to controls. Our results suggest that CAML is an important reg-
ulator of skin cell growth and survival and may represent a novel target in skin tumorigenesis
regulation.
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Implanted hair follicle stem cells form Schwann cells which support repair of severed periph-
eral nerves and the spinal cord
Y Amoh, L Li and RM Hoffman AntiCancer, Inc., San Diego, CA
The hair follicle bulge area is an abundant, easily accessible source of actively growing, pluripo-
tent adult stem cells. Nestin, a protein marker for neural stem cells, is also expressed in folli-
cle stem cells as well as their immediate differentiated progeny. The fluorescent protein, GFP,
whose expression is driven by the nestin regulatory element in transgenic mice, served to mark
the follicle cell fate. The pluripotent nestin driven-GFP stem cells (ND-GFP) from the trans-
genic mice are positive for the stem cell marker CD34 but negative for keratinocyte marker,
keratin 15, suggesting their relatively undifferentiated state. The hair follicle stem cells can
differentiate into neurons, glia, keratinocytes, smooth muscle cells and melanocytes in vitro.
In vivo studies show the ND-GFP hair-follicle stem cells can differentiate into blood vessels
and neural tissue after transplantation to the subcutis of nude mice. Equivalent hair-follicle
stem cells derived from beta-actin-driven-GFP (BAD-GFP) transgenic mouse hair-follicle stem
cells, implanted into the gap region of a severed sciatic nerve, greatly enhance the rate of nerve
regeneration and the restoration of nerve function. The follicle cells transdifferentiate largely
into Schwann cells which are known to support neuron regrowth.  Function of the rejoined
sciatic nerve was measured by contraction of the gastrocnemius muscle upon electrical stim-
ulation. After severing the tibial nerve and subsequent transplantation of hair-follicle stem cells,
walking print length and intermediate toe spread significantly recovered indicating the trans-
planted mice recovered the ability to walk normally. The severed spinal cord partly recovered
after injection of hair follicle stem cells. The cord rejoined and the mice partially regained the
ability to utilize their hind legs enabling them to walk. These results suggest that hair-follicle
stem cells provide an important accessible, autologous source of adult stem cells for regen-
erative medicine.
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Hair growth modulatory properties of IL-6 cytokine family members
K McElwee,1,2 M Yu,1 V Lu,1 B Lo,1 J Shapiro,1 P Freyschmidt-Paul,2 S Kissling2 and
R Hoffmann2 1 Dermatology, University of British Columbia, Vancouver, BC, Canada and 2
Dermatology, Philipp University, Marburg, Hessen, Germany
The activation of receptor complexes containing glycoprotein 130 (gp130) identifies the IL-6
cytokine family. We examined members of this family, Interleukin-6 (IL-6), interleukin-11 (IL-
11), leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF),
and cardiotrophin-1 (CT-1) in hair follicles. Quantitative RT-PCR using mRNA derived from
microdissected, anagen stage, human hair follicles and comparison to non-follicular skin
epithelium revealed mRNA for IL-6 and OSM as the most highly expressed while IL-11r, OSMr
and CNTFr were the most highly expressed receptors of the evaluated group. Immunohistol-
ogy suggested expression of IL-6, LIFr and IL-11r in the root sheaths and dermal papilla, while
OSM and IL-11, IL-6r and OSMr were expressed in root sheaths alone. CT-1 and LIF demon-
strated little if any presence. The gp130 receptor subunit was located in the root sheaths, hair
cuticle and differentiating matrix. Human hair follicles from 3 donors were exposed in vitro
to 0.1, 1, 10, or 100 ng/ml of OSM or CT-1 for 8 days. Compared to control hair follicles not
exposed to the cytokines, OSM and CT-1 exhibited a dose dependant growth inhibition capac-
ity. OSM and CT-1 incubated with agarose beads and injected subcutaneously at 1µg per
mouse into telogen skin of mice all 65 days old revealed no capacity to induce anagen hair
growth. In contrast, injection of 65 day old mice in which anagen had been induced by hair
plucking revealed a hair growth inhibitory capacity for OSM but no significant effect for CT-
1 by observation of hair growth and histology. The data identify IL-6 cytokine family members
as modulators of hair follicle growth. High expression of IL-6 cytokine family members can
occur as a constituent of skin or hair follicle inflammation such as alopecia areata. In princi-
ple, increased expression in cutaneous inflammation may contribute to the promotion of hair
loss. The nature of expression distribution circumstantially suggests a role in hair follicle ker-
atinocyte differentiation.
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Ectodysplasin regulates lymphotoxin, Wnt, BMP and SHH pathways for hair follicle forma-
tion
C Cui,1 T Hashimoto,1 SI Grivennikov,2 Y Piao,1 SA Nedospasov2 and D Schlessinger1 1
Laboratory of Genetics, National Institute on Aging, Baltimore, MD and 2 Basic Research
Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD
Mutations in the EDA gene cause anhidrotic/hypohidrotic ectodermal dysplasia, a disorder
characterized by defective formation of hair, sweat glands and teeth in humans and in a mouse
model, “Tabby”. The gene encodes ectodysplasin, a TNF ligand family member that activates
the NF-kB signaling pathway, but downstream targets and the mechanism of skin appendage
formation have been only partially analyzed. Comparative transcription profiling of embry-
onic skin during hair follicle development in wild-type and Tabby skin identified critical down-
stream effectors of EDA in four pathways, three already implicated in hair follicle formation.
They included Shh and its effectors, as well as novel antagonists for the Wnt (Dkk4), and BMP
(Sostdc1) pathways. The fourth pathway found was unexpected: Ltb/RelB, a variant NF-kB com-
plex. Previously known to participate only in lymphoid organogenesis, Ltb was selectively
augmented in developing hair follicles of wild-type, but not in Tabby mice. Furthermore, in
mice mutated to lack Ltb, all three types of mouse hair were still formed, but all were struc-
turally abnormal. Guard hairs became wavy and irregular, zigzag/auchen hairs lost their kinks,
and in a phenocopy of features of Tabby animals, the straight “awl” hairs doubled in number
and were characteristically distorted and pinched. Thus Ltb, as an EDA target, regulates the
form of hair in developing hair follicles; and when EDA is defective, failure of Ltb activation
can account for part of the Tabby phenotype.
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Hypoxia induces expression of hypoxia inducible factor 1α in mouse hair follicles
W Fan,1 Y Dai1 and Y Wan2 1 Jiangsu Provincial People’s Hospital, Nanjing, Jiangsu Province,
China and 2 Providence College, Providence, RI
A number of transcription factors have been implicated in the regulation of hair follicle cycle.
The objective of this study was to investigate the role of a transcription factor, namely hypoxia
inducible factor 1α (HIF1α), in distinct hair follicle cycle stage. C57BL/6 mice (7 weeks of age)
were divided into three groups (A, B, and C). The mice in group A were treated with 8% of
O2 in an obturation container under normal pressure, the mice in group B were treated with
CoCl2 (60 mg/kg) by peritoneal injection, and the mice in group C were treated as the con-
trol. In distinct hair follicle cycle stage, namely 10 (anagen), 18 (catagen), and 21 (telogen)
days after depilation, when the mice in group A were treated with 8% of O2 for 3 hours, the
mice in group B were treated with CoCl2 (60mg/kg) by peritoneal injection for 1.5 hour, the
back skin samples of three groups were collected and the expression of hypoxia inducible
factor 1α was detected by RT-PCR. The results showed that in distinct hair follicle cycle stage,
hypoxia inducible factor 1α was up-regulated in the skin of the mice group A and B, but no
expression of HIF1α was observed in the skin of the mice in group C. Taken together, we con-
clude that hypoxia either by low oxygen or by chemicals induces expression of hypoxia
inducible factor 1α in distinct hair follicle cycle stage. The consequence of up-regulation of
HIF1α during hypoxia in hair follicles is currently under investigation.
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Effect of incubation solution on the viability of hair follicles during hair transplantation
L Wu,1 W Fan1 and Y Wan2 1 Jiangsu Provincial People’s Hospital, Nanjing, Jiangsu Province,
China and 2 Providence College, Providence, RI
Hair transplantation remains a time-consuming work. During the tedious operation, follicle
units unavoidably have to be stored in vitro for a long period of time. In this study, we inves-
tigated the effects of different storage solutions on the viability of hair follicle by measuring
hair shaft elongation. The scalps were obtained from the patients of cosmetic surgery aged
from 20-40. The scalps were washed with ethyl alcohol and phosphate-buffered saline (PBS)
for three times. Post that, the scalps were observed under a microscope and the lengths of the
hair follicles were measured in about two hours and the follicles were incubated in three dif-
ferent buffers (Ringer’s solution, Williams E solution, and Williams E solution supplemented
with heparin) for 5 hours at room temperature. The hair follicles were than cultured for 72
hours and the hair shaft elongation was measured. Compared with Ringer’s solution, the lengths
of follicles incubated in Williams E solution and Williams E solution supplemented with heparin
were significantly increased. However, there was no deference between Williams E solution
and Williams E solution supplemented with heparin. During hair transplantation procedure,
the viability of hair follicle incubated in different buffers varied remarkably. Williams E solu-
tion is the best among solutions tested for the survival and growth of the follicle after the
transplantation.
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A new surface marker for dermal papilla cells
Y Ito,1 TS Hamazaki,1 K Tamaki,2 M Asashima3 and H Okochi1 1 Department of Tissue
Regeneration, Research Institute, International Medical Center of Japan, Tokyo, Japan, 2
Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan and
3 Graduate School of Arts and Science, The University of Tokyo, Tokyo, Japan
Dermal papilla (DP) cells play a central role in hair development and growth, contributing to
epithelial-mesenchymal interactions. DP cells have been considered to be organ-specific
pluripotent cells. However, no specific surface marker has yet been reported. In this study,
using the marker prominin-1/CD133 (CD133), we tried to isolate live DP cells with hair induc-
ing ability. CD133 is a pentaspan transmembrane glycoprotein expressed on several tissue
stem cells with unknown biological functions. We first used the CD133 antibody to survey
whether the antigen positive cells could be detected in embryonic or adult skin. Immunohis-
tochemically, the dermal condensate/papilla was exclusively positive for CD133 in stage 2 to
5 anagen during hair morphogenesis. In the adult, DP cells expressed CD133 during each ana-
gen, periodically. FACs analysis revealed that the CD133 positive (+) cells in embryonic skin
produce CD44, p75NTR, NCAM, CD90/Thy-1, and nestin. Because these CD133 (+) cells
were negative for sca-1, CD45, c-kit, and CD202/tie-2, we could exclude the possibility that
they might originate from hematopoietic/endothelial or melanocytic lineages. Moreover, the
fact that CD133 (+) cells express the twist, slug, and snail genes indicates that the cells derive
from the neural crest. To prove whether the CD133 (+) cells of DP are able to form new hairs,
we performed experiments of hair reconstitution. The CD133 (+) cells from both embryos and
adults succeeded in inducing hair follicles in athymic mice when they were grafted with embry-
onic epithelium. These results suggest that CD133 is a novel marker for DP cells and a useful
tool for elucidating the mechanisms of hair development and formation.
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Properties of cells expressing markers of the keratinocyte lineage derived from human embry-
onic stem cells
S Dabelsteen,1 S Iuchi,2 Z Gou,1 K Easley,2 M Rice,1 H Green2 and JG Rheinwald1 1
Dermatology, Brigham and Women’s, Boston, MA and 2 Cell Biology, Harvard Medical
School, Boston, MA
A previous study (Green et al. (2003) PNAS 100: 15625) identified cells that sequentially expressed
p63, basonuclin 1, K14, and Involucrin, markers consistent with the keratinocyte lineage, among
the differentiated cells arising from H9 human embryonic stem cells in culture or in nodules
formed in SCID mice. When subcultured into the 3T3 feeder/FAD culture system, these cells
formed colonies with morphology similar to normal human postnatal tissue-derived keratinocytes
(nHK), but they had a very limited proliferation potential. The purpose of the present study was
to engineer these cells to extend their replicative lifespan and permit characterization of their
growth and differentiation properties. hES-derived keratinocyte-like cells (hESderK) cells expressed
p16INK4A as they became senescent, similar to the behavior of nHK, and could not be immor-
talized by expression of TERT alone. We therefore employed expression of E6E7 or of bmi1+TERT
to generate immortalized hESderK cells (hESderKimm). We isolated and studied four clones of
distinct morphology and derivation history. All the hESderKimm clones expressed the keratinocyte
markers involucrin, K14, K1/K10, laminin 5, and alpha6 integrin. hESderKimm formed multi-
layered epithelia in organotypic culture, but these differed histologically from those formed by
immortalized nHK (nHKimm) by an absence of or very modest cornification. Unlike nHKimm,
hESderKimm cells exhibited a relaxation of keratinocyte-specific mitogen requirements and were
able to grow in the absence of EGF or feeder cells. Under these conditions, hESderKimm cells
converted reversibly to a fibroblastoid morphology. Comparative oligonucleotide microarray
analysis disclosed that hESderKimm cells retain expression of the sox2 transcription factor, a char-
acteristic of hES cells. These results suggest that hESderK cells may represent an intermediate
stage of or deviation from normal keratinocyte development.
96 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
577
Keratin 14 is a direct target of ∆Np63 in keratinocytes
R Romano, B Birkaya and S Sinha Biochemistry, SUNY at Buffalo, Buffalo, NY
Keratin 14 (K14) is a prototypic marker of the dividing basal keratinocytes where it is tran-
scribed at high levels. The transcriptional regulation of K14 is governed by an evolutionarily
conserved functional enhancer marked by DNase 1 hypersensitive sites present upstream of
the K14 gene. This enhancer is sufficient to confer epidermal-specific gene expression, which
is mediated in part by binding of AP-2, AP-1, Ets and Sp1 family of transcription factors. Here
we provide evidence that a keratinocyte-specific nuclear protein that binds to a conserved
motif within this enhancer consists of the ∆N isoform of the p63 protein, which is the pre-
dominant isoform of p63 that is expressed in keratinocytes. Interestingly, the selective expres-
sion profile of ∆Np63 in various cell lines correlates with both the nuclear complex and the
expression of K14. Biochemical studies reveal that ∆Np63 can bind to a specific DNA sequence
present in the enhancer and this binding leads to transactivation of the enhancer. In addition,
chromatin immunoprecipitation (ChIP) experiments with ∆Np63-specific antibodies demon-
strate that the enhancer is occupied by ∆Np63 in keratinocytes in vivo. Finally, contrary to
published data, we show that ectopic expression of either isoform of p63 (∆N or TA) can induce
de novo expression of K14. These studies provide novel insights into the molecular mecha-
nisms by which ∆Np63 regulates K14 in a keratinocyte-specific manner and offer one likely
explanation as to why K14 levels are downregulated in p63 null animals.
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Exogen hair characterisation in human scalp
D Van Neste, T Leroy and S Conil Skinterface, Tournai, Belgium
The hair cycle is generally described as a sequence of 3 successive phases: a hair growth phase
named anagen, a regression phase or catagen and a resting phase or telogen. Recently, hair
shedding or “exogen phase” has been described in rodents as a process distinct from other
phases in the hair cycle. The objective of our study was to present our non-invasive method
of exogen hair sampling, to characterize some of morphological and bio-physical aspects of
human exogen hair, and to quantify its presence in the scalp of controls and subjects with
androgenetic alopecia. For exogen hair collection in vivo, a two-step condensation type
polysiloxane silicone impression system is used through a template. Significant structural dif-
ferences distinguishing telogen and exogen hair have been revealed by scanning electron
and light microscopy using different staining methods. Telogen hair and exogen hair also
showed differences with extraction forces measurement. As opposed to telogen hair, exogen
hair is devoid of any undifferentiated cell and its extraction is easy (≤0.1N ) and totally pain-
less. At the first sampling, a significantly higher number of exogen was collected in AGA sub-
jects (in average 7 exogen hair per cm2) as compared to controls subjects (in average 2 exo-
gen hair per cm2) suggesting that further studies are warranted using exogen counts as a
diagnostic criterion. In all cases, we observed an exhaustion of exogen with successive col-
lections. Tracking of exogen on sequential contrast enhanced phototrichograms showed that
this sampling method was specific and did not significantly affect the evaluation of other hair
cycle stages.
581
Quantitative analysis of tryptase- and chymase-positive mast cells in male pattern hair loss
O Kwon, Y Kim, B Kim, C Choi, K Cho and K Kim Department of Dermatology, Seoul
National University Hospital, Seoul, South Korea
Two types of Mast cells (MCs) found in skin are distinguished based on anatomic localization
and staining characteristics. Tryptase, chymase, and carboxypeptidases are the main secre-
tory proteases of the MCTC subtype which tend to predominate in the skin and submucosa,
whereas only tryptase is present in the secretory granules of MCT subtype. Ten patients with
MPHL (Ludwig-Hamilton IIIv to IV) and 5 normal subjects (20 to 35 years) participated in this
study. Paired two 4-mm punch biopsies were taken from vertex and occipital promontory area.
Masson trichrome and Victoria blue staining were performed for observation of collagen frame-
work and elastic fiber structure. The number of immunoreactive MCs stained with anti-tryptase
or anti-chymase antibody was counted at 200x. A significant increase of the collagen bun-
dles was only found in balding vertex with MPHL compared to the non-balding occiput scalp,
however, interestingly, near 4-fold significant increase of elastic fiber frameworks were demon-
strated in both vertex and occipital scalp skin with MPHL compared to those of control.
Additionally, balding vertex scalp revealed a significant increase of elastic fibers than non-
balding occiput scalp. The numbers of MCs were increased not only in perifollicular area but
interfollicular dermis and tryptase-positive, total MC numbers of site-matched scalp samples
were increased about 2-fold in MPHL subjects compared to normal control. Even non-bald-
ing occiput scalp samples of MPHL subjects showed an increase in MC number compared
to those of normal control, and were near that of vertex scalp skin of normal control. The per-
centage of elastic fiber (%) was relatively well correlated with tryptase/chymase-positive mast
cells. Although the cause of the increased collagen and elastic fibers in MPHL, concerning
fibrosis and its known relationship to mast cells, mast cells may be correlated in these phe-
nomena with a negative role in MPHL.
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Senescence in cultured primary balding and non-balding dermal papilla cells their immor-
talisation and characterisation
A Bahta,1 J Bull,1 B Farjo,2 N Farjo2 and M Philpott1 1 Centre for Cutaneous Research, Barts and
The London, London, United Kingdom and 2 Farjo Medical Centre, Manchester, United Kingdom
The paradox of androgen action in human hair growth is well established but the molecular
mechanisms of androgen action in hair follicles are poorly understood. Dermal papilla (DP)
cells derived from frontal (balding) human scalp hair follicles (BDPC) have been used to study
Androgenetic Alopecia (AGA). However balding DP cells are very difficult to obtain and grow
very slowly in vitro. To investigate this we have isolated DP fibroblasts from male balding and
non-balding sites. DP from balding but not non-balding follicles have a limited life span (2-6
passages) form large flattened cells similar to senescent fibroblasts and cannot be passaged.
BDPC cells express senescence-associated beta galactosidase activity at PH-6, a biomarker for
replicative senescence. Stress induced premature senescence (SIPS) was induced with more
prominent characteristic behaviour in BDPC than non-balding DPC (NBDPC) after exposure
to sub-cytotoxic levels of H2O2. BDPC cells expressed oxidative stress markers HSP27, Super
Oxide Dismutase (SOD-1)and Catalase. The limited life span of BDPC represents a substantial
obstacle for analysis. We generated immortalized balding and non-balding human DP cell lines
(IBDPC, INBDPC) by ectopic expression of the catalytic subunit of human telomerase (hTERT).
IBDPC have undergone more than 90 passages, maintain their clumping behaviour, expres-
sion of wnt7a, wnt3a, androgen receptor and 5a reductase type 2 mRNA. Co-cultures of IBDPC
and INBDPC with keratinocytes (KC) showed that androgen suppressed the growth of KC
when grown with IBDPC but not with INBDPC, this could be partially reversed using a neu-
tralising antibody to TGF-b. IBDPC cells retained increased sensitivity towards sub-cytotoxic
H2O2 than our INBDPC cell lines. Immortalised DP cell lines show similar characteristics to
primary DPC and will be important in our attempt to understand the actions of androgens on
hair growth. We also suggest that oxidative stress may play a major role in male pattern hair
loss.
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The epidermal side population possesses the most potent tissue regenerative capacity of any
basal epidermal cells
P Kaur,1,2 RP Redvers1 and A Li1 1 Research Division, Peter MacCallum Cancer Centre,
Melbourne, VIC, Australia and 2 Biochemistry & Molecular Biology, University of Melbourne,
Melbourne, WA, Australia
The aims of this study were to determine the functional role of the epidermal Hoechst dull side
population (SP) investigating the notion that resistance to Hoechst staining represents a uni-
versal stem cell trait across many tissues. We have undertaken a thorough phenotypic and
functional characterization of the side population in adult murine epidermis utilising a vari-
ety of assays to determine the relative proliferative and tissue regenerative ability of SP versus
non-SP and unfractionated epidermal populations. The epidermal SP is a rare verapamil-sen-
sitive population comprised of SSClow / K14+ / CD34-/ Oil Red O- / c-kit- / CD45- keratinocytes.
Significantly, epidermal SPs represent a subset of the keratinocyte stem cell-enriched
alpha6briCD71dim fraction, and have the smallest cell and nuclear size with the highest
nuclear-to-cytoplasmic ratio of any fractions examined, consistent with a primitive cell type.
Although SPs demonstrated poor cumulative in vitro proliferative output, they consistently
exhibited the greatest epidermal tissue regenerative activity when transplanted as primary
isolates and after culture, as compared to unfractionated and non-SP (NSP) cells. Collectively,
these results indicate that the epidermal side population contains the most potent keratinocyte
stem cell population in skin epithelium.
582
Regions on chromosomes 7 and 11 show linkage to quantities of eumelanin and pheome-
lanin in hair
SN Shekar,1 DL Duffy,1 T Frudakis,2 MD Shriver,3 RA Sturm,4 GW Montgomery1 and
NG Martin1 1 Genetic Epidemiology Unit, Queensland Institute of Medical Research,
Herston, QLD, Australia, 2 DNAPrint, Genomics Inc., Sarasota, FL, 3 Department of
Anthropology, Penn State University, University Park, PA and 4 Institute for Molecular
Bioscience, University of Queensland, Brisbane, QLD, Australia
Spectrophotometric methods to quantify eumelanin and pheomelanin content in hair samples such
as the R and M indices (Reed, 1952; Diffey et al, 1984) were evaluated using 1472 individuals for
whom reflectance spectrums were generated. A two dimensional quantification of hair colour based
on the trichromatic nature of human perception was developed so pheomelanin content was derived
independent of eumelanin content and vice versa. These quantifications explained subjective cate-
gorisation of hair colour better than previous spectrophotometric methods in a comparison using dis-
criminant class analysis. Genetic analysis of the quantity of the two melanins based on 719 complete
twin pairs showed that for variation in pheomelanin, 57% was due to additive genetic effects with the
remainder due to environmental influences differentially affecting twins within a pair. The propor-
tions of genetic and environmental influence on eumelanin quantity differed between the sexes with
additive genetic influences causing 77% of variation in females but only 55% in males. Twins, sib-
lings and parents in 415 families were genotyped. Linkage analysis was performed on the quantifi-
cation of pheomelanin, eumelanin and the ratio between them to identify regions where genetic sim-
ilarity between related individuals explained similarity in melanin content. A linkage peak with a lod
score of 0.96 was found 13Mb from the MC1R gene (16q24.3). This is expected considering the reces-
sive inheritance of MC1R variants. A region on chromosome 11 was suggestive of linkage in the analy-
sis of eumelanin (lod score 1.86). A region on chromosome 7 approached the threshold for signifi-
cant linkage in the analysis of the ratio between pheomelanin and eumelanin content (lod score 3.08).
Searches under these peaks highlighted a number of promising candidate genes.
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Preclinical program for alopecia areata drug efficacy screening.
KE Koehler,1 C French,1 KA Silva,2 LE King,3 V Kalabokes4 and JP Sundberg2 1 In Vivo
Research Services, The Jackson Laboratory, West Sacramento, CA, 2 The Jackson Laboratory,
Bar Harbor, ME, 3 Vanderbilt University, Nashville, TN and 4 National Alopecia Areata
Foundation, San Rafael, CA
The full thickness skin graft-based C3H/HeJ mouse model for adult onset human alopecia
areata (AA) has been extensively tested and documented for nearly 10 years. This model is
now established as the best model to study the pathophysiology and therapy of human alope-
cia areata (AA) and ultimately to define the genetic bases of AA. In partnership with the National
Alopecia Areata Foundation, a program has been developed to use this mouse model to gen-
erate graft-induced alopecia areata mice on a regular basis for testing potential new therapies
for AA. Previously documented and defined protocols provide options to rapidly screen novel
therapeutic approaches proposed by basic scientists, clinical investigators and/or pharma-
ceutical companies to this cell-mediated autoimmune disease with proven positive and neg-
ative controls. Integration with The Jackson Laboratory based basic research program pro-
vides access to the latest in biomedical technology for sophisticated analyses, not only to
evaluate effects of specific agents on hair regrowth in AA, but also to provide insights into the
basic mechanisms regulating growth and differentiation. This new AA mouse modeling pro-
gram at The Jackson Laboratory’s California site is available to members of the academic com-
munity, clinical investigators, and pharmaceutical companies to test efficacy of various agents
to treat human AA. This program will expand to include many other mouse dermatologic mod-
els developed and/or maintained by The Jackson Laboratory. Interested parties may contact
The Jackson Laboratory scientists supervising this program for details.
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A subset of presumptive human keratinocyte stem cells lack MHC class I expression
P Wu,1,2 SR Simon1,2 and M Matic1,2 1 Biochemistry and Cell Biology, SUNY at Stony Brook,
Stony Brook, NY and 2 Department of Pathology, SUNY at Stony Brook, Stony Brook, NY
We investigated the major histocompatibility complex (MHC) class I expression in human
neonatal foreskin keratinocytes. The MHC encodes a group of highly polymorphic cell sur-
face antigens that enable the immune system to distinguish normal cells from foreign, mutant,
or infected cells. MHC class I molecule is expressed in almost all nucleated somatic cells.
Recently, the lack, or low level of MHC class I molecules has been described in stem cells of
several tissues.  We isolated cells from the tissue by overnight Dispase incubation followed
by trypsin/EDTA treatment. Isolated cells were immunolabeled with antibodies against β2
microglobulin (light chain) and with antibodies against monomorphic epitope of the MHC
class I heavy chain linked to R-phycoerythrin. Antibodies to α6 integrin linked to fluorescein
isothiocyanate were used to select for basal cells. Flow cytometry was employed to analyze
the labeled cells. We have identified a subset of basal cells that lack MHC class I expression.
The percentage of MHC class I-negative cells in the basal layer ranges from 0.5% to 2%.
These cells have a relatively small size (low forward scatter) and low granularity (low side scat-
ter) characteristics attributed to stem cells. MHC class I-negative cells were identified as ker-
atinocytes as they expressed keratin 14, and formed keratinocyte colonies in vitro. MHC class
I-negative keratinocytes were sorted and examined for the expression of connexin 43 (Cx43),
a negative marker for presumptive keratinocyte stem cells. MHC class I-negative kertinoctes
did not express Cx43 and thus constitute a subset of presumptive keratinocyte stem cells.
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MicroRNAs display tissue specificity and are developmentally restricted in stratified squa-
mous epithelia and their associated appendages.
DG Ryan and RM Lavker Dermatology, Northwestern University, Chicago, IL
MicroRNAs (miRNAs) are an endogenous family of small (21-27 nt), non-coding RNAs that
act as translational repressors of mRNA in mammals. Studies have identified roles for miRNAs
in stem cell regulation, developmental timing and proliferation. To date, there is little infor-
mation on the miRNA profiles in self-renewing epithelia such as the epidermis and its
appendages. We analyzed total RNA from mouse skin, whole eyes, footpad, tongue, liver,
brain, kidney, heart and spleen by Northern blots. Specific miRNAs were selected from lists
of previously published cloning data. Epithelial miRNA-enriched fractions were analyzed with
microarrays. Specially modified oligonucleotide probes were used for in situ hybridization to
elucidate the cellular distribution of miRNAs in epithelial tissues. Microarray, Northern and
in situ hybridization data indicated tissue specificity for some miRNAs. For example, mir-203
and mir-184 were enriched in the footpad and corneal epithelia, respectively. In contrast,
mir-205 was expressed in a broad range of stratified squamous epithelia. Mir-205 was highly
expressed in the basal layer of embryonic (E17.5) epidermis, as well as in the developing fol-
licular epithelium. This basal cell expression pattern continued throughout postnatal devel-
opment. Mir-129, which also was broadly expressed in epithelial tissues, was restricted to the
more differentiated layers of the epidermis. Furthermore, this miRNA was not observed in
fetal epithelium. The contrasting expression patterns of mir-205 and -129 were also evident
in the follicular epithelium. Interestingly, mir-203 was strongly expressed in sweat glands but
was not seen in hair follicles. These findings provide new knowledge about the miRNA envi-
ronment that exists in stratified squamous epithelia and associated appendages. The patterns
of expression observed for these epithelial miRNAs suggest that they may function in regulat-
ing specific aspects of development and differentiation. Furthermore, the target mRNAs that
are predicted to be regulated by these miRNAs supports this hypothesis.
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An essential role for primary cilia signalling in hair follicle morphogenesis
JM Lehman,1 E Laag,2 EJ Michaud2 and BK Yoder1 1 Cell Biology, University of Alabama
Birmingham, Birmingham, AL and 2 Mammalian Genetics Group Life Sciences Division, Oak
Ridge National Laboratory, Oak Ridge, TN
The primary cilium is a microtubule-based sensory organelle present on most mammalian cells
and linked to a variety of pathologies from Polycystic Kidney Disease to hydrocephalus. Recent
studies in mice have shown that the primary cilium is essential for mediating sonic hedgehog
(Shh) signaling during embryonic development of dorsal-ventral patterning, left-right axis spec-
ification, and the limb. Here we demonstrate that primary cilia are present on most cell types
in the skin and hair follicle, and that primary cilia are also essential for Shh signaling during
hair follicle morphogenesis. We used a Cre-loxP strategy to selectively knock out the primary
cilia genes Tg737 and Kif3a in dermal fibroblasts and dermal papillae of mice, and compared
their hair phenotypes and cilia distribution to wild-type animals using confocal immunofloures-
cence microscopy, B-galactosidase staining, in situ hybridization, 3-D imaging, and quanti-
tative histomorphometry. In wild-type mice, cilia were present in most cells of the hair folli-
cle in an apical orientation in the developing hair bud and germ. Primary cilia were particularly
prominent in the dermal papillae and matrix cells of the adult hair follicle. In Prx1-cre Tg737flox
mice, where the Tg737 gene was deleted in dermal papillae and dermal fibroblasts of the
ventrum and limbs, most hair follicles were arrested at the hair germ stage, consistent with a
block in Shh signaling. Primary cilia were also absent on the dermal papillae and dermal fibrob-
lasts. The same results were obtained with Prx1-cre Kif3aflox mice. These results suggest an
essential role for dermal primary cilia in reception of the epidermal Shh signal during hair fol-
licle morphogenesis. Future studies will focus on knocking out cilia in other specific cell pop-
ulations of the developing follicle and exploring any possible implications of an epidermal
ciliary knockout.
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TIM-1 Fusion protein (TIM-1/Fc) inhibits hair loss in alopecia areata and augments T cell pro-
liferation and Th2 cytokines in C3H/HeJ mice
RB Moss, G Sun, JA Encinas, S Yei, SE Rieder, M Thomas and DJ Carlo Telos Pharmaceuticals
LLC, San Diego, CA
Alopecia areata (AA) is a disease characterized by patchy hair loss and thought to be medi-
ated by an autoimmune etiology. Recently, a new family of molecules called the TIMs (T cell,
immunoglobulin, mucin domains) has been described. TIM-1/Fc augments T cell responses,
including Th2 cytokines, when administered to SJL/J mice immunized with a peptide of pro-
teolipid protein. We examined the effects of TIM-1/Fc in a model of alopecia. From eighteen
C3H/HeJ mice that had developed AA, alopecic skin was grafted onto the back of unaffected
mice according to the technique previously described. TIM-1/Fc or Ig control was given IP at
the onset of alopecia. Hair loss was examined weekly and photographs taken. The extent of
hair loss was assessed quantitatively by image analysis software based on the pictures taken.
At the end of the study, lymph node cells were analyzed for in vitro lymphocyte proliferation
and cytokine production. By days 49-51 post skin grafting, the animals that had received TIM-
1/Fc had a significantly smaller area of alopecia compared to the Ig treated control group
(P<0.05). Furthermore, the TIM-1/Fc treated group had stronger Con A stimulated in vitro
lymphocyte proliferation compared to the Ig treated control group (P<0.05). In vitro produc-
tion of multiple Th2 cytokines was also augmented in the TIM-1/Fc treated group compared
to the Ig Control group. These results are the first to suggest clinical effects of TIM-1/Fc in an
alopecia areata mouse model. Furthermore, the in vitro results confirm previous findings that
TIM-1/Fc modulates T cell immunity by augmenting Th2 cytokines. Thus TIM-1/Fc may offer
a novel approach to treating alopecia areata and other Th1 mediated autoimmune diseases.
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Conditional ablation of epidermal En1 reveals a postnatal regulatory role
D Pechar,1,2 P Kraus1,2 and CA Loomis1,2 1 Pathology, New York University Medical Center,
New York, NY and 2 Dermatology, New York University Medical Center, New York, NY
Previous studies identified En1, Wnt7a, and Lmx1b as critical for specifying palmoplantar/nail
skin as distinct from follicle-bearing skin during mouse embryogenesis. In addition to these
genes regulating early skin specification, their loss-of-function phenotypes also implicated later
roles for En1 in maintaining palmoplantar identity. To assess the distinct temporal requirements
for En1, we used the Cre/LoxP system of conditional gene ablation to remove En1 at time
points subsequent to the completion of skin patterning and establishment of unique skin domains.
Mice expressing a Cre recombinase fused to a tamoxifen-inducible estrogen receptor from the
En1 locus (En1CreER) were crossed to mice carrying a conditional En1 allele flanked by LoxP sites
(En1Flox). Tamoxifen was delivered to pregnant mothers at E14.5 and E17.5 via oral gavage and
En1CreER/Flox offspring were collected at E19.5, P5.5, or P60. Tamoxifen was also administered
to mature En1CreER/Flox adults and palmoplantar skin was collected one month later for analysis.
In all cases, irrespective of the time of drug delivery or age of sample collection, we observed
a shift from epidermal- to nail-type differentiation after tamoxifen-induced En1 ablation. Within
several days, “hard” keratins were detected within clustered palmoplantar suprabasal cells, con-
comitant with a decrease in keratin 1 (K1) expression. Within a few weeks, ectopic nail out-
growths were visible grossly on palmoplantar surfaces and the pre-existing dorsal nails were
elongated compared to wild types. These studies demonstrate that En1 is required throughout
the lifespan of the mouse for maintaining palmoplantar skin as distinct from nail skin. More-
over, in contrast to the popular hypothesis that dermal mesenchyme dictates ectodermal deci-
sions during skin morphogenesis and differentiation, these results indicate that palmoplantar
ectoderm retains limited regulatory control over its own fate, even postnatally.
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∆Np63 knockdown mice: a mouse model for AEC syndrome
M Koster,1 B Marinari,2 PN Kantaputra,3 AS Payne,4 A Costanzo,2 M Karin5 and DR Roop1 1
Baylor College of Medicine, Houston, TX, 2 University of Rome “Tor Vergata”, Rome, Italy, 3
Chiang Mai University, Chiang Mai, Thailand, 4 University of Pennsylvania, Philadelphia, PA
and 5 University of California, San Diego, CA
Ectodermal dysplasias comprise a group of conditions characterized by developmental abnor-
malities that affect tissues of ectodermal origin. Dominant mutations in p63, a transcription
factor expressed as six isoforms, underlie a subset of ectodermal dysplasias, including anky-
loblepharon ectodermal dysplasia and clefting (AEC) and ectrodactyly ectodermal dysplasia
and cleft lip (EEC). While p63 mutations in EEC affect all six p63 isoforms and result in limb
malformations, mutations in AEC only affect two p63 isoforms, TAp63α and ∆Np63α, and
cause skin fragility. While TAp63α is required for initiation of epithelial stratification, the role
of ∆Np63α has remained elusive. Our finding that ∆Np63α-AEC proteins have a dominant-
negative function towards wild type ∆Np63α prompted us to determine whether impaired
∆Np63α function could contribute to AEC. To this end, we generated epidermal-specific
inducible ∆Np63 knockdown mice, which developed severe skin erosions. Interestingly,
both in AEC patients and in ∆Np63 knockdown mice, skin erosions were characterized by
hyperproliferation and delayed terminal differentiation. Furthermore, we discovered that
∆Np63α regulates terminal differentiation by directly inducing IKKα, a regulator of epider-
mal and limb morphogenesis. Consequently, IKKα expression was reduced in ∆Np63 knock-
down and AEC epidermis. Although IKKα-/- mice display limb malformations, the absence of
limb abnormalities in AEC patients could be explained by our finding that ∆Np63γ, which is
not affected by AEC mutations, is expressed during epidermal morphogenesis and can induce
IKKα. This functional compensation cannot occur in mature epidermis where ∆Np63α is the
predominant p63 isoform. In summary, our data demonstrate that impaired ∆Np63α function
causes skin erosions in AEC patients, which are unable to maintain a differentiated epidermis
in the presence of mutant ∆Np63α proteins.
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Balding scalp possesses a normal complement of follicle stem cells and gene expression
changes implicate inflammation as causative
LA Garza,1 Y Liu,1,4 JW Tobias,2 DC Stanton,3 Z Yang1 and G Cotsarelis1 1 Department of
Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 2 Penn
Bioinformatics Core, Univeristy of Pennsylvania School of Medicine, Philadelphia, PA, 3 Oral
and Maxillofacial Surgery, Univeristy of Pennsylvania School of Medicine, Philadelphia, PA
and 4 Automated Biotechnology, Merck and Company, North Wales, PA
Circulating androgens such as dihydrotestosterone are required to develop male pattern alope-
cia or androgenetic alopecia (AGA). However, little else is known about the pathogenesis of
this common condition. We tested the hypothesis that loss of hair follicle stem cells contributes
to AGA. Using flow cytometry to quantitate cells expressing the stem cell markers CYTOK-
ERATIN 15 (KRT15) or FOLLISTATIN (FST), and the basal cell marker, alpha-6 integrin, we
compared stem cell numbers in paired haired and bald samples from three subjects. We also
evaluated global gene expression changes between five additional paired samples using
microarrays. We found that stem cell numbers were similar between bald and non-bald scalp,
but within the stem cell compartment there was a relative decrease in the number of suprabasal
cells. An analysis of the 250 most significantly different expressed probe sets between haired
and bald scalp demonstrated a marked increase in organogenesis genes in the haired scalp
and increase of inflammatory genes in the bald scalp. We characterized expression patterns
of six genes previously not described in human hair follicles. These results provide novel
insights into the pathogenesis of AGA and hair biology.
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Keratin 17 regulates hair follicle cycling by modulating TNFalpha signaling in a cell-
autonomous fashion
PA Coulombe1,2 and X Tong1 1 Biological Chemistry, Johns Hopkins University School of
Medicine, Baltimore, MD and 2 Dermatology, Johns Hopkins University School of Medicine,
Baltimore, MD
Mammalian hair follicles cycle between stages of rapid growth (anagen) and metabolic quies-
cence (telogen) throughout life. Transition from anagen to telogen involves an intermediate
stage, catagen, consisting of a swift, apoptosis-driven involution of the lower half of the folli-
cle. How catagen is coordinated, and spares the progenitor cells needed for anagen re-entry,
is poorly understood. Keratin 17 (K17) null mice develop alopecia in the first week post-birth,
correlating with hair shaft fragility and untimely apoptosis in the hair bulb. Here we show that
this abnormal apoptosis reflects premature entry into catagen. Of the pro-apoptotic challenges
tested, K17 null skin keratinocytes in primary culture are selectively more sensitive to TNFal-
pha. Re-expression of K17 protects null keratinocytes against TNFalpha-induced apoptosis,
indicating that this trait is cell-autonomous. K17 interacts with TRADD, a death adaptor essen-
tial for TNFR1-dependent signal relay, suggesting a mechanism for this effect. The activity of
NF-kB, a downstream target of TNFalpha, is increased in K17 null skin. We also find that TNFal-
pha is required for a timely anagen-catagen transition in mouse pelage follicles, and that its
loss partially rescues the hair cycling defect of K17 null mice. These findings identify K17 and
TNFalpha as two novel and interdependent regulators of hair follicle cycling.
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Krox20 acts as a nodal point of diverse signalling pathways in the control of hair shaft bend-
ing
T Schlake Max-Planck Institute of Immunobiology, Freiburg, Germany
Murine hair follicle morphogenesis gives rise to four distinct pelage follicle types that pro-
duce hair shafts differing in length, the number of medulla columns, and the presence and
number of bends. Recently, Igfbp5 was identified as the first molecular marker that distin-
guishes among different hair follicle types and shown to mark zigzag hairs. Further, it was
demonstrated that Igfbp5 expression is modulated by FGF signalling. Here, we identify Krox20
as a molecular marker whose expression in the proximal follicle is restricted to zigzag hair
follicles. Gene transcription occurs in precursors and early differentiating cells of the medulla.
Spatial and temporal expression of Krox20 and Igfbp5 are tightly co-regulated in wildtype fol-
licles. This correlation also holds in transgenic mice in which Igfbp5 expression is disturbed.
Inspection of the Igfbp5 promoter reveals several putative binding sites for KROX20. In trans-
fection studies, KROX20 strongly stimulates transcription from a 1.5 kb Igfbp5 promoter frag-
ment. Site-directed mutagenesis of a cluster of three putative KROX20 binding sites signifi-
cantly reduces gene expression, supporting the notion of a direct link between KROX20 action
and Igfbp5 promoter activation. Our data implicate Krox20 as a nodal point of FGF and IGF
signalling pathways amongst others in the control of Igfbp5 expression, a central determinant
of hair shaft differentiation. Thus, we identified an essential part of the regulatory hierarchy
that gives rise to the amazing periodicity of the zigzag hair.
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Evolving the specificity of cytoskeletal remodeling by diverging the activation domains of
MIM and ABBA
J Jin, G Quinones, R Gonzalez-Quevedo, J Hui and AE Oro Program in Epithelial Biology,
Stanford University, Stanford, CA
Remodeling of the actin cytoskeleton drives cell migration invasion and proliferation, hall-
marks of skin regeneration and carcinogenesis.  A consortium of modular actin-binding, poly-
merization, and bundling proteins coordinate development and tumor invasion, but how spe-
cific spatial rearrangments occur in response to global and local patterning signals remains
poorly understood. We have previously identified the inducible actin bundling protein Miss-
ing in Metastasis (MIM), whose levels are controlled by the morphogen Sonic hedgehog. MIM
activity is regulated at the membrane by the activation domain, a region distinct from the
actin bundling domain required for activity, binding to Receptor Protein Tyrosine Phosphatase
(RPTP) delta. Here we show how these modular regulatory proteins evolve by examining the
function of ABBA, a protein that shares with MIM 95% identity in the IMD actin bundling
domain and 55% identity in the activation domain.  Both proteins alter the actin cytoskele-
ton by cross-linking individual actin filaments to form thick bundlings thus promoting cell
adhesion. The IMD domains appear interchangeable, as they readily form heterodimers. In
contrast to MIM, levels of ABBA RNA are not responsive to Shh signaling, but instead appear
to be more uniformly distributed in the tissues. Moreover, MIM and ABBA have distinct acti-
vation domains that respond to different membrane signals. MIM binds and relocalizes RPT-
Pdelta to the plasma membrane while ABBA responds to a non-RPTPdelta protein. Chimeric
protein analysis demonstrates that the MIM activation domain confers the specificity to inter-
act with and relocate RPTP delta. Our data show how small alterations in the activation domain
can confer new cytoskeletal remodeling paradigms during evolution.
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Foxq1 allelic mutations result in hair medulla abnormalities
KA Silva,1 M Hasham,1 C Potter,2 KA Giehl,3 A Awgulewitsch2 and JP Sundberg1 1 Research,
The Jackson Laboratory, Bar Harbor, ME, 2 Department of Medicine, Medical University of
South Carolina, Charleston, SC and 3 Department of Dermatology, Ludwig-Maximilian
University, Munich, Germany
The spontaneous autosomal recessive mouse satin mutation (Foxq1sa) on the C57BL/6J inbred
strain results in mice with abnormalities in the hair fiber medulla. This mutation cosegregates
with beige (Lystbg) making visualization of the defect difficult by light microscopy. A new
allelic mutation, Foxq1sa-J, arose spontaneously on the MRL/MpJ-Faslpr strain. Scanning elec-
tron microscopy and X-ray element analysis revealed the hair fibers were normal. However,
light microscopic evaluation of mounted hair fibers and transmission electron microscopy of
digested hairs revealed severe abnormalities in the medulla. We found similar changes in
FVB/N-Hoxc13 transgenic mice which in gene expression studies demonstrated dowregula-
tion of Foxq1 in the follicular medulla. DNA binding and transient co-transfection assays sug-
gested that this downregulation is due to direct interaction of Hoxc13 with cognate binding
sites located in the Foxq1 promoter region, thus implicating both genes in the same pathway
of medulla differentiation. The mutant Foxq1sa-J allele characterized here promises to be an
important addition to our set of molecular tools used for the dissection of the regulatory cir-
cuitry controlling medulla differentiation.
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North American Hair Research Society mentorship program
JG Hickman,1 M Duvic,2 AJ McMichael,3 D Elston,4 JL Roberts5 and JP Sundberg6 1
Dermatology Consultants, Lynchburg, VA, 2 M D Anderson Cancer Center, University of
Texas, Houston, TX, 3 Department of Dermatology, Wake Forest University School of
Medicine, Winston-Salem, NC, 4 Department of Dermatology, Geisinger Medical Center,
Danville, PA, 5 Northwest Dermatology and Research Center, Portland, OR and 6 The
Jackson Laboratory, Bar Harbor, ME
Grants up to $3000 each are available to scientists in training, dermatology or dermatopathology
residents, fellows, or junior faculty to enable study with an expert in hair research or clinical
hair disorders. Either the mentor or the applicant must be a member of the North American
Hair Research Society. The goal is to foster the careers of young physicians and scientists
interested in hair biology or hair disorders by acquiring additional research or clinical skills,
thereby furthering their careers as leaders in the field of hair research. The focus of the pro-
gram is on establishing mentoring relationships. In the first 3 years of the program, we have
funded 20 individual mentorships working on projects ranging from learning specific clinical
procedures to mapping mutated genes responsible for specific hair diseases. The short appli-
cations are due 31 December each year with funding beginning in mid February.
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Pragmatic guidelines for systematic skin phenotype analysis of mutant laboratory mice:
I.Pilosebaceous unit phenotyping
JP Sundberg,3 LE King1 and R Paus2 1 Vanderbilt University, Nashville, TN, 2 University of
Lubeck, Lubeck, Germany and 3 The Jackson Laboratory, Bar Harbor, ME
Pilosebacous units (hair follicle + sebaceous gland) are complicated anatomic structures gen-
erated by highly organized terminal differentiation of epithelial cells under the stringent con-
trol of inductive mesenchyme arising from prototypic neuroectodermal-mesodermal interac-
tion systems. Not surprisingly, these complex biofactories for pigmented keratin-fibers are
extremely sensitive to genetic manipulation varying from very obvious and not so obvious hair
fibers changes in mutant laboratory mice. Identifying such less obvious changes may be very
difficult. Published claims that a novel mutant mouse does or does not show any skin or hair
phenotype often turn out to be erroneous. These interpretation errors imply that uniquely instruc-
tive insights into previously unknown biological functions of the expressed gene product in
question in skin and hair follicles are often missed. Therefore, a minimal set of guidelines
needs to be developed and followed to improve the chances that a discrete, yet biologically
highly instructive phenotype is not missed. Two laboratories independently summarized and
blended the essentials of analysis of functional pilosebaceous unit morphogenesis, anatomy,
and cycling. The resultant merger of these two and well-established hair phenotype analysis-
protocols provide pragmatic, validated, systematic, yet easy-to-apply guidelines to analyze the
pilosebaceous unit phenotype of defined age groups of mice. These guidelines include advice
on how, where, and when to harvest and process skin samples for histology and immunohis-
tochemistry, essential panels of antibodies, and special histochemical stains to use, and instruc-
tive ancillary methods. Standard approaches to interpreting results using a quantitative approach
to hair follicle histomorphometry, careful distinction between hair follicle subtypes as well as
normal anatomic structures are provided at http:// eulep.anat.cam.uk/~skinbase/index.php
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Human hair follicles express the genes for two types of potassium channels, only one of which
is sensitive to the common hair growth promoter, minoxidil.
K Shorter, SM Picksley and VA Randall Biomedical Sciences, The University of Bradford,
Bradford, United Kingdom
Hair’s importance in human communication means that hair loss causes psychological dis-
tress but negatively affects life quality. Balding is poorly controlled but how a common treat-
ment, minoxidil, works is unclear. Suggestions include acting indirectly on the vasculature or
directly on the growth of hair follicle cells. Minoxidil opens some ATP-sensitive potassium
(K+ATP) channels. Drugs regulate these channels by binding to the sulfonylurea receptor com-
ponents (SUR). These exist in SUR1, SUR2A and SUR2B forms giving differing sensitivities.
Recently, we showed stimulation of deer hair growth in vitro by drugs acting on two different
receptors (Davies et al 2005). The aim of this study was to investigate if these forms are expressed
in human follicles. Human scalp skin was treated with mRNA stabilisation reagent before indi-
vidual anagen follicles were isolated by microdissection, pooled and total RNA extracted. RNA
quality was checked and poly (A+) RNA isolated. DNase treatment removed any contaminat-
ing DNA, before cDNA synthesis by reverse transcription. Reverse transcription-polymerase
chain reaction (RT-PCR) was carried out using primer sets designed to detect SUR1, SUR2A
and SUR2B and the highly expressed gene, β-actin. PCR products were separated by gel elec-
trophoresis. The β-actin gene was expressed in all samples, confirming cDNA quality.DNA
products were produced from each of 5 individuals’ follicles which correlated to SUR1 and
SUR2B. Sequencing confirmed 100% concordance with the known human sequences. SUR2A
was not detected. This indicates that human hair follicles contain two different forms of K+ATP
channels with SUR1 and SUR2B sulphonylurea receptors, like our deer studies. The SUR2B
form, previously detected in human cultured dermal papilla cells (Li et al, 2001), would per-
mit direct hair growth stimulation by minoxidil. However, the SUR1 form would not respond
to minoxidil and has not previously been reported in human follicles. These observations could
lead to new treatments for balding.
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Neural crest like stem cells in the bulge area of human hair follicle
H Yu,1 D Fang,2 SM Kumar,1 G Acs,1 L Li,2 TK Nguyen,2 M Herlyn2 and X Xu1 1 Pathology
and Lab Med, University of Pennsylvania, Philadelphia, PA and 2 The Wistar Institute,
Philadelphia, PA
Adult stem cells have been isolated from a variety of human tissues. Epithelial stem cells are
known to be present in hair follicles, which give rise to squamous and sebaceous structures;
while melanocytes stem cells give rise to melanocytes in the hair bulb. These stem cells are
located in the bulge area, a well known stem cell niche. Recently pluripotent stem cells have
been isolated from mouse hairs using bulge explants or Nestin-GFP transgenic mice. How-
ever, whether a similar pluripotent stem cell population present in human hair follicles is
unknown. Using a culture condition for human embryonic stem cells, we isolated a popula-
tion of multipotent stem cells from human hair follicles, these cells do not express epithelial
or melanocytic markers, but express neural crest and neuron stem cell markers. In additional,
these cells also express embryonic stem cell transcription factor, Oct4 and Nanog. These cells
proliferate as spheres (hair spheres) and are clonogenic. They can be differentiated into mul-
tiple lineages including osteocytes, adipocytes, chondrocytes, neurons, smooth muscle cells
and melanocytes. We showed that Oct4 positive cells are present in vivo in human hair folli-
cles and majority of the Oct4 positive cells in skin are located in the upper and mid portion
of the hair follicles, in an area that can be highlighted by cytokeratin 15 staining. In addition,
we were able to follow the growth of sphere like structures on individual hair shafts when
they were cultured in the stem cell medium. The spheres appear to emerge from the bulge area
of hair follicles. Our study indicates that there are previously unidentified multipotent adult
stem cells in human hair follicles. These cells likely represent neural crest stem cells in the
hair follicles, and they apparently retain their multipotent potential.
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Localized autosomal recessive hypotrichosis due to a deletion in the desmoglein 4 gene
exhibits extensive phenotypic variability within a Pakistani family
M Wajid,1 H Bazzi,2 J Rockey2 and AM Christiano1,2 1 Dermatology, Columbia University,
New York, NY and 2 Genetics & Development, Columbia University, New York, NY
Localized autosomal recessive hypotrichosis (LAH) is a recently described form of genetically
determined hair loss (OMIM 607903). LAH affects mainly the hair on the scalp, trunk and
extremities but not facial, axillary or pubic hair. Using linkage analysis on two Pakistani fam-
ilies, we initially identified desmoglein 4 (DSG4) as the gene whose mutation leads to the LAH
phenotype. We and others have subsequently found that the same in frame intragenic dele-
tion of exons 5-8 in DSG4 is recurrent in other families of Pakistani origin. We have also shown
that lanceolate (lah) mice and rats with hypotrichosis phenotypes harbor mutations in Dsg4.
Recently, we have identified a novel allelic missense mutation in the cadherin interaction site
of DSG4 in an Iraqi proband affected with LAH. We have also expanded the allelic series of
DSG4 mutations to include a compound heterozygous missense and splice site mutations in
a patient of Iraqi-Iranian descent who also shows monilethrix hairs. In this study, we describe
a deletion mutation in DSG4 in a large pedigree from Pakistan with extensive consanguinity,
that we believe to be the first report of a human null mutation. The mutation is a single nucleotide
deletion in exon 3 of DSG4 (87delG) that leads to a premature termination codon downstream
of the mutation. Interestingly, the affected individuals show a wide spectrum of variable clin-
ical phenotypes ranging from a complete absence of scalp hair to an abundance of abnormal
hair fibers resembling the lance tip hairs of lah mice.
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WNT/beta-catenin signaling acts upstream of EDA/EDAR/NFkappaB in hair follicle placode
development
Y Zhang,1 R Schmidt-Ullrich,2 A Glick,3 M Mikkola4 and SE Millar1 1 Department of
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Department of Cell Growth and
Differentiation, Max-Belbruck-Center for Molecular Medicine, Berlin-Buch, Germany, 3 Center
for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, State College,
PA and 4 Developmental Biology Program, Institute of Biotechnology, Helsinki, Finland
WNT/β-catenin and ectodysplasin (EDA)/EDA receptor (EDAR)/NF-κB signaling pathways are
required for early stages of primary hair follicle placode formation, but the precise interac-
tions between these pathways are not clear. Ectopic expression of the secreted WNT inhibitor
Dickkopf 1 (Dkk1) blocks localization of Edar expression to developing placodes. To deter-
mine whether Edar localization depends on WNT signaling within the epidermis or is regu-
lated indirectly via the dermis, we generated mice lacking β-catenin in the epidermis prior to
hair follicle initiation. Patterned localization of Edar was not detected in β-catenin-mutant
embryos, indicating that epidermal WNT/β-catenin signaling is required for patterned Edar
expression. These data suggest that WNT signaling lies upstream of EDA/EDAR/NF-κB signal-
ing in placode development. To test this we examined expression of an NF-κB reporter trans-
gene in control and Dkk1-expressing embryonic skin at E14.5 and E15.5. Consistent with our
hypothesis, reporter gene expression was absent from Dkk1-expressing skin, but was detected
in a patterned fashion in control littermate embryos. Eda has been implicated as a direct tar-
get of WNT signaling in the skin. To test whether Eda can rescue the effects of WNT inhibi-
tion, we made use of transgenic mice constitutively expressing Eda under the control of a K14
promoter. In K14-Eda embryos that also expressed ectopic Dkk1 in the surface ectoderm, hair
follicle placode development was not initiated, assayed by histological analysis and whole
mount in situ hybridization for the placode markers Edar, Lef1 and Wnt10b. Thus Wnt/β-catenin
signaling must activate additional target genes for establishment of hair follicle placodes.
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Unraveling the molecular mechanism regulating p63 isoform switching during skin devel-
opment
D Dai, MI Koster and DR Roop Baylor College of Medicine, Houston, TX
p63 plays an important role in epidermal development, as demonstrated by the phenotype of
p63-/- mice. Newborn mice lacking functional p63 fail to form stratified epithelia and epithe-
lial appendages. The p63 gene encodes at least six different isoforms. Alternative promoter
usage gives rise to three p63 isoforms containing an N-terminal transactivation domain (TA)
and three p63 isoforms lacking this domain (∆N). During epidermal development, TA- and
∆Np63 isoforms have a distinct temporal expression profile. TAp63 is expressed in the ecto-
derm as early as E7.5. This is required for the commitment to an epithelial stratification pro-
gram resulting in the induction of keratin 14 expression, a marker for stratified epithelia. How-
ever, ∆Np63 isoforms are not expressed until E9.5 and they are the predominant isoforms
expressed in newborn skin. It has been demonstrated that this TA- to ∆Np63 shift is required
for terminal differentiation. However, the regulatory mechanism by which TAp63 is shifted
towards ∆Np63 expression is not known. We hypothesized that TAp63 can initiate the expres-
sion of ∆Np63 and that ∆Np63 can maintain its expression. Since p63 has been shown to
transactivate gene expression by binding to degenerate p53 response elements (p53RE), we
first searched for degenerate p53RE in the ∆Np63 promoter and located a cluster of p53RE
~10kb upstream of the ∆Np63 start site (p53RE-∆N). To determine if p63 is bound to p53RE-
∆N, we performed chromatin immunoprecipitation assays on embryos at stages when ∆Np63
is first expressed. We found that p63 is bound to p53RE-∆N in surface ectoderms isolated from
E9.5 and E10.5 embryos. In addition, p63 is also bound to this region in newborn skin. We
then ectopically expressed TAp63α in HR9 cells, which do not express endogenous p63, and
found that this resulted in induction of ∆Np63α expression. Taken together, these data sug-
gest that TAp63 isoforms can regulate the ∆Np63 promoter resulting in ∆Np63 expression.
Additionally, ∆Np63 isoforms may regulate themselves to maintain high ∆Np63 expression
levels at later developmental stages and in mature epidermis.
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Increased incidence of self-reported autoimmunity and atopy in alopecia areata
N Barahmani,1 Q Zhang,2 M Hordinsky,3 V Price,4 A Christiano,5 D Norris6 and M Duvic1 1
Dermatology, MD Anderson Cancer Center, Houston, TX, 2 Epidemiology, MD Anderson
Cancer Center, Houston, TX, 3 Dermatology, University of Minnesota, Minneapolis, MN, 4
Dermatology, University of California, San Francisco, CA, 5 Dermatology, Columbia
University, New York, NY and 6 Dermatology, University of Colorado, Denver, CO
The National Alopecia Areata Registry (NAAR) funded by NIAMS in 2000 has collected epi-
demiological data from all patients and DNA samples from examined patients with Alopecia
Areata (AA), an organ-specific T-cell mediated disease with phenotypic severity. The web-
based page alopeciaareataregistry.org allows patients to register online and selected patients
are examined at five central sites.  Of the total 4676 self-reported registrants, 1059 had AU,
424 had AT, 974 had patchy AA for more than one year (AAP), 900 had patchy AA for less
than one year (AAT), and 1319 were unrelated controls or unaffected family members. The
self-reported incidence of autoimmune disorders or atopy in the 4676 registrants was Hashimo-
tos’ thyroiditis (2.6%), vitiligo (2.9%), diabetes (1.9%), and atopy (atopic dermatitis, asthma,
hayfever) (40%), respectively. There were significant differences between the AA patients ver-
sus controls composed of unrelated and unaffected relatives for Hashimotos’ thyroiditis (2.6%
versus 1.4%, p =0.009), vitiligo (2.9% versus 1.7%, p =0.019), atopy (40% versus 26%, p
<0.0001) and diabetes (1.9% versus 3.0%, p=0.006) using Chi square test. The frequency of
autoimmunity was higher in patients with AT/AU versus AAT for Hashimotos’ thyroiditis (3.0%
versus 1.2%, p =0.005), vitiligo (3.5% versus 1.8%, p =0.01), and atopy (43% versus 35%, p
<0.0001). All thyroiditis (hypothyroidism, hyperthyroidism, Graves’disease, and Hashimoto-
s’thyroiditis) was significantly increased in all AA patients versus controls (4.7% versus 2.7%,
p =0.0026) and AT/AU versus AAT patients (5.3% versus 3.2%, p =0.009). These data con-
firm a lower incidence of diabetes in AA patients, and further support the association between
alopecia areata, thyroiditis, vitiligo, and atopy, especially in patients with AT/AU.
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Molecular characterization and comparison of gene expression between epithelial pla-
codes of the mammary gland and hair follicle during skin morphogenesis
AA Sharov, TY Sharova, R Atoyan, AN Mardaryev, A Sargsyan and VA Botchkarev
Dermatology, Boston University School of Medicine, Boston, MA
Mammalian skin develops as an organ in which two embryologically different compartments
(epithelium and mesenchyme) interact with each other to give raise the formation of epider-
mis and a variety of appendages. Morphogenesis of the mammary gland (MG) and hair folli-
cle (HF) begins from the focal thickening of the epidermis (epithelial placodes) and localized
cell condensation in underlying dermis that later develop into epithelial and mesenchymal
compartments of these organs. To characterize and compare the molecular signature of the
MG and HF epithelial placodes, laser capture miscrodissection, microarray and real-time PCR
analyses were applied. MG and HF placodes, as well as inter-placode epidermis were cap-
tured using Arcturus Laser Microdissection system from cryosections of the ventral part of
murine embryos at E11.5 and E18.5, respectively. Agilent microarray analysis of gene expres-
sion validated by real-time PCR revealed that MG and HF placodes showed distinct expres-
sion profiles of adhesion/extracellular matrix molecules, structural proteins, signaling com-
ponents and transcription regulators, while expression of genes involved in the control of tissue
proteolysis was quite similar. In particular, MG placodes showed increased expression of genes
encoded adhesion molecule Ceacam11, neurofilament L, endothelin type B receptor, neu-
rotrophin receptor TrkB, gastrointestinal peptide secretin, transcription factors Dach1/2 and
Nhlh1, compared to skin epithelium. In contrast to interfollicular epidermis, HF placodes
displayed increased expression of the gap junction protein Gjb2, selected keratins (Krt2-6g
and Krt1c-29), BMP inhibitor ectodin, platelet-derived growth factor alpha and transcription
factors Krox-20 and Irx6. These data suggest that already at early stages of development epithe-
lial cells of the MGs and HFs are characterized by distinct gene expression profile which may
underlie fundamental differences in their fate and function in these ectodermal organs.
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Multi-potentiality and other properties of a new immortalized epithelial stem cell line derived
from human hair follicles
C Roh,1 Q Tao2 and S Lyle2 1 Pathology, Beth Israel Deaconess Med. Ctr., Boston, MA and 2
Cancer Biology and Pathology, University of Massachusetts Medical School, Worcester, MA
It is evident that stem cells have become a valuable tool in biomedical research, due to their
utility as an in vitro system for studying cell biology and for possible therapeutic use. How-
ever, stem cells are difficult to be maintained in culture because once they are released from
the stem cell niche, primary cells reach senescence after months in culture or passing 6-8
passages. In an effort to relieve this problem, we generated an immortalized skin stem cell
line (Tel-E6E7) derived from human hair follicle stem cells and compared them with primary
stem cells. We isolated and cultured a relatively pure population of skin stem cells from the
telogen hair follicles of human skin. We infected the stem cells with a retroviral vector con-
taining the human papillomavirus-16 E6E7 genes and passaged the cells using standard tech-
niques for normal stem cells. The immortalized cells were also compared to primary stem cells
for expression of stem cell specific proteins, stem cell properties, and their capacity for dif-
ferentiation. The Tel-E6E7 cell line was continuously cultured over 8 months and >30 passages
without senescence, consistent with a stable cell line. The cell line expresses a number of stem
cell markers including K15, beta-1 integrin, alpha-6 integrin and low CD71. The cells main-
tain other in vitro stem cell properties including rapid adhesion, slow migration, and differ-
entiation along 3 epithelial cell lineages. By infecting primary adult epithelial stem cells from
human skin with the HPV-16 E6E7 genes, we have generated a stable stem cell line that main-
tains stem cell properties in culture.
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Expression of TRPS1 and identification of potential downstream targets during murine hair
follicle morphogenesis
KA Fantauzzo,1 M Tadin-Strapps,5 E Magnusdottir,3 KL Calame4 and AM Christiano1,2 1
Genetics and Development, Columbia University, New York, NY, 2 Dermatology, Columbia
University, New York, NY, 3 Biological Sciences, Columbia University, New York, NY, 4
Microbiology, Biochemistry and Molecular Biophysics, Columbia University, New York, NY
and 5 Sirna Therapeutics Inc., Boulder, CO
Tricho-rhino-phalangeal syndrome I (TRPS1) is a vertebrate protein which contains multiple
zinc finger motifs, including a GATA-type zinc finger and two Ikaros-like zinc fingers. The
mouse homolog of TRPS1 localizes to the nucleus, where one of its functions is to act as a
sequence-specific repressor of transcriptional activation by other GATA factors. Patients with
tricho-rhino-phalangeal syndrome have sparse scalp hair and numerous craniofacial and skele-
tal abnormalities. Mice in which the GATA domain of TRPS1 has been deleted (TRPS1∆gt/∆gt)
display characteristics of human TRP syndrome and have a reduced number of pelage folli-
cles, and completely lack vibrissae follicles. We have characterized the expression of TRPS1
during hair follicle morphogenesis and postnatal hair cycling in the mouse by immunofluo-
rescence. During morphogenesis, the expression of TRPS1 changes from diffuse, spotty stain-
ing in the dorsal epidermis at embryonic day (e) 14.0 to nuclear staining in the dermal papilla
and the mesenchymal cells surrounding the hair follicle from e16.5 onwards. Postnatally, TRPS1
continues to be expressed in the dermal papilla, localizing to the nucleus during telogen and
anagen. Microarray hybridization analysis was performed comparing expression patterns in
the whisker pads of e12.5 wild-type versus TRPS1∆gt/∆gt mice. Of interest, Sox18 and Prdm1
were detected among genes downregulated in the mutant animals. Sox18 and Prdm1 have
been previously localized to the hair follicle dermis and contain 8 and 10 GATA-1 sites respec-
tively within 2kb of the transcriptional start site. Our findings suggest that these genes may be
regulated by TRPS1 in the developing hair follicle, and provide evidence for a new transcrip-
tional pathway active in the developing hair follicle dermis.
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Primary and secondary hair follicles show distinct patterns of catagen development and apop-
tosis: leads and lessons from Msx2-Noggin transgenic mice
TY Sharova, AA Sharov and VA Botchkarev Dermatology, Boston University School of
Medicine, Boston, MA
BMP signaling is involved in regulating a wide variety of programs during development and is
critically important for proper control of hair follicle (HF) development, cycling, as well as for
hair pigmentation. To explore whether BMP signaling is involved in the control of apoptosis and
catagen development, Msx2-Noggin transgenic mice, in which noggin expression is targeted to
hair matrix keratinocytes, were used as a model (Kulessa et al. EMBO J, 2000, 19, 6664). In trans-
genic mice, primary (guard or tylotrich) and secondary (non-tylotrich) HFs showed strikingly dif-
ferent patterns of catagen development, compared with wild-type mice. In secondary HFs of
Msx2-Noggin mice, catagen onset accompanied by the appearance of TUNEL+ cells was seen
prematurely at P10.5, while primary HFs remained in anagen until P16.5. To understand mech-
anisms underlying differential response of primary and secondary HFs to noggin overexpres-
sion, laser capture microdissection, microarray and real-time PCR analyses were applied. In wild-
type mice, fully developed primary HFs showed increased expression of anti-apoptotic genes
Bag-3, Bcl-6 and metalloproteinase inhibitors TIMP-2 and TIMP-4, compared to secondary HFs.
However, secondary HFs of wild-type mice showed increased expression of BMPR-IB, a num-
ber of regulatory molecules (Edar, Edarradd, Hhip, Wif-1), as well as molecules involved in apop-
tosis control (TNF-alpha, NGF, p53), compared to primary HFs. In contrast to the corresponding
HFs of wild-type mice, secondary HFs of Msx2-Noggin mice showed increased expression of
genes encoding pro-apoptotic molecules (p55 kD TNF receptor, TRAF3, APAF, p53, caspases-
7/12), as well as increased expression of markers known to control catagen development (BDNF,
TGF-beta2). These data suggest that BMP signaling is involved in the control of apoptosis-driven
hair follicle regression and that differential expression of BMPR-IB in primary and secondary HFs
may mediate their distinct sensitivity to noggin overexpression and apoptosis.
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Patterns of expression of the BMP antagonists during hair follicle morphogenesis
AN Mardaryev, AA Sharov, TY Sharova and VA Botchkarev Dermatology, Boston University
School of Medicine, Boston, MA
Bone morphogenetic protein (BMP) signaling pathway is involved in the control of cell pro-
liferation, differentiation, and apoptosis in different cell types during embryonic development
and postnatal life. At extracellular space, BMP signaling is modulated by a number of proteins
(noggin, chordin, DAN/cerberus family, sclerostin, ectodin, twisted gastrulation) that can
bind BMPs and inhibit signal transduction. The expression patterns and biological functions
of BMP antagonists in developing skin and hair follicles (HFs) remain to be elucidated. To
explore the expression of sclerostin, gremlin and DAN during murine skin development, in
situ hybridization was employed. While expression of all genes was seen in the interfollicu-
lar epithelium at E14.5-E18.5, significant differences in their expression were observed in
developing HFs. Sclerostin was highly expressed in the placodes of primary HFs at E14.5, how-
ever, its expression was decreased in the placodes of secondary HFs at E16.5. In contrast to
sclerostin, gremlin expression was seen in the placodes of primary and secondary HFs, while
DAN expression in all HF placodes was seen only at low levels. In stage 3-4 HFs, expression
of sclerostin was largely restricted to the proximal HF epithelium, high levels of gremlin expres-
sion were seen throughout the follicular epithelium, while DAN was moderately expressed in
all epithelial cells. In fully developed primary and secondary HFs, expressions of sclerostin,
gremlin and DAN were seen in the outer/inner root sheaths and differentiating hair shaft ker-
atinocytes. These data suggest that sclerostin, gremlin and DAN show distinct, yet overlap-
ping expression patterns in the developing skin and HFs. Spatiotemporal differences in expres-
sion of these BMP antagonists suggest their distinct roles in modulating the activity of BMP
ligands during skin and HF morphogenesis.
608
Molecular analysis of skin development using gene expression profiling
S Kim, MI Koster and DR Roop Baylor College of Medicine, Houston, TX
Epidermal keratinocytes derive from the single-layered surface ectoderm when the underly-
ing mesenchyme releases an inductive signal. The induced surface epithelium develops into
the basal layer of the epidermis. During skin development, basal keratinocytes differentiate
into spinous and granular layer cells, which ultimately mature into the stratum corneum. Epi-
dermal development and differentiation are multi-step processes, which involve the sequen-
tial action of many, mostly unidentified, molecular events. To identify the changes in gene
expression that occur during critical stages of mouse embryonic skin development, we initi-
ated a project utilizing gene expression profiling. RNA was extracted from two different pools
of embryos beginning at E7.5 through birth. Samples were hybridized onto mouse 430 2.0
Affymetrix chips and the data were analyzed using Genespring7.2. Scatter plots showed that
overall gene expression levels between biological replicates were similar. Furthermore, we
examined expression profiles of K14, K1, K6a, loricrin, and filaggrin in our data and found
that their expression profiles were consistent with previous reports, further validating our analy-
sis. Cluster analysis of embryonic skin from different developmental stages highlighted two
major transitions that occur during epidermal development: commitment to terminal differ-
entiation and epidermal barrier formation. When commitment to terminal differentiation occurs,
201 significant genes are induced many of which are involved in cell adhesion and Ca2+-
dependent signaling pathways. Those include desmoglein, desmocollin, calmodulin, and S100
calcium binding protein. During epidermal barrier formation, expression of 48 significant
genes is initiated and the majority of these are precursors of the cornified envelope including
small proline-rich-like proteins. In summary, we have carried out the first large-scale analysis
of gene expression throughout all stages of mouse embryonic skin development. Data result-
ing from this analysis will provide a framework to understand the molecular basis of skin devel-
opment.
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IGF-1 regulates CDK1-dependent cell cycle and survival by up-regulation of cIAP2
S Lee,1 J Lee,2 C Kim2 and J Lim1 1 Traditional Medicine and Bioscience, Daejeon University,
Daejeon, South Korea and 2 Dermatology, Chungnam National University, Daejeon, South
Korea
Insulin-like growth factor (IGF) plays an important role in a number of disease states, such as
cancer and psoriasis, through its ability to modulate cell proliferation, attachment, and migra-
tion. Insulin-like growth factor family (IGFs) is composed of somatomedin A (IGF-2),
somatomedin B and somatomedin C (IGF-1). IGF-1 is well established to stimulate prolifera-
tion and to contribute to hair follicle morphogenesis in keratinocyte. It is also known that IGF-
1 stimulates Akt/PKB in various cell types. To investigate the effect of IGF-1 on cell prolifera-
tion, we treated HaCaT cells with IGF-1 and analyzed the alterations in the expression of the
cell cycle regulatory proteins. Interestingly, CDK1 mRNA was increased in time-dependent
manner. However, other CDK mRNAs were not changed. Also, flowcytometry analyses showed
that treatment with IGF-1 induced the accumulation of HaCaT cells into the G2 phase. Thus,
IGF1-induced proliferation of HaCaT cells growth is thought to be mediated by CDK1-depend-
ent manner. We further investigated the effect of IGF-1 on the apoptosis-related genes, and
found that IGF-1 induced the expression of transcripts of cIAP2. Transient over-expression of
cIAP2 in HaCaT protected the UVB-induced apoptosis. These findings suggest that cIAP2
expression is up-regulated by IGF1, and contribute to an IGF1-dependent anti-apoptotic effect
on human keratinocytes.
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Human skin and hair follicles are targets and sources of erythropoietin
A Kromminga,1 E Bodo,2 M Laugsch,3 W Funk,4 U Duske,1 W Jelkmann3 and P Ralf2 1
Institute for Immunology, Clinical Pathology, Molecular Medicine, Hamburg, Germany, 2
Dermatology, University of Luebeck, Luebeck, Germany, 3 Department of Physiology,
University of Luebeck, Luebeck, Germany and 4 Klinik Dr. Koslowski, Munich, Germany
The glycolylated hormone erythropoietin (EPO), primarily synthesized in kidney and liver
and regulated by hypoxia, activates its specific receptor (EPO-R). However, the expression and
function of the EPO/EPO-R signaling system are not limited to the hematopoietic sytem. This
system has recently been found to be expressed in multiple non-hematopoietic tissues, e.g.
for inhibiting apoptosis. The expression of EPO/EPO-R has not yet been reported in normal
mammalian skin. To investigate the expression of EPO/EPO-R in human skin, we have stud-
ied whether normal human scalp skin expresses EPO and/or EPO-R transcripts. By real time
RT-PCR, we detected specific PCR products for both EPO (132 bp) and EPOR (315 bp) in
human scalp skin. Even stronger EPO and EPO-R transcript signals have been found in microdis-
sected human anagen VI hair bulbs. By immunohistology (EnVision-AP method), specific
EPO immunoreactivity was confined to the skin epithelium. EPO immunoreactivity was most
prominent in the central outer root sheath of anagen VI hair follicles, while epidermal and
hair matrix keratinocytes showed only a faint signal. Using ELISA we were able to detect EPO
in the culture medium. Our preliminary data suggest furthermore that this system is function-
ally active in organ-cultured human hair follicles. These data provide the first evidence that
normal human skin expresses EPO and EPO-R in situ, and suggest that hair follicles are the
predominant sources and targets of EPO/EPO-R signaling in human skin.
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Desmoglein 4 mutations and monilethrix hairs: a new twist on hair follicle differentiation
JV Schaffer,1 H Bazzi,2 A Vitebsky,2 A Witkiewicz,1 O Kovich,1 H Kamino,1 LS Shapiro,3
SJ Orlow1 and AM Christiano2,4 1 Dermatology, NYU, New York, NY, 2 Genetics &
Development, Columbia University, New York, NY, 3 Biochemistry & Molecular Biophysics,
Columbia University, New York, NY and 4 Dermatology, Columbia University, New York, NY
Localized autosomal recessive hypotrichosis (LAH) is a recently defined disorder character-
ized by fragile, short, sparse hairs on the scalp, trunk and extremities. Mutations in the
desmoglein 4 (DSG4) gene, a member of the desmosomal cadherin family that is expressed
in the hair follicle as well as the suprabasal epidermis, underlie LAH. To date, the allelic series
includes a recurrent intragenic deletion identified in Pakistani kindreds and a missense muta-
tion detected in an Iraqi family. We describe 3 siblings of Iraqi and Iranian origin with 2 novel
features of LAH: monilethrix hairs and congenital scalp erosions. The 2-year-old proband was
noted at birth to have sparse, stubbly scalp hairs, a lack of eyebrows and eyelashes and sev-
eral large, irregularly-shaped erosions on the superior scalp. An infectious cause for the ero-
sions was excluded, and they healed within a few months. Over time, hyperkeratotic follicu-
lar papules and marked pruritus accompanied the brittle, coarse scalp hair. The 6-month-old
fraternal twin boys were born with patchy scalp stubble and transient small, crusted scalp
erosions. Hair shafts exhibited periodic fusiform swellings, and scalp biopsies showed dis-
torted hair shafts and dilated “blebs” reminiscent of the lanceolate hair rodent models of
LAH. After exclusion of hair keratin genes, novel compound heterozygous DSG4 mutations
were identified in all 3 children. The maternal mutation (216+1G>T) affects the 5’ donor splice
site of intron 3 and significantly reduces splicing efficiency, while the paternal missense
mutation (P267R) disrupts a conserved calcium-binding site in the extracellular EC2-EC3 inter-
face. Perturbation of keratinocyte adhesion and differentiation due to defective DSG4 can thus
lead to neonatal skin fragility and a hair shaft abnormality identical to that resulting from the
direct hair keratin defect of monilethrix.
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Differences in expression of specific biomarkers distinguish human beard from scalp dermal
papilla cells
SE Rutberg, M Kolpak, G Tan, J Henry and D Shander The Gillette Company/P&G, Needham,
MA
Androgen exposure stimulates the growth of beard hair follicles. The follicle dermal papilla
appears to be the site of androgen action, however the molecular mechanisms that regulate
this process are not well understood. In an attempt to identify genes that contribute to the
androgen-responsive phenotype, we compared gene expression patterns in unstimulated and
androgen-treated cultured human dermal papilla cells isolated from beard (androgen-sensi-
tive) and occipital scalp (androgen-insensitive) hair follicles. Through this analysis, we iden-
tified 3 genes that are expressed at significantly higher levels in beard dermal papilla cells.
One of these genes, sFRP-2, has been identified as a dermal papilla signature gene in mouse
pelage follicles. Two of these genes, MN1 and ATP1β1 have not been studied in the hair fol-
licle. A fourth, fibulin-1D, was slightly upregulated in beard dermal papilla cells. The differ-
ences in the expression of these genes in cultured beard and scalp dermal papilla cells reflected
similar differences in micro-dissected dermal papilla isolated from intact beard and scalp fol-
licles. Our findings introduce potentially novel signaling pathways in dermal papilla cells. In
addition, this study supports that cultured dermal papilla cells provide a cell-based model
system that is reflective of the biology of in vivo hair follicle cells.
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Reduction of hair growth by PPARγ ligands thiazolidinediones
C Hwang and D Shander Gillette Company, Needham, MA
Thiazolidinediones are a novel class of anti-diabetic drugs that increase insulin sensitivity and
stimulate glucose utilization. Recent studies have reported that thiazolidinediones can improve
psorasis by inhibition of keratinocyte proliferation and reduction of inflammatory reaction.
Thiazolidinediones are the ligands for peroxisome proliferator-activated receptor gamma
(PPARγ). PPARgamma is a member of the nuclear receptor superfamily of ligand-activated
transcription factors known to play a role in adipocyte differentiation, macrophage activation
and cytokine production. Our present studies were designed to gain insight into the role of
PPARγ in hair growth and evaluate the effect of thiazolidinediones on hair growth in an ani-
mal model that shows androgen-dependent hair growth, as well as in a human hair follicle
organ culture. Thiazolidinediones were topically applied to one of the two flank organs of
each male Golden Syrian hamster. Vehicle without thiazolidinediones was applied to the con-
tralateral side. After thirteen applications, once a day, the flank organ was shaved and the
amount of hair (hair mass) recovered from each was determined. A statistically significant
reduction of hair mass was observed following thiazolidinediones treatment. The hair growth
inhibitory activity of thiazolidinediones was further verified in a human hair follicle organ cul-
ture. Hair follicles in anagen growth phase were isolated from human facial skin and exposed
to 3 ~ 60 micromolar concentration of thiazolidinediones. The length of hair follicle was
assessed by image analysis system after 7 days of culture. A statistically significant and dose-
dependent reduction of hair growth was observed. Moreover, RT-PCR analysis indicated that
PPARγ was expressed in human hair follicle. Taken together, the results of present studies sug-
gest that ligand-activated PPARγ plays an inhibitory role in hair growth and thiazolidinediones
may be developed as hair removing agents.
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A novel pattern of gene expression following anagen reinitiation in murine hair follicles
L Gu1,2 and PA Coulombe1,2 1 Biological Chemistry, Johns Hopkins University School of
Medicine, Baltimore, MD and 2 Dermatology, Johns Hopkins University School of Medicine,
Baltimore, MD
Mammalian hair follicles cycle between stages of rapid growth (anagen) and metabolic qui-
escence (telogen) throughout life. In mature follicles, transition from telogen back into ana-
gen involves the activation, proliferation, and differentiation of epithelial stem cells located
in the bulge, a specialized region of the outer root sheath. Recent microarray-based studies
of mouse skin identified keratin 6 (K6) alpha mRNA transcripts as being enriched in bulge
epithelial stem cells. Prior to this, K6alpha was known to occur in the companion layer of
hair follicles, and induced in the would-proximal epithelium following injury. We took advan-
tage of mRNA probes, antibodies and a LacZ reporter mouse model to investigate the regu-
lation of K6alpha during murine hair cycling using whole-mount staining assays. This gene is
expressed in a ring-like pattern in the innermost part of bulge throughout the hair cycle. We
find that these cells are distinct from BrdU label-retaining, slow-cycling epithelial cells, and
are highly responsive to a nearby skin injury event. In addition, a distinct set of hair epithe-
lial cells, located underneath the bulge, initiate K6alpha expression by anagen IIIc. Subse-
quently, a wave of K6alpha gene expression occurs in a bulge-to-hair bulb direction. This is
in contrast to the pattern of gene expression seen with another marker of the companion layer,
K6hf, and with inner root sheath markers, for which gene expression occurs in a bulb-to-bulge
direction, coinciding with the main axis of hair tissue formation. These findings suggest that
for the companion-layer, differentiation-related gene expression is initiated at least two sites,
bulge-proximal and bulb-proximal, and proceed in opposing directions. This novel gene expres-
sion pattern may contribute to providing a slippery plane allowing the hair shaft to move past
the surrounding tissue sheaths during anagen.
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Peroxisomes and lipid metabolism in the pathogenesis of primary cicatricial alopecia
P Karnik,2,1 M Smetanick,2,1 TS McCormick,2,1 KD Cooper1,2 and P Mirmirani2,1 1
Dermatology, University Hospitals of Cleveland, Cleveland, OH and 2 Dermatology, Case
Western Reserve University, Cleveland, OH
Primary cicatricial alopecias (CA) are a poorly understood group of disorders characterized
by the permanent destruction of hair follicles. To understand the molecular pathogenesis, we
analyzed gene expression profiles of scalp biopsies from patients with lichen planopilaris (LPP)
(n=10, pooled) and normal controls (n=10, pooled) using Affymetrix Human U133B chips. A
significant decrease (p<0.00001, FC<2.0) in expression of peroxisomal genes involved in cho-
lesterol biosynthesis and lipid metabolism (fatty acid β-oxidation and desaturation) was observed
in LPP. Indirect immunofluorescence staining of the peroxisomal membrane protein PMP-70
showed an abundant staining of peroxisomes in the sebaceous glands and in the inner (IRS)
and outer (ORS) root sheaths of the hair follicles in normal tissue. In stark contrast, there was
a complete absence of peroxisomal staining in LPP tissue. Nuclear staining with DAPI con-
firmed that the lack of PMP70 staining in LPP is due to lack of peroxisomes and not due to
the absence of sebaceous glands. Our microarray data confirmed the downregulation of per-
oxin genes PEX3, PEX16 and PMP22 that are necessary for peroxisome biogenesis. Peroxiso-
mal deficiency should cause an accumulation of unmetabolized lipids in LPP tissue. Indeed,
Nile Red staining showed large lipid droplets in the perifolliculum of LPP tissue. In contrast,
normal tissue showed no lipid droplets in the perifollicular region. Lipid analysis confirmed
a 110% increase in tri-acylglycerols and a significant increase in long chain fatty acids (linoleic
and arachidonic acids) in LPP. There was also a 50% decrease in cholesterol esters in LPP
compared to normal tissue. We propose that peroxisomes are a crucial determinant of lipid
homeostasis in the hair follicle and that increased lipid accumulation causes tissue damage
(lipotoxicity), triggers inflammation and activates a lipid-mediated programmed cell death
(lipoapoptosis) causing destruction of hair follicle stem cells and permanent hair loss in LPP.
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A genome-wide scan maps a first susceptibility locus for alopecia areata to human chromo-
some 6q23.3
J Mo,1 A Zlotogorski,2 A Martinez-Mir,1 M Duvic,9 M Hordinsky,5 D Norris,6 V Price,7
K Nanova,2 T Gilliam,8 D Londono,4 D Gordon 4 and A Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Department of Genetics and Development, Columbia
University, New York, NY, 3 Medical Center, Hadassah-Hebrew University, Jerusalem, Israel,
4 Laboratory of Statistical Genetics, Rockefeller University, New York, NY, 5 Dermatology,
University of Minnesota, Minneapolis, MN, 6 Dermatology, University of Colorado, Denver,
CO, 7 Dermatology, University of California, San Francisco, CA, 8 Human Genetics,
University of Chicago, Chicago, IL and 9 Dermatology, University of Texas, MD Anderson
Cancer Center, Houston, TX
Alopecia areata (AA) is a genetically determined chronic inflammatory disease characterized
by patchy or extensive hair loss with T-cell infiltration of hair follicles (MIM, 104000). Famil-
ial clustering of AA indicates that genetic factors may play a role in the pathogenesis of AA
and/or confer susceptibility to AA. Previous genetic association analyses suggest that a per-
missive HLA haplotype on chromosome 6p21 may potentiate the development of AA. We per-
formed genome-wide linkage study using a panel of 324 microsatellite markers on a cohort
of 177 DNA samples from 22 multiplex AA pedigrees, comprised of 78 affected and 69 unaf-
fected family members. Statistical analyses demonstrate a LOD score of 4.831 for the Affected
Sib Pair method and a MAXHLOD score of 3.554 at marker D6S1009 on chromosome 6q23.3.
Other loci on chromosomes 10, 16, 18 also showed suggestive evidence for linkage (LOD≥1.5)
to AA. In conclusion, we found significant evidence of at least one genetic determinant of AA
on chromosome 6q23.3, outside the region of the HLA gene cluster.
614
Analysis of hamster ear sebaceous gland area using immunohistochemical staining for fatty
acid synthase
EM Drummond,1 K Wade,1 T Cody2 and R Dunstan2 1 Anaderm, Pfizer, Ann Arbor, MI and 2
Worldwide Safety Sciences, Pfizer, Ann Arbor, MI
The most established method to define the effects of treatment and physiology on sebaceous
gland function is the assessment of sebaceous gland area. Current methods have low through-
put and/or are subject to error due to either lack of specificity in staining the glands or vari-
ability associated with manual measurements. We report here a method to evaluate the area
of sebaceous glands in the hamster ear model using immunohistochemical staining for fatty
acid synthase (FAS). This method has greater specificity than those currently reported, such as
trichrome staining and transillumination, and can be performed with higher throughput, mak-
ing it amenable to drug discovery screening. Differences in sebaceous gland area were defined
based on analysis of sample location (proximal and distal pinnae), reproductive status (males,
females and castrated males) and treatment with oral isotretinoin and topical flutamide. Eval-
uation was performed on samples of hamster pinnae that were formalin-fixed, paraffin-embed-
ded, and sectioned. Sections were stained with a monoclonal antibody to murine FAS, with
appropriate biotinylated secondary antibody and diaminobenzidine as the chromagen. Mea-
surement of sebaceous gland area was performed on digital images of the sections using Image-
Pro Plus 5.0 software. Proximal punch biopsy samples from males had a 46.8% greater seba-
ceous gland area than distal samples. Compared to males, females and castrated males exhibited
an 84.1% and 87.5% reduction in sebaceous gland area, respectively, with a relative stan-
dard error of approximately 10% or less. Males treated with isotretinoin had a 38.9% decrease
in sebaceous gland area and flutamide-treated males had a 19.8% decrease, compared to con-
trols. Using these methods, measurements required less than one minute per slide. In con-
clusion, anti-FAS antibody staining to define sebaceous gland area represents an improvement
over existing methods, enabling researchers to obtain reproducible measurements with min-
imal time and effort.
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CGRP inhibits human hair follicle pigmentation and growth in vitro
S Hasse,1 A Spiegelberger,1 W Funk2 and R Paus1 1 Department of Dermatology, University
Hospital, Campus Luebeck, Luebeck, Germany and 2 Klinik Dr. Koslowski, Munich, Germany
The human hair follicle is one of the most densely innervated organs of the human body, and
is subject to bioregulation by neuropeptides and neurotrophins. Previously it was shown that
substance P (SP) manipulates murine hair growth in vivo and mediates stress-induced growth
inhibitory effects on hair follicles. Since SP frequently coexists with CGRP in sensory nerves,
we have studied whether and how CGRP influences the human hair follicle. Isolated human
scalp hair follicles were cultured in the presence of CGRP (10-9 and 10-7M) or its antagonist
CGRP 8-37 (10-9 and 10-7M). After 7 days of culture, we found no significant difference in
hair shaft elongation between CGRP-, CGRP 8-37 treated and vehicle treated hair follicles.
Histological analyses of the hair follicles revealed a moderate induction of catagen by CGRP,
alongside with an inhibition of hair matrix keratinocyte proliferation (Ki67). This fits well to
our previous finding that CGRP inhibits anagen development in murine skin organ culture.
CGRP has been described to stimulate melanogenesis and melanocyte dendricity in human
epidermal melanocytes. In our study, however, we did not see this positive effect on the hair
follicle melanocytes. To the contrary, the melanin content was significantly reduced in CGRP-
treated hair follicles after 7 days as determined by quantitative Fontana-Masson histochem-
istry. Since CGRP has been described to have immuno suppressive effects in the human skin,
we are currently investigating its effect on the hair follicle immune privilege. These findings
give further insight in the stress response of the human hair follicle.
www.jidonline.org   103
ABSTRACTS
619
Development and characterization of an in vitro-assay for the study of human chemother-
apy-induced dystrophy
E Bodo,1 DJ Tobin,2 W Funk3 and R Paus1 1 Dermatology, University-Hospital Schleswig-
Holstein, Luebeck, Germany, 2 Department of Biomedical Sciences, University of Bradford,
Bradford, United Kingdom and 3 Klinik Dr. Koslowski, Munich, Germany
Chemotherapy-induced alopecia (CIA) is a common side effect and one of the major unre-
solved problems of clinical oncology. Although the molecular mechanisms of CIA are becom-
ing increasingly defined in the murine system, for which a well-established and instructive
CIA model (=CIA induction by cyclophosphamide in C57BL/6 mice) exists, they are virtually
unknown in the human system. Largely, this is due to the lack of adequate research models
for human CIA. Therefore, we have explored whether microdissected, organ-cultured bulbi of
human scalp hair follicles in anagen VI (hHF) can be exploited as such a model. Here, we
show that hHF respond by the typical morphological changes of chemotherapy-induced fol-
licle dystrophy when the cyclophosphamide metabolite, 4-hydroperoxycyclophosphamide (4-
HC), which spontaneously converts to highly toxic metabolites: melanin clumping and incon-
tinence, shrinkage of the hair matrix, premature catagen entry, downregulation of proliferation,
ectopic and massively upregulated apoptosis. These effects are dose-dependent. We are cur-
rently investigating, how major regulators of intrafollicular apoptosis (p53, Bcl-2, Fas/FasL)
are affected by 4-HC application on fibroblasts, melanocytes and epithelial cells which cell
types besides hair matrix keratinocytes respond with increased apoptosis to 4-HC adminis-
tration. This novel, pragmatic and clinically highly relevant in vitro-assay for the study of human
CIA can now be employed a) to dissect the underlying molecular controls and b) to explore
the efficacy of agents that we and others have already reported to modulate rodent CIA (e.g.
estrogens, calcitriols, glucocortidosteroids, cyclosporine A, CDK inhibitors).
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An essential role for WNT/beta-catenin signaling in fungiform taste papilla morphogenesis
F Liu,1 NM Gallant,1 A Glick2 and SE Millar1 1 Departments of Dermatology and Cell and
Developmental Biology, University of Pennsylvania, Philadelphia, PA and 2 The Pennsylvania
State University, State College, PA
Taste papillae are unique sensory compartments that develop through epithelial-mesenchy-
mal interactions and are comprised of tongue epithelium and underlying connective tissue,
and the taste bud cells and their progenitors. Fungiform papillae, the taste papillae on the ante-
rior part of the tongue, develop in a regular, patterned array. Early stages in the development
of fungiform papillae are characterized by expression of signaling molecules such as Sonic
Hedgehog (Shh), Bmp2 and Bmp4 that are also important for the morphogenesis of other
epithelial appendages. However, the molecular mechanisms involved in taste papilla forma-
tion are largely unknown. We find that WNT/beta-catenin signaling is active in fungiform
papilla placodes. In vivo expression of the secreted WNT inhibitor Dickkopf 1, or K14-Cre-
mediated deletion of beta-catenin, in the embryo surface epithelium blocks fungiform papilla
formation and prevents localized expression of Shh. These data indicate that WNT/ beta-catenin
signaling is required upstream of Shh for fungiform papilla morphogenesis. As WNT/ beta-
catenin signaling is also essential for initial stages in the development of hair follicles, mam-
mary glands and teeth, our results suggest that taste papillae develop through mechanisms
similar to those involved in the morphogenesis of other epidermal appendages.
621
The utilization of in-vitro hamster primary sebocyte model in drug discovery
B Barr, M Meade and K Wade Dermatology, Pfizer, Ann Arbor, MI
The purpose of this study was to determine if the primary hamster sebaceous gland tissue cul-
ture model, originally reported by Ito etal, could be adapted to a format that were more
amenable to drug discovery. Primary sebocytes were isolated from Syrian hamsters utilizing
the method described by Ito etal with adaptations. Adaptations include isolation of glands via
scraping with forceps rather then isolation by microdissection, removal of stratum corneum
by D-Squame sampling discs or waxing prior to isolation of the sebocytes and growing the
cells with and omission of the 3T3 feeder layer. Scraping utilizing blunt forceps or a cell scraper
results in viable sebocytes required significantly less time to isolate than the microdissection
methods and produce comparable lipids 14 days after first subculture as measured by quan-
tification of oil red staining. In addition, lipids were isolated and characterized by ELSD-
HPLC and found to contain cholesterol ester, wax ester, triglycerides, and cholesterol in ratios
previously reported in literature. The modulation of this tissue culture model was tested by
treating with 1 µM 5α-dehydrotestosterone (DHT) to increase the total amount of lipids pro-
duced. Removal of the stratum corneum increased the total cell yield as compared to waxing
the auricle as measure by MTS tetrazolium metabolism. Growing the cells in the absence of
3T3 cells did not negatively effect lipid production and reduced background noise in staining
and lipid analysis. The adaptations described represent significant improvements to increase
the throughput of this system to support drug discovery.
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Indications that normal human hair follicles have established a hypothalamic-pituitary-thy-
roid (HPT) axis
R Paus,1 E Bodo,1 U Duske,2 E Gaspar,3 W Funk,4 BE Wenzel3 and A Kromminga2 1
Dermatology, University of Luebeck, Luebeck, Germany, 2 Institute for Immunology, Clinical
Pathology, Molecular Medicine, Hamburg, Germany, 3 Cell and Immunbiological Laboratory,
Department of Med. I., University of Luebeck, Luebeck, Germany and 4 Klinik Dr. Koslowski,
Luebeck, Germany
Hair follicles are among the most thyroid hormone-sensitive tissues of mammals. Thyroid hor-
mone synthesis and release are under the control of pituitary thyroid-stimulating hormone
(TSH), for which thyroid epithelial cells express a cognate receptor (TSH-R). Pituitary TSH
release, in turn, is under control of the hypothalamic hormone, thyroid-releasing hormone
(TRH), which stimulates pituitary TRH receptors (TRH-R). Recent research has indicated that
the expression of TRH and TSH is not confined to hypothalamus and pituitary gland, and tran-
scripts for several elements of the hypothalamic-pituitary-thyroid (HPT) axis have recently been
identified e.g. in cultured human skin cells. Therefore, we wished to clarify whether normal
human scalp hair follicles express elements of the HPT axis. Total RNA extracted from microdis-
sected normal human anagen VI hair bulbs was analyzed by reverse transcription PCR. Spe-
cific PCR products with a size of 348 bp (=TSH), 264 bp (=TSH-R), 501 bp (=TRH) and 582
bp (=TRH-R) were identified, as analyzed by agarose gel electrophoresis. Total RNA from thy-
roid gland, hypothalamus and pituitary gland served as template for the positive control, and
yielded the expected results. Cryostat sections of normal human scalp skin were stained for
TSH-R. TSH-R immunreactivity was localized to several compartments of human skin and hair
follicle. While these data are currently complemented by further protein expression and func-
tional analyses, they already provide the first evidence that normal human scalp hair follicles
transcribe all key hypothalamic and pituitary elements of the HPT, and demonstrate for the
first time that normal human skin expresses the TSH and TRH-R genes in situ.
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Finger length ratios in male androgenetic alopecia: is there an in-utero effect of androgens?
P Birch and A Messenger Dermatology, Royal Hallamshire Hospital, Sheffield, United
Kingdom
The ratio between the lengths of the second and fourth finger digits (2D:4D) shows sexual
dimorphism, being lower in men than in women, and is thought to be determined by in utero
exposure to androgens. Differences in 2D:4D ratios between members of the same sex have
been linked to a variety of characteristics including reproductive success, aggressive behav-
iour, athletic prowess and sexual orientation. Differences in 2D:4D ratios have also been asso-
ciated with sexually dimorphic traits which are largely determined at puberty, including Body
Mass Index and female body shape. Male balding (androgenetic alopecia) is an androgen-
dependent trait and the aim of this study was to test whether in utero exposure to androgens
is involved in its aetiology. We measured 2D:4D ratios on both hands in 153 men, of whom
70 were non-bald (Norwood-Hamilton I or II) and 83 had vertex balding (Norwood-Hamil-
ton IIIv or greater). Mean 2D:4D ratios in non-bald men (Right Hand 0.974 SD 0.042, Left
Hand 0.970 SD 0.031) were similar to those in men with vertex balding (Right Hand 0.969
SD 0.056, Left Hand 0.969 SD 0.055). As balding is an age-related trait we also calculated
2D:4D ratios in non-bald men aged 50+ (n=35) but the values (Right Hand 0.974 SD 0.046,
Left Hand 0.969 SD 0.031) were still the same as those in balding men. These results suggest
that, unlike some other sexually dimorphic traits, in utero exposure to androgens does not play
a significant role in the subsequent development of male androgenetic alopecia.
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Gene mutation in the rough coat mice
T Cao,1,2 P Racz,1 KM Szauter,1 G Groma,1 E Pankotai,1 B Fogelgren,1 Q He1 and K Csiszar1,2
1 Cardiovascular Research Center, John A. Burns School of Medicine, University of Hawaii at
Manoa, Honolulu, HI and 2 Department of Complementary and Alternative Medicine, John
A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI
The rough coat (rc) mutation arose spontaneously in the C57BL/6J inbred mouse strain. Homozy-
gous rc mice were born indistinguishable from their normal littermates, but showed unkempt
looking coat by weaning age, and developed cyclic and progressive hair loss. The rc muta-
tion was inherited in an autosomal recessive mode, and was previously mapped to chromo-
some 9. The purpose of this study is to further characterize the skin and hair abnormalities of
the rc/rc mice and identify the gene mutation underlying such abnormalities. Scanning elec-
tron microscopy revealed that hair loss in the rc/rc mice was not due to hair shaft breakage.
However, the hair shafts from the rc/rc mice appeared much smoother than those from nor-
mal C57BL/6J mice. Histological analysis showed severe sebocyte hyperplasia in the rc/rc
mice. Additionally, more than half of the rc/rc mice over 10 months old developed sponta-
neous and persistent wounds in the skin, suggesting a defect in epidermal maintenance. Because
the multipotent keratinocyte stem cells are the source for the cyclic growth of the hair follicle
root sheaths and the proliferating, basal cells of the sebaceous glands, as well as epidermal
maintenance upon wounding, our observations suggest a possible over-commitment of hair
follicle stem cells to sebaceous differentiation in the rc/rc mice. To understand the genetic basis
of the rc phenotype development, we carried out positional cloning in backcross mice. We
identified a mapping interval for the rc locus and reduced it to 246 kb, and identified a muta-
tion in a candidate gene. We are currently analyzing the expression of this gene during skin
and hair development in normal and rc/rc mice.
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The miRNA processing enzyme Dicer is essential for normal hair follicle morphogenesis
T Andl,1 EP Murchison,2 F Liu,1 Y Zhang,1 GJ Hannon2 and SE Millar1 1 Departments of
Dermatology and Cell and Developmental Biology, University of Pennsylvania, Philadelphia,
PA and 2 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
MicroRNAs (miRNAs) are endogenous ≈22 nucleotide RNAs that can regulate gene expres-
sion by pairing to the messages of protein coding genes, resulting in mRNA cleavage or inhi-
bition of translation. Conserved vertebrate miRNAs are predicted to target more than 400
regulatory genes, suggesting broad roles in biology, and so far have been implicated in devel-
opment of the limb, brain, heart and hematopoietic system. However, their roles in the skin
have not been investigated. Pre-miRNAs are exported to the cytoplasm and cleaved to their
mature forms by the essential multi-domain enzyme Dicer. We discovered that Dicer is
expressed in embryonic mouse skin, with elevated expression in developing hair follicle epithe-
lial cells, suggesting that miRNAs might play important roles in hair follicle morphogenesis.
To test this hypothesis we generated an epidermal specific deletion of the Dicer gene. Mice
homozygous for a floxed Dicer allele and carrying a K14-Cre transgene displayed efficient
deletion of epidermal Dicer by the time of birth. Hair follicle density was lower in Dicer mutant
newborn skin than in control littermates, and the primary hair follicles were much shorter
than normal. Secondary hair follicles failed to develop, instead appearing as balls of follicle-
like cells within the epidermis. By postnatal day seven, hair follicle development had not
proceeded beyond the stage seen at birth, hair bulbs were underdeveloped, and dermal papil-
lae had disappeared from the hair follicles. Precursor cells of the hair shaft and inner root
sheath, assayed by immunofluorescence for AE13, S100A3 and GATA3, were present in mutant
primary hair follicles, but in much lower numbers than in control follicles, and normal hair
shafts did not form. However, apoptosis was not markedly elevated in mutant follicles com-
pared with controls. Our results demonstrate that Dicer is essential for hair follicle morpho-
genesis and provide the first evidence for miRNA function in the skin.
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Terminally differentiated epidermal keratinocytes can revert into functional skin epithelial
stem cells
J Mannik and S Ghazizadeh Dermatology, Columbia University, New York, NY
Epidermal stem cells are a major contributor to epidermal regeneration and therefore are the
target for cell- and gene-based therapies. However it is not clear if cells are functioning as
stem cells because of instructive signals from their microenvironment or because of their intrin-
sic characteristics. While a degree of plasticity exist between stem cells and transit amplify-
ing cells, the state of terminal differentiation is viewed as irreversible. The question then
arises as to what point a keratinocyte cease the ability to be reprogrammed and function as
a stem cell. In this study we investigated the ability of terminally differentiated mouse ker-
atinocytes to de-differentiate to stem cells and participate in long-term regeneration of epi-
dermis, hair follicle and sebaceous glands. Cultures were established from newborn mouse
keratinocytes and were grown for at least three days in medium with a calcium concentra-
tion of 1.2 mM to trigger terminal differentiation. This well characterized culture model closely
resembles terminal differentiation as it occurs in vivo including growth arrest, cytoskeletal
changes, stratification and cornification. Grafting of terminally differentiated cells combined
with trichogenic dermal fibroblasts onto the back of mice resulted in regeneration of epider-
mis and its appendages. Terminally differentiated cells were as efficient as basal keratinocytes
in regenerating a fully functional skin. Our data indicates that in a permissible environment
terminally differentiated cells can de-differentiate to stem cells and participate in long-term
epithelial regeneration.
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Downregulation of BPAG1 gene expression in zebrafish results in hemidesmosomal pathol-
ogy
H Choi,1,2 N Fujimoto1,3 and J Uitto1 1 Dermatology, Jefferson Medical College, Philadelphia,
PA, 2 Dermatology, Ewha Womans University, Seoul, South Korea and 3 Dermatology,
National Defense Medical College, Saitama, Japan
The 230-kD bullous pemphigoid antigen (BPAG1) is a hemidesmosomal protein of the cuta-
neous basement membrane zone and has a neural isoform of BPAG1, dystonin, which has an
actin binding domain close to the N-terminus. We cloned the BPAG1 gene in zebrafish (Danio
rerio) which does not have an actin binding domain. A 5’ RACE-PCR was performed with
primers designed from mRNA sequence of the dystonin gene in Danio rerio on NCBI data-
base (Gene ID: 324678). mRNA of the cloned BPAG1 gene was expressed on the zebrafish
skin. Anti-sense morpholino was injected into fertilized eggs at the 1-4 cell stage. Zebrafish
injected with anti-sense morpholino showed short blunt tail with the cobblestone surface,
but no tapering of caudal peduncle and transparent caudal fin as was noted in the controls.
Electron microscopy of epidermal cells of abnormal zebrafish revealed to have large indented
nuclei with distinct nucleoli and loosening of the intercellular desmosomal adherence. More-
over, lamina densa was diffuse and hemidesmosomes were decreased in number. This study
attest to the role of BPAG1 in hemidesmosomal pathology and illustrates the utility of zebrafish
as a model to study dermal-epidermal basement membrane biology and pathology.
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Safety and efficacy results of a clinical study of efalizumab in patients with alopecia areata
V Price,1 M Hordinsky,2 C Leonardi,3 J Roberts,4 E Olsen,5 E Rafal,6 N Korman,7 H Leung,8
M Garovoy,9 I Caro10 and D Whiting11 1 University of California, San Francisco, CA, 2
University of Minnesota, Minneapolis, MN, 3 Central Dermatology, St. Louis, MO, 4
Northwest Dermatology and Research Center, Portland, OR, 5 Duke University, Durham, NC,
6 DermResearchCenter of New York, New York, NY, 7 University Hospitals, Cleveland, OH,
8 XOMA (US) LLC, Berkeley, CA, 9 Arriva Pharmaceuticals, Alameda, CA, 10 Genentech, Inc.,
South San Francisco, CT and 11 Baylor Hair Reseach & Treatment Center, Dallas, TX
Efalizumab, a T-cell–targeted recombinant humanized monoclonal IgG1 antibody, effectively
treats the T-cell–mediated disease, psoriasis, by interfering with ICAM-1 function. Alopecia
areata (AA) is also thought to be a T-cell–mediated autoimmune disease. A Phase II double-
blind, randomized, placebo-controlled study was conducted to investigate the safety and effi-
cacy of efalizumab in patients with moderate to severe patchy AA of less than 2-years’ dura-
tion. Patients were treated once weekly with efalizumab 1 mg/kg or placebo for 12 weeks.
The double-blind treatment period was followed by a 12-week open-label treatment period
in which all patients received efalizumab. Efficacy was evaluated by estimating hair regrowth
by patient and physician assessments and global photographs, and patient global assessment
of quality of life. In addition, scalp biopsies were obtained at selected study centers for deter-
mination of changes in hair growth parameters by image analysis. Safety was assessed by the
occurrence of adverse events. The efficacy results indicate that efalizumab was not effective
in promoting hair regrowth in these patients. There were no drug-related serious adverse events,
and the overall safety results indicate that efalizumab was safe and well tolerated by these
patients. Although the mechanism of action of efalizumab in the inhibition of the T-cell–medi-
ated inflammatory response is well established in psoriasis, the results of this trial indicate
that interfering with LFA-1/ICAM-1 function alone is not sufficient to promote hair regrowth
in patients with AA.
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Vitamin D receptor co-regulator interactions
AE Teichert,1 A Arnold,2 Y Oda,1 R Guy2 and D Bikle1 1 NCIRE, San Francisco, CA and 2 St
Jude Hospital, Memphis, TN
The vitamin D receptor (VDR) regulates a diverse set of genes that control keratinocyte pro-
liferation and differentiation and hair follicle cycling, and interact with many transcriptional
co-activators such as DRIP and the SRC family via a conserved NR box and with co-repres-
sors such as NCoR and SMRT via a CoRNR box. We have shown that VDR recruits sequen-
tially the co-activators DRIP205, SRC2 and 3 during the keratinocyte differentiation process.
Among the different co-repressors characterized, hairless (Hr) has been shown to interact
with the VDR. Both VDR and Hr play a role in the hair follicle cycle, as mutations in either
result in alopecia. This phenotype is not dependent on the presence of a functional VDR lig-
and binding domain and is not observed in the absence of 1,25-dihydroxyvitamin D3
(1,25(OH)2D3) suggesting that this interaction is ligand independent. Hr is unusual in having
two NR and two CoRNR boxes, one of each being in the VDR contact site. To understand the
principles underlying VDR-co-regulator selectivity, we used an in vitro binding assay to meas-
ure the equilibrium affinity of VDR to a library of potential co-regulators in the presence or
absence of 1,25(OH)2D3. Using this method several NR boxes capable of associating with
liganded VDR at physiologically relevant concentrations were identified including ones found
in traditional co-activating proteins such as DRIP205, SRC1, 2 and 3. We also identified a lig-
and dependent binding of the second Hr NR box and a ligand independent binding of the first
Hr CoRNR box. Other co-repressors such as NCoR and SMRT also bind in a ligand inde-
pendent manner to the VDR but with a higher Kd. These data were confirmed using chro-
matin immuno-precipitation, documenting the ligand dependence of co-activators binding to
VDR and the displacement of Hr which binds VDR only in the absence of 1,25(OH)2D3. These
data suggest VDR has two co-regulator selectivities. In interaction with its ligand, VDR inter-
acts with NR boxes in co-activators DRIP205, SRC1, 2 and 3. In the absence of ligand, VDR
interacts with several co-repressor CoRNR boxes but preferentially with Hr.
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Differential expression of estrogen receptor α and β in the mouse hair cycle
AN Schmidt,1 LE King,1 JP Sundberg2 and HB Everts1 1 Vanderbilt University Medical Center,
Nashville, TN and 2 The Jackson Laboratory, Bar Harbor, ME
Estrogens (17b-estradiol, E2) profoundly modulate hair growth, acting as hair growth inhibitors
in most species. However, the localization of estrogen receptors alpha and beta (Esr1 and Esr2)
during all 17 stages of the mouse hair cycle has not yet been determined. Paus et al. described
the distribution of these two receptors during anagen VI, catagen, and telogen. Immunohisto-
chemistry was used to evaluate wax stripped C57BL/6J mouse dorsal skin biopsies collected
every three days for 33 days using commercial antibodies for expression of Esr1 and Esr2.
Esr1 expression was strongest in the dermal papilla during telogen/anagen I. Esr1 expression
was also seen in the inner root sheath (IRS) during anagen IIIa-catagen VII, with strong label-
ing seen during anagen IV and catagen III. Esr1 was expressed in the sebaceous gland during
all 17 stages except catagen VI, with increased expression seen in the basal sebocytes relative
to the differentiated sebocytes in most stages. Esr1 was also expressed in the matrix during
anagen II –catagen IV. Esr2 expression was strongest in the companion layer (CL), and was
present during all stages. During anagen IIIb – catagen VI, Esr2 expression in the companion
layer showed a gradient of increased expression from the bulbar region to the suprabulbar
region or isthmus, with the strongest expression seen at the isthmus during anagen V. In con-
clusion, these immunolocalization patterns suggest Esr1 may regulate the telogen-anagen tran-
sition as demonstrated in previous in vivo studies with topical estrogens and antiestrogens.
Esr1 may also play a pivotal role(s) in differentiation of the epithelial layers of the hair follicle
due to its expression in the IRS and matrix, as well as in regulation of sebaceous gland func-
tion throughout the hair cycle. The presence of Esr2 in the companion layer throughout the
hair cycle suggests Esr2 regulates the release of the hair shaft from the hair follicle, a finding
that could be important to our understanding of cicatricial alopecia.
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Downregulation of type XVII collagen gene expression in zebrafish - a model for cutaneous
basement membrane zone pathology
H Choi,1,2 S Kim,2 J So,3 C Kim,3 N Fujimoto,1 Q Jiang1 and J Uitto1 1 Dermatology, Jefferson
Medical College, Philadelphia, PA, 2 Dermatology, Ewha Woman’s University, Seoul, South
Korea and 3 School of Bioscience and Biotechnology, Chungnam National University,
Daejeon, South Korea
Zebrafish (Danio rerio) has provided an excellent model to study a number of developmen-
tal, physiological and pathological processes in vertebrates. In this study, we examined the
dermal-epidermal basement membrane zone with an emphasis on type XVII collagen genes.
First, transmission electron microscopy of the zebrafish skin revealed a well developed base-
ment membrane with prominent hemidesmosomes at the epidermal/dermal interface. Sec-
ondly, we cloned the Col17 genes which, together with NCBI database analysis, revealed two
different Col17 transcripts corresponding to chromosomes 1 and 13, respectively. Third, devel-
opment of morpholinos corresponding to the 5’end of the Col17 mRNAs, followed by injec-
tions into fertilized eggs at the 1-4 cell stage, resulted in developmental abnormalities and skin
pathology. Specifically, all fish injected with 1.3 ng of anti-sense morpholinos from mRNA
sequence of Col17 gene mapped on chromosome 1 showed at postfertilization days 1-5 curved,
rough tail not noted in controls injected with control morpholinos. Even more strikingly, 17%
(15/89) injected fish demonstrated tense bullae of the skin reminiscent of those seen in patients
with epidermolysis bullosa. Thus, this animal model provides a system to study the compo-
nents of the cutaneous basement membrane zone and specifically attests to the critical role
of type XVII collagen in providing integrity to the dermal-epidermal adhesion in vertebrates.
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Effect of IL-1α on cytokine and androgen receptor (AR) expression by dermal papilla cells
(DPC)
WA Boivin, H Jiang, OB Utting and DW Hunt Scientific Affairs: Dermatology, QLT, Inc.,
Vancouver, BC, Canada
We studied the effect of IL-1α and dihydrotestosterone (DHT) on AR expression and cytokine
secretion by human temporal DPC in vitro. DPC control the growth character of the hair fol-
licle through elaboration of mitogenic factors and extracellular matrix components. Further,
these cells are a primary site of androgen action in the hair follicle. IL-1α is prominent in skin
wounding and inflammatory responses although regarded as a negative hair growth regula-
tor. IL-1α reduced AR mRNA and protein expression levels for DHT-stimulated DPC. This
cytokine increased DPC supernatant keratinocyte growth factor (KGF), vascular endothelial
growth factor (VEGF), IL-8 and granulocyte-macrophage colony-stimulating factor (GM-CSF)
concentrations. VEGF and KGF have been characterized for their stimulatory roles in hair
growth while no direct action of IL-8 or GM-CSF on hair growth has been ascribed. IL-1α did
not influence DPC supernatant levels of transforming growth factor-β1, a negative hair growth
regulator. IL-1α increased DPC mRNA transcript levels for protease nexin-1 (PN-1), a secreted
serine protease inhibitor up-regulated within the dermal papilla of anagen-stage hair follicles.
In contrast, DHT did not affect PN-1 mRNA levels, supernatant concentrations of the cytokines
evaluated or modify IL-1α-induced responses. In consideration of its in vitro activity profile,
IL-1α may provide an inductive stimulus to the dermal papilla within certain physiological
contexts as well as potentially modify androgen-regulated gene expression in DPC.
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Topical application of neuroimmunophilin ligand analogs alters cutaneous innervation in
C57BL/6J mice.
S Nakib,1 M Hordinsky,1 J Steiner2 and ME Ericson1 1 Dermatology, U of MN, Minneapolis,
MN and 2 Neurology, Johns Hopkins, Baltimore, MD
We previously demonstrated that the non-immunosuppressive neuroimmunophilin ligand
analogs (NILs), GPI1046 and GPI1511 (Guilford Pharmaceuticals Inc., Baltimore, MD) as well
as the immunosuppressive NIL FK506, will induce anagen hair growth when topically applied
to the backs of C57Bl/6J mice (Ericson, J Invest Dermatol 122:A114). All three compounds are
neurotrophic. Knowing that innervation of the murine hair follicle, epidermis and dermis under-
goes hair cycle dependent changes in both architecture and composition (Botchkarev, J Comp
Neurol 386:1997), we hypothesized that topically-applied NILs would induce changes in cuta-
neous and perifollicular innervation. Dorsal skin samples from vehicle-, FK506-, GPI1046-
and GPI1511-treated mice were multi-immunostained with antibodies to PGP9.5, (pan-neu-
ronal marker), GAP43, (nerve fiber growth and neural plasticity) and CGRP (neurogenic inflam-
mation and pain). (Only anagen hairs were analyzed in this phase of the study.) Histomor-
phometric counting revealed FK506-, GPI1046-, and GPI1511-treated samples had significantly
more GAP43-immunoreactive (ir) subepidermal nerve fibers and GPI1046 treatment signifi-
cantly increased GAP43-ir perifollicular circular nerves. These results are consistent with the
increase in GAP43-ir nerves observed in the telogen to anagen II transition of the murine hair
cycle. Though we see no difference in CGRP-ir nerve fiber counts in the subepidermal nerve
plexus or in the perifollicular circular nerves of the treated samples, there was a significant
decrease in the deep dermal plexus nerves, as compared to vehicle. Interestingly, FK506
treatment elicited a significantly greater decrease of CGRP-ir nerves in the deep dermal nerve
plexus than GPI1046 and GPI1511 treatments: perhaps attributable to the immunosuppres-
sive activity of FK506. The neurotrophic activity of the non-immunosuppressive NILs, GPI1046
and GPI1511, as well as their anagen-inducing activity in the C57Bl/6J mouse model, impli-
cate these compounds as novel pharmacologic agents for manipulating hair growth.
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Smad7 overexpression in keratinocytes induces β-catenin degradation that contributes to
developmental abnormalities in hair follicles and sebaceous glands
G Han,1 A Li,1 Y Liang,2 P Owens,1 W He,1 Y Yoshimatsu,1 D Wang,1 P ten Dijke,3 X Lin2 and
X Wang1 1 Oregon Health & Science University, Portland, OR, 2 Baylor College of Medicine,
Houston, OR and 3 Leiden University Medical Center, Leiden, Netherlands
We have demonstrated that blockage of transforming growth factor beta (TGFβ)/Smad signal-
ing transduction in keratinocytes by constitutive overexpression of Smad7 results in multiple
defects in skin development. These mice however die within 10 days after birth due to a severe
defect in the digestive tract and thymus. To further assess the molecular mechanisms of Smad
signaling in skin development, the present study applied our inducible gene-switch-Smad7
mice in which Smad7 transgene expression can be induced in keratinocytes by the applica-
tion of RU486. Smad7 transgene induction in utero significantly delayed hair follicle mor-
phogenesis but accelerated sebaceous gland development. Further analysis revealed that
although Smad7 overexpression did not change the RNA levels of the gene encoding β-catenin,
it induced a reduction of β-catenin protein after acute and chronic transgene expression. The
protein levels of β-catenin were also significantly reduced in cultured Smad7 transgenic ker-
atinocytes as compared to control cells. The addition of MG132, an ubiquitin-proteasome
inhibitor, to Smad7 transgenic keratinocytes recovered β-catenin levels back to the normal
level, suggesting that Smad7 induces β-catenin degradation through the ubiquitin-proteasome
pathway. To examine whether this low level of β-catenin is sufficient to affect Wnt signaling,
we cross-bred gene-switch-Smad7 mice with a Wnt reporter mouse line, i.e., TOPGAL mice.
There was a significant reduction in β-gal staining in TOPGAL/Smad7 hair follicles in com-
parison with TOPGAL mice. Our data suggest that Smad7 overexpression not only antago-
nizes Smad signaling, but also antagonizes Wnt signaling via regulation of β-catenin degra-
dation, thereby leading to multiple defects during skin development. Therefore, this study
provides a novel mechanism by which Smad signaling interacts with Wnt signaling during skin
development.
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Hairless mutations underlie APL in four families of Pakistani origin
H Kim,1 M Wajid,2 H Lam1 and AM Christiano1,2 1 Genetics and Development, Columbia
University, New York, NY and 2 Dermatology, Columbia University, New York, NY
Atrichia with papular lesions (APL) (OMIM#209500) is rare autosomal recessive form of irre-
versible alopecia. Affected individuals present with a distinct pattern of total hair loss on the
scalp, axilla and body shortly after birth and are almost completely devoid of eyelashes and
eyebrows. This form of hair loss is irreversible and histology is consistent with an absence of
mature hair follicles. In addition to total atrichia, APL patients also present with papules and
follicular cysts filled with cornified material.  Mutations in the Hairless (HR) gene were pre-
viously found to be responsible for APL by our lab and others. Recently, we identified four
Pakistani families with clinical manifestations of APL, a high degree of consanguinity. DNA
sequencing of the HR gene in APL patients revealed a unique mutation in each family. Affected
individuals in three of the four families are homozygous for a nonsense mutation due to a C-
to-T transition at different positions in the amino acid sequence. The mutations are located at
Q323 (CAG-TAG) in exon 3, Q502 (CAG-TAG) in exon 6, and R940 (CGA-TGA) in exon 14.
The fourth family carried a missense mutation consisting of an A-to-G transition resulting in
the substitution N970S in exon 14. N970 is a conserved amino acid in the HR sequence com-
pared between from mouse, rat, human and monkey. Interestingly, this mutation has previ-
ously been reported in a South Tyrolian APL family, suggesting in may represent a recurrent
mutation, or alternatively an allele that is widely dispersed around the world.
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Analysis of Dlx3 gene expression in LacZ knock-in mice
J Hwang and MI Morasso Developmental Skin Biology Unit, NIAMS/NIH, Bethesda, MD
The Dlx homeobox proteins comprise a class of transcription factors that are crucial regula-
tors of many developmental processes and differentiation of individual tissues. Dlx3 is a mem-
ber of the Dlx vertebrate family that is comprised of 6 members (Dlx1-6). Embryonic Dlx3
expression is being examined in Dlx3-lacZ knock-in mice and shows specific temporal and
spatial expression in many structures that are derived from epithelial-mesenchymal interac-
tions: hair follicle, tooth, limb, and craniofacial development. Dlx3 rises as a potential tran-
scriptional regulator of essential genes in these structures. Anomalies in hair and teeth, as well
as other epithelial/mesenchymal derived organs, are characteristics of a large group of human
pathological conditions termed Ectodermal Dysplasias. Disruption of the human DLX3 cod-
ing sequence is linked to the autosomal dominant human disorder, Tricho-Dento-Osseus (TDO)
syndrome, that is characterized by defects in the development of hair, teeth and increased
bone density in the cranium. The role that Dlx3 plays in tooth formation is underscored by
the presence of Taurodontism and enamel hypoplasia in individuals with TDO. The compre-
hensive analysis of Dlx3 expression in hair, tooth, bone and epidermis during embryonic
development will provide insight into the function of this transcription factor in the morpho-
genesis of these structures.
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Plant extracts increase breakdown of triglycerides in normal human adipocytes
MD Hines, D Gan, L Mangos and BC Jones Skin Care Research, Mary Kay Inc., Dallas, TX
Natural materials are routinely added to skin care regimes to reduce fat accumulation. We
examined glycolic extracts derived from plants to examine their potential effects on lipolysis
in human adipocytes. Lipolysis was measured by the amount of glycerol released by human
adipocytes into the cell culture medium. The concentration of glycerol released after expo-
sure to the plant extracts was compared to diluent controls. We tested twenty natural extracts
that are routinely used in fat reducing formulations. We found four extracts that induced a
significant increase in soluble glycerol release by human adipocytes. These materials were
able to increase the breakdown of triglycerides (272-620%) compared to the negative con-
trol. Additionally, we found a separate group of extracts that were able to inhibit the differ-
entiation of preadipocytes into mature fat-producing adipocytes. However, those materials
that increased fat degradation in mature adipocytes had no effect on preadipocyte differenti-
ation. Together, these data demonstrate that some natural plant extracts may have effects on
fat production through multiple pathways.
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Scales in the zebrafish: a model for hair development
VH Nguyen,1 J He2 and MC Mullins2 1 Department of Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Cell & Developmental Biology, University of
Pennsylvania School of Medicine, Philadelphia, PA
We are undertaking a forward genetics approach in the zebrafish to isolate mutants with defects
in the development of their scales, an organ which we show to be analogous to the hair fol-
licle during the early stages of its development. We report evidence of signaling via the Wnt,
BMP (Bone Morphogenetic Protein), and Sonic Hedgehog Pathways during scale develop-
ment, similar to what has been reported in hair development. These findings gave us the impe-
tus to take advantage of forward genetics in the zebrafish in order to isolate genes which are
essential for scale development. We reason that these genes would likely be involved in hair
follicle development in mouse and human, thereby making zebrafish an invaluable comple-
ment to existing murine models. Our mutagenesis screen is an adult homozygous recessive
screen for zebrafish mutants with scale defects. Our screen represents the first large-scale adult
screen performed in the zebrafish (Dosch et al., 2004; Wagner et al., 2004). To date, we have
six mutants which exhibit scale defects. These mutants are distributed into at least four com-
plementation groups: finless (fls)), scaleless (sca), armor all (aal), and large shield (lsh). Recently,
we have identified the gene mutated in fls to be ectodysplasin receptor (EDAR). fls/EDAR
mutants make few or no scales. Humans with a genetic defect in EDAR exhibit significant
hair defects including hypotrichosis as part of a syndrome named hypohydrotic ectodermal
dysplasia (HED). In mouse, the spontaneous mutant lines named downless with genetic defects
in EDAR display no primary hair follicles. Therefore, comparisons among zebrafish, mouse,
humans with defects in EDAR establish fls/EDAR as a model for HED and add to our proposal
that these vertebrates use the same molecular signals for the development of their cutaneous
appendages.
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The transcriptional repressor Blimp-1 regulates keratinocyte terminal differentiation
E Magnusdottir,1 S Kalachikov,1 K Mizukoshi,2 A Ishida-Yamamoto,2 A Panteleyev1 and
K Calame1 1 Columbia University, New York, NY and 2 Asahikawa Medical College,
Asahikawa, Japan
Blimp-1 is a transcriptional repressor that plays critical roles in differentiated lymphocytes. In
this study we investigated the role of Blimp-1 in the epidermis. Using immunohistochemistry
we determined the expression pattern of Blimp-1 in both mouse and human skin and then
analyzed a mouse harboring an epidermis specific deletion of prdm-1, the gene encoding
Blimp-1, (Blimp-1 CKO). We found that Blimp-1 is expressed in granular layer cells of the epi-
dermis, in mature sebocytes and in inner root sheath cells of the hair follicle in both mouse
and human skin. Blimp-1 CKO mice have delayed permeability barrier formation in embryos,
neonatal epidermal hyperplasia, hyperkeratinization of epidermis and enlarged sebaceous
glands. Adult mice scratch extensively causing wounding and hair loss. Immunofluorescence
analysis of loricrin showed an increased thickness of the epidermal granular layer in both
neonates and adult mice. This result was confirmed by electron microscopy that also revealed
an accumulation of keratohyalin granules, indicating a hyper-maturation of the granular layer
cells and a delay in the transition from the granular- to the cornified layer. Genome wide gene
expression profiling revealed abnormal expression of more than 50 mRNAs in neonates lack-
ing Blimp-1, including mRNAs encoding proteins associated with the final steps of cornifica-
tion, transcription factors, enzymes in proteinase cascades, enzymes involved in lipid metab-
olism and signal transduction components. Of particular interest was the failure to express a
number of epidermis specific Late envelope protein genes (LEPs) and the overexpression of
LEPs normally restricted to internal epithelia. The transcription factor ESE-2/Elf5 had increased
expression in Blimp-1 deficient epidermis and is a potential direct target of Blimp-1 repres-
sion. Thus, we conclude that Blimp-1 is a critical regulator of terminal differentiation in the
epidermis.
638
Smad4 regulates desmoglein4 expression during hair follicle differentiation
P Owens,1 H Bazzi,2 A Li,1 AM Christiano2 and X Wang1 1 Cell & Development,
Dermatology, Otolaryngology, OHSU, Portland, OR and 2 Genetics & Development,
Columbia University, New York, NY
Smad4 is positioned at the nexus of TGFβ signaling, which has vast implications for cell fate
choices including, but not limited to, differentiation, proliferation, and quiescence. We have
previously shown that deletion of Smad4 in keratinocytes results in aberrant hair follicle dif-
ferentiation and subsequent degeneration. To further assess the molecular mechanisms of
Smad4 function in hair follicle differentiation, we performed real-time PCR on 2 day-old
postnatal skin for key components of hair follicle differentiation. Among the alterations iden-
tified, Desmoglein4 transcripts were down-regulated over 3 fold in the Smad4-deleted skin of
2 day-old neonates in comparison with wildtype littermates. Desmoglein4 exhibited a grad-
ual loss, and by day 35, all hair follicles exhibited depletion of Desmoglein4 mRNA. To assess
whether Smad4 directly regulates Desmoglein4 expression, we searched the Desmoglein 4
promoter for Smad binding elements (SBE) and found a putative SBE located 2173bp upstream
of the transcription start site. We confirmed Smad4 binding to the Desmoglein4 promoter in
vivo by performing chromatin immuno-precipitation (ChIP). Furthermore, we used a luciferase
reporter to show that binding of Smad4 to the SBE of the Desmoglein4 promoter enhanced
desmoglein4 transcription. Our data demonstrate that Desmoglein4 is a direct Smad4 target
gene. Loss of Desmoglein4 contributed, at least in part, to the abnormalities of hair follicle
differentiation and regeneration after Smad4 was ablated.
642
Molecular dissection of mesenchymal-epithelial interactions in the hair follicle
M Rendl, L Lewis and E Fuchs Mammalian Cell Biology and Development, The Rockefeller
University, New York, NY
De novo hair follicle formation in embryonic skin and new hair growth in adult skin are ini-
tiated when specialized mesenchymal dermal papilla cells send cues to multipotent epithe-
lial stem cells. Subsequently, DP cells are enveloped by epithelial stem cell progeny and
other cell types to form a niche orchestrating hair growth. Understanding the general biolog-
ical principles that govern the mesenchymal-epithelial interactions within the DP niche,
however, has been hampered so far by the lack of systematic approaches to dissect the com-
plete molecular make-up of this complex tissue. Here, we take a novel multicolor labeling
approach, using cell-type specific transgenic expression of red and green fluorescent proteins
in combination with immunolabeling of specific antigens, to isolate pure populations of DP
and four of its surrounding cell types: dermal fibroblasts, melanocytes and two different pop-
ulations of epithelial progenitors (matrix and outer root sheath cells). By defining their tran-
scriptional profiles, we develop molecular signatures characteristic for the DP and its niche.
Validating the functional importance of these signatures is a group of genes linked to hair dis-
orders but previously unexplored. Additionally, the DP signature reveals novel signaling and
transcription factors that distinguish them from other cell types. The epithelial-mesenchymal
signatures include key factors previously implicated in ectodermal-neural fate determination
as well as a myriad of regulators of BMP signaling. These findings establish a foundation for
future functional analyses of the roles of these genes in hair development.
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New onset, debilitating arthritis in psoriasis patients receiving efalizumab
WA Myers, D Najarian and AB Gottlieb Psoriasis Center of Excellence, UMDNJ-Robert Wood
Johnson Medical School, New Brunswick, NJ
Efalizumab is a humanized anti-CD11a monoclonal IgG1 antibody approved for the treatment
of moderate to severe plaque psoriasis. This case report describes two cases of new-onset debil-
itating psoriatic arthritis in patients with plaque psoriasis on long-standing efalizumab ther-
apy, despite the fact that their skin disease was in remission. Although during the clinical tri-
als involving over 2700 study subjects, arthralgia was seen only at a rate 1 to 2% higher than
in those subjects receiving placebo, the cases presented here are interesting in that it appears
that efalizumab treatment “uncoupled” the psoriatic arthritic component from the cutaneous
disease. It can be speculated that a possible mechanism for efalizumab induced psoriatic arthri-
tis is related to the blockade of regulatory T cells from joint tissue.
644
Antimycotics suppress CCL27 production in human keratinocytes by increasing prostaglandin
E2 release
N Kanda, Y Tada and S Watanabe Dermatology, Teikyo University, School of Medicine, Tokyo,
Japan
A chemokine CCL27 attracts skin-homing T cells. CCL27 production by keratinocytes is depend-
ent on nuclear factor-κB (NF-κB) activity and enhanced in lesions with atopic dermatitis.
Prostaglandin E2 (PGE2) suppresses TNF-α-induced CCL27 production in human keratinocytes.
Antimycotic agents are reported to be effective for the treatment of patients with atopic der-
matitis. We examined in vitro effects of antimycotics on TNF-α-induced CCL27 production in
human keratinocytes. Keratinocytes were incubated with TNF-α and antimycotics, ketocona-
zole, fluconazole or terbinafine hydrochloride. CCL27 secretion and mRNA level were ana-
lyzed by ELISA and RT-PCR, respectively. NF-κB activities were analyzed by luciferase assays.
Results: Ketoconazole and terbinafine hydrochloride suppressed TNF-α-induced CCL27 secre-
tion and mRNA expression and NF-κB activity in keratinocytes while fluconazole was inef-
fective. Anti-PGE2 antiserum increased TNF-α-induced CCL27 production and NF-κB activ-
ity, indicating the inhibitory activity of endogenous PGE2. In the presence of anti-PGE2,
ketoconazole and terbinafine hydrochloride did not inhibit TNF-α-induced CCL27 produc-
tion and NF-κB activity, indicating the involvement of PGE2 in the inhibitory effects. Keto-
conazole, terbinafine hydrochloride and thromboxane A2 synthase inhibitor carboxyheptyl
imidazole increased PGE2 release from keratinocytes and reduced that of thromboxane B2,
stable metabolite of thromboxane A2. Carboxyheptyl imidazole also suppressed TNF-α-induced
CCL27 production and NF-κB activity. Ketoconazole and terbinafine hydrochloride suppress
TNF-α-induced NF-κB activity and CCL27 production by increasing PGE2 release from ker-
atinocytes. These antimycotics may suppress thromboxane A2 synthesis and redirect the con-
version of common precursor PGH2 toward PGE2. These antimycotics may alleviate T cell-
mediated inflammation in atopic dermatitis via suppression of CCL27 production.
645
Psoriasis-like skin pathology in human amphiregulin transgenic mice correlates with CD44hi
CD62Llo effector memory T cell phenotype and TCR repertoire restriction
J Lu, K Squillace and M Pittelkow Department of Dermatology, Mayo Foundation, Rochester,
MN
Expression of human amphiregulin (AR) in the basal epidermis of transgenic mice has been
previously shown to induce early-onset and severe skin pathology similar to psoriasis. In this
study, we further investigate the immunophenotype and functional characterization of the
inflammatory T cell responses involved in this skin pathology. Immunofluorescence staining
of frozen sections demonstrated prominent infiltrates of both CD4 and CD8 T cells within
lesional skin from AR transgenic mice but not in normal skin samples from control mice. How-
ever, the two different T cell subsets had very distinctive histological distribution. Whereas
CD4 T cell were mostly detected in upper dermis, the majority of CD8 T cells localized to the
epidermis. In addition to cutaneous inflammatory changes, AR transgenic mice also exhibited
systemic immunological responses with significant lymphadenopathy and splenomegaly. The
number of both CD 4 and CD 8 T cells harvested from draining lymph node and spleen of AR
transgenic mice were increased more than two fold compared with those from control mice.
Moreover, AR transgenic mice had significant increase in frequency of CD44hi CD62Llo T cell
subsets from both peripheral blood and secondary lymphoid organs, indicating a distinct T
cell phenotypic shift from naïve to effector memory/effector phase. TCR BV CDR 3 spec-
trotyping suggested restricted complexity of the T cell repertoire in lesional skin but not periph-
eral blood of transgenic mice. These results demonstrate that AR transgenic mice not only
exhibit cutaneous lesions similar to psoriasis but also share similar characteristics in immune
dysfunction. These findings also suggest that psoriasis-like skin pathology in human amphireg-
ulin transgenic mice correlates with CD44hi CD62Llo effector memory T cell phenotype and
TCR repertoire restriction.
646
Effects of de-capsulation of Malassezia spp. on the pro-inflammatory cytokine production of
normal human keratinocytes
DS Thomas,1 E Ingham,1 H Meldrum2 and KT Holland1 1 Skin Research Centre, Institute for
Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom and 2 Unilever
Research and Development, Trumbull, CT
Malassezia spp. are lipophilic yeast that form an intergral part of the commensal, cutaneous
microflora of man, yet they have been strongly implicated in a number of inflammatory skin
diseases, such as seborrheic dermatitis and dandruff. The aetiology of these diseases is not
understood, but previous work has shown that Malassezia can down-regulate pro-inflamma-
tory cytokine release from peripheral blood mononuclear cells and this immunoevasion is
abrogated by removal of the lipid-rich capsule surrounding the organism. It is important to
determine whether skin cells, which may come into contact with the yeast, are also stimu-
lated by the de-capsulated cells. Consequently, both capsulated and de-capsulated M. furfur,
M. globosa, M. restricta, M. obtusa, M. slooffiae and M. sympodialis were co-cultured with nor-
mal human keratinocytes and the pro-inflammatory cytokine (IL-1α, IL-6 and TNF-α) pro-
duction was measured using enzyme-linked immunosorbent assays. The de-capsulated
Malassezia spp. (stationary phase, formaldehyde-fixed) stimulated a higher production of IL-
6, compared to capsulated Malassezia (between 2.6 and 50-fold difference). The same phe-
nomenon was observed with M. globosa and M. slooffiae on the production of IL-1α (3 and
2.3-fold difference, respectively). In addition, it was consistently found that de-capsulated M.
globosa stimulated a significantly higher production of IL-6 and IL-1α, compared to the cap-
sulated yeast cells, regardless of their stage of growth or whether they were viable or formalde-
hyde-fixed. TNF-α production by the keratinocytes was not observed. These findings suggest
a mechanism by which Malassezia spp., in particular M. globosa, may contribute to the causes
of inflammatory skin disorders, such as seborrheic dermatitis.
647
Increase CCR5 and CCR6 expression during UV therapy in psoriasis patients. Immunomod-
ulator effect of oral adjuvant administration of Polypodium leucotomos extract (PL)
E Reyes,1 P Jaen,2 L Munoz,1 E de Eusebio,2 MG Rodriguez,3 J Cuevas,4 S Gonzalez5 and
M Alvarez-Mon1,6 1 National Biotechnology Center (CNB-CSIC) Associated Unit, Medicine,
University of Alcala, Alcala de Henares, Spain, 2 Dermatology, Hospital of Guadalajara,
Guadalajara, Spain, 3 Dermatology, Hospital Principe de Asturias, Alcala de Henares, Spain,
4 Pathology, Hospital of Guadalajara, Guadalajara, Spain, 5 Dermatology, Memorial Sloan-
Kettering Cancer Center, New York, NY and 6 Immune System Diseases and Oncology,
Hospital Principe de Asturias, Alcala de Henares, Spain
Adhesion molecules, chemokines and their receptors have been implicated in T cell and mono-
cyte extravasation in psoriasis. Activation and differentiation of naïve T lymphocytes are associ-
ated to down-regulation of CXCR4 and acquisition of CCR5, increasing capacity to migrate into
inflamed tissues. PL have shown photoprotective and immunomodulatory properties preserving
skin cells against damaging effects of UV radiation. This research work was aimed to investigate
whether PL may modulate UV effects on expression of adhesion molecules and on their recep-
tors when administered as adjuvant to phototherapy on psoriatic patients. Twenty patients were
included in a double-blinded, randomized trial. Phototherapy was administered at doses of 0.05-
0.08 J/cm2 with a solar simulator (80% UVA-20% UVB)+720 mg/d of placebo (n=11) or PL (n=9)
given orally during 90 days. Analysis were performed at baseline and after 90 days. Age-matched
healthy donors were included as experimental controls. UV+placebo treatment induced a sig-
nificant enhancement in the percentages of CD11b+, CCR5+, CCR6+ T cells and CCR5+CD14+
cells. However, PL administration to UV therapy was not associated to these phenotypical changes
of PBMCs. No changes were found neither in CD11a, CD62L nor CXCR4 expression in both
groups of patients during treatment. We concluded that the UV treatment in psoriasis patients
induces proinflammatory effects on T cells and monocytes that can be partially prevented by the
adjuvant use of PL. The clinical significance of these findings remains to be investigated.
648
The effect of retinoid acid and calcipotriol on expression of human β defensin-2 and LL-37
in cultured human keratinocyte
S Cho, S Seo and C Hong Chungang Univ,, Seoul, South Korea
Human skin is able to mount a fast response against harmful injury through the rapid pro-
duction of inducible antimicrobial peptide such as the human β-defensins (hBD), cathelicidin-
family termed LL-37. Keratinocytes secrete AMPs upon stimulation with exogenous factor, such
as lipopolysaccharides, UV radiation and proinflammatory cytokines, tumor necrosis factor-
α and interleukin-1. In psoriasis patients, antimicrobial peptides tend to be expressed abun-
dantly in the epidermal layer of the skin. Retinoic acid(RA) modulates immunological and
inflammatory response and it also affects epidermal cell growth and differentiation by activa-
tion the retinoid acid receptor. Calcipotriol, vitamin D analogue, blocks proliferation and
promotes differentiation of human keratinocyte. And it acts on many cell types involved in
immunoligic reactions such as Langerhans cells, monocytes and activated lymphocytes. RA
and calcipotriol are effective and safe in the treatment of psoriasis. We investigated that hBD-
2 and LL-37 expression after exposure of human keratinocytes to the RA and calcipotriol.
Expression of hBD-2 and LL-37 was measured by reverse transcription polymerase chain reac-
tion(RT-PCR), Western blotting, and immunohistochemistry(IHC).
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Regulation of plasma cell homing from spleen to bone marrow by sphingosine 1 phosphate
K Kabashima,1,2 JG Cyster2 and Y Tokura1 1 Dermatology, University of Environmental and
Occupational Health, Kitakyushu, Fukuoka, Japan and 2 Microbiology and Immunology,
University of California, San Francisco, San Francisco, CA
Autoimmune skin diseases, such as pemphigus vulgaris, are induced by autoreactive antibody
produced by plasma cells. Plasma cells are developed from B cells usually in the germinal
center of secondary lymphoid organs like spleen and lymph nodes. Most of plasma cells die
in the secondary lymphoid organs shortly, but a fraction of plasma cells home into bone mar-
row through blood vessels to become long-lived plasma cells producing antibody for a long
period. Therefore, the control of plasma cell homing might be a good candidate to control
autoimmune skin disease. However, the underlying homing mechanism remains to be eluci-
dated. We first examined that the new immunosuppressant, FTY720, completely inhibited
plasma cell egress from spleen to blood vessels after immunization with NP-CGG and alum
using ELISPOT assay. Since FTY720 is known to inactivate the effect of sphingosine-1-phos-
phate (S1P), we examined the effect of FTY720 on plasma cell chemotaxis to S1P. Although
wild type plasma cells have good chemotactic activity to S1P by transwell assay, this activity
was completely inhibited by FTY720 pretreatment. Then we immunized Blimp-1, a marker
of plasma cell, GFP knock-in mice and found that there were two plasma cell subsets, Blimp-
1GFPhi+ and GFPint+ in the spleen, but only Blimp-1GFPint+ subset in the blood. Moreover,
this Blimp-1GFPint+ subset showed that the mRNA level of CXCR4, the ligand of which was
SDF-1 enriched in the spleen, was very low. And this Blimp-1GFPint+ subset has better chemo-
tactic activity to S1P than Blimp-1GFPhi+ subset. These data suggest that Blimp-1GFPint+
CXCR4lo+ plasma cell subset can egress from secondary lymphoid tissue into blood, and
home to bone marrow depending on the balance of responsiveness to chemoattractants made
in separate zones.
651
Alpha-melanocyte stimulating hormone treated CD8+ T cells control contact allergy and
anti-tumoral immunity
K Loser, T Brzoska, S Beissert and TA Luger Department of Dermatology, University of
Muenster, Muenster, Germany
The neuropeptide alpha-melanocyte-stimulating hormone (α-MSH) is a potent immunomod-
ulator that is able to induce immunosuppression and tolerance. In the skin α-MSH is expressed
by keratinocytes and released into the circulation. To elucidate the mechanisms underlying
α-MSH-induced immunomodulation we investigated whether α-MSH affects T cell function
since especially T cell subsets play an important role in the regulation of immune responses.
Interestingly, only CD8+ but not CD4+ T cells expressed the melanocortin receptor-1 (MC-
1R). Accordingly, in vitro stimulation with α-MSH did not affect surface marker expression or
proliferation of CD4+ T cells. However, α-MSH induced a strong suppressor activity in CD8+
cells. MC-1R-mediated signalling played an important role in the induction of the suppressor
phenotype since CD8+ T cells from MC-1R deficient mice treated with α-MSH were not sup-
pressive. To test whether α-MSH-treated CD8+ T cells were suppressive in vivo PBS- as well
as α-MSH-stimulated CD8+ T cells were injected into mice previously sensitized to the con-
tact allergen DNFB. Upon ear challenge with DNFB, mice that had been injected with α-
MSH-treated CD8+ T cells showed a reduced contact allergy suggesting that α-MSH-stimu-
lated CD8+ T cells were indeed suppressive in vivo. Real-time RT-PCR and chromium release
assays suggested that the suppressive effect of α-MSH-stimulated CD8+ T cells might be medi-
ated by increased kill activity as well as enhanced expression of cytotoxic molecules. To fur-
ther analyze the cytotoxic potency of α-MSH-treated CD8+ T cells in vivo C57BL/6 mice bear-
ing B16-melanomas were injected with either PBS or α-MSH stimulated CD8+ T cells.
Surprisingly, vaccination with α-MSH-stimulated CD8+ T cells reduced tumor growth dra-
matically compared to mice injected with PBS-treated CD8+ T cells. Together, these findings
indicate that α-MSH induced a suppressor phenotype associated with increased cytotoxic
activity in CD8+ T cells.
653
CCL17 transgenic mice show enhanced Th2-type response to both allergic and non-allergic
stimuli
Y Tsunemi,1 H Saeki,1 K Nakamura,2 D Nagakubo,3 T Nakayama,3 O Yoshie,3 S Kagami,1
K Shimazu,1 T Kadono,1 M Sugaya,1 M Komine,1 K Matsushima4 and K Tamaki1 1
Dermatology, Tokyo University, Tokyo, Japan, 2 Dermatology, Fukushima Medical University,
Fukushima, Japan, 3 Microbiology, Kinki University, Osaka, Japan and 4 Molecular Preventive
Medicine, Tokyo University, Tokyo, Japan
CC chemokine ligand (CCL)17 is implicated in the pathogenesis of atopic dermatitis (AD). To
study the effect of CCL17 produced by keratinocytes (KCs) during inflammation, we have cre-
ated the transgenic (Tg) mice where CCL17 is overexpressed in KCs. Th2-type contact hyper-
sensitivity (CHS) was enhanced and Th1-type was suppressed in Tg mice. Increased number
of CC chemokine receptor (CCR)4+ cells and mast cells infiltrated in Tg mice. IL-4 mRNA
expression was higher and that of IFN-γ was lower in Tg mice in both acute and chronic CHS.
Higher levels of serum IgE was observed in Tg mice after CHS. CCR4+ cells in PBMC were
increased in Tg mice challenged acutely on the trunk. Chronic irritation with croton oil induced
dermatitis and elevation of serum IgE in Tg mice. Tg mice showed enhanced ear swelling
after tape stripping. CCL17 was considered to modify the inflammation caused by sensitizing
reagents as well as irritant reagents by attracting CCR4+ cells into the lesional skin and mak-
ing a Th2-dominated condition. AD-like condition such as increased mast cells and elevated
levels of serum IgE were observed. Thus CCL17 may participate in the pathogenesis of skin
diseases such as AD through regulating both allergic and irritant inflammation.
652
The peripheral homeostasis of regulatory T cells is controlled by epidermal Langerhans cells
via CD254
K Loser, J Apelt, S Balkow, A Mehling, TA Luger and S Beissert Department of Dermatology,
University of Muenster, Muenster, Germany
The CD265-CD254 (RANK-RANKL) interaction has various effects on immune cells includ-
ing T cell activation and inhibition of apoptosis. CD265 is expressed on dendritic cells (DC),
whereas CD254 is found on activated T cells. Accordingly, epidermal Langerhans cells (LC)
express CD265 and CD254 is detectable in the skin upon inflammation. We have previously
shown that increased epidermal CD254 expression in Keratin-14-CD254 transgenic (tg) mice
induced 2 – 3 fold elevated numbers of CD4+CD25+ regulatory T cells. The increased num-
ber of regulatory T cells was dependent on CD254-mediated signaling since blocking this path-
way with RANK-Fc resulted in a reduction of regulatory T cells to normal levels. Since Ker-
atin-14 is also expressed on thymic epithelium we performed day 3 thymectomy followed by
thymus transplantation to test if thymic CD254 expression in tg mice was responsible for the
increased numbers of regulatory T cells. Wild type recipient mice of tg thymi developed nor-
mal numbers of CD4+CD25+ T cells but increased numbers of CD4+CD25+ T cells were pres-
ent in tg mice grafted with a wild type thymus. Interestingly, LC isolated from the epidermis
of tg mice induced significantly enhanced proliferation of CD4+CD25+ T cells compared to
LCs from wild type and showed increased expression of CD205 which has been associated
with DC-mediated induction of regulatory T cells. Furthermore, CD4+CD25- T cells cocul-
tured with CD254-stimulated bmDCs displayed enhanced expression of markers characteris-
tic for regulatory T cells. To analyze the relevance of epidermal LC to expand regulatory T
cells LC were depleted from the epidermis by topical mometason fuorate treatment. Surpris-
ingly, depletion of LC reduced the frequencies of CD4+CD25+ T cells in skin draining lymph
nodes of tg mice dramatically. Together, these data show that CD254 stimulated cutaneous
LC/DC are important for the peripheral homeostasis and expansion of CD4+CD25+ regula-
tory T cells in vivo.
650
Exogenous administration of IL-15 breaks peripheral tolerance towards low dose antigen in
experimental graft vs. host disease (GvHD)
F Miyagawa,1 BS Kim,1 HJ Patel,2 Y Tagaya,2 TA Waldmann2 and SI Katz1 1 Dermatology
Branch, National Institutes of Health, Bethesda, MD and 2 Metabolism Branch, National
Institutes of Health, Bethesda, MD
Two of the parameters that distinguish whether peripheral tolerance or immunity ensue are
self-antigen (Ag)levels and antigen presenting cell maturation. To elucidate the mechanisms
controlling the maintenance or reversal of peripheral tolerance, we established two transgenic
(Tg) mouse strains expressing different levels of ovalbumin (OVA)as a skin-associated self-Ag
using a K14 promoter. These two Tg mouse strains, K14mOVAhighand K14mOVAlowTg mice,
express high or low levels of membrane-associated OVA(mOVA), respectively. When we adop-
tively transferred OT-1CD8T cells that recognize OVA as nominal Ag into K14mOVAhighTg
mice, GvHD developed. OT-I cells in these K14mOVAhighTg mice were fully activated with
full development of effector functions. In contrast, transferred OT-1 cells did not cause GvHD
in K14mOVAlowTg mice despite their proliferation in vivo. OT-I cells in K14mOVAlowTg mice
were only partially activated without gain of effector functions. Using the K14mOVAlowTg
mouse as a model, we sought to determine factors that may contribute to reversing the periph-
eral tolerance. Among several γc-user cytokines tested, IL-15 potently facilitated the develop-
ment of GvHD in these K14mOVAlowTg mice. IL-15 induced full activation of the OT-I cells
with full development of effector functions. When OT-I cells were isolated from K14mOVAl-
owTg mice on day 5 after transfer of OT-I cells, they produced robust amounts of IFN-γ and
displayed enhanced proliferation when incubated in vitro with IL-15. Furthermore, we also
demonstrated that administration of anti-IL-2/IL-15Rβ Ab prevented GvHD in K14mOVAhighTg
mice, suggesting that endogenous IL-15 plays a role. Collectively these results suggest that cer-
tain γc-user cytokines can co-operate with suboptimal doses of Ag to trigger full T cell activa-
tion and that blocking IL-2/15 functions may be therapeutic for some types of GvHD or autoim-
munity where a breach in peripheral tolerance is suspected.
654
Ganglioside GD1a inhibits antigen presentation by Langerhans cells
RD Granstein, J Sun, J Beschloss, J Gaan, J Huang, JA Wagner and W Ding Dermatology,
Weill Medical College of Cornell University, New York, NY
Gangliosides are a class of complex lipids in plasma membranes. Some are immunosuppres-
sive and shedding of gangliosides by tumor cells may contribute to escape of malignancies from
immune control. Ganglioside GD1a (GD1a) inhibits the maturation and antigen presenting
function of human monocyte-derived dendritic cells. To examine possible ganglioside regula-
tion of cutaneous immunity, we asked whether GD1a can alter Langerhans cell (LC) antigen
presenting function. Suspensions of epidermal cells (ECs) from BALB/c mice were cultured for
24 h in graded concentrations of GD1a (0-100 µM). Then, keyhole limpet hemocyanin (KLH)
was added to a concentration of 50 µg/ml and incubation continued for an additional 24 h.
Cells were then washed 3 times and 105 ECs were co-cultured with 5 x 104 HDK-1 cells, a T
cell clone that responds to presentation of KLH by I-Ad with production of IFNγ. Supernatants
were harvested after 24 h and IFNγ content measured by ELISA. GD1a exposure dose-depend-
ently decreased antigen presentation. To ensure that the effect of GD1a was directly on LCs,
~95% pure LCs were prepared using anti-I-Ad antibodies conjugated to magnetic beads. GD1a
also inhibited presentation of KLH by purified LCs. To determine mechanisms by which GD1a
produces its effects, we used the LC-like cell line XS106, derived from neonatal A/J epidermis,
as a surrogate for LCs. We cultured XS106 cells with and without 50 µg/ml of GD1a for 24 h
followed by addition of LPS to 1 µg/ml, GM-CSF to 50 u/ml and ATPγS to 0.7 µM. After 24 h,
IL-1β content of supernatants was assessed. GD1a decreased IL-1β secretion induced by LPS/GM-
CSF/ATPγS and inhibited the upregulation of IL-1β mRNA. XS106 cells cultured for 48 h in 50
µg/ml of GD1a had decreased expression of I-Ad by FACS compared to cells cultured in medium
alone. Thus, GD1a inhibits antigen presentation by LCs, perhaps by inhibiting expression of IL-
1β and I-A. Overcoming ganglioside effects may enhance the efficiency of vaccines and agents
that act as ganglioside agonists may reduce unwanted immune responses.
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The humanized alloreactive dermatitis SCID mouse model in drug discovery
FH Igney,1 W Docke1 and TM Zollner2 1 CRBA Inflammation, Schering AG, Berlin, Germany
and 2 CRBA Inflammation, Berlex Biosciences, Richmond, CA
Inflammatory skin diseases, such as psoriasis, have a high prevalence in Western countries,
and pharmaceutical companies spend increasing amounts of money to develop drugs for these
disorders. However, their complex pathophysiology is only partially represented in classical
rodent models, and new compounds frequently fail in clinical trials. Moreover, efficacy of
agents such as antibodies against human antigens cannot be tested. Therefore, we character-
ized the humanized alloreactive dermatitis SCID mouse model and adopted it for use in drug
discovery. In this model immunodeficient SCID/Beige mice are transplanted with human skin
and injected with human peripheral blood mononuclear cells from a different donor, result-
ing in an allograft response against the human tissue. We found that the model reflects sev-
eral key aspects of T cell dependent dermatitis, as determined by quantitative analysis of
(immuno-) histological markers and cytokine levels in skin and blood. For example, in inflamed
skin T cell numbers, epidermal thickness, papillomatosis and levels of cytokines such as IL-6,
IFNg and TNFa were enhanced. The effect of immunosuppressive therapies, such as calcineurin
inhibitors, could be quantified. In this way, the model is valuable for target validation and com-
pound characterization in drug discovery.
656
Efficacious vaccination with polyarginine-containing antigen preferentially elicits Tc1 cell
activation
N Shibagaki, H Mitsui, T Inozume and S Shimada Dermatology, University of Yamanashi,
School of Medicine, Nakakoma-gun, Yamanashi, Japan
We have previously shown that polyarginine (R9)-protein transduction domain (PTD), the most
efficacious known PTD, induced more efficient protein transduction to dendritic cells (DC) in
vitro than other PTDs studied including TAT-PTD. Immunization with R9-containing antigen
(Ag)-treated DC resulted in efficient induction of Ag-specific immune responses mediated by
CD8+ and CD4+ T cells, and in a superior antitumor effects. Our recent data demonstrated
that R9-PTD-treated DC did not alter their phonotype, and that R9-PTD-protein was trans-
duced by the endocytosis in the early phase. All these results indicated that R9-PTD-mediated
Ag delivery might facilitate efficient Ag cross-presentation. The purpose of this study was to
analyze the immune responses by directly immunization with R9-PTD-containing protein Ag
in vivo. For this purpose we generated a fusion proteins comprised of the OVA protein with
(rR9-OVA) / without (rOVA) R9-PTD. Multiple immunization with rOVA (100 µg) to naive
C57BL/6 mice induced only IgG1-dominant anti-OVA Ab production (Th2). In contrast, immu-
nization with rR9-OVA induced higher OVA-specific IgG2 Ab production and SIINFEKL-spe-
cific CTL. With this setting, when (OVA-expressing) EG.7-bearing mice were vaccinated with
rOVA or rR9-OVA in vivo, tumor growth was temporally suppressed in both groups. How-
ever, co-administration with Th1-inducible adjuvant (OK432) at peri-tumor site preferentially
enhanced antitumor effects only in rR9-OVA-treated group. Our results indicated that effica-
cious vaccination with R9-PTD-containing Ag might preferentially elicits Tc1 cell activation.
Thus, this simple vaccination approach without DC could offers theoretical and practical advan-
tages to those that are in current use.
657
CD8+ IL-17 producing T cells are important in effector functions for the elicitation of con-
tact hypersensitivity
D He, L Wu, H Kim, H Li, C Elmets and H Xu Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Allergen induced contact hypersensitivity (CHS) has been considered to be primarily medi-
ated by CD8+ CTL and/or Tc1 cells. IFN-γ, the prototype Tc1 (Th1) cytokine, has been impli-
cated as the primary inflammatory cytokine for CHS. However, accumulating evidence indi-
cates that IFN-γ may not play a major role in the elicitation of CHS. Therefore, effector
mechanisms for CHS remain to be fully defined. The current studies intend to specifically
examine the role of IL-17, a pro-inflammatory cytokine, in the elicitation of CHS and to char-
acterize hapten primed T cells that produce IFN-γ and IL-17 in animal models. Results indi-
cated that neutralization of IL-17 prior to hapten challenge suppressed CHS, which was inde-
pendent of CD4+ T cells. However, neutralization of IL-17 did not have significant effects on
the proliferation of primed T cells and did not affect CHS following re-challenge of the treated
mice after three weeks rest. In contrast, neutralization of IFN-γ had little effect on the elicita-
tion of CHS. While both CD4+ and CD8+ primed T cells produced IL-17, the level in CD8+
was higher than in CD4+ T cells. Further analysis with intracellular staining of cytokines demon-
strated that distinct subpopulations of CD4+ and CD8+ T cells produced IL-17 or IFN-γ.
While the activity of CD4+ and CD8+ IL-17 producing cells was stimulated by IL-23, it was
inhibited by IL-12, a strong stimulator for IFN-γ producing Th1 or Tc1 cells. These data, for the
first time, demonstrate that IL-17 has important effector functions at the elicitation phase of
CHS and hapten primed T cells are able to produce IL-17. Moreover, hapten primed CD8+
IL-17 producing cells are distinct from IFN-γ producing Tc1 cells and are designated as T-IL-
17 by us. This CD8+ T cell subset is important in effector functions for CHS. To our knowl-
edge, identification of CD8+ T-IL-17 and its functions in immune responses were not previ-
ously reported. The studies provide insights into a novel mechanism for CHS and may lead to
new strategies for treatment of this cutaneous inflammatory disease.
658
Molecular events in human T cells treated with diesel exhaust particles or formaldehyde lead-
ing to diminished Th1 response
Y Sasaki, T Ohtani, Y Ito, M Mizuashi, S Nakagawa and S Aiba Dermatology, Tohoku
University, Sendai, Japan
A series of epidemiological studies and animal and human models have suggested that both
diesel exhausted particles (DEP) and formaldehyde (FA) have a role in triggering Th2-medi-
ated allergic responses. At first, we demonstrated that FA selectively suppressed IFN-γ and IL-
10 mRNA expression and protein production, but not those of IL-4 or IL-5, in human T cells
stimulated with anti-CD3/anti-CD28 mAb, which was identical to our previous observations
concerning the responses induced by DEP. Therefore, to explore the molecular events under-
lying the diminished IFN-γ and IL-10 production by DEP- or FA-treated T cells, we examined
their effects on mRNA expression by T cells stimulated with anti-CD3/anti-CD28 mAb using
microarrays and real-time PCR. By real-time PCR, we found that both DEP and FA significantly
suppressed mRNA expression of T-bet, Txk and c-Maf but not that of GATA-3, SOCS3, SOCS5,
or Gadd45b. The microarrays revealed significant augmentations of two FoxO3a-dependent
genes, GILZ and Gadd45a, in addition to several other oxidative stress genes, which was con-
firmed by real-time PCR. Treatment of T cells with N-acetyl cystein, which partially recovered
the IFN-γ mRNA and protein production, did not restore T-bet or Txk mRNA but suppressed
the augmentation of Gadd45a mRNA. These data suggest that both DEP and FA modulate
mRNA expression of several transcription factors that play a role in T cell stimulation or Th1/Th2
deviation. Among them, Gadd45a and/or GILZ genes in DEP- or FA-treated T cells may link
the stress response with the diminished IFN-γ and IL-10 production.
659
Serotonin activates human monocytes and prolongs their life span via the 5-HT1 receptor
F Soga, N Katoh, T Inoue and S Kishimoto Department of Dermatology, Kyoto Prefectural
University of Medicine Graduate School of Medical Science, Kyoto, Japan
It has been well established that activated platelets release a variety of mediators, which con-
tribute to allergic inflammation. However, the role of platelets in allergic inflammation of the
skin remains unclear. Serotonin (5-hydroxytryptamine, 5-HT) is one of the prototypic media-
tors that can be derived from activated platelets. Since activation of platelets often occurs in
atopic dermatitis (AD) lesions, because of excoriation due to scratching and the engagement
of FcεRI with antigens on their surface, we examined the effect of serotonin on the function
and lifespan of human monocytes that play a critical role in chronic AD. Treatment of mono-
cytes with 5-HT (10 µM) up-regulated the expression of co-stimulatory molecules, such as
CD80 and CD86, and enhanced the capacity to stimulate allogeneic CD4+ T cells. Further-
more. 5-HT induced the production of IL-6 and TNF-α in LPS-stimulated monocytes. These
finding suggest that 5-HT activates monocytes. In addition, 5-HT reduced the apoptosis induced
by serum deprivation or CD95/Fas ligation in human monocytes in a dose-dependent man-
ner. The inhibitory effects of 5-HT on monocyte apoptosis were blocked by a 5-HT1R antag-
onist, but not by 5-HT2R or 5-HT3R antagonists, and were mimicked by a 5-HT1R agonist.
5-HT also up-regulated Bcl-2 and Mcl-1, and inhibited the activation of caspase-3. 5-HT and
a 5-HT1R agonist, but not 5-HT2R or 5-HT3R agonists, induced ERK1/2 phosphorylation.
Taken together, these findings support that 5-HT activates monocytes via the 5-HT1 receptor
and inhibits apoptosis, thereby contributing to chronic inflammation.
660
The establishment of cell line, CMDC-1, a candidate for novel immunocompetent cell in mes-
enchymal origin
M Deguchi, Y Sasaki, S Nakagawa, T Fujimura and S Aiba Dermatology, Tohoku University
Graduate School of Medicine, Sendai, Miyagi, Japan
Based on our hypothesis that in vivo pathway of development of dendritic cells (DCs) may be
different from that in vitro, and that the existence of a population of DC in mesenchymal ori-
gin can be suspected, we carried out isolation and establishment of such cell line in the der-
mis. We prepared single cell suspensions from epidermal sheet of ears of BALB/c mice. They
were cultured in RPMI1640-based complete medium supplemented with 10% fetal bovine
serum (FBS) using plastic flasks. We performed the cloning by limiting dilution, and finally
established a cell line, CMDC-1. Cells from 6th to 8th passages were used in this study. Mor-
phologically, they were mononuclear cells and had relatively large cytoplasm. In addition,
they showed polydendritic contours. They proliferate vigorously in vitro, depending on FBS.
Then CMDC-1 cells were applied to commercially available DNA microarray analysis serv-
ice (KURABO, Osaka, Japan) by using CodeLink™ Bioarray (Amersham Biosciences, Tokyo,
Japan) comparing with BALB/3T3 fibroblasts. For 2386 out of 36227 analyzed genes, CMDC-
1 showed positive expression, in contrast to the insignificant signals by BALB/3T3. Among
such 2386 genes we got more than 10-fold signal ratios from 97 messages for CMDC-1. Gene
expression by this cell line included CD6, 7, 14, 19, 22, 24a, 59, 68, 80, 97, 123, 154, 163,
interleukin-4 receptor and granulocyte-macrophage colony-stimulating factor receptor α,
histocompatibility 2 and class ΙΙ antigen Aβ1, while it showed negativity for factor ΧΙΙΙa,
CD3, 33, 86. CD45 protein were negative by flowcytometry. Based on these data, we con-
clude that CMDC-1 may present a novel dermal population of immunocompetent cell in
mesenchymal origin.
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CD25+/CD4+ regulatory T cells affect the maturation of dendritic cells, resulting in a DC-
phenotype with immunosuppressive properties
K Mahnke, S Ring, V Storn, S Schallenberg and AH Enk Dept.of Dermatology, University
Hospital Heidelberg, Heidelberg, Germany
Previous results have shown that immature dendritic cells (DC) play a crucial role in the acti-
vation of regulatory T cells (Treg). Vice versa, only few reports suggest that Treg affect DC devel-
opment. Therefore we set out to investigate the effects of Treg on DC maturation, activation
and phenotype in vitro and in vivo. To determine whether Tregs interfere with DC maturation,
we cultured immature bone marrow derived DC as well as magnetic-bead separated lymph
node DC in the presence of isolated CD4+/CD25+ Treg and assessed their maturation status
by FACS and mixed lymphocyte reactions. In these assays it became evident that DC after co-
culture with Treg retained their immature status as indicated by low expression of CD80, CD86
and inferior T cell stimulatory capacity. Parallel to this downregulation of activation markers,
inhibitory molecules were upregulated. I.e., co-culture with Treg induced surface expression
of B7-H3 and induced IL-10 expression in DCs. These effects required largely cell - cell con-
tact, since supernatant of cultivated Treg did not affected DC maturation. Using MHC-class II
– HEL peptide specific antibodies (C4H3), we could show that MHC - peptide complex for-
mation by DCs was impaired after contact to Treg. This also resulted in functional conse-
quences since DCs that had been pulsed with peptide (OVA) or haptens (TNBS) were inferior
in priming mice against the respective antigens. Thus this data indicate that Treg can impair
the maturation of developing DC. In a “feedback-loop” immature DC may stimulate genera-
tion of Treg, which in turn then further affect DC maturation keeping them immature and thus
ensuring their Treg- activating properties.
663
The antitumor activity of interferon-λ against murine tumors
A Sato,1,2 M Ohtsuki,1 E Kobayashi2 and T Murakami1,2 1 Department of Dermatology, Jichi
Medical School, Tochigi, Japan and 2 Division of Organ Replacement Research, Jichi Medical
School, Tochigi, Japan
Cytokines, including the interferons (IFNs), play a critical role in modulating the innate and
adaptive immune systems. The IFN-lambdas have been discovered as the latest members of
the class II cytokine receptor family (IL-10 family and IFN family). While this new IFN, the
IFN-lambda, shares limited sequence similarity with type I IFNs, expressed by peripheral blood
mononuclear cells and dendritic cells upon infection with viruses or stimulation with
poly(I):poly(C), and has been shown to possess antiviral activity as with the case of type I IFNs.
Here in we set out to determine whether IFN-lambda possesses antitumor effect. We trans-
duced murine B16 melanoma and Colon26 cancer cells with mouse IFN-lambda cDNA. Over-
expression of IFN-lambda facilitated MHC class I expression and Fas/CD95 antigen on their
cell surface, and could induce significant caspase-3/7 activity and increased p21Waf1/Cip1
and dephosphorylated Rb (Ser780) in B16 cells in vitro. IFN-lambda expression in tumor cell
lines strikingly inhibited subcutaneous and metastatic tumor formation in vivo(C57BL6 mice),
compared with mock transfection (p<0.05). Moreover, IFN-lambda expression induced lym-
phocytic infiltrates, and the antibody-mediated immune cell depletion assay showed that
natural killer (NK) cells were critical to IFN-lambda-mediated tumor growth inhibition. Hydro-
dynamic injection of IFN-lambda cDNA successfully targeted liver metastatic foci of Colon26
cells in BALB/c mice, and moderately decreased the mortality of mice with tumors(p<0.05).
IFN-lambda over-expression in the liver increased NK/NKT cells and enhanced their tumor
killing activity, and suggested the activation of innate immune responses. Thus, IFN-lambda
induced both tumor apoptosis and NK cell-mediated immunological tumor destruction through
innate immune responses. These findings suggested that local delivery of IFN-lambda might
prove a useful adjunctive strategy in the clinical treatment of human malignancies.
665
CTCL patients exhibit elevated levels of regulatory T-cells that correspond with disease sever-
ity and response to therapy
S Kwon, L Geskin, T Patton, S McCann, K Paley and LD Falo, Jr. Dept of Dermatology,
University of Pittsburgh-School of Medicine, Pittsburgh, PA
Regulatory T-cells (Tregs) have been implicated in the progression of cancer and in resistance
to immunotherapies. We sought to evaluate and compare Treg populations in CTCL patients
and in healthy volunteers. Patients with advanced disease (stages IIB-IVA) were enrolled in the
study under IRB guidelines. Patients were subdivided into 3 groups: responders to current ther-
apy (no evidence of disease or minimal clinical disease); non-responders without peripheral
blood involvement (progressive or active skin disease); and active disease with peripheral blood
involvement (Sezary Syndrome, SzS). Using multicolor flow cytometry, Tregs were defined as
the CD4+CD25+FoxP3+ population. In patients without evidence of disease or with minimal
disease at the time of evaluation, Treg levels were comparable to those of healthy volunteers.
Patients with progressive skin disease had markedly elevated levels of cells with a Treg phe-
notype (mean 13.5%, compared to 3% healthy volunteers). Patients with profound leukemic
involvement, demonstrated intermediate levels of Treg cells (mean 9%). In all but one SzS patient
(N=8) T-regs resided within nonmalignant population (malignant clone defined by TCR-Vbeta
expression). Interestingly, in one patient, the malignant population included a significant por-
tion of CD4+CD25+FoxP3+ cells (60% of the tumor population), suggesting that a subset of
tumor cells expressed a Treg phenotype. In conclusion, we demonstrate that the percentage of
T-regs is significantly higher in CTCL patients when compared to normal volunteers regardless
of the stage of their disease. Patients with progressive and active disease have the highest lev-
els of T-regs as compared to normal volunteers. In SzS patients the overall numbers of T-regs
may appear lower due to tumor expansion, but are high relative to the population of non-malig-
nant T-cells. Further studies are warranted to evaluate Tregs in CTCL patients, including evalu-
ation of Treg elimination regimens in combination with immunotherapeutic approaches.
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A role for regulatory T cells in cutaneous T cell lymphoma; Induction of a CD4+CD25+Foxp3+
T cell phenotype associated with HTLV-1 infection
PT Walsh, BM Benoit, M Wysocka, NM Dalton, LA Turka and AH Rook Dermatology,
University of Pennsylvania, Philadelphia, PA
Cutaneous T-cell lymphomas (CTCL) consist of a group of clonal, T-cell proliferative disorders
of skin-trafficking lymphocytes which include mycosis fungoides, Sezary syndrome (SS) and
adult T-cell leukemia/lymphoma (ATL). Similarities between these disorders typically include
a proliferation of CD4+ T-cells and a high frequency of infections. In the vast majority of cases
of ATL and in many cases of SS, the malignant population of CD4+ T-cells also expresses CD25,
which is the phenotype expressed by a major population of regulatory T cells (Treg) known to
suppress in vivo immune responses. Because ATL is associated with infection by HTLV-1, we
studied the role of this retrovirus in the induction of a Treg phenotype. Among 15 patients pre-
senting with SS clinically, 3 were HTLV-1 sero and PCR positive. All three exhibited high lev-
els of expression in their PBMC of the Foxp3 transcription factor typical of Treg cells. 3 of 12
of the HTLV-1 negative patients also had high levels of Foxp3 expression in their PBMC. Eight
weeks after HTLV-1 infection of CD4+/CD25-/Foxp3- FACS purified normal volunteer T-cells,
these cells expressed high levels of CD25 and Foxp3 compared to uninfected cells. Further-
more, the HTLV-1 infected cells secreted significantly higher levels of the immunosuppressive
cytokine TGF-beta compared to uninfected cells. Interestingly, the PBMC isolated directly from
the ATL patients as well as from the high Foxp3 expressing but HTLV-1 negative SS patients
also secreted high levels of TGF-beta. These data indicate the acquisition of a regulatory T cell
phenotype and provide a potential mechanism to explain the broad immunosuppression
observed in ATL patients. Similarly, the finding of enhanced Foxp3 expression and TGF-beta
secretion among some patients with HTLV-1 negative SS also suggests an underlying basis for
depressed cellular immunity among this group of patients.
662
Cytokine-dependent regulation of Langerhans cell behaviors in living animals
A Nishibu,1 BR Ward,1 HL Ploegh,2 M Boes3 and A Takashima1 1 Dermatology, UT
Southwestern, Dallas, TX, 2 MIT, Cambridge, MA and 3 Harvard, Boston, MA
In an attempt to understand the behavioral biology of Langerhans cells (LCs), we recently devel-
oped an intravital confocal imaging system. Briefly, we recorded 3D confocal images of EGFP+
epidermal LCs every 2 min in anesthetized I-Aβ-EGFP knock-in mice, in which the endoge-
nous MHC class II I-Aβ chain is replaced by an EGFP-tagged version. EGFP+ LCs showed
only marginal motility in the steady state. By contrast, topical application of 0.5% dinitroflu-
orobenzene (DNFB) triggered: 1) markedly augmented dendrite movement, termed dSEARCH,
characterized by rhythmic and repetitive extension and retraction of dendritic processes through
intercellular spaces between adjacent keratinocytes, 2) amoeba-like lateral migration of cell
bodies between keratinocytes, and 3) physical contact between two or more adjacent LCs. To
study potential roles of cytokines in regulating LC behaviors, we s.c. injected recombinant
TNFα or IL-1α (50 ng/animal), each of which reportedly mediates hapten-induced LC hom-
ing to draining lymph nodes. EGFP+ LCs in the injection site of each cytokine, in fact, exhib-
ited significantly (P<0.05, n = 20) amplified dSEARCH motion of dendritic processes com-
pared to those in PBS injection sites. In time-kinetics experiments, apparent dSEARCH activity
was detectable as early as 3 h after local injection of each cytokine and it persisted for up to
24 h. On the other hand, unlike DNFB application, neither TNFα nor IL-1α significantly trig-
gered lateral LC migration or LC-LC contact formation, suggesting the involvement of addi-
tional factor(s). Nevertheless, our results provide the first in vivo evidence that dynamic in situ
behaviors of LCs can be altered in a predictable and selective manner by proinflammatory
cytokines known to be elaborated by keratinocytes in response to hapten application. We
propose that cytokine-dependent amplification of dSEARCH motion of dendrites may repre-
sent a unique mechanism by which LCs improve their immunosurveillance function (i.e., detec-
tion of danger signals and sampling of antigens) under pathological conditions.
666
Cutaneous immunity does not predict systemic immunity in old individuals.
K Lacy,1,2 M Vukmanovic-Stejic,2 JR Reed,2 AN Akbar2 and MH Rustin1 1 Dermatology, Royal
Free Hospital, London, United Kingdom and 2 Immunology and Molecular Pathology,
University College, London University, London, United Kingdom
The cutaneous response to antigenic injection is used to assess cell-mediated immunity to
tuberculosis. The aim of this study was to establish whether the reduced skin response to anti-
genic challenge in the old is reflective of impaired systemic immunity. Skin test solutions for
candida and tuberculin purified protein derivative (PPD) antigens were injected intradermally
in to healthy individuals aged under 40 (n=25) and over 70 years (n=42). Suction blisters
were induced over the site of injection and CD4+T lymphocytes were isolated from both blis-
ter fluid and peripheral blood mononuclear cells (PBMCs). Blood and blister CD4+ T cells
were stained for CD69 and Ki67 to assess cellular activation and proliferation respectively. In
addition, antigenic specificity was determined by staining for interferon-γ production after
overnight stimulation with antigen. To assess skin homing capacity, cells were also stained for
cutaneous lymphocyte antigen (CLA) and CCR4. The concentration of cytokines within the
blister fluid was determined. The clinical response in the skin following antigen injection was
significantly reduced in the old compared with the young (P=0.0001). In spite of good PBMC
responses to antigen in the old there was an absent cellular response in the skin. CLA and
CCR4 expression on antigen specific PBMCs was the same in young and old suggesting a skin
specific defect. A reduction in TNF, MCP-1 and MIP1α levels were observed in the old blis-
ter fluid that may be associated with the defective migration of T cells in to the skin after anti-
genic challenge. There is therefore dissociation between systemic and cutaneous immune
responses in the old that may account for the increase in cutaneous malignancy and infection
seen in the old.
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Heat shock protein GRP78 stimulates CTCL cell maturation into T regulatory cells
CL Berger and RL Edelson Dermatology, Yale University, New Haven, CT
We demonstrated that clonal expansion of the malignant CD4 T cells of cutaneous T cell lym-
phoma (CTCL)is driven by an interaction between the class II major histocompatibility com-
plex of autologous immature dendritic cells (DC) and the clonal CTCL T cell receptor (TCR).
The stimulatory autoantigen is derived from apoptotic T cells, which have been internalized
and processed by the DC. The CTCL cells are converted into phenotypic and functional T-
regulatory cells (Treg), possibly explaining the in vivo immunosuppressive capacity of these
cells. We hypothesized that GRP78 heat shock protein (HSP), which is upregulated during
apoptosis, may be a source of the relevant CTCL stimulatory antigen. CTCL cells were cul-
tured with immature DC preloaded with apoptotic T cells or T cells that were heat shocked
(42oC, 1 hr) and rendered apoptotic. In addition, GRP78 HSP was pulsed directly onto DC.
Assumption of a Treg phenotype by the CTCL cells was monitored by up-regulation of CTLA-
4, CD25 and FoxP3. Inhibition of Treg conversion was tested with quercetin (anti-HSP agent),
or anti-GRP78 antibody, BE2. T cell heat shock, prior to apoptosis, increased the percentage
of CTLA-4+ cells by 43% and mediated a 2.4-fold increase in FoxP3+ CTCL cells. DC pulsed
with GRP78 protein were also effective, nearly doubling FoxP3 expression. Specificity of the
stimulation by GRP78 was supported by the much lower response to control HSP. Specificity
was also demonstrated by quercetin-induced reduction of CTLA-4 and FoxP3 expression on
the CTCL cells. The role of GRP78 derived peptides in direct engagement of the CTCL TCR
was further buttressed by inhibition of FoxP3 induction in CTCL cells by BE2 antibody. The
results demonstrate that peptides from GRP78 HSP stimulate CTCL cell conversion into Treg.
CTCL appears to be a expansion of malignant CD4 T cells, driven to proliferate and differen-
tiate into Tregs by stimulation of the clonal CTCL TCR by DC presenting HSP derived anti-
genic peptides. Apoptotic cells internalized by immature DC are a likely source of these
autoantigens.
668
Rapid production of immunogenic tumor-loaded dendritic cells
X Shen, CL Berger and RL Edelson Dermatology, Yale University, New Haven, CT
The malignant cells of cutaneous T cell lymphoma (CTCL) display immunogenic tumor-spe-
cific antigens. Induction of clinically relevant anti-CTCL immune reactions likely requires the
introduction of these antigens into autologous immature dendritic cells (DC), followed by mat-
uration of the tumor-loaded DC into high expressers of costimulatory molecules. To produce
DC, synchronized for immaturity, we passed human blood mononuclear cells through a 400
µM silica bead column, in which sequential adherence/disadherence mimics in vivo interac-
tion with vascular endothelium, and then loaded the resulting immature DC with autologous
CTCL cells rendered apoptotic by anti-CD3 antibody, prior to using them to expand the autol-
ogous anti-CTCL CD8 T cell population. Results were analyzed by flow cytometry and con-
focal microscopy. The processed monocytes differentiated into immature DC, compared with
monocytes cultured overnight alone, as shown by 1.4× increase in mean fluorescence inten-
sity (MFI) of class II and 2.5× increase in CCR7. CD80 (costimulatory molecule) MFI increased
6.3× and CD83 (DC marker) percentage increased 1.7×, while expression of monocyte mark-
ers CD14 and CD36 were significantly reduced from 65.4±17.8% to 25.9±15.3% (p≤0.005)
and 49.8±14.1% to 26.5±10.8% (n=5, p≤0.02) respectively, confirming transformation of
monocytes into new DC. Confocal microscopy revealed that expression of apoptosis marker
APO2.7 and lysosomal antigen Lamp-2 increased in the cytoplasm of transitioning DC. Autol-
ogous CD8 T cells cultured with CTCL cell-loaded immature DC increased (p≤0.001) in per-
centage and number. The induced anti-CTCL CD8 T cells had increased perforin levels and
mediated CTCL cell apoptosis. These studies reveal that DC generated by physical contact with
silica beads and loading with malignant T cells increase DC-related markers and expand func-
tional anti-CTCL CD8 T cells. This methodology has promise for construction of DC based
immunotherapy for CTCL.
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Effective conversion of human proIL-18 into a novel functional IL-18 by human mast cell
chymase
Y Omoto,1 K Tokime,1 K Yamanaka,1 T Morioka,1 I Kurokawa,1 H Tsutsui,2 K Yamanishi,3
K Nakanishi2 and H Mizutani1 1 Dermatology, Mie University, Tsu, Japan, 2 Immunology &
Medical Zoology, Hyogo College of Medicine, Nishinomiya, Japan and 3 Dermatology,
Hyogo College of Medicine, Nishinomiya, Japan
Cutaneous overproduction of interleukin-18 (IL-18) induces atopic dermatitis (AD)-like skin
lesions, suggesting IL-18 as the major AD inducing factor. IL-18 is produced as an inactive
pro-form and stored in cells including keratinocytes. For activation and secretion, it needs pro-
cessing by specific enzymes. Caspase-1 is a known specific activator for IL-18. However, cas-
pase-1 knockout mice still exhibit biologically active forms of IL-18 and develop the skin lesion,
although the normal skin itself cannot releases functional IL-18. This observation suggests the
presence of alternative IL-18 activation pathway. Chymase and tryptase positive connective
tissue-associated mast cells accumulate in the skin lesions of AD patients and experimental
mouse models. Functional role of human mast cell chymase in proIL-18 activation was inves-
tigated in this study. Recombinant human proIL-18 was produced and purified for processing
by recombinant human mast cell chymase and caspase-1. Caspase-1 produced stable 18kD
(p18) IL-18, but chymase produced unique 16kD (p16) IL-18 species. These reactions were
abrogated by chymase inhibitors. The amino acid sequences of both molecules were deter-
mined as and 56-phenylalanine, respectively. Interferon-gamma was successfully produced
by addition of p16 in KG-1 cell culture, which was neutralized by specific monoclonal anti-
IL-18 antibodies. Thus, human mast cell chymase rapidly cleaves proIL-18 into a novel bio-
logically active IL-18 specie. The present results declared a new paracrine system of IL-18 in
skin, which also supports important roles of mast cells in AD and Th2 skin diseases.
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Neuropeptide inhibition of NFκB activation in Langerhans cells
W Ding, JA Wagner and RD Granstein Weill Medical College of Cornell University, New York,
NY
Langerhans cells (LC) and nerves are anatomically associated and neuropeptides such as cal-
citonin gene-related peptide (CGRP), vasoactive intestinal peptide (VIP) and pituitary adeny-
late cyclase-activating polypeptide (PACAP) modulate LC function including cytokine expres-
sion. TNFα has an essential role in normal and pathologic inflammatory reactions as well as
in LC maturation and migration. Production of TNFα and activation of NFκB are strongly
related. To examine neuropeptide effects on TNFα production by LCs, we used the LC-like
cell line XS52, which is derived from neonatal BALB/c mouse epidermis, as a LC surrogate.
XS52 cells were cultured for 24 hr with 0.1 µg/ml of lipopolysacchride in the absence or pres-
ence of a concentration range (10-6-10-9 M) of VIP, PACAP or CGRP. Supernatants were col-
lected at 4, 8, 12, and 24 hr and assayed for TNFα. CGRP, PACAP and VIP all inhibited TNFα
production in a dose-dependent manner. To determine if neuropeptides affect NFκB activa-
tion, both XS52 cells and fresh LCs (~95% homogeneous) from BALB/c mice were stimulated
with 0.1 µg/ml of LPS in the absence or presence of VIP, PACAP or CGRP. After 3 hr, nuclear
protein was extracted and NFκB binding was assessed by electrophoretic mobility shift assay.
In similar experiments, we examined the degradation and phosphorylation of IκB kinase (P-
IKKα/β) using Western blotting with two polyclonal antisera (anti-IκBα and anti-phosphory-
lated IKKα/β). VIP, PACAP and CGRP suppressed the phosphorylation of IKKα/β, prevented
degradation of the IκBα, and inhibited the activation of NFκB by LPS. Bay 11-7085, an inhibitor
of IKKα/β kinase, also inhibited TNFα production from LPS-simulated XS52 cells, suggesting
that NFκB mediates the effects of LPS on TNFα production and suporting our hypothesis that
that the inhibitory activity of PACAP, VIP and CGRP on TNFα production and LC function are
mediated, at least in part, by inhibition of the phosphorylation of IKKα/β, which prevents
IκBα degradation and activation of NFκB.
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Anti-microbial peptide, beta-defensine-2 in the stratum corneum is not responsible for sus-
ceptibility to S. aureus colonization in atopic dermatitis
S Asano,1 Y Ichikawa,2 T Kumagai,1 J Arikawa,1 M Ishibashi,1 M Kawashima1 and
G Imokawa3,1 1 Department of Dermatology, Tokyo Women’s Medical University, Tokyo,
Japan, 2 Kao Biological Science Laboratories, Tochigi, Japan and 3 Skin Science Research
Institute, Tokyo, Japan
Anti-microbial peptides such as defensin and cathelicidin have recently been reported to play
an important role in host defense and cutaneous innate immunity. Although beta-defensine-
2(BD2) is reported to be down-regulated in the whole skin of atopic dermatitis (AD) com-
pared with healthy control or psoriasis, little is known about their role in the colonization of
S. aureus in the stratum corneum(SC) from AD patients because an evaluation of these pep-
tides for the precise quantitation in SC as a front anti-microbial barrier against St. aureus col-
onization has not been yet performed. In this study, we have developed microanalysis of BD2
in SC by combination of immunoprecipitation and western blotting and compared BD2 con-
tent between AD and healthy control. Microanalysis demonstrated that there is no significant
difference in BD2 level between the different depths of SC but with its higher content in AD
non-lesion than in healthy control in the whole SC. Microanalysis in the upper SC(3 strips)
revealed that BD2 significantly increases in the AD lesion and occurs at a similar or slightly
higher level in the AD non-lesion compared with healthy control. The BD2 contents in the
lesional skin also increased in proportion to the severity of AD. The counting of bacterial
colonies revealed that there is a higher population of S. aureus on the lesional and non-lesional
skin surface of patients with AD compared with healthy controls. Comparison between the
colony number and BD2 content demonstrated that there is a positive correlation (r=0.427,
p=0.006, n=38) between the both factors in the lesional skin. Collectively, these findings sug-
gest that BD2 becomes inducible in response to bacteria, injury or inflammatory stimuli and
is not associated with vulnerability to S. aureus colonization in the skin of patients with AD.
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Epidermal Langerhans cell deficient mice develop enhanced contact hypersensitivity
DH Kaplan,1 MC Jenison,1 S Saeland,3 WD Shlomchik4 and MJ Shlomchik2 1 Dermatology,
Yale University, New Haven, CT, 2 Lab Medicine and Immunobiology, Yale University, New
Haven, CT, 3 INSERM, Lyon, France and 4 Sections of Immunobiology and Medical
Oncology, Yale University, New Haven, CT
Epidermal Langerhans Cells (LC), a distinct, TGFb-dependent, skin resident DC population,
acquire antigen in the skin and migrate to draining lymph nodes where they have traditionally
been thought to initiate adaptive immune responses.  We have generated mice with a selective
absence of LCs using BAC transgenic mice in which the regulatory elements from human Lan-
gerin were used to drive expression of an attenuated form of the diphtheria toxin A subunit (Lan-
gerin-DTA). Langerin-DTA mice have a constitutive and durable absence of epidermal LCs.
Other dendritic cell subsets in the dermis, lymph node, and spleen are intact. Although migrat-
ing epidermal LCs are not seen in skin draining lymph nodes of Langerin-DTA mice after FITC
painting, we do not see a decrease in the number of Langerin+ cells in secondary lymphoid
tissues (SLT) in the steady state.  This suggests that the majority of Langerin+ cells found in SLT
are in fact not derived from the LCs. Unexpectedly, contact hypersensitivity (CHS) responses to
both DNFB and Oxazalone were increased by approximately two fold in the absence of LCs.
Moreover, adoptive transfer experiments demonstrate that LCs act during the priming and not
the effector phase. Thus, LCs are not only dispensable for CHS, but rather serve to regulate the
response. We have also generated mice using a similar BAC transgenic approach that express
Cre recombinase (Langerin-Cre). As expected, Langerin-Cre mice bred to the ROSA26-eGFP
reporter line have selective expression of Cre in all epidermal LCs.  Langerin-Cre mice bred to
floxed TGFβRII mice show a dramatically reduced number of LCs in the epidermis thereby for-
mally demonstrating that TGFβ acts directly on LCs to promote maturation and/or survival of
LCs. Combining Langerin-Cre mice with mice carrying other floxed target genes should pro-
vide a valuable tool for examining the mechanism of LC mediated regulation of CHS.
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A full vitamin D3 agonist with a highly reduced Calcium mobilizing potential in rodent skin
inflammation models
A Steinmeyer,1 M Lehmann,3 K Asadullah2 and UA Zuegel2 1 Medicinal Chemistry, Schering
AG, Berlin, Germany, 2 Corporate Research Business Area Inflammation, Schering AG, Berlin,
Germany and 3 Medicinal Biochemistry, University of Rostock, Rostock, Germany
1α,25-Dihydroxyvitamin D3 (Calcitriol), the biologically active form of vitamin D3 has potent
immunomodulatory activity, however its clinical use is limited due to disturbance of calcium
homeostasis in anti-inflammatory active doses. Recently, we described a vitamin D3 analog
(ZK 191784) which is characterized by a dissociated profile in rodent skin inflammation
models leaving a small but defined window between maximum immunomodulatory activity
versus significant Calcium effects. Here, a further analog (ZK 203278) is presented which is
structurally different from other analogs and has a superior therapeutic window in rodent
skin inflammation models. ZK 203278 binds with the same degree of affinity to the Vitamin
D receptor as the natural ligand, Calcitriol. It exerts potent immunomodulatory effects on
monocyte and lymphocyte activity. Release of cytokines that are central in inflammation, such
as TNFα and IL-12 are significantly suppressed in human monocytes by ZK 203278 with IC50’s
in the low nanomolar range. Similarly, expression of cell surface molecules involved in cell
adhesion (ICAM-1) and presentation of antigen (HLA-DR, B7.1), e.g. to T cells, is down-reg-
ulated on human monocytes when exposed to low nanomolar concentrations of ZK 203278.
Potent anti-inflammatory activity has been demonstrated in skin inflammation or transplan-
tation models in rodents. Here, ZK 203278 inhibited allergic contact dermatitis in mice and
rats after intragastrical administration in doses approximately two orders of magnitude below
the hypercalcemic threshold dose. Moreover, ZK 203278 significantly prolonged skin allo-
graft survival in rats in well-tolerated doses. Altogether the data generated with ZK 203278
shows that this novel Vitamin D3 analog exerts considerable immunomodulatory activity at
non-hypercalcemic dosages and might have therapeutic potential in immune disorders.
675
The role of MAPKAP2 in cutaneous inflammation
Z Ulrich,1 A Schottelius,1 W Doecke,1 M Gaestel2 and K Asadullah1 1 Corporate Research
Business Area Inflammation, Schering AG, Berlin, Germany and 2 Institute of Biochemistry,
University of Hannover, Hannover, Germany
The p38 mitogen-activated protein kinase (MAPK) pathway is activated by stress and is involved
in phosphorylation of transcription factors. The MAPK-activated protein kinase 2 (MK2) is
regulated through direct phosphorylation by p38 and involved in post-transcriptional regula-
tion of inflammatory and stress responses. It was shown that MK2 k.o. mice develop an
increased resistance to stress and an elevated survival rate in the LPS-induced endotoxic shock
model due to inpaired post-transcriptional stimulation of cytokine biosynthesis especially in
macrophages. For analysis of MK2 in cutaneous inflammation we applied the MK2 k.o. mice
to skin inflammation models. While initial studies confirmed the published role of MK2 in
the endotoxin shock model, MK2 deficiency had no significant impact on acute cutaneous
inflammation (unspecific phorbolester-induced or T cell-specific DNFB-induced inflamma-
tion). Thus, other than in the acute endotoxin shock model, MK2 k.o. mice showed no reduced
acute cutaneous inflammatory response when compared to WT mice. Analysis in subchronic
T cell-dependent skin inflammation models gave a somewhat differential outcome. Repeated
DNFB challenge (once daily for 3 subsequent days) resulted in significant reduced net increase
of skin inflammation (measured by ear thickness) in MK2 k.o. vs WT mice. In contrast, repeated
DNCB challenge caused a slightly more pronounced net increase of skin inflammation in
MK2 k.o. vs. WT mice. In conclusion, our studies confirm the role of MK2 in acute systemic
inflammation whereas MK2 seems to play only a minor role in acute skin inflammation. The
role of MK2 in subchronic T cell-dependent skin inflammation is not fully understood and
awaits further analysis. Since expression analysis of MK2 in human lesional skin from patients
with chronic plaque-type psoriasis revealed an upregulation of MK2 protein in inflamed pso-
riatic skin, the role of MK2 in T cell-mediated skin inflammation (e.g. psoriasis) is still subject
of further investigations.
677
Epidermal regulation of AQP3 expression and hyaluronan synthesis (1); Proinflammatory
cytokines produced by infiltrating lymphocytes reciprocally regulate hyaluronan synthesis
and AQP3 expression by keratinocytes in spongiotic dermatitis
T Ohtani,1 R Saito,1 T Sayo,2 Y Endo,2 Y Sugiyama,2 S Inoue2 and S Aiba1 1 Department of
Dermatolory, Tohoku University, Sendai, Japan and 2 Basic Research Laboratory, Kanebo
Cosmetics Inc.,, Odawara, Japan
T-cell-mediated keratinocyte apoptosis with E-cadherin cleavage plays a key pathogenic role in
eczematous dermatitis. However, it remains unanswered how spongiosis retains water in the
intercellular space of epidermis. Recently, we have reported that IFN-gamma-treated human ker-
atinocytes significantly augmented the production of hyaluronic acid (HA), which has profound
effects on the distribution and movement of water, and that keratinocytes express aquaporin 3
(AQP3) which belongs to a family of water channel and is up-regulated by osmotic stress. In this
study, to clarify the pathomechanism of spongiosis, we examined the expression of HA and AQP3
in 20 cases of spongiotic dermatitis and 10 cases of normal skin by immunohistochemical stain-
ing with hyaluronic acid binding protein (HABP) and anti-AQP3 antibody, respectively. The lesion
of spongiotic dermatitis significantly augmented the immunoreactivity with HABP, while AQP3
expression was down-regulated around spongiotic vesicles. The reciprocal regulation of HA pro-
duction and AP3 expression was confirmed by Texas Red-labeled HABP and FITC-labeled anti-
AQP3 Ab. Since IL-1beta, TNF-alpha, and IFN-gamma play crucial roles in the efferent phase of
contact dermatitis, we examined the effects of these cytokines on HA production and AQP3 expres-
sion by keratinocytes in vitro. IL-1beta and IFN-gamma significantly augmented HA production
by keratinocytes, while TNF-alpha down-regulated it. In contrast, the immunoblotting demonstrated
that both IL-1beta and TNF-alpha suppressed AQP3 expression, while IFN-gamma significantly
augmented it. We also confirmed these phenomenon by real-time PCR. These studies suggest that
the proinflammatory cytokines produced by infiltrating lymphocytes in contact dermatitis regulate
HA production and AQP3 expression, which may lead to the intercellular edema in spongiosis.
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Ligation of syndecan-4 by DC-HIL inhibits T cell activation
J Chung, I Dougherty, P Cruz, Jr and K Ariizumi Dermatology, UT Southwestern Medical
Center, Dallas, TX
T cell activation is regulated by positive and negative signals transduced by binding of regu-
latory molecules on APC to corresponding ligands on T cells. Previously we reported that: DC-
HIL on mouse APC can bind activated (but not resting) T cells; such binding potently inhib-
ited T cell activation; and this negative regulation can be antagonized by treatment with
recombinant DC-HIL protein, leading to augmented mixed lymphocyte reactions (MLR) in
vitro and exacerbated contact hypersensitivity (CH) in vivo. To understand how DC-HIL exerts
its inhibitory function, we identified its T cell ligand. Having shown previously that DC-HIL
recognizes heparin/heparan sulfate (HS) on endothelial cells, we posited a role for HS in
binding of DC-HIL to T cells and found exogenous HS to completely block this event. Because
HS is expressed on the surface of only a few proteoglycans (CD44, syndecans, glypicans), we
screened these candidate ligands on T cells for: (1) upregulated expression following T cell
activation; and (2) co-precipitation with DC-HIL. Syndecan-4 was the sole candidate whose
mRNA and surface protein expressions were upregulated by T cell activation. Moreover, a pro-
tein of 40 Kda (equivalent to molecular weight of syndecan-4) was among the proteins in acti-
vated T cell extracts that co-precipitated with DC-HIL. We next showed ligation of engi-
neered cyndecan-4 expression on COS-1 cells by DC-HIL to autophosphorylation its
intracellular tyrosine and serine residues. Finally, we showed anti-syndecan-4 mAb to mimic
DC-HIL’s attenuation of T cell activation in vitro and antagonism of the inhibitory function of
endogenous DC-HIL (exogenous DC-HIL or anti-syndean-4 given intraperitoneally during elic-
itation) for CH in mice. These findings indicate that syndecan-4 on activated T cells is a lig-
and DC-HIL employs to mediate its inhibitory function. Our discovery of DC-HIL/syndecan-
4 as a new pair of negative co-regulators of T cell activation is an opportunity to better understand
mechanisms of APC/T cell function that may yield potentially important clinical applications.
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Osteopontin is a new member of mast cell-mediators, which affects multiple functions of
mast cells
A Nagasaka,1 H Matsue,1 R Aoki,1 SR Rittiling,2 S Kon,3 T Uede3 and S Shimada1 1
Dermatology, University of yamanashi, Yamanashi, Japan, 2 Department of Genetics, Rutgers
University, Piscataway, NJ and 3 Institute for Genetic Medicine, Hokkaido University,
Hokkaido, Japan
Osteopontin (OPN) is an extracellular matrix protein with an Arg-Gly-Asp (RGD) motif that
was primarily found in bone. However, it has been identified in many immune cells (i.e.,
macrophages, dendritic cells, NKT cells, and activated T cells) and has diverse functions in
the immune system. For instance, OPN functions as a Th1 cytokine and a chemotactic factor
to immune cells, being involved in many aspects of pathogenesis of inflammatory and immune
diseases (e.g., multiple sclerosis and allergic contact dermatitis). On the other hand, mast cells
are also involved in many pathological aspects of those diseases by secreting multiple medi-
ators. However, it remains unknown whether mast cells produce OPN. We hypothesized that
mast cells may produce OPN and it may affect mast cell functions. To address this, we used
murine fetal skin-derived culture mast cells (FSMC) and bone-marrow-derived mast cells
(BMMC). We found that OPN was constitutively detected only in FSMC but not in BMMC at
mRNA and protein levels (RT-PCR and ELISA). In the presence of mast cell growth factors (IL-
3 and SCF), FSMC have been generated similarly from both OPN-deficient (-/-) and -sufficient
(+/+) mice without significant differences of yield, purity, granularity, and viability. However,
without their growth factors, FSMC derived from -/- mice showed significant apoptosis, com-
pared to those from +/+ mice. In addition, we found that OPN attracted FSMC (chemotaxis
assay) and it augmented IgE-mediated degranulation by FSMC (beta-hexosaminidase assay).
These results indicate that cutaneous mast cells produce OPN, which affects many aspects of
mast cell functions (i.e., cell survival, chemotaxis, and degranulation). Our study suggests
that OPN is a new member of multiple mediators secreted by mast cells, and it may exert
multiple functions to immune cells including mast cells in many physiological and patholog-
ical settings.
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The reduced cell surface thiols in dendritic cells as the first hit of sensitizers to the immune
system
S Kagatani,1 Y Sasaki,1 M Mizuashi,1 M Suzuki,2 M Hirota,2 H Itagaki2 and S Aiba1 1
Dermatology, Graduate School of Tohoku University, Sendai, Japan and 2 Shiseido Safety and
Analytical Center, Yokohama, Japan
Although we and other groups demonstrated that p38 mitogen-activated protein kinases (MAPK)
plays a crucial role in the activation of monocyte-derived dendritic cells (MoDC) by contact
sensitizers such as NiCl2 and 2,4-dinitrochlorobenzene (DNCB), the upstream signals of p38
MAPK remain undetermined. Recently, we have demonstrated that the imbalanced ratio of
the oxidized (GSSG) vs. reduced (GSH) form of cellular glutathione plays a crucial role in
triggering DC maturation by sensitizers. This observation raises the next question of how the
imbalance of the intracellular GSH/GSSG ratio is induced by sensitizers. Since it has been
reported that treatment with exogenous nonpermeable GSSG, which results in a significant
decrease of exofacial cell membrane thiol groups and the intracellular GSH content, phos-
phorylates p38 MAPK, we examined the effects of several sensitizers and irritants on the exo-
facial cell membrane thiol groups of MoDC. In this study, MoDC were treated with DNCB,
NiCl2, formaldehyde, and SLS for 2 hr, incubated with a nonpermeable thiol-reactive com-
pound, Alexa fluor 488 C5 maleimide (AFM), or anti-phospho-p38 MAPK after fixation and
permeabilization. The cells were washed and analyzed by flow cytometry. DNCB, NiCl2, and
formaldehyde significantly reduced cell-surface thiols at non-toxic concentrations while SLS
did not. In parallel with the decreased cell-surface thiols, these three sensitizers phosphory-
lated p38 MAPK in MoDC. These data suggest cross-links between the intracellular redox bal-
ance and the cell-surface thiol groups, and between the activation of p38 MAPK and the
intracellular or cell surface redox imbalance.
www.jidonline.org   113
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Toll-like receptor ligation of epidermal cells upregulates hapten-presenting ability of Langer-
hans cells by promoting keratinocyte production of cytokines
K Sugita, M Kobayashi, K Atarashi, T Shimauchi, K Kabashima and Y Tokura Dermatology,
University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan
Toll-like receptor (TLR) family recognizes conserved microbial structures, such as peptido-
glycan (PGN), lipopolysaccharide (LPS), CpG oligonucleotide (CpG). We investigated whether
TLR ligation of epidermal cells (EC) enhances the antigen-presenting ability of Langerhans cells
(LC) in mice. Freshly isolated EC suspensions were incubated with PGN (0.2, 2 or 20
<g>µ<g>g/ml), LPS (0.1, 1, or 10 <g>µ<g>g/ml), or CpG (0.1, 1, or 10 <g>µ<g>g/ml) for 24
h. After enrichment for LC with the gradient method or anti-CD11c magnetic beads in some
experiments, LC-enriched EC (LC-EC) or purified LC were modified with trinitrophenyl (TNP).
As responders, single cell suspensions were prepared from inguinal and axillary lymph nodes
5 days after epicutaneous sensitization of mice with PCl. CD4+ T cells were prepared nega-
tively with a cocktail of conjugated mAbs. Triplicate cultures of immune CD4+ T cells were
incubated with TNP-modified LC-EC or LC in the presence or absence of TLR ligands. The lig-
ands PGN, LPS and CpG unaffected the proliferation of PCl-immune T cells without LC-EC.
The ligands were capable of enhancing the hapten-presenting ability of LC-EC but not puri-
fied LC. When LC-EC were cultured for 24 h in the presence of TLR ligands, the expression of
CD86 on LC was significantly augmented. The ligands enhanced the production of IL-
1<g>α<g>, GM-CSF, and TNF-<g>α<g> by keratinocytes. Moreover, the addition of a cock-
tail of neutralizing antibodies to IL-1<g>α<g>, GM-CSF, and TNF-<g>α<g> abrogated the
ligand-promoted antigen-presenting ability of LC-EC. Finally, immune T cells proliferated
well in response to purified LC derivatized with TNP in the presence of culture supernatants
from ligand-stimulated keratinocytes. Our study suggests that LC function is upregulated indi-
rectly by cytokines released by ligation-stimulated keratinocytes.
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To study the clinical features, histopathology and immunopathology in Erythema Annulare
Centrifugum
L Yang,1,2 M Li1,2 and X Zhu1,2 1 Department of Dermatology, The Wuxi Second Affiliated
Hospital of Nanjing Medical University, Wuxi, Jiangsu, China and 2 Department of
Dermatology, Wuxi No.2 People’s Hospital, Wuxi, Jiangsu, China
The objective of this study is to investigate the clinical features, histopathology and
immunopathology in Erythema Annulare Centrifugum (EAC), and their relationships. Erythema
annulare centrifugum (EAC) is a rare disease entity characterized by dense perivascular lym-
phocytic infiltrates in dermis. It has been associated with a few conditions, though its etiol-
ogy is largely unknown. Here, We analyzed AEC patients for the sex, age, stage, distribution
and morphology of eruptions, symptoms and complications. Furthermore, the lesions were
examined by HE staining and direct immunofluorescence. We found that 54 cases of EAC clin-
ically diagnosed in our hospital were retrospectively studied. EAC most commonly involved
in lower limb and had many complications, especially fungal diseases. Histological exami-
nation revealed compact lymphocyte infiltration in the upper dermis or deeper vascles in 32
of 54. Direct immunofluorescence showed the deposits of IgG, IgM, or C3 in small vessels
wall in 6 of 12 cases. The results suggested that the pathogenesis of EAC was complicated and
lymphocytes infiltration and deposit of immune complex in small blood vessels of dermis
play important roles in its development. Its pathogenesis needed further studies.
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Identification of crassin acetate as a potent immunosuppressant with dual target specificity
inhibiting both dendritic cell and T cell functions
H Matsushima, H Tanaka, N Mizumoto and A Takashima Dermatology, UT Southwestern
Medical Center, Dallas, TX
In an attempt to discover newer immunosuppressants, we tested structurally diverse chemi-
cals in four different libraries using a simple, two-way allo-MLR assay, in which spleen cells
isolated from BALB/c mice and from C57BL/6 mice were co-cultured in the presence of a test
drug. Crassin acetate (CRA), a coral-derived diterpenoid with a 14-carbon cembrane ring,
was identified as a promising hit from MicroSource Natural Compound Library. When added
to one-way MLR, CRA dose-dependently inhibited the proliferation of CD3 T cells (C57BL/6
origin) induced by allogeneic bone marrow-derived dendritic cells (BM-DCs) generated from
BALB/c mice, with >95% inhibition achieved at 6 µM. With respect to mechanisms, CRA dose-
dependently suppressed LPS-induced secretion of IL-1β, IL-6, IL-12 p40, IL-12 p70, and
TNFα by BM-DCs in a sub-toxic concentration range (1-10 µM). Moreover, CRA potently inhib-
ited PMA/ionophore-induced proliferation of CD3 T cells, as well as their secretion of IL-2,
IL-4, IL-10, and interferon-γ and surface expression of CD25, CD44, and CD69 in the same
dose range without causing significant T cell death. The extent of oxazolone (OX)-induced
Langerhans cell migration in BALB/c mice was significantly (P<0.01) diminished by i.p. injec-
tion of CRA (100 µg/animal), indicating its in vivo pharmacological activity. Finally, OX admin-
istration either during the sensitization or elicitation phase significantly (P<0.01) suppressed
allergic contact hypersensitivity responses to OX without causing long-term immunological
tolerance to OX or an irrelevant hapten, DNFB. None of the CRA-treated mice (>70 mice in
total) exhibited significant body weight loss or other apparent adverse effects. Thus, we pro-
pose that CRA may be used clinically as a safe and efficacious immunosuppressant with dual
target specificity inhibiting immune functions of both DCs and effector T cells.
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Human IL-12/23 mAb inhibits Cutaneous Lymphocyte Antigen, IL-12R, and IL-2Rα expres-
sion on activated peripheral blood T lymphocytes and secretion of IFN- γ, IL-17, IL-2, IL-10,
and TNF-α cytokines
M Reddy, C Davis, J Wong, N Fried, C Pendley and U Prabhakar Clinical Pharmacology and
Experimental Medicine, Centocor Research & Development, Inc., Radnor, PA
Psoriasis is a chronic inflammatory T-cell mediated Th1 type skin disease. IL-12 is known to
be the predominant inducer of the Th1 pathway and is central to the initiation and promotion
of the pathogenesis of psoriasis. Further, IL-12 is reported to be the physiological inducer of
the skin homing molecule, Cutaneous Lymphocyte Antigen (CLA), which is expressed on the
majority of T-cells infiltrating psoriatic lesions. We investigated the effect of a fully human mAb
for IL-12/IL-23 p40 (CNTO 1275) on CLA, IL-2Rα, IL-12 receptor expression and IFN-γ, IL-17,
TNF α, IL-2, and IL-10 cytokine secretion in vitro using normal human peripheral blood
mononuclear cells (PBMCs). PBMCs were cultured with various polyclonal activators in the
presence or absence of exogenous rhIL-12 or IL-23 with or without CNTO 1275. We demon-
strated up regulation of CLA, IL-12R, and IL-2Rα in response to activation and exogenous IL-
12, but not IL-23. Activation and IL-12 induced up regulation of CLA, IL-12Rβ2, IL-2Rα was
inhibited by CNTO 1275. CNTO 1275 also inhibited IL-12 induced secretion of IFN-γ, TNF
α, IL-2, IL-10 cytokines along with IL-23 induced secretion of IL-17. The inhibitory effect of
CNTO 1275 was overcome in the presence of neutralizing idiotypic antibody specific to CNTO
1275. A possible therapeutic effect of the IL-12/23 mAb treatment in subjects with psoriasis
may be attributed to the neutralization of IL-12/IL-23 activity, thereby affecting IL-12 depend-
ent expression of markers associated with skin homing and activation along with inhibition
of IL-12 and IL-23 induced cytokine secretion.
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Mice deficient in β2 integrin reveal altered lymphocyte trafficking and differentiation yield-
ing a distinct T cell phenotype
T Oreshkova,1 H Wang,1 A Seier,1 A Renkl,1 G Varga,2 K Loser,2 A Sindrilaru,1 S Grabbe,2,3
K Scharffetter-Kochanek1 and T Peters1 1 Dermatology, Ulm Univ, Ulm, Germany, 2
Dermatology, Munster Univ, Munster, Germany and 3 Dermatology, Essen Univ, Essen, Germany
Beta2 integrins form four heterodimeric membrane receptors in combination with four alpha
chains (CD11/CD18). These are differentially expressed only on leukocytes and contribute cru-
cially to their transmigration and re-circulation. To investigate in detail the role of CD18 in hom-
ing of lymphocytes, we analyzed CD18 deficient (CD18-/-) mice with regard to phenotypic and
functional changes of re-circulating T cells in primary and secondary lymphoid tissues using in
vivo adoptive cell transfers, flow cytometry, fluorescence microscopy and in vitro proliferation
assays. We showed that loss of CD18 led to a defective homing of lymphocytes to secondary
lymphoid organs, whereas an aberrant localization to (non-lymphoid) tissues within the lung
and liver occurred. We found that a decrease in mature CD4+ and CD8+ T cells, which was
due to a defective homing, was contrasted by high numbers of CD3+ CD4-CD8- (DN) T cells
in the peripheral lymphoid organs of CD18-/- mice. These DN T cells had either αβ or γδ TCR
composition. Since also TCRαβ T cells lacked the co-receptors CD4 and CD8, this classified
them as either aberrantly differentiated or aberrantly located T cells. Interestingly, these cells
showed an activated antigen-experienced phenotype characterized by high expression of CD44
and CD25, and down-regulated CD45RB. When cultured ex vivo, they were highly responsive
even to low concentrations of IL-2. Despite their expression of CD25 and responsiveness to IL-
2, TCRαβ DN cells did not express the transcription factor Foxp3, thus widely ruling out that
they were regulatory T cells. We here show that β2 integrins not only guide transmigration and
re-circulation but also critically influence T-cell maturation and differentiation. Adoptive trans-
fers of CD18-/- cells onto RAG-deficient versus athymic nude mice are now on the way to elu-
cidate the role of thymus in the development of the abnormal T-cell phenotype in CD18-/- mice.
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Interleukin-23 is increased in mycosis fungoides lesions and decreased in Sézary syndrome
SD Doherty,1,3 X Ni,1 CM Badgwell,1,3 D Jones,2 X Zhao,1 LB Owen-Schaub4 and M Duvic2
1 Dermatology, MD Anderson Cancer Center, Houston, TX, 2 Hematopathology, MD
Anderson Cancer Center, Houston, TX, 3 Baylor College of Medicine, Houston, TX and 4
Biolegend, San Diego, CA
Progression of mycosis fungoides (MF) to Sézary Syndrome (SS) is accompanied by a shift from
TH1 to a TH2 cytokine profile. Interleukin (IL)-23 is a novel cytokine that shares a common
p40 subunit with the TH1 inducer, IL-12. IL-23 induces a third profile, THIL-17, that is dom-
inant in inflammation and autoimmunity (Hunter, Nat Rev Immunol, 2005). Although IL-23
induces an eczematous-like skin reaction in mice (Kopp et al, J Immunol, 2003), and is
expressed in TH1-mediated skin disorders such as psoriasis, it has not been evaluated in MF.
To study the expression of IL-23 in MF/SS, 40 MF/SS lesions of all stages were immunohisto-
chemically analyzed with a novel anti-human IL-23 antibody raised against full-length human
IL-23 (clone HTL 2376, 10 µg/mL, Biolegend, San Diego, CA). IL-23 was detected with the
catalyzed signal amplification (CSA) system (DAKO). The intensity and frequency of IL-23
staining were semi-quantitatively graded in both the dermal infiltrate and the epidermis.
Increased expression of IL-23 was observed throughout the epidermis and in dermal lym-
phocytes compared to normal skin. IL-23 intensity did not differ significantly among the stages
of MF however, in stage IVB patients, we observed lower IL-23 expression in dermal lym-
phocytes than in other stage patients (p=0.13, ANOVA). In 18 of 40 (45%) MF/SS lesions from
all stages, epidermotrophic lymphocytes had decreased IL-23 expression, compared to 7 of
11 (64%) lesions from Sézary patients. These data indicate that although IL-23 expression is
increased in MF lesions compared to normal skin, epidermotrophic and dermal malignant
lymphocytes in MF patients who have progressed to SS have decreased IL-23 expression.
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CD1B/C+ cells penetrate aggregates of human basal cell carcinoma and are present in high
numbers in adjacent peritumoral dermis
H Kaporis,1 A Khatcherian,1 JG Krueger1 and JA Carucci2 1 Investigative Dermatology,
Rockefeller University, New York, NY and 2 Dermatology, Cornell-WMC, New York, NY
BCC, the most common human cancer undergoes immune mediated regression in select cir-
cumstances, however, the specific nature of the anti-tumor response remains undefined. In
this study we have characterized BCC associated dendritic cells and T Lymphocytes within
epithelial tumor nests, peritumoral stroma and uninvolved epidermis. 15 cases of nodular BCC
were studied via immunohistochemistry for markers including CD11c, CD1a, CD8, CD83,
Langerin, CD1B/C, CD40, CD86 and DC Lamp. Quantification and localization in epithelial
tumor aggregates, adjacent peritumoral dermis and uninvolved epidermis was performed in
NIH IMAGE Analysis. Eight specimens of normal skin served as controls. CD1B/C+ cells pen-
etrated epithelial tumor aggregates albeit in lower numbers than adjacent peritumoral dermis.
The peritumoral dermis showed high numbers of CD11C+ and CD8+ cells in addition to
CD1B/C+ cells when compared to normal dermis (all p values <.05). Few CD1a+, Langerin+
and DCLAMP+ cells were found in epithelial tumor aggregates or adjacent peritumoral der-
mis.  Furthermore, CD83+, CD86+ and CD40+ were nearly absent from these areas. CD1a+
and Langerin+ cells were consistently low in tumor aggregates, absent from peritumoral der-
mis but present in consistently higher numbers in uninvolved epidermis. CD1B/C+ cells, poten-
tially dendritic cells of intermmediate maturity, appear to be migrating into epithelial tumor
nests and adjacent stroma where they are present in higher numbers. The accumulation of
high numbers of CD8+ T cells supports the potential for generating a specific dendritic cell
mediated anti-tumor immune response.
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Antigen-driven bystander effect of effector/ memory T cells on epicutaneous sensitization
with protein antigen
L Wang, C Hsu, H Chiu, C Liu and H Yu Dermatology, National Taiwan University Hospital,
Taipei, Taiwan
Spreading of Th2 immune response to multiple aeroallergens in atopic diseases is well known.
However, its mechanism remains obscure. Here, we show that antigen-driven bystander effect
of effector/ memory T cells contributes to this process. Mice pretreated with polarizing immu-
nization either by subcutaneous or intraperitoneal injection of bovine serum albumin (BSA)
with adjuvant showed polarized T cell immune response when they were later exposed to
ovalbumin (OVA) epicutaneously. By contrast, both groups of mice showed enhanced Th2
immune response to OVA when they were later co-exposed to BSA and OVA epicutaneously.
Effector/ memory CD4 T cells and dendritic cells seem mediating this effect. Collectively, these
data highlight the mechanism underlying the exacerbation of aeroallergen sensitization in
atopic patients and will be useful in the prevention and treatment of atopic disease.
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Transcriptional modulation using the HDAC inhibitor FK228 promotes immune cell-medi-
ated tumor destruction against murine B16 melanoma
T Murakami,1 A Sato,1,2 M Ohtsuki,2 Y Kano,3 Y Furukawa4 and E Kobayashi1 1 Div. Organ
Replacement Res., Jichi Medical School, Shimotsuke, Tochigi, Japan, 2 Dept. Dermatology,
Jichi Medical School, Shimotsuke, Tochigi, Japan, 3 Tochigi Cancer Center, Utsunomiya,
Tochigi, Japan and 4 Div.Stem Cell Reg., Jichi Medical School, Shimotsuke, Tochigi, Japan
With melanoma, as in many other malignancies, aberrant transcriptional repression is a hall-
mark of refractory cancer. The histone deacetylase (HDAC) inhibitor is expected to be effec-
tive against cancer since it is able to restore gene expression that is aberrantly repressed in
cancer cells and the mechanism of action differs from that of conventional antineoplastic
agents. Our recent DNA micro-array analysis has demonstrated that the HDAC inhibitor FK228
markedly augments expression of gp100/pmel17 melanoma antigen, which is repressed in
human melanoma cell lines. Herein, we set out to determine whether the HDAC inhibitor
FK228 enhances tumor-specific T-cell-mediated killing of B16/F10 murine melanoma cells.
Firstly, by quantitative assay of caspase-3/7 activity, we determined that a low dose of FK228
(ED50: 5nM) moderately induced apoptosis in vitro, in which transcriptional recovery (e.g.,
p21Waf1/Cip1, MHC class I and Fas/CD95) was sufficiently evoked concomitantly with his-
tone H3 acetylation. Secondly, FK228 (5nM) treatment with Fas engagement (10nM recom-
binant FasL) synergistically promoted apoptosis in B16/F10 cells (p<0.05). Spleen cells from
immunized C57BL/6 mice using irradiated IL-12/IL-18-expressing B16 cells also killed the
FK228-treated B16 cells in vitro to a great extent (p=0.014 vs. untreated B16 cells). Thus, a
limited dose of FK228 can attenuate anti-apoptotic properties in B16 cells. Furthermore, in
vivo metastatic growth of B16/F10 to the lung was suppressed by a combination of FK228
treatment (1 mg/kg, i.p. only at day 1 following tumor implantation) with immune cell adop-
tive transfer from immunized mice using the irradiated B16 cells (p=0.036, vs. PBS, at day
11). Consequently, the transcriptional modulation strategy using HDAC inhibitors might prove
to be useful adjunct in human immunotherapy strategies against cancer.
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Evidence for the involvement of the endogenous cannabinoid system in the regulation of
contact hypersensitivity
E Gaffal,1 M Karsak,2 E Basner-Tschakarjan,1 D Tormo,1 A Zimmer2 and T Tuting1 1
Experimental Dermatology, University of Bonn, Bonn, Germany and 2 Molecular
Neurobiology, University of Bonn, Bonn, Germany
Cannabis preparations have been used in traditional medicine for the treatment of inflamma-
tory diseases. The major active constituent of the plant Cannabis sativa is delta-9-THC (tetrahy-
drocannabinol). Two specific receptors mediate the effects of cannabinoids (CB1- and CB2-
receptor). The discovery of endogenous CB-receptor ligands prooved the existence of an
endogenous CB-system with many physiological functions. A participation of CB-receptors in
the downregulation of inflammatory processes was demonstrated in experimental models for
atherosclerosis or colitis. Therefore, we investigated the role of the CB-system in experimen-
tal contact hypersensitivity (CHS). CHS was induced in C57Bl/6, C57Bl/6-CB1-/-, -CB2-/- and
-CB1/2-/- mice by application of 0,2 % DNFB on the shaved abdomen and elicited by paint-
ing the ears with 0,3 % DNFB. Ear swelling was measured after 24h, 48h and 72h. Addition-
ally, wildtype mice were treated s.c. with the CB-antagonists SR141716 and SR144528 or the
CB-agonist delta-9-THC. Histopathological analyses were performed on inflamed skin.
Contact allergy in mice lacking the CB-receptors was increased more than 100% in compar-
ison to wildtype mice. Pharmacological blockade of CB-receptors with SR141716 and
SR144528 also induced an increased ear swelling in wildtype mice. Histological analysis
demonstrated elevated numbers of infiltrating Gr-1+- and MHC-II+-cells in CB-receptor defi-
cient and SR141716- or SR144528-treated mice. delta-9-THC reduced ear swelling and tis-
sue infiltration of inflammatory cells. Our results demonstrated that the endogenous CB-sys-
tem is involved in downregulating cutaneous hypersensitivity responses. Future experiments
will have to address how cannabinoids participate in this regulation. Furthermore, novel CB-
receptor ligands may be developed for the treatment of inflammatory skin diseases.
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Th2-type immune deviations in the skin lesion of MRL/lpr mice deficient for IL-27 receptor
(WSX-1)
K Makiko, T Satoshi, M Youichi, U Kazunori and F Masutaka Department of Dermatology
Graduate School of Medical Sciences Kyushu University, Fukuoka, Kyushu, Japan
WSX-1 (IL-27R) is typically expressed on T cells with homology to IL-12R, and IL-27/WSX-1
signaling reportedly plays critical roles in both initiation of Th1 responses and attenuation of
cytokine production during inflammation. MRL/lpr mice are an animal model for systemic
lupus erythematosus with Th1-type nephritis, lymphoproliferative disorders, and naturally
occurring erythematous skin lesions. Recently, others reported that, in MRL/lpr deficient for
WSX-1 (WSX-1 KO) mice, the Th1 type nephritis is converted into Th2 type nephritis, charac-
terized by predominant deposition of IgG1, a Th2-associated subclass, in the glomeruli accom-
panied by increased serum IgG1 and IgE. The WSX-1 KO mice remain to develop skin dis-
ease, but the detailed analysis lesion has not been done by far. Thus, the purpose of this study
was to assess whether the WSX-1 KO mice develop Th2 deviated skin lesions as compared to
controls (MRL/lpr WSX+/-). Histologically, the epidermal hyperplasia with erosion and con-
siderable dermal infiltration of mononuclear cells were observed in both WSX-1 KO and con-
trols, however, the ratio of IL-4 positive cells per total infiltrates in the WSX-1 KO mice was
significantly higher (14.0%±2.4%) than that of control mice (7.4%±1.2%) with comparable
level of IFN-γ positive cells (4.1%±1.9% and 3.6%±0.7%, respectively). Significantly increased
number of mast cells per total infiltrates was also observed in the lesional dermis of the KO
mice (25.6%±5.9%), as compared to that of control mice (8.2%±3.2%). Lupus band test were
positive in the skin lesion from both mice, detailed analysis using subclass antibodies revealed
that deposition of IgG2a, a Th1-associated subclass, was detected only in control, but not in
the KO mice. Taken together, we assessed Th1/ Th2 balance in the skin lesions in the WSX-1
KO mice and control mice, and found significant Th2 deviation in the skin lesion of the KO.
The MRL/lpr mice deficient for WSX-1 thus may provide a new model to assess Th2-type skin
disease, such as atopic dermatitis.
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Inhibitory effect of the Polyinosinic-Polycytidylic Acid/Cationic Liposome Complex on the
progression of murine B16F10 melanoma
T Fujimura,1 S Nakagawa,1 Y Ito,1 K Hirabayashi,2 J Yano2 and S Aiba1 1 Dermatology, Tohoku
University, Graduate School of Medicine, Sendai, Japan and 2 Discovery Research
Laboratories, Nippon Shinyaku Co., Kyoto, Japan
Recently, it has become clear that cellular protein retinoic acid inducible gene-I other than
Toll-like receptor 3 sense dsRNA including polyinosinic-polycytidylic acid (PIC) to stimulate
the dsRNA-induced innate immune response. Although the local administration of PIC has
been demonstrated to be effective in anti-tumor immunotherapy, the effects of PIC delivered
cross the cell membrane have not been examined yet. To address this issue, we used a com-
plex of PIC and cationic liposome (PIC liposome). In this study, at first, we examined whether
PIC liposome could directly suppress the growth of B16 melanoma in vitro. Next, we exam-
ined the antitumor effects of repeated peritumoral injections of PIC liposome for the estab-
lished B16 melanoma. PIC liposome could directly suppress the growth of B16 melanoma in
vitro and repeated peritumoral injections of PIC liposome inhibited the tumor growth in a
dose-dependent manner. Interestingly, this treatment induced TRP2 tetramer-positive CD8+
cells in the draining lymph nodes. As one of the mechanisms for the induction of the antitu-
mor immune response by PIC liposome, we showed that the intradermal injection of PIC lipo-
some induced the maturation of both dermal DC and epidermal LC and that PIC liposome
induced phenotypic and functional maturation of human monocyte-derived DC. Finally, we
demonstrated that the intratumoral injection of immature DC after treatment with PIC lipo-
some significantly increased the number of TRP2-specific IFN-γ producing cells in the drain-
ing lymph nodes as well as spleen, which resulted in the augmentation of the antitumor immune
response by PIC liposome. These studies demonstrate the potential of peritumoral injection of
PIC liposome for immunotherapy of malignant melanoma.
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Human β-defensin-2 expression in superficial mycosis
C Oh, H Jang, H Park, B Jang, M Kim and K Kwon  Dermatology, Pusan National University,
Busan, South Korea
Normal human skin is resistant to infection from various kinds of microorganisms by produc-
tion of anti-microbial chemicals. Human β-defensin-2(hBD-2) is an anti-microbial peptide that
has recently been shown to be expressed in various epithelial cells and inflammatory diseases.
However expression of hBD-2 in fungus-infected skin is not well-known. This study was per-
formed to investigate the expression pattern of hBD-2 in superficial mycosis. Using immuno-
histochemical method with formalin-fixed, paraffin-embedded sections, we investigated the
expression levels and localization of hBD-2 in skin samples from tinea capitis (5 patients),
tinea corporis (6 patients), candidiasis (3 patients), Malassezia folliculitis (2 patients), and
psoriasis (3 patients) as postive control and normal skin samples from 6 healthy subjects as
negative control. The expression of hBD-2 was not observed in normal skin but moderate to
strong expression of hBD-2 was observed in epidermis and papillary dermal infiltrating cells
in psoriasis. In tinea capitis, strong hBD-2 expression was found in upper spinous layer of epi-
dermis and follicular epidermis, and perifollicular inflammatory cells. In tinea corporis and
candidiasis, mild to strong expression of hBD-2 was found in horny or spinous layer of epi-
dermis and infiltrating inflammatory cells. Strong hBD-2 expression was also present in fol-
licular epidermis and perifollicular inflammatory cells in Malassezia folliculitis. These results
may suggest that hBD-2 plays an important role in cutaneous innate immune defense against
fungal infection.
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Consequences of PPAR-alpha deficiency in Langerhans cells and T-cells
S Dubrac,1 P Stoitzner,1 K Shoonjans,2 J Auwerx,2 N Romani1 and M Schmuth1 1 Department
of Dermatology, Innsbruck Medical University, Innsbruck, Austria and 2 IGBMC, University
of Strasbourg, Illkirch, France
Peroxisome proliferator-activated receptor (PPAR) alpha is a nuclear hormone type transcrip-
tion factor that is activated by fatty acid-derived ligands. In skin, PPAR-alpha regulates cellu-
lar proliferation, differentiation and inflammation. We recently reported expression of PPAR-
alpha in epidermal Langerhans cells (LC) and anti-inflammatory effects of pharmacologic
PPAR-alpha activation in a mouse model of allergic contact dermatitis. We here report that
PPAR-alpha deficient mouse ears exhibit increased inflammatory infiltrates after exposure to
a contact allergen. Maturation and migratory capacity of LC were normal in these animals,
LC expressed normal quantities of cytokines and their ability to drive T cell proliferation in
mixed lymphocyte reactions did not differ from wild-type cells. However, PPAR-alpha defi-
cient LC were less viable. Importantly, draining lymph nodes isolated from PPAR-alpha defi-
cient mice showed increased total cell numbers and T cells isolated from lymph nodes after
sensitization with a contact allergen showed increased expression of CD25, IL-2 and IL-10.
Together, PPAR-alpha deficiency results in an exaggerated T-cell response to contact allergen
that accounts for increased skin inflammation.
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Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-
tumor immunity following challenge at a secondary location
T Kakinuma,1 H Nadiminti,1 T Murakami,1 BA Perez,1 H Kobayashi,3 SE Finkelstein2 and
ST Hwang1 1 Dermatology Branch, National Cancer Institute, Bethesda, MD, 2 Surgery
Branch, National Cancer Institute, Bethesda, MD and 3 Metabolism Branch, National Cancer
Institute, Bethesda, MD
Under some conditions, tumor cells inoculated in immunocompetent hosts fail to form tumors,
yet remain alive as single cells for many days. Herein, we address immunological impact of
such cells on host anti-tumor immunity. We utilized a tumor model in which luciferase-trans-
duced B16 murine melanoma cells (luc-B16) injected in ear skin protected mice against B16
cell (but not RMA lymphoma) tumor challenge in the footpad. Serial analysis showed that
(without forming tumors) luc-B16 cells were present in ear skin for up to 50 d post inocula-
tion by in vitro luciferase assay and that these “residual” tumor cells were recoverable in cul-
ture. In the first 14 d post ear skin injection, CD4+CD25+ T cells increased by 7-fold (by flow
cytometry) and FoxP3 mRNA expression (real-time RT-PCR) increased by more than 500-fold
in injected (vs. non-injected) skin. Residual tumor cells in ears were reduced in mice treated
with anti-CD25 mAb by 3-fold and in CD4-deficient mice by 5-fold, but increased in CD8-
deficient mice by 3-fold. Strikingly, the loss of residual luc-B16 cells in the ear skin following
amputation of the injected ear resulted in significantly enhanced (9-fold, p<0.001) tumor for-
mation by luc-B16 cells after footpad challenge. Moreover, mice that spontaneously lost resid-
ual tumor cells in ear skin developed tumors that were ~4-fold (p=0.03) larger (compared to
those that retained residual tumor cells) when challenged in the footpad with parental B16
tumor cells. These studies suggest that small numbers of living tumor cells (possibly regulated
in number by CD4+CD25+ T regulatory cells expressing Foxp3) elicit (and are required for)
effective host anti-tumor responses at alternate inoculation sites.
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Keratinocyte expression of receptors relevant for the innate immune response to Staphylo-
coccus aureus in subjects with atopic dermatitis<b/>
L McGirt,1 ME Brummet,1 L Bankova1 and LA Beck1,2 1 Department of Medicine, Division of
Clinical Immunology, Johns Hopkins Medical Institute, Baltimore, MD and 2 Department of
Dermatology, Johns Hopkins Medical Institute, Baltimore, MD
To evaluate the expression of pathogen recognition receptors (PRR) relevant for the innate
immune response to Staphylococcus aureus on keratinocytes (KC) from adult subjects with
atopic dermatitis (AD) as compared to nonatopic controls (NA). We enrolled subjects with
AD (n=3) and NA (n=9), and employed a suction-blister apparatus applied to the forearm to
isolate KCs. The KCs (3rd passage) were stimulated with the pathogen-associated molecular
patterns (PAMP) lipoteichoic acid (LTA, 2µg/ml for 24 hr) and peptidoglycan (PGN, 20µg/ml
for 24 hr). Flow cytometry and immunohistochemistry were used to evaluate innate receptor
protein expression (TLR2, CD14, PGRP-1α, PGRP-1β, NOD2), and real-time PCR for relative
mRNA expression. We identified mRNA and protein expression for PGRP-1α, but not PGRP-
1β on KCs. LTA stimulation increased TLR2, CD14, and PGRP-1α protein expression on KCs
from all donors. PGN stimulation had no effect on any of the PRRs in either population. LTA
stimulation led to a greater increase in PGRP-1α expression in non-atopic KCs (n=6) as com-
pared to AD KCs (n=3) (net MFI: 3.3±0.4 vs. 1.7±0.5, p=0.03). The constitutive cell surface
expression of TLR2, CD14, and PGRP-1α were reduced in AD KCs compared to NA, but did
not reach statistical significance. We did not see statistically significant differences in mRNA
expression of any PRRs after 24 hour stimulation with either LTA or PGN. We identified the
expression of an important S. aureus PRR, PGRP-1α, on KCs of both NA and AD donors. LTA
was shown to upregulate TLR2, CD14, and PGRP-1α on NA and AD KCs. We also demon-
strated an impaired induction of PGRP-1α after stimulation with the S. aureus-specific PAMP,
LTA, in AD subjects compared to NA. This work suggests that AD KCs have an aberrant innate
immune response to relevant skin pathogens such as S. aureus.
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Improved generation of anti-tumor immunity by antigen dose limitation
JD Shofner, J Vasquez, CL Berger, K Mariwalla and RL Edelson Dermatology, Yale University,
New Haven, CT
Since the malignant cells of cutaneous T cell lymphoma (CTCL) display immunogenic anti-
gens derived from the clonal T cell receptor (TCR), CTCL offers a model for the refinement of
anti-tumor immunization methodology. To produce a clinically meaningful anti-tumor response,
induction of a cytotoxic anti-CTCL response must be maximized while a suppressive T regu-
latory cell (Treg) response is minimized. We demonstrated that processing of apoptotic CTCL
cells by dendritic cells (DC) can lead to either CD8 anti-CTCL responses or Treg induction.
Treg induction is favored when the number of apoptotic cells in co-culture is high. In this study,
we determined whether that balance could be shifted towards a positive anti-CTCL response
by lowering the ratio of apoptotic CTCL cells to DC. CTCL cell apoptosis was produced by
engagement of the TCR by anti-CD3 antibody affixed to magnetic beads. The physical pertur-
bation inherent in passage through the separation column simultaneously induced mono-
cytes to differentiate into DC, which could internalize and process the apoptotic CTCL cells.
Purified CD8 T cells were added overnight, phenotyped and analyzed by flow cytometry.
At low levels of apoptotic cell/DC loading (<1.15±0.42), CD8 T cells increased perforin expres-
sion (8.1%±2.3 to 10.1%±1.9), and mediated a 1.74X increase in T cell death (p≤0.05). Absolute
CD8 cell counts (27.8x104±6.5 to 38.8x104±4.0, p≤0.03) increased significantly upon co-
culture with loaded DC compared to controls. A dose dependent increase in CD3+/CTLA-4+
cells was found as the number of apoptotic cells ingested by DC increased (p=0.0008), with
a high apoptotic cell/DC ratio favoring Treg generation and decreased CD8 perforin expres-
sion. These findings suggest that the ratio of tumor antigen to DC is an important determinant
of whether a CD8 anti-tumor or suppressive immune response is generated. A high ratio induces
Treg cells while a lower ratio favors generation of a CD8 anti-tumor response.
116 Journal of Investigative Dermatology (2006), Volume 126
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Norepinephrine inhibits Langerhans cell activation by altering cytokine release
E Goyarts, M Matsui, D Maes and T Mammone Estee Lauder Research Laboratories, Melville,
NY
Psychological stress is potentially harmful to the skin because the nervous system responds
by releasing norepinephrine, which may suppress cellular immunity by reducing the ability
of Langerhans cells (LCs) to be activated. Published results on murine dendritic cells indicate
a short exposure of norepinephrine in the presence of lipopolysaccharides (LPS) alters cytokine
release and reduces T cell stimulation. We investigated the effect of norepinephrine on human
LC activation. LC activation was evaluated by the release of LPS-inducible cytokines as well
as the activation of T cells. Human bone-marrow-derived LCs, containing 40% plasmacytoid
dendritic cells, were stimulated by LPS in the presence of norepinephrine. LCs were given a
short-term (3h) exposure of norepinephrine at the beginning of the LPS treatment. The LPS-
inducible markers, TNF alpha and IL-12 p40, were down-regulated in the presence of nor-
epinephrine. The LPS-inducible marker, IL10, was not affected. The specificity of the response
was evaluated with alpha and beta adrenergic receptor antagonists. The beta adrenergic recep-
tor antagonists, propranolol and ICI-118,551, increased the LPS-inducible markers, TNF alpha
and IL-12 p40, in the presence of norepinephrine and LPS. The alpha adrenergic receptor
antagonist, yohimbine, had no affect. Beta adrenergic receptors expressed on the surface of
human LC mediate the decrease in immune function. A beta adrenergic receptor antagonist
is likely to reverse stress-induced immunosuppression by directly inhibiting norepinephrine
engagement of the beta adrenergic receptor.
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Psoriatic peripheral CD4+CD25- effector T cells display heightened activation signaling
WA Goodman,1 H Sugiyama,2 R Gyulai,3 TS McCormick1 and KD Cooper1 1 Dermatology,
Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, 2
Dermatology, University of Yamanashi, Nakakoma, Japan and 3 Dermatology, University of
Szeged, Szeged, Hungary
Homing and activation of effector/memory T cells in psoriatic skin is critical to maintaining
lesions. A subset of these skin-resident cells likely originates from circulating T cells, perhaps
via receptor expression for chemokines strongly expressed in psoriatic plaques, such as IP-10
and its cognate receptor CXCR3. Because psoriatic T cells already over-express CXCR3 in the
peripheral blood, we hypothesized that these cells display heightened signaling responses,
causing pathogenic activation in the skin. Peripheral-blood derived lymphocytes from psori-
atic patients and healthy controls were sorted by high-speed flow cytometry into CD4+CD25-
(“resting”) and CD4+CD25low+ (“recently activated”) populations. Using these Treg-free
responder T cells, there was increased alloantigen-induced proliferation among psoriatic
CD4+CD25- cells compared to healthy control T cells (p=0.002, n=7). Additionally, low con-
centrations of anti-CD28 were sufficient for stimulating resting psoriatic, but not normal, T
cells. A higher proportion of circulating CD4+ T cells in psoriasis expressed mid to high lev-
els of CD25 compared to normal cells (p<0.002, n=12), suggesting that psoriatic effector cells
may exhibit an abnormal intracellular signaling state before ever even reaching the skin.
Immunoblots performed on protein extracts from our purified T cell populations showed ele-
vated and sustained hyper-phosphorylation of the T-cell receptor signaling molecule lck fol-
lowing anti-CD3/anti-CD28 stimulation within the psoriatic resting T cell population, indi-
cating that early signaling events in these cells are not properly regulated. Dysregulated T cell
signaling, whether constitutive or due to a distant, prior activation, may create a pathogeni-
cally lower activation threshold for psoriatic T cells in response to normally subthreshold sig-
nals in the skin or lymph nodes.
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CCR7-dependent lymph node metastasis is associated with tumor development and striking
alterations in the composition of immune cells within B16 melanoma tumors
L Fang and ST Hwang Dermatology Branch, National Cancer Institute, Bethesda, MD
Lymph node (LN) metastasis is a poor prognostic indicator in most human cancers. Overex-
pression of the chemokine receptor, CCR7, by B16 melanoma cells has been shown to enhance
LN metastasis although the impact of LN metastasis in that model on tumor formation and
host immunity is unclear. We inoculated B16 cells transduced with CCR7 cDNA (CCR7-B16
cells) or empty vector (pLNCX2-B16 cells) in C57BL/6 mice at two different sites: ear skin or
footpad.  Following injection at either site, visible metastases in popliteal and cervical LN
were present in >90% of mice inoculated with CCR7-B16 cells (but not pLNCX2-B16 cells).
Following injection of 1x105 CCR7-B16 or pLNCX2-B16 cells in ear skin, tumors formed with
greater frequency in mice injected with the former (>95% vs. <10% of mice, respectively).
After injection of either 4x105 CCR7- or pLNCX2-B16 cells in the footpad, tumors of similar
size developed in nearly all mice. Tumor-infiltrating leukocytes were ~3-fold reduced in CCR7-
B16 tumors compared to pLNCX2-B16 tumors. Moreover, flow cytometric analysis of tumor-
infiltrating cells revealed striking 10-, 4-, and 2-fold reductions in CD8+ T cells, F4/80+ cells,
and CD4+ cells, respectively, within tumors arising from injection of CCR7-B16 cells (vs.
pLNCX2-B16 cells). No changes were noted in frequency of B220+ and CD11c+ cells, and
no differences in these leukocyte populations were detected in the draining LN. In summary,
depending on the site of inoculation, CCR7-mediated LN metastasis was associated with B16
cell tumor formation (ear skin) or with striking alterations in the composition of immune cells
localized within tumors (footpad), including profound decreases in CD8+ T cells.  This model
provides an experimental framework for investigating the role of LN metastasis in human tumor
progression.
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Whole recombinant yeast expressing hMART-1 activates CD4+ T cells and induces proin-
flammatory and Th1 cytokines
H Riemann, A Tanaka, K Okamura, DA Norris and M Fujita Department of Dermatology,
University of Colorado Health Sciences Center, Aurora, CO
Yeast represents a vehicle of antigen loading and immunostimulation. We have shown that
administration of whole recombinant yeast expressing human MART-1 (hMART-IT) induces
protective anti-melanoma immunity in mice. In order to understand the mechanism how the
hMART-IT stimulates anti-tumor immune response, we have analyzed phenotypes of T cells
and cytokine profiling from naïve or vaccinated mice during in vitro re-stimulation by hMART-
IT. Splenocytes from hMART-IT vaccinated mice showed early and profound proliferation of
both CD4+ and CD8+ cells after in vitro re-stimulation, while those from naïve mice showed
proliferation of CD4+ cells followed by gradual increase of CD8+ cells. Interestingly, during
in vitro re-stimulation, frequency of CD4+CD25+ cells slightly decreased in hMART-1 vacci-
nated mice while it significantly increased in naïve mice. Cytokine profiling using Bio-Plex
mouse cytokine Th1/Th2 panel showed brisk production of IL-2 followed by production of
high amounts of IL-6, IFNγ, GM-CSF, TNFα by splenocytes from hMART-IT vaccinated mice.
While small amounts of Th2 cytokines (IL-4, IL-5, and IL-10) were produced after day 3, the
production of IL-6, IFNγ, GM-CSF, TNFα remained constantly high. In contrast, splenocytes
from naïve mice produced little cytokines except IL-12. We further tested if the cytokine pro-
duction from vaccinated mice was dependent on CD4+ or CD8+ cells and if it was depend-
ing on vaccinated T cells. Depletion / repletion experiments revealed that antigen-specific
CD4 cells are the major source of IFNγ, IL-6, GM-CSF, IL-5, and IL-10 and that production of
TNFα and IL-12 was not significantly affected by depletion of either CD4+ or CD8+ T cells.
Our data demonstrate that vaccination with whole recombinant yeast induces activation of
CD4+ T cells with the ability to rapidly produce pro-inflammatory and Th1 cytokines in response
to re-exposure to antigen. In addition, suppression of regulatory CD4+CD25+ T cells might
also contribute to effective anti-tumor immune response by hMART-IT.
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Activation of the IL-1beta-processing inflammasome in the skin mediates contact hypersen-
sitivity
H Watanabe,1 O Gaide,1 V Petrilli,2 F Martinon,2 E Contassot,1 S Roques,1 J Tschopp2 and
L French1 1 Dermatology, Geneva University Hospital, Geneva, Switzerland and 2
Biochemistry, Lausanne University, Lausanne, Switzerland
An innate immune response can be triggered by the assembly of the inflammasome, a cytoso-
lic complex of proteins that activates caspase-1 to process the proinflammatory cytokines inter-
leukin (IL)-1β and IL-18. The inflammasome can be activated by “danger signals” that trigger
assembly of NALPs with the adaptor protein ASC and caspase-1 and/or 5. In the skin, expo-
sure to contact allergens causes allergic contact hypersensitivity (CHS), an immune response
involving IL-1β. To determine if the inflammasome contributes to CHS, we analyzed IL-1β pro-
cessing components and their function in keratinocytes and monoctye-derived cells, as well
as the CHS response to trinitro-1-chlorobenzine (TNCB) in ASC- and NALP3-deficient mice.
Here we show that IL-1 receptor-deficient mice display impaired CHS to TNCB, and that
components required to form an active inflammasome are present in both keratinocytes and
monoctye-derived cells. In these cells, in vitro exposure to TNCB also triggers cleavage of
caspase-1 and pro-IL-1β. In a mouse model of CHS to TNCB, ASC- and NALP3-deficient mice
were less responsive to the contact allergen as determined by ear swelling and dermal edema
at the site of challenge. These findings reveal a novel role of the NALP-3 inflammasome as a
mediator of contact hypersensitivity, and furthermore suggest that NALP-3 acts as the sensor
for the contact allergen TNCB. Targeting the inflammasome with small molecule inhibitors
may thus represent a new modality for the treatment of CHS.
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Depletion of Tregs as immunological adjuvant for allergic contact dermatitis in mice
HC Maguire , M Kutzler, R Parkinson, K Schoenly, S Kumar, J Boyer and D Weiner Pathology
and Dermatology, University of Penn, Philadelphia, PA
We have studied the effect in mice of the depletion of CD4+CD25+ T cells (Tregs) on the acqui-
sition of allergic contact dermatitis (ACD) in mice. Balb/c female mice were injected IP with
a monoclonal antibody (PC61) that depletes Tregs. Six hours later, these mice and a control
group were sensitized by the application of 20 ul of 5% oxazolin to the rear flank skin. Day
10, both groups were ear challenged with 0.2 % oxaxalone. Twenty-four hours later, the ear
thicknesses were measured. The average increases in ear thickness of the experimental mice
were several fold that of the control mice. Histology of the tested ears at that time showed an
infiltrate of round cells and edema that was much more marked in the mice pretreated with
the monoclonal antibody. Depletion of Tregs has been shown to up-regulate the immune
response to a number of microbial pathogens, tumor antigens and allogeneic cells. We now
find that it is a substantial immunological adjuvant for contact allergens. It can be used in the-
oretical and practical studies of ACD phenomena.
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The role of CD11c+ dendritic cells for low zone tolerance to allergens
N Lorenz, W Seidel-Guyenot, R Alt, J Knop and K Steinbrink Department of Dermatology,
University of Mainz, Mainz, Germany
The induction of tolerance may be a promising target of strategies aimed at preventing harm-
ful immune responses. Low zone tolerance (LZT), induced by epicutaneous application of low
doses of contact allergens, requires the generation of CD8+ suppressor Tc2 cells that inhibit
the development of Tc1-mediated contact hypersensitivity (CHS). Since skin-related dendritic
cells (epidermal Langerhans cells, dermal DC) and B cells were previously excluded to be
involved in the development of LZT, we analyzed the role of APC located in the lymphatic
system for tolerance induction to allergens. FACS analysis revealed a significant increase in
the number of CD11c+ DC in the lymph nodes of mice tolerized by subimmunogenic doses
of contact allergens (TNCB 5 x, 4.5 µg) as compared to control animals. To study whether
CD11c+ DC contributed to LZT, we use CD11c-DTR mice. In this mice, systemic administra-
tion of diphteria toxin leads to a transient and rapid decline in CD11c+ DC in lymph nodes
and spleen. Notably, depletion of CD11c+ DC by injection of diphteria toxin during the induc-
tion of LZT abolished the characteristic features of LZT, including reduced ear swelling, gen-
eration of CD8+ suppressor T cells of LZT and skewing to a Tc2 cytokine pattern. As compared
to PBS-treated CD11c-DTR animals, an unrestricted CHS reaction was observed in these
mice resulting in an marked ear swelling mediated by the development of Tc1-effector T cells
of CHS. Furthermore, adoptive transfer experiments of purified CD11c+ DC obtained from LN
of tolerized mice induced LZT in the recipients independent of the route of application. Our
findings identify CD11c+ DC as key APC of LZT to allergens that are necessary and sufficient
for Tc2 priming during induction of LZT and indentify DC as a novel target for directed ther-
apy of allergic diseases.
704
The MAP kinase p38-related suppressor function of regulatory T cells does not require IL-10
H Adler, E Graulich, J Knop and K Steinbrink Department of Dermatology, University of
Mainz, Mainz, Germany
Anergic regulatory T cells (iTreg) induced by stimulation with IL-10 modulated tolerogenic
dendritic cells (IL-10DC) display an altered pattern of MAP kinase activation as compared to
effector T cells. MAP kinase p38 activity is enhanced in iTreg, whereas ERK and JNK activity
are reduced. As shown by inhibition of p38 by the specific inhibitor SB203580, the activity
of p38 is essential for both, induction of the anergic state and the regulatory function of iTreg.
MAP kinase p38 is known to be involved in the regulation of IL-10 in T cells. Thus, we analysed
IL-10 expression in iTreg or effector T cells in the presence or absence of SB203580. We per-
formed qRT-PCR for IL-10 mRNA and quantified secreted IL-10 protein in high-sensitive ELISA.
Expression and secretion of IL-10 protein was low in both populations after restimulation
though iTreg expressed higher levels of mRNA and secreted higher amounts of protein (0-207
pg/ml, 24.3+/-43.3 pg/ml) as compared to effector T cells (0-17 pg/ml, 2.35+/-4.9 pg/ml). iTreg
pretreated with SB203580 showed reduced expression of IL-10 mRNA and secretion of IL-10
protein after restimulation. In contrast, effector T cells pretreated with SB203580 showed only
slightly reduced mRNA expression whereas secretion of IL-10 protein reached the level of
untreated iTreg. In coculture of iTreg and effector T-cells production of IL-10 protein was within
the range observed for iTreg alone (38-207 pg/ml, 120.3+/-84.6 pg/ml). Pretreatment of iTreg
with SB203580 before coculture with effector T cells resulted in reduced IL-10 production
during coculture assays (33-49 pg/ml, 40.3+/-8.0 pg/ml). Blocking experiments with antibod-
ies against IL-10 or IL-10R did not show any effect on regulatory activity of iTreg. In summary,
in our hands production of IL-10 by iTreg is comparable to IL-10 levels of effector T cells treated
with SB203580 and is far lower than reported for Tr1 cells. Our results suggest that p38-medi-
ated IL-10 production of iTreg is not involved in the anergic state and suppressor function of
regulatory T cells induced by tolerogenic DC.
705
Effect of TS-022 on experimental pruritis, cutaneous barrier disruption and atopic dermati-
tis models in mice
I Arai, Y Hashimoto, Y Honma, C Koizumi, N Futaki, M Sugimoto, N Takahashi, T Inoue,
Y Nakanishi, T Sakurai and S Nakaike Medicinal Research Laboratories, Taisho
Pharmaceutical Co., Ltd., Saitama, Japan
TS-022 inhibits ADP-induced platelet aggregation and this anti-aggregatory activity was sig-
nificantly antagonized by BWA868C as in the case of PGD2. TS-022 is a prostanoid DP1 recep-
tor agonist, originally developed as a novel anti-pruritic drug for patients with atopic dermatitis.
We examined the effect of TS-022 on experimental pruritis, cutaneous barrier disruption, atopic
dermatitis models and in vitro immune function test. Topically applied TS-022 significantly
suppressed the scratching of skin-lesioned NC/Nga mice from the concentration of 10-6%, and
tacrolimus (FK-506), used as a reference drug for atopic dermatitis, also suppressed only a
concentration at 0.1%. Topically applied TS-022, once a day for 4 days, significantly accel-
erated the recovery of cutaneous barrier disruption by mechanical scratching or chemical treat-
ment from the concentration at 10-6, and 10-2%, but not at all in 0.1% FK-506. Repeated top-
ical applied 0.01% TS-022 and 0.1% FK-506 once a day for 6 weeks significantly improved
the onset of skin inflammation score of NC/Nga mice. As in vitro, concanavarin A-activated
limphokines production and proliferation by splenocytes, inhibitory activity of TS-022 was
marginal effect as compared to FK-506 or dexamethasone. Anti-pruritic and anti-dermatitis
effects of TS-022 were not based on the immunosuppressive activity. These results suggest that
therapeutic effect of TS-022 for atopic dermatitis in NC/Nga mice were due to suppressed
scratching behavior and/or accelerated the recovery of cutaneous barrier disruption via spe-
cific prostanoid DP1 receptor. TS-022 is a novel type of drug for atopic dermatitis whose mech-
anism clearly different from currently used drugs.
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Langerhans cells preferentially develop from c-kit positive hematopoietic progenitors through
thymic-independent pathways
S Takeuchi,1,2 F Takeuchi,1,2 M Furue2 and SI Katz1 1 Dermatology, Graduate School of
Medical Sciences, Kyushu University, Fukuoka, Japan and 2 Dermatology, NCI, NIH,
Bethesda, MD
Despite extensive efforts, the precise developmental pathway and cellular precursor(s) for
epidermal Langerhans cells (LC) remain unclear. We previously reported that LC precursors
exist within peripheral blood, thymus, spleen and bone marrow (BM). For the LC lineage, we
have reported that IL-7Rα, a key mediator for lymphopoiesis, is not required for the develop-
ment of LC or other dendritic cells in vivo, suggesting their lymphoid independence. How-
ever, the thymic LC pathway demonstrated by us and others is likely to be a lymphoid line-
age. Thus, the purpose of this study was (1) to assess the significance of the thymic pathway
for LC development in vivo and (2) to determine the LC precursor phenotype in vivo. We exam-
ined the kinetics of LC reconstitution by cell transfer from CD45 congenic donor into irradi-
ated mice and found that donor derived LC appeared in the epidermal sheets as early as at
day 3 and more so at day 5 (or later) with vigorous reconstitution of myeloid lineages and c-
kit+ progenitors in the BM (>80% at day 5), while reconstitution of thymic precursors was min-
imal (<3% at day 5) at those times. We further demonstrated that the thymic microenviron-
ment was not required for LC engraftment since it occurred even when we used athymic nude
mice as recipients. Thus, we conclude that, although a thymic LC pathway may exist, it is not
a major pathway for LC development in vivo. Assays using sorted cell populations demon-
strated that LC derived from c-kit+ splenocytes (mean LC chimerism; 5.0%) or BM (14.1%)
but not from their negative fractions (0.0%, 0.0% respectively), and that depletion of BM cells
expressing Sca-l, a stem cell marker, did not abrogate the engraftment of LC by Sca-1- BM
(17.4%, 9.6% for Sca-1+ and Sca-1- BM, respectively). Taken together with our previous find-
ings, we propose that c-kit+Sca-1-IL-7Rα- hematopoietic progenitor cells may be efficient
intermediate LC precursors.
707
Corticotropin-releasing hormone down-regulates CXCL 1 expression via E74-like factor 3 in
primary keratinocytes
S Lee,1 J Lee,2 C Kim2 and J Lim1 1 Traditional Medicine and Bioscience, Daejeon University,
Daejeon, South Korea and 2 Dermatology, Chungnam National University, Daejeon, South
Korea
Dysregulation of cytokines production is implicated in many skin disorders including psoria-
sis. In our previous study, we found that the addition of fetal bovine serum to normal ker-
atinocyte culture, a condition mimicking the abnormal differentiation similar to psoriasis, led
to the dysregulated expression of many chemokines. Among them, GRO-alpha (CXCL1) that
has been known to play a role in the infiltration of neutrophils into the lesional skin has been
found to be increased. Corticotropin-releasing hormone (CRH) has been shown to inhibit
proliferation of epidermal keratinocytes and modulate their cytokine production, suggesting
that CRH is one of important regulator of skin homeostasis. In order to find the regulatory
effects of CRH on the expression of GRO-alpha in epidermal keratinocytes, the effects of
CRH on the expression of GRO-alpha mRNA in primary keratinocytes were determined. Our
results showed that CRH reduced the expression of GRO-alpha mRNA in a concentration-
dependent manner. In order to investigate the transcription factors involved in this process,
we made the several constructs harboring the deletion mutants of GRO-alpha promoter that
were fused to luciferase gene. Each constructs was transfected into the primary keratinoctye,
and investigated the promoter activities. Our results showed that CRH regulates GRO-alpha
production through binding of E74-like factor 3 to GRO-alpha promoter.
708
Characterization of subchronic vs. acute mouse models of DNFB-induced skin inflamma-
tion
L Roese and W Doecke CRBA Inflammation, Schering AG, Berlin, Berlin, Germany
This study evaluates whether an elaborated 2,4-dinitrofluorobenzene (DNFB) dosing sched-
ule in comparison to an acute standard schedule i) is suitable for a subchronic mouse model
of contact hypersensitivity (CHS), ii) exhibits improved chronic characteristics of skin inflam-
mation, and iii) closer reflects the therapeutic response pattern of chronic T cell-dependent
skin diseases like psoriasis. The type 1 cytokine-dominated DNFB-induced CHS model is struc-
tured in sensitization phase (first exposure), leading to establishment of T cell memory, and
challenge or elicitation phase (second exposure) leading to T cell-dependent skin inflamma-
tion. We compared single challenge (acute model) vs. repeated challenges with reduced
allergen load (subchronic model) and searched for chronic features of skin inflammation. In
subchronic model ear edema formation and treatment response could be followed over time
courses of 3-4 days pursuing ear thickness. Strong cutaneous T cell infiltration as well as dis-
ability of athymic nude mice to respond to subchronic DNFB challenges demonstrate the piv-
otal role of T cells. Moreover, only in subchronic setting characteristics of psoriasis as epider-
mal thickening, hypervascularization and a strongly enhanced cytokine expression are observed.
Systemic or topical treatment with standard glucocorticoids over the elicitation phase is dose-
dependently efficacious. Remarkably, antagonization of cytokines is anti-inflammatory active
in psoriasis and in subchronic model but not in acute CHS. Taken together, repetitive hapten
challenges facilitate the development of hallmarks of chronic skin inflammation in DNFB-
induced CHS model in mice and increase the similarity to chronic inflammatory skin diseases
like psoriasis.
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Elimination of epidermal Langerhans cells or impairment of dermal dendritic cells does not
abrogate the induction of localized graft-versus-host-disease-like skin disease
BS Kim,1,2 F Miyagawa,1 CL Bennett,3 BE Clausen3 and SI Katz1 1 Dermatology Branch, NIH,
Bethesda, MD, 2 HHMI-NIH Research Scholars Program, HHMI, Bethesda, MD and 3
Department of Cell Biology and Histology, University of Amsterdam, Amsterdam,
Netherlands
The exact contribution(s) of epidermal Langerhans cells (LCs) and dermal dendritic cells (dDCs)
to graft-versus-host-disease (GvHD) in the skin has not been well delineated. We therefore
developed an intradermal (ID) injection model whereby CD8+ (OT-I) T cells that express oval-
bumin (OVA)-peptide-specific T-cell receptors (Vα2/Vβ5) are delivered directly to the dermis
of transgenic (Tg) mice expressing OVA targeted to the epidermis under a keratin 14 (K14)
promoter. To determine the relative contribution of dDCs to the GvHD reaction we generated
K14-OVA Tg chimeras using β2-microglobulin-deficient (b2m) donor bone marrow cells. These
mice were chimerized with donor b2m splenocytes (90% of spleen), lymph node DCs (98%
of CD205+ cells), but not epidermal LCs (5%), the majority of which remained recipient-
derived (95%). The dDCs in these mice do not have the antigen-presenting capacity to pres-
ent OVA to OT-I cells while the LC maintain their antigen-presenting functions as previously
reported. Conversely, to determine the contribution of LCs, we have generated K14-OVA x
Langerin-Diphtheria-Toxin-Receptor (Langerin-DTR) Tg mice to conditionally ablate LCs in
the epidermis. Following ID injection of OT-I cells, the K14-OVA Tg mice developed local-
ized skin GvHD on day 7 regardless of the level of OVA expression in the epidermis. ID
injection of OT-I cells into the b2mÇK14-OVA chimeric mice resulted in skin GvHD by day
7, no different than in normal K14-OVA Tg mice. ID injection of OT-I cells into K14-OVA x
Langerin-DTR mice pretreated with diphtheria toxin resulted in skin GvHD by day 7 as well.
In summary, the elimination of LCs in the epidermis or the impairment of dDCs in the dermis
alone did not abrogate the local GvHD reaction. Our results suggest that the absence of DCs
in one compartment can be compensated for by DCs in the other.
711
Dermal fibroblasts and IL-15 induce the proliferation of natural regulatory T cells isolated
from human skin
RA Clark, TS Kupper and R Dowgiert Dermatology, Brigham and Women’s Hospital/Harvard
Medical School, Boston, MA
Regulatory T cells (Treg) are crucial for the induction and maintenance of self-tolerance. Treg
are present in peripheral tissues such as skin and gut under normal, non-inflamed conditions.
We report isolation and expansion of the Treg resident in normal human skin. Cutaneous Treg
expressed high levels of CD25, L-selectin, GITR, FOXP3 and intracellular CTLA-4, and low
levels of CD69. Skin Treg expressed high levels of the skin homing addressins CLA, CCR4
and CCR6 and suppressed the proliferation of CD25- T cells from the same skin sample in
response to CD3 and CD28 antibodies. Suppression was cell contact-dependent and not
affected by neutralizing antibodies to IL-10 and TGF-beta. Surprisingly, natural Treg from skin
proliferated in an antigen-independent manner when cultured in contact with dermal fibrob-
lasts and IL-15. Fibroblasts and keratinocytes from chronically inflamed skin produce func-
tional IL-15. Thus, natural Treg populating the dermis in areas of inflammation are exposed
to IL-15 and are in contact with dermal fibroblasts, conditions we have shown to support
their expansion. Although IL-15 has been previously reported to support proliferation of induced
Tr1-type Treg, this is the first demonstration of antigen-independent proliferation of natural
Treg. Natural Treg from the blood proliferate only in the presence of very high levels of IL-2
and supra-physiologic TCR and CD28 crosslinking, conditions that are difficult to replicate
in an intact organism. By contrast, we find that natural Treg from the skin can proliferate in
the absence of specific antigen, under conditions similar to those seen in inflamed skin. We
hypothesize that local proliferation of Treg may occur within inflamed skin and could serve
as brake for cutaneous inflammation as well as one mechanism for the previously unexplained
homeostatic proliferation of natural Treg within intact organisms.
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Downregulation of E-selectin on squamous cell carcinoma vasculature: immune evasion and
its reversal by imiquimod therapy
RA Clark,1 GF Murphy,2 CF Schanbacher 1 and TS Kupper1 1 Department of Dermatology,
Brigham and Women’s Hospital/Harvard Medical School, Boston, MA and 2 Department of
Pathology, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA
Squamous cell carcinomas (SCC) are a major cause of morbidity and mortality for individuals
on immunosuppressive medications. Increased incidence of SCC in these patients suggests
these tumors are controlled in most normal individuals by an intact cutaneous immune sys-
tem. When SCC do develop in otherwise normal individuals, these tumors likely have evolved
a way to evade the immune response. We isolated the T cells from SCC tumors and from sur-
rounding perilesional skin in normal patients. Surprisingly, T cells from SCC tumors were not
cutaneous T cells. These cells did not express the cutaneous addressins CLA, CCR4 and CCR6,
in contrast to high expression of these markers by T cells from normal and perilesional skin.
SCC T cells were memory T cells, had a very diverse T cell repertoire, and >75% expressed
high levels of CCR7 and L-selectin, indicating they were central memory T cells. The lack of
CLA expression in SCC T cells suggested that tumor vessels might not express E-selectin. Immuno-
histochemistry of SCC lesions confirmed that vessels within tumor areas did not express E-
selectin, whereas E-selectin was present in perilesional areas. T cells specific for SCC-associ-
ated antigens would be expected to reside within the CLA+ pool of cutaneous T cells. Therefore,
downregulation of E-selectin by SCC tumor vessels may exclude these T cells from entering the
tumor, preventing an immune response. Imiquimod, a topical immune modifier, is thought to
induce immune destruction of SCC by a number of mechanisms. T cells from imiquimod-treated
invasive SCC expressed high levels of CLA, suggesting that one of the earliest effects of imiquimod
may be to upregulate E-selectin on tumor vessels, allowing entry of skin-homing T cells capa-
ble of destroying the tumor. Examination of how SCC downregulate vascular E-selectin may
lead to novel therapies for this tumor in both normal and immunocompromised individuals.
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Skin derived dendritic cells play a dominant role in priming naïve T cells after genetic immu-
nization using lentiviral vectors
Y He,1,2 J Zhang,1 C Donahue1 and LD Falo1 1 Dermatology, University of Pittsburgh,
Pittsburgh, PA and 2 Immunology, University of Pittsburgh, Pittsburgh, PA
Genetic immunization has the potential to elicit more potent humoral and celluar immunity
than other vaccine approaches that could enable efficacious vaccination against diseases for
which traditional vaccines and treatments have not worked such as tuberculosis, malaria, and
chronic viral infections. Viral vectors represent one of the most effective approaches for trans-
ducing and expressing sufficient antigen for elicitation of antigen specific immune responses
in vivo. However, the mechanism by which T cells are primed in vivo remains to be eluci-
dated. Recent studies challenge a central paradigm of skin immune function by suggesting that
both viral antigens and transgenic antigens expressed by many cutaneously delivered viral
vectors including HSV, VV, and IAV, are primarily presented by non-skin derived CD8+ DCs
through cross-priming, rather than by CD8- skin derived DCs. Lentivectors offer several poten-
tial advantages over other viral vectors. We demonstrate that DNA immunization utilizing
lentivectors can induce stronger and longer-lasting T cell mediated immune responses com-
pared to other vectors. Importantly, in contrast to previous studies using other viral vectors,
our studies demonstrate that CD8- DCs from lentivector immunized mice function as antigen
presenting cells to prime naïve T cells. In addition, we demonstrated that skin derived DC
subsets are the APCs for priming naïve T cells after lentivector immunization. In contrast, LN
resident CD8+ DCs are responsible for T cell activation in vaccinia vector immunization. The
direct T cell priming by transduced skin DC subsets with prolonged Ag presentation under
optimal inflammation milieu may account for the induction of effective T cell immunity induced
by lentivector immunization. This study demonstrates the importance of the cutaneous DC
network in generating T cell responses, and has important implications for the development
of cutaneous genetic immunization strategies against infectious diseases or tumors.
710
Optimization of DC-based cancer immunotherapy using activated SeV/DC for murine malig-
nant melanoma
S Shibata,1,2 Y Yonemitsu,2 S Okano,2 Y Moroi1 and M Furue1 1 Dermatology, Kyushu
University, Fukuoka, Japan, 2 Division of Pathophysiological and Experimental Pathology,
Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka,
Japan and 3 DNAVEC Corporation, Ibaraki, Tsukuba, Japan
Dendritic cells (DCs) could be a promising tool for cancer immunotherapy. The early clinical
trials showed the therapeutic potential of DC therapy, however, its clinical response is lim-
ited. The current issues of DC therapy include that less information for the optimal route for
administration and the optimal dose and frequency of DC therapy. In the previous congress,
we reported that activated DCs could be generated by transfection of recombinant SeV with-
out other stimulus and induced efficient antitumor immunity against murine melanoma. The
aim of the current study is to assess the aforementioned issues using SeV/DC for tumor-bur-
den mice. Female C57BL/6 mice were subcutaneously inoculated with B16F10 melanoma
cells on day 0. On day 3, 10, 17, the mice were treated with 1x104, 1x105 or 1x106 tumor-
lysate-pulsed bone marrow-derived DCs that were activated with SeV. The antitumor effect
was apparently dose-dependent. To assess the optimized route for DC administration, the
tumor-burden mice were treated with SeV/DCs by intratumoral, contra-lateral subcutaneous,
or intravenous administration. The significant antitumor effect was only recognized in the group
of intratumoral administration, and in this case, tumor lysate was not important to show sig-
nificant antitumor effect. In addition, co-treatment of DC therapy and recombinant murine
IFN-β protein significantly enhanced the anti-tumor effect for tumor-burden mice. The intra-
tumoral administration of DCs could induce efficient and optimized antitumor immunity irre-
spective of pulsing tumor antigens ex vivo, and it is suggested that at least more than 106 in
mice are required. Furthermore, the combination therapy, SeV/DCs and IFN-β, could dra-
matically enhance the anti-tumor effect of DC immunotherapy.
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Alternative mRNA splicing and utilization of facultative start sites of translation lead to mul-
tiple isoforms of caspase-5 in human lymphocytes
L Eckhart,1 C Kittel,1 F Gruber,1 S Gawlas,1 M Mildner,1 B Jilma2 and E Tschachler1,3 1
Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2 Medical
University of Vienna, Department of Clinical Pharmacology, Austria and 3 Centre d
Investigations Epidermiques et Sensorielles (CE. R. I. E. S.), Neuilly, France
Caspase-5 is implicated in apoptosis and in the inflammatory response to lipopolysaccharide
(LPS). Since the murine ortholog of caspase-5, i.e. caspase-11, contains important 5’-regula-
tory and coding sequences that are not present in current GenBank files of caspase-5, we re-
investigated the structure of the human caspase-5 gene and the regulation of caspase-5 expres-
sion. We identified a novel exon 1 which was flanked by a region homologous to the promoter
of caspase-11. Like caspase-11 in the mouse, expression of caspase-5 was strongly upregu-
lated by LPS in peripheral blood lymphocytes of healthy human volunteers who had received
a bolus of 2 ng/kg LPS i.v. Lymphocytes expressed six alternatively spliced caspase-5 mRNA
variants that encoded distinct protein isoforms. Overexpression and Western blot analysis
revealed that the translation of the caspase-5 variants was initiated predominantly at a site
within the novel exon 1 which generated a previously unknown N-terminus at the protein
level. In addition, truncated caspase-5 protein variants were formed by utilization of alterna-
tive start sites of translation in exon 3. The isoforms of caspase-5 differed significantly in their
propensity to induce apoptosis in 293 cells. Caspase-5/b, the structural equivalent of caspase-
11, was most efficient in the activation of the apoptotic executioner protease caspase-3. In
conclusion, our findings lead to a revision of the primary structure of the human caspase-5
gene and demonstrate that expression of caspase-5 is controlled by transcriptional and post-
transcriptional mechanisms.
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Mechanisms of cell death induced by tumor necrosis factor antagonists
T Arora Khare, SR Stevens, JS Louie and T Kohno Amgen Inc., Thousand Oaks, CA
Two classes of tumor necrosis factor (TNF) antagonists, soluble TNF receptors (etanercept)
and anti-TNF monoclonal antibodies (adalimumab and infliximab), are currently approved for
the treatment of several immune-related disorders, including psoriatic arthritis and rheuma-
toid arthritis. The classes differ in safety and efficacy profiles. Previously, we showed that anti-
TNF monoclonal antibodies, but not soluble receptors, bind to immunoglobulin receptors (Fcγ)
and a complement component (C1q) in the presence of TNF, raising the possibility that the
monoclonal antibodies may induce antibody-dependent cellular cytotoxicity (ADCC) or com-
plement-dependent cytotoxicity (CDC). The purpose of this study was to assess the ability of
monoclonal antibodies and soluble receptors to bind to membrane-bound TNF (mTNF) and
to induce ADCC and CDC. All assays were performed using Chinese hamster ovary (CHO)
cells expressing mTNF as target cells. Binding of flourochrome-tagged drugs to mTNF expressed
on CHO target cells was assessed by flow cytometry. In ADCC experiments, purified periph-
eral blood mononuclear cells were used as effector cells, which were incubated with target
cells and test drugs. CDC was evaluated by incubation of target cells and test drug with serum
containing complement. Cell death was assessed by staining with propidium iodide and annexin
V and analyzed by flow cytometry. Both monoclonal antibodies and soluble receptors bound
to mTNF on CHO cells. Monoclonal antibodies, but not soluble receptors, killed cells express-
ing mTNF in CDC assays. Monoclonal antibodies also induced ADCC at lower effector:target
ratios than soluble receptors. Our data suggest that monoclonal antibodies and soluble recep-
tors differ in the ability to effect cytotoxic mechanisms in these in vitro assays. Differences in
the ability to bind ligand and mediate cell killing may account for differing efficacies and safety
profiles seen in TNF antagonists.
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Presence of lytic proteins in myeloid and plasmacytoid dendritic cells
C Bangert, S Altrichter, G Stary, G Stingl and T Kopp Medical University of Vienna, Vienna,
Austria
Prevailing opinion holds that T-cells are the major effector cells within the cellular infiltrate of
eczematous skin diseases like allergic contact dermatitis (ACD) or atopic dermatitis (AD). One
of their functions is the induction of apoptosis in keratinocytes via the expression of death mol-
ecules like FASL, TRAIL or perforin. By investigating skin biopsies from 72h epicutaneous patch
test lesions (EPT) and atopic dermatitis (AD) we detected molecules of the death machinery
not only in infiltrating T-cells, but also in non T-cells. A more thorough investigation of the non
T-cells in these biopsies demonstrated that a substantial portion of these cells represent myeloid
and plasmacytoid dendritic cells (DC). Interestingly, we demonstrate that in EPT as well as in
AD lesions CD123+MHCII+ pDC are positive for granzyme B and TRAIL L. In contrast,
CD1c+MHCII+ mDC display a broader variety of death molecules including granzyme B, per-
forin, TRAIL L, FAS L and the death receptors TRAIL R1 and FAS. Further analysis conducted
by flow cytometry from peripheral blood DC endorsed our finding that expression of lytic
proteins on CD123+MHCII+ BDCA-2+ pDC is limited to granzyme B and TRAIL L, whereas
CD11c+MHCII+CD14- mDC exhibit a wide spectrum of death molecules intra- and extra-
cellularly. Taken together these results indicate that DC utilize molecules of the death machin-
ery to regulate T-cell mediated allergic inflammation.
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Toll-like receptor 7/8-activated dendritic cells exhibit molecules of the lytic machineries
G Stary,1 C Bangert,1 S Altrichter,1 R Strohal,2 T Kopp1 and G Stingl1 1 Dermatology, Medical
University of Vienna, Vienna, Austria and 2 Dermatology, Federal Academic Hospital
Feldkirch, Feldkirch, Austria
As a synthetic agonist to toll-like receptor (TLR) 7/8, imiquimod acts as an immune response
modifier and has been successfully used for the treatment of certain skin neoplasms. In order
to get an insight into the underlying mechanisms of tumor clearance, we analyzed lytic mol-
ecules expressed by the local cellular imiquimod-induced inflammatory infiltrate of basal
cell carcinomas (BCC) (n=7) at particular clinical time points of tumor regression (untreated
BCC, after 2 and after 6 weeks of imiquimod therapy) by single- and multicolor immunos-
tainings. In addition, we stimulated dendritic cells from peripheral blood with TLR7/8 ligands
and analyzed expression of cytotoxic molecules. In untreated BCC we found a sparse expres-
sion of Fas ligand, perforin and granzyme B, and a more pronounced anti-TRAIL (TNF-related
apoptosis-inducing ligand) reactivity of inflammatory immune cells. Upon 2 weeks of
imiquimod treatment, we observed a massive increase of the infiltrate that correlated with the
upregulation of perforin, granzyme B and TRAIL, but not of Fas ligand. Somewhat to our sur-
prise, we found that CD11c+HLA-DR+CD14-TNF+iNOS+ myeloid dendritic cells, and not NK-
cells or CD8+ T-cells, were the main source of these lytic proteins. After 6 weeks of therapy,
the tumors had resolved and the cellular infiltrate as well as the expression of lytic molecules
had returned to baseline levels. In peripheral blood, TLR7/8 ligand-stimulated, but not freshly
isolated CD11c+ mDCs displayed perforin and granzyme B within their cytoplasm. We enter-
tain the possibility that CD11c+HLA-DR+CD14-TNF+iNOS+ myeloid dendritic cells, referred
to as Tip-DCs (TNF-iNOS-producing dendritic cells), are directly involved in imiquimod-
induced tumor destruction.
718
Chemokine receptor CCR4 is necessary for antigen-specific homing of CD4 T cells to inflamed
skin under physiological conditions
J Campbell and M Wurbel Department of Pathology, Harvard Medical School, Boston, MA
Dual expression of CCR4 and E-selectin ligand (E-lig) identifies skin-specific CD4 T cells from
blood, lymphoid organs and the skin itself. The chemokine ligand for CCR4 (CCL17/TARC) is
presented by endothelial cells within the skin but not by endothelial cells within other organs.
Despite this strong and specific correlation between CCR4 and its ligand with cutaneous lym-
phocytes and endothelium (respectively), CCR4 function has not yet been convincingly proven
necessary for skin-specific lymphocyte homing. In this study, we have developed a CD4 T cell
adoptive transfer model for antigen-specific skin inflammation. Adoptively-transferred anti-
gen-specific CD4 T cells from CCR4-/- and CCR4+/+ donors are equally capable of contributing
to the circulating E-lig+ cutaneous T cell populations in the blood of chimeric hosts. How-
ever, only CCR4+/+ transferred cells are capable of antigen-specific homing into inflamed
skin. The defect in cutaneous homing observed for CCR4-/- cells is indeed specific to skin, as
CCR4-/- and CCR4+/+ cells home equally well to non cutaneous organs. To our knowledge,
this is the first demonstration that CCR4 is required for T cell homing to inflamed skin under
physiological in vivo conditions.
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Solid tumor immunotherapy utilizing DC loaded with biodegradable tumor particles
DJ Hanlon,1 V Cody,1 C Solbrig,2 S Roberts,1 R Edelson,1 M Girardi1 and M Saltzman2 1
Dermatology, Yale School of Medicine, New Haven, CT and 2 Biomedical Engineering, Yale
University, New Haven, CT
Dendritic cell (DC)-based therapies for solid tumors have failed to achieve large-scale clini-
cal utilization because at present no unified technology exists to overcome two fundamental
obstacles. These are the lack of known tumor-associated antigens (TAA) from most solid malig-
nancies and the lack of efficient methodologies to transfer antigen from tumor to DC. Here
we describe the development of an alternative technology for antigen delivery that appears to
transfer a broad spectrum of tumor antigens to DC with extremely high efficiency. We used
this methodology, termed “nanoparticle (NP)- mediated tumor delivery”, to encapsulate whole
melanoma isolates into PLGA biodegradable microspheres and targeted these conjugates to
DC. In both in vitro assays monitoring CD8 T cell stimulation (utilizing DC and gp100-spe-
cific pmel splenic T-cells), and in vivo vaccination/challenge assays (utilizing the B16 tumor
model), these NP/tumor conjugates delivered antigen more efficiently and for longer durations
than currently favored antigen delivery methodologies. Cytometric bead array (CBA) assays
indicated that NP-loaded DC drove increased levels of Th1-associated cytokines in CD8 T-
cells and vaccination with these DC led to increased survival following B16 challenge. These
results indicate that tumor-loaded PLGA particles may represent a universally applicable
reagent, capable of delivering the panoply of antigens present in virtually any tumor sample
to DC by methodologies that are sterile, rapid and scalable to be compatible with clinical and
GMP constraints.
720
Characterization of IL-17 secreting T-helper cells (ThIL-17)
J Listopad, K Asadullah and W Doecke CRBA Inflammation, Schering AG, Berlin, Germany
IL-23 selectively induces the differentiation of ThIL-17 cells. For characterization of this new
Th cell population, naive human CD4+ cells were differentiated by anti-CD3/CD28 stimula-
tion in the presence of IL-23, IL-12, IL-4, IFNg, anti-IFNg, anti-IL-4 as well as other cytokines
and hormones. Expression of transcription factors, cytokines and receptors was determined
by ELISA, TaqMan-PCR and FACS. i) In comparison to IL-12-induced Th1 cells, IL-23-differ-
entiated ThIL-17 cells show increased IL-17 secretion and diminished production of IL-2, IL-
22, IFNg, TNFa, and GM-CSF. Expression of T-bet and Foxp3 is lower in ThIL-17 cells. No dif-
ferences are found for IL-4, IL-10 and GATA-3. ii) A differential cytokine and chemokine receptor
expression is seen in comparison to Th1 and Th2 cells. iii) IFNg and IL-4 inhibit ThIL-17 dif-
ferentiation whereas IL-17 increases the differentiation of Th1 and Th2 cells. iv) Small effects
on PHA-induced IL-17 secretion of PBMC are observed. Whereas IL-23 and IL-4 increase, IL-
12 and IFNg decrease IL-17 secretion. Low concentrations of stress hormones tend to increase
PHA-induced IL-17 secretion while suppressing IFNg. High concentrations have a suppres-
sive effect for both cytokines. ThIL-17 cells represent a new Th subset with distinct cytokine
and receptor profile. Besides IL-23, other cytokines and hormones influence ThIL-17 differ-
entiation and IL-17 secretion of T cells. ThIL-17 exhibit a non-symmetrical cross-regulation
with Th1 and Th2 cells. The induction of IL-17 secretion by low doses of Th1 depressors (e.g.
glucocorticoids, epinephrine) may be relevant for immunosuppressive approaches (e.g. rebound
phenomena) as well as for inflammation in trauma and stress.
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Evaluation of CD25-targeting approaches for Treg depletion in CTCL
L Geskin, S Kwon, T Patton, S McCann, K Paley and LD Falo, Jr. Dept of Dermatology,
University of Pittsburgh School of Medicine, Pittsburgh, PA
We sought to determine the effects of denileukin diftitox (ONTAK) on regulatory T cells (Tregs)
in Cutaneous T cell Lymphoma (CTCL) patients. CD25 is a low affinity IL-2 receptor transiently
expressed on activated lymphocytes, but also highly and constitutively expressed on Tregs. In
Mycosis Fungoides (MF), the utilization of CD25 as a target molecule is complex because it
is a malignancy of mature memory CD4+ lymphocytes that frequently expresses CD25. ONTAK
is an IL-2-diphteria recombinant fusion protein (DAB389IL-2) that is postulated to exert a ther-
apeutic effect in MF by targeting and eliminating CD25 expressing tumor cells, though its
mechanism of action has not yet been conclusively established. Patients undergoing routine
therapy with ONTAK were enrolled in this study under IRB regulations. Peripheral blood was
obtained before the first course of ONTAK, immediately after the first course (day 5), and 3
weeks after the first course (day 19). Using multicolor flow cytometry, we phenotypically iden-
tified T-regs as cells co-expressing CD4, CD25, and FOXP3 markers.  We found that ONTAK
therapy significantly depleted Tregs during initial administration in the patient naïve to the
drug. This depletion was completely reversed in one month. However, for patients receiving
ongoing ONTAK therapy Tregs numbers were lower overall than in ONTAK naïve patients. In
conclusion, we demonstrate that denileukin diftitox (ONTAK) transiently depletes Tregs in
CTCL patients, as evident by a decrease in CD4+CD25+FOXP3+ population by flow cytom-
etry. This study provides proof of principle that Tregs can be depleted from the peripheral blood
of CTCL patients, and represents a clinically feasible strategy to accomplish this goal in con-
junction with other immunotherapeutic approaches, including DC-based immunotherapy.
723
Induction of a fulminant T-cell mediated autoimmune disease after adoptive transfer of OT-
I T cells into K14-sOVA transgenic mice
KE Nograles, F Miyagawa, BS Kim and SI Katz Dermatology Branch, NCI, National Institutes
of Health, Bethesda, MD
To establish an animal model for T-cell mediated autoimmune disease against an epithelium-
derived soluble antigen, we developed transgenic mice that produce a soluble model self-
antigen, ovalbumin (sOVA), under the control of the K14 promoter (K14). The K14-sOVA mice
express ovalbumin mRNA in organs with a stratified squamous epithelium, and OVA protein
can be detected in epithelial lysates by Western blot. OT-I cells are CD8+ T cells that have
OVA-specific Vα2Vβ5+ T-cell receptors. When as few as 5x105 OT-I cells are injected into
K14-sOVA mice intravenously, these mice lose weight rapidly and die in 5-8 days. The cause
of death is severe inflammation of the epithelium of the tongue and esophagus preventing
adequate ingestion of nutrition. Very little, if any, inflammation is seen in the skin. CFSE
labeling of transferred cells show rapid division in both skin-draining lymph nodes and spleen
by day 2. Four days after adoptive transfer of OT-I cells, they markedly expand and express
activation markers in the spleen (7.41±0.029% vs. 0.425±0.06% in C57BL/6 controls) but
not in skin-draining lymph nodes (1.5±0.71% vs. 0.815±0.09% in C57BL/6 controls). When
the mice are splenectomized prior to intravenous introduction of OT-I cells, the disease process,
measured by percentage of weight loss and time to death, is retarded.  Histological sections
of the tongue and esophagus show a dramatic decrease in the severity of inflammation com-
pared to that seen in non-splenectomized K14-sOVA mice. Interestingly, FACS analysis of the
skin-draining lymph nodes from the splenectomized mice show vigorous expansion
(17.89±6.8%) and full activation of OT-I cells by day 5, probably accounting for the attenua-
tion rather than abrogation of disease in the splenectomized mice. These results suggest that
the expansion and activation of intravenously injected OVA-specific Vα2Vβ5+ T cells in the
spleen play a major role in causing a rapidly fatal T-cell mediated autoimmune disease in these
K14-sOVA transgenic mice.
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Melanoma: the unprofessional antigen presenting cell
D Askew and AC Gilliam Dermatology, Case Western Reserve University, Cleveland Ohio,
OH
While professional antigen presenting cells (APCs) communicate with T cells to promote and
maintain an immune response, it is our hypothesis that melanoma cells function as “unpro-
fessional” APCs and subvert the immune response. Recent advances in immunologically-based
treatments against advanced melanoma have shown some success, it is often temporary and
recurrent disease can be refractory to treatment. To determine if the “unprofessional” APCs
are responsible for this immune failure, we examined the ability of melanoma to function as
an antigen-presenting cell (APC) using the murine C57BL/6-derived melanoma cell line B16-
F0. To evaluate their ability to function as APCs, we determined the expression of surface pro-
teins that are essential for interaction with T cells. We found that B16-F0 cells constitutively
expressed low levels of MHC-I and MHC-II, but did not express any CD80 or CD86, impor-
tant co-stimulatory molecules. Instead, they constitutively expressed PDL1, a protein associ-
ated with down-regulating immune response. To understand what the consequences of inter-
action between melanoma and T cell we used a B16-F0 cell line that was transfected with a
model antigen chicken ovalbumin (B16-OVA) and T cell-receptor transgenic mice that rec-
ognized processed OVA peptide in the context of MHC-II. We found that B16-OVA cells are
capable of inducing limited T cell proliferation. Of interest was that CD4+ T cells failed to
produce IFNγ when cultured with B16-OVA an important feature of effector T cells. These
results suggest that while B16 can function as an APC it does not promote the development
of effector CD4+ T cells. This may be one mechanism by which melanoma cells can escape
immune surveillance.
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Identifying a novel skin-homing receptor on inflammatory lymphocytes
ME Gainers, L Descheny and CJ Dimitroff Department of Dermatology, Brigham and
Women’s Hospital, Boston, MA
E- and P- selectin on dermal endothelium play a central role in lymphocyte trafficking to skin.
P-selectin glycoprotein ligand-1 (PSGL-1), a well characterized E- and P-selectin ligand on
inflammatory lymphocytes, has been implicated as a critical effector molecule on skin-hom-
ing lymphocytes. However, recent studies utilizing in vivo mouse models have indicated that
PSGL-1 is only a minor contributor to allergic contact dermatitis (ACD), indicating that there
are other selectin ligands more important for lymphocyte recruitment into inflamed skin. We
employed a number of biochemical strategies to identify candidate skin-homing receptors on
freshly-isolated effector T cells from mice with ACD. Skin-draining lymph nodes from antigen
(DNFB) sensitized mice were harvested and T cells were isolated by immunomagnetic bead
technology. As controls, we included PSGL-1 null mice and α1,3 fucosyltransferase IV/VII null
mice, which are deficient in T cell E-selectin ligand (ESL) expression. By Western blot and FACS
analysis, more than a four-fold increase in ESL expression was demonstrated with DNFB treated
mice compared with naïve mice. PSGL-1 deficient and wild type mice lysate revealed a dis-
tinct ESL glycoprotein at 100 kDa. This did not correspond to the molecular weight of any
other known ESLs (CD44, CD43, PSGL-1, ESL-1) and was different from those ESLs expressed
on in vitro-generated Th1 cells. Moreover, parallel plate flow chamber experiments using PSGL-
1 null cells displayed rolling on E-selectin that was not dramatically different from the amount
of rolling seen with wild type cells. N-glycosidase F and O-sialoglycoprotein endopeptidase
treatments indicated that the molecule is both N- and O-glycosylated with the E-selectin bind-
ing determinants being displayed on the O-glycosylated sites. Our data suggest that this pre-
viously unrecognized receptor may be critical for T cell adhesion to dermal endothelium and
trafficking to skin and, thus, could be targeted for treatment of T cell-mediated skin diseases.
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To establish an in vitro co-culture system to study cytokine production using immortalized
human epidermal keratinocytes and monocytes
M Spitzer, W Lee, E Shnitkind, Y E, S Geen and AR Shalita Dermatology, SUNY Downstate
Med Ctr, Brooklyn, NY
Cytokines have been demonstrated to play a critical role in the development of inflammation.
The expression of proinflammatory cytokines such as IL-1α and ICAM-1 have been shown to
result in the expression of vascular and dermal adhesion molecules, the chemotaxis of inflam-
matory cells, and the stimulation of other inflammatory mediators. This study was conducted
to quantitatively access the inflammatory cytokines produced by human epidermal keratinocytes
in the presence and absence of THP-1 monocytes. An immortalized keratinocyte cell line
hTERT (obtained by stable transfection of primary cell culture with human telomerase reverse
transcriptase) was used throughout the study. Cells were treated with LPS, P. acnes cell wall
preparation using UVB (312 nm at 50 mJ/cm2) as positive control. The expression of IL-1α
and ICAM-1 was measured by quantitative ELISA. Previous reports from our group indicated
that UVB as well as proinflmmatory cytokines (TNF α and IFNγ)increased ICAM-1 expression
on cultured human keratinocytes (HaCaT cells). Our data showed that IFNγ treatment of hTERT
cells resulted in a significant up-regulation (p<0.001) of cytokine-induced production of ICAM-
1. The data also showed that cytokine induced ICAM-1 expression increased by 20 % to 30%
when hTERT cells were co-cultured with THP-1 cells grown in Transwell plates. When com-
pared to untreated cells, the level of ICAM-1 expression was increased up to two fold when
measured in hTERT cells co-cultured with LPS (10ng/ml) pretreated THP-1 cells. Both UVB
and LPS appeared to play a role in cytokine-induced inflammatory responses on keratinocytes-
monocyte co-culture system. These results expand the properties of cytokine production in
modulating the inflammatory process and will facilitate testing of its photo-therapeutic appli-
cations in different inflammatory skin conditions.
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Enhanced immune response to vaccinia virus scarification in K14/IL-1α transgenic mice
T Tian,1 L Liu,1 E Freyschmidt,2 TS Kupper1 and RC Fuhlbrigge1,2 1 Dermatology, Brigham and
Women, Boston, MA and 2 Immunology, Children’s Hospital, Boston, MA
Transepidermal inoculation of live vaccinia virus (VV), a technique called scarification, induces
specific and long-lasting immunity to smallpox in humans. However, in susceptible individ-
uals, including patients with atopic skin disease, persistent viral replication can cause signif-
icant morbidity and mortality. We hypothesize that the response to VV scarification is likely
dependent on the balance of immune response elements present in skin. To test this hypoth-
esis, we utilized transgenic mice engineered to overexpress interleukin-1α (IL-1α) in the epi-
dermis (K14/IL-1α Tg mice). We established methods for scarification of mouse tail skin with
VV and demonstrated mice have the ability to generate a local pox reaction similar to that
seen on humans. To detect cytokine production after VV inoculation, we performed in vitro
restimulation assays using infected syngenic splenocyte APC and measured IL-4, IFN-γ in the
supernatant by ELISA and IFN-γ secreting cells by ELISPOT. K14/IL-1α Tg mice demonstrated
enhanced immunity to vaccinia virus in comparison with control FVB/N mice. T cells from
the draining inguinal lymph nodes of scarified K14/IL-1α Tg mice expressed over 200-fold
more IFN-γ than scarified control mice (K14/IL-1α lymph node: 47.3 ± 1.8 ng/ml vs. FVB/N
lymph node: 0.2 ± .05 ng/ml on day 7 after inoculation). No detectable IL-4 was found in
either K14/IL-1α or control mice. Assessment of vaccinia specific immunoglobulin in the serum
of infected mice by ELISA showed VV inoculation elicited both IgG1 and IgG2a antibodies,
with significant enhancement of both subclasses in K14/IL-1α Tg mice relative to controls. 
These studies confirm the Th1 dominance of the immune response to VV scarification and indi-
cate IL-1 can influence the development of antiviral T cell immunity. Further development and
extension of this model to other cytokine systems will assist our understanding of the immune
response to VV and promote the creation of safer and more effective vaccination strategies.
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Development of NKT cells, a regulatory T cell population, is dependent on the adapter mol-
ecule, SAP.
PL Stein,1 J Jain,1 L Guzman1 and KE Nichols2 1 Dermatology, Northwestern University,
Chicago, IL and 2 Children’s Hospital of Philadelphia, Philadelphia, PA
NKT cells are a unique lymphoid population that exhibits regulatory properties. They are
thought to help control autoimmunity, but can also suppress tumor immunity to UV induced
skin cancer. NKT cells can be distinguished from conventional T cells by expression of mark-
ers typically found on NK cells and use of a specific TCR α chain encoding a Vα14Jα18 junc-
tion. Rather than recognizing peptides, NKT cells respond to glycolipid antigens, such as α-
GalCer, when presented by the non-classical MHC molecule CD1d. We had previously shown
that the Fyn tyrosine kinase is critically important for development of this lineage but not for
other lymphoid cells. However the mechanism remained unclear. We now show that SAP, an
adaptor molecule that recruits Fyn to SLAM family receptors is selectively required for devel-
opment of both human and mouse NKT cells, but not other lineages. Introducing a transgene
encoding the Vα14Jα18 TCR α chain into sap mutants restored NKT cell development as
assessed by binding of CD1d tetramers. However, the numbers were slightly reduced relative
to littermate controls. This system also allowed us to examine whether the SAP deficient NKT
cells were functional. Injection of α-galcer into the mutant animals failed to induce IL-4 or
IFN-γ, two cytokines that are rapidly produced by activated NKT cells. In addition, the induc-
tion of secondary lymphoid responses is severely blunted. These results indicate that SAP is
required for NKT cell development. Since the TCR transgene restores development, it argues
that SAP functions early in NKT cell ontogeny, possibly before TCR alpha chain rearrange-
ment. Additionally, the data suggests that, in contrast to conventional T cells, SAP dependent
pathways work in concert with TCR mediated signaling to promote effector functions. Under-
standing the mechanisms that control NKT cell development and function may provide piv-
otal insights into the role these cells play in cutaneous homeostasis.
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IL-1α-mediated suppression of OVA-induced allergic asthma
P Caucig,1 S Dinges,1 D Teschner,1 JH Maxeiner,2 J Knop,1 S Finotto2 and E von Stebut1 1
Dept. of Dermatology, Johannes Gutenberg-University, Mainz, Germany and 2 Asthma Core
Facility, Johannes Gutenberg-University, Mainz, Germany
Using a Th1/Th2 model disease (cutaneous leishmaniasis), we have previously shown that
genetic determination of Th development is dependent on the release of proinflammatory IL-
1α from activated dendritic cells (DC). In L. major-infections, Th1 immunity develops if IL-1α
is present during T-cell priming (e.g. in Leishmania-resistant C57BL/6 mice). Due to decreased
production of DC-derived IL-1α, BALB/c mice show Th2-dependent progressive disease. Admin-
istration of IL-1α to infected BALB/c induced a shift towards Th1 and resulted in limited dis-
ease. To determine the role of IL-1α in Th immunity in other diseases, we used the model of
OVA/Alum induced allergic asthma. On days 0+14, BALB/c mice were sensitized with
OVA/Alum complexes. IL-1α was administered i.p. on days 0-2 during sensitization. On days
27-29, mice were challenged with OVA followed by invasive lung function measurements on
day 30. Significantly decreased airway hypersensitivity responses were detected in IL-1α-
treated mice as compared to controls (p≤0.05, n=9). In contrast to control lungs, IL-1α-treated
mice showed reduced inflammatory infiltrates (57±3% vs. 81±8% infiltrated bronchi, p≤0.05,
n=9). The bronchoalveolar lavage (BAL) of IL-1α-treated mice contained fewer inflammatory
cells (2-fold). Significantly decreased numbers of eosinophils were present in BAL of IL-1α-
treated mice as compared to controls (33±3 vs. 51±2%, p≤0.002, n=9). Interestingly, 7-fold
more neutrophils were detected in IL-1α mice. The BAL of IL-1α-treated BALB/c contained
increased levels of IFNγ and reduced amounts of IL-4, IL-5 and IL-13 (p≤0.05, n=9). In sum-
mary, IL-1α administration during the early sensitization phase of OVA-induced allergic asthma
suppresses the course of disease by shifting the immune response towards Th1. Future stud-
ies will have to elucidate the therapeutic value of IL-1α in asthmatic patients.
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Propionibacterium acnes differentiates monocytes into CD209+ macrophages and CD1b+
dendritic cells
JN Phan,1 SR Krutzik,1,2 RL Modlin1,2 and J Kim1 1 Division of Dermatology, Department of
Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA and 2 Department of
Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at
UCLA, Los Angeles, CA
In acne vulgaris, Propionibacterium acnes triggers host inflammatory responses that contribute
to the pathogenesis of the disease. Toll-like receptors are a family of pattern recognition
receptors that play a key role in the innate immune response and can also activate adaptive
immunity. Data from our lab have shown that in response to stimulation with P. acnes mono-
cytes secrete proinflammatory cytokines in a Toll-like receptor 2 (TLR2)-dependent mecha-
nism. In addition, TLR2 activation triggers the differentiation of human monocytes into two
distinct subsets, CD209+ macrophages and CD1b+ dendritic cells. In this study, we investi-
gated whether P. acnes, which contains a TLR2 ligand, could trigger the differentiation of human
monocytes. We found that monocytes stimulated with a P. acnes sonicate differentiated into
both CD209+ macrophages and CD1b+ dendritic cells. The P. acnes-induced differentiation
of monocytes into CD209+ cells was dependent on TLR2 since the presence of an anti-TLR2
blocking antibody decreased the number of CD209+ cells. Furthermore, CD209+ cells stim-
ulated with P. acnes secreted high levels of IL-12, a cytokine important in inducing inflam-
mation in acne. The increased number of CD209+ macrophages after stimulation with P. acnes
and the high level of IL-12 production suggest that CD209+ cells may play a role in the patho-
genesis of acne.
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IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular dif-
ferentiation, and mobility in keratinocytes: a potential role in psoriasis
K Wolk,1 E Witte,1 E Wallace,1 W Doecke,2 S Kunz,1 K Asadullah,2 H Volk,3 W Sterry4 and
R Sabat1 1 Interdisciplinary Group of Molecular Immunopathology, Dermatology / Medical
Immunology, University Hospital Charite, Berlin, Germany, 2 CRBA Dermatology, Schering
AG, Berlin, Germany, 3 Institute of Medical Immunology, University Hospital Charite, Berlin,
Germany and 4 Department of Dermatology, University Hospital Charite, Berlin, Germany
This study aimed to expand the knowledge on the biological role of IL-22, a recently discov-
ered mediator of the IFN - IL-10 cytokine family. As epithelial cells are the major targets of IL-
22, we performed a search for IL-22 effects on primary human keratinocytes by use of a gene
expression array and characterized the IL-22 effects at the mRNA and protein level in vitro and
in vivo. Here we demonstrate that IL-22, in contrast to its kin IFN-γ, regulates the expression
of only a few genes in keratinocytes. This is due to varied signal transduction. Gene expres-
sions regulated by IL-22 should enhance antimicrobial defense (S100A7, S100A8, S100A9),
inhibit cellular differentiation (e.g. FLG, KRT1, KRT10, KLK7), and increase cellular mobility
(e.g. MMP1, MMP3, DSC1). In contrast, IFN-γ favored the expression of MHC pathway mol-
ecules, adhesion molecules, cytokines, chemokines, and their receptors. The IL-22 effects were
transcriptionally regulated, and either independent of protein synthesis and secretion or medi-
ated by a secreted protein. Inflammatory conditions but not the keratinocyte differentiation
state amplified the IL-22 effects. High IL-22 levels in psoriatic skin were associated with strongly
upregulated cutaneous S100A7, S100A8, S100A9, and MMP1 expression. Psoriatic patients
showed strongly elevated IL-22 plasma levels. In summary, despite similarities, IFN-γ prima-
rily amplifies inflammation, while IL-22 may be important in the innate immunity and reor-
ganization of epithelia and simultaneous action of both cytokines may be responsible for pso-
riatic skin alterations.
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Enhanced bacteria internalization but inhibition of DC maturation by the alternative com-
plement cascade
C Cruijsen,1 A Visser,1 T Kupper,1 A van der Velden,3 M Starnbach3 and M Boes1,2 1
Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Immunology, Utrecht Medical
Center, Utrecht, Netherlands and 3 Microbiology and Molecular genetics, Harvard Medical
School, Boston, MA
Polyclonal antibodies and complement are innate defense mechanisms. They are present in
the serum and tissues of the host prior to infection, ready to bind pathogens upon entry and
provide early protection. Dendritic cells (DCs) are considered critical for T cell priming and
express receptors for uptake of pathogens opsonized with these serum components: Fc and
complement receptors, respectively. We addressed the question what role natural antibodies
and complement play in bacteria uptake, and subsequent degradation, antigen presentation
and DC maturation. We show for the first time that uptake through Fc or complement recep-
tors leads to distinct endosomal processing and maturation pathways in DCs. Although uptake
of E. coli opsonized with serum containing active complement components was enhanced
compared to inactivated or knock-out controls, DC maturation and antigen presentation was
inhibited in the presence of complement. Accordingly, OVA-specific CD4 T cells were acti-
vated more efficiently by DCs exposed to OVA-containing bacteria opsonized with serum
that lacks the essential C3 complement component than with serum that contains no anti-
bodies. Hence pathogen internalization through Fc receptors leads to better antigen presen-
tation in DCs than uptake through complement receptors does. This provides a new insight in
the way innate defenses determine adaptive immune responses.
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Distinct priming signals trigger Tem and Tcm lineage commitment and differentiation
L Liu, K Karibian and TS Kupper Dermatology, Brigham and Women, Boston, MA
Development of long-term T cell memory is an important goal for vaccination. Two subsets of
memory T cells have been described: peripheral tissue specific effector memory T cells (Tem)
lacking the LN homing markers CD62L/ CCR7, and lymphoid tissue-homing central memory
T cells(Tcm) expressing CD62L/ CCR7. It is presently unknown, however, whether Tem and
Tcm are generated by a linear and progressive developmental program, or if they arise from
different lineages through different pathways. To address this question, we monitored the
early events of CD8 memory T cell differentiation by adoptively transferring Thy1.1+OT-I
CD8 T cells (which recognize OVA peptide OVA258-276) into Thy1.2+ mice prior to cuta-
neous infection with live recombinant vaccinia virus expressing OVA258-276 (rVV-ova).
Prior to infection, all of the transferred OT-1 T cells expressed CD62L. Based on CFSE expres-
sion, OT-1 cells were activated at different times over the first 5 days of infection. The major-
ity of CD8 T cells activated within the first 60 hours downregulated LN-homing molecule
CD62L and upregulated skin-homing receptors (resembling Tem), while a smaller subset of
activated CD8 T cells remained strongly CD62L+ (resembling Tcm). However, virtually all the
OT-I cells first activated after 60 hours remained CD62Lhi and did not express skin homing
molecules, resembling Tcm. This suggested that different inductive signals were being deliv-
ered to T cells at different stages of infection. We next tested the hypothesis that during VV
infection, later activation of T cells favored Tcm generation over Tem. We therefore transferred
equal numbers of naive OT-I cells into mice either one day prior to, or two days after rVV-ova
infection. Mice that received OT-1 cells two days after infection yielded 9 times as many Tcm
cells compared to those receiving cells one day prior to infection. These results suggest that T
cells may receive distinct priming signals at different stages of the infection, resulting in dif-
ferent T memory cell lineage commitment.
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Human peripheral blood CD4+CD25high regulatory T cells bear skin homing receptors and
are constitutively recruited into normal skin1
K Hirahara,2,1 L Liu,1 RA Clark,1 K Yamanaka,1 RC Fuhlbrigge1 and TS Kupper1 1
Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Biological Research
Laboratories, Sankyo Co., Ltd, Tokyo, Shinagawa-ku, Japan
CD4+CD25+ T regulatory cells (Treg) are thought to be important in the peripheral tolerance.
Recent evidence suggests that human peripheral blood CD4+CD25+ T cells are heteroge-
neous and contain both CD4+CD25high Treg as well as a populations of CD4+CD25low/med
T cells that lack regulatory activity. In the present study, we found that virtually all peripheral
blood CD4+CD25high Treg expressed high levels of the chemokine receptor CCR4. In addi-
tion, 73% of Treg expressed cutaneous lymphocyte Ag (CLA), and a similar number expressed
CCR6. These molecules were functional, as CLA+ Treg showed CD62E ligand activity and
demonstrable chemotactic responses to the CCR4 ligands CCL22 and CCL17 and the CCR6
ligand CCL20. The phenotype and chemotactic response of these Treg were significantly dif-
ferent from those of CD4+CD25med non-regulatory T cells. We further demonstrated that
blood CLA+ Treg inhibited CD4+CD25- T cell proliferation induced by anti-CD3. Based on
homing receptor profile, CLA+ Treg should enter normal skin constitutively. We next isolated
CD4+CD25high T cells directly from normal human skin; these cells suppressed proliferation
of skin CD4+CD25- T cells. Therefore, the majority of true circulating Treg express functional
skin-homing receptors and appear to be recruited into normal skin, where they may regulate
local immune responses.
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Circulating tumor-antigen specific CD4 T cells in melanoma patients have a pro-apoptotic
phenotype
A Wesa,1 M Mandic,1 JM Kirkwood,2 W Kwok4 and WJ Storkus1,3 1 Dermatology, University
of Pittsburgh, Pittsburgh, PA, 2 Medicine, University of Pittsburgh, Pittsburgh, PA, 3
Immunology, University of Pittsburgh, Pittsburgh, PA and 4 Benaroya Research Institute at
Virginia Mason, Seattle, WA
CD4+ T cells are crucial for the induction of cellular responses that result in anti-tumor immu-
nity. Tumors employ a number of methods to evade destruction by the immune system, some
of which affect the performance of CD4+ T cells. Indeed, differences in CD4+ T cells are
observed in cancer patients, relative to normal patients. We have reported that melanoma
patients frequently develop counter-productive Th2 type immunity towards melanoma anti-
gens, which may lead to ineffective cellular immunity against melanoma in those patients.
We hypothesized that the decline in Th1 responses to melanoma associated antigens (in par-
ticular, MAGE-A6 and EphA2) could be due to increased apoptosis of antigen-specific CD4+
T cells as a consequence of chronic antigenic stimulation by over-expressed tumor antigens.
Thus, we employed MHC Class II (HLA-DR*0401) tetramer constructs designed with epi-
topes from EphA2 and MAGE-A6 to measure the frequency and rate of apoptosis of antigen-
specific CD4+ T cells in a cohort of HLA-DR*0401 melanoma patients. A flu-specific MHC
Class II tetramer was used for comparison and as a control. In melanoma patients, flu-spe-
cific CD4 T cells ranged up to 0.17-3.54%, while 0-0.45% of CD4+ T cells recognized EphA2
or MAGEA6 epitopes. We measured the expression of CD45RO, CD62L and CD25 on the
surface of antigen-specific CD4+ T cells, but noted no differences among cells with specificity
for either EphA2, MAGE-A6 or flu. Among live, antigen-specific CD4+ populations, signifi-
cantly higher frequencies of MAGE-A6 and EphA2-specific T cells were found to be in the
early stages of apoptosis as compared with flu-specific or total CD4+ T cells. These results
suggest that increased death among tumor-specific CD4 T cells could contribute to immune
dysfunction, and that providing survival signals to endogenous tumor-specific CD4+ Th1 T
cells could form the basis of a novel therapeutic strategy.
737
Human beta defensin 3 induces maturation of human monocyte-derived dendritic cells
L Ferris, E Fluharty and LD Falo Dermatology, University of Pittsburgh, Pittsburgh, PA
Beta defensins (BDs) are antimicrobial peptides made in skin and other epithelial surfaces that
cause direct lysis of microorganisms. They also help to link the innate and acquired immune
responses by acting as chemoattractants for immature dendritic cells, monocytes, and mem-
ory T cells. In mice, one BD, murine BD2 (mBD2), has been shown to induce dendritic cell
maturation, characterized by production of inflammatory cytokines and upregulation of the
expression of costimulatory molecules, via toll-like receptor 4. However, an analogous func-
tion has not been demonstrated in humans. We hypothesized that human beta defensins may
induce maturation of cultured dendritic cells. A panel of four human BDs, hBD1-4, were tested
for their ability to induce maturation of immature human dendritic cells. One molecule, hBD3,
induced upregulation of the costimulatory molecules CD80 and CD86 as well as the chemokine
receptor CCR7 in immature dendritic cells. hBD3 induced a function maturation of dendritic
cells, as evidenced by their increased production of IL-12 p70 and their ability to enhance
Th1-type T cell activation in a mixed lymphocyte reaction. Following exposure to hBD3, imma-
ture dendritic cells gain the ability to migrate in response to the CCR7 ligands CCL19 and
CCL21, suggesting a lymph node homing phenotype. Interestingly, hBD3 also enhances uptake
of antigen by dendritic cells, an unusual quality in a maturation stimulus. In summary, hBD3
induces phenotypic and functional maturation of human monocyte-derived dendritic cells
and enhances their uptake of antigen. Our data suggest that hBD3 is an endogenous cuta-
neous danger signal that directs dendritic cells to become more efficient antigen presenting
cells and to traffic to the draining lymph node where T cell priming can occurs.
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Tissue inflammation requires a direct crosstalk between mast cell-TNF and TNFR1-express-
ing endothelia
M Kneilling,1 R Mailhammer,2 L Hultner,2 T Schonberger,3 S Massberg,4 C Sander,5
M Eichner,6 K Maier,2 B Pichler,7 M Gawaz,3 K Pfeffer,8 T Biedermann1 and M Rocken1 1
Dermatology, Eberhard-Karls-University Tubingen, Tubingen, Germany, 2 Institute of Clinical
Molecular Biology and Tumor Genetics, GSF-National Research, Munich, Germany, 3
Medicine, Eberhard-Karls-University Tubingen, Tubingen, Germany, 4 Medicine, Technische
University Munich, Munich, Germany, 5 Dermatology, St. Georg Hospital, Hamburg,
Germany, 6 Medical Biometry, Eberhard-Karls-University Tubingen, Tubingen, Germany, 7
Radiology, Eberhard-Karls-University Tubingen, Tubingen, Germany and 8 Microbiology,
University of Dusseldorf, Dusseldorf, Germany
Signaling through tumor necrosis factor receptor 1 (TNFR1) is central in controlling bacterial
infections and the induction of inflammatory Th1 cell-mediated autoimmune diseases, includ-
ing non-obese diabetes or autoimmune encephalitis. Yet, the underlying mechanisms remain
enigmatic and various models have been proposed. Dissecting Th1 cell-mediated delayed type
hypersensitivity responses (DTHR) into single steps, here we localize the central defect to the
missing TNFR1-expression by endothelial cells (EC). TNFR1 is not needed for in vivo priming
and imprinting of effector-Th1 cells capable to induce strong DTHR. Mast cell-knock-in exper-
iments, using TNF-/- or TNFR1-/- mice as recipients, show that the signaling defect affects
exclusively the mast cell-EC interaction, but neither T cells nor APC. In consequence, TNFR1-
/- mice have strongly reduced mRNA-expression of P-selectin, ICAM-1 and VCAM-1 during
DTHR elicitation. Intra-vital fluorescence microscopy demonstrates that reduced mRNA expres-
sion correlates with defective adhesion to EC, as in TNFR1-/- mice leukocyte rolling and firm
adhesion are reduced to ≤20%. As additional findings identified mast cells as the predomi-
nant source of the TNF responsible for leukocyte recruitment, signaling of mast cell-derived
TNF through TNFR1-expressing EC is essential for recruitment of leukocytes controlling intra-
cellular pathogens or the induction of inflammatory autoimmune diseases.
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Vitamin A and D derivatives block cutaneous lymphocyte-associated antigen expression on
human T cells via selective glycosyltransferase inhibition
K Yamanaka,2,1 CJ Dimitroff,1 H Mizutani2 and TS Kupper1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Dermatology, Mie University, Graduate School of
Medicine, Mie, Japan
Lymphocyte trafficking to skin is dependent on the expression of cutaneous lymphocyte-asso-
ciated antigen (CLA), a sialyl Lewis X-related epitope on P-selectin glycoprotein ligand-1 (PSGL-
1). CLA is highly expressed on skin-infiltrating T cells in both normal and diseased skin and
is an important ligand for dermal vascular endothelial (E)-selectin. We explored the affect of
retinoic acid as well as 1a, 25-Dihydroxyvitamin D3 [1,25(OH)2D3], the hormonally active
form of vitamin D, on the expression of CLA on human T cells, as well as on the expression
of gut- and LN-homing and chemokine receptors. Using flow cytometry, western blotting,
and immunoprecipitation approaches, we found that both retinoic acid and 1,25(OH)2D3
interfered with the decoration of CLA epitopes on PSGL-1 at physiologically attainable levels.
Retinoic acid also blocked L selectin expression and enhanced expression of a4b7 integrin
and CCR9, which would be expected to favor gut homing of T cells. However, 1,25(OH)2D3
did not alter the expression of gut- and LN-homing receptors and of chemokine receptors.
Quantitative PCR of mRNA of glycosyltransferases responsible for CLA biosynthesis showed
that diminished CLA expression was associated with reduced a1,3 fucosyltransferase VII (FucT-
VII) mRNA levels. Thus, both vitamin A and D derivatives are potent inhibitors of CLA. Unlike
retinoic acid, 1,25(OH)2D3 appears to selectively downregulate CLA expression without alter-
ing non-skin homing receptor expression. In the course of a cutaneous immune response, CLA
is initially upregulated in skin draining lymph nodes during T cell activation. These are anatomic
sites that collect 1,25(OH)2D3 enriched lymph from UVB irradiated skin. Downregulation of
CLA by 1,25(OH)2D3 may represent yet another mechanism by which UVB selectively inhibits
cutaneous immune responses.
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TLR2/1 induction of a vitamin D dependent antimicrobial response is related to skin pig-
mentation
R Modlin,1 P Liu,1 S Stenger,4 H Li,1 L Wenzel,4 BH Tan,1 J Schauber,2 K Wu,1 C Meinken,4
M Wagner,1 R Bals,1 A Steinmeyer,3 U Zugel,3 RL Gallo,2 D Eisenberg,1 M Hewison,6
BW Hollis,1 JS Adams3 and BR Bloom7 1 Medicine/Dermatology, UCLA, Los Angeles, CA, 2
Dermatology, University of California San Diego, San Diego, CA, 3 CRBA Dermatology,
Schering AG, Berlin, Germany, 4 Mikrobiologie, Immunologie, und Hygiene, Universtat
Erlangen, Erlangen, Germany, 5 Pneumologie, Universtat Marburg, Marburn, Germany, 6
Dept. of Medicine/Endocrinology, Ceders-Sinai Medical Center, Los Angeles, CA and 7 Office
of the Dean, Harvard School of Public Health, Boston, MA
Toll-like receptor (TLR)-induced antimicrobial activity of the innate immune response against
intracellular bacteria is mediated mainly by nitric oxide in mouse monocytes/macrophages,
but in humans is largely unknown. We report that the TLR-induced antimicrobial activity in
human monocytes/macrophages against intracellular mycobacteria is vitamin D receptor
(VDR)-dependent. Activation of the TLR2/1 heterodimer on human monocytes by bacterial
lipopeptide upregulated gene expression of both the VDR and the vitamin D1-hydroxylase,
Cyp27B1, leading to induction of cathelicidin, an antimicrobial peptide. This induction of
cathelicidin required the conversion of the vitamin D3 prohormone (25D3) into the active
form (1,25D3) by Cyp27B1. The VDR-induced cathelicidin is capable of co-localizing with
mycobacteria within an infected monocyte, and has direct antimicrobial activity against
mycobacteria. African-Americans, known to have increased susceptibility to tuberculosis, had
low serum levels of 25D3, and their sera were inefficient in supporting TLR2/1-induced cathe-
licidin mRNA in monocytes as compared to Caucasians. Supplementation of the African Amer-
ican sera with exogenous 25D3 resulted in the recovery of TLR2/1 induced cathelicidin mRNA
in monocytes. These data support a link between vitamin D and innate antimicrobial immu-
nity, and suggest that differences in ability of human populations according to produce vita-
min D related in part to skin pigmentation may contribute to differences in susceptibility to
microbial infection. www.jidonline.org   123
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The murine keratinocyte cell line PAM 212 expresses functional TLR2
R Prado, J Son, Y Lu, H Chen, PI Song, CA Armstrong and JC Ansel Dermatology, University
of Colorado at Denver and Health Sciences Center, Denver, CO
Toll-like receptors (TLR) have recently been shown to play an important role in innate immu-
nity to a wide variety of pathogens. Mammalian TLRs were first described in myeloid cells,
but recently it was demonstrated that other non-myeloid cells including human keratinocytes
express functional TLRs. The presence of TLR on epithelial cells is especially important since
those cells represent the first line of defense against environmental pathogens. Compared to
human keratinocytes, much less is known regarding murine keratinocyte TLR. To determine
the validity and relevance of using a murine model system to examine keratinocyte TLR, we
have initiated studies assessing the expression and function of murine keratinocyte TLR. In
this study we examined the expression of TLR2 in murine PAM 212 keratinocytes and the
response of these cells to gram positive bacteria derived lipoteichoic acid (LTA). Our results
indicated that PAM 212 constitutively expressed TLR1, TLR2 and TLR6 mRNA as well as the
protein for these receptors on the cell surface. LTA augmented PAM 212 TLR2 expression,
which could be inhibited by either pre-incubation of cells with anti-TLR2 antibodies or trans-
fecting cells with dominant negative TLR2 constructs, therefore demonstrating the TLR2 speci-
ficity of this response. LTA also induced increased expression of pro-inflammatory cytokines
(IL-1a, IL-1b, IL-6 and TNF-a) and the murine chemokine KC. Again the TLR2 specificity of
these responses was demonstrated by using TLR2 blocking antibodies as well as transfecting
cells with dominant negative TLR2 constructs. Therefore in this study we demonstrated for the
first time that the murine keratinocyte cell line PAM 212 cell expresses functional TLR2, and
that this receptor is essential for LTA mediated cellular responses in these cells. This finding
has important implications for our understanding of the innate immune responses to cuta-
neous bacterial infections, and supports the use of a mouse model for the study of keratinocyte
TLR mediated immunity in the skin.
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Extracellular SOD suppresses TNCB-induced contact hypersensitivity in mice
K Na, E Kim, S Park, Y Kim, K Lee and T Kim Laboratory of Dermato-Immunology, The
Catholic University of Korea, Seoul, South Korea
Superoxide dismutases (SODs) are believed to play a crucial role in protecting cells against
oxidative stress. There are three forms of SOD: cytosolic Cu-Zn SOD, mitochondrial Mn SOD,
and extracellular SOD (EC-SOD). EC-SOD is primarily a tissue enzyme, but the role of EC-
SOD in skin was rarely studied. In this study, we aimed to explore the effect of EC-SOD on
contact hypersensitivity (CHS) in mice. For this purpose, the EC-SOD overexpressing mice skin
was sensitized and elicitated with 2,4,6-trinitro-1-chlorobenzene (TNCB). The EC-SOD trans-
genic mice showed significantly reduced CHS responses compared with wild-type mice. Fur-
thermore, when these mice were re-immunized with TNCB in 2 weeks, the degree of ear
swelling in EC-SOD transgenic mice showed meaningfully suppressed. Histopathologically,
the ear of the mice showed the decreased infiltrations of inflammatory cells in the EC-SOD
transgenic mice compared with wild-type mice. In immunofluorescence staining, infiltrations
of CD4+ and CD8+ T cells were more increased in wild-type mice than EC-SOD transgenic
mice. These results may suggest that EC-SOD down-regulate the CHS through reducing oxida-
tive stress and inhibiting inflammatory cell infiltration, and be a therapeutic candidate for treat-
ing of inflammatory skin disease.
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Propionibacterium acnes induces expression of matrix metalloproteinase-9 through a toll-
like receptor 2 dependent mechanism
H Jalian,1 PT Liu,2 RL Modlin1,2 and J Kim1 1 Division of Dermatology, Department of
Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA and 2 Department of
Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at
UCLA, Los Angeles, CA
Propionibacterium acnes, a Gram-positive anaerobe, is known to be a critical component in
the pathogenesis of acne vulgaris. It has previously been shown that P. acnes stimulates the
production of various inflammatory mediators, such as cytokines and metalloproteinases,
important in the immune response in acne. This study explored the role of P. acnes and its abil-
ity to induce matrix metalloproteinases (MMP) mRNA in human primary monocytes as meas-
ured by quantitative PCR. P. acnes was found to induce MMP mRNA, notably MMP-1, 3, and
9, which are known to be present in acne lesions. P. acnes also induced MMP-9 expression
in human primary keratinocytes, but was unable to increase the expression of MMP-1 or 3.
The expression of tissue inhibitors of metalloproteinases (TIMP) -1, the main regulator in vivo
of MMP-1, 3, and 9, but not TIMP-2, was induced by P. acnes. Furthermore, MMP-9 was found
to be TLR-2 dependent as mRNA expression was decreased by the addition of a TLR2 block-
ing antibody. Finally, we explored the role of retinoids, which have previously been shown to
modulate TLR2 function in monocytes, on MMP expression. Co-treatment of monocytes with
all-trans retinoic acid (ATRA) significantly decreased MMP-9 expression. In addition, pre-
treatment of monocytes with ATRA abrogated MMP-1 expression. These data indicate that P.
acnes-induced MMPs and TIMPs may be involved in acne pathogenesis, and retinoic acid-
induced reduction in MMPs may contribute to its therapeutic effects seen in acne.
742
Keratinocyte TLR inflammatory responses to fungal wall derived mannan
J Son, R Prado, Y Lu, H Chen, PI Song, CA Armstrong and JC Ansel Dermatology, University
of Colorado at Denver and Health Sciences Center, Denver, CO
Keratinocyte Toll like receptors (TLR) are believed to play an important role in cutaneous innate
immunity to a variety of microbial pathogens. The effect of fungal-derived agents on TLR medi-
ated keratinocyte responses is unclear. In this study, we examined the effect of mannan, an
essential fungal wall component, on murine PAM 212 keratinocyte TLR mediated inflamma-
tory responses. Previous studies in other cell types indicate that mannan activates the TLR4
receptor signaling pathway to initiate the host immune response to different types of fungi.
Our results indicated that mannan induced nuclear translocation of NF-κB and increased
expression of PAM 212 TNFα, IL-1, IL-6, and KC in addition to upregulation of TLR4 itself.
PAM 212 cells transfected with a TLR4 dominant negative construct failed to elicit this response
to mannan, therefore demonstrating the TLR4 specificity of the PAM 212 inflammatory response
to this fungal wall component.  These studies demonstrate the capacity of keratinocyte TLR to
mediate innate immune responses to a commonly encountered fungal derived agent, which
further supports the importance of this receptor in host cutaneous defenses to a variety of
microbes.
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The suppression of human keratinocyte Toll like receptor mediated responses by Alpha-
melanocyte stimulating hormone
Y Lu, R Prado, J Son, H Chen, PI Song, CA Armstrong and JC Ansel Dermatology, University
of Colorado at Denver and Health Sciences Center, Denver, CO
Alpha-melanocyte-stimulating hormone (α-MSH) is a potent neuropeptide that has been
reported to have a wide range of immunosuppressive activities in the skin. The effect of α-MSH
on keratinocyte TLR expression and function is unknown. Since keratinocyte TLR is believed
to play an important role in cutaneous innate immunity, we determined if α-MSH was capa-
ble of modulating keratinocyte TLR mediated responses. Our results indicated that Staphylo-
coccus aureus derived lipoteichoic acid (LTA) augmented the expression of both TLR2 as well
as the chemokine IL-8 in human keratinocytes. Pretreatment of cells with α-MSH effectively
blocked this response to LTA. To determine the specificity of this response, Agouti protein, an
α-MSH receptor antagonist, was utilized in these studies. Our results demonstrated that the
α-MSH immunosuppressive effects on TLR2 expression and IL-8 production was inhibited by
the addition of Agouti protein to the cultured keratinocytes prior to α-MSH. These studies
indicate for the first time that α-MSH is capable of suppressing keratinocyte TLR responses,
thus demonstrating another novel immunomodulatory activity of this neuromodulator in the
skin.
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Modulation of Toll like receptor expression in murine and human keratinocytes by sub-
stance P: another link between the neurosensory and innate immune systems in the skin
H Chen, Y Lu, J Son, R Prado, PI Song, CA Armstrong and JC Ansel Dermatology, University
of Colorado at Denver and Health Sciences Center, Denver, CO
Skin is constantly exposed to a large number of external pathogens. Toll-like receptors (TLRs)
have been reported to be expressed in a constitutive or inducible manner in the skin. TLRs
belong to an expanding class of microbial pattern recognition receptors that are believed to
play an essential role in host innate immune responses. Neuropeptides released by cutaneous
sensory nerves such as substance P (SP) have been demonstrated to have a broad range of
immunoregulatory effects on skin cells such as keratinocytes, dermal microvascular endothe-
lial cells, mast cells, and Langerhans cells. A possible contribution of the cutaneous neu-
rosensory system to TLR immune responses in the skin has not previously been investigated.
The results of this study indicate that SP can upregulate the expression of keratinocyte TLR. SP
(50 nM) augmented the expression of PAM 212 murine keratinocyte TLR2 and TLR4. This effect
could be inhibited by blocking SP receptors on PAM 212 cells using a specific neurokinin-1
receptor antagonist (NK-1 RA) or a neurokinin-2 receptor antagonist (NK-2 RA). Likewise, SP
did not induce the expression of TLR2 and TLR4 in PAM 212 cells transfected with dominant
negative TLR2 and TLR4 constructs. We then examined the effect of SP on human keratinocyte
TLR expression. In human HaCaT keratinocytes, the expression of TLR2 and TLR4 was increased
after treatment with SP (50 nM). Thus, SP that is released from sensory nerve fibers in the skin
may provide a new link between the cutaneous neurosensory system and innate immune
responses in the skin.
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Using gene expression to delineate functional roles of murine memory B cells
MM Tomayko,1 SM Anderson,2 CE Brayton,2 TW Behrens3 and MJ Shlomchik2 1
Dermatology, Yale University, New Haven, CT, 2 Immunobiology, Yale University, New
Haven, CT and 3 Center for Immunology, University of Minnesota, Minneapolis, MN
Memory B cells that differentiate into antigen presenting and antibody-producing cells play
a key role in vaccine-induced protection and, when directed against self-antigens, in medi-
ating the clinical manifestations of autoimmune diseases. Memory B cells themselves, how-
ever, are poorly understood. A significant barrier to the study of B cell memory is that the low
frequency of memory B cells specific for any particular antigen nearly precludes their isola-
tion and further study. Our laboratory has developed a mouse model that overcomes this obsta-
cle. In mice carrying a Vh186.2 IgH transgene, ~3% of splenic B cells bind the hapten NP
(compared with <0.2% in a wild-type mouse). After immunization, the frequency of memory
B cells approaches 13% of splenic B cells. We have isolated highly purified samples of mem-
ory B cells and their naïve precursors and have compared of gene expression using Affymetrix
microarrays. We have identified a panel of genes that are differentially expressed between
memory and naïve B cells, have confirmed more than 50 of these with quantitative PCR and
have further confirmed a subset of these at the protein level. Using this approach, we have
identified several signaling pathways that are likely responsible for fundamental functional
differences between naïve and memory B cells. A better understanding of memory B cells
will lead to improved vaccine strategies and targeted therapies for autoimmune diseases.
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Characterization of a small molecule inhibitor of tumor necrosis factor-alpha production
G Yang Dermatology Dept., First Hospital of Tsinghua University, West Chester, PA
Numerous studies have shown that reducing the levels of tumor necrosis factor-alpha (TNF)
through the use of anti-TNF antibodies or soluble TNF receptor is a safe and efficacious treat-
ment for inflammatory diseases such as rheumatoid arthritis and psoriasis. Therefore, novel
approaches to achieve this outcome are desired. We report here the characterization of a small
molecule inhibitor, G4016, that block TNF mRNA levels in response to LPS-stimulated mono-
cytes. G4016 inhibits the upregulation of TNF mRNA levels in response to LPS and also pre-
vents production of IL-1 and IL-6. In contrast, G4016 augments the production of IL-10 in
LPS-stimulated monocytes. G4016 also fails to prevent the production of IL-2 and TNF in anti-
gen-stimulated T cells, suggesting that its effects may be cell-type specific. G4016 prevents
the phosphorylation and activation of the MAP kinase, ERK, and therefore appears to medi-
ate its effects on TNF by acting at an early point in the signaling cascade induced in response
to LPS.
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The association between Pityrosporum Ovale and hair loss
J Nematian,1 A Gholamrezanezhad2,1 and M Ravaghi1 1 Islamic Azad University of Medical
Sciences, Tehran, Iran and 2 Tehran University of Medical Sciences, Tehran, Iran
Available data show that hair loss is an important cosmetic problem all over the world, but
the pathogenesis of common hair shedding is not fully understood. The aim of our study was
to evaluate the association between hair shedding with cutaneous Pityrosporum Ovale infec-
tion. During 4 years we obtained 300 samples from students of medical faculty. According to
the clinical history and hair pull test, participants were divided into two groups of normal sub-
jects and subjects suffering from hair shedding. The students’ dandruff was scraped and smeared
on a slide and colored by methylene blue and observed under 10 power field of microscope.
76% of students were P. Ovale carrier. The prevalence of positive smears was significantly
higher among the group of cases than the group of controls (89.92% versus 9.52%). Also
among those participants with positive smears, there was significantly higher frequency of hair
loss complaints and positive pull test. The frequency of carrying P. Ovale is significantly higher
among those suffering from hair loss and therefore our results raise the possibility of a rela-
tionship between this unicellular organism and hair loss. The study findings must be addressed
in larger series of patients.
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Streptococcus salivarius inhibition of group a streptococcus and propionibacterium acnes
in individuals with acne
JC Filip,2 WP Bowe,1 JM DiRienzo,3 A Volgina3 and DJ Margolis1,2 1 Dermatology, University
of Pennsylvania, Philadelphia, PA, 2 Biostatistics and Epidemiology, University of
Pennsylvania, Philadelphia, PA and 3 University of Pennsylvania School of Dental Medicine,
Philadelphia, PA
Antibiotic use in acne patients has been associated with oro-pharyngeal colonization with
Group A Streptococcus (GAS) and an increased risk of upper respiratory tract infections. S.
salivarius is generally believed to be the main regulator of GAS of the oro-pharynx through
the production of BLIS (bacteriocin-like inhibitory substances). The goal of this study was to
determine the prevalence of oro-pharyngeal colonization by S. salivarius in individuals with
and without acne. Additionally, we determined antibiotic resistance patterns, and the capa-
bility of the isolated S. salivarius to inhibit the growth of GAS and P. acnes. A total of 106
patients were recruited to participate in this cross-sectional study. S. salivarius was cultured
from the oro-pharynx from 55% and 29% of the participants (without and with acne, respec-
tively, p=0.01). More than two-thirds of those with acne on antibiotics had S. salivarius that
were resistant to acne antibiotics. Antibiotic resistance was noted in less than half of those
with acne not on antibiotics and less than one third of those without acne. About 38% of the
S. salivarius isolated from acne patients on antibiotics were inhibitory to GAS (BLIS-produc-
ing) and GAS inhibition was found in 20% of S. salivarius isolated from acne patients not on
antibiotics. In contrast, 47% of the S. salivarius isolated from subjects without acne inhibited
GAS. Interestingly P. acnes inhibition by S. salivarius also occurred in 54% of isolates from
acne patients using antibiotics, 20% of isolates from acne patients not using antibiotics, and
20% of isolates from subjects without acne. To the best of our knowledge this is the first time
that the capability of S. salivarius to produce a substance inhibitory to P. acnes has been reported.
The substances we identified might be promising as future treatments for infections caused by
GAS, such as pharyngitis and impetigo, as well as for acne.
746
Toll-like receptor expression and function in human macrophages and dendritic cells
SR Krutzik, K Grossheider and RL Modlin Medicine-Dermatology, UCLA, Los Angeles, CA
The skin acts not only as a physical barrier to infection but is also home to cells of the innate
immune system including dendritic cells and macrophages. Dendritic cells and macrophages
express Toll-like receptors, a family of pattern recognition receptors that recognize distinct
microbial ligands and lead to immune cell activation. We were interested in determining the
ability of cytokine-differentiated CD209+ macrophages and CD1b+ dendritic cells to respond
to various pathogens by measuring their TLR expression patterns via qPCR. Our data indicate
that CD209+ cells express higher levels of TLR3, 7, and 8 while CD1b+ cells express higher
levels of TLR1, 2, 4, 5, 6, and 9. Next, we examined the ability of CD209+ macrophages and
CD1b+ dendritic cells to respond to TLR activation and determined their cytokine profiles.
Following stimulation with a TLR2/1 ligand, CD209+ macrophages selectively secrete IL-10
while CD1b+ dendritic cells secrete IL-12, ITAC, IP-10, MIP-1α, and MIP-3α. Both cell sub-
sets equally secrete IL-8, NAP2, and MCP-1. Together, these data suggest that CD209+
macrophages and CD1b+ dendritic cells have distinct TLR expression patterns that may allow
them to respond to different microbial pathogens. Furthermore, based on their unique TLR-
induced cytokine profiles, CD209+ macrophages and CD1b+ dendritic cells may have dis-
tinct functional roles during skin infection.
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In vitro nail penetration profile of AN2690, a novel broad-spectrum antifungal agent in devel-
opment for the topical treatment of onychomycosis
S Baker,1 X Hui,2 RC Wester,2 S Barbadillo,2 AK Cashmore,2 KM Hold,1 V Sanders1 and
HI Maibach2 1 Anacor Pharmaceuticals, Palo Alto, CA and 2 Dermatology, University of
California, San Francisco, CA
We have investigated the nail penetration ability of AN2690, a novel benzoxaborole-based
antifungal agent designed for the topical treatment of onychomycosis. It has an MIC of 1 µg/mL
against T. rubrum. First, human cadaver fingernails were mounted on a wetted cotton ball reser-
voir in a one-chamber diffusion cell. Radioactive AN2690 (10% w/v in ethanol/propylene
glycol 4:1), or ciclopirox (8% w/w in commercial lacquer) were dosed daily for 14 days. At
study end, the top and bottom halves of the micro-dissected nails, cotton balls and surface
washings were analyzed by scintillation counting for AN2690 or ciclopirox. Then, AN2690
was formulated in a lacquer at concentrations ranging from 1-15% w/v and dosed once on
top of fingernails mounted on supporting gels. After 24 hrs the nail was removed and gels were
analyzed by LC/MS/MS for AN2690. The first study found concentrations of AN2690 in the
top and bottom halves of the nail plate were 25.6 ±8.8 and 20.5 ±4.7 µg eq/mg nail, respec-
tively, and ciclopirox 7.4 ±3.5 and 3.1 ±2.1 µg eq/mg nail, respectively, (P = 0.0008 (top),
0.0001 (bottom)). The total amount of AN2690 found in the supporting cotton balls was 2240
µg eq/sample and ciclopirox was 9 µg eq/sample, (P = 0.0022). The second study found the
amount of AN2690 that penetrated through the nail from formulations containing 1, 2.5, 5,
7.5, 10 and 15% w/v AN2690 was 4.4 ±1.6, 13 ±1.7, 24 ±7.0, 41 ±8.7, 44 ±4.5 and 52 ±9.8
µg, respectively. In conclusion, after 14 days of dosing, AN2690 was nearly equally distrib-
uted throughout the upper and lower nail plate and a significant proportion of the applied
dose was found under the nail plate. Penetration of AN2690 was found to increase linearly
with concentration up to 7.5 % w/v. The exceptional nail penetration profile of AN2690 in a
simple vehicle makes it a promising candidate for onychomycosis topical treatment.
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Notch inhibition in Kaposi’s sarcoma (KS) tumor cells leads to mitotic catastrophe
C Curry,1,2 L Reed,1 BJ Nickoloff,1,2 L Miele1 and KE Foreman1,2 1 Oncology Institute, Loyola
University Medical Center, Maywood, IL and 2 Microbiology/Immunology, Loyola University
Medical Center, Maywood, IL
KS is the most common neoplasm in untreated HIV-1 infection, and accounts for significant
morbidity and mortality worldwide. We have previously reported that the Notch signaling
pathway is constitutively active in KS cells. During these studies, we noted that treatment of
a KS cell line, SLK, with Z-Leu-Leu-Nle-CHO, a small peptide inhibitor of γ-secretase (an
enzyme required for Notch activation), led to a prolonged G2/M cell cycle arrest, and even-
tually cell death. Additionally, LY411,575, a more specific inhibitor of γ-secretase, or Notch-
1 knockdown using siRNA also led to G2/M arrest. Therefore, we hypothesized that inhibi-
tion of Notch signaling induces mitotic catastrophe in KS cells. Mitotic catastrophe is the result
of aberrant mitosis, often arising from improper G2/M checkpoint control and re-entry of tumor
cells into the cell cycle after prolonged growth arrest. It can resolve in cell death or senes-
cence. To determine if Notch inhibition leads to mitotic catastrophe in KS cells, micronucle-
ation, a characteristic sign of mitotic catastrophe, was evaluated. The results demonstrated a
significant increase in micronucleation in KS cells treated with Z-Leu-Leu-Nle-CHO, LY411,575
or Notch1 siRNA. Because mitotic catastrophe can result from aberrant entry into mitosis, we
examined expression and localization of G2/M checkpoint proteins. Western blot and immuno-
fluorescent microscopy revealed that treatment with Z-Leu-Leu-Nle-CHO, LY411,575 or Notch1
siRNA lead to a sustained increase in cyclin B1 and induced its translocation to the nucleus,
both of which are normally transient events at the onset of mitosis. Additionally, Cdc25C, the
protein responsible for activating the cyclin B1/cdk1 complex, translocated to the nucleus with
Z-Leu-Leu-Nle-CHO treatment and cdk1 kinase activity was increased further suggesting entry
into mitosis. Taken together, the results suggest that Notch inhibition in KS cells leads to mitotic
catastrophe after a prolonged arrest in the M phase of the cell cycle.
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Detection of human papillomavirus DNA in peripheral blood mononuclear cells other than
local lesions from patients with condyloma acuminate
X Tang,1 H Shen1 and H Chen2 1 Department of Dermatology, The 3rd Hospital of
Hangzhou, Hangzhou, Zhejiang, China and 2 Department of Dermatology, No.1 Hospital of
China Medical University, Shenyang, Liaoning, China
In previous studies, human papillomavirus (HPV) has been purported to infect only the skin
and mucosa. However, little is known whether HPV DNA also can be detected in blood. In
knowing the behavior of the infected virus other than the local invasions, we detected and
typed HPV DNA in peripheral blood mononuclear cells (PBMCs) and in local lesions of patients
with condyloma acuminata (CA). Polymerase chain reaction (PCR) assays were employed to
detect HPV DNA in blood and local lesions of 30 CA patients, as well as in blood from 20
normal donors. PCR products were treated by restriction enzymes Rsa I and Pst I for HPV typ-
ing. The amplified fragments from the three patients cloned were verified by sequence. HPV
DNA was detected in the local lesions but not in serum samples of all 30 patients and in 10
of these patients, PBMC preparations were also HPV DNA positive. On the other hand, none
of 20 normal donors revealed positive PCR amplification in PBMC extractions. Restriction
enzyme analyses confirmed that both local lesions and PBMCs from individual patients con-
tained the same HPV DNA type. HPV6 in six cases, HPV11 in two cases and HPV16 in one.
Although a mixed infection of HPV6 and 11 was found in the lesions of one patient, only
HPV 11 DNA was amplified from her PBMC fraction. The PCR products from three patients
were further cloned and sequenced, verifying HPV L1 DNA respectively. Our results also
indicate that the patients with HPV DNA positive PBMCs have significantly more local lesions
than patients with HPV DNA negative PBMCs (p<0.05). In conclusion, HPV DNA can be
detected in the PBMCs of CA patients. The frequency of circulating virus is correlated with the
numbers of local lesions. Thus, one must be aware that the contagiousness of CA is not only
from the local but may also from systemic contacts.
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Epidermal Langerhans cells infected with CCR5-tropic HIV, but not dermal dendritic cells,
transmit virus to T cells in a novel skin explant model system
T Kawamura,1 Y Nakamura,1 Y Ogawa,1 Y Koyanagi,2 A Blauvelt3 and S Shimada1 1 Dept. of
Derm., Univ. of Yamanashi, Yamanashi, Japan, 2 Laboratory of Viral Pathogenesis, Kyoto
Univ., Kyoto, Japan and 3 Dept. of Derm.,, Oregon Health & Science Univ., Portland, OR
Mucosal Langerhans cells (LC) or submucosal dendritic cells (DC) are suspected to be the ini-
tial cells that support HIV replication following sexual exposure to virus. Recently, novel C-
type lectins, langerin and DC-SIGN, expressed on LC and DC, respectively, have been shown
to bind HIV and facilitate viral infection of resting T cells in trans. Therefore, we studied the
mechanisms of HIV dissemination from resident LC and DC to T cells using a novel skin explant
model system. CCR5-tropic HIV was applied to abraded epidermal surface of split-thickness
skin explants. After 3 days, emigrant cells from skin explants were collected and co-cultured
with allogeneic T cells. Interestingly, pre-incubation of skin explants with anti-CD4 mAb
completely blocked subsequent HIV transmission from emigrant skin cells to T cells, whereas
anti-langerin mAb or anti-DC-SIGN mAb did not. Bead depletion studies demonstrated that
LC accounted for more than 95% of HIV dissemination. When infection levels of emigrant
skin cells were determined by flow cytometry 3 days following HIV exposure, HIV p24+ cells
were detected only in LC and not in DC. To further test whether HIV could replicate within
LC, skin explants were exposed to HIV variants engineered to express GFP during productive
infection. Strikingly, GFP+ cells were detected only in LC within emigrant cells following HIV
exposure. In addition, GFP+ LC were only detected when a CCR5-tropic HIV strain was applied
to skin, and not when a CXCR4-tropic HIV strain was utilized. When emigrant cells were
labeled with PKH prior to co-culture with T cells, PKH—GFP+ T cells were found adjacent to
PKH+GFP+ LC, proving that HIV-infected LC directly transmitted HIV to T cells. Thus, these
results suggest that productive HIV infection of mucosal LC, and not submucosal DC, may
play a critical role in virus dissemination during sexual transmission of HIV.
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Vaccinia virus down-regulates NF-kappaB pathway through a novel mechanism
L Deng,1,2 P Dai1 and S Shuman1 1 Dermatology Service, Memorial Sloan-Kettering Cancer
Center, New York, NY and 2 Dermatology, Weill Medical College of Cornell University, New
York, NY
Vaccinia virus (VV) belongs to the Poxviridae family, orthopoxvirus genus. It has been used
for immunization against smallpox virus for the last 200 years. Vaccine–related complications
such as eczema vaccinatum are more commonly seen in individuals with abnormal skin immu-
nity, such as atopic dermatitis. Therefore, understanding the complex interactions of the virus
and the skin immune system is important in delineating the biological events that occur dur-
ing natural poxvirus infection in the skin or during vaccination. Epidermal Langerhans cells
(LCs) are professional antigen presenting cells in the skin. They play essential roles in host
immune defense and the development of immunity. We previously reported that VV could
replicate in XS52 cell line (a murine epidermis-derived dendritic cell) that was used as a sur-
rogate for LC. VV attenuated pro-inflammatory cytokine production in infected cells stimu-
lated by lipopolysaccharide (LPS) or poly (I:C). In this study, we compared the attenuation
effect on cytokine production in XS52 cells infected with wild type VV (WTVV) or VV with
deletion of E3L gene (VV∆E3L). E3L encodes two related dsRNA binding proteins that block
the activation of IFN pathway. VV∆E3L is attenuated, has limited host range and is being devel-
oped as a safer vaccine for smallpox. We found that VV∆E3L did not replicate in XS52 cells,
and late viral protein synthesis was blocked in infected cells. Deletion of E3L partially restored
pro-inflammatory cytokine production in XS52 cells in response to LPS or poly (I:C). Western
Blot analysis revealed that VV∆E3L but not WTVV infection lead to activation of NF-κB path-
way through degradation of IκBα. In contrast, WTVV but not VV∆E3L infection lead to cleav-
age of IKKβ during late phase of infection. Viral protein synthesis was required for both events.
In conclusion, we provide evidence that VV down-regulates NF-κB pathway through prote-
olytic cleavage of IKKβ and we propose that a novel viral protein may be responsible for this.
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Construction of eukaryotic expression plasmid of HPV11-E7/human IFNα-2b fusion gene
and its expression in CHO cell
W Xiang,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial People’s Hospital, Nanjing, Jiangsu Province,
China and 2 Providence College, Providence, RI
Molecular epidemiologic observations suggest that HPVs are likely a part of the commensal
microflora of human epithelia, held in a subclinical state by a competent immune system but
able to be reactivated under immunosuppressive conditions. Furthermore, because of the sub-
stantial homology of E7 protein across HPV types, it is likely that most individuals have been
exposed to common E7 epitope. Thus, few individuals are likely to be HPV E7 immunologi-
cally naive. The early gene E7 of HPV is involved in the regulation of viral DNA reproduction,
plasmid maintenance and transformation. E7 protein of HPV has been thus identified as a
promising candidate for a therapeutic vaccine. Genital warts are due primarily to HPV types
6 and 11. Type I IFNs have been implicated as potent immunoregulatory cytokines in the adap-
tive immune response; moreover, Type I IFNs facilitate differentiation of native T cell along
Th1 pathway, IFNα-2b belongs to Type I IFNs. In this study, pET-32a-IFNα-2b-linker-HPV11-
E7 (including the gene fragment IFNα-2b and HPV11-E7) and pcDNA3.1(+) were digested by
KpnI and EcoRI, digested products were linked by T4DNA ligase. DH5αwas transformed with
the linked product, positive clones were identified after KpnI and EcoRI digestion. The recom-
binant plasmid carrying HPV11-E7/ human IFNα-2b fusion gene was introduced into CHO
cell by lipofectin. The CHO cell containing pcDNA3.1(+)-IFNα-2b-linker-HPV11-E7 was exam-
ined by immunofluorescence staining. The DNA sequencing result showed that HPV11-E7/
human IFNα-2b fusion gene was successfully inserted into the pcDNA3.1(+) plasmid between
by Kpn I and EcoRI. The successful construction of eukaryotic expression plasmid of HPV11-
E7/ human IFNα-2b fusion gene and its expression in CHO have laid the foundation for the
elevation of immunological result of DNA vaccine.
756
Transfection of dendritic cells with HPV-11 E7 recombinant adenovirus
F Wang,1 W Xiang,1 Z Bi,1 G Li,1 F Liu,1 H Wu,1 Z Zhang1 and Y Wan2 1 Zhongda Hospital
of Southeast University, Nanjing, Jiangsu Province, China and 2 Providence College,
Providence, RI
Accumulating evidence demonstrates that DC with HPV genetic modification could elicit
HPV specific CTR and efficiently boost protective anti-HPV immune response. The early gene
E7 of HPV is involved with regulation of viral DNA reproduction, plasmid maintenance, and
transformation. E7 protein of HPV has been identified as a promising candidate for a thera-
peutic vaccine. We therefore chose to construct recombinant adenovirus encoding the HPV-
11 E7 gene, analyze the change of the mature DC surface markers and function after transfec-
tion in hopes to develop the treatment of CA with HPV-11 E7 transfected DC. DCs were
transfected with pAD-E7 recombinant adenovirus at different multiplicity of infection (MOI).
The expression of E7 protein on transfected mature DC was analyzed by FACS, and the dead
cells were counted by typan blue staining. The alteration of surface markers on mature DC
including CD1a, CD83, CD40, CD80 and HLA-DR was detected by FACS. The functions includ-
ing stimulating allogeneic T cell proliferation and secreting cytokines IL-10, IL-12, IFN-γ on co-
culture supernatant of DC and T cell IL-12 were also measured by a method of 3H-thymidine
uptake and ELISA, respectively. The results showed MOI 100 is the optimal MOI. With MOI
100 transfection, the above 89% of mature DC expressed E7 protein and above 93% of the cells
were viable. No significant changes in the surface markers and the cytomorphosis of mature
DC were examined during the transfection. Transfected DC still had strong potential to stimu-
late the proliferation of allergenic T cell. The level of cytokines IL-12, IFN-γ in supernatant of
co-culture cell was increased with no change of IL-10. The results suggest that pAD-E7 recom-
binant adenovirus could be transferred into DC more efficiently. The function of mature DC was
not affected significantly by the transfection of pAD-E7, and could induce Th1 polarization of
co-culture T cell. The study provides a rationale for the development of immunotherapy of CA.
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Molecular cloning and expression of E6 and E7 genes of human papillomavirus type 6b
Q Wang,1 Z Bi2 and Y Wan3 1 Guangdong Provincial People’s Hospital, Guangzhou,
Guangdong Province, China, 2 Jiangsu Provincial People’s Hospital, Nanjing, Jiangsu
Province, China and 3 Providence College, Providence, RI
To provide target antigens for the development of condyloma acuminatum (CA) therapeutic
vaccine against HPV infection, molecular cloning and expression of E6 and E7 genes of HPV
type 6b was carried out. Clinical specimens of genital warts were collected and treated for
PCR. The L1 consensus primers GP6+ and GP5+ were used for initial amplification round to
target a 150bp product by using HPV general primer-mediated polymerase chain reaction
(GP-PCR). To screen for HPV-6 and HPV-11 from the samples, two HPV type-specific PCR
(TS-PCR) were carried out by two-type specific primer sets, respectively. According to E6 and
E7 gene sequences of the two types of HPV from GenBank, E6 and E7 genes cloning primers
with EcoRI and SalI sites were designed, and DNA extracts of HPV-6 and HPV-11 which were
confirmed formerly by GP-PCR and TS-PCR were used as PCR templates. The ligation mix-
tures were transformed into the competent E. coli JM109. The recombinants were initially
screened by plates with ampicillin, IPTG and X-gal. The recombinant pUC plasmid DNA by
alkaline lysis with SDS was screened. The positive recombinants harboring the fragment of
interest were analyzed by automated sequencing. The results showed that the clone from E6
and E7 was HPV-6b exactly, a subtype of HPV-6. The E6, E7 genes of HPV 6b were success-
fully amplified by using PCR. The recombinant plasmids pUCm/HPV 6bE6 and pUCm/HPV
6bE7 were constructed and confirmed with enzyme digestion and sequencing. The recombi-
nant expression plasmids of pGEX-5X-1/HPV 6bE6 and pGEX-5X-1/HPV 6bE7 were obtained.
In E. coli BL21, GST fusion proteins of HPV 6b E6 and E7 were stably expressed about 41kD
and 37kD, respectively. These results could serve as a basis for further studies on the useful-
ness of the genes and their expression products may be used for the development of new
therapeutic vaccine against HPV infection.
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Role of the HSV gene Pol in the pathogenesis of herpes associated erythema multiforme
(HAEM)
MD Gober,1 JM Laing,1 JW Burnett2 and L Aurelian1 1 Pharmacology and Experimental
Therapeutics, University of Maryland School of Medicine, Baltimore, MD and 2
Dermatology, University of Maryland School of Medicine, Baltimore, MD
HAEM pathogensis is characterized by lesional skin positive for: (i) presence/expression of
HSV polymerase (Pol) DNA, (ii) TGF-β, p21WAF, and IFN-γ expression, and (iii) autoantigen-
specific T-cell infiltration. Our studies were designed to examine the role of Pol in HAEM
pathogenesis. A431 (keratinocyte) cells transfected with a Pol expression vector expressed
TGF-β and p21WAF, as determined by immunobloting and immunohistochemistry. Expres-
sion was not seen in cells transfected with the empty vector. Because Pol is molecularly sim-
ilar to HPIP (hematopoietic Pbx interacting protein), which is known to upregulate the SP1
transcription factor, we used immunoblotting to examine SP1 expression. SP1 was seen in
cells transfected with Pol, but not the empty vector and it, in turn, upregulated TGF-β and
p21WAF. p21WAF was localized in the cytoplasm of Pol transfected cells and HAEM lesional
skin, likely due to its phosphorylation by TGF-β activated Akt (P-Akt). Phosphorylated p21WAF
was seen in Pol transfected A431 cells. Akt was activated in HAEM (7/7) but not normal or
drug induced EM (DIEM) skin (0/8), as determined by staining with P-Akt antibody. Its acti-
vation was correlated with SP1 expression [10/12 (83%) and 0/10 for HAEM as compared to
normal or DIEM skin].  Significantly, heat shock protein 27 (Hsp27), which is Sp1 regulated
and is involved in autoimmune diseases, was also expressed in skin from HAEM patients [21/24
(86%)], but not in normal or DIEM skin [2/10 (20%)]. The data indicate that Pol induces SP1
expression, thereby altering the regulation of cellular genes which contribute to HAEM patho-
genesis including their function as potential autoantigens.
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A clue for Epstein-Barr virus reactivation in cutaneous lesions of severe hydroa vacciniforme
and hypersensitivity to mosquito bites
T Yamamoto, K Tsuji, D Suzuki and K Iwatsuki Dermatology, Okayama University Graduate
School of Medicine, Dentistry and Pahmaceutical Sciences, Okayama, Japan
Epstein-Barr virus (EBV) related cutaneous disorders include hydroa vacciniforme (HV), hyper-
sensitivity to mosquito bites (HMB), NK/T cell lymphoma, and so on. Although HV does not
cause general symptom, a high risk group, including HMB, severe HV and NK/T cell lym-
phoma may cause high grade fever and liver dysfunction as well as topical cutaneous lesion.
EBV reactivation usually occurs in pharynx epithelial cell. EBV BamHI A rightward tran-
scripts (BARTs) have been demonstrated that these would exist in all EBV-infected cells. But
little has reported BARTs expression in EBV lytic infection and these pathogenesis. We inves-
tigated expression of EBV reactivation and BARTs mRNA expression using the tissue and cell
lines. Reverse transcription-polymerase chain reaction (RT-PCR) method was done using the
specific primers for BZLF1 and BARTs splicing pattern. In situ hybridization for BZLF1 and
BARTs mRNA was examined using the specific probes for BZLF1 and BARTs, respectively.
Although no BZLF1 mRNA was found in the skin lesions and peripheral blood mononuclear
cells (PBMC) from patients with HV, we could detect it in the skin lesions of a high risk group.
No BZLF1 mRNA was detected in all PBMC and lymph nodes irrelevant to EBV-associated
diseases, whereas nodal lesions of EBV-associated T cell lymphoma and angioimmunoblas-
tic T-cell lymphoma were positive for BZLF1 mRNA. BARTs mRNA was commonly expressed
in all EBV infected cells. In tissue samples, BARTs mRNA was highly expressed in BZLF1
mRNA positive samples. Drug induced lytic infected cell lines had much higher BARTs mRNA
than latently infected cell lines. EBV reactivation may occur in not only pharynx but lymph
node and topical cutaneous lesion. We expect specific cytotoxic T cells against EBV reacti-
vation related antigens may cause infectious mononucleosis like general symptoms i.e. high
grade fever. And we belive BARTs overexpression is necessary to reactivate EBV.
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The expression of RAGE and EN-RAGE in the leprosy
M Kim,1 Y Choi,2 H Choi,2 K Myung2 and S Cho3 1 Dermatology, Dankook University,
Cheonan, Chungnam, South Korea, 2 Dermatology, Ewha Womans University, Seoul, South
Korea and 3 Microbiology, Yonsei University, Seoul, South Korea
Extracellular newly identified RAGE binding protein(EN-RAGE) is a ligand of receptor for
advanced glycation endproducts(RAGE) and has been termed S100A12. The ligation of EN-
RAGE with RAGE on the endothelium, mononuclear phagocytes, and lymphocytes triggers
cellular activation with the generation of the key proinflammatory mediators, IL-1β and TNF-
α. The aim of this study is to investigate the expression of RAGE and EN-RAGE, their spatial
localization, and their co-expression in leprosy lesions. The summary of the results are as fol-
lows: 1. In the multibacillary (MB) and paucibacillary (PB) groups, the level of RAGE expres-
sion was significantly higher than in patients with the atypical mycobacterial infection or the
sarcoidosis (p<0.01). In the MB group, the expression of RAGE was higher than in the PB group
(p<0.01), and it was higher in patients without the lepra reaction than patients with the lepra
reaction (p<0.05). 2. In the MB, PB, and atypical mycobacterial infection, the expression of
EN-RAGE was significantly higher than in the sarcoidosis (p<0.01). 3. In the confocal laser
scanning microscopic examination, RAGE and EN-RAGE protein was detected in the lepro-
matous leprosy. They are spatially colocalized along the cell surface, which is in agreement
with their receptor-ligand interaction. 4. The comparable amount of EN-RAGE was detected
in the serum of the MB and PB groups. Patients with the reaction showed the higher level of
EN-RAGE than patients without the reaction in leprosy. Our data suggest that in the leprosy,
the RAGE and EN-RAGE may be involved in the proinflammatory process rather than the
antimycobactierial activity, especially during the lepra reaction. The blockade of the interac-
tion RAGE and EN-RAGE at the early stage of the inflammatory process may minimize the
inflammatory response and consequent tissue damage or the sequelae of leprosy.
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High mRNA levels of the IFN-g-inducible Th1-type chemokines, CXCL10 and CXCL9, in the
lesional skin of patients with erythema migrans or acrodermatitis chronica atrophicans and
of the B Cell-active chemokine, CXCL13, in borrelial lymphocytoma
RR Muellegger,1 T Means,3 M Lee,2 L Glickstein,2 A Luster3 and AC Steere2 1 Department of
Dermatology, Medical University of Graz, Graz, Austria, 2 Division of Rheumatology,
Harvard Medical School, Charlestown, MA and 3 Center of Immunology and Inflammatory
Diseases, Harvard Medical School, Charlestown, MA
Two previous studies showed that both pro- and antiinflammatory cytokines, particularly
IFN-g and IL-10, were present in erythema migrans (EM) lesions. However, chemokine expres-
sion has not yet been determined in the lesional skin of patients with the various dermato-
borrelioses (DB). Using quantitative PCR, we analyzed mRNA expression of 12 chemokines,
8 cytokines, and 5 leukocyte markers in skin biopsy samples from 64 patients with EM, 25
with ACA, 11 with borrelial lymphocytoma (BL), and 25 healthy control subjects. Patients were
required to meet clinical, histologic, and serologic criteria of Lyme borreliosis. In EM and ACA,
high levels of mRNA for the IFN-g-inducible Th1-type chemokines, CXCL10 and CXCL9, which
are strong chemoattractants for effector CD8 and Th1-type CD4 T cells, were predominant,
whereas chemoattractants for Th2 cells, such as CCL1 and CCL22, were virtually absent. In
addition, intermediate mRNA levels of the macrophage chemoattractant, CCL2, and low lev-
els of the B cell-active chemoattractant, CXCL13, were often found. In contrast, BL lesions
had significantly higher levels of CXCL13 and proportionally lower values of CXCL10 and
CXCL9. These chemokine results were consistent with high mRNA levels for the CD8 and CD4
T cell markers in EM and ACA, and for the CD19 B cell marker in BL. In each of the DB,
mRNA expression for proinflammatory cytokines was dominant. These results point at a dom-
inant Th1-type immune response in the lesional skin of patients with the DB. However, a B
cell response is also found, especially in BL. Together, these data support the concept that both
macrophage and antibody-mediated killing are necessary for optimal control of B. burgdor-
feri, the causative extracellular pathogen.
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CD4+CD25+ adult T-cell leukemia/lymphoma cells express CTLA-4, but have no function of
regulatory T cells
S Takatoshi,  Kenji and T Yoshiki Department of Dermatology, University of Occupational
and Environmental Health, Kitakyusyu, Japan
Adult T cell leukemia/lymphoma (ATL) cells share the CD4+CD25+ surface expression mol-
ecule phenotype with regulatory T cells (Treg). However, it is still controversial whether ATL
cells belong to Treg. Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is one of the spe-
cific markers for Treg. In this study, we examined the seventeen ATL patients with skin involve-
ment. Flow cytometric analysis of the expression of CTLA-4 on CD4+CD25+ cells or Foxp3
on CD4+ cells in peripheral blood mononuclear cells (PBMC) demonstrated that circulating
tumor cells from two patients with the leukemic change highly expressed CTLA-4 as com-
pared to those from the normal healthy donors. ATL cells isolated from skin tumors of other
three cases also bore high CTLA-4 expression. Moreover, an immunohistochemical study
also demonstrated that, in five out of the nine examined patients, skin-infiltrating tumor cells
were positive for CTLA-4. Furthermore, after 12 hr activation of crude PBMC with anti-
CD3/CD28 antibodies, an expression of CTLA-4 on the CD4+CD25+ cells was significantly
higher than that from normal healthy donors. Although, there was no difference of IL-10 con-
centration of those supernatants between the patients and normal controls by ELISA assay.
Finally, to evaluate the function of Treg, we prepared the skin-infiltrating tumor cells or
CD4+CD25+ T cells derived from the patient with high CTLA-4 expression by immunomag-
netic beads. These tumor cells, however, did not suppress allogenic mixed lymphocytes reac-
tion, suggesting that those tumor cells have no Treg function. Therefore, our study demon-
strated that ATL tumor cells express CTLA-4, especially upon activation, skin infiltration or
leukemic change, but have no function of Treg.
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1,25(OH)2 vitamin D3 controls toll-like receptor 2,6 expression and function in keratinocytes
J Schauber,1 RA Dorschner,1 K Yamasaki,1 AB Coda,1 SW Kang2 and RL Gallo1 1 Division of
Dermatology, UCSD, San Diego, CA and 2 Division of Dermatology, University of Michigan,
Ann Arbor, MI
Immune defence depends on innate elements of pattern recognition (e.g. toll-like receptors,
TLRs) and response (e.g. antimicrobial peptides, AMPs). Cathelicidin AMP is increased in ker-
atinocytes upon differentiation by 1,25(OH)2 Vit. D3 (VD3). We hypothesized that keratinocyte
differentiation by VD3 may also modify the function of TLRs. We found by quantitative-real
time PCR (qPCR) that VD3 (100nM, 24h) increased cathelicidin expression (80-100 fold) while
simultaneously stimulating a 5-fold increase in TLR2, and a 250-fold increase in CD-14.
Immunocytochemistry confirmed a corresponding increase in these proteins. Calcium induced
differentiation had no effect on AMP or TLR expression although Ca++ and VD3 similarly
increased involucrin. Keratinocytes in organotypic culture also responded to VD3 (3-fold TLR2
mRNA, 30-fold CD14 mRNA), as did human skin treated 4 days with 1.0mM VD3 analogs
(2.5 fold increase in TLR-2 protein). TLR1, TLR6 and CD36 were unchanged. To test the func-
tion of the observed change in TLRs, expression of AMPs, IL-8 and the innate antimicrobial
action of keratinocytes was tested. In the presence of VD3, IL-8 and HBD-2 were relatively
suppressed after exposure to the TLR2/6 ligand Malp-2, but cathelicidin was induced (as seen
by qPCR) and processed to active peptide (as seen by SELDI-TOF mass spec). TLR2 antibody
blocked cathelicidin induction. Activation of TLR2 by VD3 and Malp-2 was relevant as shown
by enhanced ability to kill Staphylococcus aureus mprF. In sum, these findings show for the
first time that VD3 alters pattern recognition responses by keratinocytes to enable enhanced
antimicrobial activity but blunt secretion of pro-inflammatory cytokines. These results in cul-
ture and on clinical samples uncover a previously unknown role for VD3 in modifying innate
immune responses in skin, and demonstrate differential modifications of antimicrobial and
pro-inflammatory molecules.
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Comparative activity of antifungal compounds using three in vitro models
J Lenn,1 W Chern,1 B Hunt,2 M Larm,2 R Buchta2 and H Hofland1 1 Preclinical R&D,
Connetics Corp., Palo Alto, CA and 2 Technical Operations, Connetics Corp, Melbourne, VIC,
Australia
Onychomycosis is a fungal disease in which the finger and toe nails are infected by der-
matophytes, such as Trichophyton rubrum and Trichophyton mentagrophytes. Most cases of
onychomycosis (85%) are chronic and do not respond well to topical therapies, and require
long treatment regimens. There is a clear unmet medical need for better treatment options. In
vitro antifungal activity of five compounds and three topical formulations were compared using
three different assays: a liquid broth assay, a nail powder assay, and the TurChub® assay. The
liquid broth assay allows for the determination of antifungal activity against T. rubrum and T.
mentagrophytes grown in a nutrient rich media. The nail powder assay offers a more clinically
relevant evaluation of these actives against the infectious organism as dermatophytes grow on
the natural substrate, nail keratin. The TurChub® assay uses a modified Franz-cell to grow the
organism in an agar filled receptor chamber and uses the nail as the membrane barrier to assess
drug penetration through the nail.  All five drugs tested (terbinafine, ciclopirox, econazole, tio-
conazole, and ketoconazole) showed lower minimum inhibitory concentrations (MIC) with
shorter exposure times in the liquid broth assay when compared to their antifungal activity in
the nail powder assay. There was no difference in activity against the two dermatophytes in
the liquid broth assay. However, in the nail powder assay T. mentagrophytes appeared more
resistant to the treatment than T. rubrum. The nail powder model showed a difference in the
ranking of the antifungal activity for both dermatophytes for the 5 compounds tested com-
pared to the liquid broth assay. The TurChub® assay was validated using a marketed ciclopirox
nail lacquer. Release and penetration of ciclopirox from novel foam and gel formulations were
assessed in the Turchub® assay. Antifungal activity of the compounds varied in the three mod-
els used, suggesting the complexity of this disease may warrant a multi-model assessment for
new treatment options.
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Resident skin cells utilize IL-1R/MyD88 signaling to promote neutrophil recruitment against
Staphylococcus aureus
LS Miller,1 RM O’Connell,1 MA Guiterrez,1 EM Pietras,1 A Shahangian,1 L Uricchio,1
A Thirumala,2 AL Cheung,2 G Cheng1 and ML Robert1 1 Division of Dermatology and Dept.
of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA and 2 Dept.
of Microbiology & Immunology, Dartmouth Medical School, Hanover, NH
The role of IL-1R/MyD88 signaling in host defense was investigated using Staphylococcus
aureus cutaneous infection as a model. We previously reported that IL-1R and TLR2, which
both signal via the adapter protein MyD88, are important for an effective immune response
against S. aureus. However, MyD88- and IL-1R- but not TLR2-deficient mice had severely
decreased recruitment of neutrophils to the site of infection. Since the S. aureus-induced skin
lesions are composed of resident cells and bone marrow (BM)-derived recruited cells we uti-
lized techniques of BM-reconstitution to delineate which population of cells was important
in promoting IL-1R/MyD88-mediated neutrophil recruitment. We found that IL-1R-deficient
mice reconstituted with either wild-type (wt) BM or IL-1R-deficient BM had increased lesion
size (3-4 fold), with increased bacterial counts (~10 fold), and had a severe defect in neutrophil
recruitment and in myeloperoxidase activity (2-3 fold), compared with wt control mice (p<0.05).
Conversely, wt mice reconstituted with IL-1R-deficient, MyD88-deficient, or wt BM had sim-
ilar lesion sizes, bacterial counts, neutrophil recruitment and myeloperoxidase activity as wt
control mice indicating that IL-1R or MyD88 expression by recruited BM-derived cells had no
impact on neutrophil recruitment or in the eradication of the infection. These data suggest
that effective neutrophil recruitment and bacterial clearance is dependent upon IL-1R/MyD88
signaling by resident skin cells and not by BM-derived recruited cells. Thus, resident skin cells
may act as first responders and send appropriate signals via IL-1R/MyD88 activation to pro-
mote neutrophil recruitment to the site of bacterial infection in the skin.
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Multiplex real-time PCR for dermatophytes detection and identification
M Arabatzis,1,2 L Bruijnesteijn van Coppenraet,1 E Kuijper,1 S de Hoog,2 A Lavrijsen,3
K Templeton,1 E van der Raaij-Helmer,3 A Velegraki4 and R Summerbell2 1 Medical
Microbiology Department, Leiden University Medical Center, Leiden, Netherlands, 2
Centraalbureau voor Schimmelcultures, Utrecht, Netherlands, 3 Dermatology Department,
Leiden University Medical Center, Leiden, Netherlands and 4 Microbiology Department,
Athens Medical School, Athens, Greece
Current diagnosis of dermatophyte infections is slow and has low sensitivity, especially in infec-
tions of hair and nails. In addition, phenotypic isolate identification requires great expertise.
The objective of the study was to develop a rapid real-time PCR assay for diagnosis of der-
matophytoses. Two assays were designed and optimised. One was for detecting the Trichophyton
mentagrophytes species complex as well as T. tonsurans and T. violaceum. It was based on
amplification of the ITS1 region. A second assay was developed for the T. rubrum species com-
plex, Microsporum canis and M. audouinii; it was based on the ITS2. The assays were per-
formed using minor groove binding probes carrying different fluorophores allowing target
discrimination. Specificity was tested on a panel of 36 different species including all der-
matophytes, dermatophytoids, yeasts and bacteria. The protocol was evaluated by blindly test-
ing 92 clinical specimens, collected prospectively from suspicious skin-nail-hair lesions over
6 months. The system correctly identified cultures of the above-mentioned dermatophyte
species. The analytical sensitivity of both assays was 0.1 pg, corresponding to 2.5 genomes
per sample. The method detected all the microscopy- and/or culture-positive samples (n=40),
and correctly identified all the species (T. rubrum, T. mentagrophytes, M. audouinii, T. vio-
laceum) grown in culture (n=29). It also detected 7 additional positive samples that were neg-
ative by microscopy/culture and identified 2 mixed infections. The proposed real-time PCR
assay has a high sensitivity, enables accurate diagnosis of six commonly encountered der-
matophyte species and could potentially be incorporated into the routine diagnostic proce-
dures of the clinical laboratory.
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Chromogranin A, a stress-induced prohormone that enhances innate host defense in skin
KA Radek,1,2 B Lopez-Garcia,1,2 SK Mahata,1,2 L Taupenot,1,2 DT O’Connor2,3 and RL Gallo1,2
1 Veterans Affairs San Diego Healthcare System, La Jolla, CA, 2 Medicine, University of
California at San Diego, La Jolla, CA and 3 Center for Molecular Genetics, University of
California at San Diego, La Jolla, CA
Chromogranin A (ChgA) is a neuropeptide prohormone that is stored with catecholamines in
secretory vesicles and secreted in response to stress. Post-translational processing of ChgA results
in the generation of bioactive peptides, one of which is Catestatin (Cst). We previously demon-
strated that Cst displays antimicrobial activity against several bacteria, yeast, and fungi and is
expressed in the epidermis of human and mouse skin. In the present study, we sought to deter-
mine if ChgA influenced the ability of the skin to combat infection. Protein from the skin of
ChgA wild-type (WT) and knock-out (KO) mice was extracted and subjected to HPLC purifica-
tion. Collected fractions (1-32) were used in a radial diffusion assay against S. aureus (mprF
mutant). Fractions 9-15 from WT mice contained Cst as determined by immunoblot and exhib-
ited significant antimicrobial activity, whereas these extracts from KO mice exhibited little or no
clearing (2.5mm (WT) vs. 1mm (KO), fraction 9). ChgA WT and KO mice were then tested for
their ability to resist infection in vivo by the highly invasive bacteria, Group A streptococcus
(GAS). Mice were injected s.c. with GAS on the dorsum and observed for 4 days. Lesions from
WT mice were smaller at day 4 post-injection compared to KO mice (2.45±0.16mm vs.
3.50±0.37mm). When the lesions were excised and GAS quantitated, lesions from KO mice con-
tained significantly more GAS CFU/ml compared to those from WT mice (1.44x10^7±4.83x10^6
CFU/ml vs. 4.02x10^7±1.15x10^7 CFU/ml). These observations demonstrate that the loss of
ChgA, a prohormone involved in the stress response, results in a significant decrease in innate
immunity, possibly mediated by loss of Cst. These data emphasize the significance of the neural
response to cutaneous immune defense and provide the first in vivo demonstration that a neu-
ropeptide is required for normal immune defense of the skin.
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Differential expression of angiogenic and chemotactic genes in immune complex mediated
skin disease:leprosy as a model
DJ Lee, HY Li, D Eisenberg and RL Modlin UCLA, Los Angeles, CA
To examine the immunopathogenesis of immune complex mediated skin disease, we studied
erythema nodosum leprosum (ENL) as a model. ENL occurs in patients with lepromatous lep-
rosy, and is characterized by the infiltration of neutrophils in lesions and the depositions of Ig
and complement in cutaneous blood vessels. Using gene expression profiling, we examined
the gene expression profiles in ENL skin lesions (n=6) and compared them to lepromatous lep-
rosy L-lep lesions (n=7). Statistical analysis revealed that the gene expression patterns corre-
lated with and accurately classified the clinical form of disease (unsupervised hierarchical
clustering grouped patients according to their clinical diagnosis and fewer than 1% of the
random groupings performed as well as the clinically defined L-lep-ENL grouping at classify-
ing the withheld samples using leave-one-out cross validation). The most informative differ-
entially expressed genes between the two leprosy subclasses were identified according to the
probability that the means of its expression values are statistically distinct between the ENL
and L-lep patients using the Student’s t-test and the fold change in mean expression of each
gene between the two groups, with significance p ≤0.05 and a fold change of ≥2. A total of
2104 genes were found to be comparatively upregulated in ENL lesions, and 1311 were upreg-
ulated in L-lep lesions. Interestingly, of the differentially expressed genes, 79% of the angio-
genesis genes and 70% of the chemotaxis/cell motility/cell adhesion genes were increased in
ENL. Important for neutrophil recruitment, the increased expression of E-selectin (P=0.048)
was further examined by immunoperoxidase labeling and found to be expressed prominently
in ENL in a vascular pattern while the expression in leprosy was minimal. Vascular endothe-
lial growth factor genes were also increased in ENL compared to L-lep such as VEGF (0.03)
and Angiopoietin-2 (P=0.004). These data suggest an important role for activated endothe-
lium in the pathogenesis of ENL and immune hypersensitivity reactions.
128 Journal of Investigative Dermatology (2006), Volume 126
ABSTRACTS
769
A new class of antifungals with a novel mechanism of action, which is in development for
the topical treatment of onychomycosis
W Mao, FL Rock and M Alley Discovery Biology, Anacor Pharmaceuticals Inc., Palo Alto, CA
Onychomycosis is a fungal nail infection with high prevalence, especially in people over 70.
Unlike oral antifungals, topical antifungals are much less prone to toxicity and drug interac-
tions. With this in mind Anacor has developed AN2690 a new class of antifungal agent for
the topical treatment of onychomycosis. AN2690 has a broad-spectrum of activity with MICs
ranging from, 0.5 µg/ml for the yeast Candida albicans to 1 µg/ml for the filamentous fungi
Trichophyton rubrum. Since T. rubrum is refractory for most molecular genetic techniques,
we used the more genetically tractable fungi Saccharomyces cerevisiae to determine the mech-
anism of action for AN2690. We have mapped mutations from 23 AN2690 resistant mutants
to the CDC60 gene, which codes for the essential cytoplasmic protein synthesis enzyme,
leucyl-tRNA synthetase. Furthermore, we have shown that AN2690 inhibits protein synthesis
in S. cerevisiae. Leucyl-tRNA synthetase, like the enzymes for isoleucine and valine, possess
two structural domains. One domain uses ATP to attach the amino acid to the 3’ of tRNA,
while the other domains edits incorrectly charged tRNAs further increasing the specificity of
these enzymes. Surprisingly, all mutations map to the editing domain. This is completely dif-
ferent from other aminoacyl-tRNA synthetase inhibitors for example mupirocin resistant muta-
tions are located in the synthetic domain of isoleucyl-tRNA synthetase. To further character-
ize AN2690 we over-expressed and purified the cytoplasmic leucyl-tRNA synthetase from S.
cerevisiae. Using the aminoacylation assay we have shown that AN2690 is a noncompetitive
inhibitor of leucyl-tRNA synthetase with respect to both leucine and ATP. In contrast, mupirocin
is a competitive inhibitor of isoleucyl-tRNA synthetase because it binds to the synthetic active
site. The mechanism of action of AN2690 suggests that the editing domain of aminoacyl-tRNA
synthetases represents a novel way of inhibiting this well characterized family of enzymes.
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Cytotoxic T lymphocyte-mediated immune responses against Epstein-Barr virus-infected cells
induce hydroa vacciniforme-like eruptions
S Morizane, T Yamamoto, D Suzuki, K Tsuji and K Iwatsuki Dermatology, Okayama
University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama,
Japan
Both classical hydroa vacciniforme(HV) and HV-like eruptions are composed of infiltration
of Epstein-Barr virus(EBV)-infected cells and a majority of reactive lymphocytes. [Purpose] We
have clarified the cellular events leading to herpetic vesiculopapules in HV-like eruptions.
Eighteen patients with HV or HV-like eruptions were examined for histopathological and viro-
logical findings, including EBV-encoded small nuclear RNA (EBER) by in situ hybridization
and BZLF-1 mRNA by RT-PCR, and the amount of EBV DNA was measured in the peripheral
blood. The cellular infiltrates were examined by immunochemical staining, using antibodies
to lymphocyte subsets and cytotoxic molecules including TIA-1, granzyme B and granulysin.
EBER+ T cells were detected, to various degrees, in the cutaneous infiltrates in 17 (94%) of
18 patients, including all 6 patients with ‘classical’ HV with a positive phototest reaction,
and 11 of 12 patients with ‘probable’ HV without evidence for photosensitivity. In addition
to EBER+ T cells, many cytotoxic T lymphocytes (CTLs) expressing TIA-1, granzyme B and
granulysin were present in the cutaneous lesions. These histopathologic features are similar
to other herpetic vesicles induced by herpes simplex or varicella-zoster virus, but distinct from
those of spongiotic dermatitis. Natural killer (NK) cells were absent or at a background level.
Both CD4+ and CD8+ CTLs expressed these cytotoxic molecules. The amounts of EBV DNA
were increased in the peripheral blood mononuclear cells, but rather in low levels as com-
pared with patients with systemic EBV-associated NK/T-cell lymphoproliferative disorders. No
BZLF-1 mRNA, suggestive of reactivation of EBV, was detected in the cutaneous lesions. HV-
like eruptions characterized by herpetic vesiculopapules are induced by CD4+ and CD8+
CTLs against EBV-infected lymphocytes.
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Evaluation of CJ9-gD, a novel replication-defective and dominant-negative recombinant her-
pes simplex virus type 1 (HSV-1), as prophylactic vaccine against HSV-1 skin infection in
guinea pigs
R Brans, R Gheerardyn, O Bleiziffer and F Yao Surgery/Plastic Surgery, Brigham and
Women’s Hospital, Boston, MA
Using the tetracycline gene switch technology (T-REx, Invitrogen Inc., CA) developed in our
laboratory, we recently generated a prototype herpes simplex virus type 1 (HSV-1) recombi-
nant virus, CJ83193, that is capable of inhibiting its own replication as well as that of wild-
type HSV-1 and HSV-2 and could serve as an effective vaccine against wild-type HSV-1
infection in a mouse ocular model. To further improve its safety and efficacy against HSV infec-
tion, we have generated a CJ83193-like recombinant CJ9-gD that contains a large deletion in
an additional essential gene and an extra copy of a gene encoding glycoprotein D (gD), a
major surface antigen of HSV. CJ9-gD is completely replication-defective and cannot estab-
lish detectable latent infection in mice following ocular inoculation with HSV-1. The ability
of CJ9-gD as a safe and effective vaccine against wild-type HSV-1 infection was tested in a
guinea pig model of skin infection. Immunized guinea pigs exhibited complete protection
from primary HSV-1 skin disease in strong contrast to unvaccinated animals, which devel-
oped multiple herpes lesions upon challenge. Vaccination with CJ9-gD resulted in high HSV-
1-specific neutralizing antibody titers at least 2500-fold higher than in mock-immunized
controls and 2.6-fold higher than those observed after natural infection with wild-type HSV-
1. Quantitative real-time PCR analysis of HSV-1 viral DNA isolated from dorsal root ganglia
after recovery from challenge with wild-type HSV-1 revealed a significant reduction of HSV-
1-specific DNA detected in immunized animals. Thus, we demonstrate that immunization
with CJ9-gD can elicit strong protective immune responses against primary herpes skin dis-
ease and reduces frequency and magnitude of latent infection.
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DNase1L2 suppresses biofilm formation by Pseudomona aeruginosa and Staphylococcus
aureus in vitro
H Fischer,1 L Eckhart,1 K Bundvig Barken,3 M Ghannadan,1 T Tolker-Nielsen3 and
E Tschachler1,2 1 Dermatology, Medical University of Vienna, Vienna, Austria, 2 CE.R.I.E.S.,
Neuilly, France and 3 BioCentrum-DTU, Technical University of Denmark, Lyngby, Denmark
We have recently identified DNase1L2 as the first DNase that is upregulated during keratinocyte
differentiation. Suprabasal keratinocytes of normal skin contain high amounts of DNase1L2
whereas parakeratotic lesions lacked DNase1L2, a finding which is in line with a possible
role of DNase1L2 in differentiation-associated nuclear DNA breakdown. Here we investigated
a potential alternative function of DNase1L2 in the prevention of extracellular DNA-depend-
ent biofilm formation. In a previously established in vitro assay extracellular DNA was shown
to be required for bacterial biofilm formation. Recombinant DNase1L2 potently suppressed
biofilm formation of an adherent strain of P. aeruginosa whereas it did not affect the growth
of planktonic growing P. aeruginosa. In a modification of this assay, DNase1L2 also blocked
biofilm formation by S. aureus, which previously has been shown to grow in biofilms on lesional
skin of atopic dermatitis patients. Western blot analysis demonstrated that DNase1L2 was pres-
ent in the soluble fraction of stratum corneum of normal skin and DNase activity analysis
confirmed that DNase1L2 prepared from stratum corneum by immuno-affinity enrichment
was enzymatically active. Together these data suggest that DNase1L2 may contribute to the
anti-microbial defence of human skin.
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Virologic, immunologic, and clinical characterization of a patient with Epidermodysplasia
verruciformis
R Tiberio,1 B Azzimonti,2 M Mondini,2 V Dell’Oste,2 E Zavattaro,1,2 S Nicola,3 G Pertusi,1
L Angeli,1 M Gattoni,1 P Boggio,1 G Delrosso,1 U Dianzani,3 M Gariglio2 and G Leigheb1 1
Clinical and Experimental Medicine, Dermatologic Clinic, Novara, Italy, 2 Clinical and
Experimental Medicine, Laboratory of Microbiology, Novara, Italy and 3 Medical Science,
Laboratory of Immunology, Novara, Italy
Epidermodysplasia verruciformis (EV) is a rare, genetically determined disease, characterized
by abnormal susceptibility to human papillomaviruses (HPVs). We investigated some genetic,
virologic, immunologic and clinical parameters in a 58-year-old female patient with a diag-
nosis of EV. Her family did not display other EV cases and her parents were not consanguineous.
Physical examination of the patient revealed multiple flat whitish and reddish papular lesions
on the hands, and pityriasis versicolor-like lesions on the trunk. Biopsy specimens from papu-
lar lesions showed numerous large cells with pale staining cytoplasm and perinuclear vac-
uolisation in the spinous and granular layers, resembling the typical histological features of
EV. Surprisingly, she has never developed either cutaneous premalignant or malignant lesions
even in sun-exposed areas such as forehead which is typically affected by multiple skin can-
cers in EV patients. Her medical history showed recurrent esophageal candidiasis resistant to
therapy and gastric carcinoma. HPV detection by PCR analysis from samples collected with
prewetted cotton-tipped swabs from different sites of the skin revealed mixed infection with
multiple HPV genotypes (all from the β-genus) in both affected and unaffected area. She dis-
played low serum levels of IgA but normal IgG and IgM, did not develop contact allergy to
DNCB sensitization, and the intradermal tests were also negative. Immunophenotype analy-
sis of peripheral lymphocytes showed normal counts of total T cells (CD3+ cells) and the CD4+
and CD8+ T cell populations, but a significant expansion (9%) of an atypical T cell popula-
tion expressing the TCRαβ but not CD4 or CD8, which has been previously described in the
autoimmune lymphoproliferative syndrome (ALPS), but did not display any other sign of this
disease.
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Mast cells protect against invasive bacterial infection and generate novel cathelicidin antimi-
crobial peptides in response to IL-4
A Di Nardo, K Yamasaki and RL Gallo Dermatology Section, VAMC, University of California
San Diego, San Diego, CA
Mast cells (MC) have recently been shown to express cathelicidins (Caths), peptides that act
as natural antibiotics by directly killing microbes. We hypothesized that presence of MC will
influence skin infections and that the control of Cath release and processing will be impor-
tant for MC function. To evaluate the role of MC in infection, MC-deficient mice (c-Kit wsash
KO) were compared to normal controls for resistance to invasive Group A Streptococcus (GAS).
C-Kit wsash KO mice had 30% larger lesions, 80% more lesional bacteria and 30% more bac-
teria in the blood 4 days after subcutaneous challenge with GAS when compared to control
mice. To study Cath expression in MC, connective tissue derived MC were challenged with
LTA, LPS, or lipid A. FACS analysis of Cath expression showed a increase in Cath immuno-
reactivity in the presence of LPS 1µg/ml (30%) and LTA 1µg/ml (20%). Unexpectedly, when
MC were exposed to IL-4 (10ng/ml), Cath increased 5 to 10% over that seen in response to
LTA and LPS, and this was accompanied by an increase in killing of bacteria (Staph A Mprf).
Since Cath activity is dependent on processing of the mature peptide, we analyzed the influ-
ence of IL-4 on peptide processing by SELDI-TOF mass spectrometry. SELDI-chips were con-
jugated with an anti Cath C-terminal antibody and detected at small MW peptide resolution.
MC stimulated with IL-4 showed a unique profile of processed Cath fragments compared to
that seen in any other cell type with an increase in the fragments in the MW range 2800 to
3000. These findings show that MC are important for cutaneous resistance to invasive bacte-
rial infection and suggest that the expression and processing of Cath by MC is vital to the abil-
ity of these cells to participate in antimicrobial defense. Moreover, a previously unsuspected
interaction between a Th2 stimulus and Cath production and processing is uncovered, thus
further supporting the interdependence of innate and adaptive immune elements in skin defense.
www.jidonline.org   129
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Medicinal chemistry of AN2690, a novel broad-spectrum antifungal agent in development
for the topical treatment of onychomycosis
JJ Plattner,1 S Baker,1 Y Zhang,1 T Akama,1 V Sanders1 and SJ Benkovic2 1 Anacor
Pharmaceuticals, Inc., Palo Alto, CA and 2 Pennsylvania State University, University Park, PA
We report the synthesis and structure-activity relationships that led to the development of
AN2690, a first-in-class antifungal agent with unique properties for the topical treatment of
onychomycosis. AN2690 was developed from our novel organoboron library. It has a dihy-
drobenzoxaborole structure, (a five-membered heterocyclic ring containing boron, fused to a
benzene ring) and is synthesized in four steps from commercial materials. In routine screen-
ing of library members we found our benzoxaborole compounds have broad-spectrum anti-
fungal activity. We synthesized a series of analogues including expanding the oxaborole ring,
making various substitutions around the molecule and replacing boron with carbon. All com-
pounds were screened for their MIC values against C. albicans, A. fumigatus, C. neoformans,
T. mentagrophytes and T. rubrum. From these results, we found that an unsubstituted five-mem-
bered oxaborole ring was essential for activity. Expanding this ring or installing a substituent
on this ring reduced activity 8 fold. The benzene ring was also sensitive to substituents. An
appropriately placed fluoro- or chloro- group increased activity 2-4 fold, while most other sub-
stituents reduced activity from 4 fold to inactive. We found we could substitute the exocyclic
substituent on boron with many different groups without affecting the MIC. Using the posi-
tive attributes of the structure-activity relationships that emerged, we routinely synthesized
compounds that had similar activity profiles with MIC values of 1-2 µg/mL. We then focused
on developing the appropriate physicochemical and ADME properties for topical dosing. From
this effort, AN2690 emerged as having the optimum properties. It has a plasma protein bind-
ing value of 66%, is not metabolized in vitro and has plasma half-life of 11 minutes in mice.
In conclusion, a focused medicinal chemistry effort to develop a topical treatment for ony-
chomycosis led to the discovery of AN2690.
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TAT-fusion protein-transduced dendritic cells (DC) efficiently induce CD8+ T cells (TC) and
vaccinate against leishmaniasis
K Moelle,1 Y Tada,2 N Shibagaki,2 J Knop,1 MC Udey2 and E von Stebut1 1 Dept. of
Dermatology, Johannes Gutenberg-University, Mainz, Germany and 2 National Institutes of
Health, Dermatology Branch, NCI, Bethesda, MD
In murine leishmaniasis, healing is dependent on IFNγ+ CD4 and CD8 TC. Thus, an efficacious
vaccine should induce Th1/Tc1 cells. We generated fusion proteins of the Leishmania-antigen
LACK (L) and the protein transduction domain of HIV-1 TAT. TAT-LACK (TL) accumulates in
DC and facilitates MHC I-dependent antigen presentation. Vaccination with TL-transduced
DC efficiently protected BALB/c mice from progressive L. major infection. Administration of
DC+TL was superior to injection of DC+L. Herein, we investigated the mechanisms respon-
sible for the vaccination efficacy of TL. In vitro, TL-transduced DC induced stronger prolifer-
ation of ex vivo-isolated, Leishmania-specific CD8 TC as compared to DC+L (6±1 vs. 2±1%,
*p≤0.05). No difference was found regarding CD4 TC. To determine which TC mediate pro-
tection in vivo, naive BALB/c mice were vaccinated and TC responses in lymph nodes were
analyzed. Vaccination with DC+TL resulted in higher proliferation of CD8 TC as compared to
immunization with DC+L alone (16±4 vs. 5±2%, *p≤0.05). Induction of CD4 TC was com-
parable in both groups. Next, TC were depleted during vaccination and low dose infections
were initiated 3 wks later after complete restoration of TC. By depleting CD4 or CD8 TC,
TL+DC-mediated protection was lost (lesion sizes contr: 37±3, αCD4: 56±5, αCD8: 54±6
mm3, wk7,*p≤0.05). DC+L did not induce protection against progressive disease and TC-deple-
tion did not alter the course of infection (Contr: 62±5, αCD4: 50±7, αCD8: 50±6 mm3). In
parallel, depletion of DC+TL-vaccinated mice resulted in higher lesional parasite burdens as
compared to control mice (Contr: 3.8x104, αCD4: 2x107, αCD8: 2x106 Lm/lesion,*p≤0.05).
In DC+L-treated groups, the number of parasites was similiarly independent of TC depletion.
These data demonstrate that TL-mediated protection is dependent on both CD4 and CD8 TC
and that TAT-fusion proteins are superior in activating cytotoxic T cells as compared to anti-
gen alone.
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Interleukin-17 in cutaneous leishmaniasis
S Lopez Kostka,1 S Dinges,1 J Knop,1 MC Udey,2 Y Iwakura3 and E von Stebut1 1 Dept. of
Dermatology, Johannes Gutenberg-University, Mainz, Germany, 2 National Cancer Institute,
Dermatology Branch, NCI, Bethesda, MD and 3 University of Tokyo, Center for Experimental
Medicine, Tokyo, Japan
As observed in genetically resistant C57BL/6 mice, protective immunity against murine exper-
imental leishmaniasis is dependent on Th1/Tc1 cells. BALB/c mice, in contrast, succumb to
infection due to uncontrolled Th2 development. IL-17 is a proinflammatory cytokine secreted
by activated T cells (CD4 > CD8+ T-cells). We sought to determine the role of IL-17 in the
pathogenesis of leishmaniasis. During the course of infection with L. major, lymph node cul-
tures from wild type BALB/c mice released dramatically increased amounts of IL-17 as com-
pared to those of C57BL/6 mice. We subsequently used IL-17-/- (BALB/c) mice to study the
role of IL-17 in L. major infections. IL-17-/- mice were infected with high dose (2x105) and phys-
iologically relevant low dose (103) inocula of L. major and lesion development was monitored
over the course of >3 months. Lesion sizes in IL-17 deficient mice were smaller from wk6 on
as compared to those in control BALB/c mice (e.g. 27±3 vs. 72±12 mm3 in wk9, n=12, p<0.002).
Control mice developed uncontrolled lesion progression at wk 12, whereas lesions in IL-17-
/- mice remained stable for additional 2 months. In parallel, ears of IL-17-/- mice contained sig-
nificantly fewer parasites (2.2x105) as compared to control ears (2x106, wk3, n=12, p<0.05).
Interestingly, similar amounts of IFNγ were detected in lymph node cultures from IL-17-/- as
compared to controls and the amounts of IL-10/IL-4 were only slightly lower, suggesting that
the regulation of Th-cytokines does not play an important role in the increased resistance of
IL-17-/- BALB/c mice. Finally, neutrophil recruitment into lesional tissue was significantly
decreased in IL-17-/- mice at several time points during the course of infection. Our study
excludes an important role for IL-17 in Th activation in L. major-infected BALB/c mice and
strongly suggests that increased IL-17-dependent neutrophil recruitment in BALB/c mice may
be involved in enhanced disease susceptibility.
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Dynamic programming of CD8 T cell trafficking following cutaneous viral immunization
L Liu, RC Fuhlbrigge, K Karibian and TS Kupper Dermatology, Brigham and Women, Boston,
MA
The selective imprinting of skin specific homing receptors on T cells activated in lymph nodes
draining skin is an attractive but still unproven hypothesis. Alternative hypotheses suggest that
effector T cells traffic indiscriminately, and that “tissue specific homing receptors” are acquired
by T cells after their entry into tissue. We used live vaccinia virus containing the gene encod-
ing a specific antigen (OVA) to establish infection at two distinct anatomic sites, by skin scar-
ification or i.p injection, and sought to temporally map the trafficking pattern of CD8 T cells
after activation. Adoptive transfer of OVA specific TCR transgenic CD8 T cells (OT-1) bearing
a congenic marker allowed us to track the in vivo activation and migration of CD8 T cells dur-
ing the course of viral infection. At 2.5 days, CD8 T cells in lymph nodes draining skin (SLN)
upregulate E selectin ligands, but not α4β7, after five cell divisions, the converse is seen in
mesenteric (M)LN. At this time point, T cells can be identified in skin and gut, respectively.
However, after the third cell division, a subset of T cells activated in SLN disseminate sys-
temically and enter distant LN, where they continue to divide in the absence of antigen. By 5
days, those originally SLN-activated T cells that have migrated to MLN acquire expression of
α4β7, while originally MLN-activated T cells in SLN upregulate E selectin ligands. Many of
these cells transiently bear both skin and gut homing molecules at this stage of the immune
response. Finally, we examined homing markers in normal recipients 30 days post viral infec-
tion. The predominant homing phenotype on CD8 memory T cells at this time point is con-
sistent with the initial tissue specific homing imprint seen early after infection. The kinetics of
the immune response outlined above allow immediate distribution of effector cells to the rel-
evant peripheral tissue while still providing the flexibility for a systemic response during acute
infection. Importantly, long term tissue specific memory is maintained.
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Staphylococcus aureus in atopic dermatitis lesions: the association of biofilm-forming abil-
ity, toxin production, and clinical severity
N Bouzari,1 LR Plano,2 B Zhou,2 C Aber,1 C Wang,2 F Pissani,1 SC Davis1 and EA Connelly1
1 Dermatology, University of Miami, Miami, FL and 2 Pediatrics, University of Miami, Miami,
FL
A majority of patients with AD are secondarily colonized or infected with Staphylococcus aureus.
Recent studies demonstrate that Staphylococcus species are capable of forming biofilms which
render these organisms markedly more resistant to antibiotics and host immune responses. Biofilms
are complex structures consisting of microbial-associated cells embedded in an extracellular matrix
of hydrated extrapolymeric substances (EPS), which are irreversibly attached to a biological or
non-biological surface. In atopic patients the quantity of bacteria present on a host and the potency
of their toxins may contribute to the manifestation of the disease. Excreted bacterial toxins are
considered the main effector molecules in a wide variety of childhood exanthems. Since colo-
nized AD skin lesions show evidence of immune dysregulation, harmacophysiologic abnormal-
ities and disease persistence, we aim to investigate the presence of bacterial biofilms in children
with AD. Our objectives is to examine whether clinical isolates of S. aureus from atopic dermati-
tis lesions can form biofilms and that associated exotoxins made by S. aureus are contributing to
the disease process. Specimens for bacteriological examination were obtained from the lesions
and nose of patients with AD using a cotton swab. The degree of colonization was assessed using
a saline-scrub technique. The biofilm formation was quantitatively evaluated using optical den-
sity and cell quantification methods. The isolated bacteria were also amplified for coding regions
of genes of interest by standard polymerase chain reactions (PCR). We also performed spa typing
on all S. aureus isolates as an accurate screening technique to identify clonal populations. All iso-
lated bacteria produced biofilm. Biofilm formation was not associated to the presence of Panton-
Valentine leucocidin, or the examined bacterial exotoxins (ETA, ETB, TSST-1, etc.). Clinical iso-
lates from AD skin lesions are able to produce biofilm.
780
Local TLR2 activation exacerbates the course of Leishmania Major infection in mice
Z Darejeh,1,4 TS McCormick,1,2 KD Cooper1,2 and FP Heinzel3,4 1 Dermatology, Case Western
Reserve University, Cleveland, OH, 2 University Hospitals, Cleveland, OH, 3 VA Medical
Center, Cleveland, OH and 4 Center for Global Health and Diseases, Cleveland, OH
It has been shown previously that innate immunity can regulate the outcome of adaptive
immune response. We decided to test whether different toll like receptor agonists given at the
time of cutaneous Leishmania Major infection alter the course of the disease. BALB/c mice
were inoculated with 2 X 106 stationary phase promastigotes of L.major in the foot pads con-
current with a single injection of saline, LPS (40µg), Bacterial lipopeptide Pam3cys (40µg),
R848 compound (40µg) and CpG1826 (50µg) at the site of infection. As expected CpG cured
infected BALB/c mice with reduced parasite load and Th1 bias. Unexpectedly, Pam3Cys sig-
nificantly exacerbated progressive lesions in BALB/c mice with increased parasite load at 3
weeks. LPS had lesser exacerbative effects, whereas R848 only delayed onset of progression
by one week. Interestingly the pam3Cys exacerbation was not associated with altered ratios
of Th1/Th2 cytokines and the lesion acceleration was observed in the injected foot, but not in
the infected contralateral foot. Local injections of Pam3Cys also exacerbated disease in nor-
mally resistant C57BL/6 mice. Our conclusion is that co-exposure to the TLR2 agonist Pam3Cys
during inoculation of L. major accelerates early parasite load and lesion development through
local effects not associated with developing a Th1/Th2 bias and this may signify disease-alter-
ing effects of intrinsic (Pam3 Cys) or –extrinsic (cutaneous bacteria) TLR2 agonists at the time
of parasitic inoculation in the course of Cutaneous Leishmaniasis.
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Identification of immunodominant vaccinia virus antigens using expression cloning
D Jones, A Baldor and T Kupper Dermatology, Brigham and Women’s Hospital, Boston, MA
Vaccinia virus (VV) is used for immunization against smallpox. It is highly effective, but carries
a risk of adverse events in immunocompromised individuals and individuals with atopic der-
matitis. The modified Ankara strain (MVA) is an attenuated strain of VV which is believed to be
safer, although its efficacy is unknown. In preparation for an upcoming clinical trial comparing
VV and MVA, we sought to identify the complete repertoire of antigenic epitopes in VV. This
will allow comparison of immune responses to MVA vs. VV as well as immune responses in
atopics vs. non-atopics. We initially utilized expression cloning of a whole-genome VV library
in phage, and identified 7 dominant antigens (D8L, A26L, J6R, O1L/O2L, I1L, D13L, and I8L)
from pooled human vaccinia immune globulin (VIG). However, other previously identified
antigens were not found in the library screening (including H3L, B5R, A17L, and L1R). To iden-
tify a more complete repertoire of antigens we implemented a newly described in vitro library
immunoscreening approach called CIS display. Using this technique we were able to efficiently
identify a broad range of VV genes recognized by VIG including essentially all previously described
antigens as well as antigens not previously described. We conclude that a reasonably complete
repertoire of VV antigens has been defined, which will allow comparison of VV and MVA immune
responses, as well as immune responses in atopics and non-atopics. Furthermore, the CIS dis-
play technique should be useful for immunoscreening in other settings such as vaccine and infec-
tious disease research, autoimmunity, and cancer immunology.
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Galectin-3 protects keratinocytes from UVB-induced apoptosis
J Saegusa, DK Hsu, I Kuwabara, W Liu, Y Kuwabara, L Yu and F Liu Dermatology, University
of California, Davis, Sacramento, CA
Galectin-3 is a member of a family of β-galactoside-binding animal lectins and is expressed
abundantly by epithelial cells including keratinocytes. Previous studies have shown that
galectin-3 has anti-apoptosis functions in a number of cell types. However, the role of this
lectin in regulation of apoptosis in keratinocytes remains to be determined. We have studied
the role of galectin-3 in UVB-induced apoptosis of mouse keratinocytes by performing in vitro
and ex vivo experiments using gene-targeted knockout mice lacking galectin-3. In the in vitro
studies, keratinocytes derived from wild-type and mutant mice were irradiated with UVB,
and the degree of apoptosis was determined by flow cytometry, nuclear staining with Hoechst
33342, and detection of soluble DNA-histone complexes using ELISA. In the ex-vivo experi-
ment, skin sections from wild-type and mutant mice were exposed to UVB, and apoptotic ker-
atinocytes were detected by examining DNA fragmentation using in situ nick-end labeling
(TUNEL assay). Both in vitro and ex vivo studies demonstrated that galectin-3 deficient ker-
atinocytes were more sensitive to UVB-induced apoptosis than cells from wild-type mice.
Gene expression profile analysis showed that cultured wild-type mouse keratinocytes expressed
primarily galectin-1 and -7, in addition to galectin-3 and that galectin-3 deficiency did not
alter the expression of all other galectins. Interestingly, real-time PCR analysis revealed that
galectin-3 mRNA in normal human keratinocytes increased significantly at 1 hr after UVB irra-
diation in a dose dependent manner and thereafter returned to normal levels. These results
demonstrate an antiapoptotic role for galectin-3 in skin damage induced by UVB irradiation.
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Modulation of melanoblast physiologic functions by low-energy helium-neon laser
H Yu,1 C Lan,2 C Wu2 and M Chiou2 1 Dermatology, National Taiwan University Hospital,
School of Medicine, Taipei, Taiwan and 2 Dermatology, Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan
Helium-Neon laser (He-Ne Laser, 632.8nm) is a low energy laser which has biostimulatory
effects on cultured cells. Previous studies demonstrated that low-energy He-Ne laser can
induce repigmentation in vitiligo patients, but the mechanisms involved in the process remains
obscure. The melanoblasts (MBs) in the outer root sheaths of the hair follicles serve as the
source for repigmenation for vitiligo vulgaris. Recovery from vitiligo began by the migration
of the immture MBs to the epidermis. Subsequently, these cells undergo functional develop-
ment and bring melanin to the vitiliginous skin. In the present study, we evaluated the phys-
iologic effects and investigated the involved molecular mechanisms of He-Ne laser irradia-
tion on two MB cell lines: the immature NCCmelb4 and the more differentiated NCCmelan5.
The intricate interactions between MBs with their innate extracelluar matrix, fibronectin, were
also addressed. Our results showed that He-Ne laser irradiation enhanced immature MB
(NCCmelb4) mobility via enhanced phosphorylated focal adhesion kinase (pp125FAK) expres-
sion and promoted melanogenesis in the more mature MB (NCCmelan5). In addition, treat-
ment with He-Ne laser decreased the affinity between NCCmelb4 cells and fibronectin while
the attachment of NCCmelan5 to fibronectin increased after He-Ne laser treatment. The
α5β1 integrin expression on NCCmelb4 cells was significantly enhanced by He-Ne laser
irradiation. In summary, our results demonstrated that He-Ne laser induced different physio-
logic changes on MBs at different maturation stages. More importantly, our work recapitu-
lated the early molecular events that took place during the repigmentation process of vitiligo
induced by He-Ne laser in vitro.
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Effectiveness of sunscreens in a novel artificial skin cell mimic
R Krishnan and T Nordlund Department of Physics, University of Alabama at Birmingham,
Birmingham, AL
Sunscreens applied to skin exist primarily in a complex environment of stratum corneum,
formed by dead keratinocytes. Basic optical properties of sunscreens such as absorption and
fluorescence, on which the UV–filtering effect is based, are difficult to study in a heteroge-
neous, realistic environment like epidermis, because of the large background scattering con-
tribution. These properties are usually studied in solvents that do not simulate the conditions
of the skin system. Most sunscreens are hydrophobic, to study their properties in a skin-like
environment we need an adsorbing surface which mimics the environment of cells: lipid mem-
brane and proteins on one side and water on other. A polystyrene sphere suspension seems
to mimic the heterogeneous physical environment present in the epidermis and stratum
corneum. We confirmed this by comparing the fluorescence emission spectral shape and inten-
sity of sunscreens adsorbed to the spheres with that of sunscreens adsorbed to HaCat cells.
The fluorescence excitation spectrum of HaCat cells is similar to excitation spectra of stratum
corneum and epidermis, which indicates that our photo-physical studies of sunscreens adsorbed
to HaCat cell and spheres is relevant. Using the polystyrene sphere mimic we propose a new
method to quantify the effectiveness of sunscreens. This opens a new way to study UV–B and
UV–AII sunscreen ingredients (potential) in an environment which mimics the skin cell sys-
tem. We will present the % effectiveness of UV–B sunscreens octisalate, octinoxate and padi-
mateO resulting from this method for various concentrations of spheres and sunscreens. To
show this method can be used to study hydrophilic potential sunscreens we studied a water-
soluble, non-sunscreen molecule, 2–aminopurine. The new method utilizes the intrinsic flu-
orescence of polystyrene spheres, which spans the UV–B and UV–AII when excited with
260nm light. In this method simultaneous evaluation of other photo-physical properties, such
as fluorescence of sunscreens in the same skin-like environment, is straightforward.
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Bacteriostatic antibiotics protect bacterial pathogens from killing by innate immune mech-
anisms
SA Kristian,1,2 AM Timmer,1 GY Liu,1 X Lauth,1 RL Gallo2 and V Nizet1 1 Pediatrics, University
of California, San Diego, San Diego, CA and 2 Dermatology, UCSD, San Diego, CA
Important elements of innate immune defense against microbial infections include produc-
tion of cationic antimicrobial peptides (AMPs) and complement. These typically kill suscep-
tible bacteria by pore formation and act most effectively on growing bacteria. Pharmaceuti-
cal antibiotics aid the host’s immune system in fighting infection, but unlike genetically
programmed antimicrobial systems they are frequently rendered useless when present in the
environment for several years. In this study, we hypothesized that bacteriostatic antibiotics
may have a detrimental effect on the capacity of the innate immune system to kill important
human pathogens. To test this, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia
coli were cultured in the presence of erythromycin (Em) or chloramphenicol (Cm) at bacte-
riostatic conditions. The cathelicidin AMP mCRAMP at 8-32 µM decreased bacterial colony
counts from 1e7 CFU/ml to 0 CFU/ml while in the presence of antibiotics mCRAMP was much
less effective, decreasing bacteria from 1e7 CFU/ml to 1e4 – 1e6 CFU/ml at 5 hrs. Along this
line, K. preumoniae and E. coli both survived the bactericidal action of human complement
better if either Em or Cm was present. The negative influence of Cm and Em on the bacterici-
dal capacity of complement factors and AMP could be attributed to their effect on the bacte-
ria rather than to an interaction of the drugs with these innate immune effectors as bacteria
which were resistant to the bacteriostatics were killed to the same extent no matter if the
drugs were present or not. Finally, S. aureus, K. pneumoniae and E. coli were killed slower by
human whole blood which employs both AMPs and complement to inactivate microbes. These
findings suggest that the use of bacteriostatic antibiotics can negatively influence the ability
of the host to fight bacterial infections. Thus, in addition to promoting drug resistance, the inap-
propriate use of topical and systemic antibiotics may be hindering the function of innate
immune defense systems.
786
Photodegradation of folic acid during extracorporeal photopheresis
M Der-Petrossian,1 M Foedinger,2 H Hoenigsmann,1 R Knobler1 and F Trautinger1 1
Department of Dermatology, Division of Special and Environmental Dermatology, Medical
Universitiy of Vienna, Vienna, Austria and 2 Department of Medical and Chemical Laboratory
Diagnostics, Medical Universitiy of Vienna, Vienna, Austria
Photodegradation of folic acid by UV radiation is a well documented photochemical reaction
and decreased serum levels of folic acid have been found in patients receiving pho-
tochemotherapy (PUVA). During extracorporeal photopheresis (ECP) leukocytes and plasma
are subjected to 8-MOP/UVA and in the current study we investigated whether ECP leads to
the photodegradation of folic acid in the extracorporeal system. Thirty patients undergoing
ECP on two consecutive days were enrolled into the study. Heparinized plasma was obtained
from the extracorporeal system before and immediately after UVA exposure on both treatment
days. Healthy donor plasma was exposed to 8-MOP and increasing doses of UVA in vitro.
Folic acid (5-methyltetrahydrofolate) was determined by a radioassay (Simultrac-SNB, Becton-
Dickinson). Vitamin B12 and homocysteine, not undergoing photodegradation, were used as
control parameters. On the first day of ECP folic acid levels decreased from 7.11 ± 5.8 nmol/l
(mean ± SD, p<0,005) to 3.9 ± 2.6 nmol/l (mean ± SD, p<0,005) after UVA exposure. On the
second day the reduction was from 5.9 ± 4.9 nmol/l (mean ± SD, p<0,005) to 3.4 ± 3.0 nmol/l
(mean ± SD, p<0,005). This correlates to a decrease after UVA of 45.1 % and 42.4 %, respec-
tively. This effect could be reproduced in vitro demonstrating that folic acid reduction depends
on the UVA dose but not on the presence of 8-MOP. Only minor changes were observed for
vitamin B12 and homocysteine. From these results we conclude that extracorporeal exposure
of plasma to UVA during ECP leads to photodegradation of folic acid. Further investigations
are required to determine the biological effects of folate photoproducts and whether clini-
cally relevant loss of folic acid might be a consequence of ECP.
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Activation of p53 gene differentially corresponds with its downstream molecules of human
keratinocytes after Ultraviolet B injury
P Wang,1 X Song,1 Z Bi,2 S Jing,2 Y Cui2 and A Xu1 1 Department of Dermatology, The 3rd
Hospital of Hangzhou, Hangzhou, China and 2 Department of Dermatology, The 1st
Affiliated Hospital of Nanjing Medical University, Nanjing, China
P53, a nuclear phosphoprotein, functions as a transcription factor, mainly dealing with the
stress-response of keratinocytes once exposed to the environmental insults, such as ultravio-
let B (UVB) injury. Additionally, p53 plays a central role in the recovery from cells injury by
transactivation of genes with activation in either cell cycle arrest and DNA repair or even apop-
tosis when damage is not resumable. We, thus, have carefully got an insight into a panel of
downstream of p53-dependent gene signaling after UVB irradiation in a different manner. Cul-
tured normal human epidermal keratinocytes (NHEK) and HaCaT keratinocytes were irradi-
ated with UVB varied in doses of 20, 60 and 120 mJ/cm2. On the time points of 0, 2, 24, and
48 hour following irradiation, the expression of p53, MDM2 (negative regulator of p53), p21
and GADD45 (induced in cell cycle arrest and DNA repair), and Bax (control over apoptosis)
were detected by RT-PCR for mRNA and Western blotting for protein levels. After UVB irra-
diation, p53 accumulation of NHEK and HaCaT was sustained at high levels of both up to 48
hours. MDM2 was progressively reduced from 2 to 48h post-irradiation in NHEK, whereas
slightly increased temporarily with a peak at 2-hour in HaCaT. P21 and GADD45 were increased
at both levels even following low dose of UVB irradiation. In NHEK, p21 was higher than
GADD45, in HaCaT, GADD45 was higher than p21, with cell cycle arrested predominantly
in G1/S and G2/M respectively. When UVB doses were higher than 60mJ/cm2, Bax increased
sharply both in NHEK and HaCaT with the rising of apoptosis. Our results demonstrate that
UVB can trigger the activation of a panel of downstream of p53 genes in keratinocytes. The
expression of p53 downstream molecules depends on the p53 status, and shows apparently
in a dose- and time-dependent manner.
788
(-)-Epigallocatechin-3-gallate from green tea prevents photocarcinogenesis in mice through
augmentation of repair of UV-damaged DNA via interleukin-12-dependent mechanisms
SK Katiyar,1,2 SK Mantena,1 SM Meeran1 and CA Elmets1,2 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL and 2 Birmingham VA Medical Center,
Birmingham, AL
We have previously shown that topical application of (-)-epigallocatechin-3-gallate (EGCG)
prevents photocarcinogenesis in mice. EGCG also prevents ultraviolet (UV) radiation-induced
immunosuppression through the induction of interleukin (IL)-12. As IL-12 possesses DNA repair
ability, we determined whether prevention of photocarcinogenesis by EGCG is mediated
through EGCG-induced IL-12-dependent DNA repair. For this purpose we used genetically
modified mouse model (IL-12 knockout (KO) mice on C3H/HeN background) and DNA repair-
deficient cells from patients suffering from xeroderma pigmentosum complementation group
A (XPA). The effect of EGCG was determined on photocarcinogenesis and UVB-induced DNA
damage in the form of cyclobutane pyrimidine dimers (CPDs) in IL-12 KO mice and in their
wild-types (WT), and in XPA-deficient and proficient cells using immunohistochemistry and
dot-blot analysis. In photocarcinogenesis protocol, mice were exposed to UVB (180 mJ/cm2)
with or without the pretreatment of EGCG (1 mg/cm2 skin) three times a week for 30 weeks.
We found that treatment of EGCG prevented photocarcinogenesis in WT mice in terms of
tumor incidence and tumor multiplicity but did not prevent it in IL-12 KO mice, suggesting
the role of EGCG-induced IL-12 in prevention of photocarcinogenesis. EGCG reduced UVB-
induced DNA damage in the form of CPDs in the skin of WT mice more rapidly compared to
non-EGCG treated mice. In contrast this effect of EGCG was not observed in IL-12 KO mice.
Further, EGCG was able to repair UVB-induced CPDs in in vitro XPA-proficient cells obtained
from healthy person but did not repair in XPA-deficient cells indicating that nucleotide exci-
sion repair mechanism is involved in DNA repair. These results identify a new mechanism of
anti-photocarcinogenic effect of EGCG which indicates that prevention of photocarcinogen-
esis by EGCG is mediated through EGCG-induced IL-12-dependent DNA repair.
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Skin photoprotection by phytic acid
M Andreassi,1 E Stanghellini,2 E Pulsinelli,1,3 C Anselmi,1,3 M Centini1,3 and L Andreassi2,1 1
Centre of Cosmetic Science and Technology, University of Siena, Siena, Italy, 2 Department
of Dermatology, University of Siena, Siena, Italy and 3 Department of Pharmaceutical
Technology, University of Siena, Siena, Italy
Phytic acid, also known as inositol hexaphosphate (IP6), is a component of most cereal grains
and seeds. Its phosphate grouping in positions 1, 2, and 3 provides a specific interaction with
iron to completely inhibit its ability to catalyze hydroxyl radical formation, making IP6 a strong
antioxidant. Moreover it is a broad-spectrum antineoplastic agent, affecting different systems,
including cells and tissues derived from the skin. For such characteristics phytic acid appears
an appropriate ingredient to be used in topical preparations against UV damage. We have
studied topical preparations containing phytic acid and inositol in comparison with similar
products containing tocopheryl acetate and ascorbic acid, whose protective ability has been
proved. The substances were incorporated into O/W emulsion as a standard formulation at
percent concentration of 0.5 for IP6, 2.0 for inositol, 2.0 for tocopheryl acetate and 0.5 for
ascorbic acid. The investigation was carried out on 20 healthy male and female volunteers
with phototypes II and III. Each product was applied to the volar surface of the forearm at a
dose of 3 mg/cm2. As control, the same cream without active ingredients was applied to the
other forearm. Thirty minutes after application, using a solar simulator, the treated areas were
irradiated with scalar UV doses. Before the test and 24 and 48 h after irradiation, the magni-
tude of the reaction was evaluated with visual scoring as well as with instrumental measure-
ment of skin colour, TEWL and hydration. The product containing phytic acid revealed an abil-
ity to protect the skin against UV exposure similar to that of the product containing tocopheryl
acetate. Such an effect was proved by the degree of erythematous response to UV radiation
both at 24 and 48 hours after photo stimulation. Our study established that phytic acid can
be a useful ingredient for the preparation of products able to protect the skin against UV-dam-
age.
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UVB-induced HIF1alpha and VEGF and TFR expression is dependent on DEC1
Y Li,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial Hospital, Nanjing, China and 2 Providence
College, Providence, RI
UV radiation causes human skin photoaging and skin cancer through cell signaling pathways
mediated by a number of transcription factors. Transcription factor DEC1 has been recently
shown to be involved in cell survival. DEC1 protects against UV-induced cell death. The func-
tions of DEC1 in UV signaling remain unknown. This project was to investigate the effect of
DEC1 on UV-induced HIF1alpha and VEGF and TFR expression in cultured human skin ker-
atinocytes (HaCat cells). HIF1alpha protein was measured by Western blot method. UVB-
induced VEGF level was determined by ELISA. Protein expression of TFR after UVB irradia-
tion was determined by FACS analysis. After UVB irradiation, mRNA level of HIF1alpha and
VEGF and TFR were detected by real time-PCR. The results showed that compared with con-
trol groups, UVB induced HIF1alpha and VEGF and TFR protein expression in a dose- and
time-dependent manner in HaCat cells. Real time-PCR results indicated that UV induced VEGF
mRNA expression in a time dependent manner, VEGF mRNA expression reached a peak at 4
h post UV radiation, UVB-induced TFR mRNA expression also in a time dependent manner
and expression reached a peak at 8h, whereas UVB treatment did not induce HIF1alpha mRNA
expression. However, in DEC1 knockout cells (DEC1-/-, derived from HaCat cells), UVB radi-
ation did not induce VEGF, TFR and HIF1alpha expression neither at mRNA level nor at pro-
tein level. Taken together, our results indicated that UVB irradiation-induced HIF1alpha and
VEGF and TFR expression is dependent on DEC1 in cultured human keratinocytes.
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Ultraviolet B radiation induces expression of hypoxia-inducible factor 1α and vascular
endothelial growth factor through EGFR/PI3K/AKT Pathway
Y Li,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial Hospital, Nanjing, China and 2 Providence
College, Providence, RI
It has been shown that UV radiation induces hypoxia inducible factor 1 activating its target
genes such as VEGF. The cell signaling pathways leading to UV-induced HIF1α expression and
VEGF remain to be elucidated. Using cultured human keratinocytes and various inhibitors we
studied the cell signaling pathways. HIF1α protein was measured by Western blot method.
UVB-induced VEGF level was determined by ELISA. Expression of EGFR after UVB irradiation
was determined with FACS analysis. After UVB irradiation, mRNA level of HIF1α and VEGF
were detected by real time-PCR method. The results show that compared with control groups,
UVB induced HIF1α and VEGF protein expression in a dose- and time-dependent manner in
HaCat cells. VEGF mRNA expression reached a peak at 4h post UVB radiation in HaCat cells,
whereas HIF1α mRNA expression was not affected by UVB treatment. UV induced activation
of EGFR in HaCat cells in a time dependent manner which was inhibited by pretreatment of
EGFR inhibitor PD153035. UVB radiation did not induce HIF1α and VEGF expression in egfr
(-/-) MEF cells. In contrast, in egfr (+/+) MEF cells UVB radiation strongly enhanced VEGF and
HIF1α expression. PD153035, a selective inhibitor of EGFR tyrosine kinase activity, also inhib-
ited UVB-induced HIF1α and VEGF protein expression in a dose-dependent manner. PI3K
inhibitors, LY294002 and Wortmannin, also inhibited UVB-induced HIF1α and VEGF expres-
sion. Taken together, we conclude that UV-induced HIF1α expression and VEGF secretion via
EGFR/PI3K/AKT signaling way.
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Effects of antisense NF-κB p65 and EGFR oligodeoxynucleotides on UVB-induced IL6 secre-
tion and c-Jun activation in cultured human skin keratinocytes
J Xia,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial Hospital, Nanjing, China and 2 Providence
College, Providence, RI
NFκB is involved in UV-induced cytokine secretion and EGFR is involved in UV-induced c-
Jun activity in human skin. Both are considered as molecular targets for UV-induced human
skin photoaging and skin cancer. This project was to explore the effect of antisense NFκB p65
oligodeoxynucleotides on UV-induced IL-6 secretion and the effect of antisense EGFR oligonu-
cleotides on UV-induced c-Jun activity in cultured human keratinocytes. NFκB p65 protein
was measured by Western blot. UVB-induced IL-6 level was determined by ELISA. c-Jun DNA
binding activity after UVB irradiation and EGFR oligonucleotide transfection was determined
with a highly sensitive and specific colorimetric method. After NFκB p65 oligodeoxynucleotide
and EGFR oligonucleotide transfection respectively, mRNA level of NFκB p65 and EGFR was
detected by RT-PCR. The results showed that compared with control groups, the NFκB p65
protein and c-Jun activity increased significantly in UVB (10, 20, 30mJ/cm2) irradiation groups.
p65 mRNA and IL-6 induced by UVB were inhibited when keratinocytes were transfected with
p65 antisense oligodeoxynucleotides at concentrations of 2, 4 and 8 µg/ml. Similarly, EGFR
mRNA and c-jun activity induced by UVB were inhibited by EGFR antisense oligonucleotides
at concentrations of 2, 4 and 8 µg/ml. Taken together, we conclude that antisense NFκB
nucleotides effectively inhibited UV-induced IL-6 secretion and antisense EGFR nucleotides
inhibited UV-induced c-Jun activity. Both of those reagents might be useful for prevention from
UV-induced skin photoaging and skin cancer.
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Protective effect of gingkgo extracts on UVB-induced premature senescence in human skin
fibroblasts
X Wang,1 Z Bi1 and Y Wan2 1 Jiangsu Provincial Hospital, Nanjing, Jiangsu Province, China
and 2 Providence College, Providence, RI
Exposure of human proliferative cells to subcytotoxic stresses such as UV radiation results in
stress-induced premature senescence (SIPS). In this study, we investigated the changes of senes-
cence-associated biomarkers in UVB-induced primary human dermal fibroblasts. After a series
of 10 subcytotoxic exposures to UVB (5 mJ/cm2), the senescence-associated biomarkers were
markedly expressed. UVB-radiated fibroblasts became bigger and flat. The electromicroscopic
analysis showed that in UVB-radiated human skin fibroblasts, cytoplasm contained higher
number of secondary lysosomes, glycogen and fat. The results of FACS analysis showed that
G1 phase cells in UVB-radiated fibroblasts increased to 89.5%, while in control cells were
54.5%. p53/p21 and p16/Rb are two important pathways in regulating cell-cycle. The results
of immunohistochemical staining showed that the levels of p53, p21 and p16 were all ele-
vated in UVB-radiated fibroblasts, suggesting that most fibroblasts were retarded at G1 phase.
Using SA β-gal histochemical staining, we found that positive cells in UVB-radiated fibrob-
lasts were 91.5%, while in control cells were 62.3%. We next investigated the effects and
action mechanisms of gingkgo on UVB-induced senescence. Gingkgo extracts were added
at a concentration of 0.3 g/l and pre-incubated before each UVB exposure for 2 h. Our results
showed that compared with UVB-radiated fibroblasts, cells pretreated with gingkgo became
small and not so flat; secondary lysosomes decreased significantly; cells in G1 phase decreased
to 65.4%. The levels of p53, p21 and p16 were all decreased, and the decrease of p53 and
p21 was more significant than p16; SA β-gal-positive cells decreased to 70.2%. Taken together,
we conclude that a series of 10 subcytotoxic UVB induces SIPS in dermal fibroblasts and
gingkgo extracts have significant protective effects.
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Polypodium leucotomos protects from ultraviolet-induced DNA damage in human dendritic
cells
H de la Fuente,2 R Tejedor,1 M Mittelbrunn,2 F Sanchez-Madrid,2 JL Alonso-Lebrero1 and
S Gonzalez3 1 Farmaceutica Cantabria, Madrid, Madrid, Spain, 2 Inmunologia, Hospital
Universitario de la Princesa, UAM, Madrid, Spain and 3 Memorial Sloan-Kettering Cancer
Center, New York, NY
Polypodium leucotomos (PL) is a fern plant grown in Central America. In vitro and in vivo
studies have shown that PL extract (Fernblock®, PLE) acts as an effective antioxidant with pho-
toimmunoprotective properties. The aim of this work was to analyse the effect of PL extract
on the cellular damage of human dendritic cells (DCs) induced by ultraviolet (UV) radiation.
Immature human DCs were incubated in presence or absence of PL extract at several doses
for 4 h at 37°C, and irradiated using an ultraviolet solar simulator. Twenty-four hours after
ultraviolet solar-simulated radiation, apoptosis was determined and supernatants collected to
analyse IL-12 and IL-10 levels. DCs pre-treated with PL (0.05 mg/ml) showed a lower percent
of apoptosis compared with those untreated (inhibition >50%) when apoptosis was deter-
mined by hypodiploid cells, TUNEL or DAPI. We have also analyzed activation of caspase 3
in response to UV radiation in presence or not of PL extract, as well as the expression of sev-
eral members of Bcl-2 family proteins. Preliminary results have shown that UV-induced cas-
pase 3 activation is prevented by the preincubation with PL extract. Moreover, analysis of
Bcl-2 family members have shown that expression of bak and bclx-s, two pro-apoptotic pro-
teins, is diminished in DCs irradiated in presence of PL extract compared with those irradi-
ated in its absence. Finally, cytokine production analyses show that IL-12 is produced in
response to PL extract (0,05 mg/ml) even in those irradiated DCs. Also, UV-induced IL-10
secretion was not affected by the presence of PL extract. Our results show that PL extract exerts
a protective effect on DCs from UV-induced apoptotic changes associated to DNA damage,
which could be associated to the inhibition of caspase 3 activation and to the lower expres-
sion of pro-apoptotic proteins.
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Overexpression of a putative ubiquitin c-hydrolase identified by subtractive hybridization
in PUVA-senesced fibroblasts results in a senescence-like phenotype
Y Chen, M Wlaschek, C Hinrichs, W Ma and K Scharffetter-Kochanek Department of
Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany
Premature ageing of the skin is a prominent side effect of psoralen plus UVA (PUVA) pho-
tochemotherapy used for various skin disorders. Following PUVA-treatment fibroblasts undergo
long-term growth arrest, increased expression of interstitial collagenase and senescence
associated β-galactosidase reminiscent of replicative senescence. Since the molecular basis
of the functional and morphological changes is unknown, we applied subtractive hybridiza-
tion to isolated genes that might be involved in this senescent phenotype. Among several dif-
ferentially expressed cDNAs, one cDNA of an unknown gene showed the highest change with
a 6-fold induction post PUVA-treatment. Using RT-PCR and RACE (Rapid Amplification of
cDNA Ends), we isolated a full length cDNA revealing a 53bp 5-end untranslated region, a
3222bp open reading frame and a 2269bp 3-end untranslated region. In addition, three tran-
scripts with high homolog were detected. Northern blot analysis revealed strong expression
of this gene in postmitotic human tissues like brain and heart, with virtually no expression in
proliferating cells. From the translated cDNA sequence, the first 400 amino acids show high
homology to a putative murine ubiquitin c-terminal hydrolase releasing ubiquitin from uniq-
uitinated proteins. Stable overexpression of this novel gene in juvenile fibroblasts resulted in
a premature senescent phenotype with enlarged cell size, cessation of proliferation, expres-
sion of senescence associated β-galactosidase and of matrix metalloproteinase-1, and high
levels of reactive oxygen species within several weeks in culture. As the de-ubiquitination
enzymes are involved in biologically important processes including growth and differentia-
tion, cell cycle progression, and signal transduction, the analysis of this unknown gene prom-
ise useful insights into the role of de-ubiquitination in stress-induced and replicative senes-
cence and degenerative disorders of connective tissue.
796
Polypodium leucotomos extract reduces tumor necrosis factor-alpha and nitric oxide pro-
duction induced by ultraviolet solar simulated radiation
A Janczyk,2 M Garcia-Lopez,4 H de la Fuente,3 R Tejedor,1 A Diez,4 JL Alonso-Lebrero,1
PF Penas4 and S Gonzalez5 1 Farmaceutica Cantabria, Madrid, Madrid, Spain, 2 Biologia
Molecular, Hospital Universitario Princesa, UAM, Madrid, Spain, 3 Inmunologia, Hospital
Universitario Princesa, UAM, Madrid, Spain, 4 Dermatologia, Hospital Universitario Princesa,
UAM, Madrid, Spain and 5 Memorial Sloan-Kettering Cancer Center, New York, NY
The purpose of this study was to evaluate the ability of Polypodium leucotomos extract (Fern-
block®, PLE) to inhibit inflammatory damage by analyzing tumor necrosis factor-alpha (TNF-
alpha) release and nitric oxide (NO) production induced by ultraviolet solar simulated radia-
tion (SSR) in a well-known human keratinocyte cell line (HaCaT). HaCat cells were incubated
with PLE before and after exposure to SSR. TNF-alpha and NO were analyzed by ELISA and
Griess method respectively. iNOS expression was assayed by Western-blot using anti-iNOS
antibody. Our results show that SSR induces TNF-alpha production in a dose-dependent man-
ner. However, PLE treatment reduced TNF-alpha release induced by SSR by at least 50%. Fur-
thermore, PLE treatment also disminished nitric oxide production. By western-blot analysis,
we demonstrated that this inhibition in the NO production corresponded to an iNOS expres-
sion reduction. In conclusion, we postulate that photoprotective activity of PLE observed in
human beings is due, at least partially, to its interaction with ultraviolet-induced inflamma-
tory pathways, inhibiting partially its inflammatory signalling cascade.
794
ATP-sensitive potassium channel opener Pinacidil attenuates ultraviolet-induced apoptosis
in cultured human keratinocytes
C Cao,1,3 Y Sun,2 Z Bi,3 G Hu,3 N Kouttab4 and Y Wan1 1 Providence College, Providence,
RI, 2 Shanghai Second Medical University, Shanghai, China, 3 Nanjing Medical University,
Nanjing, Jiangsu Province, China and 4 Brown University, Providence, RI
Ultraviolet radiation induces cell damages that lead to skin photoaging and skin cancer. While
the molecular mechanisms of UV-induced cell damages are being unraveled, agents natural
or otherwise that could prevent from such damages are being intensively sought. ATP-sensi-
tive potassium (KATP) channel openers (KCOs) have been shown to exert significant myocar-
dial preservation and neuroprotection in vivo and in vitro, and yet the potential role of those
KCOs in protection against UV-induced skin cell death is unknown. We investigated the
effect of pinacidil, a classical KCO, on UV-induced apoptosis using cultured human ker-
atinocytes (HaCat cells). When cells were pre-conditioned with pinacidil prior to UVB expo-
sure, UVB-induced cell death was significantly reduced, and UVB-induced phosphorylation
of c-Jun-NH2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) was also
inhibited. And when cells were treated with pinacidil alone, phosphorylation of JNK and ERK
was also induced. Unexpectedly, we found that the level of intracellular reactive oxygen species
(ROS), directly measured by the fluorescent probe dihydrorhodamine 123 (DHR-123) using
FACS, was slightly elevated in HaCaT cells pretreated with pinacidil. Taken together, we con-
tend that pinacidil during preconditioning period opens KATP channel leading to net K+ influx
into the matrix with a result of a moderate ROS increase, which protects cells from second-
ary and widespread apoptosis induced by UV radiation. This protection mechanism involves
a signaling pathway that is modulated by the low dosage of ROS. Our findings suggest that
KATP openers such as pinacidil may be used to prevent from UV-induced skin aging and skin
cancer.
798
Microarray analysis reveals significance of α-MSH in counteracting the UV effects on human
melanocytes
A Kadekaro,2 D Supp,1 RJ Kavanagh,2 S Terzieva,2 M Sartor,3 C Tomlinson3 and Z Abdel-Malek2
1 Dermatology, Univ. Cincinnati, Cincinnati, OH, 2 Surgery, Univ. Cincinnati and Shriners Burns
Hospital, Cincinnati, OH and 3 Environmental Health, Univ. Cincinnati, Cincinnati, OH
The melanocortin α-melanocyte stimulating hormone (α-MSH) is a paracrine/autocrine regulator
of human melanocyte (hMC) proliferation and melanogenesis. It enhances nucleotide excision
repair, reduces generation of hydrogen peroxide, and consequently inhibits UV-induced apopto-
sis. These effects are mediated by the melanocortin 1 receptor (MC1R), and are absent in hMC
expressing loss-of-function MC1R (nfhMC). We used microarray-based analysis to compare gene
expression in hMC with functional (fhMC) vs. nfhMC in response to α-MSH and UV. Results were
validated for selected genes by either Northern or Western blot analysis. The analysis confirmed
the importance of functional MC1R for response of hMC to α-MSH: 2676 genes were altered in
expression by α-MSH in fhMC, compared to only 2 in nfhMC. Additionally, 1226 genes were
affected by UV in fhMC, compared to 808 in nfhMC, indicating different responses to UV. Among
the melanocyte-specific genes analyzed, 7 out of the 8 genes that were reduced in expression by
UV were increased in expression by α-MSH, and included MC1R, ETBR,MITF, SILV, and TYR.
Expression analysis of genes involved in DNA repair, stress response, and apoptosis further indi-
cated antagonistic effects of UV and α-MSH (p=0.0001, determined by testing for binomial dis-
tribution). For example, 18 DNA repair genes were down regulated by UV; of those, 9 were
increased by α-MSH. Analysis of 25 stress response genes affected by UV identified 19 whose
expression was altered in the opposite direction by α-MSH. Of 73 apoptosis regulatory genes that
were affected by UV, the expression of 43 was altered in the reverse direction by α-MSH, includ-
ing Bcl2, Bcl2A1, Bcl2L2, DDX41, DDXX, GADD45B, GAS2, BIRC1, and APG12L. These results
underscore the importance of MC1R in reversing the effects of UV, and suggest mechanisms for
increased melanoma susceptibility in hMC expressing loss-of-function mutations in MC1R.
www.jidonline.org   133
ABSTRACTS
799
The UVB-induced gene expression profile of human epidermis in vivo is different from that
of cultured kerationcytes
CD Enk,1 J Jacob-Hirsch,2 H Gal,3 N Amariglio,2 D Givol,3 G Rechavi2 and M Hochberg1 1
Dermatology, Hadassah Medical Center, Jerusalem, Israel, 2 Functional Genomics, Sheba
Medical Center, Tel Aviv, Israel and 3 Molecular Cell Biology, Weizmann Institute of Science,
Rehovot, Israel
Intact human epidermis differs substantially from normal human epidermal keratinocyte (NHEK)
cultures in terms of cell composition and keratinocyte maturation. In order to investigate
whether differences in maturation influence the molecular repertoire of epidermal cells in
response to UVB, we compared the in vivo expression profiles of epidermal sheets to that of
NHEK exposed to UVB in vitro by means of Affymetrix oligonucleotide arrays. Suction blister
roofs obtained after a single dose of in vivo exposure and cultured NHEK exposed to UVB in
vitro underwent microarray profiling. In total, we identified 1,931 genes that differed in their
expression profiles between the two groups. When directly comparing the UVB response of
individual genes, we found multiple differences in genes governing crucial cellular functions
such as p53, cell cycle arrest, DNA repair and apoptosis. Thus, key cell-cycle progression
markers were downregulated in NHEK but not in intact epidermis. Pro-apoptitic genes were
upregulated mostly in NHEK, whereas anti-apoptotic genes were upregulated in intact epi-
dermis. Key DNA repair genes were upregulated in intact epidermis. And in the p53 group,
key target genes such as GADD45A, GADD45B and WAF1/CIP1/p21 were upregulated in
NHEK, but were unaffected in intact epidermis. Overall, the expression profile in intact epi-
dermis was geared towards DNA repair, whereas in vitro irradiated NHEK responded by acti-
vating genes associated with cell-cycle arrest and apoptosis. These differences in expression
profiles might reflect differences between mature differentiating keratinocytes in the suprabasal
layers of intact epidermis versus exponentially proliferating keratinocytes in cell culture. Our
findings show that extreme care should be taken when extrapolating from findings based on
keratinocyte cultures to changes in intact epidermis.
800
The photo-protective effect of (–)-epigallocatechin-3-gallate on injury of BALB/C mouse skin
induced by ultraviolet B irradiation 
D Luo, L Xu, J Xu, X Lin, X Ji and J Zhu Department of Dermatology, the First Affiliated
Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China
BLAB/C mice were pretreated with (–)-epigallocatechin-3-gallate (EGCG) daily then irradiated
with ultraviolet B (UVB) for 30 consecutive days. Hematoxylin-eosin-stained tissue speci-
mens from BALB/c mice were obtained to investigate the pathological changes in the skin of
BALB/C mouse irradiated by chronic UVB and the photo-protective effects of topical appli-
cation of EGCG on the skin damaged by UVB. We found obvious pathological changes in the
skin of BALB/C mouse after chronic UVB irradiation, such as hyperkeratosis, acanthosis, sponge-
like edematization, sunburn cells occurring in the epidermis, oedema in the papillary layer of
dermis, telangiectasis and so on. Infiltrating leukocytes were present in higher numbers in the
UVB-exposed skin, particularly in the dermis than non-UVB-exposed skin, while application
of EGCG before UVB exposure significantly reduced the number of infiltrating leukocytes
into the skin, when compared with UVB alone-exposed skin. The intervention of EGCG could
also reduce other pathological changes induced by UVB irradiation. In addition, we detected
the apoptosis of epidermal cells by TUNEL and found EGCG showed to promote apoptosis
after chronic low dosage of UVB irradiation, which may play a major role in its photoprotec-
tion mechanism. In conclusion, EGCG show the photo-protective effects on UVB-induced skin
damage of BALB/c mice .
801
Effects of (–)-epigallocatechin-3-gallate on immunomodulatory cytokines in BALB/C mouse
skin irradiated by chronic ultraviolet B
L Xu, D Luo, X Lin, X Ji and J Zhu Department of Dermatology, the First Affiliated Hospital
of Nanjing Medical University, Nanjing, Jiangsu Province, China
UVB irradiation can suppresses the immune response. Immunomodulatory cytokines play an
important role in the process of UVB-induced immunosuppression. (–)-epigallocatechin-3-
gallate (EGCG), present in green tea, is the major and the most effective constituent among
the polyphenolic constituents in the protection against UVB-induced immunosuppression and
carcinogenic effects. In our study, BALB/C mice were pretreated with or without topical appli-
cation of EGCG, then exposed to different doses of UVB daily for 30 consecutive days. In order
to investigate the cytokines involved in immunosuppression, gamma interferon (IFN-γ), inter-
leukin 10(IL-10) and tumor necrosis factor alpha (TNF-α) cytokine mRNA levels in BALB/C
mouse skin were examined by RT-PCR method. Compared with sham group,IFN-γ mRNA
expression in the skin of BALB/C mouse was statistically decreased after chronic UVB irradi-
ation while IL-10 and TNF-α mRNA expression was increased after UVB irradiation, which
may play a crucial role in UVB induced immunosuppression mechanism. Pretreatment with
EGCG could obviously inverse the alteration of the three cytokines mRNA expression levels
caused by UVB irradiation, showing that EGCG has a potential protective effect from local
immunosuppression in BALB/C mouse skin induced by UVB.
802
Effect of EGCG on apoptosis and phosphorylated p53 protein expressions of Langerhans cells
after UVB irradiation
X Ji, D Luo, X Lin and X Miao Department of Dermatology, The First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu Province, China
Langerhans cells are epidermal dendritic cells that play a crucial role in skin immune responses,
including the induction of skin tumor. To abserve photoprotection of epigallocatethi-3-gallate
(EGCG) to langerhans cells damaged by UVB irradiation, we studied the effect of EGCG on
apoptosis and phosphorylated p53 protein expression induced by UVB irradiation in Langer-
hans cells. The normal adults foreskin were separated, then digested into epidermal cell sus-
pension, density gradient centrifugation and magnetic cell sorting was used simultaneously
to purify the Langerhans cells from human epidermal cell suspension. Langerhans cells were
divided into three groups (control, UVB and EGCG). The cells were irradiated by 30 mJ/cm2
UVB and none for the control group. After irradiation, Langerhans cells were incubated with
RPMI-1640 containing 10% bovine serum or the same medium containing 200 µg/ml of EGCG
for 4 hours. The cells were collected 4 hours after treatment. The apoptosis rate and phos-
phorylated p53 protein expressions were detected. Under 30 mJ/cm2 UVB, apoptosis rate and
phosphorylated p53 protein expressions of Langerhans cells were statistically higher than con-
trol. And when EGCG was added into the RPMI-1640, both of them was decreased compared
with the control. Thus we might get the initial conclusion that apoptosis rate of Langerhans
cells was increased after UVB irradiation and EGCG could prevent the increased apoptosis
rate, and EGCG might induce the phosphorylation of p53 to perform its functions consequently.
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Effect of (-)-epigallocatechin-3-gallate in different formation on Apoptosis of Epidermal
cells of BALB/C mouse irradiated by UVB 
J Xu,1 D Luo1 and X Hao2 1 Department of Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu Province, China and 2 Department of Chemistry
and Chemical Engineering, Southeast University, Nanjing, China
Many reports showed that polyphenols extracted from green tea can protect skin from photo-
damage by ultraviolet B(UVB) radiation.(-)-Epigallocatechin-3-gallate (EGCG) is the rather
effective component of polyphenols. To investigate the influence of (-)-epigallocatechin-3-gal-
late in the formation of solution, cream and liposome to the apoptosis of epidermal cells of
BALB/C mouse irradiated by UVB, BLAB/C mice were divided into eight groups(control group,
UVB group, UVB+EGCG solution group, UVB+EGCG cream group, UVB+EGCG liposome
group, UVB+acetone solution group, UVB+cream base group and UVB+blank liposome group),
treated with EGCG in different formation to the skin and then irradiated with UVB in the dosage
of 30mJ/cm2 once a day for 30 days. The apoptotic cells were detected by TUNEL method.
EGCG in different formation all showed to promote apoptosis, the effect of EGCG cream and
liposome were better than solution(P<0.05) and there was no statistical significance between
EGCG cream and liposome.
804
Experimental study of photo-protective mechanisms of szechwan lovge rhizome on CPDs in
keratinacytes after UVB irradiation
X Lin, D Luo, J Xu, X Ji, J Zhu and L Xu Department of Dermatology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
For investigating the photo-protective mechanisms of szechwan lovge rhizome on formation
of CPDs in keratinacytes after UVB irradiation, Subconfluent HaCaT cells were shammed or
irradiated with 30 mJ/cm2 of UVB irradiation and treated with szechwan lovge rhizome. The
production and removal of CPDs were examined by immunohistochemical method. The mRNA
and protein expressions of p53 and proliferating cell nuclear antigen (PCNA) were detected
by RT-PCR and western blot assay respectively. CPDs appeared in HaCaT cells and reached
the peak at 0.5 h and removed rapidly during the first 4 h and then removed slowly until 24h
after UVB irradiation. The quantity of CPDs was decreased when irradiated HaCaT cells were
preincubated with szechwan lovge rhizome(u=2.000, p<0.05). The mRNA expression of p53
and PCNA was down regulated by 34.9% and 30.9%; and the protein expression of p53 and
PCNA was decreased by 23.1% and 24.9% respectively by szechwan lovge rhizome. There
seems to be two phases in the removal of CPDs: a rapid phase and a slower phase after UVB
irradiation. szechwan lovge rhizome could decrease the level of CPDs. Down regulation of
the mRNA and protein expressions of DNA damage and repair related proteins p53 and PCNA
may be part of photo-protective mechanisms mechanisms of szechwan lovge rhizome.
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Effects of intense intense pulse light on the cell activity and the procollagen mRNA expres-
sion of the human fibroblasts
D Wu, D Luo, L Xu, W Min, J Zhu and X Lin Department of Dermatology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
The aim of our present study is to investigate the effects of intense pulse light (IPL) on the cell
activity and on the type I and III procollagen mRNA expression levels of cultured human
fibroblasts. The human fibroblasts were cultured and irradiated by IPL (570—950 nm, 15
J/cm2). We detected the cell activity by MTT method and type I, III procollagen mRNA expres-
sion levels by RT-PCR 1, 12, 24 and 48 hours after IPL irradiation respectively. The cell activ-
ity was promoted by IPL 24 and 48h after irradiation(p<0.05). In addition, Compared to the
sham-irradiation group, the levels of the type I,III procollagen mRNA expression of fibrob-
lasts were increased 12 h,24 h and 48 h after IPL irradiation(p<0.05) and this up-regulation
effect of IPL was time-dependent. From our study, we can conclude that IPL irradiation can
promote the cell activity and the transcription of type I,III procollagen mRNA in fibroblasts,
so as to stimulate the growth of collagen and alleviate the photo-aging.
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Protection effect of EGCG on the immune function of dendritic cells after UVB irradiation
B Zhou, D Luo and X Ji Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, Jiangsu Province, China
Chronic exposure of human skin to solar ultraviolet (UV) radiation is a major environmental
factor that has serious adverse effects on the structure and function of the skin. Results of our
previous studies show that epigallocatechingallate(EGCG) has protect effect on irradiated epi-
dermal cells,such as keratinocytes, fibroblasts. As epidermal dendritic cells (DCs) are seen as
the major targets of UV light, the present study was conducted to evaluate the protection effect
of EGCG on the immune function of dendritic cells after UVB irradiation in vitro.The mono-
cytes were isolated from peripheral blood and cultivated into DCs with cytokines such as GM-
CSF and IL-4. DCs were harvested after culture for 7 days and irradiated by different dose of
UVB.200µg /ml EGCG was added in certain groups immediately after UVB irradiation. T
lymphocytes were co-cultured with DCs which were irradiated only by UVB or treated by
both UVB irradiation and EGCG. MTT assay was used to detect the ability of DCs stimulat-
ing lymphocytes to proliferate. After UVB irradiation,the ability of DCs stimulating lympho-
cyte proliferation was inhibited in a dose-dependence. The inhibition rate reached 100% when
UVB dose was higher than 10mJ/cm2. The inhibition rate of DCs was improved to some degree,
respectively after treated with 200µg/mL EGCG. These results suggest that the irradiation of
UVB inhibits cellular immune function of DCs directly and EGCG can antagonize such an
immunosuppression induced by UVB irradiation.
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Relative individual contribution of ultraviolet, infrared rays and heat components of the
natural sunlight in eliciting acute cutaneous response
S Cho,1,3 M Kim,3 S Lee,3 Y Kim,3 M Lee,3 C Lee,2,3 K Kim2,3 and J Chung2,3 1 Dermatology,
Seoul National University(SNU) Boramae Hospital, Seoul, South Korea, 2 Dermatology, SNU
College of Medicine, Seoul, South Korea and 3 Laboratory of Cutaneous Aging Research,
Clinical Research Institute, SNU, Seoul, South Korea
Compared to the detailed characterization of the UV response in cutaneous photoaging, stud-
ies on the effects of IR and other spectral regions of the sunlight are few. We investigated the
relative individual effects and contribution of UV, IR and heat components of the sunlight on
the development of acute cutaneous reactions and their molecular mechanisms in human skin
in vivo. Sixteen healthy volunteers (aged 24 to 43 years, 10 male and 6 female) were irradiated
on their back with an average of 2MED dose of natural sunlight. To determine the differential
effects of the whole sunlight, sunlight minus UV, and solar heat alone, the exposed skin was
subdivided, before irradiation, into 3 sections, the second and third sections of which were
covered with a UV filter and black cloth, respectively. Skin samples were taken 24 hours after
irradiation for H&E, immunohistochemical stains, TUNEL analysis, real-time RT-PCR, Western
blot and zymography. Sunlight caused epidermal thickening, cellular proliferation, reduction
in Langerhans’ cell population, and increased apoptosis. Only UV region of the sunlight recruited
neutrophils into the dermis, and UV also caused the most number of macrophage infiltration.
UV region of the sunlight caused the most reduction in procollagen synthesis and most increase
in MMP-1 and MMP-9 synthesis. However, MMP-2 expression was not altered by the sunlight.
Severe neutrophil infiltration unique to the UV region of the sunlight may be associated with
the most pronounced MMP activation, leading to the most severe ECM damage. Albeit to a
lesser degree, visible+IR rays and heat of the sun also contribute to the matrix modulation.
These data demonstrate, for the first time, the relative contribution of UV, visible+IR spectral
regions, and heat of the sunlight in eliciting acute cutaneous responses.
808
Non-linear optics for evaluation of dermal photoaging
S Lin,1 H Chen,1 W Lo,2 R Wu,2 C Dong2 and S Jee1 1 Dermatology, National Taiwan
University Hospital and College of Medicine, Taipei, Taiwan and 2 Department of Physics,
National Taiwan University, Taipei, Taiwan
Photoaging, caused by cumulative sunlight damage,is a field of great interest. However, the
severity of photoaging and clinical response to rejuvenation therapy can not be easily deter-
mined due to lack of a reliable non-invasive method to quantify photoaging. Recently, non-
linear optics including mutliphoton excitation and harmonic generation has gained much pop-
ularity in biomedical imaging. Multiphoton excitation is able to acquire enhanced axial depth
discrimination images with reduced photodamage and enhanced imaging depths. In addition
to multiphoton fluorescence, non-centrosymmetric molecules including collagen can con-
tribute to a second harmonic generation signal. In this study, dermal photoaging process is
investigated by use of multiphoton fluorescence and second harmonic generation microscopy.
We obtain the autofluorescence and second harmonic generation images of superficial der-
mis from facial skin of patients of different ages. The results show that autofluorescence increases
with age while second harmonic generation decreases with age. The results are consistent with
the histological findings in which collagen is progressively replaced by elastic fibers. In severe
photoaging, masses of autofluorescent materials representative of solar elastosis can be clearly
demonstrated. We propose a second harmonic generation to autofluorescence aging index of
dermis (SAAID) to quantify photoaging. This index is demonstrated to be a good indicator of
photoaging. Our results suggest that multiphoton fluorescence and second harmonic gener-
ation microscopy can be further developed into a non-invasive imaging tool for the evalua-
tion of photoaging.
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Down-regulation of IFN-γ induced CD40 expression on normal human keratinocytes by ultra-
violet B
J Zhu, D Luo, J Zhu, L Xu, X Ji and X Ji Department of Dermatology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
CD40 is a member of the TNF receptor family of cell surface proteins expressed by many kinds
of cells including epidermal keratinocytes, its ligation with gp39 is known to be an important
pathway leading to inflammatory skin disorders such as psoriasis and AD. We investigate
whether UVB irradiation can affect IFN-γ-induced CD40 expression on normal human ker-
atinocytes in vitro. A routine culture of keratinocytes was established, cells were pre-incubated
with recombinant human IFN-γ, and then were irradiated with UVB in a suitable dosage. FACS
analysis was introduced to detect the rate of their CD40 expression and RIA was used to detect
the concentrations of α-MSH from their supernatants before and after UVB irradiation. The
levels of supernatant cytokines such as IL-6,IL-8 and TNF-αwere determined by ELISA. We
found normal human keratinocytes expressed low but detectable CD40, which could be sig-
nificantly enhanced after IFN-γ stimulation(P<0.01). The expression of CD40 on the IFN-γ-
treated cells was markedly down-regulated after UVB irradiation(P<0.01). Meanwhile, the
concentration of α-MSH increased with a maximum(P<0.01)72h after irradiation. In addi-
tion, the expression of CD54 and the release of IL-8 were related to CD40 expression and
could be magnified through the ligation with soluble CD40L. Our results suggest that UVB
irradiation can down-regulate IFN-γ-induced CD40 expression on keratinocytes, this maybe
highly relevant with α-MSH, which is a strong immunosuppressive factor, and UVB is a potent
therapeutic intervention by disrupting the CD40/gp39 pathway.
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A specific inhibitor of Omi/HtrA2 protease prevents production of inflammatory cytokines
in UVB-irradiated human keratinocytes
S Yahagi,1 Y Okano,1 A Zervos3 and H Masaki1,2 1 Cosmos Technical Center Co., Ltd., Tokyo,
Japan, 2 Nikko Chemicals Co., Ltd., Tokyo, Japan and 3 Biomolecular Science Center, Burnett
College of Biomedical Science, University of Central Florida, Orlando, FL
Omi/HtrA2 is a stress-activated pro-apoptotic mitochondrial serine protease involved in cas-
pase-dependent as well as caspase-independent cell death. Recent studies suggest a pro-apop-
totic reaction takes place following cytokine production induced by various signals in human
epidermis. Furthermore, it is widely known that excess cytokine production, including inflam-
matory cytokines, can cause adverse effects in skin as typified by wrinkle formation, pigmen-
tation and rough dry skin. However, the role of Omi/HtrA2 in human skin tissue remains
unknown. This study was designed to investigate the potential role of Omi/HtrA2 in cytokine
production, and to elucidate the relationship between Omi/HtrA2 activation and skin alter-
ations following UVB irradiation. Firstly, we investigated the expression of Omi/HtrA2 in epi-
dermal cells using RT-PCR and Western blot analysis. We then examined the role of Omi/HtrA2’s
proteolytic activity in the induction of proinflammatory cytokines, PGE2 and IL-1α. For these
experiments we used ucf-101, a specific inhibitor of the proteolytic activity of Omi/HtrA2.
Ucf-101 was able to dramatically reduce the production of both, PGE2 and IL-1α, in UVB-
irradiated epidermal keratinocytes. We also investigated whether the suppressive effect of
ucf-101 is mediated by scavenging of the reactive oxygen species (ROS), which can be induc-
ers of the proinflammatory response. In these experiments ucf-101 did not show any scav-
enging activity towards two ROS species tested, hydrogen peroxide and superoxide anion rad-
ical. The results of our studies suggest that Omi/HtrA2, through its proteolytic activity, can
stimulate the production of proinflammatory cytokines. Therefore, we propose a new role of
Omi/HtrA2 protein as a promoter of skin inflammation following UVB irradiation.
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UVB and PUVA-induced immune suppression and inflammation in platelet-activating factor
(PAF) receptor knock-out mice
P Wolf,1,2 S Byrne,2 JP Walterscheid,2 N Kazimi,2 HN Ananthaswamy2 and UE Stephen2 1
Dermatology, Medical University Graz, Graz, Austria and 2 Immunology, The University of
Texas MD Anderson Cancer Center, Houston, TX
Both ultraviolet B (UVB) and psoralen+UVA (PUVA) have profound immunosuppressive effects.
However, the exact mechanisms, by which these treatment modalities lead to immune sup-
pression, are not well understood. Previous work from our laboratory has shown that block-
ade of the platelet activating factor (PAF) pathway by different PAF receptor (PAFR) antago-
nists abrogated both UVB and PUVA-induced immune suppression and inflammation. However,
since certain PAFR antagonists have been shown to have dual activities in blockading PAFR
but also inhibiting enzymes, including COX and phospholipase A2, we have now used PAFR
knock-out (PAFR-/-) mice to substantiate the significance of the PAF pathway in immune sup-
pression upon UVB and PUVA exposure. To study immune function, we used the model of
systemic suppression of induction of delayed type hypersensitivity to Candida albicans. Eight
to 20 wk old PAFR-/- mice and C57/BL/6 wild type littermates were exposed to 15kJ/m2 UVB
produced by FS40 sunlamps or painted on the their shaved backs with 8-methoxypsoralen
(100µl/100µl ethanol) 30min before exposure to 50kJ/m2 UVA (i.e. minimal phototoxic PUVA
dose, as determined in dose respose studies) and 5 days before sensitization with C. albicans.
UVB and PUVA exposure led to significant immune suppression in wild type mice by 63 to
75% (p<0.05, ANOVA) but not in PAFR-/- mice (immune suppression, 23 to 29%, n.s.). Sur-
prisingly however, both UVB and PUVA-induced skin inflammation, as measured by macro-
scopic skin swelling 48 hours after exposure, was not reduced but rather increased in PAFR-
/- mice compared to wild type controls. This study definitely demonstrates the significance of
PAFR activation for both UVB- and PUVA-induced immune suppression. However, compen-
satory mechanisms might play a role in PAFR-/- mice to increase inflammation upon expo-
sure to UVB and PUVA.
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DNA repair biochip: an in vitro miniaturized and parallelized assay for the determination of
DNA repair capacities in skin cells
J Millau,2 T Oddos,1 O von Stetten,1 A Favier2 and S Sauvaigo2 1 Pharmacology, Johnson &
Johnson Consumer France, Val de Reuil, France and 2 LCIB (UMR-E3 CEA-UJF), DRFMC,
CEA, Grenoble, France
DNA repair as a major defence against damage to cells is present in all living organisms. Abnor-
malities in DNA repair have been implicated in cancer and aging. Therefore the detection of
the functionality of DNA repair enzymes in skin is of the utmost interest as skin cells are exposed
to environmental challenges, e.g. solar light known to damage DNA through either the direct
absorption of UV light by nucleotide bases or the generation of reactive oxygen species. Most
in vitro repair assays assess the ability of cell-free extracts to correct DNA damage introduced
into plasmid DNA. Briefly, repair enzymes incise the DNA near the site of the lesion, remove
one or several nucleotides and then copy the intact DNA strand incorporating radioactive
dNTP. Usually these assays are performed in solution and are followed by the electrophoretic
separation of the plasmid and quantification of the incorporated radioactivity.  We have devised
a miniaturized tool to characterize the repair capacities of different lesion types of a given cell
extract better, allowing the simultaneous quantification of different repair systems. For this pur-
pose, DNA plasmids containing each a specific lesion such as UV-induced damage, oxida-
tive damage, alkylated bases, psoralen and cisplatin adducts were spotted onto a glass-slide
(Biochip). Repair reactions were then performed in situ by adding cell extracts in the presence
of a fluorescent dNTP. The use of the biochip technology results in a gain of sensitivity and in
a drastic reduction of the biological material required for the repair assay. Specific repair pro-
files were obtained for the different cell types tested, demonstrating that the capacity to repair
specific lesions may vary from one tissue to another. We also observed that UV light modu-
lates DNA repair capacity in reconstituted epidermis suggesting that environmental factors
could not only damage DNA but also modulate repair capacity of skin cells.
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Protective effects of catalase and hydrogen peroxide on UVB-induced apoptosis in normal
human keratinocytes
HR Rezvani, M Cario-Andre, C Pain, C Ged, H de Verneuil and A Taien Inserm 0217,
Bordeaux2, Bordeaux, France
UV-induced apoptosis in keratinocytes is a highly complex process in which various molec-
ular pathways are involved. These include the extrinsic pathway via triggering of death recep-
tors and the intrinsic pathway via DNA damage and reactive oxygen species (ROS) formation.
In this study we investigated the effect of catalase and Cu/ZnSOD overexpression on apopto-
sis induced by UVB exposure at room temperature or 4°C on normal human keratinocytes.
Cell death (apoptosis and necrosis) was measured by following the activation of caspases
with FITC-VAD-FMK (which binds to activated caspases) and plasma membrane permeabil-
ity using propidium iodide (PI). DNA fragmentation was studied by PI labelling and cytofluo-
rimetry. Caspase-3, -8 and -9 activities were quantified by western blotting. Intracellular for-
mation of ROS was detected by the fluorescent probe CM-H2DCF-DA.
Irradiation at low temperature reduced UV-induced apoptosis by 40% in normal keratinocytes
in a p53-independent manner accompanied by a decrease in caspase-8 activation. Catalase
overexpression decreased apoptosis by 40% with a reduction of caspase-9 activation in a p53-
dependent manner. Keeping cells at low temperature and catalase overexpression had addi-
tive effects. Cu/ZnSOD overexpression had no significant effect on UVB-induced apoptosis.
ROS transiently increased at irradiation time even in cells overexpressing catalase. Further-
more, H2O2 addition at irradiation time reduced UV-induced apoptosis. We conclude that
catalase overexpression has a protective role against UVB irradiation by preventing DNA dam-
age by ROS and that immediate ROS increase at irradiation time has anti-apoptotic effects.
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Bicyclic monoterprene diols increase collagen production and decrease metalloproteinases
KK Dong, MT Canning and DB Yarosh AGI Dermatics, Freeport, NY
Bicyclic monoterprene diols (BMTd) increase nitric oxide and this mediator was recently
reported to increase collagen. This study looked directly at the effects of an equimolar mix-
ture of the BMTd’s 2,3-cis/exo-pinanediol and 2,3-cis/exo-camphanediol in 1,3-butylene gly-
col on both collagen production and metalloproteinase expression in normal human dermal
fibroblasts (NHDF) cells treated for 48 hours or 7 days. Collagenases, such as MMP-1, degrade
collagen and damage the dermal matrix. On the other hand, the gelatinases MMP-2 and MMP-
9 clean up debris from collagen degradation and allow the skin to function normally. Treat-
ing the fibroblasts with BMTd produced an increase in collagen with increasing doses of the
BMTd mixture as measured by ELISA or immunohistochemistry. There was also a dose depend-
ent decrease in MMP-1 production as measured by ELISA with increasing doses of the BMTd
mixture. Using zymography, there was a dose dependent increase in active MMP-2 with increas-
ing doses of the BMTd mixture. To examine metalloproteinase expression through a paracrine
mechanism, media from normal human epidermal keratinocytes (NHEK) treated with the BMTd
mixture for 24 hrs were transferred to NHDF for 48 hrs and then examined for metallopro-
teinase production. There was a dose dependent increase in the secretion of MMP-1 and active
MMP-2, while there was a dose dependent decrease in the secretion of active MMP-9 with
increasing doses of the BMTd mixture. When media from NHEK were irradiated with 500 J/m2
UVB, left for 24 hours and transferred to NHDF for 48 hrs, there was an increase MMP-1,
active MMP-2, and active MMP-9 production. When media from NHEK treated with the BMTd
mixture for 24 hrs prior to UVB irradiation was transferred to NHDF for 48 hrs, there was a
dose dependent decrease in all three metalloproteinases with increasing doses of the BMTd
mixture. These results show that a mixture of BMTd decreases UVB-stimulated MMP-1 and
increases collagen production thereby maintaining the high collagen levels within the skin.
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OGG1-encapsulated liposomes repair oxidative damage in keratinocytes
AV Pena, MT Canning and DB Yarosh AGI Dermatics, Freeport, NY
A common type of oxidative damage found in DNA occurs when guanine is oxidized to pro-
duce 8-hydroxy-guanine (8-oxo-G). Production of 8-oxo-G is activated by various reactive
oxygen species such as environmental stressors, UVA, cigarette smoke and endogenous enzy-
matic peroxidation reactions. 8-oxoguanine DNA glycosylase-1, (OGG1), is an enzyme that
excises 8-oxo-G from DNA. We encapsulated recombinant OGG-1 from Arabidopsis thaliana
in phospholipids liposomes for delivery into cells. The ability of liposome-encapsulated OGG1
to enhance repair of 8-oxo-G was examined in HaCaT cells and normal keratinocytes. Cells
were treated with H2O2+FeSO4+CuSO4 and the frequency of 8-oxo-G was measured in an
alkaline agarose gel assay, in which breaks in DNA produced at these sites by purified OGG1
is detected by changes in number average molecular weight of the DNA . Cellular repair over
2 hrs reduce the amount of 8-oxo-G by 60%. Liposome-encapsulated OGG1 increase this
repair in a dose response manner with complete repair at a concentration of 0.18ug/mL OGG1.
Cells treated with empty liposomes did not exhibit enhanced repair. Experiments with normal
human keratinocytes produced similar results. However, repair was maximized after 30 min-
utes incubation with 0.07ug/mL liposomal OGG1. These results suggest that treatment of
cells with liposome-encapsulated OGG1 increases repair of oxidative DNA damage in ker-
atinocytes.
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The UV apoptotic effector PKCδ phosphorylates Mcl-1 to trigger the release of Bak
LA Sitailo1 and MF Denning1,2 1 Oncology Institute, Loyola University Chicago, Maywood, IL
and 2 Pathology, Loyola University Chicago, Maywood, IL
Caspase-mediated cleavage and subsequent activation of protein kinase C (PKC) δ are required
for apoptosis induced by a variety of agents, including UV radiation. Furthermore, over-expres-
sion of the constitutively active PKCδ catalytic fragment (PKCδ-cat) is sufficient to trigger apop-
tosis via the intrinsic or mitochondrial pathway. Previously, we demonstrated that expression
of PKCδ-cat in HaCaT cells down-regulated the anti-apoptotic Bcl-2 family member Mcl-1,
similar to UV radiation. Indeed, Mcl-1 over-expression and siRNA studies indicated that the
down-regulation of Mcl-1 triggered by PKCδ-cat was necessary and sufficient for apoptosis.
To further explore the molecular mechanism by which PKCδ-cat targets Mcl-1 to induce apop-
tosis, we performed in vitro kinase experiments and found that Mcl-1 was a direct substrate
for PKCδ-cat. Sequence analysis revealed a potential PKCδ phosphorylation site in Mcl-1 at
threonine 212 within the conserved BH3 domain. Mutagenesis of threonine 212 to alanine
(T212A) dramatically abrogated phosphorylation by PKCδ-cat, indicating that threonine 212
was required for Mcl-1 phosphorylation by PKCδ-cat. Mcl-1 mediates its anti-apoptotic effects
by binding to and sequestering pro-apoptotic Bcl-2 family members such as Bax and Bak.
Using pull-down assays with GST-Mcl-1, we identified Bak, but not Bax, as a Mcl-1 binding
partner in non-apoptotic HaCaT cells. Phosphorylation of wild type GST-Mcl-1 with PKCδ-
cat disrupted Bak binding. Moreover, the GST-Mcl-1(T212A) mutant displayed reduced Bak
binding, demonstrating that threonine 212 was required for Mcl-1/Bak binding. Taken together,
we propose a model in which PKCδ-cat phosphorylates Mcl-1 at threonine 212 to liberate
Bak, which in turn mediates cytochrome c release from the mitochondria and triggers activa-
tion of the caspase cascade. Overall our results identify Mcl-1 as an important target for the
pro-apoptotic signaling of PKCδ-cat, and help define the positive feedback loop involving cas-
pase activation and PKCδ activation during UV apoptotic signaling.
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MITF phosphorylation by p38 activation is associated with increased expression of c-KIT in
UVB-exposed human melanocyte
M Yuki,1,2 N Hayashi,1 M Kawashima1 and G Imokawa1,3 1 Department of Dermatology,
Tokyo Women’s Medical University, Tokyo, Japan, 2 Fundamental Research Center, KOSE
corporation, Tokyo, Japan and 3 Skin Science Research Institute, Tokyo, Japan
Proto-oncogene, stem cell factor receptor, c-KIT in melanocytes serves an essential regula-
tory factor in altered melanogenesis in several pigmentary disorders including UVB melanosis.
However, little is known about signaling mechanisms by which the expression of c-KIT is mod-
ulated in human melanocytes. In this study, we determined signaling molecules responsible
for increased c-KIT expression in UVB-exposed human melanocytes in vitro by real-time RT-
PCR and Western blotting analysis. Exposure of UVB (40-80 mJ/cm2) to human melanocytes
in culture significantly increased the expression of c-KIT at the gene and protein levels 12-24
hr after irradiation. The UVB-induced stimulation of c-KIT protein expression was completely
abolished by treatment with p38 inhibitor (SB 203580), but not substantially affected by
inhibitors of MEK (PD98059), JNK (SP600125), Akt (Akt inhibitor III), PKC (Calphostine C) and
PKA (H-89). Consistently, UVB exposure markedly stimulated prolonged phosphorylation of
p38 with a plateau at 240 min post-irradiation which was accompanied by a sustained increase
in MITF phosphorylation during an initial comparable timing. The increased MITF phospho-
rylation was completely abolished by the inhibitor of p38, strongly suggesting one of target
molecules by activated p38 to be at least MITF. In contrast, the inhibitor of MEK rather stim-
ulated MITF phosphorylation in non-UVB exposed human melanocytes, which occurred in
concert with the increased expression of c-KIT protein. These findings suggest that p38 depend-
ent-mechanism leading to the increased c-KIT expression in UVB-exposed human melanocytes
is associated with MITF phosphorylation and is modulated by a possible feedback mechanism
using MAPK pathway.
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The role of RhoE in the UVB response of human keratinocytes
SA Boswell, P Ongusaha and SW Lee Cutaneous Biology Research Center, Massachusetts
General Hospital and Harvard Medical School, Charlestown, MA
Apoptosis of keratinocytes that have sustained UV-induced DNA damage is a key step in pro-
tecting cells from transformation. We identified RhoE as a critical factor for the survival of
human keratinocytes in response to UVB. Rho GTPases have important regulatory functions
in cell cycle timing, cytoskeleton rearrangements, and apoptosis. Unlike typical Rho family
proteins, RhoE is GTPase deficient, thus expected be constitutively active. We have found
that RhoE is upregulated upon DNA damage in several cell types, including keratinocytes,
however its relevance/role in the UVB response was not known. In this study, we investigated
the response of cultured human keratinocyte cells to UVB irradiation (0–100 mJ/cm2). RhoE
protein levels increased upon exposure to UVB, and ablation of RhoE induction through siRNA
resulted in a significant increase in cell death/apoptosis as measured by: cell death ELISA,
trypan blue exclusion, PARP cleavage by caspases, and increased sub-G1 population. After
UVB exposure, cells with ablated RhoE levels demonstrated a reduction in p21 and COX-2
levels compared to control cells, while phosphorylation of p38 and JNK were increased. Cyclin
D1 protein levels were drastically reduced after treatment with RhoE siRNA even in the absence
of UVB irradiation. Simultaneous overexpression of Cyclin D1 and knockdown of RhoE with
siRNA resulted in significantly less cell death than by treatment of RhoE siRNA alone. This
data indicates that RhoE is a pro-survival factor acting upstream of p38, JNK, p21, and Cyclin
D1. Ras and Rho are involved in the regulation of Cyclin D1 and p21, both of which are
known to be important in the apoptotic response. Therefore, we propose that RhoE’s pro-sur-
vival role is, at least in part, due to a role in regulating Cyclin D1 and p21. This data points
to an important role for RhoE in keratinocyte biology in the cells DNA damage response and
possibly regulating the cell cycle.
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Mechanisms of UVB stimulated corticotropin-releasing hormone and proopiomelanocortin
production in the human epidermis
B Zbytek1,2 and A Slominski1 1 Pathology, University of Tennessee, Memphis, TN and 2
Histology and Immunology, Medical University, Gdansk, Poland
Corticotropin releasing hormone (CRH), the main regulator of systemic response to stress, is
expressed in the skin, where it is incorporated into local equivalent of hypothalamic-pituitary-
adrenal axis. Since UVB is a tissue-specific stressor for the skin, we investigated the steps
involved in the induction of the CRH-POMC response to UVB in human melanocytes cul-
tured in vitro. In our studies we used reporter gene assays, site directed mutagenesis, real
time RT-PCR and ELISA. UVB was found to stimulate CRH promoter, mRNA expression and
release of the peptide by the human epidermal neonatal melanocytes. UVB-induced stimu-
lation of CRH promoter was suppressed by pharmacological inhibitors of PKA and by plas-
mid overexpressing dominant mutant CREB. UVB stimulated phosphorylation of CREB, bind-
ing of phosphorylated CREB to CRE sites in CRH promoter and activity of the reporter gene
construct driven by consensus CRE sites. UVB stimulated phosphorylation of CREB and CRH
promoter activity in malignant melanocytes. Mutation in the CRE site in the CRH promoter
rendered the respective reporter gene construct less responsive to UVB in both normal and
malignant melanocytes. UVB induced POMC promoter, POMC mRNA expression and ACTH
release. Antagonist of CRH-R1 abrogated the UVB-stimulated induction of POMC-promoter
driven transcriptional activity and POMC mRNA expression. In the human adult epidermal
keratinocytes, neither UVB stimulated CRH production nor CRH stimulated POMC produc-
tion, when added to keratinocyte cultures. We conclude that induction of CRH production
by UVB is mediated by the PKA dependent pathway and that CRH - CRH-R1 axis participates
in the UVB stimulation of POMC in melanocytes but not keratinocytes. Thus, melanocytes
may be able to suppress UVB-induced damage and inflammation in the skin through sequen-
tial activation of local HPA mediators as suggested previously.
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A Nox1-containing isoform of NADPH oxidase is the major source of UVA-induced reactive
oxygen species in human keratinocytes
A Valencia1,2 and IE Kochevar1,2 1 Wellman Center for Photomedicine, Massachusetts
General Hospital, Boston, MA and 2 Dermatology, Harvard Medical School, Boston, MA
UVA elicits inflammation, contributes to chronic skin photodamage including skin cancer and
photoaging, and is used to treat skin diseases. Responses to UVA are mediated by reactive oxy-
gen species (ROS), although the cellular source(s) of these ROS is unknown. We tested the
hypotheses that NADPH oxidase is a major source of UVA-induced ROS in human keratinocytes
(HK) and that these ROS initiate PGE2 synthesis. HK were treated with 5 J/cm
2 UVA and the
ROS level was measured by fluorescence from oxidized H2DCF. The increase in ROS was max-
imal after 15 min (4-fold) and was partially blocked (65% decrease) by DPI, a NADPH oxi-
dase inhibitor, and to a much lesser extent by MitoQ, which blocks mitochondrial radicals.
UVA-induced NADPH oxidase activity (2-fold increase), measured by ferricytochrome c reduc-
tion, showed the same kinetics as the ROS level. The Nox 1 isoform of the catalytic subunit
of NADPH oxidase was detected in HK by western blot, and Nox1 RNAi markedly decreased
the UVA-induced ROS level. UVA stimulated synthesis of PGE2 (measured by ELISA), which
was maximal at 15 min and at 120 min (6.5-fold increase at both times) and was inhibited by
DPI and Nox1 RNAi. UVA elicited a 4-fold increase in intracellular Ca2+, which maximized
at 15 min (measured by Calcium Orange fluorescence), and chelating Ca2+ with BAPTA inhib-
ited the UVA-induced increase in NADPH oxidase activity by 70%. Ceramide has been pro-
posed to mediate other responses to UVA in HK. Addition of C6-ceramide (10 µM) increased
the ROS level 6-fold after 10 min, which was inhibited >90% by DPI, and increased NADPH
oxidase activity. In summary, these results indicate that the ROS formed in HK after UVA expo-
sure largely are produced by a Nox1-containing isoform of NADPH oxidase, which is acti-
vated by a Ca2+-dependent mechanism, possibly involving ceramide, and that these ROS stim-
ulate PGE2 synthesis.
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Constitutive melatonin metabolism in keratinocytes and its UV radiation dependent stimu-
lation
TW Fischer,1,4 TW Sweatman,2 I Semak,1,5 RM Sayre,3 J Wortsman6 and A Slominski1 1
Department of Pathology and Laboratory Medicine, University of Tennessee Health Science
Center, Memphis, TN, 2 Department of Pharmacology, UTHSC, Memphis, TN, 3 Division of
Dermatology, Department of Medicine, UTHSC, Memphis, TN, 4 Deparment of Dermatology
and Allergology, Friedrich-Schiller-University Jena, Jena, Germany, 5 Department of
Biochemistry, Belarus State University, Minsk, Belarus and 6 Department of Internal
Medicine, Southern Illinois University, Springfield, IL
Melatonin, which can be produced in the skin, exerts a protective effect against damage induced
by ultraviolet radiation (UVR). We have investigated the effect of UVB, the most damaging
wavelength of UVR, on melatonin metabolism in HaCaT keratinocytes and in a cell-free sys-
tem. Four metabolites were identified by HPLC and LC-MS in a cell-free system: 6-hydrox-
ymelatonin, 2-hydroxymelatonin, 4-hydroxymelatonin and AFMK. Metabolite production was
directly proportional to UVR-doses and melatonin substrate content. Moreover, a time depend-
ent accumulation of 2-hydroxymelatonin, 4-hydroxymelatonin and AFMK over 6 hrs was
observed. Also in keratinocytes preincubated with melatonin, an UVR-dependent increase of
AFMK and 2-hydroxymelatonin was detected. Simultaneously, intracellular melatonin con-
sumption was observed. Melatonin and its metabolites, 2-hydroxymelatonin, 6-hydrox-
ymelatonin and AFMK, were also detected in keratinocytes, which have neither been irradi-
ated nor preincubated with melatonin indicative for autonomous melatonin metabolism. Finally,
keratinocyte metabolism showed a 24-hrs dynamic with consumption of melatonin and pro-
duction of 2-hydroxymelatonin and AFMK. 6-hydroxymelatonin showed a decrease after 24
hrs. Thus, we could identify photooxidation products of melatonin in cell-free systems and
intense melatonin metabolism in keratinocytes. This process was directly enhanced by UVR.
Melatonin and its UV-induced metabolites which are protective substances themselves play
an important role in cutaneous biology by protecting the skin against solar radiation. This may
be defined as a novel melatoninergic antioxidative system (MAS) of the skin.
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Eosinophilic drug photoallergy induced by afloqualone and UVA in mice
D Nishio, K Kabashima and Y Tokura Dermatology, University of Occupational and
Environmental Health, Kitakyushu, Japan
Drug photoallergy is one of the common adverse effects, which is clinically recognized as
photosensitivity dermatitis. We established a murine model of this hypersensitivity by admin-
istration of representative photosensitizing drug, afloqualone(AQ), in combination with UVA
irradiation. AKR/J mice were sensitized with AQ (2 mg/kg/mouse) and subsequent irradiation
of the shaved abdomen with UVA (12 J/cm2). This sensitization procedure was repeated 2, 4,
6, 8, 10 or 12 times (twice a week). Three days after the last immunization, they were chal-
lenged by a subcutaneous injection of AQ solution and irradiation of the same site with UVA
(12 J/cm2). Mice receiving more than 10 times of sensitization exhibited a massive infiltrate
of eosinophils and lymphocytes at the challenged site. Both afloqualone and UVA were required
for this reaction, and the eosinophilic infiltrate was specific to AQ. AKR/J mice were high
responders of this sensitivity, because BALB/c mice showed no substantial cell infiltrate.
Transfer study was performed with immune lymph node cells (LNCs) and spleen cells from
AKR/J mice sensitized with afloqualone plus UVA 10 times. The sensitivity was successfully
transferred with 5-8x107 cells into naive mice. At least CD4+ T cells were responsible for this
sensitivity, since 1x107 CD4+ cells alone induced a high level of sensitivity reaction. Culture
supernatants from LNCs of AQ-photosensitized mice contained higher levels of IL-5 and IL-4
than those from naive mice. It is suggested that eosinophilic drug photoallergy is medated by
Th2 cells and this model is useful for exploring the mechanism of eosinophil-infiltrating pho-
tosensitivity.
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Skin taurine levels determine the sensitivity to UVB radiation-induced membrane damage
leading to immunosuppression
N Schade,1 C Esser,1 U Warskulat,2 U Floegel,3 A Schwarz,4 T Schwarz,4 D Yarosh,5 S Grether-
Beck,1 D Haeussinger2 and J Krutmann1 1 Inst. f. Umweltmed. Forschung (IUF), University
Duesseldorf, Duesseldorf, Germany, 2 Dept. of Hepatol., Gastroenterol. and Infectiol.,
University Duesseldorf, Duesseldorf, Germany, 3 Dept. of Physiol., University Duesseldorf,
Duesseldorf, Germany, 4 Dept. of Dermatol., Allergol. and Venerol., University Kiel, Kiel,
Germany and 5 AGI Dermatics, Freeport, NY
We have previously shown that taurine transporter (TAUT) deficient mice are significantly more
sensitive to UVB-induced immunosuppression (IS) than wild type mice. Taut ko mice have
more than 90% reduction of taurine levels in the skin. Thus, taurine uptake might be involved
in skin protection against UVB-induced IS. In general, UVB-induced IS is thought to result
from (i) DNA damage, e.g. the formation of cyclobutyl pyrimidine dimers (CPDs), and (ii) mem-
brane damage leading to the formation of platelet activating factor (PAF) and subsequently to
the generation of immunosuppressive cytokines like IL-10. We did not detect higher CPD for-
mation by UVB in the skin of taut ko mice. Since PAF can be generated from keratinocyte cell
membrane phospholipids and taurine can strongly bind to phospholipids, we asked whether
increased UVB sensitivity of taut ko mice is correlated with PAF production. Indeed, ker-
atinocytes from taut ko mice produced higher levels of PAF upon UVB than keratinocytes from
WT mice. Likewise, UVB-irradiated keratinocytes of taut ko mice expressed higher levels of
IL-10. In addition, we observed that treatment of taut ko mice with a PAF receptor antagonist
abrogated their increased sensitivity to UVB-induced IS. PAF itself, however, induced IS, irre-
spective of TAUT expression. We propose that taurine deficiency results in elevated release of
PAF from keratinocyte cell membranes by UVB and thus to IS. Taken together these studies
suggest that taurine uptake – similar to DNA repair and pigmentation – is critically involved
in endogenous photoprotection of skin cells against UVB-induced detrimental effects.
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Platelet-activating factor receptor-mediated augmentation of UVB-induced apoptosis does
not involve the proliferation pathway
ML Landis, AR Travers and JB Travers Dermatology, Indiana University, Indianapolis, IN
Platelet-Activating Factor (1-alkyl-2-acetyl glycerophosphocholine; PAF) is a lipid mediator
which has pro-inflammatory and trophic effects on numerous cell types, including keratinocytes.
PAF exerts its actions via a specific receptor (PAF-R), which is a seven-transmembrane G-pro-
tein coupled receptor present in keratinocytes. It has previously been shown that ultraviolet
B (UVB) radiation acts as a pro-oxidant stressor of keratinocytes, resulting in the production
of oxidized lipids that are potent PAF-R agonists. Of significance, we have previously demon-
strated that expression of the PAF-R in a PAF-R-negative epidermal cell line KB or overex-
pression of the PAF-R in keratinocytes results in an augmentation of UVB-mediated apopto-
sis. We have also demonstrated that PAF-R activation results in a proliferative response via
PAF-R-mediated activation of metalloproteinase which cleaves heparin binding epidermal
growth factor (HB-EGF) that then stimulates the epidermal growth factor receptor (EGF-R) with
resultant MAPK activation. The objective of these studies is to define the pathway by which
PAF-R activation can augment UVB-mediated apoptosis and compare it to the PAF-R-medi-
ated proliferative pathway. Using KB cells transduced with PAF-R (KBP cells) or vector alone
(KBM cells) – we show that PAF-R mediated proliferation is a separate pathway than the aug-
mentation of UVB-induced apoptosis. The PAF-R-mediated proliferative pathway in these cells
was blocked by inhibitors of matrix metalloproteinase (GM6001), HB-EGF (CRM-197), EGF-
R (DAPH, AG1478), or MAP-K (MEK inhibitor, PD98059) . Yet these inhibitors did not affect
the augmentation of UVB-mediated apoptosis seen in KBP over KBM cells as measured by
caspase-3 enzymatic activity levels. These studies indicate that the PAF-R pathways involved
in proliferation are different that apoptosis.
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Involvement of the platelet-activating factor system in ultraviolet B radiation-mediated
cytokine production, apoptosis, and immunosuppression
JB Travers, Q Zhang and RL Konger Dermatology, Indiana University, Indianapolis, IN
Platelet-Activating Factor (1-alkyl-2-acetyl glycerophosphocholine, PAF) is a lipid mediator
which has pro-inflammatory and trophic effects on numerous cell types, including keratinocytes.
PAF exerts its actions via a specific receptor (PAF-R). We have previously demonstrated that
ultraviolet B (UVB) radiation results in the production of novel oxidized lipids that are potent
PAF-R agonists. Using the PAF-R-negative human epidermoid cell line KB transduced with
the PAF-R, as well as mice which are deficient in PAF-Rs, we examined the role of the PAF-R
in UVB-mediated gene expression, apoptosis, and systemic immunosuppression. An affyma-
trix strategy using a gene chip with over 20,000 genes demonstrated that UVB-mediated expres-
sion of genes including the cytokine tumor necrosis factor-alpha and chemokines CCL20,
CXCL1, CXCL2 and CXCL3 were dependent upon the PAF-R. Immunohistochemical and RTPCR
studies using PAF-R-deficient mice confirmed the importance of the PAF-R in UVB-mediated
production of these cytokines. UVB irradiation of KB cells expressing an ectopic PAF-R or pri-
mary cultures of human keratinocytes overexpressing PAF-Rs resulted in enhanced apoptosis.
Similarly, loss of the PAF-R resulted in decreased levels of apoptosis in mouse skin in vivo.
Finally, UVB-mediated systemic immunosuppression (as measured by the inhibition of delayed
type hypersensitivity to the chemical DNFB) was attenuated in PAF-R-negative mice. Intra-
dermal injection of a PAF-R agonist mimicked UVB in inducing systemic immunosuppression.
The involvement of COX-2 and IL-10 in PAF-R-mediated immunosuppression was shown using
inhibitors in mice. These studies indicate that the PAF system is an important target for UVB.
The availability of potent PAF-R antagonists could provide novel therapies for subjects with
photosensitive disorders.
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Lightening up the UV response: the arylhydrocarbon receptor is a cytoplasmic photosensor
E Fritsche,1 C Schaefer,1 T Bernsmann,3 C Calles,2 M Wurm,4 U Huebenthal,1 JE Cline,1
P Schroeder,2 A Rannug,6 L Klotz,5 P Fuerst,3 H Hanenberg,4 J Abel1 and J Krutmann7 1
Toxicology, Institut fuer umweltmedizinische Forschung, Duesseldorf, Germany, 2 Cell
Biology, Institut fuer umweltmedizinische Forschung, Duesseldorf, Germany, 3 Chemisches
Landes- und Staatliches Veterinaeruntersuchungsamt, Muenster, Germany, 4 Department of
Paediatric Oncology, Heinrich-Heine University, Duesseldorf, Germany, 5 Institute of
Biochem. and Mol. Biol., Heinrich-Heine University, Duesseldorf, Germany, 6 Institute of
Environmental Medicine, Karolinska Institutet, Stockholm, Sweden and 7 Institut fuer
umweltmedizinische Forschung, Duesseldorf, Germany
UVB radiation-induced signaling in mammalian cells has previously shown to involve two
major pathways: one that is initiated through the generation of DNA photoproducts in the
nucleus and a second one that is triggered at the level of the cell membrane and character-
ized by cell surface receptor clustering. The chromophore for the latter one is unknown. In
the present study we show that the cytoplasmic aryl hydrocarbon receptor (AhR) is involved
in the UVB response. Accordingly, UVB shuttles the AhR from the cytoplasm into the nucleus
of HaCaT cells and this leads to increased transcriptional expression of CYP1A1 mRNA as well
as EGFR clustering, internalization and subsequent activation of MAPK and increased COX-
2 expression. These UVB-induced effects were blocked by treatment of cells with the AhR
antagonist 3’methoxy-4’nitroflavone or in UVB-irradiated AhR knockdown HaCaT cells. We
identified the photoproduct formylindolo[3,2b]carbazole (FICZ) that is formed after UVB irra-
diation from the chromophore tryptophan (trp) and is a high affinity AhR ligand in UVB irra-
diated cells. The role of trp in the UVB response was confirmed by depleting the cells of trp
which abrogated the effects mentioned above. Taken together these studies indicate the exis-
tence of a 3rd molecular pathway involved in UVB radiation-induced signaling and gene
expression, which is initiated in the cytoplasm, involves trp as a chromophore, is mediated
through the AhR and is responsible for the nuclear and membrane effects.
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Inducible photoprotective responses in human skin
S Arad, DA Goukassian and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
The thymidine dinucleotide pTT and other telomere homolog oligonucleotides (T-oligos) increase
melanogenesis, activate p53, and enhance DNA repair in cultured human cells and murine mod-
els. To document the presumptive UV-mimetic photoprotective effects of pTT in human skin,
paired skin explants were treated once with pTT 100µM or diluent alone or UV-irradiated (30
mJ/cm2). By immunostaining, pTT increased (p<0.03) the level of melanogenic enzymes (tyrosi-
nase and TRP-1/Mel5) and hence the number of detectable melanocytes on days 1-5 after treat-
ment. By 72h, pTT also increased (p<0.01) melanocyte dendricity and epidermal melanin con-
tent as determined by Fontana-Masson staining and did not lead to melanocyte proliferation as
determined by double positivity for Ki67 and Tyrosinase or Mel5 similarly to paired UV-irradi-
ated explants (N=7). Diluent-treated explants had no increase in dendricity or melanin content.
To determine whether pTT and UV comparably protect against subsequent UV irradiation, paired
explants were treated with pTT or diluent alone or UV-irradiated, then after 72h again irradiated
with the same UV dose. Compared to controls, the number of epidermal cells positively immunos-
tained for cyclobutane pyrimidine dimers (CPDs) was decreased ~50% (CPD + cells: 27±6 vs
14±4 vs 14±4, diluent vs pTT vs UVB, respectively, p<0.001, N=8) immediately after irradiation
in pTT-treated or UV-irradiated explants, attributable to the greater melanization of the explants.
In addition, CPD removal was far more rapid over the next 72h, compared to diluent-treated irra-
diated explants exposed to the same UV dose (% remaining CPDs: 42±12 vs 14±13 vs 18±14,
diluent vs pTT vs UVB, respectively, p<0.0001, N=3). These data confirm that a single supple-
mentation with pTT induces a tanning response in human skin that is quantitatively and quali-
tatively similar to that induced by a moderately damaging UV dose. Moreover, the data docu-
ment an inducible SOS-like increase in DNA repair capacity in human skin following UV-induced
damage that is also produced by pTT in the absence of initial damage.
828
Photopheresis induces the generation of regulatory T cells
FJ Strobl, K Campbell, A Krutsick and D Peritt Research & Development, Therakos, Inc.,
Exton, PA
Extracorporeal photopheresis (ECP) involves the clinical reinfusion of autologous apoptotic
peripheral blood leukocytes that have been exposed ex vivo to 8-methoxypsoralen (8-MOP)
and UVA light. ECP is approved for the palliative treatment of cutaneous T cell lymphoma
and has exhibited promising activity in several other dermatologic conditions. The biological
mechanism of action of ECP, however, remains unclear. In animal models, delivery of apop-
totic cells has been shown to regulate immune responses through the down regulation of
antigen-presenting cell (APC) function, the modulation of cytokines, and the generation of reg-
ulatory T cells. We and others, have shown that activation of naive T cells in the presence of
APCs that have engulfed ECP-treated apoptotic cells leads to the generation of a T cell popu-
lation that can suppress syngeneic T cell proliferation and function. In the present study, we
demonstrate that the direct interaction of ECP-treated peripheral blood mononuclear cells
(PBMCs) with naive human CD4+ T cells in vitro also promotes a T cell phenotype with reg-
ulatory activity. Transfer of ECP-derived regulatory T cells to a secondary mixed lymphocyte
reaction results in a greater than 50% inhibition of syngeneic responder T cell proliferation
and IFNγ production at a Treg:responder ratio of 1:10. In addition, transwell assays demon-
strate that inhibition of responder T cells by ECP-derived regulatory T cells is contact-depend-
ent. The generation of human regulatory T cells by ECP is dependent on the presence of ECP-
treated monocytes and can be reversed by the addition of IL-2. These regulatory T cells also
proliferate in response to concanavalin-A, but do not express increased levels of Foxp3 or IL-
10, nor do they secrete significant levels of the pro-inflammatory cytokines IL-2, IFNγ, IL-4,
and TNFa. Additional studies are underway to further characterize the phenotype of these reg-
ulatory cells and to determine their suppressive capacity in vivo.
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Oral Polypodium leucotomos extract decreases UV-induced COX-2 expression and accel-
erates removal of UV-induced photoproducts in Xpc +/- mice
A Guillaume,1 S Arad,1 E Helms,1 S Gonzales2 and DA Goukassian1 1 Dermatology, Boston
University School of Medicine, Boston, MA and 2 Dermatology, Memorial Sloan-Kettering
Cancer Center, Boston, MA
Chronically irradiated murine skin and UV-induced SCC overexpress the inducible isoform
of cyclooxygenase-2 (COX-2), and COX-2 inhibition reduces photocarcinogenesis in mice.
We have previously reported that oral administration of Polypodium leucotomos (PL) is an
effective chemophotoprotective agent against harmful effects of UV in human and murine
skin. To determine if oral administration of PL affect UV-induced COX-2 expression and removal
of UV-induced photoproducts cyclobutane pyrimidine dimers (CPDs), we fed hairless Xpc+/-
mice with 150 mg/kg PL or vehicle alone for 10d then irradiated with single dose of UVB (25
mJ/cm2). Before, immediately after (time 0), 6, 24, 48 and 72h post-UVB skin (n=3/time-
point/treatment) were harvested and processed for histology, evaluation of COX-2 expression
by western analysis of skin homogenates and of photoproduct removal by CPD immunos-
taining. Histologically, PL-fed mice showed marked decrease in UVB-induced inflammatory
infiltrate at 24 and 48h. Compared to vehicle-fed mice by 48h UVB-induced epidermal hyper-
proliferation was inhibited in PL-fed mice. As expected, by 24h UVB-induced COX-2 levels
were increased in both vehicle- as well as PL-fed mice. Interestingly, compared to vehicle-
fed mice, COX-2 levels were significantly (6-7-fold) lower in PL-fed mice (p<0.04 and p<0.05,
48 and 72h, respectively). Maximum and comparable CPDs were detected immediately after
UVB in vehicle- vs PL-fed skin (n=3/group), confirming similar initial UVB damage. By 48h
about 50% were removed in both vehicle and PL-fed mouse skin. However, by 72h 54±5%
CPDs remained in vehicle-fed skin vs only 31±5% in PL-fed skin (p<0.003). These data demon-
strate that oral supplementation of PL affords photoprotection by reducing acute inflamma-
tory responses, inhibition of COX-2 enzyme and acceleration of CPD removal. This may con-
tribute the ability of PL to reduce photocarcinogenesis by means of systemic therapy.
831
Degradation of E-cadherin via the proteosome and lysosome: a potential mechanism for UV-
induced E-cadherin downregulation and squamous cell carcinoma progression
S Brouxhon,1,2 B Erdle,2 S Kyrkanides,3 J VanBuskirk2 and AP Pentland2 1 Emergency
Medicine, University of Rochester, Rochester, NY, 2 Dermatology, University Of Rochester,
Rochester, NY and 3 Dentistry, University of Rochester, Rochester, NY
The incidence of skin cancer is increasing annually. These cancers are due to chronic ultra-
violet (UV) light. How chronic UV injury transforms normal epithelial cells with tight cell-
cell contacts into an invasive phenotype is not clear. Recent data suggests E-cadherin plays a
causal role in this process. We used SKH-1 hairless mice to study acute and chronic UV effects
on E-cadherin expression and subcellular distribution. Using western blot analysis, subcellu-
lar fractionation and immunohistochemistry (ICC) our data show that E-cadherin expression
is sequentially downregulated as lesions progress from epithelial dysplasia to overt SCC. Within
30min of acute UV exposure, E-cadherin is upregulated in the cytosol, whereas between 24
and 72hr E-cadherin is completely degraded. When primary mouse keratinocytes (PMK) in
vitro are exposed to acute doses of UV, a similar loss of E-cadherin is noted. Immunofluores-
cence microscopy of cultured cells shows UV increased the endocytosis of E-cadherin into
prominent perinuclear vesicles. Since UV-induced E-cadherin degradation could occur via
shuttling to the lysosome or the proteosome, we used specific inhibitors to block these path-
ways in vitro. We found that each inhibitor abrogated UV-induced loss of E-cadherin, sug-
gesting that both pathways play a role in UV-induced downregulation. These data suggest
that UV-induced suppression of E-cadherin expression and activation of pathways that facil-
itate its internalization and degradation may contribute to carcinogenic progression. In this
manner tumor cells would evade E-cadherin mediated cell-cell contacts, promoting enhanced
migration and invasion. Further understanding of how tumor cells may evade the recycling
of E-cadherin back to the cell surface or promote pathways involved in its degradation may
identify novel chemopreventive targets for a wide array of epithelial cancers.
833
An unique wrinkle model on foreskin xenografts after ultraviolet B irradiation
A Hachiya,1,2 P Sriwiriyanont,3 T Fujimura,1 A Ohuchi,1 T Kitahara,1 Y Takema,1 R Tsuboi,2
MO Visscher3 and RE Boissy4 1 Biological Science Laboratories, Kao Corporation, Haga,
Japan, 2 Dermatology, Tokyo Medical University, Shinjuku, Japan, 3 The Skin Sciences
Institute, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH and 4
Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH
Wrinkling of skin is known to be a consequence of photoaging after chronic ultraviolet B
(UVB) irradiation. Denaturation of elastic fibers, decrease in collagen and glycosaminogly-
can contents in the dermis, and increase in keratin content with deterioration of keratin inter-
mediate filaments (KIFs) in the epidermis have been reported to be involved in wrinkle aggra-
vation after chronic UVB exposure. However, the precise and temporal mechanism(s) in human
wrinkle formation has not been delineated due to the lack of an UVB-induced wrinkle model
system using human skin. Therefore, we created a xenograft model system utilizing human
foreskin. Foreskins grafted onto severe combined immunodeficient mice were exposed to UVB
irradiation with one to two minimal erythema doses (80 – 100 mJ/cm2) for 6 weeks. Within
the subsequent 4 weeks without exposure, photos and image analysis of skin replicas demon-
strated that wrinkle formation was significantly (p<0.05) aggravated by chronic UVB irradia-
tion. Immunohistological, quantitative RT-PCR, and western blotting analyses performed dur-
ing wrinkle aggravation demonstrated that expression of collagen IV and keratins K6 and K16
were significantly increased in the dermis and the epidermis, respectively, after UVB expo-
sure. In addition, TEM analysis revealed that KIFs was deteriorated in the stratum corneum
after chronic UVB irradiation. Taken together, these findings suggest that our foreskin xenograft
is an attractive and promising photoaging model to assess the effect of chronic UVB irradia-
tion. This model also demonstrated that increased keratins K6 and K16 expression and dete-
rioration of KIFs in the epidermis are involved in the mechanisms underlying human wrinkle
aggravation after chronic UVB irradiation.
832
Role of recombination repair in the cellular response to ultraviolet light
TM Ruenger, J Dunn, M Potter and A Rees Dermatology, Boston University, Boston, MA
Recently, we reported that UVB-irradiation during S-phase activates the Fanconi anemia
(FA)/BRCA DNA damage response pathway in primary human fibroblasts. This pathway is
thought to mediate DNA repair through recombination. As UV is not commonly thought to
generate types of DNA damage that require recombination for repair, we further character-
ized the response of the FA/BRCA pathway to UVB and its putative role in mediating recom-
bination. UVB and ionizing radiation (IR) induced FANCD2 foci in app. 45 % of cells. Those
strongly co-localized with BRCA1 and γ-H2AX. While all IR-exposed cells showed γ-H2AX
foci, with UVB only FANCD2 foci-positive cells also showed γ-H2AX foci. As γ-H2AX foci
are considered markers for DNA double strand breaks (DSBs), the observation with IR is con-
sistent with its clastogenic properties. As UV induces only very few DSBs directly, if any, the
γ-H2AX observation suggests that UVB induces DSBs indirectly as repair intermediates. This
is further supported by the observation that UVB-induced formation of γ-H2AX foci was 45
min. delayed, whereas IR induced them almost immediately. UVB-induced γ-H2AX foci/DSBs
are most likely due to recombination repair, as DSBs are not generated by any other repair
pathway, and as UVB also induced nuclear foci of the recombinase RAD51. When cells enter
S-phase with unrepaired DNA damage, and regular DNA polymerases stall at these lesions,
specialized translesional DNA polymerases can facilitate continuation of DNA synthesis. We
found that in cells from patients with xeroderma pigmentosum variant (XPV), known to have
a defect in translesional DNA synthesis across DNA photoproducts, UVB activates the FA/BRCA
pathway earlier and for a longer time than in normal fibroblasts (2–24 hours vs. 6–12 hours
post UVB-exposure). This suggests that in the absence of translesional DNA synthesis, XPV
cells rely more on DNA recombination to release replication forks stalled at unrepaired DNA
photoproducts. In summary, our data provide evidence that recombination repair is an impor-
tant part of the cellular response to UV-induced DNA damage.
830
Topically applied liposome-encapsulated T4 endonuclease V increases repair of UV-induced
cyclobutane pyrimidine dimers in reconstructed skin
SL Nay, MT Canning and DB Yarosh AGI Dermatics, Freeport, NY
Reconstructed skin is a useful model because it uses human cells and avoids the use of ani-
mals. We used an epidermal full thickness model (MatTek EFT-200) to determine DNA repair
ability in a human skin equivalent. To measure the repair of cyclobutane pyrimidine dimers
(CPD) in DNA, reconstructed skin inserts were exposed to UVB from a Kodacel-filtered FS40
sunlamp over the dose range of 750 J/m2 to 4,000 J/m2. DNA was extracted from either a 2-
mm or 4-mm punch biopsy and then loaded onto a dot blot, which was stained with an anti-
body specific for thymine-thymine dimers. The blot was calibrated with samples of UV-irra-
diated λ-DNA for which the CPD frequency was known. We found that sufficient DNA could
be recovered from a 2-mm punch biopsy to permit triplicate measurements, and that a UVB
dose of at least 750J/m2 was required for reproducible measurements. A dose of 4,000 J/m2
produced approximately 600 CPD per million bases. This CPD frequency declined by 13.9%
over 24 hrs, which is somewhat less than is reported for normal skin. Liposomal T4 endonu-
clease V, in a hydrogel lotion, was applied to the reconstructed skin inserts following UVB irra-
diation. T4 endonuclease V cleaves DNA at the site of UV-induced CPD and initiates its removal,
and the liposome delivery facilitates its entry into skin. Reconstructed skin irradiated with
4,000 J/m2 and treated with 1µg/mL liposomal T4 endonuclease V exhibited repair of CPD
which was approximately 60% greater than that in the placebo treated samples. These results
indicate that reconstructed skin can be used as a model for DNA repair in human skin and to
investigate the effects of topical application of liposomal DNA repair enzymes.
834
Recovery effect of CpG-ODNs on ultraviolet irradiation-induced immunosuppression of con-
tact hypersensitivity in mice
S Park, K Lee and T Kim Department of Dermato-Immunology, The Catholic University of
Korea, Seoul, South Korea
It is well known that ultraviolet (UV) radiation plays a critical role in immune suppression to
generate antigen-specific T cells, which inhibit anti-tumor immunity as well as the other cell-
mediated responses such as contact hypersensitivity (CHS) reactions. Synthetic oligodeoxynu-
cleotides (ODNs) containing unmethylated CpG dinucleotide in the context of particular
base sequences (CpG motifs) are known to have immunostimulatory activities in mice and to
convert from Th2 to Th1 immune responses in atopic disease. In this study, we aimed to inves-
tigate the effects of CpG-ODNs on UVB irradiation-induced immunosuppression of contact
hypersensitivity in Balb/c mice. Female Balb/c mice were exposed to UVB (10 kJ/m2) and 20
µg of CpG-ODNs intraperitoneally or intraveneously were injected into the mice immedi-
ately or 1 day after UVB-irradiation. Then, the mice were sensitized and challenged with TNCB.
The efficacy of CpG-ODNs was measured by ear swelling and histopathological examina-
tions. Both i.p. and i.v. injection of the CpG-ODNs resulted in the significant recovery of the
contact hypersensitivity down-regulated by UVB. On histologic examination, UVB-irradiated
and CpG-ODN injected mice showed pronounced inflammatory cell infiltration compared
with UVB-irradiated and CpG-ODN non-injected mice. UVB-irradiated and CpG-ODN treated
mice showed almost the same degree of ear swelling compared with TNCB sensitized mice
without UVB-irradiation. Taken together, this result suggests that CpG-ODNs can restore the
UVB-induced immunosuppression and might be applied in clinical field for preventing UVB-
induced harmful effects.
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Protective effects of 1,2,3,4,6-penta-O-galloyl-β-D-glucose obtained by tannic acid methanol-
ysis on skin photoaging
K Lee, Y Kim and T Kim Department of Dermato-Immunology, The Catholic University of
Korea, Seoul, South Korea
The long term and repeated exposures of ultraviolet light on the skin induces various harmful
changes such as thickening, wrinkle formation, inflammation and carcinogenesis, and the
mechanisms of these skin damages are closely associated with both up-regulation of matrix
metalloproteinase’s (MMPs) activities and reactive oxygen species (ROS). A variety of natural
or synthetic compounds have been studied to prevent the UV-induced harmful effects. Pen-
tagalloyl gallate (1,2,3,4,6-penta-O-galloyl-β-D-glucose, PGG) is one of the gallotannin and
structurally similar with EGCG abundant in green tea. PGG has been shown to possess the
potent anti-oxidant, anti-mutagenic, anti-proliferative and anti-invasive effects. In this study,
we aimed to investigate the effect of PGG, obtained by tannic acid methanolysis, on UVB-
induced oxidative stress such as ROS formation, type I procollagen production and matrix
metalloproteinase-1 (MMP-1:interstitial collagenase) production in HaCaT and cultured pri-
mary human skin fibroblast. It was found that acute UVB irradiation enhanced the formation
of ROS and cyclooxygenase 2 (COX-2) gene expression via p38 MAPK activation in the HaCaT.
However, pre-treatment of PGG showed significant reduction of the levels of intracellular ROS
using DCFH-DA assay and suppressed the UVB-induced COX-2 expression via p38 MAPK in
a dose-dependent manner. PGG increased type I procollagen production and decreased MMP-
1 expression in UVB-irradiated fibroblast. Moreover, topical PGG treatment (10 mg/kg) onto
the female albino hairless mouse (SKH:HR-1) significantly improved UVB-induced morpho-
logic skin damages and type I procollagen expression compared with UVB-irradiated mice.
PGG treatment also significantly decreased the MMP-1 expression. Taken together, these results
may indicate that PGG treatment prevent from UVB-induced skin damages. Therefore, the
PGG may be a therapeutic candidate for preventing and/or treating UVB-induced premature
skin aging in humans.
836
UVB-induced Langerhans’ cell, CD11b+ and iC3b+ cell trafficking is normal in polymorphic
light eruption (PLE)
A Blackburn, SM Winhoven, M Brownrigg, LE Rhodes and NK Gibbs Dermatological
Sciences Research Group, University of Manchester, Manchester, United Kingdom
Recent in vivo studies suggest that reduced UVB-induced immunosuppression may be involved
in the aetiology of PLE. Photoimmunosuppression is associated with epidermal Langerhans’
cell (LC) loss and an influx of CD11b+ macrophage-like cells. If stimulated with the CD11b
ligand, iC3b, these cells produce IL-10. We have investigated whether CD1a+LC, CD11b+
and iC3b+ cell trafficking is aberrant in PLE and whether TL-01 phototherapy modulates these
cell responses. 10 PLE patients and 10 healthy volunteers were irradiated on buttock skin
with a series (21-200mJ/cm2) of broad-band (TL-12) UVB. 24h later, MEDs were recorded and
punch biopsies taken from the 200mJ/cm2 site and a non-irradiated site. A subset of 7 PLE
patients underwent TL-01 phototherapy (5wk; 3x/wk; starting at 70% TL-01 MED; 20% incre-
ments) after which the MED testing/biopsy protocol was repeated. CD1a+LC were counted in
epidermal sheets. CD11b+ (% area) and iC3b+cells were scored in cryosections. Before pho-
totherapy, both healthy and PLE subjects showed CD1a+LC loss 24h after 200mJ/cm2 TL-12
(p<0.001) with depletion being inversely correlated with TL-12 MED (R2>0.58). In both healthy
and PLE subjects CD11b+ (p<0.02) and iC3b+ (p≤0.05) cell scores increased 24h after 200mJ/cm2
TL-12. In PLE subjects, TL-01 phototherapy per se reduced CD1a+LC (p<0.05) but had no sig-
nificant effect on CD11b+ expression or iC3b+ cell number (p>0.57). 200mJ/cm2 TL-12 aug-
mented CD1a+LC loss (p<0.02) and increased iC3b+ cells (p<0.02) and CD11b+ staining
(p<0.04). These results confirm that prior to phototherapy, CD1a+LC, CD11b+ and iC3b+
responses to UVB challenge are normal in PLE. TL-01 phototherapy reduced LC but had no
effect on CD11b+ and iC3b+. Interestingly, UVB challenge after phototherapy further depleted
CD1a+LC and upregulated CD11b+ staining and iC3b+ cells suggesting that these photoim-
munosuppressive mechanisms could still be stimulated. European Union funded ‘SUNALL’
project, QLK4-CT01-00115.
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Plasmacytoid dendritic cells are absent in skin lesions of polymorphic light eruption
A Wackernagel,1 C Massone,1 G Hoefler,2 E Steinbauer,2 H Kerl1 and P Wolf1 1 Dermatology,
Medical University Graz, Graz, Austria and 2 Institute of Pathology, Medical University Graz,
Graz, Austria
Polymorphic light eruption (PLE) is a common photodermatosis of potential autoimmune ori-
gin. Overlap with lupus erythematosus (LE) and the presence of antinuclear antibodies has
been described in subsets of PLE patients. Plasmacytoid dendritic cell (pDC)-induced expres-
sion of interferon (IFN)-alpha has been found to be present in LE skin lesions and play a piv-
otal role in the pathogenesis of LE. IFN-alpha, an immunostimulatory cytokine, has been shown
to be an important factor in inducing different forms of autoimmunity with development of
autoantibodies and autoimmune diseases. We therefore hypothesized that in response to
described triggering agents such as UV light, the presence of pDCs (recognizable by their
high levels of IL3+receptor alpha chain [CD123] combined with other markers such as CD45RA,
CD68 or HLA-DR) in PLE skin in conjunction with increased production of IFN-alpha might
contribute to loss of tolerance and promote immune reactions to UV-induced antigens in PLE.
In this study, paraffin-embedded biopsy specimens from a total of 27 patients with clinically
and histologically confirmed PLE (9 women, mean age 32.7 years, age range 18-43), LE (7
women, 4 men, CDLE: n=4, SCLE: n=2, lupus tumidus: n=5, mean age 48.5 years, age range
41-65) or psoriasis (4 women, 3 men, mean age 43.3 years, age range 19-54) (as control group)
were analysed by immunohistochemical CD68/CD123 double staining. Quantification of the
dermal infiltrate by visual cell counting at x400 microscopic magnification revealed that
CD68/CD123 positive cells were present at a mean±SEM field density of 5.6±1.3 in LE, 1.6±0.6
in psoriasis but totally absent in PLE (p=0.001 vs. LE, p=0.0135 vs. psoriasis by unpaired Stu-
dent T test). The results of this study confirm the presence of pDCs in LE and psoriasis, how-
ever, the absence of pDCs in PLE contradicts the hypothesis that these cells might play a role
in the latter disease.
838
Hardening therapy in patients with polymorphic light eruption: comparison between broad-
band and narrowband ultraviolet B
FJ Legat, A Wackernagel, A Hofer, F Quehenberger, C Hoffmann, H Kerl and P Wolf
Dermatology, Medical University of Graz, Graz, Austria
Polymorphic light eruption (PLE) is the most common idiopathic photodermatosis. The ultra-
violet (UV) radiation component of the sunlight primarily by the first sun exposures during
spring and early summer months induces typical skin lesions in PLE patients. Repeated expo-
sures to sunlight, however, reduce the patient’s susceptibility to PLE. This natural “hardening”
effect can also be induced by repeated exposure to artificial UV light sources. Both broadband
(BB) and narrowband (NB) UVB have been reported to reduce the susceptibility of patients to
PLE, however, a direct comparison between the efficacy of BB-UVB and NB-UVB has not been
yet performed. In a crossover trial in PLE patients, hardening therapy with equi-erythemogenic
dosage regimens of BB-UVB and NB-UVB was randomly applied in the first and second year,
respectively. At the end of each year, patients retrospectively evaluated the PLE-protective
effects of the employed UV therapy using a questionnaire. Eighteen patients completed the
trial. Data of 15 patients (14F/1M, 36+/-3y, skin type II-III) are currently available for analy-
sis. During spring and summer months following BB-UVB or NB-UVB therapy, a) the suscep-
tibility of patients to PLE was reduced in 12 and 13 patients, b) the time period of sun expo-
sure to induce PLE was prolonged in 10 and 12 patients, and c) the severity of sun-induced
PLE lesions was reduced in 12 and 13 patients, respectively. Restrictions in outdoor activities
due to the patients’ susceptibility to PLE, rated on a scale from 0 to 3 (0=no, 1=mild, 2=mod-
erate, 3=severe), were significantly decreased from 2.40+/-0.21 in the years before hardening
therapies to 0.73+/-0.27 and 1.2+/-0.28 in the years after BB-UVB and NB-UVB, respectively
(difference between BB-UVB and NB-UVB statistically not significant). In conclusion, hard-
ening therapy with equi-erythemogenic dosage regimens of BB-UVB or NB-UVB appears to
be equally effective in reducing the susceptibility to sun-induced skin eruptions in PLE patients.
839
Partial depletion of mitochondrial DNA causes a gene expression pattern reminiscent of pho-
toaging of human skin
P Schroeder, T Gremmel, M Berneburg and J Krutmann IUF, Duesseldorf, Germany
It is now generally appreciated that mitochondrial (mt) DNA mutations in human dermal fibrob-
lasts are a hallmark of photoaged human skin. The functional relevance of mtDNA mutations for
the pathogenesis of photoaging, however, is currently unknown. This question has been difficult
to address because repetitive UVA irradiation of human dermal fibroblasts in vitro or in vivo,
which has proven to be very effective in inducing large scale mtDNA mutations, does not allow
discriminating whether a given functional consequence is due to the induction of mtDNA muta-
tions in irradiated cells or independent from mtDNA mutagenesis. In the present study we have
approached this problem by creating a situation in unirradiated fibroblasts which mimics the
presence of UV-induced large scale mtDNA mutations. A protocol to gradually deplete mtDNA
in human fibroblasts by treatment with sublethal concentrations of ethidiumbromide (EtBr) over
a period of 14 weeks was applied. EtBr-treatment resulted in a time-dependent depletion of
mtDNA which was complete 5 weeks after initiation and –similar to UV-induced mtDNA muta-
genesis– was associated with a time-dependent reduction in mt membrane potential and oxy-
gen consumption. Affymetrix DNA chip analysis of these cells revealed that in particular at a
very early stage, when only a small part of the mt genome was missing, fibroblasts expressed a
gene pattern which was characterized by upregulated MMP-1, unaltered TIMP-1 and downreg-
ulated COL1A1 expression and thus indicative of increased collagen degradation and decreased
collage de novo synthesis. This expression pattern, which was confirmed by Tacman PCR, was
associated with (i) unpregulation of genes involved in oxidative stress defense, (ii) increased pro-
duction of mt-derived ROS and (iii) abrogated by treatment of EtBr cells with the mt-targeted
antioxidant MitoQ. Taken together these studies indicate that partial depletion of mtDNA from
human fibroblasts causes a gene expression pattern which is reminescent of photoaged human
skin indicating that mtDNA mutagenesis may be causally involved in photoaging.
840
Effect of ultraviolet light on murine cutaneous nerves: visualization and characterization of
YFP-tagged nerves in a mouse model.
E Benlhabib,1 MK Hordinsky,1 GL Wilcox1,2 and ME Ericson1 1 Dermatology, University of
Minnesota, Minneapolis, MN and 2 Neuroscience, University of Minnesota, Minneapolis,
MN
Loss or malformation of epidermal nerve fibers is a hallmark sign of neuropathic pain in humans
and in animal models. Understanding the conditions under which nerve fibers are altered
would enhance our understanding of the etiology and possibly; therapy of neuropathic pain.
Ultraviolet (UV) irradiation is known to induce many changes in skin structure, function and
interaction with nerves, and can induce both inflammation and alterations in the skin immune
system. The aim of the present study is to develop a model allowing visualization of changes
in skin/nerve structure and nerve/tissue interactions over time, in mice with yellow fluores-
cent protein (YFP) tagged neurons (compared with wildtype C57BL/6J mice as controls) by
visualizing and characterizing epidermal and dermal nerves after UVB irradiation. We used
mice expressing YFP in peripheral nerves, B6.Cg-Tg(Thy1-YFP)16Jrs/J, and wildtype, C57BL/6-
TgN (ACTbEGFP) 10 sb (The Jackson Lab, Bar Harbor, ME). The transgenic mouse expresses
YFP only in motor and sensory neurons that are fluorescent into adulthood and amenable to
aldehyde fixation. Intravital imaging using a multi-photon laser microscope (Bio-Rad MRC
multi-photon) of anesthetized mice allowed repeated monitoring of changes in epidermal
and dermal innervation after UVB irradiation. Analysis of intravital imaging and fixed immunos-
tained (PGP 9.5, CGRP, and collagen type IV) biopsy sections (60 µm) of non-irradiated or
UVB-irradiated male YFP and wildtype mouse ear skin after a single exposure to UVB light
(10 mJ/cm2) revealed a decrease in nerve density compared to non-irradiated ears at 24
hours post irradiation. These preliminary results enabled us to monitor changes in cutaneous
innervation, in vivo and vitro, after UVB irradiation over time.
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Loss of PGE2 EP2 receptor enhances UV-induced synthesis of MMP-2 and MMP-9 in asso-
ciation with aggressive squamous cell cancer phenotype
J Ryan,1 S Brouxhon,2,1 R Konger,3 J VanBuskirk,1 R Breyer,4 G Scott1 and AP Pentland1 1
Dermatology, University of Rochester, Rochester, NY, 2 Emergency Medicine, University of
Rochester, Rochester, NY, 3 Pathology, Indiana University, Indianapolis, IN and 4 Cell Biology,
Vanderbilt University, Nashville, TN
Ultraviolet (UV) light is a major cause of squamous cell carcinoma (SCC) of the skin. Research
has shown that SCC initiation and promotion are enhanced by prostaglandin E2 (PGE2).
Decreasing PGE2 synthesis could be a successful strategy for cancer prevention. Our previ-
ous work has shown that SKH-1 mice lacking the EP2 receptor (EP2-/-) had 50% less tumors,
but more large (>1cm) poorly differentiated tumors, than wild-type (WT) mice. Despite the
invasive morphology of the EP2-/- mouse tumors, there was no evidence of metastasis. Recent
work suggests that type VII collagen fragments increase squamous cell tumorigenesis. Extra-
cellular matrix remodeling enzymes play an important role in the migration of cells through
the extracellular space. Keratinocytes are capable of synthesizing an assortment metallopro-
teinases. In this study, we examined the expression of matrix metalloproteinases (MMP) in
EP2-/- and WT mice. Catalysis assays were performed on epidermal extracts using specific
substrates of MMP-2 and MMP-9. Increased activity of MMP-2 and MMP-9 was observed in
EP2-/- mice 24 hours after UV exposure. In WT mice, exposure to 180 mJ/cm2 UV resulted
in little increase in the expression of pro- and activated MMP-2 by 24 hours. In contrast, MMP-
2 in EP2 -/- extracts after UV exposure showed proMMP-2 levels similar to WT mice while
the amount of active MMP-2 was substantially increased. Zymography confirmed these UV-
induced changes in epidermal MMP-2 and MMP-9. Further, extracts from WT mice contained
very little MMP-9 activity, and UV exposure did not alter its expression. In contrast, MMP-9
was significantly increased after UV exposure in EP 2-1- mice. Our findings suggest that the
aggressive phenotype of EP2-/- cells is associated with increased synthesis of MMP-2 and
MMP-9 after UV exposure.
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Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced
carcinogenesis in SKH-1 hairless mouse epidermis
F Afaq, B Hafeez, DN Syed, MH Kweon and H Mukhtar Dermatology, University of
Wisconsin, Madison, WI
Solar ultraviolet (UV) exposure, particularly its UVB (290-320 nm) component, is the primary
cause of skin cancers and other cutaneous pathologies in human population, more so in
Caucasian individuals.There has been considerable interest in the identification of natural
agents capable of affording protection to skin from the adverse effects of solar UVB radiation.
Pomegranate from the plant Punica granatum possesses strong antioxidant and anti-inflam-
matory properties. Recently, we have demonstrated that treatment of normal human epider-
mal keratinocytes (NHEK) with pomegranate fruit extract (PFE) inhibits UVB-mediated acti-
vation of NF-κB and MAPK pathways. Here, we evaluated the effect of PFE on early biomarkers
of photocarcinogenesis employing SKH-1 hairless mice. PFE was provided in drinking water
(0.2%, wt/vol) to SKH-1 hairless mice for 14 days before a single UVB (180 mJ/cm2) irradia-
tion. At 1, 8 and 24 hrs following UVB exposure, animals were sacrificed and skin biopsies
were harvested for biomarker assessment. We found that oral feeding of PFE inhibited UVB-
induced: (i) skin edema, (ii) hyperplasia, (iii) infiltration of leukocytes, (iv) lipid peroxidation
and, (v) hydrogen peroxide generation. We next assessed the effect of PFE on markers of UV-
induced DNA damage in the form of cyclobutane pyrimidine dimers (CPDs) and 8-hydroxy-
2’-deoxyguanosine (8-OHdG). Oral feeding of PFE significantly inhibited UVB-induced for-
mation of CPDs and 8-OHdG. Employing western blot and/or immunohistochemical analyses,
we found that oral feeding of PFE inhibited UVB-induced: (i) PCNA, (ii) ODC, and (iii) COX-
2. Importantly, PFE treatment further enhanced UVB-mediated increase in tumor suppressor
p53 and cyclin kinase inhibitor p21. Taken together, our data suggest that oral feeding of PFE
to mice affords substantial protection from the adverse effects of UVB radiation via modula-
tion in early biomarkers of photocarcinogenesis and provide suggestion for its photochemo-
preventive potential.
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UVB-induction of TNF-α gene transcription requires a response element, overlapping the
AP-1-binding site, of the proximal promoter
M Bashir,1 M Sharma1 and V Werth1,2 1 Dermatology, U of Penn, Philadelphia, PA and 2
Dermatology, Phil V.A.M.C., Philadelphia, PA
Exposure of skin to UVB induces local expression of TNF-α, a key cytokine in the inflammatory
response and a likely contributor to cutaneous photodamage. UVB-induction of TNF-α expres-
sion is mainly through enhanced transcription, but the control elements have been incompletely
characterized. In the current study, we developed a series of constructs that contain between
1.2 kbp and 0.1 kbp of the TNF-α promoter (5’ end at -1179 through -109, with the 3’ end fixed
at +1), driving the CAT reporter gene. Promoter-reporter constructs were transfected into neona-
tal human keratinocytes (NHK), which were then irradiated with sham or 30 mJ/cm2 of UVB.
Surprisingly, we found that UVB exposure induced a persistent increase in CAT expression from
all of these constructs (~10 fold over sham-irradiated controls). These results imply the presence
of a UVB responsive element in a single proximal region (-109 to +1) of the TNF-α promoter.
We also identified, with our series of constructs, other regions containing negative (-525 to-
201) and positive (-200 to -109) elements, but these were evident after sham irradiation and
were unaffected by UVB treatment. The single UVB-responsive region that we identified (-109
to +1) contains an AP-1 binding site (TGAGCTTA, at -106 to -99), which was previously shown
to participate in LPS-induced activation of the human TNF-α promoter. To determine its role in
the UVB response, we introduced a base-pair mutation to disrupt AP-1 binding (TGATCTTA).
The mutated construct exhibited drastically reduced activity after sham irradiation and there was
no induction at all after UVB exposure. Overall, our results indicate that the UVB responsive
cis-acting elements of the TNF-α promoter reside exclusively in the short 109-bp proximal region.
Furthermore, the UVB-responsive element is embedded in or overlapping with the AP-1 bind-
ing site. Further experiments will delineate whether other elements in the 109-bp proximal pro-
moter participate with the AP-1 binding site in this important response of the TNF-α gene.
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The novel antioxidant 3-O-caffeoyl-1-methylquinic acid enhances UVA-induced apoptosis
in HaCaT cells through induction of hypoxia-dependent p21 Waf1/Cip1
M Kweon, F Afaq and H Mukhtar Dermatology, University of Wisconsin, Madison, WI
From bamboo leaves we isolated an antioxidant 3-O-caffeoyl-1-methylquinic acid(MCGA3)
and showed that it protects ROS-induced necrosis via induction of Nrf2-modulated phase II
detoxifying genes in endothelial cells. Agents that could enhance apoptosis of UV-induced
damaged cells could have promise as preventive agents against skin malignancy. In this study,
using human immortalized epidermal keratinocytes(HaCaT, p53-/-), we show that MCGA3
pretreatment further enhances UVA-induced apoptosis through hypoxia-dependent p21 induc-
tion. When confluent monolayer of HaCaT cells were treated with MCGA3(2.5-50 µM, 24 h)
and subsequently irradiated with UVA(5-30 J/cm2, 24 h) and UVB(15-60 mJ/cm2, 24 h), they
were more sensitive to UV irradiation and this effect was more pronounced for UVA than for
UVB. We found that MCGA3 further enhanced UVA-mediated apoptosis as determined by i)
confocal microscopy, ii) DNA fragmentation, iii) PARP cleavage iv) activation of Caspase-3,
and v) expression of Bcl2 family. MCGA3 treatment to HaCaT cells was without any effect on
cell viability and apoptosis. Furthermore, we found that MCGA3 pretreatment inhibited UVA-
induced i) upregulation of p-ERK1/2 and p-PKCα, which were activated and sustained by UVA
exposure unlike other MAPKs, ii) downregulation of p21, iii) upregulation of ferritin, and iv)
generation of ROS. Interestingly, MCGA3 itself was found to increase the mRNA and protein
expression of p21 but not of p27, Bax and GADD, suggesting p53-independent induction of
p21. The induction of p21 by MCGA3 was ameliorated by combination of deferroxamine
whereas FeCl3 blocked MCGA3-mediated p21 induction, indicating that a hypoxic signal by
iron deprivation may be involved in the p21 induction. Employing siRNA-silencing of p21,
we found a pivotal role of p21 induction by MCGA3 in enhancing UVA-induced apoptosis.
In summary, we show that MCGA3 may protect skin cells from UV-mediated damages via
apoptotic elimination of DNA-repair deficient cells by UV mutation.
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Vitamin D and its analogs modulate photosensitizer production in 5-aminolevulinic acid
(ALA) treated psoriasis plaques and epidermal organotypic cultures.<b/>
C Gasbarre,1,2 A Khachemoune,3 N Sato,2 B Moore,2 S Keevey,2 T Hasan3 and E Maytin1,2 1
Dermatology, Cleveland Clinic, Cleveland, OH, 2 Biomedical Engineering, Cleveland Clinic,
Cleveland, OH and 3 Wellman Center for Photomedicine, Massachusetts General Hospital,
Boston, MA
Our purpose was to investigate the feasibility of using calcipotriol to enhance protoporphyrin
IX (PpIX) levels in psoriatic plaques. Previous attempts to treat psoriasis with ALA-dependent
photodynamic therapy (ALA-PDT) have yielded marginal results. Our long-term goal is to
develop a combination therapy using Vitamin D (Vit D) and topical ALA-PDT. Calcipotriol, a
Vit D analog commonly used for psoriasis, is a potent inducer of epidermal differentiation,
and differentiation in keratinocyte cultures is accompanied by increased PpIX. To test whether
a differentiating agent might increase PpIX in psoriasis, patients were treated with calcipotriol
cream 0.005% and Eucerin on contralateral symmetric plaques of the elbows or knees, twice
daily for 6 days. In vivo fluorescence (PpIX-specific) measurements were taken before and after
application of ALA, and after delivery of light (635 nm diode laser at 10, 20, and 40 J/cm2).
Compared to baseline fluorescence levels (similar in control and calcipotriol treated plaques),
the fluorescence signal after application of ALA increased 3-fold in calcipotriol treated plaques
versus 2-fold in controls, and was more homogenous in calcipotriol treated areas. Photo-
bleaching was similar between calcipotriol and control. No significant clinical improvement
was noted after a single treatment. To confirm induction of differentiation and increased PpIX
in an in vitro system, organotypic cultures of rat epidermal keratinocytes were incubated with
sub-nanomolar doses of Vit D. Immunohistochemical analysis showed increased expression
of loricrin and a thickened stratum corneum, suggesting increased differentiation. A Vit D dose-
related increase in PpIX fluorescence was detected with confocal microscopy. These results
suggest that Vit D and its analogs may have a role in the development of improved PDT pro-
tocols.
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Plant alkaloid sanguinarine prevents ultraviolet B radiation-mediated damages in the skin of
SKH1 hairless mouse
H Ahsan, S Reagan-Shaw, D Eggert, F Afaq, H Mukhtar and N Ahmad Dermatology,
University of Wisconsin, Madison, WI
Solar ultraviolet (UV) radiation, particularly its UVB component (290-320 nm), elicits many adverse
effects on skin and is the major cause of skin cancer. Prevailing approaches have proven to be
inadequate for the management of UV damages including skin cancers. Thus, there is an imme-
diate need to develop novel approaches for the management of UV-mediated damages. Chemo-
prevention is being investigated as a potential approach for the management of UV damages
including skin cancer. We have earlier shown that sanguinarine, a benzophenanthridine alka-
loid, inhibits UVB-exposure-mediated damages in HaCaT keratinocytes. This study was designed
to investigate the relevance of these findings to in vivo situations in SKH-1 hairless mouse model
that possesses relevance to human situations. For our studies, the mice were subjected to a sin-
gle dose of UVB radiation (180 mJ/cm2). In addition, the animals received either a pre-treatment
(30 min prior to UVB) or post-treatment (5 minutes after UVB) of sanguinarine (5 µmol/0.2 ml
ethanol per mouse). The mice were euthanized 24 h following UVB exposure for further studies.
Our data demonstrated that sanguinarine (both pre- and post- treatments) resulted in a significant
decrease in UVB radiation-mediated increases in bi-fold skin thickness, hyperplasia, and infiltra-
tion of leukocytes. Further, sanguinarine treatments (pre- and post-) also resulted in a significant
decrease in H2O2 production. Furthermore, we found that sanguinarine (pre- and post- treatments)
resulted in a significant inhibition of UVB-mediated increases in the protein levels of known mark-
ers of tumor promotion/proliferation viz. (i) ornithine decarboxylase (ODC), (ii) proliferating cell
nuclear antigen (PCNA), and (iii) inducible-nitric oxide synthase (iNOS). Interestingly, the post-
treatment of sanguinarine was found to impart equal protection compared to the pre-treatment;
suggesting that sanguinarine-mediated responses are not sunscreen effects. We suggest that san-
guinarine could be developed as an agent for the management of skin cancer.
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The role of platelet-activating factor receptor in ultraviolet B-induced hyperalgesia
Q Zhang,1,2 A Mohammad,1,2 JB Travers1,2 and CM Hingtgen3,4 1 Dermatology, Indiana
University, Indianapolis, IN, 2 Pediatrics, Indiana University, Indianapolis, IN, 3 Neurology,
Indiana University, Indianapolis, IN and 4 Pharmacology and Toxicology, Indiana University,
Indianapolis, IN
Ultraviolet B (UVB) radiation causes cutaneous inflammation. One important clinical conse-
quence of UVB-induced inflammation is an increased pain response or hyperalgesia, which
is likely due to enhanced sensitivity of cutaneous sensory neurons of the nociceptor classes.
Previous studies have demonstrated that UVB radiation generates the inflammatory lipid medi-
ator, platelet-activating factor (PAF), and oxidized phospholipids that act as PAF-mimetics
and exert their effects via the PAF receptor (PAF-R). This study was designed to assess whether
the PAF-R is involved in UVB-induced hyperalgesia. Intradermal injection of 250 ng CPAF (a
PAF-R agonist) into mouse hind paws resulted in a significantly enhanced paw withdrawal
response to mechanical stimuli within 4 hours in PAF-R expressing wildtype control mice but
not in PAF-R knock-out mice. This effect in control mice was both dose- and time-dependent.
There was no significant change in paw withdrawal to noxious thermal stimuli in either wild-
type or knock-out mice after intradermal injection of CPAF. Four to 28 hours after exposure
of the hind paw to 1,800J/m2 UVB radiation, there was a significantly enhanced nociceptive
response to both mechanical and thermal stimulation in wildtype mice but not in knock-out
mice. These data indicate that the PAF-R is important for UVB-induced hyperalgesia. Unlike
UVB irradiation, exogenous administration of CPAF induced hyperalgesia to mechanical stim-
uli but not to thermal stimuli. This suggests that the PAF-R may be necessary for UVB-induced
mechanical hyperalgesia but is one of many components involved in the development of UVB-
induced thermal hyperalgesia. Since different sensory modalities are often subserved by unique
receptors and neuron groups, investigation of the role of PAF-R in regulating the response of
cutaneous nociceptive neurons exposed to UVB radiation is an intriguing area for further study.
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Prior UVB creates a predisposition to chemical hapten targeting HaCaT membrane proteins
that control cytosolic Ca++ and subsequent Ca++ -driven NADPH Oxidase,NOX5
L Liu,1 K Kang,1,4 SG Chen,2 Q Yang,2 KD Cooper1,3 and TS McCormick1 1 Dermatology, Case
Western Reserve University, Cleveland, OH, 2 Pathology, Case Western Reserve University,
Cleveland, OH, 3 Dermatology, VA Medical Center, Cleveland, OH and 4 Dermatology, 3rd
Hospital of Hangzhou, Hangzhou, Zhejiang Province, China
Combined exposure to toxic agents can alter the dose response threshold toward more adverse
consequences compared to the individual agent alone. We examined, by proteomic profil-
ing, HaCaT cells response to combined UVB and 2,4-Dinitrobenzene Sulfonic acid (DNBS)
as compared to single exposure to each agent which,in vivo, converts an immunogenic sig-
nal to immunosuppression. HaCaT cells were initially exposed to a single dose of UVB (20
mj/cm2). 18h later, the cells were further exposed to 0.05% DNBS for 2h and cultured with
fresh medium for 6h. Cell membranes were extracted and labeled with cleavable isotope-
coded affinity tag (cICAT) reagents. The purified peptide mixtures were subjected to online 2D-
LC ESI MS/MS analysis. A total of 157 changed proteins were successfully identified and quan-
tified relative to the control cells in all three experimental conditions. Among the identified
proteins, 72 changed more than 2-fold while 85 were altered less than 2-fold. The most dra-
matic effect of the combined treatment was a 100-fold upregulation of the NADPH oxidase
protein, NOX5, while UVB and DNBS alone upregulated NOX5 by 33 fold and 2.7 fold, respec-
tively, suggesting a synergistic combined effect of UVB and DNBS. NOX5 is specifically driven
by Ca++ binding and its upregulation suggests a Ca++ imbalance in the post-UVB treated
cells. Indeed, there was a 90-fold decrease in each of 4 ATPase Ca++ transporting proteins in
the combined exposure, whereas neither UVB nor DNBS alone induced any change. Pro-
teomic analysis suggests that prior UVB exposure renders DNBS capable of markedly abro-
gating multiple ATPase Ca++ transporters, leading to abnormal Ca++ regulation and induc-
tion of multiple Ca++ -sensitive proteins, espcially the Ca++ binding NADPH oxidase, NOX5.
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Suppression of ultraviolet B-mediated activation of PI3K/Akt and NF-κB signaling in SKH1
hairless mouse skin by sanguinarine
H Ahsan, S Reagan-Shaw, D Eggert, F Afaq, H Mukhtar and N Ahmad Dermatology,
University of Wisconsin, Madison, WI
Excessive exposure to solar ultraviolet (UV) radiation, particularly its UVB component (290-
320 nm), to human skin is the major cause for more than a million new cases of skin cancers
diagnosed annually in the USA. Exposure to UV radiation also results in the development of
precancerous conditions such as actinic keratosis and elicits a variety of other adverse effects
including erythema, sunburn cells, inflammation, hyperplasia, hyperpigmentation, immuno-
suppression and skin aging. Therefore, there is a need to intensify our efforts towards the devel-
opment of novel mechanism-based agents for protection of UVB-mediated damages includ-
ing skin cancer. Studies from our laboratory have shown that sanguinarine, a
benzophenanthridine alkaloid, inhibits UVB-exposure-mediated damages in HaCaT ker-
atinocytes and in the skin of SKH-1 hairless mouse. This study was designed to evaluate the
effect of sanguinarine on UVB-mediated activation of phosphatidylinositol 3-kinase (PI3K)/Akt
and nuclear factor kappa B (NF-κB) signaling. These related pathways have been shown to
play critical role in the development of skin cancer and other skin diseases. The SKH-1 mice
were subjected to a single exposure of UVB radiation (180 mJ/cm2) and also received either
a pre-treatment (30 min prior to UVB) or post-treatment (5 minutes after UVB) of sanguinar-
ine (5 µmol/0.2 ml ethanol per mouse). The mice were euthanized 24 h following UVB expo-
sure for further studies. Our data demonstrated that both pre- and post-treatment of sanguinarine
resulted in an inhibition of UVB exposure-mediated (i) increase in the protein levels of PI3K
and phosphorylation of Akt, ii) nuclear activation of NF-κB, iii) increased phosphorylation and
degradation of IkBα, in the skin. These data suggested that sanguinarine protects against the
adverse effects of UV radiation via modulations in NF-κB and PI3K/Akt signaling pathways,
and provides molecular basis for the photoprotective effects of sanguinarine in an in vivo ani-
mal model system that possesses relevance to human situations.
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Photoprotection of epidermal keratinocytes with Bifidobacterium Bifidum extracts occurs
through induction of DNA repair
ML Ingrassia, J McCarthy, D Maes and T Mammone Skin Biology, Estee Lauder Co., Melville,
NY
Aqueous extracts of Bifidus have been reported by some groups to protect UV irradiated cells
by inducing DNA repair, however some have asserted that there is no beneficial effect afforded
by Bifidus with respect to repair of UV damaged DNA. In this study, we investigated the capac-
ity of Bifidus extracts to protect normal human epidermal keratinocytes and organotypic
models from UVB irradiation. Cells and/or tissue were evaluated for viability, DNA repair, TT
dimers and sunburn cell formation. Treatment with aqueous extracts of Bifidus yielded statis-
tically significant increases in viability in normal human epidermal keratinocytes subjected to
UVB, when compared to untreated cells. DNA repair was induced in Bifidus treated cells when
measured by unscheduled DNA synthesis: Bifidus treated irradiated cells had higher levels of
unscheduled DNA repair than vehicle treated irradiated cells. Organotypic models responded
to treatment with Bifidus extract in a similar manner. In these models we observed decreases
in the Bifidus treated cells for both TT dimers and sunburn cells. These data suggest that extracts
of Bifidus are able to protect human skin from the detrimental effects of UV irradiation, and
that the observed protection is occurring through DNA repair.
851
In vivo evaluation of a cosmetic complex of ingredients on dendritic cells migration
E Noblesse, M Juan, N Lachmann, M Bonnet-Duquennoy, C Heusele, R Kurfurst, S Schnebert
and F Bonte LVMH Recherche, St Jean de Braye, France
The skin may be considered as well as a target and an initiator of self immune reactions. 2 to
5% of the epidermal cells are Langerhans cells which are the only cells to specifically take
process and present the antigens to lymphocytes in order to induce an immune response. The
object of this study is an evaluation of a two active ingredients complex containing a sweet
white Lupin peptides (MMP inhibitor) and a PKC inhibitor, on skin aging, versus placebo. These
active molecules are able to limited Langerhans cells migration. For this in vivo clinical study,
the protocol to evaluate the activity of the formulated association was as follows : Twenty
Caucasian women applied on forearms, a cosmetic formulae containing or not the active ingre-
dients, during 8 weeks. The attribution of the treated side versus placebo was randomised
before the beginning of the study. The evaluation was realized by histological and immuno-
histological analysis on skin biopsies taken before or after treatments on photoexposed zones
(forearm) in comparison with a basal level on photoprotected skin (upper arm). 3 mm biop-
sies were done by a dermatologist and immediately embedded in OCT and frozen in liquid
nitrogen. Results of this study showed that photoexposition is able to influence some cellular
and tissular skin markers. Indeed, we notice that photoexposed zones are characterized by a
thickening of the epidermis (+27% in comparison with photoprotected skin), a decrease in the
quantity of Langerhans cells and b1 integrin expression (-32.5% and –16.4% respectively).
The 56 days treatment with the active complex, permit to increase the number of Langerhans
cells (+25% of CD1a+ cells and +36.7% of Langerin+ cells) as well as beta1 integrin expres-
sion (+11.8% in comparison with the placebo treatment).
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Differential induction of inflammatory and photo-aging pathways in skin are mediated by
dose of UV exposure
M Garay, P Lyte and M Southall Johnson &Johnson CPPW, Skillman, NJ
Previous studies have demonstrated cross talk between signal transduction pathways in skin
that are involved in generation of pro-inflammatory mediators and those involved with matrix
degradation. Such an interaction could suggest a relationship between UV-induced inflam-
mation and the photo-aging process. The purpose of this study was to characterize the response
of keratinocytes and fibroblasts to the effects of increasing doses of irradiation and correlate
the subsequent pro-inflammatory and photo-aging responses in vitro. Interleukin-1 (IL-1) alpha
release, matrix metalloprotein expression (MMP1 and MMP2), and reactive oxygen species
production were assessed from cultured primary human keratinocytes after exposure to solar
simulated radiation. In addition, activation of the transcription factor, AP-1, in fibroblasts was
measured after exposure to solar simulated radiation. Keratinocytes or fibroblasts were treated
with increasing exposures of UV from 0.2 to 60 kJ/m2. The threshold of activation was defined
as the dose of UV that resulted in a fifty-percent increase in mediator production compared
to mediator production in untreated cells. In keratinocytes, the threshold of activation for UV-
induced reactive oxygen species production, and production of MMP1 and MMP2 was between
1-2 kJ/m2.  In fibroblasts, the threshold of activation for UV-induced AP-1 activity was between
0.25-0.5 kJ/m2.  In contrast the UV-induced threshold of activation for release of the pro-
inflammatory cytokine, IL-1a, from keratinocytes was approximately 50 kJ/m2. Thus, the thresh-
old of activation of MMP expression was 50X greater compared to cytokine release. Taken
together, these results indicate that keratinocytes and fibroblasts respond to low dose UV expo-
sure by activation of photo-aging pathway (AP1 and MMP’s) while substantially greater expo-
sure to UV is necessary for activation of inflammatory responses.
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Modulation of IL-20 expression in cultured human epithelial keratinocytes (NHEK)
OB Utting, LA Fairley, SP Cowell and DW Hunt Scientific Affairs:Dermatology, QLT, Inc.,
Vancouver, BC, Canada
The IL-10 cytokine family member IL-20 may exert the majority of its activity in the skin
although the stimuli that influence IL-20 expression have not been fully delineated. Routinely
cultured NHEK secreted IL-20. UVB light and recombinant (r)IL-1 further increased super-
natant IL-20 levels. IL-20 mRNA expression and supernatant IL-20 levels were increased at a
UVB light dose (40 mJ/cm2) that lowered overall cell viability by approximately 50%. In con-
trast, supernatants conditioned by normal human corneal epithelial cells contained IL-20 but
UVB light did not stimulate IL-20 secretion by these cells. Although UVB light also elevated
supernatant IL-1α levels, antibody neutralization studies indicated that IL-1α was not required
for IL-20 induction. Photodynamic therapy (PDT) with the photosensitizer lemuteporfin,
UVA light, cis-platin, lipopolysacchraride, TNF-α or IFN-γ either had no effect or decreased
NHEK supernatant IL-20 levels. Of these treatments, reduced IL-20 levels paralleled the cyto-
toxic impact of PDT, UVA light and cis-platin and the anti-proliferative effect of IFN-γ. Nei-
ther rIL-20 supplementation nor antibody neutralization of IL-20 altered the impact of UVB
light on NHEK viability suggesting that soluble IL-20 does not influence the short-term sur-
vival of UVB light-irradiated NHEK. Increased IL-20 expression by UVB light-exposed ker-
atinocytes suggests that this cytokine might participate in skin responses to this environmen-
tal factor and potentially has a role in certain UV light-associated dermatoses.
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Clinical features of photodamaged human skin are associated with a reduction in Type XVII
collagen and laminin-5, the main components of anchoring filaments
T Roudner,1 M Matsui,2 J Uitto3 and R Ghohestani3 1 Surgery, Pennsylvania Hospital,
Philadelphia, PA, 2 Clinical Research, Estee Lauder, Melville, NY and 3 Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Little is known about the molecular mechanisms that underlie wrinkle formation in photo-
damaged skin. We here examined whether type XVII collagen and laminin-5, the main com-
ponents of anchoring filaments, are affected by chronic sun exposure. Skin samples, corre-
sponding to different parts of the body, were obtained from 31 volunteers with mild, moderate
or severe photodamage. Additionally, we obtained pre- and post-auricular skin samples from
8 volunteers. Using a computer assisted intensitometer, we compared expression of type XVII
collagen and laminin-5 as detected by immunohistochemistry and Western blot assays. Der-
mal photodamage was further assessed by elastin staining of frozen skin sections. Ultrastruc-
tural assessment of anchoring filaments was performed using transmission electron microscopy.
Analysis of the dermal-epidermal junction proteins in sun-exposed vs. sun-protected skin
showed a dramatic change in the expression of type XVII collagen and laminin-5. In sun-
exposed skin expression of type XVII collagen and laminin-5, by keratinocytes, was signfi-
cantly reduced as compared to non-exposed samples (P<0.05). Transmission electron
microscopy further revealed a significant reduction in anchoring filaments in sun-exposed
skin. These findings suggest that decreased expression of type XVII collagen and laminin-5,
in photodamaged skin, cause skin fragility by weakening the dermal-epidermal junction.
Collectively, these data attest to basement membrane changes induced by chronic UV expo-
sure, and further define anchoring filament molecules as novel molecular markers of the
photodamaged skin.
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Identifying biosensor genes that quantify human epidermal response to UV radiation
A Altiner,1,2 CL Tock,1 LR Turner,1 A Terunuma,1 S Miller,3 J Beer,3 CL Yee,1 MC Udey1 and
JC Vogel1 1 Dermatology Branch, NIH, Bethesda, MD, 2 Howard Hughes Medical Institute,
Bethesda, MD and 3 FDA, FDA, Rockville, MD
Currently, the understanding of the effects of different doses of UVA and UVB on global gene
expression in human epidermis is limited. Assays that utilize patterns of gene expression as bio-
markers to quantify effects of various doses of solar-simulated UVR (ssUVR) and UVA may
advance the understanding of UV biology, and also facilitate development of efficacious assays
to assess protection offered by sunscreens. To identify predictive gene panels, 20 healthy vol-
unteers with Fitzpatrick type 2 skin were exposed to various doses of ssUVR and UVA related
to their individual erythema dose (0.1 MED, 1 MED) and a standard dose of 100 J/m2, with
and without prior application of sunscreen (spf 15). We measured global RNA expression lev-
els 24 hours after exposure using Affymetrix HG-U133A2 high-density microarray genechips.
Data from 140 chips was subjected to the RMA algorithm, and analyzed according to their
exposure dose and type (control, 0.1 MED ssUVR, 1 MED UVA etc). Two thirds of the samples
were used as training sets, with the remaining samples used to verify the results. Using a
paired t-test analysis, we initially compared ssUVR samples (100J/m2 and 1 MED) with con-
trols, and identified 26 genes that were consistently up or down regulated in a dose depend-
ent manner (p<0.001). These genes correctly predicted the ssUVR dose with 100% accuracy
for 100J/m2 and 1 MED genechips, and with 70% accuracy for 0.1 MED genechips (p<0.001).
Similar analyses revealed that the 26 genes were not able to predict the dose of UVA genechips,
but continued to function as reliable biosensors for sunscreen-treated ssUVR samples with
100% accuracy (p<0.001). These findings suggest that these discreet set of genes function as
biosensors to assess doses of UVB and not UVA, and that the UVB blockage offered by spf 15
sunscreen is incomplete. Further analyses to elucidate the biosensor gene panels for different
UVA doses can lead to a better understanding the epidermal response to UVA exposure.
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Use of a highly differentiated skin model to evaluate the phototoxic potential of systemi-
cally administered drugs
J Kubilus, PJ Hayden, Y Kaluzhny and M Klausner R & D, MatTek Corporation, Ashland, MA
Both topically applied and systemically administered medications have the potential to induce
photosensitivity. Photosensitivity includes photoallergic reactions, which are immunologically
mediated, and phototoxic effects, which can occur following an initial exposure to the drug
and sunlight. Phototoxicity is much more common than photoallergy and the majority of med-
ications causing photosensitivity are systemic phototoxicants. Previously, the three dimen-
sional, highly differentiated EpiDerm skin model (EPI-200) was used to determine whether top-
ically applied materials were phototoxins. In the current work, these results were extended to
investigate the effects of a known phototoxin, chlorpromazine (CP), following systemic expo-
sure. EPI-200 tissues were cultured for 3 hours in the presence of 0-10 mg% CP. Next, the tis-
sues were rinsed, placed in phosphate buffered saline, and exposed to a non-photoxic dose
of UVA (10 J/cm2) using a solar simulator. After irradiation, the tissues were again rinsed, cul-
tured for an additional 18 hours in fresh medium, and evaluated for viability using the MTT
assay. The viability of parallel CP-exposed, non-irradiated tissues was also evaluated. For all
tissues exposed to CP concentrations in excess of 1.2 mg%, the viability of the irradiated tis-
sues decreased by 33-75% more than the non-irradiated tissues. Based on these and the pre-
vious topical application results, it appears that the EpiDerm skin model will have utility in
determining the phototoxicity potential of systemically applied drugs.
854
Comparative analysis of UVB and heat-treated primary human keratinocytes
M Krishnan,1 T Harvinder,1 C Young,1 B Aufiero,1 G Murakawa,2 J Hatfield3 and LB Savoy2 1
Dermatology, Wayne State University, Detroit, MI, 2 DermCenter, Troy, MI and 3 VA medical
Center, Detroit, MI
Injury to the epidermis from ultraviolet (UVB) radiation and heat (5°C above normal growth
temperature) results in cytotoxic effects, inflammatory and system dysfunctions which lead to
hyperthermia and/or hyperosmotic stress. In this study, we evaluated morphological changes
in primary human keratinocytes as a result of exposure to UVB radiation and heat (41°C). Ker-
atinocytes exposed to narrow-band UVB (NB-UVB: 312/311nm) and broad-band UVB (BB-
UVB: 315-280nm) exhibited apoptosis at specific doses. Transmission electron micrographs
(TEM) showed that NB-UVB and BB-UVB irradiated keratinocytes contained marked chro-
matin condensation, extensive cytoplasmic vacuolization and fragmentation of the nuclear
envelope. DNA ladder assays confirmed and revealed that UVB-mediated apoptotic doses for
NB-UVB (1000 mJ/cm2) were approximately ten fold higher than for BB-UVB (125 mJ/cm2).
Furthermore, intracellular activation of apoptosis was confirmed by Western blot analysis of
activated caspase 3, an apoptosis-specific enzyme. By comparison, heat-treated (41oC, 1hr)
keratinocytes differed morphologically from UVB-treated cells. Ultrastructural features obtained
from TEM revealed increased cytoplasmic vacuolization and blebbing around the nucleus, an
increased number of mitochondria and significant mitochondrial swelling, typical of heat-
stressed and ischemic cells. Importantly, heat-treated keratinocytes did not exhibit chromatin
condensation suggesting that apoptosis is not a prominent outcome. In conclusion, heat and
UVB radiation cause injury to keratinocytes. However, the mechanism of action may differ as
suggested by ultrastructural studies that demonstrated unique morphological features in UVB-
versus heat-treated keratinocytes.
858
Changes in chromatin structure induced by ultraviolet radiation
BP Pollack1,2 and JM Boss3 1 Dermatology, Emory University, Atlanta, GA, 2 Pathology, Emory
University, Atlanta, GA and 3 Microbiology and Immunology, Emory University, Atlanta, GA
The purpose of these investigations was to characterize changes in chromatin structure and
histone modifications that occur in response to ultraviolet radiation (UVR). Using HaCaT
cells as a model system, we used Dnase I hypersensitivity assays, chromatin immunoprecip-
itation (ChIP) and Western blot analysis to evaluate histone modifications and chromatin struc-
ture. DNase I hypersensitivity assays are commonly used to identify the location(s) of alter-
ations in chromatin structure involved in gene regulation. Genomic DNA from UVR-treated
HaCaT cells showed increased sensitivity to DNase I digestion eight hours after UVR expo-
sure.  While cellular DNase is induced by UVR, we hypothesized that changes in chromatin
structure contributed to this increased sensitivity to DNase I digestion. To test this hypothesis,
we investigated changes in histone modifications induced by UVR. Following UVB treat-
ment, we observed a marked decrease in cellular histone H4 acetylation. This decrease occurred
within thirty minutes and returned to near baseline levels after twenty-four hours. To charac-
terize the histone modifications within a specific UVR-induced gene, we analyzed the ATF3
promoter using ChIP assays. These assays revealed an increase in histone H3 acetylation after
UVB treatment. This data supports the hypothesis that UVR can induce changes in histone
modifications and chromatin structure in human keratinocytes. Given the central role of
chromatin in gene regulation and DNA repair, it is important to fully characterize how UVR
impacts chromatin both globally and within UVR-regulated genes.
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The proapoptotic protein Bid plays an essential role in Langerhans cell and keratinocyte pho-
todamage
S Pradhan, C Thrash, S Mantena, S Katiyar, C Elmets and L Timares Dermatology, University
of Alabama, Birmingham, Birmingham, AL
UVB irradiation induces skin cancer through multiple mechanisms, including the generation
of DNA mutations in epidermal cells and the development of immunosuppression. Apopto-
sis plays an important role in eliminating UV-mutagenized cells but its role in immunosup-
pression is not clear. We have shown that LCs normally undergo apoptosis after successful
antigen presentation by recruiting proapoptotic Bid (BH3 interacting death domain) protein,
and that Bid knockout (KO) LCs resist apoptosis and mediate exaggerated immune responses.
However, the role Bid plays in response to UV-induced damage in LCs and keratinocytes is
not known. Therefore, we first compared UVB-induced sunburn responses and the formation
of sunburn cells after UVB exposure in C57Bl/6 wild-type (WT) and Bid KO mice. Then, to
determine if apoptosis-resistant Bid KO LCs respond differently from WT LCs to UVB expo-
sure, we examined the levels of LCs remaining in epidermis and UV-induced immunosup-
pression to hapten sensitization. Sunburn responses were measured 24 hours after graded
doses of UVB exposure on shaved backs and ears of mice. The minimal dose of UVB required
to produce a sunburn response was less than 50 mJ/cm2 for WT mice, and greater than 100
mJ/cm2 for Bid KO mice (p<0.003). This correlated with a marked reduction in sunburn/apop-
totic cells (TUNEL+) and retention of LC (I-A+) density observed in the epidermis of Bid KO
as compared to WT mice. UV-induced immunosuppression is thought to correlate with the
level of DNA damage in LCs, suggesting a role for LC apoptosis in mediating suppression.
Therefore we tested the susceptibility of Bid KO mice to immunosuppression of hapten sen-
sitization for contact hypersensitivity (CHS). Bid KO mice were resistant to UV-induced immuno-
suppression, where the CHS response was inhibited by only 29% as compared to 98% in WT
mice (p<0.03). Thus, Bid KO epidermal cells undergo reduced apoptosis and provide an
enhanced immunogenic environment for maintaining LC function after UVB exposure.
860
Oxidative stress induces prostaglandin E2 formation via PPARγ in human epidermal ker-
atinocytes
RL Konger,1,2 Q Zhang2 and JB Travers2 1 Pathology & Lab Medicine, Indiana University
School of Medicine, Indianapolis, IN and 2 Dermatology, Indiana University School of
Medicine, Indianapolis, IN
We have recently demonstrated that ultraviolet B (UVB) and oxidative stress result in the pro-
duction of oxidized glycerophosphocholine species that exhibit potent peroxisome prolifera-
tor activated receptor gamma (PPARγ) ligand activity. In several epithelial cell lines, this PPARγ
activation is necessary for UVB and oxidative stress-induced cyclooxygenase (COX)-2 induc-
tion and prostaglandin E2 production. Since UVB irradiation and oxidative stress play impor-
tant roles in epidermal pathophysiology, we sought to determine if a PPARγ dependent mech-
anism for UVB-induced PGE2 formation is seen in epidermal keratinocytes. In this study, we
verify that primary human keratinocytes (PHKs) express PPARγ and that pretreatment of human
epidermal explants with the specific PPARγ antagonist, GW9662, inhibits UVB-induced PGE2
formation. To verify that this response is keratinocyte specific, we demonstrate in PHKs that
GW9662 significantly blocks UVB- and tert-butylhydroperoxide (TBH)-induced PGE2 pro-
duction. We further demonstrate that two different PPARγ agonists, ciglitazone and 1-hexa-
decyl 2-azelaoyl phosphatidylcholine (azPC), both significantly induce PGE2 production in
PHKs. In contrast, a PPARδ agonist (GW501516) is ineffective, while a PPARα agonist (WY-
14,643) induces a weak response. Interestingly, the ability of PPARγ agonists to induce PGE2
production was dependent on cellular adhesion to type I collagen, suggesting a role for inte-
grin signaling in PPARγ-dependent COX-2 induction. PPARγ expression was not altered by
cellular adhesion to collagen. Finally, it was noted that PPARγ agonists induce a motile phe-
notype in PHKs plated on collagen. This phenotypic change was reversed by pretreatment with
GW9662. This may indicate bidirectional cross-talk between integrin- and PPARγ-dependent
signaling pathways. These data indicate that PPARγ likely plays an important role in epider-
mal UVB and oxidative stress responses and wound healing.
861
Serial image capture and comparison with an automated, software-driven, digital, whole-
body photography system (Melanoscan) results in detection of thinner melanomas
RJ Drugge,1 C Nguyen,1 PA Broderick,2 SA McClain3 and CC Brown4 1 Dermatology Imaging
Center, Stamford, CT, 2 The Stamford Hospital, Stamford, CT, 3 McClain Laboratories, LLC,
Smithtown, NY and 4 Dermazone Solutions, LLC, Clearwater, FL
We tested the hypothesis that serial, automated, whole-body photographic screening of at-
risk individuals would lead to diagnosis of melanoma at an earlier pathologic stage compared
to traditional screening methods. Mean Breslow depths of melanoma biopsies were deter-
mined for six cohorts. The test cohort of 22 melanomas was comprised of at-risk patients seri-
ally screened with the Melanoscan system. Two cohorts were pathology laboratories. Three
cohorts were as follows: non-dermatologist referrals, self-referred patients, and patients fol-
lowed by a dermatologist without the benefit of serial photography. The total number of
melanoma biopsies was 1865, with 1753 biopsies from two pathology laboratories, and 112
from four clinical cohorts. Mean Breslow depths were statistically compared. The mean Bres-
low depth of the serial scanning cohort of 22 melanomas was 0.073mm and was significantly
thinner than that of all comparison groups: pathology lab #1 cohort (mean depth of 1.45mm,
p=0.0036), pathology lab #2 cohort (mean depth of 0.195mm, p=0.0004); non-dermatologist
physician referred patient cohort(mean depth of 0.728mm, p=0.0369); self-referred patient
cohort (mean depth of 0.553, p=0.0088) followed by dermatologist without serial photogra-
phy cohort (mean depth of 0.226 mm p=0.0478). When mean depths for only the invasive
melanomas in each cohort were analyzed, the mean of the serial scanning cohort was simi-
larly found to be significantly thinner than the means for each comparison group. Serial,
automated, whole-body, photographic screening of at-risk individuals is superior to other par-
adigms of melanoma screening and diagnosis. The mean Breslow depth of the serial scanning
cohort was the lowest reported in our review of the melanoma screening literature.
862
Sentinel lymph node status as a prognostic indicator in patients with thick (T4) primary
melanoma
M Council,1 RC Bowers,1 JB Lowe,1 CJ Hussussian2 and LA Cornelius1 1 Dermatology,
Washington University School of Medicine, St. Louis, MO and 2 Plastic Surgery Associates,
S.C., Waukesha, WI
The purpose of this study was to determine whether sentinel lymph node status is predictive
of survival in patients with thick melanoma. Although sentinel node biopsy is standard of care
in Stage I patients with T2 and T3 melanoma, less is known regarding its use in T4 (> 4mm)
melanoma patients. A retrospective review of a computerized database identified 25 patients
with thick melanoma who underwent sentinel node biopsy at our institution from January
1992 to June 2003. The database and patient charts were reviewed for patient information
including age at diagnosis, sex, tumor location, Breslow depth, Clark level, presence of ulcer-
ation, histologic subtype, sentinel node status, methods of treatment, and patient outcome.
Survival curves were constructed using Kaplan-Meier estimates and analyzed with log-rank
tests to determine statistical significance. Eleven patients (44%) were found to have a positive
sentinel lymph node. Patient age at diagnosis, sex, tumor location, tumor thickness, Clark level,
and histological subtype were not significantly different between sentinel lymph node groups.
The mean follow-up was 26.1 months. Patients were restaged based upon sentinel node sta-
tus. The 3-year disease-free and overall survival of the entire cohort (Stage II and III patients)
was 29%. Node-negative T4 patients (Stage II) had a significantly higher 3-year disease-free
survival when compared with node-positive T4 patients (Stage III) (38% vs. 21%, P=0.0252).
Overall survival did not differ between the groups. Additionally, age at diagnosis, tumor loca-
tion, and Breslow depth were not predictive of disease-free survival. Based upon these lim-
ited numbers, sentinel node status is predictive of 3-year disease-free survival in T4 melanoma
patients. We conclude that the technique may be useful in determining the disease-free sur-
vival in T4 melanoma patients with clinically negative nodes, and are continuing accrual and
analysis to further substantiate our results.
863
Changes in expression of melanogenic cytokines after narrowband UV-B therapy in Japan-
ese vitiligo patients
K Kikuchi, T Hoashi, M Komine and K Tamaki Department of Dermatology, University of
Tokyo, Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
Vitiligo is a major medical problem, especially for pigmented races. Narrowband UV-B (NBUVB),
a new light source, which is not yet available widely, is effective without the use of psoralens. Ten
Japanese patients with active, non-segmental vitiligo, received NBUVB treatments 5 times per
week, with an initial dose of 0.1 J/cm2. The dose was increased by 10% to 20% per treatment for
20 treatments. Biopsies were obtained from lesional skin and from non-lesional skin before NBUVB
and from repigmented skin after NBUVB. The dose was then increased by 2% to 5% per treat-
ment 2 times per week until 50% repigmentation was observed or persistent erythema developed.
After NBUVB treatment, 8 of 10 patients (80%) achieved more than 50% repigmentation on the
face, trunk, arms, and legs, confirming the effectiveness of NBUVB for treating vitiligo. The rela-
tive expression of a number of key mediators of pigmentation including S100α, tyrosinase, TRP-
1, MART-1, MITF and cytokines such as ET-1, ETAR, ETBR, basic fibroblast growth factor (bFGF)
and c-kit were analysed and quantified in immunohistochemically stained skin. After NBUVB,
melanocyte number was increased 3-fold in the repigmented skin and the number of keratinocyte
layers was increased. Tyrosinase, TRP-1 and MART-1 expression in melanocytes was significantly
elevated after NBUVB. ET-1 and ETAR expression by keratinocytes was elevated after irradiation.
ETBR expression on keratinocytes was decreased after NBUVB, while ETBR expression on
melanocytes was increased. MITF and c-kit was not expressed on melanocytes before NBUVB,
but their expression was observed after irradiation. The elevated expression of bFGF on keratinocytes
were found in vitiligous skin, but after NBUVB, bFGF protein decreased to the level of normal
control. A slight elevation of expression of bFGF on melanocytes was observed after NBUVB.
Endothelins, SCF and bFGF ligand-receptor interactions between keratinocytes and melanocytes
might be in involved in the pathogenic and therapeutic chain of events in vitiligo.
864
Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-perme-
able Survivin antagonist
H Yan,3 J Thomas,3 T Liu,3 D Raj,3 N London,3 T Tandeski,3 S Leachman,1,3 R Lee2,3 and
D Grossman1,3 1 Dermatology, University of Utah, Salt Lake City, UT, 2 Medicine, University
of Utah, Salt Lake City, UT and 3 Huntsman Cancer Institute, University of Utah, Salt Lake
City, UT
The inhibitor of apoptosis gene family member Survivin is highly expressed in most tumors,
and appears to be a promising target for cancer therapy. Although a variety of Survivin antag-
onists have been shown to induce apoptosis in malignant cells, the potential utility of these
agents is limited by inefficient delivery and cell permeability. We generated recombinant fusion
proteins containing the TAT protein transduction domain and either wild-type Survivin (TAT-
Surv-WT) or a dominant-negative mutant (TAT-Surv-T34A). The TAT-Surv proteins were puri-
fied by sequential affinity and ion-exchange chromatography, and at 30 nM concentration
demonstrated rapid entry into cells at 1 h. While TAT-Surv-WT (100-500 nM) had no effect on
YUSAC2 melanoma cells over a 24-h period, TAT-Surv-T34A under similar conditions induced
DNA fragmentation, caspase-3 activation, and mitochondrial release of apoptosis-inducing
factor. Intraperitoneal injection of mice bearing subcutaneous YUSAC2 xenografts with TAT-
Surv-T34A (10 mg/kg) was associated with increased tumor cell apoptosis, and repeated i.p.
injection (every 3 d) resulted in a 40-50% reduction in tumor growth and mass, compared to
those in animals similarly injected with saline buffer or TAT-Surv-WT. These studies demon-
strate the feasibility of systemic tumor treatment using a cell-permeable Survivin antagonist.
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Complex inhibition of tyrosinase by thiol-composed copper chelators: a clue for designing
tyrosinase inhibitor
Y Park,1,2 Y Lyou,2 D Lee1 and J Yang1,2 1 Dermatology, Sungkyunkwan University School of
Medicine, Samsung Medical Center, Seoul, South Korea and 2 Clinical Research Center,
Samsung Biomedical Research Institute, Seoul, South Korea
Investigators have paid special attention to tyrosinase inhibition because to its potential for
medicinal and cosmetic applications, as well as its important uses for agricultural purposes.
In this study, we investigated the inhibition effects of thiol-associated Cu2+ chelators and we
deduced a strategy for designing and/or selecting tyrosinase inhibitors that was based on our
observations. Among the several tested compounds used in the present study, we selected
dithioglycerine (DTGC) to conduct experiments for the inhibition kinetics on tyrosinase. Dif-
ferent kinds of tyrosinase derived from mushroom and from the transient overexpression in
HEK293 cells were individually tested. The results showed that DTGC conspicuously inhib-
ited human tyrosinase in a complex manner (slope-parabolic mixed-type inhibition) com-
parative to mushroom tyrosinase. To evaluate DTGC’s affinity to human tyrosinase, we have
set up the Ki slope equation. Consequently, we suggest that a Cu2+ chelator modified with
thiol groups might have excellent potential as a tyrosinase inhibitor. In addition, a strategy to
design and/or select tyrosinase inhibitors that target to the active enzyme site is also suggested.
867
Glossy privet fruit extract, tyrosol, a component of a potent melanogenic stimulator for
human melanocytes
A Xu, Y Li, X Wei and D Zhang Department of Dermatology, The Third Hospital of
Hangzhou, Hangzhou, Zhejiang, China
Vitiligo is a disorder presenting with progressive depigmentation of the skin. Treatment is
frustrating owing to the lack of satisfactory therapies. Traditional Chinese Medicines (TCM)
have been explored to treat vitiligo patients with some encouraging effects. Here we have
measured the biological effects of a Chinese medicine, glossy privet fruit extracts (GPFE), and
its two main monomers, tyrosol and oleanolic acid, on cultured human melanocytes to deter-
mine their potential in activating melanocytes. Our studies have shown that GPFE had a pos-
itive effect on proliferation of melanocyte and melanogenesis with an elevated expression of
tyrosinase and c-kit analyzed by western blotting. In order to elucidate the mechanisms under-
lying the increased melanin synthesis by treating with GPFE, melanocytes were treated with
two monomers respectively to identify the main effective component. The addition of 20, 40,
80, or 160µg/mL tyrosol to cultured human melanocytes significantly stimulated tyrosinase
activity assessed by DOPA-oxidation and melanogenesis in a dose dependant manner, although
it had no obvious effects on melanocyte proliferation measured by MTT assay. RT-PCR for
mRNA isolated from human melanocytes exposed to tyrosol revealed an upregulation of mRNA
transcripts for tyrosinase and tyrosinase related protein-1 (TRP-1). Moreover, melanocytes
treated with oleanolic acid (5µg/ml), also obviously stimulated the expression of tyrosinase
(p<0.01). Our findings suggest that GPFE is a promising TCM, and it may be a melanogenic
stimulator of human melanocytes playing an active role in upregulation of various melanogenic
molecules, including its receptor c-kit.
869
The microenvironment is the key determinant of melanoma drug resistance
NK Haass, KS Smalley and M Herlyn The Wistar Institute, Philadelphia, PA
Melanoma is highly resistant to chemo-, immuno- and targeted therapy. Thus, new therapeu-
tic targets are urgently needed to improve the dismal prognosis. Despite promising results in
vitro, no clinical trial has shown a survival advantage over dacarbazine. One reason for this
is the lack of good melanoma models. In vivo, tumor cells interact with the stroma and cells
in their microenvironment, which is critical for determining therapeutic outcome. Existing
models which reflect the melanoma microenvironment are ill-suited to drug screening. Instead,
we have used an approach where melanoma cells are grown under anchorage independent
conditions so that they form spheroids. The spheroids are then implanted in collagen I which
mimics the microenvironment of human skin. In this study, we investigated the responses to
inhibitors of pathways active in melanoma, such as the PI3K/Akt- and the Raf/MEK/ERK path-
way. In adherent cultures, treatment of metastatic melanoma cells with either a PI3K or a
MEK inhibitor led to concentration-dependent reductions in cell growth. In contrast, when
the cells were grown as 3D collagen implanted spheroids they displayed a drastically reduced
sensitivity to the same inhibitors, whereas earlier stage melanoma cells did not. To determine
whether the 3D architecture of the spheroids or the interaction of the tumor cells with the
collagen were responsible for the observed drug resistance, we investigated cells grown as
monolayer on plastic or on top of collagen, single cells in collagen, spheroids on agar, and
spheroids in collagen. Whereas the treatment of metastatic melanoma cells as a monolayer
on plastic and on top of collagen led to similar results, there was less growth inhibition when
cells were embedded in collagen. In contrast to spheroids in collagen, the treatment of sphe-
roids grown on top of agar led to growth inhibition, similar to the effect on adherent cells.
Together, these results demonstrate that growing metastatic melanoma lines in the correct tis-
sue environment reveals their true drug-resistant phenotype and that the microenvironment
is key determinant of this resistance.
868
Further development of human skin xenografts towards modeling melanoma
A Yoneta, M Kogan, R McDaid, L Li, S Kazianis and M Herlyn The Wistar Institute,
Philadelphia, PA
Within our laboratory, an experimental model of human melanoma is established, in which
human skin from healthy donors is grafted to immunodeficient mice, followed by intradermal
adenovirus vector-mediated expression of three growth factors, bFGF, ET-3, and SCF and con-
comitant irradiation with UVB. After a treatment period of 4 weeks, lesions develop in the
human skin that histologically resemble primary melanomas in patients. The lesions regress
when the growth factors are no longer active. This model allows for a systematic dissection of
the biological and molecular events leading to melanoma formation. Oncogenic kinase acti-
vation plays a central role in tumor initiation and progression. Constitutive activation of the
MAPK and AKT pathways has been identified in human melanoma cell lines and lesions. In
this study, we further examine which pathways are activated by the application of growth fac-
tors and UVB in human skin grafted to SCID mice. Like in melanoma lesions from patients,
experimentally induced lesions show phosphorylation of ERK and AKT, suggesting that these
pathways are critical for inducing a malignant phenotype of melanocytic cells. However,
their activation is not yet sufficient for malignant transformation. The foreskin graft model has
limitations because each specimen is unique. In order to minimize heterogeneity, we aim to
take advantage of a skin reconstruction model. Melanocytes, fibroblasts, or keratinocytes are
stably transduced with growth factor genes using lentiviral vectors, which are then incorpo-
rated into skin reconstructs. A panel of lentiviral constructs including mutant and wild type
BRAF, bFGF, ET-3, SCF and knockdowns of tumor suppressor genes such as p53, p16 and ARF
have been constructed and functionally characterized. Subsequently, the reconstructs are
grafted to mice, and irradiated with UVB. This model will give us more detailed information
on development of melanoma, and we can easily manipulate other genes in cells prior to
their inclusion into the skin reconstructs.
866
Analysis of molecular character of gene “VIT1” in Chinese patients with vitiligo
Y Li, X Wei, D Zhang and A Xu Department of Dermotology, The Third Hospital of
Hangzhou, Hangzhou, Zhejiang, China
Vitiligo is a multigenic disorder presenting with progressive depigmentation of the skin. These
genes underlying sensitivity to melanocytes loss remain an enigma. “VIT1”, a novel gene down-
regulated in vitiligo melanocytes has been reported by Caroline. In order to approach the
expression of “VIT1” gene in melanocyte of Chinese patients with vitiligo, the gene expres-
sion was first compared in melanocytes cultured from non-lesional skin of generalized vitiligo
patients (12), normal (3) and melanomas (2). The cloned “VIT1” ORF cDNA fragments were
sequenced, and the sequences were compared by the Basic local alignment search tool (BLAST,
NCBI). Semi-quantitative RT-PCR was conducted and demonstrated the expression levels of
“VIT1” in non-lesional melanocytes from vitiligo patients were significantly lower than those
in normal melanocytes,in contrast, the expression levels of “VIT1” in melanoma were higher.
Interestingly, we found that the cDNA sequence revealed one more 81bp fragment included
in “VIT1” ORF in normal and vitiligo melanocytes, and this fragment containing GT–AG splice
site was a potential intron. Sequence analysis revealed that “VIT1” actually was a part of
FBXO11 belonging to F-box protein family. The F-box protein constitutes one of the four sub-
units of ubiquitin protein ligase complex called SCF (SKP1-cullin-F-box), which function in
phosphorylation -dependent ubiquitination. The SCF may induce the protein degradation, and
the reduced SCF may cause the dilated endoplasmic reticulum resulting in a deficiency of
melanogenesis. Our findings suggest that “VIT1” at least at our hands is a part of already defined
gene. Future studies will hopefully clarify our findings and lead to a better understanding of
the role of this protein in pathogenesis of vitiligo.
870
A mimotope-based anti-cancer vaccine against malignant melanoma
C Hafner,1 S Wagner,2 C Krepler,1 U Wiedermann,3 O Scheiner,2 H Pehamberger1 and
H Breiteneder2 1 Department of Dermatology, Medical University of Vienna, Vienna, Austria,
2 Department of Pathophysiology, Medical University of Vienna, Vienna, Austria and 3
Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna,
Vienna, Austria
The high resistance of malignant melanoma to chemotherapy and radiotherapy emphasizes
the need to develop novel therapeutic strategies to prevent melanoma growth. Anticancer vac-
cines formulated with peptide mimics of a conformational epitope that is recognized by a
monoclonal antibody with antitumor activity represent promising vaccine candidates. We have
designed such a vaccine consisting of a mimotope of the human high molecular weight
melanoma-associated antigen (HMW-MAA) coupled to an immunogenic carrier protein. We
had previously described the immunogenicity and the in vitro biological activity of the induced
antibodies. Here, we investigated whether the immune response elicited by the mimotope
vaccine was able to suppress human melanoma tumor growth in SCID mice. Tumors were
established by subcutaneous injection of the human melanoma cell line 518A2 into SCID
mice. On the same day, purified antibodies derived from immunization of rabbits with the
mimotope vaccine were administered intravenously and then in 3 days intervals at 50 µg/injec-
tion or at 200 µg/injection. For control purposes mice were also treated with 200 µg/injection
of antibodies derived from immunization with the carrier protein alone. Within 23 days fol-
lowing injection of the 518A2 cells, tumor growth was reduced by 8% in the group treated
with 50 µg/injection and by 52% in the group with 200 µg/injection as compared to control
mice. Determination of tumor weight after this time period revealed a reduction of tumor
weight of 32% in the group treated with 50 µg/injection and of 49% in the group with 200
µg/injection as compared to control mice. The results from our studies indicate that our mimo-
tope vaccine represent a powerful immunotherapeutic agent for the treatment of malignant
melanoma.
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TC1 inhibits melanogenesis by down-regulation of protein levels of melanogenic enzymes in
B16 melanoma cells
J Shin,1 E Hong,2 DT Nguyen,2 DH Nguyen,2 J Kim2 and E Kim2 1 Dermatology, Inha
University, Incheon, South Korea and 2 Biological Engineering, Inha University, Incheon,
South Korea
Few skin-depigmenting compounds have been used for the treatment of hyperpigmentary dis-
orders in human. Among them, those well known are hydroquinon, kojic acid and arbutin.
However, the efficacy and safety of these are still controversial. Recently, looking for a more
effective and safer depigmenting material, researchers tend to investigate natural compounds
from plants. In this work, we investigated the effect of TC1, a crude extract from Tibet herb,
on melanogenesis and viability of cultured B16 mouse melanoma cells. TC1 downregulated
melanin synthesis effectively and was not toxic. An effective fraction of TC1 was extracted ini-
tially with 95% methanol (w/v) and separated into five fractions using recycling HPLC with
GS310 column (21.5×500mm, 10-15µM). The fraction 1 (#1) of TC1 showed melanin inhibi-
tion by 48% at 100ppm and minimal cell toxicity, 2.5 times more efficient than the depig-
menting effect of arbutin(17.5%) commercial. To elucidate the depigmenting mechanism of
TC1 #1, we investigated in vitro and intracellular tyrosinase activity, antioxidant activity, and
changes in protein level of the main melanogenic enzymes, such as tyrosinase, TRP-1 and
TRP-2. In conclusion, TC1 #1 inhibits melanin synthesis in B16 melanoma cells by decreas-
ing protein levels of melanogenic enzymes, especially tyrosinase. We suggest that TC1 #1 may
be a safe and effective compound for depigmentation.
872
CCN3 controls proliferation and localization of melanocytes in the human epidermis
M Fukunaga,1 G Martinez,1 P Mrass,1 W Weninger,1 B Perbal2 and M Herlyn1 1 The Wistar
Institute, Philadelphia, PA and 2 Universite Paris, Paris, France
Melanocytes are located within the basal layer of the human epidermis where they attach to
the basement membrane and extend dendrites to surrounding keratinocytes for transfer of
pigment-containing melanosomes. The functions of melanocytes are regulated by keratinocytes
through as yet unknown mechanisms. We have now identified CCN3 (NOV, nephroblastoma
overexpressed), which is a member of the matricellular protein family as critical for melanocyte
localization and growth inhibiton in human skin. CCN3 was upregulated in melancytes by
co-culture with keratinocytes or exposure to pro-inflammatory cytokines IL-1β and TNF-α.
Knockdown of CCN3 dysregulated growth and localization of melanocytes in the epidermis,
which migrated similar to transformed cells to the suprabasal layers of the epidermis or invaded
into the dermis whereas overexpression increased adhesion to collagen type IV, the major
component of the basement membrane. CCN3 regulated melanocyte growth and localiza-
tion by upregulating DDR1, a receptor tyrosine kinase that acts as a collagen IV adhesion
receptor. Knockdown of DDR1 decreased melanocyte adhesion to collagen IV and increased
proliferation similar to CCN3 knockdown. Since the growth inhibitory and basement mem-
brane localizing roles for CCN3 are important for melanocyte homeostasis in the normal
skin, transformed cells have little needs for this protein. Indeed, CCN3 is highly expressed by
melanocytes in situ and very little is expressed by invasive melanoma cells suggesting that dys-
regulation of CCN3 could provide the first step in disrupting the normal balance between
melanocytes and keratinocytes.
873
Secretory phospholipases A2 (sPLA2) type X mediates human melanocyte dendricity through
lysophosphatidyl choline induced activation of protein kinase C zeta
G Scott and S Jacobs Dermatology, University of Rochester, Rochester, NY
The mechanisms of melanocyte (MC) dendricity are of interest because of the importance of
melanin transfer in skin photoprotection. Secretory phospholipases are enzymes that liberate
arachidonic acid as well as lysophospholipids from cell membranes. The main secretory phos-
pholipase expressed by keratinocytes is group X sPLA2, which is upregulated by UV irradia-
tion. We have shown previously that low doses (100 nM) of lysophosphatidylcholine (LPC),
the main lysophospholipid released in response to sPLA2-X activity, stimulate MC dendricity.
We now examine the signaling intermediates involved in LPC-dependent human MC den-
dricity. LPC binds to the G-protein coupled receptor G2A which we have shown to be expressed
by MC. G2A activates a variety of second messenger systems including cAMP, inositol phos-
phate accumulation, intracellular Ca+2 mobilization and PKC. The novel PKC isoform PKCζ,
and the atypical PKC isoform PKCδ have both been shown to regulate cell shape in other cell
types. To determine if LPC activates these and other PKC isoforms known to be expressed in
MC, cells were treated with LPC (100nM) and Western blotting was performed for analysis of
phospho-PKC. Of the PKC isoforms expressed by MC, only PKCζ and PKCδ were phospho-
rylated following treatment with LPC. Phosphorylation occurred within 30 min, and gener-
ally peaked at 90 min. MC were next incubated with LPC in the presence of PKCζ pseudo-
substrate or Rottlerin, a PKCδ inhibitor. Inhibition of PKCζ, but not PKCδ, abrogated LPC
induced dendricity, indicating a novel and important role for PKCζ in LPC dependent den-
dricity. cAMP regulates cell shape in many cell types and in MC we have shown previously
that cAMP regulates dendricity in part through inhibition of the small GTP-binding protein
Rho and activation of Rac. Quantitation of cAMP levels in MC following treatment with LPC
showed no changes in cAMP. These studies indicate a primary role for the PKCζ isoform in
LPC-dependent MC dendricity. The role of the G2A receptor in MC dendricity is currently
being explored.
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Rapid growth of invasive metastatic melanoma in carcinogen-treated HGF/SF-transgenic
mice carrying an oncogenic CDK4 mutation
D Tormo,1 A Ferrer,1 E Gaffal,1 J Wenzel,1 J Steitz,1 L Heukamp,2 I Gutgemann,2 R Buttner,2
M Malumbres,3 M Barbacid,3 G Merlino4 and T Tuting1 1 Laboratory of Experimental
Dermatology, University of Bonn, Bonn, Germany, 2 Institute of Pathology, University of
Bonn, Bonn, Germany, 3 CNIO, Madrid, Spain and 4 Lab of Cell Regulation and
Carcinogenesis, NCI, Bethesda, MD
Currently, novel mouse models of melanoma are being generated which recapitulate the
histopathology and molecular pathogenesis observed in the human disease. Deregulated recep-
tor tyrosine kinase signaling and impaired cell cycle control are hallmarks of both familial and
sporadic melanoma. Here we investigated whether a germline mutation in the cyclin-depend-
ent kinase 4 (CDK4R24C) would synergize with overexpression of hepatocyte growth factor
(HGF) in melanomagenesis. C57BL/6 mice overexpressing HGF/SF in combination with wild-
type CDK4 or mutant CDK4 mutant CDK4 were treated with 0,2 mg DMBA at day 4 after birth
followed by twice weekly application of TPA from week 3 to 8. Carcinogen treatment signifi-
cantly promoted the development of melanomas in HGF/SF mice. The simultaneous expression
of mutant CDK4 had a dramatic effect on the number and the growth kinetics of melanocytic
neoplams. HGF/SF mice homozygous for mutant CDK4 had to be sacrificed with around 50
rapidly growing melanomas at the early age of about 12 weeks. HGF/SF mice with wildtype
CDK4 survived more than 30 weeks with an average of 10 slowly growing melanocytic neo-
plasms. Mutant CDK4 also promoted growth of metastatic melanoma in the lymph nodes and
the lungs of HGF/SF mice. Apart from very few skin papillomas, we did not observe tumors of
other histology in CDK4R24C x HGF/SF mice at the time of sacrifice. Our results show that
overexpression of HGF/SF and mutant CDK4 synergistically promote the rapid development of
wide-spread carcinogen-induced melanomas in the skin of C57BL/6 mice which spontaneously
metastasize in lymph nodes and lung. This new experimental mouse model can now be exploited
to further study the biology of melanoma and evaluate new treatment modalities.
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A melanoma prevention strategy based on using potent melanocortin 1 agonists to reduce
UV-induced DNA damage in melanocytes
ZA Abdel-Malek,1 A Kadekaro,1 RJ Kavanagh,1 L Koikov,2 A Todorovic,3 C Haskell-Luevano3
and JJ Knittel2 1 Dermatology, University of Cincinnati, Cincinnati, OH, 2 College of
Pharmacy, University of Cincinnati, Cincinnati, OH and 3 Department of Medicinal
Chemistry, University of Florida, Gainesville, FL
α-Melanocyte stimulating hormone (α-MSH) stimulates proliferation and eumelanin synthe-
sis in human melanocytes (hMC). Recently we reported that α-MSH enhances the repair of
DNA photoproducts, reduces the generation of hydrogen peroxide, and inhibits apoptosis of
UV-irradiated hMC. These effects that are mediated by the melanocortin 1 receptor (MC1R)
led us to propose the use of α-MSH fragment analogs that act as MC1R agonists in a melanoma
prevention strategy. We have tested the effects of 3 tetrapeptide analogs of α-MSH, Ac-His-D-
Phe-Arg-Trp-NH2 (1), n-pentadecanoyl- (2) and 4-phenylbutyryl-His-D-Phe-Arg-Trp-NH 2 (3).
We found that 1 was less potent than α-MSH in stimulating the activity of tyrosinase, hence
melanogenesis, with EC50 value ten fold higher than that of α-MSH. Analogs 2 and 3 had
comparable EC50 values that were –5 fold higher than that of α-MSH. Analogs 2 and 3 had
greater residual effects on tyrosinase activity, and were more potent than α-MSH in inhibiting
UV-induced apoptosis of hMC. These two analogs proved to be MC1R agonists, since their
effects on tyrosinase activity and survival of hMC were absent in hMC expressing loss-of-
function MC1R. Additionally, their effects on tyrosinase activity were abrogated by an analog
of agouti signaling protein, the physiological antagonist of α-MSH. Analogs 2 and 3, particu-
larly 3, mimicked α-MSH in inhibiting hydrogen peroxide generation and enhancing repair
of DNA photoproducts in UV-irradiated hMC. We propose that melanocortin analogs, such
as 3 that proved to have prolonged and reversible melanogenic effect, can potentially be devel-
oped into topical agents that can prevent melanoma by abrogating the deleterious effects of
UV exposure on hMC.
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Cortactin: defining its role in melanocytic tumor progression
H Wu, X Xu, S Dadke, C Spittle and S Lessin Pathology and Medical Oncology, Fox Chase
Cancer Center, Philadelphia, PA
Cortactin (CTN), a family of highly conserved actin-binding proteins known to be important in
remodeling cortical actin cytoskeleton, represents a potential novel biomarker in melanoma.
First, we analyzed the level and pattern of its expression in human nevi and melanomas. Immuno-
histochemical (IHC) staining using specific anti-CTN monoclonal antibody 4F11 on human
melanocytic lesions from tissue microarrays and individual sections showed negative or low-
level expression in most benign nevi (19/35 54% negative, 15/35 43% weakly positive, 1/35
3% positive). In contrast, CTN staining was positive in most metastatic (29/31 93.5% positive)
and deeply invasive melanomas (15/15 100%). Furthermore, the expression pattern differed in
nevi and melanomas. A significant number of metastatic melanomas showed strong cell bor-
der accentuation, or a distinct dot-like pattern, while the staining in nevi was even and diffuse
within the cytoplasm. Preliminary immunofluorescence studies indicate that this altered distri-
bution pattern may correlate with enrichment of CTN in the cell cortex seen in melanoma cell
lines. Since CTN is known to be a substrate for protein kinases in other cell types, we next stud-
ied its tyrosine phosphorylation in melanoma cell lines. Tests on one melanocyte cell line showed
lower overall protein tyrosine phosphorylation level in comparison to melanoma cell lines. In
melanoma cell line 451Lu, the level of CTN tyrosine phosphorylation was increased in response
to serum or insulin stimulation. Our preliminary data indicate that CTN is differentially expressed
across melanocytic tumor progression. We hypothesize that the alteration in the level and pat-
tern of CTN expression in malignant melanomas may contribute to abnormalities in the cytoskele-
ton structure, which may result in a change in the cell’s directionality, polarity and interaction
with its microenvironment. This phenotypic change may contribute to melanocytic transfor-
mation. Future studies will include IHC stains on a larger numbers of tumors, and functional
significance of CTN expression in melanoma cell lines.
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The potential role of Rap1 in ERK activation in human melanoma tissues
L Gao,1 G Bowers,1 J Gardner,1 M Council,1 G Linette,2 H Zhao3 and LA Cornelius1 1
Dermatology, Washington University School of Medicine, St. Louis, MO, 2
Medicine/Oncology, Washington University School of Medicine, St. Louis, MO and 3
Pathology, Washington University School of Medicine, St. Louis, MO
Melanoma is rising in incidence and there is a lack of effective treatments for advanced dis-
ease. Compelling evidence suggests that Ras associated protein-1 (Rap1) a Ras family mem-
ber of the small GTPases plays a role in tumorigenesis. We have previously reported that
Rap1 activation regulates melanoma cell proliferation and migration. Here, we demonstrate
Rap1 activation in cells isolated from human metastatic melanoma and also in cutaneous
metastatic melanoma tissue and that this increased Rap1 activation is coincident with increased
Rap1A expression. We also find increased ERK activity in all tumors examined. Interestingly,
two samples with detected Rap1 activation harbored neither BRAF nor N-Ras mutations, sug-
gesting a role for Rap1 in ERK activation in vivo. One sample with both Rap1 activation and
BRAF mutation had the highest levels of ERK activity, indicating a possible active feedback
loop involving Rap1/B-Raf/ERK activation. In vitro, we further demonstrate that Rap1 activa-
tion is regulated by melanoma growth factor HGF. Upon HGF stimulation, Rap1 activation
was evident as early as 5 min together with an increase in ERK phosphorylation. By real time
PCR, we show that Rap1A is the predominantly expressed Rap1 isoform in A375 and MeWo
melanoma cells. Introduction of a dominant negative Rap1 isoform (Rap1A-17N) into MeWo
cells (wild type BRAF and N-Ras) diminishes Rap1 and ERK activation following HGF stimu-
lation compared to controls, indicating that Rap1 activation is at least partially involved in
HGF induced ERK phosphorylation. Finally, we show BRAF is co-immunoprecipitated with
active Rap1, and further demonstrate by immunofluorescent and confocal microscopy mem-
brane translocation of Rap1 and BRAF upon Rap1 activation, supporting a possible BRAF/Rap1
module in melanoma cells. Taken together, our data suggests a potential role for Rap1 in
melanoma tumorigenesis and metastasis.
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Inhibitory effects of icariin on melanogenesis of human epidermal melanocytes
D Wang, W Zhu and H Ma Department of Dermatology, The First Affiliated Hospital of
Nanjing Medical University, Nanjing, Jiangsu Province, China
Chinese medicines have been used to treat hyperpigmentation disorders for centuries. Some
monomers extracted from Chinese medicines are effective ingridents of lightening agents.
We showed Icariin can inhibit the melanogenesis in Cloudman S91 melanoma cells in pre-
vious study. we evaluate the influence of Icariin on tyrosinase activity and melanogenesis in
human epidermal melanocytes in the report. Different concentrations of Icariin and hydro-
quinone were incubated with melanocytes, then activity of tyrosinase, melanin content and
rate of proliferation of melanocytes were measured respectively. Indirect immunofluorescence
staining was used to label tyrosinase (TYR), tyrosinase related protein 1 (TRP-1) and tyrosi-
nase related protein 2 (TRP-2) of the melanocytes. Laser scanning microscopy was employed
to carry out semi-quantitive analysis of expressions of TYR,TRP-1 and TRP-2. Our results
showed Icariin inhibited tyrosinase activity and melanogenesis in dose-dependent man-
ner(P∠0.01). However, the effect of Icariin was weaker than that of hydroquinone. Icariin
could stimulate the proliferation of melanocyte, however the hydroquinone showed an oppo-
site effect. There were no effect of Icariin on the expression of TYR and TRP-2, but increasing
expression of TRP-1. Thus we conclude the Icariin can inhibit melanogenesis of human epi-
dermal melanocytes through inhibiting tyrosinase activity.
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Cell surface integrins alter sites of metastases in melanoma
C Chia,1 K Yoshimura,1,2 L Laird,1 N Iizuka,1 J Park,1 D Pardoll1 and R Schulick1 1 Medical
Oncology- Immunology and Hematopoiesis Division, Johns Hopkins Sidney Kimmel Cancer
Center, Baltimore, MD and 2 Surgery, Yamaguchi University School of Medicine, Yamaguchi,
Japan
We developed a substrain of B16 murine melanoma cells (B16 KY8) with a high affinity to
metastasize to liver. We characterized differences between this substrain, a CD49b (integrin
alpha2) gene transferred strain (SKY), and the parental B16 F0 strain that has a high affinity to
metastasize to the lungs. A substrain B16 KY8 was derived from B16 F0 cells by repeated injec-
tion into the spleen of B6 mice and harvesting of cells from liver metastases for 8 cycles. The
strains were compared in terms of cell surface molecule expression, ability to attach to col-
lagen substrates, and ability to metastasize to the liver versus lungs. Integrin alpha2 in com-
bination with integrin beta1 binds to collagen type IV. B16 KY8 expresses integrin alpha2,
whereas B16 F0 does not. Both express integrin beta1. The liver expresses high amounts of
collagen type IV. B16 KY8 and SKY cells densely adhere to collagen IV coated plates, whereas
the B16 F0 cells do not. Hemispleen challenge of the B6 mice with SKY as well as with B16
KY8 showed significant increase in hepatic nodules compared to the B16 F0 strain. The B16
KY8 cells were sorted based on high and low expression of integrin alpha2. When B6 mice
were given tail vein challenges, 80 % of mice given B16 KY8 integrin alpha2-high cells had
liver metastases, 0% of mice given B16 KY8 integrin alpha2-low cells had liver metastases,
and 0% of mice given B16 F0 cells had liver metastases. Liver metastases from the B16 KY8
integrin alpha2-high cells could be prevented with antibody against the integrin which resulted
only in lung metastases. The expression of integrin alpha2 on the surface of B16 murine
melanoma cells enhances the formation of liver metastases in B6 mice. This can be reversed
by specific antibody blockade. The differential expression of surface integrins may affect the
site to which cells metastasize.
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Three-dimensional multicellular spheroids: new growth behavior of human melanocytes and
associated functional modification
S Lin,1,2 W Hsiao,2 T Young,2 H Yu 1 and S Jee1 1 Department of Dermatology, National
Taiwan University Hospital and College of Medicine, Taipei, Taiwan and 2 Institute of
Biomedical Engineering, National Taiwan University, Taipei, Taiwan
Human cells other than that of immune and hematopoietic systems usually have intimate inter-
cellular contact in a 3-dimensional organization in vivo. However, behavior of human cells
is usually investigated in monolayered condition in vitro. It has been shown that the viability,
function, proliferation and differentiation of cells are related to the cell morphology and inter-
cellular organization. Conventionally, melanocytes are maintained in monolayered culture
condition. In this work, we describe unique behavior of human melanocytes cultured on bio-
materials. Under appropriate seeding densities, melanocytes spontaneously grow into 3-dimen-
sional multicellular spheroids on chitosan, a polysaccharide derived from natural chitin. More
than 900 cells can be present in a single spheroid. The formation of melanocyte spheroid
requires intact cytoskeleton networks and is not dependent on serum-derived factors. By use
of time-lapse microscopy, we find that increased cell densities and active migration enable
frequent intercellular contact of melanocytes. Upon appropriate intercellular contact,
melanocytes cells translocate and aggregate into spheroids. This process can be inhibited by
disturbing surface adhesion molecules. Functionally, cells are still viable and express melanin
in the spheroid. Most strikingly, compared with monolayered melanocytes, cell sruvival in a
growth factor and serum deprived condition is much enhanced in melanocyte spheroids. Our
results show that melanocytes are morphologically transformable depending on the substra-
tum used and spheroidal melanocytes have a superior survival to that of monolayered den-
dritic melanocytes in stringent conditions. Preculturing melanocytes into spheroids can pro-
vide melanocytes a survival advantage. Melanocyte spheroid may increase the engraftment
rate of melanocyte transplantation for vitiligo treatment.
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Prognostic significance of nuclear factor kappaB p105/p50 in human melanoma and its role
in cell migration
K Gao,1 M Martinka2 and G Li1 1 Department of Dermatology, Jack Bell Research Center,
Vancouver, BC, Canada and 2 Department of Pathology, Vancouver Coastal Health Research
Institute, University of British Columbia, Vancouver, BC, Canada
Transcriptional factor NF-κB family has been demonstrated to play an important role in tumor
pathogenesis and serve as a potential target in cancer therapy. However, total inhibition of NF-
κB activity results in severe side effects such as immune suppression because its complex role
in normal cellular functions and homeostasis. Thus it is necessary to clarify the specific func-
tions of NF-κB members, which would provide the basis for the selective blockade of their
functions and reduction of therapeutic side effects. In this study we explored the role of NF-
κB p105/p50 in melanoma pathogenesis in vitro and in vivo. We found that the expression of
NF-κB p105/p50 was significantly increased in dysplastic nevi, primary melanoma and metasta-
tic melanoma compared to normal nevi (p<0.001, chi-square test). Furthermore, NF-κB
p105/p50 nuclear staining increased with melanoma progression. In addition, strong NF-κB
p105/p50 nuclear staining is inversely correlated with overall and disease-specific 5-year sur-
vival of patients with primary and metastastic melanoma (p<0.03 and p<0.026, respectively,
log-rank test). We further investigated the molecular basis underlying evaluated expression of
NF-κB p105/p50 in melanoma. Our data revealed that upregulation of NF-κB p50 enhanced
melanoma cell migration whereas siRNA knockdown inhibited cell migration. Interestingly,
increased activity of RhoA was correlated with overexpression of NF-κB p50 in melanoma
cells. Taken together, our data indicated NF-κB p105/p50 may be an important marker for
human melanoma progression and prognosis as well as a potentially selective therapeutic tar-
get.
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A new lipophilic provitamin C, tetra-isopalmitoyl ascorbic acid (VC-IP), prevents UV-induced
skin pigmentation through its anti-oxidative properties
H Masaki,1,2 Y Ochiai,1 S Kaburagi,1 K Obayashi,1 N Ujiie,1 S Hashimoto,1 Y Okano1 and
M Ichihashi3 1 Cosmos Technical Center Co., Ltd., Tokyo, Japan, 2 Nikko Chemicals Co.,
LTD., Tokyo, Japan and 3 Sun Clinic Sun-Care Research Institute, Osaka, Japan
Vitamin C, which is a strong anti-oxidant, plays an important role in maintaining physiologi-
cal states. In dermatology, vitamin C is used for treatment of various skin problems such as
acne vulgaris and for de-pigmentation of hyperpigmented spots. However, vitamin C has lim-
ited stability and permeability, and development of a vitamin C derivative with improved prop-
erties is needed. In this study, we evaluated the effect of a lipophilic vitamin C derivative, tetra-
isopalmitoyl ascorbic acid (VC-IP), on UV-induced skin pigmentation, to determine its potential
as a more effective form of vitamin C. The release of vitamin C from VC-IP was examined
using a reconstructed skin model following topical application of VC-IP for 48 h. VC-IP released
vitamin C in physiological conditions and worked as pro-vitamin C. In subsequent experi-
ments, we found that VC-IP suppressed the elevation of intracellular peroxide after UVB irra-
diation, and enhanced cellular tolerance against UVB and ROS such as H2O2 and t-BHP. Fur-
thermore, VC-IP reduced the production of IL-1α and PGE2 in UVB-irradiated keratinocytes
and suppressed melanocyte proliferation in conditioned culture medium prepared from UVB-
irradiated keratinocytes. Finally, in a clinical study, topical application of a 3 % VC-IP cream
for three weeks suppressed pigmentation after UVB irradiation. These results demonstrate that
VC-IP is a precursor of VC, and effectively suppresses UVB-induced skin pigmentation, pos-
sibly through its anti-oxidative activity.
www.jidonline.org   147
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Histon deacetylase inhibitor, depsipeptide (fk228) triggers mitf function leading to apopto-
sis via down-regulation of cell cycle regulatory proteins in human malignant melanoma
cells
K Futaki,1 Y Kobayashi,2 Y Furukawa,3 M Ohtsuki,2 H Nakagawa1 and G Imokawa1,4 1
Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan, 2
Department of Dermatology, Jichi Medical School, Tochigi, Japan, 3 Division of Stem Cell
Regulation, Jichi Medical School, Tochigi, Japan and 4 Skin Science Research Institute, Tokyo,
Japan
Histon deacylase (HDAC) inhibitors are expected to act as a novel anti-cancer agent for refrac-
tory cancers such as malignant melanoma, based upon the fact that their action mechanisms dif-
fer from conventional anti-cancer agents. We have already reported that FK228 suppressed Ras/MAP
kinase signaling pathway via up-regulated expression of Rap1 which was followed by the induc-
tion of apoptosis in human malignant melanoma cells (Oncogene in press, 2006). In this study,
we examined a signalling mechanisms involved in HDAC inhibitor, depsipeptide (FK228)-induced
growth inhibition in association with the expression of MITF/cell cycle regulatory proteins in 5
human malignant melanoma cell lines. An addition of FK228 at concentrations ranging from 2-
10 nM elicited an inhibition of DNA synthesis in all human malignant melanoma cell lines tested
in a dose-dependent manner which was accompanied by G1 arrest and whose effect was signif-
icantly remarkable compared with conventionally used anti-cancer agents. Upon the time course
analysis, the level of the protein expression of CDK2 was well correlated with suppressed expres-
sion of MITF protein, supporting an essential role of MITF as transcriptional factor for CDK2. On
the other hand, CDK2 inhibitor protein p21(Cip1) which was not constitutively expressed in non-
treated cells was markedly up-regulated at 12-24 hr after FK228 treatment concomitantly with
suppressed expression of MITF protein while Bcl2 protein expression remained almost unaffected.
These findings suggest the possibility that in addition to the up-regulation of Rap1, FK228 exerts
its anti-cancer effects via down-regulated function of MITF, which leads to an attenuated effect
on cell cycle regulatory proteins including CDK2/p21 lineage.
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RNAi-induced suppression of endogenous neurofibromin does not modulate the cell cycle
in cultured primary human epidermal melanocytes
J Boucneau, S De Schepper, M Van Gele, J Naeyaert and JL Lambert Dermatology, Ghent
University Hospital, Gent, Belgium
Neurofibromin, gene product of the NF1 tumor suppressor gene, has been assigned a role in
the regulation of cell proliferation as its central GTPase-activating protein (GAP)-related domain
(GRD) is able to inhibit p21Ras activation and hence activate downstream effectors. This results
in subsequent inhibition of cell proliferation, manifested through a halt in cell cycle progres-
sion. Via siRNA-mediated RNA interference over an 8 day period, we have investigated the
effects of suppression of endogenous neurofibromin on the cell cycle profile and proliferative
capacities of primary human epidermal melanocytes. We did not observe any changes in the
proportion of melanocytes reaching the S and/or G2/M phase of the cell cycle, nor did we
find any changes in cell proliferation in NF1 gene-silenced melanocytes. Furthermore, ERK
activation (p21Ras effector) did not increase upon neurofibromin suppression. Our data sug-
gest that neurofibromin does not have a major role in cell cycle regulation in human epider-
mal melanocytes.
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Dermal melanocytomas are predominant tumor type induced in UV-irradiated HGF/B6xC3H
mice
SR Florell,1 JThomas,4 G Merlino,2 F Noonan3 and D Grossman1,4 1 Dermatology,University of Utah,
Salt Lake City, UT, 2 National Cancer Institute, Bethesda, MD, 3 Dermatology, George Washington
Univ. Medical Center, Washington, DC, DC and 4 Huntsman Cancer Institute, Salt Lake City, UT
Albino (FVB) and C57BL/6 transgenic mice expressing hepatocyte growth factor (HGF) develop
predominantly radial growth phase melanoma following neonatal UV exposure (Nature 413:271
and F. Noonan, unpublished observation). In this study, we examined the histologic spectrum
of UV-induced melanocytic lesions in HGF mice on a C57Bl/6 x C3H/HeN background.
Mice were UV-irradiated (4,000 J/m2) 1-2 days after birth and then monitored for tumor devel-
opment. Animals were euthanized at experimental endpoints of 43 weeks or development of
a cutaneous tumor >1 cm, and all lesions >2 mm were excised for histologic examination.
Analysis of 53 lesions from 28 mice revealed three distinct histologic patterns: (1) dermal
melanocytosis, (2) spindle cell pigmented dermal melanoma, and (3) radial growth phase
melanoma. The great majority (50/53, 94%) of pigmented lesions demonstrated dermal col-
lections of epithelioid cells with voluminous, densely pigmented cytoplasm. Bleached sec-
tions showed immunoreactivity of the epithelioid cells with S100 and Melan-A, confirming
melanocytic origin. These lesions resembled equine (animal-type) melanomas or the pigmented
epithelioid melanocytomas more recently described in humans (Am J Surg Pathol 28:31). Of
the three remaining lesions, two were composed of a dermal population of cytologically malig-
nant and mitotically active pigmented spindled cells without an epidermal component, and
one lesion demonstrated features of invasive melanoma with a radial growth phase compo-
nent. Thus in contrast to HGF transgenic animals on the albino FVB or C57BL/6 background,
HGF animals on the C57Bl/6 x C3H/HeN background rarely developed classic radial growth
phase melanoma and largely developed dermal tumors resembling equine melanoma or
melanocytoma in humans. These results demonstrate the influence of genetic background on
histologic pattern of UV-induced melanomas in mice.
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High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in
melanoma
SD Doherty,1,3 S George,1,3 P Hazarika,1 VG Prieto2 and M Duvic1 1 Dermatology, MD
Anderson Cancer Center, Houston, TX, 2 Dermatopathology, MD Anderson Cancer Center,
Houston, TX and 3 Baylor College of Medicine, Houston, TX
Flotillin-2 (flot-2) is a 41.7 kDa highly conserved caveolae / lipid raft domain protein impli-
cated in signal transduction pathways. We have shown that flot-2 is high in metastatic melanoma
cell lines and that it can transform a non-metastatic, non-tumorigenic melanoma cell line (SB2).
Flot-2 staining intensity increases significantly across an array of benign to malignant
melanocytic lesions. To determine whether the expression of flot-2 protein is associated with
melanoma metastasis or survival in patients, we studied 17 primary melanomas and their cor-
responding positive sentinel lymph nodes. Specimens were stained with antibody to flot-2
(1:100), detected with tyramine-catalyzed amplification (DAKO), and counter-stained with
azure B. Melanomas were graded (0-3) for the percentage of cells that stained and for stain-
ing intensity by a blinded dermatopathologist. Flot-2 intensity did not differ between primary
lesions and the corresponding positive lymph node (p=0.06, McNemar Test), suggesting that
high flot-2 expression is an innate property of melanomas that do metastasize. Another set of
20 primary melanomas was evaluated for the correlation of flot-2 intensity with Breslow depth,
a well-defined, prognostic marker for survival. When flot-2 intensity in 11 primary melanomas
(Breslow < 1mm) was compared with 9 primaries (Breslow > 1 mm), the former were signif-
icantly lower in flot-2 intensity (p=0.03, Fisher’s Exact Test). These data demonstrate that high
flot-2 expression may be found in primary melanomas that metastasize to lymph nodes and
that flot-2 is correlated with Breslow level, a surrogate marker of survival.
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Sertraline exhibits anti-proliferative activity against B16 mouse and A375 human melanoma
cell lines in-vitro
K Reddy, B Lefkove and JL Arbiser Department of Dermatology, Emory University, Atlanta,
GA
Malignant melanoma is one of the most common malignancies worldwide. Furthermore, the
incidence of this disease has been rising. Few effective therapies for malignant melanoma exist
and the response rates to current therapies remain low, with significant toxicities often reported.
Melanocytes are derived from embryonic neural crest cells and therefore melanoma cells
may respond to neuropsychiatric drugs. Sertraline, a widely used member of the SSRI class of
antidepressants, has been shown to have a good safety profile since its approval more than a
decade ago by the FDA. In our study we found that sertraline exhibited potent, dose-depend-
ent anti-proliferative activity against B16 mouse and A375 human melanoma cell lines in-vitro.
Western blotting revealed that in-vitro treatment of A375 human melanoma cells with sertra-
line at a concentration of 10 uM induced several protein markers of ER stress, including GRP
78. ER stress markers were visualized at 0,1,2,4,8, and 24 hours of treatment and were noted
to increase with duration of treatment. Activation of caspases such as caspase-12, caspase-2,
and caspase-9 were also visualized by Western blot as well as increases in ER stress-associ-
ated proapoptotic markers such as CHOP/GADD 153 and cleaved caspase-12. Our data sug-
gests that sertraline should be further investigated as a therapeutic agent in the treatment of
malignant melanoma and that induction of ER stress may be a potential mechanism for the
anti-proliferative activity of sertraline in A375 and B16 melanoma cell lines.
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Dermoscopy-to-reflectance confocal microscopy correlation of melanocytic lesions
A Scope, C Benvenuto-Andrade, A Agero, A Halpern, S Gonzalez and A Marghoob
Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY
Reflectance confocal microscopy (RCM) allows for the in-vivo evaluation of skin lesions with
a resolution comparable to histology. RCM images melanocytic lesions en-face, enabling direct
comparison with subsurface structures seen on dermoscopy. The study aimed to describe the
RCM correlates of dermoscopic global pattern and specific structures. Eleven patients with 7
atypical nevi, 1 common nevus, 1 Spitz nevus and 2 melanomas, were analyzed in the study.
For each described dermoscopic feature, we evaluated by RCM at least 2 separate melanocytic
lesions. A digital camera connected to the RCM enabled direct analysis of the dermoscopic
structures. To ascertain precision of correlation, the orientation of the dermoscopic and RCM
mosaic images were compared. There was good correlation between the global dermoscopic
pattern and the findings on RCM-mosaic images at the dermal-epidermal junction level. For
atypical network on dermoscopy, RCM showed architectural disarray with interlacing cords
of basal cells creating an irregular mesh with variable brightness and with holes of variable
size and shape. Globules on dermoscopy corresponded with aggregates of bright cells on
RCM, with diameter equivalence between dermoscopy and RCM. For peripheral streaks on
dermoscopy, RCM showed dense aggregates of bright pleomorphic cells (melanocytes) with
ill-defined cellular borders that were continuous with the bright mesh that composed the cen-
tral part of the lesion. For bluish-white areas on dermoscopy, RCM demonstrated disruption
of the mesh-like architecture and the presence of dermal plump bright cells (melanophages),
as well as increased capillary blood flow visualized during realtime evaluation. In conclusion,
correlating dermoscopic structures with RCM features is possible and jointly, dermoscopy and
RCM may provide new insights into the in-vivo dynamics of melanocytic neoplasms.
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Functional analysis of keratinocytes in skin color using a human skin substitute model com-
posed of cells derived from different skin pigmentation types
Y Yoshida,1 A Hachiya,1 P Sriwiriyanont,2 A Ohuchi,1 T Kitahara,1 Y Takema,1 MO Visscher2
and RE Boissy3,2 1 Biological Science Laboratory, Kao Corporation, Tochigi, Japan, 2 The Skin
Sciences Institute, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH and
3 Dermatology, University of Cincinnati, Cincinnati, OH
Skin color is one of the most distinct features in human races, which has a wide-range of diver-
sity. To assess the mechanisms of skin color variations, human skin substitutes (HSS) were con-
structed by grafting mixtures of cultured skin cells into chambers inserted onto the back skin
of severe combined immunodeficient (SCID) mice. The human skin substitute demonstrated
melanocytes in the basal layer and normal distribution of epidermal differenciation markers.
When dark skin-derived melanocyte was combined with light/dark skin-derived keratinocytes,
HSS demonstrated significantly more melanin in the epidermis composed of dark as oppose
to light keratinocyte, whereas the number of melanocytes were similar in both types of HSS.
To analyze the mechanism of the differences in pigmentation, mRNA expressions were also
evaluated in HSS for six melanogenesis-related genes including Tyrosinase, dopachrome tau-
tomerase (DCT) and Tyrosinase-related protein1 (Tyrp1), and 3 cytokines, pro-opiomelanocortin
(POMC), endthelin-1 and stem cell factor (SCF), which have been known to be expressed in
keratinocyte and/or melanocyte after ultraviolet B irradiation and seniles lentigo. Expression
of mRNA for all melanogenesis-related genes as well as cytokines were higher in HSS com-
posed of dark keratinocyte. The ratio of singular melanosomes was higher in HSS composed
of dark keratinocyte (83.4%±8.1) compared to HSS composed of light keratinocyte (80.2%±8.2,
p<0.05), even though there was no difference in number of melanosomes between HSSs com-
posed of light and dark keratinocytes. These data suggested (1) the higher expression of the
melanogenic cytokines stimulate melanocytes, resulting in higher melanin production in
HSS composed of dark keratinocyte, and (2) the distribution pattern of melanosomes is ker-
atinocyte specific.
891
Expression of neuropeptide galanin in melanocytic lesions
Y Gilaberte,1 J Vera,2 C Coscojuela,1 C Parrado 3 and S Gonzalez4 1 Dermatology, Hospital
San Jorge, Huesca, Spain, 2 Pathology, Hospital San Jorge, Huesca, Spain, 3 Morphological
Sciences, Malaga Medical University, Malaga, Spain and 4 Dermatology, Memorial Sloan
Kettering Cancer Center, New York, NY
Galanin is a neuropeptide with wide-ranging effects, especially within the neuroendocrine
and the nervous system. Galanin and its receptors are expressed in human skin in a neuronal
and extra-neuronal position which suggests that this neuropeptide could exert multiple bio-
logical functions, including mitogenic and immunomodulatory effects on the skin. Galanin
was demonstrated to be expressed in neural-crest derived tumors. Several neuropeptides, espe-
cially α-MSH, appear to play a role in the genesis of melanoma. Since melanocytes are neu-
ral crest-derived cells, we investigated the expression of galanin in melanocyte skin tumours
by immunohistochemistry, correlating it with the α-MSH expression. We performed an obser-
vational descriptive retrospective study of immunohistochemical expression of galanin, α-
MSH and ki-67 in samples of melanomas diagnosed in the last 5 years in the San Jorge Gen-
eral Hospital (Huesca, Spain), and in a similar number of different types of melanocytic nevi.
A total of 110 pigmented lesions were studied: 35 primary cutaneous melanomas, 10 cuta-
neous metastasis and 65 melanocytic nevi. Immunostaining with galanin was significantly
higher in melanomas than in melanocytic nevus (p<0.001). Among melanomas, superficial
spreading melanoma was the histological subtype which showed the highest percentage of
positive cells for galanin (mean 39.69 [R=0-90]), as well as for α-MSH (mean 67.67% [R=0-
90]. A positive correlation of 0.765 was found between levels of immumostaining for both
neuro-peptides. Our study demonstrates, for the first time, the presence of galanin in cuta-
neous melanoma. More studies are needed to confirm our results and to understand the role
of this neuropeptide in melanocytic tumors and its relationship with α-MSH.
893
Pbx1 is a major target of PLZF-mediated melanoma cell growth suppression
K Shiraishi,1,2 Y Shirakata,1 K Yamasaki,1 Y Hanakawa,1 S Higashiyama2 and K Hashimoto1 1
Dermatology, Ehime University School of Medicine, Toon City, Ehime, Japan and 2 Molecular
and Cellular Biology, Division of Biochemistry and Molecular Genetics, Ehime University
School of Medicine, Toon City, Ehime, Japan
Promyelocytic leukemia zinc finger (PLZF) is a transcriptional repressor and tumor suppres-
sor. PLZF is expressed in melanocytes but not melanoma cells. We have already reported that
recovery of PLZF expression remarkably suppresses melanoma cell growth. Several target
genes regulated by PLZF have been reported, but the precise function of PLZF remains unclear.
In the current study, we searched for candidate target genes of PLZF by DNA microarray analy-
sis. Transfection of PLZF expressing adenovirus vector to melanoma cells prominently sup-
pressed Pbx1 that is highly expressed in melanoma cells. Pbx1 was found as pre-B cell leukemia
transcription factor and acts as a partner of Hox proteins. Interestingly, the growth suppres-
sion mediated by PLZF was reversed by enforced expression of Pbx1. Moreover, knockdown
of Pbx1 by specific small interfering RNAs suppressed melanoma cell growth. We also found
that Pbx1 binds to HoxB4 and HoxB7. Reverse transcription-polymerase chain reaction analy-
sis showed that repression of Pbx1 by PLZF reduces the expression of HoxB4 and HoxB7 and
their target genes, including tumor-associated neoangiogenesis factors such as basic fibrob-
last growth factor, angiopoietin-2, and matrix metalloprotease 9. These findings demonstrate
that deregulation of the expression of Pbx1 and its binding partner Hox due to loss of PLZF
expression contribute to the progression or pathogenesis of melanoma
892
Characterization of melatonin oncostatic effects and cytosolic and nuclear receptor expres-
sion in growth-stage defined human melanoma cell lines
MA Zmijewski,1 TW Fischer,1,3 B Zbytek,1 TW Sweatman,2 RM Slominski,1 J Wortsman3 and
S Andrzej1 1 Department of Pathology and Laboratory Medicine, University of
Tennessee,Health Science Center, Memphis, TN, 2 Department of Pharmacology, University
of Tennessee Health Science Center, Memphis, TN, 3 Department of Dermatology and
Allergology, Friedrich-Schiller-University, Jena, Germany and 4 Department of Internal
Medicine, Southern Illinois University, Springfield, IN
Melatonin has been shown to have oncostatic effects on malignant melanoma in vitro and in
vivo. We studied the effective concentrations of melatonin over a wide range of concentra-
tions in four melanoma cell lines representative for different growth stages. We also deter-
mined the expression of melatonin cytosolic and nuclear receptors. Four melanoma cell lines
representing vertical and radial growth, metastatic and late-stage differentiation were incu-
bated with melatonin 10-14 to 10-3 M. Proliferation was assessed at 12 hrs with [3H]-thymi-
dine incorporation and long-term survival (14 days) with a clonogenic assay. Expression of
cytosolic quinone oxidoreductases: NQO1 (has no affinity for melatonin), NQO2 (known as
putative MT3 receptor) and nuclear receptor RORα was determined by RT-PCR. Melatonin at
concentrations of 10-3 to 10-7 M strongly suppressed proliferation in SBCE2 (radial growth),
WM-164 (metastatic) and WM-98 (vertical growth) melanoma cell lines. In SKMEL-188 (late
stage differentiation), although suppression of proliferation was attenuated, the effect was still
observed at melatonin concentrations as low as 10-14 M. The results were confirmed in the
clonogenic assay showing reduced colony formation after melatonin treatment. NQO1 was
expressed in all cell lines; NQO2 and nuclear receptor RORα including its isoform RORα4
were present in SBCE2, WM-164 and WM-98, but not in SKMEL-188 cells. Thus, melatonin
differentially suppressed proliferation in melanoma cell lines of different growth pattern. The
intensity of the oncostatic response to melatonin could be related to the cell-line specific pat-
tern of melatonin cellular receptor and binding protein expression.
890
Laser capture microdissection and DNA sequencing analysis of melanoma biopsies from xero-
derma pigmentosum patients
Y Wang,1 JJ DiGiovanna,1,2 J Stern,3,4 TJ Hornyak,3 M Raffeld4 and KH Kraemer1 1 Basic
Research Laboratory, National Cancer Institute, Bethesda, MD, 2 Dermatology, Brown Med
School, Providence, RI, 3 Dermatology Br, National Cancer Institute, Bethesda, MD and 4
Pathology, National Cancer Institute, Bethesda, MD
Xeroderma pigmentosum (XP), a rare inherited disease, is characterized by sun-sensitivity
and a high frequency of skin cancers including multiple primary melanomas. Exposure to ultra-
violet radiation (UV) is a major causative factor in melanoma, although the relationship between
risk and exposure is complex. We are investigating the role of UV in the induction of melanomas
in XP patients. We recut archived blocks from melanoma biopsies of 4 XP patients studied at
NIH. MelanA staining was performed on thin sections for each tumor. Two hundred to 300
stained cells were excised from formalin-fixed, paraffin-embedded sections of melanoma biop-
sies using PixCell II laser capture microdissector. DNA from the microdissected XP melanomas
was extracted. We PCR-amplified and sequenced directly the coding exons of the tumor sup-
pressor genes PTEN, CDKN2A and P14ARF . We are determining whether C to T or tandem
CC to TT mutations that are characteristic of UV exposure are present. These mutations would
indicate a direct role of UV in melanoma induction. As proof of principle, using this technique
we have detected a UV type mutation in the PTEN gene in 1 of 4 melanomas from 4 XP
patients. Further analysis is in progress.
894
Inhibition of melanoma metastasis by 4-methylumbelliferone and its derivatives, specific
inhibitors of hyaluronan synthesis
A Kon, H Morohashi, N Ito, M Yamaguchi, K Kojima, I Kakizaki and K Takagaki Biochemistry,
Hirosaki University School of Medicine, Hirosaki, Aomori, Japan
Hyaluronan (HA), a non-sulfated glycosaminoglycan of high molecular mass, ubiquitously
presents in the extracellular matrix of various kinds of tissues. Many reports have shown that HA
participates in the phases of tumor metastasis. HA overproduction by malignant tumor cells
enhances their metastatic potential and leads to a worse clinical prognosis. We have previously
reported that 4-methylumbelliferone (MU) is an inhibitor of HA synthesis and may be an anti-
metastatic agent for malignant tumor treatment. In this study, we have investigated whether MU
and synthesized MU-derivatives inhibit the metastasis of melanoma cells with high metastatic
potential. The formation of cell surface HA by cultured B16-F10 melanoma cells, and release of
HA into the culture medium, are inhibited by MU. The adhesion and locomotion were also dose-
dependently inhibited by MU. Conversely, treatment with exogenous HA enhanced both adhe-
sion and locomotion. Similar inhibitory effects of MU-derivatives were observed, and interest-
ingly, MU-derivatives with two hydroxyl groups showed more potent inhibitory effects. Thus,
preventing the formation of cell surface HA reduced both the adhesion and locomotion of
melanoma cells, suggesting that MU and MU-derivatives may act as an inhibitor of tumor metas-
tasis. Finally, we demonstrated that oral administration of MU reduced both HA production in
the mice liver and the formation of metastatic nodules when melanoma cells are injected into
the lateral tail vein in vivo. Formation of metastatic nodules is also decreased by injection of
melanoma cells pre-treated with MU. Furthermore, 4-methylesculetin, a MU-derivative with two
hydroxyl groups which has the most potent inhibitory effect on HA synthesis, inhibited the liver
metastasis more potently than MU. Thus, reduction of both melanoma cell surface HA and host
liver HA inhibit metastasis. Therefore, MU and MU-derivatives with a hydroxyl group have poten-
tial as a novel therapeutic agent that inhibits the metastasis of melanoma cells.
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Diacylglycerol kinase α suppresses TNF-α-induced apoptosis of human melanoma cells through
activation of NF-κB
K Yanagisawa,1 K Jimbow,1 H Kanoh2 and F Sakane2 1 Department of Dermatology, Sapporo
Medical University School of Medicine, Sapporo, Japan and 2 Department of Biochemistry,
Sapporo Medical University School of Medicine, Sapporo, Japan
Diacylglycerol kinase (DGK) is thought to regulate many cellular processes through modu-
lating the balance between two signaling lipids, diacylglycerol and phosphatidic acid. Mam-
malian DGK exists as a large protein family consisting of ten isozymes. However, the physi-
ological functions of DGK isozymes in melanoma cells remain unclear. We found that DGKα
(type I isozyme) was expressed in several human melanoma cell lines but not in noncancer-
ous melanocytes. To study melanoma-specific functions of DGKα, this isozyme was down-
regulated or, conversely, overexpressed in AKI human melanoma cells. The overexpression of
wild-type (WT) DGKα considerably suppressed tumor necrosis factor (TNF)-α-induced apop-
tosis of AKI cells (TUNEL-positive cell: 6.7%), compared with the vector control (20.3%). How-
ever, a kinase-dead (KD) mutant failed to affect the extent of the apoptosis (18.2%). Moreover,
siRNA-mediated knockdown of DGKα markedly enhanced the apoptosis (10.2%) compared
with the control RNA (4.0%). In contrast, overexpression and knockdown of other type I
isozymes (DGKs β and γ) had no detectable effects on the apoptosis. These results indicate
that DGKα is uniquely involved in the suppression of AKI cell apoptosis induced by TNF-α.
The overexpression of DGKα-WT further enhanced the TNF-α-stimulated transcription activ-
ity of an anti-apoptotic factor, NF-κB (~2-fold increase), whereas DGKα-KD failed to affect
the activity. Conversely, DGKα-knockdown considerably inhibited the TNF-α-dependent NF-
κB activity (~30% inhibition). Moreover, an NF-κB inhibitor, MG-132, blunted the anti-apop-
totic effect of DGKα overexpression. These results collectively indicate that DGKα negatively
regulates TNF-α-induced apoptosis through NF-κB activation.
896
Rab7 interacts with the melanosomal matrix protein gp100/Pmel17/Silv and regulates its
maturation in MMAc human melanoma cells
A Kawakami,1 F Sakane,2 S Imai,2 H Kanoh,2 M Okura,1 K Hirosaki,1 T Yamashita1 and
K Jimbow1 1 Department of Dermatology, Sapporo Medical University School of Medicine,
Sapporo, Japan and 2 Department of Biochemistry (Section II), Sapporo Medical University
School of Medicine, Sapporo, Japan
Rab7 is a small GTPase that plays a crucial role in lysosomal/endosomal traffic in mammalian
cells. We have previously identified Rab7 as a melanosome-associated protein involved in
the intracellular transport of the melanocyte-specific protein, tyrosinase-related protein 1, from
the trans-Golgi network to melanosomes. In order to further identify a potential partner for
Rab7-binding, we performed a yeast two-hybrid screening using a cDNA library of the human
melanoma cell line MMAc. We found that wild-type Rab7 and its dominant-active mutant
(Rab7-Q67L), but not its dominant-negative mutants (Rab7-T22N and Rab7-N125I), bound
to the carboxyl-terminal one-third of melanosomal matrix protein, gp100/Pmel17/Silv (amino
acid 422-661). Although Rab9 also weakly interacted with gp100-422-661 in the two-hybrid
assay, other small GTPases examined (Rab2, Rab4, Rab8, Rab22 and Rac1) failed to show the
interaction. Rab7-Q67L and wild-type Rab7 were co-localized in the perinuclear region with
granules containing stage I-melanosomes where the full-length gp100 was present. On the
other hand, Rab7-T22N was diffusely distributed in the cytoplasm, showing no significant co-
localization with melanosomes. Next, using western blot analysis, we quantified proteolyti-
cally processed, mature gp100, which appeared in stage II- and later stage-melanosomes, in
MMAc cells transfected with Rab7 mutants for 48 h. Interestingly, we found that Rab7-Q67L
and, to a lesser extent, wild-type Rab7 increased the amount of the mature gp100. However,
Rab7-T22N did not show such effect. These results collectively suggest that Rab7 specifically
interacts with gp100, playing an important role in melanogenesis through the regulation of
gp100 maturation in melanoma cells.
897
Role of RKIP in endothelin-induced activation of MAPK cascade in normal human melanocytes
E Akasaka,1 K Sato,1 H Nakano,1 K Hanada1 and G Imokawa1,2 1 Dermatology, Hirosaki
University of Medecine, Hirosaki, Japan and 2 Skin Science Research Institute, Tokyo, Japan
It has been reported that Raf-1 kinase inhibitory protein (RKIP) plays a pivotal role in regulat-
ing MAP kinase cascade by down-regulating the MAPKKK activity of activated Raf-1, attrib-
utable to growth modulation in variety of cells. In malignant melanoma cells, there is a recip-
rocal relationship between growth rate and RKIP expression, accounting for their higher
proliferative properties. In non-melanocytic cells, the stimulation by TPA or EGF triggers RKIP
phosphorylation to elicit the activation of MAP kinase cascade due to dissociation between
RKIP and Raf-1. However, little is still known about intrinsic role of RKIP in modulating cell
growth signallings in normal human melanocytes. In this study, we used ET-1 stimulated MAP
kinase cascade to examine roles of RKIP in regulating melanocyte proliferation. Western blot-
ting revealed that while RKIP protein expression occurred in non-stimulated human
melanocytes, the stimulation with ET-1(10nM) did not elicit any changes in the level of RKIP
protein. Although ET-1 stimulation induced a rapid phosphorylation of MEK and subsequently
ERK1/2, indicative for the activation of MAP kinase cascade, analysis using immuno-precipi-
tation combined with western blotting demonstrated that while in non-stimulated human
melanocytes, there is not a detectable level of protein complex consisting of RKIP and Raf-1,
the stimulation with ET-1 accompanying MAP kinase activation did not form the protein com-
plex. These findings suggest the possibility that the inhibitory interaction between RKIP and
Raf-1 is not attributable to signalling mechanisms underlying the activation of MAP kinase cas-
cade by ET-1 stimulation in normal human melanocytes.
898
Endothelin-1 signaling triggers dual stimulatory actions of phosphorylation and production
of MITF in human melanocytes leading to its potent melanogenic effects
K Sato,1 E Akasaka,1 H Nakano,1 K Hanada1 and G Imokawa1,2 1 Dermatology, Hirosaki
University School of Medicine, Hirosaki, Japan and 2 Skin Science Research Institute, Tokyo,
Japan
Recently, new roles of MITF in melanocytes have been proposed to serve as regulatory fac-
tors for apoptotic inhibitor, Bcl-2 and cyclin-dependent kinase (CDK)2 or its inhibitory pro-
tein p21(Cip1) in addition to tyrosinase transcription. Since these proposals are mainly based
upon analysis using mouse melanocytes or melanoma cells, little is still known about intrin-
sic roles of MITF-M in human melanocytes. In this study, we used endothelin-1 stimulated
intracellular signallings to examine intrinsic roles of MITF-M in human melanocytes by RT-
PCR and western blotting analysis. An addition of ET-1 (10 nM) to cultured human melanocytes
elicited a marked phosphorylation of MITF with a peak at 5-20 min post-incubation which
was accompanied by preceding phosphorylation of ERK1/2. The MITF phosphorylation was
completely abolished by MEK inhibitor PD98059 or PKC inhibitor Calphostine C but not by
PKA inhibitor H89 or p38 MAP kinase inhibitor SB 203580. The expression of MITF-M mRNA
transcripts was markedly augmented at 40-120 min post-incubation which was followed by
an increased expression of MITF-M protein with a peak at 2-3 h post-incubation. The increased
production of MITF protein was significantly down-regulated by the PKA inhibitor, indicating
the stimulation via cAMP pathway. These findings suggest that the marked stimulatory effect
of ET-1 on both proliferation and differentiation is mediated through its dual stimulatory actions
on MITF phosphorylation as well as its production.
899
New role of the endoplasmic reticulum in the control of melanocyte transformation
G Abou-Rjaily,1 C Denoyelle,1 RJ Kaufman2 and MS Soengas1 1 Dermatology, University of
Michigan, Ann Arbor, MI and 2 Biological Chemistry, University of Michigan, Ann Arbor, MI
Melanoma is the 5th most frequent cancer in males, and the 6th in females. However, the inci-
dence of melanoma could be much higher. Thus, nearly all individuals of fair skin bear mul-
tiple benign melanocytic neoplasms (nevi), which in the vast majority of cases express pro-
tumorigenic mutations in the MAPK pathway, usually in BRAF or NRAS genes. How nevus
cells become mitotically inactive and whether oncogenic BRAF and RAS proteins are blocked
by similar mechanisms is unclear. In fact, why HRAS, which can be up to 60-fold more potent
than BRAF, is rarely mutated in nevi is unknown. To address these questions, we performed a
combined genetic and biochemical characterization of the impact of tumor-associated vari-
ants of BRAF, NRAS and HRAS on normal human melanocytes. The BRAF mutation V600E
(BRAFV600E) was well-tolerated, and melanocytes accumulated for nearly two weeks until they
became senescent. This slow effect of BRAFV600E allowed for melanocyte transformation in the
presence of additional oncogenes. In contrast, NRASQ61R and in particular, HRASG12V, engaged
a fast cell cycle arrest mechanistically different to the response to BRAFV600E. Electron and opti-
cal microscopy, showed that HRASG12V, and to a lesser extent, NRASQ61R (but not BRAFV600E)
induced a massive cellular vacuolization and expansion of the endoplasmic reticulum (ER).
Using RNA interference, we demonstrated that the blockage of RAS-mediated transformation
was driven by the Unfolded Protein Response (UPR), a stress-program selectively induced at
the ER. Importantly, RAS-driven UPR occurred even in the absence of classical tumor sup-
pressors such as p16INK4a or p53. In summary, these results provide a mechanistic explanation
for the mutational preference for BRAFV600E in melanocytes. Moreover, our data reveal an
entirely new function of the endoplasmic reticulum as a rheostat of oncogene-driven stress
and a novel fail-safe mechanism in the control of melanocyte transformation.
900
What is FDA doing about indoor tanning?
JZ Beer, W Cyr, SG Coelho, BZ Zmudzka and SA Miller Food and Drug Administration,
Rockville, MD
In 1994, the American Medical Association (AMA), with the support of the American Acad-
emy of Dermatology (AAD), requested that the FDA ban the sale and use of sunlamps for cos-
metic purposes (because of their association with increasing melanoma incidence.) FDA con-
cluded that a ban was not warranted because (1) unregulated sunlamps may result in more
damage to the skin and eyes, and (2) the evidence linking sunlamp use to melanoma was sug-
gestive, but not conclusive. Recently, the AMA and AAD urged the FDA to ban the use of sun-
lamps for persons <18 years of age. However, FDA has jurisdiction primarily over manufac-
turing of sunlamps. Nevertheless, FDA supports state or local governments in their efforts to
regulate sunlamps use. In addition, FDA monitors research reports suggesting beneficial effects
of UV exposure that may be associated with enhanced production of vitamin D. Some gov-
ernments and the World Health Organization recommend that humans take supplemental
vitamin D or seek regular small UV exposures. All of these developments impact on our efforts
to modernize FDA regulations and recommendations in this area. FDA takes an active part in
the revisions of the International Electotechnical Committee standard for sunlamps and is con-
sidering adopting portions of this standard for use in the U.S. To reduce the risks taken by delib-
erate tanners, we conduct a clinical study to determine if the doses currently used for tanning
can be reduced. The results of our study show that indeed a comparable visual tan can be
produced with 3-4-fold smaller cumulative UV doses than currently indicated in our guidance
(by increasing intervals between exposures). A reduction in the UV burden to deliberate tan-
ners should result in a reduction of the deleterious effects of UV exposure, such as skin can-
cer and photoaging (at least in those for whom exposure to sunlamps contributes significantly
to overall UV exposure).
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Bortezomib triggers two distinct modes of death in melanoma cells
J Qin, H Xin, L Stennett and BJ Nickoloff Pathology, Loyola University Chicago, Maywood,
IL
The ubiquitin-proteasome pathway is an important target for cancer therapy, but many mech-
anistic details remain to be defined for killing tumor cells. Using a panel of human melanoma
cell lines, two distinct modes of death following proteasome inhibitor (Bortezomib) exposure
were observed. One Bortezomib (1µM) mediated response was characterized by apoptosis
as assessed by both annexin V and hypodiploid (sub G0 DNA content) populations by FACS
at 24 hrs with minimal cell cycle changes. By contrast, the second Bortezomib response was
characterized by growth arrest at both S and G2/M cell cycle stages beginning 3 hrs and
peaking at 14 hrs. Overt cell death in the second response required a longer time interval
than the first response, and was preceded by mitotic catastrophe. Characteristics of mitotic
catastrophe included a round and enlarged cell morphology, presence of micronuclei, increased
phosphorylated histone H3 staining, and abnormal spindle formation 24 hrs post treatment.
To define molecular mechanisms underlying different modes of death, a role for critical cell
cycle proteins controlled by the proteasome pathway were studied. During Bortezomib induced
apoptosis in the first response, cyclin B1 level showed a rapid increase (3-6 hrs) accompa-
nied by a similar patten of histone H1 associated Cdk1 kinase activity. By contrast, during
Bortezomib induced death via mitotic catastrophe, cyclin B1 levels increased more gradually
beginning at 3 hrs up to 48 hrs, concurrent with sustained Cdk1 kinase activity. Treatment
with roscovitine (10 µM), a chemical inhibitor of Cdk1, significantly blocked the S and G2/M
phase growth arrest triggered by Bortezomib in cells undergoing mitotic catastrophe. Roscov-
itine also enhanced viability (assessed by MTT) in cells undergoing mitotic catastrophe, but
reduced viability in cells undergoing apoptosis by Bortezomib. These results demonstrate pro-
teasome inhibition triggers cell death directly through apoptosis or by mitotic catastrophe,
and differential regulation of cyclin B1/Cdk1 activity governs the two distinct modes of cell
death in melanoma.
903
Genetics of dark skin: keratinocyte gene action
KA McGowan,1 H Fuchs,2 M Hrabe de Angelis2 and G Barsh1 1 Department of Genetics,
Stanford University, Stanford, CA and 2 Institute of Experimental Genetics, GSF, Neuherberg,
Germany
Pigment cell behavior in the skin represents the integration of cell-cell interactions and cell-
autonomous developmental programs. Among 12 new mouse mutations recognized by dom-
inant inheritance of dark skin (Dsk1-Dsk12), we identified two mutants, Dsk3 and Dsk4, in
which an increased number of epidermal melanocytes gives rise to dark feet, ears and tail.
Genetic and molecular studies indicate that Dsk3 and Dsk4 are caused by loss-of-function
mutations in two components of the small ribosomal subunit, Rps19 and Rps20, respectively.
A series of developmental and experimental genetic studies demonstrate that accumulation
of epidermal melanocytes in Dsk3 and Dsk4 mutant mice is caused by defects in keratinocyte
rather than melanocyte gene action. Together with other Dsk mutants, this work provides
new insight into the signals that integrate melanocyte and keratinocyte behavior to yield pig-
mentary phenotypes.
905
B-RAF V 600E gene mutation detection in DNA isolated from serum and plasma
FA Sanchez ,1 K Cradic,4,5 S Grebe,4,5 R McWilliams2,3 and M Pittelkow1 1 Dermatology,
Mayo Clinic, Rochester, MN, 2 Hematology and Oncology, Mayo Clinic, Rochester, MN, 3
Medicine, Mayo Clinic, Rochester, MN, 4 Laboratory Medicine, Mayo Clinic, Rochester, MN
and 5 Pathology, Mayo Clinic, Rochester, MN
Detection of metastatic malignant melanoma by sensitive molecular techniques provides
potentially useful diagnostic and prognostic information. Mutations of the BRAF gene have
been identified in melanoma, a mutation located at the V600 region. Current thought suggests
that cancer cells may circulate in peripheral blood for some period prior to metastatic growth.
Since cells that have been shed from solid tumors are not well adapted to the unique rigors
of the cardiovascular system they may be lysed, leaving the tumorgenic DNA to circulate in
the blood. It is hypothesized that DNA might be extracted from plasma that is enriched for
cancer mutations and thus be used as a tumor marker for early recurrence of metastatic dis-
ease. We adapted a real-time PCR assay for detection of the V600E mutation in B-RAF to use
DNA isolated from plasma and serum. Specimens are processed using a modified Purgene®
liquid-liquid extraction protocol. Extracted DNA is universally amplified with a standard Gen-
tra™ kit. Amplification products are used as template material for a real-time reaction that is
based on allele-specific amplification of mutant and normal genes. Using this customized pro-
tocol, we can reliably and consistently detect normal copies (wild-type) of the B-RAF gene in
serum or plasma. To date, our results using serum and plasma spiked with known amounts of
wild-type and mutant DNA show that we can detect the V600E mutation to at least a level of
1 copy in 10,000. These results provide a sensitive and specific framework for the detection
of BRAF mutation load in melanoma patient’s blood. Current work includes testing plasma
from late stage melanoma patients in an effort to validate the use of this assay as a marker for
metastatic disease. Testing in other pigmented lesions such as dysplastic nevi and spitz nevi
are also being examined.
904
Developing protective anti-melanoma immunity with whole recombinant yeast expressing
MART-1
M Fujita, H Riemann, J Takao, Y Shellman and DA Norris Department of Dermatology,
University of Colorado Health Sciences Center, Aurora, CO
Yeast work as an efficient vehicle of antigen loading and immunostimulation. Yeast are avidly
phagocytized by dendritic cells (DCs), thereby delivering tumor antigens directly and effi-
ciently to DCs. Cell wall components of yeast, α-mannan and β-glucan, possess adjuvant
potential to activate innate immunity and induce DC maturation and activation. In this study,
we engineered Saccharomyces cerevisiae to carry full-length human MART-1
(melanocyte/melanoma antigen recognized by T cells-1), and used this vaccine (“hMART-IT”)
as immunotherapy in the B16F10 murine melanoma model. Immunization of C57BL/6 mice
with hMART-IT provided significant protection against development of lethal melanoma in
vivo, and induced antigen-specific cytotoxic T cells in vitro. Although both CD8+ and CD4+
T cells were required for the induction of cytotoxicity, CD8+ T cells represented a major sub-
set of effectors. Immunization of mice with hMART-IT induced CD4+ T cell-dependent GM-
CSF and IFNγ production from splenocytes after in vitro re-stimulation.  Interestingly, tumors
that escaped from hMART-IT showed tumor-infiltrating CD3+ lymphocytes and downregula-
tion of MART-1 expression, suggesting immunoevasion mechanism by B16F10 melanoma
cells. These data demonstrate that whole recombinant yeast can deliver non-mutated self
antigens to break tolerance in vivo and induce potent CD4+ and CD8+ T cell-mediated immune
responses when administered subcutaneously as a tumor vaccine against non-mutated self
tumor antigens.
902
The heat shock protein H11 is silenced by aberrant DNA methylation in melanoma but not
in benign melanocytic lesions providing a target for chemogene therapy
BK Sharma,1 CC Smith,1 D Rucker,2 JW Burnett2 and L Aurelian1 1 Pharmacology and
Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, MD and
2 Dermatology, University of Maryland School of Medicine, Baltimore, MD
We have previously shown that forced expression of the small heat shock protein H11 by treat-
ment of melanoma cell lines with the de-methylating agent Aza-C triggers apoptosis in
melanoma cells, but not in normal melanocytes. Melanoma cells are intrinsically resistant to
chemotherapy as well as apoptosis. Therefore, these findings suggest that H11 may be a
promising target for chemogene therapy, defined as the use of pharmacologic agents to impede
or arrest tumor development through the upregulation or activation of appropriate target genes.
The present studies were designed to examine whether H11 is also silenced in melanoma tis-
sues. RT-PCR and immunohistochemisty with H11 antibody indicated that H11 is expressed
in 85.7% of benign nevi, but only 40% of atypical nevi and 44% of melanoma tissues. Two
fluorescent color staining with H11 and S100 antibodies indicated that H11 was also expressed
in normal melanocytes, where it localized in the cytoplasm from 75-90% of the cells together
with S100. H11 DNA was methylated in melanoma and atypical nevi (60-70% of the tissues)
but not in the benign nevi or normal tissues, as determined by methylation specific PCR (MS-
PCR). Collectively, the data indicate that H11 is silenced by aberrant DNA methylation in a
relatively high proportion of melanoma tissues, but not benign nevi. Methylation appears to
be an early event in tumor development, as it was seen in a similar proportion of atypical
nevi. The data suggest that H11 is a promising target for chemogene therapy of melanoma.
906
Regulation of melanoma cell adhesion molecule by endothelin-1 in human melanocytes
S Jamal and BS Williams Dermatology, NYU School of Medicine, New York, NY
Melanoma cell adhesion molecule (MCAM) is upregulated during melanoma progression
and its expression correlates with melanoma invasion and metastasis. Little is known about
the factors that regulate MCAM expression in vivo. To date, endothelin-1 and endothelin-3 (ET-
1, ET-3) are the only known factors capable of upregulating MCAM in melanocytic cells. In
this study, we investigate the mechanisms by which ET-3 upregulates MCAM in melanocytes.
Previous characterization of the MCAM promoter has identified the presence of cAMP response
element binding protein (CREB) sites, the mutation of which impair MCAM promoter activity.
This suggests that CREB plays a role in MCAM regulation. Other studies have demonstrated
that ET-3 stimulation of melanocytes activates CREB. To investigate whether CREB is required
for upregulation of MCAM by ET-3, we suppressed CREB expression through the use of siRNA
technology. siRNA directed against CREB was transfected into primary human melanocytes.
This resulted in a marked suppression of CREB protein levels relative to that seen in melanocytes
transfected with control siRNA. However, ET-3 stimulation of cells transfected with CREB siRNA
resulted in a robust upregulation of MCAM protein and RNA. Our results therefore demon-
strate that silencing of CREB expression does not significantly block the ability of ET-3 to upreg-
ulate MCAM mRNA and protein in human primary melanocytes. These results suggest that
CREB is not required for upregulation of MCAM by ET-3. Studies using small molecule inhibitors
are currently underway to identify alternate signaling cascades responsible for the regulation
of MCAM by ET-3.
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Whole recombinant yeast expressing hMART-1 induces protective immunity against melanoma
tumors arising spontaneously in genetically-engineered mice
A Tanaka, H Riemann, K Okamura, Y Shellman, DA Norris and M Fujita Department of
Dermatology, University of Colorado Health Sciences Center, Aurora, CO
We have previously shown that administration of whole recombinant yeast expressing human
MART-1 (hMART-IT) induces protective anti-melanoma immunity in B16F10 transplantable
mouse model. While transplantable models are good animal models for in vivo studies, they
do not always represent human cancers. Genetically-engineered mouse models are better pre-
clinical models than transplantable tumor models since tumors arise from the original tissue,
evolve in the natural tumor environment, follow step-wise progression and sometimes carry
the same gene alteration as human tumors. In the present study, we evaluated the efficacy of
hMART-IT using genetically engineered mice, which were originally established by L Chin.
Cross-breeding of the transgenic (TG) mouse overexpressing melanocyte-specific H-rasG12V
and the Ink4a/Arf knockout (KO) mouse generates “TG/KO mouse” that develops spontaneous
multiple melanomas with high penetrance (91%) at around 3-4 months of age. Cutaneous
melanoma expressed melanocyte differentiation antigens including tyrosinase, TRP-1, TRP-2,
MART-1 and gp 100. Subcutaneous administration of hMART-IT into mice induced IL-2 and
TNF-α production, proliferation of CD4+ T cells, cytotoxicity in vitro and significantly pro-
longed the survival of TG/KO mice compared with naïve mice and mice treated with yeast
transfected with empty vector. Our data demonstrate that vaccination with whole recombi-
nant yeast breaks tolerance against the MART-1 protein and inhibits spontaneous melanoma
tumor development in a genetically-engineered melanoma model.
908
Genomic analysis of malignant melanoma by integration of high resolution array Compara-
tive Genomic Hybridization (aCGH) and gene expression profiling
A Sekulic,1 K Brown,2 C Gooden,2 K Hamacher,1 S Markovic,3 M Bittner,2 M Pittelkow1 and
J Trent2 1 Dermatology, Mayo Clinic, Rochester, MN, 2 Translational Genomics Research
Institute, Phoenix, AZ, 3 Oncology, Mayo Clinic, Rochester, MN and 4 Surgery, Mayo Clinic,
Scottsdale, AZ
Molecular aberrations in melanoma remain poorly characterized. Changes in DNA copy num-
ber and gene expression lead to altered cellular behavior and tumor progression. Recognition
of such changes in melanoma would significantly impact our ability to diagnose, classify and
predict the disease course as well as facilitate the development of tailored therapeutic
approaches. Here we present an integrative approach for comprehensive analysis of malig-
nant melanoma using genomic and transcriptional level profiling which utilizes a novel aCGH
platform coupled with expression profiling analysis. The aCGH used in this study utilizes
44,000 60-mer olignucleotides specifically designed to have sensitivity to detect single-copy
number changes at single exon resolution. This approach allows identification of previously
undetectable small intra-genic deletions, gene duplications and unbalanced translocation lead-
ing to identification of novel recurrent abnormalities. In our hands, analysis of frozen melanoma
tissues using this approach identified small homozygous changes in loci of known tumor sup-
pressor genes (e.g. p16 deletion), as well as changes in novel loci not previously recognized
(e.g. BMI1 amplification). In addition, expression-profiling analysis was performed using the
RNA extracted from the same set of frozen blocks. Expression profiling data was integrated
against the aCGH and patterns of expression changes for the most common gene copy num-
ber changes were mapped. The combined analysis of two platforms allows identification of
compound abnormalities affecting functionally important genes and their products at differ-
ent levels and detects the dynamics of gene expression as functional consequence of indi-
vidual gene copy number changes. These molecular signatures can be used for disease clas-
sification and development of novel, class-specific therapeutic approaches.
909
Oligonucleotides homologous to the telomere 3’ overhang induce chromatin remodeling and
decrease hTERT expression in melanoma
F Kuo, G Li, MS Eller, M Yaar and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Treatment with DNA oligonucleotides homologous to the telomere 3’ overhang (T-oligos)
results in melanoma cell apoptosis or growth arrest and differentiation in vitro and in vivo
through upregulation or activation of ATM, p53 and other signaling molecules. Because his-
tone deacetylators can have potent anti-cancer effects, we asked if T-oligos also affect histone
acetylation. Human melanoma lines derived from primary (A375, SKMEL-28) and metastatic
(MMAN, MMRU) melanomas were treated with T-oligos or diluent (control) and processed
for western blotting. In all lines, within 24-48 hours acetylation of histone H2A and H4 on
lysines 5 and 8, respectively, was decreased to hardly detectable levels in T-oligo treated cul-
tures. To a variable degree among the 4 lines, T-oligo also decreased the level of p300 and the
acetylation (activation) status of CBP/p300, c-Myc acetylators and transcriptional co-factors.
In MMAN cells the level of histone deacetylase 1 was induced by >350% within 24 hours.
Consistent with the hypothesis that T-oligos act by mimicking exposure of the 3’ overhang at
the time of telomere loop disruption, sequestration of the TRF2 binding factor that normally
holds the telomere loop intact also decreased H2A and H4 acetylation. hTERT, the catalytic
subunit of telomerase that is over-expressed in cancer cells, rendering them immortal, is pos-
itively regulated epigenetically by histone hyperacetylation or transcriptionally through c-Myc
that recruits p300 to the hTERT promoter. Within 48 hours, c-Myc protein was undetectable
in T-oligo treated MMAN cells. To examine T-oligo effect on hTERT expression, cDNA of MMAN
cells treated with T-oligo or diluent alone was amplified with hTERT specific primers. Within
72 hours, hTERT was substantially reduced only in T-oligo treated cultures. These data suggest
that T-oligos, as well as telomere loop disruption, exert their anti-cancer effects in part via his-
tone deacetylation. Downregulation of telomerase (hTERT) may be among the resulting ther-
apeutic changes in gene expression.
910
No discernible pattern of mitochondrial (mt) DNA deletions in basal and squamous cell car-
cinoma samples isolated by laser capture microdissection
Y Kamenisch,1 J Wenz,1 G Metzler,1 J Bauer,1 H Neubauer,2 C Garbe,1 M Rocken1 and
M Berneburg1 1 Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
and 2 Department of Gynecology, Eberhard Karls University, Tuebingen, Germany
Mutations of mitochondrial DNA have been shown to be increased in a number of tumors
including breast cancer, prostate cancer, colon carcinoma, as well as head and neck cancer.
We have previously shown that mtDNA mutations are increased in chronically ultraviolet radi-
ation (UV)-exposed skin. Therefore, we employed an established real time PCR technique to
investigate whether mtDNA deletions are increased in histological samples from patients
with basal (BCC) and squamous cell carcinoma (SCC) as compared to adjacent non-tumor
but chronically UV-exposed skin of the same individual. Tumor and non-tumor samples were
confirmed by an independent pathologist, hematoxylin eosin stained and then laser capture
microdissected with a PixCell® IIe Laser Capture Microdissection (LCM2105) System device
to avoid non-tumor contamination. Subsequently, DNA extraction and real time PCR for the
4977bp common deletion, considered to be a marker for mtDNA deletions, was carried out
in 24 BCC and 22 SCC. Of these samples 19 showed a decrease, 5 an increase for BCC as
well as 18 with a decrease and 4 with an increase for SCC with maximum and minimum 2-
delta delta ct values. These values ranged from 0.013 to 7.396 for BCC and from 0.006 to
6.964 for SCC, respectively, where values below one indicate a decrease and values above
one an increase compared to control samples. Furthermore there was no influence of age and
gender of the investigated patients. Thus, these findings indicate that there is no discernible
pattern of large mtDNA deletions in basal and squamous cell carcinoma.
911
In vitro and in vivo evidence for senescence-associated mutations of mitochondrial (mt) DNA
as an early event in transformation from nevi to malignant melanoma
W Schuller,1 Y Kamenisch,1 J Wenz,1 G Metzler,1 J Bauer,1 H Neubauer,2 C Garbe,1
M Rocken1 and M Berneburg1 1 Department of Dermatology, Eberhard Karls University,
Tuebingen, Germany and 2 Department of Gynecology, Eberhard Karls University,
Tuebingen, Germany
It has recently been reported that senescence-associated growth control represents an important
protection from tumors including malignant melanoma. We and others have previously shown
that aging-associated mutations of mtDNA can be induced by ultraviolet (UV)-A-radiation in vitro
and in vivo and that these mutations persist or even increase in resting cells while they disap-
pear in proliferating cells. However, the question whether UV-A-induced mtDNA mutations play
a role in the pathogenesis of malignant melanoma has not been addressed. In the present study,
we could show in vitro by real time PCR that melanoma cells are highly susceptible to induc-
tion of functionally relevant mtDNA mutations by repetitive UV-A-irradiation with a decrease of
mitochondrial oxygen consumption and mitochondrial membrane potential. Expression of senes-
cence marker beta-galactosidase was increased in oxidatively stressed cells, indicating an asso-
ciation of mtDNA mutations with senescence. In vivo in laser capture microdissected samples
from normal human nevi we detected background levels of mtDNA mutations. However, in sam-
ples from nevi showing clinical and histological signs of dysplasia, these mutations were increased
2.5 fold. Interestingly, in malignant melanoma, initially high mutation levels later decreased from
small to large tumor thickness (range 0.25 to 25.0 mm). In addition to known mutations, an unre-
ported mtDNA deletion of 4866bp in length was detected (real time PCR, sequence analysis) in
tumor samples and UV-A-irradiated melanoma cells. These results indicate high susceptibility
of melanoma cells to the induction of functionally relevant UV-A-mediated mtDNA mutations
and this loss of senescence associated growth-control may represent an early event in the malig-
nant transformation from inert nevi to proliferative and invasive malignant melanoma.
912
Interaction of BRAF and BRAFV600E with HSP90 in melanoma cells and inhibition of RAF-
dependent signaling by the geldanamycin analog 17-AAG
S Jiang,1 SA Kahn,1 JB Trepel,2 LM Neckers3 and TJ Hornyak1 1 Dermatology Branch, CCR,
NCI, NIH, Bethesda, MD, 2 Medical Oncology Branch, CCR, NCI, NIH, Bethesda, MD and
3 Urologic Oncology Branch, CCR, NCI, NIH, Bethesda, MD
The geldanamycin analog 17-allylamino-17-demethoxy geldanamycin (17-AAG) is an inhibitor
of the molecular chaperone HSP90. 17-AAG has previously been reported to destabilize inter-
actions between HSP90 and known client proteins such as c-Raf-1, c-ErbB2, and v-Src, resulting
in client protein inactivation and degradation. We asked whether 17-AAG-dependent inhibition
of HSP90 could also induce inactivation and degradation of both BRAF and BRAFV600E in human
melanoma cells. Mass spectrometry analysis of a BRAF immunoprecipitate and co-immunopre-
cipitation studies revealed that BRAF binds to HSP90 in 3 BRAFwild-type and 4 BRAFV600E human
melanoma cell lines examined. 17-AAG (up to 1 µM) resulted in loss of BRAF or BRAFV600E in 2/6
melanoma cell lines and loss of c-RAF in 4/6 cell lines. Despite the persistence of c- RAF and/or
BRAF or BRAFV600E in the majority of treated cell lines, 17-AAG inhibited RAF-dependent MAP
kinase signaling, demonstrated by reduced amounts of phosphorylated MEK and/or ERK1/2, in
7/7 melanoma cell lines exhibiting phosphorylated MEK and/or ERK1/ERK2 prior to treatment.
There was no reduction of the total amounts of MEK and ERK. Submicromolar concentrations of
17-AAG inhibited melanoma cell proliferation, as shown by the MTT assay, in 5/6 cell lines tested.
The single exception was the line MALME-3M, which had undetectable levels of phosphorylated
MEK and ERK without 17-AAG treatment and has previously been shown to have an amplifica-
tion of MITF, a transcription factor that is a direct ERK target in melanoma cells. In contrast to c-
RAF, HSP90 remains associated with BRAF and BRAFV600E upon incubation with 17-AAG. These
results suggest that 17-AAG can inhibit the activities of both RAS-activated BRAF (wild-type) and
c-RAF, as well as the higher intrinsic kinase activity of BRAFV600E, in human melanoma cells with-
out inducing their dissociation from HSP90 and subsequent degradation.
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Increased expression of Bmi-1 in human melanoma cell lines
N Chung, L Longo, E Achebe and T Hornyak Dermatology Branch, CCR, NCI, NIH,
Bethesda, MD
The protein Bmi-1 is encoded by PCGF4, a member of the Polycomb group of genes, and has
been shown to be important in normal development, carcinogenesis, and maintenance of
neural and hematopoietic stem cells. The purpose of this study is to determine if Bmi-1 plays
a role in melanoma development. Comparison of protein expression between normal human
primary melanocytes from neonatal foreskin and several human melanoma cell lines was
made by Western blot. Immunofluorescence was conducted on cultured cells to observe cel-
lular location of Bmi-1. In addition, RNA quantification assays were analyzed to evaluate
mRNA expression levels between human primary melanocytes and melanoma cell lines. West-
ern blot analysis showed Bmi-1 is more highly expressed in the melanoma cell lines Mel
juso, Malme 3M, SK Mel 2, SK Mel 28, and SK Mel 30 in comparison to normal primary
melanocytes. The cell line Mel 1011 levels of Bmi-1 appeared comparable to normal
melanocytes. Immunofluorescence localized Bmi-1 to the nucleus as previously reported.
mRNA levels appeared to correlate with protein expression. These findings suggest that Bmi-
1 may be an important protein in differentiating many melanomas from the normal melanocyte.
Bmi-1 knock down experiments will be carried out in order to determine if this protein has a
functional role in the malignant phenotype of melanoma.
915
Wilms tumor 1 (WT1) expression distinguishes nevi from melanoma
B Perry,1 C Cohen,2 B Govindarajan,1 G Cotsonis3 and JL Arbiser1,4 1 Dermatology, Emory
Univ. School of Medicine, Atlanta, GA, 2 Pathology, Emory Univ. School of Medicine, Atlanta,
GA, 3 Rollins School of Public Health, Emory Univ. School of Medicine, Atlanta, GA and 4
Veterans Administration Hospital, Atlanta, GA
Pigmented lesions are common, yet they present diagnostic and therapeutic challenges. They
range from clinically stable nevi to melanoma, which is notorious for distant metastasis and
death. Both nevi and melanoma arise from melanocytes, which are neural crest derivatives.
Atypical nevi are clinically considered to be precursors of melanoma, and recently, biochemical
abnormalities have been found in both nevi and melanoma, including inactivation of the
p16ink4a tumor suppressor gene and mutation in B-raf. These mutations suggest that nevi
and melanoma share a common origin, but that additional events are required for transfor-
mation to malignant melanoma. In an attempt to uncover potential genes involved in malig-
nant transformation to melanoma, we performed a human TFcDNA array comparing 120 pos-
sible transcription factors involved in the human melanoma cell lines PMWK and MMAN,
which are derived from radial growth and vertical growth melanomas, respectively, and found
that vertical growth cells express the transcription factor Wilms tumor 1 (WT1) significantly
more than the radial growth cell line. This finding was also confirmed by Western blot for WT1
protein in PMWK and MMAN cells. Because both WT1 RNA and protein were abundant in
vertical growth melanoma cell lines and WT1 is a standard part of hospital immunohisto-
chemistry panels, we evaluated WT1 expression by tissue microarray in 27 nevi and 49
melanomas and found that WT1 is expressed in most melanomas but is nearly absent in nevi.
Lesions that stained strongly positive for WT1 had 29.7 times greater odds of being a melanoma
(95% CI 5.6-156.2) than those whose WT1 scores were <10%. Similarly, those lesions that
stained greater than 10% had 5.9 times more likelihood of being a melanoma, compared to
those which stained less than 10% (95% CI 0.9-37.2). Immunohistochemistry for WT1 may
be clinically useful in distinguishing nevi from melanoma.
917
BMP-4 reduces the protein levels of TRP-1, MART-1 AND MC1-R in cultered human
melanocytes
H Park, C Stachur and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
Bone Morphogenetic Protein -4 (BMP-4) was shown to down-regulate melanogenesis in cul-
tured human melanocytes, in part by down-regulating the message and/or protein levels of
tyrosinase, protein kinase C-β and microphthalmia-associated transcription factor (MITF). To
further delineate the mechanism by which BMP-4 down-regulates melanogenesis, we inves-
tigated the effects of BMP-4 on the expression of tyrosinase-related protein-1 (TRP-1) and
melanoma antigen recognized by T-cells-1 (MART-1), two important proteins involved in
melanogenesis. Paired cultures of subconfluent human melanocytes were treated with vehi-
cle or BMP-4 (25 ng/ml) for 4, 8 and 24 hours. At each time point cells were harvested and
immunoblot analysis using specific antibodies against TRP-1 and MART-1 was performed. The
level of MART-1 was decreased in the BMP-4 treated samples compared to the vehicle treated
samples at 4 hours by 72 ± 5% (p<0.001) and remained at this reduced level over the 24 hour
BMP-4 treatment period. The level of TRP-1 decreased after 8 hrs of BMP-4 treatment by 48
± 7% (p<0.01) and remained suppressed at this level through 24 hours. Cell surface receptor
melanocortin-1 receptor (MC1-R) plays a critical role in upregulating melanogenesis in response
to its ligand, α-melanocyte stimulating hormone. To examine whether BMP-4 regulates the
level of MC1-R, paired cultures of melanocytes were treated with BMP-4 (25 ng/ml) or vehi-
cle alone for 24 and 48 hrs. BMP-4 decreased in the level of MC1-R protein by 50 ± 10%
(p<0.001) at 24hrs and 35 ± 5% (p<0.05) at 48hrs. Thus BMP-4 negatively regulates melano-
genesis by decreasing the levels of TRP-1, MART-1, and MC1-R as well as tyrosinase, PKC-β
and MITF, as previously reported. These results suggest that BMP-4 is a key physiologic neg-
ative modulator of human melanogenesis.
916
CCL21 mediated melanoma immuno-targeting
L Novak and V Alexeev Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
Over past few years there has been growing interest in chemokines within the fields of tumor
immunotherapy. The goal of this study was to investigate whether its enforced, melanoma-spe-
cific expression results in recruitment of CD4+ helper T (Th) and CD8+ cytotoxic (CTL) lympho-
cytes to melanoma and facilitate active recognition of tumor-specific antigens with consequent,
immune-mediated eradication of the melanocytic malignancy. To investigate the proposed hypoth-
esis, B16F0 melanoma cells stably expressing murine CCL21 under the control of ubiqutin pro-
moter we transplanted intradermally into mouse skin. Wild type, CCL21-negative melanoma cells
were used as a control. As indicated in our initial studies, stable expression of murine CCL21 in
poorly immunogenic B16F0 cells results in chemokine-mediated attraction of immune cells to
the tumor and complete eradication of intradermal melanomas within 3 weeks after tumor inoc-
ulation. Tumor rejection was seen in all mice that receive CCL21-expressing B16F0 cells. Mice
that rejected primary B16F0-CCL21 tumors also rejected secondary tumors within a week after
challenging inoculation of wild-type B16F0 cells. Immunological and histological analyses showed
massive infiltration of the CCL21-positive tumors with mononucleated, CD45+ cells. The major-
ity of tumor-infiltrating cells were presented by CD4+ Th lymphocytes. CD8+ CTL cells were also
found inside tumor masses by primarily were detected around tumors. The analysis of blood serum
samples obtained from B16F0-CCL21 inoculated mice showed the presence of high-titer melanoma-
specific antibodies. Overall, our findings suggest that melanoma-specific expression of the CCL21
chemokine facilitate active cytotoxic and humoral immune responses and consequent complete
immune-mediated eradication of melanoma. In the upcoming future we plan to optimize intra-
tumoral delivery of the CCL21 encoding plasmids and transient melanoma-specific expression of
the chemokine in pre-existing tumors to evaluate the applicability of the chemokine-mediated
activation of immune responses for in vivo melanoma immuno-targeting.
914
Treatment of melanoma by suppression of MAGE gene expression; MAGE proteins affect pro-
liferation and apoptosis in melanomas
B Yang, SM O’Herrin, S Reagan-Shaw, J Wu and BJ Longley Dermatology, University of
Wisconsin, Madison, WI
The cancer testes (CT) antigens include the X-chromosome encoded, melanoma associated (X-
MAGE) antigens. CT-X-MAGE antigens are proteins originally defined by their normal expres-
sion in testes and their aberrant expression in melanomas and other “cancers.” CT-X-MAGE pro-
teins are widely known as tumor specific targets for immunotherapy of melanoma and other
malignancies. The functions of most CT-X-MAGE proteins are unknown but evidence in sev-
eral systems is accumulating suggesting expression of CT-X-MAGE proteins may contribute to
the development of malignancies. To determine the functional significance of CT-X-MAGE gene
expression, we used CT-X-MAGE specific siRNA and found that suppression of select CT-X-
MAGE mRNA and proteins significantly slowed proliferation and induced caspase independ-
ent apoptosis in human and murine melanoma cell lines. Furthermore, in five separate in vivo
trials analyzed by Kaplan-Meier, Log-Rank, and Regression analysis, pre-treatment of cells
with MAGE specific siRNA (one trial, combined control and experimental n=26, p< 0.001 for
all three analyses) or parenteral administration of cholesterol conjugated CT-X-MAGE siRNA
(four trials combined n = 27, 26, 28, and 10, significance range p= 0.01859 to 1.198X10-6 for
all analyses) suppressed tumor growth in a syngenic murine model of established melanoma
when compared to treatment with control siRNA. In addition, CT-X-MAGE siRNA decreased
tumor CT-X-MAGE mRNA but control siRNA did not. We conclude that CT-X-MAGE gene expres-
sion may actively contribute to the development of melanomas by promoting the growth and
survival of malignant cells. A generally accepted clinical paradigm regards CT-X-MAGE pro-
teins as targets for immunotherapy, but our results support a major shift to a paradigm in which
CT-X-MAGE proteins are targets for functional manipulation. Since the expression of these CT-
X-MAGE proteins is limited in normal tissues, inhibition of CT-X-MAGE gene expression rep-
resents a novel and specific treatment opportunity for melanoma and diverse malignancies.
918
Clinical and functional significance of CTHRC1 in melanoma cells: implications for thera-
peutic development
L Tang,1 M Su,1 D Dai,1 M Martinka,2 Y Zhang,1 G Li1 and Y Zhou1 1 Medicine, University of
British Columbia, Vancouver, BC, Canada and 2 Pathology, University of British Columbia,
Vancouver, BC, Canada
The CTHRC1 (collagen triple helix repeat containing 1) is a pro-migratory protein first found
during rat tissue repair process. Accumulating evidences support that tissue repair and car-
cinogenesis are tightly linked. However, no investigation has addressed on the roles of CTHRC1
gene in human carcinogenesis. This study was designed to characterize the clinical and func-
tional relevance of CTHRC1 in melanoma and other human solid cancers. First, semi-quan-
titative immunohistochemistry analysis was performed on 304 clinically-annotated, paraffin-
embedded biopsies representing different stages of melanoma progression. In benign nevi and
non-invasive melanoma biopsies, there was little CTHRC1 protein expression. In contrast, in
invasive primary melanomas, a significant increase of CTHRC1 protein was observed. There
was a further increase of CTHRC1 protein in metastatic melanoma specimens compared with
non-metastatic lesions. Second, the CTHRC1 mRNA expression was surveyed in 310 samples
representing 19 types of human solid cancers. The aberrant CTHRC1 transcription was found
in 16 cancer types, especially cancers of the gastrointestinal tract, lung, breast, thyroid, ovar-
ian, cervix, liver and the pancreas. Finally, when the expression of CTHRC1 protein was inhib-
ited by short interfering RNA on cultured melanoma cells, cell migration and cell survival were
significantly reduced. We conclude that aberrant expression of CTHRC1 is widely present in
human solid cancers, and appears to be associated with cancer tissue invasion and metasta-
sis in melanoma. This novel cancer-associated gene may play important functional roles in
tumor progression by promoting both cell survival and migration. Therefore, targeting CTHRC1
gene may represent an attractive approach for developing cancer therapies.
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Gene silencing of p150Glued significantly reduces centripetal migration and perinuclear accu-
mulation of phagocytosed fluorescent beads in cultured human keratinocytes
H Byers1 and SG Dykstra1 1 Dermatology, Boston University School of Medicine, Boston, MA
and 2 Dermatology, Boston University School of Medicine, Boston, MA
The keratinocyte microparasol protects the nucleus from UV-induced DNA damage. It is
composed of a supranuclear microtubular/melano-phagolysosomal complex and siRNA tar-
geted against the p150Glued dynactin subunit reduces both melano-phagolysosomal aggrega-
tion and p150Glued dynactin expression. To better define the mechanism of the microparasol,
siRNA treated human keratinocytes were cultured with 0.5 µm fluorescent dextrose beads and
followed by time-lapse analysis, confocal immunolocalization and Western immunoblotting.
Quantitative analysis of fluorescent beads in time lapse images revealed decreased cytoplas-
mic trafficking in siRNA treated cells. Lipofectamine alone treated keratinocytes showed pro-
gressive perinuclear aggregation of phagocytosed fluorescent beads whereas siRNA treated
cells showed marked inhibition of centripetal migration with dispersed peripheral cytoplas-
mic beads. Statistical analysis of multiple cells revealed perinuclear mean fluorescence inten-
sity of phagocytosed fluorescently labeled dextrose beads was significantly reduced in siRNA
treated cells compared to mock transfectants at 24 and 48h. Analysis of individual bead cyto-
plasmic migration pathways at high magnification revealed random movements with mean
nuclear envelope to bead distance significantly greater in siRNA p150Glued transfectants com-
pared to mock transfectants which showed linear displacements. Confocal immunofluores-
cence and Western blots confirmed a significant reduction of the p150Glued subunit by gene
silencing, which was associated with decreased microtubular radial focusing in the micropara-
sol. These findings indicate that phagocytosed particles acquire the necessary components for
directed migration along microtubules in the keratinocyte microparasol and that one of these
functional components is the p150Glued subunit of dynactin. They also demonstrate that
melanosomes need only to be phagocytosed to acquire microparasol-targeting ability.
920
Comparison of the transduction efficiency of primary human melanocytes by lentivirus pro-
duced using different transfection reagents.
E Achebe, L Longo, N Chung and T Hornyak Dermatology Branch, CCR, NCI, NIH, Bethesda,
MD
Previous research has shown that lentiviral vectors can efficiently and stably transduce genes
of interest into primary human melanocytes. Different transfection reagents have been used
for lentivirus production, with calcium phosphate being the most common. The purpose of
this study was to determine which transfection method results in lentivirus production having
the highest transduction efficiency in primary human melanocytes. Three transfection reagents
were compared: calcium phosphate N,N-bis (2-hydroxyethyl)-2-aminoethanesulfonic acid
(BES), calcium phosphate HEPES-buffered saline (HBS), and lipid-based Fugene 6 transfec-
tion reagent in 3µl:1µg, 3µl:2µg and 6µl:1µg reagent to DNA ratios. Lentivirus was produced
by transfecting the pMD2.G envelope plasmid, psPAX2 packaging plasmid, and pLOXgfp-
iresTK green fluorescent protein (GFP) plasmid in a 1:3:4 ratio, respectively, into 293T human
embryonic kidney cells using the different reagents. Lentiviral-containing supernatant was har-
vested from the transfected 293T cells. Primary human melanocytes cultured from neonatal
foreskins were then transduced with the GFP-encoding lentivirus in the presence of 8µg per
mL of polybrene. The expression of GFP was assessed using immunofluorescence microscopy
and transduction efficiency was quantified using fluorescence activated cell sorter (FACS) analy-
sis. We found that the lentivirus generated with Fugene 6 using the 6µl:1µg reagent to DNA
ratio resulted in the highest lentiviral transduction efficiency (57% efficiency) of primary human
melanocytes when compared to the other Fugene 6 ratios and the calcium phosphate meth-
ods. Our preliminary results suggest that higher-efficiency gene transduction in primary human
melanocytes can be achieved using lentivirus produced from Fugene 6 than the often-utilized
calcium phosphate method.
921
UV exposure regimens for indoor tanning – an update
SA Miller, BZ Zmudzka, SG Coelho and JZ Beer Food and Drug Administration, Rockville,
MD
Despite its risks, indoor tanning continues to be popular, especially among young adults. The
FDA regulates the manufacture of sunlamp products and has published guidelines for expo-
sure schedules (1986). Based on recent data on tanning, we predicted that a tan could be
achieved with lower doses than indicated in the guidelines. Thus, we conducted a study com-
paring the effects of three tanning schedules, each requiring much lower UV exposures than
those recommended in the FDA guidance. Here, we are reporting results of tanning in 40
human subjects (phototypes 2 or 3) with two different commercially-available sunlamp prod-
ucts. Half of the subjects were exposed to a relatively high UVB (5.7%) sunlamp while the
other half was exposed to a sunlamp with a relatively low proportion (2%) of UVB. Small, 3x3
cm, areas on the backs of these subjects were exposed ~10 times over 8 weeks to accumu-
late, respectively, 1900 J/m2 (schedule A), 2900 J/m2 (schedule B), and 4300 J/m2 (schedule
C). The current policies would allow accumulation of up to 12000 J/m2 over the same time.
The intensity of tan developed in our experiments and its erythemal component were assessed
by diffuse reflectance spectroscopy. Additionally, we used visual analysis and computer-assisted
digital image evaluation to assess color changes. Schedule A produced a light tan, schedules
B and C produced a moderate to dark brown tan. The difference between tanning effects (by
visual evaluation) of schedules B and C was small. In addition, the low UVB (high UVA) lamp
produced darker and more rapid tanning. The erythemal component of the tan produced by
different schedules is being analyzed. Our results confirm that the current exposure sched-
ules permit excessive doses of UV that may not be necessary for producing a tan. Upon com-
pletion of this study, we will propose appropriate changes in the recommendations for expo-
sure schedules.
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Oncogene c-Myc as a target for melanoma chemotherapy
MA Nikiforov, S Mannava, VN Grachtchouk and M Tkachuk Dermatology, University of
Michigan, Ann Arbor, MI
Malignant melanoma is one of the most aggressive types of human cancers. Its ability to invade
and metastasize to distant organs, in combination with high resistance to conventional anti-
cancer agents, makes melanoma extremely difficult to cure and subsequently, the median
survival of metastatic melanoma patients is 8.5 months. We have identified oncogene C-MYC
as an attractive target for anti-melanoma chemotherapy. We found that levels of C-MYC pro-
tein are increased in human samples from advanced melanomas and in metastatic melanoma
cell lines compared to benign nevi and primary melanocytes, respectively. Depletion of C-
MYC in several human metastatic melanoma lines by stably expressing C-MYC shRNA resulted
in apoptotic cell death or in substantial inhibition of proliferation, accompanied by reduced
tumorigenicity and increased sensitivity to anticancer chemotherapeutic drugs. A functional
screening of DIVERSet small molecule library (ChemBridge) containing 34,000 individual
compounds revealed several inhibitors of MYC ability to activate transcription. We have demon-
strated that effects of MYC-inhibitors on viability of melanoma cells and melanocytes are sim-
ilar to those caused by C-MYC shRNA. Effects of tested compounds on melanoma cells com-
pared to normal melanocytes indicate that it could be possible to develop anti-melanoma
pharmaceuticals that will attack melanoma cells without adversely affecting normal tissues.
923
Observation of quantum dot dynamics in the vasculature in a mouse model of intracutaneous
melanoma
Y Li,1 Y Li,2 D Entenberg,2 S Gonzalez,1 AN Houghton,3 J Wolchok,3 R Toledo-Crow2 and
AC Halpern1 1 Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY,
2 Research Engineering Lab, MSKCC, New York, NY and 3 Tumor Immunology, MSKCC, New
York, NY
Quantum dots are promising labels for non-invasive in vivo optical imaging for translational
research. The purpose of this experiment was to investigate the movement and localization of
intravenously injected quantum dots into the vasculature of mice with melanoma. C57/BL6 mice
were intradermally inoculated with B16-eGFP cells to produce melanoma tumors on the leg.
When the tumors could be seen, a retro-orbital vein injection of quantum dots was applied and
the transport of the quantum dots in the vasculature was observed in vivo, both in normal/healthy
tissue and in the vicinity of the melanoma. The observations were repeated at selected time points
during 9 days to observe the localization and elimination of the quantum dots in normal skin
and tumor. The observations were correlated with conventional histology. The observations
were made transdermally with a real-time multiphoton scanning microscope. This mode of imag-
ing is non invasive and allows multiple observations over the course of tumor progression. Quan-
tum dots were observed in blood vessels in and around tumors and in normal tissues immedi-
ately after injection. Approximately 20 minutes later, some quantum dots started to aggregate
along the vessel lumen to form bright clusters, while others remained in the blood flow. On day
2 the quantum dots persisted along the blood vessel walls but could no longer be detected in
the blood flow. During observations on the following days the number of quantum dot clusters
decreased both in the tumor and in the normal skin. However, the rate of decrease in the tumor
sites appeared to be slower than in normal skin. We have observed that quantum dots accumu-
late and persist longer in tumors than in normal skin. This may reflect effects of the tumor vas-
culature on quantum dot aggregation, extravasation, or clearance. The stability of the quantum
dots allows us to observe them in the tumors for a period of 10 days or longer.
924
Lupeol, a novel diet based triterpene, inhibits growth and induces apoptosis of primary and
metastatic melanoma cells by modulating NFκB signaling
M Saleem, N Maddodi, N Khan, BB Hafeez, M Kweon, V Setaluri and H Mukhtar
Dermatology, University of Wisconsin, Madison, WI
Melanoma is the most aggressive form of skin cancer and its incidence is continuously increas-
ing. The treatment of melanoma has largely been unsuccessful due to higher resistance of
tumor cells to chemotherapy and therefore novel approaches for prevention and treatment of
this disease are needed. Chemoprevention through dietary agents has shown benefits in cer-
tain cancers, however, chemoprevention of melanoma is poorly studied. Recently, we have
shown that Lupeol, a triterpene found in fruits and vegetables, such as strawberry, mango,
grapes and olive, kills prostate and pancreatic cancer cells without exhibiting toxicity to nor-
mal cells. In this study, using human primary melanoma cells WM35 and metastatic melanoma
cells 451Lu, we investigated the effect of Lupeol on cell growth and on NFκB and PI3K/Akt
signaling pathways that are implicated to confer chemoresistance and promotion of survival
of melanoma cells. Since cell cycle has been reported to be dysregulated during the patho-
genesis of melanoma, we also determined the effect of Lupeol on the expression levels of cell
cycle regulatory molecules viz., cyclins, cyclin-dependent kinases (cdks), and cdk-inhibitory
proteins p27 and p21. As assessed by the activation of caspase-3 and reduction of Bcl-2, Lupeol
treatment caused a dose-dependent inhibition of growth and induction of apoptosis in both
melanoma WM35 and 451Lu cells. Lupeol treatment also reduced the protein expression of
cyclins D-1, and D-2, and cdk-2, induced the expression of p27 and p21 and inhibited the
PI3K signaling with a concomitant inhibition of NFκB signaling pathway. Our data suggest that
Lupeol can target multiple signaling pathways in melanoma cells leading to inhibition of growth
and induction of apoptosis. It is tempting to suggest that Lupeol alone or in conjunction with
current therapies could be useful for the management of melanoma.
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Integrin-linked Kinase (ILK) regulates the migration of melanoma cells
K Ng,1 S Dedhar2 and G Li1 1 Department of Medicine, The University of British Columbia,
Vancouver, BC, Canada and 2 BC Cancer Agency, The University of British Columbia,
Vancouver, BC, Canada
The highly invasive potential of melanoma cells presents a major obstacle in melanoma ther-
apy. Cell migration and invasion are complex processes involving a variety of cytoskeletal
constituents. Integrin-linked kinase (ILK), a serine/threonine kinase and intracellular adaptor
that anchor integrins to actin filaments, is likely implicated in these processes. Cell migration
assays were performed on melanoma cell lines MMRU and Sk-mel-110. Treating melanoma
cells with a small molecule inhibitor of ILK kinase activity have been shown to decrease cell
migration in a dose-dependent manner. Knocking down ILK expression transiently using small
interfering RNA in melanoma cells also reduces migration. It is well known that cell migra-
tion is regulated by Rho family of small GTPases including Rac, RhoA and cdc42 through
growth factor signaling and adhesion to extracellular matrix (ECM). However, inhibiting ILK
kinase activity or knocking down ILK expression in melanoma cell lines stimulated with serum
either results in only a small reduction or no change in Rho GTPases activation. Thus, ILK
may not be involved in growth factor-dependent stimulation of Rho GTPases activities, but
instead may regulate Rho GTPases activation upon integrin-dependent cell adhesion.
927
Functional regulatory T cells are present in peripheral blood but absent from skin of vitiligo
patients
I Le Poole,1 C Denman,1 AE Martin,1 D Wainwright,1 J Qin,1 C Hernandez2 and A Overbeck3
1 Pathology/Oncology Institute, Loyola University Medical Center, Maywood, IL, 2
Dermatology, UIC, Chicago, IL and 3 Lumiderm, Madrid, Spain
Regulatory T cells (Treg) interfere with effective immunity to melanoma tumors by suppress-
ing the activity of tumor reactive T cells. By contrast, we hypothesized that depigmentation
in autoimmune vitiligo skin can progress in the absence of Treg activity. Treg infiltrating vitiligo
non-lesional, peri-lesional and lesional skin were quantified in cryosections of 5 patients com-
pared to 3 unaffected controls by FoxP3/CD3 immuno double staining. To evaluate potential
systemic differences in Treg quantity or function, PBMC were immuno-double stained with
CD4 and CD25 antibodies and sorted by FACS. The percentage of CD4+/CD25+ cells was
twice measured among 3 control and 3 vitiligo samples. Moreover, Treg activity was estimated
as suppression of allogeneic dendritic cell-stimulated proliferation of helper T cells. A signif-
icantly reduced number of Treg was observed in non-lesional (P<0.01), peri-lesional (P<0.01)
and lesional (P<0.02) vitiligo skin versus control skin. Interestingly, the proportion of
CD4+/CD25(high) among PBMC was significantly increased (P<0.01) in vitiligo peripheral
blood compared to controls, whereas the difference was insignificant comparing
CD4+/CD25(low) among PBMC of patients and controls. Proliferation measured after com-
bining CD4+/CD25- T cells with and without autologous CD4/CD25+ T cells in presence of
allogeneic DC (cultured from adherent monocytes in presence of GM-CSF and IL-4) revealed
that regulatory T cell function is not inhibited among peripheral T cells in vitiligo. It thus
appears that functional circulating Tregs do not extravasate to the skin in vitiligo patients,
thereby perpetuating an ongoing cytotoxic response to epidermal melanocytes.
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Enhanced primer-blocking polymerase chain reaction for detection of single nucleotide
minority mutations in B-raf using Real-Time PCR
SS Saadat Harbor-UCLA Medical Center, Torrance, CA
BRAF is a serine/threonine kinase in the MAPK pathway that regulates cell growth and malig-
nant transformation. Approximately sixty percent of melanomas exhibit a mutation in the
kinase domain of BRAF, with nearly all of these mutations occurring at codons 598-600. In
order to augment the sensitivity of BRAF mutation detection in heterogeneous specimens, we
developed Enhanced Primer Blocking PCR (EPB-PCR). In this technique, mutated B-raf exon
is selectively amplified while the amplification of the wild-type exon is inhibited. We use a
short, locked nucleic acid substituted oligonucleotide specifically targeting the wild-type
primer binding site to inhibit amplification of wild-type template. The inhibition of amplifi-
cation is further enhanced by the addition of the restriction enzyme TSP RI, which specifi-
cally targets the wild-type BRAF sequence. Our assay, which is adapted to real-time PCR with
SYBR green detection, can be performed in approximately two and one half hours and can
detect as few as 10 copies of mutant B-raf while simultaneously blocking the signal from 105
copies of wild type exon.
928
Detection of braf mutated melanoma cells by specifically inhibiting reverse transcription of
wild-type mrna
HN Thai, M Kolodney and H Suzuki Internal Medicine - Dermatology, LA BioMed, Torrance,
CA
Locked nucleic acid (LNA) substituted oligonucleotides can be used to identify minority muta-
tions by specifically inhibiting PCR amplification of wild-type sequences. We have extended
this use of LNA oligonucleotides to identify mutations in RNA by inhibiting reverse transcrip-
tion in a sequence specific fashion. Mutation specific reverse transcription is then followed
by wild type blocking real time PCR amplification using wild type blocking LNA oligonu-
cleotides. The method is highly specific for mutated RNA and mutations caused by the reverse
transcriptase are reduced. This approach can quantitatively detect a small number of melanoma
cells expressing mutated BRAF mRNA in the presence of a large excess of non-mutated cells.
Our data show that sequence specific reverse transcription inhibition delays wild type ampli-
fication by about 10 cycles. In contrast, the blocking LNA oligonucleotide has a negligible
effect on reverse transcription of mutant mRNA. By blocking reverse transcription and PCR in
a sequence specific manner, we inhibit reverse transcriptase PCR amplification of RNA from
up to 10^6 cells carrying wild-type BRAF sequence, while detecting a much smaller quantity
of BRAF mutated cells. Specific detection of mutated RNA may be useful for detecting circu-
lating melanoma cells or other clinical applications.
926
Neuronal differentiation of melanoma: role of neurogenic transcription factors and repres-
sors in activation of microtubule associate protein 2
V Setaluri,1 KM Bhat,1 N Maddodi,1 R Kedlaya1 and SS Cooduvalli2 1 Dermatology,
University of Wisconsin, Madison, WI and 2 Pennsylvania State University, University Park,
PA
Malignant melanoma exhibits molecular plasticity and often expresses genes of several cell
lineages including neuronal cells. The mechanisms of melanoma transdifferentiation and its
effects on tumor progression are not well understood. We showed that microtubule associ-
ated protein 2 (MAP2), a neuron-specific protein, is activated in melanoma and that MAP2
expression in primary melanoma is inversely correlated with its aggressiveness. We also showed
that MAP2 gene can be activated in metastatic melanoma cells by pharmacological agents
and that MAP2 induces cell cycle arrest and apoptosis of metastatic melanoma cells. There-
fore, reactivation of MAP2 expression is potentially a therapeutic strategy for melanoma. To
understand the mechanism of MAP2 gene activation in melanoma, we identified the 5’ regu-
latory region of human MAP2 gene. Here, we show that MAP2 promoter is regulated by neu-
ronal basic helix-loop-helix (bHLH) factors. We cloned MAP2 5’ genomic DNA and identi-
fied the region that is sufficient for neuronal-specific expression in vitro and in vivo. Gel shift
analysis showed that NeuroD, a bHLH factor involved in neuronal differentiation, binds to a
consensus E box. Mutagenesis and co-transfection experiments showed a role for this E box
in NeuroD mediated upregulation of the promoter in melanoma cells. A consensus N box,
which is recognized and bound by the transcription repressor HES1, is involved in downreg-
ulation of the promoter activity. Although melanoma cells express both NeuroD and HES1,
co-transfection experiments showed that HES1 is a dominant regulator of MAP2 promoter
activity. Chromatin immunoprecipitation showed that in metastatic melanoma cells N box
region of the MAP2 promoter is occupied by endogenous HES1 protein suggesting that HES1
may be critical regulator of MAP2 gene transcription during melanoma progression.
930
Vitiligo and melanoma: autoimmunity and tumor immunity, unique commonalities and ther-
apeutic prospects
K Oyarbide-Valencia,1 JG van den Boorn,2 M Li,3 MI Nishimura,3 RM Luiten2 and I Le Poole1
1 LUMC, Maywood, IL, 2 AMC/SNIP, Amsterdam, Netherlands and 3 U of C, Chicago, IL
Patches of depigmented skin that characterize generalized vitiligo can result from melanocyte
killing by autoreactive T-cells that have evaded clonal deletion during T-cell development. T-
cells isolated from vitiligo lesions selectively react with melanocyte differentiation antigens.
We hypothesize that high affinity T-cell receptors (TCR) from vitiligo patient-derived T-cells
contribute to the efficacy of melanocyte killing in vitiligo. A T-cell population infiltrating the
borders of an expanding lesion was isolated from a skin biopsy of an HLA-A2+ patient with
active vitiligo. T-cells were propagated using anti-CD3/CD28 coated beads and 250 IU/ml IL-
2. The avidity of resulting VIT1 T-cells was compared to existing HLA-A2 restricted melanoma
tumor-derived MART-1 (TIL 1235) or gp100 (TIL 1200, TIL 1250) T-cells lines by cytotoxicity
assays and IFN-γ ELISA. T-cell clones were isolated by sorting T-cells stained with gp100 (209-
217) peptide/MHC dimers followed by limiting dilution cloning. Peptide reactivity was veri-
fied by ELISPOT. In vitro cytotoxic assays showed that unsorted VIT1 cells kill 624.38 and F003
melanoma cells at approximately 3-fold lower effector:target ratios than melanoma-derived
T-cells. Individual VIT1 clones required 2-fold lower doses of gp100 peptide than TIL1520 for
half-maximum IFN-γ secretion, illustrating that vitiligo T-cells are of high avidity probably due
to the expression of high affinity TCR. Using 5’RACE of reverse transcribed RNA, TCR genes
were amplified from 3 VIT1 clones. Interestingly, we have identified two TCRα variants that
share the joining region Jα29, but have different variable segments, namely Vα1 or Vα2. From
one clone we have also identified the β-chain Vβ17S1/Jβ 2.1/Cβ2. Our data support the exist-
ing notion that a restricted TCR repertoire is responsible for melanocyte recognition. Thus,
genes encoding high affinity TCR derived from vitiligo T-cells may be of therapeutic value for
melanoma patients in the near future.
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Combination of (-)-epigallocatechin-3-gallate (EGCG) and interferon-alpha (IFNα) exerts
synergistic inhibitory effects against melanoma xenografts in athymic nude mice
M Nihal,1 H Ahsan,1 N Ahmad,1 H Mukhtar1 and GS Wood1,2 1 Dermatology, UW-Madison,
Madison, WI and 2 Dermatology, VAMC, Madison, WI
We earlier demonstrated that epigallocatechin-3-gallate (EGCG), the major polyphenolic con-
stituent of green tea caused cell cycle arrest and apoptosis of human melanoma cells via
modulation in cki-cyclin-cdk machinery and Bcl2 family proteins. We also demonstrated that
EGCG inhibited the growth of melanoma xenografts in athymic nude mice via induction of
apoptosis. IFNα, an immunomodulatory cytokine commonly used in melanoma treatment,
has shown marginal efficacy and often results in discontinuation of therapy due to its toxic-
ity. The present study was designed to test our hypothesis that a combination of EGCG and
IFNα will impart a synergistic anti-melanoma effect and will ameliorate the toxicity of IFNα.
Employing athymic nude (nu/nu) mice (6 weeks old; 8 animals/group) implanted with Hs-294T
human metastatic melanoma cells, we determined the effects of EGCG (1 mg/0.1 ml saline,
i.p.; 5 days/week), IFNα (15,000 IU/0.1 ml saline, s.c.; 5 days/week) or combination of the
two agents on tumor growth and development. The treatment regimen started either on the
day of implantation of tumor cells or when tumor reached about 70 mm3 and was continued
for 4 and 6 weeks, respectively. The animals were monitored daily for any visible sign of mor-
bidity and tumor volume was measured weekly. At the termination of the experiment, tumors
were harvested, weighed and processed for further immunohistological and biochemical analy-
sis. Our data demonstrated that in both the protocols, EGCG as well as IFNα treatments resulted
in significant reduction in tumor size and weight. Importantly, combination of the two agents
was found to be more effective than EGCG and IFNα alone. These findings provide evidence
that EGCG in combination with IFNα may be useful both as a chemopreventive and chemother-
apeutic agent in the treatment of human melanoma.
932
Development and characterisation of a new mouse model of spontaneously occurring cuta-
neous metastatic melanoma
P Schuler,1 E Contassot,1 O Preynat-Seauve,1 F Beermann,2 B Huard1 and LE French1 1 Louis-
Jeantet Skin Cancer Laboratory, Dept. of Pathology–Immunology and Dermatology, Geneva
University Medical Center, Geneva, Switzerland and 2 Swiss Institute for Experimental
Cancer Research, Epalinges, Switzerland
Melanoma is characterized by a high metastatic potential, resistance to systemic therapies and an
increasing incidence. To further understand melanoma pathogenesis and develop new therapeutic
strategies better animal models are urgently needed. Here we report the generation of a new murine
model of metastatic melanoma that spontaneously originates and develops in the skin. Transgenic
C57BL/6 mice were generated to express a mutated human N-Ras gene under the control of the
melanocyte-specific tyrosinase promotor (TyrRas), and subsequently treated with epicutaneous appli-
cations of 7,12- dimethylbenzanthracene (DMBA) between 3 and 8 weeks of age. Such TyrRas mice
exposed to DMBA (TyrRas-DMBA), spontaneously developped cutaneous melanoma in 80% of
cases by 19 weeks of age, whereas TyrRas mice not exposed to DMBA only developped melanoma
in 30% of cases at 52 weeks of age. Thus a short period of topical exposure to DMBA significantly
decreased the latency and increased the incidence of melanoma development in TyrRas mice. Impor-
tantly, melanoma development in the skin of TyrRas-DMBA mice resulted in subsequent metastati-
sation to draining lymph nodes, a feature reminiscent of human melanoma. Furthermore, primary
tumors and metastases thereof were readily transplantable, since intradermal inoculation of melanoma
cells from TyrRas-DMBA mice into wild-type syngeneic mice led to melanoma outgrowth and sub-
sequent lymph node metastasis. Finally, expression of classical melanoma-associated antigens includ-
ing TRP-1, TRP-2, pmel-17 (gp100) and melan-A (MART-1) was detectable in primary cutaneous
tumors and lymph node metastases. This TyrRas-DMBA mouse model of spontaneously occuring
cutaneous melanoma with metastatic potential that is reminiscent of human melanoma should be
a useful tool for studying melanoma pathogenesis and therapy.
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